PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dwyer, J; Le Guelte, A; Moya, EMG; Sumbal, M; Carlotti, A; Douguet, L; Gutkind, JS; Grange, PA; Dupin, N; Gavard, J				Dwyer, J.; Le Guelte, A.; Moya, E. M. Galan; Sumbal, M.; Carlotti, A.; Douguet, L.; Gutkind, J. S.; Grange, P. A.; Dupin, N.; Gavard, J.			Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor	ONCOGENE			English	Article						cell junctions; permeability; rac; PI(3)K; VE-cadherin; kaposi sarcoma	SARCOMA-ASSOCIATED-HERPESVIRUS; KAPOSIS-SARCOMA; ENDOTHELIAL PERMEABILITY; VASCULAR-PERMEABILITY; PARACRINE NEOPLASIA; ADHERENS JUNCTIONS; GENE-EXPRESSION; GROWTH-FACTOR; CELL; VGPCR	Kaposi Sarcoma (KS) are opportunistic tumors, associated with human herpes virus 8 (HHV8) infection. KS development is highly favored by immune-depression and remains the second most frequent tumor in acquired immune deficiency syndrome patients. Although it has been shown that experimental expression of the HHV8 G-protein-coupled receptor (vGPCR) in the endothelial compartment is alone sufficient to recapitulate the formation and progression of KS-like lesions, its functional effects on endothelial homeostasis are not fully understood. Here we show that vGPCR expression in endothelial cells induces an increase in paracellular permeability both in vivo and in vitro. By using pharmacological inhibitors and small interference RNA-based knockdown, we demonstrate an essential role for the PI(3)Kinase-gamma/Rac nexus in vGPCR-mediated permeability. This was further accompanied by dramatic remodeling of VE-cadherin-dependent cell-cell junctions. Importantly, this in vitro vGPCR-initiated signaling signature was observed in a large panel of human KS. Altogether, our results support the hypothesis that endothelial vGPCR signaling is co-opted in KS, and unveil new key cellular targets for therapeutic intervention. Oncogene (2011) 30, 190-200; doi: 10.1038/onc.2010.411; published online 6 September 2010	[Dwyer, J.; Le Guelte, A.; Moya, E. M. Galan; Sumbal, M.; Douguet, L.; Gavard, J.] Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM,U1016, F-75014 Paris, France; [Carlotti, A.] Univ Paris 05, Grp Hosp Cochin Port Royal, AP HP, Serv Anat & Cytol Pathol,Fac Med, F-75014 Paris, France; [Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Grange, P. A.; Dupin, N.] Univ Paris 05, Lab Rech Dermatol, EA 1833, Fac Med, F-75014 Paris, France; [Dupin, N.] Univ Paris 05, Grp Hosp Cochin Port Royal Pavillon Tarnier, AP HP, Serv Dermatol,Fac Med, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Gavard, J (corresponding author), Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM,U1016, 22 Rue Mechain,Rm 306, F-75014 Paris, France.	julie.gavard@inserm.fr	Gavard, Julie/I-5487-2012; Galan-Moya, Eva M/I-2912-2015; Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Gavard, Julie/I-5487-2012; Grange, Philippe/W-3442-2017	Gavard, Julie/0000-0002-7985-9007; Galan-Moya, Eva M/0000-0001-5758-7592; Gutkind, J. Silvio/0000-0002-5150-4482; Dupin, Nicolas/0000-0002-6237-4951; Gavard, Julie/0000-0003-3107-2026; Grange, Philippe/0000-0001-8151-748X; Douguet, Laetitia/0000-0003-4319-491X	Ligue Nationale contre le Cancer, comite de Paris; European Community [PIRG04-GA-2008-239126]; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	Ligue Nationale contre le Cancer, comite de Paris; European Community(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We would like to thank N. Bidere (Inserm U1014, Universite Paris-Sud, Hopital Paul Brousse, Villejuif, France) for helpful discussions and comments, A Schmitt (Institut Cochin, Paris, France) for technical help on electron microscopy experiments, Anne Audebourg and Brigitte Radenen (Service d'Anatomie et de Cytologie Pathologique, Hopital Cochin, Paris, France) for technical help on histological staining, and Nina Feinberg (OPCB, NIDCR, NIH, Bethesda, MD, USA) for technical help on the initial project. This research was funded by Ligue Nationale contre le Cancer, comite de Paris and by a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (PIRG04-GA-2008-239126). JD is supported by a post-doctoral fellowship from Fondation pour la Recherche Medicale, ALG by the PhD program from Universite Paris 5 and EMGM by a post-doctoral fellowship from Association pour la Recherche sur le Cancer.	Ascherl G, 1999, BLOOD, V93, P4232; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cesarman E, 2007, CURR TOP MICROBIOL, V312, P263; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chiou CJ, 2002, J VIROL, V76, P3421, DOI 10.1128/JVI.76.7.3421-3439.2002; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Dupin N, 2006, J INVEST DERMATOL, V126, P545, DOI 10.1038/sj.jid.5700132; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Grisotto MG, 2006, J CLIN INVEST, V116, P1264, DOI 10.1172/JCI26666; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Maurer T, 2007, NEW ENGL J MED, V357, P1352, DOI 10.1056/NEJMc070508; Mitsuyasu RT, 2000, CURR OPIN ONCOL, V12, P174, DOI 10.1097/00001622-200003000-00013; Monini P, 2009, AIDS, V23, P534, DOI 10.1097/QAD.0b013e3283262a8d; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2001, CANCER RES, V61, P2641; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Oksenhendler E, 2002, BLOOD, V99, P2331, DOI 10.1182/blood.V99.7.2331; Orenstein JM, 1997, AIDS, V11, pF35, DOI 10.1097/00002030-199705000-00001; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Sgadari C, 2002, NAT MED, V8, P225, DOI 10.1038/nm0302-225; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Szajerka T, 2007, AIDS REV, V9, P230; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987	38	22	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					190	200		10.1038/onc.2010.411	http://dx.doi.org/10.1038/onc.2010.411			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20818438				2022-12-25	WOS:000286438900007
J	Smits, NC; Kurup, S; Rops, AL; ten Dam, GB; Massuger, LF; Hafmans, T; Turnbull, JE; Spillmann, D; Li, JP; Kennel, SJ; Wall, JS; Shworak, NW; Dekhuijzen, PNR; van der Vlag, J; van Kuppevelt, TH				Smits, Nicole C.; Kurup, Sindhulakshmi; Rops, Angelique L.; ten Dam, Gerdy B.; Massuger, Leon F.; Hafmans, Theo; Turnbull, Jeremy E.; Spillmann, Dorothe; Li, Jin-ping; Kennel, Stephen J.; Wall, Jonathan S.; Shworak, Nicholas W.; Dekhuijzen, P. N. Richard; van der Vlag, Johan; van Kuppevelt, Toin H.			The Heparan Sulfate Motif (GlcNS6S-IdoA2S)(3), Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PHAGE DISPLAY ANTIBODIES; ENDOTHELIAL-CELLS; AA AMYLOIDOSIS; HETEROGENEITY; PROTEOGLYCANS; DIVERSITY; DOMAINS; BINDING; MURINE	Heparan sulfate (HS) is a structurally complex polysaccharide that interacts with a broad spectrum of extracellular effector ligands and thereby is thought to regulate a diverse array of biologic processes. The specificity of HS-ligand interactions is determined by the arrangement of sulfate groups on HS, which creates distinct binding motifs. Biologically important HS motifs are expected to exhibit regulated expression, yet there is a profound lack of tools to identify such motifs; consequently, little is known of their structures and functions. We have identified a novel phage display-derived antibody (NS4F5) that recognizes a highly regulated HS motif (HSNS4F5), which we have rigorously identified as (GlcNS6S-IdoA2S)(3).HSNS4F5 exhibits a restricted expression in healthy adult tissues. Blocking HSNS4F5 on cells in culture resulted in reduced proliferation and enhanced sensitivity to apoptosis. HSNS4F5 is up-regulated in tumor endothelial cells, consistent with a role in endothelial cell activation. Indeed, TNF-alpha stimulated endothelial expression of HSNS4F5, which contributed to leukocyte adhesion. In a mouse model of severe systemic amyloid protein A amyloidosis, HSNS4F5 was expressed within amyloid deposits, which were successfully detected by microSPECT imaging using NS4F5 as a molecularly targeted probe. Combined, our results demonstrate that NS4F5 is a powerful tool for elucidating the biological function of HSNS4F5 and can be exploited as a probe to detect novel polysaccharide biomarkers of disease processes.	[Smits, Nicole C.; ten Dam, Gerdy B.; Hafmans, Theo; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Kurup, Sindhulakshmi; Spillmann, Dorothe; Li, Jin-ping] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Rops, Angelique L.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Nephrol Res Lab,Dept Nephrol, NL-6500 HB Nijmegen, Netherlands; [Massuger, Leon F.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands; [Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England; [Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA; [Smits, Nicole C.; Shworak, Nicholas W.] Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Dekhuijzen, P. N. Richard] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Uppsala University; Radboud University Nijmegen; Radboud University Nijmegen; University of Liverpool; University of Tennessee System; University of Tennessee Health Science Center; Dartmouth College; Radboud University Nijmegen	van Kuppevelt, TH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.	a.vankuppevelt@ncmls.ru.nl	Dekhuijzen, P NR/H-8024-2014; van Kuppevelt, A.H.M.S.M./L-4463-2015; Van der Vlag, Johan/E-4636-2010; Massuger, Leon F.A.G./H-8072-2014; Shworak, Nicholas/AAJ-6770-2020	Dekhuijzen, P NR/0000-0003-1365-900X; Van der Vlag, Johan/0000-0001-7843-5918; Shworak, Nicholas/0000-0001-7783-4634; Wall, Jonathan/0000-0002-5516-8578	International Human Frontier Science Program Organization [RGP0062/2004-C101]; Dutch Cancer Society [2008-4058]; Netherlands Organization for Scientific Research [902-27-292]; Dutch Kidney Foundation [C05.2152, KJPB09.010]; Swedish Foundation for Strategic Research [A303:156e]; Swedish Research Council [32X-15023]; Swedish Cancer Society [4708-B02-01XAA]; Polysackaridforskning AB (Uppsala, Sweden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Polysackaridforskning AB (Uppsala, Sweden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by International Human Frontier Science Program Organization Grant RGP0062/2004-C101, Dutch Cancer Society Grant nr 2008-4058, Netherlands Organization for Scientific Research Grant 902-27-292 (to A.L.R.), Dutch Kidney Foundation Grants C05.2152 and KJPB09.010 (to A.L.R.), Swedish Foundation for Strategic Research Grant A303:156e, Swedish Research Council Grant 32X-15023, Swedish Cancer Society Grant 4708-B02-01XAA, and Polysackaridforskning AB (Uppsala, Sweden).	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Jayson GC, 1999, INT J CANCER, V82, P298, DOI 10.1002/(SICI)1097-0215(19990719)82:2<298::AID-IJC23>3.3.CO;2-0; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Leali D, 2001, J BIOL CHEM, V276, P37900; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MULLER M, 1980, ELECTRON MICROS, V2, P720; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2007, NEPHROL DIAL TRANSPL, V22, P1891, DOI 10.1093/ndt/gfm194; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; vanSetten PA, 1997, KIDNEY INT, V51, P1245, DOI 10.1038/ki.1997.170; Waksman G, 1998, NAT STRUCT BIOL, V5, P527, DOI 10.1038/778; Wall JS, 2006, J NUCL MED, V47, P2016; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2005, AMYLOID, V12, P149, DOI 10.1080/13506120500222359	46	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41143	41151		10.1074/jbc.M110.153791	http://dx.doi.org/10.1074/jbc.M110.153791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20837479	Green Published, hybrid			2022-12-25	WOS:000285414400076
J	Lacher, MD; Pincheira, R; Zhu, Z; Camoretti-Mercado, B; Matli, M; Warren, RS; Castro, AF				Lacher, M. D.; Pincheira, R.; Zhu, Z.; Camoretti-Mercado, B.; Matli, M.; Warren, R. S.; Castro, A. F.			Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis	ONCOGENE			English	Article						Rheb; p27; AMPK; mTORC1; TSC/LAM; cancer	TUBEROUS SCLEROSIS COMPLEX; PROTEIN-KINASE; MAMMALIAN TARGET; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CYTOPLASMIC SEQUESTRATION; PROMOTES BINDING; CANCER-THERAPY; NULL-CELLS; PHOSPHORYLATION; TSC2	Tuberous sclerosis complex (TSC) is an autosomally inherited disorder that causes tumors to form in many organs. It is frequently caused by inactivating mutations in the TSC2 tumor-suppressor gene. TSC2 negatively regulates the activity of the GTPase Rheb and thereby inhibits mammalian target of rapamycin complex 1 (mTORC1) signaling. Activation of mTORC1 as a result of lack of TSC2 function is observed in TSC and sporadic lymphangioleiomyomatosis (LAM). TSC2 deficiency has recently been associated with elevated AMP-activated protein kinase (AMPK) activity, which in turn correlated with cytoplasmic localization of p27Kip1 (p27), a negative regulator of cyclin-dependent kinase 2 (Cdk2). How AMPK in the absence of TSC2 is stimulated is not fully understood. In this study, we demonstrate that Rheb activates AMPK and reduces p27 levels in Tsc2-null cells. Importantly, both effects occur largely independent of mTORC1. Furthermore, increased p27 levels following Rheb depletion correlated with reduced Cdk2 activity and cell proliferation in vitro, and with inhibition of tumor formation by Tsc2-null cells in vivo. Taken together, our data suggest that Rheb controls proliferation of TSC2-deficient cells by a mechanism that involves regulation of AMPK and p27, and that Rheb is a potential target for TSC/LAM therapy. Oncogene (2010) 29, 6543-6556; doi:10.1038/onc.2010.393; published online 6 September 2010	[Lacher, M. D.; Castro, A. F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Pincheira, R.] Univ Concepcion, Dept Biochem & Mol Biol, Concepcion, Chile; [Zhu, Z.; Matli, M.; Warren, R. S.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Camoretti-Mercado, B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Castro, A. F.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universidad de Concepcion; University of California System; University of California San Francisco; University of Chicago; University of California System; University of California San Francisco	Castro, AF (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	arcastro@udec.cl	Lacher, Markus D/F-3772-2012	Pincheira, Roxana/0000-0003-4277-5245	Department of Defense (DOD) [DOD TS043006, TS043006]; Academic Senate (UCSF); LAM Foundation; ATS; ALA; Blowitz-Ridgeway Foundation; DOD [TS043006]	Department of Defense (DOD)(United States Department of Defense); Academic Senate (UCSF); LAM Foundation; ATS; ALA; Blowitz-Ridgeway Foundation; DOD(United States Department of Defense)	We are grateful to the NIH-LAM registry, the LAM foundation and especially to the LAM patients for providing LAM specimens. We thank Prema S Idumalla and Xiaochen Yuan for technical assistance, and Drs David Donner and Martin McMahon for review of the paper and suggestions. Special thanks to Pamela Derish at UCSF for editing the paper. We also thank Dr Geoffrey Clark for providing the custom Rheb antibody, Dr Cheryl Walker for the ELT3 cells and Dr David Kwiatkowski for the MEFs Tsc2-/- and Tsc2+/+. This work was supported by grants from the Department of Defense (DOD TS043006) and Academic Senate (UCSF) (AFC), and LAM Foundation, ATS, ALA, and Blowitz-Ridgeway Foundation (BC-M). Zhe Zhu was supported by the DOD TS043006 grant to AFC.	Alkarain A, 2004, BREAST CANCER RES, V6, P13, DOI 10.1186/bcr722; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2006, CANCER CELL, V9, P77, DOI 10.1016/j.ccr.2006.01.021; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Finlay GA, 2007, CANCER RES, V67, P9878, DOI 10.1158/0008-5472.CAN-07-1394; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Halayko AJ, 1999, AM J PHYSIOL-LUNG C, V276, pL197, DOI 10.1152/ajplung.1999.276.1.L197; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; HOWE SR, 1995, AM J PATHOL, V146, P1568; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Kim J, 2009, CLIN CANCER RES, V15, P81, DOI 10.1158/1078-0432.CCR-08-0170; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Paul E, 2008, NEW ENGL J MED, V358, P190, DOI 10.1056/NEJMe0707153; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; Rosner M, 2007, HUM MOL GENET, V16, P1541, DOI 10.1093/hmg/ddm103; Rosner M, 2006, MUTAT RES-REV MUTAT, V613, P10, DOI 10.1016/j.mrrev.2006.03.001; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato M, 2004, DEV CELL, V6, P458, DOI 10.1016/S1534-5807(04)00103-0; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Short JD, 2008, CANCER RES, V68, P6496, DOI 10.1158/0008-5472.CAN-07-5756; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	52	32	33	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6543	6556		10.1038/onc.2010.393	http://dx.doi.org/10.1038/onc.2010.393			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20818424				2022-12-25	WOS:000285380200004
J	McIntosh, J; Dennison, G; Holly, JMP; Jarrett, C; Frankow, A; Foulstone, EJ; Winters, ZE; Perks, CM				McIntosh, Jamie; Dennison, Godwin; Holly, Jeff M. P.; Jarrett, Caroline; Frankow, Alexandra; Foulstone, Emily J.; Winters, Zoe E.; Perks, Claire M.			IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-3; CARCINOMA IN-SITU; FACTOR RECEPTOR; CANCER-CELLS; IMMUNOHISTOCHEMICAL EXPRESSION; SIGNAL-TRANSDUCTION; PROGNOSTIC VALUE; RHO-GTPASES; CCN FAMILY; INTEGRIN	Progression of breast cancer is associated with remodeling of the extracellular matrix, often involving a switch from estrogen dependence to a dependence on EGF receptor (EGFR)/HER-2 and is accompanied by increased expression of the main binding protein for insulin-like growth factors (IGFBP-3). We have examined the effects of IGFBP-3 on EGF responses of breast epithelial cells in the context of changes in the extracellular matrix. On plastic and laminin with MCF-10A normal breast epithelial cells, EGF and IGFBP-3 each increased cell growth and together produced a synergistic response, whereas with T47D breast cancer cells IGFBP-3 alone had no effect, but the ability of EGF to increase cell proliferation was markedly inhibited in the presence of IGFBP-3. In contrast on fibronectin with MCF-10A cells, IGFBP-3 alone inhibited cell growth and blocked EGF-induced proliferation. With the cancer cells, IGFBP-3 alone had no effect but enhanced the EGF-induced increase in cell growth. The insulin-like growth factor-independent effects of IGFBP-3 alone on cell proliferation were completely abrogated in the presence of an EGFR, tyrosine kinase inhibitor, Iressa. Although IGFBP-3 did not affect EGFR phosphorylation [Tyr(1068)], it was found to modulate receptor internalization and was associated with activation of Rho and subsequent changes in MAPK phosphorylation. The levels of fibronectin and IGFBP-3 within breast tumors may determine their dependence on EGFR and their response to therapies targeting this receptor.	[McIntosh, Jamie; Dennison, Godwin; Holly, Jeff M. P.; Jarrett, Caroline; Frankow, Alexandra; Foulstone, Emily J.; Winters, Zoe E.; Perks, Claire M.] Univ Bristol, Southmead Hosp, IGFs & Metab Endocrinol Grp, Sch Clin Sci, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Winters, ZE (corresponding author), Univ Bristol, Southmead Hosp, IGFs & Metab Endocrinol Grp, Sch Clin Sci, Learning & Res Bldg,2nd Floor, Bristol BS10 5NB, Avon, England.	Zoe.Winters@bristol.ac.uk	Winters, Zoe Ellen/GYE-7947-2022	Perks, Claire/0000-0003-1562-891X	Bristol University	Bristol University	This work was supported by The Bristol University Cancer Research Fund.	Abrass CK, 1997, AM J PHYSIOL-RENAL, V273, pF899, DOI 10.1152/ajprenal.1997.273.6.F899; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Bohlke K, 1998, EPIDEMIOLOGY, V9, P570, DOI 10.1097/00001648-199809000-00018; BRUNING PF, 1995, INT J CANCER, V62, P266, DOI 10.1002/ijc.2910620306; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; DAVIES SC, 1991, CLIN ENDOCRINOL, V34, P501, DOI 10.1111/j.1365-2265.1991.tb00331.x; Edmondson SR, 1999, J CELL PHYSIOL, V179, P201, DOI 10.1002/(SICI)1097-4652(199905)179:2<201::AID-JCP10>3.0.CO;2-9; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Firth SM, 1998, BIOCHEM BIOPH RES CO, V246, P325, DOI 10.1006/bbrc.1998.8615; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; GORCZYCA W, 1993, ANTICANCER RES, V13, P851; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Hollowood AD, 2002, J CELL BIOCHEM, V86, P583, DOI 10.1002/jcb.10223; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Ioachim E, 1997, VIRCHOWS ARCH, V431, P311, DOI 10.1007/s004280050104; Kansra S, 2000, INT J CANCER, V87, P373, DOI 10.1002/1097-0215(20000801)87:3<373::AID-IJC10>3.0.CO;2-X; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656; McCaig C, 2002, BRIT J CANCER, V86, P1963, DOI 10.1038/sj.bjc.6600355; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mochizuki T, 2006, GROWTH HORM IGF RES, V16, P202, DOI 10.1016/j.ghir.2006.05.002; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nicholson RI, 2005, ENDOCR-RELAT CANCER, V12, pS29, DOI 10.1677/erc.1.00991; Oesterreicher S, 2005, J BIOL CHEM, V280, P9994, DOI 10.1074/jbc.M411754200; Pellegrin Stephanie, 2008, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1408s38; Perbal B, 2001, B CANCER, V88, P645; Perks C, 2003, HORM METAB RES, V35, P828; Pollak M. N., 2004, BIOCHIM BIOPHYS ACTA, V262, p[84, 165]; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Ricort JM, 2004, BIOCHEM BIOPH RES CO, V314, P1044, DOI 10.1016/j.bbrc.2004.01.001; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; SAINSBURY JRC, 1985, J CLIN PATHOL, V38, P1225, DOI 10.1136/jcp.38.11.1225; Singh B, 2004, J BIOL CHEM, V279, P477, DOI 10.1074/jbc.M307322200; SOULE HD, 1990, CANCER RES, V50, P6075; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tsutsui S, 2002, BREAST CANCER RES TR, V71, P67, DOI 10.1023/A:1013397232011; Vellon L, 2005, ONCOGENE, V24, P3759, DOI 10.1038/sj.onc.1208452; Vestey SB, 2005, BREAST CANCER RES, V7, pR119, DOI 10.1186/bcr963; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Yu X, 2000, J CELL SCI, V113, P2139	64	29	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38788	38800		10.1074/jbc.M110.177311	http://dx.doi.org/10.1074/jbc.M110.177311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20851879	hybrid, Green Published			2022-12-25	WOS:000284941300008
J	Bontjer, I; Melchers, M; Eggink, D; David, K; Moore, JP; Berkhout, B; Sanders, RW				Bontjer, Ilja; Melchers, Mark; Eggink, Dirk; David, Kathryn; Moore, John P.; Berkhout, Ben; Sanders, Rogier W.			Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; INTERMOLECULAR DISULFIDE BOND; CD4 BINDING-SITE; TYPE-1 ENVELOPE; NEUTRALIZING ANTIBODIES; GP120 GLYCOPROTEIN; MOLECULAR CLONES; PARTIAL DELETION; VARIABLE LOOPS	The envelope glycoproteins (Env) are the focus of HIV-1 vaccine development strategies based on the induction of humoral immunity, but the mechanisms the virus has evolved to limit the induction and binding of neutralizing antibodies (NAbs) constitute substantial obstacles. Conserved neutralization epitopes are shielded by variable regions and carbohydrates, so one strategy to increase their exposure and, it is hoped, their immunogenicity is to delete the overlying variable loops. However, deleting the variable regions from Env trimers can be problematic, because hydrophobic patches that are normally solvent-inaccessible now become exposed, causing protein misfolding or aggregation, for example. Here, we describe the construction and characterization of recombinant gp140 trimers lacking variable domains 1 and 2 (Delta V1V2). The design of the trimers was guided by HIV-1 evolution studies that identified compensatory changes in V1V2-deleted but functional Env proteins (Bontjer, I., Land, A., Eggink, D., Verkade, E., Tuin, K., Baldwin, C., Pollakis, G., Paxton, W. A., Braakman, I., Berkhout, B., and Sanders, R. W. (2009) J. Virol. 83, 368-383). We now show that specific compensatory changes improved the function of Delta V1V2 Env proteins and hence HIV-1 replication. The changes acted by reducing the exposure of a hydrophobic surface either by replacing a hydrophobic residue with a hydrophilic one or by covering the surface with a glycan. The compensatory changes allowed the efficient expression of well folded, soluble gp140 trimers derived from various HIV-1 isolates. The evolved Delta V1V2 Env viruses were extremely sensitive to NAbs, indicating that neutralization epitopes are well exposed, which was confirmed by studies of NAb binding to the soluble Delta V1V2 gp140 trimers. These evolved Delta V1V2 trimers could be useful reagents for immunogenicity and structural studies.	[Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [David, Kathryn; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Eggink, Dirk/0000-0002-4248-6008	National Institutes of Health [AI36082, AI45463]; AIDS Fund (Amsterdam, The Netherlands) [2005021, 2008013]; International AIDS Vaccine Initiative; Netherlands Organization for Scientific Research (NWO) Chemical Sciences; American Foundation for AIDS Research; Anton Meelmeijer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, R01AI036082, R01AI045463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fund (Amsterdam, The Netherlands)(Netherlands Government); International AIDS Vaccine Initiative; Netherlands Organization for Scientific Research (NWO) Chemical Sciences(Netherlands Organization for Scientific Research (NWO)); American Foundation for AIDS Research; Anton Meelmeijer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI36082 and AI45463 (to J. P. M.). This work was also supported by AIDS Fund (Amsterdam, The Netherlands) Grants 2005021 (to B. B.) and 2008013 (to R. W. S.) and by the International AIDS Vaccine Initiative.; Recipient of an Anton Meelmeijer fellowship, a VENI fellowship from the Netherlands Organization for Scientific Research (NWO) Chemical Sciences, and a Mathilde Krim fellowship from the American Foundation for AIDS Research.	ALLAWAY GP, 1993, AIDS RES HUM RETROV, V9, P581, DOI 10.1089/aid.1993.9.581; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Beddows S, 2006, AIDS RES HUM RETROV, V22, P569, DOI 10.1089/aid.2006.22.569; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Das AT, 1999, VIROLOGY, V263, P55, DOI 10.1006/viro.1999.9898; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Eggink D, 2007, TRENDS MICROBIOL, V15, P291, DOI 10.1016/j.tim.2007.05.006; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Gzy J, 2004, VIROLOGY, V318, P493, DOI 10.1016/j.virol.2003.10.009; Harrison JE, 2008, J VIROL, V82, P11695, DOI 10.1128/JVI.01303-08; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Jacobs A, 2008, VACCINE, V26, P3026, DOI 10.1016/j.vaccine.2007.12.026; Jeffs SA, 2002, J GEN VIROL, V83, P2723, DOI 10.1099/0022-1317-83-11-2723; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laakso MM, 2007, PLOS PATHOG, V3, P1118, DOI 10.1371/journal.ppat.0030117; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Lu S, 1998, AIDS RES HUM RETROV, V14, P151, DOI 10.1089/aid.1998.14.151; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McKeating JA, 1996, IMMUNOL LETT, V51, P101, DOI 10.1016/0165-2478(96)02562-X; MOORE JP, 1988, AIDS RES HUM RETROV, V4, P369, DOI 10.1089/aid.1988.4.369; MOORE JP, 1993, AIDS RES HUM RETROV, V9, P1185, DOI 10.1089/aid.1993.9.1185; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; POSNER MR, 1991, J IMMUNOL, V146, P4325; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Robinson J., 1992, J CELL BIOCHEM, V50, P71; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders Rogier W, 2004, Retrovirology, V1, P3, DOI 10.1186/1742-4690-1-3; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Schrodinger L., 2020, PYMOL; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; SUBRAMANIAM S, 2010, KEYSTONE S HIV VACCI; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiang SH, 2005, J VIROL, V79, P6068, DOI 10.1128/JVI.79.10.6068-6077.2005; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	87	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36456	36470		10.1074/jbc.M110.156588	http://dx.doi.org/10.1074/jbc.M110.156588			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20826824	hybrid, Green Published			2022-12-25	WOS:000284146100054
J	Eapen, A; Sundivakkam, P; Song, YQ; Ravindran, S; Ramachandran, A; Tiruppathi, C; George, A				Eapen, Asha; Sundivakkam, Premanand; Song, Yiqiang; Ravindran, Sriram; Ramachandran, Amsaveni; Tiruppathi, Chinnaswammy; George, Anne			Calcium-mediated Stress Kinase Activation by DMP1 Promotes Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; ENDOPLASMIC-RETICULUM STRESS; BONE-FORMATION; TRANSCRIPTIONAL REGULATION; P38; CELLS; APOPTOSIS; OSTERIX; SIGNAL; RUNX2	Calcium signaling and calcium transport play a key role during osteoblast differentiation and bone formation. Here, we demonstrate that DMP1 mediated calcium signaling, and its downstream effectors play an essential role in the differentiation of preosteoblasts to fully functional osteoblasts. DMP1, a key regulatory bone matrix protein, can be endocytosed by preosteoblasts, triggering a rise in cytosolic levels of calcium that initiates a series of downstream events leading to cellular stress. These events include release of store-operated calcium that facilitates the activation of stress-induced p38 MAPK leading to osteoblast differentiation. However, chelation of intracellular calcium and inhibition of the p38 signaling pathway by specific pharmacological inhibitors and dominant negative plasmid suppressed this activation. Interestingly, activated p38 MAPK can translocate to the nucleus to phosphorylate transcription factors that coordinate the expression of downstream target genes such as Runx 2, a key modulator of osteoblast differentiation. These studies suggest a novel paradigm by which DMP1-mediated release of intracellular calcium activates p38 MAPK signaling cascade to regulate gene expression and osteoblast differentiation.	[George, Anne] Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Chicago, IL 60612 USA; [Sundivakkam, Premanand; Tiruppathi, Chinnaswammy] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 11657]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 11657.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BODEN SD, 1990, ORTHOP CLIN N AM, V21, P31; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Davidson SM, 2000, DEV BIOL, V218, P146, DOI 10.1006/dbio.1999.9596; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Goodman SB, 2007, J BIOMED MATER RES A, V81A, P310, DOI 10.1002/jbm.a.30983; GREEN J, 1992, AM J PHYSIOL, V263, pE1070; Hamamura K, 2007, FEBS LETT, V581, P1769, DOI 10.1016/j.febslet.2007.03.063; Hino S, 2010, J BONE MINER METAB, V28, P131, DOI 10.1007/s00774-009-0117-z; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Kim IS, 2008, DEV GROWTH DIFFER, V50, P553, DOI 10.1111/j.1440-169X.2008.01052.x; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Leonardi R, 2004, CALCIFIED TISSUE INT, V75, P509, DOI 10.1007/s00223-004-0077-1; Liao JH, 2006, CANCER METAST REV, V25, P559, DOI 10.1007/s10555-006-9033-z; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; MUNDY GR, 1995, BONE, V17, pS71, DOI 10.1016/8756-3282(95)00182-D; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; Narayanan K, 2002, CONNECT TISSUE RES, V43, P365, DOI 10.1080/03008200290000592; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Nishihara A, 2003, BIOCHEM BIOPH RES CO, V301, P617, DOI 10.1016/S0006-291X(02)03068-1; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Reilly Gwendolen C, 2005, Cell Commun Signal, V3, P3, DOI 10.1186/1478-811X-3-3; San Miguel SM, 2005, J BIOL CHEM, V280, P37495, DOI 10.1074/jbc.M503861200; Seeman E, 2002, J BONE MINER RES, V17, P373, DOI 10.1359/jbmr.2002.17.3.373; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Sharan K, 2008, INDIAN J MED RES, V127, P274; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Tindberg N, 2000, NEUROCHEM RES, V25, P527, DOI 10.1023/A:1007520311457; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Walsh David, 1999, Environmental Medicine (Nagoya), V43, P79; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Zayzafoon M, 2002, J BIOL CHEM, V277, P37212, DOI 10.1074/jbc.M200129200	51	45	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36339	36351		10.1074/jbc.M110.145607	http://dx.doi.org/10.1074/jbc.M110.145607			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841352	Green Published, hybrid			2022-12-25	WOS:000284146100079
J	Rodriguez-Colman, MJ; Reverter-Branchat, G; Sorolla, MA; Tamarit, J; Ros, J; Cabiscol, E				Jose Rodriguez-Colman, Maria; Reverter-Branchat, Gemma; Alba Sorolla, M.; Tamarit, Jordi; Ros, Joaquim; Cabiscol, Elisa			The Forkhead Transcription Factor Hcm1 Promotes Mitochondrial Biogenesis and Stress Resistance in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP PROTEIN; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; CELL-CYCLE; LIFE-SPAN; IN-VIVO; INCREASED DOSAGE; GENE-EXPRESSION; BUDDING YEAST; FOXO PROTEINS	In Saccharomyces cerevisiae, the forkhead transcription factor Hcm1 is involved in chromosome segregation, spindle pole dynamics, and budding. We found that Hcm1 interacts with the histone deacetylase Sir2 and shifts from cytoplasm to the nucleus in the G(1)/S phase or in response to oxidative stress stimuli. The nuclear localization of Hcm1 depends on the activity of Sir2 as revealed by activators and inhibitors of the sirtuins and the Delta sir2 mutant. Hcm1-overexpressing cells display more mitochondria that can be attributed to increased amounts of Abf2, a protein involved in mitochondrial biogenesis. These cells also show higher rates of oxygen consumption and improved resistance to oxidative stress that would be explained by increased catalase and Sod2 activities and molecular chaperones such as Hsp26, Hsp30, and members of Hsp70 family. Microarray analyses also reveal increased expression of genes involved in mitochondrial energy pathways and those allowing the transition from the exponential to the stationary phase. Taken together, these results describe a new and relevant role of Hcm1 for mitochondrial functions, suggesting that this transcription factor would participate in the adaptation of cells from fermentative to respiratory metabolism.	[Jose Rodriguez-Colman, Maria; Reverter-Branchat, Gemma; Alba Sorolla, M.; Tamarit, Jordi; Ros, Joaquim; Cabiscol, Elisa] Univ Lleida, IRBLleida, Biochem Oxidat Stress Grp, Lleida 25008, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Ros, J (corresponding author), Univ Lleida, IRBLleida, Biochem Oxidat Stress Grp, C Montserrat Roig 2, Lleida 25008, Spain.	joaquim.ros@cmb.udl.cat	Sorolla, Maria Alba/E-4780-2012; Tamarit, Jordi/C-6316-2008; Cabiscol, Elisa/A-4584-2009; Rodriguez-Colman Von Gebhardt, Maria José/C-6447-2011; Ros, Joaquim/A-7507-2010; ROS, Joaquim/ABG-7487-2020; Sorolla, Maria Alba/E-4780-2012	Sorolla, Maria Alba/0000-0002-2180-0408; Tamarit, Jordi/0000-0003-3227-6928; Cabiscol, Elisa/0000-0003-2795-7999; ROS, Joaquim/0000-0003-0901-8648; Sorolla, Maria Alba/0000-0002-1728-341X; Rodriguez-Colman, Maria J./0000-0001-8382-5128	Ministerio de Ciencia e Innovacion (Spain) [BFU2007-66249, CSD2007-20]; Generalitat de Catalunya [SGR2009-00196]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by grants BFU2007-66249 and CSD2007-20 Consolider Ingenio 2010 from the Ministerio de Ciencia e Innovacion (Spain) and SGR2009-00196 from the Generalitat de Catalunya.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cho JH, 2001, BBA-GENE STRUCT EXPR, V1522, P175, DOI 10.1016/S0167-4781(01)00333-5; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DAIGNANFORNIER B, 1994, MOL GEN GENET, V243, P575, DOI 10.1007/BF00284206; DENIS CL, 1983, MOL CELL BIOL, V3, P360, DOI 10.1128/MCB.3.3.360; DESTRUELLE M, 1994, MOL CELL BIOL, V14, P2740, DOI 10.1128/MCB.14.4.2740; DIFFLEY JFX, 1992, J BIOL CHEM, V267, P3368; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FISHER RP, 1992, J BIOL CHEM, V267, P3358; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Hollenhorst PC, 2000, GENETICS, V154, P1533; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; Jin C, 2007, FEBS LETT, V581, P5658, DOI 10.1016/j.febslet.2007.11.027; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaestner KH, 2000, GENE DEV, V14, P142; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kleinschmidt M, 2006, CURR GENET, V49, P218, DOI 10.1007/s00294-005-0049-7; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LIEBERMAN HB, 2003, METHOD MOL BIOL, P55; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MAITRA PK, 1971, J BIOL CHEM, V246, P475; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Puig S, 2000, YEAST, V16, P139, DOI 10.1002/(SICI)1097-0061(20000130)16:2<139::AID-YEA512>3.3.CO;2-A; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Reverter-Branchat G, 2007, MICROBIOL-SGM, V153, P3667, DOI 10.1099/mic.0.2007/009340-0; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Saxena D, 2003, EUKARYOT CELL, V2, P552, DOI 10.1128/EC.2.3.552-559.2003; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763; ZHU GF, 1993, MOL CELL BIOL, V13, P1779, DOI 10.1128/MCB.13.3.1779; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	71	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37092	37101		10.1074/jbc.M110.174763	http://dx.doi.org/10.1074/jbc.M110.174763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847055	Green Published, hybrid			2022-12-25	WOS:000284146100053
J	Xu, XP; Vysotskaya, ZV; Liu, QL; Zhou, L				Xu, Xinping; Vysotskaya, Zhanna V.; Liu, Qinglian; Zhou, Lei			Structural Basis for the cAMP-dependent Gating in the Human HCN4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT ACTIVATION KINETICS; CYCLIC-NUCLEOTIDE BINDING; PACEMAKER CHANNELS; HUMAN HEART; TERMINAL REGION; MOLECULAR-BASIS; GATED CHANNELS; MODULATION; MOVEMENT; LIGAND	Hyperpolarization-activated cAMP-regulated (HCN) channels play important physiological roles in both cardiovascular and central nervous systems. Among the four HCN isoforms, HCN2 and HCN4 show high expression levels in the human heart, with HCN4 being the major cardiac isoform. The previously published crystal structure of the mouse HCN2 (mHCN2) C-terminal fragment, including the C-linker and the cyclic-nucleotide binding domain (CNBD), has provided many insights into cAMP-dependent gating in HCN channels. However, structures of other mammalian HCN channel isoforms have been lacking. Here we used a combination of approaches including structural biology, biochemistry, and electrophysiology to study cAMP-dependent gating in HCN4 channel. First we solved the crystal structure of the C-terminal fragment of human HCN4 (hHCN4) channel at 2.4 angstrom. Overall we observed a high similarity between mHCN2 and hHCN4 crystal structures. Functional comparison between two isoforms revealed that compared with mHCN2, the hHCN4 protein exhibited marked different contributions to channel function, such as a similar to 3-fold reduction in the response to cAMP. Guided by structural differences in the loop region between beta 4 and beta 5 strands, we identified residues that could partially account for the differences in response to cAMP between mHCN2 and hHCN4 proteins. Moreover, upon cAMP binding, the hHCN4 C-terminal protein exerts a much prolonged effect in channel deactivation that could have significant physiological contributions.	[Xu, Xinping; Vysotskaya, Zhanna V.; Liu, Qinglian; Zhou, Lei] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Zhou, L (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA.	lzhou@vcu.edu	Xu, Xinping/AAA-1304-2020	XU, XINPING/0000-0002-9568-4171	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by startup funds from the Virginia Commonwealth University School of Medicine (to L. Z. and Q. L.) and a New Scholar Award in Aging from the Ellison Medical Foundation (to Q. L.).	[Anonymous], 2002, CURR PROTOC BIOINFOR; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DiFrancesco D, 2005, CURR MED RES OPIN, V21, P1115, DOI 10.1185/030079905X50543; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Harzheim D, 2008, EMBO J, V27, P692, DOI 10.1038/emboj.2008.3; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Ludwig A, 2008, PROG BIOPHYS MOL BIO, V98, P179, DOI 10.1016/j.pbiomolbio.2009.01.001; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Nof E, 2010, PACE, V33, P100, DOI 10.1111/j.1540-8159.2009.02563.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Stillitano F, 2008, J MOL CELL CARDIOL, V45, P289, DOI 10.1016/j.yjmcc.2008.04.013; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Verkerk AO, 2009, INT J CARDIOL, V132, P318, DOI 10.1016/j.ijcard.2008.12.196; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2008, BIOPHYS J, V94, pL90, DOI 10.1529/biophysj.108.130872; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	50	74	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37082	37091		10.1074/jbc.M110.152033	http://dx.doi.org/10.1074/jbc.M110.152033			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829353	Green Published, hybrid			2022-12-25	WOS:000284146100065
J	Ariyoshi, W; Knudson, CB; Luo, N; Fosang, AJ; Knudson, W				Ariyoshi, Wataru; Knudson, Cheryl B.; Luo, Na; Fosang, Amanda J.; Knudson, Warren			Internalization of Aggrecan G1 Domain Neoepitope ITEGE in Chondrocytes Requires CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ARTICULAR CHONDROCYTES; RECEPTOR-MEDIATED ENDOCYTOSIS; ANTIGEN-INDUCED ARTHRITIS; MATRIX-METALLOPROTEINASE; SYNOVIAL-FLUID; CARTILAGE DEGRADATION; INTERGLOBULAR DOMAIN; HUMAN OSTEOARTHRITIS; ADAMTS FAMILY; IN-VIVO	Degradation of the cartilage proteoglycan aggrecan is one of the earliest events that occurs in association with osteoarthritis. Little is known concerning the fate of the residual N-terminal G1 domains of cleaved aggrecan; domains that remain bound to hyaluronan. In this study, 68-72-kDa bands representative of aggrecan G1 domains containing ITEGE(373) neoepitope were detected within a hyaluronidase-sensitive pool at the cell surface of bovine articular chondrocytes and within a hyaluronidase-insensitive, intracellular pool. To determine the mechanisms that contribute to this distribution, CD44 expression was knocked down by siRNA or function by CD44-DN. Both approaches prevented the retention and internalization of G1-ITEGE. Inhibition of CD44 transit into lipid rafts blocked the endocytosis of G1-ITEGE but not the retention at the cell surface. Chondrocytes derived from CD44 null mice also exhibited limited potential for retention and internalization of G1-VTEGE. The consequence of a lack of chondrocyte-mediated endocytosis of these domains in cartilage of the CD44 null mice was the accumulation of the degradation fragments within the tissue. Additionally, chondrocytes or fibroblasts derived from CD44 null mice exhibited little capacity for retention and internalization of exogenous G1-ITEGE derived from bovine cartilage explants. Bovine or wild type mouse fibroblasts were able to bind and internalize bovine-derived G1-ITEGE. Although several pathways are available for the clearance of these domains, CD44-mediated cellular internalization is the most prominent.	[Knudson, Warren] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Fosang, Amanda J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Fosang, Amanda J.] Royal Childrens Hosp, Arthrit Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of North Carolina; East Carolina University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Knudson, W (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd, Greenville, NC 27834 USA.	knudsonw@ecu.edu		Fosang, Amanda/0000-0002-5523-5427	National Institutes of Health [RO1-AR43384, R01-AR39507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039507, R01AR043384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AR43384 (to W. K.) and R01-AR39507 (to C. B. K.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641; Chockalingam PS, 2004, ARTHRITIS RHEUM-US, V50, P2839, DOI 10.1002/art.20496; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Embry JJ, 2003, ARTHRITIS RHEUM-US, V48, P3431, DOI 10.1002/art.11323; Flory JJE, 2006, ARTHRITIS RHEUM-US, V54, P443, DOI 10.1002/art.21623; Fosang AJ, 2000, J BIOL CHEM, V275, P33027, DOI 10.1074/jbc.M910207199; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HUA Q, 1993, J CELL SCI, V106, P365; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KNUDSON W, 2004, CURR OPIN ORTHOP, V15, P369; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; LARK MW, 1995, J BIOL CHEM, V270, P2550, DOI 10.1074/jbc.270.6.2550; Little CB, 2002, MATRIX BIOL, V21, P271, DOI 10.1016/S0945-053X(02)00004-5; LOHMANDER LS, 1993, ARTHRITIS RHEUM-US, V36, P181, DOI 10.1002/art.1780360207; Mercuri FA, 1999, J BIOL CHEM, V274, P32387, DOI 10.1074/jbc.274.45.32387; MORALES TI, 1988, J BIOL CHEM, V263, P3632; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Szanto S, 2004, J IMMUNOL, V172, P6723, DOI 10.4049/jimmunol.172.11.6723; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; van Meurs JBJ, 1998, ARTHRITIS RHEUM, V41, P647, DOI 10.1002/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T; van Meurs JBJ, 1999, ANN RHEUM DIS, V58, P350, DOI 10.1136/ard.58.6.350; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2	41	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36216	36224		10.1074/jbc.M110.129270	http://dx.doi.org/10.1074/jbc.M110.129270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843796	Green Published, hybrid			2022-12-25	WOS:000283845300097
J	Wang, HJ; Holloway, MP; Ma, L; Cooper, ZA; Riolo, M; Samkari, A; Elenitoba-Johnson, KSJ; Chin, YE; Altura, RA				Wang, Haijuan; Holloway, Michael P.; Ma, Li; Cooper, Zachary A.; Riolo, Matthew; Samkari, Ayman; Elenitoba-Johnson, Kojo S. J.; Chin, Y. Eugene; Altura, Rachel A.			Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE RESPONSE FACTOR; SIGNAL TRANSDUCER; IDENTIFICATION; GENE; TRANSCRIPTION-3; EXPRESSION; INHIBITOR; ACTIVATOR; CANCER; EXPORT	The multiple functions of the oncofetal protein survivin are dependent on its selective expression patterns within immuno-chemically distinct subcellular pools. The mechanism by which survivin localizes to these compartments, however, is only partly understood. Here we show that nuclear accumulation of survivin is promoted by CREB-binding protein (CBP)-dependent acetylation on lysine 129 (129K, Lys-129). We demonstrate a mechanism by which survivin acetylation at this position results in its homodimerization, while deacetylation promotes the formation of survivin monomers that heterodimerize with CRM1 and facilitate its nuclear export. Using proteomic analysis, we identified the oncogenic transcription factor STAT3 as a binding partner of nuclear survivin. We show that acetylated survivin binds to the N-terminal transcriptional activation domain of the STAT3 dimer and represses STAT3 transactivation of target gene promoters. Using multiplex PCR and DNA sequencing, we identified a single-nucleotide polymorphism (A -> ) at Lys-129 that exists as a homozygous mutation in a neuroblastoma cell line and corresponds with a defect in survivin nuclear localization. Our results demonstrate that the dynamic equilibrium between survivin acetylation and deacetylation at amino acid 129 determines its interaction with CRM1, its subsequent subcellular localization, and its ability to inhibit STAT3 transactivation, providing a potential route for therapeutic intervention in STAT3-dependent tumors.	[Altura, Rachel A.] Brown Univ, Dept Pediat, Providence, RI 02903 USA; [Ma, Li; Chin, Y. Eugene] Brown Univ, Dept Surg, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA; [Elenitoba-Johnson, Kojo S. J.] Univ Michigan Hlth Sci, Dept Pathol, Ann Arbor, MI 48109 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Michigan System; University of Michigan	Altura, RA (corresponding author), 1 Hoppin St, Providence, RI 02903 USA.	rachel_altura@brown.edu		Cooper, Zachary/0000-0003-1059-0940; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health Cancer Research Center [P20RR017695-6A2]; Center for Excellence in Women's Health/Brown University; Women and Infants Hospital Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	National Institutes of Health Cancer Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Excellence in Women's Health/Brown University; Women and Infants Hospital Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Cancer Research Center Grant P20RR017695-6A2 ( to R. A. A.) and by a Center for Excellence in Women's Health/Brown University and Women and Infants Hospital Award (to R. A. A.).	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Engelsma D, 2007, TRAFFIC, V8, P1495, DOI 10.1111/j.1600-0854.2007.00629.x; Fortugno P, 2002, J CELL SCI, V115, P575; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Haynes PA, 1998, ELECTROPHORESIS, V19, P939, DOI 10.1002/elps.1150190609; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Mahboubi K, 2001, LAB INVEST, V81, P327, DOI 10.1038/labinvest.3780241; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Stauber RH, 2006, TRAFFIC, V7, P1461, DOI 10.1111/j.1600-0854.2006.00486.x; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	33	69	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36129	36137		10.1074/jbc.M110.152777	http://dx.doi.org/10.1074/jbc.M110.152777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826784	hybrid, Green Published			2022-12-25	WOS:000283845300089
J	Miller, A; Chen, JJ; Takasuka, TE; Jacobi, JL; Kaufman, PD; Irudayaraj, JMK; Kirchmaier, AL				Miller, Andrew; Chen, Jiji; Takasuka, Taichi E.; Jacobi, Jennifer L.; Kaufman, Paul D.; Irudayaraj, Joseph M. K.; Kirchmaier, Ann L.			Proliferating Cell Nuclear Antigen (PCNA) Is Required for Cell Cycle-regulated Silent Chromatin on Replicated and Nonreplicated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; H3 LYSINE-56 ACETYLATION; DNA-POLYMERASE-DELTA; HISTONE H3; SACCHAROMYCES-CEREVISIAE; EPIGENETIC INHERITANCE; FACTOR-C; S-PHASE; PROTEIN; YEAST	In Saccharomyces cerevisiae, silent chromatin is formed at HMR upon the passage through S phase, yet neither the initiation of DNA replication at silencers nor the passage of a replication fork through HMR is required for silencing. Paradoxically, mutations in the DNA replication processivity factor, POL30, disrupt silencing despite this lack of requirement for DNA replication in the establishment of silencing. We tested whether pol30 mutants could establish silencing at either replicated or non-replicated HMR loci during S phase and found that pol30 mutants were defective in establishing silencing at HMR regardless of its replication status. Although previous studies tie the silencing defect of pol30 mutants to the chromatin assembly factors Asf1p and CAF-1, we found pol30 mutants did not exhibit a gross defect in packaging HMR into chromatin. Rather, the pol30 mutants exhibited defects in histone modifications linked to ASF1 and CAF-1-dependent pathways, including SAS-I-and Rtt109p-dependent acetylation events at H4-K16 and H3-K9 (plus H3-K56; Miller, A., Yang, B., Foster, T., and Kirchmaier, A. L. (2008) Genetics 179, 793-809). Additional experiments using FLIM-FRET revealed that Pol30p interacted with SAS-I and Rtt109p in the nuclei of living cells. However, these interactions were disrupted in pol30 mutants with defects linked to ASF1- and CAF-1-dependent pathways. Together, these results imply that Pol30p affects epigenetic processes by influencing the composition of chromosomal histone modifications.	[Miller, Andrew; Takasuka, Taichi E.; Jacobi, Jennifer L.; Kirchmaier, Ann L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Chen, Jiji; Irudayaraj, Joseph M. K.] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Miller, Andrew; Chen, Jiji; Takasuka, Taichi E.; Jacobi, Jennifer L.; Irudayaraj, Joseph M. K.; Kirchmaier, Ann L.] Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA; [Kaufman, Paul D.] Univ Massachusetts, Sch Med, Program Gene Funct & Gene Express, Slippery Rock, PA 16057 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kirchmaier, AL (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	kirchmaier@purdue.edu	Chen, Jiji/K-5551-2012; Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Kirchmaier, Ann/0000-0001-9938-9105; Kaufman, Paul/0000-0003-3089-313X; Irudayaraj, Joseph/0000-0002-0630-1520	National Institutes of Health [R01 GM55712, GM31105]; Kimmel Scholar Award [SKF-03-010]; National Science Foundation; Purdue Office of the Vice President of Research; American Cancer Society [PF-01-126-01-MBC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031105, R01GM055712, R01GM031105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Scholar Award; National Science Foundation(National Science Foundation (NSF)); Purdue Office of the Vice President of Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM55712 (to P. D. K.) and GM31105 (to J. Rine, with whom A. L. K. worked at the time). This work was also supported by Kimmel Scholar Award SKF-03-010 (to A. L. K.), a National Science Foundation award (to A. L. K.), a grant from the Purdue Office of the Vice President of Research (to A. L. K. and J. M. K. I.), and an American Cancer Society institutional research grant to the Purdue University Center for Cancer Research. Support for initial experiments was provided by the American Cancer Society (PF-01-126-01-MBC to A. L. K.).	Adams A, 1997, METHODS YEAST GENETI; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bose ME, 2004, MOL CELL BIOL, V24, P774, DOI 10.1128/MCB.24.2.774-786.2004; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Ehrenhofer-Murray AE, 1999, GENETICS, V153, P1171; EHRENHOFERMURRA.AE, 1997, J GENETICS */* GENET, P923; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Gardner KA, 1999, GENETICS, V151, P31; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; HUBSCHER U, 1996, DNA REPLICATION EUKA, P525; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Kamakaka RT, 1996, MOL CELL BIOL, V16, P810; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KIMMERLY W, 1988, EMBO J, V7, P2241, DOI 10.1002/j.1460-2075.1988.tb03064.x; Kirchmaier AL, 2006, MOL CELL BIOL, V26, P852, DOI 10.1128/MCB.26.3.852-862.2006; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; MAGA G, 1995, BIOCHEMISTRY-US, V34, P891, DOI 10.1021/bi00003a023; Martins-Taylor K, 2004, GENETICS, V168, P65, DOI 10.1534/genetics.103.020149; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matecic M, 2006, GENETICS, V173, P1939, DOI 10.1534/genetics.106.055491; McAlear MA, 1996, GENETICS, V142, P65; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; MILLER AM, 1984, EMBO J, V3, P1061, DOI 10.1002/j.1460-2075.1984.tb01927.x; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Miller A, 2008, GENETICS, V179, P793, DOI 10.1534/genetics.107.084525; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Reifnyder C, 1997, NAT GENET, V16, P109, DOI 10.1038/ng0597-109b; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Shia WJ, 2005, J BIOL CHEM, V280, P11987, DOI 10.1074/jbc.M500276200; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SIEGEL RM, 2000, SCI STKE, pPL1; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1999, MOL CELL BIOL, V19, P3184; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; STEARNS T, 1990, METHOD ENZYMOL, V185, P280; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Sutton A, 2001, GENETICS, V158, P587; Tamburini BA, 2006, GENETICS, V173, P599, DOI 10.1534/genetics.105.054783; TAN CK, 1986, J BIOL CHEM, V261, P2310; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; VAN L, 2002, METHODS */* D E METH, V350, P165; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; Varghese LT, 2008, ANAL CHIM ACTA, V625, P103, DOI 10.1016/j.aca.2008.07.021; Vidi PA, 2008, FEBS LETT, V582, P3985, DOI 10.1016/j.febslet.2008.09.062; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WANG JC, 1982, CELL, V29, P724, DOI 10.1016/0092-8674(82)90433-0; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Xu EY, 1999, GENETICS, V153, P13; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yang B, 2008, J MOL BIOL, V381, P826, DOI 10.1016/j.jmb.2008.06.059; Yang B, 2006, MOL BIOL CELL, V17, P5287, DOI 10.1091/mbc.E06-08-0669; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	119	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35142	35154		10.1074/jbc.M110.166918	http://dx.doi.org/10.1074/jbc.M110.166918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813847	hybrid, Green Published			2022-12-25	WOS:000283659100088
J	Seymour, LM; Deutscher, AT; Jenkins, C; Kuit, TA; Falconer, L; Minion, FC; Crossett, B; Padula, M; Dixon, NE; Djordjevic, SP; Walker, MJ				Seymour, Lisa M.; Deutscher, Ania T.; Jenkins, Cheryl; Kuit, Tracey A.; Falconer, Linda; Minion, F. Chris; Crossett, Ben; Padula, Matthew; Dixon, Nicholas E.; Djordjevic, Steven P.; Walker, Mark J.			A Processed Multidomain Mycoplasma hyopneumoniae Adhesin Binds Fibronectin, Plasminogen, and Swine Respiratory Cilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCAL M-PROTEIN; ELONGATION-FACTOR TU; ALPHA-ENOLASE; ADHERENCE; GENE; IDENTIFICATION; DOMAINS; VACCINE; REGION; PIGS	Porcine enzootic pneumonia is a chronic respiratory disease that affects swine. The etiological agent of the disease, Mycoplasma hyopneumoniae, is a bacterium that adheres to cilia of the swine respiratory tract, resulting in loss of cilia and epithelial cell damage. A M. hyopneumoniae protein P116, encoded by mhp108, was investigated as a potential adhesin. Examination of P116 expression using proteomic analyses observed P116 as a full-length protein and also as fragments, ranging from 17 to 70 kDa in size. A variety of pathogenic bacterial species have been shown to bind the extracellular matrix component fibronectin as an adherence mechanism. M. hyopneumoniae cells were found to bind fibronectin in a dose-dependent and saturable manner. Surface plasmon resonance was used to show that a recombinant C-terminal domain of P116 bound fibronectin at physiologically relevant concentrations (K-D 24 +/- 6 nM). Plasmin(ogen)-binding proteins are also expressed by many bacterial pathogens, facilitating extracellular matrix degradation. M. hyopneumoniae cells were found to also bind plasminogen in a dose-dependent and saturable manner; the C-terminal domain of P116 binds to plasminogen (K-D 44 +/- 5 nM). Plasminogen binding was abolished when the C-terminal lysine of P116 was deleted, implicating this residue as part of the plasminogen binding site. P116 fragments adhere to the PK15 porcine kidney epithelial-like cell line and swine respiratory cilia. Collectively these data suggest that P116 is an important adhesin and virulence factor of M. hyopneumoniae.	[Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Seymour, Lisa M.; Deutscher, Ania T.; Kuit, Tracey A.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Dixon, Nicholas E.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Minion, F. Chris] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Crossett, Ben] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Padula, Matthew; Djordjevic, Steven P.] Univ Technol Sydney, Inst i3, Sydney, NSW 2007, Australia	University of Queensland; University of Wollongong; University of Wollongong; Iowa State University; University of Sydney; University of Technology Sydney	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Cooper Rd, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Jenkins, Cheryl/N-1937-2015; Walker, Mark J./F-6940-2011; djordjevic, steven/GNP-4000-2022; Dixon, Nicholas E/A-1226-2008; Padula, Matthew P/R-6150-2016; Djordjevic, Steven/A-2024-2013; Minion, Chris/A-2955-2015; Crossett, Ben/G-2316-2011	Jenkins, Cheryl/0000-0002-5966-072X; djordjevic, steven/0000-0001-9301-5372; Dixon, Nicholas E/0000-0002-5958-6945; Padula, Matthew P/0000-0002-8283-0643; Djordjevic, Steven/0000-0001-9301-5372; Minion, Chris/0000-0003-4876-8396; Walker, Mark/0000-0001-7423-2769; Deutscher, Ania/0000-0002-5917-9223				Adams C, 2005, INFECT IMMUN, V73, P7784, DOI 10.1128/IAI.73.11.7784-7787.2005; Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baseggio N, 1996, MICROBIOL-SGM, V142, P1429, DOI 10.1099/13500872-142-6-1429; BLANCHARD B, 1992, VET MICROBIOL, V30, P329, DOI 10.1016/0378-1135(92)90020-T; Bower K, 2003, INFECT IMMUN, V71, P4823, DOI 10.1128/IAI.71.8.4823-4827.2003; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; CIPRIAN A, 1988, CAN J VET RES, V52, P434; Cole Jason N., 2008, V425, P295, DOI 10.1007/978-1-60327-210-0_24; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Djordjevic SP, 1997, AUST VET J, V75, P504, DOI 10.1111/j.1751-0813.1997.tb14383.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fagan PK, 1996, INFECT IMMUN, V64, P1060, DOI 10.1128/IAI.64.3.1060-1064.1996; Giron JA, 1996, INFECT IMMUN, V64, P197; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; Henrich S, 2007, BBA-PROTEINS PROTEOM, V1774, P413, DOI 10.1016/j.bbapap.2006.12.011; Hsu T, 1998, GENE, V214, P13, DOI 10.1016/S0378-1119(98)00247-9; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; King KW, 1997, VACCINE, V15, P25, DOI 10.1016/S0264-410X(96)00121-1; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Marois C, 2007, VET MICROBIOL, V120, P96, DOI 10.1016/j.vetmic.2006.10.015; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; Mongodin E, 2002, INFECT IMMUN, V70, P620; Oehmcke S, 2004, INFECT IMMUN, V72, P4302, DOI 10.1128/IAI.72.7.4302-4308.2004; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; REDDY SP, 1995, J BACTERIOL, V177, P5943, DOI 10.1128/jb.177.20.5943-5951.1995; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Scarman AL, 1997, MICROBIOL-SGM, V143, P663, DOI 10.1099/00221287-143-2-663; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Wilton JL, 1998, MICROBIOL-UK, V144, P1931, DOI 10.1099/00221287-144-7-1931; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; WISE KS, 1987, J BACTERIOL, V169, P5546, DOI 10.1128/jb.169.12.5546-5555.1987; YAGIHASHI T, 1984, JPN J VET SCI, V46, P705; Yavlovich A, 2001, INFECT IMMUN, V69, P1977, DOI 10.1128/IAI.69.4.1977-1982.2001; Yavlovich A, 2007, FEMS MICROBIOL LETT, V266, P158, DOI 10.1111/j.1574-6968.2006.00534.x; Yazawa S, 2004, VET MICROBIOL, V98, P221, DOI 10.1016/j.vetmic.2003.11.005; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995; ZHANG QJ, 1994, INFECT IMMUN, V62, P4367, DOI 10.1128/IAI.62.10.4367-4373.1994; ZIELINSKI GC, 1990, AM J VET RES, V51, P339	49	65	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33971	33978		10.1074/jbc.M110.104463	http://dx.doi.org/10.1074/jbc.M110.104463			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20813843	Green Published, hybrid			2022-12-25	WOS:000283354000044
J	Esposito, E; Mazzon, E; Paterniti, I; Impellizzeri, D; Bramanti, P; Cuzzocrea, S				Esposito, Emanuela; Mazzon, Emanuela; Paterniti, Irene; Impellizzeri, Daniela; Bramanti, Placido; Cuzzocrea, Salvatore			Olprinone Attenuates the Acute Inflammatory Response and Apoptosis after Spinal Cord Trauma in Mice	PLOS ONE			English	Article							PHOSPHODIESTERASE-III INHIBITOR; FAS-MEDIATED APOPTOSIS; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; THERAPEUTIC TARGETS; RECEPTOR ACTIVATION; NEURON DEGENERATION; ADENOSINE RECEPTOR; SIGNALING PATHWAYS	Background: Olprinone hydrochloride is a newly developed compound that selectively inhibits PDE type III and is characterized by several properties, including positive inotropic effects, peripheral vasodilatory effects, and a bronchodilator effect. In clinical settings, olprinone is commonly used to treat congestive cardiac failure, due to its inotropic and vasodilating effects. The mechanism of these cardiac effects is attributed to increased cellular concentrations of cAMP. The aim of the present study was to evaluate the pharmacological action of olprinone on the secondary damage in experimental spinal cord injury (SCI) in mice. Methodology/Principal Findings: Traumatic SCI is characterized by an immediate, irreversible loss of tissue at the lesion site, as well as a secondary expansion of tissue damage over time. Although secondary injury should be preventable, no effective treatment options currently exist for patients with SCI. Spinal cord trauma was induced in mice by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and production of inflammatory mediators, tissue damage, apoptosis, and locomotor disturbance. Olprinone treatment (0.2 mg/kg, i.p.) 1 and 6 h after the SCI significantly reduced: (1) the degree of spinal cord inflammation and tissue injury (histological score), (2) neutrophil infiltration (myeloperoxidase activity), (3) nitrotyrosine formation, (4) pro-inflammatory cytokines, (5) NF-kappa B expression, (6) p-ERK1/2 and p38 expression and (7) apoptosis (TUNEL staining, FAS ligand, Bax and Bcl-2 expression). Moreover, olprinone significantly ameliorated the recovery of hind-limb function (evaluated by motor recovery score). Conclusions/Significance: Taken together, our results clearly demonstrate that olprinone treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.	[Esposito, Emanuela; Paterniti, Irene; Impellizzeri, Daniela; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Esposito, Emanuela; Mazzon, Emanuela; Bramanti, Placido; Cuzzocrea, Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	University of Messina; IRCCS Bonino Pulejo	Esposito, E (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	Bramanti, Placido/K-5117-2016; Mazzon, Emanuela/AAL-4334-2020	Impellizzeri, Daniela/0000-0001-9492-3161; Esposito, Emanuela/0000-0002-2663-6387; mazzon, emanuela/0000-0002-5073-717X	Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)	Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)	This study was supported by a grant from Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Bonino Pulejo''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Aggarwal S, 1999, CLIN EXP IMMUNOL, V117, P285; Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Anas C, 2007, INT J UROL, V14, P219, DOI 10.1111/j.1442-2042.2007.01689.x; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bhat NR, 1998, J NEUROSCI, V18, P1633; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen XL, 1996, AM J PHYSIOL-HEART C, V271, pH962, DOI 10.1152/ajpheart.1996.271.3.H962; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Choi SH, 2003, J NEUROSCI, V23, P5877; CRISAFULLI C, 2010, INTENSIVE CARE MED; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Fitch MT, 1999, J NEUROSCI, V19, P8182; Genovese T, 2008, CURR MED CHEM, V15, P477; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Genovese T, 2005, J PHARMACOL EXP THER, V312, P449, DOI 10.1124/jpet.104.076711; Genovese T, 2010, J BIOL REG HOMEOS AG, V24, P73; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Hirota K, 2001, ACTA ANAESTH SCAND, V45, P510, DOI 10.1034/j.1399-6576.2001.045004510.x; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Lee HT, 2001, AM J KIDNEY DIS, V38, P610, DOI 10.1053/ajkd.2001.26888; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; MALEFYT RD, 1991, J EXP MED, V174, P1209; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Miyakawa H, 2008, J ANESTH, V22, P27, DOI 10.1007/s00540-007-0572-4; Miyamoto N, 2010, J CEREBR BLOOD F MET, V30, P299, DOI 10.1038/jcbfm.2009.210; Mizushige K, 2002, CARDIOVASC DRUG REV, V20, P163; Mizutani A, 2005, SHOCK, V24, P281, DOI 10.1097/01.shk.0000175555.95676.34; Mullane K, 1989, Prog Clin Biol Res, V301, P39; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; OHHARA H, 1989, ARZNEIMITTELFORSCH, V39-1, P38; Okayama N, 2010, ANESTH ANALG, V110, P888, DOI 10.1213/ANE.0b013e3181cb5cdd; Okuda K, 1997, Masui, V46, P1580; Okusa MD, 2001, KIDNEY INT, V59, P2114, DOI 10.1046/j.1523-1755.2001.0590062114.x; Okusa MD, 2002, AM J PHYSIOL-RENAL, V282, pF10, DOI 10.1152/ajprenal.2002.282.1.F10; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004; Rivlin A S, 1978, Surg Neurol, V10, P38; Sadiq A, 2003, THROMB RES, V111, P357, DOI 10.1016/j.thromres.2003.09.024; Sanada S, 2001, CIRCULATION, V104, P705, DOI 10.1161/hc3201.092216; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; TAJIMI M, 1991, N-S ARCH PHARMACOL, V344, P602; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; YAMAGUCHI K, 2009, SHOCK; Yamaguchi K, 2010, SHOCK, V33, P436, DOI 10.1097/SHK.0b013e3181be3d7a; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005	73	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12170	10.1371/journal.pone.0012170	http://dx.doi.org/10.1371/journal.pone.0012170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830289	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300001
J	Goletti, D; Raja, A; Kabeer, BSA; Rodrigues, C; Sodha, A; Carrara, S; Vernet, G; Longuet, C; Ippolito, G; Thangaraj, S; Leportier, M; Girardi, E; Lagrange, PH				Goletti, Delia; Raja, Alamelu; Kabeer, Basirudeen Syed Ahamed; Rodrigues, Camilla; Sodha, Archana; Carrara, Stefania; Vernet, Guy; Longuet, Christophe; Ippolito, Giuseppe; Thangaraj, Satheesh; Leportier, Marc; Girardi, Enrico; Lagrange, Philippe Henri			Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; DIAGNOSIS; ASSAY; BIOMARKERS	The suboptimal sensitivity of Interferon (IFN)-gamma-based in-vitro assays, especially in immunocompromised individuals, emphasizes the need for alternative markers for diagnosing tuberculosis (TB). The objective of this study was to evaluate whether interferon-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-2 and interleukin (IL)-2 can be useful biomarkers for evaluating a specific response to RD1 antigens associated to active TB disease in HIV-infected individuals. Methodology/Principal Findings: The study was carried out in India, the country with the highest TB burden in the world. Sixty-six HIV-infected individuals were prospectively enrolled, 28 with active-pulmonary-TB and 38 without. The whole blood assay based on RD1-selected peptides (experimental test) and QuantiFERON-TB Gold In tube (QFT-IT) was performed. Plasma was harvested at day-1-post-culture and soluble factors were evaluated by ELISA. The results indicate that by detecting IP-10, the sensitivity of the experimental test and QFT-antigen (75% and 85.7% respectively) for active TB was higher compared to the same assays based on IFN-gamma (42.9% and 60.7% respectively) and was not influenced by the ability to respond to the mitogen. By detecting IP-10, the specificity of the experimental test and QFT-antigen (57.9% and 13.2% respectively) for active TB was lower than what was reported for the same assays using IFN-gamma-detection (78.9% and 68.4% respectively). On the other side, in vitro IL-2 and MCP-2 responses were not significantly associated with active TB. Conclusions: HIV infection does not impair RD1-specific response detected by IP-10, while it significantly decreases IFN-gamma-mediated responses. At the moment it is unclear whether higher detection is related to higher sensitivity or lower specificity of the assay. Further studies in high and low TB endemic countries are needed to elucidate this.	[Goletti, Delia; Carrara, Stefania] Lazzaro Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Raja, Alamelu; Kabeer, Basirudeen Syed Ahamed] TB Res Ctr ICMR, Dept Immunol, Madras, Tamil Nadu, India; [Rodrigues, Camilla; Sodha, Archana] PD Hinduja Natl Hosp & Res Ctr, Dept Microbiol, Bombay, Maharashtra, India; [Vernet, Guy; Longuet, Christophe] Fdn Merieux, Sci Direct, Lyon, France; [Ippolito, Giuseppe] INMI, Sci Direct, Rome, Italy; [Thangaraj, Satheesh; Leportier, Marc] BioMerieux, Res & Dev Immunoassays, Marcy Letoile, France; [Girardi, Enrico] INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Lagrange, Philippe Henri] St Louis Hosp, Microbiol Serv, Paris, France	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); IRCCS Lazzaro Spallanzani; bioMerieux; IRCCS Lazzaro Spallanzani; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Goletti, D (corresponding author), Lazzaro Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy.	delia.goletti@inmi.it	Ippolito, Giuseppe/J-7207-2017; Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020; goletti, delia/AAM-6577-2020	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636; Goletti, Delia/0000-0001-8360-4376; Girardi, Enrico/0000-0001-8182-5896; Ippolito, Giuseppe/0000-0002-1076-2979	Fondation Merieux; Italian Ministry of Health and Ricerca Finalizzata [06.76.1, 07.103]	Fondation Merieux; Italian Ministry of Health and Ricerca Finalizzata(Ministry of Health, Italy)	The study was supported by grants from Fondation Merieux and from the Italian Ministry of Health and Ricerca Finalizzata 06.76.1 and 07.103. ML and ST are employees of Biomerieux. Biomeriueux through their employees' involvement established the scientific, laboratory and medical network that allowed the accomplishment of a main project on "tool box for tuberculosis diagnosis'' and consequently of the satellite studies. The study described in this manuscript was a satellite study of the main project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Berktas M, 2004, J INT MED RES, V32, P324, DOI 10.1177/147323000403200313; BISELLI R, 2010, CLIN MICROB IN PRESS; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chadha VK, 2003, INT J TUBERC LUNG D, V7, P172; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Goletti D, 2005, CLIN DIAGN LAB IMMUN, V12, P1311, DOI 10.1128/CDLI.12.11.1311-1316.2005; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, CLIN INFECT DIS, V45, P1652, DOI 10.1086/523012; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kabeer BSA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005718; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-99; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Ministry of Health & Family Welfare, 2009, REV NAT TUB CONTR PR; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Vincenti D, 2003, MOL MED, V9, P105, DOI 10.1007/BF03402042; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901	38	74	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12577	10.1371/journal.pone.0012577	http://dx.doi.org/10.1371/journal.pone.0012577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830287	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000281631300010
J	Fischer, T; Langner, R; Diers, K; Brocke, B; Birbaumer, N				Fischer, Thomas; Langner, Robert; Diers, Kersten; Brocke, Burkhard; Birbaumer, Niels			Temporo-Spatial Dynamics of Event-Related EEG Beta Activity during the Initial Contingent Negative Variation	PLOS ONE			English	Article							ELECTROMAGNETIC TOMOGRAPHY; RESPONSE ANTICIPATION; MOTOR PREPARATION; BRAIN NETWORKS; CORTEX; SYNCHRONIZATION; HUMANS; TASK; POTENTIALS; ATTENTION	In the electroencephalogram (EEG), early anticipatory processes are accompanied by a slow negative potential, the initial contingent negative variation (iCNV), occurring between 500 and 1500 ms after cue onset over prefrontal cortical regions in tasks with cue-target intervals of about 3 s or longer. However, the temporal sequence of the distributed cortical activity contributing to iCNV generation remains unclear. During iCNV generation, selectively enhanced low-beta activity has been reported. Here we studied the temporal order of activation foci in cortical regions assumed to underlie iCNV generation using source reconstruction of low-beta (13-18 Hz) activity. During the iCNV, elicited by a cued simple reaction-time task, low-beta power peaked first (750 ms after cue onset) in anterior frontal and limbic regions and last (140 ms later) in posterior areas. This activity occurred 3300 ms before target onset and provides evidence for the temporally ordered involvement of both cognitive-control and motor-preparation processes already at early stages during the preparation for speeded action.	[Fischer, Thomas; Diers, Kersten; Brocke, Burkhard] Tech Univ Dresden, Dept Psychol, Chair Differential & Personal Psychol, Dresden, Germany; [Langner, Robert] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany; [Fischer, Thomas; Langner, Robert] Rhein Westfal TH Aachen, Dept Neurol, Neuropsychol Sect, Aachen, Germany; [Langner, Robert] Res Ctr Juelich, Inst Neurosci & Med INM 2, Julich, Germany; [Birbaumer, Niels] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy	Technische Universitat Dresden; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fischer, T (corresponding author), Tech Univ Dresden, Dept Psychol, Chair Differential & Personal Psychol, Dresden, Germany.	thomas.fischer@tu-dresden.de		Birbaumer, Niels/0000-0002-6786-5127; Langner, Robert/0000-0002-3237-001X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2006, CLIN NEUROPHYSIOL, V117, P16, DOI 10.1016/j.clinph.2005.08.030; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; BIRBAUMER N, 1981, BIOL PSYCHOL, V13, P251, DOI 10.1016/0301-0511(81)90040-5; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Flores AB, 2009, BRAIN COGNITION, V71, P129, DOI 10.1016/j.bandc.2009.04.011; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Hamano T, 1997, EVOKED POTENTIAL, V104, P257, DOI 10.1016/S0168-5597(97)96107-4; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; KAMP A, 1972, ELECTROEN CLIN NEURO, V33, P257, DOI 10.1016/0013-4694(72)90152-6; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; Lutcke H, 2009, J COGNITIVE NEUROSCI, V21, P2172, DOI 10.1162/jocn.2008.21165; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mantanus H, 1984, Rev Electroencephalogr Neurophysiol Clin, V14, P97, DOI 10.1016/S0370-4475(84)80013-1; Molnar M, 2008, PSYCHOPHYSIOLOGY, V45, P412, DOI 10.1111/j.1469-8986.2008.00648.x; MONTARON MF, 1988, EXP BRAIN RES, V69, P559; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui Roberto D., 2009, P121; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tang AC, 2005, NEUROIMAGE, V25, P539, DOI 10.1016/j.neuroimage.2004.11.027; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0	32	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12514	10.1371/journal.pone.0012514	http://dx.doi.org/10.1371/journal.pone.0012514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824080	Green Published, Green Submitted, gold			2022-12-25	WOS:000281480900007
J	Chen, MI; Barr, IG; Koh, GCH; Lee, VJ; Lee, CPS; Shaw, R; Lin, C; Yap, J; Cook, AR; Tan, BH; Loh, JP; Barkham, T; Chow, VTK; Lin, RTP; Leo, YS				Chen, Mark I.; Barr, Ian G.; Koh, Gerald C. H.; Lee, Vernon J.; Lee, Caroline P. S.; Shaw, Robert; Lin, Cui; Yap, Jonathan; Cook, Alex R.; Tan, Boon Huan; Loh, Jin Phang; Barkham, Timothy; Chow, Vincent T. K.; Lin, Raymond T. P.; Leo, Yee-Sin			Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study	PLOS ONE			English	Article							H1N1; INFECTION	Background: We describe the serological response following H1N1-2009 influenza A infections confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). Methodology and Principal Findings: The study included patients admitted to hospital, subjects of a seroepidemiologic cohort study, and participants identified from outbreak studies in Singapore. Baseline (first available blood sample) and follow-up blood samples were analyzed for antibody titers to H1N1-2009 and recently circulating seasonal influenza A virus strains by hemagglutination inhibition (HI) and virus micro-neutralization (VM) assays. 267 samples from 118 cases of H1N1-2009 were analyzed. Geometric mean titers by HI peaked at 123 (95% confidence interval, CI 43-356) between days 30 to 39. The chance of observing seroconversion (four-fold or greater increase of antibodies) was maximized when restricting analysis to 45 participants with baseline sera collected within 5 days of onset and follow-up sera collected 15 or more days after onset; for these participants, 82% and 89% seroconverted to A/California/7/2009 H1N1 by HI and VM respectively. A four-fold or greater increase in cross-reactive antibody titers to seasonal A/Brisbane/59/2007 H1N1, A/Brisbane/10/2007 H3N2 and A/Wisconsin/15/2009 H3N2 occurred in 20%, 18% and 16% of participants respectively. Conclusions and Significance: Appropriately timed paired serology detects 80-90% RT-PCR confirmed H1N1-2009; Antibodies from infection with H1N1-2009 cross-reacted with seasonal influenza viruses.	[Chen, Mark I.; Lee, Caroline P. S.; Leo, Yee-Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Koh, Gerald C. H.; Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Chen, Mark I.] Duke NUS Grad Med Sch, Singapore, Singapore; [Barr, Ian G.; Shaw, Robert] World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Lee, Vernon J.; Yap, Jonathan] Minist Def, Biodefence Ctr, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lin, Cui; Lin, Raymond T. P.] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tan, Boon Huan; Loh, Jin Phang] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Barkham, Timothy] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore; [Chow, Vincent T. K.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; World Health Organization; Australian National University; Ministry of Health-Singapore; National University of Singapore; Tan Tock Seng Hospital; National University of Singapore	Chen, MI (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	Mark_IC_Chen@ttsh.com.sg	Yap, Jonathan/AAJ-7266-2020; Chen, Mark/AGC-5338-2022; Cook, Alex/S-3576-2019; Cook, Alex/B-5941-2011; Chen, Mark/CAG-2949-2022; Tan, Boon Huan/ABB-8381-2021	Yap, Jonathan/0000-0002-5227-8536; Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830; Tan, Boon Huan/0000-0002-4976-7988; Barr, Ian/0000-0002-7351-418X; Chow, Vincent/0000-0003-2634-6213; Koh, Choon Huat Gerald/0000-0002-6453-6897	National Medical Research Council of Singapore [NMRC/H1N1O/002/2009]; Australian Government Department of Health and Ageing	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The project was funded as part of the grant NMRC/H1N1O/002/2009 awarded by the National Medical Research Council of Singapore (www.nmrc.gov.sg/corp/index.aspx). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P81; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; CHEN MI, 2009, EMERG INFEC IN PRESS; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FLAHAULT A, 2009, PLOS CURR INFLUENZA, DOI DOI 10.1371/CURRENTS.RRN1140; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; LEE VJ, J INFECT DI IN PRESS; LEO YS, 2009, EMERG INFECT DIS; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; ROSS T, 2010, PLOS CURR INFLUENZA; Tay J, 2010, ANN ACAD MED SINGAP, V39, P313; WHO, 2009, WHO PAND H1N1 2009 U, P112; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; *WHO, 1982, CONC PROC LAB BAS IN; World Health Organization, 2009, WHO CDC PROT REALT R; Yin-Murphy M, 1970, Singapore Med J, V11, P33; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	24	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12474	10.1371/journal.pone.0012474	http://dx.doi.org/10.1371/journal.pone.0012474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814575	gold, Green Published			2022-12-25	WOS:000281375500008
J	Kaplan, FM; Shao, Y; Mayberry, MM; Aplin, AE				Kaplan, F. M.; Shao, Y.; Mayberry, M. M.; Aplin, A. E.			Hyperactivation of MEK-ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells	ONCOGENE			English	Article						apoptosis; B-RAF; N-RAS; PLX4720	KINASE INHIBITOR; BRAF; MUTATIONS; ACTIVATION; PATHWAY; PHOSPHORYLATION; PROGRESSION	Activating mutations in B-RAF and N-RAS occur in similar to 60 and similar to 15% of melanomas, respectively. The most common mutation in B-RAF is V600E, which activates B-RAF and the downstream MEK-ERK1/2 pathway. Thus, B-RAF(V600E) is a viable therapeutic target. PLX4720 is a selective inhibitor of mutant B-RAF and its analog, PLX4032, is currently undergoing clinical trials in melanoma. However, the effects of PLX4720 across the genotypic spectrum in melanoma remain unclear. Here, we describe that PLX4720 treatment rapidly induces hyperactivation of the MEK-ERK1/2 pathway in mutant N-RAS melanoma cells. Furthermore, we demonstrate that C-RAF is the major RAF isoform involved in this process. Importantly, PLX4720-induced hyperactivation of the MEK-ERK1/2 pathway promotes resistance to apoptosis in both non-invasive and invasive mutant N-RAS melanoma cells but does not enhance cell cycle properties. These findings underscore the need to genotypically stratify melanoma patients before enrollment on a mutant B-RAF inhibitor trial. Oncogene (2011) 30, 366-371; doi:10.1038/onc.2010.408; published online 6 September 2010	[Aplin, A. E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	Aplin, AE (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	Andrew.Aplin@KimmelCancerCenter.Org	Shao, Yongping/D-9966-2011		National Institutes of Health [R01-GM067893, R01-CA125103]; Pennsylvania Department of Health [AF0301]; NATIONAL CANCER INSTITUTE [R01CA125103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Gideon Bollag (Plexxikon) for providing PLX4720, Dr Meenhard Herlyn (Wistar Institute) for cell lines and Dr Michele Weiss for comments on the manuscript. This work was supported by National Institutes of Health Grants (R01-GM067893 and R01-CA125103), and Pennsylvania Department of Health (AF0301) to AE Aplin.	ALBINO AP, 1989, ONCOGENE, V4, P1363; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Conner SR, 2003, J BIOL CHEM, V278, P34548, DOI 10.1074/jbc.M305797200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Salerno P, 2010, J CLIN ENDOCR METAB, V95, P450, DOI 10.1210/jc.2009-0373; Satyamoorthy K, 2003, CANCER RES, V63, P756; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sondak Vernon K, 2009, Pigment Cell Melanoma Res, V22, P386, DOI 10.1111/j.1755-148X.2009.00593.x; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6	26	92	94	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					366	371		10.1038/onc.2010.408	http://dx.doi.org/10.1038/onc.2010.408			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20818433	Green Accepted			2022-12-25	WOS:000286418800011
J	Mayeenuddin, LH; Yu, Y; Kang, Z; Helman, LJ; Cao, L				Mayeenuddin, L. H.; Yu, Y.; Kang, Z.; Helman, L. J.; Cao, L.			Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L)	ONCOGENE			English	Article						IGF1R therapeutic antibody; apoptosis; tumor regression; predictive biomarker; Bcl-x(L); Bcl-2	FACTOR-I RECEPTOR; MONOCLONAL-ANTIBODY; CYTOCHROME-C; TUMOR-GROWTH; IGF-I; APOPTOSIS; SURVIVAL; BCL-2; INHIBITION; THERAPY	Insulin-like growth factors (IGFs) and their receptor, IGF-1 receptor (IGF1R), have important roles in growth, development, stress response, aging and cancer. There are many agents that inhibit IGF1R in oncology clinical development, and in some cases, they have been associated with rapid tumor regression. However, it is not clear by which process these targeted agents induce cancer cell death and how to predict such tumor responses. Here, we showed that IGF1R antibody led to rapid cell death and tumor regression in some rhabdomyosarcoma (RMS) cells. Mechanistic analysis revealed a rapid onset of mitochondrial-dependent apoptosis, including mitochondrial depolarization, cytochrome C release and the activation of specific caspases. The antibody sensitive cells had greater dependence on AKT for maintaining downstream signaling and the expression of a constitutively active AKT, which restored AKT-signaling in these cells, inhibited anti-IGF1R induced cell death. Further analysis showed IGF1R antibody-induced hypophosphorylation of BAD and activation of downstream BAX. Interestingly, the examination of RMS cell lines and tumors revealed an inverse correlation between elevated IGF1R and Bcl-2 level (P = 0.033), with the sensitive cells lacking Bcl-2 expression. The overexpression of BAD specific target, Bcl-x(L), conferred resistance, whereas Bcl-x(L) knockdown sensitized cells lacking Bcl-2 to anti-IGF1R-induced cell death. We propose that RMS pathogenesis involves increased IGF1R expression that enhances AKT and Bcl-x(L)-mediated cell survival, and the blockage of IGF1R results in inhibition of survival signal from Bcl-x(L) and cell death in the sensitive Bcl-2 negative cells. Oncogene (2010) 29, 6367-6377; doi:10.1038/onc.2010.364; published online 6 September 2010	[Mayeenuddin, L. H.; Yu, Y.; Kang, Z.; Cao, L.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Mayeenuddin, L. H.; Yu, Y.; Kang, Z.] NCI Frederick, Lab Prote & Analyt Technol, SAIC Frederick Inc, Frederick, MD USA; [Helman, L. J.] NCI, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cao, L (corresponding author), NCI, Genet Branch, Ctr Canc Res, 37 Convent Dr,MSC 4265,Bldg 37,Room 6134, Bethesda, MD 20892 USA.	caoli@mail.nih.gov	Cao, Liang/K-7806-2017	Cao, Liang/0000-0001-7293-8338; Kang, zhigang/0000-0003-3444-4315	US National Cancer Institute (NCI); NCI, NIH [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIASC006892, ZICBC011048] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Andrius Kazlauskas for providing the lentivirus expressing Bcl-x<INF>L</INF>, and Arnulfo Mendoza, Vanessa Moore, Susan Garfield and Barbara Taylor for excellent technical assistance. This research was supported by the Intramural Research Program of the US National Cancer Institute (NCI). This project was also funded in part with federal funds from the NCI, NIH, under contract N01-CO-12400.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Barcia RN, 2007, AM J TRANSPLANT, V7, P2082, DOI 10.1111/j.1600-6143.2007.01897.x; Burtrum D, 2003, CANCER RES, V63, P8912; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Haluska P, 2007, CLIN CANCER RES, V13, P5834, DOI 10.1158/1078-0432.CCR-07-1118; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Minshall C, 1997, J IMMUNOL, V159, P1225; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1355, DOI 10.1210/en.138.3.1355; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Phillips DC, 2007, CANCER RES, V67, P756, DOI 10.1158/0008-5472.CAN-06-2374; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; Sachdev D, 2003, CANCER RES, V63, P627; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang JH, 2004, DEV BRAIN RES, V152, P255, DOI 10.1016/j.devbrainres.2004.07.008	33	22	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6367	6377		10.1038/onc.2010.364	http://dx.doi.org/10.1038/onc.2010.364			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20818434	Green Accepted			2022-12-25	WOS:000284874700007
J	Lai, AL; Tamm, LK				Lai, Alex L.; Tamm, Lukas K.			Shallow Boomerang-shaped Influenza Hemagglutinin G13A Mutant Structure Promotes Leaky Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYERS; CONFORMATIONAL CHANGE; SECONDARY STRUCTURE; PEPTIDE; DOMAIN; HEMIFUSION; MECHANISM; PROTEIN; NMR; SPECTROSCOPY	Our previous studies showed that an angled boomerang-shaped structure of the influenza hemagglutinin (HA) fusion domain is critical for virus entry into host cells by membrane fusion. Because the acute angle of similar to 105 degrees of the wild-type fusion domain promotes efficient non-leaky membrane fusion, we asked whether different angles would still support fusion and thus facilitate virus entry. Here, we show that the G13A fusion domain mutant produces a new leaky fusion phenotype. The mutant fusion domain structure was solved by NMR spectroscopy in a lipid environment at fusion pH. The mutant adopted a boomerang structure similar to that of wild type but with a shallower kink angle of similar to 150 degrees. G13A perturbed the structure of model membranes to a lesser degree than wild type but to a greater degree than non-fusogenic fusion domain mutants. The strength of G13A binding to lipid bilayers was also intermediate between that of wild type and non-fusogenic mutants. Thesemembrane interactions provide a clear link between structure and function of influenza fusion domains: an acute angle is required to promote clean non-leaky fusion suitable for virus entry presumably by interaction of the fusion domain with the transmembrane domain deep in the lipid bilayer. A shallower angle perturbs the bilayer of the target membrane so that it becomes leaky and unable to form a clean fusion pore. Mutants with no fixed boomerang angle interacted with bilayers weakly and did not promote any fusion or membrane perturbation.	[Lai, Alex L.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA	University of Virginia	Tamm, LK (corresponding author), Univ Virginia, Ctr Membrane Biol, Dept Mol Physiol & Biol Phys, 480 Ray C Hunt Dr,POB 800886,Snyder Bldg,Rm 350, Charlottesville, VA 22908 USA.	Lkt2e@virginia.edu	Lai, Alex/G-8668-2014		National Institutes of Health [R37 AI030557]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AI030557.	Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bonnafous P, 2000, J BIOL CHEM, V275, P6160, DOI 10.1074/jbc.275.9.6160; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Goddard T. D., 2008, SPARKY 3; Gray C, 1996, BIOPHYS J, V70, pWP269; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Han X, 2000, J MOL BIOL, V304, P953, DOI 10.1006/jmbi.2000.4251; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jiricek R, 1997, BBA-BIOMEMBRANES, V1330, P17, DOI 10.1016/S0005-2736(97)00134-X; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Lai AL, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P279; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Li YL, 2003, BIOCHEMISTRY-US, V42, P7245, DOI 10.1021/bi0341760; Luginbuhl P, 1996, J BIOMOL NMR, V8, P136; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Tamm LK, 2003, BBA-BIOMEMBRANES, V1614, P14, DOI 10.1016/S0005-2736(03)00159-7; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Tamm LK, 2007, BBA-BIOMEMBRANES, V1768, P3052, DOI 10.1016/j.bbamem.2007.09.010; Tong SG, 1996, BIOCHEMISTRY-US, V35, P4956, DOI 10.1021/bi9526903; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]	30	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37467	37475		10.1074/jbc.M110.153700	http://dx.doi.org/10.1074/jbc.M110.153700			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20826788	Green Published, hybrid			2022-12-25	WOS:000284424000039
J	Adapala, NS; Barbe, MF; Langdon, WY; Nakamura, MC; Tsygankov, AY; Sanjay, A				Adapala, Naga Suresh; Barbe, Mary F.; Langdon, Wallace Y.; Nakamura, Mary C.; Tsygankov, Alexander Y.; Sanjay, Archana			The Loss of Cbl-Phosphatidylinositol 3-Kinase Interaction Perturbs RANKL-mediated Signaling, Inhibiting Bone Resorption and Promoting Osteoclast Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC KINASE-ACTIVITY; NF-KAPPA-B; C-CBL; TYROSINE PHOSPHORYLATION; ENERGY-EXPENDITURE; RESORBING ACTIVITY; FAMILY PROTEINS; BINDING-SITE; DC-STAMP; RECEPTOR	Cbl is an adaptor protein and an E3 ligase that plays both positive and negative roles in several signaling pathways that affect various cellular functions. Tyrosine 737 is unique to Cbl and is phosphorylated by Syk and Src family kinases. Phosphorylated Cbl Tyr(737) creates a binding site for the p85 regulatory subunit of PI3K, which also plays an important role in the regulation of bone resorption by osteoclasts. To investigate the role of Cbl-PI3K interaction in bone homeostasis, we examined the knock-in mice (Cbl(YF/YF)) in which the PI3K binding site in Cbl is ablated due to the mutation in the regulatory tyrosine. We report that in CblYF/YF mice, despite increased numbers of osteoclasts, bone volume is increased due to defective osteoclast function. Additionally, in ex vivo cultures, mature CblYF/YF osteoclasts showed an increased ability to survive in the presence of RANKL due to delayed onset of apoptosis. RANKL-mediated signaling is perturbed in CblYF/YF osteoclasts, and most interestingly, AKT phosphorylation is up-regulated, suggesting that the lack of PI3K sequestration by Cbl results in increased survival and decreased bone resorption. Cumulatively, these in vivo and in vitro results show that, on one hand, binding of Cbl to PI3K negatively regulates osteoclast differentiation, survival, and signaling events (e.g. AKT phosphorylation), whereas on the other hand it positively influences osteoclast function.	[Adapala, Naga Suresh; Barbe, Mary F.; Sanjay, Archana] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Barbe, Mary F.] Temple Univ, Sch Med, Dept Phys Therapy, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.; Sanjay, Archana] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia; [Nakamura, Mary C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Nakamura, Mary C.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Western Australia; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sanjay, A (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA.	asanjay@temple.edu	Nakamura, Mary/ABI-2887-2020; Tsygankov, Alexander Y/K-6205-2017	Nakamura, Mary/0000-0001-8127-9426; 	National Institutes of Health [AR055601]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR055601 (to A.S.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Andoniou CE, 1996, ONCOGENE, V12, P1981; Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baron R.A., 1983, BONE HISTOMORPHOMETR, P13; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chiusaroli R, 2003, DEV BIOL, V261, P537, DOI 10.1016/S0012-1606(03)00299-9; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Feshchenko EA, 1999, ONCOGENE, V18, P3703, DOI 10.1038/sj.onc.1202672; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lakkakorpi PT, 1997, EXP CELL RES, V237, P296, DOI 10.1006/excr.1997.3797; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; Marengere LEM, 1997, J IMMUNOL, V159, P70; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; Nakajima A, 2009, J BONE MINER RES, V24, P1162, DOI [10.1359/JBMR.090205, 10.1359/jbmr.090205]; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patra AK, 2004, J IMMUNOL, V172, P4812, DOI 10.4049/jimmunol.172.8.4812; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sanjay A., 2001, SCI STKE; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Thien CBF, 2010, J BIOL CHEM, V285, P10969, DOI 10.1074/jbc.M109.094920; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Ueno H, 1998, BLOOD, V91, P46, DOI 10.1182/blood.V91.1.46.46_46_53; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xue LZ, 2007, BIOCHEM PHARMACOL, V73, P843, DOI 10.1016/j.bcp.2006.11.021; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8	64	31	31	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36745	36758		10.1074/jbc.M110.124628	http://dx.doi.org/10.1074/jbc.M110.124628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851882	Green Published, hybrid			2022-12-25	WOS:000284146100086
J	Uejima, T; Ihara, K; Goh, T; Ito, E; Sunada, M; Ueda, T; Nakano, A; Wakatsuki, S				Uejima, Tamami; Ihara, Kentaro; Goh, Tatsuaki; Ito, Emi; Sunada, Mariko; Ueda, Takashi; Nakano, Akihiko; Wakatsuki, Soichi			GDP-bound and Nucleotide-free Intermediates of the Guanine Nucleotide Exchange in the Rab5.Vps9 System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RAB GTPASE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; ACTIVATION; PROGRAM; COMPLEX; SNAPSHOTS; MECHANISM; PHOSPHATE	Many GTPases regulate intracellular transport and signaling in eukaryotes. Guanine nucleotide exchange factors (GEFs) activate GTPases by catalyzing the exchange of their GDP for GTP. Here we present crystallographic and biochemical studies of a GEF reaction with four crystal structures of Arabidopsis thaliana ARA7, a plant homolog of Rab5 GTPase, in complex with its GEF, VPS9a, in the nucleotide-free and GDP-bound forms, as well as a complex with aminophosphonic acid-guanylate ester and ARA7.VPS9a(D185N) with GDP. Upon complex formation with ARA7, VPS9 wedges into the interswitch region of ARA7, inhibiting the coordination of Mg2+ and decreasing the stability of GDP binding. The aspartate finger of VPS9a recognizes GDP beta-phosphate directly and pulls the P-loop lysine of ARA7 away from GDP beta-phosphate toward switch II to further destabilize GDP for its release during the transition from the GDP-bound to nucleotide-free intermediates in the nucleotide exchange reaction.	[Wakatsuki, Soichi] High Energy Accelerator Res Org, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; [Goh, Tatsuaki; Ito, Emi; Sunada, Mariko; Ueda, Takashi; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Lab Dev Cell Biol, Tokyo 1130033, Japan; [Nakano, Akihiko] RIKEN Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	High Energy Accelerator Research Organization (KEK); University of Tokyo; RIKEN		tamami.uejima@kek.jp; kentaro.ihara@kek.jp; soichi.wakatsuki@kek.jp	UEDA, TAKASHI/G-4939-2014; Ueda, Takashi/G-6984-2011; Nakano, Akihiko/G-4942-2014; Goh, Tatsuaki/H-4538-2011; Uejima, Tamami/C-4128-2017; Nakano, Akihiko/A-6420-2016	Ueda, Takashi/0000-0002-5190-892X; Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Wakatsuki, Soichi/0000-0001-5896-7968	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Protein 3000 Project grant and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Goh T, 2007, PLANT CELL, V19, P3504, DOI 10.1105/tpc.107.053876; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Resat H, 2001, P NATL ACAD SCI USA, V98, P6033, DOI 10.1073/pnas.091506998; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Thomas C, 2009, BIOL CHEM, V390, P427, DOI 10.1515/BC.2009.049; Ueda T, 2002, CURR OPIN PLANT BIOL, V5, P513, DOI 10.1016/S1369-5266(02)00299-6; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200	43	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36689	36697		10.1074/jbc.M110.152132	http://dx.doi.org/10.1074/jbc.M110.152132			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833725	Green Published, hybrid			2022-12-25	WOS:000284146100070
J	Hou, YZ; Mortimer, L; Chadee, K				Hou, Yongzhong; Mortimer, Leanne; Chadee, Kris			Entamoeba histolytica Cysteine Proteinase 5 Binds Integrin on Colonic Cells and Stimulates NF kappa B-mediated Pro-inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED KINASE; ANTISENSE INHIBITION; IN-VITRO; EXPRESSION; BETA; COMPLEX; ALPHA; AKT; PHOSPHORYLATION; INTERNALIZATION	Integrins are important mammalian receptors involved in normal cellular functions and the pathogenesis of inflammation and disease. Entamoeba histolytica is a protozoan parasite that colonizes the gut, and in 10% of infected individuals, causes amebic colitis and liver abscess resulting in 10(5) deaths/year. E. histolytica-induced host inflammatory responses are critical in the pathogenesis of the disease, yet the host and parasite factors involved in disease are poorly defined. Here we show that pro-mature cysteine proteinase 5 (PCP5), a major virulent factor that is abundantly secreted and/or present on the surface of ameba, binds via its RGD motif to alpha(V)beta(3) integrin on Caco-2 colonic cells and stimulates NF kappa B-mediated pro-inflammatory responses. PCP5 RGD binding to alpha(V)beta(3) integrin triggered integrin-linked kinase(ILK)-mediated phosphorylation of Akt473 that bound and induced the ubiquitination of NF-kappa B essential modulator (NEMO). As NEMO is required for activation of the IKK alpha-IKK beta complex and NF kappa B signaling, these events markedly up-regulated pro-inflammatory mediator expressions in vitro in Caco-2 cells and in vivo in colonic loop studies in wild-type and Muc2(-/-) mice lacking an intact protective mucus barrier. These results have revealed that EhPCP5 RGD motif is a ligand for alpha(V)beta(3) integrin-mediated adhesion on colonic cells and represents a novel mechanism that E. histolytica trophozoites use to trigger an inflammatory response in the pathogenesis of intestinal amebiasis.	[Chadee, Kris] Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chadee, K (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	kchadee@ucalgary.ca	hou, YONGZHONG/K-7771-2013; hou, yongzhong/E-4658-2011	Hou, Yongzhong/0000-0003-2019-8686	Canadian Institute of Health Research (CIHR); Canadian Association of Gastroenterology-Astra Zeneca-CIHR	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology-Astra Zeneca-CIHR(Canadian Institutes of Health Research (CIHR)AstraZeneca)	This work was supported by a grant from the Canadian Institute of Health Research (CIHR) (to K. C.) and a Canadian Association of Gastroenterology-Astra Zeneca-CIHR Research and Fellowship Award (to Y. H.).	Ankri S, 1998, MOL MICROBIOL, V28, P777, DOI 10.1046/j.1365-2958.1998.00837.x; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Ben-Neriah Y, 2007, NAT IMMUNOL, V8, P479, DOI 10.1038/ni0507-479; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Croyle MA, 1998, HUM GENE THER, V9, P561, DOI 10.1089/hum.1998.9.4-561; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hellberg A, 2001, CELL MICROBIOL, V3, P13, DOI 10.1046/j.1462-5822.2001.00086.x; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; Kammanadiminti SJ, 2007, INFECT IMMUN, V75, P1765, DOI 10.1128/IAI.01442-06; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Lejeune M, 2009, FUTURE MICROBIOL, V4, P105, DOI 10.2217/17460913.4.1.105; Li QT, 2000, GENE DEV, V14, P1729; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Moncada DM, 2006, GASTROENTEROLOGY, V130, P721, DOI 10.1053/j.gastro.2005.11.012; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nowak N, 2004, J BIOL CHEM, V279, P38260, DOI 10.1074/jbc.M405308200; Papaconstantinou ME, 2005, J BIOL CHEM, V280, P29393, DOI 10.1074/jbc.C500248200; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; REED SL, 1995, J IMMUNOL, V155, P266; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Scatena MT, 2002, TRENDS CARDIOVAS MED, V12, P83, DOI 10.1016/S1050-1738(01)00151-7; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tran VQ, 1998, J INFECT DIS, V177, P508, DOI 10.1086/517388; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Verreault M, 2009, OLIGONUCLEOTIDES, V19, P129, DOI 10.1089/oli.2008.0157; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; World Health Organization W, 1998, QUAL CONTR METH MED; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	43	66	66	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35497	35504		10.1074/jbc.M109.066035	http://dx.doi.org/10.1074/jbc.M109.066035			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837477	Green Published, hybrid			2022-12-25	WOS:000283845300028
J	Fischer, MJM; Leffler, A; Niedermirtl, F; Kistner, K; Eberhardt, M; Reeh, PW; Nau, C				Fischer, Michael J. M.; Leffler, Andreas; Niedermirtl, Florian; Kistner, Katrin; Eberhardt, Mirjam; Reeh, Peter W.; Nau, Carla			The General Anesthetic Propofol Excites Nociceptors by Activating TRPV1 and TRPA1 Rather than GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-ROOT-GANGLIA; PRIMARY AFFERENT NEURONS; SUBUNIT MESSENGER-RNAS; ION-CHANNEL TRPA1; SPINAL-CORD; CAPSAICIN RECEPTOR; SENSORY NEURONS; SUBSTANCE-P; IN-VITRO; MOLECULAR DETERMINANT	Anesthetic agents can induce a paradox activation and sensitization of nociceptive sensory neurons and, thus, potentially facilitate pain processing. Here we identify distinct molecular mechanisms that mediate an activation of sensory neurons by 2,6-diisopropylphenol (propofol), a commonly used intravenous anesthetic known to elicit intense pain upon injection. Clinically relevant concentrations of propofol activated the recombinant transient receptor potential (TRP) receptors TRPA1 and TRPV1 heterologously expressed in HEK293t cells. In dorsal root ganglion (DRG) neurons, propofol-induced activation correlated better to expression of TRPA1 than of TRPV1. However, pretreatment with the protein kinase C activator 4 beta-phorbol 12-myristate 13-acetate (PMA) resulted in a significantly sensitized propofol-induced activation of TRPV1 in DRG neurons as well as in HEK293t cells. Pharmacological and genetic silencing of both TRPA1 and TRPV1 only partially abrogated propofol-induced responses in DRG neurons. The remaining propofol-induced activation was abolished by the selective gamma-aminobutyric acid, type A (GABA(A)) receptor antagonist picrotoxin. Propofol but not GABA evokes a release of calcitonin gene-related peptide, a key component of neurogenic inflammation, from isolated peripheral nerves of wild-type but not TRPV1 and TRPA1-deficient mice. Moreover, propofol but not GABA induced an intense pain upon intracutaneous injection. As both the release of calcitonin gene-related peptide and injection pain by propofol seem to be independent of GABA(A) receptors, our data identify TRPV1 and TRPA1 as key molecules for propofol-induced excitation of sensory neurons. This study warrants further investigations into the role of anesthetics to induce nociceptor sensitization and to foster postoperative pain.	[Leffler, Andreas; Niedermirtl, Florian; Nau, Carla] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Fischer, Michael J. M.; Kistner, Katrin; Eberhardt, Mirjam; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Fischer, Michael J. M.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Cambridge	Leffler, A (corresponding author), Univ Erlangen Nurnberg, Dept Anesthesiol, Krankenhausstr 12, D-91054 Erlangen, Germany.	andreas.leffler@kfa.imed.uni-erlangen.de	Leffler, Andreas/K-1191-2012; Reeh, Peter W./J-8981-2012; Fischer, Michael J.M./P-8715-2014	Leffler, Andreas/0000-0003-1121-6387; Reeh, Peter W./0000-0002-4367-094X; Fischer, Michael J.M./0000-0002-3811-7066	Deutsche Forschungsgemeinschaft [NA-350/3-3, LU 728/3-1, KFO 130]; Dr. Robert Pfleger-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Robert Pfleger-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grants NA-350/3-3 and LU 728/3-1, KFO 130 (to A. L., C. N., and P. W. R.) and by the Dr. Robert Pfleger-Stiftung (to K. K.).	Aptel H, 2007, MOL CELL NEUROSCI, V36, P293, DOI 10.1016/j.mcn.2007.07.009; AULT B, 1994, NEUROPHARMACOLOGY, V33, P109, DOI 10.1016/0028-3908(94)90104-X; Averbeck B, 2001, NEUROPHARMACOLOGY, V40, P416, DOI 10.1016/S0028-3908(00)00171-4; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BARKER JL, 1975, J PHYSIOL-LONDON, V245, P521, DOI 10.1113/jphysiol.1975.sp010859; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Carlton SM, 1999, NEUROSCIENCE, V93, P713, DOI 10.1016/S0306-4522(99)00101-3; Carr RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008780; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; COLLINS GGS, 1988, BRIT J PHARMACOL, V95, P939, DOI 10.1111/j.1476-5381.1988.tb11724.x; CONCAS A, 1991, BRAIN RES, V542, P225, DOI 10.1016/0006-8993(91)91571-H; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DESARMENIEN M, 1984, EXP BRAIN RES, V54, P521; DESCHENES M, 1976, BRAIN RES, V118, P486, DOI 10.1016/0006-8993(76)90318-8; Dittert I, 1998, J NEUROSCI METH, V82, P195, DOI 10.1016/S0165-0270(98)00051-X; Doenicke AW, 1996, ANESTH ANALG, V82, P472, DOI 10.1097/00000539-199603000-00007; Fischer MJM, 2007, EUR J NEUROSCI, V25, P3570, DOI 10.1111/j.1460-9568.2007.05582.x; FURUYAMA T, 1992, MOL BRAIN RES, V12, P335, DOI 10.1016/0169-328X(92)90136-Y; GALLAGHER JP, 1978, J PHYSIOL-LONDON, V275, P263, DOI 10.1113/jphysiol.1978.sp012189; GO VLW, 1987, J PHYSIOL-LONDON, V391, P141, DOI 10.1113/jphysiol.1987.sp016731; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KLEMENT W, 1991, BRIT J ANAESTH, V67, P281, DOI 10.1093/bja/67.3.281; Koplas PA, 1997, J NEUROSCI, V17, P3525; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lao L, 2005, NEUROSCIENCE, V130, P1013, DOI 10.1016/j.neuroscience.2004.10.019; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MALCANGIO M, 1993, J PHARMACOL EXP THER, V266, P1490; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; PERSOHN E, 1991, NEUROSCIENCE, V42, P497, DOI 10.1016/0306-4522(91)90392-2; Picard P, 2000, ANESTH ANALG, V90, P963; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Poenie M, 1986, Prog Clin Biol Res, V210, P53; Riley RC, 2001, NEUROSCIENCE, V103, P725, DOI 10.1016/S0306-4522(00)00571-6; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; SANTICIOLI P, 1991, LIFE SCI, V48, pPL69, DOI 10.1016/0024-3205(91)90188-H; Sauer SK, 2001, EUR J NEUROSCI, V14, P1203, DOI 10.1046/j.0953-816x.2001.01741.x; STOKES DN, 1989, BRIT J ANAESTH, V62, P202, DOI 10.1093/bja/62.2.202; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sung KW, 2000, J NEUROSCI, V20, P7531; Tsutsumi S, 2001, NEUROSCI LETT, V312, P45, DOI 10.1016/S0304-3940(01)02185-1; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Watt EE, 2008, EUR J PHARMACOL, V590, P120, DOI 10.1016/j.ejphar.2008.06.003; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Yamakage M, 2005, ANESTH ANALG, V101, P385, DOI 10.1213/01.ANE.0000154191.86608.AC; Zhang XB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003386; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	62	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34781	34792		10.1074/jbc.M110.143958	http://dx.doi.org/10.1074/jbc.M110.143958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826794	Green Published, hybrid			2022-12-25	WOS:000283659100054
J	Kasahara, M; Torii, M; Fujita, A; Tainaka, K				Kasahara, Masahiro; Torii, Mayumi; Fujita, Akimitsu; Tainaka, Kengo			FMN Binding and Photochemical Properties of Plant Putative Photoreceptors Containing Two LOV Domains, LOV/LOV Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT RECEPTORS; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; ARABIDOPSIS; PHOTOTROPIN; OXYGEN; CLOCK; MECHANISM; KINASE; SWITCH	LOV domains function as blue light-sensing modules in various photoreceptors in plants, fungi, algae, and bacteria. A LOV/LOV protein (LLP) has been found from Arabidopsis thaliana (AtLLP) as a two LOV domain-containing protein. However, its function remains unknown. We isolated cDNA clones coding for an LLP homolog from tomato (Solanum lycopersicum) and two homologs from the moss Physcomitrella patens. The tomato LLP (SlLLP) contains two LOV domains (LOV1 and LOV2 domains), as in AtLLP. Most of the amino acids required for association with chromophore are conserved in both LOV domains, except that the amino acid at the position equivalent to the cysteine essential for cysteinyl adduct formation is glycine in the LOV1 domain as in AtLLP. When expressed in Escherichia coli, SlLLP binds FMN and undergoes a self-contained photocycle upon irradiation of blue light. Analyses using mutant SlLLPs revealed that SlLLP binds FMN in both LOV domains, although the LOV1 domain does not show spectral changes on irradiation. However, when Gly(66) in the LOV1 domain, which is located at the position equivalent to the essential cysteine of LOV domains, is replaced by cysteine, the mutated LOV1 domain shows light-induced spectral changes. In addition, all four LOV domains of P. patens LLPs (PpLLP1 and PpLLP2) show the typical features of LOV domains, including the reactive cysteine in each. This study shows that plants have a new LOV domain-containing protein family with the typical biochemical and photochemical properties of other LOV domain-containing proteins such as the phototropins.	[Kasahara, Masahiro; Torii, Mayumi; Fujita, Akimitsu; Tainaka, Kengo] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Shiga 5258577, Japan	Ritsumeikan University	Kasahara, M (corresponding author), 1-1-1 Nojihigashi, Shiga 5258577, Japan.	kasa@sk.ritsumei.ac.jp			Ministry of Education, Sciences and Culture	Ministry of Education, Sciences and Culture	This work was supported in part by the Ministry of Education, Sciences and Culture with a Grant-in-Aid for Young Scientists (B) (to M. K.).	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Briggs WR, 2007, J BIOMED SCI, V14, P499, DOI 10.1007/s11373-007-9162-6; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kottke T, 2006, BIOPOLYMERS, V82, P373, DOI 10.1002/bip.20510; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Narikawa R, 2006, PHOTOCHEM PHOTOBIOL, V82, P1627, DOI 10.1562/2006-05-02-RA-888; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Ogura Y, 2008, J PLANT RES, V121, P97, DOI 10.1007/s10265-007-0118-8; Ogura Y, 2008, PLANT SIGNAL BEHAV, V3, P966, DOI 10.4161/psb.6150; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tokutomi S, 2008, BBA-PROTEINS PROTEOM, V1784, P133, DOI 10.1016/j.bbapap.2007.09.010	28	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34765	34772		10.1074/jbc.M110.145367	http://dx.doi.org/10.1074/jbc.M110.145367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826774	hybrid, Green Published			2022-12-25	WOS:000283659100052
J	Zannetti, C; Bonnay, F; Takeshita, F; Parroche, P; Menetrier-Caux, C; Tommasino, M; Hasan, UA				Zannetti, Claudia; Bonnay, Francois; Takeshita, Fumihiko; Parroche, Peggy; Menetrier-Caux, Christine; Tommasino, Massimo; Hasan, Uzma A.			C/EBP delta and STAT-1 Are Required for TLR8 Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; DENDRITIC CELLS; BINDING PROTEIN; EXPRESSION; GENE; ACTIVATION; RNA; RECOGNITION; MONOCYTES	Toll-like receptor 8 (TLR8), which is expressed primarily in myeloid cells, plays a central role in initiating immune responses to viral single-stranded RNA. Despite the great interest in the field of TLR8 research, very little is known in terms of TLR8 biology and its transcriptional regulation. Here, we describe the isolation of the hTLR8 promoter and the characterization of the molecular mechanisms involved in its regulation. Reporter gene analysis and ChIP assays demonstrated that the hTLR8 regulation of the basal transcription is regulated via three C/EBP cis-acting elements that required C/EBP delta and C/EBP beta activity. In addition, we observed that R848 stimulation increases TLR8 transcriptional activity via an enhanced binding of C/EBP delta, and not C/EBP beta, to its responsive sites within the TLR8 promoter. Moreover, we showed that IFN-gamma also increased TLR8 transcription activity via the binding of STAT1 transcription factor to IFN-gamma activated sequence elements on the TLR8 promoter and enhanced TLR8 functionality. These results shed new light on the mechanisms involved during TLR8-mediated innate immune response.	[Zannetti, Claudia; Parroche, Peggy; Tommasino, Massimo; Hasan, Uzma A.] Int Agcy Res Canc, Infect & Canc Biol Grp, F-69008 Lyon, France; [Zannetti, Claudia; Parroche, Peggy; Hasan, Uzma A.] Univ Lyon 1, Fac Med, INSERM, U851, F-69310 Pierre Benite, France; [Bonnay, Francois] CNRS, Inst Mol & Cellular Biol, UPR 9022, F-67084 Strasbourg, France; [Takeshita, Fumihiko] Yokohama City Univ, Grad Sch Med, Dept Mol Biodefense Res, Yokohama, Kanagawa 2360004, Japan; [Menetrier-Caux, Christine] INSERM, Ctr Leon Berard, U590, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yokohama City University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Zannetti, C (corresponding author), Int Agcy Res Canc, Infect & Canc Biol Grp, F-69008 Lyon, France.	claudia.zannetti@inserm.fr	hasan, uzma A/G-3247-2013	Bonnay, Francois/0000-0002-3860-645X; Menetrier-Caux, christine/0000-0003-4863-374X; Hasan, Uzma/0000-0002-1770-5539				Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Berger M, 2009, J IMMUNOTHER, V32, P262, DOI 10.1097/CJI.0b013e318198bd2a; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Clarke S, 1998, J LEUKOCYTE BIOL, V63, P153, DOI 10.1002/jlb.63.2.153; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Diebold SS, 2008, ADV DRUG DELIVER REV, V60, P813, DOI 10.1016/j.addr.2007.11.004; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; MANIATIS T, 2000, MOL CLONING LAB MANU; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Menetrier-Caux C, 2001, CANCER RES, V61, P3096; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002; Severa M, 2007, J IMMUNOL, V178, P6208, DOI 10.4049/jimmunol.178.10.6208; Stevenson BJ, 2003, J INFECT DIS, V187, pS308, DOI 10.1086/374755; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Triantafilou K, 2005, EUR J IMMUNOL, V35, P2416, DOI 10.1002/eji.200526149; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Xu SW, 2006, SURGERY, V140, P170, DOI 10.1016/j.surg.2006.03.006	41	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34773	34780		10.1074/jbc.M110.133884	http://dx.doi.org/10.1074/jbc.M110.133884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20829351	Green Published, hybrid			2022-12-25	WOS:000283659100053
J	Wu, SP; Liu, J; Reedy, MC; Tregear, RT; Winkler, H; Franzini-Armstrong, C; Sasaki, H; Lucaveche, C; Goldman, YE; Reedy, MK; Taylor, KA				Wu, Shenping; Liu, Jun; Reedy, Mary C.; Tregear, Richard T.; Winkler, Hanspeter; Franzini-Armstrong, Clara; Sasaki, Hiroyuki; Lucaveche, Carmen; Goldman, Yale E.; Reedy, Michael K.; Taylor, Kenneth A.			Electron Tomography of Cryofixed, Isometrically Contracting Insect Flight Muscle Reveals Novel Actin-Myosin Interactions	PLOS ONE			English	Article							X-RAY-DIFFRACTION; CROSS-BRIDGES; FORCE GENERATION; STRUCTURAL-CHANGES; SKELETAL-MUSCLE; POWER STROKE; 3-DIMENSIONAL RECONSTRUCTION; STRETCH-ACTIVATION; STRONG BINDING; THIN FILAMENT	Background: Isometric muscle contraction, where force is generated without muscle shortening, is a molecular traffic jam in which the number of actin-attached motors is maximized and all states of motor action are trapped with consequently high heterogeneity. This heterogeneity is a major limitation to deciphering myosin conformational changes in situ. Methodology: We used multivariate data analysis to group repeat segments in electron tomograms of isometrically contracting insect flight muscle, mechanically monitored, rapidly frozen, freeze substituted, and thin sectioned. Improved resolution reveals the helical arrangement of F-actin subunits in the thin filament enabling an atomic model to be built into the thin filament density independent of the myosin. Actin-myosin attachments can now be assigned as weak or strong by their motor domain orientation relative to actin. Myosin attachments were quantified everywhere along the thin filament including troponin. Strong binding myosin attachments are found on only four F-actin subunits, the "target zone'', situated exactly midway between successive troponin complexes. They show an axial lever arm range of 77 degrees/12.9 nm. The lever arm azimuthal range of strong binding attachments has a highly skewed, 127 degrees range compared with X-ray crystallographic structures. Two types of weak actin attachments are described. One type, found exclusively in the target zone, appears to represent pre-working-stroke intermediates. The other, which contacts tropomyosin rather than actin, is positioned M-ward of the target zone, i.e. the position toward which thin filaments slide during shortening. Conclusion: We present a model for the weak to strong transition in the myosin ATPase cycle that incorporates azimuthal movements of the motor domain on actin. Stress/strain in the S2 domain may explain azimuthal lever arm changes in the strong binding attachments. The results support previous conclusions that the weak attachments preceding force generation are very different from strong binding attachments.	[Wu, Shenping; Liu, Jun; Winkler, Hanspeter; Taylor, Kenneth A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Tregear, Richard T.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Reedy, Mary C.; Lucaveche, Carmen; Reedy, Michael K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Franzini-Armstrong, Clara; Goldman, Yale E.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Sasaki, Hiroyuki] Jikei Univ, Sch Med, Core Res Facil, Div Fine Morphol, Tokyo, Japan	State University System of Florida; Florida State University; MRC Laboratory Molecular Biology; Duke University; University of Pennsylvania; Jikei University	Wu, SP (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	taylor@bio.fsu.edu		Sasaki, Hiroyuki/0000-0002-5358-5853	National Institute of General Medical Sciences (NIGMS) [GM30598]; National Heart, Lung and Blood Institute (NHLBI) [HL15835]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) [AR14317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL015835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR014317, R01AR014317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030598, R01GM082948] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (NIGMS) grant GM30598 to KAT, the National Heart, Lung and Blood Institute (NHLBI) grant HL15835 to YEG and CF-A and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) grant AR14317 to MKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL-Khayat HA, 2003, BIOPHYS J, V85, P1063, DOI 10.1016/S0006-3495(03)74545-7; Baker TS, 1996, CURR OPIN STRUC BIOL, V6, P585, DOI 10.1016/S0959-440X(96)80023-6; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Bershitsky SY, 1997, NATURE, V388, P186, DOI 10.1038/40651; BRENNER B, 1993, P NATL ACAD SCI USA, V90, P5252, DOI 10.1073/pnas.90.11.5252; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; BULLARD B, 1985, J MOL BIOL, V182, P443, DOI 10.1016/0022-2836(85)90203-7; Burgess S, 2004, J MOL BIOL, V341, P1161, DOI 10.1016/j.jmb.2004.06.077; Conibear PB, 1998, BIOPHYS J, V75, P926, DOI 10.1016/S0006-3495(98)77581-2; Cooke R, 1997, PHYSIOL REV, V77, P671, DOI 10.1152/physrev.1997.77.3.671; COOKE R, 1982, NATURE, V300, P776, DOI 10.1038/300776a0; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Esaki S, 2007, BIOSYSTEMS, V88, P293, DOI 10.1016/j.biosystems.2006.03.013; Farman GP, 2009, J STRUCT BIOL, V168, P240, DOI 10.1016/j.jsb.2009.07.020; Ferenczi MA, 2005, STRUCTURE, V13, P131, DOI 10.1016/j.str.2004.11.007; FRADO LL, 1992, J MOL BIOL, V223, P391, DOI 10.1016/0022-2836(92)90659-8; Frank J, 2006, 3 DIMENSIONAL ELECT; Galkin VE, 2003, J MOL BIOL, V325, P623, DOI 10.1016/S0022-2836(02)01309-8; Geeves M. A., 1995, Biophysical Journal, V68, P194; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gu J, 2002, BIOPHYS J, V82, P2123, DOI 10.1016/S0006-3495(02)75559-8; HASELGROVE JC, 1984, J MUSCLE RES CELL M, V5, P3, DOI 10.1007/BF00713149; HASELGROVE JC, 1973, J MOL BIOL, V77, P549, DOI 10.1016/0022-2836(73)90222-2; Heinrich B., 1996, THERMAL WARRIORS STR; HIROSE K, 1994, J CELL BIOL, V127, P763, DOI 10.1083/jcb.127.3.763; HIROSE K, 1993, BIOPHYS J, V65, P397, DOI 10.1016/S0006-3495(93)81061-0; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HOLMES KC, 1980, PROC R SOC SER B-BIO, V207, P13, DOI 10.1098/rspb.1980.0012; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1968, J MOL BIOL, V37, P507, DOI 10.1016/0022-2836(68)90118-6; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juanhuix J, 2001, BIOPHYS J, V80, P1429, DOI 10.1016/S0006-3495(01)76115-2; Katayama E, 1998, ADV EXP MED BIOL, V453, P37; KOSTER AJ, 1992, ULTRAMICROSCOPY, V46, P207, DOI 10.1016/0304-3991(92)90016-D; Lenart TD, 1996, BIOPHYS J, V71, P2289, DOI 10.1016/S0006-3495(96)79464-X; Leonard KR, 2006, MOL B INT U, P141, DOI 10.1007/0-387-31213-7_11; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Littlefield KP, 2008, J MOL BIOL, V381, P519, DOI 10.1016/j.jmb.2008.06.029; Liu J, 2004, J STRUCT BIOL, V147, P268, DOI 10.1016/j.jsb.2004.03.008; Liu J, 2006, J MOL BIOL, V362, P844, DOI 10.1016/j.jmb.2006.07.084; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; MARSTON EV, 1984, J MUSCLE RES CELL M, V5, P363; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Narita A, 2001, J MOL BIOL, V308, P241, DOI 10.1006/jmbi.2001.4598; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; OSTAP EM, 1995, BIOPHYS J, V69, P177, DOI 10.1016/S0006-3495(95)79888-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reedy M, 1998, PFLUG ARCH EUR J PHY, V436, pR20; REEDY MC, 1987, J MUSCLE RES CELL M, V8, P473, DOI 10.1007/BF01567908; REEDY MC, 1988, J MOL BIOL, V204, P357, DOI 10.1016/0022-2836(88)90582-7; REEDY MK, 1985, J MOL BIOL, V185, P145, DOI 10.1016/0022-2836(85)90188-3; REEDY MK, 1983, J MUSCLE RES CELL M, V4, P25, DOI 10.1007/BF00711957; REEDY MK, 1968, J MOL BIOL, V31, P155, DOI 10.1016/0022-2836(68)90437-3; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Schmitz H, 1996, J MOL BIOL, V264, P279, DOI 10.1006/jmbi.1996.0641; Schmitz H, 1997, J CELL BIOL, V139, P695, DOI 10.1083/jcb.139.3.695; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SQUIRE JM, 1988, J MUSCLE RES CELL M, V9, P344, DOI 10.1007/BF01773878; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Taylor KA, 2007, METHOD CELL BIOL, V79, P321, DOI 10.1016/S0091-679X(06)79013-6; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; Tsaturyan AK, 2005, BIOPHYS J, V88, P1902, DOI 10.1529/biophysj.104.050047; Tsaturyan AK, 1999, BIOPHYS J, V77, P354, DOI 10.1016/S0006-3495(99)76895-5; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vilfan A, 2009, BIOPHYS J, V97, P1130, DOI 10.1016/j.bpj.2009.06.008; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Walker M, 1999, P NATL ACAD SCI USA, V96, P465, DOI 10.1073/pnas.96.2.465; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Winkler H, 1996, J MOL BIOL, V264, P302, DOI 10.1006/jmbi.1996.0642; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Wong WNW, 1999, BIOCHEMISTRY-US, V38, P1365, DOI 10.1021/bi982467g; Wu SP, 2009, J STRUCT BIOL, V168, P485, DOI 10.1016/j.jsb.2009.08.007; Yanagida T, 2000, CURR OPIN CELL BIOL, V12, P20, DOI 10.1016/S0955-0674(99)00052-6; Yanagida T, 2000, PHILOS T ROY SOC B, V355, P441, DOI 10.1098/rstb.2000.0585	98	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12643	10.1371/journal.pone.0012643	http://dx.doi.org/10.1371/journal.pone.0012643			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844746	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687200010
J	Steer, CD; Golding, J; Bolton, PF				Steer, Colin D.; Golding, Jean; Bolton, Patrick F.			Traits Contributing to the Autistic Spectrum	PLOS ONE			English	Article							DISORDERS; COMMUNICATION; POPULATION; CHILDREN; ALSPAC; TWIN; ASSOCIATION; PREVALENCE; DIAGNOSIS; QUOTIENT	Background: It is increasingly recognised that traits associated with autism reflect a spectrum with no clear boundary between typical and atypical behaviour. Dimensional traits are needed to investigate the broader autism phenotype. Methods and Principal Findings: Ninety-three individual measures reflecting components of social, communication and repetitive behaviours characterising autistic spectrum disorder (ASD) were identified between the ages of 6 months and 9 years from the ALSPAC database. Using missing value imputation, data for 13,138 children were analysed. Factor analysis suggested the existence of 7 factors explaining 85% of the variance. The factors were labelled: verbal ability, language acquisition, social understanding, semantic-pragmatic skills, repetitive-stereotyped behaviour, articulation and social inhibition. Four factors (1, 3, 5 and 7) were specific to ASD being more strongly associated with this phenotype than other co-morbid conditions while other factors were more associated with learning difficulties and specific language impairment. Nevertheless, all 7 factors contributed independently to the explanation of ASD (p<0.001). Exploration of putative genetic causal factors such as variants in the CNTNAP2 gene showed a varying pattern of associations with these traits. An alternative predictive model of ASD was derived using four individual measures: the coherence subscale of the Children's Communication Checklist (9y), the Social and Communication Disorders Checklist (91 m), repetitive behaviour (69 m) and the sociability subscale of the Emotionality Activity and Sociability measure (38 m). Although univarably these traits performed better than some factors, their combined explanations of ASD were similar (R(2) = 0.48). Conclusions and Significance: These results support the fractional nature of ASD with different aetiological origins for these components despite pleiotropic genetic effects being observed. These traits are likely to be useful in the exploration of ASD.	[Steer, Colin D.; Golding, Jean] Univ Bristol, Bristol, Avon, England; [Bolton, Patrick F.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Bristol; University of London; King's College London	Steer, CD (corresponding author), Univ Bristol, Bristol, Avon, England.	Colin.Steer@bristol.ac.uk		Golding, Jean/0000-0003-2826-3307	UK Medical Research Council [RD1589]; UK NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry; Kings College London; South London and Maudsley NHS Foundation Trust; UK Medical Research Council; Wellcome Trust; University of Bristol; Medical Research Council [G9817803B, G0400085, G9815508, G0500870] Funding Source: researchfish; MRC [G0400085, G0500870] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry; Kings College London(General Electric); South London and Maudsley NHS Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the UK Medical Research Council grant RD1589. Patrick Bolton is supported by the UK NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London and The South London and Maudsley NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This publication is the work of the authors and Jean Golding and Colin Steer will serve as guarantors for the contents of this paper.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bandalos DL, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P61; Barbeau EB, 2009, BRIT J PSYCHOL, V100, P23, DOI 10.1348/000712608X337788; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Boomsma A, 2008, J CHILD PSYCHOL PSYC, V49, P809, DOI 10.1111/j.1469-7610.2008.01897.x; Buss A., 1984, TEMPERAMENT EARLY DE; CASPI A, 1995, CHILD DEV, V66, P55, DOI 10.1111/j.1467-8624.1995.tb00855.x; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Dworzynski K, 2009, J AUTISM DEV DISORD, V39, P1197, DOI 10.1007/s10803-009-0736-1; Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; Fenson L., 1993, MACARTHUR COMMUNICAT; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Frazier TW, 2008, J AUTISM DEV DISORD, V38, P474, DOI 10.1007/s10803-007-0415-z; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Grice JW, 2001, PSYCHOL METHODS, V6, P430, DOI 10.1037//1082-989X.6.4.430; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Harman H.H., 1976, MODERN FACTOR ANAL; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HU LT, 1999, STRUCTURAL EQUATION, V1, P55; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; London E, 2007, BRAIN PATHOL, V17, P408, DOI 10.1111/j.1750-3639.2007.00103.x; Mandy WPL, 2008, J CHILD PSYCHOL PSYC, V49, P795, DOI 10.1111/j.1469-7610.2008.01911.x; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Rust J., 1996, MANUAL WECHSLER OBJE; Skuse DH, 2009, J AM ACAD CHILD PSY, V48, P128, DOI 10.1097/CHI.0b013e31819176b8; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Snow AV, 2009, J CHILD PSYCHOL PSYC, V50, P734, DOI 10.1111/j.1469-7610.2008.02018.x; STPOURCAIN B, AM J PSYCHI IN PRESS; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wechsler D., 1992, WECHSLER INTELLIGENC; WIDAMAN KF, 1993, MULTIVAR BEHAV RES, V28, P263, DOI 10.1207/s15327906mbr2803_1; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; Wing L., 1988, DIAGNOSIS ASSESSMENT, P91, DOI 10.1007/978-1-4899-0792-9_7; World Health Organization, 1992, INT CLASS DIS REL HL	52	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12633	10.1371/journal.pone.0012633	http://dx.doi.org/10.1371/journal.pone.0012633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	648IV	20838614	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687100012
J	Carpaneto, A; Koepsell, H; Bamberg, E; Hedrich, R; Geiger, D				Carpaneto, Armando; Koepsell, Hermann; Bamberg, Ernst; Hedrich, Rainer; Geiger, Dietmar			Sucrose- and H+-Dependent Charge Movements Associated with the Gating of Sucrose Transporter ZmSUT1	PLOS ONE			English	Article							NA+ GLUCOSE COTRANSPORTER; ALTERNATING ACCESS MODEL; NA+/GLUCOSE COTRANSPORTER; XENOPUS-OOCYTES; CONFORMATIONAL-CHANGES; ELECTROGENIC PROPERTIES; ARABIDOPSIS-THALIANA; VOLTAGE-DEPENDENCE; ION CHANNELS; KINETICS	Background: In contrast to man the majority of higher plants use sucrose as mobile carbohydrate. Accordingly proton-driven sucrose transporters are crucial for cell-to-cell and long-distance distribution within the plant body. Generally very negative plant membrane potentials and the ability to accumulate sucrose quantities of more than 1 M document that plants must have evolved transporters with unique structural and functional features. Methodology/Principal Findings: To unravel the functional properties of one specific high capacity plasma membrane sucrose transporter in detail, we expressed the sucrose/H+ co-transporter from maize ZmSUT1 in Xenopus oocytes. Application of sucrose in an acidic pH environment elicited inward proton currents. Interestingly the sucrose-dependent H+ transport was associated with a decrease in membrane capacitance (C-m). In addition to sucrose C-m was modulated by the membrane potential and external protons. In order to explore the molecular mechanism underlying these C-m changes, presteady-state currents (I-pre) of ZmSUT1 transport were analyzed. Decay of I-pre could be best fitted by double exponentials. When plotted against the voltage the charge Q, associated to I-pre, was dependent on sucrose and protons. The mathematical derivative of the charge Q versus voltage was well in line with the observed C-m changes. Based on these parameters a turnover rate of 500 molecules sucrose/s was calculated. In contrast to gating currents of voltage dependent-potassium channels the analysis of ZmSUT1-derived presteady-state currents in the absence of sucrose (I = Q/iota) was sufficient to predict ZmSUT1 transport-associated currents. Conclusions: Taken together our results indicate that in the absence of sucrose, 'trapped' protons move back and forth between an outer and an inner site within the transmembrane domains of ZmSUT1. This movement of protons in the electric field of the membrane gives rise to the presteady-state currents and in turn to C-m changes. Upon application of external sucrose, protons can pass the membrane turning presteady-state into transport currents.	[Carpaneto, Armando] CNR, Ist Biofis, Genoa, Italy; [Koepsell, Hermann] Univ Wurzburg, Inst Anat & Zellbiol, Wurzburg, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, D-6000 Frankfurt, Germany; [Hedrich, Rainer; Geiger, Dietmar] Univ Wurzburg, Julis von Sachs Inst, Wurzburg, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Wurzburg; Max Planck Society; University of Wurzburg	Carpaneto, A (corresponding author), CNR, Ist Biofis, Genoa, Italy.	geiger@botanik.uni-wuerzburg.de	Hedrich, Rainer/G-8771-2011; Carpaneto, Armando/F-7754-2013; Geiger, Dietmar/D-6914-2014; Geiger, Dietmar/AAH-8140-2019	Hedrich, Rainer/0000-0003-3224-1362; Geiger, Dietmar/0000-0003-0715-5710; Geiger, Dietmar/0000-0003-0715-5710; Carpaneto, Armando/0000-0002-5060-3657	Deutsche Forschungsgemeinschaft (DFG) [SFB487, GE2195/1-1]; Italian Consiglio Nazionale delle Ricerche (CNR)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Italian Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/index.jsp) grants within SFB487 to RH and HK. DG was supported by DFG grant GE2195/1-1. AC was supported by Italian Consiglio Nazionale delle Ricerche (CNR, Short-term Mobility program 2007 and 2009, http://www.cnr.it/sitocnr/Englishversion/CNR/Dataandstatistics/International-activities/Shorttermmobilityprogram.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1976, J PHYSIOL-LONDON, V254, P317, DOI 10.1113/jphysiol.1976.sp011234; Aoki N, 1999, PLANT CELL PHYSIOL, V40, P1072, DOI 10.1093/oxfordjournals.pcp.a029489; ARMSTRONG CM, 1975, BIOPHYS J, V15, P932, DOI 10.1016/S0006-3495(75)85868-1; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BIRNIR B, 1991, PFLUG ARCH EUR J PHY, V418, P79, DOI 10.1007/BF00370455; Boorer KJ, 1996, J BIOL CHEM, V271, P25139, DOI 10.1074/jbc.271.41.25139; BOORER KJ, 1994, J BIOL CHEM, V269, P20417; Bossi E, 1999, J PHYSIOL-LONDON, V515, P729, DOI 10.1111/j.1469-7793.1999.729ab.x; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Cherubino F, 2010, J MOL NEUROSCI, V41, P243, DOI 10.1007/s12031-009-9281-9; Fesce R, 2002, J PHYSIOL-LONDON, V545, P739, DOI 10.1113/jphysiol.2002.026823; Forster I, 1998, J GEN PHYSIOL, V112, P1, DOI 10.1085/jgp.112.1.1; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; KEYNES RD, 1994, Q REV BIOPHYS, V27, P339, DOI 10.1017/S0033583500003097; Klamo EM, 1996, J BIOL CHEM, V271, P14937, DOI 10.1074/jbc.271.25.14937; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Loo DDF, 2005, J GEN PHYSIOL, V125, P13, DOI 10.1085/jgp.200409150; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Nussberger S, 1997, J BIOL CHEM, V272, P7777, DOI 10.1074/jbc.272.12.7777; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Peres A, 2004, NEWS PHYSIOL SCI, V19, P80, DOI 10.1152/nips.01504.2003; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Sauer Norbert, 1994, Plant Journal, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Schmitt BM, 2002, BIOPHYS J, V82, P1345, DOI 10.1016/S0006-3495(02)75490-8; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Su A, 1996, BIOPHYS J, V70, P762, DOI 10.1016/S0006-3495(96)79616-9; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; Zhou JJ, 1997, J MEMBRANE BIOL, V159, P113, DOI 10.1007/s002329900275	37	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12605	10.1371/journal.pone.0012605	http://dx.doi.org/10.1371/journal.pone.0012605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838661	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300028
J	Weldon, WC; Wang, BZ; Martin, MP; Koutsonanos, DG; Skountzou, I; Compans, RW				Weldon, William C.; Wang, Bao-Zhong; Martin, Maria P.; Koutsonanos, Dimitrios G.; Skountzou, Ioanna; Compans, Richard W.			Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin	PLOS ONE			English	Article							A VIRUS HEMAGGLUTININ; MEMBRANE-FUSION; RECEPTOR-BINDING; LEUCINE-ZIPPER; VACCINE; BACULOVIRUS; ANTIBODIES; GLYCOPROTEIN; IMMUNIZATION; PROTEIN	Background: The recent swine-origin H1N1 pandemic illustrates the need to develop improved procedures for rapid production of influenza vaccines. One alternative to the current egg-based manufacture of influenza vaccine is to produce a hemagglutinin (HA) subunit vaccine using a recombinant expression system with the potential for high protein yields, ease of cloning new antigenic variants, and an established safety record in humans. Methodology/Principal Findings: We generated a soluble HA (sHA), derived from the H3N2 virus A/Aichi/2/68, modified at the C-terminus with a GCN4pII trimerization repeat to stabilize the native trimeric structure of HA. When expressed in the baculovirus system, the modified sHA formed native trimers. In contrast, the unmodified sHA was found to present epitopes recognized by a low-pH conformation specific monoclonal antibody. We found that mice primed and boosted with 3 mu g of trimeric sHA in the absence of adjuvants had significantly higher IgG and HAI titers than mice that received the unmodified sHA. This correlated with an increased survival and reduced body weight loss following lethal challenge with mouse-adapted A/Aichi/2/68 virus. In addition, mice receiving a single vaccination of the trimeric sHA in the absence of adjuvants had improved survival and body weight loss compared to mice vaccinated with the unmodified sHA. Conclusions/Significance: Our data indicate that the recombinant trimeric sHA presents native trimeric epitopes while the unmodified sHA presents epitopes not exposed in the native HA molecule. The epitopes presented in the unmodified sHA constitute a "silent face'' which may skew the antibody response to epitopes not accessible in live virus at neutral pH. The results demonstrate that the trimeric sHA is a more effective influenza vaccine candidate and emphasize the importance of structure-based antigen design in improving recombinant HA vaccines.	[Weldon, William C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Weldon, WC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu	Compans, Richard W/I-4087-2013; Skountzou, Ioanna/A-4454-2010	Compans, Richard W/0000-0003-2360-335X; Skountzou, Ioanna/0000-0002-6429-244X; Wang, Bao-Zhong/0000-0002-1561-4318; Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health [AI074579, EB006369]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by National Institutes of Health grants AI074579 and EB006369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; CDC, 2010, 2009 2010 INFL SEAS; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOCART MJ, 1989, J GEN VIROL, V70, P809, DOI 10.1099/0022-1317-70-4-809; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Johansson BE, 1999, VACCINE, V17, P2073, DOI 10.1016/S0264-410X(98)00413-7; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; King JC, 2009, VACCINE, V27, P6589, DOI 10.1016/j.vaccine.2009.08.032; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; NESTOROWICZ AN, 1985, VACCINE, V3, P175, DOI 10.1016/0264-410X(85)90099-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Ronnelid J, 2008, ADV EXP MED BIOL, V632, P187, DOI 10.1007/978-0-387-78952-1_14; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Vanlandschoot P, 1996, ARCH VIROL, V141, P1715, DOI 10.1007/BF01718294; Vanlandschoot P, 1998, ARCH VIROL, V143, P227, DOI 10.1007/s007050050282; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Webby RJ, 2007, CURR TOP MICROBIOL, V315, P67; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	43	87	105	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12466	10.1371/journal.pone.0012466	http://dx.doi.org/10.1371/journal.pone.0012466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824188	gold, Green Submitted, Green Published			2022-12-25	WOS:000281456100004
J	Gotte, M; Mohr, C; Koo, CY; Stock, C; Vaske, AK; Viola, M; Ibrahim, SA; Peddibhotla, S; Teng, YHF; Low, JY; Ebnet, K; Kiesel, L; Yip, GW				Goette, M.; Mohr, C.; Koo, C-Y; Stock, C.; Vaske, A-K; Viola, M.; Ibrahim, S. A.; Peddibhotla, S.; Teng, Y. H-F; Low, J-Y; Ebnet, K.; Kiesel, L.; Yip, G. W.			miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness	ONCOGENE			English	Article						F11R; microRNA; actin cytoskeleton; metastasis; nuclear rotation; endometrial carcinoma	SUPPRESSIVE MICRORNAS; PROSTATE-CANCER; MIR-145; METASTASIS; MIGRATION; PROTEIN; INVASION; GROWTH; MATURATION; PHENOTYPE	Micro RNAs are small non-coding RNAs, which regulate fundamental cellular and developmental processes at the transcriptional and translational level. In breast cancer, miR-145 expression is downregulated compared with healthy control tissue. As several predicted targets of miR-145 potentially regulate cell motility, we aimed at investigating a potential role for miR-145 in breast cancer cell motility and invasiveness. Assisted by Affymetrix array technology, we demonstrate that overexpression of miR-145 in MDA-MB-231, MCF-7, MDA-MB-468 and SK-BR-3 breast cancer cells and in Ishikawa endometrial carcinoma cells leads to a downregulation of the cell-cell adhesion protein JAM-A and of the actin bundling protein fascin. Moreover, podocalyxin and Serpin E1 mRNA levels were downregulated, and gamma-actin, transgelin and MYL9 were upregulated upon miR-145 overexpression. These miR-145-dependent expression changes drastically decreased cancer cell motility, as revealed by time-lapse video microscopy, scratch wound closure assays and matrigel invasion assays. Immunofluorescence microscopy demonstrated restructuring of the actin cytoskeleton and a change in cell morphology by miR-145 overexpression, resulting in a more cortical actin distribution, and reduced actin stress fiber and filopodia formation. Nuclear rotation was observed in 10% of the pre-miR-145 transfected MDA-MB-231 cells, accompanied by a reduction of perinuclear actin. Luciferase activation assays confirmed direct miR-145-dependent regulation of the 3'UTR of JAM-A, whereas siRNA-mediated knockdown of JAM-A expression resulted in decreased motility and invasiveness of MDA-MB-231 and MCF-7 breast cancer cells. Our data identify JAM-A and fascin as novel targets of miR-145, firmly establishing a role for miR-145 in modulating breast cancer cell motility. Our data provide a rationale for future miR-145-targeted approaches of antimetastatic cancer therapy. Oncogene (2010) 29, 6569-6580; doi:10.1038/onc.2010.386; published online 6 September 2010	[Goette, M.; Mohr, C.; Vaske, A-K; Viola, M.; Ibrahim, S. A.; Kiesel, L.] Munster Univ Hosp, Dept Gynecol & Obstet, D-48149 Munster, Germany; [Yip, G. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Stock, C.] Munster Univ Hosp, Inst Physiol 2, D-48149 Munster, Germany; [Ibrahim, S. A.] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [Peddibhotla, S.; Ebnet, K.] Univ Munster, ZMBE, Inst Med Biochem, Cell Adhes & Cell Polar Grp, Munster, Germany	University of Munster; National University of Singapore; University of Munster; Egyptian Knowledge Bank (EKB); Cairo University; University of Munster	Gotte, M (corresponding author), Munster Univ Hosp, Dept Gynecol & Obstet, Domagkstr 11, D-48149 Munster, Germany.	mgotte@uni-muenster.de; georgeyip@nus.edu.sg	Viola, Manuela/B-7120-2011; Ebnet, Klaus T/C-8314-2009; Kiesel, Ludwig/ABC-5333-2020; Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Viola, Manuela/0000-0002-0634-6390; Ebnet, Klaus T/0000-0002-0417-7888; Kiesel, Ludwig/0000-0002-7247-9247; Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496; Ibrahim, Sherif Abdelaziz/0000-0001-6403-7345; Koo, Chuay Yeng/0000-0002-9495-0554	National Medical Research Council, Singapore [NMRC/1023/2005]; German Academic Exchange Service DAAD [A/08/15601, A/06/90277]; Forderkreis Universitat Munster	National Medical Research Council, Singapore(National Medical Research Council, Singapore); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Forderkreis Universitat Munster	We would like to thank Birgit Pers, Ruth Goez, and Barbara Kloke for expert technical assistance, Professor Anna Starzinski-Powitz for providing Ishikawa cells, and Christian Adams MSc, for help with luciferase assays. Funding was provided by Grant NMRC/1023/2005 from the National Medical Research Council, Singapore (to GWY), by German Academic Exchange Service DAAD Grants A/08/15601 (to MV), and A/06/90277 (to SAI), and by the Forderkreis Universitat Munster (to MG).	Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Darnel AD, 2009, CLIN CANCER RES, V15, P1376, DOI 10.1158/1078-0432.CCR-08-1789; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gerashchenko MV, 2009, CELL BIOL INT, V33, P1057, DOI 10.1016/j.cellbi.2009.06.020; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Gotte M, 2010, AM J PATHOL, V176, P25, DOI 10.2353/ajpath.2010.090775; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; ISHIWATA I, 1984, GYNECOL ONCOL, V17, P281, DOI 10.1016/0090-8258(84)90212-9; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; KIM SJ, 2009, GASTROENTEROLOGY, V138, pE1; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levy JR, 2008, J CELL SCI, V121, P3187, DOI 10.1242/jcs.033878; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Qualtrough D, 2009, BRIT J CANCER, V101, P1124, DOI 10.1038/sj.bjc.6605286; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Sempere LF, 2009, THESCIENTIFICWORLDJO, V9, P626, DOI 10.1100/tsw.2009.88; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106	56	175	187	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6569	6580		10.1038/onc.2010.386	http://dx.doi.org/10.1038/onc.2010.386			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20818426	Bronze			2022-12-25	WOS:000285380200006
J	Li, SL; Shimono, C; Norioka, N; Nakano, I; Okubo, T; Yagi, Y; Hayashi, M; Sato, Y; Fujisaki, H; Hattori, S; Sugiura, N; Kimata, K; Sekiguchi, K				Li, Shaoliang; Shimono, Chisei; Norioka, Naoko; Nakano, Itsuko; Okubo, Tetsuo; Yagi, Yoshiko; Hayashi, Maria; Sato, Yuya; Fujisaki, Hitomi; Hattori, Shunji; Sugiura, Nobuo; Kimata, Koji; Sekiguchi, Kiyotoshi			Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-4; EXTRACELLULAR-MATRIX PROTEINS; HEPARAN-SULFATE; CHONDROITIN SULFATE; BASEMENT-MEMBRANES; CRYSTAL-STRUCTURE; ACTIVATION; CELLS; GLYCOSAMINOGLYCANS	Activin A, a member of the transforming growth factor-beta family, plays important roles in hormonal homeostasis and embryogenesis. In this study, we produced recombinant human activin A and examined its abilities to bind to extracellular matrix proteins. Recombinant activin A expressed in 293-F cells was purified as complexes of mature dimeric activin A with its pro-region. Among a panel of extracellular matrix proteins tested, recombinant activin A bound to perlecan and agrin, but not to laminins, nidogens, collagens I and IV, fibronectin, and nephronectin. The binding of recombinant activin A to perlecan was inhibited by heparin and high concentrations of NaCl and abolished by heparitinase treatment of perlecan, suggesting that activin A binds to the heparan sulfate chains of perlecan. In support of this possibility, recombinant activin A was capable of directly binding to heparin and heparan sulfate chains. Site-directed mutagenesis of recombinant activin A revealed that clusters of basic amino acid residues, Lys(259)-Lys(263) and Lys(270)-Lys(272), in the pro-region were required for binding to perlecan. Interestingly, deletion of the peptide segment Lys(259)-Gly(277) containing both basic amino acid clusters from the pro-region did not impair the activity of activin A to stimulate Smad-dependent gene expressions, although it completely ablated the perle-can-binding activity. The binding of activin A to basement membrane heparan sulfate proteoglycans through the basic residues in the pro-region was further confirmed by in situ activin A overlay assays using frozen tissue sections. Taken together, the present results indicate that activin A binds to heparan sulfate proteoglycans through its pro-region and thereby regulates its localization within tissues.	[Sato, Yuya; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Fujisaki, Hitomi; Hattori, Shunji] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Sugiura, Nobuo; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Osaka University; Aichi Medical University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization of Japan [06001294-0]	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by Research Contract No. 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan.	Arai KY, 2006, PROTEIN EXPRES PURIF, V49, P78, DOI 10.1016/j.pep.2006.04.003; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Asashima M, 2008, DEV GROWTH DIFFER, V50, pS35, DOI 10.1111/j.1440-169X.2008.00990.x; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Flaumenhaft R, 1991, CURR OPIN CELL BIOL, V3, P817, DOI 10.1016/0955-0674(91)90055-4; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; HUSKENHINDI P, 1994, J BIOL CHEM, V269, P19380; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; IWATA M, 1995, J BIOCHEM-TOKYO, V117, P1298, DOI 10.1093/oxfordjournals.jbchem.a124858; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Khan SA, 2008, AM J PHYSIOL-CELL PH, V294, pC1387, DOI 10.1152/ajpcell.00346.2007; Lamszus K, 1996, AM J PATHOL, V149, P805; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LYON M, 1994, J BIOL CHEM, V269, P11216; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Mellor SL, 2000, J CLIN ENDOCR METAB, V85, P4851, DOI 10.1210/jc.85.12.4851; MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; SPENCER SJ, 1992, J CLIN INVEST, V90, P142, DOI 10.1172/JCI115827; SUGIURA N, 1993, J BIOL CHEM, V268, P15779; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	58	49	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36645	36655		10.1074/jbc.M110.177865	http://dx.doi.org/10.1074/jbc.M110.177865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843788	Green Published, hybrid			2022-12-25	WOS:000284146100035
J	Williams, JA; Kane, M; Okabe, T; Enomoto-Iwamoto, M; Napoli, JL; Pacifici, M; Iwamoto, M				Williams, Julie A.; Kane, Maureen; Okabe, Takahiro; Enomoto-Iwamoto, Motomi; Napoli, Joseph L.; Pacifici, Maurizio; Iwamoto, Masahiro			Endogenous Retinoids in Mammalian Growth Plate Cartilage ANALYSIS AND ROLES IN MATRIX HOMEOSTASIS AND TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL PROGENITOR DIFFERENTIATION; ACID RECEPTORS; LOCAL APPLICATION; LIMB DEVELOPMENT; EXPRESSION; GENE; REPRESSION; CHONDROGENESIS; ABNORMALITIES; L-SOX5	The growth plate contains resting and proliferating chondrocytes in its upper zones (UGP) and maturing and hypertrophic chondrocytes in its lower zones (LGP), but the mechanisms by which it operates to sustain skeletal growth are not fully clear. Retinoid signaling was previously found to be nearly absent in UGP, but to be much stronger in LGP coincident with hypertrophy, extracellular matrix turnover and endochondral bone formation. To determine whether such distinct signaling levels and phenotypic events reflect different endogenous retinoid levels, the upper two-thirds and lower one-third of rabbit rib growth plates were microsurgically isolated and processed for ultrasensitive retinoid LC-tandem MS quantification. Indeed, the UGP samples contained only about a 0.6 nM concentration of all-trans- retinoic acid (atRA) that is the most active natural retinoid in tissues, whereas LGP samples contained nearly 3-fold higher atRA levels (about 1.8 nM). Perichondrium was quite rich in atRA (about 4.9 nM). Interestingly, the levels of retinol, the major but inactive atRA precursor, were similar in all tissues (1.1-1.6 mu M), suggesting that the distinct atRA levels in UGP and LGP reflect different retinoid anabolic capacity. Indeed, RALDH2 and CRABP1 transcript levels were much higher in LGP than UGP samples. To determine the minimum effective atRA concentration, chondrogenic cells transfected with a retinoic acid response element (RARE)-luc reporter plasmid were treated with different concentrations of exogenous atRA (0-100 nM). About 3 nM atRA was needed to elicit appreciable RARE-luc reporter activity and to decrease proteoglycan synthesis and activity of an aggrecan enhancer reporter plasmid. In sum, the data indicate that (i) the endogenous levels of atRA are significantly higher in hypertrophic than upper zones of growth plate; (ii) such difference likely reflects distinct retinoid anabolic capacity; and (iii) importantly, atRA levels in hypertrophic portion are within effective ranges to elicit retinoid signaling and action, but those in upper zones are not.	[Williams, Julie A.; Okabe, Takahiro; Enomoto-Iwamoto, Motomi; Pacifici, Maurizio; Iwamoto, Masahiro] Thomas Jefferson Univ, Coll Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Kane, Maureen; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Jefferson University; University of California System; University of California Berkeley	Iwamoto, M (corresponding author), Thomas Jefferson Univ, Coll Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.	masahiro.iwamoto@jefferson.edu			National Institutes of Health [1RO1 AR056837]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant 1RO1 AR056837 (to M. I. and M. P.).	Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hoffman UM, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300002-00017; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010; IWAMOTO M, 1994, J BIOL CHEM, V269, P17245; IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; KOCHHAR DM, 1973, TERATOLOGY, V7, P289, DOI 10.1002/tera.1420070310; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mangelsdorf David J., 1994, P319; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; Okuno M, 1999, J HEPATOL, V30, P1073, DOI 10.1016/S0168-8278(99)80262-1; PACIFICI M, 1980, EXP CELL RES, V129, P469, DOI 10.1016/0014-4827(80)90517-0; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674; Thacher SM, 2000, CURR PHARM DESIGN, V6, P25, DOI 10.2174/1381612003401415; TICKLE C, 1988, ROUX ARCH DEV BIOL, V197, P27, DOI 10.1007/BF00376038; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; von Schroeder HP, 1998, J ORTHOP RES, V16, P355, DOI 10.1002/jor.1100160312; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Welch ID, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2604; Weston AD, 2000, J CELL BIOL, V148, P679, DOI 10.1083/jcb.148.4.679; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Yamaguchi M, 1998, P NATL ACAD SCI USA, V95, P7491, DOI 10.1073/pnas.95.13.7491	38	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36674	36681		10.1074/jbc.M110.151878	http://dx.doi.org/10.1074/jbc.M110.151878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843807	Green Published, hybrid			2022-12-25	WOS:000284146100018
J	Cottonham, CL; Kaneko, S; Xu, L				Cottonham, Charisa L.; Kaneko, Satoshi; Xu, Lan			miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER METASTASIS; RAC ACTIVATOR TIAM1; GROWTH-FACTOR-BETA; TGF-BETA; COLORECTAL-CANCER; E-CADHERIN; REPRESSORS ZEB1; LINE MODEL; MICRORNA	TGF-beta promotes cell migration and invasion, an attribute that is linked to the pro-metastasis function of this cytokine in late stage cancers. The LIM 1863 colon carcinoma organoid undergoes epithelial-mesenchymal transition (EMT) in response to TGF-beta. This process is markedly accelerated by TNF-alpha, and we found that the levels of miR-21 and miR-31 were prominently elevated under the synergistic actions of TGF-beta/TNF-alpha. Consistent with this, overexpression of either miR-21 or miR-31 significantly enhanced the effect of TGF-beta alone on LIM 1863 morphological changes. More importantly, transwell assays demonstrated the positive effects of both miR-21 and miR-31 in TGF-beta regulation of LIM 1863 motility and invasiveness. Elevated levels of miR-21 and miR-31 also enhanced motility and invasiveness of other colon carcinoma cell lines. We present compelling evidence that TIAM1, a guanidine exchange factor of the Rac GTPase, is a direct target of both miR-21 and miR-31. Indeed in LIM 1863 cells, suppression of TIAM1 is required for miR-21/miR-31 to enhance cell migration and invasion. Therefore, we have uncovered miR-21 and miR-31 as downstream effectors of TGF-beta in facilitating invasion and metastasis of colon carcinoma cells.	[Cottonham, Charisa L.; Kaneko, Satoshi; Xu, Lan] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Xu, L (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Rm 308, Worcester, MA 01605 USA.	lan.xu@umassmed.edu			National Institutes of Health [R01CA108509]; Ruth L. Kirschstein NRSA [F31CA142216]; NATIONAL CANCER INSTITUTE [F31CA142216, R01CA108509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108509 (to L. X.) and a Ruth L. Kirschstein NRSA Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research F31CA142216 (to C. L. C.).	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; DALAL BI, 1993, AM J PATHOL, V143, P381; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; HAYWARD IP, 1995, IMMUNOL CELL BIOL, V73, P249, DOI 10.1038/icb.1995.41; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vincan E, 2007, ONCOGENE, V26, P2340, DOI 10.1038/sj.onc.1210026; Vincan E, 2007, CELLS TISSUES ORGANS, V185, P20, DOI 10.1159/000101299; Vincan Elizabeth, 2008, V468, P263, DOI 10.1007/978-1-59745-249-6_21; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WHITEHEAD RH, 1987, CANCER RES, V47, P2683; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316	52	213	225	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35293	35302		10.1074/jbc.M110.160069	http://dx.doi.org/10.1074/jbc.M110.160069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826792	hybrid, Green Published			2022-12-25	WOS:000283845300007
J	Park, SH; Choi, HJ; Yang, H; Do, KH; Kim, J; Lee, DW; Moon, Y				Park, Seong-Hwan; Choi, Hye Jin; Yang, Hyun; Do, Kee Hun; Kim, Juil; Lee, Dong Won; Moon, Yuseok			Endoplasmic Reticulum Stress-activated C/EBP Homologous Protein Enhances Nuclear Factor-kappa B Signals via Repression of Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ER STRESS; EXPRESSION; CHOP; CELLS; BETA; GENE; TRANSCRIPTION; COLITIS; DISEASE	Endoplasmic reticulum (ER) stress is a causative factor of inflammatory bowel diseases. ER stress mediators, including CCAAT enhancer-binding protein (C/EBP) homologous protein (CHOP), are elevated in intestinal epithelia from patients with inflammatory bowel diseases. The present study arose from the question of how chemical ER stress and CHOP protein were associated with nuclear factor-kappa B (NF-kappa B)-mediated epithelial inflammatory response. In a human intestinal epithelial cell culture model, chemical ER stresses induced proinflammatory cytokine interleukin-8 (IL-8) expression and the nuclear translocation of CHOP protein. CHOP was positively involved in ER-activated IL-8 production and was negatively associated with expression of peroxisome proliferator-activated receptor gamma (PPAR gamma). ER stress-induced IL-8 production was enhanced by NF-kappa B activation that was negatively regulated by PPAR gamma. Mechanistically, ER stress-induced CHOP suppressed PPAR gamma transcription by sequestering C/EBP beta and limiting availability of C/EBP beta binding to the PPAR gamma promoter. Due to the CHOP-mediated regulation of PPAR gamma action, ER stress can enhance proinflammatory NF-kappa B activation and maintain an increased level of IL-8 production in human intestinal epithelial cells. In contrast, PPAR gamma was a counteracting regulator of gut inflammatory response through attenuation of NF-kappa B activation. The collective results support the view that balances between CHOP and PPAR gamma are crucial for epithelial homeostasis, and disruption of these balances in mucosal ER stress can etiologically affect the progress of human inflammatory bowel diseases.	[Park, Seong-Hwan; Choi, Hye Jin; Yang, Hyun; Do, Kee Hun; Kim, Juil; Moon, Yuseok] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Syst Mucosal Biomodulat, Yangsan 626813, South Korea; [Lee, Dong Won] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan 626813, South Korea; [Moon, Yuseok] Pusan Natl Univ, Res Inst Basic Sci, Pusan 609735, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Syst Mucosal Biomodulat, Yangsan 626813, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020	MOON, YUSEOK/0000-0001-8686-8166	Ministry of Education, Science and Technology [2009-0087028]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2009-0087028).	Araki E, 2003, INTERNAL MED, V42, P7, DOI 10.2169/internalmedicine.42.7; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Cowan MJ, 2006, J APPL PHYSIOL, V101, P1127, DOI 10.1152/japplphysiol.01287.2005; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moon Y, 2008, TOXICOL APPL PHARM, V231, P94, DOI 10.1016/j.taap.2008.03.016; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Noiri E, 1996, AM J PHYSIOL-CELL PH, V270, pC794, DOI 10.1152/ajpcell.1996.270.3.C794; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sansonetti PJ, 2008, CURR OPIN GASTROEN, V24, P435, DOI 10.1097/MOG.0b013e32830007f7; Scholmerich J, 2006, ANN NY ACAD SCI, V1072, P365, DOI 10.1196/annals.1326.026; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sifuentes LY, 2007, APPL ENVIRON MICROB, V73, P7548, DOI 10.1128/AEM.01579-07; Srinivasan M, 2009, CLIN IMMUNOL, V133, P411, DOI 10.1016/j.clim.2009.09.001; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Suyama K, 2008, BIOCHEM BIOPH RES CO, V367, P176, DOI 10.1016/j.bbrc.2007.12.132; Thebault S, 2006, PROTEOMICS, V6, P3926, DOI 10.1002/pmic.200500714; Tsianos EV, 2009, WORLD J GASTROENTERO, V15, P521, DOI 10.3748/wjg.15.521; Von Knethen A, 2001, FASEB J, V15, P535, DOI 10.1096/fj.00-0187com; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Warren CA, 2008, J INFECT DIS, V198, P143, DOI 10.1086/588819; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	57	60	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35330	35339		10.1074/jbc.M110.136259	http://dx.doi.org/10.1074/jbc.M110.136259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829347	Green Published, hybrid			2022-12-25	WOS:000283845300011
J	Sato, H; Hashimoto, Y; Fukatsu, H; Kobayashi, M				Sato, Hiroyoshi; Hashimoto, Yoshiteru; Fukatsu, Hiroshi; Kobayashi, Michihiko			Novel Isonitrile Hydratase Involved in Isonitrile Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS J1; SUBSTITUTED FORMAMIDE DEFORMYLASE; METALLOENZYME NITRILE HYDRATASE; CYSTEINE RESIDUES; REACTION-PRODUCT; GENE-EXPRESSION; PURIFICATION; DISCOVERY; CLONING; ENZYME	We previously discovered N-substituted formamide deformylase (NfdA) in Arthrobacter pascens F164, which degrades N-substituted formamide (Fukatsu, H., Hashimoto, Y., Goda, M., Higashibata, H., and Kobayashi, M. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 13726-13731). In this study, we found an enzyme involved in the first step of isonitrile metabolism, isonitrile hydratase, that hydrates isonitrile to the corresponding N-substituted formamide. First, we investigated the optimum culture conditions for the production of isonitrile hydratase. The highest enzyme activity was obtained when A. pascens F164 was cultured in a nutrient medium containing N-benzylformamide. This Arthrobacter isonitrile hydratase was purified, characterized, and compared with Pseudomonas putida N19-2 isonitrile hydratase (InhA), which is the sole one reported at present. Arthrobacter isonitrile hydratase was found to have a molecular mass of about 530 kDa and to consist of 12 identical subunits. The apparent K-m value for cyclohexyl isocyanide was 0.95 +/- 0.05 mM. A. pascens F164 grew and exhibited the isonitrile hydratase and N-substituted formamide deformylase activities when cultured in a medium containing an isonitrile as the sole carbon and nitrogen sources. However, both enzyme activities were not observed on culture in a medium containing glycerol and (NH4)(2)SO4 as the sole carbon and nitrogen sources, respectively. These findings suggested that the Arthrobacter enzyme is an inducible enzyme, possibly involved in assimilation and/or detoxification of isonitrile. Moreover, gene cloning of the Arthrobacter enzyme revealed no sequence similarity between this enzyme and InhA. Comparison of their properties and features demonstrated that the two enzymes are biochemically, immunologically, and structurally different from each other. Thus, we discovered a new isonitrile hydratase named InhB.	[Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.				Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAFIERI F, 1973, TETRAHEDRON, V29, P4259, DOI 10.1016/0040-4020(73)80267-4; EDENBOROUGH MS, 1988, NAT PROD REP, V5, P229, DOI 10.1039/np9880500229; Fukatsu H, 2005, BIOSCI BIOTECH BIOCH, V69, P228, DOI 10.1271/bbb.69.228; Fukatsu H, 2004, P NATL ACAD SCI USA, V101, P13726, DOI 10.1073/pnas.0405082101; Goda M, 2002, J BIOL CHEM, V277, P45860, DOI 10.1074/jbc.M208571200; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; KOBAYASHI M, 1992, J BIOL CHEM, V267, P20746; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; KOBAYASHI M, 1994, FEMS MICROBIOL LETT, V120, P217, DOI 10.1016/0378-1097(94)90474-X; KOBAYASHI M, 1990, J BACTERIOL, V172, P4807, DOI 10.1128/jb.172.9.4807-4815.1990; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1989, MOL CLONING LAB MANU; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; SCHEUER PJ, 1992, ACCOUNTS CHEM RES, V25, P433, DOI 10.1021/ar00022a001; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	25	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34793	34802		10.1074/jbc.M110.150227	http://dx.doi.org/10.1074/jbc.M110.150227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826798	hybrid, Green Published			2022-12-25	WOS:000283659100055
J	Duning, K; Rosenbusch, D; Schluter, MA; Tian, YM; Kunzelmann, K; Meyer, N; Schulze, U; Markoff, A; Pavenstadt, H; Weide, T				Duning, Kerstin; Rosenbusch, Deike; Schlueter, Marc A.; Tian, Yuemin; Kunzelmann, Karl; Meyer, Nina; Schulze, Ulf; Markoff, Arseni; Pavenstaedt, Hermann; Weide, Thomas			Polycystin-2 Activity Is Controlled by Transcriptional Coactivator with PDZ Binding Motif and PALS1-associated Tight Junction Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN EPITHELIAL-CELLS; KIDNEY-DISEASE; DIRECTIONAL MIGRATION; SIGNALING COMPLEX; CYSTIC-FIBROSIS; PRIMARY CILIUM; HIPPO PATHWAY; TAZ; CHANNEL; INAD	Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent monogenic cause of kidney failure, characterized by the development of renal cysts. ADPKD is caused by mutations of the polycystin-1 (PC1) or polycystin-2 (PC2) genes. PC2 encodes a Ca2+-permeable cation channel, and its dysfunction has been implicated in cyst development. The transcriptional coactivator with PDZ binding motif (TAZ) is required for the integrity of renal cilia. Its absence results in the development of renal cysts in a knock-out mouse model. TAZ directly interacts with PC2, and it has been suggested that another yet unidentified PDZ domain protein may be involved in the TAZ/PC2 interaction. Here we describe a novel interaction of TAZ with the multi-PDZ-containing PALS1-associated tight junction protein (PATJ). TAZ interacts with both the N-terminal PDZ domains 1-3 and the C-terminal PDZ domains 8-10 of PATJ, suggesting two distinct TAZ binding domains. We also show that the C terminus of PC2 strongly interacts with PDZ domains 8-10 and to a weaker extent with PDZ domains 1-3 of PATJ. Finally, we demonstrate that both TAZ and PATJ impair PC2 channel activity when co-expressed with PC2 in oocytes of Xenopus laevis. These results implicate TAZ and PATJ as novel regulatory elements of the PC2 channel and might thus be involved in ADPKD pathology.	[Duning, Kerstin; Rosenbusch, Deike; Schlueter, Marc A.; Meyer, Nina; Schulze, Ulf; Pavenstaedt, Hermann; Weide, Thomas] Univ Munster, Univ Clin Munster, Dept Internal Med D, D-48149 Munster, Germany; [Tian, Yuemin; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany; [Markoff, Arseni] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	University of Munster; University of Regensburg; University of Munster	Duning, K (corresponding author), Univ Munster, Univ Clin Munster, Dept Internal Med D, D-48149 Munster, Germany.	duning@uni-muenster.de; pavensth@mednet.uni-muenster.de	Tian, Yuemin/AAE-8827-2021	Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft [PA 483/14-2, DFG SFB699 A6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grants PA 483/14-2 and DFG SFB699 A6.	Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fu X, 2008, J AM SOC NEPHROL, V19, P1342, DOI 10.1681/ASN.2007070730; Hackmann K, 2005, HUM MOL GENET, V14, P3249, DOI 10.1093/hmg/ddi356; Hamaratoglu F, 2009, J CELL SCI, V122, P2351, DOI 10.1242/jcs.046482; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Houslay MD, 2009, BRIT J PHARMACOL, V158, P483, DOI 10.1111/j.1476-5381.2009.00359.x; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Lee NPY, 2006, FEBS LETT, V580, P923, DOI 10.1016/j.febslet.2006.01.019; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Schluter MA, 2009, J AM SOC NEPHROL, V20, P1444, DOI 10.1681/ASN.2008090949; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V18, P243, DOI 10.1159/000097671; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Treharne KJ, 2007, J BIOL CHEM, V282, P10804, DOI 10.1074/jbc.M610956200; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	46	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33584	33588		10.1074/jbc.C110.146381	http://dx.doi.org/10.1074/jbc.C110.146381			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20833712	hybrid, Green Published			2022-12-25	WOS:000283354000003
J	Thompson, PD; Tipney, H; Brass, A; Noyes, H; Kemp, S; Naessens, J; Tassabehji, M				Thompson, Pamela D.; Tipney, Hannah; Brass, Andy; Noyes, Harry; Kemp, Steve; Naessens, Jan; Tassabehji, May			Claudin 13, a Member of the Claudin Family Regulated in Mouse Stress Induced Erythropoiesis	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; TIGHT JUNCTION; TRYPANOSOMA-CONGOLENSE; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; C-KIT; GENE-EXPRESSION; PROTEIN; CELLS; SURVIVIN	Mammals are able to rapidly produce red blood cells in response to stress. The molecular pathways used in this process are important in understanding responses to anaemia in multiple biological settings. Here we characterise the novel gene Claudin 13 (Cldn13), a member of the Claudin family of tight junction proteins using RNA expression, microarray and phylogenetic analysis. We present evidence that Cldn13 appears to be co-ordinately regulated as part of a stress induced erythropoiesis pathway and is a mouse-specific gene mainly expressed in tissues associated with haematopoietic function. CLDN13 phylogenetically groups with its genomic neighbour CLDN4, a conserved tight junction protein with a putative role in epithelial to mesenchymal transition, suggesting a recent duplication event. Mechanisms of mammalian stress erythropoiesis are of importance in anaemic responses and expression microarray analyses demonstrate that Cldn13 is the most abundant Claudin in spleen from mice infected with Trypanosoma congolense. In mice prone to anaemia (C57BL/6), its expression is reduced compared to strains which display a less severe anaemic response (A/J and BALB/c) and is differentially regulated in spleen during disease progression. Genes clustering with Cldn13 on microarrays are key regulators of erythropoiesis (Tal1, Trim10, E2f2), erythrocyte membrane proteins (Rhd and Gypa), associated with red cell volume (Tmcc2) and indirectly associated with erythropoietic pathways (Cdca8, Cdkn2d, Cenpk). Relationships between genes appearing co-ordinately regulated with Cldn13 post-infection suggest new insights into the molecular regulation and pathways involved in stress induced erythropoiesis and suggest a novel, previously unreported role for claudins in correct cell polarisation and protein partitioning prior to erythroblast enucleation.	[Thompson, Pamela D.; Tassabehji, May] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Tipney, Hannah] Univ Colorado Denver, Ctr Computat Pharmacol, Aurora, CO USA; [Brass, Andy] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Brass, Andy] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Noyes, Harry; Kemp, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Kemp, Steve; Naessens, Jan] Int Livestock Res Inst, Nairobi, Kenya	University of Manchester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Manchester; University of Manchester; University of Liverpool; CGIAR; International Livestock Research Institute (ILRI)	Thompson, PD (corresponding author), Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England.	m.tassabehji@manchester.ac.uk	Noyes, Harry A/B-1151-2010	Noyes, Harry A/0000-0002-0656-200X; Thompson, Pamela/0000-0002-2660-6348; Brass, Andrew/0000-0002-0389-7058	Wellcome Trust [GR1061183, WT066764MF, GR066764MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust (grant nos. GR1061183, WT066764MF, GR066764MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuazza G, 2006, AM J PHYSIOL-RENAL, V291, pF1132, DOI 10.1152/ajprenal.00063.2006; Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Adelman CA, 2002, DEVELOPMENT, V129, P539; ANDRIANARIVO AG, 1995, EXP PARASITOL, V80, P407, DOI 10.1006/expr.1995.1053; Blaybel R, 2008, CELL RES, V18, P834, DOI 10.1038/cr.2008.68; BRODSKY I, 1966, CANCER RES, V26, P198; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Chagraoui J, 2003, BLOOD, V101, P2973, DOI 10.1182/blood-2002-05-1341; Chasis JA, 2006, CURR OPIN HEMATOL, V13, P137, DOI 10.1097/01.moh.0000219657.57915.30; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cramer EM, 1999, BLOOD, V94, P3683, DOI 10.1182/blood.V94.11.3683.423a23_3683_3693; D'Souza T, 2007, EXP CELL RES, V313, P3364, DOI 10.1016/j.yexcr.2007.06.026; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; Delhommeau F, 2002, BLOOD, V100, P2629, DOI 10.1182/blood.V100.7.2629; DOMINIQUE G, BRIT J HAEMATOLOGY, V148, P161; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; HAMAZAKI Y, 2007, NAT IMMUNOL ADV ONLI; Hancock D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-264; Harada H, 1999, MOL CELL BIOL, V19, P3808; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hua VB, 2003, J MEMBRANE BIOL, V194, P59, DOI 10.1007/s00232-003-2026-8; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito S, 2007, BLOOD, V109, P1923, DOI 10.1182/blood-2006-06-030841; JIANG J, BLOOD; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; Kierstein S, 2006, GENES IMMUN, V7, P667, DOI 10.1038/sj.gene.6364345; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kollmar R, 2001, P NATL ACAD SCI USA, V98, P10196, DOI 10.1073/pnas.171325898; Kumada M, 2002, GENE, V299, P165, DOI 10.1016/S0378-1119(02)01054-5; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LATASHA C, 2008, DEV DYNAM, V237, P436; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Matsuoka M, 1998, ONCOGENE, V16, P2075, DOI 10.1038/sj.onc.1201745; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; MCMILLAN BJ, 2007, J BIOL CHEM; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Michl P, 2003, CANCER RES, V63, P6265; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Naessens J, 2005, CLIN EXP IMMUNOL, V139, P405, DOI 10.1111/j.1365-2249.2004.02717.x; Nakamura Y, 2003, PARASITOL RES, V90, P171, DOI 10.1007/s00436-003-0844-3; Noyes HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005170; O'Donovan KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010045; Ojok L, 2001, J COMP PATHOL, V124, P149, DOI 10.1053/jcpa.2000.0445; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Uehara K, 2008, HISTOCHEM CELL BIOL, V129, P95, DOI 10.1007/s00418-007-0343-1; Umehara D, 2010, J VIROL, V84, P7675, DOI 10.1128/JVI.00488-10; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Van Itallie Christina M, 2004, Proc Am Thorac Soc, V1, P38, DOI 10.1513/pats.2306013; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; XIANG Z, 2009, AM J HEMATOL, V84, P492; Yamashita A, 2000, FEBS LETT, V481, P147, DOI 10.1016/S0014-5793(00)01987-6; Yi ZH, 2006, PLOS GENET, V2, P129, DOI 10.1371/journal.pgen.0020014	96	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12667	10.1371/journal.pone.0012667	http://dx.doi.org/10.1371/journal.pone.0012667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844758	gold, Green Published			2022-12-25	WOS:000281687300011
J	Gullick, NJ; Evans, HG; Church, LD; Jayaraj, DM; Filer, A; Kirkham, BW; Taams, LS				Gullick, Nicola J.; Evans, Hayley G.; Church, Leigh D.; Jayaraj, David M.; Filer, Andrew; Kirkham, Bruce W.; Taams, Leonie S.			Linking Power Doppler Ultrasound to the Presence of Th17 Cells in the Rheumatoid Arthritis Joint	PLOS ONE			English	Article							RECEIVING CONCOMITANT METHOTREXATE; NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; TNF-ALPHA; DESTRUCTIVE ARTHRITIS; ACTIVATED MONOCYTES; INHIBITORY FACTOR; DISEASE-ACTIVITY; SYNOVIAL TISSUE; T-CELLS	Background: Power Doppler ultrasound (PDUS) is increasingly used to assess synovitis in Rheumatoid Arthritis (RA). Prior studies have shown correlations between PDUS scores and vessel counts, but relationships with T cell immunopathology have not been described. Methodology/Principal Findings: PBMC were isolated from healthy controls (HC) or RA patients and stimulated ex vivo with PMA and ionomycin for 3 hours in the presence of Golgistop. Paired synovial fluid (SF) or synovial tissue (ST) were analysed where available. Intracellular expression of IL-17, IFN gamma, and TNF alpha by CD4+ T cells was determined by flow cytometry. Synovial blood flow was evaluated by PDUS signal at the knees, wrists and metacarpophalangeal joints of RA patients. Serum, SF and fibroblast culture supernatant levels of vascular endothelial growth factor-A (VEGF-A) were measured by ELISA. The frequency of IL17+IFN gamma-CD4+ T cells (Th17 cells) was significantly elevated in peripheral blood (PB) from RA patients vs. HC (median (IQR) 0.5 (0.28-1.59)% vs. 0.32 (0.21-0.54)%, p = 0.005). Th17 cells were further enriched (mean 6.6-fold increase) in RA SF relative to RA PB. Patients with active disease had a higher percentage of IL-17+ T cells in ST than patients in remission, suggesting a possible role for Th17 cells in active synovitis in RA. Indeed, the percentage of Th17 cells, but not Th1, in SF positively correlated with CRP (r = 0.51, p = 0.04) and local PDUS-defined synovitis (r = 0.61, p = 0.002). Furthermore, patients with high levels of IL-17+ CD4+ T cells in SF had increased levels of the angiogenic factor VEGF-A in SF. Finally, IL-17, but not IFN gamma, increased VEGF-A production by RA synovial fibroblasts in vitro. Conclusions/Significance: Our data demonstrate a link between the presence of pro-inflammatory Th17 cells in SF and local PDUS scores, and offer a novel immunological explanation for the observation that rapid joint damage progression occurs in patients with persistent positive PDUS signal.	[Gullick, Nicola J.; Evans, Hayley G.; Jayaraj, David M.; Taams, Leonie S.] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Gullick, Nicola J.; Evans, Hayley G.; Jayaraj, David M.; Kirkham, Bruce W.; Taams, Leonie S.] Guys & St Thomas Hosp, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London SE1 9RT, England; [Gullick, Nicola J.; Kirkham, Bruce W.] Guys & St Thomas NHS Fdn Trust, Dept Rheumatol, London, England; [Church, Leigh D.; Filer, Andrew] Univ Birmingham, Rheumatol Res Grp, Div Immun & Infect, Birmingham, W Midlands, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham	Gullick, NJ (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England.	leonie.taams@kcl.ac.uk	Filer, Andrew/AAP-9179-2021; Gullick, Nicola J/GWZ-1369-2022	Filer, Andrew/0000-0001-8164-6249; Church, Leigh/0000-0001-9081-1445; Gullick, Nicola/0000-0001-8970-4116; Taams, Leonie/0000-0002-9337-7194	Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust [R050719]; Versus Arthritis [18547] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College Hospital NHS Foundation Trust; Versus Arthritis(Versus Arthritis)	The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust (to NG, HE, DJ, BK and LT), and from the Guy's and St Thomas' Charity (R050719 to NG and BK). AF is funded by Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 2002, Eur J Echocardiogr, V3, P240; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; Chabaud M, 2000, CYTOKINE, V12, P1092, DOI 10.1006/cyto.2000.0681; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Cope AP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2412; Doodes PD, 2008, J IMMUNOL, V181, P329, DOI 10.4049/jimmunol.181.1.329; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P479, DOI 10.1002/art.1780400314; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Koenders MI, 2006, J IMMUNOL, V176, P6262, DOI 10.4049/jimmunol.176.10.6262; Leipe J., 2010, ARTHRITIS RHEUM; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Naredo E, 2008, ARTHRITIS RHEUM, V58, P2248, DOI 10.1002/art.23682; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; Nishimoto N, 2006, CURR OPIN RHEUMATOL, V18, P277, DOI 10.1097/01.bor.0000218949.19860.d1; Paleolog EM, 2002, ARTHRITIS RES THER, V4, pS81, DOI 10.1186/ar575; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Ryu S, 2006, CLIN RHEUMATOL, V25, P16, DOI 10.1007/s10067-005-1081-1; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Skapenko A, 2009, NAT REV RHEUMATOL, V5, P491, DOI 10.1038/nrrheum.2009.157; Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Taylor PC, 2006, ARTHRITIS RHEUM-US, V54, P47, DOI 10.1002/art.21544; VANROON JAG, 1995, ANN RHEUM DIS, V54, P836, DOI 10.1136/ard.54.10.836; VERWILGHEN J, 1993, IMMUNOLOGY, V80, P96; Walther M, 2001, ARTHRITIS RHEUM, V44, P331, DOI 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0; WILBRINK B, 1991, BRIT J RHEUMATOL, V30, P265; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341	50	66	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12516	10.1371/journal.pone.0012516	http://dx.doi.org/10.1371/journal.pone.0012516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824142	Green Published, gold, Green Submitted			2022-12-25	WOS:000281456100017
J	Di Marcotullio, L; Greco, A; Mazza, D; Canettieri, G; Pietrosanti, L; Infante, P; Coni, S; Moretti, M; De Smaele, E; Ferretti, E; Screpanti, I; Gulino, A				Di Marcotullio, L.; Greco, A.; Mazza, D.; Canettieri, G.; Pietrosanti, L.; Infante, P.; Coni, S.; Moretti, M.; De Smaele, E.; Ferretti, E.; Screpanti, I.; Gulino, A.			Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal	ONCOGENE			English	Article						Hedgehog; Gli1; Itch; Numb; ubiquitination; medulloblastoma	UBIQUITIN-PROTEIN LIGASE; WW DOMAINS; IN-VITRO; MEDULLOBLASTOMA; TARGETS; PROLIFERATION; ENZYME; FAMILY; PHOSPHORYLATION; TRANSCRIPTION	Hedgehog pathway regulates tissue patterning and cell proliferation. Gli1 transcription factor is the major effector of Hedgehog signaling and its deregulation is often associated to medulloblastoma formation. Proteolytic processes represent a critical mechanism by which this pathway is turned off. Here, we characterize the regulation of an ubiquitin-mediated mechanism of Gli1 degradation, promoted by the coordinated action of the E3 ligase Itch and the adaptor protein Numb. We show that Numb activates the catalytic activity of Itch, releasing it from an inhibitory intramolecular interaction between its homologous to E6-AP C-terminus and WW domains. The consequent activation of Itch, together with the recruitment of Gli1 through direct binding with Numb, allows Gli1 to enter into the complex, resulting in Gli1 ubiquitination and degradation. This process is mediated by a novel Itch-dependent degron, composed of a combination of two PPXYs and a phospho-serine/proline motifs, localized in Gli1 C-terminal region, indicating the role of two different WW docking sites in Gli1 ubiquitination. Remarkably, Gli1 protein mutated in these modules is no longer regulated by Itch and Numb, and determines enhanced Gli1-dependent medulloblastoma growth, migration and invasion abilities, as well as in vitro transforming activity. Our data reveal a novel mechanism of regulation of Gli1 stability and function, which influences Hedgehog/Gli1 oncogenic potential. Oncogene (2011) 30, 65-76; doi: 10.1038/onc.2010.394; published online 6 September 2010	[Moretti, M.; De Smaele, E.; Ferretti, E.; Gulino, A.] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Di Marcotullio, L.; Greco, A.; Mazza, D.; Canettieri, G.; Pietrosanti, L.; Infante, P.; Coni, S.; Screpanti, I.; Gulino, A.] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy; [Screpanti, I.; Gulino, A.] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, I-00161 Rome, Italy; [Gulino, A.] Neuromed Inst, Pozzilli, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Neuromed	Gulino, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med, 324 Viale Regina Elena, I-00161 Rome, Italy.	alberto.gulino@uniroma1.it	Infante, Paola/G-9094-2018; De Smaele, Enrico/C-1124-2013; Mazzà, Daniela/AAK-3687-2021; Moretti, Marta/AAQ-7090-2020; Ferretti, Elisabetta/G-5413-2013	De Smaele, Enrico/0000-0003-4524-4423; Mazzà, Daniela/0000-0003-4754-9394; Infante, Paola/0000-0003-0682-3916; CANETTIERI, Gianluca/0000-0001-6694-2613; Ferretti, Elisabetta/0000-0001-7265-6429; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178	Associazione Italiana per la Ricerca sul Cancro (AIRC); Telethon [GGP07118]; Ministry of University and Research, (FIRB); Ministry of Health, Fondazione Roma and Fondazione Mariani	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Ministry of University and Research, (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministry of Health, Fondazione Roma and Fondazione Mariani	We thank Dr A Oro for providing the various Gli1 mutants and G Giannini for advice and critical discussion. This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), Telethon Grant GGP07118 and the Ministry of University and Research, (FIRB), the Ministry of Health, Fondazione Roma and Fondazione Mariani.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Argenti B, 2005, J NEUROSCI, V25, P8338, DOI 10.1523/JNEUROSCI.2438-05.2005; Bar EE, 2007, AM J PATHOL, V170, P347, DOI 10.2353/ajpath.2007.060066; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Galvin KE, 2008, STEM CELLS, V26, P1027, DOI 10.1634/stemcells.2007-0879; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guerreiro AS, 2008, CLIN CANCER RES, V14, P6761, DOI 10.1158/1078-0432.CCR-08-0385; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Haas AL, 1997, FASEB J, V11, P1257; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ikeda A, 2003, J VIROL, V77, P5529, DOI 10.1128/JVI.77.9.5529-5534.2003; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Van Sant C, 2001, P NATL ACAD SCI USA, V98, P8815, DOI 10.1073/pnas.161283098; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004	55	82	83	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					65	76		10.1038/onc.2010.394	http://dx.doi.org/10.1038/onc.2010.394			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20818436				2022-12-25	WOS:000285959300006
J	Atkin, KE; Brentnall, AS; Harris, G; Bingham, RJ; Erat, MC; Millard, CJ; Schwarz-Linek, U; Staunton, D; Vakonakis, I; Campbell, ID; Potts, JR				Atkin, Kate E.; Brentnall, Andrew S.; Harris, Gemma; Bingham, Richard J.; Erat, Michele C.; Millard, Christopher J.; Schwarz-Linek, Ulrich; Staunton, David; Vakonakis, Ioannis; Campbell, Iain D.; Potts, Jennifer R.			The Streptococcal Binding Site in the Gelatin-binding Domain of Fibronectin Is Consistent with a Non-linear Arrangement of Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; MEDIATE ADHERENCE; ENDOTHELIAL-CELLS; NMR-SPECTROSCOPY; MATRIX TURNOVER; PROTEIN; INTERNALIZATION; BACTERIA	Fibronectin-binding proteins (FnBPs) of Staphylococcus aureus and Streptococcus pyogenes mediate invasion of human endothelial and epithelial cells in a process likely to aid the persistence and/or dissemination of infection. In addition to binding sites for the N-terminal domain (NTD) of fibronectin (Fn), a number of streptococcal FnBPs also contain an upstream region (UR) that is closely associated with an NTD-binding region; UR binds to the adjacent gelatin-binding domain (GBD) of Fn. Previously, UR was shown to be required for efficient streptococcal invasion of epithelial cells. Here we show, using a Streptococcus zooepidemicus FnBP, that the UR-binding site in GBD resides largely in the (8)F1(9)F1 module pair. We also show that UR inhibits binding of a peptide from the alpha 1 chain of type I collagen to (8)F1(9)F1 and that UR binding to (8)F1 is likely to occur through anti-parallel beta-zipper formation. Thus, we propose that streptococcal proteins that contain adjacent NTD- and GBD-binding sites form a highly unusual extended tandem beta-zipper that spans the two domains and mediates high affinity binding to Fn through a large intermolecular interface. The proximity of the UR- and NTD-binding sequences in streptococcal FnBPs is consistent with a non-linear arrangement of modules in the tertiary structure of the GBD of Fn.	[Atkin, Kate E.; Brentnall, Andrew S.; Harris, Gemma; Bingham, Richard J.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Erat, Michele C.; Millard, Christopher J.; Staunton, David; Vakonakis, Ioannis; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Schwarz-Linek, Ulrich] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of York - UK; University of York - UK; University of Oxford; University of St Andrews	Potts, JR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jp516@york.ac.uk	Bingham, Richard J/H-6169-2019	Bingham, Richard J/0000-0003-3805-0364; Schwarz-Linek, Ulrich/0000-0003-0526-223X; Harris, Gemma/0000-0002-4587-4620; Millard, Chris/0000-0002-1012-0829	BBSRC; British Heart Foundation; FP7 Marie Curie Fellowship; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D010608/1] Funding Source: researchfish; British Heart Foundation [FS/09/023/27460, FS/07/034/22969] Funding Source: researchfish; BBSRC [BB/D010608/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); FP7 Marie Curie Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the BBSRC.; Supported by the British Heart Foundation.; Supported by a FP7 Marie Curie Fellowship.; Supported by the Wellcome Trust.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; FORASTIERI H, 1985, J BIOL CHEM, V260, P546; Hynes RO, 1990, FIBRONECTINS; Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002; JOH HJ, 1994, BIOCHEMISTRY-US, V33, P6086, DOI 10.1021/bi00186a007; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Lindmark H, 1996, INFECT IMMUN, V64, P3993, DOI 10.1128/IAI.64.10.3993-3999.1996; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Schor SL, 1999, J CELL SCI, V112, P3879; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	35	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36977	36983		10.1074/jbc.M110.156935	http://dx.doi.org/10.1074/jbc.M110.156935			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843804	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000284146100036
J	Jun, JH; Yoon, WJ; Seo, SB; Woo, KM; Kim, GS; Ryoo, HM; Baek, JH				Jun, Ji Hae; Yoon, Won-Joon; Seo, Sang-Beom; Woo, Kyung-Mi; Kim, Gwan-Shik; Ryoo, Hyun-Mo; Baek, Jeong-Hwa			BMP2-activated Erk/MAP Kinase Stabilizes Runx2 by Increasing p300 Levels and Histone Acetyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; SERINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PATHWAY; MAPK	Runx2 is a critical transcription factor for osteoblast differentiation. Regulation of Runx2 expression levels and transcriptional activity is important for bone morphogenetic protein (BMP)-induced osteoblast differentiation. Previous studies have shown that extracellular signal-regulated kinase (Erk) activation enhances the transcriptional activity of Runx2 and that BMP-induced Runx2 acetylation increases Runx2 stability and transcriptional activity. Because BMP signaling induces Erk activation in osteoblasts, we sought to investigate whether BMP-induced Erk signaling regulates Runx2 acetylation and stability. Erk activation by overexpression of constitutively active MEK1 increased Runx2 transcriptional activity, whereas U0126, an inhibitor of MEK1/2, suppressed basal Runx2 transcriptional activity and BMP-induced Runx2 acetylation and stabilization. Overexpression of constitutively active MEK1 stabilized Runx2 protein via up-regulation of acetylation and down-regulation of ubiquitination. Erk activation increased p300 protein levels and histone acetyltransferase activity. Knockdown of p300 using siRNA diminished Erk-induced Runx2 stabilization. Overexpression of Smad5 increased Runx2 acetylation and stabilization. Erk activation further increased Smad-induced Runx2 acetylation and stabilization, whereas U0126 suppressed these functions. On the other hand, knockdown of Smad1 and Smad5 by siRNA suppressed both basal and Erk-induced Runx2 protein levels. Erk activation enhanced the association of Runx2 with p300 and Smad1. Taken together these results indicate that Erk signaling increases Runx2 stability and transcriptional activity, partly via increasing p300 protein levels and histone acetyltransferase activity and subsequently increasing Runx2 acetylation by p300. In addition to the canonical Smad pathway, a BMP-induced non-Smad Erk signaling pathway cooperatively regulates osteoblast differentiation partly via increasing the stability and transcriptional activity of Runx2.	[Jun, Ji Hae; Yoon, Won-Joon; Woo, Kyung-Mi; Kim, Gwan-Shik; Ryoo, Hyun-Mo; Baek, Jeong-Hwa] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Jun, Ji Hae; Yoon, Won-Joon; Woo, Kyung-Mi; Kim, Gwan-Shik; Ryoo, Hyun-Mo; Baek, Jeong-Hwa] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [Seo, Sang-Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chung Ang University	Ryoo, HM (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Genet, 28 Yeongun Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr; baekjh@snu.ac.kr	Woo, Kyung Mi/A-2793-2009; Baek, Jeong-Hwa/A-8628-2012; Ryoo, Hyun-Mo/D-5839-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341	Ministry of Education, Science, and Technology [311-2006-1-E00093, 531-2007-1-E00070]; Ministry of Health and Welfare [A085021]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grants 311-2006-1-E00093 and 531-2007-1-E00070) and by the Korea Health 21 R&D Project, Ministry of Health and Welfare (Grant A085021).	Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen C, 2004, J BIOL CHEM, V279, P29121, DOI 10.1074/jbc.M313000200; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Hurley MM, 1996, J BONE MINER RES, V11, P1256; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yakmovych I, 2001, FASEB J, V15, P553; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yue JB, 2000, METH MOL B, V142, P125; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	56	124	129	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36410	36419		10.1074/jbc.M110.142307	http://dx.doi.org/10.1074/jbc.M110.142307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851880	Green Published, hybrid			2022-12-25	WOS:000284146100032
J	Ma, BY; Nussinov, R				Ma, Buyong; Nussinov, Ruth			Polymorphic C-terminal beta-Sheet Interactions Determine the Formation of Fibril or Amyloid beta-derived Diffusible Ligand-like Globulomer for the Alzheimer A beta 42 Dodecamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ION CHANNELS; EXPERIMENTAL CONSTRAINTS; MOLECULAR-DYNAMICS; SOLVENT PROTECTION; OXIDATIVE STRESS; EMERGING ROLE; PROTEIN; OLIGOMERS; PEPTIDE	The relationship between amyloid deposition and cellular toxicity is still controversial. In addition to fibril-forming oligomers, other soluble A beta forms (amyloid beta-derived diffusible ligands (ADDLs)) were also suggested to form and to present different morphologies and mechanisms of toxicity. One ADDL type, the "globulomer," apparently forms independently of the fibril aggregation pathway. Even though many studies argue that such soluble A beta oligomers are off fibril formation pathways, they may nonetheless share some structural similarity with protofibrils. NMR data of globulomer intermediates, "preglobulomers," suggested parallel in-register C-terminal beta-sheets, with different N-terminal conformations. Based on experimental data, we computationally investigate four classes of A beta dodecamers: fibril, fibril oligomer, prefibril/preglobulomer cluster, and globulomer models. Our simulations of the solvent protection of double-layered fibril and globulomer models reproduce experimental observations. Using a single layer A beta fibril oligomer beta-sheet model, we found that the C-terminal beta-sheet in the fibril oligomer is mostly curved, preventing it from quickly forming a fibril and leading to its breaking into shorter pieces. The simulations also indicate that beta-sheets packed orthogonally could be the most stable species for A beta dodecamers. The major difference between fibril-forming oligomers and ADDL-like oligomers (globulomers) could be the exposure of Met-35 patches. Although the Met-35 patches are necessarily exposed in fibril-forming oligomers to allow their maturation into fibrils, the Met-35 patches in the globulomer are covered by other residues in the orthogonally packed A beta peptides. Our results call attention to the possible existence of certain "critical intermediates" that can lead to both seeds and other soluble ADDL-like oligomers.	[Ma, Buyong; Nussinov, Ruth] NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program, Bldg 469,Rm 151, Frederick, MD 21702 USA.	mabuyong@mail.nih.gov	Ma, Buyong/F-9491-2011	Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Cancer Institute, National Institutes of Health under contract number HHSN261200800001E and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035; Butterfield DA, 2002, PEPTIDES, V23, P1299, DOI 10.1016/S0196-9781(02)00066-9; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kanski J, 2002, BBA-MOL BASIS DIS, V1586, P190, DOI 10.1016/S0925-4439(01)00097-7; Kanski J, 2002, NEUROTOX RES, V4, P219, DOI 10.1080/10298420290023945; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Misiti F, 2010, NEUROCHEM INT, V56, P597, DOI 10.1016/j.neuint.2010.01.002; Mustata M, 2009, J AM CHEM SOC, V131, P14938, DOI 10.1021/ja9049299; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	56	31	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37102	37110		10.1074/jbc.M110.133488	http://dx.doi.org/10.1074/jbc.M110.133488			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847046	Green Published, hybrid			2022-12-25	WOS:000284146100066
J	Agarwal, V; Asmat, TM; Dierdorf, NI; Hauck, CR; Hammerschmidt, S				Agarwal, Vaibhav; Asmat, Tauseef M.; Dierdorf, Nina I.; Hauck, Christof R.; Hammerschmidt, Sven			Polymeric Immunoglobulin Receptor-mediated Invasion of Streptococcus pneumoniae into Host Cells Requires a Coordinate Signaling of SRC Family of Protein-tyrosine Kinases, ERK, and c-Jun N-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MICROVASCULAR ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; IG RECEPTOR; BACTERIAL PATHOGENS; MAMMALIAN-CELLS; SECRETORY IGA; ACTIVATION; INTEGRIN	Streptococcus pneumoniae are commensals of the human nasopharynx with the capacity to invade mucosal respiratory cells. PspC, a pneumococcal surface protein, interacts with the human polymeric immunoglobulin receptor (pIgR) to promote bacterial adherence to and invasion into epithelial cells. Internalization of pneumococci requires the coordinated action of actin cytoskeleton rearrangements and the retrograde machinery of pIgR. Here, we demonstrate the involvement of Src protein-tyrosine kinases (PTKs), focal adhesion kinase (FAK), extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) but not p38 mitogen-activated protein kinases (MAPK) in pneumococcal invasion via pIgR. Pharmacological inhibitors of PTKs and MAPKs and genetic interference with Src PTK and FAK functions caused a significant reduction of pIgR-mediated pneumococcal invasion but did not influence bacterial adhesion to host cells. Furthermore, pneumococcal ingestion by host cells induces activation of ERK1/2 and JNK. In agreement with activated JNK, its target molecule and DNA-binding protein c-Jun was phosphorylated. We also show that functionally active Src PTK is essential for activation of ERK1/2 upon pneumococcal infections. In conclusion, these data illustrate the importance of a coordinated signaling between Src PTKs, ERK1/2, and JNK during PspC-pIgR-mediated uptake of pneumococci by host epithelial cells.	[Agarwal, Vaibhav; Asmat, Tauseef M.; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Agarwal, Vaibhav; Hammerschmidt, Sven] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Dierdorf, Nina I.; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Dierdorf, Nina I.; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Konstanz; University of Konstanz	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010; Asmat, Tauseef M/Q-3801-2019	Hammerschmidt, Sven/0000-0002-6382-6681; 	Deutsche Forschungsgemeinschaft [DFG Ha 3125/2-1, Ha 3125/4-1]; European Union [FP7 CAREPNEUMO EU-CP223111]; German Academic Exchange Service (DAAD)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG Ha 3125/2-1 and Ha 3125/4-1 and European Union Grant FP7 CAREPNEUMO EU-CP223111.; Recipients of German Academic Exchange Service (DAAD) fellowships.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Czerucka D, 2001, INFECT IMMUN, V69, P1298, DOI 10.1128/IAI.69.3.1298-1305.2001; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Ellington JK, 2001, INFECT IMMUN, V69, P5235, DOI 10.1128/IAI.69.9.5235-5242.2001; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; Luton F, 1999, MOL BIOL CELL, V10, P1409, DOI 10.1091/mbc.10.5.1409; Luton F, 1998, MOL BIOL CELL, V9, P1787, DOI 10.1091/mbc.9.7.1787; Maza PK, 2008, MICROBES INFECT, V10, P540, DOI 10.1016/j.micinf.2008.02.004; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; MOSTOV KE, 1984, NATURE, V308, P37, DOI 10.1038/308037a0; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; N'Guessan PD, 2005, THROMB HAEMOSTASIS, V94, P295, DOI 10.1160/TH04-12-0822; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naumann M, 1998, J EXP MED, V188, P1277, DOI 10.1084/jem.188.7.1277; Nerlich A, 2009, J BIOL CHEM, V284, P20319, DOI 10.1074/jbc.M109.016501; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; PISKURICH JF, 1995, J IMMUNOL, V154, P1735; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rovedo M, 2008, J VIROL, V82, P8520, DOI 10.1128/JVI.00843-08; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Shimada S, 1999, J IMMUNOL, V163, P5367; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; TAMER CM, 1995, J IMMUNOL, V155, P707; Tang P, 1998, INFECT IMMUN, V66, P1106, DOI 10.1128/IAI.66.3.1106-1112.1998; Watanabe K, 2001, INFECT IMMUN, V69, P6731, DOI 10.1128/IAI.69.11.6731-6737.2001; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	63	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35615	35623		10.1074/jbc.M110.172999	http://dx.doi.org/10.1074/jbc.M110.172999			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829350	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000283845300040
J	Kular, RK; Gogliotti, RG; Opal, P				Kular, Rupinder K.; Gogliotti, Rocky G.; Opal, Puneet			Cpd-1 Null Mice Display a Subtle Neurological Phenotype	PLOS ONE			English	Article							ACIDIC NUCLEAR-PROTEIN; MICROTUBULE-ASSOCIATED PROTEINS; LEUCINE-RICH REPEATS; PP32 EXPRESSION; PROSTATE-CANCER; MAPMODULIN; INHIBITOR; ATAXIN-1; BINDS; GENE	Background: CPD1 (also known as ANP32-E) belongs to a family of evolutionarily conserved acidic proteins with leucine rich repeats implicated in a variety of cellular processes regulating gene expression, vesicular trafficking, intracellular signaling and apoptosis. Because of its spatiotemporal expression pattern, CPD1 has been proposed to play an important role in brain morphogenesis and synaptic development. Methodology/Principal Findings: We have generated CPD1 knock-out mice that we have subsequently characterized. These mice are viable and fertile. However, they display a subtle neurological clasping phenotype and mild motor deficits. Conclusions/Significance: CPD1 is not essential for normal development; however, it appears to play a role in the regulation of fine motor functions. The minimal phenotype suggests compensatory biological mechanisms.	[Kular, Rupinder K.; Opal, Puneet] NW Univ Feinberg, Sch Med, Davee Dept Neurol, Chicago, IL USA; [Kular, Rupinder K.; Opal, Puneet] NW Univ Feinberg, Sch Med, Dept Cell & Mol Biol, Chicago, IL USA; [Gogliotti, Rocky G.] NW Univ Feinberg, Sch Med, Integrated Grad Program, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kular, RK (corresponding author), NW Univ Feinberg, Sch Med, Davee Dept Neurol, Chicago, IL USA.	p-opal@northwestern.edu			NIH [K02 NS051340, R03HD054612-01A2, R21 NS060080-01A1, R01 NS062051, 5T32 NS41234-01]; National Ataxia Foundation; Brain Research Foundation; National Organization for Rare Disorders (NORD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD054612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082351, T32NS041234, R21NS060080, R01NS062051, K02NS051340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; Brain Research Foundation; National Organization for Rare Disorders (NORD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by NIH (grants K02 NS051340, R03HD054612-01A2, R21 NS060080-01A1, R01 NS062051), the National Ataxia Foundation, the Brain Research Foundation and the National Organization for Rare Disorders (NORD). An NIH training grant: 5T32 NS41234-01 sponsored the work of R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Costes E., 2006, Horticultural Reviews, V32, P1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Itin C, 1999, MOL BIOL CELL, V10, P2191, DOI 10.1091/mbc.10.7.2191; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kadkol SS, 1999, NAT MED, V5, P275, DOI 10.1038/6488; Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO;2-F; Kular RK, 2009, J BIOL CHEM, V284, P7783, DOI 10.1074/jbc.M806150200; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Mutai H, 2000, BIOCHEM BIOPH RES CO, V274, P427, DOI 10.1006/bbrc.2000.3133; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Opal P, 2004, MOL CELL BIOL, V24, P3140, DOI 10.1128/MCB.24.8.3140-3149.2004; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Ulitzur N, 1997, P NATL ACAD SCI USA, V94, P5084, DOI 10.1073/pnas.94.10.5084; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003	28	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12649	10.1371/journal.pone.0012649	http://dx.doi.org/10.1371/journal.pone.0012649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844742	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687200014
J	Francis, CM; Borisenko, AV; Ivanova, NV; Eger, JL; Lim, BK; Guillen-Servent, A; Kruskop, SV; Mackie, I; Hebert, PDN				Francis, Charles M.; Borisenko, Alex V.; Ivanova, Natalia V.; Eger, Judith L.; Lim, Burton K.; Guillen-Servent, Antonio; Kruskop, Sergei V.; Mackie, Iain; Hebert, Paul D. N.			The Role of DNA Barcodes in Understanding and Conservation of Mammal Diversity in Southeast Asia	PLOS ONE			English	Article							ANCIENT DNA; VESPERTILIONIDAE; CHIROPTERA; BATS	Background: Southeast Asia is recognized as a region of very high biodiversity, much of which is currently at risk due to habitat loss and other threats. However, many aspects of this diversity, even for relatively well-known groups such as mammals, are poorly known, limiting ability to develop conservation plans. This study examines the value of DNA barcodes, sequences of the mitochondrial COI gene, to enhance understanding of mammalian diversity in the region and hence to aid conservation planning. Methodology and Principal Findings: DNA barcodes were obtained from nearly 1900 specimens representing 165 recognized species of bats. All morphologically or acoustically distinct species, based on classical taxonomy, could be discriminated with DNA barcodes except four closely allied species pairs. Many currently recognized species contained multiple barcode lineages, often with deep divergence suggesting unrecognized species. In addition, most widespread species showed substantial genetic differentiation across their distributions. Our results suggest that mammal species richness within the region may be underestimated by at least 50%, and there are higher levels of endemism and greater intra-specific population structure than previously recognized. Conclusions: DNA barcodes can aid conservation and research by assisting field workers in identifying species, by helping taxonomists determine species groups needing more detailed analysis, and by facilitating the recognition of the appropriate units and scales for conservation planning.	[Francis, Charles M.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada; [Borisenko, Alex V.; Ivanova, Natalia V.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Eger, Judith L.; Lim, Burton K.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Guillen-Servent, Antonio] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Kruskop, Sergei V.] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [Mackie, Iain] Univ Aberdeen, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland	Environment & Climate Change Canada; Canadian Wildlife Service; University of Guelph; Royal Ontario Museum; Instituto de Ecologia - Mexico; Lomonosov Moscow State University; University of Aberdeen	Francis, CM (corresponding author), Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada.	charles.francis@ec.gc.ca	Hebert, Paul DN/C-4161-2013; Borisenko, Alex/GQZ-9054-2022; Lim, Burton K/A-1148-2011; Guillén Servent, Antonio/R-2167-2018; Borisenko, Alex/G-9107-2014	Hebert, Paul DN/0000-0002-3081-6700; Lim, Burton K/0000-0002-0884-0421; Guillén Servent, Antonio/0000-0001-6273-485X; Borisenko, Alex/0000-0002-3061-3057; Kruskop, Sergei/0000-0002-9846-0317	Canada Foundation for Innovation; Ontario Innovation Trust; Natural Sciences and Engineering Research Council of Canada; Gordon and Betty Moore Foundation; Wildlife Conservation Society; Royal Ontario Museum (ROM); Vietnamese-Russian Tropical Centre; Harrison Museum; U.S. National Science Foundation [DEB-0244430]; Darwin Initiative [14-036]; Carnegie Trust for the Universities of Scotland; University of Missouri	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Wildlife Conservation Society; Royal Ontario Museum (ROM); Vietnamese-Russian Tropical Centre; Harrison Museum; U.S. National Science Foundation(National Science Foundation (NSF)); Darwin Initiative; Carnegie Trust for the Universities of Scotland; University of Missouri	DNA analyses were supported by grants to PDNH from the Canada Foundation for Innovation, the Ontario Innovation Trust, the Natural Sciences and Engineering Research Council of Canada, and the Gordon and Betty Moore Foundation. Field work was supported by the Wildlife Conservation Society, Royal Ontario Museum (ROM) and ROM Governors, Vietnamese-Russian Tropical Centre, the Harrison Museum, the U.S. National Science Foundation (DEB-0244430), the Darwin Initiative (Grant 14-036), the Carnegie Trust for the Universities of Scotland, the University of Missouri Research Board grants to Dr. Robert E. Ricklefs, as well as in-kind and financial support from various host institutions in local countries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise John C., 2004, P1; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bates P. J. J., 1997, BATS INDIAN SUBCONTI; Bates PJJ, 2007, ACTA CHIROPTEROL, V9, P323, DOI 10.3161/1733-5329(2007)9[323:ANSOKC]2.0.CO;2; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; BORISENKO AV, 1999, PLECOTUS ET AL, P10; BORISSENKO AV, 2003, BATS VIETNAM ADJACEN; Campbell P, 2004, MOL PHYLOGENET EVOL, V33, P764, DOI 10.1016/j.ympev.2004.06.019; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Cooper A, 2000, SCIENCE, V289, P1139; Corbet G.B., 1992, P1; CSORBA G, 2003, ALANA BOOKS, V30, P160; FRANCIS CM, 1989, J MAMMAL, V70, P865, DOI 10.2307/1381730; FRANCIS CM, 2008, FIELD GUIDE MAMMALS; Grubb P, 2005, MAMMAL SPECIES WORLD, P637; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; INSKIPP T, CHECKLIST BIRDS ORIE; IUCN, 2012, IUCN RED LIST CATEGO, VSecond; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kitchener AC, 2006, CURR BIOL, V16, P2377, DOI 10.1016/j.cub.2006.10.066; Kruskop SV, 2008, ACTA CHIROPTEROL, V10, P213, DOI 10.3161/150811008X414809; Kruskop SV, 2001, MAMMALIA, V65, P63, DOI 10.1515/mamm.2001.65.1.63; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PAYNE J, 1985, FIELD GUIDE MAMMALS; Pfunder M, 2004, MOL ECOL, V13, P1277, DOI 10.1111/j.1365-294X.2004.02126.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Robson C., 2000, FIELD GUIDE BIRDS S; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith Andrew T., 2008, P1; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Xu XF, 1996, J MOL EVOL, V43, P431, DOI 10.1007/PL00006103	46	168	183	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12575	10.1371/journal.pone.0012575	http://dx.doi.org/10.1371/journal.pone.0012575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838635	gold, Green Published, Green Submitted			2022-12-25	WOS:000281627700022
J	Fedrigo, O; Warner, LR; Pfefferle, AD; Babbitt, CC; Cruz-Gordillo, P; Wray, GA				Fedrigo, Olivier; Warner, Lisa R.; Pfefferle, Adam D.; Babbitt, Courtney C.; Cruz-Gordillo, Peter; Wray, Gregory A.			A Pipeline to Determine RT-QPCR Control Genes for Evolutionary Studies: Application to Primate Gene Expression across Multiple Tissues	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; HUMAN BRAIN; CHIMPANZEE GENOME; RNA QUANTITATION; SELECTION; NORMALIZATION; PATTERNS; HUMANS; IDENTIFICATION	Because many species-specific phenotypic differences are assumed to be caused by differential regulation of gene expression, many recent investigations have focused on measuring transcript abundance. Despite the availability of high-throughput platforms, quantitative real-time polymerase chain reaction (RT-QPCR) is often the method of choice because of its low cost and wider dynamic range. However, the accuracy of this technique heavily relies on the use of multiple valid control genes for normalization. We created a pipeline for choosing genes potentially useful as RT-QPCR control genes for measuring expression between human and chimpanzee samples across multiple tissues, using published microarrays and a measure of tissue-specificity. We identified 13 genes from the pipeline and from commonly used control genes: ACTB, USP49, ARGHGEF2, GSK3A, TBP, SDHA, EIF2B2, GPDH, YWHAZ, HPTR1, RPL13A, HMBS, and EEF2. We then tested these candidate genes and validated their expression stability across species. We established the rank order of the most preferable set of genes for single and combined tissues. Our results suggest that for at least three tissues (cerebral cortex, liver, and skeletal muscle), EIF2B2, EEF2, HMBS, and SDHA are useful genes for normalizing human and chimpanzee expression using RT-QPCR. Interestingly, other commonly used control genes, including TBP, GAPDH, and, especially ACTB do not perform as well. This pipeline could be easily adapted to other species for which expression data exist, providing taxonomically appropriate control genes for comparisons of gene expression among species.	[Fedrigo, Olivier; Warner, Lisa R.; Pfefferle, Adam D.; Babbitt, Courtney C.; Cruz-Gordillo, Peter; Wray, Gregory A.] Duke Univ, Dept Biol, Durham, NC 27710 USA; [Fedrigo, Olivier; Warner, Lisa R.; Babbitt, Courtney C.; Cruz-Gordillo, Peter; Wray, Gregory A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Wray, Gregory A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; Duke University; Duke University	Fedrigo, O (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	ofedrigo@duke.edu		Cruz-Gordillo, Peter/0000-0002-0264-7348	National Science Foundation [NSF-BCS-08-27552]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant NSF-BCS-08-27552 (HOMINID) awarded to GAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABBITT CC, 2010, GENOME BIOL EVOL, V67, P79; Blekhman R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000271; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Infante C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-28; Jeong AR, 2008, J MED PRIMATOL, V37, P290, DOI 10.1111/j.1600-0684.2008.00289.x; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rozen S, 2000, Methods Mol Biol, V132, P365; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	37	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12545	10.1371/journal.pone.0012545	http://dx.doi.org/10.1371/journal.pone.0012545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824057	Green Published, gold			2022-12-25	WOS:000281480900026
J	Grabarczyk, P; Nahse, V; Delin, M; Przybylski, G; Depke, M; Hildebrandt, P; Volker, U; Schmidt, CA				Grabarczyk, Piotr; Naehse, Viola; Delin, Martin; Przybylski, Grzegorz; Depke, Maren; Hildebrandt, Petra; Voelker, Uwe; Schmidt, Christian A.			Increased Expression of Bcl11b Leads to Chemoresistance Accompanied by G1 Accumulation	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; ZINC-FINGER PROTEINS; T-LYMPHOCYTES; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; UP-REGULATION; NURD COMPLEX; PROMOTER; CTIP2; CELLS	Background: The expression of BCL11B was reported in T-cells, neurons and keratinocytes. Aberrations of BCL11B locus leading to abnormal gene transcription were identified in human hematological disorders and corresponding animal models. Recently, the elevated levels of Bcl11b protein have been described in a subset of squameous cell carcinoma cases. Despite the rapidly accumulating knowledge concerning Bcl11b biology, the contribution of this protein to normal or transformed cell homeostasis remains open. Methodology/Principal Findings: Here, by employing an overexpression strategy we revealed formerly unidentified features of Bcl11b. Two different T-cell lines were forced to express BCL11B at levels similar to those observed in primary Tcell leukemias. This resulted in markedly increased resistance to radiomimetic drugs while no influence on death-receptor apoptotic pathway was observed. Apoptosis resistance triggered by BCL11B overexpression was accompanied by a cell cycle delay caused by accumulation of cells at G1. This cell cycle restriction was associated with upregulation of CDKN1C (p57) and CDKN2C (p18) cyclin dependent kinase inhibitors. Moreover, p27 and p130 proteins accumulated and the SKP2 gene encoding a protein of the ubiquitin-binding complex responsible for their degradation was repressed. Furthermore, the expression of the MYCN oncogene was silenced which resulted in significant depletion of the protein in cells expressing high BCL11B levels. Both cell cycle restriction and resistance to DNA-damage-induced apoptosis coincided and required the histone deacetylase binding N-terminal domain of Bcl11b. The sensitivity to genotoxic stress could be restored by the histone deacetylase inhibitor trichostatine A. Conclusions: The data presented here suggest a potential role of BCL11B in tumor survival and encourage developing Bcl11b-inhibitory approaches as a potential tool to specifically target chemoresistant tumor cells.	[Grabarczyk, Piotr; Naehse, Viola; Delin, Martin; Przybylski, Grzegorz; Schmidt, Christian A.] Ernst Moritz Arndt Univ Greifswald, Dept Hematol & Oncol, Greifswald, Germany; [Depke, Maren; Hildebrandt, Petra; Voelker, Uwe] Interfac Inst Genet & Funct Gen, Dept Funct Gen, Greifswald, Germany; [Przybylski, Grzegorz] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Ernst Moritz Arndt Universitat Greifswald; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Grabarczyk, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Hematol & Oncol, Greifswald, Germany.	christian.schmidt@uni-greifswald.de		Volker, Uwe/0000-0002-5689-3448; Przybylski, Grzegorz/0000-0001-5783-1567	Deutsche Jose Carreras Leukemia Stiftung e.V [DJCLS R 09/31f]; Interfaculty Institute for Genetics and Functional Genomics; Bundesministerium fur Bildung und Forschung; Zentrum fur Innovationskompetenz Funktionelle Genomforschung [03ZIK331]	Deutsche Jose Carreras Leukemia Stiftung e.V; Interfaculty Institute for Genetics and Functional Genomics; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Zentrum fur Innovationskompetenz Funktionelle Genomforschung	The studies performed in the Department of Molecular Hematology were supported by Deutsche Jose Carreras Leukemia Stiftung e.V (Grant No. DJCLS R 09/31f). Work in the Interfaculty Institute for Genetics and Functional Genomics (U. V.) was supported by the Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz Funktionelle Genomforschung (ZIK FunGene 03ZIK331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2009, BIOCHEM J, V417, P457, DOI 10.1042/BJ20080925; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; CISMASIU VB, 2005, ONCOGENE; Ganguli-Indra G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005367; GOLONZHKA O, 2009, J INVESTIGATIVE DERM; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; GORCZYCA W, 1993, CANCER RES, V53, P3186; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; KAMIMURA K, 2007, ONCOGENE        0319; KAMIMURA K, 2007, BIOCH BIOPHYSICAL RE; KARLSSON A, 2007, BIOMEDCENTRAL CANC, V7; Ky N, 2009, APOPTOSIS, V14, P1095, DOI 10.1007/s10495-009-0368-0; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Liu DX, 2005, GENE DEV, V19, P719, DOI 10.1101/gad.1296405; Ma Y, 2007, ONCOGENE, V26, P3532, DOI 10.1038/sj.onc.1210143; Marban C, 2005, NUCLEIC ACIDS RES, V33, P2318, DOI 10.1093/nar/gki529; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; NAGAMACHI A, 2009, CANCER SCI, P1; Nagel S, 2003, CANCER RES, V63, P5329; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; OHI H, 2007, ONCOGENE; OSHIRO A, 2006, BLOOD; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Shinbo T, 1999, ONCOGENE, V18, P4131, DOI 10.1038/sj.onc.1202767; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; TOPARKNGARM A, 2006, J BIOL CHEM; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	44	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12532	10.1371/journal.pone.0012532	http://dx.doi.org/10.1371/journal.pone.0012532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824091	Green Submitted, gold, Green Published			2022-12-25	WOS:000281480900015
J	Uchida, K; Aramaki, M; Nakazawa, M; Yamagishi, C; Makino, S; Fukuda, K; Nakamura, T; Takahashi, T; Mikoshiba, K; Yamagishi, H				Uchida, Keiko; Aramaki, Megumi; Nakazawa, Maki; Yamagishi, Chihiro; Makino, Shinji; Fukuda, Keiichi; Nakamura, Takeshi; Takahashi, Takao; Mikoshiba, Katsuhiko; Yamagishi, Hiroyuki			Gene Knock-Outs of Inositol 1,4,5-Trisphosphate Receptors Types 1 and 2 Result in Perturbation of Cardiogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; 2-AMINOETHOXYDIPHENYL BORATE; NF-ATC; EXPRESSION; CA2+; CELL; CALCINEURIN; INDUCTION; PULMONARY; PROMOTER	Background: Inositol 1,4,5-trisphosphate receptors (IP(3)R1, 2, and 3) are intracellular Ca2+ release channels that regulate various vital processes. Although the ryanodine receptor type 2, another type of intracellular Ca2+ release channel, has been shown to play a role in embryonic cardiomyocytes, the functions of the IP(3)Rs in cardiogenesis remain unclear. Methodology/Principal Findings: We found that IP(3)R1(-/-)-IP(3)R2(-/-) double-mutant mice died in utero with developmental defects of the ventricular myocardium and atrioventricular (AV) canal of the heart by embryonic day (E) 11.5, even though no cardiac defect was detectable in IP(3)R1(-/-) or IP(3)R2(-/-) single-mutant mice at this developmental stage. The double-mutant phenotype resembled that of mice deficient for calcineurin/NFATc signaling, and NFATc was inactive in embryonic hearts from the double knockout-mutant mice. The double mutation of IP(3)R1/R2 and pharmacologic inhibition of IP(3)Rs mimicked the phenotype of the AV valve defect that result from the inhibition of calcineurin, and it could be rescued by constitutively active calcineurin. Conclusions/Significance: Our results suggest an essential role for IP(3)Rs in cardiogenesis in part through the regulation of calcineurin-NFAT signaling.	[Uchida, Keiko; Aramaki, Megumi; Nakazawa, Maki; Yamagishi, Chihiro; Takahashi, Takao; Yamagishi, Hiroyuki] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Makino, Shinji; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo, Japan; [Nakamura, Takeshi; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, ICORP SORST, Calcium Oscillat Project, Saitama, Japan; [Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Saitama, Japan	Keio University; Keio University; Japan Science & Technology Agency (JST); RIKEN	Uchida, K (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	mikosiba@brain.riken.jp; hyamag@sc.itc.keio.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Fukuda, Keiichi/L-3777-2013; Yamagishi, Hiroyuki/A-6345-2017		Ministry of Education, Culture, Sports, Science and Technology, Japan; Pfizer; Japan Automobile Association	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer(Pfizer); Japan Automobile Association	This work was supported by a Grant-in-Aid for Scientific Research (H.Y.) and a Grant-in-Aid for Young Scientists (K. U.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Pfizer Fund for Development Research (H.Y.), and a Research Fund from the Japan Automobile Association (H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; BROCK TA, 1991, AM J PATHOL, V138, P213; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; HOGAN PG, ANN REV IMMUNOL, V28, P491; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Jayaraman T, 2000, J BIOL CHEM, V275, P6417, DOI 10.1074/jbc.275.9.6417; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MJAATVEDT CH, 1989, DEV BIOL, V136, P118, DOI 10.1016/0012-1606(89)90135-8; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Oka T, 2005, MOL CELL BIOL, V25, P6649, DOI 10.1128/MCB.25.15.6649-6659.2005; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	37	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12500	10.1371/journal.pone.0012500	http://dx.doi.org/10.1371/journal.pone.0012500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824138	Green Submitted, Green Published, gold			2022-12-25	WOS:000281456100012
J	Baki, SGA; Schwab, B; Haber, M; Fenton, AA; Bergold, PJ				Baki, Samah G. Abdel; Schwab, Ben; Haber, Margalit; Fenton, Andre A.; Bergold, Peter J.			Minocycline Synergizes with N-Acetylcysteine and Improves Cognition and Memory Following Traumatic Brain Injury in Rats	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; PLACE AVOIDANCE; SPATIAL INFORMATION; BEHAVIORAL EVIDENCE; MICE; NEURODEGENERATION; SEGREGATION	Background: There are no drugs presently available to treat traumatic brain injury (TBI). A variety of single drugs have failed clinical trials suggesting a role for drug combinations. Drug combinations acting synergistically often provide the greatest combination of potency and safety. The drugs examined (minocycline (MINO), N-acetylcysteine (NAC), simvastatin, cyclosporine A, and progesterone) had FDA-approval for uses other than TBI and limited brain injury in experimental TBI models. Methodology/Principal Findings: Drugs were dosed one hour after injury using the controlled cortical impact (CCI) TBI model in adult rats. One week later, drugs were tested for efficacy and drug combinations tested for synergy on a hierarchy of behavioral tests that included active place avoidance testing. As monotherapy, only MINO improved acquisition of the massed version of active place avoidance that required memory lasting less than two hours. MINO-treated animals, however, were impaired during the spaced version of the same avoidance task that required 24-hour memory retention. Co-administration of NAC with MINO synergistically improved spaced learning. Examination of brain histology 2 weeks after injury suggested that MINO plus NAC preserved white, but not grey matter, since lesion volume was unaffected, yet myelin loss was attenuated. When dosed 3 hours before injury, MINO plus NAC as single drugs had no effect on interleukin-1 formation; together they synergistically lowered interleukin-1 levels. This effect on interleukin-1 was not observed when the drugs were dosed one hour after injury. Conclusions/Significance: These observations suggest a potentially valuable role for MINO plus NAC to treat TBI.	[Baki, Samah G. Abdel] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Baki, SGA (corresponding author), Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380; Fenton, Andre/0000-0002-5063-1156	Traumatic Brain Injury/Post-Traumatic Stress Disorder [W81XWH-08-1-0293]	Traumatic Brain Injury/Post-Traumatic Stress Disorder	This work was supported by a Traumatic Brain Injury/Post-Traumatic Stress Disorder Congressionally Directed Medical Research Programs award W81XWH-08-1-0293 (http://cdmrp.army.mil) to P.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P11493, DOI 10.1073/pnas.95.19.11493; Frei E., 2003, CANC MED; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Moreno S, 2010, J ANTIMICROB CHEMOTH, V65, P827, DOI 10.1093/jac/dkq061; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Paintlia MK, 2004, J NEUROSCI RES, V78, P347, DOI 10.1002/jnr.20261; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vafaei AA, 2007, NEUROBIOL LEARN MEM, V88, P87, DOI 10.1016/j.nlm.2007.02.004; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang S, 2009, AM J NEURORADIOL, V30, P1907, DOI 10.3174/ajnr.A1697; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; White WB, 2010, NAT REV CARDIOL, V7, P303, DOI 10.1038/nrcardio.2010.55; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8	42	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12490	10.1371/journal.pone.0012490	http://dx.doi.org/10.1371/journal.pone.0012490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824218	Green Published, Green Submitted, gold			2022-12-25	WOS:000281405300016
J	Noel, JT; Arrach, N; Alagely, A; McClelland, M; Teplitski, M				Noel, Jason T.; Arrach, Nabil; Alagely, Ali; McClelland, Michael; Teplitski, Max			Specific Responses of Salmonella enterica to Tomato Varieties and Fruit Ripeness Identified by In Vivo Expression Technology	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; BIOFILM FORMATION; SEROVAR TYPHIMURIUM; GENES; COLONIZATION; VIRULENCE; CURLI; INFECTION; CELLULOSE; GROWTH	Background: Recent outbreaks of vegetable-associated gastroenteritis suggest that enteric pathogens colonize, multiply and persist in plants for extended periods of time, eventually infecting people. Genetic and physiological pathways, by which enterics colonize plants, are still poorly understood. Methodology/Principal Findings: To better understand interactions between Salmonella enterica sv. Typhimurium and tomatoes, a gfp-tagged Salmonella promoter library was screened inside red ripe fruits. Fifty-one unique constructs that were potentially differentially regulated in tomato relative to in vitro growth were identified. The expression of a subset of these promoters was tested in planta using recombinase-based in vivo expression technology ( RIVET) and fitness of the corresponding mutants was tested. Gene expression in Salmonella was affected by fruit maturity and tomato cultivar. A putative fadH promoter was upregulated most strongly in immature tomatoes. Expression of the fadH construct depended on the presence of linoleic acid, which is consistent with the reduced accumulation of this compound in mature tomato fruits. The cysB construct was activated in the fruit of cv. Hawaii 7997 ( resistant to a race of Ralstonia solanacearum) more strongly than in the universally susceptible tomato cv. Bonny Best. Known Salmonella motility and animal virulence genes ( hilA, flhDC, fliF and those encoded on the pSLT virulence plasmid) did not contribute significantly to fitness of the bacteria inside tomatoes, even though deletions of sirA and motA modestly increased fitness of Salmonella inside tomatoes. Conclusions/Significance: This study reveals the genetic basis of the interactions of Salmonella with plant hosts. Salmonella relies on a distinct set of metabolic and regulatory genes, which are differentially regulated in planta in response to host genotype and fruit maturity. This enteric pathogen colonizes tissues of tomatoes differently than plant pathogens, and relies little on its animal virulence genes for persistence within the fruit.	[Noel, Jason T.; Alagely, Ali; Teplitski, Max] Univ Florida, Genet Inst, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Arrach, Nabil; McClelland, Michael] Vaccine Res Inst San Diego, La Jolla, CA USA; [Arrach, Nabil] Sanford Burnham Med Res Inst, La Jolla, CA USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Irvine	Noel, JT (corresponding author), Univ Florida, Genet Inst, Dept Soil & Water Sci, Gainesville, FL 32611 USA.	maxtep@ufl.edu	Arrach, Nabil/AAE-6806-2020; McClelland, Michael/A-8583-2011	McClelland, Michael/0000-0003-1788-9347	Florida Tomato Council; Center for Produce Safety, University of California, Davis; California Department of Food and Agriculture under Florida Agricultural Experiment Station [SCB09052, 0208876]; BARD [IS-4267-09]; National Institutes of Health [R01AI075093-01]; Tobacco [16KT-0045]; University of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075093] Funding Source: NIH RePORTER	Florida Tomato Council; Center for Produce Safety, University of California, Davis(University of California System); California Department of Food and Agriculture under Florida Agricultural Experiment Station; BARD(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco; University of Florida(University of Florida); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by Florida Tomato Council and by the Center for Produce Safety, University of California, Davis and the California Department of Food and Agriculture through Specialty Crop Block Grant Program grant # SCB09052 under CRIS project # 0208876 of Florida Agricultural Experiment Station (MT, JTN). MM was supported, in part, by BARD IS-4267-09 and National Institutes of Health grant R01AI075093-01. NA was supported by Tobacco-Related Disease Research Program grant 16KT-0045. AA acknowledges support from the University of Florida Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868; Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Ahmer BMM, 1999, MOL MICROBIOL, V31, P971, DOI 10.1046/j.1365-2958.1999.01244.x; Andrews-Polymenis HL, 2009, CURR OPIN BIOTECH, V20, P149, DOI 10.1016/j.copbio.2009.02.002; Arrach N, 2008, CANCER RES, V68, P4827, DOI 10.1158/0008-5472.CAN-08-0552; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2008, APPL ENVIRON MICROB, V74, P5568, DOI 10.1128/AEM.01077-08; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Boch J, 2002, MOL MICROBIOL, V44, P73, DOI 10.1046/j.1365-2958.2002.02877.x; Boyer RR, 2007, J FOOD PROTECT, V70, P1339, DOI 10.4315/0362-028X-70.6.1339; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brown DG, 2004, MOL MICROBIOL, V53, P1641, DOI 10.1111/j.1365-2958.2004.04237.x; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; CHELLEMI DO, 1994, J AM SOC HORTIC SCI, V119, P325, DOI 10.21273/JASHS.119.2.325; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Fortune DR, 2006, INFECT IMMUN, V74, P331, DOI 10.1128/IAI.74.1.331-339.2006; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Marco ML, 2005, ENVIRON MICROBIOL, V7, P1379, DOI 10.1111/j.1462-2920.2005.00825.x; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Noel JT, 2010, MOL PLANT MICROBE IN, V23, P273, DOI 10.1094/MPMI-23-3-0273; Osorio CG, 2005, INFECT IMMUN, V73, P972, DOI 10.1128/IAI.73.2.972-980.2005; OSTROWSKI J, 1991, J BACTERIOL, V173, P2212, DOI 10.1128/JB.173.7.2212-2218.1991; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shi X, 2007, J FOOD PROTECT, V70, P2725, DOI 10.4315/0362-028X-70.12.2725; Silby MW, 2004, J BACTERIOL, V186, P7411, DOI 10.1128/JB.186.21.7411-7419.2004; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; TEPLITSKI M, 2004, GLOBAL REGULATORY NE; Teplitski M, 2006, MICROBIOL-SGM, V152, P3411, DOI 10.1099/mic.0.29118-0; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; Turnbull AL, 2008, MICROBIOL-SGM, V154, P3410, DOI 10.1099/mic.0.2008/020347-0; Wang QF, 2009, MOL MICROBIOL, V74, P71, DOI 10.1111/j.1365-2958.2009.06851.x; Zhao YF, 2005, J BACTERIOL, V187, P8088, DOI 10.1128/JB.187.23.8088-8103.2005	53	55	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12406	10.1371/journal.pone.0012406	http://dx.doi.org/10.1371/journal.pone.0012406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824208	Green Published, gold			2022-12-25	WOS:000281405300007
J	Rincon, MT; Dassa, B; Flint, HJ; Travis, AJ; Jindou, S; Borovok, I; Lamed, R; Bayer, EA; Henrissat, B; Coutinho, PM; Antonopoulos, DA; Miller, MEB; White, BA				Rincon, Marco T.; Dassa, Bareket; Flint, Harry J.; Travis, Anthony J.; Jindou, Sadanari; Borovok, Ilya; Lamed, Raphael; Bayer, Edward A.; Henrissat, Bernard; Coutinho, Pedro M.; Antonopoulos, Dion A.; Miller, Margret E. Berg; White, Bryan A.			Abundance and Diversity of Dockerin-Containing Proteins in the Fiber-Degrading Rumen Bacterium, Ruminococcus flavefaciens FD-1	PLOS ONE			English	Article							GENE-CLUSTER; CELLULOSOME; COHESIN; RUMINOCOCCUS-FLAVEFACIENS-17; ORGANIZATION; DEGRADATION; SPECIFICITY; CELLULASE; XYLANASE; DOMAINS	Background: The cellulosome is a multi-enzyme machine, which plays a key role in the breakdown of plant cell walls in many anaerobic cellulose-degrading microorganisms. Ruminococcus flavefaciens FD-1, a major fiber-degrading bacterium present in the gut of herbivores, has the most intricate cellulosomal organization thus far described. Cellulosome complexes are assembled through high-affinity cohesin-dockerin interactions. More than two-hundred dockerin-containing proteins have been identified in the R. flavefaciens genome, yet the reason for the expansion of these crucial cellulosomal components is yet unknown. Methodology/Principal Findings: We have explored the full spectrum of 222 dockerin-containing proteins potentially involved in the assembly of cellulosome-like complexes of R. flavefaciens. Bioinformatic analysis of the various dockerin modules showed distinctive conservation patterns within their two Ca2+-binding repeats and their flanking regions. Thus, we established the conceptual framework for six major groups of dockerin types, according to their unique sequence features. Within this framework, the modular architecture of the parent proteins, some of which are multi-functional proteins, was evaluated together with their gene expression levels. Specific dockerin types were found to be associated with selected groups of functional components, such as carbohydrate-binding modules, numerous peptidases, and/or carbohydrate-active enzymes. In addition, members of other dockerin groups were linked to structural proteins, e. g., cohesin-containing proteins, belonging to the scaffoldins. Conclusions/Significance: This report profiles the abundance and sequence diversity of the R. flavefaciens FD-1 dockerins, and provides the molecular basis for future understanding of the potential for a wide array of cohesin-dockerin specificities. Conserved differences between dockerins may be reflected in their stability, function or expression within the context of the parent protein, in response to their role in the rumen environment.	[Rincon, Marco T.; Flint, Harry J.; Travis, Anthony J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland; [Dassa, Bareket; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Jindou, Sadanari; Borovok, Ilya; Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Henrissat, Bernard; Coutinho, Pedro M.] CNRS, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Antonopoulos, Dion A.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Dept Anim Sci, N Amer Consortium Genom Fibrolyt Ruminal Bacteria, Div Nutr Sci, Urbana, IL 61801 USA	University of Aberdeen; Weizmann Institute of Science; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Illinois System; University of Illinois Urbana-Champaign	Rincon, MT (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland.	h.flint@abdn.ac.uk	Henrissat, Bernard/J-2475-2012; Antonopoulos, Dionysios/ABE-6212-2020; BOROVOK, ILYA/ABB-7370-2022; Rincon, Marco T/T-4798-2019	Henrissat, Bernard/0000-0002-3434-8588; Antonopoulos, Dionysios/0000-0002-2238-5031; Berg, Margret/0000-0002-0411-1619; Travis, Anthony/0000-0001-9895-8310; BOROVOK, ILYA/0000-0003-1602-4499	Scottish Government Rural and Environment Research and Analysis Directorate; United States Department of Agriculture [2002-35206-11634]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Israel Science Foundation [966/09, 159/07]	Scottish Government Rural and Environment Research and Analysis Directorate; United States Department of Agriculture(United States Department of Agriculture (USDA)); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	The Rowett Institute receives support from the Scottish Government Rural and Environment Research and Analysis Directorate. This work was supported by a United States Department of Agriculture grant for Functional Genomics of Ruminococcus flavefaciens FD-1 (Grant No. 2002-35206-11634). Additional support from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel, and the Israel Science Foundation (Grant Nos. 966/09 and 159/07) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Aurilia V, 2000, ANAEROBE, V6, P333, DOI 10.1006/anae.2000.0358; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; BRYANT MP, 1958, J BACTERIOL, V76, P529, DOI 10.1128/JB.76.5.529-537.1958; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; DOERNER KC, 1990, APPL ENVIRON MICROB, V56, P1844, DOI 10.1128/AEM.56.6.1844-1850.1990; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; FLINT HJ, 1989, APPL ENVIRON MICROB, V55, P1230, DOI 10.1128/AEM.55.5.1230-1233.1989; FLINT HJ, 1993, J BACTERIOL, V175, P2943, DOI 10.1128/JB.175.10.2943-2951.1993; GARDNER RM, 1987, J BACTERIOL, V169, P4581, DOI 10.1128/jb.169.10.4581-4588.1987; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Kirby J, 1997, FEMS MICROBIOL LETT, V149, P213, DOI 10.1111/j.1574-6968.1997.tb10331.x; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Peer A, 2009, FEMS MICROBIOL LETT, V291, P1, DOI 10.1111/j.1574-6968.2008.01420.x; PETTIPHER GL, 1979, J GEN MICROBIOL, V110, P21, DOI 10.1099/00221287-110-1-21; RASMUSSEN MA, 1988, APPL ENVIRON MICROB, V54, P890, DOI 10.1128/AEM.54.4.890-897.1988; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rincon MT, 2001, APPL ENVIRON MICROB, V67, P4426, DOI 10.1128/AEM.67.10.4426-4431.2001; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOOD TM, 1982, BIOCHEM J, V205, P129, DOI 10.1042/bj2050129	34	55	55	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12476	10.1371/journal.pone.0012476	http://dx.doi.org/10.1371/journal.pone.0012476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814577	Green Published, Green Submitted, gold			2022-12-25	WOS:000281375500009
J	Kirmse, R; Qin, ZA; Weinert, CM; Hoenger, A; Buehler, MJ; Kreplak, L				Kirmse, Robert; Qin, Zhao; Weinert, Carl M.; Hoenger, Andrea; Buehler, Markus J.; Kreplak, Laurent			Plasticity of Intermediate Filament Subunits	PLOS ONE			English	Article							MOLECULAR ARCHITECTURE; TETRAMERIC VIMENTIN; COILED-COIL; DYNAMICS; PROTEIN; IDENTIFICATION; MICROSCOPY; KERATIN; UNITS; HEAD	Intermediate filaments (IFs) assembled in vitro from recombinantly expressed proteins have a diameter of 8-12 nm and can reach several micrometers in length. IFs assemble from a soluble pool of subunits, tetramers in the case of vimentin. Upon salt addition, the subunits form first unit length filaments (ULFs) within seconds and then assembly proceeds further by end-to-end fusion of ULFs and short filaments. So far, IF subunits have mainly been observed by electron microscopy of glycerol sprayed and rotary metal shadowed specimens. Due to the shear forces during spraying the IF subunits appear generally as straight thin rods. In this study, we used atomic force microscopy (AFM), cryo-electron microscopy (cryo-EM) combined with molecular modeling to investigate the conformation of the subunits of vimentin, desmin and keratin K5/K14 IFs in various conditions. Due to their anisotropic shape the subunits are difficult to image at high resolution by cryo-EM. In order to enhance contrast we used a cryo-negative staining approach. The subunits were clearly identified as thin, slightly curved rods. However the staining agent also forced the subunits to aggregate into two-dimensional networks of dot-like structures. To test this conformational change further, we imaged dried unfixed subunits on mica by AFM revealing a mixture of extended and dot-like conformations. The use of divalent ions such as calcium and magnesium, as well as glutaraldehyde exposure favored compact conformations over elongated ones. These experimental results as well as coarse-grained molecular dynamics simulations of a vimentin tetramer highlight the plasticity of IF subunits.	[Kirmse, Robert; Hoenger, Andrea] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Qin, Zhao; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Weinert, Carl M.; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada	University of Colorado System; University of Colorado Boulder; Massachusetts Institute of Technology (MIT); Dalhousie University	Kirmse, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	kreplak@dal.ca	Buehler, Markus J./C-4580-2008; Qin, Zhao/B-4667-2010	Buehler, Markus J./0000-0002-4173-9659; Qin, Zhao/0000-0001-5696-8553; kreplak, laurent/0000-0001-9370-9809; Hoenger, Andreas/0000-0001-9176-6658	Natural Sciences and Engineering Research Council of Canada; Air Force Office of Scientific Research [FA9550081-0321]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Natural Sciences and Engineering Research Council of Canada discovery grant awarded to Laurent Kreplak and Air Force Office of Scientific Research Grant No. FA9550081-0321 awarded to Markus J. Buehler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131; Ando S, 2004, BBA-PROTEINS PROTEOM, V1702, P53, DOI 10.1016/j.bbapap.2004.07.008; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8; Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166; De Carlo S, 2002, J STRUCT BIOL, V138, P216, DOI 10.1016/S1047-8477(02)00035-7; De Carlo S, 2008, MICRON, V39, P934, DOI 10.1016/j.micron.2007.11.003; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HISANAGA S, 1989, J NEUROSCI, V9, P959; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; LEE SH, 1994, J CHEM PHYS, V100, P3334, DOI 10.1063/1.466425; Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; NORTH ACT, 1994, PROTEINS, V20, P174, DOI 10.1002/prot.340200207; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Qin Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007294; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; VIKSTROM KL, 1992, J CELL BIOL, V118, P121, DOI 10.1083/jcb.118.1.121	31	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12115	10.1371/journal.pone.0012115	http://dx.doi.org/10.1371/journal.pone.0012115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20814582	Green Submitted, gold, Green Published			2022-12-25	WOS:000280859700010
J	Huang, RY; Li, MY; Hsin, MKY; Underwood, MJ; Ma, LT; Mok, TSK; Warner, TD; Chen, GG				Huang, R-Y; Li, M-Y; Hsin, M. K. Y.; Underwood, M. J.; Ma, L. T.; Mok, T. S. K.; Warner, T. D.; Chen, G. G.			4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A(2) and its receptor	ONCOGENE			English	Article						lung cancer; NNK; thromboxane A(2); cell proliferation; CREB	ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; AIRWAY EPITHELIAL-CELLS; LIPID-PEROXIDATION; BCL-2 EXPRESSION; N-NITROSAMINES; CYCLOOXYGENASE-2; SYNTHASE; ADENOCARCINOMA; PROLIFERATION	The role of thromboxane A(2) (TxA(2)) in smoking-associated lung cancer is poorly understood. This study was conducted to study the role of TxA(2) in smoking carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-promoted cell survival and growth in human lung cancer cells. We found that NNK increased TxA(2) synthase (TxAS) expression and thromboxane B-2 (TxB(2)) generation in cultured lung cancer cells, the result of which was supported by the increased level of TxAS in lung cancer tissues of smokers. Both TxAS-specific inhibitor furegrelate and TxA(2) receptor antagonist SQ29548 completely blocked NNK-mediated cell survival and growth via inducting apoptosis. TxA(2) receptor agonist U46619 reconstituted a near-full survival and growth response to NNK when TxAS was inhibited, affirming the role of TxA(2) receptor in NNK-mediated cell survival and growth. Suppression of cyclic adenosine monophosphate response element binding protein (CREB) activity by its small interference RNA blocked the effect of NNK. Phosphatidylinositol 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK) also had a positive role. Altogether, our results have revealed that NNK stimulates TxA(2) synthesis and activates its receptor in lung cancer cells. The increased TxA(2) may then activate CREB through PI3K/Akt and extracellular ERK pathways, thereby contributing to the NNK-promoted survival and growth of lung cancer cells. Oncogene (2011) 30, 106-116; doi: 10.1038/onc.2010.390; published online 6 September 2010	[Huang, R-Y; Li, M-Y; Hsin, M. K. Y.; Underwood, M. J.; Chen, G. G.] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Ma, L. T.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Mok, T. S. K.] Chinese Univ Hong Kong, Dept Clin Oncol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Warner, T. D.] Queen Mary Univ London, William Harvey Res Inst, London, England	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of London; Queen Mary University London	Chen, GG (corresponding author), Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	gchen@cuhk.edu.hk	Mok, Tony Shu Kam/B-2310-2019; Underwood, Malcolm John/L-6823-2016; Warner, Timothy D/A-1980-2009; Chen, George Gong/I-2757-2016; LI, Ming-Yue/I-2727-2016	Mok, Tony Shu Kam/0000-0002-8251-0551; Warner, Timothy D/0000-0003-3988-4408; 	CUHK [2007.2.045, 2008.2.038]	CUHK(Chinese University of Hong Kong)	We thank Suk Ying Chun, Ernest Chi Wai Chak and Billy Cheuk Sing Leung for their technical assistance. This study was supported by the CUHK direct grants (2007.2.045 and 2008.2.038).	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Amin S, 1996, CRIT REV TOXICOL, V26, P139, DOI 10.3109/10408449609017927; Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Cailleteau C, 2008, ANAL BIOCHEM, V380, P26, DOI 10.1016/j.ab.2008.05.026; Calapai G, 2009, INHAL TOXICOL, V21, P1138, DOI 10.3109/08958370902798455; Cathcart MC, 2010, BBA-REV CANCER, V1805, P153, DOI 10.1016/j.bbcan.2010.01.006; Chen GG, 2006, CANCER LETT, V234, P193, DOI 10.1016/j.canlet.2005.03.032; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; COLEMAN RA, 1981, BRIT J PHARMACOL, V73, P773, DOI 10.1111/j.1476-5381.1981.tb16814.x; Daniel TO, 1999, CANCER RES, V59, P4574; de Leval X, 2006, J PHARMACOL EXP THER, V318, P1057, DOI 10.1124/jpet.106.101188; El-Bayoumy K, 1999, CANCER RES, V59, P1400; Ermert L, 2003, CLIN CANCER RES, V9, P1577; Fahn HJ, 1998, AM J RESP CELL MOL, V19, P901, DOI 10.1165/ajrcmb.19.6.3130; Grozio A, 2007, ANTI-CANCER AGENT ME, V7, P461; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; HOFFMANN D, 1994, J TOXICOL ENV HEALTH, V41, P1, DOI 10.1080/15287399409531825; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Hung YH, 2009, CHEM-BIOL INTERACT, V179, P154, DOI 10.1016/j.cbi.2008.10.042; Kelley DJ, 1997, CARCINOGENESIS, V18, P795, DOI 10.1093/carcin/18.4.795; Kim Y, 2006, CARCINOGENESIS, V27, P1410, DOI 10.1093/carcin/bgi340; Laag E, 2006, INT J CANCER, V119, P1547, DOI 10.1002/ijc.21987; Leung KC, 2009, EXP CELL RES, V315, P2974, DOI 10.1016/j.yexcr.2009.06.025; Li MY, 2008, EUR RESPIR J, V32, P911, DOI 10.1183/09031936.00064508; Li MY, 2010, AM J RESP CELL MOL, V42, P113, DOI 10.1165/rcmb.2008-0463OC; Li XL, 2007, ARCH BIOCHEM BIOPHYS, V467, P20, DOI 10.1016/j.abb.2007.08.005; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Lu G, 2006, CANCER RES, V66, P11494, DOI 10.1158/0008-5472.CAN-06-1497; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; MCLEMORE TL, 1988, CANCER RES, V48, P3140; Merighi Stefania, 2006, Purinergic Signal, V2, P627, DOI 10.1007/s11302-006-9020-4; Miggin SM, 2001, BBA-MOL CELL RES, V1539, P147, DOI 10.1016/S0167-4889(01)00103-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moussa O, 2008, ONCOGENE, V27, P55, DOI 10.1038/sj.onc.1210629; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Nie DT, 2004, AM J PATHOL, V164, P429, DOI 10.1016/S0002-9440(10)63133-1; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Nishioka T, 2010, J CELL BIOCHEM, V109, P152, DOI 10.1002/jcb.22392; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Proulx LI, 2005, CLIN EXP IMMUNOL, V140, P46, DOI 10.1111/j.1365-2249.2005.02739.x; Sakai H, 2006, FEBS LETT, V580, P3368, DOI 10.1016/j.febslet.2006.05.007; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Wei J, 2007, BIOCHEM PHARMACOL, V74, P787, DOI 10.1016/j.bcp.2007.06.008; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147	47	49	52	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					106	116		10.1038/onc.2010.390	http://dx.doi.org/10.1038/onc.2010.390			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20818420				2022-12-25	WOS:000285959300010
J	Pineiro, R; Maffucci, T; Falasca, M				Pineiro, R.; Maffucci, T.; Falasca, M.			The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation	ONCOGENE			English	Article						G-protein-coupled receptor; lysophosphatidylinositol; GPR55; prostate cancer; ABC transporters; phospholipase A2	PROTEIN-COUPLED RECEPTOR; L-ALPHA-LYSOPHOSPHATIDYLINOSITOL; HUMAN PROSTATE-CANCER; DRUG-RESISTANCE; LYSOPHOSPHOLIPIDS; IDENTIFICATION; ACTIVATION; EXPRESSION; MIGRATION	Recently, the orphan receptor G protein-coupled receptor 55 (GPR55) has been proposed as a potential cannabinoid receptor, although controversy remains on its physiological roles. Current evidence suggests a role for GPR55 as a receptor for the lysophospholipid lysophosphatidylinositol (LPI). In this study, we show that GPR55 is expressed in several prostate and ovarian cancer cell lines, both at the mRNA and at the protein level, and that it has a critical role in regulating proliferation and anchorage-independent growth. We further show that GPR55 mediates the effects of LPI in prostate and ovarian cancer cells. Indeed we demonstrate that LPI is able to induce calcium mobilization and activation of Akt and extracellular signal-regulated kinase (ERK)1/2 in these cells and that both pharmacological blockade of GPR55 and its downregulation using specific small interfering RNA strongly inhibits these processes. We further identify an autocrine loop by which LPI is synthesized by cytosolic phospholipase A2, pumped out of the cell by the ATP-binding cassette transporter ABCC1/MRP1, and is then able to initialize cascades downstream of GPR55. All together, these data demonstrate a role of LPI and its receptor GPR55 in cancer cells in activating an autocrine loop that regulates cell proliferation. These findings may have important implications for LPI as a novel cancer biomarker and for its receptor GPR55 as a potential therapeutic target. Oncogene (2011) 30, 142-152; doi:10.1038/onc.2010.417; published online 13 September 2010	[Pineiro, R.; Maffucci, T.; Falasca, M.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Diabet,Inositide Signalling Grp, London E1 2AT, England	University of London; Queen Mary University London	Falasca, M (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Diabet,Inositide Signalling Grp, 4 Newark St, London E1 2AT, England.	m.falasca@qmul.ac.uk	Piñeiro, Roberto/AAN-5561-2020; Falasca, Marco/S-4020-2016	Piñeiro, Roberto/0000-0001-9479-139X; Falasca, Marco/0000-0002-9801-7235	British Heart Foundation [PG/06/022/204348]	British Heart Foundation(British Heart Foundation)	We thank Prof D Baker (Queen Mary University of London), Prof WH Moolenaar (The Netherlands Cancer Institute), Dr N Divecha (The Paterson Institute for Cancer Research, Manchester) and Dr R Sabatini (LPath Inc) for critical reading of the paper. We also thank the National Institute of Drug Abuse, Bethesda, MD, USA for providing SR141716A. RP was supported by the British Heart Foundation (grant PG/06/022/204348 to MF).	Davies MA, 1999, CANCER RES, V59, P2551; Falasca M, 1998, ONCOGENE, V16, P2357, DOI 10.1038/sj.onc.1201758; FALASCA M, 1995, ONCOGENE, V10, P2113; FALASCA M, 1994, EUR J BIOCHEM, V221, P383, DOI 10.1111/j.1432-1033.1994.tb18750.x; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hoffmann U, 2004, DRUG METAB REV, V36, P669, DOI 10.1081/DMR-200033473; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kreitzer FR, 2009, PHARMACOL THERAPEUT, V122, P83, DOI 10.1016/j.pharmthera.2009.01.005; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Nevalainen T, 2010, CURR TOP MED CHEM, V10, P799, DOI 10.2174/156802610791164229; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Patel MI, 2008, CLIN CANCER RES, V14, P8070, DOI 10.1158/1078-0432.CCR-08-0566; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sullivan GF, 2000, J CLIN INVEST, V105, P1261, DOI 10.1172/JCI9290; Sullivan GF, 1998, CLIN CANCER RES, V4, P1393; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xiao YJ, 2000, ANN NY ACAD SCI, V905, P242; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	31	162	169	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					142	152		10.1038/onc.2010.417	http://dx.doi.org/10.1038/onc.2010.417			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20838378				2022-12-25	WOS:000286438900003
J	LeBleu, V; Sund, M; Sugimoto, H; Birrane, G; Kanasaki, K; Finan, E; Miller, CA; Gattone, VH; McLaughlin, H; Shield, CF; Kalluri, R				LeBleu, Valerie; Sund, Malin; Sugimoto, Hikaru; Birrane, Gabriel; Kanasaki, Keizo; Finan, Elizabeth; Miller, Caroline A.; Gattone, Vincent H., II; McLaughlin, Heather; Shield, Charles F., III; Kalluri, Raghu			Identification of the NC1 Domain of alpha 3 Chain as Critical for alpha 3 alpha 4 alpha 5 Type IV Collagen Network Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; LINKED ALPORT-SYNDROME; BASEMENT-MEMBRANE; CRYSTAL-STRUCTURE; NATURAL-HISTORY; 195 FAMILIES; ORGANIZATION; MODEL; GOODPASTURE; ALIGNMENT	The network organization of type IV collagen consisting of alpha 3, alpha 4, and alpha 5 chains in the glomerular basement membrane (GBM) is speculated to involve interactions of the triple helical and NC1 domain of individual alpha-chains, but in vivo evidence is lacking. To specifically address the contribution of the NC1 domain in the GBM collagen network organization, we generated a mouse with specific loss of alpha 3NC1 domain while keeping the triple helical alpha 3 chain intact by connecting it to the human alpha 5NC1 domain. The absence of alpha 3NC1 domain leads to the complete loss of the alpha 4 chain. The alpha 3 collagenous domain is incapable of incorporating the alpha 5 chain, resulting in the impaired organization of the alpha 3 alpha 4 alpha 5 chain-containing network. Although the alpha 5 chain can assemble with the alpha 1, alpha 2, and alpha 6 chains, such assembly is incapable of functionally replacing the alpha 3 alpha 4 alpha 5 protomer. This novel approach to explore the assembly type IV collagen in vivo offers novel insights in the specific role of the NC1 domain in the assembly and function of GBM during health and disease.	[McLaughlin, Heather; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Boston, MA 02115 USA; [Birrane, Gabriel] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02115 USA; [LeBleu, Valerie; Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Miller, Caroline A.; Gattone, Vincent H., II] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46227 USA; [Shield, Charles F., III] Univ Kansas, Sch Med, Dept Surg, Wichita, KS 66160 USA; [Kalluri, Raghu] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; University of Kansas; University of Kansas Medical Center; Harvard University; Massachusetts Institute of Technology (MIT)	Kalluri, R (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Matrix Biol, Ctr Life Sci E CLS 11-090,330 Brookline Ave, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Sund, Malin/0000-0002-7516-9543; Kalluri, Raghu/0000-0002-2190-547X; Birrane, Gabriel/0000-0002-1759-5499				Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; HUDSON BG, 1994, CONTRIB NEPHROL, V107, P163; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kang JS, 2008, J BIOL CHEM, V283, P35070, DOI 10.1074/jbc.M806396200; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kobayashi T, 2003, KIDNEY INT, V64, P1986, DOI 10.1046/j.1523-1755.2003.00323.x; Kobayashi T, 2008, BIOCHEM BIOPH RES CO, V366, P60, DOI 10.1016/j.bbrc.2007.12.037; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LeBleu V, 2009, J AM SOC NEPHROL, V20, P2359, DOI 10.1681/ASN.2009010123; LeBleu VS, 2008, LAB INVEST, V88, P284, DOI 10.1038/labinvest.3700715; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; REDDY GK, 1993, BIOCHIM BIOPHYS ACTA, V1157, P241, DOI 10.1016/0304-4165(93)90106-I; RIES A, 1995, J BIOL CHEM, V270, P23790, DOI 10.1074/jbc.270.40.23790; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soder S, 2004, BIOCHEM BIOPH RES CO, V325, P276, DOI 10.1016/j.bbrc.2004.10.034; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040	36	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41874	41885		10.1074/jbc.M110.149534	http://dx.doi.org/10.1074/jbc.M110.149534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20847057	hybrid, Green Published			2022-12-25	WOS:000285622600075
J	Mitchell, DA; Mitchell, G; Ling, YP; Budde, C; Deschenes, RJ				Mitchell, David A.; Mitchell, Gayatri; Ling, Yiping; Budde, Cheryl; Deschenes, Robert J.			Mutational Analysis of Saccharomyces cerevisiae Erf2 Reveals a Two-step Reaction Mechanism for Protein Palmitoylation by DHHC Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; H-RAS; PALMITOYLTRANSFERASE; YEAST; TRANSFERASE; DOMAIN; ACYLTRANSFERASES; LIPIDATION; STABILITY; COENZYME	DHHC protein acyltransferases (PATs) catalyze the palmitoylation of eukaryotic proteins through an enzymatic mechanism that remains largely unexplored. In this study we have combined genetic and biochemical approaches to examine the molecular mechanism of palmitate transfer of the yeast Ras PAT, which is composed of Erf2 and Erf4. The palmitoylation reaction consists of two steps; they are autopalmitoylation of the enzyme to create a palmitoyl-Erf2 intermediate followed by the transfer of the palmitoyl moiety to the Ras substrate. Palmitoyl-CoA serves as the palmitate donor. To elucidate the kinetic properties of the Erf2.Erf4 PAT, we have developed a coupled enzyme assay that monitors the turnover of the palmitoyl-enzyme species indirectly by measuring the rate of CoASH release. Mutational analysis indicates that the DHHC motif constitutes the catalytic core of the enzyme required for autopalmitoylation and palmitoyl transfer to the Ras2 substrate. In the absence of Ras2, the palmitoyl-Erf2.Erf4 complex undergoes a cycle of hydrolysis and repalmitoylation, implying that in the presence of palmitoyl-CoA, the complex is autopalmitoylated and competent to transfer palmitate to a protein substrate.	[Mitchell, David A.; Mitchell, Gayatri; Ling, Yiping; Deschenes, Robert J.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Budde, Cheryl] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	State University System of Florida; University of South Florida; Medical College of Wisconsin	Deschenes, RJ (corresponding author), Univ S Florida, Dept Mol Med, MDC7,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	rdeschen@health.usf.edu	Mitchell, David/A-1378-2012; Deschenes, Robert J/E-4926-2010	Deschenes, Robert J/0000-0001-8325-4257	National Institutes of Health [CA50211, GM73976]; NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50211 and GM73976 (to R.J.D.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Budde C, 2006, METHODS, V40, P143, DOI 10.1016/j.ymeth.2006.07.017; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Coats SG, 1999, BIOCHEMISTRY-US, V38, P12926, DOI 10.1021/bi9909290; DEVENDITTIS E, 1981, ANAL BIOCHEM, V115, P278, DOI 10.1016/0003-2697(81)90006-3; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kurz LC, 2009, BIOCHEMISTRY-US, V48, P7878, DOI 10.1021/bi9006447; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MANN WR, 1995, J ENZYM INHIB, V9, P303, DOI 10.3109/14756369509036559; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V38, P447, DOI 10.1016/0006-3002(60)91280-4; Mesilaty-Gross S, 1999, GENE, V231, P173, DOI 10.1016/S0378-1119(99)00053-0; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Sherman F, 1986, LAB COURSE MANUAL ME; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x	31	115	115	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38104	38114		10.1074/jbc.M110.169102	http://dx.doi.org/10.1074/jbc.M110.169102			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20851885	Green Published, hybrid			2022-12-25	WOS:000284625600018
J	Czeh, M; Loddenkemper, C; Shalapour, S; Schon, C; Robine, S; Goldscheid, E; Stein, H; Schuler, T; Willimsky, G; Blankenstein, T				Czeh, M.; Loddenkemper, C.; Shalapour, S.; Schoen, C.; Robine, S.; Goldscheid, E.; Stein, H.; Schueler, T.; Willimsky, G.; Blankenstein, T.			The immune response to sporadic colorectal cancer in a novel mouse model	ONCOGENE			English	Article						colorectal cancer; sporadic cancer; mouse model; antitumor immune response	SV40 T-ANTIGEN; ONCOGENIC K-RAS; TRANSGENIC MICE; GENE-EXPRESSION; TUMOR-ANTIGEN; VILLIN GENE; JC VIRUS; INTESTINAL EPITHELIUM; CELL TOLERANCE; DEVELOP TUMORS	Current mouse models do not reflect the sporadic nature of colon cancer and do not allow the analysis of antitumor immune response because of the lack of known tumor-specific antigens. Two transgenic mouse models with spontaneous tumor development were generated, directing the expression of SV40T antigen (Tag) either constitutively (Vil-Cre x LoxP-Tag-transgenic mice) or stochastically (Vil-Cre-ERT2 x LoxP-Tag-transgenic mice) into the putative stem cell region of the crypt of Lieberkuhn. Tumor development and antitumor immune response were monitored. Vil-Cre x LoxP-Tag mice developed multiple adenocarcinomas of the small intestine and colon at an average age of 6 months. During the tumor development, Tag-specific immunoglobulin G (IgG) antibodies were induced in half of the mice, although they had developed neonatal cytotoxic T lymphocyte (CTL) tolerance. This model shows similarity to hereditary colon cancer but not to the sporadic tumor development. Therefore, the conditional Vil-Cre-ERT2 x LoxP-Tag mice were established, in which expression of the dormant Tag was induced by stochastic, tissue-specific activation of Cre recombinase. These mice spontaneously developed highly invasive, metastasizing colon carcinomas at an average age of 20 months. Colon carcinomas expressed epithelial and/or neuroendocrine markers depending on the grade of differentiation. Young Vil-Cre-ERT2 x LoxP-Tag mice had retained CTL responses against epitope IV of Tag. The tumors induced strong anti-Tag IgG responses. We report, for the first time, a mouse model based on stochastic, tissue-specific activation of a dormant oncogene in the colon allowing the analysis of antitumor immune response against primary colorectal cancer. Oncogene (2010) 29, 6591-6602; doi:10.1038/onc.2010.388; published online 6 September 2010	[Goldscheid, E.; Willimsky, G.; Blankenstein, T.] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Czeh, M.; Shalapour, S.; Schoen, C.; Schueler, T.; Willimsky, G.; Blankenstein, T.] Charite Campus Benjamin Franklin, Inst Immunol, Berlin, Germany; [Loddenkemper, C.; Stein, H.] Charite Campus Benjamin Franklin, Inst Pathol, Berlin, Germany; [Loddenkemper, C.] Charite Campus Benjamin Franklin, Res Ctr ImmunoSci, Berlin, Germany; [Robine, S.] Inst Curie, CNRS, Dept Morphogenesis & Intracellular Signali, F-75231 Paris, France	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Blankenstein, T (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	tblanke@mdc-berlin.de	Willimsky, Gerald/AAA-2445-2021	Willimsky, Gerald/0000-0002-9693-948X	Sonderforschungsbereich [SFB 633, TR 36]	Sonderforschungsbereich(German Research Foundation (DFG))	We thank S Spieckermann, M Rosch, C Westen and S Horn for excellent technical assistance and JC Schmollinger for reading the paper. This study was supported by the Research grants Sonderforschungsbereich SFB 633 and TR 36.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Bos R, 2008, CANCER RES, V68, P8446, DOI 10.1158/0008-5472.CAN-08-1864; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BURKE AB, 1991, AM J CLIN PATHOL, V95, P315, DOI 10.1093/ajcp/95.3.315; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CORBETT TH, 1975, CANCER RES, V35, P2434; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Enam S, 2002, CANCER RES, V62, P7093; FAAS SJ, 1987, J EXP MED, V165, P417, DOI 10.1084/jem.165.2.417; Gum JR, 2004, MOL CANCER RES, V2, P504; Gum JR, 2001, CANCER RES, V61, P3472; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; Heyer J, 1999, ONCOGENE, V18, P5325, DOI 10.1038/sj.onc.1203036; HORI R, 2005, VIRCHOWS ARCH, V14, P1; Janssen KP, 2002, GASTROENTEROLOGY, V123, P492, DOI 10.1053/gast.2002.34786; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Lauwen MM, 2008, CANCER RES, V68, P893, DOI 10.1158/0008-5472.CAN-07-3166; LUDLOW JW, 1993, FASEB J, V7, P866, DOI 10.1096/fasebj.7.10.8344486; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Newcomb PA, 2004, CANCER EPIDEM BIOMAR, V13, P662; Otahal P, 2006, J IMMUNOL, V177, P3089, DOI 10.4049/jimmunol.177.5.3089; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; PALMITER RD, 1985, NATURE, V316, P457, DOI 10.1038/316457a0; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; SARSFIELD P, 1990, HISTOPATHOLOGY, V16, P357, DOI 10.1111/j.1365-2559.1990.tb01139.x; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schell TD, 2000, CANCER RES, V60, P3002; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Syder AJ, 2004, P NATL ACAD SCI USA, V101, P4471, DOI 10.1073/pnas.0307983101; Weinreb D, 2006, VIRCHOWS ARCH, V448, P239, DOI 10.1007/s00428-005-0128-7; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	45	16	17	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6591	6602		10.1038/onc.2010.388	http://dx.doi.org/10.1038/onc.2010.388			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20818425				2022-12-25	WOS:000285380200008
J	Atzei, P; Gargan, S; Curran, N; Moynagh, PN				Atzei, Paola; Gargan, Siobhan; Curran, Niamh; Moynagh, Paul N.			Cactin Targets the MHC Class III Protein I kappa B-like (I kappa BL) and Inhibits NF-kappa B and Interferon-regulatory Factor Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR FAMILY; TOLL; ACTIVATION; ADAPTER; EXPRESSION; INTERACTS; MICE; SUSCEPTIBILITY; INTERLEUKIN-1; REQUIRES	Toll-like receptors (TLRs) act as primary sensors of the immune system by recognizing specific microbial motifs and inducing proinflammatory genes that facilitate innate and adaptive immunity. TLRs regulate gene expression by activating transcription factors, such as NF-kappa B and interferon-regulatory factors. Dysregulation of these pathways can lead to inflammatory diseases, and thus they are subject to stringent control by negative regulators of innate immune signaling. Cactin (Cactus interactor) was initially discovered as a novel interactor of Drosophila Cactus, a regulator of Drosophila Toll signaling. We now describe the first functional characterization of the human ortholog of Cactin (hCactin) and show that it acts as a negative regulator of TLRs. Overexpression of hCactin suppresses TLR-induced activation of NF-kappa B and interferon-regulatory factor transcription factors and induction of TLR-responsive genes, whereas knockdown of endogenous hCactin augments TLR induction of these responses. hCactin also interacts with I kappa B-like protein and targets other proteins that are encoded by genes in the MHC Class III region of chromosome 6. We demonstrate that hCactin localizes to the nucleus, and this nuclear localization is critical for manifesting its inhibitory effects on TLR signaling. This study thus defines hCactin as a novel negative regulator of TLR signaling and reveals its capacity to target MHC Class III genes at the molecular and functional level.	[Atzei, Paola; Gargan, Siobhan; Curran, Niamh; Moynagh, Paul N.] Natl Univ Ireland, Inst Immunol, Maynooth 1, Kildare, Ireland	Maynooth University	Moynagh, PN (corresponding author), Natl Univ Ireland, Inst Immunol, Maynooth 1, Kildare, Ireland.	Paul.Moynagh@nuim.ie		Moynagh, Paul/0000-0002-4139-3061; atzei, paola/0000-0002-5986-620X	Science Foundation Ireland [SFI/RFP/BIC1501]; Health Research Board of Ireland; European Union Marie Curie Action (MNIEST)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; European Union Marie Curie Action (MNIEST)(European Commission)	This work was funded by Science Foundation Ireland Grant SFI/RFP/BIC1501, the Health Research Board of Ireland, and the European Union Marie Curie Action (MNIEST).	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Atzei P, 2010, GENE EXPR PATTERNS, V10, P199, DOI 10.1016/j.gep.2010.03.003; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Bourke E, 2000, J BIOL CHEM, V275, P39996, DOI 10.1074/jbc.M007693200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; De La Concha EG, 2000, GASTROENTEROLOGY, V119, P1491, DOI 10.1053/gast.2000.20258; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin PH, 2000, MECH DEVELOP, V94, P57, DOI 10.1016/S0925-4773(00)00314-2; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Okamoto K, 2003, AM J HUM GENET, V72, P303, DOI 10.1086/346067; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tannoury H, 2010, DEV BIOL, V341, P176, DOI 10.1016/j.ydbio.2010.02.025; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xie G, 2002, GENOME BIOL, V3; Xie T, 2003, GENOME RES, V13, P2621, DOI 10.1101/gr.1736803; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	42	26	29	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36804	36817		10.1074/jbc.M110.139113	http://dx.doi.org/10.1074/jbc.M110.139113			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829348	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000284146100040
J	Cirit, M; Wang, CC; Haugh, JM				Cirit, Murat; Wang, Chun-Chao; Haugh, Jason M.			Systematic Quantification of Negative Feedback Mechanisms in the Extracellular Signal-regulated Kinase (ERK) Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; BACTERIAL CHEMOTAXIS; SERUM COMPONENTS; CANCER; CELLS; FIBROBLASTS; ACTIVATION; DESENSITIZATION; ADAPTATION	Cell responses are actuated by tightly controlled signal transduction pathways. Although the concept of an integrated signaling network replete with interpathway cross-talk and feedback regulation is broadly appreciated, kinetic data of the type needed to characterize such interactions in conjunction with mathematical models are lacking. In mammalian cells, the Ras/ERK pathway controls cell proliferation and other responses stimulated by growth factors, and several cross-talk and feedback mechanisms affecting its activation have been identified. In this work, we take a systematic approach to parse the magnitudes of multiple regulatory mechanisms that attenuate ERK activation through canonical (Ras-dependent) and non-canonical (PI3K-dependent) pathways. In addition to regulation of receptor and ligand levels, we consider three layers of ERK-dependent feedback: desensitization of Ras activation, negative regulation of MEK kinase (e.g. Raf) activities, and up-regulation of dual-specificity ERK phosphatases. Our results establish the second of these as the dominant mode of ERK self-regulation in mouse fibroblasts. We further demonstrate that kinetic models of signaling networks, trained on a sufficient diversity of quantitative data, can be reasonably comprehensive, accurate, and predictive in the dynamical sense.	[Cirit, Murat; Wang, Chun-Chao; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Haugh, JM (corresponding author), Box 7905,911 Partners Way, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu	Wang, Chun-Chao/I-5691-2012	Wang, Chun-Chao/0000-0003-4884-3835; Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [GM088987]; NCSU Biomanufacturing Training & Education Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCSU Biomanufacturing Training & Education Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088987 and through a graduate fellowship ( to M. C.) from the NCSU Biomanufacturing Training & Education Center.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Iyengar R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264eg3; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Klarlund JK, 1996, J BIOL CHEM, V271, P16674, DOI 10.1074/jbc.271.28.16674; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Mogilner A, 2006, DEV CELL, V11, P279, DOI 10.1016/j.devcel.2006.08.004; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; REDDY CC, 1994, BIOTECHNOL PROGR, V10, P377, DOI 10.1021/bp00028a006; Reddy CC, 1996, J CELL PHYSIOL, V166, P512, DOI 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Schneider IC, 2004, BIOPHYS J, V86, P599, DOI 10.1016/S0006-3495(04)74138-7; SEGEL LA, 1986, J THEOR BIOL, V120, P151, DOI 10.1016/S0022-5193(86)80171-0; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; VOGEL A, 1980, J CELL BIOL, V85, P377, DOI 10.1083/jcb.85.2.377; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; WATERS SB, 1995, J BIOL CHEM, V270, P20883, DOI 10.1074/jbc.270.36.20883; WHITMARSH AJ, 2007, J BIOCHIM BIOPHYS AC, V1773, P1285; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	56	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36736	36744		10.1074/jbc.M110.148759	http://dx.doi.org/10.1074/jbc.M110.148759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847054	hybrid, Green Published			2022-12-25	WOS:000284146100085
J	Higashi, Y; Holder, K; Delafontaine, P				Higashi, Yusuke; Holder, Kevin; Delafontaine, Patrice			Thiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor gamma-Independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA; GENE-EXPRESSION; DEFICIENT MICE; ATHEROSCLEROTIC LESIONS; MONOCLONAL-ANTIBODY; OXIDATIVE STRESS; IGF-1; TROGLITAZONE	There is increasing evidence that thiazolidinediones (TZDs), antidiabetic compounds that are synthetic ligands for the peroxisome proliferator-activated receptor gamma (PPAR gamma), have cardiovascular effects through as yet poorly defined mechanisms. We tested the effect of two TZD class drugs, rosiglitazone and pioglitazone, on human aortic smooth muscle cell (SMC) expression of insulin-like growth factor-1 receptor (IGF-1R). Both TZDs dose dependently up-regulated IGF-1R protein levels (rosiglitazone, 10 mu mol/liter, 67% increase, n = 4, p < 0.01; pioglitazone, 10 mu mol/liter, 41% increase, n = 4, p < 0.01) and increased IGF-1R signaling activity (36% increase in Akt phosphorylation). However, the endogenous PPAR gamma ligand, 15-deoxy-Delta(12,14)-prostaglandin J(2), dose dependently reduced IGF-1R (10 mu mol/liter, 80% decrease, n = 4, p < 0.01), and overexpression of PPAR gamma using an adenovirus likewise reduced IGF-1R (50% decrease versus SMC infected with control adenovirus), suggesting a PPAR gamma-independent action of TZDs. All three PPAR gamma ligands (rosiglitazone, pioglitazone, and 15-deoxy-Delta(12,14)-prostaglandin J2), however, did not change IGF-1R mRNA levels, indicating that their effects were posttranscriptional. Use of bicistronic constructs revealed that TZD induction of IGF-1R translation occurred via internal ribosomal entry. To examine the potential physiological relevance of TZD up-regulation of IGF-1R, we determined the effect of rosiglitazone on oxidized LDL (oxLDL)-induced apoptosis. 20 mu mol/liter of rosiglitazone reduced oxidized LDL-induced apoptosis by 40% and neutralizing antibody to IGF-1R (alpha IR3) counteracted this rescue, suggesting the rosiglitazone survival effect was, at least in part, mediated by IGF-1R. In conclusion, TZDs markedly up-regulate SMC IGF-1R expression and signaling, likely via a PPAR gamma-independent mechanism. This novel action of TZDs may play an important role in their cardiovascular effects.	[Higashi, Yusuke; Holder, Kevin; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA	Tulane University	Delafontaine, P (corresponding author), 1430 Tulane Ave,SL-48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Delafontaine, Patrice/0000-0003-3744-3617	NHLBI, National Institutes of Health [R01HL070241, R01HL080682]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL070241 and R01HL080682 from the NHLBI.	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Barish GD, 2006, J NUTR, V136, P690, DOI 10.1093/jn/136.3.690; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Chisalita SI, 2009, J MOL ENDOCRINOL, V43, P231, DOI 10.1677/JME-09-0021; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Festuccia WT, 2009, J MOL CELL CARDIOL, V47, P85, DOI 10.1016/j.yjmcc.2009.04.011; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu MG, 2002, BIOCHEM BIOPH RES CO, V294, P597, DOI 10.1016/S0006-291X(02)00533-8; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Goetze S, 1999, J CARDIOVASC PHARM, V33, P798, DOI 10.1097/00005344-199905000-00018; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; He GB, 2006, CANCER RES, V66, P1873, DOI 10.1158/0008-5472.CAN-05-3111; Higashi Y, 2005, J LIPID RES, V46, P1266, DOI 10.1194/jlr.M400478-JLR200; Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Itabe H, 1996, J LIPID RES, V37, P45; ITABE H, 1994, J BIOL CHEM, V269, P15274; KHORSANDI MJ, 1992, J CLIN INVEST, V90, P1926, DOI 10.1172/JCI116070; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB; Lonn EM, 2009, J AM COLL CARDIOL, V53, P2028, DOI 10.1016/j.jacc.2008.12.072; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Meng Z, 2008, J CELL PHYSIOL, V217, P172, DOI 10.1002/jcp.21486; Minamikawa J, 1998, J CLIN ENDOCR METAB, V83, P1818, DOI 10.1210/jc.83.5.1818; Nichols TC, 1999, CIRC RES, V85, P1040; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Scheidegger KJ, 2000, J BIOL CHEM, V275, P26864; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; Scheidegger KJ, 2000, J BIOL CHEM, V275, P38921, DOI 10.1074/jbc.M004691200; Schiffrin EL, 2005, AM J PHYSIOL-HEART C, V288, pH1037, DOI 10.1152/ajpheart.00677.2004; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257	45	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36361	36368		10.1074/jbc.M110.137661	http://dx.doi.org/10.1074/jbc.M110.137661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843793	Green Published, hybrid			2022-12-25	WOS:000284146100028
J	Lewis, TL; Cao, DF; Lu, HL; Mans, RA; Su, YR; Jungbauer, L; Linton, MF; Fazio, S; LaDu, MJ; Li, L				Lewis, Terry L.; Cao, Dongfeng; Lu, Hailin; Mans, Robert A.; Su, Yan Ru; Jungbauer, Lisa; Linton, MacRae F.; Fazio, Sergio; LaDu, Mary Jo; Li, Ling			Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; SERUM PARAOXONASE ACTIVITY; HUMAN CEREBROSPINAL-FLUID; VASCULAR DEMENTIA; CARDIOVASCULAR-DISEASE; EXCEPTIONAL LONGEVITY; LEARNING-DEFICITS; PRECURSOR PROTEIN; TRANSGENIC MICE	To date there is no effective therapy for Alzheimer disease (AD). High levels of circulating high density lipoprotein (HDL) and its main protein, apolipoprotein A-I (apoA-I), reduce the risk of cardiovascular disease. Clinical studies show that plasma HDL cholesterol and apoA-I levels are low in patients with AD. To investigate if increasing plasma apoA-I/HDL levels ameliorates AD-like memory deficits and amyloid-beta (A beta) deposition, we generated a line of triple transgenic (Tg) mice overexpressing mutant forms of amyloid-beta precursor protein (APP) and presenilin 1 (PS1) as well as human apoA-I (AI). Here we show that APP/PS1/AI triple Tg mice have a 2-fold increase of plasma HDL cholesterol levels. When tested in the Morris water maze for spatial orientation abilities, whereas APP/PS1 mice develop age-related learning and memory deficits, APP/PS1/AI mice continue to perform normally during aging. Interestingly, no significant differences were found in the total level and deposition of A beta in the brains of APP/PS1 and APP/PS1/AI mice, but cerebral amyloid angiopathy was reduced in APP/PS1/AI mice. Also, consistent with the anti-inflammatory properties of apoA-I/HDL, glial activation was reduced in the brain of APP/PS1/AI mice. In addition, A beta-induced production of proinflammatory chemokines/cytokines was decreased in mouse organotypic hippocampal slice cultures expressing human apoA-I. Therefore, we conclude that overexpression of human apoA-I in the circulation prevents learning and memory deficits in APP/PS1 mice, partly by attenuating neuroinflammation and cerebral amyloid angiopathy. These findings suggest that elevating plasma apoA-I/HDL levels may be an effective approach to preserve cognitive function in patients with AD.	[Lewis, Terry L.; Cao, Dongfeng; Lu, Hailin; Mans, Robert A.; Li, Ling] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lewis, Terry L.; Li, Ling] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mans, Robert A.; Li, Ling] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Cao, Dongfeng; Li, Ling] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Su, Yan Ru; Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Jungbauer, Lisa; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, L (corresponding author), 2001 6th St SE,MTRF 4-208, Minneapolis, MN 55455 USA.	lil@umn.edu		LaDu, Mary Jo/0000-0003-2141-1450; Li, Ling/0000-0002-9245-7387; Jungbauer Nikolas, Lisa/0000-0002-5429-3393	National Institutes of Health [AG031846, HL65709, HL086988, AG03012801]; American Health Assistance Foundation [A2010328]; Alzheimer's Association [IIRG-09-131791, ZEN-08-99900]; American Heart Association [0455304B]; University of Illinois Chicago Center for Clinical and Translational Science [UL1RR029879]; Anonymous philanthropic foundations; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065709, R01HL086988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG031846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); University of Illinois Chicago Center for Clinical and Translational Science; Anonymous philanthropic foundations; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG031846, HL65709, HL086988, and AG03012801. This work was also supported by American Health Assistance Foundation Grant A2010328, Alzheimer's Association Grants IIRG-09-131791 and ZEN-08-99900, American Heart Association Grant 0455304B, University of Illinois Chicago Center for Clinical and Translational Science Pilot Grant UL1RR029879, and anonymous philanthropic foundations.	ABBOTT CA, 1995, ARTERIOSCL THROM VAS, V15, P1812, DOI 10.1161/01.ATV.15.11.1812; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Buga GM, 2006, J LIPID RES, V47, P2148, DOI 10.1194/jlr.M600214-JLR200; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Duffy D, 2006, CIRCULATION, V113, P1140, DOI 10.1161/CIRCULATIONAHA.105.593855; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Harr SD, 1996, J NEUROCHEM, V66, P2429; Helbecque N, 2008, DEMENT GERIATR COGN, V25, P97, DOI 10.1159/000112176; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ishiguro H, 2001, J BIOL CHEM, V276, P36742, DOI 10.1074/jbc.M106027200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Koch S, 2001, J LIPID RES, V42, P1143; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kontush A, 2008, ARTERIOSCL THROM VAS, V28, P1418, DOI 10.1161/ATVBAHA.108.169714; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Launer LJ, 2001, NEUROLOGY, V57, P1447, DOI 10.1212/WNL.57.8.1447; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Major AS, 2001, ARTERIOSCL THROM VAS, V21, P1790, DOI 10.1161/hq1101.097798; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208; Navab M, 1998, CURR OPIN LIPIDOL, V9, P449, DOI 10.1097/00041433-199810000-00009; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Paragh G, 2002, EUR ARCH PSY CLIN N, V252, P63, DOI 10.1007/s004060200013; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Prat E, 2000, NEUROSCI LETT, V283, P177, DOI 10.1016/S0304-3940(00)00966-6; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Scarmeas N, 2007, AM J EPIDEMIOL, V165, P993, DOI 10.1093/aje/kwm033; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; SEGREST JP, 1994, CURR OPIN CARDIOL, V9, P404; Shih DM, 2009, CURR OPIN LIPIDOL, V20, P288, DOI 10.1097/MOL.0b013e32832ca1ee; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Smoak KA, 2010, CELL METAB, V11, P493, DOI 10.1016/j.cmet.2010.04.006; Song H, 1997, NEUROSCI LETT, V231, P175, DOI 10.1016/S0304-3940(97)00558-2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Su YR, 2008, ARTERIOSCL THROM VAS, V28, P1439, DOI 10.1161/ATVBAHA.107.160093; Su YR, 2003, MOL THER, V8, P576, DOI 10.1016/S1525-0016(03)00214-4; Szczepanik AM, 2001, J NEUROCHEM, V77, P304, DOI 10.1046/j.1471-4159.2001.t01-1-00240.x; Vergnes L, 2000, ARTERIOSCL THROM VAS, V20, P2267, DOI 10.1161/01.ATV.20.10.2267; Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283	68	145	158	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36958	36968		10.1074/jbc.M110.127829	http://dx.doi.org/10.1074/jbc.M110.127829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847045	Green Published, hybrid			2022-12-25	WOS:000284146100062
J	Shamay, M; Greenway, M; Liao, GL; Ambinder, RF; Hayward, SD				Shamay, Meir; Greenway, Melanie; Liao, Gangling; Ambinder, Richard F.; Hayward, S. Diane			De Novo DNA Methyltransferase DNMT3b Interacts with NEDD8-modified Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; UBIQUITIN LIGASE ACTIVITY; HUMAN CANCER-CELLS; MAMMALIAN DEVELOPMENT; ENZYMATIC-PROPERTIES; HISTONE METHYLATION; NEDD8 MODIFICATION; IN-VIVO; HETEROCHROMATIN; PATHWAY	DNA methylation and histone modifications play an important role in transcription regulation. In cancer cells, many promoters become aberrantly methylated through the activity of the de novo DNA methyltransferases DNMT3a and DNMT3b and acquire repressive chromatin marks. NEDD8 is a ubiquitin-like protein modifier that is conjugated to target proteins, such as cullins, to regulate their activity, and cullin 4A (CUL4A) in its NEDD8-modified form is essential for repressive chromatin formation. We found that DNMT3b associates with NEDD8-modified proteins. Whereas DNMT3b interacts directly in vitro with NEDD8, conjugation of NEDD8 to target proteins enhances this interaction in vivo. DNMT3b immunoprecipitated two major bands of endogenously NEDDylated proteins at the size of NEDDylated cullins, and indeed DNMT3b interacted with CUL1, CUL2, CUL3, CUL4A, and CUL5. Moreover, DNMT3b preferentially immunoprecipitated the NEDDylated form of endogenous CUL4A. NEDD8 enhanced DNMT3b-dependent DNA methylation. Chromatin immunoprecipitation assays suggest that DNMT3b recruits CUL4A and NEDD8 to chromatin, whereas deletion of Dnmt3b reduces the association of CUL4A and NEDD8 at a repressed promoter in a cancer cell line.	[Shamay, Meir; Greenway, Melanie; Liao, Gangling; Ambinder, Richard F.; Hayward, S. Diane] Johns Hopkins Sch Med, Sidney Kimmel Canc Ctr, Viral Oncol Program, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Shamay, M (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB1 310, Baltimore, MD 21231 USA.	mshamay1@jhmi.edu			National Institutes of Health [P01 CA113239, P50 CA96888]; NATIONAL CANCER INSTITUTE [P50CA096888, P01CA113239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA113239 (to S. D. H.) and P50 CA96888 (to R. F. A. and M. S.).	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Chairatvit K, 2007, MOL CELL BIOCHEM, V306, P163, DOI 10.1007/s11010-007-9566-7; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Chen LC, 1998, CANCER RES, V58, P3677; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Geiman TM, 2004, BIOCHEM BIOPH RES CO, V318, P544, DOI 10.1016/j.bbrc.2004.04.058; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kang ES, 2001, BIOCHEM BIOPH RES CO, V289, P862, DOI 10.1006/bbrc.2001.6057; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lee B, 2009, BIOCHEM J, V421, P449, DOI 10.1042/BJ20090142; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lu F, 2003, J VIROL, V77, P11425, DOI 10.1128/JVI.77.21.11425-11435.2003; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	68	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36377	36386		10.1074/jbc.M110.155721	http://dx.doi.org/10.1074/jbc.M110.155721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847044	Green Published, hybrid			2022-12-25	WOS:000284146100030
J	Um, JW; Im, E; Park, J; Oh, Y; Min, B; Lee, HJ; Yoon, JB; Chung, KC				Um, Ji Won; Im, Eunju; Park, Joongkyu; Oh, Yohan; Min, Boram; Lee, Hyun Jung; Yoon, Jong Bok; Chung, Kwang Chul			ASK1 Negatively Regulates the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CASPASE ACTIVATION; FAMILY PROTEINS; ATPASE SUBUNIT; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION; PATHWAY; KINASE; STRESS	The 26 S proteasome, composed of the 20 S core and 19 S regulatory particle, plays a central role in ubiquitin-dependent proteolysis. Disruption of this process contributes to the pathogenesis of the various diseases; however, the mechanisms underlying the regulation of 26 S proteasome activity remain elusive. Here, cell culture experiments and in vitro assays demonstrated that apoptosis signal-regulating kinase 1 (ASK1), a member of the MAPK kinase kinase family, negatively regulated 26 S proteasome activity. Immunoprecipitation/Western blot analyses revealed that ASK1 did not interact with 20 S catalytic core but did interact with ATPases making up the 19 S particle, which is responsible for recognizing polyubiquitinated proteins, unfolding them, and translocating them into the 20 S catalytic core in an ATP-dependent process. Importantly, ASK1 phosphorylated Rpt5, an AAA ATPase of the 19 S proteasome, and inhibited its ATPase activity, an effect that may underlie the ability of ASK1 to inhibit 26 S proteasome activity. The current findings point to a novel role for ASK1 in the regulation of 26 S proteasome and offer new strategies for treating human diseases caused by proteasome malfunction.	[Um, Ji Won; Im, Eunju; Park, Joongkyu; Oh, Yohan; Min, Boram; Lee, Hyun Jung; Chung, Kwang Chul] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Yoon, Jong Bok] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University; Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seongsan No 262, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Park, Joongkyu/ADZ-1994-2022; Oh, Yohan/C-9107-2013; Im, Eunju/Y-2601-2018; rchnds, rchnds/D-7595-2016	Park, Joongkyu/0000-0002-5675-2872; Oh, Yohan/0000-0002-9249-8664; Im, Eunju/0000-0002-7839-8878; Yoon, Jong-Bok/0000-0002-3563-0702	Ministry of Education, Science and Technology (MEST), Republic of Korea [2009K-001251]; MEST [2010-0018916]; NRF [20100001668]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A092004]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Brain Research Center of the 21st Century Frontier Research Program Technology (Grant 2009K-001251 to K. C. C.) funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea. This work was also supported by the National Research Foundation of Korea (NRF) grant funded by MEST (Grant 2010-0018916 to K. C. C.) and by Basic Science Research Program through NRF (Grant 20100001668 to K. C. C.). This work was also partially supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (Grant A092004 to K. C. C.).	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bardag-Gorce F, 2004, LIFE SCI, V75, P585, DOI 10.1016/j.lfs.2003.12.027; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Beyette J, 1998, BIOCHEM J, V332, P315, DOI 10.1042/bj3320315; Bose S, 1999, MOL BIOL REP, V26, P11, DOI 10.1023/A:1006969517958; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Checler F, 2000, BBA-MOL BASIS DIS, V1502, P133, DOI 10.1016/S0925-4439(00)00039-9; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cohen GM, 2005, CELL DEATH DIFFER, V12, P1218, DOI 10.1038/sj.cdd.4401693; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; He XG, 2003, AM J PATHOL, V163, P243, DOI 10.1016/S0002-9440(10)63647-4; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kohler A, 2001, BIOCHIMIE, V83, P325, DOI 10.1016/S0300-9084(01)01242-1; Kutuzov MA, 2005, J BIOL CHEM, V280, P25388, DOI 10.1074/jbc.M413202200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Marambaud P, 1996, J NEUROCHEM, V67, P2616; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakayama K, 2001, J IMMUNOL, V167, P1145, DOI 10.4049/jimmunol.167.3.1145; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Reinheckel T, 2000, METH MOL B, V99, P49; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Starace D, 2004, FASEB J, V18, P473, DOI 10.1096/fj.04-2726fje; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	45	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36434	36446		10.1074/jbc.M110.133777	http://dx.doi.org/10.1074/jbc.M110.133777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843792	hybrid, Green Published			2022-12-25	WOS:000284146100073
J	Wang, WJ; Mazurkewich, S; Kimber, MS; Seah, SYK				Wang, Weijun; Mazurkewich, Scott; Kimber, Matthew S.; Seah, Stephen Y. K.			Structural and Kinetic Characterization of 4-Hydroxy-4-methyl-2-oxoglutarate/4-Carboxy-4-hydroxy-2-oxoadipate Aldolase, a Protocatechuate Degradation Enzyme Evolutionarily Convergent with the HpaI and DmpG Pyruvate Aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR PHOSPHOTRANSFERASE SYSTEM; CLASS-II ALDOLASE; CRYSTAL-STRUCTURE; PROTEIN INHIBITOR; MECHANISM; RRAA; PURIFICATION; PATHWAY; DEHYDROGENASE; EXPRESSION	4-Hydroxy-4-methyl-2-oxoglutarate/4-carboxy-4-hydroxy-2- oxoadipate (HMG/CHA) aldolase from Pseudomonas putida F1 catalyzes the last step of the bacterial protocatechuate 4,5-cleavage pathway. The preferred substrates of the enzyme are 2-keto-4-hydroxy acids with a 4-carboxylate substitution. The enzyme also exhibits oxaloacetate decarboxylation and pyruvate alpha-proton exchange activity. Sodium oxalate is a competitive inhibitor of the aldolase reaction. The pH dependence of k(cat)/K-m and k(cat) for the enzyme is consistent with a single deprotonation with pK(a) values of 8.0 +/- 0.1 and 7.0 +/- 0.1 for free enzyme and enzyme substrate complex, respectively. The 1.8 angstrom x-ray structure shows a four-layered alpha-beta-beta-alpha sandwich structure with the active site at the interface of two adjacent subunits of a hexamer; this fold resembles the RNase E inhibitor, RraA, but is novel for an aldolase. The catalytic site contains a magnesium ion ligated by Asp-124 as well as three water molecules bound by Asp-102 and Glu-199'. A pyruvate molecule binds the magnesium ion through both carboxylate and keto oxygen atoms, completing the octahedral geometry. The carbonyl oxygen also forms hydrogen bonds with the guanadinium group of Arg-123, which site-directed mutagenesis confirms is essential for catalysis. A mechanism for HMG/CHA aldolase is proposed on the basis of the structure, kinetics, and previously established features of other aldolase mechanisms.	[Wang, Weijun; Mazurkewich, Scott; Kimber, Matthew S.; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Seah, SYK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	sseah@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Mazurkewich, Scott/0000-0002-9238-0615; wang, weijun/0000-0001-9283-5619; Kimber, Matthew/0000-0001-9454-5586	National Science and Engineering Research Council of Canada [238284, 327280]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Research Council of Canada Discovery Grants 238284 (to S. Y. K. S.) and 327280 (to M. S. K.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker P, 2009, BIOCHEMISTRY-US, V48, P6551, DOI 10.1021/bi9006644; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhuri BN, 2003, STRUCTURE, V11, P753, DOI 10.1016/S0969-2126(03)00106-0; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENNIS DA, 1973, J BACTERIOL, V113, P521, DOI 10.1128/JB.113.1.521-523.1973; DREYER MK, 1993, J MOL BIOL, V231, P549, DOI 10.1006/jmbi.1993.1307; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Helaine V, 2001, ADV SYNTH CATAL, V343, P692, DOI 10.1002/1615-4169(200108)343:6/7<692::AID-ADSC692>3.3.CO;2-Y; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Horecker B. L, 1972, ENZYMES, P213, DOI DOI 10.1016/S1874-6047(08)60450-3; Johnston JM, 2003, J BACTERIOL, V185, P4057, DOI 10.1128/JB.185.14.4057-4065.2003; KEYSER P, 1976, ENVIRON HEALTH PERSP, V18, P159, DOI 10.2307/3428698; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; Leulliot N, 2005, PROTEIN SCI, V14, P2751, DOI 10.1110/ps.051684005; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Maruyama K, 2001, BIOSCI BIOTECH BIOCH, V65, P2701, DOI 10.1271/bbb.65.2701; MARUYAMA K, 1990, J BIOCHEM-TOKYO, V108, P327, DOI 10.1093/oxfordjournals.jbchem.a123201; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monzingo AF, 2003, J MOL BIOL, V332, P1015, DOI 10.1016/S0022-2836(03)00970-7; Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWLOWSKI J, 1993, J BACTERIOL, V175, P377, DOI 10.1128/JB.175.2.377-385.1993; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; Rehse PH, 2004, ACTA CRYSTALLOGR D, V60, P1997, DOI 10.1107/S0907444904021146; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TACK BF, 1972, J BIOL CHEM, V247, P6444; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Wang WJ, 2010, BIOCHEMISTRY-US, V49, P3774, DOI 10.1021/bi100251u; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	44	22	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36608	36615		10.1074/jbc.M110.159509	http://dx.doi.org/10.1074/jbc.M110.159509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843800	hybrid, Green Published			2022-12-25	WOS:000284146100024
J	Xiao, CY; Kim, HS; Lahusen, T; Wang, RH; Xu, XL; Gavrilova, O; Jou, W; Gius, D; Deng, CX				Xiao, Cuiying; Kim, Hyun-Seok; Lahusen, Tyler; Wang, Rui-Hong; Xu, Xiaoling; Gavrilova, Oksana; Jou, William; Gius, David; Deng, Chu-Xia			SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; IN-VIVO; EXPRESSION; GLUT1; TRANSPORTERS; METABOLISM; SIRTUINS; ROLES; MOUSE; CELLS	Glucose homeostasis in mammals is mainly regulated by insulin signaling. It was previously shown that SIRT6 mutant mice die before 4 weeks of age, displaying profound abnormalities, including low insulin, hypoglycemia, and premature aging. To investigate mechanisms underlying the pleiotropic phenotypes associated with SIRT6 deficiency, we generated mice carrying targeted disruption of SIRT6. We found that 60% of SIRT6(-/-) animals had very low levels of blood glucose and died shortly after weaning. The remaining animals, which have relatively higher concentrations of glucose, survived the early post-weaning lethality, but most died within one year of age. Significantly, feeding the mice with glucose-containing water increased blood glucose and rescued 83% of mutant mice, suggesting that the hypoglycemia is a major cause for the lethality. We showed that SIRT6 deficiency results in more abundant membrane association of glucose transporters 1 and 4, which enhances glucose uptake. We further demonstrated that SIRT6 negatively regulates AKT phosphorylation at Ser-473 and Thr-308 through inhibition of multiple upstream molecules, including insulin receptor, IRS1, and IRS2. The absence of SIRT6, consequently, enhances insulin signaling and activation of AKT, leading to hypoglycemia. These data uncover an essential role of SIRT6 in modulating glucose metabolism through mediating insulin sensitivity.	[Xiao, Cuiying; Kim, Hyun-Seok; Lahusen, Tyler; Wang, Rui-Hong; Xu, Xiaoling; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Gavrilova, Oksana; Jou, William] NIDDK, Mouse Metab Core Lab, Bethesda, MD 20892 USA; [Kim, Hyun-Seok; Gius, David] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Deng, CX (corresponding author), 10 Ctr Dr, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016		NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, ZIADK056009, ZICDK070002, ZIADK056010, ZIADK056004, ZIADK056011] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of NIDDK, National Institutes of Health.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deng Chu-Xia, 2004, Methods Mol Biol, V280, P185; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Diaz M, 2009, AM J PHYSIOL-REG I, V296, pR794, DOI 10.1152/ajpregu.90673.2008; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guettier JM, 2006, ENDOCRIN METAB CLIN, V35, P753, DOI 10.1016/j.ecl.2006.09.005; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAUSDORFF SF, 1995, J BIOL CHEM, V270, P12965, DOI 10.1074/jbc.270.22.12965; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Johnson ES, 2002, J CLIN EPIDEMIOL, V55, P253, DOI 10.1016/S0895-4356(01)00479-6; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laybutt DR, 1997, AM J PHYSIOL-HEART C, V273, pH1309, DOI 10.1152/ajpheart.1997.273.3.H1309; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Quinn L, 2001, NURS CLIN N AM, V36, pXI; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; TAHA C, 1995, J BIOL CHEM, V270, P24678, DOI 10.1074/jbc.270.42.24678; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wada T, 2007, YAKUGAKU ZASSHI, V127, P143, DOI 10.1248/yakushi.127.143; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Xu XL, 2001, GENESIS, V30, P1, DOI 10.1002/gene.1025; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	44	165	170	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36776	36784		10.1074/jbc.M110.168039	http://dx.doi.org/10.1074/jbc.M110.168039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847051	Green Published, hybrid			2022-12-25	WOS:000284146100051
J	Durante-Rodriguez, G; Valderrama, JA; Mancheno, JM; Rivas, G; Alfonso, C; Arias-Palomo, E; Llorca, O; Garcia, JL; Diaz, E; Carmona, M				Durante-Rodriguez, Gonzalo; Andres Valderrama, J.; Miguel Mancheno, Jose; Rivas, German; Alfonso, Carlos; Arias-Palomo, Ernesto; Llorca, Oscar; Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel			Biochemical Characterization of the Transcriptional Regulator BzdR from Azoarcus sp. CIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAEROBIC CATABOLISM; CRYSTAL-STRUCTURE; SHIKIMATE KINASE; BINDING; GENE; BENZOATE; REPRESSOR; BIOSYNTHESIS; ASSEMBLIES; EXPRESSION	The BzdR transcriptional regulator that controls the P-N promoter responsible for the anaerobic catabolism of benzoate in Azoarcus sp. CIB constitutes the prototype of a new subfamily of transcriptional regulators. Here, we provide some insights about the functional-structural relationships of the BzdR protein. Analytical ultracentrifugation studies revealed that BzdR is homodimeric in solution. An electron microscopy three-dimensional reconstruction of the BzdR dimer has been obtained, and the predicted structures of the respective N- and C-terminal domains of each BzdR monomer could be fitted into such a reconstruction. Gel retardation and ultracentrifugation experiments have shown that the binding of BzdR to its cognate promoter is cooperative. Different biochemical approaches revealed that the effector molecule benzoyl-CoA induces conformational changes in BzdR without affecting its oligomeric state. The BzdR-dependent inhibition of the P-N promoter and its activation in the presence of benzoyl-CoA have been established by in vitro transcription assays. The monomeric BzdR4 and BzdR5 mutant regulators revealed that dimerization of BzdR is essential for DNA binding. Remarkably, a BzdR Delta L protein lacking the linker region connecting the N- and C-terminal domains of BzdR is also dimeric and behaves as a super-repressor of the P-N promoter. These data suggest that the linker region of BzdR is not essential for protein dimerization, but rather it is required to transfer the conformational changes induced by the benzoyl-CoA to the DNA binding domain leading to the release of the repressor. A model of action of the BzdR regulator has been proposed.	[Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Miguel Mancheno, Jose] CSIC, Inst Quim Fis Rocasolano, Dept Crystallog, E-28006 Madrid, Spain; [Rivas, German; Alfonso, Carlos; Arias-Palomo, Ernesto; Llorca, Oscar] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Carmona, M (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	mcarmona@cib.csic.es	Valderrama, Jonathan Andres/AAC-1098-2021; Llorca, Oscar/K-1144-2014; Mancheno, Jose/K-4984-2014; Arias Palomo, Ernesto/L-1853-2017; Alfonso, Carlos/K-1316-2014; Durante-Rodríguez, Gonzalo/H-3000-2013; Bustelo, Xose R./A-9526-2010; Rivas, German/AFL-7528-2022; Diaz, Eduardo/F-8605-2016; Rivas, German/AAG-7458-2022; Llorca, Oscar/P-2784-2019; Garcia, Pedro/L-2808-2017; Garcia Lopez, Jose Luis/G-9139-2015	Llorca, Oscar/0000-0001-5705-0699; Mancheno, Jose/0000-0001-6943-3291; Alfonso, Carlos/0000-0001-7165-4800; Durante-Rodríguez, Gonzalo/0000-0003-3113-9868; Bustelo, Xose R./0000-0001-9398-6072; Rivas, German/0000-0003-3450-7478; Diaz, Eduardo/0000-0002-9731-6524; Rivas, German/0000-0003-3450-7478; Llorca, Oscar/0000-0001-5705-0699; Valderrama Traslavina, J. Andres/0000-0001-7440-4225; Garcia, Pedro/0000-0001-6717-8717; Arias-Palomo, Ernesto/0000-0002-2706-7411; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Carmona, Manuel/0000-0002-1591-7618	Comision Interministerial de Ciencia y Tecnologia [BIO2006-05957, BIO2009-10438, BIO2008-04478-C03-03, BFU2007-67404/BMC, SAF2008-00451, CSD2007-00005]; Comunidad Autonoma de Madrid [P-AMB-259-0505, CAM S-BIO-0214-2006]; Plan Nacional de Formacion de Personal Investigador-MEC; "Factoria de Cristalizacion" Consolider-Ingenio; Autonomous Region of Madrid (Consejer a de Educacion de la Comunidad de Madrid y Fondo Social Europeo); Human Frontiers Science Program [RGP39/2008]; RTICC from the "Instituto de Salud Carlos III" [RD06/0020/1001]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad Autonoma de Madrid(Comunidad de Madrid); Plan Nacional de Formacion de Personal Investigador-MEC; "Factoria de Cristalizacion" Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Region of Madrid (Consejer a de Educacion de la Comunidad de Madrid y Fondo Social Europeo); Human Frontiers Science Program(Human Frontier Science Program); RTICC from the "Instituto de Salud Carlos III"	This work was supported in part by Comision Interministerial de Ciencia y Tecnologia Grants BIO2006-05957, BIO2009-10438, BIO2008-04478-C03-03, BFU2007-67404/BMC, SAF2008-00451, and CSD2007-00005 and Comunidad Autonoma de Madrid Grants P-AMB-259-0505 and CAM S-BIO-0214-2006.; Recipient of a predoctoral fellowship from the Plan Nacional de Formacion de Personal Investigador-MEC.; Supported by "Factoria de Cristalizacion" Consolider-Ingenio 2010.; Supported by a fellowship from the Autonomous Region of Madrid (Consejer a de Educacion de la Comunidad de Madrid y Fondo Social Europeo).; Supported by the Human Frontiers Science Program RGP39/2008 and the RTICC from the "Instituto de Salud Carlos III" Grant RD06/0020/1001.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8399, DOI 10.1021/bi00194a003; Carmona M, 1996, J MOL BIOL, V261, P348, DOI 10.1006/jmbi.1996.0468; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Cervin MA, 1998, NUCLEIC ACIDS RES, V26, P3806, DOI 10.1093/nar/26.16.3806; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Clark TJ, 2004, J BACTERIOL, V186, P1200, DOI 10.1128/JB.186.4.1200-1204.2004; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Durante-Rodriguez G, 2008, MICROBIOL-SGM, V154, P306, DOI 10.1099/mic.0.2007/011361-0; ELY B, 1979, J BACTERIOL, V138, P933, DOI 10.1128/JB.138.3.933-943.1979; GAN J, 2006, X BIOCH, V45, P8539; GAUR NK, 1991, J BACTERIOL, V173, P678, DOI 10.1128/jb.173.2.678-686.1991; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Gu YJ, 2002, J MOL BIOL, V319, P779, DOI 10.1016/S0022-2836(02)00339-X; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Howlett GJ, 2000, METHOD ENZYMOL, V323, P231; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; Koudelka GB, 1998, NUCLEIC ACIDS RES, V26, P669, DOI 10.1093/nar/26.2.669; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1995, BIOPHYS CHEM, V56, P263, DOI 10.1016/0301-4622(95)00040-5; LAMZIN VS, 1992, EUR J BIOCHEM, V206, P441, DOI 10.1111/j.1432-1033.1992.tb16945.x; Larquet E, 2004, J MOL BIOL, V343, P1159, DOI 10.1016/j.jmb.2004.09.010; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LeFevre KR, 2003, P NATL ACAD SCI USA, V100, P2345, DOI 10.1073/pnas.0537925100; Lewis RJ, 1998, J MOL BIOL, V283, P907, DOI 10.1006/jmbi.1998.2163; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Mattison K, 2002, J BIOL CHEM, V277, P32714, DOI 10.1074/jbc.M204122200; Maxam A M, 1980, Methods Enzymol, V65, P499; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PTASHNE M, 1976, SCIENCE, V194, P156, DOI 10.1126/science.959843; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; ROBERTS TM, 1977, NATURE, V270, P274, DOI 10.1038/270274a0; Russell A D, 1976, Prog Med Chem, V13, P271, DOI 10.1016/S0079-6468(08)70140-1; Sambrook J, 2001, MOL CLONING LAB MANU; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; TAO T, 1991, J BACTERIOL, V173, P1367, DOI 10.1128/jb.173.4.1367-1375.1991; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; TISHKOV VI, 1991, DOKL AKAD NAUK SSSR+, V317, P745; VANHOLDE KE, 1985, PHYS BIOCH; Venien-Bryan C, 2000, J MOL BIOL, V296, P863, DOI 10.1006/jmbi.1999.3480; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; WEISS MA, 1987, BIOCHEMISTRY-US, V26, P897, DOI 10.1021/bi00377a034; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	64	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35694	35705		10.1074/jbc.M110.143503	http://dx.doi.org/10.1074/jbc.M110.143503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826820	Green Published, hybrid			2022-12-25	WOS:000283845300048
J	Orr, CR; Montie, HL; Liu, YH; Bolzoni, E; Jenkins, SC; Wilson, EM; Joseph, JD; McDonnell, DP; Merry, DE				Orr, Christopher R.; Montie, Heather L.; Liu, Yuhong; Bolzoni, Elena; Jenkins, Shannon C.; Wilson, Elizabeth M.; Joseph, James D.; McDonnell, Donald P.; Merry, Diane E.			An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; COOH-TERMINAL INTERACTION; LIGAND-BINDING DOMAIN; ACTIVATION FUNCTION 2; PROSTATE-CANCER; PHOSPHORYLATION SITES; STRUCTURAL BASIS; INDUCED DISEASE; IDENTIFICATION; COACTIVATOR	Polyglutamine expansion within the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA) and is associated with misfolded and aggregated species of the mutant AR. We showed previously that nuclear localization of the mutant AR was necessary but not sufficient for SBMA. Here we show that an interdomain interaction of the AR that is central to its function within the nucleus is required for AR aggregation and toxicity. Ligands that prevent the interaction between the amino-terminal FXXLF motif and carboxyl-terminal AF-2 domain (N/C interaction) prevented toxicity and AR aggregation in an SBMA cell model and rescued primary SBMA motor neurons from 5 alpha-dihydrotestosterone-induced toxicity. Moreover, genetic mutation of the FXXLF motif prevented AR aggregation and 5 alpha-dihydrotestosterone toxicity. Finally, selective androgen receptor modulators, which prevent the N/C interaction, ameliorated AR aggregation and toxicity while maintaining AR function, highlighting a novel therapeutic strategy to prevent the SBMA phenotype while retaining AR transcriptional function.	[Orr, Christopher R.; Montie, Heather L.; Liu, Yuhong; Bolzoni, Elena; Jenkins, Shannon C.; Merry, Diane E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Joseph, James D.; McDonnell, Donald P.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Labs Reprod Biol, Chapel Hill, NC 27599 USA	Jefferson University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Merry, DE (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 228 Bluemle Life Sci Bldg,223 S 10th St, Philadelphia, PA 19107 USA.	diane.merry@jefferson.edu			National Institutes of Health [R01 NS32214, DK07705, CA139818, HD16910]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA139818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS32214 (to D. E. M.), DK07705 (to H. L. M.), CA139818 (to D. P. M.), and HD16910 (to E. M. W.).	Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Chandra S, 2008, J BIOL CHEM, V283, P23950, DOI 10.1074/jbc.M800467200; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Furutani T, 2005, J PHARMACOL EXP THER, V315, P545, DOI 10.1124/jpet.105.087643; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LAVERY DN, 2008, J BIOCH, V47, P3360; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Norris JD, 2009, CHEM BIOL, V16, P452, DOI 10.1016/j.chembiol.2009.01.016; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perutz MF, 1996, CURR OPIN STRUC BIOL, V6, P848, DOI 10.1016/S0959-440X(96)80016-9; PINSKY L, 1992, CLIN INVEST MED, V15, P456; Pratt William B., 1994, Seminars in Cell Biology, V5, P83; Roy J, 1998, J NEUROSCI, V18, P9673; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathya G, 2003, CANCER RES, V63, P8029; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Shen HC, 2005, BIOL CHEM, V386, P69, DOI 10.1515/BC.2005.009; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; Zhu ZX, 2001, BIOCHEM BIOPH RES CO, V284, P836, DOI 10.1006/bbrc.2001.5030	53	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35567	35577		10.1074/jbc.M110.146845	http://dx.doi.org/10.1074/jbc.M110.146845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826791	Green Published, hybrid			2022-12-25	WOS:000283845300035
J	Salvador-Recatala, V; Greenberg, RM				Salvador-Recatala, Vicenta; Greenberg, Robert M.			The N Terminus of a Schistosome beta Subunit Regulates Inactivation and Current Density of a Ca(v)2 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; CA2+ CHANNELS; MODULATION; SENSITIVITY; ACTIVATION; CONTRIBUTE; MANSONI; RELEASE; DOMAIN; SITES	The beta subunit of high voltage-activated Ca2+ (Ca-v) channels targets the pore-forming alpha(1) subunit to the plasma membrane and tunes the biophysical phenotype of the Ca-v channel complex. We used a combination of molecular biology and whole-cell patch clamp to investigate the functional role of a long N-terminal polyacidic motif (NPAM) in a Ca-v beta subunit of the human parasite Schistosoma mansoni (beta(Sm)), a motif that does not occur in other known Ca-v beta subunits. When expressed in human embryonic kidney cells stably expressing Ca(v)2.3, beta(Sm) accelerates Ca2+/calmodulin-independent inactivation of Ca(v)2.3. Deleting the first 44 amino acids of beta(Sm), a region that includes NPAM, significantly slows the predominant time constant of inactivation (tau(fast)) under conditions that prevent Ca2+/CaM-dependent inactivation (beta(Sm): tau(fast) = 66 ms; beta(Sm Delta 2-44): tau(fast) = 111 ms, p < 0.01). Interestingly, deleting the amino acids that are N-terminal to NPAM (2-24 or 2-17) results in faster inactivation than with an intact N terminus (tau(fast) = 42 ms with beta(Sm Delta 2-17); tau(fast) = 40 ms with beta(Sm Delta 2-24), p < 0.01). This suggests that NPAM is the structural determinant for accelerating Ca2+/calmodulin-independent inactivation. We also created three chimeric subunits that contain the first 44 amino acids of beta(Sm) attached to mammalian beta(1b), beta(2a), and beta(3) subunits. For any given mammalian beta subunit, inactivation was faster if it contained the N terminus of beta(Sm) than if it did not. Co-expression of the mammalian alpha(2)delta-1 subunit resulted in doubling of the inactivation rate, but the effects of NPAM persisted. Thus, it appears that the schistosome Ca-v channel complex has acquired a new function that likely contributes to reducing the amount of Ca2+ that enters the cells in vivo. This feature is of potential interest as a target for new antihelminthics.	[Salvador-Recatala, Vicenta; Greenberg, Robert M.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Salvador-Recatala, V (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 226 Rosenthal Bldg,3800 Spruce St, Philadelphia, PA 19104 USA.	vicenta@vet.upenn.edu	Salvador, Vicenta/AAE-9733-2020	Salvador Recatala, Vicenta/0000-0002-6094-1422	National Institutes of Health [AI 4052, AI 73660, AI 082390]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030026, R21AI082390, R01AI040522, R01AI073660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 4052, AI 73660, and AI 082390.	Albillos A, 2000, J NEUROSCI, V20, P8323, DOI 10.1523/JNEUROSCI.20-22-08323.2000; ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Carabelli V, 1996, BIOPHYS J, V70, P2144, DOI 10.1016/S0006-3495(96)79780-1; Castro A, 2009, J COMP NEUROL, V513, P188, DOI 10.1002/cne.21952; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; DE WM, 1997, NATURE, V385, P446; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Doenhoff MJ, 2009, PARASITOLOGY, V136, P1825, DOI 10.1017/S0031182009000493; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kamp MA, 2005, EUR J NEUROSCI, V21, P1617, DOI 10.1111/j.1460-9568.2005.03984.x; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; Kohn AB, 2003, PARASITOLOGY, V127, P349, DOI 10.1017/S003118200300386X; Kohn AB, 2001, PARASITOLOGY, V123, P489, DOI 10.1017/S0031182001008691; Kohn AB, 2001, J BIOL CHEM, V276, P36873, DOI 10.1074/jbc.C100273200; Leroy J, 2003, EUR J NEUROSCI, V18, P841, DOI 10.1046/j.1460-9568.2003.02819.x; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mendonca-Silva DL, 2006, PARASITOLOGY, V133, P67, DOI 10.1017/S0031182006000023; Morad M, 2005, CELL CALCIUM, V38, P223, DOI 10.1016/j.ceca.2005.06.027; Nakhasi HL, 1998, PARASITOL TODAY, V14, P157, DOI 10.1016/S0169-4758(97)01180-0; Novozhilova E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000790; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; Qin N, 1998, AM J PHYSIOL-CELL PH, V274, pC1324, DOI 10.1152/ajpcell.1998.274.5.C1324; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Salvador-Recatala Vicenta, 2008, BMC Physiology, V8, P6, DOI 10.1186/1472-6793-8-6; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHAW MK, 1983, PARASITOLOGY, V86, P439, DOI 10.1017/S0031182000050630; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Twede VD, 2009, IDRUGS, V12, P231; Vais H, 2000, FEBS LETT, V470, P135, DOI 10.1016/S0014-5793(00)01305-3; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; Wang G, 1999, J NEUROSCI, V19, P9235; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yamada Y, 2001, J BIOL CHEM, V276, P47163, DOI 10.1074/jbc.M108049200; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x	49	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35878	35888		10.1074/jbc.M110.144725	http://dx.doi.org/10.1074/jbc.M110.144725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826800	Green Published, hybrid			2022-12-25	WOS:000283845300065
J	Yeligar, SM; Machida, K; Kalra, VK				Yeligar, Samantha M.; Machida, Keigo; Kalra, Vijay K.			Ethanol-induced HO-1 and NQO1 Are Differentially Regulated by HIF-1 alpha and Nrf2 to Attenuate Inflammatory Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1 GENE; ANTIOXIDANT RESPONSE ELEMENT; HYPOXIA-INDUCIBLE FACTOR; INDUCED LIVER-INJURY; C-JUN; CELL-PROLIFERATION; KINASE PATHWAYS; ACTIVATION; ALCOHOL; JNK1	Oxidative stress plays an important role in alcohol-induced inflammation and liver injury. Relatively less is known about how Kupffer cells respond to oxidative stress-induced expression of heme oxygenase-1 (HO-1) and NAD(P) H: quinone oxidoreductase (NQO1) to blunt inflammation and liver injury. We showed that Kupffer cells from ethanol-fed rats and ethanol-treated rat Kupffer cells and THP-1 cells displayed increased mRNA expression of HO-1, NQO1, and hypoxia-inducible factor-1 alpha (HIF-1 alpha). Our studies showed that silencing with HIF-1 alpha and JNK-1 siRNAs attenuated ethanol-mediated mRNA expression of HO-1, but not NQO1, whereas Nrf2 siRNA attenuated the mRNA expression of both HO-1 and NQO1. Additionally, JunD but not JunB formed an activator protein-1 (AP-1) oligomeric complex to augment HO-1 promoter activity. Ethanol-induced HO-1 transcription involved antioxidant response elements, hypoxia-response elements, and an AP-1 binding motif in its promoter, as demonstrated by mutation analysis of the promoter, EMSA, and ChIP. Furthermore, livers of ethanol-fed c-Jun(fl/fl) mice showed reduced levels of mRNA for HO-1 but not of NQO1 compared with ethanol-fed control rats, supporting the role of c-Jun or the AP-1 transcriptional complex in ethanol-induced HO-1 expression. Additionally, attenuation of HO-1 levels in ethanol-fed c-Jun(fl/fl) mice led to increased proinflammatory cytokine expression in the liver. These results for the first time show that ethanol regulates HO-1 and NQO1 transcription by different signaling pathways. Additionally, up-regulation of HO-1 protects the liver from excessive formation of inflammatory cytokines. These studies provide novel therapeutic targets to ameliorate alcohol induced inflammation and liver injury.	[Yeligar, Samantha M.; Kalra, Vijay K.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Machida, Keigo] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Yeligar, SM (corresponding author), Emory Univ, Dept Pulmonol, Atlanta, GA 30322 USA.	syeliga@emory.edu; vkalra@usc.edu			Hide Tsukamoto Pilot [P50-AA011999]; Non-Parenchymal Liver Cell Core [R24-AA012885]; Predoctoral Fellowship [T32-AA07578]; National Institutes of Health [CA108302, AA018857]; University of Southern California Research Center for Liver Diseases [P30-DK048522]; NATIONAL CANCER INSTITUTE [R01CA108302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, R01AA018857, P50AA011999, T32AA007578] Funding Source: NIH RePORTER	Hide Tsukamoto Pilot; Non-Parenchymal Liver Cell Core; Predoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Research Center for Liver Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Hide Tsukamoto Pilot Grant P50-AA011999 (to V. K. K.), Non-Parenchymal Liver Cell Core Grant R24-AA012885 (to Hide Tsukamoto), Predoctoral Fellowship T32-AA07578 (to S. M. Y.). This work was also supported, in whole or in part, by National Institutes of Health Grants CA108302 and AA018857 (to K. M.) and Analytical-Metabolic-Instrumentation Core, University of Southern California Research Center for Liver Diseases Grant P30-DK048522.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Gukovsky I, 2008, AM J PHYSIOL-GASTR L, V294, pG68, DOI 10.1152/ajpgi.00006.2007; Haseba T, 2006, BBA-MOL BASIS DIS, V1762, P276, DOI 10.1016/j.bbadis.2005.11.008; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kodama Y, 2009, HEPATOLOGY, V49, P6, DOI 10.1002/hep.22710; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Liangpunsakul S, 2009, TXB GASTROENTEROLOGY, P2247; LIEBER CS, 1986, ALCOHOL CLIN EXP RES, V10, P550, DOI 10.1111/j.1530-0277.1986.tb05140.x; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; NGUYEN T, 1994, J BIOL CHEM, V269, P13656; Ohlmann A, 2003, EXP BIOL MED, V228, P584, DOI 10.1177/15353702-0322805-51; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Rushworth SA, 2008, J IMMUNOL, V181, P6730, DOI 10.4049/jimmunol.181.10.6730; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; TSUKAMOTO H, 1996, LIVER BILIARY DIS, P125; Tsukamoto Hide, 2008, V447, P33, DOI 10.1007/978-1-59745-242-7_3; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang RJ, 2008, INT J BIOCHEM CELL B, V40, P2702, DOI 10.1016/j.biocel.2008.06.012; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06	55	104	108	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35359	35373		10.1074/jbc.M110.138636	http://dx.doi.org/10.1074/jbc.M110.138636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833713	Green Published, hybrid			2022-12-25	WOS:000283845300014
J	Ceylan, S; Seidel, V; Ziebart, N; Berndt, C; Dirdjaja, N; Krauth-Siegel, RL				Ceylan, Sevgi; Seidel, Vera; Ziebart, Nicole; Berndt, Carsten; Dirdjaja, Natalie; Krauth-Siegel, R. Luise			The Dithiol Glutaredoxins of African Trypanosomes Have Distinct Roles and Are Closely Linked to the Unique Trypanothione Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; IRON-SULFUR CLUSTER; MIXED DISULFIDE; TRYPAREDOXIN PEROXIDASE; DEPENDENT SYNTHESIS; GLUTATHIONE; THIOREDOXIN; BRUCEI; THIOLTRANSFERASE; PURIFICATION	Trypanosoma brucei, the causative agent of African sleeping sickness, possesses two dithiol glutaredoxins (Grx1 and Grx2). Grx1 occurs in the cytosol and catalyzes protein deglutathionylations with k(cat)/K-m-values of up to 2 x 10(5) M-1 s(-1). It accelerates the reduction of ribonucleotide reductase by trypanothione although less efficiently than the parasite tryparedoxin and has low insulin disulfide reductase activity. Despite its classical CPYC active site, Grx1 forms dimeric iron-sulfur complexes with GSH, glutathionylspermidine, or trypanothione as nonprotein ligands. Thus, contrary to the generally accepted assumption, replacement of the Pro is not a prerequisite for cluster formation. T. brucei Grx2 shows an unusual CQFC active site, and orthologues occur exclusively in trypanosomatids. Grx2 is enriched in mitoplasts, and fractionated digitonin lysis resulted in a co-elution with cytochrome c, suggesting localization in the mitochondrial intermembrane space. Grx2 catalyzes the reduction of insulin disulfide but not of ribonucleotide reductase and exerts deglutathionylation activity 10-fold lower than that of Grx1. RNA interference against Grx2 caused a growth retardation of procyclic cells consistent with an essential role. Grx1 and Grx2 are constitutively expressed with cellular concentrations of about 2 mu M and 200 nM, respectively, in both the mammalian bloodstream and insect procyclic forms. Trypanothione reduces the disulfide form of both proteins with apparent rate constants that are 3 orders of magnitude higher than those with glutathione. Grx1 and, less efficiently, also Grx2 catalyze the reduction of GSSG by trypanothione. Thus, the Grxs play exclusive roles in the trypanothione-based thiol redox metabolism of African trypanosomes.	[Ceylan, Sevgi; Seidel, Vera; Ziebart, Nicole; Dirdjaja, Natalie; Krauth-Siegel, R. Luise] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Berndt, Carsten] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden	Ruprecht Karls University Heidelberg; Karolinska Institutet	Krauth-Siegel, RL (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	luise.krauth-siegel@bzh.uni-heidelberg.de	Berndt, Carsten/X-6260-2018	Berndt, Carsten/0000-0001-8583-7966	Deutsche Forschungsgemeinschaft [SFB 544, B3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 544, "Control of Infectious Tropical Diseases," Project B3 (to R. L. K.-S.).	Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BO H, 1975, J Protozool */* H J, V22, P463; Bocedi A, 2010, FASEB J, V24, P1035, DOI 10.1096/fj.09-146407; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; Caplan JF, 2004, J BIOL CHEM, V279, P7740, DOI 10.1074/jbc.M313049200; Collinson EJ, 2003, J BIOL CHEM, V278, P22492, DOI 10.1074/jbc.M301387200; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2009, INT J PARASITOL, V39, P1059, DOI 10.1016/j.ijpara.2009.05.002; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; ELGA NTH, 2008, J BIOL CHEM */* K D, V283, P32839; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Filser M, 2008, BIOL CHEM, V389, P21, DOI 10.1515/BC.2007.147; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Gommel DU, 1997, EUR J BIOCHEM, V248, P913, DOI 10.1111/j.1432-1033.1997.t01-1-00913.x; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Krauth-Siegel Luise R., 2007, V44, P231; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; LO NNME, 2008, Antioxid Redox Signa, V10, P547; LU D, 1998, FEBS LETT */* R L FE, V431, P381; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; Marquez VE, 2010, ANTIOXID REDOX SIGN, V12, P787, DOI 10.1089/ars.2009.2907; Melchers J, 2008, BIOMOL NMR ASSIGM, V2, P65, DOI 10.1007/s12104-008-9086-8; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P8883, DOI 10.1021/bi00100a023; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; Noguera V, 2005, J MOL BIOL, V353, P629, DOI 10.1016/j.jmb.2005.08.035; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; PATTON AR, 1968, BIOCH ENERGETICS KIN, P56; PEDRAJAS JR, 2002, J A BIOCH J */* BIOC, V364, P617; Piattoni CV, 2006, ACTA TROP, V97, P151, DOI 10.1016/j.actatropica.2005.10.005; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Reckenfelderbaumer N, 2000, J BIOL CHEM, V275, P7547, DOI 10.1074/jbc.275.11.7547; Reckenfelderbaumer N, 2002, J BIOL CHEM, V277, P17548, DOI 10.1074/jbc.M112115200; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Schmidt A, 2002, MOL BIOCHEM PARASIT, V125, P207, DOI 10.1016/S0166-6851(02)00215-3; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; TABOR H, 1975, J BIOL CHEM, V250, P2648; Xiao RY, 2005, J BIOL CHEM, V280, P21099, DOI 10.1074/jbc.M411476200; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504	64	59	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35224	35237		10.1074/jbc.M110.165860	http://dx.doi.org/10.1074/jbc.M110.165860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826822	Green Published, hybrid			2022-12-25	WOS:000283659100096
J	Kintner, DB; Chen, XZ; Currie, J; Chanana, V; Ferrazzano, P; Baba, A; Matsuda, T; Cohen, M; Orlowski, J; Chiu, SY; Taunton, J; Sun, DD				Kintner, Douglas B.; Chen, Xinzhi; Currie, Julia; Chanana, Vishal; Ferrazzano, Peter; Baba, Akemichi; Matsuda, Toshio; Cohen, Mike; Orlowski, John; Chiu, Shing-Yan; Taunton, Jack; Sun, Dandan			Excessive Na+/H+ Exchange in Disruption of Dendritic Na+ and Ca2+ Homeostasis and Mitochondrial Dysfunction following in Vitro Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL-NEURONS; NA+/CA2+ EXCHANGE; CULTURED NEURONS; RAT; INHIBITOR; SODIUM; ASTROCYTES; EXPRESSION; INJURY	Neuronal dendrites are vulnerable to injury under diverse pathological conditions. However, the underlying mechanisms for dendritic Na+ overload and the selective dendritic injury remain poorly understood. Our current study demonstrates that activation of NHE-1 (Na+/H+ exchanger isoform 1) in dendrites presents a major pathway for Na+ overload. Neuronal dendrites exhibited higher pH(i) regulation rates than soma as a result of a larger surface area/volume ratio. Following a 2-h oxygen glucose deprivation and a 1-h reoxygenation, NHE-1 activity was increased by similar to 70-200% in dendrites. This elevation depended on activation of p90 ribosomal S6 kinase. Moreover, stimulation of NHE-1 caused dendritic Na-i(+) accumulation, swelling, and a concurrent loss of Ca-i(2+) homeostasis. The Ca-i(2+) overload in dendrites preceded the changes in soma. Inhibition of NHE-1 or the reverse mode of Na+/Ca2+ exchange prevented these changes. Mitochondrial membrane potential in dendrites depolarized 40 min earlier than soma following oxygen glucose deprivation/reoxygenation. Blocking NHE-1 activity not only attenuated loss of dendritic mitochondrial membrane potential and mitochondrial Ca2+ homeostasis but also preserved dendritic membrane integrity. Taken together, our study demonstrates that NHE-1-mediated Na+ entry and subsequent Na+/Ca2+ exchange activation contribute to the selective dendritic vulnerability to in vitro ischemia.	[Kintner, Douglas B.; Chen, Xinzhi; Currie, Julia; Sun, Dandan] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol Surg, Madison, WI 53705 USA; [Chen, Xinzhi] Univ Wisconsin, Sch Med & Publ Hlth, Neurosci Training Program, Madison, WI 53705 USA; [Chiu, Shing-Yan] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53705 USA; [Chanana, Vishal; Ferrazzano, Peter; Sun, Dandan] Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI 53705 USA; [Baba, Akemichi; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Cohen, Mike; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Cohen, Mike; Taunton, Jack] Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Osaka University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McGill University	Sun, DD (corresponding author), T513 Waisman Ctr,1500 Highland Ave, Madison, WI 53705 USA.	sun@neurosurgery.wisc.edu	sun, dandan/GZG-6540-2022; chanana, vishal/F-3738-2014; Chen, X. Richard/A-7141-2012	Orlowski, John/0000-0001-7371-175X	National Institutes of Health [RO1NS48216, R01 GM071434, RG-4054-A-8, P30 HD03352]; CTSA (University of Wisconsin Institute for Clinical and Translational Research) [1UL1RR02511]; American Heart Association [EIA 0540154]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA (University of Wisconsin Institute for Clinical and Translational Research); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS48216 (to D. S.), R01 GM071434 (to J. T.), MS RG-4054-A-8 (to S.-Y. C.), P30 HD03352 (to the Waisman Center), and CTSA 1UL1RR02511 (University of Wisconsin Institute for Clinical and Translational Research) (to P. F.). This work was also supported by American Heart Association Grant EIA 0540154 (to D. S.).	Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; CHOI DW, 1987, J NEUROSCI, V7, P357; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Dietz RM, 2007, HIPPOCAMPUS, V17, P1049, DOI 10.1002/hipo.20336; Douglas RM, 2001, NEUROSCIENCE, V102, P217, DOI 10.1016/S0306-4522(00)00473-5; FRIEDMAN JE, 1994, BRAIN RES, V641, P57, DOI 10.1016/0006-8993(94)91815-5; Garciarena CD, 2008, J APPL PHYSIOL, V105, P1706, DOI 10.1152/japplphysiol.90616.2008; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Hasbani MJ, 2001, NEUROREPORT, V12, P2731, DOI 10.1097/00001756-200108280-00028; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Iwamoto T, 2004, J BIOL CHEM, V279, P7544, DOI 10.1074/jbc.M310491200; Javadov S, 2005, J MOL CELL CARDIOL, V38, P135, DOI 10.1016/j.yjmcc.2004.10.007; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Kintner DB, 2004, AM J PHYSIOL-CELL PH, V287, pC12, DOI 10.1152/ajpcell.00560.2003; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; Kleeman H W, 1999, IDrugs, V2, P1009; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Luo J, 2007, J BIOL CHEM, V282, P28274, DOI 10.1074/jbc.M702373200; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; Makani S, 2007, J NEUROSCI, V27, P7438, DOI 10.1523/JNEUROSCI.2304-07.2007; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; MORIYAMA Y, 1990, J BIOCHEM, V108, P689, DOI 10.1093/oxfordjournals.jbchem.a123264; MU L, 2000, J NEUROPHYSIOL */* G, V84, P1869; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Musch MW, 2002, AM J PHYSIOL-GASTR L, V283, pG975, DOI 10.1152/ajpgi.00528.2001; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; PAPPAS CA, 1993, GLIA, V9, P280, DOI 10.1002/glia.440090406; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Philippe JM, 2002, GLIA, V37, P365, DOI 10.1002/glia.10041; Raley-Susman KM, 2001, J NEUROPHYSIOL, V86, P2715, DOI 10.1152/jn.2001.86.6.2715; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sheldon C, 2004, J NEUROSCI, V24, P11057, DOI 10.1523/JNEUROSCI.2829-04.2004; Shuttleworth CWR, 2001, J NEUROSCI, V21, P4225, DOI 10.1523/JNEUROSCI.21-12-04225.2001; SPA TA, 2008, CELL CALCIUM */* G C, V44, P51; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Teshima Y, 2003, CIRCULATION, V108, P2275, DOI 10.1161/01.CIR.0000093277.20968.C7; Toda T, 2007, AM J PHYSIOL-HEART C, V293, pH3517, DOI 10.1152/ajpheart.00483.2006; Trudeau LE, 1999, J NEUROPHYSIOL, V81, P2627, DOI 10.1152/jn.1999.81.6.2627; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; VANDER J, 2008, J NEUROSCI */* C W J, V28, P5029; Vitzthum L, 2010, INTEGR BIOL-UK, V2, P58, DOI 10.1039/b918440f	45	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35155	35168		10.1074/jbc.M110.101212	http://dx.doi.org/10.1074/jbc.M110.101212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817726	Green Published, hybrid			2022-12-25	WOS:000283659100089
J	Majewski, PM; Thurston, RD; Ramalingam, R; Kiela, PR; Ghishan, FK				Majewski, Pawel M.; Thurston, Robert D.; Ramalingam, Rajalakshmy; Kiela, Pawel R.; Ghishan, Fayez K.			Cooperative Role of NF-kappa B and Poly(ADP-ribose) Polymerase 1 (PARP-1) in the TNF-induced Inhibition of PHEX Expression in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED HYPOPHOSPHATEMIA; SIBLING-ASARM-PEPTIDES; DOWN-REGULATION; NUCLEAR TRANSLOCATION; GENE-EXPRESSION; DEFICIENT MICE; BONE-FORMATION; COLITIS; MINERALIZATION; DISEASE	Reduced bone mass is a common complication in chronic inflammatory diseases, although the mechanisms are not completely understood. The PHEX gene encodes a zinc endopeptidase expressed in osteoblasts and contributes to bone mineralization. The aim of this study was to determine the molecular mechanism involved in TNF-mediated down-regulation of Phex gene transcription. We demonstrate down-regulation of the Phex gene in two models of colitis: naive T-cell transfer and in gnotobiotic IL-10(-/-) mice. In vitro, TNF decreased expression of Phex in UMR106 cells and did not require de novo synthesis of a transrepressor. Transfecting UMR-106 cells with a series of deletion constructs of the proximal Phex promoter identified a region located within -74 nucleotides containing NF-kappa B and AP-1 binding sites. After TNF treatment, the RelA/p50 NF-kappa B complex interacted with two cis-elements at positions -70/-66 and -29/-25 nucleotides in the proximal Phex promoter. Inhibition of NF-kappa B signaling increased the basal level of Phex transcription and abrogated the effects of TNF, whereas overexpression of RelA mimicked the effect of TNF. We identified poly(ADP-ribose) polymerase 1 (PARP-1) binding immediately upstream of the NF-kappa B sites and showed that TNF induced poly( ADP-ribosyl)ation of RelA when bound to the Phex promoter. TNF-mediated Phex down-regulation was completely abrogated in vitro by PARP-1 inhibitor and overexpression of poly( ADP-ribose) glucohydrolase (PARG) and in vivo in PARP-1(-/-) mice. Our results suggest that NF-kappa B signaling and PARP-1 enzymatic activity cooperatively contribute to the constitutive and inducible suppression of Phex. The described phenomenon likely contributes to the loss of bone mass density in chronic inflammatory diseases, such as inflammatory bowel disease.	[Majewski, Pawel M.; Thurston, Robert D.; Ramalingam, Rajalakshmy; Kiela, Pawel R.; Ghishan, Fayez K.] Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ 85724 USA; [Majewski, Pawel M.] Univ Warsaw, Fac Biol, Dept Anim Physiol, PL-02096 Warsaw, Poland	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; University of Warsaw	Ghishan, FK (corresponding author), 1501 N Campbell Ave, Tucson, AZ 85724 USA.	fghishan@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Majewski, Pawel/0000-0002-5361-1935; Kiela, Pawel/0000-0002-0014-3517	National Institutes of Health [2P40RR018603, R37DK033209]; NIEHS [ES06694]; NCI [CA023074]; BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Access to the National Gnotobiotic Rodent Resource Center at the University of North Carolina at Chapel Hill was supported by National Institutes of Health Grant 2P40RR018603 provided courtesy of Dr. Balfour R. Sartor.; This work was supported, in whole or in part, by National Institutes of Health Grant R37DK033209 (to F.K.G.). Mass spectrometric data acquired by the Arizona Proteomics Consortium was supported by National Institutes of Health Grant ES06694 from the NIEHS to The Southwest Environmental Health Sciences Center, Grant CA023074 from the NCI to the Arizona Cancer Center, and by the BIO5 Institute of the University of Arizona.	Addison WN, 2008, J BONE MINER RES, V23, pS56; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Alos N, 2005, BONE, V37, P589, DOI 10.1016/j.bone.2005.05.006; BENETPAGES A, 2004, T M BONE, V35, P455; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; COLLINS JF, 1995, AM J PHYSIOL-RENAL, V269, pF439, DOI 10.1152/ajprenal.1995.269.3.F439; Di Paola R, 2005, EUR J PHARMACOL, V527, P163, DOI 10.1016/j.ejphar.2005.09.055; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Hines ER, 2004, J BIOL CHEM, V279, P46406, DOI 10.1074/jbc.M404278200; Hines ER, 2002, AM J PHYSIOL-RENAL, V283, pF356, DOI 10.1152/ajprenal.00357.2001; Hyams JS, 1997, J PEDIATR GASTR NUTR, V24, P289, DOI 10.1097/00005176-199703000-00011; Jijon HB, 2000, AM J PHYSIOL-GASTR L, V279, pG641, DOI 10.1152/ajpgi.2000.279.3.G641; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kiela PR, 2009, LAB INVEST, V89, P7, DOI 10.1038/labinvest.2008.114; Larmonier CB, 2008, AM J PHYSIOL-GASTR L, V295, pG1079, DOI 10.1152/ajpgi.90365.2008; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Popoff I, 2002, J PHARMACOL EXP THER, V303, P1145, DOI 10.1124/jpet.102.039768; Rodriguez-Bores L, 2007, WORLD J GASTROENTERO, V13, P6156, DOI 10.3748/wjg.v13.i46.6156; Sanchez-Fidalgo S, 2007, EUR J PHARMACOL, V563, P216, DOI 10.1016/j.ejphar.2007.01.070; Slomiany BA, 2000, BIOTECHNIQUES, V28, P938, DOI 10.2144/00285st08; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; Tenenhouse HS, 2005, ANNU REV NUTR, V25, P197, DOI 10.1146/annurev.nutr.25.050304.092642; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Uno JK, 2006, GASTROENTEROLOGY, V131, P497, DOI 10.1053/j.gastro.2006.05.020; Vargas MA, 2003, ENDOCRINOLOGY, V144, P4876, DOI 10.1210/en.2003-0253; Varghese S, 2002, J PEDIATR GASTR NUTR, V35, P641, DOI 10.1097/00005176-200211000-00010; Xiao ZS, 1998, AM J PHYSIOL-ENDOC M, V275, pE700, DOI 10.1152/ajpendo.1998.275.4.E700; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zingarelli B, 2004, IMMUNOLOGY, V113, P509, DOI 10.1111/j.1365-2567.2004.01991.x; Zingarelli B, 2003, EUR J PHARMACOL, V469, P183, DOI 10.1016/S0014-2999(03)01726-6; Zoidis E, 2002, EUR J ENDOCRINOL, V146, P97, DOI 10.1530/eje.0.1460097	41	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34828	34838		10.1074/jbc.M110.152868	http://dx.doi.org/10.1074/jbc.M110.152868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817730	Green Published, hybrid			2022-12-25	WOS:000283659100058
J	Berniker, M; Voss, M; Kording, K				Berniker, Max; Voss, Martin; Kording, Konrad			Learning Priors for Bayesian Computations in the Nervous System	PLOS ONE			English	Article							REACHING MOVEMENTS; PARIETAL CORTEX; ADAPTATION; UNCERTAINTY; REPRESENTATION; INTEGRATION; INFORMATION; PERCEPTION; DYNAMICS; DECISION	Our nervous system continuously combines new information from our senses with information it has acquired throughout life. Numerous studies have found that human subjects manage this by integrating their observations with their previous experience (priors) in a way that is close to the statistical optimum. However, little is known about the way the nervous system acquires or learns priors. Here we present results from experiments where the underlying distribution of target locations in an estimation task was switched, manipulating the prior subjects should use. Our experimental design allowed us to measure a subject's evolving prior while they learned. We confirm that through extensive practice subjects learn the correct prior for the task. We found that subjects can rapidly learn the mean of a new prior while the variance is learned more slowly and with a variable learning rate. In addition, we found that a Bayesian inference model could predict the time course of the observed learning while offering an intuitive explanation for the findings. The evidence suggests the nervous system continuously updates its priors to enable efficient behavior.	[Berniker, Max; Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Berniker, Max; Kording, Konrad] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Voss, Martin] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Voss, Martin] St Hedwig Hosp, Berlin, Germany	Northwestern University; Shirley Ryan AbilityLab; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Berniker, M (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	mbernike@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Voss, Martin/0000-0002-5221-4647	NIH [1R01NS063399, 5P01NS0044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grant nrs. 1R01NS063399 and 5P01NS0044393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Chen HY, 2006, CEREB CORTEX, V16, P1462, DOI 10.1093/bhj087; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; DIMA D, 2009, NEUROIMAGE; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Hudson TE, 2007, J NEUROPHYSIOL, V98, P3034, DOI 10.1152/jn.00858.2007; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lewis RF, 2001, EXP BRAIN RES, V138, P263, DOI 10.1007/s002210100719; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Nezafat R, 2001, EXP BRAIN RES, V140, P66, DOI 10.1007/s002210100787; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	29	88	88	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12686	10.1371/journal.pone.0012686	http://dx.doi.org/10.1371/journal.pone.0012686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844766	Green Submitted, gold, Green Published			2022-12-25	WOS:000281687300020
J	Lin, YC; Liu, YC; Huang, YY; Lien, CC				Lin, Yen-Chu; Liu, Yu-Chao; Huang, Yu-Yin; Lien, Cheng-Chang			High-Density Expression of Ca2+-Permeable ASIC1a Channels in NG2 Glia of Rat Hippocampus	PLOS ONE			English	Article							SENSING ION CHANNELS; CHONDROITIN-SULFATE PROTEOGLYCAN; OLIGODENDROCYTE PRECURSOR CELLS; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; CEREBRAL-CORTEX; NA+ CHANNELS; WHITE-MATTER; NEURONS; BRAIN	NG2 cells, a fourth type of glial cell in the mammalian CNS, undergo reactive changes in response to a wide variety of brain insults. Recent studies have demonstrated that neuronally expressed acid-sensing ion channels (ASICs) are implicated in various neurological disorders including brain ischemia and seizures. Acidosis is a common feature of acute neurological conditions. It is postulated that a drop in pH may be the link between the pathological process and activation of NG2 cells. Such postulate immediately prompts the following questions: Do NG2 cells express ASICs? If so, what are their functional properties and subunit composition? Here, using a combination of electrophysiology, Ca2+ imaging and immunocytochemistry, we present evidence to demonstrate that NG2 cells of the rat hippocampus express high density of Ca2+-permeable ASIC1a channels compared with several types of hippocampal neurons. First, nucleated patch recordings from NG2 cells revealed high density of proton-activated currents. The magnitude of proton-activated current was pH dependent, with a pH for half-maximal activation of 6.3. Second, the current-voltage relationship showed a reversal close to the equilibrium potential for Na+. Third, psalmotoxin 1, a blocker specific for the ASIC1a channel, largely inhibited proton-activated currents. Fourth, Ca2+ imaging showed that activation of proton-activated channels led to an increase of [Ca2+](i). Finally, immunocytochemistry showed co-localization of ASIC1a and NG2 proteins in the hippocampus. Thus the acid chemosensor, the ASIC1a channel, may serve for inducing membrane depolarization and Ca2+ influx, thereby playing a crucial role in the NG2 cell response to injury following ischemia.	[Lin, Yen-Chu; Liu, Yu-Chao; Lien, Cheng-Chang] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Lin, Yen-Chu; Liu, Yu-Chao; Lien, Cheng-Chang] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Huang, Yu-Yin] Cheng Hsin Gen Hosp, Dept Anesthesiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital	Lin, YC (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	cclien@ym.edu.tw	Lien, Cheng-Chang/AAO-6249-2020	Lien, Cheng-Chang/0000-0002-6692-9942; Liu, Yu-Chao/0000-0001-8285-6328	Ministry of Education, Taiwan; National Health Research Institutes [NHRI-EX99-9720NC]; NHRI-EX99-9720NC), Taiwan National Science Council [NSC98-2321-B-010-001]; Cheng Hsin General Hospital [98-59]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); NHRI-EX99-9720NC), Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	Ministry of Education, Taiwan (Aim for The Top University Plan), National Health Research Institutes (NHRI-EX99-9720NC), Taiwan National Science Council (NSC98-2321-B-010-001) and Cheng Hsin General Hospital (98-59 to Y.Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bolshakov KV, 2002, NEUROSCIENCE, V110, P723, DOI 10.1016/S0306-4522(01)00582-6; Bordey A, 1997, J NEUROPHYSIOL, V78, P461, DOI 10.1152/jn.1997.78.1.461; Brilli E, 2009, J NEUROSCI RES, V87, P636, DOI 10.1002/jnr.21879; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHU KC, 2010, EUR J NEURO IN PRESS; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Ge WP, 2009, P NATL ACAD SCI USA, V106, P328, DOI 10.1073/pnas.0811353106; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liao CW, 2009, NEUROSCIENCE, V164, P1701, DOI 10.1016/j.neuroscience.2009.09.052; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Matsumoto K, 1996, J CEREBR BLOOD F MET, V16, P114, DOI 10.1097/00004647-199601000-00014; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; PHILLIS JW, 1994, BRAIN RES BULL, V34, P457, DOI 10.1016/0361-9230(94)90019-1; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Tanaka Y, 2009, CEREB CORTEX, V19, P2181, DOI 10.1093/cercor/bhn238; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wennstrom M, 2003, BIOL PSYCHIAT, V54, P1015, DOI 10.1016/S0006-3223(03)00693-0; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109; Zhang M, 2008, NEUROSCIENCE, V154, P461, DOI 10.1016/j.neuroscience.2008.03.040; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	48	27	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12665	10.1371/journal.pone.0012665	http://dx.doi.org/10.1371/journal.pone.0012665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844750	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687300010
J	Mueller, UG; Scott, JJ; Ishak, HD; Cooper, M; Rodrigues, A				Mueller, Ulrich G.; Scott, Jarrod J.; Ishak, Heather D.; Cooper, Michael; Rodrigues, Andre			Monoculture of Leafcutter Ant Gardens	PLOS ONE			English	Article							FUNGUS-GROWING ANTS; ATTINE ANT; SYMBIONT CHOICE; EVOLUTION; ATTA; CONFLICT; COEVOLUTION; MICROSATELLITES; PSEUDONOCARDIA; AGRICULTURE	Background: Leafcutter ants depend on the cultivation of symbiotic Attamyces fungi for food, which are thought to be grown by the ants in single-strain, clonal monoculture throughout the hundreds to thousands of gardens within a leafcutter nest. Monoculture eliminates cultivar-cultivar competition that would select for competitive fungal traits that are detrimental to the ants, whereas polyculture of several fungi could increase nutritional diversity and disease resistance of genetically variable gardens. Methodology/Principal Findings: Using three experimental approaches, we assessed cultivar diversity within nests of Atta leafcutter ants, which are most likely among all fungus-growing ants to cultivate distinct cultivar genotypes per nest because of the nests' enormous sizes (up to 5000 gardens) and extended lifespans (10-20 years). In Atta texana and in A. cephalotes, we resampled nests over a 5-year period to test for persistence of resident cultivar genotypes within each nest, and we tested for genetic differences between fungi from different nest sectors accessed through excavation. In A. texana, we also determined the number of Attamyces cells carried as a starter inoculum by a dispersing queens (minimally several thousand Attamyces cells), and we tested for genetic differences between Attamyces carried by sister queens dispersing from the same nest. Except for mutational variation arising during clonal Attamyces propagation, DNA fingerprinting revealed no evidence for fungal polyculture and no genotype turnover during the 5-year surveys. Conclusions/Significance: Atta leafcutter ants can achieve stable, fungal monoculture over many years. Mutational variation emerging within an Attamyces monoculture could provide genetic diversity for symbiont choice (gardening biases of the ants favoring specific mutational variants), an analog of artificial selection.	[Mueller, Ulrich G.; Scott, Jarrod J.; Ishak, Heather D.; Cooper, Michael; Rodrigues, Andre] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Mueller, Ulrich G.; Scott, Jarrod J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Scott, Jarrod J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Rodrigues, Andre] State Univ Sao Paulo UNESP, Ctr Study Social Insects, Sao Paulo, Brazil; [Rodrigues, Andre] Santa Cruz State Univ UESC, Dept Biol Sci, Ilheus, BA, Brazil	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Wisconsin System; University of Wisconsin Madison; Universidade Estadual Paulista; Universidade Estadual de Santa Cruz	Mueller, UG (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	umueller@mail.utexas.edu	Rodrigues, Andre/B-8148-2012	Rodrigues, Andre/0000-0002-4164-9362; Scott, Jarrod/0000-0001-9863-1318	National Science Foundation [DEB-0920138, DEB-0639879, DEB-0110073, DEB-0949689]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [02/05]; Division Of Environmental Biology [0919519] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by National Science Foundation awards DEB-0920138, DEB-0639879, and DEB-0110073 to UGM; DEB-0949689 to T. R. Schultz, N. Mehdiabadi, and UGM; and a Fellowship (02/05) from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to AR. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Advani NK, 2006, INSECT SOC, V53, P446, DOI 10.1007/s00040-005-0892-7; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Boomsma JJ, 2009, P NATL ACAD SCI USA, V106, P17611, DOI 10.1073/pnas.0910004106; BRUCH C, 1919, REV SOC ARGENT CIENC, V4, P579; Cahan S, 1999, BEHAV ECOL, V10, P585, DOI 10.1093/beheco/10.5.585; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Fernandez-Marin H, 2009, P ROY SOC B-BIOL SCI, V276, P2263, DOI 10.1098/rspb.2009.0184; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Gerardo NM, 2006, PLOS BIOL, V4, P1358, DOI 10.1371/journal.pbio.0040235; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Goncalves C. R., 1961, Studia Entomologica Petropolis (NS), V4, P113; Grosberg RK, 1998, TRENDS ECOL EVOL, V13, P112, DOI 10.1016/S0169-5347(97)01313-X; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; HERVEY A, 1977, BRITTONIA, V29, P226, DOI 10.2307/2805856; Huber J, 1905, BIOL CENTRALBLATT, V25, P606; Huber J., 1905, BIOL CENTRALBLATT, V25, P606; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; Lim S, 2004, FUNGAL GENET BIOL, V41, P1025, DOI 10.1016/j.fgb.2004.08.004; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Mehdiabadi NJ, 2006, BEHAV ECOL, V17, P291, DOI 10.1093/beheco/arj028; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; MINTZER A C, 1991, Psyche (Cambridge), V98, P1, DOI 10.1155/1991/71624; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; Mohali Sari, 1998, Revista de Ecologia LatinoAmericana, V5, P1; Moller A., 1893, BOT MITT TROP, V6, P1; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, P NATL ACAD SCI USA, V99, P15247, DOI 10.1073/pnas.242594799; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Mueller UG, 2008, P NATL ACAD SCI USA, V105, P5287, DOI 10.1073/pnas.0801464105; Mueller UG, 2010, ANTON LEEUW INT J G, V98, P195, DOI 10.1007/s10482-010-9427-3; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Pagnocca FC, 2001, MYCOL RES, V105, P173, DOI 10.1017/S0953756200003191; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2009, ANTON LEEUW INT J G, V96, P331, DOI 10.1007/s10482-009-9350-7; Roze D, 2001, AM NAT, V158, P638, DOI 10.1086/323590; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santos AV, 2004, FEMS MICROBIOL LETT, V239, P319, DOI 10.1016/j.femsle.2004.09.005; Scott JJ, 2009, MOL ECOL RESOUR, V9, P1391, DOI 10.1111/j.1755-0998.2009.02684.x; Sen R, 2010, BEHAV ECOL SOCIOBIOL, V64, P1125, DOI 10.1007/s00265-010-0928-x; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; STAHEL G, 1939, REV ENTOMOL, V102, P27; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vellinga EC, 2004, NOVA HEDWIGIA, V78, P273, DOI 10.1127/0029-5035/2004/0078-0273; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Wang Y, 1999, J CHEM ECOL, V25, P935, DOI 10.1023/A:1020861221126; Weber N. A., 1937, Tropical Agriculture Trinidad, V14, P223; Weber N. A., 1972, GARDENING ANTS ATTIN; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; Wirth R., 2003, HERBIVORY LEAFCUTTIN; YEK SH, 2010, BIOL REV IN PRESS	71	53	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12668	10.1371/journal.pone.0012668	http://dx.doi.org/10.1371/journal.pone.0012668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844760	Green Submitted, Green Published, gold			2022-12-25	WOS:000281687300012
J	Philip, SS; Yu, XS; Donnell, D; Vittinghoff, E; Buchbinder, S				Philip, Susan S.; Yu, Xuesong; Donnell, Deborah; Vittinghoff, Eric; Buchbinder, Susan			Serosorting Is Associated with a Decreased Risk of HIV Seroconversion in the EXPLORE Study Cohort	PLOS ONE			English	Article							SEXUAL PARTNERS; HOMOSEXUAL-MEN; GAY MEN; REDUCTION; INFECTION; BEHAVIORS; PERCEPTIONS; INCREASE; MSM	Background: Seroadaptation strategies such as serosorting and seropositioning originated within communities of men who have sex with men (MSM), but there are limited data about their effectiveness in preventing HIV transmission when utilized by HIV-negative men. Methodology/Principal Findings: Data from the EXPLORE cohort of HIV-negative MSM who reported both seroconcordant and serodiscordant partners were used to evaluate serosorting and seropositioning. The association of serosorting and seropositioning with HIV seroconversion was evaluated in this cohort of high risk MSM from six U.S. cities. Serosorting was independently associated with a small decrease in risk of HIV seroconversion (OR = 0.88; 95% CI, 0.81-0.95), even among participants reporting >= 10 partners. Those who more consistently practiced serosorting were more likely to be white (p = 0.01), have completed college (p = <0.0002) and to have had 10 or more partners in the six months before the baseline visit (p = 0.01) but did not differ in age, reporting HIV-infected partners, or drug use. There was no evidence of a seroconversion effect with seropositioning (OR 1.02, 95% CI, 0.92-1.14). Significance: In high risk HIV uninfected MSM who report unprotected anal intercourse with both seroconcordant and serodiscordant partners, serosorting was associated with a modest decreased risk of HIV infection. To maximize any potential benefit, it will be important to increase accurate knowledge of HIV status, through increased testing frequency, improved test technology, and continued development of strategies to increase disclosure.	[Philip, Susan S.; Buchbinder, Susan] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Yu, Xuesong; Donnell, Deborah] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA; [Philip, Susan S.; Vittinghoff, Eric; Buchbinder, Susan] Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco Department of Public Health; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Philip, SS (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA USA.	Susan.Philip@sfdph.org		Donnell, Deborah/0000-0002-0587-7480	National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; Office of AIDS Research, of the National Institutes of Health, United States Department of Health and Human Services [5 U01 AI46749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI047981, U01AI047995, U01AI046749] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the National Institutes of Health, United States Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the HIV Prevention Trials Network and sponsored by the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the Office of AIDS Research, of the National Institutes of Health, United States Department of Health and Human Services, through a cooperative agreement with Family Health International (cooperative agreement 5 U01 AI46749) with a subsequent subcontract to Abt Associates Inc., with cooperative agreement U01 AI47981 to the University of Washington; and cooperative agreement U01 AI47995 to the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Cox J, 2004, SEX TRANSM INFECT, V80, P518, DOI 10.1136/sti.2004.011288; Eaton LA, 2007, AM J PREV MED, V33, P479, DOI 10.1016/j.amepre.2007.08.004; Elford J, 2007, AIDS, V21, P243, DOI 10.1097/QAD.0b013e3280118fdb; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Grov C, 2007, AIDS BEHAV, V11, P527, DOI 10.1007/s10461-007-9234-7; Jin FY, 2007, JAIDS-J ACQ IMM DEF, V46, P245, DOI 10.1097/QAI.0b013e3181565db5; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Klitzman R, 2007, AIDS CARE, V19, P749, DOI 10.1080/09540120600983971; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; THIEDE H, 2008, AM J PUBLIC HLTH; TRUONG HM, 2004, INCREASES SEROSORTIN; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2	22	62	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12662	10.1371/journal.pone.0012662	http://dx.doi.org/10.1371/journal.pone.0012662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	648IW	20844744	gold, Green Published, Green Submitted			2022-12-25	WOS:000281687200020
J	Lee, Y; Bang, WY; Kim, S; Lazar, P; Kim, CW; Bahk, JD; Lee, KW				Lee, Yuno; Bang, Woo Young; Kim, Songmi; Lazar, Prettina; Kim, Chul Wook; Bahk, Jeong Dong; Lee, Keun Woo			Molecular Modeling Study for Interaction between Bacillus subtilis Obg and Nucleotides	PLOS ONE			English	Article							GTP-BINDING PROTEIN; 50S RIBOSOMAL-SUBUNIT; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MUTATION; GTPASES; DOMAIN; GENE; OVEREXPRESSION; SPORULATION	The bacterial Obg proteins (Spo0B-associated GTP-binding protein) belong to the subfamily of P-loop GTPase proteins that contain two equally and highly conserved domains, a C-terminal GTP binding domain and an N-terminal glycine-rich domain which is referred as the "Obg fold'' and now it is considered as one of the new targets for antibacterial drug. When the Obg protein is associated with GTP, it becomes activated, because conformation of Obg fold changes due to the structural changes of GTPase switch elements in GTP binding site. In order to investigate the effects and structural changes in GTP bound to Obg and GTPase switch elements for activation, four different molecular dynamics (MD) simulations were performed with/without the three different nucleotides (GTP, GDP, and GDP + Pi) using the Bacillus subtilis Obg (BsObg) structure. The protein structures generated from the four different systems were compared using their representative structures. The pattern of C(alpha)-C(alpha) distance plot and angle between the two Obg fold domains of simulated apo form and each system (GTP, GDP, and GDP+Pi) were significantly different in the GTP-bound system from the others. The switch 2 element was significantly changed in GTP-bound system. Also root-mean-square fluctuation (RMSF) analysis revealed that the flexibility of the switch 2 element region was much higher than the others. This was caused by the characteristic binding mode of the nucleotides. When GTP was bound to Obg, its gamma-phosphate oxygen was found to interact with the key residue (D212) of the switch 2 element, on the contrary there was no such interaction found in other systems. Based on the results, we were able to predict the possible binding conformation of the activated form of Obg with L13, which is essential for the assembly with ribosome.	[Lee, Yuno; Bang, Woo Young; Kim, Songmi; Lazar, Prettina; Bahk, Jeong Dong; Lee, Keun Woo] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Environm Biotechnol Natl Core Res Ctr, Div Appl Life Sci, Jinju, Gyeongsangnam D, South Korea; [Bang, Woo Young; Kim, Chul Wook] Jinju Natl Univ, Swine Sci & Technol Ctr, Jinju, Gyeongsangnam D, South Korea	Gyeongsang National University	Lee, Y (corresponding author), Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Environm Biotechnol Natl Core Res Ctr, Div Appl Life Sci, Jinju, Gyeongsangnam D, South Korea.	kwlee@gnu.ac.kr			Ministry of Education, Science and Technology (MEST) [2009-0073267, 2009-0081539, 2009-0093813, 20090091489]	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program (2009-0073267), Pioneer Research Center Program (2009-0081539), Priority Research Centers Program (2009-0093813), and Environmental Biotechnology National Core Research Center program (20090091489) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST). All students were recipients of fellowship from the BK21 Program of MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brigo A, 2005, BIOPHYS J, V88, P3072, DOI 10.1529/biophysj.104.050286; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Comartin DJ, 2006, CURR OPIN PHARMACOL, V6, P453, DOI 10.1016/j.coph.2006.05.005; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; Dutkiewicz R, 2002, CURR MICROBIOL, V45, P440, DOI 10.1007/s00284-002-3713-x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kobayashi G, 2001, MOL MICROBIOL, V41, P1037, DOI 10.1046/j.1365-2958.2001.02574.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; Kuo S, 2008, J BACTERIOL, V190, P6625, DOI 10.1128/JB.00799-08; LEE Y, 2009, INTERDISCIPLINARY BI, V1, P1; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Lin B, 2001, MOL MICROBIOL, V39, P924, DOI 10.1046/j.1365-2958.2001.02285.x; Maddock J, 1997, J BACTERIOL, V179, P6426, DOI 10.1128/jb.179.20.6426-6431.1997; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott JM, 2000, J BACTERIOL, V182, P2771, DOI 10.1128/JB.182.10.2771-2777.2000; Scott JM, 1999, J BACTERIOL, V181, P4653, DOI 10.1128/JB.181.15.4653-4660.1999; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Slominska M, 2002, BIOCHEM J, V362, P579, DOI 10.1042/0264-6021:3620579; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; van der Spoel D., 2005, GROMACS USER MANUAL; VIDWANS SJ, 1995, J BACTERIOL, V177, P3308, DOI 10.1128/jb.177.11.3308-3311.1995; Wittinghofer A, 2002, STRUCTURE, V10, P1471, DOI 10.1016/S0969-2126(02)00892-4; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004	36	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12597	10.1371/journal.pone.0012597	http://dx.doi.org/10.1371/journal.pone.0012597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830302	gold, Green Published, Green Submitted			2022-12-25	WOS:000281631300024
J	Loebig, M; Klement, J; Schmoller, A; Betz, S; Heuck, N; Schweiger, U; Peters, A; Schultes, B; Oltmanns, KM				Loebig, Michaela; Klement, Johanna; Schmoller, Andre; Betz, Simone; Heuck, Nicole; Schweiger, Ulrich; Peters, Achim; Schultes, Bernd; Oltmanns, Kerstin M.			Evidence for a Relationship between VEGF and BMI Independent of Insulin Sensitivity by Glucose Clamp Procedure in a Homogenous Group Healthy Young Men	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; RESISTANCE; HYPOGLYCEMIA; INDIVIDUALS; TURNOVER; CELLS	Background: This is the first study to experimentally explore the direct relationship between circulating VEGF levels and body mass index (BMI) as well as to unravel the role of insulin sensitivity in this context under standardized glucose clamp conditions as the methodical gold-standard. In order to control for known influencing factors such as gender, medication, and arterial hypertension, we examined a highly homogeneous group of young male subjects. Moreover, to encompass also subjects beyond the normal BMI range, low weight and obese participants were additionally included and stress hormones as a main regulator of VEGF were assessed. Methodology/Principal Findings: Under euglycemic clamp conditions, VEGF was measured in 15 normal weight (BMI 20-25 kg/m(2)), 15 low weight (BMI<20 kg/m(2)), and 15 obese (BMI>30 kg/m(2)) male subjects aged 18-30 years and the insulin sensitivity index (ISI) was calculated. Since stress axis activation promotes VEGF secretion, concentrations of ACTH, cortisol, and catecholamines were monitored. Despite of comparable ACTH (P = 0.145), cortisol (P = 0.840), and norepinephrine (P = 0.065) levels, VEGF concentrations differed significantly between BMI-groups (P = 0.008) with higher concentrations in obese subjects as compared to normal weight (P = 0.061) and low weight subjects (P = 0.002). Pearson's correlation analysis revealed a positive relationship between BMI and VEGF levels (r = 0.407; P = 0.010) but no correlation of VEGF with ISI (r = 0.224; P = 0.175). Conclusions/Significance: Our data demonstrate a positive correlation between concentrations of circulating VEGF levels and BMI in healthy male subjects under highly controlled conditions. This relationship which is apparently disconnected from insulin sensitivity may be part of some pathogenetic mechanisms underlying obesity and type 2 diabetes.	[Loebig, Michaela; Schmoller, Andre; Betz, Simone; Heuck, Nicole; Schweiger, Ulrich; Oltmanns, Kerstin M.] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Klement, Johanna; Peters, Achim] Univ Lubeck, Dept Internal Med 1, Lubeck, Germany; [Schultes, Bernd] Kantonsspital St Gallen, Dept Interdisciplinary, Obes Ctr, Rorschach, Switzerland	University of Lubeck; University of Lubeck; Kantonsspital St. Gallen	Loebig, M (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	michaela.voss@psychiatrie.uk-sh.de			German research Foundation (DFG)	German research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants of the German research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderwald C, 2008, EUR J CLIN INVEST, V38, P227, DOI 10.1111/j.1365-2362.2008.01932.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Bates DO, 2002, J ANAT, V200, P581, DOI 10.1046/j.1469-7580.2002.00066.x; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Dandona P, 2003, DIABETES CARE, V26, P3310, DOI 10.2337/diacare.26.12.3310; Dantz D, 2002, J CLIN ENDOCR METAB, V87, P835, DOI 10.1210/jc.87.2.835; DeFronzo RA, 1979, AM J PHYSIOL, V233, P214; DELATORRE NG, 2008, J CLIN ENDOCRINOL ME; Eriksson JW, 1999, DIABETES, V48, P1572, DOI 10.2337/diabetes.48.8.1572; Esteghamati A, 2008, ARCH MED RES, V39, P803, DOI 10.1016/j.arcmed.2008.08.004; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Gagne D, 2003, FERTIL STERIL, V80, P43, DOI 10.1016/S0015-0282(03)00552-1; Gaillard I, 2000, J CELL PHYSIOL, V185, P226, DOI 10.1002/1097-4652(200011)185:2<226::AID-JCP7>3.3.CO;2-5; Gunsilius E, 2002, BLOOD, V99, P393, DOI 10.1182/blood.V99.1.393; Kakizawa H, 2004, METABOLISM, V53, P550, DOI 10.1016/j.metabol.2003.12.002; Kimura K, 2007, ATHEROSCLEROSIS, V194, P182, DOI 10.1016/j.atherosclerosis.2006.07.025; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Merl V, 2005, DIABETIC MED, V22, P1278, DOI 10.1111/j.1464-5491.2005.01590.x; Mick GJ, 2002, ENDOCRINOLOGY, V143, P948, DOI 10.1210/en.143.3.948; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Nammi S, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-3; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; Oltmanns KM, 2006, AM J PHYSIOL-ENDOC M, V290, pE434, DOI 10.1152/ajpendo.00508.2004; Randeva HS, 2004, CIRCULATION, V109, P2405, DOI 10.1161/01.CIR.0000129763.51060.77; SANDHOFER A, 2009, ATHEROSCLEROSIS; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Sone H, 1996, BIOCHEM BIOPH RES CO, V221, P193, DOI 10.1006/bbrc.1996.0568; Toft I, 1998, HYPERTENSION, V32, P115, DOI 10.1161/01.HYP.32.1.115; WADA H, 2009, ATHEROSCLEROSIS; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496	32	59	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12610	10.1371/journal.pone.0012610	http://dx.doi.org/10.1371/journal.pone.0012610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830305	gold, Green Published, Green Submitted			2022-12-25	WOS:000281631300031
J	Fernandez, P; Petres, S; Mecheri, S; Gysin, J; Scherf, A				Fernandez, Pablo; Petres, Stephane; Mecheri, Salaheddine; Gysin, Juerg; Scherf, Artur			Strain-Transcendent Immune Response to Recombinant Var2CSA DBL5-epsilon Domain Block P. falciparum Adhesion to Placenta-Derived BeWo Cells under Flow Conditions	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; MICROVASCULAR ENDOTHELIAL-CELLS; CROSS-REACTIVE ANTIBODIES; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; PARASITE ADHESION; PREGNANCY; MALARIA; CYTOADHESION; SURFACE	Background: Pregnancy-associated malaria (PAM) is a serious consequence of the adhesion to the placental receptor chondroitin sulfate A (CSA) of Plasmodium falciparum-infected erythrocytes (PE) expressing the large cysteine-rich multidomain protein var2CSA. Women become resistant to PAM, and develop strain-transcending immunity against CSA-binding parasites. The identification of var2CSA regions that could elicit broadly neutralizing and adhesion-blocking antibodies is a key step for the design of prophylactic vaccine strategies. Methodology: Escherichia coli expressed var2CSA DBL domains were refolded and purified prior to immunization of mice and a goat. Protein-G-purified antibodies were tested for their ability to block FCR3(CSA)-infected erythrocytes binding to placental (BeWo) and monkey brain endothelial (ScC2) cell lines using a flow cytoadhesion inhibition assay mimicking closely the physiological conditions present in the placenta at shear stress of 0.05 Pa. DBL5-epsilon, DBL6-epsilon and DBL5-6-epsilon induced cross-reactive antibodies using Alum and Freund as adjuvants, which blocked cytoadhesion at values ranging between 40 to 96% at 0.5 mg IgG per ml. Importantly, antibodies raised against recombinant DBL5-epsilon from 3 distinct parasites genotypes (HB3, Dd2 and 7G8) showed strain-transcending inhibition ranging from 38 to 64% for the heterologuous FCR3(CSA). Conclusions: Using single and double DBL domains from var2CSA and Alum as adjuvant, we identified recombinant subunits inducing an immune response in experimental animals which is able to block efficiently parasite adhesion in a flow cytoadhesion assay that mimics closely the erythrocyte flow in the placenta. These subunits show promising features for inclusion into a vaccine aiming to protect against PAM.	[Fernandez, Pablo; Mecheri, Salaheddine; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France; [Fernandez, Pablo; Mecheri, Salaheddine; Scherf, Artur] CNRS, URA2581, Paris, France; [Petres, Stephane; Gysin, Juerg] Inst Pasteur, Host Pathogen Interact Unit, Abymes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Fernandez, P (corresponding author), Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France.	artur.scherf@pasteur.fr	Scherf, Artur/A-9674-2014; Mecheri, Salah/M-8315-2013	Scherf, Artur/0000-0003-2411-3328; petres, stephane/0000-0002-4716-565X	PMI; Bill and Melinda Gates Foundation; Fondation pour la Recherche Medicale [DMI20091117309]	PMI(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	PMI Gates Malaria Programme grant, Bill and Melinda Gates Foundation. Fondation pour la Recherche Medicale (DMI20091117309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2004, MICROBES INFECT, V6, P249, DOI 10.1016/j.micinf.2003.12.007; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fusai T, 2000, MOL BIOCHEM PARASIT, V108, P25, DOI 10.1016/S0166-6851(00)00199-7; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; GAY F, 1995, J IMMUNOL METHODS, V184, P15, DOI 10.1016/0022-1759(95)00070-Q; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	25	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12558	10.1371/journal.pone.0012558	http://dx.doi.org/10.1371/journal.pone.0012558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838433	gold, Green Submitted, Green Published			2022-12-25	WOS:000281627700011
J	Zheng, ZQ; de Iongh, RU; Rathjen, PD; Rathjen, J				Zheng, Zhiqiang; de Iongh, Robb U.; Rathjen, Peter D.; Rathjen, Joy			A Requirement for FGF Signalling in the Formation of Primitive Streak-Like Intermediates from Primitive Ectoderm in Culture	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EMBRYONIC STEM-CELLS; BONE MORPHOGENETIC PROTEIN-4; MOUSE ES CELLS; MESODERM INDUCTION; MAINTAIN PLURIPOTENCY; FACTOR RECEPTOR-1; BASIC FGF; DIFFERENTIATION; ENDODERM	Background: Embryonic stem (ES) cells hold considerable promise as a source of cells with therapeutic potential, including cells that can be used for drug screening and in cell replacement therapies. Differentiation of ES cells into the somatic lineages is a regulated process; before the promise of these cells can be realised robust and rational methods for directing differentiation into normal, functional and safe cells need to be developed. Previous in vivo studies have implicated fibroblast growth factor (FGF) signalling in lineage specification from pluripotent cells. Although FGF signalling has been suggested as essential for specification of mesoderm and endoderm in vivo and in culture, the exact role of this pathway remains unclear. Methodology/Principal Findings: Using a culture model based on early primitive ectoderm-like (EPL) cells we have investigated the role of FGF signalling in the specification of mesoderm. We were unable to demonstrate any mesoderm inductive capability associated with FGF1, 4 or 8 signalling, even when the factors were present at high concentrations, nor any enhancement in mesoderm formation induced by exogenous BMP4. Furthermore, there was no evidence of alteration of mesoderm sub-type formed with addition of FGF1, 4 or 8. Inhibition of endogenous FGF signalling, however, prevented mesoderm and favoured neural differentiation, suggesting FGF signalling was required but not sufficient for the differentiation of primitive ectoderm into primitive streak-like intermediates. The maintenance of ES cell/early epiblast pluripotent marker expression was also observed in cultures when FGF signalling was inhibited. Conclusions/Significance: FGF signalling has been shown to be required for the differentiation of primitive ectoderm to neurectoderm. This, coupled with our observations, suggest FGF signalling is required for differentiation of the primitive ectoderm into the germ lineages at gastrulation.	[Zheng, Zhiqiang; Rathjen, Peter D.; Rathjen, Joy] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [de Iongh, Robb U.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Zheng, ZQ (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	jrathjen@unimelb.edu.au	De Iongh, Robb U/H-9646-2019	De Iongh, Robb U/0000-0001-7013-1610; Zheng, Zhiqiang/0000-0003-1028-3246	University of Melbourne; Australian Stem Cell Centre (Monash University, Clayton, Victoria, Australia)	University of Melbourne(University of Melbourne); Australian Stem Cell Centre (Monash University, Clayton, Victoria, Australia)(Monash University)	This work was supported by the University of Melbourne and an equipment loan from the Australian Stem Cell Centre (Monash University, Clayton, Victoria, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; CORNELL RA, 1994, DEVELOPMENT, V120, P453; DELLERA P, 2003, CIRC RES, P414; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezzat S, 2005, CLIN CANCER RES, V11, P1336; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Fisher LJ, 1997, NEUROBIOL DIS, V4, P1, DOI 10.1006/nbdi.1997.0137; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; HAUB O, 1991, DEVELOPMENT, V112, P397; Hughes JN, 2009, STEM CELLS, V27, P2941, DOI 10.1002/stem.218; Hughes JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005579; Isaacs HV, 1997, CELL MOL LIFE SCI, V53, P350, DOI 10.1007/PL00000611; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lake JA, 2000, J CELL SCI, V113, P555; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Maye P, 2000, MECH DEVELOP, V94, P117, DOI 10.1016/S0925-4773(00)00304-X; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; MITRANI E, 1990, DEVELOPMENT, V109, P387; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MONTELL DJ, 1994, TRENDS GENET, V10, P59, DOI 10.1016/0168-9525(94)90150-3; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Ornitz DM, 2001, GENOME BIOL, V2; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; OSHEA K, 2004, BIOL REPROD SOC STUD, P1755; Pelton TA, 2002, J CELL SCI, V115, P329; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Rathjen J, 1999, J CELL SCI, V112, P601; Rathjen J, 2003, METHOD ENZYMOL, V365, P3; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J, 2001, CURR OPIN GENET DEV, V11, P587, DOI 10.1016/S0959-437X(00)00237-9; Sadlon TJ, 2004, STEM CELLS, V22, P457, DOI 10.1634/stemcells.22-4-457; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; SCHULZ MW, 1993, DEVELOPMENT, V118, P117; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang JK, 1997, ONCOGENE, V14, P1767, DOI 10.1038/sj.onc.1201021; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Willems E, 2008, DIFFERENTIATION, V76, P745, DOI 10.1111/j.1432-0436.2007.00257.x; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YAMAGUCHI TP, 1995, CURR OPIN GENET DEV, V5, P485, DOI 10.1016/0959-437X(95)90053-J; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; ZHAN X, 1994, J BIOL CHEM, V269, P20221	72	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12555	10.1371/journal.pone.0012555	http://dx.doi.org/10.1371/journal.pone.0012555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838439	Green Published, gold			2022-12-25	WOS:000281627700008
J	Rolland, M; Carlson, JM; Manocheewa, S; Swain, JV; Lanxon-Cookson, E; Deng, WJ; Rousseau, CM; Raugi, DN; Learn, GH; Maust, BS; Coovadia, H; Ndung'u, T; Goulder, PJR; Walker, BD; Brander, C; Heckerman, DE; Mullins, JI				Rolland, Morgane; Carlson, Jonathan M.; Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Deng, Wenjie; Rousseau, Christine M.; Raugi, Dana N.; Learn, Gerald H.; Maust, Brandon S.; Coovadia, Hoosen; Ndung'u, Thumbi; Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian; Heckerman, David E.; Mullins, James I.			Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE ESCAPE; PROTEASE INHIBITORS; ELITE CONTROLLERS; VIRAL LOAD; ASSOCIATIONS; MUTATIONS; POLYMORPHISMS; TRANSMISSION; INFECTION	Background: Despite high potential for HIV-1 genetic variation, the emergence of some mutations is constrained by fitness costs, and may be associated with compensatory amino acid (AA) co-variation. To characterize the interplay between Cytotoxic T Lymphocyte (CTL)-mediated pressure and HIV-1 evolutionary pathways, we investigated AA co-variation in Gag sequences obtained from 449 South African individuals chronically infected with HIV-1 subtype C. Methodology/Principal Findings: Individuals with CTL responses biased toward Gag presented lower viral loads than individuals with under-represented Gag-specific CTL responses. Using methods that account for founder effects and HLA linkage disequilibrium, we identified 35 AA sites under Human Leukocyte Antigen (HLA)-restricted CTL selection pressure and 534 AA-to-AA interactions. Analysis of two-dimensional distances between co-varying residues revealed local stabilization mechanisms since 40% of associations involved neighboring residues. Key features of our co-variation analysis included sites with a high number of co-varying partners, such as HLA-associated sites, which had on average 55% more connections than other co-varying sites. Conclusions/Significance: Clusters of co-varying AA around HLA-associated sites (especially at typically conserved sites) suggested that cooperative interactions act to preserve the local structural stability and protein function when CTL escape mutations occur. These results expose HLA-imprinted HIV-1 polymorphisms and their interlinked mutational paths in Gag that are likely due to opposite selective pressures from host CTL-mediated responses and viral fitness constraints.	[Rolland, Morgane; Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Deng, Wenjie; Rousseau, Christine M.; Raugi, Dana N.; Learn, Gerald H.; Maust, Brandon S.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Carlson, Jonathan M.; Heckerman, David E.] Microsoft Res, Redmond, WA USA; [Coovadia, Hoosen; Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, HIV Pathogenesis Program, Nelson Mandela Sch Med, Durban, South Africa; [Goulder, Philip J. R.] Univ Oxford, Dept Pediat, Nuffield Dept Med, Oxford, England; [Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian] Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian] Harvard Univ, Sch Med, Boston, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Microsoft; University of Kwazulu Natal; University of Oxford; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rolland, M (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mrolland@u.washington.edu	Learn, Jerry/E-3356-2012; Learn, Gerald H/B-6934-2011	Learn, Gerald H/0000-0003-0434-7733; Brander, Christian/0000-0002-0548-5778; Ndung'u, Thumbi/0000-0003-2962-3992	Bill and Melinda Gates Foundation [43437]; amfAR Mathilde Krim Fellowship [107005-43-RFNT]; US Public Health Services [AI057005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); amfAR Mathilde Krim Fellowship; US Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Bill and Melinda Gates Foundation to JM [# 43437], an amfAR Mathilde Krim Fellowship to MR [# 107005-43-RFNT] and the US Public Health Services [AI057005], including to M. R. and the Computational Biology Core of the University of Washington Center for AIDS Research and STDs [AI27757]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carlson J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000591; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gonzales MJ, 2003, AIDS, V17, P791, DOI 10.1097/00002030-200304110-00003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; MADDISON W.P., 2001, MACCLADE ANAL PHYLOG; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Menendez-Arias Luis, 2003, Current Drug Targets - Infectious Disorders, V3, P355, DOI 10.2174/1568005033481033; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Perno CF, 2006, ANTIVIR RES, V71, P293, DOI 10.1016/j.antiviral.2006.05.015; Plana M, 2002, J ACQ IMMUN DEF SYND, V29, P429, DOI 10.1097/00126334-200204150-00001; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030045; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Schneidewind A, 2007, J VIROL; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Storey John D, 2003, Methods Mol Biol, V224, P149; Svicher V, 2005, ANTIMICROB AGENTS CH, V49, P2015, DOI 10.1128/AAC.49.5.2015-2025.2005; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593	42	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12463	10.1371/journal.pone.0012463	http://dx.doi.org/10.1371/journal.pone.0012463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824187	Green Published, Green Submitted, gold			2022-12-25	WOS:000281456100003
J	Hoffmann, C; Galle, M; Dilling, S; Kappeli, R; Muller, AJ; Songhet, P; Beyaert, R; Hardt, WD				Hoffmann, Claudia; Galle, Marlies; Dilling, Sabrina; Kaeppeli, Rina; Mueller, Andreas J.; Songhet, Pascal; Beyaert, Rudi; Hardt, Wolf-Dietrich			In Macrophages, Caspase-1 Activation by SopE and the Type III Secretion System-1 of S. Typhimurium Can Proceed in the Absence of Flagellin	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; STREPTOMYCIN-PRETREATED MICE; SALMONELLA-TYPHIMURIUM; HOST-CELL; BACTERIAL INTERNALIZATION; PROTEIN SECRETION; INFLAMMASOME; IDENTIFICATION; RECOGNITION; INVASION	The innate immune system is of vital importance for protection against infectious pathogens. Inflammasome mediated caspase-1 activation and subsequent release of pro-inflammatory cytokines like IL-1 beta and IL-18 is an important arm of the innate immune system. Salmonella enterica subspecies 1 serovar Typhimurium (S. Typhimurium, SL1344) is an enteropathogenic bacterium causing diarrheal diseases. Different reports have shown that in macrophages, S. Typhimurium may activate caspase-1 by at least three different types of stimuli: flagellin, the type III secretion system 1 (T1) and the T1 effector protein SopE. However, the relative importance and interdependence of the different factors in caspase-1 activation is still a matter of debate. Here, we have analyzed their relative contributions to caspase-1 activation in LPS-pretreated RAW264.7 macrophages. Using flagellar mutants (fliGHI, flgK) and centrifugation to mediate pathogen-host cell contact, we show that flagellins account for a small part of the caspase-1 activation in RAW264.7 cells. In addition, functional flagella are of key importance for motility and host cell attachment which is a prerequisite for mediating caspase-1 activation via these three stimuli. Using site directed mutants lacking several T1 effector proteins and flagellin expression, we found that SopE elicits caspase-1 activation even when flagellins are absent. In contrast, disruption of essential genes of the T1 protein injection system (invG, sip beta) completely abolished caspase-1 activation. However, a robust level of caspase-1 activation is retained by the T1 system (or unidentified T1 effectors) in the absence of flagellin and SopE. T1-mediated inflammasome activation is in line with recent work by others and suggests that the T1 system itself may represent the basic caspase-1 activating stimulus in RAW264.7 macrophages which is further enhanced independently by SopE and/or flagellin.	[Hoffmann, Claudia; Dilling, Sabrina; Kaeppeli, Rina; Mueller, Andreas J.; Songhet, Pascal; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol, D BIOL, Inst Microbiol, Zurich, Switzerland; [Galle, Marlies; Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Belgium; [Galle, Marlies; Beyaert, Rudi] Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium	Swiss Federal Institutes of Technology Domain; ETH Zurich; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hoffmann, C (corresponding author), Swiss Fed Inst Technol, D BIOL, Inst Microbiol, Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Beyaert, Rudi/B-2589-2009	Muller, Andreas/0000-0002-0281-6383; Beyaert, Rudi/0000-0002-5704-582X; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Swiss National Science Foundation [310000-113623/1]; ETH Zurich Research foundation [ETH-08 08-3]; Interuniversitaire Attractiepolen [IAP6/18]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO); University of Ghent [01G06B6]; Swiss SystemsX.ch initiative	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich Research foundation(ETH Zurich); Interuniversitaire Attractiepolen; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO); University of Ghent(Ghent University); Swiss SystemsX.ch initiative	This work was supported in part by grants to WDH from the Swiss National Science Foundation (310000-113623/1), a grant (InfectX) from the Swiss SystemsX.ch initiative, evaluated by the Swiss National Science Foundation and the ETH Zurich Research foundation (ETH-08 08-3; WDH), as well as grants to RB from the Interuniversitaire Attractiepolen (IAP6/18), the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO), and the University of Ghent (GOA grant 01G06B6 and BOF predoctoral fellowship to M. Galle). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrbar K, 2004, J BACTERIOL, V186, P1215, DOI 10.1128/JB.186.4.1215-1219.2004; Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Johnston JB, 2007, SEMIN IMMUNOPATHOL, V29, P261, DOI 10.1007/s00281-007-0080-5; JONES GW, 1981, J GEN MICROBIOL, V127, P351; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; Schlumberger MC, 2007, MOL MICROBIOL, V65, P741, DOI 10.1111/j.1365-2958.2007.05823.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; VANDENABEELE P, 1990, J IMMUNOL METHODS, V135, P25, DOI 10.1016/0022-1759(90)90252-Q; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	48	34	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12477	10.1371/journal.pone.0012477	http://dx.doi.org/10.1371/journal.pone.0012477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814576	Green Published, Green Submitted, gold			2022-12-25	WOS:000281375500010
J	Wang, Z; Liu, TA; Lin, ZW; Hegarty, J; Koltun, WA; Wu, RL				Wang, Zhong; Liu, Tian; Lin, Zhenwu; Hegarty, John; Koltun, Walter A.; Wu, Rongling			A General Model for Multilocus Epistatic Interactions in Case-Control Studies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; HIGH-ORDER INTERACTIONS; BREAST-CANCER; METABOLISM; HAPLOTYPE; INFERENCE; PATHWAYS; SYSTEMS; POWER	Background: Epistasis, i.e., the interaction of alleles at different loci, is thought to play a central role in the formation and progression of complex diseases. The complexity of disease expression should arise from a complex network of epistatic interactions involving multiple genes. Methodology: We develop a general model for testing high-order epistatic interactions for a complex disease in a case-control study. We incorporate the quantitative genetic theory of high-order epistasis into the setting of cases and controls sampled from a natural population. The new model allows the identification and testing of epistasis and its various genetic components. Conclusions: Simulation studies were used to examine the power and false positive rates of the model under different sampling strategies. The model was used to detect epistasis in a case-control study of inflammatory bowel disease, in which five SNPs at a candidate gene were typed, leading to the identification of a significant three-locus epistasis.	[Wang, Zhong; Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA; [Wang, Zhong; Wu, Rongling] Penn State Univ, Penn State Canc Inst, Hershey, PA USA; [Liu, Tian] Genome Inst Singapore, Human Genet Grp, Singapore, Singapore; [Lin, Zhenwu; Hegarty, John; Koltun, Walter A.] Penn State Univ, Dept Surg, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wang, Z (corresponding author), Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA.	rwu@hes.hmc.psu.edu	Wang, Zhong/C-3737-2014	Hegarty, John/0000-0003-3401-848X	National Science Foundation (NSF) [DMS/NIGMS-0540745]; Changjiang Scholars Award	National Science Foundation (NSF)(National Science Foundation (NSF)); Changjiang Scholars Award	This work is supported by National Science Foundation (NSF) grant DMS/NIGMS-0540745 and the Changjiang Scholars Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALISON M, 2009, BMC RES NOTES, V1; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; BARTUAL R, 1993, EUPHYTICA, V72, P149; BATESON W, 1910, MOL GEN GENETICS MGG, V3, P108; Beerenwinkel N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-60; Carlborg O, 2002, GENET RES, V79, P175, DOI 10.1017/S001667230200558X; EDWARDS T, 2010, GEN FRAMEWORK FORMAL; Gabutero E, 2007, AIDS, V21, P65, DOI 10.1097/QAD.0b013e3280117f49; Gayan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-360; Hansen TF, 2001, GENETICS, V158, P477; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; HLAVACEK W, 2009, SCI STKE, V2; Huang LS, 1995, METHOD CELL BIOL, V48, P97; Imielinski M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-40; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Judson R, 2000, Pharmacogenomics, V1, P15, DOI 10.1517/14622416.1.1.15; Kayano M, 2009, BIOINFORMATICS, V25, P2735, DOI 10.1093/bioinformatics/btp531; Liang YL, 2008, STAT SURV, V2, P43, DOI 10.1214/07-SS026; Lin Z, 2009, DIS MARKERS, V27, P193, DOI [10.1155/2009/167534, 10.3233/DMA-2009-0662]; LIU T, 2010, BIOSTATISTI IN PRESS; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; McMullen MD, 1998, P NATL ACAD SCI USA, V95, P1996, DOI 10.1073/pnas.95.5.1996; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Nunkesser R, 2007, BIOINFORMATICS, V23, P3280, DOI 10.1093/bioinformatics/btm522; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RA F, 1968, AM J HUM GENET, V20, P402; Rha SY, 2007, ONCOLOGIST, V12, P622, DOI 10.1634/theoncologist.12-6-622; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Stich B, 2007, GENETICS, V176, P563, DOI 10.1534/genetics.106.067033; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tian L, 2004, GENETICS, V168, P503, DOI 10.1534/genetics.104.029603; Wan X, 2010, BIOINFORMATICS, V26, P30, DOI 10.1093/bioinformatics/btp622; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WORKMAN P, 1973, AM J HUM GENET, V25, P461; Wu RL, 1996, THEOR APPL GENET, V93, P102, DOI 10.1007/BF00225734; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	39	32	33	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11384	10.1371/journal.pone.0011384	http://dx.doi.org/10.1371/journal.pone.0011384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20814428	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600001
J	Harada, Y; Li, H; Wall, JS; Li, HL; Lennarz, WJ				Harada, Yoichiro; Li, Hua; Wall, Joseph S.; Li, Huilin; Lennarz, William J.			Structural Studies and the Assembly of the Heptameric Post-translational Translocon Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL SEQUENCE RECOGNITION; PROTEIN-TRANSLOCATION; ENDOPLASMIC-RETICULUM; SEC PROTEINS; BINDING; YEAST; TRANSPORT; RIBOSOME; ATPASE; COMPONENT	In Saccharomyces cerevisiae, some of the nascent chains can be post-translationally translocated into the endoplasmic reticulum through the heptameric post-translational translocon complex (post-translocon). This membrane-protein complex is composed of the protein-conducting channel and the tetrameric Sec62/63 complex. The Sec62/63 complex plays crucial roles in targeting of the signal recognition particle-independent protein substrate to the protein-conducting channel and in assembly of the post-translocon. Although the molecular mechanism of the post-translational translocation process has been well established, the structure of the post-translocon and how the channel and the Sec62/63 complex form the heptameric complex are largely uncharacterized. Here, we report a 20-angstrom resolution cryo-electron microscopy structure of the post-translocon. The purified post-translocon was found to have a mass of 287 kDa, which is consistent with the unit stoichiometry of the seven sub-units as determined by a cysteine labeling experiment. We demonstrated that Triton X-100 dissociated the heptameric complex into three subcomplexes identified as the trimeric translocon Sec61-Sbh1-Sss1, the Sec63-Sec71-Sec72 trimer, and the heterotetramer Sec62-Sec63-Sec71-Sec72, respectively. Additionally, a role of the sixth cytosolic loop of Sec61 in assembly of the post-translocon was demonstrated. Mutations of conserved, positively charged amino acid residues in the loop caused decreased formation of the post-translocon. These studies provide the first architectural description of the yeast post-translocon.	[Lennarz, William J.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Li, Hua; Wall, Joseph S.; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Lennarz, WJ (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	wlennarz@notes.cc.sunysb.edu	Li, Hua/N-6658-2017	Li, Hua/0000-0002-8786-4295; Li, Huilin/0000-0001-8085-8928	National Institutes of Health [GM33185, GM74985]; Brookhaven National Laboratory Laboratory-directed Research and Development [10-016]; Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033185, R01GM074985, R01GM033185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brookhaven National Laboratory Laboratory-directed Research and Development; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33185 (to W. J. L.) and GM74985 (to H. L.). This work was also supported by Brookhaven National Laboratory Laboratory-directed Research and Development Grant 10-016 (to H. L.) and in part by the Department of Energy.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; McClellan AJ, 2000, GENETICS, V156, P501; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Stroud RM, 1999, CURR OPIN STRUC BIOL, V9, P754, DOI 10.1016/S0959-440X(99)00040-8; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tziatzios C, 2004, J MOL BIOL, V340, P513, DOI 10.1016/j.jmb.2004.04.076; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wall JS, 2000, METH MOL B, V148, P589; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	37	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2956	2965		10.1074/jbc.M110.159517	http://dx.doi.org/10.1074/jbc.M110.159517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20826819	Green Published, hybrid			2022-12-25	WOS:000286464300059
J	Boal, F; Laguerre, M; Milochau, A; Lang, JC; Scotti, PA				Boal, Frederic; Laguerre, Michel; Milochau, Alexandra; Lang, Jochen; Scotti, Pier A.			A charged prominence in the linker domain of the cysteine-string protein Csp alpha mediates its regulated interaction with the calcium sensor synaptotagmin 9 during exocytosis	FASEB JOURNAL			English	Article						chaperone; FRET-FLIM; insulin; DnaJ-like protein; calcium-binding protein; C(2)A domain; SNARE	SYNAPTIC VESICLE PROTEIN; ENDOCRINE BETA-CELLS; INSULIN EXOCYTOSIS; NEUROTRANSMITTER RELEASE; DEPENDENT INTERACTION; PLASMA-MEMBRANE; CA2+ CHANNELS; C-TERMINUS; DROSOPHILA; SECRETION	The cochaperone cysteine-string protein (Csp) is located on vesicles and participates in the control of neurotransmission and hormone exocytosis. Csp contains several domains, and our previous work demonstrated the requirement of the Csp linker domain in regulated exocytosis of insulin in rodent pancreatic beta cells. We now address the molecular details to gain insight into the sequence of events during exocytosis. According to pulldown experiments and in vitro binding assays, Csp alpha interacts indirectly with SNAP-25 and directly with the calcium sensor synaptotagmin 9 (Syt9), which could be an intermediate between the chaperone and the t-SNARE. The C(2)A calcium binding domain of Syt9 and the linker domain of Csp alpha constituted the minimal interacting module. FRET-FLIM experiments confirmed the interaction between Syt9 and Csp alpha. Moreover, the point mutation E93V in the linker domain of Csp alpha significantly reduced the interaction between the two proteins. Molecular modeling revealed that this point mutation abolished a charged prominence on the surface of Csp alpha required for interaction. Strikingly, free calcium in the physiological low micromolar range enhanced the interaction between Syt9 and the linker domain of Csp alpha in vitro. These data indicate that Csp alpha interacts with Syt9, and such a complex may be relevant in the calcium-mediated control of a late stage of exocytosis by triggering the specific recruitment of a folding catalyst at the fusion point.-Boal, F., Laguerre, M., Milochau, A., Lang, J., Scotti., P. A. A charged prominence in the linker domain of the cysteine-string protein CSP alpha mediates its regulated interaction with the calcium sensor synaptotagmin 9 during exocytosis. FASEB J. 25, 132-143 (2011). www.fasebj.org	[Scotti, Pier A.] Univ Bordeaux 1, CNRS, Inst Europeen Chim & Biol, UMR 5248, F-33607 Pessac, France; [Boal, Frederic] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; University of Bristol	Scotti, PA (corresponding author), Univ Bordeaux 1, CNRS, Inst Europeen Chim & Biol, UMR 5248, 2 Av Robert Escarpit, F-33607 Pessac, France.	p.scotti@iecb.u-bordeaux.fr	Boal, Frédéric/O-6306-2018; Lang, Jochen/B-1215-2010; Lang, Jochen/F-5782-2014	Boal, Frédéric/0000-0001-7607-4573; Lang, Jochen/0000-0001-6847-5641; Lang, Jochen/0000-0001-6847-5641; SCOTTI, Pier-Arnaldo/0000-0003-4427-3695				Boal F, 2004, BIOCHEMISTRY-US, V43, P16212, DOI 10.1021/bi048612+; Boal F, 2007, BBA-MOL CELL RES, V1773, P109, DOI 10.1016/j.bbamcr.2006.08.054; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chamberlain LH, 2001, J CELL SCI, V114, P445; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Evans GJO, 2006, J BIOL CHEM, V281, P1564, DOI 10.1074/jbc.M503628200; Evans GJO, 2003, TRAFFIC, V4, P653, DOI 10.1034/j.1600-0854.2003.00127.x; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Grise F, 2007, BIOCHEM J, V403, P483, DOI 10.1042/BJ20061182; Gut A, 2001, J CELL SCI, V114, P1709; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JONAS JC, 1994, BIOCHEM J, V301, P523, DOI 10.1042/bj3010523; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Laguerre M, 1997, PHARM SCI, V3, P217; Lajus S, 2006, J BIOL CHEM, V281, P5522, DOI 10.1074/jbc.M510528200; Lang J., 1997, BACT TOXINS, P217; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Matos MF, 2000, EUR J CELL BIOL, V79, P377, DOI 10.1078/0171-9335-00063; Monterrat C, 2006, BBA-MOL CELL RES, V1763, P73, DOI 10.1016/j.bbamcr.2005.11.008; Nie ZP, 1999, J NEUROSCI, V19, P10270; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Rapoport I, 2008, MOL BIOL CELL, V19, P405, DOI 10.1091/mbc.E07-09-0870; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Thoumine O, 2008, CHEM REV, V108, P1565, DOI 10.1021/cr078204m; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tobaben S., 2003, J BIOL CHEM, V23, P23; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VALLAR L, 1987, J BIOL CHEM, V262, P5049; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; Zhang H, 1999, J CELL SCI, V112, P1345; Zhang Z, 2010, MOL BIOL CELL, V21, P2821, DOI 10.1091/mbc.E10-04-0285; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	68	19	22	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					132	143		10.1096/fj.09-152033	http://dx.doi.org/10.1096/fj.09-152033			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20847230				2022-12-25	WOS:000285869500013
J	Lee, HW; Brice, AR; Wright, CB; Dominy, BN; Cao, WG				Lee, Hyun-Wook; Brice, Allyn R.; Wright, Charles B.; Dominy, Brian N.; Cao, Weiguo			Identification of Escherichia coli Mismatch-specific Uracil DNA Glycosylase as a Robust Xanthine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDONUCLEASE-V; NITRIC-OXIDE; BASE DAMAGE; CRYSTAL-STRUCTURE; PRIMARY SUBSTRATE; NITROUS-ACID; HUMAN-CELLS; REPAIR; THYMINE; RECOGNITION	The gene for the mismatch-specific uracil DNA glycosylase (MUG) was identified in the Escherichia coli genome as a sequence homolog of the human thymine DNA glycosylase with activity against mismatched uracil base pairs. Examination of cell extracts led us to detect a previously unknown xanthine DNA glycosylase (XDG) activity in E. coli. DNA glycosylase assays with purified enzymes indicated the novel XDG activity is attributable to MUG. Here, we report a biochemical characterization of xanthine DNA glycosylase activity in MUG. The wild type MUG possesses more robust activity against xanthine than uracil and is active against all xanthine-containing DNA (C/X, T/X, G/X, A/X and single-stranded X). Analysis of potentials of mean force indicates that the double-stranded xanthine base pairs have a relatively narrow energetic difference in base flipping, whereas the tendency for uracil base flipping follows the order of C/U > G/U > T/U > A/U. Site-directed mutagenesis performed on conserved motifs revealed that Asn-140 and Ser-23 are important determinants for XDG activity in E. coli MUG. Molecular modeling and molecular dynamics simulations reveal distinct hydrogen-bonding patterns in the active site of E. coli MUG that account for the specificity differences between E. coli MUG and human thymine DNA glycosylase as well as that between the wild type MUG and the Asn-140 and Ser-23 mutants. This study underscores the role of the favorable binding interactions in modulating the specificity of DNA glycosylases.	[Lee, Hyun-Wook; Wright, Charles B.; Cao, Weiguo] Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Clemson, SC 29634 USA; [Brice, Allyn R.; Dominy, Brian N.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, WG (corresponding author), Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Rm 219 Biosyst Res Complex,51 New Cherry St, Clemson, SC 29634 USA.	wgc@clemson.edu	Dominy, Brian/AAA-4541-2020	Dominy, Brian/0000-0002-5635-2879	National Institutes of Health [GM090141]; Cooperative State Research, Education, and Extension Service/United States Department of Agriculture [SC-1700274]; Department of Defense [W911NF-05-10335, W911NF-07-1-0141, W81XWH-10-1-0385]; National Science Foundation [MCB-0953783]; SC-Life; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative State Research, Education, and Extension Service/United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); SC-Life; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090141 (to W.C.). This project was also supported in part by the Cooperative State Research, Education, and Extension Service/United States Department of Agriculture (SC-1700274, technical contribution no. 5805), Department of Defense Grants W911NF-05-10335, W911NF-07-1-0141, and W81XWH-10-1-0385 (to W.C.), National Science Foundation Grant MCB-0953783 (to B.N.D.), and SC-Life.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CHAKRAVARTI D, 1991, J BIOL CHEM, V266, P15710; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; Coligan JE., 1998, CURRENT PROTOCOLS PR; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Dong L, 2008, DNA REPAIR, V7, P1962, DOI 10.1016/j.dnarep.2008.08.006; Dong M, 2006, MUTAT RES-FUND MOL M, V594, P120, DOI 10.1016/j.mrfmmm.2005.08.008; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Feng H, 2005, BIOCHEMISTRY-US, V44, P11486, DOI 10.1021/bi050837c; Feng H, 2005, BIOCHEMISTRY-US, V44, P675, DOI 10.1021/bi048752j; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hang B, 2002, BIOCHEMISTRY-US, V41, P2158, DOI 10.1021/bi011542b; He B, 2000, MUTAT RES-DNA REPAIR, V459, P109, DOI 10.1016/S0921-8777(99)00063-4; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hitchcock TM, 2004, J BIOL CHEM, V279, P38177, DOI 10.1074/jbc.M405882200; Huang JM, 2001, BIOCHEMISTRY-US, V40, P8738, DOI 10.1021/bi010183h; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Jaruga P, 1996, NUCLEIC ACIDS RES, V24, P1389, DOI 10.1093/nar/24.8.1389; KAWASE Y, 1986, NUCLEIC ACIDS RES, V14, P7727, DOI 10.1093/nar/14.19.7727; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu PF, 2008, J BIOL CHEM, V283, P8829, DOI 10.1074/jbc.M707174200; Lutsenko E, 1999, J BIOL CHEM, V274, P31034, DOI 10.1074/jbc.274.43.31034; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mi RJ, 2009, J MOL BIOL, V385, P761, DOI 10.1016/j.jmb.2008.09.038; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; SAMSON L, 1991, P NATL ACAD SCI USA, V88, P9127, DOI 10.1073/pnas.88.20.9127; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Shapiro R., 1981, CHROMOSOME DAMAGE RE; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P8013, DOI 10.1021/bi970166l; Suzuki T, 1996, J AM CHEM SOC, V118, P2515, DOI 10.1021/ja952550g; Terato H, 2002, NUCLEIC ACIDS RES, V30, P4975, DOI 10.1093/nar/gkf630; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Vongchampa V, 2003, NUCLEIC ACIDS RES, V31, P1045, DOI 10.1093/nar/gkg177; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Wuenschell GE, 2003, BIOCHEMISTRY-US, V42, P3608, DOI 10.1021/bi0205597; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004	46	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41483	41490		10.1074/jbc.M110.150003	http://dx.doi.org/10.1074/jbc.M110.150003			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20852254	Green Published, hybrid			2022-12-25	WOS:000285622600034
J	Berna, MJ; Seiz, O; Nast, JF; Benten, D; Blaker, M; Koch, J; Lohse, AW; Pace, A				Berna, Marc J.; Seiz, Oliver; Nast, Jan Friso; Benten, Daniel; Blaeker, Michael; Koch, Johannes; Lohse, Ansgar W.; Pace, Andrea			CCK1 and CCK2 Receptors Are Expressed on Pancreatic Stellate Cells and Induce Collagen Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL-REGULATED KINASE; ACINAR-CELLS; MAP-KINASE; CHOLECYSTOKININ; ACTIVATION; PROLIFERATION; FIBROGENESIS; PATHWAYS; FIBROSIS	The gastrointestinal hormone cholecystokinin (CCK) can induce acute pancreatitis in rodents through its action on acinar cells. Treatment with CCK, in combination with other agents, represents the most commonly used model to induce experimental chronic pancreatitis. Pancreatic stellate cells (PSC) are responsible for pancreatic fibrosis and therefore play a predominant role in the genesis of chronic pancreatitis. However, it is not known whether PSC express CCK receptors. Using real time PCR techniques, we demonstrate that CCK1 and CCK2 receptors are expressed on rat PSC. Interestingly both CCK and gastrin significantly induced type I collagen synthesis. Moreover, both inhibit proliferation. These effects are comparable with TGF-beta-stimulated PSC. Furthermore, the natural agonists CCK and gastrin induce activation of pro-fibrogenic pathways Akt, ERK, and Src. Using specific CCK1 and CCK2 receptor (CCK2R) inhibitors, we found that Akt activation is mainly mediated by CCK2R. Akt activation by CCK and gastrin could be inhibited by the PI3K inhibitor wortmannin. Activation of ERK and the downstream target Elk-1 could be inhibited by the MEK inhibitor U0126. These data suggest that CCK and gastrin have direct activating effects on PSC, are able to induce collagen synthesis in these cells, and therefore appear to be important regulators of pancreatic fibrogenesis. Furthermore, similar to TGF-beta, both CCK and gastrin inhibit proliferation in PSC.	[Berna, Marc J.; Seiz, Oliver; Nast, Jan Friso; Benten, Daniel; Blaeker, Michael; Koch, Johannes; Lohse, Ansgar W.; Pace, Andrea] Univ Klinikum Eppendorf, Med Klin 1, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Pace, A (corresponding author), Univ Klinikum Eppendorf, Med Klin 1, D-20246 Hamburg, Germany.	pace@uke.de						ABDE M, 2008, EXPERT REV MOL MED, V10, pE19; Apte M, 2007, Novartis Found Symp, V285, P200; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 2000, GASTROENTEROLOGY, V118, P780, DOI 10.1016/S0016-5085(00)70148-X; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Berna MJ, 2007, BBA-MOL CELL RES, V1773, P483, DOI 10.1016/j.bbamcr.2006.12.008; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Bourassa J, 1999, BIOCHEM BIOPH RES CO, V260, P820, DOI 10.1006/bbrc.1999.0988; Cayrol C, 2006, ONCOGENE, V25, P4421, DOI 10.1038/sj.onc.1209484; CEREZO JG, 1991, DIGESTION, V48, P134; Dabrowski A, 1997, DIGESTION, V58, P361, DOI 10.1159/000201466; Deng XY, 2005, AM J PATHOL, V166, P93, DOI 10.1016/S0002-9440(10)62235-3; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hama K, 2006, BIOCHEM BIOPH RES CO, V340, P742, DOI 10.1016/j.bbrc.2005.12.069; Jaster R, 2002, GUT, V51, P579, DOI 10.1136/gut.51.4.579; Kordes C, 2005, PANCREAS, V31, P156, DOI 10.1097/01.mpa.0000168222.05591.a0; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Masamune A, 2009, GUT, V58, P550, DOI 10.1136/gut.2008.154401; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Masamune A, 2005, WORLD J GASTROENTERO, V11, P6144, DOI 10.3748/wjg.v11.i39.6144; Masamune A, 2005, WORLD J GASTROENTERO, V11, P3385, DOI 10.3748/wjg.v11.i22.3385; Masamune A, 2010, DIGEST DIS SCI, V55, P204, DOI 10.1007/s10620-008-0695-y; McCarroll JA, 2003, PANCREAS, V27, P150, DOI 10.1097/00006676-200308000-00008; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Ohnishi H, 2004, J BIOL CHEM, V279, P8873, DOI 10.1074/jbc.M309698200; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; SALUJA AK, 1989, P NATL ACAD SCI USA, V86, P8968, DOI 10.1073/pnas.86.22.8968; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHAFMAYER A, 1985, DIGESTION, V32, P136, DOI 10.1159/000199231; Schneider A, 2002, BEST PRACT RES CL GA, V16, P347, DOI 10.1053/bega.2002.0311; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Seva C, 1997, BIOCHEM BIOPH RES CO, V238, P202, DOI 10.1006/bbrc.1997.7163; Shiratori Keiko, 2002, Pancreas, V25, pe1, DOI 10.1097/00006676-200207000-00003; SLAFF J, 1984, GASTROENTEROLOGY, V87, P44; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vaquero E, 1999, GUT, V45, P269, DOI 10.1136/gut.45.2.269; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wan Y., 2005, J HUAZHONG U SCI TEC, V25, P306; Wan Yuantai, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P297; Williams JA, 2002, PHARMACOL TOXICOL, V91, P297, DOI 10.1034/j.1600-0773.2002.910606.x; Zieger M, 2000, BIOL CHEM, V381, P763, DOI 10.1515/BC.2000.097	50	50	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38905	38914		10.1074/jbc.M110.125534	http://dx.doi.org/10.1074/jbc.M110.125534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20843811	Green Published, hybrid			2022-12-25	WOS:000284941300020
J	Bortolozzi, M; Brini, M; Parkinson, N; Crispino, G; Scimemi, P; De Siati, RD; Di Leva, F; Parker, A; Ortolano, S; Arslan, E; Brown, SD; Carafoli, E; Mammano, F				Bortolozzi, Mario; Brini, Marisa; Parkinson, Nick; Crispino, Giulia; Scimemi, Pietro; De Siati, Romolo Daniele; Di Leva, Francesca; Parker, Andrew; Ortolano, Saida; Arslan, Edoardo; Brown, Steve D.; Carafoli, Ernesto; Mammano, Fabio			The Novel PMCA2 Pump Mutation Tommy Impairs Cytosolic Calcium Clearance in Hair Cells and Links to Deafness in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOTRANSDUCER CHANNEL; MOUSE MUTANTS; HEARING-LOSS; CA2+ CONCENTRATION; DEAFWADDLER MICE; TRANSDUCTION; ENDOLYMPH; GENE; STEREOCILIA; CADHERIN-23	The mechanotransduction process in hair cells in the inner ear is associated with the influx of calcium from the endolymph. Calcium is exported back to the endolymph via the splice variant w/a of the PMCA2 of the stereocilia membrane. To further investigate the role of the pump, we have identified and characterized a novel ENU-induced mouse mutation, Tommy, in the PMCA2 gene. The mutation causes a non-conservative E629K change in the second intracellular loop of the pump that harbors the active site. Tommy mice show profound hearing impairment from P18, with significant differences in hearing thresholds between wild type and heterozygotes. Expression of mutant PMCA2 in CHO cells shows calcium extrusion impairment; specifically, the long term, non-stimulated calcium extrusion activity of the pump is inhibited. Calcium extrusion was investigated directly in neonatal organotypic cultures of the utricle sensory epithelium in Tommy mice. Confocal imaging combined with flash photolysis of caged calcium showed impairment of calcium export in both Tommy heterozygotes and homozygotes. Immunofluorescence studies of the organ of Corti in homozygous Tommy mice showed a progressive base to apex degeneration of hair cells after P40. Our results on the Tommy mutation along with previously observed interactions between cadherin-23 and PMCA2 mutations in mouse and humans underline the importance of maintaining the appropriate calcium concentrations in the endolymph to control the rigidity of cadherin and ensure the function of interstereocilia links, including tip links, of the stereocilia bundle.	[Bortolozzi, Mario; Mammano, Fabio] Univ Padua, Dept Phys G Galilei, I-35131 Padua, Italy; [Bortolozzi, Mario; Crispino, Giulia; Ortolano, Saida; Carafoli, Ernesto; Mammano, Fabio] Venetian Inst Mol Med, I-35129 Padua, Italy; [Brini, Marisa; Di Leva, Francesca] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy; [Parkinson, Nick; Parker, Andrew; Brown, Steve D.] MRC Harwell, MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; [Scimemi, Pietro; De Siati, Romolo Daniele; Arslan, Edoardo] Univ Padua, Dept Med & Surg Specialities, Audiol & Phoniatr Serv, I-35128 Padua, Italy	University of Padua; Veneto Institute Molecular Medicine; University of Padua; MRC Harwell; University of Padua	Mammano, F (corresponding author), Via G Orus 2, I-35129 Padua, Italy.	fabio.mammano@unipd.it	Mammano, Fabio/AAM-3902-2020; Scimemi, Pietro/T-5390-2017; Bortolozzi, Mario/H-6872-2015; Carafoli, Ernesto/K-5192-2016; Mammano, Fabio/I-5064-2012; Brini, Marisa/K-5189-2016	Mammano, Fabio/0000-0003-3751-1691; Scimemi, Pietro/0000-0001-5273-1938; Bortolozzi, Mario/0000-0001-7198-9838; Carafoli, Ernesto/0000-0002-7826-0094; Mammano, Fabio/0000-0003-3751-1691; ortolano, saida/0000-0002-1098-3376; Brini, Marisa/0000-0001-5141-0243; DI LEVA, Francesca/0000-0002-6167-0679	European Commission [LSHGCT20054512063]; Fondazione Cariparo (Progetti di Eccellenza), Telethon Italy [2007BZ4RX3_003]; Telethon Foundation [GGP04169]; Italian Ministry of University and Research [PRIN 2005]; MRC [MC_U142684175, MC_U142684172] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_U142684175] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cariparo (Progetti di Eccellenza), Telethon Italy(Fondazione TelethonFondazione Cariparo); Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Commission under the Sixth Research Frame Program of the European Union (FP6 Integrated Project EuroHear, Grant LSHGCT20054512063) (to F. M., E. C., and S. D. B.), by the Fondazione Cariparo (Progetti di Eccellenza 2006-2007), Telethon Italy Grant GGP09137, by the Italian Ministry of Research (PRIN 2007, Grant 2007BZ4RX3_003) (to F. M.), and by Telethon Foundation Grant GGP04169 and the Italian Ministry of University and Research (PRIN 2005) (to M. Brini).	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; BOSHER SK, 1978, NATURE, V273, P377, DOI 10.1038/273377a0; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Crouch JJ, 1995, HEARING RES, V92, P112, DOI 10.1016/0378-5955(95)00201-4; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Furness DN, 2002, HEARING RES, V173, P10, DOI 10.1016/S0378-5955(02)00584-1; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Isaacs AM, 2000, HUM MOL GENET, V9, P1865, DOI 10.1093/hmg/9.12.1865; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; KUBITSCHECK U, 1995, BIOPHYS J, V69, P30, DOI 10.1016/S0006-3495(95)79875-7; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Mammano F, 2010, NEUROMETHODS, V43, P57, DOI 10.1007/978-1-60761-476-0_3; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Parkinson N. J., 2003, TOMMY MOUSE MUTANT I; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Spiden SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000238; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Takahashi K, 1999, BIOCHEM BIOPH RES CO, V261, P773, DOI 10.1006/bbrc.1999.1102; Tsai YS, 2006, MAMM GENOME, V17, P716, DOI 10.1007/s00335-005-0191-z; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Wood JD, 2004, JARO-J ASSOC RES OTO, V5, P99, DOI 10.1007/s10162-003-4022-1	48	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37693	37703		10.1074/jbc.M110.170092	http://dx.doi.org/10.1074/jbc.M110.170092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20826782	hybrid, Green Published			2022-12-25	WOS:000284424000061
J	Henard, CA; Bourret, TJ; Song, M; Vazquez-Torres, A				Henard, Calvin A.; Bourret, Travis J.; Song, Miryoung; Vazquez-Torres, Andres			Control of Redox Balance by the Stringent Response Regulatory Protein Promotes Antioxidant Defenses of Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CHRONIC GRANULOMATOUS-DISEASE; NADPH PHAGOCYTE OXIDASE; ESCHERICHIA-COLI; PATHOGENICITY ISLAND; OXIDATIVE STRESS; ANTIMICROBIAL ACTIONS; DNA-DAMAGE; DKSA; PPGPP	We report herein a critical role for the stringent response regulatory DnaK suppressor protein (DksA) in the coordination of antioxidant defenses. DksA helps fine-tune the expression of glutathione biosynthetic genes and discrete steps in the pentose phosphate pathway and tricarboxylic acid cycle that are associated with the generation of reducing power. Control of NAD(P)H/NAD(P)(+) redox balance by DksA fuels downstream antioxidant enzymatic systems in nutritionally starving Salmonella. Conditional expression of the glucose-6-phosphate dehydrogenase-encoding gene zwf, shown here to be under DksA control, increases both the NADPH pool and antioxidant defenses of dksA mutant Salmonella. The DksA-mediated coordination of redox balance boosts the antioxidant defenses of stationary phase bacteria. Not only does DksA increase resistance of Salmonella against hydrogen peroxide (H2O2), but it also promotes fitness of this intracellular pathogen when exposed to oxyradicals produced by the NADPH phagocyte oxidase in an acute model of infection. Given the role of DksA in the adjustment of gene expression in most bacteria undergoing nutritional deprivation, our findings raise the possibility that the control of central metabolic pathways by this regulatory protein maintains redox homeostasis essential for antioxidant defenses in phylogenetically diverse bacterial species.	[Henard, Calvin A.; Bourret, Travis J.; Song, Miryoung; Vazquez-Torres, Andres] Univ Colorado, Sch Med, Anschutz Med Ctr, Dept Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Vazquez-Torres, A (corresponding author), Mail Box 8333,POB 6511,Rm P18-9120, Aurora, CO 80045 USA.	andres.vazquez-torres@ucdenver.edu	Bourret, Travis/J-4673-2019	Bourret, Travis/0000-0002-4154-929X	National Institute of Health [AI54959]; Burroughs Welcome Fund; Institutional Training Grant [T32 AI052066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054959, T32AI052066, R56AI054959] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); Institutional Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health Grant AI54959. This work was also supported by the Burroughs Welcome Fund and the Institutional Training Grant T32 AI052066.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bourret TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001833; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CLARK WM, 1960, OXIDATION REDUCTION, P487; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean RT, 1997, BIOCHEM J, V324, P1; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; LUNDQUIST R, 1971, J BIOL CHEM, V246, P1107; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Woodmansee AN, 2003, MOL MICROBIOL, V49, P11, DOI 10.1046/j.1365-2958.2003.03530.x; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9	47	55	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36785	36793		10.1074/jbc.M110.160960	http://dx.doi.org/10.1074/jbc.M110.160960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851888	hybrid, Green Published			2022-12-25	WOS:000284146100056
J	Ichi, S; Costa, FF; Bischof, JM; Nakazaki, H; Shen, YW; Boshnjaku, V; Sharma, S; Mania-Farnell, B; McLone, DG; Tomita, T; Soares, MB; Mayanil, CSK				Ichi, Shunsuke; Costa, Fabricio F.; Bischof, Jared M.; Nakazaki, Hiromichi; Shen, Yueh-Wei; Boshnjaku, Vanda; Sharma, Saurabh; Mania-Farnell, Barbara; McLone, David G.; Tomita, Tadanori; Soares, Marcelo B.; Mayanil, Chandra S. K.			Folic Acid Remodels Chromatin on Hes1 and Neurog2 Promoters during Caudal Neural Tube Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MOUSE MUTANT; PAX-3 GENE; MICRORNA; DIFFERENTIATION; DEFECTS; SUPPLEMENTATION; TGF-BETA-2; EXPRESSION; RESPONSES	The mechanism(s) behind folate rescue of neural tube closure are not well understood. In this study we show that maternal intake of folate prior to conception reverses the proliferation potential of neural crest stem cells in homozygous Splotch embryos (Sp(-/-)) via epigenetic mechanisms. It is also shown that the pattern of differentiation seen in these cells is similar to wild-type (WT). Cells from open caudal neural tubes of Sp(-/-) embryos exhibit increased H3K27 methylation and decreased expression of KDM6B possibly due to up-regulation of KDM6B targeting micro-RNAs such as miR-138, miR-148a, miR-185, and miR-339-5p. In our model, folate reversed these epigenetic marks in folate-rescued Sp(-/-) embryos. Using tissue from caudal neural tubes of murine embryos we also examined H3K27me2 and KDM6B association with Hes1 and Neurog2 promoters at embryonic day E10.5, the proliferative stage, and E12.5, when neural differentiation begins. In Sp(-/-) embryos compared with WT, levels of H3K27me2 associated with the Hes1 promoter were increased at E10.5, and levels associated with the Neurog2 promoter were increased at E12.5. KDM6B association with Hes1 and Neurog2 promoters was inversely related to H3K27me2 levels. These epigenetic changes were reversed in folate-rescued Sp(-/-) embryos. Thus, one of the mechanisms by which folate may rescue the Sp(-/-) phenotype is by increasing the expression of KDM6B, which in turn decreases H3K27 methylation marks on Hes1 and Neurog2 promoters thereby affecting gene transcription.	[Sharma, Saurabh; McLone, David G.; Tomita, Tadanori; Mayanil, Chandra S. K.] Childrens Mem Res Ctr, Dev Neurobiol Lab, Dept Pediat Neurosurg, Dev Biol Program, Chicago, IL 60614 USA; [Costa, Fabricio F.; Bischof, Jared M.; Soares, Marcelo B.] Childrens Mem Res Ctr, Canc Biol & Epigenom Program, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60614 USA; [Mania-Farnell, Barbara] Purdue Univ Calumet, Dept Biol, Hammond, IN 46323 USA; [Ichi, Shunsuke] Univ Tokyo, Dept Neurosurg, Tokyo 1138656, Japan; [Nakazaki, Hiromichi] Jikei Univ, Dept Neurosurg, Sch Med, Tokyo 1058461, Japan	Northwestern University; Feinberg School of Medicine; Purdue University System; Purdue University; University of Tokyo; Jikei University	Mayanil, CSK (corresponding author), Childrens Mem Res Ctr, Dev Neurobiol Lab, Dept Pediat Neurosurg, Dev Biol Program, Box 204,2430 N Halsted St, Chicago, IL 60614 USA.	smayanil@northwestern.edu	Costa, Fabricio/M-5309-2017; Sharma, Saurabh/E-1221-2011		McLone; State of Illinois; Spina Bifida Association; Spastic Paralysis Research Foundation of Illinois-Eastern Iowa District of Kiwanis; Maeve McNicholas Memorial Foundation; Institute of Child Health, London	McLone; State of Illinois; Spina Bifida Association; Spastic Paralysis Research Foundation of Illinois-Eastern Iowa District of Kiwanis; Maeve McNicholas Memorial Foundation; Institute of Child Health, London	This work was supported by grants from the McLone Professorship Fund (to C. S. K. M.), a State of Illinois Excellence in Academic Medicine award (to C. S. K. M.), the Spina Bifida Association (to C. S. K. M.), the Spastic Paralysis Research Foundation of Illinois-Eastern Iowa District of Kiwanis (to C. S. K. M. and D. G. M.), and the Maeve McNicholas Memorial Foundation (to F. F. C.).; We thank Dr. M. Calissano, Institute of Child Health, London, for the generous gift of ND7 cells, Dr. Mary Hendrix for critical reading of the manuscript, and Dr. Elio F. Vanin for valuable discussions.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Burren KA, 2008, HUM MOL GENET, V17, P3675, DOI 10.1093/hmg/ddn262; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Gray JD, 2009, BIRTH DEFECTS RES A, V85, P314, DOI 10.1002/bdra.20542; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Latchman D. S., 1995, Methods (Orlando), V7, P277, DOI 10.1006/meth.1995.1033; Lo LC, 2002, DEVELOPMENT, V129, P1553; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mayanil CSK, 2006, J BIOL CHEM, V281, P24544, DOI 10.1074/jbc.M512449200; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakazaki H, 2008, DEV BIOL, V316, P510, DOI 10.1016/j.ydbio.2008.01.008; Nakazaki H, 2009, INT J DEV BIOL, V53, P69, DOI 10.1387/ijdb.082682hn; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Wlodarczyk BJ, 2006, TOXICOL APPL PHARM, V213, P55, DOI 10.1016/j.taap.2005.09.008; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017	31	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36922	36932		10.1074/jbc.M110.126714	http://dx.doi.org/10.1074/jbc.M110.126714			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833714	hybrid, Green Published			2022-12-25	WOS:000284146100019
J	Kanamori, Y; Hayakawa, Y; Matsumoto, H; Yasukochi, Y; Shimura, S; Nakahara, Y; Kiuchi, M; Kamimura, M				Kanamori, Yasushi; Hayakawa, Yoichi; Matsumoto, Hitoshi; Yasukochi, Yuji; Shimura, Sachiko; Nakahara, Yuichi; Kiuchi, Makoto; Kamimura, Manabu			A Eukaryotic (Insect) Tricistronic mRNA Encodes Three Proteins Selected by Context-dependent Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILKWORM PARALYTIC PEPTIDE; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; BICISTRONIC TRANSCRIPT; NERVOUS-SYSTEM; GENE; TRANSLATION; INITIATION; MECHANISM; EXPRESSION	Eukaryotic mRNAs are generally considered monocistronic and encode only one protein. Although dicistronic mRNAs encoding two proteins were found in fungi, plants, and animals, polycistronic mRNAs encoding more than two proteins have remained elusive so far in any eukaryote. Here we demonstrate that a single mRNA from silkworm encodes the precursor of an insect cytokine paralytic peptide (PP) and two new cytokine precursor-like proteins, uENF1 and uENF2. RT-PCR analysis showed that this mRNA is widely conserved in moths. Western blot analyses and reporter assays using its modified mRNAs, created by replacing each one of the three ORFs with the firefly luciferase ORF, showed that all three proteins were translated from this mRNA in cell lines, larval tissues, and cell-free systems. Insertion experiments using the Renilla luciferase ORF or a stem loop ruled out the possible involvement of internal ribosome entry site in the three protein translation. On the other hand, systematic mutation analysis of the translation initiation sequence of the 5'-proximal uENF1 ORF suggested that the context-dependent leaky-scanning mechanism is involved in translation of the downstream uENF2 and PP ORFs. In vitro, a synthetic peptide corresponding to the putative mature form of uENF1 stimulated spreading of hemocytes as did the synthetic PP, whereas that of uENF2 antagonized the stimulating activities of PP and the uENF1 peptide, suggesting that the three proteins control cellular immunity interactively. Thus, eukaryotes have a cellular tricistronic mRNA that encodes three functionally related proteins as in an operon.	[Kamimura, Manabu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Hayakawa, Yoichi; Matsumoto, Hitoshi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan	National Institute of Agrobiological Sciences - Japan; Saga University	Kamimura, M (corresponding author), Natl Inst Agrobiol Sci, Div Insect Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	kamimura@affrc.go.jp			Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Education, Culture, Sports, Science, and Technology, Japan [22380039]	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Grants-in-aid for Scientific Research 22380039 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ADHYA S, 2003, SCI STKE, pPE22; Andrews J, 1996, GENETICS, V143, P1699; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chung KR, 2003, CURR GENET, V43, P415, DOI 10.1007/s00294-003-0414-3; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; GODA SK, 1995, NUCLEIC ACIDS RES, V23, P3357, DOI 10.1093/nar/23.16.3357; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hayakawa Y, 1998, EUR J BIOCHEM, V253, P810, DOI 10.1046/j.1432-1327.1998.2530810.x; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 1981, Curr Top Microbiol Immunol, V93, P81; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Lee JM, 2005, CELL BIOL INT, V29, P976, DOI 10.1016/j.cellbi.2005.07.007; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Liu H, 2000, GENETICS, V154, P1735; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Mil'gotina EI, 2003, RUSS J BIOORG CHEM+, V29, P511, DOI 10.1023/B:RUBI.0000008891.51576.d0; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Pavlik P, 2006, GENOMICS, V88, P347, DOI 10.1016/j.ygeno.2006.04.009; Ramanathan P, 2008, RNA BIOL, V5, P149, DOI 10.4161/rna.5.3.6676; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Tsuzuki S, 2005, MECH DEVELOP, V122, P189, DOI 10.1016/j.mod.2004.10.005; Wall AA, 2005, J BIOL CHEM, V280, P27670, DOI 10.1074/jbc.M500255200; Wu C, 1999, MOL GEN GENET, V261, P698, DOI 10.1007/s004380050013	39	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36933	36944		10.1074/jbc.M110.180398	http://dx.doi.org/10.1074/jbc.M110.180398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829361	Green Published, hybrid			2022-12-25	WOS:000284146100077
J	Foley, JF; Singh, SP; Cantu, M; Chen, LY; Zhang, HWH; Farber, JM				Foley, John F.; Singh, Satya P.; Cantu, Michelle; Chen, Lingye; Zhang, Hongwei H.; Farber, Joshua M.			Differentiation of Human T Cells Alters Their Repertoire of G Protein alpha-Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; STIMULATING-HORMONE INCREASES; OPIOID RECEPTOR EXPRESSION; MESSENGER-RNA; SIGNALING PATHWAYS; ADENYLYL-CYCLASE; CALCIUM-CHANNELS; MICE DEFICIENT; SERTOLI CELLS; CUTTING EDGE	Because T cell differentiation leads to an expanded repertoire of chemokine receptors, a subgroup of G protein-coupled receptors, we hypothesized that the repertoire of G proteins might be altered in parallel. We analyzed the abundance of mRNA and/or protein of six G protein alpha-subunits in human CD4(+) and CD8(+) T cell subsets from blood. Although most G protein alpha-subunits were similarly expressed in all subsets, the abundance of G alpha(o), a protein not previously described in hematopoietic cells, was much higher in memory versus naive cells. Consistent with these data, activation of naive CD4(+) T cells in vitro significantly increased the abundance of G alpha(o) in cells stimulated under nonpolarizing or T(H)17 (but not T(H)1 or T(H)2)-polarizing conditions. In functional studies, the use of a chimeric G protein alpha-subunit, G alpha(qo5), demonstrated that chemokine receptors could couple to G alpha(o)-containing G proteins. We also found that G alpha(i1), another alpha-subunit not described previously in leukocytes, was expressed in naive T cells but virtually absent from memory subsets. Corresponding to their patterns of expression, siRNA-mediated knockdown of G alpha(o) in memory (but not naive) and G alpha(i1) in naive (but not memory) CD4(+) T cells inhibited chemokine-dependent migration. Moreover, although even in G alpha(o)- and G alpha(i1)-expressing cells mRNAs of these alpha-subunits were much less abundant than G alpha(i2) or G alpha(i3), knockdown of any of these subunits impaired chemokine receptor-mediated migration similarly. Together, our data reveal a change in the repertoire of G alpha(i/o) subunits during T cell differentiation and suggest functional equivalence among G alpha(i/o) subunits irrespective of their relative abundance.	[Foley, John F.; Singh, Satya P.; Cantu, Michelle; Chen, Lingye; Zhang, Hongwei H.; Farber, Joshua M.] NIAID, Inflammat Biol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Farber, JM (corresponding author), NIAID, Inflammat Biol Sect, Lab Mol Immunol, NIH, Rm 11N112,Bldg 10,MSC 1886,10 Ctr Dr, Bethesda, MD 20892 USA.	jfarber@niaid.nih.gov		Foley, John/0000-0003-0395-5390	National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000749] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health NIAID Intramural Research Program.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BAHOUTH SW, 1995, BIOCHEM J, V307, P831, DOI 10.1042/bj3070831; BERKE G, 1995, IMMUNOL TODAY, V16, P343, DOI 10.1016/0167-5699(95)80152-9; Cardoso A, 1998, J CELL BIOCHEM, V68, P62, DOI 10.1002/(SICI)1097-4644(19980101)68:1<62::AID-JCB6>3.0.CO;2-U; CARTER BD, 1993, P NATL ACAD SCI USA, V90, P4062, DOI 10.1073/pnas.90.9.4062; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Cho HH, 2006, STEM CELLS DEV, V15, P853, DOI 10.1089/scd.2006.15.853; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; El Ghamrawy C, 1999, PEPTIDES, V20, P305, DOI 10.1016/S0196-9781(99)00036-4; El Jamali A, 1998, J NEUROCHEM, V71, P2271; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; Farber DL, 2009, SEMIN IMMUNOL, V21, P84, DOI 10.1016/j.smim.2009.02.003; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; Fujii T, 2003, NEUROCHEM RES, V28, P423, DOI 10.1023/A:1022840416292; Fujino H, 1997, MOL PHARMACOL, V51, P1007, DOI 10.1124/mol.51.6.1007; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GAVERIAUX C, 1995, FEBS LETT, V369, P272, DOI 10.1016/0014-5793(95)00766-3; GOLDMAN DW, 1985, J EXP MED, V162, P145, DOI 10.1084/jem.162.1.145; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; HADCOCK JR, 1990, J BIOL CHEM, V265, P14784; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; HARRISWARRICK RM, 1988, NEURON, V1, P27, DOI 10.1016/0896-6273(88)90206-1; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HSU WH, 1990, J BIOL CHEM, V265, P11220; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2006, P NATL ACAD SCI USA, V103, P6524, DOI 10.1073/pnas.0601853103; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; KUROSE H, 1986, J BIOL CHEM, V261, P6423; Li MD, 1999, J LEUKOCYTE BIOL, V65, P707, DOI 10.1002/jlb.65.5.707; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; Liao F, 1999, J IMMUNOL, V162, P186; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGANZO F, 1993, MOL ENDOCRINOL, V7, P434, DOI 10.1210/me.7.3.434; LOGANZO F, 1992, MOL ENDOCRINOL, V6, P1259, DOI 10.1210/me.6.8.1259; Luo AH, 2002, BRAIN RES, V941, P62, DOI 10.1016/S0006-8993(02)02566-0; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; McIntire WE, 1998, J BIOL CHEM, V273, P33135, DOI 10.1074/jbc.273.50.33135; Miller B, 1996, J IMMUNOL, V157, P5324; Miller RK, 2009, MOL BIOL CELL, V20, P3608, DOI 10.1091/mbc.E09-03-0208; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURTAGH JJ, 1994, NUCLEIC ACIDS RES, V22, P842, DOI 10.1093/nar/22.5.842; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; NEER EJ, 1984, J BIOL CHEM, V259, P4222; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857; Preece G, 1996, J BIOL CHEM, V271, P11634, DOI 10.1074/jbc.271.20.11634; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rabin RL, 2003, J IMMUNOL, V171, P2812, DOI 10.4049/jimmunol.171.6.2812; Ricci A, 2002, J NEUROIMMUNOL, V129, P178, DOI 10.1016/S0165-5728(02)00177-7; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Tanaka M, 1999, P NATL ACAD SCI USA, V96, P14106, DOI 10.1073/pnas.96.24.14106; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yu CR, 2000, J IMMUNOL, V164, P1293, DOI 10.4049/jimmunol.164.3.1293	83	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35537	35550		10.1074/jbc.M110.128033	http://dx.doi.org/10.1074/jbc.M110.128033			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829352	Green Published, hybrid			2022-12-25	WOS:000283845300032
J	Kilbride, SM; Farrelly, AM; Bonner, C; Ward, MW; Nyhan, KC; Concannon, CG; Wollheim, CB; Byrne, MM; Prehn, JHM				Kilbride, Sean M.; Farrelly, Angela M.; Bonner, Caroline; Ward, Manus W.; Nyhan, Kristine C.; Concannon, Caoimhin G.; Wollheim, Claes B.; Byrne, Maria M.; Prehn, Jochen H. M.			RETRACTED: AMP-activated Protein Kinase Mediates Apoptosis in Response to Bioenergetic Stress through Activation of the Pro-apoptotic Bcl-2 Homology Domain-3-only Protein BMF (Retracted article. See vol. 295, pg. 671, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							DOMINANT-NEGATIVE SUPPRESSION; PANCREATIC BETA-CELLS; MITOCHONDRIAL DYSFUNCTION; EXPRESSION; METFORMIN; GENE; STIMULATION; HNF-1-ALPHA; METABOLISM; MUTATIONS	Heterozygous loss-of-function mutations in the hepatocyte nuclear factor 1A (HNF1A) gene result in the pathogenesis of maturity-onset diabetes-of-the-young type 3, (HNF1A-MODY). This disorder is characterized by a primary defect in metabolism-secretion coupling and decreased beta cell mass, attributed to excessive beta cell apoptosis. Here, we investigated the link between energy stress and apoptosis activation following HNF1A inactivation. This study employed single cell fluorescent microscopy, flow cytometry, gene expression analysis, and gene silencing to study the effects of overexpression of dominant-negative (DN)-HNF1A expression on cellular bioenergetics and apoptosis in INS-1 cells. Induction of DN-HNF1A expression led to reduced ATP levels and diminished the bioenergetic response to glucose. This was coupled with activation of the bioenergetic stress sensor AMP-activated protein kinase (AMPK), which preceded the onset of apoptosis. Pharmacological activation of AMPK using aminoimidazole carboxamide ribonucleotide (AICAR) was sufficient to induce apoptosis in naive cells. Conversely, inhibition of AMPK with compound C or AMPK alpha gene silencing protected against DN-HNF1A-induced apoptosis. Interestingly, AMPK mediated the induction of the pro-apoptotic Bcl-2 homology domain-3-only protein Bmf (Bcl-2-modifying factor). Bmf expression was also elevated in islets of DN-HNF1A transgenic mice. Furthermore, knockdown of Bmf expression in INS-1 cells using siRNA was sufficient to protect against DN-HNF1A-induced apoptosis. Our study suggests that overexpression of DN-HNF1A induces bioenergetic stress and activation of AMPK. This in turn mediates the transcriptional activation of the pro-apoptotic Bcl-2-homology protein BMF, coupling prolonged energy stress to apoptosis activation.	[Kilbride, Sean M.; Bonner, Caroline; Ward, Manus W.; Concannon, Caoimhin G.; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Farrelly, Angela M.; Nyhan, Kristine C.; Byrne, Maria M.] Mater Misericordiae Univ Hosp, Dublin 7, Ireland; [Wollheim, Claes B.] Univ Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Royal College of Surgeons - Ireland; Mater Misericordiae University Hospital; University College Dublin; University of Geneva	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, 123 St Stephens Green, Dublin 2, Ireland.	prehn@rcsi.ie	Concannon, Caoimhin/B-2075-2010; Byrne, Maria/A-8310-2017; Pattou, Francois/O-6151-2017; Prehn, Jochen HM/A-3928-2010; Bonner, Caroline/A-9819-2015; Farrelly, Angela/E-8010-2017	Byrne, Maria/0000-0002-9394-8698; Pattou, Francois/0000-0001-8388-3766; Prehn, Jochen HM/0000-0003-3479-7794; Bonner, Caroline/0000-0002-4430-8280; Ward, Manus/0000-0002-7085-9668; Farrelly, Angela/0000-0002-1242-5693	Health Research Board [RP/2008/14]; Science Foundation Ireland [08/IN1/1949]; Swiss National Foundation [32-66907.01];  [RP/2004/220];  [RP/2007/316]	Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); ; 	This work was supported by Health Research Board Grant RP/2008/14 and Science Foundation Ireland Grant 08/IN1/1949 (to J. H. M. P.), Grants RP/2004/220 and RP/2007/316 (to M. M. B.), and Swiss National Foundation Grant 32-66907.01 (to C. B. W.).	BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Farrelly AM, 2009, DIABETOLOGIA, V52, P136, DOI 10.1007/s00125-008-1168-8; Ghanaat-Pour H, 2009, DIABETES-METAB RES, V25, P163, DOI 10.1002/dmrr.896; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Leclerc I, 2004, DIABETES, V53, pS67, DOI 10.2337/diabetes.53.suppl_3.S67; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; Pongratz RL, 2009, J BIOL CHEM, V284, P16808, DOI 10.1074/jbc.M807723200; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rachmani Rita, 2002, Eur J Intern Med, V13, P428, DOI 10.1016/S0953-6205(02)00131-0; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schutte B, 1998, J NEUROSCI METH, V86, P63, DOI 10.1016/S0165-0270(98)00147-2; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Vaxillaire M, 2006, ENDOCRIN METAB CLIN, V35, P371, DOI 10.1016/j.ecl.2006.02.009; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Wobser H, 2006, DIABETOLOGIA, V49, P519, DOI 10.1007/s00125-005-0119-x; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	35	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36199	36206		10.1074/jbc.M110.138107	http://dx.doi.org/10.1074/jbc.M110.138107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20841353	Green Published, hybrid			2022-12-25	WOS:000283845300095
J	Pacchiana, G; Chiriaco, C; Stella, MC; Petronzelli, F; De Santis, R; Galluzzo, M; Carminati, P; Comoglio, PM; Michieli, P; Vigna, E				Pacchiana, Giovanni; Chiriaco, Cristina; Stella, Maria C.; Petronzelli, Fiorella; De Santis, Rita; Galluzzo, Maria; Carminati, Paolo; Comoglio, Paolo M.; Michieli, Paolo; Vigna, Elisa			Monovalency Unleashes the Full Therapeutic Potential of the DN-30 Anti-Met Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE; INVASIVE GROWTH; LIVER-REGENERATION; ALBUMIN-BINDING; DOWN-REGULATION; FUSION PROTEIN; GENE-TRANSFER; IN-VIVO; C-MET	Met, the high affinity receptor for hepatocyte growth factor, is one of the most frequently activated tyrosine kinases in human cancer and a validated target for cancer therapy. We previously developed a mouse monoclonal antibody directed against the extracellular portion of Met (DN-30) that induces Met proteolytic cleavage (receptor "shedding") followed by proteasome-mediated receptor degradation. This translates into inhibition of hepatocyte growth factor/Met-mediated biological activities. However, DN-30 binding to Met also results in partial activation of the Met kinase due to antibody-mediated receptor homodimerization. To safely harness the therapeutic potential of DN-30, its shedding activity must be disassociated from its agonistic activity. Here we show that the DN-30 Fab fragment maintains high affinity Met binding, elicits efficient receptor shedding and down-regulation, and does not promote kinase activation. In Met-addicted tumor cell lines, DN-30 Fab displays potent cytostatic and cytotoxic activity in a dose-dependent fashion. DN-30 Fab also inhibits anchorage-independent growth of several tumor cell lines. In mouse tumorigenesis assays using Met-addicted carcinoma cells, intratumor administration of DN-30 Fab or systemic delivery of a chemically stabilized form of the same molecule results in reduction of Met phosphorylation and inhibition of tumor growth. These data provide proof of concept that monovalency unleashes the full therapeutic potential of the DN-30 antibody and point at DN-30 Fab as a promising tool for Met-targeted therapy.	[Comoglio, Paolo M.; Michieli, Paolo; Vigna, Elisa] Univ Turin, Lab Expt Therapy & Gene Transfer, Inst Canc Res & Treatment, Sch Med, I-10060 Turin, Italy; [Comoglio, Paolo M.; Michieli, Paolo; Vigna, Elisa] Univ Turin, Dept Oncol Sci, Sch Med, I-10060 Turin, Italy; [Petronzelli, Fiorella; De Santis, Rita] Sigma Tau SpA R&D, I-00040 Rome, Italy; [Carminati, Paolo] Metheresis Translat Res SA, CH-6900 Lugano, Switzerland	University of Turin; University of Turin	Vigna, E (corresponding author), Univ Turin, Lab Expt Therapy & Gene Transfer, Inst Canc Res & Treatment, Sch Med, SP 142,Km 3-95, I-10060 Turin, Italy.	e.vigna@ircc.it	Michieli, Paolo/A-2588-2011	Michieli, Paolo/0000-0002-3093-8871; Comoglio, Paolo/0000-0002-7056-5328; DE SANTIS, Rita/0000-0002-5037-0611; Vigna, Elisa/0000-0001-9787-5732	Italian Association for Cancer Research (AIRC); European Commission [FP7-HEALTH-2007-A, 201640]; Fondazione Piemontese per la Ricerca sul Cancro; Italian Ministry of University and Research	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Piemontese per la Ricerca sul Cancro; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Association for Cancer Research (AIRC), European Commission FP7-HEALTH-2007-A Grant 201640, the Fondazione Piemontese per la Ricerca sul Cancro, and the Italian Ministry of University and Research.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bardelli C, 2005, BIOCHEM BIOPH RES CO, V334, P1172, DOI 10.1016/j.bbrc.2005.07.020; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chambers RS, 2005, CURR OPIN CHEM BIOL, V9, P46, DOI 10.1016/j.cbpa.2004.10.011; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; GIORDANO S, 1988, MOL CELL BIOL, V8, P3510, DOI 10.1128/MCB.8.8.3510; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Labrijn AF, 2008, CURR OPIN IMMUNOL, V20, P479, DOI 10.1016/j.coi.2008.05.010; LONGATI P, 1994, ONCOGENE, V9, P49; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488; Ohashi K, 2000, NAT MED, V6, P327; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Prat M, 1998, J CELL SCI, V111, P237; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2008, CANCER RES, V68, P9176, DOI 10.1158/0008-5472.CAN-08-1688; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8	31	67	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36149	36157		10.1074/jbc.M110.134031	http://dx.doi.org/10.1074/jbc.M110.134031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833723	hybrid, Green Published			2022-12-25	WOS:000283845300091
J	Weisbart, RH; Chan, G; Heinze, E; Mory, R; Nishimura, RN; Colburn, K				Weisbart, Richard H.; Chan, Grace; Heinze, Emil; Mory, Rachel; Nishimura, Robert N.; Colburn, Keith			BRAF Drives Synovial Fibroblast Transformation in Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; SIGNALING PATHWAY; JOINT DESTRUCTION; MUTATIONS; CANCER; GENE; ACTIVATION; MECHANISM; MELANOMA	Synovial fibroblasts destroy articular cartilage and bone in rheumatoid arthritis, but the mechanism of fibroblast transformation remains elusive. Because gain-of-function mutations of BRAF can transform fibroblasts, we examined BRAF in rheumatoid synovial fibroblasts. The strong gain-of-function mutation, V600R, of BRAF found in melanomas and other cancers was identified in first passage synovial fibroblasts from two of nine rheumatoid arthritis patients and confirmed by restriction site mapping. BRAF-specific siRNA inhibited proliferation of synovial fibroblasts with V600R mutations. A BRAF aberrant splice variant with an intact kinase domain and partial loss of the N-terminal autoinhibitory domain was identified in fibroblasts from an additional patient, and fibroblast proliferation was inhibited by BRAF-specific siRNA. Our finding is the first to establish mechanisms for fibroblast transformation responsible for destruction of articular cartilage and bone in rheumatoid arthritis and establishes a new target for therapeutic intervention.	[Weisbart, Richard H.; Chan, Grace] Vet Affairs Greater Los Angeles Hlth Care Syst, Dept Res, Sepulveda, CA 91343 USA; [Heinze, Emil; Mory, Rachel] Olive View UCLA Med Ctr, Dept Med, Sylmar, CA 91342 USA; [Nishimura, Robert N.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Colburn, Keith] Vet Affairs Med Ctr, Dept Med, Loma Linda, CA 92357 USA; [Colburn, Keith] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loma Linda University	Weisbart, RH (corresponding author), 16111 Plummer St, North Hills, CA 91343 USA.	rweisbar@ucla.edu						Auger I, 2009, ANN RHEUM DIS, V68, P591, DOI 10.1136/ard.2008.096917; Baitei EY, 2009, J PATHOL, V217, P707, DOI 10.1002/path.2496; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fensterle J, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-62; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Inazuka M, 2000, RHEUMATOLOGY, V39, P262, DOI 10.1093/rheumatology/39.3.262; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Karouzakis E, 2006, IMMUNOL LETT, V106, P8, DOI 10.1016/j.imlet.2006.04.011; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li J, 2009, BIOCHEM SOC T, V37, P427, DOI 10.1042/BST0370427; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; MU L, 1996, Am J Pathol */* S AM, V149, P1607; MU L, 2005, Nat Clin Pract Rheum, V1, P102; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yamanishi Y, 2005, ARTHRITIS RES THER, V7, pR12, DOI 10.1186/ar1448; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057	22	13	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34299	34303		10.1074/jbc.C110.168195	http://dx.doi.org/10.1074/jbc.C110.168195			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20843808	Green Published, hybrid			2022-12-25	WOS:000283659100002
J	Ponugoti, B; Kim, DH; Xiao, Z; Smith, Z; Miao, J; Zang, MW; Wu, SY; Chiang, CM; Veenstra, TD; Kemper, JK				Ponugoti, Bhaskar; Kim, Dong-Hyun; Xiao, Zhen; Smith, Zachary; Miao, Ji; Zang, Mengwei; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Veenstra, Timothy D.; Kemper, Jongsook Kim			SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; GAMMA COACTIVATOR 1-ALPHA; TRANSCRIPTIONAL COACTIVATOR; INSULIN REGULATION; GENE ACTIVATION; ACETYLATION; COMPLEX; PGC-1-ALPHA; EXPRESSION; GLUCOSE	The SIRT1 deacetylase inhibits fat synthesis and stimulates fat oxidation in response to fasting, but the underlying mechanisms remain unclear. Here we report that SREBP-1c, a key lipogenic activator, is an in vivo target of SIRT1. SIRT1 interaction with SREBP-1c was increased during fasting and decreased upon feeding, and consistently, SREBP-1c acetylation levels were decreased during fasting in mouse liver. Acetylated SREBP-1c levels were also increased in HepG2 cells treated with insulin and glucose to mimic feeding conditions, and down-regulation of p300 by siRNA decreased the acetylation. Depletion of hepatic SIRT1 by adenoviral siRNA increased acetylation of SREBP-1c with increased lipogenic gene expression. Tandem mass spectrometry and mutagenesis studies revealed that SREBP-1c is acetylated by p300 at Lys-289 and Lys-309. Mechanistic studies using acetylation-defective mutants showed that SIRT1 deacetylates and inhibits SREBP-1c transactivation by decreasing its stability and its occupancy at the lipogenic genes. Remarkably, SREBP-1c acetylation levels were elevated in diet-induced obese mice, and hepatic overexpression of SIRT1 or treatment with resveratrol, a SIRT1 activator, daily for 1 week decreased acetylated SREBP-1c levels with beneficial functional outcomes. These results demonstrate an intriguing connection between elevated SREBP-1c acetylation and increased lipogenic gene expression, suggesting that abnormally elevated SREBP-1c acetylation increases SREBP-1c lipogenic activity in obese mice. Reducing acetylation of SREBP-1c by targeting SIRT1 may be useful for treating metabolic disorders, including fatty liver, obesity, and type II diabetes.	[Ponugoti, Bhaskar; Kim, Dong-Hyun; Smith, Zachary; Miao, Ji; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiao, Zhen; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc,NIH, Frederick, MD 21702 USA; [Zang, Mengwei] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@uiuc.edu	Miao, Ji/F-9398-2015; Sanguansri, Luz/B-6630-2011; PONUGOTI, BHASKAR/H-2230-2011	Miao, Ji/0000-0003-0869-4492; Sanguansri, Luz/0000-0003-1908-7604; Zang, Mengwei/0000-0002-2502-2586	National Institutes of Health [CA103867, CA124760, DK062777, DK80032]; NCI [N01-CO-12400]; American Diabetes Association; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080032, R56DK062777, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760 (to C.-M. C.), DK062777, and DK80032 (to J. K. K.) and National Institutes of Health, NCI, Contract N01-CO-12400 (to T. D. V.). This work was also supported by an American Diabetes Association basic research award (to J. K. K.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang S, 2008, J BIOL CHEM, V283, P35086, DOI 10.1074/jbc.M803531200; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Im SS, 2009, MOL CELL BIOL, V29, P4864, DOI 10.1128/MCB.00553-09; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Sinclair DA, 2006, SCIENCE, V312, P195; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007	45	367	388	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33959	33970		10.1074/jbc.M110.122978	http://dx.doi.org/10.1074/jbc.M110.122978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20817729	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000283354000043
J	Deb, C; LaFrance-Corey, RG; Schmalstieg, WF; Sauer, BM; Wang, HA; German, CL; Windebank, AJ; Rodriguez, M; Howe, CL				Deb, Chandra; LaFrance-Corey, Reghann G.; Schmalstieg, William F.; Sauer, Brian M.; Wang, Huan; German, Christopher L.; Windebank, Anthony J.; Rodriguez, Moses; Howe, Charles L.			CD8(+) T Cells Cause Disability and Axon Loss in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							NERVOUS-SYSTEM REMYELINATION; CEREBROSPINAL-FLUID; CLONAL EXPANSIONS; MOTOR FUNCTION; VIRAL MODEL; NATALIZUMAB; EXPRESSION; PERFORIN; INFILTRATE; ABSENCE	Background: The objective of this study was to test the hypothesis that CD8(+) T cells directly mediate motor disability and axon injury in the demyelinated central nervous system. We have previously observed that genetic deletion of the CD8(+) T cell effector molecule perforin leads to preservation of motor function and preservation of spinal axons in chronically demyelinated mice. Methodology/Principal Findings: To determine if CD8(+) T cells are necessary and sufficient to directly injure demyelinated axons, we adoptively transferred purified perforin-competent CD8(+) spinal cord-infiltrating T cells into profoundly demyelinated but functionally preserved perforin-deficient host mice. Transfer of CD8(+) spinal cord-infiltrating T cells rapidly and irreversibly impaired motor function, disrupted spinal cord motor conduction, and reduced the number of medium and large-caliber spinal axons. Likewise, immunodepletion of CD8(+) T cells from chronically demyelinated wildtype mice preserved motor function and limited axon loss without altering other disease parameters. Conclusions/Significance: In multiple sclerosis patients, CD8(+) T cells outnumber CD4(+) T cells in active lesions and the number of CD8(+) T cells correlates with the extent of ongoing axon injury and functional disability. Our findings suggest that CD8(+) T cells may directly injure demyelinated axons and are therefore a viable therapeutic target to protect axons and motor function in patients with multiple sclerosis.	[Deb, Chandra; LaFrance-Corey, Reghann G.; Schmalstieg, William F.; Windebank, Anthony J.; Rodriguez, Moses; Howe, Charles L.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Sauer, Brian M.; German, Christopher L.; Howe, Charles L.] Mayo Clin, Coll Med, Neurobiol Dis PhD Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Deb, C (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	howe@mayo.edu	Sauer, Brian/AAI-1407-2021	Rodriguez, Moses/0000-0001-6328-6497; Howe, Charles/0000-0002-3889-8739	Mayo early career development award; National MS Society [RG3636]; NIH [NS32129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032129] Funding Source: NIH RePORTER	Mayo early career development award; National MS Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a generous gift from Donald and Frances Herdrich to CLH, by a Mayo early career development award to CLH, by grant RG3636 from the National MS Society to CLH (www.nmss.org), and by grant NS32129 from the NIH to MR (www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Begolka WS, 2001, J NEUROVIROL, V7, P409; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; CHEN ML, 2009, EUR J IMMUNOL; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Deb C, 2009, J NEUROIMMUNOL, V214, P33, DOI 10.1016/j.jneuroim.2009.06.013; Deb C, 2009, J NEUROPATH EXP NEUR, V68, P1037, DOI 10.1097/NEN.0b013e3181b5417e; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Govermant Joan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P239, DOI 10.2174/1568010053586264; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Hoftberger R, 2004, BRAIN PATHOL, V14, P43; Howe CL, 2008, CURR TOP MICROBIOL, V318, P93; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Malmestrom C, 2008, J NEUROIMMUNOL, V196, P159, DOI 10.1016/j.jneuroim.2008.03.001; Murray PD, 1998, J NEUROSCI, V18, P7306; Okuda DT, 2009, NAT REV NEUROL, V5, P591, DOI 10.1038/nrneurol.2009.157; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; RODRIGUEZ M, 1991, LAB INVEST, V64, P358; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Sobottka B, 2009, AM J PATHOL, V175, P1160, DOI 10.2353/ajpath.2009.090340; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640	31	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12478	10.1371/journal.pone.0012478	http://dx.doi.org/10.1371/journal.pone.0012478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814579	Green Submitted, gold, Green Published			2022-12-25	WOS:000281375500011
J	Keinath, NF; Kierszniowska, S; Lorek, J; Bourdais, G; Kessler, SA; Shimosato-Asano, H; Grossniklaus, U; Schulze, WX; Robatzek, S; Panstruga, R				Keinath, Nana F.; Kierszniowska, Sylwia; Lorek, Justine; Bourdais, Gildas; Kessler, Sharon A.; Shimosato-Asano, Hiroko; Grossniklaus, Ueli; Schulze, Waltraud X.; Robatzek, Silke; Panstruga, Ralph			PAMP (Pathogen-associated Molecular Pattern)-induced Changes in Plasma Membrane Compartmentalization Reveal Novel Components of Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS REVEALS; ARABIDOPSIS-THALIANA; QUANTITATIVE PROTEOMICS; SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; CALLOSE SYNTHASE; INNATE IMMUNITY; PROTON PUMPS	Plasma membrane compartmentalization spatiotemporally regulates cell-autonomous immune signaling in animal cells. To elucidate immediate early protein dynamics at the plant plasma membrane in response to the bacterial pathogen-associated molecular pattern (PAMP) flagellin (flg22) we employed quantitative mass spectrometric analysis on detergent-resistant membranes (DRMs) of Arabidopsis thaliana suspension cells. This approach revealed rapid and profound changes in DRM protein composition following PAMP treatment, prominently affecting proton ATPases and receptor-like kinases, including the flagellin receptor FLS2. We employed reverse genetics to address a potential contribution of a subset of these proteins in flg22-triggered cellular responses. Mutants of three candidates (DET3, AHA1, FER) exhibited a conspicuous defect in the PAMP-triggered accumulation of reactive oxygen species. In addition, these mutants showed altered mitogen-activated protein kinase (MAPK) activation, a defect in PAMP-triggered stomatal closure as well as altered bacterial infection phenotypes, which revealed three novel players in elicitor-dependent oxidative burst control and innate immunity. Our data provide evidence for dynamic elicitor-induced changes in the membrane compartmentalization of PAMP signaling components.	[Keinath, Nana F.; Lorek, Justine; Robatzek, Silke; Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Kierszniowska, Sylwia; Schulze, Waltraud X.] Max Planck Inst Mol Plant Physiol, D-14476 Golm, Germany; [Bourdais, Gildas] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Kessler, Sharon A.; Shimosato-Asano, Hiroko; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Kessler, Sharon A.; Shimosato-Asano, Hiroko; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	Max Planck Society; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Zurich; University of Zurich	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de	Robatzek, Silke/B-6844-2013; Kessler, Sharon A/T-4784-2017; Grossniklaus, Ueli/E-9995-2016; Schulze, Waltraud X/E-9800-2011; Grossniklaus, Ueli/A-2736-2012; Panstruga, Ralph/F-3340-2011	Kessler, Sharon A/0000-0002-7964-0451; Grossniklaus, Ueli/0000-0002-0522-8974; Schulze, Waltraud X/0000-0001-9957-7245; Panstruga, Ralph/0000-0002-3756-8957; Bourdais, Gildas/0000-0001-9409-1107; Kierszniowska, Sylwia/0000-0002-4736-9222	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [SFB670]; University of Zurich; Swiss National Science Foundation; Emmy Noether-Programm (DFG); International Max Planck Research School (IMPRS); Forschungskredit der Universitat Zurich	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Emmy Noether-Programm (DFG)(German Research Foundation (DFG)); International Max Planck Research School (IMPRS); Forschungskredit der Universitat Zurich	This work was supported in part by grants from the Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG; SFB670) (to R. P. and S. R.). This work was also supported by the University of Zurich and the Swiss National Science Foundation (to U. G.) and the Emmy Noether-Programm (DFG, to W. X. S.).; Supported by an International Max Planck Research School (IMPRS) fellowship. Present address: Heidelberg Institute for Plant Sciences (HIP), Universitat Heidelberg, Im Neuenheimer Feld 230, 69120 Heidelberg, Germany.; Supported by the Forschungskredit der Universitat Zurich. Present address: Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0192, Japan.; Supported by DFG and SFB670. Present address: The Sainsbury Laboratory, Norwich Research Park, Norwich NR4 7UH, UK.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Engelsberger WR, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-14; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kierszniowska S, 2009, PROTEOMICS, V9, P1916, DOI 10.1002/pmic.200800443; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Minami A, 2009, PLANT CELL PHYSIOL, V50, P341, DOI 10.1093/pcp/pcn202; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nelson CJ, 2006, MOL CELL PROTEOMICS, V5, P1382, DOI 10.1074/mcp.M500414-MCP200; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Schumacher K, 2006, CURR OPIN PLANT BIOL, V9, P595, DOI 10.1016/j.pbi.2006.09.001; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Stanislas T, 2009, MOL CELL PROTEOMICS, V8, P2186, DOI 10.1074/mcp.M900090-MCP200; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Varet A, 2002, MOL PLANT MICROBE IN, V15, P608, DOI 10.1094/MPMI.2002.15.6.608; Zappel NF, 2008, CURR OPIN PLANT BIOL, V11, P632, DOI 10.1016/j.pbi.2008.07.002; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	49	219	228	1	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39140	39149		10.1074/jbc.M110.160531	http://dx.doi.org/10.1074/jbc.M110.160531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20843791	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000284941300044
J	Moore, HC; Jordan, LB; Bray, SE; Baker, L; Quinlan, PR; Purdie, CA; Thompson, AM; Bourdon, JC; Fuller-Pace, FV				Moore, H. C.; Jordan, L. B.; Bray, S. E.; Baker, L.; Quinlan, P. R.; Purdie, C. A.; Thompson, A. M.; Bourdon, J-C; Fuller-Pace, F. V.			The RNA helicase p68 modulates expression and function of the Delta 133 isoform(s) of p53, and is inversely associated with Delta 133p53 expression in breast cancer	ONCOGENE			English	Article						breast cancer; p68 RNA helicase; p53; Delta 133p53; gene expression/regulation	TUMOR-SUPPRESSOR P53; ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTIONAL COACTIVATOR; RIBOSOMAL-RNA; DNA-DAMAGE; BOX; PROTEINS; GENE; DIFFERENTIATION; ACTIVATION	The RNA helicase p68 is a potent co-activator of p53-dependent transcription in response to DNA damage. Previous independent studies have indicated that p68 and the Delta 133p53 isoforms, which modulate the function of full-length p53, are aberrantly expressed in breast cancers. Here we identify a striking inverse association of p68 and Delta 133p53 expression in primary breast cancers. Consistent with these findings, small interfering RNA depletion of p68 in cell lines results in a p53-dependant increase of Delta 133p53 in response to DNA damage, suggesting that increased Delta 133p53 expression could result from downregulation of p68 and provide a potential mechanistic explanation for our observations in breast cancer. Delta 133p53 alpha, which has been shown to negatively regulate the function of full-length p53, reciprocally inhibits the ability of p68 to stimulate p53-dependent transcription from the p21 promoter, suggesting that Delta 133p53 alpha may be competing with p68 to regulate p53 function. This hypothesis is underscored by our observations that p68 interacts with the C-terminal domain of p53, co-immunoprecipitates 133p53 alpha from cell extracts and interacts only with p53 molecules that are able to form tetramers. These data suggest that p68, p53 and 133p53 alpha may form part of a complex feedback mechanism to regulate the expression of Delta 133p53, with consequent modification of p53-mediated transcription, and may modulate the function of p53 in breast and other cancers that harbour wild-type p53. Oncogene (2010) 29, 6475-6484; doi:10.1038/onc.2010.381; published online 6 September 2010	[Moore, H. C.; Baker, L.; Thompson, A. M.; Bourdon, J-C; Fuller-Pace, F. V.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Dundee DD1 9SY, Tayside, Scotland; [Jordan, L. B.; Purdie, C. A.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Tayside, Scotland; [Thompson, A. M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Dundee; University of Dundee; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Fuller-Pace, FV (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Dundee DD1 9SY, Tayside, Scotland.	f.v.fullerpace@dundee.ac.uk	JC, Bourdon/A-4439-2008	JC, Bourdon/0000-0003-4623-9386; Purdie, Colin/0000-0002-1258-4010; Quinlan, Philip/0000-0002-3012-6646	Tenovus Scotland; Cancer Research UK; Breast Cancer Research Scotland	Tenovus Scotland; Cancer Research UK(Cancer Research UK); Breast Cancer Research Scotland	This work was supported by grants from Tenovus Scotland, Cancer Research UK and Breast Cancer Research Scotland. We thank David Meek for helpful discussions.	Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bertheau P, 2008, PATHOBIOLOGY, V75, P132, DOI 10.1159/000123851; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bond AT, 2001, MOL CELL BIOL, V21, P7366, DOI 10.1128/MCB.21.21.7366-7379.2001; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caretti G, 2007, CELL CYCLE, V6, P1172, DOI 10.4161/cc.6.10.4228; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Marcel V, 2010, ONCOGENE, V29, P2691, DOI 10.1038/onc.2010.26; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Salzman DW, 2007, J BIOL CHEM, V282, P32773, DOI 10.1074/jbc.M705054200; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748	44	27	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	49					6475	6484		10.1038/onc.2010.381	http://dx.doi.org/10.1038/onc.2010.381			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20818423	Green Accepted			2022-12-25	WOS:000285138900007
J	Nakamaru-Ogiso, E; Kao, MC; Chen, H; Sinha, SC; Yagi, T; Ohnishi, T				Nakamaru-Ogiso, Eiko; Kao, Mou-Chieh; Chen, Han; Sinha, Subhash C.; Yagi, Takao; Ohnishi, Tomoko			The Membrane Subunit NuoL(ND5) Is Involved in the Indirect Proton Pumping Mechanism of Escherichia coli Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; BINDING-SITE; PHOTOAFFINITY ANALOG; CRYSTAL-STRUCTURE; DOMAIN; IDENTIFICATION; INHIBITOR	Complex I pumps protons across the membrane by using downhill redox energy. Here, to investigate the proton pumping mechanism by complex I, we focused on the largest transmembrane subunit NuoL (Escherichia coli ND5 homolog). NuoL/ND5 is believed to have H+ translocation site(s), because of a high sequence similarity to multi-subunit Na+/H+ antiporters. We mutated thirteen highly conserved residues between NuoL/ND5 and MrpA of Na+/H+ antiporters in the chromosomal nuoL gene. The dNADH oxidase activities in mutant membranes were mostly at the control level or modestly reduced, except mutants of Glu-144, Lys-229, and Lys-399. In contrast, the peripheral dNADH-K3Fe(CN)(6) reductase activities basically remained unchanged in all the NuoL mutants, suggesting that the peripheral arm of complex I was not affected by point mutations in NuoL. The proton pumping efficiency (the ratio of H+/e(+)), however, was decreased in most NuoL mutants by 30-50%, while the IC50 values for asimicin (a potent complex I inhibitor) remained unchanged. This suggests that the H+/e(+) stoichiometry has changed from 4H(+)/2e(-) to 3H(+) or 2H(+)/2e(-) without affecting the direct coupling site. Furthermore, 50 mu M of 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), a specific inhibitor for Na+/H+ antiporters, caused a 38 +/- 5% decrease in the initial H+ pump activity in the wild type, while no change was observed in D178N, D303A, and D400A mutants where the H+ pumping efficiency had already been significantly decreased. The electron transfer activities were basically unaffected by EIPA in both control and mutants. Taken together, our data strongly indicate that the NuoL subunit is involved in the indirect coupling mechanism.	[Nakamaru-Ogiso, Eiko] Univ Penn, Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Kao, Mou-Chieh; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Sinha, Subhash C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Pennsylvania; Scripps Research Institute; Scripps Research Institute	Nakamaru-Ogiso, E (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, 36th & Hamilton Walk, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu			United States Public Health Service [R01GM33712, R01GM030736]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712, R01GM030736] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grants R01GM33712 (to T. Y.) and R01GM030736 (to T. O.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Benit P, 2008, MOL CELL BIOCHEM, V314, P45, DOI 10.1007/s11010-008-9763-z; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Fillingame RH, 1997, J EXP BIOL, V200, P217; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Gemperli AC, 2007, ARCH MICROBIOL, V188, P509, DOI 10.1007/s00203-007-0272-3; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Han HN, 2004, CHEM-EUR J, V10, P2149, DOI 10.1002/chem.200305557; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KITA K, 1984, J BIOL CHEM, V259, P3375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Oberlies NH, 1997, J MED CHEM, V40, P2102, DOI 10.1021/jm9700169; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Pedersen SF, 2007, J BIOL CHEM, V282, P19716, DOI 10.1074/jbc.M701637200; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; YAGI T, 1988, J BIOL CHEM, V263, P16150; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Zannoni D., 2004, RESP ARCHAEA BACTERI	64	67	70	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39070	39078		10.1074/jbc.M110.157826	http://dx.doi.org/10.1074/jbc.M110.157826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20826797	Green Published, hybrid			2022-12-25	WOS:000284941300037
J	Fraser, JA; Vojtesek, B; Hupp, TR				Fraser, Jennifer A.; Vojtesek, Borivoj; Hupp, Ted R.			A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal I. PHOSPHORYLATION AT SER269 IN VIVO IS LINKED TO INACTIVATION OF p53 FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR PROTEIN P53; DNA-BINDING DOMAIN; TRANSACTIVATION DOMAIN; P53-DEPENDENT TRANSCRIPTION; INTERACTION NETWORKS; TUMOR SUPPRESSION; POINT MUTATION; KINASE; ACTIVATION; APOPTOSIS	p53 is a thermodynamically unstable protein containing a conformationally flexible multiprotein docking site within the DNA-binding domain. A combinatorial peptide chip used to identify the novel kinase consensus site RXS Phi (K/D) led to the discovery of a homologous phosphorylation site in the S10 beta-strand of p53 at Ser(269). Overlapping peptide libraries confirmed that Ser(269) was a phosphoacceptor site in vitro, and immunochemical approaches evaluated whether p53 is phosphorylated in vivo at Ser(269). Mutation or phosphorylation of p53 at Ser(269) attenuates binding of the p53-specific monoclonal antibody DO-12, identifying an assay for measuring Ser(269) phosphorylation of p53 in vivo. The mAb DO-12 epitope of p53 is masked via phosphorylation in a range of human tumor cells with WT p53 status, as defined by increased mAb DO-12 binding to endogenous p53 after phosphatase treatment. Phospho-Ser(269)-specific monoclonal antibodies were generated and used to demonstrate that p53 phosphorylation is induced at Ser(269) after irradiation with kinetics similar to those of p53 protein induction. Phosphomimetic mutation at Ser(269) inactivated the transcription activation function and clonogenic suppressor activity of p53. These data suggest that the dynamic equilibrium between native and unfolded states of WT p53 can be modulated by phosphorylation of the conformationally flexible multiprotein binding site in the p53 DNA-binding domain.	[Fraser, Jennifer A.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, CRUK Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Brno 65653, Czech Republic	University of Edinburgh; Masaryk Memorial Cancer Institute	Hupp, TR (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, CRUK Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk		Fraser, Jennifer/0000-0001-5546-3916	Grant Agency of the Czech Republic [C483]; Ministry of Education, Youth, and Sports of the Czech Republic [6354]; Moravian-Biotechnology;  [301/08/1468];  [LC06035]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Moravian-Biotechnology; ; 	This work was supported by CRUK Programme Grants C483 (Grant Agency of the Czech Republic) and 6354 (Ministry of Education, Youth, and Sports of the Czech Republic) (to T. R. H.). Development of monoclonal antibodies was supported by Moravian-Biotechnology.; Supported by Grants 301/08/1468 and LC06035.	Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Craig A, 2003, EMBO REP, V4, P787, DOI 10.1038/sj.embor.embor901; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Craig Ashley L, 2003, Methods Mol Biol, V234, P171; Craig AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-195; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Finlan LE, 2006, CELL CYCLE, V5, P2489, DOI 10.4161/cc.5.21.3393; Fraser JA, 2007, BIOCHEMISTRY-US, V46, P2655, DOI 10.1021/bi061562j; Fraser JA, 2010, J BIOL CHEM, V285, P37773, DOI 10.1074/jbc.M110.143107; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Horn HF, 2004, NATURE, V427, P110, DOI 10.1038/427110a; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Hupp TR, 2007, NAT STRUCT MOL BIOL, V14, P885, DOI 10.1038/nsmb1007-885; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Maya R, 2000, ONCOGENE, V19, P3213, DOI 10.1038/sj.onc.1203658; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Nicholson J, 2010, CELL CYCLE, V9, P1878, DOI 10.4161/cc.9.10.11597; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Pospisilova S, 2004, BIOCHEM J, V378, P939, DOI 10.1042/BJ20030662; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shimizu H, 2006, BIOCHEM J, V397, P355, DOI 10.1042/BJ20051521; STEPHEN CW, 1995, J MOL BIOL, V248, P58, DOI 10.1006/jmbi.1995.0202; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200; VOJTESEK B, 1995, ONCOGENE, V10, P389; Wallace M, 2001, ONCOGENE, V20, P3597, DOI 10.1038/sj.onc.1204496; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	65	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37762	37772		10.1074/jbc.M110.143099	http://dx.doi.org/10.1074/jbc.M110.143099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851891	Green Published, hybrid			2022-12-25	WOS:000284424000068
J	Schjoldager, KTBG; Vester-Christensen, MB; Bennett, EP; Levery, SB; Schwientek, T; Yin, W; Blixt, O; Clausen, H				Schjoldager, Katrine T. -B. G.; Vester-Christensen, Malene B.; Bennett, Eric Paul; Levery, Steven B.; Schwientek, Tilo; Yin, Wu; Blixt, Ola; Clausen, Henrik			O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 POSSIBLE ROLE OF POLYPEPTIDE GalNAc-TRANSFERASE-2 IN REGULATION OF CONCENTRATIONS OF PLASMA LIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL TUMORAL CALCINOSIS; ALPHA-D-GALACTOSAMINE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; BRAIN NATRIURETIC PEPTIDE; STRUCTURAL-CHARACTERIZATION; LINKED GLYCOSYLATION; LIPID CONCENTRATIONS; ENDOTHELIAL LIPASE; HDL METABOLISM; CELL-ADHESION	The angiopoietin-like protein 3 (ANGPTL3) is an important inhibitor of the endothelial and lipoprotein lipases and a promising drug target. ANGPTL3 undergoes proprotein convertase processing (RAPR(224) down arrow TT) for activation, and the processing site contains two potential GalNAc O-glycosylation sites immediately C-terminal (TT226). We developed an in vivo model system in CHO ldlD cells that was used to show that O-glycosylation in the processing site blocked processing of ANGPTL3. Genome-wide SNP association studies have identified the polypeptide GalNAc-transferase gene, GALNT2, as a candidate gene for low HDL and high triglyceride blood levels. We hypothesized that the GalNAc-T2 transferase performed critical O-glycosylation of proteins involved in lipid metabolism. Screening of a panel of proteins known to affect lipid metabolism for potential sites glycosylated by GalNAc-T2 led to identification of Thr(226) adjacent to the proprotein convertase processing site in ANGPTL3. We demonstrated that GalNAc-T2 glycosylation of Thr(226) in a peptide with the RAPR(224) down arrow TT processing site blocks in vitro furin cleavage. The study demonstrates that ANGPTL3 activation is modulated by O-glycosylation and that this step is probably controlled by GalNAc-T2.	[Schjoldager, Katrine T. -B. G.; Vester-Christensen, Malene B.; Bennett, Eric Paul; Levery, Steven B.; Blixt, Ola; Clausen, Henrik] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Yin, Wu] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Ctr, Dallas, TX 75390 USA; [Schjoldager, Katrine T. -B. G.; Vester-Christensen, Malene B.; Bennett, Eric Paul; Levery, Steven B.; Blixt, Ola; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark; [Schwientek, Tilo] Univ Cologne, D-50923 Cologne, Germany	University of Copenhagen; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Copenhagen; University of Cologne	Clausen, H (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hclau@sund.ku.dk	Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021	Bennett, Eric/0000-0002-4976-0647; Blixt, Ola/0000-0003-4143-6276; Clausen, Henrik/0000-0002-0915-5055	Carlsberg Foundation; Alfred Benzon Foundation; Danish Research Councils; University of Copenhagen	Carlsberg Foundation(Carlsberg Foundation); Alfred Benzon Foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen	This work was supported by the Carlsberg Foundation, the Alfred Benzon Foundation, The Danish Research Councils, and a Program of Excellence from the University of Copenhagen.	Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P61, DOI 10.1016/j.bbadis.2008.09.016; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hassan H, 2000, CARBOHYDRATES CHEM B, P273, DOI DOI 10.1002/9783527618255.CH55; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Jaye M, 2004, CURR OPIN LIPIDOL, V15, P183, DOI 10.1097/00041433-200404000-00011; Jiang JJ, 2010, CLIN CHEM, V56, P959, DOI 10.1373/clinchem.2009.140558; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Li C, 2009, CURR OPIN LIPIDOL, V20, P357, DOI 10.1097/MOL.0b013e32832dd55a; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; REMALEY AT, 1993, J BIOL CHEM, V268, P6785; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; SCHINDLER PA, 1995, PROTEIN SCI, V4, P791; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; SEGER MA, 1986, J STEROID BIOCHEM, V25, P703, DOI 10.1016/0022-4731(86)90298-0; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145	43	109	111	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36293	36303		10.1074/jbc.M110.156950	http://dx.doi.org/10.1074/jbc.M110.156950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837471	Green Published, hybrid			2022-12-25	WOS:000284146100034
J	Tong, X; Muchnik, M; Chen, Z; Patel, M; Wu, N; Joshi, S; Rui, LY; Lazar, MA; Yin, L				Tong, Xin; Muchnik, Marina; Chen, Zheng; Patel, Manish; Wu, Nan; Joshi, Shree; Rui, Liangyou; Lazar, Mitchell A.; Yin, Lei			Transcriptional Repressor E4-binding Protein 4 (E4BP4) Regulates Metabolic Hormone Fibroblast Growth Factor 21 (FGF21) during Circadian Cycles and Feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WIDE EXPRESSION ANALYSIS; PPAR-ALPHA; GENE-EXPRESSION; MOUSE-LIVER; BZIP FACTOR; ERB-ALPHA; KINASE-B; CLOCK; INSULIN; RECEPTOR	Fibroblast growth factor 21 (FGF21) is a potent antidiabetic and triglyceride-lowering hormone whose hepatic expression is highly responsive to food intake. FGF21 induction in the adaptive response to fasting has been well studied, but the molecular mechanism responsible for feeding-induced repression remains unknown. In this study, we demonstrate a novel link between FGF21 and a key circadian output protein, E4BP4. Expression of Fgf21 displays a circadian rhythm, which peaks during the fasting phase and is anti-phase to E4bp4, which is elevated during feeding periods. E4BP4 strongly suppresses Fgf21 transcription by binding to a D-box element in the distal promoter region. Depletion of E4BP4 in synchronized Hepa1c1c-7 liver cells augments the amplitude of Fgf21 expression, and overexpression of E4BP4 represses FGF21 secretion from primary mouse hepatocytes. Mimicking feeding effects, insulin significantly increases E4BP4 expression and binding to the Fgf21 promoter through AKT activation. Thus, E4BP4 is a novel insulin-responsive repressor of FGF21 expression during circadian cycles and feeding.	[Tong, Xin; Muchnik, Marina; Chen, Zheng; Patel, Manish; Rui, Liangyou; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wu, Nan; Joshi, Shree; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Wu, Nan; Joshi, Shree; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	chen, zheng/J-4600-2014; Lazar, Mitchell A/AAF-3738-2019	chen, zheng/0000-0003-2161-6106; TONG, XIN/0000-0002-4832-8940	National Institutes of Health [K99/R00 DK 077449, R01 DK45586]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, K99DK077449, R00DK077449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K99/R00 DK 077449 (to L. Y.) and R01 DK45586 (to M. A. L.).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Ando H, 2006, BIOCHEM BIOPH RES CO, V346, P1297, DOI 10.1016/j.bbrc.2006.06.044; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bozek K, 2007, GENOME INFORM SER, V18, P65; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; COWELL IG, 1994, NUCLEIC ACIDS RES, V22, P59, DOI 10.1093/nar/22.1.59; Cowell IG, 1996, NUCLEIC ACIDS RES, V24, P3607, DOI 10.1093/nar/24.18.3607; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Duguay D, 2009, CHRONOBIOL INT, V26, P1479, DOI 10.3109/07420520903497575; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Eto K, 2010, DIABETES RES CLIN PR, V89, P52, DOI 10.1016/j.diabres.2010.03.019; Feillet CA, 2006, J PHYSIOL-PARIS, V100, P252, DOI 10.1016/j.jphysparis.2007.05.002; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Fukuda H, 1999, FEBS LETT, V464, P113, DOI 10.1016/S0014-5793(99)01700-7; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hardin Paul E, 2003, Novartis Found Symp, V253, P140; HARDIN PE, 2003, NOVART FDN SYMP, V253, P150; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Innominato PF, 2010, ADV DRUG DELIVER REV, V62, P979, DOI 10.1016/j.addr.2010.06.002; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kotaka M, 2008, NEUROSCI RES, V60, P307, DOI 10.1016/j.neures.2007.11.014; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE126, DOI 10.1152/ajpendo.00020.2010; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohno T, 2007, BIOCHEM BIOPH RES CO, V354, P1010, DOI 10.1016/j.bbrc.2007.01.084; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wu X, 2009, INT J OBESITY, V33, P971, DOI 10.1038/ijo.2009.137; Yang F, 2009, BIOCHEM BIOPH RES CO, V380, P22, DOI 10.1016/j.bbrc.2008.12.186; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	79	72	73	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36401	36409		10.1074/jbc.M110.172866	http://dx.doi.org/10.1074/jbc.M110.172866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851878	Green Published, hybrid			2022-12-25	WOS:000284146100031
J	Daily, NJ; Boswell, KL; James, DJ; Martin, TFJ				Daily, Neil J.; Boswell, Kristin L.; James, Declan J.; Martin, Thomas F. J.			Novel Interactions of CAPS (Ca2+-dependent Activator Protein for Secretion) with the Three Neuronal SNARE Proteins Required for Vesicle Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; COMPLEX-FORMATION; 3-DIMENSIONAL STRUCTURE; REGULATED EXOCYTOSIS; MUN DOMAIN; SYNTAXIN; BINDING; CORE; SYNAPTOBREVIN; PHOSPHORYLATION	CAPS (aka CADPS) is required for optimal vesicle exocytosis in neurons and endocrine cells where it functions to prime the exocytic machinery for Ca2+-triggered fusion. Fusion is mediated by trans complexes of the SNARE proteins VAMP-2, syntaxin-1, and SNAP-25 that bridge vesicle and plasma membrane. CAPS promotes SNARE complex formation on liposomes, but the SNARE binding properties of CAPS are unknown. The current work revealed that CAPS exhibits high affinity binding to syntaxin-1 and SNAP-25 and moderate affinity binding to VAMP-2. CAPS binding is specific for a subset of exocytic SNARE protein isoforms and requires membrane integration of the SNARE proteins. SNARE protein binding by CAPS is novel and mediated by interactions with the SNARE motifs in the three proteins. The C-terminal site for CAPS binding on syntaxin-1 does not overlap the Munc18-1 binding site and both proteins can coreside on membrane-integrated syntaxin-1. As expected for a C-terminal binding site on syntaxin-1, CAPS stimulates SNARE-dependent liposome fusion with N-terminal truncated syntaxin-1 but exhibits impaired activity with C-terminal syntaxin-1 mutants. Overall the results suggest that SNARE complex formation promoted by CAPS may be mediated by direct interactions of CAPS with each of the three SNARE proteins required for vesicle exocytosis.	[Daily, Neil J.; Boswell, Kristin L.; James, Declan J.; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	tfmartin@wisc.edu			National Institutes of Health [DK040428, S10 RR13790]; AHA; National Science Foundation [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK040428 (to T.F.J.M.) and by an AHA fellowship (to D.J.J.).; SPR data were obtained at the University of Wisconsin Biophysics Instrumentation Facility established with grants from the National Science Foundation (BIR-9512577) and National Institutes of Health (S10 RR13790).	Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 1997, J BIOL CHEM, V272, P2520; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nojiri M, 2009, J BIOL CHEM, V284, P18707, DOI 10.1074/jbc.M109.017483; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878	48	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35320	35329		10.1074/jbc.M110.145169	http://dx.doi.org/10.1074/jbc.M110.145169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826818	hybrid, Green Published			2022-12-25	WOS:000283845300010
J	Shen, SD; Chuck, MI; Zhu, MH; Fuller, DM; Yang, CWO; Zhang, WG				Shen, Shudan; Chuck, Mariana I.; Zhu, Minghua; Fuller, Deirdre M.; Yang, Chih-wen Ou; Zhang, Weiguo			The Importance of LAT in the Activation, Homeostasis, and Regulatory Function of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; ADAPTER PROTEINS; ANTIGEN RECEPTOR; LYMPHOPROLIFERATIVE DISORDER; SIGNAL-TRANSDUCTION; MUTANT MICE; TCR-ZETA; PROLIFERATION; MUTATION; RAS	LAT (linker for activation of T cells) is a transmembrane adaptor protein that plays an essential role in TCR-mediated signaling and thymocyte development. Because LAT-deficient mice have an early block in thymocyte development, we utilized an inducible system to delete LAT in primary T cells to study LAT function in T cell activation, homeostasis, and survival. Deletion of LAT caused primary T cells to become unresponsive to stimulation from the TCR and impaired T cell homeostatic proliferation and long term survival. Furthermore, deletion of LAT led to reduced expression of Foxp3, CTLA-4, and CD25 in T-reg cells and impaired their function. Consequently, mice with LAT deleted developed a lymphoproliferative syndrome similar to that in LATY136F mice, although less severe. Our data implicate that LAT has positive and negative roles in the regulation of mature T cells.	[Shen, Shudan; Chuck, Mariana I.; Zhu, Minghua; Fuller, Deirdre M.; Yang, Chih-wen Ou; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Zhang, WG (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Box 3010, Durham, NC 27710 USA.	zhang033@mc.duke.edu	Zhu, Minghua/ABH-2671-2020		National Institutes of Health [AI048674, AI056156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056156, R01AI056156, R01AI048674, R56AI048674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI048674 and AI056156.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Archambaud C, 2009, J IMMUNOL, V182, P2680, DOI 10.4049/jimmunol.0803257; Chau LA, 1999, J IMMUNOL, V163, P1853; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 2000, BLOOD, V95, P3199; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu MH, 2006, IMMUNITY, V25, P757, DOI 10.1016/j.immuni.2006.08.025	49	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35393	35405		10.1074/jbc.M110.145052	http://dx.doi.org/10.1074/jbc.M110.145052			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837489	Green Published, hybrid			2022-12-25	WOS:000283845300017
J	Wilhelm, AJ; Zabalawi, M; Owen, JS; Shah, D; Grayson, JM; Major, AS; Bhat, S; Gibbs, DP; Thomas, MJ; Sorci-Thomas, MG				Wilhelm, Ashley J.; Zabalawi, Manal; Owen, John S.; Shah, Dharika; Grayson, Jason M.; Major, Amy S.; Bhat, Shaila; Gibbs, Dwayne P., Jr.; Thomas, Michael J.; Sorci-Thomas, Mary G.			Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr-/-, ApoA-I-/- Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; WILD-TYPE; CHOLESTEROL HOMEOSTASIS; ENDOTHELIAL FUNCTION; DENDRITIC CELLS; INFLAMMATION; ATHEROSCLEROSIS; HDL; SUPPRESSION	The immune system is complex, with multiple layers of regulation that serve to prevent the production of self-antigens. One layer of regulation involves regulatory T cells (Tregs) that play an essential role in maintaining peripheral self-tolerance. Patients with autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis have decreased levels of HDL, suggesting that apoA-I concentrations may be important in preventing autoimmunity and the loss of self-tolerance. In published studies, hypercholesterolemic mice lacking HDL apoA-I or LDLr-/-, apoA-I-/- (DKO), exhibit characteristics of autoimmunity in response to an atherogenic diet. This phenotype is characterized by enlarged cholesterol-enriched lymph nodes (LNs), as well as increased T cell activation, proliferation, and the production of autoantibodies in plasma. In this study, we investigated whether treatment of mice with lipid-free apoA-I could attenuate the autoimmune phenotype. To do this, DKO mice were first fed an atherogenic diet containing 0.1% cholesterol, 10% fat for 6 weeks, after which treatment with apoA-I was begun. Subcutaneous injections of 500 mu g of lipid-free apoA-I was administered every 48 h during the treatment phase. These and control mice were maintained for an additional 6 weeks on the diet. At the end of the 12-week study, DKO mice showed decreased numbers of LN immune cells, whereas Tregs were proportionately increased. Accompanying this increase in Tregs was a decrease in the percentage of effector/effector memory T cells. Furthermore, lipid accumulation in LN and skin was reduced. These results suggest that treatment with apoA-I reduces inflammation in DKO mice by augmenting the effectiveness of the LN Treg response.	[Sorci-Thomas, Mary G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27157 USA; [Owen, John S.; Thomas, Michael J.; Sorci-Thomas, Mary G.] Wake Forest Univ, Bowman Gray Sch Med, Lipid Sci Res Ctr, Winston Salem, NC 27157 USA; [Grayson, Jason M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem Microbiol & Immunol, Winston Salem, NC 27157 USA; [Major, Amy S.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37240 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Vanderbilt University	Sorci-Thomas, MG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	msthomas@wfubmc.edu		Sorci-Thomas, Mary/0000-0002-6464-5006	National Institutes of Health [HL-49373, HL-64163, A1-068952, HL-089310, SR25HL092618-02]; NHLBI [T32HL091797]; American Heart Association; American Cancer Society [RSG-04-066-01 MBC]; Lupus Research Institute, New York; American Heart Association [09GRNT2280053]; North Carolina Biotechnology Shared Instrumentation Program; Winston-Salem Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092618, P01HL049373, R01HL088364, R01HL089310, T32HL091797, R01HL064163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Lupus Research Institute, New York; American Heart Association(American Heart Association); North Carolina Biotechnology Shared Instrumentation Program; Winston-Salem Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-49373 and HL-64163 (to M. G. S.-T.).; Supported by National Institutes of Health Training Grant T32HL091797 from the NHLBI and in part by an American Heart Association predoctoral fellowship.; Supported by National Institutes of Health Grant A1-068952 and American Cancer Society Research Scholar Grant RSG-04-066-01 MBC.; Supported by National Institutes of Health Grant HL-089310 and The Lupus Research Institute, New York.; Supported by National Institutes of Health Training Grant SR25HL092618-02.; Supported by American Heart Association Grant 09GRNT2280053.; The Trace MS was purchased with funds from the North Carolina Biotechnology Shared Instrumentation Program and the Winston-Salem Foundation.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bisoendial RJ, 2003, CIRCULATION, V107, P2944, DOI 10.1161/01.CIR.0000070934.69310.1A; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Cao D, 2004, ARTHRITIS RES THER, V6, pS14, DOI 10.1186/ar1084; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Deng GM, 2010, J IMMUNOL, V184, P7154, DOI 10.4049/jimmunol.0902514; Escarcega RO, 2006, AUTOIMMUN REV, V6, P48, DOI 10.1016/j.autrev.2006.07.001; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; KALUZNY MA, 1985, J LIPID RES, V26, P135; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Mallat Z, 2009, J LIPID RES, V50, pS364, DOI 10.1194/jlr.R800092-JLR200; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1978, LIPIDS, V13, P914, DOI 10.1007/BF02533850; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Monte K, 2008, ARTHRITIS RHEUM-US, V58, P3730, DOI 10.1002/art.24048; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, pE36; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; NICHOLS AV, 1976, BIOCHIM BIOPHYS ACTA, V446, P226, DOI 10.1016/0005-2795(76)90113-6; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Owen JS, 2007, J LIPID RES, V48, P226, DOI 10.1194/jlr.D600031-JLR200; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Puranik R, 2008, ATHEROSCLEROSIS, V196, P240, DOI 10.1016/j.atherosclerosis.2007.05.008; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shaw J, 2008, CIRC RES, V103, pE63; Sorci-Thomas MG, 2000, J BIOL CHEM, V275, P12156, DOI 10.1074/jbc.275.16.12156; SorciThomas MG, 1996, J LIPID RES, V37, P673; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Stanic AK, 2006, P NATL ACAD SCI USA, V103, P7018, DOI 10.1073/pnas.0602311103; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vila J, 2009, CURR OPIN HEMATOL, V16, P274, DOI 10.1097/MOH.0b013e32832a9a01; Wade NS, 2010, LUPUS, V19, P34, DOI 10.1177/0961203309345785; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Wang L, 2010, CYTOKINE, V49, P194, DOI 10.1016/j.cyto.2009.08.008; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Wing K, 2003, EUR J IMMUNOL, V33, P579, DOI 10.1002/eji.200323701; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Woo JMP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3020; Zabalawi M, 2003, AM J PATHOL, V163, P1201, DOI 10.1016/S0002-9440(10)63480-3; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	63	93	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36158	36169		10.1074/jbc.M110.134130	http://dx.doi.org/10.1074/jbc.M110.134130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833724	hybrid, Green Published			2022-12-25	WOS:000283845300092
J	Lukov, GL; Goodell, MA				Lukov, Georgi L.; Goodell, Margaret A.			LYL1 Degradation by the Proteasome Is Directed by a N-Terminal PEST Rich Site in a Phosphorylation-Independent Manner	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR LYL1; ADULT HEMATOPOIETIC STEM; T-CELL; CHROMOSOMAL TRANSLOCATION; PROTEIN-DEGRADATION; GENE; SCL; MOTIF; PROTEOLYSIS	Background: The Lymphoblastic leukemia 1 (LYL1) gene is a proto-oncogenic transcription factor found upregulated in patients with T-cell acute lymphoblastic leukemia (T-cell ALL). Initially, the upregulation was described to be as a result of a translocation. However, further studies revealed that transcriptional upregulation of LYL1could also occur without translocations. In addition, post-translational mechanisms, such as protein degradation could influence LYL1 expression as well. Methodology/Principal Findings: In this study, we considered possible post-translational regulation of Lyl1, and investigated fundamental mechanisms governing LYL1 degradation in cell-based culture assays. We identify a PEST sequence motif located in the N-terminus of LYL1, which determines the efficiency of LYL1 degradation by the proteasome. The absence of the PEST degradation site leads to accumulation or upregulation of LYL1. We also show that LYL1 is phosphorylated by MAPK at S-36, and determined that proteasomal degradation of LYL1 occurs in a phosphorylation-independent manner. Conclusions/Significance: Understanding LYL1 degradation is a step forward not only towards deciphering the normal function and regulation of LYL1, but could suggest post-translational mechanisms for upregulation of LYL1 that may contribute to its oncogenic role.	[Lukov, Georgi L.; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lukov, Georgi L.; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lukov, GL (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	goodell@bcm.edu	Lukov, Georgi/AAI-8544-2021	Goodell, Margaret A./0000-0003-1111-2932	National Institutes of Health [DK58192, HL081007, P50CA126752]; NATIONAL CANCER INSTITUTE [P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The financial support for this work was provided by National Institutes of Health grants DK58192, HL081007, and P50CA126752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bruckner R, 2000, CANCER GENET CYTOGEN, V119, P77, DOI 10.1016/S0165-4608(99)00214-9; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Clarke DJ, 2002, CELL CYCLE, V1, P231, DOI 10.4161/cc.1.4.129; CLEARY ML, 1988, J EXP MED, V167, P682, DOI 10.1084/jem.167.2.682; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DIMAURO I, 2009, BRIT J HAEMATOL, V146, P689; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hirai I, 2004, ONCOGENE, V23, P5124, DOI 10.1038/sj.onc.1207658; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee SY, 2005, LEUKEMIA, V19, P1841, DOI 10.1038/sj.leu.2403896; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Meng YS, 2005, LEUKEMIA, V19, P1941, DOI 10.1038/sj.leu.2403836; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; NAGEL S, 2009, LEUK RES; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Terme JM, 2009, BLOOD, V113, P6695, DOI 10.1182/blood-2008-07-166835; VISVADER J, 1991, ONCOGENE, V6, P187; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12692	10.1371/journal.pone.0012692	http://dx.doi.org/10.1371/journal.pone.0012692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844761	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687300023
J	Corbo, V; Ritelli, R; Barbi, S; Funel, N; Campani, D; Bardelli, A; Scarpa, A				Corbo, Vincenzo; Ritelli, Rossana; Barbi, Stefano; Funel, Niccola; Campani, Daniela; Bardelli, Alberto; Scarpa, Aldo			Mutational Profiling of Kinases in Human Tumours of Pancreatic Origin Identifies Candidate Cancer Genes in Ductal and Ampulla of Vater Carcinomas	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; FACTOR RECEPTOR EGFR; COLORECTAL CANCERS; SOMATIC MUTATIONS; HUMAN BREAST; GERMLINE MUTATIONS; SOLID TUMORS; PIK3CA GENE; K-RAS; GROWTH	Background: Protein kinases are key regulators of cellular processes (such as proliferation, apoptosis and invasion) that are often deregulated in human cancers. Accordingly, kinase genes have been the first to be systematically analyzed in human tumors leading to the discovery that many oncogenes correspond to mutated kinases. In most cases the genetic alterations translate in constitutively active kinase proteins, which are amenable of therapeutic targeting. Tumours of the pancreas are aggressive neoplasms for which no effective therapeutic strategy is currently available. Methodology/Principal Findings: We conducted a DNA-sequence analysis of a selected set of 35 kinase genes in a panel of 52 pancreatic exocrine neoplasms, including 36 pancreatic ductal adenocarcinoma, and 16 ampulla of Vater cancer. Among other changes we found somatic mutations in ATM, EGFR, EPHA3, EPHB2, and KIT, none of which was previously described in cancers. Conclusions/Significance: Although the alterations identified require further experimental evaluation, the localization within defined protein domains indicates functional relevance for most of them. Some of the mutated genes, including the tyrosine kinases EPHA3 and EPHB2, are clearly amenable to pharmacological intervention and could represent novel therapeutic targets for these incurable cancers.	[Corbo, Vincenzo; Ritelli, Rossana; Scarpa, Aldo] Univ Verona, ARC NET Res Ctr, Policlin GB Rossi, I-37100 Verona, Italy; [Barbi, Stefano; Scarpa, Aldo] Univ Verona, Dept Pathol, Policlin GB Rossi, I-37100 Verona, Italy; [Funel, Niccola; Campani, Daniela] Univ Pisa, Dept Pathol, Pisa, Italy; [Bardelli, Alberto] Univ Torino, Sch Med, Mol Genet Lab, Inst Canc Res & Treatment, Candiolo, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Corbo, V (corresponding author), Univ Verona, ARC NET Res Ctr, Policlin GB Rossi, I-37100 Verona, Italy.	aldo.scarpa@univr.it	scarpa, aldo/K-6832-2016; Corbo, Vincenzo/J-7754-2016; BARDELLI, Alberto/J-9721-2018	scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Funel, Niccola/0000-0002-5028-2363; CAMPANI, DANIELA/0000-0001-5987-734X; BARDELLI, Alberto/0000-0003-1647-5070	Associazione Italiana Ricerca Cancro (AIRC); Fondazione CariParo; Fondazione Monte dei Paschi di Siena; Italian Ministry of Health, Rome, Italy; European Community [PL018771]	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione CariParo(Fondazione Cariparo); Fondazione Monte dei Paschi di Siena; Italian Ministry of Health, Rome, Italy(Ministry of Health, Italy); European Community(European Commission)	This work was supported by grants from Associazione Italiana Ricerca Cancro (AIRC, http://www.airc.it/), Fondazione CariParo (www.fondazionecariparo.it), Fondazione Monte dei Paschi di Siena (http://www.fondazionemps.it/); Italian Ministry of Health, Rome, Italy (http://www.salute.gov.it/); European Community FP VI Program Grant PL018771 (MolDiagPaca, http://www.moldiagpaca.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bateman AC, 2008, PANCREAS, V36, P76, DOI 10.1097/mpa.0b013e3181469881; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boultwood J, 2001, J CLIN PATHOL, V54, P512, DOI 10.1136/jcp.54.7.512; Buttitta F, 2006, INT J CANCER, V119, P2586, DOI 10.1002/ijc.22143; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P55, DOI 10.1007/s00534-007-1280-z; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Immervoll H, 2006, VIRCHOWS ARCH, V448, P788, DOI 10.1007/s00428-006-0191-8; Ishimura N, 2003, CANCER LETT, V199, P169, DOI 10.1016/S0304-3835(03)00384-7; Jang JH, 2001, CANCER RES, V61, P3541; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leary A, 2007, CANCER INVEST, V25, P347, DOI 10.1080/07357900701259694; Lee J, 2007, CANCER-AM CANCER SOC, V109, P1561, DOI 10.1002/cncr.22559; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Li Junsheng, 2003, Mol Cancer, V2, P32, DOI 10.1186/1476-4598-2-32; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Menoyo A, 2001, CANCER RES, V61, P7727; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorio C, 2001, VIRCHOWS ARCH, V438, P154, DOI 10.1007/s004280000343; Steeghs N, 2007, ANN SURG ONCOL, V14, P942, DOI 10.1245/s10434-006-9227-1; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tzeng CWD, 2007, SURGERY, V141, P464, DOI 10.1016/j.surg.2006.09.009; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Zamo A, 2007, J MOL DIAGN, V9, P151, DOI 10.2353/jmoldx.2007.060041	51	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12653	10.1371/journal.pone.0012653	http://dx.doi.org/10.1371/journal.pone.0012653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838624	Green Submitted, Green Published, gold			2022-12-25	WOS:000281687100014
J	Azuma, M; Sawahata, R; Akao, Y; Ebihara, T; Yamazaki, S; Matsumoto, M; Hashimoto, M; Fukase, K; Fujimoto, Y; Seya, T				Azuma, Masahiro; Sawahata, Ryoko; Akao, Yuusuke; Ebihara, Takashi; Yamazaki, Sayuri; Matsumoto, Misako; Hashimoto, Masahito; Fukase, Koichi; Fujimoto, Yukari; Seya, Tsukasa			The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NATURAL-KILLER-CELLS; STAPHYLOCOCCUS-AUREUS; CUTTING EDGE; BACTERIAL LIPOPROTEINS; MYCOBACTERIUM-BOVIS; ADAPTER MOLECULE; RECOGNITION; TLR2; ENHANCEMENT	Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naive NK cells is fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S[ 2,3-bis(palmitoyl) propyl] cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK cell activation was evaluated by three criteria: IFN-gamma production, up-regulation of NK activation markers and cytokines, and NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence. Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides critically affects the potential for NK activation.	[Azuma, Masahiro; Sawahata, Ryoko; Akao, Yuusuke; Ebihara, Takashi; Yamazaki, Sayuri; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hashimoto, Masahito] Kagoshima Univ, Dept Nanostruct & Adv Mat, Kagoshima 890, Japan; [Fukase, Koichi; Fujimoto, Yukari] Osaka Univ, Dept Chem, Grad Sch Sci, Toyonaka, Osaka 560, Japan	Hokkaido University; Kagoshima University; Osaka University	Azuma, M (corresponding author), Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Seya, Tsukasa/A-4336-2012; Fujimoto, Yukari/M-7282-2014	Ebihara, Takashi/0000-0002-6056-3230; Fujimoto, Yukari/0000-0001-5320-3192	Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Yakult Foundation; Waxmann Foundation; MEXT	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Yakult Foundation; Waxmann Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan, and by the Yakult and Waxmann Foundations. Financial support by the Sapporo Biocluster "Bio-S" the Knowledge Cluster Initiative of the MEXT, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2009, CANCER SCI, V100, P1494, DOI 10.1111/j.1349-7006.2009.01188.x; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Ebihara Takashi, 2009, Current Immunology Reviews, V5, P200; Fujimoto Y, 2009, CHEMBIOCHEM, V10, P2311, DOI 10.1002/cbic.200900242; Fujita M, 2003, J IMMUNOL, V171, P3675, DOI 10.4049/jimmunol.171.7.3675; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Granucci F, 2008, CELL MOL LIFE SCI, V65, P1683, DOI 10.1007/s00018-008-8009-2; Haller D, 2002, CLIN DIAGN LAB IMMUN, V9, P649, DOI 10.1128/CDLI.9.3.649-657.2002; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; KANG JY, 2009, IMMUNITY        1118; LINDGREN A, 2010, INNATE IMMUN    0203; Marcenaro E, 2008, INT IMMUNOL, V20, P1155, DOI 10.1093/intimm/dxn073; Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; METZGER J, 1991, J MED CHEM, V34, P1969, DOI 10.1021/jm00111a008; MIAN MF, 2010, MOL THER        0504; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Seya T, 2010, CANCER SCI, V101, P313, DOI 10.1111/j.1349-7006.2009.01442.x; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TANAKA H, 1988, CANCER RES, V48, P1456; Tawaratsumida K, 2009, J BIOL CHEM, V284, P9147, DOI 10.1074/jbc.M900429200; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	40	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12550	10.1371/journal.pone.0012550	http://dx.doi.org/10.1371/journal.pone.0012550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824059	Green Published, gold			2022-12-25	WOS:000281480900028
J	Jud, C; Hayoz, A; Albrecht, U				Jud, Corinne; Hayoz, Antoinette; Albrecht, Urs			High Amplitude Phase Resetting in Rev-Erb alpha/Per1 Double Mutant Mice	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; MPER2; LIGHT; RHYTHMS; TRANSCRIPTION; GENE; CRYPTOCHROME; OSCILLATORS; EXPRESSION; INDUCTION	Over time, organisms developed various strategies to adapt to their environment. Circadian clocks are thought to have evolved to adjust to the predictable rhythms of the light-dark cycle caused by the rotation of the Earth around its own axis. The rhythms these clocks generate persist even in the absence of environmental cues with a period of about 24 hours. To tick in time, they continuously synchronize themselves to the prevailing photoperiod by appropriate phase shifts. In this study, we disrupted two molecular components of the mammalian circadian oscillator, Rev-Erba and Period1 (Per1). We found that mice lacking these genes displayed robust circadian rhythms with significantly shorter periods under constant darkness conditions. Strikingly, they showed high amplitude resetting in response to a brief light pulse at the end of their subjective night phase, which is rare in mammals. Surprisingly, Cry1, a clock component not inducible by light in mammals, became slightly inducible in these mice. Taken together, Rev-Erba and Per1 may be part of a mechanism preventing drastic phase shifts in mammals.	[Jud, Corinne; Hayoz, Antoinette; Albrecht, Urs] Univ Fribourg, Biochem Unit, Dept Med, CH-1700 Fribourg, Switzerland	University of Fribourg	Jud, C (corresponding author), Univ Fribourg, Adolphe Merkle Inst, Marly, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676	Swiss National Science Foundation; European Union; state of Fribourg (Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); state of Fribourg (Switzerland)	This work has been supported by the Swiss National Science Foundation, the European Union FP6 Integrated Project EUCLOCK and the state of Fribourg (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Aschoff, 1965, CIRCADIAN CLOCKS, P95; ASCHOFF J, 1969, AEROSPACE MED, V40, P844; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Johnson Carl Hirschie, 1992, P209; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Winfree A., 1980, BIOMATHEMATICS; WINFREE AT, 1970, J THEOR BIOL, V28, P327, DOI 10.1016/0022-5193(70)90075-5; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12540	10.1371/journal.pone.0012540	http://dx.doi.org/10.1371/journal.pone.0012540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824053	Green Published, gold, Green Submitted			2022-12-25	WOS:000281480900022
J	Ward, C; Kuehn, D; Burden, RE; Gormley, JA; Jaquin, TJ; Gazdoiu, M; Small, D; Bicknell, R; Johnston, JA; Scott, CJ; Olwill, SA				Ward, Claire; Kuehn, Diana; Burden, Roberta E.; Gormley, Julie A.; Jaquin, Thomas J.; Gazdoiu, Mihaela; Small, Donna; Bicknell, Roy; Johnston, James A.; Scott, Christopher J.; Olwill, Shane A.			Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR EXPRESSION; TUMOR-GROWTH; BEVACIZUMAB; INVASION; MODEL; IRINOTECAN	Background: Angiogenesis is a key hallmark of tumourigenesis and its inhibition is a proven strategy for the development of novel anti-cancer therapeutics. An important aspect of early angiogenesis is the co-ordinated migration and invasion of endothelial cells through the hypoxic tumour tissue. Cathepsin S has been shown to play an important role in angiogenesis as has vascular endothelial growth factor (VEGF). We sought to assess the anti-angiogenic effect of Fsn0503, a novel cathepsin S inhibitory antibody, when combined with anti-VEGF on vascular development. Methodology/Principal Findings: Cathepsin S expression and secretion from endothelial cells was characterised using RTPCR and western blotting. We further show that cathepsin S promotes pericellular hydrolysis of extracellular matrix components in the tumour microenvironment and facilitates endothelial invasion. The cathepsin S inhibitory antibody, Fsn0503, blocks extracellular proteolysis, inhibiting endothelial invasion and tube formation in cell-based assays. The antiangiogenic effects of Fsn0503 were also shown in vivo where it significantly retarded the development of vasculature in human xenograft models. Furthermore, when Fsn0503 was combined with an anti-VEGF antibody, a synergistic inhibition of microvascular development was observed. Conclusions/Significance: Taken together, this data demonstrates that the antibody-mediated targeting of cathepsin S represents a novel method of inhibiting angiogenesis. Furthermore, when used in combination with anti-VEGF therapies, Fsn0503 has the potential to significantly enhance current treatments of tumour neovascularisation and may also be of use in the treatment of other conditions associated with inappropriate angiogenesis.	[Ward, Claire; Kuehn, Diana; Burden, Roberta E.; Gormley, Julie A.; Jaquin, Thomas J.; Gazdoiu, Mihaela; Small, Donna; Olwill, Shane A.] Fus Antibodies Ltd, Drug Discovery, Belfast, Antrim, North Ireland; [Burden, Roberta E.; Small, Donna; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent, Sch Immun & Infect, Birmingham, W Midlands, England; [Johnston, James A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent, Sch Canc Studies, Birmingham, W Midlands, England	Queens University Belfast; University of Birmingham; Queens University Belfast; University of Birmingham	Ward, C (corresponding author), Fus Antibodies Ltd, Drug Discovery, Belfast, Antrim, North Ireland.	c.scott@qub.ac.uk; shane.olwill@fusionantibodies.com	Jaquin, Thomas/AAF-8142-2020	Bicknell, Roy/0000-0002-0941-8919; Small, Donna/0000-0001-8995-2590	Fusion Antibodies Ltd. Scientists at Fusion Antibodies	Fusion Antibodies Ltd. Scientists at Fusion Antibodies	This work was funded by Fusion Antibodies Ltd. Scientists at Fusion Antibodies in conjunction with academic collaborators designed the study, collected and analysed data and prepared the manuscript for publication.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Amaya H, 1997, CANCER LETT, V119, P227, DOI 10.1016/S0304-3835(97)00280-2; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Bergsland E, 2004, ONCOLOGIST, V9, P36, DOI 10.1634/theoncologist.9-suppl_1-36; Brown NS, 2005, BRIT J CANCER, V92, P1696, DOI 10.1038/sj.bjc.6602522; Burden RE, 2008, MOL CANCER THER, V7, P538, DOI 10.1158/1535-7163.MCT-07-0528; Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Drevs J, 2002, CANCER RES, V62, P4015; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JORDANS S, 2009, BMC BIOCH, V22, P10; Lee CG, 2000, CANCER RES, V60, P5565; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ryschich E, 2006, CANCER RES, V66, P198, DOI 10.1158/0008-5472.CAN-05-1636; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SHOJAEI F, CANC RES, V68, P5501; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200	26	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12543	10.1371/journal.pone.0012543	http://dx.doi.org/10.1371/journal.pone.0012543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824056	Green Published, Green Submitted, gold			2022-12-25	WOS:000281480900024
J	Schaller, F; Fernandes, AM; Hodler, C; Munch, C; Pasantes, JJ; Rietschel, W; Schempp, W				Schaller, Felix; Fernandes, Antonio M.; Hodler, Christine; Muench, Claudia; Pasantes, Juan J.; Rietschel, Wolfram; Schempp, Werner			Y Chromosomal Variation Tracks the Evolution of Mating Systems in Chimpanzee and Bonobo	PLOS ONE			English	Article							PAN-PANISCUS; CAPTIVE BONOBOS; MALE-DOMINANCE; GENE; SEX; TROGLODYTES; HOMINOIDS; TSPY; SIZE; APES	The male-specific regions of the Y chromosome (MSY) of the human and the chimpanzee (Pan troglodytes) are fully sequenced. The most striking difference is the dramatic rearrangement of large parts of their respective MSYs. These non-recombining regions include ampliconic gene families that are known to be important for male reproduction, and are consequently under significant selective pressure. However, whether the published Y-chromosomal pattern of ampliconic fertility genes is invariable within P. troglodytes is an open but fundamental question pertinent to discussions of the evolutionary fate of the Y chromosome in different primate mating systems. To solve this question we applied fluorescence in situ hybridisation (FISH) of testis-specific expressed ampliconic fertility genes to metaphase Y chromosomes of 17 chimpanzees derived from 11 wild-born males and 16 bonobos representing seven wild-born males. We show that of eleven P. troglodytes Y-chromosomal lines, ten Y-chromosomal variants were detected based on the number and arrangement of the ampliconic fertility genes DAZ (deleted in azoospermia) and CDY (chromodomain protein Y)-a so-far never-described variation of a species' Y chromosome. In marked contrast, no variation was evident among seven Y-chromosomal lines of the bonobo, P. paniscus, the chimpanzee's closest living relative. Although, loss of variation of the Y chromosome in the bonobo by a founder effect or genetic drift cannot be excluded, these contrasting patterns might be explained in the context of the species' markedly different social and mating behaviour. In chimpanzees, multiple males copulate with a receptive female during a short period of visible anogenital swelling, and this may place significant selection on fertility genes. In bonobos, however, female mate choice may make sperm competition redundant (leading to monomorphism of fertility genes), since ovulation in this species is concealed by the prolonged anogenital swelling, and because female bonobos can occupy high-ranking positions in the group and are thus able to determine mate choice more freely.	[Schaller, Felix; Fernandes, Antonio M.; Hodler, Christine; Muench, Claudia; Pasantes, Juan J.; Schempp, Werner] Univ Freiburg, Inst Human Genet, Freiburg, Germany; [Pasantes, Juan J.] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Rietschel, Wolfram] Wilhelma Zool Bot Garten, Stuttgart, Germany	University of Freiburg; Universidade de Vigo	Schaller, F (corresponding author), Univ Freiburg, Inst Human Genet, Freiburg, Germany.	werner.schempp@uniklinik-freiburg.de		Pasantes, Juan J/0000-0001-6515-3946	Deutsche Forschungsgemeinschaft [SCHE 214/8-1/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SCHE 214/8-1/8-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begun DR, 2005, AM J PHYS ANTHROPOL, P72; BOESCH C, 1996, SOCIAL GROUPING TAI; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dixson AF, 2004, PHYSIOL BEHAV, V83, P361, DOI 10.1016/j.physbeh.2004.08.022; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Glaser B, 1998, MAMM GENOME, V9, P226, DOI 10.1007/s003359900730; Glaser B, 1997, CHROMOSOME RES, V5, P167, DOI 10.1023/A:1018490713273; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HASEGAWA T, 1990, SPERM COMPETITION MA; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kano T., 1992, LAST APE PYGMY CHIMP; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Marvan R, 2006, FOLIA PRIMATOL, V77, P364, DOI 10.1159/000093702; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; Nishida T., 1979, GREAT APES, P73; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; PEREBOOM JJM, 2008, INT STUDBOOK BONOBO; Perry GH, 2007, MOL BIOL EVOL, V24, P853, DOI 10.1093/molbev/msm002; Reinartz GE, 2000, MOL ECOL, V9, P315, DOI 10.1046/j.1365-294x.2000.00852.x; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Sannen A, 2003, BEHAVIOUR, V140, P683, DOI 10.1163/156853903322149504; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; Schmidt J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005288; Shaffer LG, 2009, INT SYST HUM CYT NOM; Skaletsky H, 2003, NATURE, V423, P855; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Thompson JAM, 2003, PRIMATES, V44, P191, DOI 10.1007/s10329-002-0029-1; Tutin C E, 1980, J Reprod Fertil Suppl, VSuppl 28, P43; Tyler-Smith C, 2006, NAT GENET, V38, P141, DOI 10.1038/ng0206-141; Van Coillie S, 2008, ANIM CONSERV, V11, P306, DOI 10.1111/j.1469-1795.2008.00186.x; WEBER B, 1986, CYTOGENET CELL GENET, V43, P72, DOI 10.1159/000132300; Yu N, 2003, GENETICS, V164, P1511; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; ZIHLMAN AL, 1978, NATURE, V275, P744, DOI 10.1038/275744a0; ZIHLMAN AL, 1978, FOLIA PRIMATOL, V29, P86, DOI 10.1159/000155830	49	10	10	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12482	10.1371/journal.pone.0012482	http://dx.doi.org/10.1371/journal.pone.0012482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824190	Green Published, Green Submitted, gold			2022-12-25	WOS:000281456100007
J	Yi, XF; Cai, YD; He, ZS; Cui, WR; Kong, XY				Yi, Xianfu; Cai, Yu-Dong; He, Zhisong; Cui, WeiRen; Kong, Xiangyin			Prediction of Nucleosome Positioning Based on Transcription Factor Binding Sites	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; DNA; YEAST; SEQUENCE; GENE; ORGANIZATION; ELONGATION; OCCUPANCY; REGIONS; BARRIER	Background: The DNA of all eukaryotic organisms is packaged into nucleosomes, the basic repeating units of chromatin. The nucleosome consists of a histone octamer around which a DNA core is wrapped and the linker histone H1, which is associated with linker DNA. By altering the accessibility of DNA sequences, the nucleosome has profound effects on all DNA-dependent processes. Understanding the factors that influence nucleosome positioning is of great importance for the study of genomic control mechanisms. Transcription factors (TFs) have been suggested to play a role in nucleosome positioning in vivo. Principal Findings: Here, the minimum redundancy maximum relevance (mRMR) feature selection algorithm, the nearest neighbor algorithm (NNA), and the incremental feature selection (IFS) method were used to identify the most important TFs that either favor or inhibit nucleosome positioning by analyzing the numbers of transcription factor binding sites (TFBSs) in 53,021 nucleosomal DNA sequences and 50,299 linker DNA sequences. A total of nine important families of TFs were extracted from 35 families, and the overall prediction accuracy was 87.4% as evaluated by the jackknife cross-validation test. Conclusions: Our results are consistent with the notion that TFs are more likely to bind linker DNA sequences than the sequences in the nucleosomes. In addition, our results imply that there may be some TFs that are important for nucleosome positioning but that play an insignificant role in discriminating nucleosome-forming DNA sequences from nucleosome-inhibiting DNA sequences. The hypothesis that TFs play a role in nucleosome positioning is, thus, confirmed by the results of this study.	[Yi, Xianfu; Kong, Xiangyin] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yi, Xianfu; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [He, Zhisong; Cui, WeiRen] Zhejiang Univ, Coll Life Sci, Dept Bioinformat, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai University; Fudan University; Zhejiang University	Yi, XF (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; xykong@sibs.ac.cn	Xianfu, Yi/H-4768-2012	Yi, Xianfu/0000-0002-8094-2676; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2004CB518603]; 11th Five-Year Plan [2008ZX10001-001]; Chinese Academy of Sciences [KSCX1-YW-22]	National Basic Research Program of China(National Basic Research Program of China); 11th Five-Year Plan(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by National Basic Research Program of China (2004CB518603), the 11th Five-Year Plan (2008ZX10001-001) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2002, LEARNING KERNELS; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bishop C. M., 1995, NEURAL NETWORKS PATT; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen KF, 2008, NUCLEIC ACIDS RES, V36, P6228, DOI 10.1093/nar/gkn626; CHODAVARAPU RK, 2010, NATURE; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHUNG HR, 2008, J MOL BIOL; Collings CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010933; Cristianini N, 2000, INTRO SUPPORT VECTOR; Edwards A.L., 1976, INTRO LINEAR REGRESS; Ercan S, 2004, MOL CELL BIOL, V24, P10026, DOI 10.1128/MCB.24.22.10026-10035.2004; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fitzgerald DJ, 1999, J MOL BIOL, V293, P477, DOI 10.1006/jmbi.1999.3171; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; He CS, 2005, LECT NOTES ARTIF INT, V3801, P927; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; KAPLAN N, 2008, NATURE, V17, P17; Kohonen T, 1998, NEUROCOMPUTING, V21, P19, DOI 10.1016/S0925-2312(98)00031-9; KOHONEN T, 1988, NEURAL NETWORKS, V1, P3, DOI 10.1016/0893-6080(88)90020-2; Kohonen T, 1997, NEURAL COMPUT, V9, P1321, DOI 10.1162/neco.1997.9.6.1321; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lewin B., 2004, GENE, VVIII; Li SJ, 2007, J BIOMOL STRUCT DYN, V25, P49, DOI 10.1080/07391102.2007.10507154; Liu HD, 2008, BIOPHYS J, V94, P4597, DOI 10.1529/biophysj.107.117028; Loden M, 2005, CHROMOSOME RES, V13, P289, DOI 10.1007/s10577-005-2166-z; Luger K., 2000, NUCLEOSOMES STRUCTUR; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Niu B, 2009, J COMPUT CHEM, V30, P33, DOI 10.1002/jcc.21024; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pusarla RH, 2007, FEBS J, V274, P2396, DOI 10.1111/j.1742-4658.2007.05775.x; Qian ZL, 2007, BIOINFORMATICS, V23, P2449, DOI 10.1093/bioinformatics/btm348; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal MR, 2008, STAT APPL GENET MOL, V7; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shen CH, 2001, J BIOL CHEM, V276, P35209, DOI 10.1074/jbc.M104733200; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Tanaka Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-309; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tolstorukov MY, 2008, BIOINFORMATICS, V24, P1456, DOI 10.1093/bioinformatics/btn212; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik V., 1998, STAT LEARNING THEORY; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; WATSON JD, 2003, MOL BIOL GENE B CUMM; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yin SY, 2009, BIOCHEM BIOPH RES CO, V385, P363, DOI 10.1016/j.bbrc.2009.05.072; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]	67	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12495	10.1371/journal.pone.0012495	http://dx.doi.org/10.1371/journal.pone.0012495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824131	gold, Green Published, Green Submitted			2022-12-25	WOS:000281456100009
J	Brothers, N; Duckworth, AR; Safina, C; Gilman, EL				Brothers, Nigel; Duckworth, Alan R.; Safina, Carl; Gilman, Eric L.			Seabird Bycatch in Pelagic Longline Fisheries Is Grossly Underestimated when Using Only Haul Data	PLOS ONE			English	Article							MORTALITY; ALBATROSS; AUSTRALIA; IMPACTS; TARGET	Hundreds of thousands of seabirds are killed each year as bycatch in longline fisheries. Seabirds are predominantly caught during line setting but bycatch is generally recorded during line hauling, many hours after birds are caught. Bird loss during this interval may lead to inaccurate bycatch information. In this 15 year study, seabird bycatch was recorded during both line setting and line hauling from four fishing regions: Indian Ocean, Southern Ocean, Coral Sea and central Pacific Ocean. Over 43,000 albatrosses, petrels and skuas representing over 25 species were counted during line setting of which almost 6,000 seabirds attempted to take the bait. Bait-taking interactions were placed into one of four categories. (i) The majority (57%) of bait-taking attempts were "unsuccessful'' involving seabirds that did not take the bait nor get caught or hooked. (ii) One-third of attempts were "successful'' with seabirds removing the bait while not getting caught. (iii) One-hundred and seventy-six seabirds (3% of attempts) were observed being "caught'' during line setting, with three albatross species - Laysan (Phoebastria immutabilis), black-footed (P. nigripes) and black-browed (Thalassarche melanophrys)-dominating this category. However, of these, only 85 (48%) seabird carcasses were retrieved during line hauling. Most caught seabirds were hooked through the bill. (iv) The remainder of seabird-bait interactions (7%) was not clearly observed, but likely involved more "caught'' seabirds. Bait taking attempts and percentage outcome (e. g. successful, caught) varied between seabird species and was not always related to species abundance around fishing vessels. Using only haul data to calculate seabird bycatch grossly underestimates actual bycatch levels, with the level of seabird bycatch from pelagic longline fishing possibly double what was previously thought.	[Duckworth, Alan R.; Safina, Carl; Gilman, Eric L.] Blue Ocean Inst, Cold Spring Harbor, NY USA; [Gilman, Eric L.] Tetra Tech Inc, Honolulu, HI USA; [Gilman, Eric L.] Hawaii Pacific Univ, Coll Nat & Computat Sci, Honolulu, HI USA			EricLGilman@gmail.com	Duckworth, Alan/F-3290-2017; Gilman, Eric/AAF-2147-2019	Duckworth, Alan/0000-0002-5451-7633; Gilman, Eric/0000-0002-4216-2513	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Financial support was provided by the Gordon and Betty Moore Foundation to the Blue Ocean Institute for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CATCHING FISH NOT BI; Baker GB, 2007, BIOL CONSERV, V137, P319, DOI 10.1016/j.biocon.2007.02.012; Brander K, 2008, MAR POLLUT BULL, V56, P1957, DOI 10.1016/j.marpolbul.2008.08.024; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; BROTHERS N, 2000, AFMA RES FUND FINAL; BROTHERS N, 1999, 937 UNFAO; *CCAMLR, 2002, 21 M SCI COMM COMM C, P288; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Gilman E, 2003, OCEAN COAST MANAGE, V46, P985, DOI 10.1016/j.ocecoaman.2003.12.001; GILMAN E, 2007, 1025 UNFAO; Gilman E., 2006, INCIDENTAL CAPTURE S; Gilman Eric, 2008, Endangered Species Research, V5, P309, DOI 10.3354/esr00133; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Gilman E, 2007, FISHERIES SCI, V73, P208, DOI 10.1111/j.1444-2906.2007.01321.x; Gilman E, 2010, FISH FISH, V11, P57, DOI 10.1111/j.1467-2979.2009.00342.x; IUCN, 2014, IUCN RED LIST THREAT; Lundin, 2009, HDB MARINE FISHERIES, P150; Melvin EF, 2001, UASGCP REP, V2001, P161; Moore JE, 2008, ANIM CONSERV, V11, P257, DOI 10.1111/j.1469-1795.2008.00197.x; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; *NMFS, 2009, 2008 ANN REP SEAB IN; Pauly D, 2005, MILLENNIUM ECOSYSTEM, V1, P477; Tasker Mark L., 1992, Netherlands Journal of Aquatic Ecology, V26, P59, DOI 10.1007/BF02298028; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; *UNFAO, 2005, 470 UNFAO; *UNFAO, 1999, INT PLAN ACT CONS MA; *UNFAO, 1999, INT PLAN ACT RED INC; *UNFAO, 2009, GUID RED SEA TURTL M; Vega R, 2009, FISH RES, V98, P22, DOI 10.1016/j.fishres.2009.03.010; Ward P, 2009, FISH RES, V97, P253, DOI 10.1016/j.fishres.2009.02.009; Watkins BP, 2008, ANIM CONSERV, V11, P247, DOI 10.1111/j.1469-1795.2008.00192.x; WEIMERSKIRCH H, 1987, OIKOS, V49, P315, DOI 10.2307/3565767	33	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12491	10.1371/journal.pone.0012491	http://dx.doi.org/10.1371/journal.pone.0012491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824163	gold, Green Submitted, Green Published			2022-12-25	WOS:000281405300017
J	Buchholz, K; Putrianti, ED; Rahlfs, S; Schirmer, RH; Becker, K; Matuschewski, K				Buchholz, Kathrin; Putrianti, Elyzana D.; Rahlfs, Stefan; Schirmer, R. Heiner; Becker, Katja; Matuschewski, Kai			Molecular Genetics Evidence for the in Vivo Roles of the Two Major NADPH-dependent Disulfide Reductases in the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM POSSESSES; GLUTATHIONE-REDUCTASE; THIOREDOXIN REDUCTASE; REDOX; TRYPANOTHIONE; METABOLISM; INHIBITORS; DIHYDROLIPOAMIDE; TRYPANOSOMES; SYSTEM	Malaria-associated pathology is caused by the continuous expansion of Plasmodium parasites inside host erythrocytes. To maintain a reducing intracellular milieu in an oxygen-rich environment, malaria parasites have evolved a complex antioxidative network based on two central electron donors, glutathione and thioredoxin. Here, we dissected the in vivo roles of both redox pathways by gene targeting of the respective NADPH-dependent disulfide reductases. We show that Plasmodium berghei glutathione reductase and thioredoxin reductase are dispensable for proliferation of the pathogenic blood stages. Intriguingly, glutathione reductase is vital for extracellular parasite development inside the insect vector, whereas thioredoxin reductase is dispensable during the entire parasite life cycle. Our findings suggest that glutathione reductase is the central player of the parasite redox network, whereas thioredoxin reductase fulfils a specialized and dispensable role for P. berghei. These results also indicate redundant roles of the Plasmodium redox pathways during the pathogenic blood phase and query their suitability as promising drug targets for antimalarial intervention strategies.	[Buchholz, Kathrin; Rahlfs, Stefan; Becker, Katja] Univ Giessen, Interdisciplinary Res Ctr, D-35390 Giessen, Germany; [Buchholz, Kathrin; Schirmer, R. Heiner] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Buchholz, Kathrin] Heidelberg Univ, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; [Putrianti, Elyzana D.; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany	Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society	Becker, K (corresponding author), Univ Giessen, Interdisciplinary Res Ctr, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	becker.katja@gmx.de; matuschewski@mpiib-berlin.mpg.de	Buchholz, Kathrin/O-3217-2017; Buchholz, Kathrin/GOK-0463-2022	Matuschewski, Kai/0000-0001-6147-8591	Deutsche Forschungsgemeinschaft [SFB 544, B2, B10, B1540/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 544, B2 and B10; B1540/15-1).	Andricopulo AD, 2006, BIOORG MED CHEM LETT, V16, P2283, DOI 10.1016/j.bmcl.2006.01.027; Becker K, 2005, MOLECULAR APPROACHES TO MALARIA, P365; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, EUR J BIOCHEM, V270, P1057, DOI 10.1046/j.1432-1033.2003.03495.x; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; BECKER K, 1994, HISTOCHEMISTRY, V102, P389, DOI 10.1007/BF00268910; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Buchholz K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002474; Davioud-Charvet E, 2001, J MED CHEM, V44, P4268, DOI 10.1021/jm010268g; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Friebolin W, 2008, J MED CHEM, V51, P1260, DOI 10.1021/jm7009292; Gallo V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007303; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; KrauthSiegel RL, 1996, EUR J BIOCHEM, V235, P345, DOI 10.1111/j.1432-1033.1996.00345.x; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V112, P219, DOI 10.1016/S0166-6851(00)00372-8; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; McMillan PJ, 2006, J BIOL CHEM, V281, P32967, DOI 10.1074/jbc.M601141200; McMillan PJ, 2005, MOL MICROBIOL, V55, P27, DOI 10.1111/j.1365-2958.2004.04398.x; Morin C, 2008, ORG BIOMOL CHEM, V6, P2731, DOI 10.1039/b802649c; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Rahlfs S, 2006, MINI-REV MED CHEM, V6, P163, DOI 10.2174/138955706775475911; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Schirmer R. H., 2002, WILEY ENCY MOL MED, P1471; Sobolewski P, 2005, INFECT IMMUN, V73, P6704, DOI 10.1128/IAI.73.10.6704-6710.2005; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302	39	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37388	37395		10.1074/jbc.M110.123323	http://dx.doi.org/10.1074/jbc.M110.123323			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20852334	Green Published, hybrid			2022-12-25	WOS:000284424000031
J	Vendelin, M; Hoerter, JA; Mateo, P; Soboll, S; Gillet, B; Mazet, JL				Vendelin, Marko; Hoerter, Jacqueline A.; Mateo, Philippe; Soboll, Sibylle; Gillet, Brigitte; Mazet, Jean-Luc			Modulation of Energy Transfer Pathways between Mitochondria and Myofibrils by Changes in Performance of Perfused Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE FLUXES; RAT-HEART; MAGNETIZATION-TRANSFER; ATP; DIFFUSION; MUSCLE; MODEL; COMPARTMENTATION; PHOSPHOCREATINE; CELLS	In the heart, the energy supplied by mitochondria to myofibrils is continuously and finely tuned to the contraction requirement over a wide range of cardiac loads. This process is mediated both by the creatine kinase (CK) shuttle and by direct ATP transfer. The aim of this study was to identify the contribution of energy transfer pathways at different cardiac performance levels. For this, five protocols of P-31 NMR inversion and saturation transfer experiments were performed at different performance levels on Langendorff perfused rat hearts. The cardiac performance was changed either through variation of external calcium in the presence or absence of isoprenaline or through variation of LV balloon inflation. The recordings were analyzed by mathematical models composed on the basis of different energy transfer pathway configurations. According to our results, the total CK unidirectional flux was relatively stable when the cardiac performance was changed by increasing the calcium concentration or variation of LV balloon volume. The stability of total CK unidirectional flux is lost at extreme energy demand levels leading to a rise in inorganic phosphate, a drop of ATP and phosphocreatine, a drop of total CK unidirectional flux, and to a bypass of CK shuttle by direct ATP transfer. Our results provide experimental evidence for the existence of two pathways of energy transfer, direct ATP transfer, and PCr transfer through the CK shuttle, whose contribution may vary depending on the metabolic status of the heart.	[Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-12618 Tallinn, Estonia; [Hoerter, Jacqueline A.; Mateo, Philippe; Mazet, Jean-Luc] INSERM, UMR S 769, F-92296 Chatenay Malabry, France; [Soboll, Sibylle] Univ Dusseldorf, Inst Biochem Mol Biol 1, D-4000 Dusseldorf, Germany; [Gillet, Brigitte] Univ Paris 11, CNRS, IR4M, UMR 8081, F-91405 Orsay, France; [Hoerter, Jacqueline A.; Mateo, Philippe; Mazet, Jean-Luc] Univ Paris 11, IFR141, F-92296 Chatenay Malabry, France	Tallinn University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Heinrich Heine University Dusseldorf; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, Akad 21, EE-12618 Tallinn, Estonia.	markov@ioc.ee	Vendelin, Marko/AAE-7137-2020	Vendelin, Marko/0000-0002-6459-0391	INSERM; CNRS; Wellcome Trust [WT081755MA]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Wellcome Trust(Wellcome Trust)	This work was supported by INSERM, CNRS (to J. -L. M.), and, in a later stage, by the Wellcome Trust (to M. V., Fellowship No. WT081755MA).	Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Birkedal R, 2006, AM J PHYSIOL-CELL PH, V291, pC1148, DOI 10.1152/ajpcell.00236.2006; BITTL JA, 1985, J BIOL CHEM, V260, P3512; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; De Sousa E, 1999, CIRC RES, V85, P68; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Hormann W., 2004, AUTOMATIC NONUNIFORM; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; Joubert F, 2000, BIOPHYS J, V79, P1, DOI 10.1016/S0006-3495(00)76269-2; Joubert F, 2004, MOL CELL BIOCHEM, V256, P43, DOI 10.1023/B:MCBI.0000009858.41434.fc; Joubert F, 2002, J BIOL CHEM, V277, P18469, DOI 10.1074/jbc.M200792200; Joubert F, 2002, MOL BIOL REP, V29, P171, DOI 10.1023/A:1020369627701; Joubert F, 2001, BIOPHYS J, V81, P2995, DOI 10.1016/S0006-3495(01)75940-1; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; KUPRIYANOV VV, 1984, BIOCHIM BIOPHYS ACTA, V805, P319, DOI 10.1016/0167-4889(84)90014-4; MARTIN JF, 1989, MAGNET RESON MED, V11, P64, DOI 10.1002/mrm.1910110106; MATTHEWS PM, 1982, BIOCHIM BIOPHYS ACTA, V721, P312, DOI 10.1016/0167-4889(82)90084-2; More J. J., 1984, SOURCES DEV MATH SOF; Nascimben L, 1996, CIRCULATION, V94, P1894, DOI 10.1161/01.CIR.94.8.1894; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; PORTMAN MA, 1992, AM J PHYSIOL, V263, pC453, DOI 10.1152/ajpcell.1992.263.2.C453; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Rivals I, 2003, IEEE T NEURAL NETWOR, V14, P804, DOI 10.1109/TNN.2003.811356; Saks V, 2003, BIOPHYS J, V84, P3436, DOI 10.1016/S0006-3495(03)70065-4; Saks V. A., 1994, CELLULAR BIOENERGETI; SAKS VA, 1975, EUR J BIOCHEM, V57, P273, DOI 10.1111/j.1432-1033.1975.tb02299.x; Sepp M, 2010, BIOPHYS J, V98, P2785, DOI 10.1016/j.bpj.2010.03.025; Soboll S, 1979, Methods Enzymol, V56, P201; Spencer RGS, 1997, AM J PHYSIOL-HEART C, V272, pH409, DOI 10.1152/ajpheart.1997.272.1.H409; Spindler M, 1999, J MOL CELL CARDIOL, V31, P2175, DOI 10.1006/jmcc.1999.1044; Stepanov V, 1997, AM J PHYSIOL-CELL PH, V273, pC1397, DOI 10.1152/ajpcell.1997.273.4.C1397; UGURBIL K, 1986, BIOCHEMISTRY-US, V25, P100, DOI 10.1021/bi00349a015; Vendelin M, 2005, AM J PHYSIOL-CELL PH, V288, pC757, DOI 10.1152/ajpcell.00281.2004; Vendelin M, 2004, BIOPHYS J, V87, P696, DOI 10.1529/biophysj.103.036210; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallimann T, 1996, J MUSCLE RES CELL M, V17, P177, DOI 10.1007/BF00124240; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; ZAHLER R, 1992, AM J PHYSIOL, V262, pH1022, DOI 10.1152/ajpheart.1992.262.4.H1022	45	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37240	37250		10.1074/jbc.M110.147116	http://dx.doi.org/10.1074/jbc.M110.147116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847056	hybrid, Green Published			2022-12-25	WOS:000284424000017
J	Smith, LK; Shah, RR; Cidlowski, JA				Smith, Lindsay K.; Shah, Ruchir R.; Cidlowski, John A.			Glucocorticoids Modulate MicroRNA Expression and Processing during Lymphocyte Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; REGULATED MICRORNAS; INDUCE APOPTOSIS; DICER; CELLS; THYMOCYTES; AUTOIMMUNITY; ACTIVATION; PATHWAYS; CLEAVAGE	Glucocorticoids modulate immune development and function through the induction of lymphocyte apoptosis via mechanisms requiring alterations in gene expression. Recently, short, noncoding, microRNAs have been identified as key regulators of lymphocyte function; however, it is unknown whether glucocorticoids regulate noncoding microRNAs and whether this regulation contributes to lymphocyte apoptosis. We now show by both microarray and deep sequencing analysis that microRNAs are substantially repressed during glucocorticoid-induced apoptosis of primary rat thymocytes. Mechanistic studies revealed that primary microRNA transcripts were not repressed, whereas the expression of the key microRNA processing enzymes: Dicer, Drosha, and DGCR8/Pasha, were significantly reduced at both the mRNA and protein levels during glucocorticoid-induced apoptosis. To delineate the role of Dicer depletion and microRNA repression in apoptosis, we silenced Dicer expression in two human leukemic cell lines and demonstrated that Dicer depletion significantly enhanced glucocorticoid-induced apoptosis in both model systems. Finally, in vitro and in vivo overexpression of the conserved miR-17-92 polycistron, which was repressed significantly by dexamethasone treatment in both our microarray and deep sequencing studies, blunted glucocorticoid-induced apoptosis. These studies provide evidence of altered post-transcriptional microRNA expression and the repression of the microRNA bioprocessing pathway during glucocorticoid-induced apoptosis of lymphocytes, suggesting a role for microRNA processors and specific microRNAs in cell life/death decisions.	NIEHS, Mol Endocrinol Grp, Lab Signal Transduct, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Smith, Lindsay K.] Univ N Carolina, Chapel Hill, NC USA; [Shah, Ruchir R.] SRA Int, Durham, NC 27713 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; SRA International	Cidlowski, JA (corresponding author), 111 TW Alexander Dr,Rm F349, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	National Institutes of Health [Z01E5090057-12]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZICES102506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01E5090057-12.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Mann CL, 2000, ENDOCRINOLOGY, V141, P528, DOI 10.1210/en.141.2.528; Matskevich AA, 2008, BIOCHEM J, V412, P527, DOI 10.1042/BJ20071461; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Rainer J, 2009, LEUKEMIA, V23, P746, DOI 10.1038/leu.2008.370; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Riml S, 2004, CELL DEATH DIFFER, V11, pS65, DOI 10.1038/sj.cdd.4401413; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017	42	70	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36698	36708		10.1074/jbc.M110.162123	http://dx.doi.org/10.1074/jbc.M110.162123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847043	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000284146100076
J	Tzeng, J; Lee, BL; Sykes, BD; Fliegel, L				Tzeng, Jennifer; Lee, Brian L.; Sykes, Brian D.; Fliegel, Larry			Structural and Functional Analysis of Transmembrane Segment VI of the NHE1 Isoform of the Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN STRUCTURE; PROLINE RESIDUES; AMINO-ACIDS; EXPRESSION; PEPTIDES; IV; RHODOPSIN; MECHANISM; INSIGHTS; PROGRAM	The Na+/H+ exchanger isoform 1 is a ubiquitously expressed integral membrane protein. It resides on the plasma membrane of cells and regulates intracellular pH in mammals by extruding an intracellular H+ in exchange for one extracellular Na+. We characterized structural and functional aspects of the transmembrane segment (TM) VI (residues 227-249) by using cysteine scanning mutagenesis and high resolution NMR. Each residue of TM VI was mutated to cysteine in the background of the cysteineless NHE1 protein, and the sensitivity to water-soluble sulfhydryl-reactive compounds (2-(trimethylammonium)ethyl)-methanethiosulfonate (MTSET) and (2-sulfonatoethyl) methanethiosulfonate (MTSES) was determined for those residues with significant activity remaining. Three residues were essentially inactive when mutated to Cys: Asp(238), Pro(239), and Glu(247). Of the remaining residues, proteins with the mutations N227C, I233C, and L243C were strongly inhibited by MTSET, whereas amino acids Phe(230), Gly(231), Ala(236), Val(237), Ala(244), Val(245), and Glu(248) were partially inhibited by MTSET. MTSES did not affect the activity of the mutant NHE1 proteins. The structure of a peptide representing TM VI was determined using high resolution NMR spectroscopy in dodecylphosphocholine micelles. TM VI contains two helical regions oriented at an approximate right angle to each other (residues 229-236 and 239-250) surrounding a central unwound region. This structure bears a resemblance to TM IV of the Escherichia coli protein NhaA. The results demonstrate that TM VI of NHE1 is a discontinuous pore-lining helix with residues Asn(227), Ile(233), and Leu(243) lining the translocation pore.	[Tzeng, Jennifer; Lee, Brian L.; Sykes, Brian D.; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca			Canadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; University of Alberta	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta(University of Alberta)	This work was supported by funding from the Canadian Institutes of Health Research (CIHR) (to L. F. and B. D. S.). The Canadian National High Field NMR Centre is funded by the Canadian Institutes of Health Research, the Natural Science and Engineering Research Council of Canada, and the University of Alberta.	Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; ARSENIEV AS, 1986, J MAGN RESON, V70, P427, DOI 10.1016/0022-2364(86)90131-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Cunningham F, 2007, METHODS, V41, P370, DOI 10.1016/j.ymeth.2006.07.003; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; KARMAZYN M, 2005, HAEMATOL DISORD, V5, P323; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Kauko A, 2008, J MOL BIOL, V380, P170, DOI 10.1016/j.jmb.2008.04.052; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; Lee BL, 2009, BBA-BIOMEMBRANES, V1788, P2481, DOI 10.1016/j.bbamem.2009.10.004; Lee BL, 2009, J BIOL CHEM, V284, P11546, DOI 10.1074/jbc.M809201200; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Rainey JK, 2006, BIOCHEM CELL BIOL, V84, P918, DOI 10.1139/O06-178; Reddy T, 2008, J BIOL CHEM, V283, P22018, DOI 10.1074/jbc.M803447200; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Slepkov E, 2007, BBA-BIOMEMBRANES, V1768, P2882, DOI 10.1016/j.bbamem.2007.08.011; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yeagle PL, 2001, BIOCHEMISTRY-US, V40, P11932, DOI 10.1021/bi015543f; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zangger K, 2009, J PHYS CHEM B, V113, P4400, DOI 10.1021/jp808501x; [No title captured]	54	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36656	36665		10.1074/jbc.M110.161471	http://dx.doi.org/10.1074/jbc.M110.161471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843797	hybrid, Green Published			2022-12-25	WOS:000284146100046
J	Gee, HY; Tang, BL; Kim, KH; Lee, MG				Gee, Heon Yung; Tang, Bor Luen; Kim, Kyung Hwan; Lee, Min Goo			Syntaxin 16 Binds to Cystic Fibrosis Transmembrane Conductance Regulator and Regulates Its Membrane Trafficking in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNELS; ENDOCYTIC TRAFFICKING; PROTEIN; GOLGI; LOCALIZATION; DEGRADATION; INTERACTS	The cystic fibrosis transmembrane conductance regulator (CFTR) is a key membrane protein in the complex network of epithelial ion transporters regulating epithelial permeability. Syntaxins are one of the major determinants in the intracellular trafficking and membrane targeting of secretory proteins. In the present study we demonstrate the biochemical and functional association between CFTR and syntaxin 16 (STX16) that mediates vesicle transport within the early/late endosomes and trans-Golgi network. Immunoprecipitation experiments in rat colon and T84 human colonic epithelial cells indicate that STX16 associates with CFTR. Further analyses using the domain-specific pulldown assay reveal that the helix domain of STX16 directly interacts with the N-terminal region of CFTR. Immunostainings in rat colon and T84 cells show that CFTR and STX16 highly co-localize at the apical and subapical regions of epithelial cells. Interestingly, CFTR-associated chloride current was reduced by the knockdown of STX16 expression in T84 cells. Surface biotinylation and recycling assays indicate that the reduction in CFTR chloride current is due to decreased CFTR expression on the plasma membrane. These results suggest that STX16 mediates recycling of CFTR and constitutes an important component of CFTR trafficking machinery in intestinal epithelial cells.	[Gee, Heon Yung; Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Inst Gastroenterol, Seoul 120752, South Korea; [Gee, Heon Yung; Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National University of Singapore	Lee, MG (corresponding author), Yonsei Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.	mlee@yuhs.ac	Lee, Min Goo/D-5635-2012; Gee, Heon Yung/K-7781-2019; Lee, Min Goo/AAS-4636-2020; Tang, Bor Luen/E-4548-2012	Lee, Min Goo/0000-0001-7436-012X; Gee, Heon Yung/0000-0002-8741-6177; Lee, Min Goo/0000-0001-7436-012X; Tang, Bor Luen/0000-0002-1925-636X	Ministry of Education, Science, and Technology, Korea [2007-0055732, 2010-0001670, 2010-0017752]	Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grants 2007-0055732, 2010-0001670, and 2010-0017752 from the Ministry of Education, Science, and Technology, Korea.	Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Bilan F, 2008, EXP CELL RES, V314, P2199, DOI 10.1016/j.yexcr.2008.04.012; Chang SY, 2002, J CELL SCI, V115, P783; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Chua CEL, 2008, MOL MEMBR BIOL, V25, P35, DOI 10.1080/09687680701504649; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Namkung W, 2005, GASTROENTEROLOGY, V129, P1979, DOI 10.1053/j.gastro.2005.08.049; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Panek HR, 2000, J CELL SCI, V113, P4545; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Saxena S, 1999, J BIOL CHEM, V274, P20812, DOI 10.1074/jbc.274.30.20812; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P673, DOI 10.1006/bbrc.1997.8029; Teng FYH, 2001, GENOME BIOL, V2; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200	39	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35519	35527		10.1074/jbc.M110.162438	http://dx.doi.org/10.1074/jbc.M110.162438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826815	Green Published, hybrid			2022-12-25	WOS:000283845300030
J	Rajasekaran, K; Xiong, V; Fong, L; Gorski, J; Malarkannan, S				Rajasekaran, Kamalakannan; Xiong, Va; Fong, Lee; Gorski, Jack; Malarkannan, Subramaniam			Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8(+) T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; CELIAC-DISEASE; KILLER-CELLS; NK CELLS; ACTIVATION; RECEPTOR; LIGANDS; VIRUS; INDUCTION; INFLUENZA	Both CD28 and NKG2D can function as co-stimulatory receptors in human CD8(+) T cells. However, their independent functional contributions in distinct CD8(+) T cell subsets are not well understood. In this study, CD8(+) T cells in human peripheral blood-and lung-derived lymphocytes were analyzed for CD28 and NKG2D expression and function. We found a higher level of CD28 expression in PBMC-derived naive (CD45RA(+)CD27(+)) and memory (CD45RA(-)CD27(+)) CD8(+) T cells (CD28(Hi)), while its expression was significantly lower in effector (CD45RA(+)CD27(-)) CD8(+) T cells (CD28(Lo)). Irrespective of the differences in the CD28 levels, NKG2D expression was comparable in all three CD8(+) T cell subsets. CD28 and NKG2D expressions followed similar patterns in human lung-resident GILGFVFTL/HLA-A2-pentamer positive CD8(+) T cells. Co-stimulation of CD28(Lo) effector T cells via NKG2D significantly increased IFN-gamma and TNF-alpha levels. On the contrary, irrespective of its comparable levels, NKG2D-mediated co-stimulation failed to augment IFN-gamma and TNF-alpha production in CD28(Hi) naive/memory T cells. Additionally, CD28-mediated co-stimulation was obligatory for IL-2 generation and thereby its production was limited only to the CD28(Hi) naive/memory subsets. MICA, a ligand for NKG2D was abundantly expressed in the tracheal epithelial cells, validating the use of NKG2D as the major co-stimulatory receptor by tissue-resident CD8(+) effector T cells. Based on these findings, we conclude that NKG2D may provide an expanded level of co-stimulation to tissue-residing effector CD8(+) T cells. Thus, incorporation of co-stimulation via NKG2D in addition to CD28 is essential to activate tumor or tissue-infiltrating effector CD8(+) T cells. However, boosting a recall immune response via memory CD8(+) T cells or vaccination to stimulate naive CD8(+) T cells would require CD28-mediated co-stimulation.	[Rajasekaran, Kamalakannan; Malarkannan, Subramaniam] Blood Res Inst, Lab Mol Immunol, Milwaukee, WI USA; [Xiong, Va; Fong, Lee; Gorski, Jack] Blood Res Inst, Mol Genet Lab, Milwaukee, WI USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Rajasekaran, K (corresponding author), Blood Res Inst, Lab Mol Immunol, Milwaukee, WI USA.	subra.malar@bcw.edu	Malarkannan, Subramaniam/AAQ-3934-2020; RAJASEKARAN, KAMALAKANNAN/F-7350-2015; Malarkannan, Subra/AAQ-9617-2020	Malarkannan, Subramaniam/0000-0002-7511-2731; RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007; 	NIH [NO1-HHSN266200500032C, U19 AI062627, R01A1064826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by NIH grants NO1-HHSN266200500032C, U19 AI062627, R01A1064826 to S. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Conejo-Garcia JR, 2003, CANCER BIOL THER, V2, P446, DOI 10.4161/cbt.2.4.479; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; FALK K, 1994, IMMUNOLOGY, V82, P337; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Liang L, 2002, CURR OPIN IMMUNOL, V14, P384, DOI 10.1016/S0952-7915(02)00342-4; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nabeshima S, 2002, CLIN EXP IMMUNOL, V128, P339, DOI 10.1046/j.1365-2249.2002.01819.x; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Textor S, 2008, INT J CANCER, V123, P2343, DOI 10.1002/ijc.23733; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12635	10.1371/journal.pone.0012635	http://dx.doi.org/10.1371/journal.pone.0012635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844584	Green Submitted, gold, Green Published			2022-12-25	WOS:000281687200005
J	Kim, B; Kan, R; Anguish, L; Nelson, LM; Coonrod, SA				Kim, Boram; Kan, Rui; Anguish, Lynne; Nelson, Lawrence M.; Coonrod, Scott A.			Potential Role for MATER in Cytoplasmic Lattice Formation in Murine Oocytes	PLOS ONE			English	Article							MOUSE EMBRYO; EFFECT GENE; MAMMALIAN EGGS; LIPID DROPLETS; PROTEIN; EXPRESSION; STORAGE; EMBRYOGENESIS; COMPETENCE; TRANSITION	Background: Mater and Padi6 are maternal effect genes that are first expressed during oocyte growth and are required for embryonic development beyond the two-cell stage in the mouse. We have recently found that PADI6 localizes to, and is required for the formation of, abundant fibrillar Triton X-100 (Triton) insoluble structures termed the oocyte cytoplasmic lattices (CPLs). Given their similar expression profiles and mutant mouse phenotypes, we have been testing the hypothesis that MATER also plays a role in CPL formation and/or function. Methodology/Findings: Herein, we show that PADI6 and MATER co-localize throughout the oocyte cytoplasm following Triton extraction, suggesting that MATER co-localizes with PADI6 at the CPLs. Additionally, the solubility of PADI6 was dramatically increased in Mater(tm/tm) oocytes following Triton extraction, suggesting that MATER is involved in CPL nucleation. This prediction is supported by transmission electron microscopic analysis of Mater(+/+) and Mater(tm/tm) germinal vesicle stage oocytes which illustrated that volume fraction of CPLs was reduced by 90% in Mater(tm/tm) oocytes compared to Mater(+/+) oocytes. Conclusions: Taken together, these results suggest that, similar to PADI6, MATER is also required for CPL formation. Given that PADI6 and MATER are essential for female fertility, these results not only strengthen the hypothesis that the lattices play a critical role in mediating events during the oocyte-to-embryo transition but also increase our understanding of the molecular nature of the CPLs.	[Kim, Boram; Kan, Rui; Anguish, Lynne; Coonrod, Scott A.] Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Nelson, Lawrence M.] NICHHD, Intramural Res Program Reprod & Adult Endocrinol, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kim, B (corresponding author), Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	sac269@cornell.edu			National Institute of Child Health and Human Development [RO1 38353]; Intramural Research Program on Reproductive and Adult Endocrinology; National Science Foundation [DMR-0520404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000633] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038353] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural Research Program on Reproductive and Adult Endocrinology; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Health and Human Development grant RO1 38353 to SAC and by the Intramural Research Program on Reproductive and Adult Endocrinology to LMN. This study also made use of the Cornell Center for Materials Research Facilities supported by the National Science Foundation under Award Number DMR-0520404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruosi B, 2009, THERIOGENOLOGY, V71, P1093, DOI 10.1016/j.theriogenology.2008.12.002; Bachvarova R, 1985, Dev Biol (N Y 1985), V1, P453; BACHVAROVA R, 1981, J EMBRYOL EXP MORPH, V62, P153; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; BURKHOLDER GD, 1971, EXP CELL RES, V69, P361, DOI 10.1016/0014-4827(71)90236-9; CAPCO DG, 1993, CELL MOTIL CYTOSKEL, V24, P85, DOI 10.1002/cm.970240202; Esposito G, 2007, MOL CELL ENDOCRINOL, V273, P25, DOI 10.1016/j.mce.2007.05.005; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; GALLICANO GI, 1991, CELL MOTIL CYTOSKEL, V18, P143; GARCIA RB, 1979, DIFFERENTIATION, V14, P101, DOI 10.1111/j.1432-0436.1979.tb01017.x; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Maraldi T, 2009, MOL HUM REPROD, V15, P499, DOI 10.1093/molehr/gap048; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MCGAUGHEY RW, 1989, CELL MOTIL CYTOSKEL, V13, P104, DOI 10.1002/cm.970130205; Nagano M, 2006, ZYGOTE, V14, P299, DOI 10.1017/S0967199406003807; Niimura Sueo, 2004, Reprod Med Biol, V3, P231, DOI 10.1111/j.1447-0578.2004.00075.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; STERNLICHT AL, 1981, J EXP ZOOL, V215, P191, DOI 10.1002/jez.1402150209; STJOHNSTON D, 1992, CELL, V68, P201; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Tashiro F, 2010, GENES CELLS, V15, P813, DOI 10.1111/j.1365-2443.2010.01420.x; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; WASSARMAN PM, 1978, J MORPHOL, V156, P209, DOI 10.1002/jmor.1051560206; WEAKLEY BS, 1969, Z ZELLFORSCH MIK ANA, V97, P438, DOI 10.1007/BF00968849; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zamboni L., 1970, Biol. Reprod., V2, P44, DOI 10.1095/biolreprod2.Supplement_2.44; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	37	39	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12587	10.1371/journal.pone.0012587	http://dx.doi.org/10.1371/journal.pone.0012587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830304	Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300016
J	Noto, CR; Grossman, A				Noto, Christopher R.; Grossman, Ari			Broad-Scale Patterns of Late Jurassic Dinosaur Paleoecology	PLOS ONE			English	Article							BODY-SIZE; SAUROPOD DINOSAURS; WESTERN INTERIOR; FOSSIL RECORD; EVOLUTION; ECOLOGY; NORTH; DIET; PALEOBIOLOGY; CONVERGENCE	Background: There have been numerous studies on dinosaur biogeographic distribution patterns. However, these distribution data have not yet been applied to ecological questions. Ecological studies of dinosaurs have tended to focus on reconstructing individual taxa, usually through comparisons to modern analogs. Fewer studies have sought to determine if the ecological structure of fossil assemblages is preserved and, if so, how dinosaur communities varied. Climate is a major component driving differences between communities. If the ecological structure of a fossil locality is preserved, we expect that dinosaur assemblages from similar environments will share a similar ecological structure. Methodology/Principal Findings: This study applies Ecological Structure Analysis (ESA) to a dataset of 100+ dinosaur taxa arranged into twelve composite fossil assemblages from around the world. Each assemblage was assigned a climate zone (biome) based on its location. Dinosaur taxa were placed into ecomorphological categories. The proportion of each category creates an ecological profile for the assemblage, which were compared using cluster and principal components analyses. Assemblages grouped according to biome, with most coming from arid or semi-arid/seasonal climates. Differences between assemblages are tied to the proportion of large high-browsing vs. small ground-foraging herbivores, which separates arid from semi-arid and moister environments, respectively. However, the effects of historical, taphonomic, and other environmental factors are still evident. Conclusions/Significance: This study is the first to show that the general ecological structure of Late Jurassic dinosaur assemblages is preserved at large scales and can be assessed quantitatively. Despite a broad similarity of climatic conditions, a degree of ecological variation is observed between assemblages, from arid to moist. Taxonomic differences between Asia and the other regions demonstrate at least one case of ecosystem convergence. The proportion of different ecomorphs, which reflects the prevailing climatic and environmental conditions present during fossil deposition, may therefore be used to differentiate Late Jurassic dinosaur fossil assemblages. This method is broadly applicable to different taxa and times, allowing one to address questions of evolutionary, biogeographic, and climatic importance.	[Noto, Christopher R.] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA; [Grossman, Ari] Midwestern Univ, Dept Anat, Glendale, AZ USA	Grand Valley State University; Midwestern University	Noto, CR (corresponding author), Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA.	notoc@gvsu.edu	Grossman, Ari/T-4975-2017	Grossman, Ari/0000-0001-5978-9614; Noto, Christopher/0000-0003-1829-2593				Abbink O, 2001, GLOBAL PLANET CHANGE, V30, P231, DOI 10.1016/S0921-8181(01)00101-1; Aberhan Martin, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P19; ABLER WL, 1992, PALEOBIOLOGY, V18, P161, DOI 10.1017/S0094837300013956; Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Alroy J, 2003, PALEOBIOLOGY, V29, P26, DOI 10.1666/0094-8373(2003)029<0026:GDWYRM>2.0.CO;2; Andrews P, 1996, BIOL REV, V71, P257, DOI 10.1111/j.1469-185X.1996.tb00749.x; ANTON M, 2003, ESTUDIOS GEOLOGICOS, V59; Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Barnosky AD, 2001, CONSERV BIOL, V15, P658, DOI 10.1046/j.1523-1739.2001.015003658.x; Barrett PM, 2002, PALAEONTOLOGY, V45, P1197, DOI 10.1111/1475-4983.00282; BENTON MJ, 1985, SP PAP PALAEONTOL, P185; Bonnan Matthew F., 2005, P346; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christian A, 1996, PALAEONTOLOGY, V39, P801; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; CURRIE RA, 1989, DICKENS QUART, V6, P60; Demko TM, 2004, SEDIMENT GEOL, V167, P115, DOI 10.1016/j.sedgeo.2004.01.003; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; DODSON P, 1980, PALEOBIOLOGY, V6, P208, DOI 10.1017/S009483730000676X; Dunagan SP, 2004, SEDIMENT GEOL, V167, P269, DOI 10.1016/j.sedgeo.2004.01.007; Eberth DA, 2001, CAN J EARTH SCI, V38, P1627, DOI 10.1139/e01-067; Engelmann GF, 2004, SEDIMENT GEOL, V167, P297, DOI 10.1016/j.sedgeo.2004.01.008; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; FARLOW JO, 1995, ANNU REV ECOL SYST, V26, P445, DOI 10.1146/annurev.es.26.110195.002305; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; FARLOW JO, 1987, PALEOBIOLOGY, V13, P60; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FLEAGLE JG, 1980, AM J PHYS ANTHROPOL, V52, P301, DOI 10.1002/ajpa.1330520302; Forster CA, 1999, J AFR EARTH SCI, V28, P169, DOI 10.1016/S0899-5362(99)00023-8; Foster J.R., 2003, NEW MEXICO MUSEUM NA, V23, P1; Garcia AJV, 2005, J S AM EARTH SCI, V19, P243, DOI 10.1016/j.jsames.2005.01.008; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Graham RW, 1996, SCIENCE, V272, P1601; Greenwood JJD, 1996, PHILOS T R SOC B, V351, P265, DOI 10.1098/rstb.1996.0023; Hadly EA, 2009, P NATL ACAD SCI USA, V106, P19707, DOI 10.1073/pnas.0901648106; HALLAM A, 1985, J GEOL SOC LONDON, V142, P433, DOI 10.1144/gsjgs.142.3.0433; Hallam A, 1998, B SOC GEOL FR, V169, P681; HALLAM A, 1993, PHILOS T ROY SOC B, V341, P287, DOI 10.1098/rstb.1993.0114; HALLAM A, 1984, PALAEOGEOGR PALAEOCL, V47, P195, DOI 10.1016/0031-0182(84)90094-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harmon LJ, 2005, EVOLUTION, V59, P409; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P627; HOPSON J A, 1975, Paleobiology, V1, P21; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Hutchinson JR, 2006, NATURE, V440, P292, DOI 10.1038/440292a; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jackson JBC, 2006, TRENDS ECOL EVOL, V21, P322, DOI 10.1016/j.tree.2006.03.017; KIDWELL SM, 1995, ANNU REV ECOL SYST, V26, P269, DOI 10.1146/annurev.es.26.110195.001413; Lamouroux N, 2002, ECOLOGY, V83, P1792, DOI 10.2307/3071765; Loeuille N, 2006, ECOL LETT, V9, P171, DOI 10.1111/j.1461-0248.2005.00861.x; Long CA, 2003, J THEOR BIOL, V224, P9, DOI 10.1016/S0022-5193(03)00116-4; Lucas S.G., 2002, CHINESE FOSSIL VERTE; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; MATEUS O, 2006, NEW MEXICO MUSEUM NA, V36; McCarthy D, 2005, J BIOGEOGR, V32, P2161, DOI 10.1111/j.1365-2699.2005.01355.x; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; Melville J, 2006, P ROY SOC B-BIOL SCI, V273, P557, DOI 10.1098/rspb.2005.3328; Midgley JJ, 2002, EVOL ECOL RES, V4, P1093; Miller ER, 1999, J HUM EVOL, V36, P519, DOI 10.1006/jhev.1998.0286; MILTON K, 1976, NATURE, V259, P459, DOI 10.1038/259459a0; MORRIS PJ, 1995, P NATL ACAD SCI USA, V92, P11269, DOI 10.1073/pnas.92.24.11269; NAKATA H, 1994, AUTOMATIC CONTROL - WORLD CONGRESS 1993, VOL 5, P1; *PAL, 2010, PAL DAT; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Plotnick RE, 2000, PALEOBIOLOGY, V26, P305, DOI 10.1666/0094-8373(2000)26[305:IBEFAI]2.0.CO;2; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reed Kaye E., 2002, P217; Reed KE, 1998, PALEOBIOLOGY, V24, P384; REED KE, 1996, PALEOECOLOGY MAKAPAN; Rees P, 2005, J VERTEBR PALEONTOL, V25, p103A; Rees PM, 2004, J GEOL, V112, P643, DOI 10.1086/424577; Rees PM, 2000, WARM CLIMATES EARTH, P297, DOI [DOI 10.1017/CB09780511564512.011, 10.1017/CBO9780511564512.011]; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Rogers RR, 2010, PALEOBIOLOGY, V36, P80, DOI 10.1666/0094-8373-36.1.80; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Salgado L, 2008, J VERTEBR PALEONTOL, V28, P529, DOI 10.1671/0272-4634(2008)28[529:FLJDBF]2.0.CO;2; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Schiermeier Q, 2003, NATURE, V424, P482, DOI 10.1038/424482a; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Sellwood BW, 2008, P GEOLOGIST ASSOC, V119, P5, DOI 10.1016/S0016-7878(59)80068-7; Sereno Paul C., 1999, National Science Museum Monographs, V15, P249; Smith RMH, 2002, PALAIOS, V17, P249, DOI 10.1669/0883-1351(2002)017<0249:CFEAVT>2.0.CO;2; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Soto M, 2008, J VERTEBR PALEONTOL, V28, P439, DOI 10.1671/0272-4634(2008)28[439:ACDTFT]2.0.CO;2; SPEAKMAN JR, 1993, EVOLUTION, V47, P336, DOI 10.1111/j.1558-5646.1993.tb01226.x; Stevens Kent A., 2005, P212; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Thulborn RA, 2003, NEUES JAHRB GEOL P-A, V229, P61; Turner CE, 2004, SEDIMENT GEOL, V167, P309, DOI 10.1016/j.sedgeo.2004.01.009; Turner Christine E., 1999, P77; Tutken T, 2004, PALAEOGEOGR PALAEOCL, V206, P217, DOI 10.1016/j.palaeo.2004.01.005; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Van Valkenburgh B, 2002, PALEOBIOLOGY, V28, P527, DOI 10.1666/0094-8373(2002)028<0527:DAMPC>2.0.CO;2; VANVALKENBURGH B, 1995, TRENDS ECOL EVOL, V10, P71, DOI 10.1016/S0169-5347(00)88980-6; Vermeij GJ, 2003, PALEOBIOLOGY, V29, P3, DOI 10.1666/0094-8373(2003)029<0003:DGDMA>2.0.CO;2; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wendler J, 2002, PALAEOGEOGR PALAEOCL, V179, P19, DOI 10.1016/S0031-0182(01)00366-2; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; Willis K. J., 2002, EVOLUTION PLANTS; Wright JL, 1999, SP PALAEONT, P209; ZIEGLER AM, 1993, PHILOS T ROY SOC B, V341, P297, DOI 10.1098/rstb.1993.0115	118	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12553	10.1371/journal.pone.0012553	http://dx.doi.org/10.1371/journal.pone.0012553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838442	Green Published, gold			2022-12-25	WOS:000281627700006
J	Brennan, SK; Wang, Q; Tressler, R; Harley, C; Go, N; Bassett, E; Huff, CA; Jones, RJ; Matsui, W				Brennan, Sarah K.; Wang, Qiuju; Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina; Huff, Carol Ann; Jones, Richard J.; Matsui, William			Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; REVERSE-TRANSCRIPTASE; IN-VIVO; TEMPLATE ANTAGONIST; GROWTH ARREST; LIFE-SPAN; CANCER; GRN163L; RNA; OLIGONUCLEOTIDE	Background: Plasma cells constitute the majority of tumor cells in multiple myeloma (MM) but lack the potential for sustained clonogenic growth. In contrast, clonotypic B cells can engraft and recapitulate disease in immunodeficient mice suggesting they serve as the MM cancer stem cell (CSC). These tumor initiating B cells also share functional features with normal stem cells such as drug resistance and self-renewal potential. Therefore, the cellular processes that regulate normal stem cells may serve as therapeutic targets in MM. Telomerase activity is required for the maintenance of normal adult stem cells, and we examined the activity of the telomerase inhibitor imetelstat against MM CSC. Moreover, we carried out both long and short-term inhibition studies to examine telomere length-dependent and independent activities. Methodology/Principal Findings: Human MM CSC were isolated from cell lines and primary clinical specimens and treated with imetelstat, a specific inhibitor of the reverse transcriptase activity of telomerase. Two weeks of exposure to imetelstat resulted in a significant reduction in telomere length and the inhibition of clonogenic MM growth both in vitro and in vivo. In addition to these relatively long-term effects, 72 hours of imetelstat treatment inhibited clonogenic growth that was associated with MM CSC differentiation based on expression of the plasma cell antigen CD138 and the stem cell marker aldehyde dehydrogenase. Short-term treatment of MM CSC also decreased the expression of genes typically expressed by stem cells (OCT3/4, SOX2, NANOG, and BMI1) as revealed by quantitative real-time PCR. Conclusions: Telomerase activity regulates the clonogenic growth of MM CSC. Moreover, reductions in MM growth following both long and short-term telomerase inhibition suggest that it impacts CSC through telomere length-dependent and independent mechanisms.	[Brennan, Sarah K.; Wang, Qiuju; Huff, Carol Ann; Jones, Richard J.; Matsui, William] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina] Geron Corp, Menlo Pk, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Geron Corporation	Brennan, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	matsuwi@jhmi.edu		Matsui, William/0000-0002-3088-0964	National Institutes of Health [R01CA127574, P01CA015396, K23CA107040]; Gabrielle Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Goodwin Foundation; Geron Corporation; NATIONAL CANCER INSTITUTE [K23CA107040, R01CA127574, P01CA015396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Goodwin Foundation; Geron Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Institutes of Health (R01CA127574, P01CA015396, K23CA107040), the Gabrielle Angel Foundation for Cancer Research, the Sidney Kimmel Foundation for Cancer Research, and the Goodwin Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for the research was also provided by the Geron Corporation to W. M. R. T., C. H., N.G., and E. B., who are employees of Geron. This funder therefore had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Akiyama M, 2003, CANCER RES, V63, P6187; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWER V, J NATL CANC I, V102, P520; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Engelhardt M, 2000, CANCER RES, V60, P610; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Galderisi U, 1999, J CELL PHYSIOL, V181, P251, DOI 10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Guo CH, 2001, J UROLOGY, V166, P694, DOI 10.1016/S0022-5347(05)66045-4; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Hashizume R, 2008, NEURO-ONCOLOGY, V10, P112, DOI 10.1215/15228517-2007-052; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Jackson SR, 2007, CANCER RES, V67, P1121, DOI 10.1158/0008-5472.CAN-06-2306; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kraemer Kai, 2007, V405, P9, DOI 10.1007/978-1-60327-070-0_2; Laubach JP, 2009, LEUKEMIA, V23, P2222, DOI 10.1038/leu.2009.179; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; MARIAN CO, CLIN CANC RES, V16, P154; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rossi A, 2009, INT J CANCER, V125, P235, DOI 10.1002/ijc.24331; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shammas MA, 2003, MOL CANCER THER, V2, P825; Shay JW, 1997, J CELL PHYSIOL, V173, P266, DOI 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shea-Herbert B, 2002, ONCOGENE, V21, P638, DOI 10.1038/sj.onc.1205064; Shiratsuchi M, 2002, CANCER, V94, P2232, DOI 10.1002/cncr.10472; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Strahl C, 1996, MOL CELL BIOL, V16, P53; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Wang ES, 2004, BLOOD, V103, P258, DOI 10.1182/blood-2003-02-0546; Wright WE, 1996, DEV GENET, V18, P173; Wu KD, 2003, BLOOD, V101, P4982, DOI 10.1182/blood-2002-11-3451; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yokoyama Y, 1998, CANCER RES, V58, P5406; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	63	60	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12487	10.1371/journal.pone.0012487	http://dx.doi.org/10.1371/journal.pone.0012487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824134	Green Published, Green Submitted, gold			2022-12-25	WOS:000281456100008
J	Steensland, P; Simms, JA; Nielsen, CK; Holgate, J; Bito-Onon, JJ; Bartlett, SE				Steensland, Pia; Simms, Jeffrey A.; Nielsen, Carsten K.; Holgate, Joan; Bito-Onon, Jade J.; Bartlett, Selena E.			The Neurokinin 1 Receptor Antagonist, Ezlopitant, Reduces Appetitive Responding for Sucrose and Ethanol	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; FOOD-INTAKE; BEHAVIORAL SENSITIZATION; INDUCED REINSTATEMENT; DRUG-ADDICTION; MICE LACKING; LONG-EVANS; SUGAR; CONSUMPTION; MORPHINE	Background: The current obesity epidemic is thought to be partly driven by over-consumption of sugar-sweetened diets and soft drinks. Loss-of-control over eating and addiction to drugs of abuse share overlapping brain mechanisms including changes in motivational drive, such that stimuli that are often no longer 'liked' are still intensely 'wanted' [7,8]. The neurokinin 1 (NK1) receptor system has been implicated in both learned appetitive behaviors and addiction to alcohol and opioids; however, its role in natural reward seeking remains unknown. Methodology/Principal Findings: We sought to determine whether the NK1-receptor system plays a role in the reinforcing properties of sucrose using a novel selective and clinically safe NK1-receptor antagonist, ezlopitant (CJ-11,974), in three animal models of sucrose consumption and seeking. Furthermore, we compared the effect of ezlopitant on ethanol consumption and seeking in rodents. The NK1-receptor antagonist, ezlopitant decreased appetitive responding for sucrose more potently than for ethanol using an operant self-administration protocol without affecting general locomotor activity. To further evaluate the selectivity of the NK1-receptor antagonist in decreasing consumption of sweetened solutions, we compared the effects of ezlopitant on water, saccharin-, and sodium chloride (NaCl) solution consumption. Ezlopitant decreased intake of saccharin but had no effect on water or salty solution consumption. Conclusions/Significance: The present study indicates that the NK1-receptor may be a part of a common pathway regulating the self-administration, motivational and reinforcing aspects of sweetened solutions, regardless of caloric value, and those of substances of abuse. Additionally, these results indicate that the NK1-receptor system may serve as a therapeutic target for obesity induced by over-consumption of natural reinforcers.	[Steensland, Pia; Simms, Jeffrey A.; Nielsen, Carsten K.; Holgate, Joan; Bito-Onon, Jade J.; Bartlett, Selena E.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Steensland, Pia] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Karolinska Institutet	Steensland, P (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	selenab@gallo.ucsf.edu	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958; Steensland, Pia/0000-0003-4443-5017; Holgate, Joan/0000-0002-7953-0180	State of California for Medical Research through University of California San Francisco (UCSF) and Department of Defense [W81XWH-08-1-0016, W81XWH-07-1-0075]; Sidney Baer Trust; Foundation BLANCEFLOR Boncompagni-Ludovisi; Sweden-America Foundation; Insamlingsstiftelsen Hjarnfonden/The Swedish Brain Foundation; Swedish Research Council; Pfizer Inc.	State of California for Medical Research through University of California San Francisco (UCSF) and Department of Defense; Sidney Baer Trust; Foundation BLANCEFLOR Boncompagni-Ludovisi; Sweden-America Foundation; Insamlingsstiftelsen Hjarnfonden/The Swedish Brain Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Pfizer Inc.(Pfizer)	This work was supported by funding from the State of California for Medical Research through University of California San Francisco (UCSF) and Department of Defense Grant W81XWH-08-1-0016 and W81XWH-07-1-0075 to S. E. B. S. E. B. and C.K.N. were supported in part by the Sidney Baer Trust as a National Alliance for Research on Schizophrenia and Depression Young Investigator. P. S. was supported in part by The Foundation BLANCEFLOR Boncompagni-Ludovisi, nee Bildt, The Sweden-America Foundation, Insamlingsstiftelsen Hjarnfonden/The Swedish Brain Foundation and The Swedish Research Council. The experiments contained herein comply with the current laws of the United States of America. S. E. B. received a research grant from Pfizer Inc. for varenicline studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2005, PHYSIOL BEHAV, V84, P359, DOI 10.1016/j.physbeh.2004.12.016; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; BECZKOWSKA IW, 1992, BRAIN RES, V589, P291, DOI 10.1016/0006-8993(92)91289-Q; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoud HR, 2006, OBESITY, V14, P197; Blundell JE, 2001, OBES RES, V9, p263S, DOI 10.1038/oby.2001.129; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; BRAY GA, 1992, AM J CLIN NUTR, V55, P151; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Dableh LJ, 2005, EUR J PHARMACOL, V507, P99, DOI 10.1016/j.ejphar.2004.11.024; DAnci KE, 1996, PHARMACOL BIOCHEM BE, V54, P693, DOI 10.1016/0091-3057(96)00016-0; Gadd CA, 2003, J NEUROSCI, V23, P8271, DOI 10.1523/jneurosci.23-23-08271.2003; Galic MA, 2002, PSYCHOL REP, V90, P58, DOI 10.2466/pr0.2002.90.1.58; George DT, 2008, SCIENCE, V319, P1536, DOI 10.1126/science.1153813; GIANOULAKIS C, 2009, CURR TOP MED CHEM; Gosnell BA, 2005, BRAIN RES, V1031, P194, DOI 10.1016/j.brainres.2004.10.037; Grimm JW, 2008, BEHAV PHARMACOL, V19, P777, DOI 10.1097/FBP.0b013e32831c3b18; Grimm JW, 2005, PHYSIOL BEHAV, V84, P73, DOI 10.1016/j.physbeh.2004.10.011; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; Hesketh PJ, 1999, J CLIN ONCOL, V17, P338, DOI 10.1200/JCO.1999.17.1.338; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Howard BV, 2002, CIRCULATION, V106, P523, DOI 10.1161/01.CIR.0000019552.77778.04; Jabourian M, 2005, EUR J NEUROSCI, V21, P3301, DOI 10.1111/j.1460-9568.2005.04154.x; Kanarek RB, 1997, PHARMACOL BIOCHEM BE, V57, P377, DOI 10.1016/S0091-3057(96)00337-1; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; LIEBLICH I, 1983, SCIENCE, V221, P871, DOI 10.1126/science.6879185; LOWE JA, 1992, J MED CHEM, V35, P2591, DOI 10.1021/jm00092a009; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Mercer ME, 1997, APPETITE, V29, P325, DOI 10.1006/appe.1997.0100; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Nielsen CK, 2008, BIOL PSYCHIAT, V64, P974, DOI 10.1016/j.biopsych.2008.07.018; Pickel VM, 2000, J COMP NEUROL, V423, P500, DOI 10.1002/1096-9861(20000731)423:3<500::AID-CNE12>3.0.CO;2-9; Poulin JF, 2006, J COMP NEUROL, V496, P859, DOI 10.1002/cne.20956; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Reed-Hagen AE, 1999, BIOPHARM DRUG DISPOS, V20, P429, DOI 10.1002/1099-081X(199912)20:9<429::AID-BDD209>3.0.CO;2-D; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Ripley TL, 2002, NEUROPHARMACOLOGY, V43, P1258, DOI 10.1016/S0028-3908(02)00295-2; Rudski JM, 1997, PHARMACOL BIOCHEM BE, V58, P679, DOI 10.1016/S0091-3057(97)00019-1; SAMSON HH, 1986, ALCOHOL CLIN EXP RES, V10, P436, DOI 10.1111/j.1530-0277.1986.tb05120.x; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Seneviratne C, 2009, NEUROPSYCHOPHARMACOL, V34, P2442, DOI 10.1038/npp.2009.65; Shalev U, 2001, J NEUROSCI, V21; Shimura T, 2002, BEHAV BRAIN RES, V134, P123, DOI 10.1016/S0166-4328(01)00461-2; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Stromberg MF, 2002, PHARMACOL BIOCHEM BE, V72, P483, DOI 10.1016/S0091-3057(02)00721-9; Tanda GL, 1998, EUR J NEUROSCI, V10, P1179, DOI 10.1046/j.1460-9568.1998.00135.x; Tsuchiya M, 2002, PHARMACOLOGY, V66, P144, DOI 10.1159/000063796; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009	62	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12527	10.1371/journal.pone.0012527	http://dx.doi.org/10.1371/journal.pone.0012527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824145	Green Published, gold, Green Submitted			2022-12-25	WOS:000281456100022
J	Drews, C; Han, WQ				Drews, Carl; Han, Weiqing			Dynamics of Wind Setdown at Suez and the Eastern Nile Delta	PLOS ONE			English	Article							STORM SURGES; RED-SEA; MODEL; ANCIENT; EGYPT; SIMULATIONS; CHANNELS; PELUSIUM; DEMISE; IMPACT	Background: Wind setdown is the drop in water level caused by wind stress acting on the surface of a body of water for an extended period of time. As the wind blows, water recedes from the upwind shore and exposes terrain that was formerly underwater. Previous researchers have suggested wind setdown as a possible hydrodynamic explanation for Moses crossing the Red Sea, as described in Exodus 14. Methodology/Principal Findings: This study analyzes the hydrodynamic mechanism proposed by earlier studies, focusing on the time needed to reach a steady-state solution. In addition, the authors investigate a site in the eastern Nile delta, where the ancient Pelusiac branch of the Nile once flowed into a coastal lagoon then known as the Lake of Tanis. We conduct a satellite and modeling survey to analyze this location, using geological evidence of the ancient bathymetry and a historical description of a strong wind event in 1882. A suite of model experiments are performed to demonstrate a new hydrodynamic mechanism that can cause an angular body of water to divide under wind stress, and to test the behavior of our study location and reconstructed topography. Conclusions/Significance: Under a uniform 28 m/s easterly wind forcing in the reconstructed model basin, the ocean model produces an area of exposed mud flats where the river mouth opens into the lake. This land bridge is 3-4 km long and 5 km wide, and it remains open for 4 hours. Model results indicate that navigation in shallow-water harbors can be significantly curtailed by wind setdown when strong winds blow offshore.	[Drews, Carl; Han, Weiqing] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Drews, Carl] Natl Ctr Atmospher Res, NCAR Earth Syst Lab, Boulder, CO 80307 USA	University of Colorado System; University of Colorado Boulder; National Center Atmospheric Research (NCAR) - USA	Drews, C (corresponding author), Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA.	drews@ucar.edu		Drews, Carl/0000-0002-0535-6538	Office of Naval Research (ONR) [N00014-07-1-0413]; NASA [1283568]; NSF [OCE 0847605]; National Science Foundation	Office of Naval Research (ONR)(Office of Naval Research); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The authors are grateful to the University Corporation for Atmospheric Research (UCAR/NCAR) for tuition and computational support for the lead author, Carl Drews, and for support by the Office of Naval Research (ONR) N00014-07-1-0413. Weiqing Han is also supported by NASA Ocean Vector Wind Science Team 1283568 and NSF CAREER OCE 0847605. The National Center for Atmospheric Research is sponsored by the National Science Foundation. Any opinions, findings and conclusions or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIETAK M, 1995, AVARIS CAPITAL HYKSO; *BIRDLIFE INT, 2008, BIRDLIFES ONL WORLD; El Mahmoudi A, 2009, ARAB J GEOSCI, V2, P53, DOI 10.1007/s12517-008-0018-9; FITZPATRICK PJ, 2007, 21 C HYDR 87 ANN M A; Goodfriend GA, 1999, GEOLOGY, V27, P147, DOI 10.1130/0091-7613(1999)027<0147:RSPAIT>2.3.CO;2; *GOOGL EARTH PRO, 2009, E NIL DELT; Haidvogel DB, 2000, DYNAM ATMOS OCEANS, V32, P239, DOI 10.1016/S0377-0265(00)00049-X; Han WQ, 2009, DYNAM ATMOS OCEANS, V47, P114, DOI 10.1016/j.dynatmoce.2008.10.007; Hipel KW, 1994, TIME SERIES MODELLIN; Hoffmeier J. K., 2005, ANCIENT ISRAEL SINAI; Jarosz E, 2007, SCIENCE, V315, P1707, DOI 10.1126/science.1136466; KITCHEN KA, 2003, RELIABILITY OLD TEST; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Moore AM, 2004, OCEAN MODEL, V7, P227, DOI 10.1016/j.ocemod.2003.11.001; Moshier SO, 2008, GEOARCHAEOLOGY, V23, P450, DOI 10.1002/gea.20227; MOUSSA AMA, 2007, 11 INT WAT TECHN C T, P423; *NASA WORLD WIND, 2009, E NIL DAT; NOF D, 1992, B AM METEOROL SOC, V73, P305, DOI 10.1175/1520-0477(1992)073<0305:ATOEFT>2.0.CO;2; NOF D, 1994, J APPL METEOROL, V33, P1017, DOI 10.1175/1520-0450(1994)033<1017:SOWOTR>2.0.CO;2; Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; PTOLEMY C, 1932, GEOGRAPHY BOOK 4, pCH5; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; RIPLEY G, 1875, AM CYCLOPAEDIA POPUL; RITTER DF, 1830, PROCESS GEOMORPHOLOG, pCH7; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; SNEH A, 1975, AM SCI, V63, P542; SNEH A, 1973, SCIENCE, V180, P59, DOI 10.1126/science.180.4081.59; STANLEY DJ, 1993, SCIENCE, V260, P628, DOI 10.1126/science.260.5108.628; Stanley JD, 2008, J COASTAL RES, V24, P451, DOI 10.2112/07A-0021.1; Tulloch A. B., 1896, J T VICTORIA I NOW F, V28, P267; *US GEOL SURV, 2008, NASA SHUTTL RAD TOP; Voltzinger NE, 2003, IZV ATMOS OCEAN PHY+, V39, P482; VONPETERMANN A, 1856, KARTE BAI SUES; Waldron J. C., 1996, NILE DELTA DRILL COR; Wang SY, 2008, OCEAN MODEL, V25, P83, DOI 10.1016/j.ocemod.2008.06.009; Warner JC, 2004, ESTUAR COAST SHELF S, V60, P213, DOI 10.1016/j.ecss.2003.12.011; Weisberg RH, 2006, ESTUAR COAST, V29, P899, DOI 10.1007/BF02798649; HERODOTUS HALICARNAS	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12481	10.1371/journal.pone.0012481	http://dx.doi.org/10.1371/journal.pone.0012481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20827299	gold, Green Published, Green Submitted			2022-12-25	WOS:000281375500014
J	Ahmad, I; Morton, JP; Singh, LB; Radulescu, SM; Ridgway, RA; Patel, S; Woodgett, J; Winton, DJ; Taketo, MM; Wu, XR; Leung, HY; Sansom, OJ				Ahmad, I.; Morton, J. P.; Singh, L. B.; Radulescu, S. M.; Ridgway, R. A.; Patel, S.; Woodgett, J.; Winton, D. J.; Taketo, M. M.; Wu, X-R; Leung, H. Y.; Sansom, O. J.			beta-Catenin activation synergizes with PTEN loss to cause bladder cancer formation	ONCOGENE			English	Article						beta-catenin; PTEN; urothelial cell carcinoma; bladder cancer	PROGNOSTIC VALUE; EPIGENETIC INACTIVATION; ADENOMATOUS POLYPOSIS; GAMMA-CATENIN; E-CADHERIN; CYCLIN D1; C-MYC; APC; EXPRESSION; GENE	Although deregulation of the Wnt signalling pathway has been implicated in urothelial cell carcinoma (UCC), the functional significance is unknown. To test its importance, we have targeted expression of an activated form of beta-catenin to the urothelium of transgenic mice using Cre-Lox technology (UroIICRE(+) beta-catenin(exon3/+)). Expression of this activated form of beta-catenin led to the formation of localized hyperproliferative lesions by 3 months, which did not progress to malignancy. These lesions were characterized by a marked increase of the phosphatase and tensin homologue (PTEN) tumour suppressor protein. This appears to be a direct consequence of activating Wnt signalling in the bladder as conditional deletion of the adenomatous polyposis coli (Apc) gene within the adult bladder led rapidly to coincident beta-catenin and PTEN expression. This PTEN expression blocked proliferation. Next, we combined PTEN deficiency with beta-catenin activation and found that this caused papillary UCC. These tumours had increased pAKT signalling and were dependent on mammalian target of rapamycin (mTOR). Importantly, in human UCC, there was a significant correlation between high levels of beta-catenin and pAKT (and low levels of PTEN). Taken together these data show that deregulated Wnt signalling has a critical role in promoting UCC, and suggests that human UCC that have high levels of Wnt and PI3 kinase signalling may be responsive to mTOR inhibition. Oncogene (2011) 30, 178-189; doi:10.1038/onc.2010.399; published online 6 September 2010	[Ahmad, I.; Morton, J. P.; Singh, L. B.; Radulescu, S. M.; Ridgway, R. A.; Leung, H. Y.; Sansom, O. J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Morton, J. P.] Univ Glasgow, Ctr Oncol & Appl Pharmacol, Glasgow, Lanark, Scotland; [Patel, S.; Woodgett, J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Winton, D. J.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Oncol, Cambridge, England; [Taketo, M. M.] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto, Japan; [Wu, X-R] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Wu, X-R] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA	Beatson Institute; University of Glasgow; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Kyoto University; New York University; New York University	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Morton, Jennifer/AAJ-5113-2021; Woodgett, Jim/F-1087-2010; Morton, Jennifer P/E-1633-2011	Morton, Jennifer/0000-0001-5766-9141; Woodgett, Jim/0000-0003-3731-5797; Morton, Jennifer P/0000-0001-5766-9141; Sansom, Owen J./0000-0001-9540-3010; Ahmad, Imran/0000-0002-4404-1926; Wu, Xue-Ru/0000-0001-6058-6291; Leung, Hing Y./0000-0002-3933-3975	Cancer Research UK; MRC; AICR; Cancer Research UK [12481] Funding Source: researchfish; Medical Research Council [G0802141, G0900871] Funding Source: researchfish; MRC [G0900871, G0802141] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AICR; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Cancer Research UK and a MRC fellowship to Imran Ahmad and AICR grant to Sorina Radulescu. We thank BICR services, biological services unit, and Colin Nixon and his histology department. We also thank the 'Think Pink' charity for the purchase of the Aperio slide scanner and the Slidepath software.	Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bohm M, 1997, INT J CANCER, V74, P291; Burger M, 2008, EUR UROL, V54, P835, DOI 10.1016/j.eururo.2007.12.026; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; DIAZ DS, 2008, MINERVA UROL NEFROL, V60, P205; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; GARCIA DX, 2000, EUR J CANCER, V36, P357; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kashibuchi K, 2006, EUR UROL, V49, P839, DOI 10.1016/j.eururo.2005.12.023; Kastritis E, 2009, INT J CANCER, V124, P103, DOI 10.1002/ijc.23917; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miyamoto H, 1996, J UROLOGY, V155, P1444, DOI 10.1016/S0022-5347(01)66304-3; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Nakopoulou L, 2000, ANTICANCER RES, V20, P4571; Namba R, 2006, CLIN CANCER RES, V12, P2613, DOI 10.1158/1078-0432.CCR-05-2170; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Polakis P, 2000, GENE DEV, V14, P1837; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schulz WA, 2006, INT J CANCER, V119, P1513, DOI 10.1002/ijc.21852; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shiina H, 2002, J UROLOGY, V168, P2220, DOI 10.1016/S0022-5347(05)64359-5; Shiina H, 2001, CANCER RES, V61, P7101; Shimazui T, 1996, CANCER RES, V56, P4154; Stoehr R, 2002, INT J ONCOL, V20, P905; Teng DHF, 1997, CANCER RES, V57, P5221; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsuruta H, 2006, CANCER RES, V66, P8389, DOI 10.1158/0008-5472.CAN-05-4627; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zhang ZT, 1999, CANCER RES, V59, P3512; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315; Zhu XD, 2000, PATHOL INT, V50, P945, DOI 10.1046/j.1440-1827.2000.01139.x	58	74	74	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					178	189		10.1038/onc.2010.399	http://dx.doi.org/10.1038/onc.2010.399			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20818428	Green Accepted			2022-12-25	WOS:000286438900006
J	Wu, H; Lin, YY; Li, WG; Sun, Z; Gao, WW; Zhang, HP; Xie, L; Jiang, FQ; Qin, B; Yan, TD; Chen, LQ; Zhao, Y; Cao, XH; Wu, Y; Lin, BZ; Zhou, H; Wong, AST; Zhang, XK; Zeng, JZ				Wu, Hua; Lin, Yayu; Li, Wengang; Sun, Zhe; Gao, Weiwei; Zhang, Haiping; Xie, Lei; Jiang, Fuquan; Qin, Bin; Yan, Tingdong; Chen, Liqun; Zhao, Yi; Cao, Xihua; Wu, Yin; Lin, Bingzhen; Zhou, Hu; Wong, Alice Sze-Tsai; Zhang, Xiao-Kun; Zeng, Jin-Zhang			Regulation of Nur77 expression by beta-catenin and its mitogenic effect in colon cancer cells	FASEB JOURNAL			English	Article						AP-1; PI3K; JNK; bile acid	ORPHAN RECEPTOR GENE; NERVE GROWTH-FACTOR; HUMAN COLORECTAL-CANCER; ABERRANT CRYPT FOCI; STEROID-RECEPTOR; BILE-ACIDS; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAYS; TUMOR-GROWTH; RAT COLON	The orphan nuclear receptor Nur77 is an immediate-early response gene whose expression is rapidly induced by various extracellular stimuli. The aims of this study were to study the role of Nur77 expression in the growth and survival of colon cancer cells and the mechanism by which Nur77 expression was regulated. We showed that levels of Nur77 were elevated in a majority of human colon tumors (9/12) compared to their nontumorous tissues and that Nur77 expression could be strongly induced by different colonic carcinogens including deoxycholic acid (DCA). DCA-induced Nur77 expression resulted in up-regulation of antiapoptotic BRE and angiogenic VEGF, and it enhanced the growth, colony formation, and migration of colon cancer cells. In studying the mechanism by which Nur77 was regulated in colon cancer cells, we found that beta-catenin was involved in induction of Nur77 expression through its activation of the transcriptional activity of AP-1 (c-Fos/c-Jun) that bound to and transactivated the Nur77 promoter. Together, our results demonstrate that Nur77 acts to promote the growth and survival of colon cancer cells and serves as an important mediator of the Wnt/beta-catenin and AP-1 signaling pathways.-Wu, H., Lin, Y., Li, W., Sun, Z., Gao, W., Zhang, H., Xie, L., Jiang, F., Qin, B., Yan, T., Chen, L., Zhao, Y., Cao, X., Wu, Y., Lin, B., Zhou, H., Wong, A.S.-T., Zhang, X.-K., Zeng, J.-Z. Regulation of Nur77 expression by beta-catenin and its mitogenic effect in colon cancer cells. FASEB J. 25, 192-205 (2011). www.fasebj.org	[Zeng, Jin-Zhang] Xiamen Univ, Inst Biomed Res, Ctr Canc, Xiamen 361005, Peoples R China; [Li, Wengang; Zhang, Haiping] Xiamen Univ, Hosp Xiamen 1, Xiamen 361005, Peoples R China; [Cao, Xihua; Wu, Yin; Lin, Bingzhen; Zhou, Hu; Zhang, Xiao-Kun] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Wong, Alice Sze-Tsai] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Xiamen University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; University of Hong Kong	Zeng, JZ (corresponding author), Xiamen Univ, Inst Biomed Res, Ctr Canc, Xiamen 361005, Peoples R China.	xzhang@burnham.org; jzzeng@xmu.edu.cn	Zeng, JZ/G-3377-2010; Wu, Hua/W-4204-2019; Wong, Alice/AFJ-4595-2022	Wong, Alice/0000-0002-0676-6475	863 Program [2007AA09Z404]; National Natural Science Foundation of China (NSFC) [30971445]; Key Science and Technology Planning Project [2007I0023]; Natural Science Foundation of Fujian Province, China [2009J01198]; NSFC/Hong Kong Research Grants Council (RGC) [30931160431]; U.S. National Institutes of Health [CA109345, CA140980, GM089927]; U.S. Army Medical Research and Material Command [PCRPW81XWH-08-1-0478]; Natural Science Foundation of Fujian Province [2008Y0062];  [N_HKU 735/09]; NATIONAL CANCER INSTITUTE [R01CA140980, R01CA109345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089927] Funding Source: NIH RePORTER	863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Science and Technology Planning Project; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); NSFC/Hong Kong Research Grants Council (RGC)(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by grants to J.-Z.Z. from the 863 Program (2007AA09Z404), the National Natural Science Foundation of China (NSFC; 30971445), the Key Science and Technology Planning Project (2007I0023), the Natural Science Foundation of Fujian Province, China (2009J01198), and the NSFC/Hong Kong Research Grants Council (RGC; 30931160431), a grant to A.S.-T.W. (N_HKU 735/09), and grants to X.Z. from the U.S. National Institutes of Health (CA109345, CA140980, GM089927), the U.S. Army Medical Research and Material Command (PCRPW81XWH-08-1-0478), and the Natural Science Foundation of Fujian Province (2008Y0062). The authors declare no conflicts of interest.	Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blum CA, 2001, CARCINOGENESIS, V22, P315, DOI 10.1093/carcin/22.2.315; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Chiu BCH, 2003, CANCER EPIDEM BIOMAR, V12, P201; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Flynn C, 2007, MOL CARCINOGEN, V46, P60, DOI 10.1002/mc.20253; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Hirose Y, 2003, CARCINOGENESIS, V24, P107, DOI 10.1093/carcin/24.1.107; Hlubek F, 2001, CANCER RES, V61, P8089; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Ikari A, 2010, J CELL PHYSIOL, V222, P481, DOI 10.1002/jcp.21988; IMRAY CHE, 1992, GUT, V33, P1239, DOI 10.1136/gut.33.9.1239; Inaoka Y, 2008, MOL REPROD DEV, V75, P931, DOI 10.1002/mrd.20788; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Lee MO, 2001, BIOCHEM BIOPH RES CO, V288, P1162, DOI 10.1006/bbrc.2001.5910; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin CX, 2001, CANCER LETT, V169, P121, DOI 10.1016/S0304-3835(01)00525-0; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2008, CANCER RES, V68, P8871, DOI 10.1158/0008-5472.CAN-08-1972; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mai V, 2003, CANCER RES, V63, P1752; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Mimori-Kiyosue Y, 2001, J CELL BIOL, V154, P1105, DOI 10.1083/jcb.200106113; Pai R, 2004, MOL BIOL CELL, V15, P2156, DOI 10.1091/mbc.E03-12-0894; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Raufman JP, 2008, J CELL PHYSIOL, V215, P538, DOI 10.1002/jcp.21332; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; UEMURA H, 1995, J BIOL CHEM, V270, P5427, DOI 10.1074/jbc.270.10.5427; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WILLIAMS GT, 1993, MOL CELL BIOL, V13, P6124, DOI 10.1128/MCB.13.10.6124; Wilson AJ, 2003, CANCER RES, V63, P5401; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Zeng Jin-Zhang, 2007, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V6, P315, DOI 10.2174/187152307783220022; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69	63	90	93	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					192	205		10.1096/fj.10-166462	http://dx.doi.org/10.1096/fj.10-166462			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20847229	Green Published			2022-12-25	WOS:000285869500018
J	Hinault, MP; Cuendet, AFH; Mattoo, RUH; Mensi, M; Dietler, G; Lashuel, HA; Goloubinoff, P				Hinault, Marie-Pierre; Cuendet, America Farina Henriquez; Mattoo, Rayees U. H.; Mensi, Mounir; Dietler, Giovanni; Lashuel, Hilal A.; Goloubinoff, Pierre			Stable alpha-Synuclein Oligomers Strongly Inhibit Chaperone Activity of the Hsp70 System by Weak Interactions with J-domain Co-chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; IN-VITRO; ESCHERICHIA-COLI; FIBRIL FORMATION; DNAK CHAPERONE; LEWY BODIES; VESICLE PERMEABILIZATION; SUBSTRATE-SPECIFICITY; MOLECULAR CHAPERONES; INDUCED TOXICITY	alpha-Synuclein aggregation and accumulation in Lewy bodies are implicated in progressive loss of dopaminergic neurons in Parkinson disease and related disorders. In neurons, the Hsp70s and their Hsp40-like J-domain co-chaperones are the only known components of chaperone network that can use ATP to convert cytotoxic protein aggregates into harmless natively refolded polypeptides. Here we developed a protocol for preparing a homogeneous population of highly stable beta-sheet enriched toroid-shaped alpha-Syn oligomers with a diameter typical of toxic pore-forming oligomers. These oligomers were partially resistant to in vitro unfolding by the bacterial Hsp70 chaperone system (DnaK, DnaJ, GrpE). Moreover, both bacterial and human Hsp70/Hsp40 unfolding/refolding activities of model chaperone substrates were strongly inhibited by the oligomers but, remarkably, not by unstructured alpha-Syn monomers even in large excess. The oligomers acted as a specific competitive inhibitor of the J-domain co-chaperones, indicating that J-domain co-chaperones may preferably bind to exposed bulky misfolded structures in misfolded proteins and, thus, complement Hsp70s that bind to extended segments. Together, our findings suggest that inhibition of the Hsp70/Hsp40 chaperone system by alpha-Syn oligomers may contribute to the disruption of protein homeostasis in dopaminergic neurons, leading to apoptosis and tissue loss in Parkinson disease and related neurodegenerative diseases.	[Hinault, Marie-Pierre; Cuendet, America Farina Henriquez; Mattoo, Rayees U. H.; Goloubinoff, Pierre] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Mensi, Mounir; Dietler, Giovanni] Ecole Polytech Fed Lausanne, IPMC SB, Lab Phys Matiere Vivante, CH-1015 Lausanne, Switzerland; [Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, Brain Mind Inst, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Goloubinoff, P (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	pierre.goloubinoff@unil.ch	Mattoo, Rayees/AAK-5052-2021; Lashuel, Hilal/M-3500-2017	Mattoo, Rayees/0000-0002-3204-6367; Goloubinoff, Pierre/0000-0002-4802-0807	Swiss National Science Foundation [3100A0-109290]; Faculty of Biology and Medicine of Lausanne University	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine of Lausanne University	This work was supported by Swiss National Science Foundation Grant 3100A0-109290 and by a Zwahlen grant from the Faculty of Biology and Medicine of Lausanne University.	Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gur E, 2004, J BACTERIOL, V186, P7236, DOI 10.1128/JB.186.21.7236-7242.2004; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Han WJ, 2004, FEBS LETT, V563, P146, DOI 10.1016/S0014-5793(04)00290-X; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hirohata M, 2008, NEUROPHARMACOLOGY, V54, P620, DOI 10.1016/j.neuropharm.2007.11.010; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Mezey E, 1998, MOL PSYCHIATR, V3, P493, DOI 10.1038/sj.mp.4000446; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; Svetlov MS, 2007, MOL BIOL+, V41, P86, DOI 10.1134/S0026893307010128; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	62	57	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38173	38182		10.1074/jbc.M110.127753	http://dx.doi.org/10.1074/jbc.M110.127753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20847048	Green Published, hybrid			2022-12-25	WOS:000284625600025
J	Lee, WY; Weber, DA; Laur, O; Stowell, SR; Mccall, I; Andargachew, R; Cummings, RD; Parkos, CA				Lee, Winston Y.; Weber, Dominique A.; Laur, Oskar; Stowell, Sean R.; Mccall, Ingrid; Andargachew, Rakieb; Cummings, Richard D.; Parkos, Charles A.			The Role of cis Dimerization of Signal Regulatory Protein alpha (SIRP alpha) in Binding to CD47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL TRANSEPITHELIAL MIGRATION; T-CELL ACTIVATION; NEGATIVE REGULATION; N-GLYCOSYLATION; IN-VITRO; RECEPTOR; SHPS-1; ASSOCIATION; DOMAIN; MACROPHAGES	Interaction of SIRP alpha with its ligand, CD47, regulates leukocyte functions, including transmigration, phagocytosis, oxidative burst, and cytokine secretion. Recent progress has provided significant insights into the structural details of the distal IgV domain (D1) of SIRP alpha. However, the structural roles of proximal IgC domains (D2 and D3) have been largely unstudied. The high degree of conservation of D2 and D3 among members of the SIRP family as well as the propensity of known IgC domains to assemble in cis has led others to hypothesize that SIRP alpha forms higher order structures on the cell surface. Here we report that SIRP alpha forms noncovalently linked cis homodimers. Treatment of SIRP alpha-expressing cells with a membrane-impermeable cross-linker resulted in the formation of SDS-stable SIRP alpha dimers and oligomers. Biochemical analyses of soluble recombinant extracellular regions of SIRP alpha, including domain truncation mutants, revealed that each of the three extracellular immunoglobulin loops of SIRP alpha formed dimers in solution. Co-immunoprecipitation experiments using cells transfected with different affinity-tagged SIRP alpha molecules revealed that SIRP alpha forms cis dimers. Interestingly, in cells treated with tunicamycin, SIRP alpha dimerization but not CD47 binding was inhibited, suggesting that a SIRP alpha dimer is probably bivalent. Last, we demonstrate robust dimerization of SIRPa in adherent, stimulated human neutrophils. Collectively, these data are consistent with SIRP alpha being expressed on the cell surface as a functional cis-linked dimer.	[Parkos, Charles A.] Emory Univ, Sch Med, Epithelial Pathobiol Unit, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Stowell, Sean R.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Parkos, CA (corresponding author), 105-B Whitehead Bldg,615 Michael St, Atlanta, GA 30332 USA.	cparkos@emory.edu			National Institutes of Health [DK079392, DK72564]; Digestive Diseases Mini-center [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK072564, R01DK079392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Mini-center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079392 and DK72564 (to C.A.P.) and Digestive Diseases Mini-center Grant DK064399 (epithelial cell culture core and microscopy core support).	ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Elkabetz Y, 2008, MOL IMMUNOL, V46, P97, DOI 10.1016/j.molimm.2008.07.005; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Lee WY, 2006, METH MOL B, V341, P205; Lee WY, 2007, J IMMUNOL, V179, P7741, DOI 10.4049/jimmunol.179.11.7741; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Miyake A, 2008, GENES CELLS, V13, P209, DOI 10.1111/j.1365-2443.2007.01161.x; Nagayama Y, 1998, J BIOL CHEM, V273, P33423, DOI 10.1074/jbc.273.50.33423; Nakaishi A, 2008, J MOL BIOL, V375, P650, DOI 10.1016/j.jmb.2007.10.085; Ogura T, 2004, J BIOL CHEM, V279, P13711, DOI 10.1074/jbc.M310276200; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Stefanidakis M, 2008, BLOOD, V112, P1280, DOI 10.1182/blood-2008-01-134429; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493	63	18	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37953	37963		10.1074/jbc.M110.180018	http://dx.doi.org/10.1074/jbc.M110.180018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20826801	hybrid, Green Published			2022-12-25	WOS:000284625600003
J	Kalra, J; Sutherland, BW; Stratford, AL; Dragowska, W; Gelmon, KA; Dedhar, S; Dunn, SE; Bally, MB				Kalra, J.; Sutherland, B. W.; Stratford, A. L.; Dragowska, W.; Gelmon, K. A.; Dedhar, S.; Dunn, S. E.; Bally, M. B.			Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1	ONCOGENE			English	Article						integrin-linked kinase; QLT0267; Her2/neu; YB-1; TWIST; STAT-3	INTEGRIN-LINKED KINASE; BOX-BINDING PROTEIN-1; GROWTH-FACTOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BREAST-CANCER; ANCHORAGE-INDEPENDENT GROWTH; GLYCOGEN-SYNTHASE KINASE; SQUAMOUS-CELL CARCINOMA; POOR PATIENT SURVIVAL; HUMAN COLON-CANCER	In a previous study it was found that the therapeutic effects of QLT0267, a small molecule inhibitor of integrin-linked kinase (ILK), were influenced by Her2/neu expression. To understand how inhibition or silencing of ILK influences Her2/neu expression, Her2/neu signaling was evaluated in six Her2/neu-positive breast cancer cell lines (LCC6(Her2), MCF7(Her2), SKBR3, BT474, JIMT-1 and KPL-4). Treatment with QLT0267 engendered suppression (32-87%) of total Her2/neu protein in these cells. Suppression of Her2/neu was also observed following small interfering RNA-mediated silencing of ILK expression. Time course studies suggest that ILK inhibition or silencing caused transient decreases in P-AKT(ser473), which were not temporally related to Her2/neu down-regulation. Attenuation of ILK activity or expression was, however, associated with decreases in YB-1 (Y-box binding protein-1) protein and transcript levels. YB-1 is a known transcriptional regulator of Her2/neu expression, and in this study it is demonstrated that inhibition of ILK activity using QLT0267 decreased YB-1 promoter activity by 50.6%. ILK inhibition was associated with changes in YB-1 localization, as reflected by localization of cytoplasmic YB-1 into stress granules. ILK inhibition also suppressed TWIST (a regulator of YB-1 expression) protein expression. To confirm the role of ILK on YB-1 and TWIST, cells were engineered to overexpress ILK. This was associated with a fourfold increase in the level of YB-1 in the nucleus, and a 2- and 1.5-fold increase in TWIST and Her2/neu protein levels, respectively. Taken together, these data indicate that ILK regulates the expression of Her2/neu through TWIST and YB-1, lending support to the use of ILK inhibitors in the treatment of aggressive Her2/neu-positive tumors. Oncogene (2010) 29, 6343-6356; doi:10.1038/onc.2010.366; published online 13 September 2010	[Kalra, J.] Univ British Columbia, British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 1L3, Canada; [Kalra, J.; Bally, M. B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada; [Stratford, A. L.; Dunn, S. E.] Women & Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada; [Dedhar, S.] Univ British Columbia, BC Canc Agcy, Dept Integrat Biol, Vancouver, BC V5Z 1L3, Canada; [Dedhar, S.] Univ British Columbia, Dept Biochem, Vancouver, BC V5Z 1L3, Canada; [Dunn, S. E.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 1L3, Canada; [Bally, M. B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1L3, Canada; [Bally, M. B.] Ctr Drug Res & Dev, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Child & Family Research Institute; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Kalra, J (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Dept Expt Therapeut, 675 W 10th Ave,5th Floor, Vancouver, BC V5Z 1L3, Canada.	jkalra@bccrc.ca		Dedhar, Shoukat/0000-0003-4355-1657; Bally, Marcel/0000-0002-1994-4787	Canadian Breast Cancer Research Alliance (CBCRA); Canadian Breast Cancer Foundation; Pacific Century Graduate Scholarship; University of British Columbia University	Canadian Breast Cancer Research Alliance (CBCRA); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Pacific Century Graduate Scholarship; University of British Columbia University	Funding for this research was from the Canadian Breast Cancer Research Alliance (CBCRA) and the Canadian Breast Cancer Foundation (BC/Yukon Chapter). JK is the recipient of the Pacific Century Graduate Scholarship and the University of British Columbia University Graduate Fellowship. We acknowledge BC Cancer Agency's Cancer Integrative Oncology Department (Mykola Maydan, Paul MacDonald and Iveta Dobreva) as well as Hong Yan for excellent management of the departmental tissue culture facilities.	Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bader AG, 2008, ONCOGENE, V27, P1179, DOI 10.1038/sj.onc.1210719; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Berquin IM, 2005, ONCOGENE, V24, P3177, DOI 10.1038/sj.onc.1208504; Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860; Bravou V, 2003, BRIT J CANCER, V89, P2340, DOI 10.1038/sj.bjc.6601482; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov KG, 2009, J BIOL CHEM, V284, P36569, DOI 10.1074/jbc.M109.042879; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Coles LS, 2005, FEBS LETT, V579, P5372, DOI 10.1016/j.febslet.2005.08.075; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dragowska WH, 2004, MOL CANCER RES, V2, P606; Dupont J, 2001, J BIOL CHEM, V276, P26699, DOI 10.1074/jbc.M102664200; Duxbury MS, 2005, CLIN CANCER RES, V11, P3433, DOI 10.1158/1078-0432.CCR-04-1510; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Fujii T, 2008, CANCER RES, V68, P1504, DOI 10.1158/0008-5472.CAN-07-2362; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Hannigan GE, 1997, GENOMICS, V42, P177, DOI 10.1006/geno.1997.4719; Hasselblatt M, 2009, CANCER RES, V69, P2219, DOI 10.1158/0008-5472.CAN-08-3176; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Ito R, 2003, VIRCHOWS ARCH, V442, P118, DOI 10.1007/s00428-002-0718-6; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Karreth F, 2004, CANCER BIOL THER, V3, P1058, DOI 10.4161/cbt.3.11.1302; Kashihara M, 2009, J THORAC ONCOL, V4, P1066, DOI 10.1097/JTO.0b013e3181ae2828; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Leonessa F, 1996, BRIT J CANCER, V73, P154, DOI 10.1038/bjc.1996.29; Li YJ, 2007, J AM SOC NEPHROL, V18, P2534, DOI 10.1681/ASN.2007030315; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Luo GQ, 2008, WORLD J GASTROENTERO, V14, P2487, DOI 10.3748/wjg.14.2487; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Obara S, 2004, CANCER LETT, V208, P115, DOI 10.1016/j.canlet.2003.11.020; Oda Y, 2007, CANCER SCI, V98, P1020, DOI 10.1111/j.1349-7006.2007.00492.x; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; OZER J, 1990, J BIOL CHEM, V265, P22143; Peinado H, 2008, NAT CELL BIOL, V10, P253, DOI 10.1038/ncb0308-253; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Sawai H, 2006, ONCOGENE, V25, P3237, DOI 10.1038/sj.onc.1209356; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Skabkina O V, 2004, Dokl Biochem Biophys, V395, P93, DOI 10.1023/B:DOBI.0000025554.28703.bf; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Takanami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-1; Takemoto S, 2009, BRIT J CANCER, V101, P967, DOI 10.1038/sj.bjc.6605212; To K, 2007, MOL PHARMACOL, V72, P641, DOI 10.1124/mol.107.036111; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Verreault M, 2009, OLIGONUCLEOTIDES, V19, P129, DOI 10.1089/oli.2008.0157; Warburton C, 2004, CLIN CANCER RES, V10, P2512, DOI 10.1158/1078-0432.CCR-03-0244; Watanabe O, 2004, ANTICANCER RES, V24, P3851; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Zhang XM, 2007, INT J CANCER, V120, P1891, DOI 10.1002/ijc.22489; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	100	42	45	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6343	6356		10.1038/onc.2010.366	http://dx.doi.org/10.1038/onc.2010.366			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20838384	Green Published, hybrid			2022-12-25	WOS:000284874700005
J	Grice, DM; Vetter, I; Faddy, HM; Kenny, PA; Roberts-Thomson, SJ; Monteith, GR				Grice, Desma M.; Vetter, Irina; Faddy, Helen M.; Kenny, Paraic A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Golgi Calcium Pump Secretory Pathway Calcium ATPase 1 (SPCA1) Is a Key Regulator of Insulin-like Growth Factor Receptor (IGF1R) Processing in the Basal-like Breast Cancer Cell Line MDA-MB-231	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; HAILEY-HAILEY-DISEASE; PROPROTEIN CONVERTASES; MAMMARY-GLAND; CA2+-ATPASE SPCA1; CA2+ HOMEOSTASIS; PLASMA-MEMBRANE; TUMOR-GROWTH; EXPRESSION; GENE	Calcium signaling is a key regulator of pathways important in tumor progression, such as proliferation and apoptosis. Most studies assessing altered calcium homeostasis in cancer cells have focused on alterations mediated through changes in cytoplasmic free calcium levels. Here, we show that basal-like breast cancers are characterized by an alteration in the secretory pathway calcium ATPase 1 (SPCA1), a calcium pump localized to the Golgi. Inhibition of SPCA1 in MDA-MB-231 cells produced pronounced changes in cell proliferation and morphology in three-dimensional culture, without alterations in sensitivity to endoplasmic reticulum stress induction or changes in global calcium signaling. Instead, the effects of SPCA1 inhibition in MDA-MB-231 cells reside in altered regulation of calcium-dependent enzymes located in the secretory pathway, such as proprotein convertases. Inhibition of SPCA1 produced a pronounced alteration in the processing of insulin-like growth factor receptor (IGF1R), with significantly reduced levels of functional IGF1R beta and accumulation of the inactive trans-Golgi network pro-IGF1R form. These studies identify for the first time a calcium transporter associated with the basal-like breast cancer subtype. The pronounced effects of SPCA1 inhibition on the processing of IGF1R in MDA-MB-231 cells independent of alterations in global calcium signaling also demonstrate that some calcium transporters can regulate the processing of proteins important in tumor progression without major alterations in cytosolic calcium signaling. Inhibitors of SPCA1 may offer an alternative strategy to direct inhibitors of IGF1R and attenuate the processing of other proprotein convertase substrates important in basal breast cancers.	[Grice, Desma M.; Faddy, Helen M.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Vetter, Irina] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Queensland; University of Queensland; Yeshiva University; Albert Einstein College of Medicine	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia.	gregm@uq.edu.au	Monteith, Gregory/B-1626-2008; Vetter, Irina/A-6035-2010; Grice, Desma M/A-7730-2011; Roberts-Thomson, Sarah/W-5676-2019; Faddy, Helen M/A-6541-2015; Roberts-Thomson, Sarah J/B-4282-2011	Monteith, Gregory/0000-0002-4345-530X; Vetter, Irina/0000-0002-3594-9588; Roberts-Thomson, Sarah/0000-0001-8202-5786; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Faddy, Helen/0000-0002-3446-8248	Cancer Council of Queensland [569644]; National Health and Medical Research Council of Australia [631347]; Australian postgraduate award; Susan G. Komen for the Cure [KG100888]; Department of Defense [W81XWH-09-1-0680]	Cancer Council of Queensland(Cancer Council Queensland); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense)	This work was supported in part by Cancer Council of Queensland Grant 569644, National Health and Medical Research Council of Australia Grant 631347, and an Australian postgraduate award (to D. M. G. and H. M. F.).; Supported by Susan G. Komen for the Cure Grant KG100888 and Department of Defense CDMRP Breast Cancer Research Program Grant W81XWH-09-1-0680.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Callewaert G, 2003, CELL CALCIUM, V34, P157, DOI 10.1016/S0143-4160(03)00070-8; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Fairclough RJ, 2004, J INVEST DERMATOL, V123, P67, DOI 10.1111/j.0022-202X.2004.22713.x; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Haupt B, 2010, ARCH PATHOL LAB MED, V134, P130, DOI 10.1043/1543-2165-134.1.130; Jones R, 2008, J MAMMARY GLAND BIOL, V13, P407, DOI 10.1007/s10911-008-9097-1; Kamath L, 2001, CANCER RES, V61, P5933; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Lehmann M, 1998, ENDOCRINOLOGY, V139, P3763, DOI 10.1210/en.139.9.3763; Lissandron V, 2010, P NATL ACAD SCI USA, V107, P9198, DOI 10.1073/pnas.1004702107; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Porgpermdee S, 2005, J DERMATOL SCI, V40, P137, DOI 10.1016/j.jdermsci.2005.08.007; Ramos-Castaneda J, 2005, J BIOL CHEM, V280, P9467, DOI 10.1074/jbc.M413243200; Reinhardt TA, 2004, AM J PHYSIOL-CELL PH, V286, pC164, DOI 10.1152/ajpcell.00065.2003; Reinhardt TA, 1999, AM J PHYSIOL-CELL PH, V276, pC796, DOI 10.1152/ajpcell.1999.276.4.C796; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Shennan DB, 2008, CELL MOL BIOL LETT, V13, P514, DOI 10.2478/s11658-008-0020-y; Sohn YS, 1998, J BACTERIOL, V180, P6736, DOI 10.1128/JB.180.24.6736-6742.1998; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Szigeti R, 2006, J INVEST DERMATOL, V126, P2370, DOI 10.1038/sj.jid.5700447; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yee D, 2008, J MAMMARY GLAND BIOL, V13, P351, DOI 10.1007/s10911-008-9096-2	52	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37458	37466		10.1074/jbc.M110.163329	http://dx.doi.org/10.1074/jbc.M110.163329			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20837466	Green Published, hybrid			2022-12-25	WOS:000284424000038
J	Johnston, JB; Ouellet, H; de Montellano, PRO				Johnston, Jonathan B.; Ouellet, Hugues; de Montellano, Paul R. Ortiz			Functional Redundancy of Steroid C-26-monooxygenase Activity in Mycobacterium tuberculosis Revealed by Biochemical and Genetic Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGES; IDENTIFICATION; DEGRADATION; ADAPTATION; METABOLISM; VIRULENCE; SURVIVAL; RACEMASE; LIPIDS	One challenge to the development of new antitubercular drugs is the existence of multiple virulent strains that differ genetically. We and others have recently demonstrated that CYP125A1 is a steroid C-26-monooxygenase that plays a key role in cholesterol catabolism in Mycobacterium tuberculosis CDC1551 but, unexpectedly, not in the M. tuberculosis H37Rv strain. This discrepancy suggests that the H37Rv strain possesses compensatory activities. Here, we examined the roles in cholesterol metabolism of two other cytochrome P450 enzymes, CYP124A1 and CYP142A1. In vitro analysis, including comparisons of the binding affinities and catalytic efficiencies, demonstrated that CYP142A1, but not CYP124A1, can support the growth of H37Rv cells on cholesterol in the absence of cyp125A1. All three enzymes can oxidize the sterol side chain to the carboxylic acid state by sequential oxidation to the alcohol, aldehyde, and acid. Interestingly, CYP125A1 generates oxidized sterols of the (25S)-26-hydroxy configuration, whereas the opposite 25R stereochemistry is obtained with CYP124A1 and CYP142A1. Western blot analysis indicated that CYP124A1 was not detectably expressed in either the H37Rv or CDC1551 strains, whereas CYP142A1 was found in H37Rv but not CDC1551. Genetic complementation of CDC1551 Delta cyp125A1 cells with the cyp124A1 or cyp142A1 genes revealed that the latter can fully rescue the growth defect on cholesterol, whereas cells overexpressing CYP124A1 grow poorly and accumulate cholest-4-en-3-one. Our data clearly establish a functional redundancy in the essential C-26-monooxygenase activity of M. tuberculosis and validate CYP125A1 and CYP142A1 as possible drug targets.	[Johnston, Jonathan B.; Ouellet, Hugues; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Genentech Hall,N572D,600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu			National Institutes of Health [RO1 AI74824]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI74824 (to P. R. O. M.).	APPLEBY CA, 1969, BIOCHIM BIOPHYS ACTA, V172, P88, DOI 10.1016/0005-2728(69)90094-2; Bhaumik P, 2003, ACTA CRYSTALLOGR D, V59, P353, DOI 10.1107/S0907444902020735; Boshoff HI, 2005, NAT MED, V11, P599, DOI 10.1038/nm0605-599; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Jefcoate C R, 1978, Methods Enzymol, V52, P258; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Mougous JD, 2006, P NATL ACAD SCI USA, V103, P4258, DOI 10.1073/pnas.0510861103; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Norlin M, 2003, J LIPID RES, V44, P1515, DOI 10.1194/jlr.M300047-JLR200; Olsen L, 2006, J MED CHEM, V49, P6489, DOI 10.1021/jm060551l; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sakai Y, 2004, J BACTERIOL, V186, P7214, DOI 10.1128/JB.186.21.7214-7220.2004; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shen CF, 2004, J CHROMATOGR B, V810, P119, DOI 10.1016/j.jchromb.2004.07.020; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; *WHO, 2009, WHO FACTS SHEETS TUB; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	40	72	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36352	36360		10.1074/jbc.M110.161117	http://dx.doi.org/10.1074/jbc.M110.161117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843794	Green Published, hybrid			2022-12-25	WOS:000284146100023
J	Devel, L; Garcia, S; Czarny, B; Beau, F; Lajeunesse, E; Vera, L; Georgiadis, D; Stura, E; Dive, V				Devel, Laurent; Garcia, Sandra; Czarny, Bertrand; Beau, Fabrice; Lajeunesse, Evelyne; Vera, Laura; Georgiadis, Dimitris; Stura, Enrico; Dive, Vincent			Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S-1 ' Loop Canonical Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; ZINC CHELATING INHIBITORS; MACROPHAGE ELASTASE; POTENTIAL TREATMENT; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; VARIABILITY; EXPRESSION; CHALLENGES; COMPLEXES	After the disappointment of clinical trials with early broad spectrum synthetic inhibitors of matrix metalloproteinases (MMPs), the field is now resurging with a new focus on the development of selective inhibitors that fully discriminate between different members of the MMP family with several therapeutic applications in perspective. Here, we report a novel class of highly selective MMP-12 inhibitors, without a phosphinic zinc-binding group, designed to plunge deeper into the S-1' cavity of the enzyme. The best inhibitor from this series, identified through a systematic chemical exploration, displays nanomolar potency toward MMP-12 and selectivity factors that range between 2 and 4 orders of magnitude toward a large set of MMPs. Comparison of the high resolution x-ray structures of MMP-12 in free state or bound to this new MMP-12 selective inhibitor reveals that this compound fits deeply within the S-1' specificity cavity, maximizing surface/volume ratios, without perturbing the S-1' loop conformation. This is in contrast with highly selective MMP-13 inhibitors that were shown to select a particular S-1' loop conformation. The search for such compounds that fit precisely to preponderant S-1' loop conformation of a particular MMP may prove to be an alternative effective strategy for developing selective inhibitors of MMPs.	[Stura, Enrico; Dive, Vincent] CEA, Serv Ingn Mol Prot, CE Saclay, F-91191 Gif Sur Yvette, France; [Georgiadis, Dimitris] Univ Athens, Dept Organ Chem, Organ Chem Lab, GR-15771 Athens, Greece	CEA; National & Kapodistrian University of Athens	Dive, V (corresponding author), CEA, Serv Ingn Mol Prot, CE Saclay, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Czarny, Bertrand/F-2001-2018; Georgiadis, Dimitris/AAB-1550-2020; Stura, Enrico A./A-2793-2010; CZARNY, bertrand/AAP-6603-2020	Czarny, Bertrand/0000-0002-9586-0913; Stura, Enrico A./0000-0001-6718-2118; CZARNY, bertrand/0000-0002-9586-0913	Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by funds from the Commissariat a l'Energie Atomique.	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Brown S, 2004, CURR TOP MED CHEM, V4, P1227, DOI 10.2174/1568026043387854; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Jullien N, 2010, J MED CHEM, V53, P208, DOI 10.1021/jm9010803; Lagente V, 2009, EXPERT OPIN THER TAR, V13, P287, DOI [10.1517/14728220902751632, 10.1517/14728220902751632 ]; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li W, 2009, J MED CHEM, V52, P5408, DOI 10.1021/jm900809r; Li W, 2009, J MED CHEM, V52, P1799, DOI 10.1021/jm900093d; Liu MZ, 2004, ARTHRITIS RHEUM-US, V50, P3112, DOI 10.1002/art.20567; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Moy FJ, 2002, J AM CHEM SOC, V124, P12658, DOI 10.1021/ja027391x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Rodriguez-Pla A, 2009, RHEUMATOLOGY, V48, P1460, DOI 10.1093/rheumatology/kep271; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Tu GG, 2008, CURR MED CHEM, V15, P1388, DOI 10.2174/092986708784567680; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001	49	44	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35900	35909		10.1074/jbc.M110.139634	http://dx.doi.org/10.1074/jbc.M110.139634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817735	hybrid, Green Published			2022-12-25	WOS:000283845300067
J	Llop-Tous, I; Madurga, S; Giralt, E; Marzabal, P; Torrent, M; Ludevid, MD				Llop-Tous, Immaculada; Madurga, Sergio; Giralt, Ernest; Marzabal, Pablo; Torrent, Margarita; Ludevid, M. Dolors			Relevant Elements of a Maize gamma-Zein Domain Involved in Protein Body Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; TRANSIENT-EXPRESSION SYSTEM; N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; QUALITY-CONTROL; RICE ENDOSPERM; RECOMBINANT PROTEINS; TRANSGENIC TOBACCO; STRUCTURAL DOMAINS	The N-terminal proline-rich domain of gamma-zein (Zera) plays an important role in protein body (PB) formation not only in the original host (maize seeds) but in a broad spectrum of eukaryotic cells. However, the elements within the Zera sequence that are involved in the biogenesis of PBs have not been clearly identified. Here, we focused on amino acid sequence motifs that could be involved in Zera oligomerization, leading to PB-like structures in Nicotiana benthamiana leaves. By using fusions of Zera with fluorescent proteins, we found that the lack of the repeat region (PPPVHL)(8) of Zera resulted in the secretion of the fusion protein but that this repeat by itself did not form PBs. Although the repeat region containing eight units was the most efficient for Zera self-assembly, shorter repeats of 4-6 units still formed small multimers. Based on site-directed mutagenesis of Zera cysteine residues and analysis of multimer formation, we conclude that the two N-terminal Cys residues of Zera (Cys(7) and Cys(9)) are critical for oligomerization. Immunoelectron microscopy and confocal studies on PB development over time revealed that early, small, Zera-derived oligomers were sequestered in buds along the rough ER and that the mature size of the PBs could be attained by both cross-linking of preformed multimers and the incorporation of new chains of Zera fusions synthesized by active membrane-bound ribosomes. Based on these results and on the behavior of the Zera structure determined by molecular dynamics simulation studies, we propose a model of Zera-induced PB biogenesis.	[Ludevid, M. Dolors] CSIC, Ctr Recerca Agrigenom, ES-08034 Barcelona, Spain; [Madurga, Sergio] Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain; [Madurga, Sergio] Univ Barcelona, IQTCUB, E-08028 Barcelona, Spain; [Giralt, Ernest] Inst Recerca Biomed, Barcelona 08028, Spain; [Marzabal, Pablo] ERA Biotech, Barcelona 08028, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Ludevid, MD (corresponding author), CSIC, Ctr Recerca Agrigenom, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	dlmgmd@cid.csic.es	giralt, ernest/N-1669-2014	giralt, ernest/0000-0001-8381-1797; Madurga, Sergio/0000-0002-8135-7057	Generalitat de Catalunya XRB [SGR00182]; XRB and Grup Consolidat; Ministerio de Ciencia y Tecnologia-Fondo Europeo de Desarrollo Regional (MCYT-FEDER) [Bio2008-00799]; ERA Biotech S.A.	Generalitat de Catalunya XRB; XRB and Grup Consolidat; Ministerio de Ciencia y Tecnologia-Fondo Europeo de Desarrollo Regional (MCYT-FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ERA Biotech S.A.	This work was supported by grants from the Generalitat de Catalunya XRB and SGR00182 (to M. D. L) and XRB and Grup Consolidat (to E. G.). This work was also supported by Ministerio de Ciencia y Tecnologia-Fondo Europeo de Desarrollo Regional (MCYT-FEDER) Grant Bio2008-00799 and ERA Biotech S.A. (to M. D. L).	Alvarez ML, 2010, PLANT MOL BIOL, V72, P75, DOI 10.1007/s11103-009-9552-4; Bagga S, 1997, PLANT CELL, V9, P1683; BAGGA S, 1995, PLANT PHYSIOL, V107, P13, DOI 10.1104/pp.107.1.13; Bicudo TC, 2008, BIOPOLYMERS, V89, P175, DOI 10.1002/bip.20884; Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Brandizzi F, 2003, PLANT J, V34, P269, DOI 10.1046/j.1365-313X.2003.01728.x; Coleman CE, 1996, PLANT CELL, V8, P2335, DOI 10.1105/tpc.8.12.2335; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; Crofts AJ, 2004, PLANT PHYSIOL, V136, P3414, DOI 10.1104/pp.104.048934; Curtis RA, 2002, BIOPHYS CHEM, V98, P249, DOI 10.1016/S0301-4622(02)00071-6; Dalcol I, 1996, J ORG CHEM, V61, P6775, DOI 10.1021/jo960987g; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foresti O, 2008, MOL PLANT, V1, P1067, DOI 10.1093/mp/ssn066; GELI MI, 1994, PLANT CELL, V6, P1911; Goytia E, 2006, J GEN VIROL, V87, P3413, DOI 10.1099/vir.0.82301-0; Herman EM, 2008, CURR OPIN PLANT BIOL, V11, P672, DOI 10.1016/j.pbi.2008.08.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kawagoe Y, 2005, PLANT CELL, V17, P1141, DOI 10.1105/tpc.105.030668; Kogan MJ, 2004, BIOPOLYMERS, V73, P258, DOI 10.1002/bip.10578; Kogan MJ, 2001, J MOL BIOL, V312, P907, DOI 10.1006/jmbi.2001.4999; Kogan MJ, 2002, BIOPHYS J, V83, P1194, DOI 10.1016/S0006-3495(02)75243-0; LARKINS BA, 1978, PLANT PHYSIOL, V62, P256, DOI 10.1104/pp.62.2.256; Li CP, 1996, PLANT MOL BIOL, V30, P873, DOI 10.1007/BF00020800; LI XX, 1993, CELL, V72, P869, DOI 10.1016/0092-8674(93)90576-C; LUDEVID MD, 2004, Patent No. 2004003207; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mainieri D, 2004, PLANT PHYSIOL, V136, P3447, DOI 10.1104/pp.104.046409; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Muench DG, 1997, PLANT CELL PHYSIOL, V38, P404, DOI 10.1093/oxfordjournals.pcp.a029183; Muntz K, 1998, PLANT MOL BIOL, V38, P77, DOI 10.1023/A:1006020208380; Onda Y, 2009, P NATL ACAD SCI USA, V106, P14156, DOI 10.1073/pnas.0904429106; PEDRAZZINI E, 1994, PLANT J, V5, P103, DOI 10.1046/j.1365-313X.1994.5010103.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Pompa A, 2006, PLANT CELL, V18, P2608, DOI 10.1105/tpc.106.042226; PUEYO JJ, 1995, PLANTA, V196, P586, DOI 10.1007/BF00203660; Pujals S, 2006, BBA-BIOMEMBRANES, V1758, P264, DOI 10.1016/j.bbamem.2006.01.006; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; RABANAL F, 1993, BIOPOLYMERS, V33, P1019, DOI 10.1002/bip.360330704; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Saito Y, 2009, J EXP BOT, V60, P615, DOI 10.1093/jxb/ern311; SHORROSH BS, 1993, PLANT PHYSIOL, V103, P719, DOI 10.1104/pp.103.3.719; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Starkuviene V, 2007, TRAFFIC, V8, P1035, DOI 10.1111/j.1600-0854.2007.00582.x; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; TORRENT M, 1994, PLANTA, V192, P512, DOI 10.1007/BF00203589; Torrent Margarita, 2009, V483, P193, DOI 10.1007/978-1-59745-407-0_11; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; Vila JA, 2004, BIOPHYS J, V86, P731, DOI 10.1016/S0006-3495(04)74151-X; Vitale A, 2004, PLANT PHYSIOL, V136, P3420, DOI 10.1104/pp.104.050351; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Washida H, 2009, PLANT J, V60, P146, DOI 10.1111/j.1365-313X.2009.03944.x; WETZEL R, 1999, METHOD ENZYMOL, V309, P189; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690	63	42	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35633	35644		10.1074/jbc.M110.116285	http://dx.doi.org/10.1074/jbc.M110.116285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829359	Green Published, hybrid			2022-12-25	WOS:000283845300042
J	Long, JS; Fujiwara, Y; Edwards, J; Tannahill, CL; Tigyi, G; Pyne, S; Pyne, NJ				Long, Jaclyn S.; Fujiwara, Yuko; Edwards, Joanne; Tannahill, Claire L.; Tigyi, Gabor; Pyne, Susan; Pyne, Nigel J.			Sphingosine 1-Phosphate Receptor 4 Uses HER2 (ERBB2) to Regulate Extracellular Signal Regulated Kinase-1/2 in MDA-MB-453 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; LYSOPHOSPHATIDIC ACID; MAMMALIAN-CELLS; MOLECULAR-CLONING; PROLIFERATION; MIGRATION; PATHWAY; SPHINGOSINE-1-PHOSPHATE; ACTIVATION	We demonstrate here that the bioactive lipid sphingosine 1-phosphate (S1P) uses sphingosine 1-phosphate receptor 4 (S1P(4)) and human epidermal growth factor receptor 2 (HER2) to stimulate the extracellular signal regulated protein kinase 1/2 (ERK-1/2) pathway in MDA-MB-453 cells. This was based on several lines of evidence. First, the S1P stimulation of ERK-1/2 was abolished by JTE013, which we show here is an S1P(2/4) antagonist and reduced by siRNA knockdown of S1P(4). Second, the S1P-stimulated activation of ERK-1/2 was almost completely abolished by a HER2 inhibitor (ErbB2 inhibitor II) and reduced by siRNA knockdown of HER2 expression. Third, phyto-S1P, which is an S1P(4) agonist, stimulated ERK-1/2 activation in an S1P(4)- and HER2-dependent manner. Fourth, FTY720 phosphate, which is an agonist at S1P(1,3,4,5) but not S1P(2) stimulated activation of ERK-1/2. Fifth, S1P stimulated the tyrosine phosphorylation of HER2, which was reduced by JTE013. HER2 which is an orphan receptor tyrosine kinase is the preferred dimerization partner of the EGF receptor. However, EGF-stimulated activation of ERK-1/2 was not affected by siRNA knockdown of HER2 or by ErbB2 (epidermal growth factor receptor 2 (or HER2)) inhibitor II in MDA-MB-453 cells. Moreover, S1P stimulated activation of ERK-1/2 does not require an EGF receptor. Thus, S1P and EGF function in a mutually exclusive manner. In conclusion, the magnitude of the signaling gain on the ERK-1/2 pathway produced in response to S1P can be increased by HER2 in MDA-MB-453 cells. The linkage of S1P with an oncogene suggests that S1P and specifically S1P(4) may have an important role in breast cancer progression.	[Long, Jaclyn S.; Pyne, Susan; Pyne, Nigel J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland; [Fujiwara, Yuko; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Edwards, Joanne; Tannahill, Claire L.] Univ Glasgow, Glasgow Royal Infirm, Fac Med, Div Canc Sci & Mol Pathol,Sect Surg, Glasgow G31 2ER, Lanark, Scotland	University of Strathclyde; University of Tennessee System; University of Tennessee Health Science Center; University of Glasgow	Pyne, NJ (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	n.j.pyne@strath.ac.uk	Edwards, Joanne/J-1903-2015; Pyne, Susan/AAF-5001-2019	Edwards, Joanne/0000-0002-7192-6906; Pyne, Susan/0000-0002-6608-9584; Pyne, Nigel/0000-0002-5657-4578	Cancer Research UK [23158/A7536]; National Institutes of Health [CA92160]; Royal College of Surgeons (Glasgow and Edinburgh branches); Glasgow Royal Infirmary endowment fund; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal College of Surgeons (Glasgow and Edinburgh branches); Glasgow Royal Infirmary endowment fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Research UK Grant 23158/A7536 (to S. P. and N. J. P.), National Institutes of Health Grant CA92160 from USPHS(to G. T.), the Royal College of Surgeons (Glasgow and Edinburgh branches), and a Glasgow Royal Infirmary endowment fund (to J. E.).	Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; An SZ, 1998, J CELL BIOCHEM, P147; An SZ, 1999, MOL PHARMACOL, V55, P787; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; BORG A, 1990, CANCER RES, V50, P4332; Cheng ZY, 2007, BIOORGAN MED CHEM, V15, P1533, DOI 10.1016/j.bmc.2006.09.041; Glickman M, 1999, MOL CELL NEUROSCI, V14, P141, DOI 10.1006/mcne.1999.0776; Goetzl EJ, 1999, CANCER RES, V59, P4732; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Gschwind A, 2002, CANCER RES, V62, P6329; HLA T, 1990, J BIOL CHEM, V265, P9308; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Koide Y, 2002, J MED CHEM, V45, P4629, DOI 10.1021/jm020080c; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; McGlynn LM, 2009, CLIN CANCER RES, V15, P1487, DOI 10.1158/1078-0432.CCR-07-4967; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Ohmori T, 2003, CARDIOVASC RES, V58, P170, DOI 10.1016/S0008-6363(03)00260-8; OKAZAKI H, 1993, BIOCHEM BIOPH RES CO, V190, P1104, DOI 10.1006/bbrc.1993.1163; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pyne NJ, 2008, BBA-MOL CELL BIOL L, V1781, P467, DOI 10.1016/j.bbalip.2008.05.004; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; Shida D, 2005, BIOCHEM BIOPH RES CO, V327, P907, DOI 10.1016/j.bbrc.2004.12.088; Shida D, 2004, FEBS LETT, V577, P333, DOI 10.1016/j.febslet.2004.10.024; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Wang F, 1999, CANCER RES, V59, P6185; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	39	63	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35957	35966		10.1074/jbc.M110.117945	http://dx.doi.org/10.1074/jbc.M110.117945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837468	Green Published, hybrid			2022-12-25	WOS:000283845300072
J	Kawasaki, A; Nakano, H; Hosokawa, A; Nakatsu, T; Kato, H; Watanabe, K				Kawasaki, Akio; Nakano, Hiroaki; Hosokawa, Allin; Nakatsu, Toru; Kato, Hiroaki; Watanabe, Kunihiko			The Exquisite Structure and Reaction Mechanism of Bacterial Pz-peptidase A toward Collagenous Peptides X-RAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS OF PZ-PEPTIDASE A REVEALS DIFFERENCES FROM MAMMALIAN THIMET OLIGOPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIMET OLIGOPEPTIDASE; CRYSTAL-STRUCTURE; PROVIDES INSIGHT; SUBSTRATE; BINDING; THERMOPHILE; NEUROLYSIN; PROTEASE; ENZYMES	Pz-peptidase A, from the thermophilic bacterium Geobacillus collagenovorans MO-1, hydrolyzes a synthetic peptide substrate, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-ProD-Arg (Pz-PLGPR), which contains a collagen-specific tripeptide sequence, -Gly-Pro-X-, but does not act on collagen proteins themselves. The mammalian enzyme, thimet oligopeptidase (TOP), which has comparable functions with bacterial Pz-peptidases but limited identity at the primary sequence level, has recently been subjected to x-ray crystallographic analysis; however, no crystal structure has yet been reported for complexes of TOP with substrate analogues. Here, we report crystallization of recombinant Pz-peptidase A in complex with two phosphinic peptide inhibitors (PPIs) that also function as inhibitors of TOP and determination of the crystal structure of these complexes at 1.80-2.00 angstrom resolution. The most striking difference between Pz-peptidase A and TOP is that there is no channel running the length of bacterial protein. Whereas the structure of TOP resembles an open bivalve, that of Pz-peptidase A is closed and globular. This suggests that collagenous peptide substrates enter the tunnel at the top gateway of the closed Pz-peptidase A molecule, and reactant peptides are released from the bottom gateway after cleavage at the active site located in the center of the tunnel. One of the two PPIs, PPI-2, which contains the collagen-specific sequence, helped to clarify the exquisite structure and reaction mechanism of Pz-peptidase A toward collagenous peptides. This study describes the mode of substrate binding and its implication for the mammalian enzymes.	[Kawasaki, Akio; Hosokawa, Allin; Watanabe, Kunihiko] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakyo Ku, Kyoto 6068522, Japan; [Nakano, Hiroaki; Nakatsu, Toru; Kato, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, Kyoto 6068501, Japan; [Nakano, Hiroaki] Hyogo Univ Hlth Sci, Dept Pharm, Chuo Ku, Kobe, Hyogo 6508530, Japan	Kyoto Prefectural University; Kyoto University	Watanabe, K (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakyo Ku, Kyoto 6068522, Japan.	kwatanab@kpu.ac.jp		Kato, Hiroaki/0000-0002-5993-4532; Nakatsu, Toru/0000-0002-9582-4023	Hyogo University of Health Sciences Research [2102]	Hyogo University of Health Sciences Research	This work was supported in part by the Hyogo University of Health Sciences Research grant for 2102 (to H. N.).	Barrett A J, 1992, Matrix Suppl, V1, P95; BARRETT AJ, 1991, J BIOCH J */* BIOCH, V277, P295; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Bruce LA, 2008, FEBS J, V275, P5607, DOI 10.1111/j.1742-4658.2008.06685.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMARAARTIGAS A, 2009, DRUG DESIGN ZINC ENZ, P751; *COLL COMP PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, pD760; Comellas-Bigier M, 2005, J MOL BIOL, V349, P99, DOI 10.1016/j.jmb.2005.03.016; Corazza A, 2006, PROTEINS, V62, P64, DOI 10.1002/prot.20703; DALI L, 1993, J MOL BIOL, V233, P123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Hay ED., 1991, CELL BIOL EXTRACELLU, P7; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; JIRA CEKJ, 1995, J BIOL CHEM */* V J, V270, P21701; JIRA CEKJ, 1996, J BIOL CHEM */* V J, V271, P19606; Kawasaki A, 2007, ACTA CRYSTALLOGR F, V63, P142, DOI 10.1107/S174430910700334X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miyake R, 2005, J BACTERIOL, V187, P4140, DOI 10.1128/JB.187.12.4140-4148.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers LK, 1998, J IMMUNOL, V161, P3589; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Niemirowicz G, 2008, MOL MICROBIOL, V70, P853, DOI 10.1111/j.1365-2958.2008.06444.x; NIMNI ME, 1983, SEMIN ARTHRITIS RHEU, V13, P1, DOI 10.1016/0049-0172(83)90024-0; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; PETERKOFSKY B, 1982, METHOD ENZYMOL, V82, P453; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Philominathan STL, 2009, J BIOL CHEM, V284, P10868, DOI 10.1074/jbc.M807684200; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Sugihara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P594, DOI 10.1271/bbb.60534; Suzuki Y, 2006, J BIOSCI BIOENG, V102, P73, DOI 10.1263/jbb.102.73; TISLJAR U, 1990, ANAL BIOCHEM, V186, P112, DOI 10.1016/0003-2697(90)90582-T; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	43	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34972	34980		10.1074/jbc.M110.141838	http://dx.doi.org/10.1074/jbc.M110.141838			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817732	Green Published, hybrid			2022-12-25	WOS:000283659100071
J	Lambrecht, JA; Browne, BA; Downs, DM				Lambrecht, Jennifer A.; Browne, Beth Ann; Downs, Diana M.			Members of the YjgF/YER057c/UK114 Family of Proteins Inhibit Phosphoribosylamine Synthesis in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; HIGHLY CONSERVED PROTEIN; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; ANTHRANILATE SYNTHETASE; THIAMINE SYNTHESIS; ISOLEUCINE BIOSYNTHESIS; THREONINE DEAMINASE; TRYPTOPHAN OPERON; ENZYME COMPLEX	The YjgF/YER057c/UK114 family of proteins is highly conserved across all three domains of life and currently lacks a consensus biochemical function. Analysis of Salmonella enterica strains lacking yjgF has led to a working model in which YjgF functions to remove potentially toxic secondary products of cellular enzymes. Strains lacking yjgF synthesize the thiamine precursor phosphoribosylamine (PRA) by a TrpD-dependent mechanism that is not present in wild-type strains. Here, PRA synthesis was reconstituted in vitro with anthranilate phosphoribosyltransferase (TrpD), threonine dehydratase (IlvA), threonine, and phosphoribosyl pyrophosphate. TrpD-dependent PRA formation in vitro was inhibited by S. enterica YjgF and the human homolog UK114. Thus, the work herein describes the first biochemical assay for diverse members of the highly conserved YjgF/YER057c/UK114 family of proteins and provides a means to dissect the cellular functions of these proteins.	[Lambrecht, Jennifer A.; Browne, Beth Ann; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), 1550 Linden Dr, Madison, WI 53706 USA.	downs@bact.wisc.edu			National Institutes of Health [GM47296, T32 GM07215]; J. S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM047296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Competitive Grant GM47296. This work was also supported by a 21st Century Scientist Scholars award from the J. S. McDonnell Foundation (to D. M. D.).; Supported by National Institutes of Health Molecular Biosciences Traineeship T32 GM07215.	BAUERLE RH, 1966, COLD SPRING HARB SYM, V31, P203, DOI 10.1101/SQB.1966.031.01.028; BLUME AJ, 1966, GENETICS, V53, P577; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; Burns RO., 1971, METHOD ENZYMOL, V17B, P555; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Chargaff E, 1943, J BIOL CHEM, V151, P273; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; D'Inca R, 2010, J PROTEOMICS, V73, P1542, DOI 10.1016/j.jprot.2010.03.017; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; EnosBerlage JL, 1996, J BACTERIOL, V178, P1476, DOI 10.1128/jb.178.5.1476-1479.1996; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; GRIESHABER M, 1974, BIOCHEMISTRY-US, V13, P373, DOI 10.1021/bi00699a024; He ZG, 1998, J BACTERIOL, V180, P2502, DOI 10.1128/JB.180.9.2502-2506.1998; HENDERSON EJ, 1970, J BIOL CHEM, V245, P1416; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Koenigsknecht MJ, 2007, J BIOL CHEM, V282, P28379, DOI 10.1074/jbc.M704024200; LUGINBUHL GH, 1974, J BACTERIOL, V120, P559, DOI 10.1128/JB.120.1.559-561.1974; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; NEWELL PC, 1968, BIOCHEM J, V106, P271, DOI 10.1042/bj1060271; NIERLICH.DP, 1965, J BIOL CHEM, V240, P366; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Parsons L, 2003, BIOCHEMISTRY-US, V42, P80, DOI 10.1021/bi020541w; Petersen L, 1996, GENETICS, V143, P37; PHILLIPS AT, 1965, J BIOL CHEM, V240, P4703; Ramos I, 2003, J BACTERIOL, V185, P5125, DOI 10.1128/JB.185.17.5125-5132.2003; Ramos I, 2008, J BACTERIOL, V190, P815, DOI 10.1128/JB.00582-07; Rappu P, 1999, J BACTERIOL, V181, P3810, DOI 10.1128/JB.181.12.3810-3815.1999; Roberts GP, 1978, THESIS U CALIFORNIA; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Schmiedeknecht G, 1996, EUR J BIOCHEM, V242, P339, DOI 10.1111/j.1432-1033.1996.0339r.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SCHMITZ G, 2006, THESIS U WISCONSIN M; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TSO JY, 1982, J BIOL CHEM, V257, P3532; UMBARGER HE, 1957, J BACTERIOL, V73, P105, DOI 10.1128/JB.73.1.105-112.1957; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; ZALKIN H, 1973, ADV ENZYMOL RAMB, V38, P1; Zelyas NJ, 2008, J BACTERIOL, V190, P7957, DOI 10.1128/JB.00698-08	45	33	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34401	34407		10.1074/jbc.M110.160515	http://dx.doi.org/10.1074/jbc.M110.160515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817725	Green Published, hybrid			2022-12-25	WOS:000283659100014
J	Tanaka, T; Rabbitts, TH				Tanaka, T.; Rabbitts, T. H.			Interfering with RAS-effector protein interactions prevent RAS-dependent tumour initiation and causes stop-start control of cancer growth	ONCOGENE			English	Article						antibody fragment; cancer; lung tumourigenesis; RAS signalling; therapy	SIGNAL-TRANSDUCTION; ONCOGENIC RAS; MOUSE MODEL; LUNG; TUMORIGENICITY; BINDING; ACTIVATION; EXPRESSION; ADDICTION; PATHWAYS	RAS mutations are the most common gain-of-function change in human cancer and promise to be a critical therapy target. As a new approach, we have used a surrogate to drug the 'undruggable' (that is, RAS-effector protein-protein interactions inside cancer cells) in preclinical mouse models of RAS-dependent cancers. Using this novel reagent, we have specifically targeted RAS signalling in a transgenic mouse model of lung cancer by directly blockading RAS-effector interactions with an antibody fragment that binds to activated RAS, and show that the interaction of RAS and effectors, such as phosphoinositide 3-kinase and RAF, is necessary for tumour initiation. Further, interference with oncogenic RAS-effector interactions result in control of tumour growth in human cancer cells but, crucially, does not necessarily cause tumour regression. These findings support the concept that ablating RAS-dependent signalling in cancer will have chemo-preventive effects that confer a chronic state in cancer and suggest that mutant RAS-targeted therapies may require conjoint targeting of other molecules and/or current cancer therapeutic strategies (for example, radiotherapy and chemotherapy) to be curative. In this context, our findings suggest that the oncogene addiction model is not universally correct in its central thesis that cancer cell death is inevitable after loss of oncogenic protein function. Oncogene (2010) 29, 6064-6070; doi:10.1038/onc.2010.346; published online 6 September 2010	[Tanaka, T.; Rabbitts, T. H.] Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Rabbitts, TH (corresponding author), Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, St Jamess Univ Hosp, Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	thr@leeds.ac.uk	Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609	Medical Research Council; University of Leeds; Medical Research Council [G0901686, G0600914] Funding Source: researchfish; MRC [G0600914, G0901686] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leeds; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council and the University of Leeds. We wish to thank Dr. Anton Berns for the conditional, Cre-dependent K-Ras<SUP>V12</SUP> transgenic mouse line. We also thank Dr Jeffrey A Whitsett for pCC10CAT-2300 for constructing the CC10 transgenic cassette. We are indebted to Debra Evans, Deborah Carter, Gillian Cardwell for animal husbandry, to Lesley Drynan for expert assistance and to Mike Shires for histology.	Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Okada F, 1998, P NATL ACAD SCI USA, V95, P3609, DOI 10.1073/pnas.95.7.3609; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Plattner R, 1996, P NATL ACAD SCI USA, V93, P6665, DOI 10.1073/pnas.93.13.6665; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004	27	50	54	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6064	6070		10.1038/onc.2010.346	http://dx.doi.org/10.1038/onc.2010.346			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20818422				2022-12-25	WOS:000284108700008
J	Castro, H; Romao, S; Carvalho, S; Teixeira, F; Sousa, C; Tomas, AM				Castro, Helena; Romao, Susana; Carvalho, Sandra; Teixeira, Filipa; Sousa, Carla; Tomas, Ana M.			Mitochondrial Redox Metabolism in Trypanosomatids Is Independent of Tryparedoxin Activity	PLOS ONE			English	Article							DEPENDENT PEROXIDE METABOLISM; LEISHMANIA-INFANTUM; DNA-REPLICATION; BINDING-PROTEIN; THIOREDOXIN; BRUCEI; CRUZI; THIOL; OVEREXPRESSION; LOCALIZATION	Tryparedoxins (TXNs) are oxidoreductases unique to trypanosomatids (including Leishmania and Trypanosoma parasites) that transfer reducing equivalents from trypanothione, the major thiol in these organisms, to sulfur-dependent peroxidases and other dithiol proteins. The existence of a TXN within the mitochondrion of trypanosomatids, capable of driving crucial redox pathways, is considered a requisite for normal parasite metabolism. Here this concept is shown not to apply to Leishmania. First, removal of the Leishmania infantum mitochondrial TXN (LiTXN2) by gene-targeting, had no significant effect on parasite survival, even in the context of an animal infection. Second, evidence is presented that no other TXN is capable of replacing LiTXN2. In fact, although a candidate substitute for LiTXN2 (LiTXN3) was found in the genome of L. infantum, this was shown in biochemical assays to be poorly reduced by trypanothione and to be unable to reduce sulfur-containing peroxidases. Definitive conclusion that LiTXN3 cannot directly reduce proteins located within inner mitochondrial compartments was provided by analysis of its subcellular localization and membrane topology, which revealed that LiTXN3 is a tail-anchored (TA) mitochondrial outer membrane protein presenting, as characteristic of TA proteins, its N-terminal end (containing the redox-active domain) exposed to the cytosol. This manuscript further proposes the separation of trypanosomatid TXN sequences into two classes and this is supported by phylogenetic analysis: i) class I, encoding active TXNs, and ii) class II, coding for TA proteins unlikely to function as TXNs. Trypanosoma possess only two TXNs, one belonging to class I (which is cytosolic) and the other to class II. Thus, as demonstrated for Leishmania, the mitochondrial redox metabolism in Trypanosoma may also be independent of TXN activity. The major implication of these findings is that mitochondrial functions previously thought to depend on the provision of electrons by a TXN enzyme must proceed differently.	[Castro, Helena; Romao, Susana; Carvalho, Sandra; Teixeira, Filipa; Sousa, Carla; Tomas, Ana M.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Tomas, Ana M.] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Castro, H (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	atomas@ibmc.up.pt	Castro, Helena/J-4794-2013; Teixeira, Filipa/P-1408-2019; Tomas, Ana/J-9919-2013	Castro, Helena/0000-0002-6021-9210; Tomas, Ana/0000-0002-0781-9567; Carvalho, Sandra/0000-0001-6695-1683	Fundacao para a Ciencia e a Tecnologia [PPCDT/SAU-IMI/59560/2004, PTDC/CVT/70275/2006]; Fundacao Calouste Gulbenkian [P-105335]; FCT [SFRH/BPD/20610/2004, SFRH/BD/18452/2004, SFRH/BD/28712/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by grants PPCDT/SAU-IMI/59560/2004 and PTDC/CVT/70275/2006 from Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/) and P-105335 from Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/). HC, SR and SC are recipients of FCT fellowships (SFRH/BPD/20610/2004, SFRH/BD/18452/2004 and SFRH/BD/28712/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Beverley S M, 1993, Methods Mol Biol, V21, P333; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Castro H, 2004, MOL BIOCHEM PARASIT, V136, P137, DOI 10.1016/j.molbiopara.2004.02.015; Castro H, 2002, FREE RADICAL BIO MED, V33, P1563, DOI 10.1016/S0891-5849(02)01088-2; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Clayton C, 1998, MOL BIOCHEM PARASIT, V97, P221, DOI 10.1016/S0166-6851(98)00115-7; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Filser M, 2008, BIOL CHEM, V389, P21, DOI 10.1515/BC.2007.147; Fulop V, 2009, FEBS J, V276, P2822, DOI 10.1111/j.1742-4658.2009.07005.x; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Konig J, 2007, FEBS J, V274, P5643, DOI 10.1111/j.1742-4658.2007.06087.x; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lin YC, 2005, MOL BIOCHEM PARASIT, V142, P66, DOI 10.1016/j.molbiopara.2005.03.009; Melchers J, 2008, J BIOL CHEM, V283, P30401, DOI 10.1074/jbc.M803563200; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Mkrtchian S, 2006, ANTIOXID REDOX SIGN, V8, P325, DOI 10.1089/ars.2006.8.325; Motyka SA, 2006, J BIOL CHEM, V281, P18499, DOI 10.1074/jbc.M602880200; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Requejo R, 2010, FEBS J, V277, P1465, DOI 10.1111/j.1742-4658.2010.07576.x; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Sela D, 2008, J BIOL CHEM, V283, P32034, DOI 10.1074/jbc.M804417200; Steinert P, 1999, FREE RADICAL BIO MED, V26, P844, DOI 10.1016/S0891-5849(98)00263-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Vlamis-Gardikas A, 2008, BBA-GEN SUBJECTS, V1780, P1170, DOI 10.1016/j.bbagen.2008.03.013; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200; Wilkinson SR, 2000, J BIOL CHEM, V275, P8220, DOI 10.1074/jbc.275.11.8220; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wilkinson SR, 2003, BIOL CHEM, V384, P517, DOI 10.1515/BC.2003.060	48	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12607	10.1371/journal.pone.0012607	http://dx.doi.org/10.1371/journal.pone.0012607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838623	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687100007
J	Cheung, CHA; Wu, SY; Lee, TR; Chang, CY; Wu, JS; Hsieh, HP; Chang, JY				Cheung, Chun Hei Antonio; Wu, Su-Ying; Lee, Tian-Ren; Chang, Chi-Yen; Wu, Jian-Sung; Hsieh, Hsing-Pang; Chang, Jang-Yang			Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes	PLOS ONE			English	Article							BREAST-CANCER; PACLITAXEL RESISTANCE; MICROTUBULE DYNAMICS; ALPHA-TUBULIN; COLCHICINE; TAXOL; SENSITIVITY; EPOTHILONE; LINES; VIVO	Background: Anti-mitotic compounds (microtubule de-stabilizers) such as vincristine and vinblastine have been shown clinically successful in treating various cancers. However, development of drug-resistance cells limits their efficacies in clinical situations. Therefore, experiments were performed to determine possible drug resistance mechanisms related to the application of anti-mitotic cancer therapy. Principal Findings: A KB-derived microtubule de-stabilizer-resistant KB-L30 cancer cell line was generated for this study. KB-L30 cells showed cross-resistance to various microtubule de-stabilizers including BPR0L075, vincristine and colchicine through multiple-drug resistant (MDR)-independent mechanisms. Surprisingly, KB-L30 cells showed hyper-sensitivity to the microtubule-stabilizer, paclitaxel. Results of the RT-PCR analysis revealed that expression of both class II and III beta-tubulin was down-regulated in KB-L30 cells as compared to its parental KB cancer cells. In addition, DNA sequencing analysis revealed six novel mutation sites present in exon four of the beta I-tubulin gene. Computational modeling indicated that a direct relationship exists between beta I-tubulin mutations and alteration in the microtubule assembly and dynamic instability in KB-L30 cells and this predicted model was supported by an increased microtubule assembly and reduced microtubule dynamic instability in KB-L30 cells, as shown by Western blot analysis. Conclusions and Significance: Our study demonstrated that these novel mutations in exon four of the beta I-tubulin induced resistance to microtubule de-stabilizers and hyper-sensitivity to microtubule stabilizer through an alteration in the microtubule assembly and dynamics in cancer cells. Importantly, the current study reveals that cancer cells may acquire drug resistance ability to anti-mitotic compounds through multiple changes in the microtubule networks. This study further provided molecular information in drug selection for patients with specific tubulin mutations.	[Cheung, Chun Hei Antonio; Lee, Tian-Ren; Chang, Chi-Yen; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Wu, Su-Ying; Wu, Jian-Sung; Hsieh, Hsing-Pang] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Tainan 70428, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Cheung, CHA (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jychang@nhri.org.tw	Hsieh, Hsing-Pang/B-2649-2010; Chang, Jang-Yang/D-2099-2010; Cheung, Chun Hei Antonio/D-4588-2009; Wu, Su-Ying/C-1370-2010	Hsieh, Hsing-Pang/0000-0002-1332-005X; Cheung, Chun Hei Antonio/0000-0003-4181-1435	National Science Council, Taiwan, Republic of China [NSC98-3114-M-006-002, NSC98-2323-B-400-004]; Department of Health, Taiwan, Republic of China [DOH99-TD-C-111-004]; National Health Research Institutes, Taiwan, Republic of China [CA-097-PP-02]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan, Republic of China; National Health Research Institutes, Taiwan, Republic of China(National Health Research Institutes - Taiwan)	This work was supported by intramural grants NSC98-3114-M-006-002 and NSC98-2323-B-400-004 from the National Science Council, Taiwan, Republic of China, DOH99-TD-C-111-004 from the Department of Health, Taiwan, Republic of China and CA-097-PP-02 from the National Health Research Institutes, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta O, 2006, CANCER-AM CANCER SOC, V107, P1852, DOI 10.1002/cncr.22198; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Hari M, 2003, MOL CANCER THER, V2, P597; He LF, 2001, MOL CANCER THER, V1, P3; Huzil JT, 2007, CANCER INFORM, V3, P159; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Kim DW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-28; KOHNO K, 1988, JPN J CANCER RES, V79, P1238, DOI 10.1111/j.1349-7006.1988.tb01550.x; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Ong V, 2008, J PHARMACOL EXP THER, V324, P434, DOI 10.1124/jpet.107.128926; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Seve P, 2007, CANCER CHEMOTH PHARM, V60, P27, DOI 10.1007/s00280-006-0343-1; Seve P, 2010, LUNG CANCER, V67, P136, DOI 10.1016/j.lungcan.2009.09.007; Shalli K, 2005, FASEB J, V19, P1299, DOI 10.1096/fj.04-3178fje; Tanaka Y, 2004, INT J GYNECOL CANCER, V14, P616, DOI 10.1111/j.1048-891X.2004.14409.x; Tommasi S, 2007, INT J CANCER, V120, P2078, DOI 10.1002/ijc.22557; Tseng CY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-131; Urano Naomi, 2003, Gastric Cancer, V6, P108; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; Wang YF, 2005, CELL CYCLE, V4, P1847, DOI 10.4161/cc.4.12.2264	27	37	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12564	10.1371/journal.pone.0012564	http://dx.doi.org/10.1371/journal.pone.0012564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838440	Green Published, Green Submitted, gold			2022-12-25	WOS:000281627700016
J	Klein, CJ; Ban, NC; Halpern, BS; Beger, M; Game, ET; Grantham, HS; Green, A; Klein, TJ; Kininmonth, S; Treml, E; Wilson, K; Possingham, HP				Klein, Carissa J.; Ban, Natalie C.; Halpern, Benjamin S.; Beger, Maria; Game, Edward T.; Grantham, Hedley S.; Green, Alison; Klein, Travis J.; Kininmonth, Stuart; Treml, Eric; Wilson, Kerrie; Possingham, Hugh P.			Prioritizing Land and Sea Conservation Investments to Protect Coral Reefs	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; HUMAN IMPACTS; MARINE; COSTS; RESILIENCE; NETWORKS; BENEFITS; HOTSPOTS; AREAS	Background: Coral reefs have exceptional biodiversity, support the livelihoods of millions of people, and are threatened by multiple human activities on land (e.g. farming) and in the sea (e.g. overfishing). Most conservation efforts occur at local scales and, when effective, can increase the resilience of coral reefs to global threats such as climate change (e.g. warming water and ocean acidification). Limited resources for conservation require that we efficiently prioritize where and how to best sustain coral reef ecosystems. Methodology/Principal Findings: Here we develop the first prioritization approach that can guide regional-scale conservation investments in land-and sea-based conservation actions that cost-effectively mitigate threats to coral reefs, and apply it to the Coral Triangle, an area of significant global attention and funding. Using information on threats to marine ecosystems, effectiveness of management actions at abating threats, and the management and opportunity costs of actions, we calculate the rate of return on investment in two conservation actions in sixteen ecoregions. We discover that marine conservation almost always trumps terrestrial conservation within any ecoregion, but terrestrial conservation in one ecoregion can be a better investment than marine conservation in another. We show how these results could be used to allocate a limited budget for conservation and compare them to priorities based on individual criteria. Conclusions/Significance: Previous prioritization approaches do not consider both land and sea-based threats or the socioeconomic costs of conserving coral reefs. A simple and transparent approach like ours is essential to support effective coral reef conservation decisions in a large and diverse region like the Coral Triangle, but can be applied at any scale and to other marine ecosystems.	[Klein, Carissa J.; Beger, Maria; Grantham, Hedley S.; Treml, Eric; Wilson, Kerrie; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia; [Ban, Natalie C.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Halpern, Benjamin S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Game, Edward T.; Green, Alison] Nature Conservancy, Brisbane, Qld, Australia; [Klein, Travis J.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Kininmonth, Stuart] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Queensland; James Cook University; National Center for Ecological Analysis & Synthesis; Nature Conservancy; Queensland University of Technology (QUT); Australian Institute of Marine Science	Klein, CJ (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia.	c.klein@uq.edu.au	Kininmonth, Stuart/N-9299-2013; Possingham, Hugh/B-1337-2008; Beger, Maria/ABC-5975-2022; Beger, Maria/F-9049-2013; Wilson, Kerrie/W-4181-2019; Wilson, Kerrie A/C-8058-2009; Ban, Natalie/C-6938-2009; POSSINGHAM, HUGH/R-8310-2019; Klein, Travis/J-1117-2012; Game, Edward/AAD-2289-2020; Klein, Carissa J/F-1632-2011; Treml, Eric A/C-7580-2013	Kininmonth, Stuart/0000-0001-9198-3396; Possingham, Hugh/0000-0001-7755-996X; Beger, Maria/0000-0003-1363-3571; Beger, Maria/0000-0003-1363-3571; Wilson, Kerrie/0000-0002-0092-935X; Wilson, Kerrie A/0000-0002-0092-935X; POSSINGHAM, HUGH/0000-0001-7755-996X; Klein, Travis/0000-0002-6669-7766; Game, Edward/0000-0003-4707-9281; Klein, Carissa J/0000-0002-6299-6451; Treml, Eric A/0000-0003-4844-4420; Ban, Natalie/0000-0002-4682-2144	Centre for Applied Environmental Decision Analysis; Australian Research Council; University of Queensland Graduate School; World Wildlife Fund	Centre for Applied Environmental Decision Analysis; Australian Research Council(Australian Research Council); University of Queensland Graduate School(University of Queensland); World Wildlife Fund	Funding was provided by the Centre for Applied Environmental Decision Analysis, the Australian Research Council, and a University of Queensland Graduate School Research Travel Grant. EAT was supported by the World Wildlife Fund Fuller Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Dodge RE, 2008, SCIENCE, V322, P189, DOI 10.1126/science.322.5899.189b; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Klein CJ, 2008, CONSERV LETT, V1, P44, DOI 10.1111/j.1755-263X.2008.00005.x; MCCLANAHAN TR, 2008, CONSERV LETT, P53; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; *REG CTI SECR, 2009, REG PLAN ACT COR TRI; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Smith RJ, 2009, NATURE, V462, P280, DOI 10.1038/462280a; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stibig HJ, 2004, APPL VEG SCI, V7, P153, DOI 10.1111/j.1654-109X.2004.tb00606.x; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; VERON J, 2009, GLOBAL CORA IN PRESS; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	41	64	64	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12431	10.1371/journal.pone.0012431	http://dx.doi.org/10.1371/journal.pone.0012431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814570	Green Accepted, Green Published, gold			2022-12-25	WOS:000281375500003
J	Limmathurotsakul, D; Jamsen, K; Arayawichanont, A; Simpson, JA; White, LJ; Lee, SJ; Wuthiekanun, V; Chantratita, N; Cheng, A; Day, NPJ; Verzilli, C; Peacock, SJ				Limmathurotsakul, Direk; Jamsen, Kris; Arayawichanont, Arkhom; Simpson, Julie A.; White, Lisa J.; Lee, Sue J.; Wuthiekanun, Vanaporn; Chantratita, Narisara; Cheng, Allen; Day, Nicholas P. J.; Verzilli, Claudio; Peacock, Sharon J.			Defining the True Sensitivity of Culture for the Diagnosis of Melioidosis Using Bayesian Latent Class Models	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; PSEUDOMONAS-PSEUDOMALLEI; CASSETTE TEST; TESTS; SPECIFICITY; ACCURACY; ABSENCE; IGM	Background: Culture remains the diagnostic gold standard for many bacterial infections, and the method against which other tests are often evaluated. Specificity of culture is 100% if the pathogenic organism is not found in healthy subjects, but the sensitivity of culture is more difficult to determine and may be low. Here, we apply Bayesian latent class models (LCMs) to data from patients with a single Gram-negative bacterial infection and define the true sensitivity of culture together with the impact of misclassification by culture on the reported accuracy of alternative diagnostic tests. Methods/Principal Findings: Data from published studies describing the application of five diagnostic tests (culture and four serological tests) to a patient cohort with suspected melioidosis were re-analysed using several Bayesian LCMs. Sensitivities, specificities, and positive and negative predictive values (PPVs and NPVs) were calculated. Of 320 patients with suspected melioidosis, 119 (37%) had culture confirmed melioidosis. Using the final model (Bayesian LCM with conditional dependence between serological tests), the sensitivity of culture was estimated to be 60.2%. Prediction accuracy of the final model was assessed using a classification tool to grade patients according to the likelihood of melioidosis, which indicated that an estimated disease prevalence of 61.6% was credible. Estimates of sensitivities, specificities, PPVs and NPVs of four serological tests were significantly different from previously published values in which culture was used as the gold standard. Conclusions/Significance: Culture has low sensitivity and low NPV for the diagnosis of melioidosis and is an imperfect gold standard against which to evaluate alternative tests. Models should be used to support the evaluation of diagnostic tests with an imperfect gold standard. It is likely that the poor sensitivity/specificity of culture is not specific for melioidosis, but rather a generic problem for many bacterial and fungal infections.	[Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Limmathurotsakul, Direk; White, Lisa J.; Lee, Sue J.; Wuthiekanun, Vanaporn; Chantratita, Narisara; Day, Nicholas P. J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Jamsen, Kris; Simpson, Julie A.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Arayawichanont, Arkhom] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Lee, Sue J.; Day, Nicholas P. J.] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Chantratita, Narisara; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Cheng, Allen] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cheng, Allen] Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, Australia; [Verzilli, Claudio] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Melbourne; University of Oxford; Mahidol University; Monash University; Charles Darwin University; Menzies School of Health Research; University of London; London School of Hygiene & Tropical Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	direk@tropmedres.ac	White, Lisa/AAC-9396-2020; Peacock, Sharon J/ABE-6331-2020; Simpson, Julie A/P-7299-2014; Chantratita, Narisara/P-2169-2019	White, Lisa/0000-0002-6523-185X; Cheng, Allen/0000-0003-3152-116X; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782; Simpson, Julie/0000-0002-2660-2013	Wellcome Trust of Great Britain; Mahidol-Oxford Tropical Medicine Research Unit; Sapprasithiprasong Hospital	Wellcome Trust of Great Britain(Wellcome Trust); Mahidol-Oxford Tropical Medicine Research Unit; Sapprasithiprasong Hospital	This study was funded by The Wellcome Trust of Great Britain. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support provided by staff at the Mahidol-Oxford Tropical Medicine Research Unit and the Sapprasithiprasong Hospital. We thank Jintana Suwannapruk, Varinthorn Praikaew, Pitchayanant Ariyaprasert, Maliwan Hongsuwan, Sukanya Pangmee, and Gumphol Vongsuwan for technical support. This article is an original report that was presented in part at the Joint International Tropical Medicine Meeting (JITMM) in Bangkok, Thailand on December 3-4, 2009.	Alexander B D, 2002, Transpl Infect Dis, V4 Suppl 3, P32, DOI 10.1034/j.1399-3062.4.s3.5.x; Chantratita N, 2007, CLIN VACCINE IMMUNOL, V14, P110, DOI 10.1128/CVI.00289-06; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2006, T ROY SOC TROP MED H, V100, P64, DOI 10.1016/j.trstmh.2005.04.019; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng Allen C, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS37, DOI 10.1016/S0035-9203(08)70010-5; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; KHUPULSUP K, 1986, AM J TROP MED HYG, V35, P366, DOI 10.4269/ajtmh.1986.35.366; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Limmathurotsakul D, 2005, J CLIN MICROBIOL, V43, P2274, DOI 10.1128/JCM.43.5.2274-2276.2005; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Menten J, 2008, STAT MED, V27, P4469, DOI 10.1002/sim.3317; Qu YS, 1998, J AM STAT ASSOC, V93, P920, DOI 10.2307/2669830; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Sangchan Apichat, 2003, J Med Assoc Thai, V86, P436; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; VATCHARAPREECHASAKUL T, 1992, CLIN INFECT DIS, V14, P412, DOI 10.1093/clinids/14.2.412; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WHITE NJ, 1989, LANCET, V2, P697, DOI 10.1016/S0140-6736(89)90768-X; Wuthiekanun V, 2004, J CLIN MICROBIOL, V42, P3435, DOI 10.1128/JCM.42.8.3435-3437.2004; Wuthiekanun V, 2001, J CLIN MICROBIOL, V39, P3801, DOI 10.1128/JCM.39.10.3801-3802.2001; WUTHIEKANUN V, 1990, J MED MICROBIOL, V33, P121, DOI 10.1099/00222615-33-2-121; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812; Wuthiekanun V, 2006, AM J TROP MED HYG, V74, P1074, DOI 10.4269/ajtmh.2006.74.1074	29	96	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12485	10.1371/journal.pone.0012485	http://dx.doi.org/10.1371/journal.pone.0012485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20830194	gold, Green Published, Green Accepted			2022-12-25	WOS:000281375500015
J	Hebbard, L; Cecena, G; Golas, J; Sawada, J; Ellies, LG; Charbono, A; Williams, R; Jimenez, RE; Wankell, M; Arndt, KT; DeJoy, SQ; Rollins, RA; Diesl, V; Follettie, M; Chen, L; Rosfjord, E; Cardiff, RD; Komatsu, M; Boschelli, F; Oshima, RG				Hebbard, L.; Cecena, G.; Golas, J.; Sawada, J.; Ellies, L. G.; Charbono, A.; Williams, R.; Jimenez, R. E.; Wankell, M.; Arndt, K. T.; DeJoy, S. Q.; Rollins, R. A.; Diesl, V.; Follettie, M.; Chen, L.; Rosfjord, E.; Cardiff, R. D.; Komatsu, M.; Boschelli, F.; Oshima, R. G.			Control of mammary tumor differentiation by SKI-606 (bosutinib)	ONCOGENE			English	Article						Src; SKI-606; mouse; breast cancer; Ezh2	SRC TYROSINE KINASE; C-SRC; BREAST-CANCER; GENE-EXPRESSION; EZH2; ACTIVATION; INHIBITOR; INDUCTION; GROWTH; MODEL	C-Src is infrequently mutated in human cancers but it mediates oncogenic signals of many activated growth factor receptors and thus remains a key target for cancer therapy. However, the broad function of Src in many cell types and processes requires evaluation of Src-targeted therapeutics within a normal developmental and immune-competent environment. In an effort to understand the appropriate clinical use of Src inhibitors, we tested an Src inhibitor, SKI-606 (bosutinib), in the MMTV-PyVmT transgenic mouse model of breast cancer. Tumor formation in this model is dependent on the presence of Src, but the necessity of Src kinase activity for tumor formation has not been determined. Furthermore, Src inhibitors have not been examined in an autochthonous tumor model that permits assessment of effects on different stages of tumor progression. Here we show that oral administration of SKI-606 inhibited the phosphorylation of Src in mammary tumors and caused a rapid decrease in the Ezh2 Polycomb group histone H3K27 methyltransferase and an increase in epithelial organization. SKI-606 prevented the appearance of palpable tumors in over 50% of the animals and stopped tumor growth in older animals with pre-existing tumors. These antitumor effects were accompanied by decreased cellular proliferation, altered tumor blood vessel organization and dramatically increased differentiation to lactational and epidermal cell fates. SKI-606 controls the development of mammary tumors by inducing differentiation. Oncogene (2011) 30, 301-312; doi:10.1038/onc.2010.412; published online 6 September 2010	[Hebbard, L.; Cecena, G.; Charbono, A.; Williams, R.; Wankell, M.; Oshima, R. G.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA; [Golas, J.; Arndt, K. T.; DeJoy, S. Q.; Rollins, R. A.; Diesl, V.; Follettie, M.; Chen, L.; Rosfjord, E.; Boschelli, F.] Pfizer Res, Ctr Integrat Biol & Biotherapeut, Pearl River, NY USA; [Sawada, J.; Komatsu, M.] Sanford Burnham Med Res Inst, Lake Nona, FL USA; [Ellies, L. G.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Jimenez, R. E.] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA; [Cardiff, R. D.] Univ Calif Davis, Ctr Genom Pathol, Davis, CA 95616 USA	Sanford Burnham Prebys Medical Discovery Institute; Pfizer; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Oshima, RG (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rgoshima@burnham.org	Hebbard, Lionel/O-1489-2017; Sawada, Junko/C-9199-2012; Hebbard, Lionel w/F-7272-2014; Komatsu, Masanobu/AAV-3013-2020; Hebbard, Lionel/W-4057-2019; Rollins, Robert/R-2978-2019	Hebbard, Lionel/0000-0002-7094-9065; Rosfjord, Edward/0000-0002-3449-7444; Komatsu, Masanobu/0000-0001-7548-137X; Williams, Roy/0000-0002-5442-9166	Pfizer Research; NCI Cancer Center [2 P30 CA030199, R01 CA125255]; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA125255] Funding Source: NIH RePORTER	Pfizer Research(Pfizer); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Mina Bissell, Lawrence Berkley National Laboratory for the gift of casein antibody, and Robert Abraham, Pfizer Research for his interest and support of the project. This work was supported by a collaborative research grant from Pfizer Research, and shared resource support from the NCI Cancer Center Support Grant 2 P30 CA030199 and R01 CA125255 (MK).	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boschelli DH, 2001, J MED CHEM, V44, P3965, DOI 10.1021/jm0102250; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cheung ATW, 1997, INT J ONCOL, V11, P69; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kim H, 2005, ONCOGENE, V24, P5629, DOI 10.1038/sj.onc.1208718; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klein A, 2005, J MOL MED, V83, P362, DOI 10.1007/s00109-004-0625-1; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Maglione JE, 2001, CANCER RES, V61, P8298; Man AK, 2003, MOL CELL BIOL, V23, P8614, DOI 10.1128/MCB.23.23.8614-8625.2003; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; MUTHUSWAMY SK, 1994, MOL CELL BIOL, V14, P735, DOI 10.1128/MCB.14.1.735; Neznanov N, 1999, CANCER RES, V59, P4242; Oshima RG, 2004, CANCER RES, V64, P169, DOI 10.1158/0008-5472.CAN-03-1944; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Silva CM, 2007, MOL ENDOCRINOL, V21, P1499, DOI 10.1210/me.2007-0109; SPECTOR DH, 1978, P NATL ACAD SCI USA, V75, P4102, DOI 10.1073/pnas.75.9.4102; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Watkin H, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-6; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; WEBSTER MA, 1995, P NATL ACAD SCI USA, V92, P7849, DOI 10.1073/pnas.92.17.7849; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130	51	21	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					301	312		10.1038/onc.2010.412	http://dx.doi.org/10.1038/onc.2010.412			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20818417	Green Accepted, Green Submitted			2022-12-25	WOS:000286418800005
J	Schaefer, JS; Klein, JR				Schaefer, Jeremy S.; Klein, John R.			Immunological regulation of metabolism-a novel quintessential role for the immune system in health and disease	FASEB JOURNAL			English	Article						immune-endocrine; infection; innate immunity; thyroid	THYROID-STIMULATING HORMONE; T-CELL DEVELOPMENT; BONE-MARROW-CELLS; VIRUS-INFECTION; BETA-SUBUNIT; DENDRITIC CELLS; THYROTROPIN; TSH; INVOLVEMENT; DYSFUNCTION	The hypothalamus-pituitary-thyroid (HPT) axis is an integrated hormone network that is essential for maintaining metabolic homeostasis. It has long been known that thyroid stimulating hormone (TSH), a central component of the HPT axis, can be made by cells of the immune system; however, the role of immune system TSH remains enigmatic and most studies have viewed it as a cytokine used to regulate immune function. Recent studies now indicate that immune system-derived TSH, in particular, a splice variant of TSH beta that is preferentially made by cells of the immune system, is produced by a subset of hematopoietic cells that traffic to the thyroid. On the basis of these and other findings, we propose the novel hypothesis that the immune system is an active participant in the regulation of basal metabolism. We further speculate that this process plays a critical role during acute and chronic infections and that it contributes to a wide range of chronic inflammatory conditions with links to thyroid dysregulation. This hypothesis, which is amenable to empirical analysis, defines a previously unknown role for the immune system in health and disease, and it provides a dynamic connection between immune-endocrine interactions at the organismic level.-Schaefer, J. S., Klein, J. R. Immunological regulation of metabolism-a novel quintessential role for the immune system in health and disease. FASEB J. 25, 29-34 (2011). www.fasebj.org	[Schaefer, Jeremy S.; Klein, John R.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost Sci, Dent Branch, Houston, TX 77054 USA	University of Texas System; University of Texas Health Science Center Houston	Klein, JR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Diagnost Sci, Dent Branch, BBSB,Rm 5813,1941 East Rd, Houston, TX 77054 USA.	john.r.klein@uth.tmc.edu			National Institutes of Health [DK035566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R23DK035566, R01DK035566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK035566. The authors are grateful to Dina Montufar-Solis for expert technical assistance.	Bagriacik EU, 2001, CELL IMMUNOL, V212, P92, DOI 10.1006/cimm.2001.1846; Bagriacik EU, 2000, J IMMUNOL, V164, P6158, DOI 10.4049/jimmunol.164.12.6158; BIANCHI GP, 1995, ITAL J GASTROENTEROL, V27, P291; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V125, P30, DOI 10.1016/S0006-291X(84)80329-0; Camargo R, 2001, THYROID, V11, P981, DOI 10.1089/105072501753211073; Campos-Rodriguez R, 2006, INFECT IMMUN, V74, P1883, DOI 10.1128/IAI.74.3.1883-1889.2006; Collins J, 2002, EUR J NUCL MED MOL I, V29, pS417, DOI 10.1007/s00259-002-0848-8; Costa LP, 2009, J AUTOIMMUN, V33, P121, DOI 10.1016/j.jaut.2009.04.001; Dall'Asta C, 2010, OBESITY, V18, P854, DOI 10.1038/oby.2009.320; Douglas R. S., J CLIN ENDOCRINOL ME, V95, P430; Eldar-Geva T, 2007, GYNECOL ENDOCRINOL, V23, P332, DOI 10.1080/09513590701267651; Grossmann M, 1997, J BIOL CHEM, V272, P15532, DOI 10.1074/jbc.272.24.15532; Gul U, 2009, EUR J DERMATOL, V19, P221, DOI 10.1684/ejd.2009.0632; HARBOUR DV, 1989, MOL CELL ENDOCRINOL, V64, P229, DOI 10.1016/0303-7207(89)90150-0; HARBOUR DV, 1991, CIRC SHOCK, V35, P181; Klein JR, 2004, J EXP BIOL, V207, P55, DOI 10.1242/jeb.00710; KRUGER TE, 1986, J IMMUNOL, V137, P197; KRUGER TE, 1989, J IMMUNOL, V142, P744; Laghi F, 2009, EUR RESPIR J, V34, P975, DOI 10.1183/09031936.00103708; Lodha R, 2007, ACTA PAEDIATR, V96, P406, DOI 10.1111/j.1651-2227.2007.00135.x; Mader R, 2007, CLIN RHEUMATOL, V26, P1891, DOI 10.1007/s10067-007-0602-5; Maksymowych WP, 2009, CLIN EXP RHEUMATOL, V27, pS20; Manzolli S, 1999, J ALLERGY CLIN IMMUN, V104, P595, DOI 10.1016/S0091-6749(99)70329-5; MATZUK MM, 1988, MOL ENDOCRINOL, V2, P95, DOI 10.1210/mend-2-2-95; Mazziotti G, 2010, BONE, V46, P747, DOI 10.1016/j.bone.2009.10.031; Mooij P, 1992, Thyroidology, V4, P45; Nolan K A, 1992, Clin Geriatr Med, V8, P19; Salmaso C, 2002, ANN NY ACAD SCI, V966, P496, DOI 10.1111/j.1749-6632.2002.tb04253.x; Schaefer JS, 2009, GEN COMP ENDOCR, V162, P241, DOI 10.1016/j.ygcen.2009.04.006; Scofield VL, 2005, IMMUNOL LETT, V99, P36, DOI 10.1016/j.imlet.2004.12.010; Silveira MG, 2009, LIVER INT, V29, P1094, DOI 10.1111/j.1478-3231.2009.02003.x; SMITH EM, 1983, P NATL ACAD SCI-BIOL, V80, P6010, DOI 10.1073/pnas.80.19.6010; Suzuki C, 2009, ENDOCRINOLOGY, V150, P2237, DOI 10.1210/en.2008-0823; Vaccaro M, 2002, THYROID, V12, P1147, DOI 10.1089/105072502321085261; Varghese S, 2008, J CELL BIOCHEM, V105, P271, DOI 10.1002/jcb.21825; Vincent BH, 2009, GENES IMMUN, V10, P18, DOI 10.1038/gene.2008.69; Wang HC, 2003, BLOOD, V101, P119, DOI 10.1182/blood-2002-02-0544; WANG J, 1994, SCIENCE, V265, P1860, DOI 10.1126/science.8091211; Wang J, 1997, SCIENCE, V275, P1937, DOI 10.1126/science.275.5308.1937; WANG J, 1995, CELL IMMUNOL, V161, P299, DOI 10.1006/cimm.1995.1040; Whetsell M, 1999, CELL IMMUNOL, V192, P159, DOI 10.1006/cimm.1998.1444	41	18	19	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					29	34		10.1096/fj.10-168203	http://dx.doi.org/10.1096/fj.10-168203			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20826543	Green Published			2022-12-25	WOS:000285869500003
J	Mai, T; Zan, H; Zhang, JS; Hawkins, JS; Xu, ZM; Casali, P				Mai, Thach; Zan, Hong; Zhang, Jinsong; Hawkins, J. Seth; Xu, Zhenming; Casali, Paolo			Estrogen Receptors Bind to and Activate the HOXC4/HoxC4 Promoter to Potentiate HoxC4-mediated Activation-induced Cytosine Deaminase Induction, Immunoglobulin Class Switch DNA Recombination, and Somatic Hypermutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOREACTIVE B-CELLS; BREAST-CANCER CELLS; NF-KAPPA-B; SEX-DIFFERENCES; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; DEPENDENT GENERATION; AID EXPRESSION; HOX GENES	Estrogen enhances antibody and autoantibody responses through yet to be defined mechanisms. It has been suggested that estrogen up-regulates the expression of activation-induced cytosine deaminase (AID), which is critical for antibody class switch DNA recombination (CSR) and somatic hypermutation (SHM), through direct activation of this gene. AID, as we have shown, is induced by the HoxC4 homeodomain transcription factor, which binds to a conserved HoxC4/Oct site in the AICDA/Aicda promoter. Here we show that estrogen-estrogen receptor (ER) complexes do not directly activate the AID gene promoter in B cells undergoing CSR. Rather, they bind to three evolutionarily conserved and cooperative estrogen response elements (EREs) we identified in the HOXC4/HoxC4 promoter. By binding to these EREs, ERs synergized with CD154 or LPS and IL-4 signaling to up-regulate HoxC4 expression, thereby inducing AID and CSR without affecting B cell proliferation or plasmacytoid differentiation. Estrogen administration in vivo significantly potentiated CSR and SHM in the specific antibody response to the 4-hydroxy-3-nitrophenylacetyl hapten conjugated with chicken gamma-globulin. Ablation of HoxC4 (HoxC4(-/-)) abrogated the estrogen-mediated enhancement of AID gene expression and decreased CSR and SHM. Thus, estrogen enhances AID expression by activating the HOXC4/HoxC4 promoter and inducing the critical AID gene activator, HoxC4.	[Mai, Thach; Zan, Hong; Zhang, Jinsong; Hawkins, J. Seth; Xu, Zhenming; Casali, Paolo] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Hawkins, J. Seth] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92697 USA; [Casali, Paolo] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Casali, P (corresponding author), Univ Calif Irvine, Inst Immunol, 3028 Hewitt Hall, Irvine, CA 92697 USA.	pcasali@uci.edu	ZHANG, JINSONG/E-1656-2011; Xu, Zhenming/C-4134-2012	ZHANG, JINSONG/0000-0002-2195-2997; 	National Institutes of Health [AI 045011, AI 060573, AI 079705, K12HD000849]; March of Dimes Birth Defects Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079705, R56AI045011, R56AI079705, T32AI060573, R01AI045011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 045011, AI 060573, and AI 079705 (to P. C.).; Supported by the Reproductive Scientist Development Program through National Institutes of Health Grant K12HD000849 and the March of Dimes Birth Defects Foundation.	Bhavanam S, 2008, VACCINE, V26, P6165, DOI 10.1016/j.vaccine.2008.08.045; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Chiba T, 2009, J MOL MED-JMM, V87, P1023, DOI 10.1007/s00109-009-0527-3; Cohen-Solal JFG, 2008, LUPUS, V17, P528, DOI 10.1177/0961203308089402; Cohen-Solal JFG, 2006, CURR TOP MICROBIOL, V305, P67, DOI 10.1007/3-540-29714-6_4; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Cutolo M, 2010, ANN NY ACAD SCI, V1193, P36, DOI 10.1111/j.1749-6632.2009.05383.x; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Dhiman N, 2008, TISSUE ANTIGENS, V72, P211, DOI 10.1111/j.1399-0039.2008.01097.x; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Diaz M, 2002, CURR OPIN IMMUNOL, V14, P235, DOI 10.1016/S0952-7915(02)00327-8; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; GREEN MS, 1994, INT J EPIDEMIOL, V23, P1078, DOI 10.1093/ije/23.5.1078; Greenstein B, 2001, INT IMMUNOPHARMACOL, V1, P1025, DOI 10.1016/S1567-5769(01)00034-0; Grimaldi CM, 2006, CURR OPIN RHEUMATOL, V18, P456, DOI 10.1097/01.bor.0000240354.37927.dd; Grimaldi CM, 2005, MOL IMMUNOL, V42, P811, DOI 10.1016/j.molimm.2004.05.014; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hughes GC, 2009, ARTHRITIS RHEUM, V60, P1775, DOI 10.1002/art.24548; Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086; Kim EC, 2004, J BIOL CHEM, V279, P42258, DOI 10.1074/jbc.M407496200; Klein S. L., 2009, NY TIMES        1028, pA33; KRAUS WL, 1994, MOL ENDOCRINOL, V8, P952, DOI 10.1210/me.8.8.952; Levy N, 2007, ENDOCRINOLOGY, V148, P3449, DOI 10.1210/en.2006-1632; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MARTINEZ E, 1989, EMBO J, V8, P3781, DOI 10.1002/j.1460-2075.1989.tb08555.x; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Ovsyannikova IG, 2004, HUM IMMUNOL, V65, P1506, DOI 10.1016/j.humimm.2004.07.001; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pauklin S, 2009, J IMMUNOL, V183, P1238, DOI 10.4049/jimmunol.0803915; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Peeva E, 2005, J IMMUNOL, V175, P1415, DOI 10.4049/jimmunol.175.3.1415; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pennock JW, 2009, VACCINE, V27, P5830, DOI 10.1016/j.vaccine.2009.07.052; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Ramsey TL, 2001, J MOL ENDOCRINOL, V27, P275, DOI 10.1677/jme.0.0270275; Rubtsov AV, 2010, AUTOIMMUN REV, V9, P494, DOI 10.1016/j.autrev.2010.02.008; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994; Sawalha AH, 2009, J AUTOIMMUN, V33, P31, DOI 10.1016/j.jaut.2009.03.006; Schaffer A, 2003, J BIOL CHEM, V278, P23141, DOI 10.1074/jbc.M212952200; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Thomas C., 2009, TOXICOLOGY IN PRESS; Tyulmenkov VV, 2000, MOL CELL ENDOCRINOL, V165, P151, DOI 10.1016/S0303-7207(00)00250-1; Weissman S, 2006, J VIRAL HEPATITIS, V13, P81, DOI 10.1111/j.1365-2893.2005.00658.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wu XP, 2006, J IMMUNOL, V176, P5426, DOI 10.4049/jimmunol.176.9.5426; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Xu ZM, 2007, ADV EXP MED BIOL, V596, P111; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Xu ZM, 2005, ANN NY ACAD SCI, V1050, P146, DOI 10.1196/annals.1313.119; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zan H, 1998, J IMMUNOL, V161, P5217; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554	85	62	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37797	37810		10.1074/jbc.M110.169086	http://dx.doi.org/10.1074/jbc.M110.169086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855884	hybrid, Green Published			2022-12-25	WOS:000284424000071
J	Chen, JF; Sun, Y; Mao, X; Liu, QZ; Wu, H; Chen, YB				Chen, Jianfeng; Sun, Yong; Mao, Xia; Liu, Qizhan; Wu, Hui; Chen, Yabing			RANKL Up-regulates Brain-type Creatine Kinase via Poly(ADP-ribose) Polymerase-1 during Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCIRG1 GENE-EXPRESSION; OSTEOPETROSIS TYPE-II; ELEVATED SERUM LEVELS; NF-KAPPA-B; BONE-RESORPTION; TRANSCRIPTIONAL REGULATION; RESPONSIVE ELEMENT; RECEPTOR ACTIVATOR; DNA-BINDING; DIFFERENTIATION	Receptor activator of nuclear factor kappa B ligand (RANKL) is the key regulator for osteoclast formation and function. During osteoclastogenesis, RANKL-stimulated signals differentially modulate expression of a large number of proteins. Using proteomics approaches, we identified that brain-type cytoplasmic creatine kinase (Ckb) was greatly induced in mature osteoclasts. Ckb has been shown to contribute to osteoclast function. However, the mechanisms of Ckb regulation and the contribution of other isoforms of creatine kinase during RANKL-induced osteoclastogenesis are unknown. We found that Ckb was the predominant isoform of creatine kinase during osteoclastogenesis. Real-time PCR confirmed that RANKL induced ckb mRNA expression by over 40-fold in primary mouse bone marrow macrophages and Raw 264.7 cells. The RANKL-responsive region was identified within the -0.4- to -0.2-kb 5'-flanking region of the ckb gene. Affinity binding purification followed by mass spectrometry analysis revealed that poly(ADP-ribose) polymerase-1 (PARP-1) bound to the -0.4/-0.2-kb fragment that negatively regulated expression of ckb in response to RANKL stimulation. Electrophoretic mobility shift assays with PARP-1-specific antibody located the binding site of PARP-1 to the TTCCCA consensus sequence. The expression of PARP-1 was reduced during RANKL-induced osteoclastogenesis, concurrently with increased expression of Ckb. Consistently, knockdown of PARP-1 by lentivirus-delivered shRNA enhanced ckb mRNA expression. The activity of PARP-1 was determined to be required for its inhibitory effect on the ckb expression. In summary, we have demonstrated that PARP-1 is a negative regulator of the ckb expression. Down-regulation of PARP-1 is responsible for the up-regulation of ckb during RANKL-induced osteoclastogenesis.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Jianfeng; Liu, Qizhan; Wu, Hui] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Chen, Yabing] Vet Affairs Med Ctr Res Serv, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wu, H (corresponding author), 802 Sch Dent Bldg,1919 7th Ave S, Birmingham, AL 35294 USA.	hwu@uab.edu; ybchen@uab.edu	SUN, YONG/F-2365-2013		National Institutes of Health [AR055339, AR046031-080003]; University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R03AR055339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055339 (to Y. C.) and AR046031-080003 (H. W.). This work was also supported by a University of Alabama at Birmingham Center for Metabolic Bone Disease pilot project award (to Y. C.).	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; BARON R, 1986, AM J PATHOL, V122, P363; Beranger GE, 2008, J BONE MINER RES, V23, P564, DOI 10.1359/JBMR.071111; Beranger GE, 2007, J BONE MINER RES, V22, P975, DOI 10.1359/JBMR.070406; Beranger GE, 2006, J BONE MINER RES, V21, P1757, DOI 10.1359/JBMR.060809; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Chen YB, 2000, ARTERIOSCL THROM VAS, V20, P2696, DOI 10.1161/01.ATV.20.12.2696; CROMBIE DL, 1994, J STEROID BIOCHEM, V49, P123, DOI 10.1016/0960-0760(94)90002-7; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Francis MJO, 2002, INT J BIOCHEM CELL B, V34, P459, DOI 10.1016/S1357-2725(01)00142-X; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; GRAM J, 1991, CALCIFIED TISSUE INT, V48, P438, DOI 10.1007/BF02556458; HOBSON GM, 1988, NUCLEIC ACIDS RES, V16, P8925, DOI 10.1093/nar/16.18.8925; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kockx MM, 1998, AM J PATHOL, V152, P885; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; MITCHELL MT, 1990, J BIOL CHEM, V265, P8259; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; RAIBLE DW, 1990, J NEUROSCI RES, V27, P43, DOI 10.1002/jnr.490270107; Ritchie ME, 1996, J BIOL CHEM, V271, P25485; SEVERSON AR, 1968, ANAT RECORD, V161, P57, DOI 10.1002/ar.1091610106; Shen W, 2002, BIOCHEM J, V367, P369, DOI 10.1042/BJ20020709; SPATZ M, 1992, J STEROID BIOCHEM, V41, P711, DOI 10.1016/0960-0760(92)90409-C; SUKOVICH DA, 1994, MOL CELL BIOL, V14, P7134, DOI 10.1128/MCB.14.11.7134; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang F, 2002, J CELL BIOCHEM, V84, P156, DOI 10.1002/jcb.1276; Willis D, 2005, BBA-GENE STRUCT EXPR, V1728, P18, DOI 10.1016/j.bbaexp.2005.01.007; WUPENG XS, 1992, MOL ENDOCRINOL, V6, P231, DOI 10.1210/me.6.2.231; YONEYAMA T, 1992, CLIN GENET, V42, P39; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zhang Z, 2002, VIROLOGY, V296, P107, DOI 10.1006/viro.2002.1385; Zhao JQ, 1996, ONCOGENE, V13, P293	53	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36315	36321		10.1074/jbc.M110.157743	http://dx.doi.org/10.1074/jbc.M110.157743			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837480	Green Published, hybrid			2022-12-25	WOS:000284146100027
J	Dixon, DP; Edwards, R				Dixon, David P.; Edwards, Robert			Roles for Stress-inducible Lambda Glutathione Transferases in Flavonoid Metabolism in Plants as Identified by Ligand Fishing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASES; REGIOSELECTIVITY; REVERSIBILITY; CONJUGATION; BINDING; FAMILY	The glutathione transferases (GSTs) of plants are a superfamily of abundant enzymes whose roles in endogenous metabolism are largely unknown. For example, the lambda class of GSTs (GSTLs) have members that are selectively induced by chemical stress treatments and based on their enzyme chemistry are predicted to have roles in redox homeostasis. However, using conventional approaches these functions have yet to be determined. To address this, recombinant GSTLs from wheat and Arabidopsis were tagged with a Strep tag and after affinity-immobilization, incubated with extracts from Arabidopsis, tobacco, and wheat. Bound ligands were then recovered by solvent extraction and identified by mass spectrometry (MS). With the wheat enzyme TaGSTL1, the ligand profiles obtained with in vitro extracts from tobacco closely matched those observed after the protein had been expressed in planta, demonstrating that these associations were physiologically representative. The stress-inducible TaGSTL1 was found to selectively recognize flavonols (e. g. taxifolin; K-d = 25 nM), with this binding being dependent upon S-glutathionylation of an active site cysteine. In the case of the wheat extracts, this selectivity in ligand recognitions lead to the detection of flavonols that had not been previously described in this cereal. Subsequent in vitro assays showed that the co-binding of flavonols, such as quercetin, to the thiolated TaGSTL1 represented an intermediate step in the reduction of the respective S-glutathionylated quinone derivatives to yield free flavonols. These results suggest a novel role for GSTLs in maintaining the flavonoid pool under stress conditions.	[Dixon, David P.; Edwards, Robert] Univ Durham, Ctr Bioact Chem, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England.	robert.edwards@fera.gsi.gov.uk	Dixon, David P/B-5413-2008	Dixon, David P/0000-0003-4644-8399; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council [BBG0017661]; Biotechnology and Biological Sciences Research Council [BB/G001766/1, BB/G001766/2] Funding Source: researchfish; BBSRC [BB/G001766/2, BB/G001766/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant Number BBG0017661.	Awad HM, 2002, CHEM RES TOXICOL, V15, P343, DOI 10.1021/tx010132l; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Boersma MG, 2000, CHEM RES TOXICOL, V13, P185, DOI 10.1021/tx990161k; Boots AW, 2005, BIOCHEM BIOPH RES CO, V338, P923, DOI 10.1016/j.bbrc.2005.10.031; Bouaziz M, 2002, PHYTOCHEMISTRY, V60, P515, DOI 10.1016/S0031-9422(02)00145-0; Cummins I, 2003, PLANT MOL BIOL, V52, P591, DOI 10.1023/A:1024858218804; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; Dangles O., 2006, Flavonoids: chemistry, biochemistry and applications, P443; Dixon DP, 2008, J BIOL CHEM, V283, P20268, DOI 10.1074/jbc.M802026200; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dixon DP, 2009, J BIOL CHEM, V284, P21249, DOI 10.1074/jbc.M109.020107; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; DIXON DP, 2010, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0131; Faizi S, 2010, HELV CHIM ACTA, V93, P466, DOI 10.1002/hlca.200900249; HERSHEY HP, 1991, PLANT MOL BIOL, V17, P679, DOI 10.1007/BF00037053; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; Jungbluth G, 2000, J CHEM SOC PERK T 2, P1946, DOI 10.1039/b002323j; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Reddy GVB, 2001, ARCH BIOCHEM BIOPHYS, V391, P271; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Theodoulou FL, 2003, PEST MANAG SCI, V59, P202, DOI 10.1002/ps.576	23	56	60	2	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36322	36329		10.1074/jbc.M110.164806	http://dx.doi.org/10.1074/jbc.M110.164806			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841361	hybrid, Green Published			2022-12-25	WOS:000284146100022
J	Henique, C; Mansouri, A; Fumey, G; Lenoir, V; Girard, J; Bouillaud, F; Prip-Buus, C; Cohen, I				Henique, Carole; Mansouri, Abdelhak; Fumey, Gwladys; Lenoir, Veronique; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle			Increased Mitochondrial Fatty Acid Oxidation Is Sufficient to Protect Skeletal Muscle Cells from Palmitate-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; CARNITINE-PALMITOYLTRANSFERASE-I; INTRAMYOCELLULAR LIPID-ACCUMULATION; GAS-LIQUID-CHROMATOGRAPHY; DIACYLGLYCEROL ACYLTRANSFERASE; OBESITY; METABOLISM; INHIBITION; GLUCOSE; CERAMIDE	The mechanisms underlying the protective effect of mono-unsaturated fatty acids (e.g. oleate) against the lipotoxic action of saturated fatty acids (e.g. palmitate) in skeletal muscle cells remain poorly understood. This study aimed to examine the role of mitochondrial long-chain fatty acid (LCFA) oxidation in mediating oleate's protective effect against palmitate-induced lipotoxicity. CPT1 (carnitine palmitoyltransferase 1), which is the key regulatory enzyme of mitochondrial LCFA oxidation, is inhibited by malonyl-CoA, an intermediate of lipogenesis. We showed that expression of a mutant form of CPT1 (CPT1mt), which is active but insensitive to malonyl-CoA inhibition, in C2C12 myotubes led to increased LCFA oxidation flux even in the presence of high concentrations of glucose and insulin. Furthermore, similar to preincubation with oleate, CPT1mt expression protected muscle cells from palmitate-induced apoptosis and insulin resistance by decreasing the content of deleterious palmitate derivates (i.e. diacylglycerols and ceramides). Oleate preincubation exerted its protective effect by two mechanisms: (i) in contrast to CPT1mt expression, oleate preincubation increased the channeling of palmitate toward triglycerides, as a result of enhanced diacylglycerol acyltransferase 2 expression, and (ii) oleate preincubation promoted palmitate oxidation through increasing CPT1 expression and modulating the activities of acetyl-CoA carboxylase and AMP-activated protein kinase. In conclusion, we demonstrated that targeting mitochondrial LCFA oxidation via CPT1mt expression leads to the same protective effect as oleate preincubation, providing strong evidence that redirecting palmitate metabolism toward oxidation is sufficient to protect against palmitate-induced lipotoxicity.	[Cohen, Isabelle] Univ Paris 05, Inst Cochin, CNRS, Dept Endocrinol Metab & Canc,Fac Med,UMRS1016,UMR, F-75014 Paris, France; [Henique, Carole; Mansouri, Abdelhak; Fumey, Gwladys; Lenoir, Veronique; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle] INSERM, U1016, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cohen, I (corresponding author), Univ Paris 05, Inst Cochin, CNRS, Dept Endocrinol Metab & Canc,Fac Med,UMRS1016,UMR, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	isabelle.cohen@inserm.fr	PRIP-BUUS, Carina/P-9084-2017; HENIQUE, Carole/AAR-2476-2020; Bouillaud, Frédéric R/L-3238-2017; Mansouri, Abdelhak/D-9100-2013	Bouillaud, Frédéric R/0000-0002-7518-9237; Mansouri, Abdelhak/0000-0003-4471-7276; HENIQUE GRECIET, Carole/0000-0001-5441-8662; Prip-Buus, Carina/0000-0002-2153-7857	Agence Nationale de la Recherche, ANR Mithycal; Association Francaise contre les Myopathies (AFM) [13714]; Ministere de l'Education Nationale, de la Recherche, et de la Technologie; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM)	Agence Nationale de la Recherche, ANR Mithycal(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de l'Education Nationale, de la Recherche, et de la Technologie; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM)	This research was funded by the Agence Nationale de la Recherche, ANR Mithycal and by Grant no. 13714 from the Association Francaise contre les Myopathies (AFM).; Supported by a graduate fellowship from the Ministere de l'Education Nationale, de la Recherche, et de la Technologie.; Supported by a Postdoctoral Award from the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM).	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Akkaoui M, 2009, BIOCHEM J, V420, P429, DOI 10.1042/BJ20081932; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kong JY, 2002, AM J PHYSIOL-HEART C, V282, pH717, DOI 10.1152/ajpheart.00257.2001; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; LILLINGTON JM, 1981, CLIN CHIM ACTA, V111, P91, DOI 10.1016/0009-8981(81)90425-3; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; SCHALCH DS, 1965, J CLIN INVEST, V44, P2010, DOI 10.1172/JCI105308; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sol ERM, 2008, BIOCHEM BIOPH RES CO, V375, P517, DOI 10.1016/j.bbrc.2008.08.013; Sparagna GC, 2001, ANTIOXID REDOX SIGN, V3, P71, DOI 10.1089/152308601750100524; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Vieu C, 2002, J LIPID RES, V43, P510; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043	42	113	117	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36818	36827		10.1074/jbc.M110.170431	http://dx.doi.org/10.1074/jbc.M110.170431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837491	Green Published, hybrid			2022-12-25	WOS:000284146100052
J	Zhou, F; Zhao, W; Zuo, ZX; Sheng, Y; Zhou, XA; Hou, Y; Cheng, HH; Zhou, RJ				Zhou, Fang; Zhao, Wei; Zuo, Zhixiang; Sheng, Yue; Zhou, Xiang; Hou, Yu; Cheng, Hanhua; Zhou, Rongjia			Characterization of Androgen Receptor Structure and Nucleocytoplasmic Shuttling of the Rice Field Eel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; CDNA CLONING; BINDING DOMAIN; PROTEIN-KINASE; LEPTOMYCIN B; EXPRESSION; TRANSCRIPTION; INSENSITIVITY; MUTATIONS; ACTIVATION	Androgen receptor (AR) plays a critical role in prostate cancer and male sexual differentiation. We have identified AR from a primitive vertebrate with a sex reversal characteristic, the rice field eel. AR of this species (eAR) is distinct from human AR, especially in the ligand binding domain (LBD), and its expression in gonads shows an increasing tendency during gonadal transformation from ovary via ovotestis to testis. eAR has a restricted androgen-dependent transactivation function after a nuclear translocation upon dihydrotestosterone exposure. A functional nuclear localization signal was further identified in the DNA binding domain and hinge region. Although nuclear export is CRM1-independent, eAR has a novel nuclear export signal, which is negatively charged, indicating that a nuclear export pathway may be mediated by electrostatic interaction. Further, our studies have identified critical sequences for ligand binding in the C terminus. A structure of three alpha-helices in the LBD has been conserved from eels to humans during vertebrate evolution, despite a distinct amino acid sequence. Mutation analysis confirmed that the LBD is essential for dihydrotestosterone-induced nuclear import of eAR and following transactivation function in the nucleus. In addition, eAR interacts with both Sox9a1 and Sox9a2, and their interaction regulates transactivation of eAR. Our data suggest that the primitive species conserves and especially acquires key novel domains, the nuclear export signal and LBD, for the eAR function in spite of a rapid sequence evolution.	[Zhou, Rongjia] Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China; Wuhan Univ, Coll Life Sci, Ctr Dev Biol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zhou, RJ (corresponding author), Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China.	rjzhou@whu.edu.cn	Zhou, Rongjia/N-9739-2019; Zuo, Zhixiang/M-4441-2016; Zhou, Rongjia/G-4660-2013	Zhou, Rongjia/0000-0002-9701-8009; Zuo, Zhixiang/0000-0002-2492-2689; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research Project [2010CB126306]; Fundamental Research Funds for the Central Universities; Program of Wuhan Subject Chief Scientist; 111 Project [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program of Wuhan Subject Chief Scientist; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China, National Key Basic Research Project Grant 2010CB126306, the Fundamental Research Funds for the Central Universities, the Program of Wuhan Subject Chief Scientist, and the 111 Project Grant B06018.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Baron D, 2008, GEN COMP ENDOCR, V156, P369, DOI 10.1016/j.ygcen.2008.01.016; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Bergerat JP, 2009, HUM MUTAT, V30, P145, DOI 10.1002/humu.20848; Blazquez M, 2005, MOL CELL ENDOCRINOL, V237, P37, DOI 10.1016/j.mce.2005.04.001; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cheng H, 2003, CYTOGENET GENOME RES, V101, P274, DOI 10.1159/000074348; Cui JZ, 2009, BIOCHEM BIOPH RES CO, V380, P115, DOI 10.1016/j.bbrc.2009.01.047; Culig Z, 2004, GROWTH FACTORS, V22, P179, DOI 10.1080/08977190412331279908; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; DEBELLIS A, 1992, MOL ENDOCRINOL, V6, P1909, DOI 10.1210/me.6.11.1909; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Hannema SE, 2004, J CLIN ENDOCR METAB, V89, P5815, DOI 10.1210/jc.2004-0709; He CL, 2003, BIOL REPROD, V69, P455, DOI 10.1095/biolreprod.102.015040; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heemers HV, 2009, CANCER CELL, V15, P245, DOI 10.1016/j.ccr.2009.03.009; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Hofman K, 2000, MOL CELL ENDOCRINOL, V168, P21, DOI 10.1016/S0303-7207(00)00311-7; Hossain MS, 2008, BIOL REPROD, V78, P361, DOI 10.1095/biolreprod.107.062018; Ikeuchi T, 1999, J BIOL CHEM, V274, P25205, DOI 10.1074/jbc.274.36.25205; Jorgensen A, 2007, COMP BIOCHEM PHYS C, V146, P561, DOI 10.1016/j.cbpc.2007.07.002; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Liu XC, 2009, GEN COMP ENDOCR, V160, P93, DOI 10.1016/j.ygcen.2008.10.026; Martyniuk CJ, 2009, J PROTEOME RES, V8, P2186, DOI 10.1021/pr800627n; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Melo Karla F.S., 2005, Arq Bras Endocrinol Metab, V49, P87, DOI 10.1590/S0004-27302005000100012; Melo KFS, 2003, J CLIN ENDOCR METAB, V88, P3241, DOI 10.1210/jc.2002-021658; Nguyen MM, 2009, MOL CELL ENDOCRINOL, V302, P65, DOI 10.1016/j.mce.2008.12.010; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Park CB, 2007, CHEMOSPHERE, V69, P32, DOI 10.1016/j.chemosphere.2007.04.072; PINSKY L, 1992, CLIN INVEST MED, V15, P456; Radmayr C, 1997, J UROLOGY, V158, P1553, DOI 10.1016/S0022-5347(01)64279-4; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Takeo J, 1999, J BIOL CHEM, V274, P5674, DOI 10.1074/jbc.274.9.5674; Todo T, 1999, BIOCHEM BIOPH RES CO, V254, P378, DOI 10.1006/bbrc.1998.9919; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; WEN W, 1994, J BIOL CHEM, V269, P32214; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zhou RJ, 2003, MOL REPROD DEV, V66, P211, DOI 10.1002/mrd.10271; Zhou RJ, 2002, REV FISH BIOL FISHER, V11, P331; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	50	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37030	37040		10.1074/jbc.M110.161968	http://dx.doi.org/10.1074/jbc.M110.161968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841357	Green Published, hybrid			2022-12-25	WOS:000284146100020
J	Keppler, BR; Archer, TK				Keppler, Brian R.; Archer, Trevor K.			Ubiquitin-dependent and Ubiquitin-independent Control of Subunit Stoichiometry in the SWI/SNF Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; HUMAN BREAST-CANCER; PROTEASOMAL DEGRADATION; NUCLEAR RECEPTORS; RHABDOID TUMORS; CELL-LINES; MUTATIONS; INI1; P53; EXPRESSION	The mammalian SWI/SNF chromatin remodeling complex is a key player in multiple chromatin transactions. Core subunits of this complex, including the ATPase, Brg-1, and various Brg-1-associated factors (BAFs), work in concert to maintain a functional remodeling complex. This intra-complex regulation is supervised by protein-protein interactions, as stoichiometric levels of BAF proteins are maintained by proteasomal degradation. We show that the mechanism of BAF155-mediated stabilization of BAF57 involves blocking its ubiquitination by preventing interaction with TRIP12, an E3 ubiquitin ligase. Consequently, as opposed to complexed BAF57, whose principal lysines are unavailable for ubiquitination, uncomplexed BAF57 can be freely ubiquitinated and degraded by the proteasome. Additionally, a BAF57 mutant, which contains no lysine residues, was found to retain its ability to be stabilized by interaction with BAF155, suggesting that in addition to the ubiquitin-dependent mechanism of BAF57 degradation, there exists a ubiquitin-independent mechanism that may involve the direct interaction of BAF57 with the proteasome. We propose that this regulatory mechanism exists to ensure functional fidelity of the complex and prevent the accumulation of uncomplexed proteins, which may disrupt the normal activity of the complex.	[Keppler, Brian R.; Archer, Trevor K.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Keppler, Bernhard/0000-0003-0877-1822; Archer, Trevor K/0000-0001-7651-3644	National Institutes of Health [Z01 ES071006-10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES071006, Z01ES071006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01 ES071006-10 (Intramural Research Program of the NIEHS).	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Biegel JA, 1999, CANCER RES, V59, P74; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Buschmann T, 2001, J BIOL CHEM, V276, P13852, DOI 10.1074/jbc.M007955200; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; DeCristofaro MF, 1999, ONCOGENE, V18, P7559, DOI 10.1038/sj.onc.1203168; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; DELBOVE JN, 2005, P AM ASS CANC RES, V46; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fryer CJ, 2000, J BIOL CHEM, V275, P17771, DOI 10.1074/jbc.M908729199; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Iba H, 2003, REV MED VIROL, V13, P99, DOI 10.1002/rmv.378; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; KLOCHENDLERYEIV.A, 2002, M CURR OPIN GENET DE, V12, P73; Lecuyer E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703939200; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507	43	32	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35665	35674		10.1074/jbc.M110.173997	http://dx.doi.org/10.1074/jbc.M110.173997			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829358	Green Published, hybrid			2022-12-25	WOS:000283845300045
J	Tondervik, A; Klinkenberg, G; Aarstad, OA; Drablos, F; Ertesvag, H; Ellingsen, TE; Skjak-Braek, G; Valla, S; Sletta, H				Tondervik, Anne; Klinkenberg, Geir; Aarstad, Olav A.; Drablos, Finn; Ertesvag, Helga; Ellingsen, Trond E.; Skjak-Braek, Gudmund; Valla, Svein; Sletta, Havard			Isolation of Mutant Alginate Lyases with Cleavage Specificity for Di-guluronic Acid Linkages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM SP; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SEQUENCE; BIOSYNTHESIS; FAMILY; OLIGOSACCHARIDES; POLYSACCHARIDES; C-5-EPIMERASE; RECOMBINANT	Alginates are commercially valuable and complex polysaccharides composed of varying amounts and distribution patterns of 1-4-linked beta-D-mannuronic acid (M) and alpha-L-guluronic acid (G). This structural variability strongly affects polymer physicochemical properties and thereby both commercial applications and biological functions. One promising approach to alginate fine structure elucidation involves the use of alginate lyases, which degrade the polysaccharide by cleaving the glycosidic linkages through a beta-elimination reaction. For such studies one would ideally like to have different lyases, each of which cleaves only one of the four possible linkages in alginates: G-G, G-M, M-G, and M-M. So far no lyase specific for only G-G linkages has been described, and here we report the construction of such an enzyme by mutating the gene encoding Klebsiella pneumoniae lyase AlyA (a polysaccharide lyase family 7 lyase), which cleaves both G-G and G-M linkages. After error-prone PCR mutagenesis and high throughput screening of similar to 7000 lyase mutants, enzyme variants with a strongly improved G-G specificity were identified. Furthermore, in the absence of Ca2+, one of these lyases (AlyA5) was found to display no detectable activity against G-M linkages. G-G linkages were cleaved with similar to 10% of the optimal activity under the same conditions. The substitutions conferring altered specificity to the mutant enzymes are located in conserved regions in the polysaccharide lyase family 7 alginate lyases. Structure-function analyses by comparison with the known three-dimensional structure of Sphingomonas sp. A1 lyase A1-II` suggests that the improved G-G specificity might be caused by increased affinity for nonproductive binding of the alternating G-M structure.	[Tondervik, Anne; Sletta, Havard] SINTEF Mat & Chem, Dept Biotechnol, N-7465 Trondheim, Norway; [Tondervik, Anne; Aarstad, Olav A.; Ertesvag, Helga; Skjak-Braek, Gudmund; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Drablos, Finn] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway	SINTEF; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Tondervik, A (corresponding author), SINTEF Mat & Chem, Dept Biotechnol, Post Box 4760, N-7465 Trondheim, Norway.	Anne.Tondervik@sintef.no	Drablos, Finn/L-4970-2019	Drablos, Finn/0000-0001-5794-828X; Ertesvag, helga/0000-0001-9437-9469; Aarstad, Olav/0000-0003-3671-9060	Research Council of Norway Project [182695-I40]; FMC Biopolymer and Algipharma AS	Research Council of Norway Project(Research Council of Norway); FMC Biopolymer and Algipharma AS	The work was supported by The Research Council of Norway Project 182695-I40 and by FMC Biopolymer and Algipharma AS.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Ballance S, 2005, J CHROMATOGR A, V1093, P59, DOI 10.1016/j.chroma.2005.07.051; BARON AJ, 1994, GENE, V143, P61, DOI 10.1016/0378-1119(94)90605-X; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; BOYD J, 1977, CARBOHYD RES, V57, P163, DOI 10.1016/S0008-6215(00)81928-X; Campa C, 2004, J CHROMATOGR A, V1026, P271, DOI 10.1016/j.chroma.2003.11.045; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Chavagnat F, 1998, CARBOHYD RES, V308, P409, DOI 10.1016/S0008-6215(98)00095-0; COTE GL, 1988, CARBOHYD RES, V181, P143, DOI 10.1016/0008-6215(88)84030-8; Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; GORIN P, 1966, J CAN J MICROBIOL, V44, P993; GOVAN JRW, 1981, J GEN MICROBIOL, V125, P217; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hashimoto T, 2005, J MATER SCI-MATER M, V16, P503, DOI 10.1007/s10856-005-0524-1; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; HAUG A, 1969, BIOCHIM BIOPHYS ACTA, V192, P557, DOI 10.1016/0304-4165(69)90414-0; HAUG A, 1971, CARBOHYD RES, V17, P297, DOI 10.1016/S0008-6215(00)82537-9; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; HAUGEN F, 1990, CARBOHYD RES, V198, P101, DOI 10.1016/0008-6215(90)84280-8; Holtan S, 2006, BIOMACROMOLECULES, V7, P2108, DOI 10.1021/bm050984q; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; LINKER A, 1964, NATURE, V204, P187, DOI 10.1038/204187a0; Matsubara Y, 1998, J PROTEIN CHEM, V17, P29, DOI 10.1023/A:1022534429792; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Onsoyen E, 1996, CARBOHYDR EUR, V46, P26; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Petrulyte S, 2008, DAN MED BULL, V55, P72; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Sambrook J, 2001, MOL CLONING LAB MANU; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; SKJAKBRAEK G, 1996, T CARBOHYDR EUR, V14, P19; Sletta H, 2007, APPL ENVIRON MICROB, V73, P906, DOI 10.1128/AEM.01804-06; Smelcerovic A, 2008, CURR PHARM DESIGN, V14, P3168, DOI 10.2174/138161208786404254; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Thomas S, 2000, J Wound Care, V9, P56; THOMPSON JD, 2003, CURR PROT BIOINFORM; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1	45	27	28	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35284	35292		10.1074/jbc.M110.162800	http://dx.doi.org/10.1074/jbc.M110.162800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826807	hybrid, Green Published			2022-12-25	WOS:000283845300006
J	Fischer, S; Benz, J; Spath, B; Maier, LK; Straub, J; Granzow, M; Raabe, M; Urlaub, H; Hoffmann, J; Brutschy, B; Allers, T; Soppa, J; Marchfelder, A				Fischer, Susan; Benz, Juliane; Spaeth, Bettina; Maier, Lisa-Katharina; Straub, Julia; Granzow, Michaela; Raabe, Monika; Urlaub, Henning; Hoffmann, Jan; Brutschy, Bernd; Allers, Thorsten; Soppa, Joerg; Marchfelder, Anita			The Archaeal Lsm Protein Binds to Small RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SM-LIKE PROTEINS; COMPLETE GENOME SEQUENCE; LASER MASS-SPECTROMETRY; HOST FACTOR-I; ESCHERICHIA-COLI; HALOFERAX-VOLCANII; CRYSTAL-STRUCTURE; HF-I; SALMONELLA-TYPHIMURIUM; RPOS TRANSLATION	Proteins of the Lsm family, including eukaryotic Sm proteins and bacterial Hfq, are key players in RNA metabolism. Little is known about the archaeal homologues of these proteins. Therefore, we characterized the Lsm protein from the haloarchaeon Haloferax volcanii using in vitro and in vivo approaches. H. volcanii encodes a single Lsm protein, which belongs to the Lsm1 subfamily. The lsm gene is co-transcribed and overlaps with the gene for the ribosomal protein L37e. Northern blot analysis shows that the lsm gene is differentially transcribed. The Lsm protein forms homoheptameric complexes and has a copy number of 4000 molecules/cell. In vitro analyses using electrophoretic mobility shift assays and ultrasoft mass spectrometry (laser-induced liquid bead ion desorption) showed a complex formation of the recombinant Lsm protein with oligo(U)-RNA, tRNAs, and an small RNA. Co-immunoprecipitation with a FLAG-tagged Lsm protein produced in vivo confirmed that the protein binds to small RNAs. Furthermore, the co-immunoprecipitation revealed several protein interaction partners, suggesting its involvement in different cellular pathways. The deletion of the lsm gene is viable, resulting in a pleiotropic phenotype, indicating that the haloarchaeal Lsm is involved in many cellular processes, which is in congruence with the number of protein interaction partners.	[Fischer, Susan; Benz, Juliane; Spaeth, Bettina; Maier, Lisa-Katharina; Marchfelder, Anita] Univ Ulm, D-89069 Ulm, Germany; [Straub, Julia; Granzow, Michaela; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Raabe, Monika; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Allers, Thorsten] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	Ulm University; Goethe University Frankfurt; Max Planck Society; Goethe University Frankfurt; University of Nottingham	Marchfelder, A (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de	Allers, Thorsten/G-5503-2010	Allers, Thorsten/0000-0002-7308-3332; Soppa, Jorg/0000-0002-6132-5840; Marchfelder, Anita/0000-0002-1382-1794	Deutsche Forschungsgemeinschaft [SPP 1258, DFG Ma1538/11-1, So264/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through SPP 1258 Priority Program "Sensory and Regulatory RNAs in Prokaryotes" Grants DFG Ma1538/11-1 and So264/14-1.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Baumann A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-21; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Collins BM, 2001, J MOL BIOL, V309, P915, DOI 10.1006/jmbi.2001.4693; DE H, 1980, BIOCHEMISTRY */* O C, V19, P6146; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dyall-Smith ML., 2001, HALOHANDBOOK PROTOCO; Herrmann U, 2002, MOL MICROBIOL, V46, P395, DOI 10.1046/j.1365-2958.2002.03181.x; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kufel J, 2002, MOL CELL BIOL, V22, P5248, DOI 10.1128/MCB.22.14.5248-5256.2002; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Muffler A, 1997, J BACTERIOL, V179, P445; Mura C, 2003, PROTEIN SCI, V12, P832, DOI 10.1110/ps.0224703; Mura C, 2003, P NATL ACAD SCI USA, V100, P4539, DOI 10.1073/pnas.0538042100; Mura C, 2001, P NATL ACAD SCI USA, V98, P5532, DOI 10.1073/pnas.091102298; Nielsen JS, 2007, RNA, V13, P2213, DOI 10.1261/rna.689007; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; PU H, 1989, P Natl Acad Sci U S, V86, P4569; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Sambrook J, 2001, MOL CLONING LAB MANU; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; SENEAR AW, 1976, J BIOL CHEM, V251, P1902; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimmin LC, 1996, J BACTERIOL, V178, P4737, DOI 10.1128/jb.178.15.4737-4741.1996; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Soppa J, 2009, BIOCHEM SOC T, V37, P133, DOI 10.1042/BST0370133; SPA THB, 2005, J BIOL CHEM */* A J, V280, P35440; Straub J, 2009, RNA BIOL, V6, P281, DOI 10.4161/rna.6.3.8357; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; TO RO, 2001, EMBO J */* D EMBO J, V20, P2293; TO RO, 2002, J MOL BIOL */* D J M, V320, P129; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; YOKOBORI S, 1995, P NATL ACAD SCI USA, V92, P10432, DOI 10.1073/pnas.92.22.10432; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061	75	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34429	34438		10.1074/jbc.M110.118950	http://dx.doi.org/10.1074/jbc.M110.118950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826804	Green Published, hybrid			2022-12-25	WOS:000283659100017
J	Avogadri, F; Merghoub, T; Maughan, MF; Hirschhorn-Cymerman, D; Morris, J; Ritter, E; Olmsted, R; Houghton, AN; Wolchok, JD				Avogadri, Francesca; Merghoub, Taha; Maughan, Maureen F.; Hirschhorn-Cymerman, Daniel; Morris, John; Ritter, Erika; Olmsted, Robert; Houghton, Alan N.; Wolchok, Jedd D.			Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; TYROSINASE-RELATED PROTEIN-2; TUMOR-IMMUNITY; DNA VACCINES; DOPACHROME TAUTOMERASE; ANTITUMOR IMMUNITY; T-LYMPHOCYTES; B16 MELANOMA; IMMUNIZATION; RESPONSES	Background: Malignant melanoma is the deadliest form of skin cancer and is refractory to conventional chemotherapy and radiotherapy. Therefore alternative approaches to treat this disease, such as immunotherapy, are needed. Melanoma vaccine design has mainly focused on targeting CD8(+) T cells. Activation of effector CD8(+) T cells has been achieved in patients, but provided limited clinical benefit, due to immune-escape mechanisms established by advanced tumors. We have previously shown that alphavirus-based virus-like replicon particles (VRP) simultaneously activate strong cellular and humoral immunity against the weakly immunogenic melanoma differentiation antigen (MDA) tyrosinase. Here we further investigate the antitumor effect and the immune mechanisms of VRP encoding different MDAs. Methodology/Principal Findings: VRP encoding different MDAs were screened for their ability to prevent the growth of the B16 mouse transplantable melanoma. The immunologic mechanisms of efficacy were investigated for the most effective vaccine identified, focusing on CD8(+) T cells and humoral responses. To this end, ex vivo immune assays and transgenic mice lacking specific immune effector functions were used. The studies identified a potent therapeutic VRP vaccine, encoding tyrosinase related protein 2 (TRP-2), which provided a durable anti-tumor effect. The efficacy of VRP-TRP2 relies on a novel immune mechanism of action requiring the activation of both IgG and CD8(+) T cell effector responses, and depends on signaling through activating Fc gamma receptors. Conclusions/Significance: This study identifies a VRP-based vaccine able to elicit humoral immunity against TRP-2, which plays a role in melanoma immunotherapy and synergizes with tumor-specific CD8(+) T cell responses. These findings will aid in the rational design of future immunotherapy clinical trials.	[Avogadri, Francesca; Merghoub, Taha; Hirschhorn-Cymerman, Daniel; Houghton, Alan N.; Wolchok, Jedd D.] Sloan Kettering Inst, Swim Amer Lab, Program Immunol, New York, NY USA; [Maughan, Maureen F.; Morris, John; Olmsted, Robert] AlphaVax Inc, Res Triangle Pk, NC USA; [Ritter, Erika; Wolchok, Jedd D.] Ludwig Inst Canc Res, New York Branch, New York, NY USA	Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research	Avogadri, F (corresponding author), Sloan Kettering Inst, Swim Amer Lab, Program Immunol, New York, NY USA.	wolchokj@mskcc.org	Merghoub, Taha/ABD-8362-2021		National Cancer Institute [R01 CA56821, P01 CA33049, P01 CA59350]; Swim Across America; Lita Annenberg Hazen Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin; Commonwealth Cancer Foundation for Research; NATIONAL CANCER INSTITUTE [R01CA056821, P01CA059350, P01CA033049] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swim Across America; Lita Annenberg Hazen Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin; Commonwealth Cancer Foundation for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (R01 CA56821, P01 CA33049 and P01 CA59350), Swim Across America, the Lita Annenberg Hazen Foundation, and the Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2010, EXP DERMATOL, V19, P157, DOI 10.1111/j.1600-0625.2009.00986.x; Berglund P, 1999, VACCINE, V17, P497, DOI 10.1016/S0264-410X(98)00224-2; Bernstein DI, 2009, VACCINE, V28, P484, DOI 10.1016/j.vaccine.2009.09.135; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Brandmaier AG, 2009, J IMMUNOTHER, V32, P677, DOI 10.1097/CJI.0b013e3181ab1824; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Bronte V, 2000, CANCER RES, V60, P253; Chen M, 2005, J VIROL, V79, P2964, DOI 10.1128/JVI.79.5.2964-2972.2005; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Colella TA, 2000, J EXP MED, V191, P1221, DOI 10.1084/jem.191.7.1221; Colmenero P, 1999, GENE THER, V6, P1728, DOI 10.1038/sj.gt.3301004; Costin GE, 2005, BIOCHEM J, V391, P249, DOI 10.1042/BJ20042070; Diebold SS, 2009, GENE THER, V16, P359, DOI 10.1038/gt.2008.164; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Durso RJ, 2007, CLIN CANCER RES, V13, P3999, DOI 10.1158/1078-0432.CCR-06-2202; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Fleeton MN, 2000, J GEN VIROL, V81, P749, DOI 10.1099/0022-1317-81-3-749; Goldberg SM, 2005, CLIN CANCER RES, V11, P8114, DOI 10.1158/1078-0432.CCR-05-1410; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; HOUGHTON AN, 1982, J EXP MED, V156, P1755, DOI 10.1084/jem.156.6.1755; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; KROUMPOUZOS G, 1994, BIOCHEM BIOPH RES CO, V202, P1060, DOI 10.1006/bbrc.1994.2036; Leitner WW, 2006, VACCINE, V24, P5110, DOI 10.1016/j.vaccine.2006.04.059; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Lyons JA, 2007, GENE THER, V14, P503, DOI 10.1038/sj.gt.3302889; Negroiu G, 2003, J BIOL CHEM, V278, P27035, DOI 10.1074/jbc.M303167200; Nelson EL, 2003, BREAST CANCER RES TR, V82, P169, DOI 10.1023/B:BREA.0000004373.09678.bb; Ni B, 2005, CANCER IMMUNOL IMMUN, V54, P489, DOI 10.1007/s00262-004-0591-z; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Otten MA, 2008, J IMMUNOL, V181, P6829, DOI 10.4049/jimmunol.181.10.6829; PAWELEK JM, 1986, CANCER RES, V46, P493; PICHLMAIR A, 2009, J VIROL; Reap EA, 2007, VACCINE, V25, P7441, DOI 10.1016/j.vaccine.2007.08.016; Riezebos-Brilman A, 2006, J CLIN VIROL, V35, P233, DOI 10.1016/j.jcv.2005.12.001; Saenger YM, 2008, CANCER RES, V68, P9884, DOI 10.1158/0008-5472.CAN-08-2233; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Sundback M, 2005, VIROLOGY, V341, P190, DOI 10.1016/j.virol.2005.07.017; Uchi H, 2006, ADV IMMUNOL, V90, P215, DOI 10.1016/S0065-2776(06)90006-6; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Weber LW, 1998, J CLIN INVEST, V102, P1258, DOI 10.1172/JCI4004; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yuan Jianda, 2010, Cancer Immun, V10, P1; ZHOU XZ, 1995, P NATL ACAD SCI USA, V92, P3009, DOI 10.1073/pnas.92.7.3009	50	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12670	10.1371/journal.pone.0012670	http://dx.doi.org/10.1371/journal.pone.0012670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844763	gold, Green Published, Green Submitted			2022-12-25	WOS:000281687300014
J	Downes, S; Parker, T; Mahon, R				Downes, Sharon; Parker, Tracey; Mahon, Rod			Incipient Resistance of Helicoverpa punctigera to the Cry2Ab Bt Toxin in Bollgard II (R) Cotton	PLOS ONE			English	Article							ALLELES CONFERRING RESISTANCE; BACILLUS-THURINGIENSIS TOXIN; ARMIGERA LEPIDOPTERA; INSECT RESISTANCE; TRANSGENIC COTTON; AUSTRALIAN POPULATIONS; F-2 SCREEN; NOCTUIDAE; CROPS; FREQUENCY	Combinations of dissimilar insecticidal proteins ("pyramids'') within transgenic plants are predicted to delay the evolution of pest resistance for significantly longer than crops expressing a single transgene. Field-evolved resistance to Bacillus thuringiensis (Bt) transgenic crops has been reported for first generation, single-toxin varieties and the Cry1 class of proteins. Our five year data set shows a significant exponential increase in the frequency of alleles conferring Cry2Ab resistance in Australian field populations of Helicoverpa punctigera since the adoption of a second generation, two-toxin Bt cotton expressing this insecticidal protein. Furthermore, the frequency of cry2Ab resistance alleles in populations from cropping areas is 8-fold higher than that found for populations from non-cropping regions. This report of field evolved resistance to a protein in a dual-toxin Bt-crop has precisely fulfilled the intended function of monitoring for resistance; namely, to provide an early warning of increases in frequencies that may lead to potential failures of the transgenic technology. Furthermore, it demonstrates that pyramids are not 'bullet proof' and that rapid evolution to Bt toxins in the Cry2 class is possible.	[Downes, Sharon; Parker, Tracey] CSIRO Entomol, ACRI, Narrabri, Australia; [Mahon, Rod] CSIRO Entomol, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Downes, S (corresponding author), CSIRO Entomol, ACRI, Narrabri, Australia.	sharon.downes@csiro.au	Downes, Sharon Joy/C-1770-2008	Downes, Sharon Joy/0000-0002-3729-1732; Parker, Tracey/0000-0002-0125-7962	Cotton Research and Development Corporation [CSE0002]	Cotton Research and Development Corporation(Cotton R&D Corp)	This work was funded by the Cotton Research and Development Corporation, http://www.crdc.com.au/, grant CSE0002 to Downes and Mahon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Ali MI, 2009, J ECON ENTOMOL, V102, P1935, DOI 10.1603/029.102.0526; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Baker GH, 2008, AUST J AGR RES, V59, P723, DOI 10.1071/AR07421; BAKER GH, 2010, B ENTOMOL R IN PRESS; Clark AG, 1998, GENETICA, V102-3, P41, DOI 10.1023/A:1017074523395; Downes S, 2009, J ECON ENTOMOL, V102, P733, DOI 10.1603/029.102.0234; DOWNES S, 2010, J EC ENTOMO IN PRESS; Downes S, 2007, J INVERTEBR PATHOL, V95, P208, DOI 10.1016/j.jip.2007.03.010; Farrell T., 2008, COTTON PEST MANAGEME; Fitt G, 1998, PEST MANAGEMENT - FUTURE CHALLENGES, VOLS 1 AND 2, PROCEEDINGS, P189; FORRESTER NW, 1993, B ENTOMOL RES S; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Gunning RV, 1997, PESTIC BIOCHEM PHYS, V58, P155, DOI 10.1006/pest.1997.2295; Jackson RE, 2004, J ECON ENTOMOL, V97, P1719, DOI 10.1603/0022-0493-97.5.1719; JOHNSON A, 2003, COTTON PEST MANAGEME; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; Mahon RJ, 2010, J ECON ENTOMOL, V103, P472, DOI 10.1603/EC09225; Matten Sharlene R., 2008, V5, P27, DOI 10.1007/978-1-4020-8373-0_2; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Stodola TJ, 2004, J ECON ENTOMOL, V97, P1756, DOI 10.1603/0022-0493-97.5.1756; Tabashnik BE, 2009, ENVIRONMENTAL IMPACT OF GENETICALLY MODIFIED CROPS, P74, DOI 10.1079/9781845934095.0074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wenes AL, 2006, HEREDITY, V97, P127, DOI 10.1038/sj.hdy.6800845; Whitburn G., 2009, AUST COTTONGROWER MA, V30, P12; Yue BS, 2008, ENTOMOL EXP APPL, V129, P172, DOI 10.1111/j.1570-7458.2008.00761.x; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	33	79	84	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12567	10.1371/journal.pone.0012567	http://dx.doi.org/10.1371/journal.pone.0012567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830203	gold, Green Submitted, Green Published			2022-12-25	WOS:000281631300007
J	Zhao, TT; Trinh, D; Addison, CL; Dimitroulakos, J				Zhao, Tong T.; Trinh, Diane; Addison, Christina L.; Dimitroulakos, Jim			Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR; MALIGNANT MESOTHELIOMA; MEVALONATE PATHWAY; INDUCED APOPTOSIS; TYROSINE KINASE; CANCER-THERAPY; PHASE-I; INTERNALIZATION	Background: In a recent study, we demonstrated the ability of lovastatin, a potent inhibitor of mevalonate synthesis, to inhibit the function of the epidermal growth factor receptor (EGFR). Lovastatin attenuated ligand-induced receptor activation and downstream signaling through the PI3K/AKT pathway. Combining lovastatin with gefitinib, a potent EGFR inhibitor, induced synergistic cytotoxicity in a variety of tumor derived cell lines. The vascular endothelial growth factor receptor (VEGFR) and EGFR share similar activation, internalization and downstream signaling characteristics. Methodology/Principal Findings: The VEGFRs, particularly VEGFR-2 (KDR, Flt-1), play important roles in regulating tumor angiogenesis by promoting endothelial cell proliferation, survival and migration. Certain tumors, such as malignant mesothelioma (MM), also express both the VEGF ligand and VEGFRs that act in an autocrine loop to directly stimulate tumor cell growth and survival. In this study, we have shown that lovastatin inhibits ligand-induced VEGFR-2 activation through inhibition of receptor internalization and also inhibits VEGF activation of AKT in human umbilical vein endothelial cells (HUVEC) and H28 MM cells employing immunofluorescence and Western blotting. Combinations of lovastatin and a VEGFR-2 inhibitor showed more robust AKT inhibition than either agent alone in the H28 MM cell line. Furthermore, combining 5 mM lovastatin treatment, a therapeutically relevant dose, with two different VEGFR-2 inhibitors in HUVEC and the H28 and H2052 mesothelioma derived cell lines demonstrated synergistic cytotoxicity as demonstrated by MTT cell viability and flow cytometric analyses. Conclusions/Significance: These results highlight a novel mechanism by which lovastatin can regulate VEGFR-2 function and a potential therapeutic approach for MM through combining statins with VEGFR-2 inhibitors.	[Zhao, Tong T.; Trinh, Diane; Addison, Christina L.; Dimitroulakos, Jim] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Zhao, Tong T.; Addison, Christina L.; Dimitroulakos, Jim] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Zhao, Tong T.; Addison, Christina L.; Dimitroulakos, Jim] Univ Ottawa, Dept Biochem, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Zhao, TT (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	jdimitroulakos@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020		Ontario Institute for Cancer Research [574]; Canadian Institute of Health Research [74558]	Ontario Institute for Cancer Research; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The Ontario Institute for Cancer Research (574) http://www.oicr.on.ca and the Canadian Institute of Health Research (74558) http://www.cihr.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; BRENNER J, 1982, CANCER, V49, P2431, DOI 10.1002/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Chan KKW, 2003, CLIN CANCER RES, V9, P10; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Dimitroulakos J, 2001, CLIN CANCER RES, V7, P158; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Endo A, 2003, J RECEPT SIG TRANSD, V23, P239, DOI 10.1081/RRS-120025567; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HALPIN RA, 1993, DRUG METAB DISPOS, V21, P1003; Herbst RS, 2002, EXPERT OPIN INV DRUG, V11, P837, DOI 10.1517/13543784.11.6.837; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Kumar-Singh S, 1999, J PATHOL, V189, P72, DOI 10.1002/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Mantha AJ, 2003, J CANCER RES CLIN, V129, P631, DOI 10.1007/s00432-003-0490-2; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nakamura K, 2004, MOL CANCER THER, V3, P1639; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Ramalingam SS, 2008, J THORAC ONCOL, V3, P1056, DOI 10.1097/JTO.0b013e3181834f66; Ringerike T, 2002, J CELL SCI, V115, P1331; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Thibault A, 1996, CLIN CANCER RES, V2, P483; Thomas AL, 2003, SEMIN ONCOL, V30, P32, DOI 10.1016/S0093-7754(03)00123-4; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang CY, 2010, INT J CANCER, V126, P578, DOI 10.1002/ijc.24760; Wang IK, 2000, ONCOLOGY-BASEL, V59, P245, DOI 10.1159/000012168; ZHAO TT, 2010, ONCOGENE	46	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12563	10.1371/journal.pone.0012563	http://dx.doi.org/10.1371/journal.pone.0012563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838437	gold, Green Published, Green Submitted			2022-12-25	WOS:000281627700015
J	Chun, CD; Madhani, HD				Chun, Cheryl D.; Madhani, Hiten D.			Ctr2 Links Copper Homeostasis to Polysaccharide Capsule Formation and Phagocytosis Inhibition in the Human Fungal Pathogen Cryptococcus neoformans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; VIRULENCE; MACROPHAGES; IRON; IDENTIFICATION; MUTANTS; TRANSPORTERS; YEAST	Cryptococcus neoformans is a human opportunistic fungal pathogen responsible for similar to 1/3 of HIV/AIDS deaths worldwide. This budding yeast expresses a polysaccharide capsule necessary for virulence. Capsule production inhibits phagocytosis by macrophages. Here we describe results that link copper homeostasis to capsule production and the inhibition of phagocytosis. Specifically, using Agrobacterium-mediated insertional mutagenesis, we identified an insertion in the promoter region of the putative copper transporter-encoding gene CTR2 that results in reduced expression of CTR2 and increased phagocytosis by murine RAW264.7 macrophages. The mutant also displayed sensitivity to copper starvation and defects in polysaccharide capsule production and melanization. These defects were all reversed by genetic correction of the promoter insertion by homologous targeting. Several melanization-defective mutants identified previously, those in the RIM20, RIM101, and VPS25 genes, also display sensitivity to copper starvation, reduced capsule production and increased phagocytosis. Together these results indicate a previously undescribed link between copper homeostasis to polysaccharide capsule production and phagocytosis inhibition in Cryptococcus neoformans.	[Chun, Cheryl D.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chun, CD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	National Institute of Allergy and Infectious Diseases/National Institutes of Health	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 1991, PCR Methods Appl, V1, P39; Belay T, 1997, INFECT IMMUN, V65, P718, DOI 10.1128/IAI.65.2.718-728.1997; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; BULMER GS, 1968, J BACTERIOL, V95, P5, DOI 10.1128/JB.95.1.5-8.1968; Chun CD, 2010, METHOD ENZYMOL, V470, P797, DOI 10.1016/S0076-6879(10)70033-1; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Gebhart D, 2006, EUKARYOT CELL, V5, P935, DOI 10.1128/EC.00028-06; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2008, CELL MICROBIOL, V10, P277, DOI 10.1111/j.1462-5822.2007.01077.x; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414, DOI 10.1128/JB.150.3.1414-1421.1982; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; LEVITZ SM, 1989, J IMMUNOL, V142, P659; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Lohse MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001473; McClelland CA, 2005, FUNGAL GENET BIOL, V42, P904, DOI 10.1016/j.fgb.2005.07.003; MELCHERS LS, 1989, MOL MICROBIOL, V3, P969, DOI 10.1111/j.1365-2958.1989.tb00246.x; MONGA DP, 1981, INFECT IMMUN, V32, P975, DOI 10.1128/IAI.32.3.975-978.1981; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Nyhus KJ, 1999, INFECT IMMUN, V67, P2357, DOI 10.1128/IAI.67.5.2357-2365.1999; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PAROD RJ, 1983, AM J PHYSIOL, V245, pC220, DOI 10.1152/ajpcell.1983.245.3.C220; Penas MM, 2005, MOL GENET GENOMICS, V274, P402, DOI 10.1007/s00438-005-0033-4; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	37	39	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12503	10.1371/journal.pone.0012503	http://dx.doi.org/10.1371/journal.pone.0012503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824073	Green Published, gold, Green Submitted			2022-12-25	WOS:000281480900003
J	Blarquez, O; Carcaillet, C				Blarquez, Olivier; Carcaillet, Christopher			Fire, Fuel Composition and Resilience Threshold in Subalpine Ecosystem	PLOS ONE			English	Article							LAND-USE CHANGE; CLIMATE-CHANGE; SPATIAL VARIABILITY; LANDSCAPE DYNAMICS; LARIX-DECIDUA; SURFACE FIRES; FOREST; VEGETATION; HISTORY; DISTURBANCES	Background: Forecasting the effects of global changes on high altitude ecosystems requires an understanding of the long-term relationships between biota and forcing factors to identify resilience thresholds. Fire is a crucial forcing factor: both fuel build-up from land-abandonment in European mountains, and more droughts linked to global warming are likely to increase fire risks. Methods: To assess the vegetation response to fire on a millennium time-scale, we analyzed evidence of stand-to-local vegetation dynamics derived from sedimentary plant macroremains from two subalpine lakes. Paleobotanical reconstructions at high temporal resolution, together with a fire frequency reconstruction inferred from sedimentary charcoal, were analyzed by Superposed Epoch Analysis to model plant behavior before, during and after fire events. Principal Findings: We show that fuel build-up from arolla pine (Pinus cembra) always precedes fires, which is immediately followed by a rapid increase of birch (Betula sp.), then by ericaceous species after 25-75 years, and by herbs after 50-100 years. European larch (Larix decidua), which is the natural co-dominant species of subalpine forests with Pinus cembra, is not sensitive to fire, while the abundance of Pinus cembra is altered within a 150-year period after fires. A long-term trend in vegetation dynamics is apparent, wherein species that abound later in succession are the functional drivers, loading the environment with fuel for fires. This system can only be functional if fires are mainly driven by external factors (e. g. climate), with the mean interval between fires being longer than the minimum time required to reach the late successional stage, here 150 years. Conclusion: Current global warming conditions which increase drought occurrences, combined with the abandonment of land in European mountain areas, creates ideal ecological conditions for the ignition and the spread of fire. A fire return interval of less than 150 years would threaten the dominant species and might override the resilience of subalpine forests.	[Blarquez, Olivier; Carcaillet, Christopher] Ecole Prat Hautes Etud, Montpellier, France; [Blarquez, Olivier; Carcaillet, Christopher] Univ Montpellier 2, CNRS, Ctr Bioarchaeol & Ecol, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Blarquez, O (corresponding author), Ecole Prat Hautes Etud, Montpellier, France.	olivier.blarquez@univ-montp2.fr	Carcaillet, Christopher/G-1218-2011	Carcaillet, Christopher/0000-0002-6632-1507	ANR/ERA-net BiodivERsA; ARTEMIS; Ecole Pratique des Hautes Etudes (EPHE-Paris); INSU	ANR/ERA-net BiodivERsA(French National Research Agency (ANR)); ARTEMIS(European Commission); Ecole Pratique des Hautes Etudes (EPHE-Paris); INSU(Centre National de la Recherche Scientifique (CNRS))	Financial support was provided by the FIREMAN program (ANR/ERA-net BiodivERsA) and the PALEO-FIRE program (ARTEMIS, INSU) to CC and by grants from the Ecole Pratique des Hautes Etudes (EPHE-Paris) to OB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Albert CH, 2008, J APPL ECOL, V45, P659, DOI 10.1111/j.1365-2664.2007.01416.x; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; BLARQUEZ O, 2010, J ECOLOGY IN PRESS; Blarquez O, 2010, HOLOCENE, V20, P139, DOI 10.1177/0959683609348857; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Caplat P, 2009, J ECOL, V97, P1028, DOI 10.1111/j.1365-2745.2009.01541.x; Carcaillet C, 2009, ECOSCIENCE, V16, P1, DOI 10.2980/16-1-3189; Chauchard S, 2010, FOREST ECOL MANAG, V259, P1406, DOI 10.1016/j.foreco.2010.01.009; CLARK JS, 1990, ECOL MONOGR, V60, P135, DOI 10.2307/1943042; Cleveland RB., 1990, J OFF STAT, V6, P3; Derose RJ, 2009, ECOSCIENCE, V16, P28, DOI 10.2980/16-1-3160; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Egler FE, 1954, VEGETATIO ACTA GEOBO, V4, P412, DOI DOI 10.1007/BF00275587; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Genries A, 2009, ECOLOGY, V90, P476, DOI 10.1890/07-1740.1; Genries A, 2009, ECOSCIENCE, V16, P13, DOI 10.2980/16-1-3180; Genries A, 2009, J ECOL, V97, P728, DOI 10.1111/j.1365-2745.2009.01518.x; Germain D, 2005, CAN J EARTH SCI, V42, P2103, DOI 10.1139/E05-087; Grissino-Mayer HD, 1995, THESIS; HELY C, 2010, GEOPHYS RES IN PRESS; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hood SM, 2007, INT J WILDLAND FIRE, V16, P679, DOI 10.1071/WF06122; Johnson EA., 2007, PLANT DISTURBANCE EC; Kipfmueller KF, 2000, US FOR SERV RMRS-P, V5, P270; Marozas V, 2007, FOREST ECOL MANAG, V250, P47, DOI 10.1016/j.foreco.2007.03.008; Mooney CZ, 1993, BOOTSTRAPPING NONPAR; Motta R, 2005, CAN J FOREST RES, V35, P1809, DOI 10.1139/x05-107; Motta R, 2009, ECOSCIENCE, V16, pIV, DOI 10.1080/11956860.2009.11649160; Pal JS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019836; Prichard SJ, 2009, QUATERNARY RES, V72, P57, DOI 10.1016/j.yqres.2009.03.008; ROMME WH, 1982, ECOL MONOGR, V52, P199, DOI 10.2307/1942611; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schimmel J, 1996, ECOLOGY, V77, P1436, DOI 10.2307/2265541; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Schulze ED, 2007, FLORA, V202, P705, DOI 10.1016/j.flora.2007.05.003; Schulze ED, 2005, OECOLOGIA, V146, P77, DOI 10.1007/s00442-005-0173-6; Schumacher S, 2006, GLOBAL CHANGE BIOL, V12, P1435, DOI 10.1111/j.1365-2486.2006.01188.x; Shang BZ, 2004, ECOL MODEL, V180, P89, DOI 10.1016/j.ecolmodel.2004.01.020; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trouet V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041695; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; VEBLEN TT, 1994, J ECOL, V82, P125, DOI 10.2307/2261392; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White P.S., 1985, ECOLOGY NATURAL DIST; Zumbrunnen T, 2009, ECOSYSTEMS, V12, P73, DOI 10.1007/s10021-008-9207-3	51	44	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12480	10.1371/journal.pone.0012480	http://dx.doi.org/10.1371/journal.pone.0012480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814580	Green Submitted, Green Published, gold			2022-12-25	WOS:000281375500013
J	Hurtado, CW; Golden-Mason, L; Brocato, M; Krull, M; Narkewicz, MR; Rosen, HR				Hurtado, Christine Waasdorp; Golden-Mason, Lucy; Brocato, Megan; Krull, Mona; Narkewicz, Michael R.; Rosen, Hugo R.			Innate Immune Function in Placenta and Cord Blood of Hepatitis C - Seropositive Mother-Infant Dyads	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PLASMACYTOID DENDRITIC CELLS; TO-CHILD TRANSMISSION; VIRUS-INFECTION; PERIPHERAL-BLOOD; SURFACE EXPRESSION; NKT CELLS; ALPHA; SUBSET; CYTOTOXICITY	Vertical transmission accounts for the majority of pediatric cases of hepatitis C viral (HCV) infection. In contrast to the adult population who develop persistent viremia in similar to 80% of cases following exposure, the rate of mother-to-child transmission (2-6%) is strikingly low. Protection from vertical transmission likely requires the coordination of multiple components of the immune system. Placenta and decidua provide a direct connection between mother and infant. We hypothesized that innate immune responses would differ across the three compartments (decidua, placenta and cord blood) and that hepatitis C exposure would modify innate immunity in these tissues. The study was comprised of HCV-infected and healthy control mother and infant pairs from whom cord blood, placenta and decidua were collected with isolation of mononuclear cells. Multiparameter flow cytometry was performed to assess the phenotype, intracellular cytokine production and cytotoxicity of the cells. In keeping with a model where the maternal-fetal interface provides antiviral protection, we found a gradient in proportional frequencies of NKT and gamma delta-T cells being higher in placenta than cord blood. Cytotoxicity of NK and NKT cells was enhanced in placenta and placental NKT cytotoxicity was further increased by HCV infection. HCV exposure had multiple effects on innate cells including a decrease in activation markers (CD69, TRAIL and NKp44) on NK cells and a decrease in plasmacytoid dendritic cells in both placenta and cord blood of exposed infants. In summary, the placenta represents an active innate immunological organ that provides antiviral protection against HCV transmission in the majority of cases; the increased incidence in preterm labor previously described in HCV-seropositive mothers may be related to enhanced cytotoxicity of NKT cells.	[Hurtado, Christine Waasdorp; Narkewicz, Michael R.] Univ Colorado, Sch Med, Dept Pediat Digest Hlth Inst, Sect Pediat Gastroenterol Hepatol & Nutr, Aurora, CO USA; [Golden-Mason, Lucy; Brocato, Megan; Rosen, Hugo R.] Univ Colorado, Sch Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Integrated Program Immunol, Denver, CO 80202 USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hosp, Denver, CO USA; [Krull, Mona] Denver Hlth Med Ctr, Dept Obstet & Gynecol, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; National Jewish Health; Denver Health Medical Center	Hurtado, CW (corresponding author), Univ Colorado, Sch Med, Dept Pediat Digest Hlth Inst, Sect Pediat Gastroenterol Hepatol & Nutr, Aurora, CO USA.	Hugo.Rosen@ucdenver.edu		Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192	Colorado Center for AIDS Research [P30 AI054907]; NIDDK NIH [T32 DK607009-04]; HCV center [U19 A 1066328-05, RO1 DK060590]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054907, K24AI083742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060590] Funding Source: NIH RePORTER	Colorado Center for AIDS Research; NIDDK NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HCV center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	P30 AI054907 Colorado Center for AIDS Research grant (http://www.uchsc.edu/ccfar); NIDDK NIH T32 DK607009-04 (http://www2.niddk.nih.gov/Funding/Grants); U19 A 1066328-05 (HCV center grant) (www.nih.gov) and RO1 DK060590 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Airoldi J, 2006, OBSTET GYNECOL SURV, V61, P666, DOI 10.1097/01.ogx.0000238671.13495.33; Aldebert D, 2007, J REPROD IMMUNOL, V73, P11, DOI 10.1016/j.jri.2006.05.002; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P13741, DOI 10.1073/pnas.162491699; Canto E, 2005, TRANSPLANTATION, V80, P850, DOI 10.1097/01.TP.0000174135.32068.65; Capparelli E, 2005, SEMIN FETAL NEONAT M, V10, P161, DOI 10.1016/j.siny.2004.10.001; Cohen SBA, 1999, HUM IMMUNOL, V60, P331, DOI 10.1016/S0198-8859(98)00126-8; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; DITZIANKADANOFF R, 1993, AM J OBSTET GYNECOL, V168, P831, DOI 10.1016/S0002-9378(12)90829-7; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fischler B, 2007, SEMIN FETAL NEONAT M, V12, P168, DOI 10.1016/j.siny.2007.01.008; Fox A, 2010, J REPROD IMMUNOL, V84, P52, DOI 10.1016/j.jri.2009.10.003; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Golden-Mason L, 2006, LIVER TRANSPLANT, V12, P363, DOI 10.1002/lt.20708; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Golden-Mason L, 2009, LIVER TRANSPLANT, V15, P357, DOI 10.1002/lt.21701; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hayashida A, 2007, J OBSTET GYNAECOL RE, V33, P417, DOI 10.1111/j.1447-0756.2007.00582.x; Huang YC, 2008, J LEUKOCYTE BIOL, V84, P1501, DOI 10.1189/jlb.0408255; Iorio R, 2005, CLIN INFECT DIS, V41, P1431, DOI 10.1086/497141; Jonas MM, 2002, HEPATOLOGY, V36, pS173, DOI 10.1053/jhep.2002.36799; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 2007, HEPATOL RES, V37, pS319, DOI 10.1111/j.1872-034X.2007.00236.x; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Le Bouteiller P, 2008, AM J REPROD IMMUNOL, V59, P401, DOI 10.1111/j.1600-0897.2008.00597.x; Le Bouteiller P, 2006, NAT MED, V12, P991, DOI 10.1038/nm0906-991; McIntyre J, 2006, CURR OPIN INFECT DIS, V19, P33, DOI 10.1097/01.qco.0000200290.99790.72; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mengshol JA, 2009, GUT, V58, P964, DOI 10.1136/gut.2008.168948; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nomura A, 2001, EXP HEMATOL, V29, P1169, DOI 10.1016/S0301-472X(01)00689-0; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009; Saito K, 2008, J VIROL, V82, P3320, DOI 10.1128/JVI.02547-07; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; SIMMS J, 1993, SEMIN PERINATOL, V17, P384; Smyk-Pearson S, 2008, J INFECT DIS, V197, P46, DOI 10.1086/523651; Szekeres-Bartho J, 2001, SEMIN IMMUNOL, V13, P229, DOI 10.1006/smim.2000.0318; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Tsuda H, 2001, AM J REPROD IMMUNOL, V45, P295, DOI 10.1111/j.8755-8920.2001.450505.x; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wilczynski JR, 2003, EUR J OBSTET GYN R B, V109, P8, DOI 10.1016/S0301-2115(02)00350-0; Yonkers NL, 2007, J IMMUNOL, V178, P4436, DOI 10.4049/jimmunol.178.7.4436; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zanetti AR, 1999, J HEPATOL, V31, P96, DOI 10.1016/S0168-8278(99)80383-3	55	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12232	10.1371/journal.pone.0012232	http://dx.doi.org/10.1371/journal.pone.0012232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814429	gold, Green Submitted, Green Published			2022-12-25	WOS:000281375500001
J	Matsuo, K; Delibegovic, M; Matsuo, I; Nagata, N; Liu, SM; Bettaieb, A; Xi, YN; Araki, K; Yang, WT; Kahn, BB; Neel, BG; Haj, FG				Matsuo, Kosuke; Delibegovic, Mirela; Matsuo, Izumi; Nagata, Naoto; Liu, Siming; Bettaieb, Ahmed; Xi, Yannan; Araki, Kazushi; Yang, Wentian; Kahn, Barbara B.; Neel, Benjamin G.; Haj, Fawaz G.			Altered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FACTOR-I RECEPTOR; INSULIN-RESISTANCE; TUBEROUS SCLEROSIS; GENE-EXPRESSION; DILATED CARDIOMYOPATHY; PHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; S6 KINASE; SHP2	The Src homology 2 domain-containing protein-tyrosine phosphatase Shp2 has been implicated in a variety of growth factor signaling pathways, but its role in insulin signaling has remained unresolved. In vitro studies suggest that Shp2 is both a negative and positive regulator of insulin signaling, although its physiological function in a number of peripheral insulin-responsive tissues remains unknown. To address the metabolic role of Shp2 in the liver, we generated mice with either chronic or acute hepatic Shp2 deletion using tissue-specific Cre-LoxP and adenoviral Cre approaches, respectively. We then analyzed insulin sensitivity, glucose tolerance, and insulin signaling in liver-specific Shp2-deficient and control mice. Mice with chronic Shp2 deletion exhibited improved insulin sensitivity and increased glucose tolerance compared with controls. Acute Shp2 deletion yielded comparable results, indicating that the observed metabolic effects are directly caused by the lack of Shp2 in the liver. These findings correlated with, and were most likely caused by, direct dephosphorylation of insulin receptor substrate (IRS) 1/2 in the liver, accompanied by increased PI3K/Akt signaling. In contrast, insulin-induced ERK activation was dramatically attenuated, yet there was no effect on the putative ERK site on IRS1 (Ser(612)) or on S6 kinase 1 activity. These studies show that Shp2 is a negative regulator of hepatic insulin action, and its deletion enhances the activation of PI3K/Akt pathway downstream of the insulin receptor.	[Matsuo, Kosuke; Matsuo, Izumi; Nagata, Naoto; Liu, Siming; Bettaieb, Ahmed; Xi, Yannan; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Delibegovic, Mirela; Araki, Kazushi; Yang, Wentian; Kahn, Barbara B.; Neel, Benjamin G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University of California System; University of California Davis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall, Davis, CA 95616 USA.	fghaj@ucdavis.edu	NAGATA, Naoto/D-9261-2012	NAGATA, Naoto/0000-0002-2389-2334; Delibegovic, Mirela/0000-0001-6193-3152	National Institutes of Health [R3749512, R01DK60838]; American Diabetes Association [7-06-JF-28]; Juvenile Diabetes Research Foundation [1-2009-337]; Ontario Ministry of Health and Long Term Care (OMHLTC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R3749512 (to to B. G. N.) and R01DK60838 (to B. B. K.). This work was also supported by a grant from Center for Health and Nutrition Research, Junior Faculty Award 7-06-JF-28 from the American Diabetes Association, and Juvenile Diabetes Research Foundation Research Grant 1-2009-337 (to F. G. H.), and by the Ontario Ministry of Health and Long Term Care (OMHLTC). The views expressed do not necessarily reflect those of OMHLTC.	Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Binder G, 2005, J CLIN ENDOCR METAB, V90, P5377, DOI 10.1210/jc.2005-0995; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; MITTAL SK, 1993, VIRUS RES, V28, P67, DOI 10.1016/0168-1702(93)90090-A; Mussig K, 2005, J BIOL CHEM, V280, P32693, DOI 10.1074/jbc.M506549200; Myers MG, 1996, MOL CELL BIOL, V16, P4147; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ouwens DM, 2001, MOL CELL ENDOCRINOL, V175, P131, DOI 10.1016/S0303-7207(01)00389-6; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Podar K, 2004, J BIOL CHEM, V279, P21658, DOI 10.1074/jbc.M305783200; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SUGIMOTO S, 1993, J BIOL CHEM, V268, P22771; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zhang SS, 2009, P NATL ACAD SCI USA, V106, P7531, DOI 10.1073/pnas.0811715106; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	55	37	37	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39750	39758		10.1074/jbc.M110.153734	http://dx.doi.org/10.1074/jbc.M110.153734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20841350	hybrid, Green Published			2022-12-25	WOS:000285185500019
J	Bharadwaj, KG; Hiyama, Y; Hu, YY; Huggins, LA; Ramakrishnan, R; Abumrad, NA; Shulman, GI; Blaner, WS; Goldberg, IJ				Bharadwaj, Kalyani G.; Hiyama, Yaeko; Hu, Yunying; Huggins, Lesley Ann; Ramakrishnan, Rajasekhar; Abumrad, Nada A.; Shulman, Gerald I.; Blaner, William S.; Goldberg, Ira J.			Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways IN VIVO EVIDENCE FOR RECEPTOR- AND NON-RECEPTOR-MEDIATED FATTY ACID UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RETINOL-BINDING-PROTEIN; KNOCKOUT MICE; RAT-HEART; RICH LIPOPROTEINS; MEMBRANE-PROTEIN; TRANSGENIC MICE; OLEATE UPTAKE; LIPASE; METABOLISM	Lipids circulate in the blood in association with plasma lipoproteins and enter the tissues either after hydrolysis or as non-hydrolyzable lipid esters. We studied cardiac lipids, lipoprotein lipid uptake, and gene expression in heart-specific lipoprotein lipase (LpL) knock-out (hLpL0), CD36 knock-out (Cd36(-/-)), and double knock-out (hLpL0/Cd36(-/-)-DKO) mice. Loss of either LpL or CD36 led to a significant reduction in heart total fatty acyl-CoA (control, 99.5 +/- 3.8; hLpL0, 36.2 +/- 3.5; Cd36(-/-), 57.7 +/- 5.5 nmol/g, p < 0.05) and an additive effect was observed in the DKO (20.2 +/- 1.4 nmol/g, p < 0.05). Myocardial VLDL-triglyceride (TG) uptake was reduced in the hLpL0 (31 +/- 6%) and Cd36(-/-) (47 +/- 4%) mice with an additive reduction in the DKO (64 +/- 5%) compared with control. However, LpL but not CD36 deficiency decreased VLDL-cholesteryl ester uptake. Endogenously labeled mouse chylomicrons were produced by tamoxifen treatment of beta-actin-MerCreMer/LpL(flox/flox) mice. Induced loss of LpL increased TG levels > 10-fold and reduced HDL by > 50%. After injection of these labeled chylomicrons in the different mice, chylomicron TG uptake was reduced by similar to 70% and retinyl ester by similar to 50% in hLpL0 hearts. Loss of CD36 did not alter either chylomicron TG or retinyl ester uptake. LpL loss did not affect uptake of remnant lipoproteins from ApoE knock-out mice. Our data are consistent with two pathways for fatty acid uptake; a CD36 process for VLDL-derived fatty acid and a non-CD36 process for chylomicron-derived fatty acid uptake. In addition, our data show that lipolysis is involved in uptake of core lipids from TG-rich lipoproteins.	[Bharadwaj, Kalyani G.; Hiyama, Yaeko; Hu, Yunying; Huggins, Lesley Ann; Blaner, William S.; Goldberg, Ira J.] Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, New York, NY 10032 USA; [Bharadwaj, Kalyani G.; Hiyama, Yaeko; Hu, Yunying; Huggins, Lesley Ann; Blaner, William S.; Goldberg, Ira J.] Columbia Univ, Dept Med, Coll Phys & Surg, Div Cardiol, New York, NY 10032 USA; [Ramakrishnan, Rajasekhar] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Atkins Ctr Excellence Obes Med, St Louis, MO 63110 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Columbia University; Columbia University; Columbia University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Yale University	Goldberg, IJ (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, 630 W 168th St, New York, NY 10032 USA.	ijg3@columbia.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	National Institutes of Health [HL73029, HL45095, DK079221, AA019413, P01 HL057278]; American Heart Association [0725829T]; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL045095, R37HL045095, R01HL073029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, R01DK033301, R01DK040936, R01DK079221, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73029 and HL45095 (to I.J.G.), DK079221 and AA019413 (to W.S.B.), and P01 HL057278 (to N.A.A.).; Supported by American Heart Association Postdoctoral Fellowship 0725829T and a mentored postdoctoral fellowship from the American Diabetes Association.	ABUMRAD NA, 1984, J BIOL CHEM, V259, P8945; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Berk PD, 1999, MOL CELL BIOCHEM, V192, P17, DOI 10.1023/A:1006832001033; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; CLARK AB, 1985, J BIOL CHEM, V260, P4778; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; de Medina P, 2004, J PHARMACOL EXP THER, V308, P1165, DOI 10.1124/jpet.103.060426; DEGRELLA RF, 1980, J BIOL CHEM, V255, P9731; DEGRELLA RF, 1985, BASIC RES CARDIOL, V80, P107; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dugi KA, 2000, ARTERIOSCL THROM VAS, V20, P793, DOI 10.1161/01.ATV.20.3.793; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; EVANS AJ, 1993, METABOLISM, V42, P105, DOI 10.1016/0026-0495(93)90180-V; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FIELDING CJ, 1978, J CLIN INVEST, V62, P141, DOI 10.1172/JCI109099; GOLDBERG IJ, 1990, J CLIN INVEST, V86, P463, DOI 10.1172/JCI114732; Hamilton JA, 2001, J MOL NEUROSCI, V16, P99, DOI 10.1385/JMN:16:2-3:99; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Kleinfeld AM, 1998, BIOCHEMISTRY-US, V37, P8011, DOI 10.1021/bi980301+; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; LEVY E, 1990, EUR J CLIN INVEST, V20, P422, DOI 10.1111/j.1365-2362.1990.tb01880.x; Maugeais C, 2003, CIRCULATION, V108, P2121, DOI 10.1161/01.CIR.0000092889.24713.DC; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Niu YG, 2004, J PHYSIOL-LONDON, V558, P225, DOI 10.1113/jphysiol.2004.061473; Noh HL, 2006, AM J PHYSIOL-ENDOC M, V291, pE755, DOI 10.1152/ajpendo.00111.2006; NUNES R, 1988, J HEPATOL, V7, pP15; O'Byrne SM, 2010, AM J PHYSIOL-ENDOC M, V298, pE862, DOI 10.1152/ajpendo.00491.2009; OSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760; Pohl J, 2004, BBA-MOL CELL BIOL L, V1686, P1, DOI 10.1016/j.bbalip.2004.06.004; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; SCHWIETERMAN W, 1988, P NATL ACAD SCI USA, V85, P359, DOI 10.1073/pnas.85.2.359; Seo T, 2000, J BIOL CHEM, V275, P30355, DOI 10.1074/jbc.M910327199; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; SPADY DK, 1983, J LIPID RES, V24, P303; STREMMEL W, 1989, BIOCHIM BIOPHYS ACTA, V1013, P218, DOI 10.1016/0167-4889(89)90138-9; STREMMEL W, 1988, J CLIN INVEST, V81, P844, DOI 10.1172/JCI113393; STUMP DD, 1992, HEPATOLOGY, V16, pA261; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tetali SD, 2010, J LIPID RES, V51, P1273, DOI 10.1194/jlr.M000406; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Xiang SQ, 1999, J LIPID RES, V40, P1655; Yamashita H, 2008, AM J PHYSIOL-ENDOC M, V295, pE705, DOI 10.1152/ajpendo.90338.2008; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6	65	88	89	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37976	37986		10.1074/jbc.M110.174458	http://dx.doi.org/10.1074/jbc.M110.174458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20852327	Green Published, hybrid			2022-12-25	WOS:000284625600005
J	Deng, Y; Liu, J; Han, G; Lu, SL; Wang, SY; Malkoski, S; Tan, AC; Deng, C; Wang, XJ; Zhang, Q				Deng, Y.; Liu, J.; Han, G.; Lu, S-L; Wang, S-Y; Malkoski, S.; Tan, A. C.; Deng, C.; Wang, X-J; Zhang, Q.			Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1	ONCOGENE			English	Article						Brca1; CtBP1; NADH; transcription; tumor suppressor; HNSCC	SQUAMOUS-CELL CARCINOMA; TERMINAL BINDING-PROTEIN; FANCONI-ANEMIA; NECK-CANCER; NEGATIVE MODULATION; ANTIOXIDANT TEMPOL; DOWN-REGULATION; BREAST-CANCER; E1A PROTEIN; RAT-LIVER	C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor and metabolic sensory protein, which often represses tumor suppressor genes. Hence, we sought to determine if CtBP1 affects expression of the tumor suppressor Brca1 in head and neck tissue, as downregulation of Brca1 begins at the early stages of head and neck squamous cell carcinomas (HNSCCs). We found that CtBP1 represses Brca1 transcription by binding to the E2F4 site of the Brca1 promoter. Additionally, the recruitment of CtBP1 to the Brca1 promoter is redox-dependent, that is, increased at high NADH levels in hypoxic conditions. Further, immunostaining using a human HNSCC tissue array revealed that nuclear CtBP1 staining began to accumulate in hyperplasic lesions and HNSCCs, this staining correlated with Brca1 downregulation in these lesions. Pharmacological disruption of CtBP1 binding to Brca1 promoter by the antioxidant Tempol, which reduces NADH levels, relieved CtBP1-mediated repression of Brca1, leading to increased DNA repair in HNSCC cells. As tumor cells are generally hypoxic with increased NADH levels, the dynamic control of Brca1 by a 'metabolic switch' found in this study not only provides an important link between tumor metabolism and tumor suppressor expression but also suggests a potential chemo preventative or therapeutic strategy for HNSCC by blocking NADH-dependent CtBP1 activity at early stages of HNSCC carcinogenesis. Oncogene (2010) 29, 6603-6608; doi:10.1038/onc.2010.406; published online 6 September 2010	[Han, G.; Wang, X-J] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Deng, Y.; Liu, J.; Zhang, Q.] Univ Colorado, Dept Dermatol, Aurora, CO 80045 USA; [Lu, S-L] Univ Colorado, Dept Otolaryngol, Aurora, CO 80045 USA; [Wang, S-Y] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Malkoski, S.] Univ Colorado, Dept Med, Div Pulm, Aurora, CO 80045 USA; [Tan, A. C.] Univ Colorado, Dept Med, Div Med Oncol, Aurora, CO 80045 USA; [Deng, C.] NIDDK, NIH, Bethesda, MD USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Oregon Health & Science University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wang, XJ (corresponding author), Univ Colorado, Dept Pathol, Aurora, CO 80045 USA.	xj.wang@UCDenver.edu; Qinghong.Zhang@UCDenver.edu	deng, chuxia/N-6713-2016; Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369	NIH [R01DE15953, R01CA115468]; NATIONAL CANCER INSTITUTE [R01CA115468, R01CA087849, K08CA131483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Grants from the NIH, R01DE15953 (to X-JW) and R01CA115468 (to QZ). We thank Dr Petra Boukamp for providing the normal human keratinocytes HaCaT cells and Dr James Mitchell for helpful discussions.	Andres JL, 1998, ONCOGENE, V16, P2229, DOI 10.1038/sj.onc.1201752; Atlas E, 2001, ONCOGENE, V20, P7110, DOI 10.1038/sj.onc.1204890; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; Barnes CJ, 2003, NAT STRUCT BIOL, V10, P622, DOI 10.1038/nsb957; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; Bindra RS, 2006, CANCER BIOL THER, V5, P1400, DOI 10.4161/cbt.5.10.3454; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; De Siervi A, 2010, CANCER RES, V70, P532, DOI 10.1158/0008-5472.CAN-09-1477; Erker L, 2005, HUM MOL GENET, V14, P1699, DOI 10.1093/hmg/ddi181; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; IANNONE A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P285, DOI 10.1016/0304-4165(90)90052-X; Kim JH, 2009, CELL DEATH DIFFER, V16, P584, DOI 10.1038/cdd.2008.186; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Metz JM, 2004, CLIN CANCER RES, V10, P6411, DOI 10.1158/1078-0432.CCR-04-0658; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Mitchell JB, 2003, FREE RADICAL BIO MED, V34, P93, DOI 10.1016/S0891-5849(02)01193-0; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sparano A, 2006, LARYNGOSCOPE, V116, P735, DOI 10.1097/01.mlg.0000205141.54471.7f; SUBRAMANIAN T, 1989, ONCOGENE, V4, P415; Thakur S, 1999, J BIOL CHEM, V274, P8837, DOI 10.1074/jbc.274.13.8837; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wreesmann VB, 2007, ORL-J OTO-RHIN-LARYN, V69, P218, DOI 10.1159/000101542; Wu WN, 2007, AM J PHYSIOL-LUNG C, V293, pL952, DOI 10.1152/ajplung.00203.2007; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QS, 2008, CANCER RES, V68, P1601, DOI 10.1158/0008-5472.CAN-07-5186; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103	44	27	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6603	6608		10.1038/onc.2010.406	http://dx.doi.org/10.1038/onc.2010.406			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20818429	Green Accepted			2022-12-25	WOS:000285380200009
J	Rokaeus, N; Shen, J; Eckhardt, I; Bykov, VJN; Wiman, KG; Wilhelm, MT				Rokaeus, N.; Shen, J.; Eckhardt, I.; Bykov, V. J. N.; Wiman, K. G.; Wilhelm, M. T.			PRIMA-1(MET)/APR-246 targets mutant forms of p53 family members p63 and p73	ONCOGENE			English	Article						PRIMA-1(MET); APR-246; reactivation; mutant p63; mutant p73; apoptosis	TUMOR-SUPPRESSOR FUNCTIONS; DNA-BINDING ACTIVITY; EEC-SYNDROME; HOMOLOG P63; APOPTOSIS; GENE; ACTIVATION; INDUCTION; CELLS; LIMB	The low molecular weight compound PRIMA-1 and the structural analog PRIMA-1(MET), also named APR-246, reactivate mutant p53 through covalent binding to the core domain and induce apoptosis in tumor cells. Here, we asked whether PRIMA-1(MET)/APR-246 can rescue mutant forms of the p53 family members p63 and p73 that share high sequence homology with p53. We found that PRIMA-1(MET)/APR-246 can restore the pro-apoptotic function to mutant TAp63 gamma and TAp73 beta in tumor cells but has less effect on TAp73 alpha. Moreover, PRIMA-1(MET)/APR-246-stimulated DNA binding of mutant TAp63 gamma and induced expression of the p53/p63/p73 downstream targets p21 and Noxa. The reactivation of mutant p53, p63 and p73 by PRIMA-1(MET)/APR-246 indicates a common mechanism, presumably involving homologous structural elements in the p53 family proteins. Our findings may open avenues for therapeutic intervention in human developmental disorders with mutations in p63. Oncogene (2010) 29, 6442-6451; doi:10.1038/onc.2010.382; published online 6 September 2010	[Wiman, K. G.] Karolinska Inst, CCK, Dept Oncol Pathol, Karolinska Univ Hosp R8 04, SE-17176 Stockholm, Sweden; [Wilhelm, M. T.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Wiman, KG (corresponding author), Karolinska Inst, CCK, Dept Oncol Pathol, Karolinska Univ Hosp R8 04, SE-17176 Stockholm, Sweden.	Klas.Wiman@ki.se	Wiman, Klas/AAB-8399-2021	Wiman, Klas/0000-0002-7113-524X; Nakade Bykov, Vladimir/0000-0002-7199-8942; Wilhelm, Margareta/0000-0002-0516-9724	EU [LSHB-CT-2005-019067]	EU(European Commission)	We thank Dr Jiandong Chen, H Lee Moffitt Cancer Center, for the ts mutant p63/p73-expressing cells, and Dr Bert Vogelstein, Johns Hopkins Oncology Center, for the HCT116 cells. This work was supported by EU 6th Framework Program within the EPISTEM Integrated Project (LSHB-CT-2005-019067).	Bernassola F, 2005, ONCOGENE, V24, P6982, DOI 10.1038/sj.onc.1208843; Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2005, ONCOGENE, V24, P3484, DOI 10.1038/sj.onc.1208419; Bykov VJN, 2002, CARCINOGENESIS, V23, P2011, DOI 10.1093/carcin/23.12.2011; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Corn PG, 1999, CANCER RES, V59, P3352; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Gonzalez S, 2005, CANCER RES, V65, P2186, DOI 10.1158/0008-5472.CAN-04-3047; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kawano S, 1999, BLOOD, V94, P1113; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ozaki T, 1999, CANCER RES, V59, P5902; Pochampally R, 2000, BIOCHEM BIOPH RES CO, V279, P1001, DOI 10.1006/bbrc.2000.4056; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rokaeus N, 2007, ONCOGENE, V26, P982, DOI 10.1038/sj.onc.1209858; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Scoumanne A, 2005, CANCER BIOL THER, V4, P1178, DOI 10.4161/cbt.4.11.2254; Shen J, 2008, ONCOGENE, V27, P6571, DOI 10.1038/onc.2008.249; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Strano S, 2001, FEBS LETT, V490, P163, DOI 10.1016/S0014-5793(01)02119-6; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Ueda Y, 1999, ONCOGENE, V18, P4993, DOI 10.1038/sj.onc.1202817; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zache N, 2008, CELL ONCOL, V30, P411, DOI 10.3233/CLO-2008-0440; Zeng XY, 2001, CARCINOGENESIS, V22, P215, DOI 10.1093/carcin/22.2.215	48	45	47	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2010	29	49					6442	6451		10.1038/onc.2010.382	http://dx.doi.org/10.1038/onc.2010.382			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20818419				2022-12-25	WOS:000285138900004
J	Soltoff, SP; Asara, JM; Hedden, L				Soltoff, Stephen P.; Asara, John M.; Hedden, Lee			Regulation and Identification of Na,K-ATPase alpha 1 Subunit Phosphorylation in Rat Parotid Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NA+-K+-ATPASE; DEPENDENT PHOSPHORYLATION; ANCHORING PROTEIN; EPITHELIAL-CELLS; SALIVARY-GLANDS; INTACT-CELLS; NA+,K+-ATPASE; STIMULATION; ERK1/2	The stimulation of fluid and electrolyte secretion in salivary cells results in ionic changes that promote rapid increases in the activity of the Na,K-ATPase. In many cell systems, there are conflicting findings concerning the regulation of the phosphorylation of the Na, K-ATPase alpha subunit, which is the catalytic moiety. Initially, we investigated the phosphorylation sites on the alpha 1 subunit in native rat parotid acinar cells using tandem mass spectrometry and identified two new phosphorylation sites (Ser(222), Ser(407)), three sites (Ser(217), Tyr(260), Ser(47)) previously found from large scale proteomic screens, and two sites (Ser(23), Ser(16)) known to be phosphorylated by PKC. Subsequently, we used phospho-specific antibodies to examine the regulation of phosphorylation on Ser(23) and Ser(16) and measured changes in ERK phosphorylation in parallel. The G-protein-coupled muscarinic receptor mimetic carbachol, the phorbol ester phorbol 12-myristate 13-acetate, the Ca2+ ionophore ionomycin, and the serine/threonine phosphatase inhibitor calyculin A increased Ser(23) alpha 1 phosphorylation. Inhibition of classical PKC proteins blocked carbachol-stimulated Ser(23) alpha 1 subunit phosphorylation but not ERK phosphorylation, which was blocked by an inhibitor of novel PKC proteins. The carbachol-initiated phosphorylation of Ser(23) alpha 1 subunit was not modified by ERK or PKA activity. The Na, K-ATPase inhibitor ouabain reduced and enhanced the carbachol-promoted phosphorylation of Ser(23) and Ser(16), respectively, the latter because ouabain itself increased Ser(16) phosphorylation; thus, both sites display conformational-dependent phosphorylation changes. Ouabain-initiated phosphorylation of Ser(16) alpha 1 was not blocked by PKC inhibitors, unlike carbachol-or phorbol 12-myristate 13-acetate-initiated phosphorylations, suggesting that this site was also a substrate for a kinase other than PKC.	[Soltoff, Stephen P.; Asara, John M.; Hedden, Lee] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, 330 Brookline Ave,EC CLS 406, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			National Institutes of Health [DE-10877, 5P30CA006516-43, 1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-10877 (to S.P.S.), 5P30CA006516-43 (to J.M.A.), and 1P01CA120964-01A (J.M.A.).	Al-Khalili L, 2004, J BIOL CHEM, V279, P25211, DOI 10.1074/jbc.M402152200; Asara JM, 1999, J AM SOC MASS SPECTR, V10, P35, DOI 10.1016/S1044-0305(98)00129-9; Asghar M, 2003, AM J PHYSIOL-RENAL, V285, pF1100, DOI 10.1152/ajprenal.00198.2003; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1981, DOI 10.1152/ajpcell.1997.273.6.C1981; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; COLLINS SA, 1987, BIOCHIM BIOPHYS ACTA, V927, P392, DOI 10.1016/0167-4889(87)90104-2; Efendiev R, 2000, BIOCHEMISTRY-US, V39, P9884, DOI 10.1021/bi0007831; Efendiev R, 2006, J AM SOC NEPHROL, V17, P31, DOI 10.1681/ASN.2005070681; El-Beialy W, 2010, J MEMBRANE BIOL, V233, P119, DOI 10.1007/s00232-010-9231-z; Feraille E, 1999, MOL BIOL CELL, V10, P2847, DOI 10.1091/mbc.10.9.2847; FERAILLE E, 1995, AM J PHYSIOL-CELL PH, V268, pC1277, DOI 10.1152/ajpcell.1995.268.5.C1277; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Hatou S, 2010, INVEST OPHTH VIS SCI, V51, P3935, DOI 10.1167/iovs.09-4027; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Kazanietz MG, 2001, ARCH BIOCHEM BIOPHYS, V388, P74, DOI 10.1006/abbi.2000.2264; Kiroytcheva M, 1999, KIDNEY INT, V55, P1819, DOI 10.1046/j.1523-1755.1999.00414.x; Kurihara K, 2003, BIOCHEM PHARMACOL, V66, P239, DOI 10.1016/S0006-2952(03)00259-4; Kurihara K, 2008, ARCH ORAL BIOL, V53, P593, DOI 10.1016/j.archoralbio.2008.01.007; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lecuona E, 2007, J BIOENERG BIOMEMBR, V39, P391, DOI 10.1007/s10863-007-9102-1; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Michlig S, 2004, J BIOL CHEM, V279, P51002, DOI 10.1074/jbc.M405674200; Pedemonte CH, 1997, J MEMBRANE BIOL, V155, P219, DOI 10.1007/s002329900174; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Sano A, 2004, ANAL SCI, V20, P565, DOI 10.2116/analsci.20.565; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Soltoff SP, 2010, J BIOL CHEM, V285, P13337, DOI 10.1074/jbc.M110.112094; Sottejeau Y, 2010, BIOCHEMISTRY-US, V49, P3602, DOI 10.1021/bi9021999; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; White CN, 2010, J BIOL CHEM, V285, P13712, DOI 10.1074/jbc.M109.090225; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297	41	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36330	36338		10.1074/jbc.M110.136465	http://dx.doi.org/10.1074/jbc.M110.136465			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841356	hybrid, Green Published			2022-12-25	WOS:000284146100078
J	Chan, J; Yamazaki, H; Ishiyama, N; Seo, MD; Mal, TK; Michikawa, T; Mikoshiba, K; Ikura, M				Chan, Jenny; Yamazaki, Haruka; Ishiyama, Noboru; Seo, Min-Duk; Mal, Tapas K.; Michikawa, Takayuki; Mikoshiba, Katsuhiko; Ikura, Mitsuhiko			Structural Studies of Inositol 1,4,5-Trisphosphate Receptor COUPLING LIGAND BINDING TO CHANNEL GATING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; SEQUENTIAL ASSIGNMENT; BACKBONE ASSIGNMENT; RYANODINE RECEPTOR; CRYSTAL-STRUCTURE; PROTEINS; SYSTEM; DOMAINS; TYPE-2; SUITE	The three isoforms of the inositol 1,4,5-trisphosphate receptor (IP3R) exhibit distinct IP3 sensitivities and cooperativities in calcium (Ca2+) channel function. The determinants underlying this isoform-specific channel gating mechanism have been localized to the N-terminal suppressor region of IP3R. We determined the 1.9 angstrom crystal structure of the suppressor domain from type 3 IP3R (IP(3)R3(SUP), amino acids 1-224) and revealed structural features contributing to isoform-specific functionality of IP3R by comparing it with our previously determined structure of the type 1 suppressor domain (IP(3)R1(SUP)). The molecular surface known to associate with the ligand binding domain (amino acids 224-604) showed marked differences between IP3R3SUP and IP3R1SUP. Our NMR and biochemical studies showed that three spatially clustered residues (Glu-20, Tyr-167, and Ser-217 in IP(3)R1 and Glu-19, Trp-168, and Ser-218 in IP(3)R3) within the N-terminal suppressor domains of IP(3)R1SUP and IP(3)R3(SUP) interact directly with their respective C-terminal fragments. Together with the accompanying paper (Yamazaki, H., Chan, J., Ikura, M., Michikawa, T., and Mikoshiba, K. (2010) J. Biol. Chem. 285, 36081-36091), we demonstrate that the single aromatic residue in this region (Tyr-167 in IP(3)R1 and Trp-168 in IP(3)R3) plays a critical role in the coupling between ligand binding and channel gating.	[Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Chan, Jenny; Ishiyama, Noboru; Seo, Min-Duk; Mal, Tapas K.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Chan, Jenny; Ishiyama, Noboru; Seo, Min-Duk; Mal, Tapas K.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Mal, Tapas K/A-9453-2011	Mal, Tapas K/0000-0002-0625-2095; Ikura, Mitsuhiko/0000-0002-9524-1303	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research (CIHR); Special Postdoctoral Researchers Program in RIKEN; Ministry of Education, Science, Sports, and Culture of Japan [20370054, 20220007]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Special Postdoctoral Researchers Program in RIKEN; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Heart and Stroke Foundation of Ontario (to M. I.), a Canadian Institutes of Health Research (CIHR) doctoral award (to J. C.) and a CIHR postdoctoral fellowship (to N. I.) and was supported by grants from the Special Postdoctoral Researchers Program in RIKEN (to H. Y.) and Ministry of Education, Science, Sports, and Culture of Japan Grants 20370054 (to T. M.) and 20220007 (to K. M.).	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSH KT, 1994, J BIOL CHEM, V269, P23694; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAGLIO F, 1995, NMRDRAW; DeSmedt H, 1997, BIOCHEM J, V322, P575; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hamada T, 2007, BIOCHEMISTRY-US, V46, P4272, DOI 10.1021/bi061557f; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; WANG AC, 1994, J MAGN RESON SER B, V105, P196, DOI 10.1006/jmrb.1994.1123; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	31	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36092	36099		10.1074/jbc.M110.140160	http://dx.doi.org/10.1074/jbc.M110.140160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843799	Green Published, hybrid			2022-12-25	WOS:000283845300085
J	Gan, NQ; Wu, YC; Brunet, M; Garrido, C; Chung, FL; Dai, CK; Mi, LX				Gan, Nanqin; Wu, Yu-Chieh; Brunet, Mathilde; Garrido, Carmen; Chung, Fung-Lung; Dai, Chengkai; Mi, Lixin			Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; ALPHA-B-CRYSTALLIN; TRANSCRIPTION FACTOR; INCREASED EXPRESSION; 26S PROTEASOME; CANCER CELLS; REDOX STATE; PROTEIN; DEGRADATION; INDUCTION	It is conceivable that stimulating proteasome activity for rapid removal of misfolded and oxidized proteins is a promising strategy to prevent and alleviate aging-related diseases. Sulforaphane (SFN), an effective cancer preventive agent derived from cruciferous vegetables, has been shown to enhance proteasome activities in mammalian cells and to reduce the level of oxidized proteins and amyloid beta-induced cytotoxicity. Here, we report that SFN activates heat shock transcription factor 1-mediated heat shock response. Specifically, SFN-induced expression of heat shock protein 27 (Hsp27) underlies SFN-stimulated proteasome activity. SFN-induced proteasome activity was significantly enhanced in Hsp27-overexpressing cells but absent in Hsp27-silenced cells. The role of Hsp27 in regulating proteasome activity was further confirmed in isogenic REG cells, in which SFN-induced proteasome activation was only observed in cells stably overexpressing Hsp27, but not in the Hsp27-free parental cells. Finally, we demonstrated that phosphorylation of Hsp27 is irrelevant to SFN-induced proteasome activation. This study provides a novel mechanism underlying SFN-induced proteasome activity. This is the first report to show that heat shock response by SFN, in addition to the antioxidant response mediated by the Keap1-Nrf2 pathway, may contribute to cytoprotection.	[Mi, Lixin] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Gan, Nanqin] Chinese Acad Sci, Inst Hydrobiol, Beijing 100864, Peoples R China; [Brunet, Mathilde; Garrido, Carmen] INSERM, Fac Med & Pharm, UMR 866, F-21049 Dijon, France; [Dai, Chengkai] Jackson Lab, Bar Harbor, ME 04609 USA	Georgetown University; Chinese Academy of Sciences; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Jackson Laboratory	Mi, LX (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3800 Reservoir Rd,LL 129,Box 571465, Washington, DC 20057 USA.	lm293@georgetown.edu	Garrido, carmen/G-1633-2018; Garrido, Carolina/GWM-5557-2022	Garrido, carmen/0000-0003-1368-1493; 	National Institutes of Health through the National Cancer Institute [CA100853]; NATIONAL CANCER INSTITUTE [R01CA100853] Funding Source: NIH RePORTER	National Institutes of Health through the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health Grant CA100853 through the National Cancer Institute (to F.-L. C.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Arrigo AP, 2001, IUBMB LIFE, V52, P303, DOI 10.1080/152165401317291156; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; BRUCE JL, 1993, CANCER RES, V53, P12; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dong GZ, 2009, INT J HYPERTHER, V25, P477, DOI 10.1080/02656730903049836; Fowke JH, 2003, CANCER RES, V63, P3980; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Hoffman L, 1996, CURR TOP CELL REGUL, V34, P1, DOI 10.1016/S0070-2137(96)80001-X; Ialenti A, 2005, MOL PHARMACOL, V67, P1620, DOI 10.1124/mol.104.004895; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Kwak MK, 2007, LIFE SCI, V80, P2411, DOI 10.1016/j.lfs.2007.04.014; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lee YK, 2009, J CELL BIOCHEM, V106, P267, DOI 10.1002/jcb.21997; Liu H, 1996, J BIOL CHEM, V271, P4805; Manalo DJ, 2001, J BIOL CHEM, V276, P23554, DOI 10.1074/jbc.M011300200; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Mi LX, 2009, BIOCHEM BIOPH RES CO, V388, P456, DOI 10.1016/j.bbrc.2009.08.047; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Vallanat B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-16; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WHO, 2004, IARC HDB CANC PREV, V9; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185; Yu XC, 2009, CURR OPIN PHARMACOL, V9, P167, DOI 10.1016/j.coph.2008.11.005; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147	50	90	93	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35528	35536		10.1074/jbc.M110.152686	http://dx.doi.org/10.1074/jbc.M110.152686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833711	hybrid, Green Published			2022-12-25	WOS:000283845300031
J	Lin, WH; Nebhan, CA; Anderson, BR; Webb, DJ				Lin, Wan-Hsin; Nebhan, Caroline A.; Anderson, Bridget R.; Webb, Donna J.			Vasodilator-stimulated Phosphoprotein (VASP) Induces Actin Assembly in Dendritic Spines to Promote Their Development and Potentiate Synaptic Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; ENA/VASP PROTEINS; AMPA RECEPTORS; FIBROBLAST MOTILITY; FILOPODIA FORMATION; NMDA RECEPTORS; EVH1 DOMAIN; MYOSIN VB; F-ACTIN	Dendritic spines are small actin-rich structures that receive the majority of excitatory synaptic input in the brain. The actin-based dynamics of spines are thought to mediate synaptic plasticity, which underlies cognitive processes, such as learning and memory. However, little is known about the molecular mechanisms that regulate actin dynamics in spines and synapses. In this study we show the multifunctional actin-binding protein vasodilator-stimulated phosphoprotein (VASP) regulates the density, size, and morphology of dendritic spines by inducing actin assembly in these structures. Knockdown of endogenous VASP by siRNA led to a significant decrease in the density of spines and synapses, whereas expression of siRNA-resistant VASP rescued this defect. The ability of VASP to modulate spine and synapse formation, maturation, and spine head enlargement is dependent on its actin binding Ena/VASP homology 2 (EVH2) domain and its EVH1 domain, which contributes to VASP localization to actin-rich structures. Moreover, VASP increases the amount of PSD-scaffolding proteins and the number of surface GluR1-containing alpha-amino-3-hydroxy-5-methyl4-isoxazole propionic acid receptors (AMPARs) in spines. VASP knockdown results in a reduction in surface AMPAR density, suggesting a role for this protein in regulating synaptic strength. Consistent with this, VASP significantly enhances the retention of GluR1 in spines as determined by fluorescence recovery after photobleaching and increases AMPAR-mediated synaptic transmission. Collectively, our results suggest that actin polymerization and bundling by VASP are critical for spine formation, expansion, and modulating synaptic strength.	[Lin, Wan-Hsin; Nebhan, Caroline A.; Anderson, Bridget R.; Webb, Donna J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Lin, Wan-Hsin; Nebhan, Caroline A.; Anderson, Bridget R.; Webb, Donna J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; [Webb, Donna J.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Webb, DJ (corresponding author), VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	donna.webb@vanderbilt.edu			National Institutes of Health [MH071674]; National Center for Research Resources [S10RR025524]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH071674 and by National Center for Research Resources Grant S10RR025524 (to D.J.W.).	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Allison DW, 1998, J NEUROSCI, V18, P2423; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; Chan AY, 1998, J CELL SCI, V111, P199; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Goslin K., 1998, RAT HIPPOCAMPAL NEUR, P339; GRAY EG, 1959, J ANAT, V93, P420; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim CH, 1999, J NEUROSCI, V19, P4314; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shen L, 2000, J NEUROSCI, V20, P7932; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zimmermann J, 2002, BIOCHEMISTRY-US, V41, P11143, DOI 10.1021/bi020379x; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	67	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36010	36020		10.1074/jbc.M110.129841	http://dx.doi.org/10.1074/jbc.M110.129841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826790	hybrid, Green Published			2022-12-25	WOS:000283845300077
J	Shahzad, MMK; Arevalo, JM; Armaiz-Pena, GN; Lu, CH; Stone, RL; Moreno-Smith, M; Nishimura, M; Lee, JW; Jennings, NB; Bottsford-Miller, J; Vivas-Mejia, P; Lutgendorf, SK; Lopez-Berestein, G; Bar-Eli, M; Cole, SW; Sood, AK				Shahzad, Mian M. K.; Arevalo, Jesusa M.; Armaiz-Pena, Guillermo N.; Lu, Chunhua; Stone, Rebecca L.; Moreno-Smith, Myrthala; Nishimura, Masato; Lee, Jeong-Won; Jennings, Nicholas B.; Bottsford-Miller, Justin; Vivas-Mejia, Pablo; Lutgendorf, Susan K.; Lopez-Berestein, Gabriel; Bar-Eli, Menashe; Cole, Steven W.; Sood, Anil K.			Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; INTERFERING RNA DELIVERY; TUMOR-GROWTH; SOCIAL SUPPORT; MELANOMA-CELLS; BREAST-CANCER; NUDE-MICE; CARCINOMA CELLS; ANGIOGENESIS; AP-1	A growing number of studies indicate that chronic stress can accelerate tumor growth due to sustained sympathetic nervous system activation. Our recent findings suggest that chronic stress is associated with increased IL8 levels. Here, we examined the molecular and biological significance of IL8 in stress-induced tumor growth. Norepinephrine (NE) treatment of ovarian cancer cells resulted in a 250-300% increase in IL8 protein and 240-320% increase in its mRNA levels. Epinephrine treatment resulted in similar increases. Moreover, NE treatment resulted in a 3.5-4-fold increase in IL8 promoter activity. These effects were blocked by propranolol. Promoter deletion analyses suggested that AP1 transcription factors might mediate catecholamine-stimulated up-regulation of IL8. siRNA inhibition studies identified FosB as the pivotal component responsible for IL8 regulation by NE. In vivo chronic stress resulted in increased tumor growth (by 221 and 235%; p < 0.01) in orthotopic xenograft models involving SKOV3ip1 and HeyA8 ovarian carcinoma cells. This enhanced tumor growth was completely blocked by IL8 or FosB gene silencing using 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine nanoliposomes. IL8 and FosB silencing reduced microvessel density (based on CD31 staining) by 2.5- and 3.5-fold, respectively (p < 0.001). Our findings indicate that neurobehavioral stress leads to FosB-driven increases in IL8, which is associated with increased tumor growth and metastases. These findings may have implications for ovarian cancer management.	[Moreno-Smith, Myrthala; Nishimura, Masato; Lee, Jeong-Won; Jennings, Nicholas B.; Bottsford-Miller, Justin; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Vivas-Mejia, Pablo; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Shahzad, Mian M. K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Obstet & Gynecol, Div Gynecol Oncol, Madison, WI 53792 USA; [Lutgendorf, Susan K.] Univ Iowa, Dept Psychol, Iowa City, IA 52241 USA; [Lee, Jeong-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul 135710, South Korea; [Arevalo, Jesusa M.; Cole, Steven W.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of Iowa; Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California Los Angeles	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, 1155 Herman Pressler,Unit 1362, Houston, TX 77030 USA.	asood@mdanderson.org	lee, jw/O-6237-2014	Armaiz-Pena, Guillermo N/0000-0002-9081-5339	National Institutes of Health [CA109298, CA110793, CA128797, RC2GM092599, CA151668]; Ovarian Cancer Research Fund, Inc.; Zarrow Foundation; Marcus Foundation; Alliance for Nanohealth; Meyer and Ida Gordon Foundation Number 2, Department of Defense [OC073399, W81XWH-10-1-0158]; University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer [P50 CA083639]; Blanton-Davis Ovarian Cancer Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD050128] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA110793, T32CA009614, R01CA128797, R01CA109298, T32CA101642, R01CA104825, P50CA083639, U54CA151668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund, Inc.; Zarrow Foundation; Marcus Foundation; Alliance for Nanohealth; Meyer and Ida Gordon Foundation Number 2, Department of Defense(United States Department of Defense); University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer; Blanton-Davis Ovarian Cancer Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109298, CA110793, CA128797, RC2GM092599, and CA151668. This work was also supported by a program project development grant from the Ovarian Cancer Research Fund, Inc., the Zarrow Foundation, the Marcus Foundation, a grant from the Alliance for Nanohealth, the Meyer and Ida Gordon Foundation Number 2, Department of Defense Grants OC073399 and W81XWH-10-1-0158, the University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer Grant P50 CA083639, and the Blanton-Davis Ovarian Cancer Research Program.	Andersen BL, 1998, JNCI-J NATL CANCER I, V90, P30, DOI 10.1093/jnci/90.1.30; Andersen BL, 2004, J CLIN ONCOL, V22, P3570, DOI 10.1200/JCO.2004.06.030; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Antoni MH, 2000, ANN BEHAV MED, V22, P29, DOI 10.1007/BF02895165; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Costanzo ES, 2005, CANCER-AM CANCER SOC, V104, P305, DOI 10.1002/cncr.21147; Drell TL, 2003, BREAST CANCER RES TR, V80, P63, DOI 10.1023/A:1024491219366; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Fawzy FI, 2003, ARCH GEN PSYCHIAT, V60, P100, DOI 10.1001/archpsyc.60.1.100; FIDLER I, 2001, J NATL CANC I MONOGR, V28, P10; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Glaser R, 2001, J GERONTOL A-BIOL, V56, pM477, DOI 10.1093/gerona/56.8.M477; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karashima T, 2003, CLIN CANCER RES, V9, P2786; Kassim SK, 2004, CLIN BIOCHEM, V37, P363, DOI 10.1016/j.clinbiochem.2004.01.014; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lang K, 2004, INT J CANCER, V112, P231, DOI 10.1002/ijc.20410; Lee JW, 2009, JNCI-J NATL CANCER I, V101, P1193, DOI 10.1093/jnci/djp231; Lev DC, 2003, MOL CANCER THER, V2, P753; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Lokshin AE, 2006, GYNECOL ONCOL, V102, P244, DOI 10.1016/j.ygyno.2005.12.011; Lu C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.028; Luca M, 1997, AM J PATHOL, V151, P1105; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Lutgendorf SK, 2002, CANCER, V94, P131, DOI 10.1002/cncr.10155; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; MARCHETTI B, 1991, J STEROID BIOCHEM, V38, P307, DOI 10.1016/0960-0760(91)90102-B; Masur K, 2001, CANCER RES, V61, P2866; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Page GG, 1999, DEV COMP IMMUNOL, V23, P87, DOI 10.1016/S0145-305X(98)00040-8; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Re G, 1996, PHARMACOL RES, V33, P255, DOI 10.1006/phrs.1996.0036; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Spiegel D, 2002, NAT REV CANCER, V2, P383, DOI 10.1038/nrc800; Thaker PH, 2005, CLIN CANCER RES, V11, P4923, DOI 10.1158/1078-0432.CCR-04-2060; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Turner-Cobb JM, 2000, PSYCHOSOM MED, V62, P337, DOI 10.1097/00006842-200005000-00007; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDEWALLE B, 1990, J CANCER RES CLIN, V116, P303, DOI 10.1007/BF01612908; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447	53	136	140	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35462	35470		10.1074/jbc.M110.109579	http://dx.doi.org/10.1074/jbc.M110.109579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826776	Green Published, hybrid			2022-12-25	WOS:000283845300024
J	Bae, JS; Yang, LK; Rezaie, AR				Bae, Jong-Sup; Yang, Likui; Rezaie, Alireza R.			Factor X/Xa Elicits Protective Signaling Responses in Endothelial Cells Directly via PAR-2 and Indirectly via Endothelial Protein C Receptor-dependent Recruitment of PAR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-THROMBOMODULIN COMPLEX; FACTOR-KAPPA-B; FACTOR-XA; BLOOD-COAGULATION; MOLECULAR-CLONING; TISSUE FACTOR; ACTIVATION; EXPRESSION; LIGAND; PATHWAY	We recently demonstrated that the Gla domain-dependent interaction of protein C with endothelial protein C receptor (EPCR) leads to dissociation of the receptor from caveolin-1 and recruitment of PAR-1 to a protective signaling pathway. Thus, the activation of PAR-1 by either thrombin or PAR-1 agonist peptide elicited a barrier-protective response if endothelial cells were preincubated with protein C. In this study, we examined whether other vitamin K-dependent coagulation protease zymogens can modulate PAR-dependent signaling responses in endothelial cells. We discovered that the activation of both PAR-1 and PAR-2 in endothelial cells pretreated with factor FX (FX)-S195A, but not other procoagulant protease zymogens, also results in initiation of protective intracellular responses. Interestingly, similar to protein C, FX interaction with endothelial cells leads to dissociation of EPCR from caveolin-1 and recruitment of PAR-1 to a protective pathway. Further studies revealed that, FX activated by factor VIIa on tissue factor bearing endothelial cells also initiates protective signaling responses through the activation of PAR-2 independent of EPCR mobilization. All results could be recapitulated by the receptor agonist peptides to both PAR-1 and PAR-2. These results suggest that a cross-talk between EPCR and an unknown FX/FXa receptor, which does not require interaction with the Gla domain of FX, recruits PAR-1 to protective signaling pathways in endothelial cells.	[Bae, Jong-Sup; Yang, Likui; Rezaie, Alireza R.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Bae, Jong-Sup/AAU-9724-2020		NHLBI [HL 101917, HL 68571]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101917, R01HL068571] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 101917 and HL 68571 from the NHLBI (to A. R. R.).	ALTIERI DC, 1994, J BIOL CHEM, V269, P3139; Ambrosini G, 1997, J BIOL CHEM, V272, P8340, DOI 10.1074/jbc.272.13.8340; Bae JS, 2010, J THROMB HAEMOST, V8, P1107, DOI 10.1111/j.1538-7836.2010.03812.x; Bae JS, 2008, THROMB HAEMOSTASIS, V100, P101, DOI 10.1160/TH08-02-0127; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bae JS, 2009, THROMB HAEMOSTASIS, V101, P513, DOI 10.1160/TH08-09-0568; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; DAHLBA CKB, 1991, THROMB HAEMOST */* B, V66, P49; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; ESMON CT, 1993, THROMB HAEMOSTASIS, V70, P29; Feistritzer C, 2005, J THROMB HAEMOST, V3, P2798, DOI 10.1111/j.1538-7836.2005.01610.x; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Krupiczojc MA, 2008, INT J BIOCHEM CELL B, V40, P1228, DOI 10.1016/j.biocel.2008.02.026; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; REZAIE AR, 1993, J BIOL CHEM, V268, P8176; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Senden NHM, 1998, J IMMUNOL, V161, P4318; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; WALKER FJ, 1992, FASEB J, V6, P2561, DOI 10.1096/fasebj.6.8.1317308; Zaman GJR, 2000, BLOOD, V96, P145, DOI 10.1182/blood.V96.1.145.013k34_145_148	39	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34803	34812		10.1074/jbc.M110.163642	http://dx.doi.org/10.1074/jbc.M110.163642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826780	Green Published, hybrid			2022-12-25	WOS:000283659100056
J	Atwood, AA; Sealy, L				Atwood, A. A.; Sealy, L.			Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence	ONCOGENE			English	Article						C/EBPbeta; Ras; senescence; MCF10A; IL6	BINDING-PROTEIN-BETA; DIFFERENTIATION; PROLIFERATION; TUMORIGENESIS; PATHWAY; ALPHA	Overexpression of Ras(V12) in MCF10A cells, an immortalized mammary epithelial cell line, leads to transformation of these cells. We demonstrate that this is accompanied by degradation of C/EBPbeta1. C/EBP beta is a transcription factor in which three protein isoforms exist because of alternative translation at three in-frame methionines. When C/EBPbeta1 is expressed in MCF10A-Ras(V12) cells, immunoblot analysis reveals that C/EBPbeta1 is degraded in these cells. Treatment of MCF10A-Ras(V12)-C/EBPbeta1 cells with the cdk inhibitor roscovitine leads to stabilization of C/EBPbeta1. It has been previously shown that cdk2 phosphorylates C/EBPbeta on Thr235. We demonstrate that mutation of Thr235 to alanine in C/EBPbeta1 is sufficient to restore the stability of C/EBPbeta1 expression in MCF10A-Ras( V12) cells. Overexpression of Ras(V12) in primary cells induces senescence rather than transformation, thus suppressing tumorigenesis. C/EBPbeta is required for Ras(V12)-induced senescence in primary mouse embryonic fibroblasts. Upregulation of interleukin-6 (IL6) by C/EBPbeta has been shown to be necessary for oncogene-induced senescence, but the specific isoform of C/EBPbeta has not been investigated. We show that the C/EBPbeta1 isoform upregulates IL6 when introduced into normal fibroblasts. In addition, we show that C/EBPbeta1 induces senescence. Taken together, degradation of C/EBPbeta1 by Ras activation may represent a mechanism to bypass OIS. Oncogene (2010) 29, 6004-6015; doi:10.1038/onc.2010.336; published online 6 September 2010	[Sealy, L.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Atwood, A. A.; Sealy, L.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Sealy, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 23rd Ave S Garland,Light Hall 702, Nashville, TN 37232 USA.	Linda.sealy@vanderbilt.edu			NIH [GM69634]; Cell Biology and Molecular Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Biology and Molecular Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Maria Abreu, Kim Boelte, Linda Bundy, Alisha Russell and David Vaught for insightful suggestions and Rachel Jerrell for technical assistance. We thank Gary Nolan (Standford University) for LZRS-BMN-lacZ and Phoenix cells, Scott Lowe (Cold Spring Harbor) for pBABE-Ras(V12)-puromycin, Hal Moses (Vanderbilt University) for WI-38 fibroblasts and S. Akira for CMV-NF-IL6-T235A. We also thank Cathy Alford in the Veterans Affairs flow cytometry core (Nashville, TN) for technical assistance. This work was funded by NIH GM69634 and by the Cell Biology and Molecular Sciences training grant.	Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Grignani F, 1998, CANCER RES, V58, P14; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Iavarone A, 1997, NATURE, V387, P417; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	24	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6004	6015		10.1038/onc.2010.336	http://dx.doi.org/10.1038/onc.2010.336			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20818427	Green Accepted			2022-12-25	WOS:000284108700003
J	Carvalho, KI; Melo, KM; Bruno, FR; Snyder-Cappione, JE; Nixon, DF; Costa-Carvalho, BT; Kallas, EG				Carvalho, Karina I.; Melo, Karina M.; Bruno, Fernanda R.; Snyder-Cappione, Jennifer E.; Nixon, Douglas F.; Costa-Carvalho, Beatriz T.; Kallas, Esper G.			Skewed Distribution of Circulating Activated Natural Killer T (NKT) Cells in Patients with Common Variable Immunodeficiency Disorders (CVID)	PLOS ONE			English	Article							MEMORY B-CELLS; CHEMOKINE RECEPTOR EXPRESSION; CD1D EXPRESSION; CUTTING EDGE; SUBSETS; DEFICIENCY; INFECTION; TRAFFICKING; RESPONSES; CAPACITY	Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure in adults and children, and characterized clinically by recurrent bacterial infections and autoimmune manifestations. Several innate immune defects have been described in CVID, but no study has yet investigated the frequency, phenotype or function of the key regulatory cell population, natural killer T (NKT) cells. We measured the frequencies and subsets of NKT cells in patients with CVID and compared these to healthy controls. Our results show a skewing of NKT cell subsets, with CD4+ NKT cells at higher frequencies, and CD8+ NKT cells at lower frequencies. However, these cells were highly activated and expression CD161. The NKT cells had a higher expression of CCR5 and concomitantly expression of CCR5+CD69+CXCR6 suggesting a compensation of the remaining population of NKT cells for rapid effector action.	[Carvalho, Karina I.; Bruno, Fernanda R.; Kallas, Esper G.] Univ Sao Paulo, Sao Paulo, Brazil; [Melo, Karina M.; Costa-Carvalho, Beatriz T.; Kallas, Esper G.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Snyder-Cappione, Jennifer E.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Carvalho, KI (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	esper.kallas@gmail.com	Kallas, Esper G/C-9539-2012; Carvalho, Karina IL/J-6789-2012; Nixon, Douglas/AAU-5734-2020	Carvalho, Karina IL/0000-0002-7763-8139; Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925; Snyder-Cappione, Jennifer/0000-0002-0941-5582	National Institutes of Health [R01-AI52731, AI060379]; Fogarty International Center [D43 TW00003]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060379, R01AI052731, R21AI060379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, grant #R01-AI52731 and AI060379 and The Fogarty International Center, grant #D43 TW00003. KIC's Ph.D. scholarship has been provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2002, CLIN IMMUNOL, V103, P34, DOI 10.1006/clim.2001.5197; Aspalter RM, 2000, CLIN EXP IMMUNOL, V121, P506, DOI 10.1046/j.1365-2249.2000.01317.x; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Bayry J, 2004, BLOOD, V104, P2441, DOI 10.1182/blood-2004-04-1325; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chan WL, 2003, IMMUNOL LETT, V85, P159, DOI 10.1016/S0165-2478(02)00223-7; CHAPEL H, 2008, BLOOD; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Falcone M, 2004, J IMMUNOL, V172, P5908, DOI 10.4049/jimmunol.172.10.5908; Fulcher DA, 2009, CLIN EXP IMMUNOL, V157, P365, DOI 10.1111/j.1365-2249.2009.03973.x; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Haymore BR, 2008, AUTOIMMUN REV, V7, P309, DOI 10.1016/j.autrev.2007.11.024; Jiang XF, 2005, J IMMUNOL, V175, P2051, DOI 10.4049/jimmunol.175.4.2051; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lang GA, 2008, BLOOD, V111, P2158, DOI 10.1182/blood-2007-10-117309; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lin YL, 2005, EUR J IMMUNOL, V35, P879, DOI 10.1002/eji.200425495; Livaditi O, 2007, IMMUNOL LETT, V114, P103, DOI 10.1016/j.imlet.2007.09.006; Oishi Y, 2001, J RHEUMATOL, V28, P275; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Rolf J, 2008, MOL IMMUNOL, V45, P2607, DOI 10.1016/j.molimm.2007.12.022; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Sandberg JK, 2003, EUR J IMMUNOL, V33, P588, DOI 10.1002/eji.200323707; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Snyder-Cappione JE, 2007, J INFECT DIS, V195, P1361, DOI 10.1086/513567; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; van der Vliet HJJ, 2002, J IMMUNOL, V168, P1490, DOI 10.4049/jimmunol.168.3.1490; Viallard JF, 2006, CLIN IMMUNOL, V119, P51, DOI 10.1016/j.clim.2005.11.011; Vodjgani M, 2007, J INVEST ALLERG CLIN, V17, P321; Yanagihara Y, 1999, CLIN EXP IMMUNOL, V118, P131; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	38	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12652	10.1371/journal.pone.0012652	http://dx.doi.org/10.1371/journal.pone.0012652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844745	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687200015
J	Rybina, OY; Pasyukova, EG				Rybina, Olga Yu.; Pasyukova, Elena G.			A Naturally Occurring Polymorphism at Drosophila melanogaster Lim3 Locus, a Homolog of Human LHX3/4, Affects Lim3 Transcription and Fly Lifespan	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; CENTRAL-NERVOUS-SYSTEM; REAL-TIME PCR; GENE-EXPRESSION; TATA-BOX; STATISTICAL-ANALYSIS; REGULATORY REGIONS; ADAPTIVE EVOLUTION; PROMOTER ELEMENT; CORE PROMOTER	Lim3 encodes an RNA polymerase II transcription factor with a key role in neuron specification. It was also identified as a candidate gene that affects lifespan. These pleiotropic effects indicate the fundamental significance of the potential interplay between neural development and lifespan control. The goal of this study was to analyze the causal relationships between Lim3 structural variations, and gene expression and lifespan changes, and to provide insights into regulatory pathways controlling lifespan. Fifty substitution lines containing second chromosomes from a Drosophila natural population were used to analyze the association between lifespan and sequence variation in the 5'-regulatory region, and first exon and intron of Lim3A, in which we discovered multiple transcription start sites (TSS). The core and proximal promoter organization for Lim3A and a previously unknown mRNA named Lim3C were described. A haplotype of two markers in the Lim3A regulatory region was significantly associated with variation in lifespan. We propose that polymorphisms in the regulatory region affect gene transcription, and consequently lifespan. Indeed, five polymorphic markers located within 380 to 680 bp of the Lim3A major TSS, including two markers associated with lifespan variation, were significantly associated with the level of Lim3A transcript, as evaluated by real time RT-PCR in embryos, adult heads, and testes. A naturally occurring polymorphism caused a six-fold change in gene transcription and a 25% change in lifespan. Markers associated with long lifespan and intermediate Lim3A transcription were present in the population at high frequencies. We hypothesize that polymorphic markers associated with Lim3A expression are located within the binding sites for proteins that regulate gene function, and provide general rather than tissue-specific regulation of transcription, and that intermediate levels of Lim3A expression confer a selective advantage and longer lifespan.	[Rybina, Olga Yu.; Pasyukova, Elena G.] RAS, Inst Mol Genet, Moscow 117901, Russia	Russian Academy of Sciences	Rybina, OY (corresponding author), RAS, Inst Mol Genet, Moscow 117901, Russia.	egpas@rambler.ru	Pasyukova, Elena G/I-8377-2017; Rybina, Olga/AAL-4026-2021	Rybina, Olga/0000-0002-3431-162X	Russian Fund of Basic Research (RFBR) [09-04-01181-a]; Russian Academy of Sciences (RAS); Ministry of Education and Science of RF [II317]	Russian Fund of Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences (RAS)(Russian Academy of Sciences); Ministry of Education and Science of RF(Ministry of Education and Science, Russian Federation)	Russian Fund of Basic Research (RFBR) grant #09-04-01181-a for EGP; Grant form Russian Academy of Sciences (RAS) Program "Biodiversity'' for EGP; Ministry of Education and Science of RF Program "Scientific and Educational Human Resources of Innovative Russia'' Contract #II317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Babu M. Madan, 2007, V3, P66, DOI 10.1159/000107604; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blastyak A, 2006, MOL CELL BIOL, V26, P1434, DOI 10.1128/MCB.26.4.1434-1444.2006; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carbone MA, 2006, CURR BIOL, V16, P912, DOI 10.1016/j.cub.2006.03.051; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; De Velasco B, 2004, DEV BIOL, V274, P280, DOI 10.1016/j.ydbio.2004.07.015; Duan ZJ, 2002, P NATL ACAD SCI USA, V99, P5509, DOI 10.1073/pnas.072084499; FU YX, 1993, GENETICS, V133, P693; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; Kuchar Jennifer, 2007, BIOS, V78, P62, DOI 10.1893/0005-3155(2007)78[62:RAHSFC]2.0.CO;2; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Landgraf M, 2006, INT REV NEUROBIOL, V75, P33, DOI 10.1016/S0074-7742(06)75002-4; MACKAY TFC, 2005, HDB BIOL AGING, P181; Maeder ML, 2007, GENETICS, V177, P1377, DOI 10.1534/genetics.107.070425; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Mullen RD, 2007, MOL CELL ENDOCRINOL, V265, P190, DOI 10.1016/j.mce.2006.12.019; NEI M, 1981, GENETICS, V97, P145; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roshina NV, 2007, RUSS J GENET+, V43, P275, DOI 10.1134/S1022795407030088; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; Shen Jie, 2009, BMC Geriatr, V9, P56, DOI 10.1186/1471-2318-9-56; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Spokony RF, 2009, J COMP NEUROL, V517, P15, DOI 10.1002/cne.22119; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; TAJIMA F, 1989, GENETICS, V123, P585; Tajima T, 2007, ENDOCR J, V54, P637, DOI 10.1507/endocrj.K06-200; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tuckfield A, 2002, MOL CELL BIOL, V22, P1936, DOI 10.1128/MCB.22.6.1936-1946.2002; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wech I, 1999, DEV GENES EVOL, V209, P370, DOI 10.1007/s004270050266; Yaden BC, 2006, ENDOCRINOLOGY, V147, P324, DOI 10.1210/en.2005-0970; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	56	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12621	10.1371/journal.pone.0012621	http://dx.doi.org/10.1371/journal.pone.0012621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838645	Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300041
J	Scherling, C; Roscher, C; Giavalisco, P; Schulze, ED; Weckwerth, W				Scherling, Christian; Roscher, Christiane; Giavalisco, Patrick; Schulze, Ernst-Detlef; Weckwerth, Wolfram			Metabolomics Unravel Contrasting Effects of Biodiversity on the Performance of Individual Plant Species	PLOS ONE			English	Article							EXPERIMENTAL GRASSLANDS; MASS-SPECTROMETRY; PRODUCTIVITY RELATIONSHIP; GAS-CHROMATOGRAPHY; DIVERSITY; ECOSYSTEMS; RICHNESS; NITROGEN; TIME; MANIPULATIONS	In spite of evidence for positive diversity-productivity relationships increasing plant diversity has highly variable effects on the performance of individual plant species, but the mechanisms behind these differential responses are far from being understood. To gain deeper insights into the physiological responses of individual plant species to increasing plant diversity we performed systematic untargeted metabolite profiling on a number of herbs derived from a grassland biodiversity experiment (Jena Experiment). The Jena Experiment comprises plots of varying species number (1, 2, 4, 8, 16 and 60) and number and composition of functional groups (1 to 4; grasses, legumes, tall herbs, small herbs). In this study the metabolomes of two tall-growing herbs (legume: Medicago x varia; non-legume: Knautia arvensis) and three small-growing herbs (legume: Lotus corniculatus; non-legumes: Bellis perennis, Leontodon autumnalis) in plant communities of increasing diversity were analyzed. For metabolite profiling we combined gas chromatography coupled to time-of-flight mass spectrometry (GC-TOF-MS) and UPLC coupled to FT-ICR-MS (LC-FT-MS) analyses from the same sample. This resulted in several thousands of detected m/z-features. ANOVA and multivariate statistical analysis revealed 139 significantly changed metabolites (30 by GC-TOF-MS and 109 by LC-FT-MS). The small-statured plants L. autumnalis, B. perennis and L. corniculatus showed metabolic response signatures to increasing plant diversity and species richness in contrast to tall-statured plants. Key-metabolites indicated C-and N-limitation for the non-leguminous small-statured species B. perennis and L. autumnalis, while the metabolic signature of the small-statured legume L. corniculatus indicated facilitation by other legumes. Thus, metabolomic analysis provided evidence for negative effects of resource competition on the investigated small-statured herbs that might mechanistically explain their decreasing performance with increasing plant diversity. In contrast, taller species often becoming dominant in mixed plant communities did not show modified metabolite profiles in response to altered resource availability with increasing plant diversity. Taken together, our study demonstrates that metabolite profiling is a strong diagnostic tool to assess individual metabolic phenotypes in response to plant diversity and ecophysiological adjustment.	[Scherling, Christian] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany; [Roscher, Christiane; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, Jena, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Giavalisco, Patrick] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Weckwerth, Wolfram] Univ Vienna, Dept Mol Syst Biol MOSYS, Vienna, Austria	Braunschweig University of Technology; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Max Planck Society; University of Vienna	Scherling, C (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany.	wolfram.weckwerth@univie.ac.at	Weckwerth, Wolfram/G-5811-2010; Schulze, Ernst-Detlef/K-9627-2014	Weckwerth, Wolfram/0000-0002-9719-6358	German Science Foundation [FOR 456]; Friedrich Schiller University Jena; Max Planck Society; University of Vienna	German Science Foundation(German Research Foundation (DFG)); Friedrich Schiller University Jena; Max Planck Society(Max Planck Society); University of Vienna	The Jena Experiment is funded by the German Science Foundation (FOR 456) with additional support from the Friedrich Schiller University Jena and the Max Planck Society. The presented project was further financially supported by the Max Planck Society and the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Dassler A, 2008, PLANT BIOLOGY, V10, P573, DOI 10.1111/j.1438-8677.2008.00073.x; Ellenberg H., 1988, VEGETATION ECOLOGY C; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Giavalisco P, 2009, ANAL CHEM, V81, P6546, DOI 10.1021/ac900979e; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hoehenwarter W, 2008, PROTEOMICS, V8, P4214, DOI 10.1002/pmic.200701047; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Morgenthal K, 2005, METABOLOMICS, V1, P109, DOI 10.1007/s11306-005-4430-9; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Oelmann Y, 2007, J ENVIRON QUAL, V36, P396, DOI 10.2134/jeq2006.0217; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; ROTHMALER R, 2002, EXKURSIONSFLORA DEUT, V4; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Thein S, 2008, BASIC APPL ECOL, V9, P475, DOI 10.1016/j.baae.2007.08.004; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weinig C, 2000, AM J BOT, V87, P1660, DOI 10.2307/2656743	42	68	68	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12569	10.1371/journal.pone.0012569	http://dx.doi.org/10.1371/journal.pone.0012569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830202	Green Published, gold			2022-12-25	WOS:000281631300009
J	van Eekelen, M; Overvoorde, J; van Rooijen, C; den Hertog, J				van Eekelen, Mark; Overvoorde, John; van Rooijen, Carina; den Hertog, Jeroen			Identification and Expression of the Family of Classical Protein-Tyrosine Phosphatases in Zebrafish	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE; MAINTENANCE; MUTATIONS; KINASES; DOMAIN; MEG2; IA-2; LAR	Protein-tyrosine phosphatases (PTPs) have an important role in cell survival, differentiation, proliferation, migration and other cellular processes in conjunction with protein-tyrosine kinases. Still relatively little is known about the function of PTPs in vivo. We set out to systematically identify all classical PTPs in the zebrafish genome and characterize their expression patterns during zebrafish development. We identified 48 PTP genes in the zebrafish genome by BLASTing of human PTP sequences. We verified all in silico hits by sequencing and established the spatio-temporal expression patterns of all PTPs by in situ hybridization of zebrafish embryos at six distinct developmental stages. The zebrafish genome encodes 48 PTP genes. 14 human orthologs are duplicated in the zebrafish genome and 3 human orthologs were not identified. Based on sequence conservation, most zebrafish orthologues of human PTP genes were readily assigned. Interestingly, the duplicated form of ptpn23, a catalytically inactive PTP, has lost its PTP domain, indicating that PTP activity is not required for its function, or that ptpn23b has lost its PTP domain in the course of evolution. All 48 PTPs are expressed in zebrafish embryos. Most PTPs are maternally provided and are broadly expressed early on. PTP expression becomes progressively restricted during development. Interestingly, some duplicated genes retained their expression pattern, whereas expression of other duplicated genes was distinct or even mutually exclusive, suggesting that the function of the latter PTPs has diverged. In conclusion, we have identified all members of the family of classical PTPs in the zebrafish genome and established their expression patterns. This is the first time the expression patterns of all members of the large family of PTP genes have been established in a vertebrate. Our results provide the first step towards elucidation of the function of the family of classical PTPs.	[van Eekelen, Mark; Overvoorde, John; van Rooijen, Carina; den Hertog, Jeroen] Hubrecht Inst, KNAW, Utrecht, Netherlands; [van Eekelen, Mark; Overvoorde, John; van Rooijen, Carina; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	van Eekelen, M (corresponding author), Hubrecht Inst, KNAW, Utrecht, Netherlands.	j.denhertog@hubrecht.eu	van Eekelen, Mark/A-6225-2010		Research Council for Earth and Life Sciences [ALW 815.02.007]; Netherlands Organisation for Scientific Research (NWO)	Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by a grant from the Research Council for Earth and Life Sciences (ALW 815.02.007) with financial aid from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerne B, 2004, DEVELOPMENT, V131, P3391, DOI 10.1242/dev.01222; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cai T, 2001, DIABETOLOGIA, V44, P81, DOI 10.1007/s001250051583; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Driever W, 1996, DEVELOPMENT, V123, P37; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Force A, 1999, GENETICS, V151, P1531; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Haffter P, 1996, DEVELOPMENT, V123, P1; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; KIMMEL CB, 1986, SCIENCE, V231, P365, DOI 10.1126/science.231.4736.365; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; LAFORGIA S, 1991, P NATL ACAD SCI USA, V88, P5036, DOI 10.1073/pnas.88.11.5036; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Saito K, 2007, J BIOL CHEM, V282, P15170, DOI 10.1074/jbc.M608682200; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; van der Sar A, 2001, MECH DEVELOP, V109, P423, DOI 10.1016/S0925-4773(01)00545-7; Van Vactor D, 1998, CURR OPIN GENET DEV, V8, P112, DOI 10.1016/S0959-437X(98)80070-1; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VANEEKELEN M, 2010, DEV BIOL; Wang YC, 2005, J EXP MED, V202, P1587, DOI 10.1084/jem.20051108; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Whited JL, 2007, DEVELOPMENT, V134, P43, DOI 10.1242/dev.02718; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H	39	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12573	10.1371/journal.pone.0012573	http://dx.doi.org/10.1371/journal.pone.0012573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838449	gold, Green Published			2022-12-25	WOS:000281627700020
J	Pereira, ER; Liao, N; Neale, GA; Hendershot, LM				Pereira, Ethel R.; Liao, Nan; Neale, Geoff A.; Hendershot, Linda M.			Transcriptional and Post-Transcriptional Regulation of Proangiogenic Factors by the Unfolded Protein Response	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; PLASMA-CELL DIFFERENTIATION; MESSENGER-RNA STABILITY; NF-KAPPA-B; TUMOR-GROWTH; FACTOR XBP-1; IN-VIVO; TRANSMEMBRANE PROTEIN; ANGIOGENIC FACTORS	Background: Inadequate extracellular conditions can adversely affect the environment of the ER and impinge on the maturation of nascent proteins. The resultant accumulation of unfolded proteins activates a signal transduction pathway, known as the unfolded protein response, which serves primarily to protect the cell during stress and helps restore homeostasis to the ER. Principal Findings: Microarray analysis of the unfolded protein response in a human medulloblastoma cell line treated with thapsigargin revealed that, in addition to known targets, a large number of proangiogenic factors were up-regulated. RealTime PCR analyses confirmed that four of these factors, VEGFA, FGF2, angiogenin and IL8, were transcriptionally upregulated in multiple cell lines by various ER stress inducers. Our studies on VEGFA regulation revealed that XBP-1(S), a UPRinducible transcription factor, bound to two regions on the VEGFA promoter, and analysis of XBP-1 null mouse embryonic fibroblasts revealed that it contributes to VEGFA expression in response to ER stress. ATF4, another UPR-inducible transcription factor, also binds to the VEGFA gene, although its contribution to VEGFA transcription appeared to be fairly modest. We also found that VEGFA mRNA stability is increased in response to UPR activation, via activation of AMP kinase, demonstrating that increased mRNA levels occur at two regulatory points. In keeping with the mRNA levels, we found that VEGFA protein is secreted at levels as high as or higher than that achieved in response to hypoxia. Conclusions and Significance: Our results indicate that the UPR plays a significant role in inducing positive regulators of angiogenesis. It also regulates VEGFA expression at transcriptional, post-transcriptional and post-translational levels and is likely to have widespread implications for promoting angiogenesis in response to normal physiological cues as well as in pathological conditions like cancer.	[Pereira, Ethel R.; Liao, Nan; Hendershot, Linda M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Pereira, Ethel R.; Liao, Nan; Hendershot, Linda M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Neale, Geoff A.] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pereira, ER (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Pereira, Ethel/0000-0003-0562-4536	National Institutes of Health [CA23099]; Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA023099, P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA23099 (LMH), the Cancer Center CORE Grant CA21765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Ghosh R, PLOS ONE, V5, pe9575; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Ozawa K, 2001, CANCER RES, V61, P4206; Ozawa K, 2001, J CLIN INVEST, V108, P41, DOI 10.1172/JCI11772; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Relf M, 1997, CANCER RES, V57, P963; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Romero-Ramirez L, 2009, TRANSL ONCOL, V2, P31, DOI 10.1593/tlo.08211; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen Y, 2007, J IMMUNOL, V179, P2969, DOI 10.4049/jimmunol.179.5.2969; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	65	106	109	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12521	10.1371/journal.pone.0012521	http://dx.doi.org/10.1371/journal.pone.0012521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824063	gold, Green Published, Green Submitted			2022-12-25	WOS:000281480900009
J	Boyden, SE; Kunkel, LM				Boyden, Steven E.; Kunkel, Louis M.			High-Density Genomewide Linkage Analysis of Exceptional Human Longevity Identifies Multiple Novel Loci	PLOS ONE			English	Article							SYNDROME GENE-PRODUCT; GENETICALLY COMPLEX TRAITS; APOLIPOPROTEIN-E GENOTYPE; AFFECTED RELATIVE PAIRS; MONTE-CARLO PROCEDURES; TOLL-LIKE RECEPTOR-4; LIFE-SPAN EXTENSION; EMPIRICAL P-VALUES; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION	Background: Human lifespan is approximately 25% heritable, and genetic factors may be particularly important for achieving exceptional longevity. Accordingly, siblings of centenarians have a dramatically higher probability of reaching extreme old age than the general population. Methodology/Principal Findings: To map the loci conferring a survival advantage, we performed the second genomewide linkage scan on human longevity and the first using a high-density marker panel of single nucleotide polymorphisms. By systematically testing a range of minimum age cutoffs in 279 families with multiple long-lived siblings, we identified a locus on chromosome 3p24-22 with a genomewide significant allele-sharing LOD score of 4.02 (empirical P = 0.037) and a locus on chromosome 9q31-34 with a highly suggestive LOD score of 3.89 (empirical P = 0.054). The empirical P value for the combined result was 0.002. A third novel locus with a LOD score of 4.05 on chromosome 12q24 was detected in a subset of the data, and we also obtained modest evidence for a previously reported interval on chromosome 4q22-25. Conclusions/Significance: Our linkage data should facilitate the discovery of both common and rare variants that determine genetic variability in lifespan.	[Boyden, Steven E.; Kunkel, Louis M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Boyden, Steven E.; Kunkel, Louis M.] Childrens Hosp Boston, Div Genet, Program Genom, Boston, MA USA; [Boyden, Steven E.; Kunkel, Louis M.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA USA; [Kunkel, Louis M.] Childrens Hosp Boston, Howard Hughes Med Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Boyden, SE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kunkel@enders.tch.harvard.edu			Howard Hughes Medical Institute; Intellectual and Developmental Disabilities Research Center [NIH-P30-HD18655]; Neuromuscular Disease Project [NIH-P50-NS40828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intellectual and Developmental Disabilities Research Center; Neuromuscular Disease Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute. Microarray genotyping experiments were performed using equipment in the Microarray Core Facility of the Molecular Genetics Core Facility at Children's Hospital Boston, supported by NIH-P30-HD18655 through the Intellectual and Developmental Disabilities Research Center and NIH-P50-NS40828 through the Neuromuscular Disease Project. LMK is an investigator with the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Balistreri CR, 2004, JAMA-J AM MED ASSOC, V292, P2339, DOI 10.1001/jama.292.19.2339; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; Bathum L, 2005, EUR J HUM GENET, V13, P1154, DOI 10.1038/sj.ejhg.5201468; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beekman M, 2006, J GERONTOL A-BIOL, V61, P355, DOI 10.1093/gerona/61.4.355; Bell F.C., 2005, NUMBER 11 11536 SOCI, P26; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Broman KW, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346175; Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ewens WJ, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346174; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Franceschi C, 2007, ANN NY ACAD SCI, V1100, P21, DOI 10.1196/annals.1395.003; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Gessert CE, 2002, J AM GERIATR SOC, V50, P1561, DOI 10.1046/j.1532-5415.2002.50413.x; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Hayden KM, 2005, J AM GERIATR SOC, V53, P935, DOI 10.1111/j.1532-5415.2005.53301.x; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Humbert N, 2009, CANCER RES, V69, P4101, DOI 10.1158/0008-5472.CAN-08-2864; Jo JY, 2005, J AGR FOOD CHEM, V53, P2489, DOI 10.1021/jf048524w; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Karasik D, 2004, J GERONTOL A-BIOL, V59, P218; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Lewis SJ, 2004, INT J EPIDEMIOL, V33, P962, DOI 10.1093/ije/dyh214; LI Y, 2009, HUM MOL GENET; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; Michishita E, 1998, BIOCHEM BIOPH RES CO, V253, P667, DOI 10.1006/bbrc.1998.9832; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Mohler PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001051; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nebel A, 2005, P NATL ACAD SCI USA, V102, P7906, DOI 10.1073/pnas.0408670102; Nebel A, 2007, MECH AGEING DEV, V128, P409, DOI 10.1016/j.mad.2007.04.001; Nemani M, 2000, MECH AGEING DEV, V119, P25, DOI 10.1016/S0047-6374(00)00165-2; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Neville MJ, 2007, J GERONTOL A-BIOL, V62, P202, DOI 10.1093/gerona/62.2.202; North BV, 2003, AM J HUM GENET, V72, P498, DOI 10.1086/346173; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Novelli V, 2008, BIOGERONTOLOGY, V9, P85, DOI 10.1007/s10522-007-9116-4; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; PUDDU PE, 1986, J ELECTROCARDIOL, V19, P203, DOI 10.1016/S0022-0736(86)80030-9; Reed T, 2004, J GERONTOL A-BIOL, V59, P227; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1992, AM J HUM GENET, V51, P673; RISCH N, 1996, SCIENCE, V273, P1517; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; SAURO J, 2005, P HUM FACT ERG SOC 4, V5, P2100; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Tan QH, 2004, GENET EPIDEMIOL, V26, P245, DOI 10.1002/gepi.10304; Tan QH, 2006, AGEING RES REV, V5, P371, DOI 10.1016/j.arr.2005.10.002; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Wang T, 2005, HUM HERED, V60, P134, DOI 10.1159/000089867; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	96	17	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12432	10.1371/journal.pone.0012432	http://dx.doi.org/10.1371/journal.pone.0012432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824210	Green Submitted, Green Published, gold			2022-12-25	WOS:000281405300009
J	Doyle, A; Zhang, GH; Fattah, EAA; Eissa, NT; Li, YP				Doyle, Alexander; Zhang, Guohua; Fattah, Elmoataz A. Abdel; Eissa, N. Tony; Li, Yi-Ping			Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways	FASEB JOURNAL			English	Article						autophagosomes; atrogin-1/MAFbx; p38 MAPK; 3-methyladenine; lactacystin	NECROSIS-FACTOR-ALPHA; RAT SKELETAL-MUSCLE; PROTEIN-DEGRADATION; SIGNALING PATHWAY; MESSENGER-RNAS; AMINO-ACIDS; TNF-ALPHA; KAPPA-B; EXPRESSION; SEPSIS	Cachectic muscle wasting is a frequent complication of many inflammatory conditions, due primarily to excessive muscle catabolism. However, the pathogenesis and intervention strategies against it remain to be established. Here, we tested the hypothesis that Toll-like receptor 4 (TLR4) is a master regulator of inflammatory muscle catabolism. We demonstrate that TLR4 activation by lipopolysaccharide (LPS) induces C2C12 myotube atrophy via up-regulating autophagosome formation and the expression of ubiquitin ligase atrogin-1/MAFbx and MuRF1. TLR4-mediated activation of p38 MAPK is necessary and sufficient for the up-regulation of atrogin1/MAFbx and autophagosomes, resulting in myotube atrophy. Similarly, LPS up-regulates muscle autophagosome formation and ubiquitin ligase expression in mice. Importantly, autophagy inhibitor 3-methyladenine completely abolishes LPS-induced muscle proteolysis, while proteasome inhibitor lactacystin partially blocks it. Furthermore, TLR4 knockout or p38 MAPK inhibition abolishes LPS-induced muscle proteolysis. Thus, TLR4 mediates LPS-induced muscle catabolism via coordinate activation of the ubiquitin-proteasome and the autophagy-lysosomal pathways.-Doyle, A., Zhang, G., Abdel Fattah, E. A., Eissa, N. T., Li, Y.-P. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J. 25, 99-110 (2011). www.fasebj.org	[Doyle, Alexander; Zhang, Guohua; Li, Yi-Ping] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Fattah, Elmoataz A. Abdel; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Li, YP (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	yi-ping.li@uth.tmc.edu	Zhang, Guohua/AFR-1220-2022; Li, Yi-Ping/ABF-9245-2020		National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR052511]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052511] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by a National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 grant to Y.-P.L. (AR052511). The authors thank S. Akira (Osaka University, Oskaka, Japan) for sharing the TLR4 <SUP>/</SUP> mice, and J. Han (Scripps Research Institute, La Jolla, CA, USA) for sharing the adenovirus construct of MKK6bE.	Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Argiles JM, 2000, EUR CYTOKINE NETW, V11, P552; Baltgalvis KA, 2009, PFLUG ARCH EUR J PHY, V457, P989, DOI 10.1007/s00424-008-0574-6; Bechet D, 2005, INT J BIOCHEM CELL B, V37, P2098, DOI 10.1016/j.biocel.2005.02.029; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Dehoux MJM, 2003, FEBS LETT, V544, P214, DOI 10.1016/S0014-5793(03)00505-2; Doan HQ, 2009, ANTICANCER RES, V29, P2473; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FULKS RM, 1975, J BIOL CHEM, V250, P290; GOLDBERG RM, 1995, J CLIN ONCOL, V13, P2856, DOI 10.1200/JCO.1995.13.11.2856; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Han DM, 2007, INT J LAB HEMATOL, V29, P185, DOI 10.1111/j.1751-553X.2006.00839.x; HASSELGREN PO, 1986, ARCH SURG-CHICAGO, V121, P918; HASSELGREN PO, 1989, METABOLISM, V38, P634, DOI 10.1016/0026-0495(89)90100-5; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Jin BW, 2007, J CELL BIOCHEM, V100, P960, DOI 10.1002/jcb.21060; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lang CH, 2003, SHOCK, V19, P538, DOI 10.1097/01.shk.0000055237.25446.80; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002; Liu KH, 2008, SURGERY, V143, P375, DOI 10.1016/j.surg.2007.09.035; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; ROSENBLATT S, 1983, ARCH SURG-CHICAGO, V118, P167; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takeda K, 2001, JPN J INFECT DIS, V54, P209; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143; TIAO G, 1994, J CLIN INVEST, V94, P2255, DOI 10.1172/JCI117588; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vary T C, 1998, Curr Opin Clin Nutr Metab Care, V1, P217, DOI 10.1097/00075197-199803000-00013; WAALKES TP, 1957, J LAB CLIN MED, V50, P733; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	57	167	178	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					99	110		10.1096/fj.10-164152	http://dx.doi.org/10.1096/fj.10-164152			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20826541	Green Published			2022-12-25	WOS:000285869500010
J	Eunju, O; Lee, BH; Ahn, HY; Shin, JC; Kim, HK; Kim, M; Park, IY; Park, YG; Joe, YA				Eunju, O.; Lee, Byung Hun; Ahn, Hyun-Young; Shin, Jong-Chul; Kim, Hyun-Kyung; Kim, Myungshin; Park, In-Yang; Park, Yong-Gyu; Joe, Young Ae			Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34(+) human cord blood fraction for effective therapeutic vascularization	FASEB JOURNAL			English	Article						ex vivo expansion; ischemia; neovascularization	HEMATOPOIETIC STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; MYOCARDIAL-INFARCTION; MONONUCLEAR-CELLS; TRANSPLANTATION; NEOVASCULARIZATION; ANGIOGENESIS; SENESCENCE; RECOVERY; POTENCY	Endothelial progenitor cells (EPCs) have been shown to have therapeutic potential in ischemic disease. However, the number of EPCs for cell therapy is limited. In this study, instead of the typical adherent culture method, we investigated a more efficient, clinically applicable nonadhesive expansion method for early EPCs using cord blood-derived cells to overcome rapid cellular senescence. After a suspension culture of isolated CD34(+) cells in serum-free medium containing each cytokine combination was maintained for 9 d, the number of expanded functional EPCs was assessed by an adherent culture assay. Compared to mononuclear cells, the CD34(+) fraction was superior in its expansion of functional EPCs that could differentiate into acLDL/UEA-1(+) cells without significant cellular senescence, whereas the CD34(-) fraction showed no EPC expansion. Among the cytokine combinations tested for the CD34(+) fraction, a combination (SFIb) consisting of stem cell factor (SCF), FMS-like tyrosine kinase 3 ligand, interleukin-3, and basic fibroblast growth factor resulted in a reproducible 64- to 1468-fold EPC expansion from various cord blood origins. Interestingly, the SFIb combination displayed markedly increased EPC expansion (2.43-fold), with a higher percentage of CD34(+) cells (2.17-fold), undifferentiated blasts (2.38-fold) and CXCR4(+) cells (1.68-fold) compared to another cytokine combination (SCF, thrombopoietin, and granulocyte colony-stimulating factor), although the two cytokine combinations had a similar level of total mononucleated cell expansion (similar to 10% difference). Accordingly, the cells expanded in the SFIb combination were more effective in recovery of blood flow and neovascularization in hind-limb ischemia in vivo. Taken together, these results suggest that the nonadhesive serum-free culture conditions of the CD34(+) fraction provide an effective EPC expansion method for cell therapy, and an expansion condition leading to high percentages of CD34(+) cells and blasts is likely important in EPC expansion.-O, E., Lee, B. H., Ahn, H.-Y., Shin, J.-C., Kim, H.-Y., Kim, M., Park, I. Y., Park, Y.-G., Joe, Y. A. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34(+) human cord blood fraction for effective therapeutic vascularization. FASEB J. 25, 159-169 (2011). www.fasebj.org	[Joe, Young Ae] Catholic Univ Korea, Canc Res Inst, Coll Med, Seocho Ku, Seoul 137701, South Korea; [Eunju, O.; Lee, Byung Hun; Kim, Hyun-Kyung; Joe, Young Ae] Catholic Univ Korea, Dept Biomed Sci, Seoul 137701, South Korea; [Ahn, Hyun-Young; Shin, Jong-Chul; Park, In-Yang] Catholic Univ Korea, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seoul 137701, South Korea; [Kim, Myungshin] Catholic Univ Korea, Dept Lab Med, Seoul 137701, South Korea; [Park, Yong-Gyu] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul 137701, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Joe, YA (corresponding author), Catholic Univ Korea, Canc Res Inst, Coll Med, Seocho Ku, Banpo Dong 505, Seoul 137701, South Korea.	youngjoe@catholic.ac.kr	Kim, Myungshin/AAP-9262-2020; Kim, Myungshin/AAK-1544-2021	Kim, Myungshin/0000-0001-8632-0168; Kim, Myungshin/0000-0001-8632-0168	Ministry of Education, Science and Technology [2006-2004327, 2009-0084059]; Catholic Institute of Cell Therapy Basic Science Programs Foundation [2006005051]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Catholic Institute of Cell Therapy Basic Science Programs Foundation	The authors thank Hyo-Eun Park for technical support and helpful advice on animal experiments. This research was supported mainly by the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2006-2004327, 2009-0084059) and, in part, by the Catholic Institute of Cell Therapy Basic Science Programs Foundation, program year 2006 (2006005051).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Burger PE, 2002, BLOOD, V100, P3527, DOI 10.1182/blood.V100.10.3527; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Dimmeler S, 2008, ARTERIOSCL THROM VAS, V28, P208, DOI 10.1161/ATVBAHA.107.155317; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; Gehling UM, 2000, BLOOD, V95, P3106; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; Hendrikx M, 2006, CIRCULATION, V114, pI101, DOI 10.1161/CIRCULATIONAHA.105.000505; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Iba O, 2002, CIRCULATION, V106, P2019, DOI 10.1161/01.CIR.0000031332.45480.79; Ishikawa M, 2004, STEM CELLS DEV, V13, P344, DOI 10.1089/1547328041797435; Kashiwakura I, 2005, LEUKEMIA LYMPHOMA, V46, P329, DOI 10.1080/10428190400019958; Kawamoto A, 2007, CATHETER CARDIO INTE, V70, P477, DOI 10.1002/ccd.21292; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kovacic JC, 2008, TRENDS CARDIOVAS MED, V18, P45, DOI 10.1016/j.tcm.2007.12.002; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Piacibello W, 2005, FOLIA HISTOCHEM CYTO, V43, P197; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Ueda T, 2001, INT J HEMATOL, V73, P457, DOI 10.1007/BF02994007; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang L, 2006, EUR J HAEMATOL, V76, P1, DOI 10.1111/j.1600-0609.2005.00579.x	36	30	33	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					159	169		10.1096/fj.10-162040	http://dx.doi.org/10.1096/fj.10-162040			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20852063				2022-12-25	WOS:000285869500015
J	Jones, GW; Stumhofer, JS; Foster, T; Twohig, JP; Hertzog, P; Topley, N; Williams, AS; Hunter, CA; Jenkins, BJ; Wang, ECY; Jones, SA				Jones, Gareth W.; Stumhofer, Jason S.; Foster, Tom; Twohig, Jason P.; Hertzog, Paul; Topley, Nicholas; Williams, Anwen S.; Hunter, Christopher A.; Jenkins, Brendan J.; Wang, Eddie C. Y.; Jones, Simon A.			Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation	FASEB JOURNAL			English	Article						cytokine; T-cell regulation; inflammation	TGF-BETA; AUTOIMMUNE INFLAMMATION; RHEUMATOID-ARTHRITIS; HELPER-CELLS; FAMILY-MEMBERS; CUTTING EDGE; RECEPTOR DR3; ROR-GAMMA; IN-VIVO; APOPTOSIS	Tumor necrosis factor (TNF)-like cytokine (TL1A) is a T-cell costimulator that bolsters cytokine-induced activation through death receptor 3 (DR3). To explore the relationship between T-cell activation and TL1A responsiveness, flow cytometry profiled DR3 expression in resting and activated T cells. In human CD4(+) T cells, DR3 was induced rapidly following activation and expressed prominently by interleukin (IL)-17-secreting T cells (Th17). Splenic T cells from wild-type and DR3-deficient mice showed that TL1A activation of DR3 inhibits Th17 generation (81 +/- 2.6% at 100 ng/ml TL1A) from naive T cells. This response was not associated with suppression of T-cell proliferation. Using neutralizing antibodies or T cells derived from genetically modified mice, TL1A inhibition of Th17 development was found to be independent of IL-2, IL-27, gamma IFN, IFNAR1, and STAT1. Under suboptimal TCR activation, TL1A continued to block IL-17A secretion, however, the reduced threshold of TCR engagement was now linked with an increase in TL1A-driven proliferation. In contrast, fully committed Th17 cells displayed an altered TL1A responsiveness and in the absence of TCR costimulation supported the maintenance of T cell IL-17A expression. Consequently, TL1A orchestrates unique outcomes in naive and effector T-helper cells, which may affect the proliferation, differentiation and maintenance of Th17 cells in peripheral compartments and inflamed tissues.-Jones, G. W., Stumhofer, J. S., Foster, T., Twohig, J. P., Hertzog, P., Topley, N., Williams, A. S., Hunter, C. A., Jenkins, B. J., Wang, E. C. Y., Jones, S. A. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 25, 409-419 (2011). www.fasebj.org	[Jones, Gareth W.; Foster, Tom; Twohig, Jason P.; Topley, Nicholas; Wang, Eddie C. Y.; Jones, Simon A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Williams, Anwen S.] Cardiff Univ, Sch Med, Dept Rheumatol, Cardiff CF14 4XN, S Glam, Wales; [Jones, Gareth W.; Hertzog, Paul; Jenkins, Brendan J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Stumhofer, Jason S.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Cardiff University; Cardiff University; Monash University; University of Pennsylvania	Jones, SA (corresponding author), Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	jonessa@cf.ac.uk	Hertzog, Paul J/I-7053-2013; Hertzog, Paul J/G-6734-2013; jenkins, brendan/J-7854-2012; Jones, Simon Arnett/Q-7017-2018	Hertzog, Paul J/0000-0002-1373-8472; Hertzog, Paul J/0000-0002-1373-8472; Jones, Gareth/0000-0002-0125-4841; Jenkins, Brendan/0000-0002-7552-4656; Jones, Simon Arnett/0000-0001-7297-9711; Wang, Eddie/0000-0002-2243-4964	Arthritis Research UK [18286, ARC19234]; Medical Research Council [G0300180, G0901119]; Wellcome Trust; National Institutes of Health [AI42334]; Mari Lowe Centre; MRC [G0300180, G0901119] Funding Source: UKRI; Versus Arthritis [18286] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042334] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mari Lowe Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded through grant support provided by Arthritis Research UK (project grant 18286 to S.A.J.; traveling fellowship ARC19234 to G.J.), the Medical Research Council (grants G0300180 and G0901119 to E.W.), the Wellcome Trust, the National Institutes of Health (grant AI42334 to C.H.), and the Mari Lowe Centre (to C.H.). The authors also acknowledge the help and advice provided by Drs. Philip Taylor and Awen Gallimore.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borysenko CW, 2006, J CELL PHYSIOL, V209, P1021, DOI 10.1002/jcp.20812; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Cejas PJ, 2010, BLOOD, V115, P4750, DOI 10.1182/blood-2009-09-242768; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Curnow SJ, 2004, J IMMUNOL, V173, P5290, DOI 10.4049/jimmunol.173.8.5290; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Papadakis KA, 2004, FASEB J, V18, pA465; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Takami N, 2006, ARTHRITIS RHEUM-US, V54, P779, DOI 10.1002/art.21637; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Teague TK, 1997, J IMMUNOL, V158, P5791; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wen L, 2003, J BIOL CHEM, V278, P39251, DOI 10.1074/jbc.M305833200; Xiao QL, 2005, BIOCHEM J, V388, P913, DOI 10.1042/BJ20041739; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zehntner SP, 2007, J IMMUNOL, V179, P7553, DOI 10.4049/jimmunol.179.11.7553; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	39	46	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					409	419		10.1096/fj.10-166843	http://dx.doi.org/10.1096/fj.10-166843			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20826539	Green Published, Green Accepted			2022-12-25	WOS:000285869500037
J	Bunse, S; Schmidt, M; Prochnow, N; Zoidl, G; Dermietzel, R				Bunse, Stefanie; Schmidt, Matthias; Prochnow, Nora; Zoidl, Georg; Dermietzel, Rolf			Intracellular Cysteine 346 Is Essentially Involved in Regulating Panx1 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; NUCLEOTIDE-GATED CHANNEL; S-NITROSYLATION; NITRIC-OXIDE; PLASMA-MEMBRANE; P2X(7) RECEPTOR; PANNEXIN FAMILY; XENOPUS OOCYTES; CELL-DEATH; HEMICHANNELS	Pannexins constitute a family of proteins exhibiting predominantly hemichannel activity. Pannexin channels have been suggested to participate in a wide spectrum of biological functions such as propagation of calcium waves, release of IL-1 beta, and responses to ischemic conditions. At present, the molecular mechanisms regulating pannexin hemichannel activity are essentially unknown. Because cysteines have been shown to constitute key elements in regulating hemichannel properties of the connexin-type we performed site-directed mutagenesis of intracellular cysteine residues of Panx1. Cysteine to serine exchange (Cys 3 Ser) at the C-terminal position amino acid 346 led to a constitutively leaky hemichannel and subsequently to cell death. Increased channel activity was demonstrated by dye uptake and electrophysiological profiling in injected Xenopus laevis oocytes and transfected N2A cells. Mutations of the remaining intracellular cysteines did not result in major changes of Panx1 channel properties. From these data we conclude that the Cys-346 residue is important for proper functioning of the Panx1 channel.	Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44780 Bochum, Germany; [Zoidl, Georg] Ruhr Univ Bochum, Dept Cytol, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Dermietzel, R (corresponding author), Univ Str 150,MA,6-159, D-44780 Bochum, Germany.	Rolf.Dermietzel@rub.de			Graduiertenkolleg [GRK 736]; Deutsche Forschungsgemeinschaft [292/11-4]	Graduiertenkolleg(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Graduiertenkolleg GRK 736 "Development and Plasticity of the Nervous System: Molecular, Synaptic and Cellular mechanisms" (to S. B.) and by Deutsche Forschungsgemeinschaft Grant 292/11-4 (to R. D. and G. Z.).	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bunse S, 2009, FEBS J, V276, P6258, DOI 10.1111/j.1742-4658.2009.07334.x; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Dvoriantchikova G, 2006, MOL VIS, V12, P1417; GOLDBERGER G, 1984, J BIOL CHEM, V259, P6492; Gonzalez D, 2006, FASEB J, V20, P2329, DOI 10.1096/fj.06-5828com; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Matos TD, 2008, HEARING RES, V240, P87, DOI 10.1016/j.heares.2008.03.004; MOUS JM, 1982, J BIOL CHEM, V257, P1822; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Renganathan M, 2002, J NEUROPHYSIOL, V87, P761, DOI 10.1152/jn.00369.2001; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1356, DOI 10.1152/ajpcell.00054.2009; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028; Zhang L, 2008, J NEUROSCI RES, V86, P2281, DOI 10.1002/jnr.21675; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061; Zoidl G, 2002, J NEUROSCI RES, V69, P448, DOI 10.1002/jnr.10284	49	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38444	38452		10.1074/jbc.M110.101014	http://dx.doi.org/10.1074/jbc.M110.101014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20829356	Green Published, hybrid			2022-12-25	WOS:000284625600050
J	Abbott, DW; Gilbert, HJ; Boraston, AB				Abbott, D. Wade; Gilbert, Harry J.; Boraston, Alisdair B.			The Active Site of Oligogalacturonate Lyase Provides Unique Insights into Cytoplasmic Oligogalacturonate beta-Elimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI 3937; PECTATE LYASE; YERSINIA-PESTIS; BACTERIAL SYMBIONT; MOLECULAR-GRAPHICS; STRUCTURAL BASIS; CALCIUM; PECTIN; DEGRADATION; PROTEINS	Oligogalacturonate lyases (OGLs; now also classified as pectate lyase family 22) are cytoplasmic enzymes found in pectinolytic members of Enterobacteriaceae, such as the enteropathogen Yersinia enterocolitica. OGLs utilize a beta-elimination mechanism to preferentially catalyze the conversion of saturated and unsaturated digalacturonate into monogalacturonate and the 4,5-unsaturated monogalacturonate-like molecule, 5-keto-4-deoxyuronate. To provide mechanistic insights into the specificity of this enzyme activity, we have characterized the OGL from Y. enterocolitica, YeOGL, on oligogalacturonides and determined its three-dimensional x-ray structure to 1.65 angstrom. The model contains a Mn2+ atom in the active site, which is coordinated by three histidines, one glutamine, and an acetate ion. The acetate mimics the binding of the uronate group of galactourono-configured substrates. These findings, in combination with enzyme kinetics and metal supplementation assays, provide a framework for modeling the active site architecture of OGL. This enzyme appears to contain a histidine for the abstraction of the alpha-proton in the -1 subsite, a residue that is highly conserved throughout the OGL family and represents a unique catalytic base among pectic active lyases. In addition, we present a hypothesis for an emerging relationship observed between the cellular distribution of pectate lyase folding and the distinct metal coordination chemistries of pectate lyases.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University System of Georgia; University of Georgia; University of Victoria		wabbott@ccrc.uga.edu; boraston@uvic.ca		Boraston, Alisdair/0000-0001-6417-0592; Abbott, Wade/0000-0003-4893-5799	Georgia Research Alliance; Natural Sciences and Engineering Research Council of Canada	Georgia Research Alliance; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Georgia Research Alliance (to H. J. G.) and the Natural Sciences and Engineering Research Council of Canada (to A. B. B.).	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hugouvieux-Cotte-Pattat N., 1996, ANNU REV MICROBIOL, V50, P213; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINERS F, 1989, PLANT PHYSIOL, V91, P1419, DOI 10.1104/pp.91.4.1419; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V125, P734, DOI 10.1016/0003-9861(68)90508-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rodionov DA, 2000, MOL MICROBIOL, V38, P673, DOI 10.1046/j.1365-2958.2000.02115.x; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Seyedarabi A, 2010, BIOCHEMISTRY-US, V49, P539, DOI 10.1021/bi901503g; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006	53	28	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39029	39038		10.1074/jbc.M110.153981	http://dx.doi.org/10.1074/jbc.M110.153981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20851883	hybrid, Green Published			2022-12-25	WOS:000284941300033
J	Fu, J; Yan, P; Li, S; Qu, Z; Xiao, G				Fu, J.; Yan, P.; Li, S.; Qu, Z.; Xiao, G.			Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis	ONCOGENE			English	Article						HTLV-I; Tax; PDLIM2; protein shuttling; protein degradation; tumorigenesis	T-CELL LEUKEMIA; VIRUS TYPE-I; NF-KAPPA-B; DOMAIN-CONTAINING PROTEIN-2; 1ST HUMAN RETROVIRUS; TRANSGENIC MICE; DNA METHYLATION; TYPE-1; GENE; TRANSFORMATION	Human T-cell leukemia virus type I (HTLV-I) encodes a Tax oncoprotein that has crucial roles in both virus replication and cell transformation. Our recent studies suggest that the counterbalance between HTLV-I/Tax and PDZ-LIM domain-containing protein PDLIM2 may determine the outcome of HTLV-I infection. Although HTLV-I represses PDLIM2 epigenetically and specifically in transformed cells, PDLIM2 shuttles Tax into the nuclear matrix for ubiquitination-mediated proteasomal degradation, thereby suppressing the transforming ability of HTLV-I. Here, we have further shown that PDLIM2 binds to Tax directly, which was mediated by a putative a-helix motif of PDLIM2 at amino acids 236-254. Consistently, selective disruption of this short-helix crippled PDLIM2 in shutting Tax to the nuclear matrix for ubiquitination-mediated degradation, therefore, PDLIM2 lost the ability in tumor suppression. Although the C-terminal LIM domain of PDLIM2 was not required for Tax binding, it was important for PDLIM2 to interact with the nuclear matrix. Accordingly, the LIM domain was essential for PDLIM2-mediated Tax repression. On the contrary, the N-terminal PDZ domain of PDLIM2 was dispensable for all these events, although the PDZ domain was involved in PDLIM2 binding to cytoskeleton. These studies dissect functional sequences within PDLIM2 and their distinct roles in Tax regulation. Oncogene (2010) 29, 6499-6507; doi:10.1038/onc.2010.374; published online 13 September 2010	[Xiao, G.] Univ Pittsburgh, Inst Canc, Dept Microbiol & Mol Genet, Hillman Canc Ctr Res Pavil,Sch Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, G (corresponding author), Univ Pittsburgh, Inst Canc, Dept Microbiol & Mol Genet, Hillman Canc Ctr Res Pavil,Sch Med, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	xiaog2@upmc.edu	fu, jing/G-6084-2012; Yan, Pengrong/H-1150-2012; Fu, Jing/C-7921-2016	Fu, Jing/0000-0002-3894-722X; Yan, Pengrong/0000-0003-0021-6461	NIH/NCI [R01 CA116616]; ACS [RSG-06-066-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA116616] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N Raab-Traub for Rat-1 cells, OJ Semmes for Tax-GFP mutants, and NIH AIDS Research & Reference Reagent Program for various reagents. This study was supported by NIH/NCI Grant R01 CA116616 and ACS Grant RSG-06-066-01-MGO to G Xiao.	AKAGI T, 1995, BLOOD, V86, P4243, DOI 10.1182/blood.V86.11.4243.bloodjournal86114243; Bex F, 1997, J VIROL, V71, P3484, DOI 10.1128/JVI.71.5.3484-3497.1997; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Fryrear KA, 2009, J VIROL, V83, P5339, DOI 10.1128/JVI.00232-09; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; OKA T, 1992, J VIROL, V66, P6686, DOI 10.1128/JVI.66.11.6686-6694.1992; PEEBLES RS, 1995, ONCOGENE, V10, P1045; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Qing GL, 2005, J BIOL CHEM, V280, P18, DOI 10.1074/jbc.M406619200; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Qu ZX, 2010, CANCER RES, V70, P1766, DOI 10.1158/0008-5472.CAN-09-3263; Qu ZX, 2010, J BIOL CHEM, V285, P11786, DOI 10.1074/jbc.M109.086561; Qu ZX, 2004, J BIOL CHEM, V279, P44563, DOI 10.1074/jbc.M403689200; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; YAMAOKA S, 1992, ONCOGENE, V7, P43; Yan PR, 2009, NEOPLASIA, V11, P1036, DOI 10.1593/neo.09752; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Yoshida M, 2005, ONCOGENE, V24, P5931, DOI 10.1038/sj.onc.1208981	35	29	29	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2010	29	49					6499	6507		10.1038/onc.2010.374	http://dx.doi.org/10.1038/onc.2010.374			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20838382	Green Accepted			2022-12-25	WOS:000285138900009
J	Choi, SS; Syn, WK; Karaca, GF; Omenetti, A; Moylan, CA; Witek, RP; Agboola, KM; Jung, Y; Michelotti, GA; Diehl, AM				Choi, Steve S.; Syn, Wing-Kin; Karaca, Gamze F.; Omenetti, Alessia; Moylan, Cynthia A.; Witek, Rafal P.; Agboola, Kolade M.; Jung, Youngmi; Michelotti, Gregory A.; Diehl, Anna Mae			Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNAL-TRANSDUCTION PATHWAYS; ADIPOCYTE DIFFERENTIATION; EXTRACELLULAR-MATRIX; UP-REGULATION; RECEPTOR; FIBROSIS; LIVER; MICE; RAT	Trans-differentiation of quiescent hepatic stellate cells (Q-HSCs), which exhibit epithelial and adipocytic features, into myofibroblastic-HSC (MF-HSCs) is a key event in liver fibrosis. Culture models demonstrated that Hedgehog (Hh) pathway activation is required for transition of epithelioid/adipocytic Q-HSCs into MF-HSCs. Hh signaling inhibits adiposity and promotes epithelial-to-mesenchymal transitions (EMTs). Leptin (anti-adipogenic, pro-EMT factor) promotes HSC trans-differentiation and liver fibrosis, suggesting that the pathways may interact to modulate cell fate. This study aimed to determine whether leptin activates Hh signaling and whether this is required for the fibrogenic effects of leptin. Cultures of primary HSCs from lean and fa/fa rats with an inherited ObRb defect were examined. Inhibitors of PI3K/Akt, JAK/STAT, and Hh signaling were used to delineate how ObRb activation influenced Hh signaling and HSC trans-differentiation. Fibrogenesis was compared in wild type and db/db mice (impaired ObRb function) to assess the profibrotic role of leptin. The results demonstrate that leptin-ObR interactions activate Hh signaling with the latter necessary to promote trans-differentiation. Leptin-related increases in Hh signaling required ObR induction of PI3K/Akt, which was sufficient for leptin to repress the epithelioid/adipocytic program. Leptin-mediated induction of JAK/STAT was required for mesenchymal gene expression. Leptin-ObRb interactions were not necessary for HSC trans-differentiation to occur in vitro or in vivo but are important because liver fibrogenesis was attenuated in db/db mice. These findings reveal that leptin activates Hh signaling to alter gene expression programs that control cell fate and have important implications for liver fibrosis and other leptin-regulated processes involving EMTs, including development, obesity, and cancer metastasis.	[Diehl, Anna Mae] Duke Univ, Div Gastroenterol, Med Ctr, Dept Med, Durham, NC 27710 USA; [Choi, Steve S.; Moylan, Cynthia A.] Durham Vet Affairs Med Ctr, Gastroenterol Sect, Durham, NC 27705 USA; [Jung, Youngmi] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Pusan National University	Diehl, AM (corresponding author), Duke Univ, Div Gastroenterol, Med Ctr, Dept Med, DUMC 3256,595 LaSalle St,Suite 1073, Durham, NC 27710 USA.	annamae.diehl@duke.edu	Choi, Steve/GZH-1598-2022; Omenetti, Alessia/K-5975-2016; Syn, Wing-Kin/AAB-8406-2020	Omenetti, Alessia/0000-0002-8220-0385; , Gregory/0000-0002-3936-4675; Michelotti, Gregory/0000-0002-7908-1979; Moylan, Cynthia/0000-0001-8454-7086	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080980, R01DK077794, R01DK053792] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK080980, R01 DK053792, R01 DK077794] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleffi S, 2005, HEPATOLOGY, V42, p254A; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Choi SS, 2006, HEPATOLOGY, V44, P1267, DOI 10.1002/hep.21375; Choi SS, 2010, HEPATOLOGY, V52, P278, DOI 10.1002/hep.23649; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Chua S, 2002, DIABETOLOGIA, V45, P976, DOI 10.1007/s00125-002-0880-z; De Minicis S, 2008, HEPATOLOGY, V48, p405A; El-Zaatari M, 2009, CURR OPIN ENDOCRINOL, V16, P60, DOI 10.1097/MED.0b013e328320a821; Fava G, 2008, CANCER RES, V68, P6752, DOI 10.1158/0008-5472.CAN-07-6682; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Honda H, 2002, HEPATOLOGY, V36, P12, DOI 10.1053/jhep.2002.33684; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Ikejima Kenichi, 2004, Comp Hepatol, V3 Suppl 1, pS12, DOI 10.1186/1476-5926-2-S1-S12; Jiang JX, 2008, HEPATOLOGY, V48, P1497, DOI 10.1002/hep.22515; Jung YM, 2008, GASTROENTEROLOGY, V134, pA785; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lang T, 2004, BIOCHEM BIOPH RES CO, V323, P1091, DOI 10.1016/j.bbrc.2004.08.192; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Nath AK, 2008, J CELL BIOL, V181, P367, DOI 10.1083/jcb.200708197; Niu LW, 2007, LIVER INT, V27, P1265, DOI 10.1111/j.1478-3231.2007.01582.x; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Sharma D, 2006, ENDOCR-RELAT CANCER, V13, P629, DOI 10.1677/erc.1.01169; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Si HF, 2007, EXP BIOL MED, V232, P427; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Tang YC, 2009, ENDOCRINOLOGY, V150, P3011, DOI 10.1210/en.2008-1601; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xue Xiulan, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P655; Yamashita T, 1998, BIOCHEM BIOPH RES CO, V246, P752, DOI 10.1006/bbrc.1998.8689; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391	46	127	139	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36551	36560		10.1074/jbc.M110.168542	http://dx.doi.org/10.1074/jbc.M110.168542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843817	Green Published, hybrid			2022-12-25	WOS:000284146100008
J	Gao, XW; Wei, SS; Lai, KR; Sheng, JH; Su, JF; Zhu, JQ; Dong, HJ; Hu, H; Xu, ZP				Gao, Xiangwei; Wei, Saisai; Lai, Kairan; Sheng, Jinghao; Su, Jinfeng; Zhu, Junqiao; Dong, Haojie; Hu, Hu; Xu, Zhengping			Nucleolar Follistatin Promotes Cancer Cell Survival under Glucose-deprived Conditions through Inhibiting Cellular rRNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I TRANSCRIPTION; NUCLEAR-LOCALIZATION; BINDING PROTEIN; GENES; MICE; RDNA; ANGIOGENESIS; DEFICIENT; RECEPTORS; HYPOXIA	Solid tumor development is frequently accompanied by energy-deficient conditions such as glucose deprivation and hypoxia. Follistatin (FST), a secretory protein originally identified from ovarian follicular fluid, has been suggested to be involved in tumor development. However, whether it plays a role in cancer cell survival under energy-deprived conditions remains elusive. In this study, we demonstrated that glucose deprivation markedly enhanced the expression and nucleolar localization of FST in HeLa cells. The nucleolar localization of FST relied on its nuclear localization signal (NLS) comprising the residues 64-87. Localization of FST to the nucleolus attenuated rRNA synthesis, a key process for cellular energy homeostasis and cell survival. Overexpression of FST delayed glucose deprivation-induced apoptosis, whereas down-regulation of FST exerted the opposite effect. These functions depended on the presence of an intact NLS because the NLS-deleted mutant of FST lost the rRNA inhibition effect and the cell protective effect. Altogether, we identified a novel nucleolar function of FST, which is of importance in the modulation of cancer cell survival in response to glucose deprivation.	[Gao, Xiangwei; Wei, Saisai; Sheng, Jinghao; Su, Jinfeng; Zhu, Junqiao; Dong, Haojie; Xu, Zhengping] Zhejiang Univ, Inst Environm Med, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Gao, Xiangwei; Xu, Zhengping] Zhejiang Univ, Sch Med, Res Ctr Environm Genom, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Hu] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Xu, ZP (corresponding author), Zhejiang Univ, Inst Environm Med, Sch Med, 388 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zpxu@zju.edu.cn	Gao, Xiangwei/J-3026-2015; Dong, Haojie/AAU-6510-2020	Gao, Xiangwei/0000-0002-8358-6320; 	National Natural Science Foundation of China [30171035, 30770470, 30900235]; Zhejiang Provincial Natural Science Foundation of China [Y2090095]; China Postdoctoral Science Foundation [20080430209, 200902638]; Program for New Century Excellent Talents in University; Ministry of Education [NCET-05-0521]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Education; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by National Natural Science Foundation of China Grants 30171035, 30770470, and 30900235 and Zhejiang Provincial Natural Science Foundation of China Grant Y2090095.; Supported by China Postdoctoral Science Foundation Grants 20080430209 and 200902638.; Supported by Program for New Century Excellent Talents in University, Ministry of Education Grant NCET-05-0521 and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. To whom correspondence should be addressed: Institute of Environmental Medicine, Zhejiang University School of Medicine, 388 Yuhangtang Rd., Hangzhou 310058, China. Tel.: 86-571-88208164; Fax: 86-571-88208163; E-mail: zpxu@zju.edu.cn.	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Bloise E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-320; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gao XW, 2007, FEBS LETT, V581, P5505, DOI 10.1016/j.febslet.2007.10.059; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HEMMATIBRIVANLO.A, 1994, D A CELL, V77, P283; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Hu HJ, 2005, BIOCHEM BIOPH RES CO, V329, P661, DOI 10.1016/j.bbrc.2005.01.158; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kang WQ, 2008, BIOCHEM BIOPH RES CO, V376, P573, DOI 10.1016/j.bbrc.2008.09.031; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Saito S, 2005, ENDOCRINOLOGY, V146, P5052, DOI 10.1210/en.2005-0833; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	42	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36857	36864		10.1074/jbc.M110.144477	http://dx.doi.org/10.1074/jbc.M110.144477			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843798	Green Published, hybrid			2022-12-25	WOS:000284146100013
J	Cornette, R; Kanamori, Y; Watanabe, M; Nakahara, Y; Gusev, O; Mitsumasu, K; Kadono-Okuda, K; Shimomura, M; Mita, K; Kikawada, T; Okuda, T				Cornette, Richard; Kanamori, Yasushi; Watanabe, Masahiko; Nakahara, Yuichi; Gusev, Oleg; Mitsumasu, Kanako; Kadono-Okuda, Keiko; Shimomura, Michihiko; Mita, Kazuei; Kikawada, Takahiro; Okuda, Takashi			Identification of Anhydrobiosis-related Genes from an Expressed Sequence Tag Database in the Cryptobiotic Midge Polypedilum vanderplanki (Diptera; Chironomidae)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; ENCYSTED EMBRYOS; ANTARCTIC MIDGE; MOLECULAR-BASIS; DEHYDRATION; TREHALOSE; RESPONSES; CHAPERONE	Some organisms are able to survive the loss of almost all their body water content, entering a latent state known as anhydrobiosis. The sleeping chironomid (Polypedilum vanderplanki) lives in the semi-arid regions of Africa, and its larvae can survive desiccation in an anhydrobiotic form during the dry season. To unveil the molecular mechanisms of this resistance to desiccation, an anhydrobiosis-related Expressed Sequence Tag (EST) database was obtained from the sequences of three cDNA libraries constructed from P. vanderplanki larvae after 0, 12, and 36 h of desiccation. The database contained 15,056 ESTs distributed into 4,807 UniGene clusters. ESTs were classified according to gene ontology categories, and putative expression patterns were deduced for all clusters on the basis of the number of clones in each library; expression patterns were confirmed by real-time PCR for selected genes. Among up-regulated genes, antioxidants, late embryogenesis abundant (LEA) proteins, and heat shock proteins (Hsps) were identified as important groups for anhydrobiosis. Genes related to trehalose metabolism and various transporters were also strongly induced by desiccation. Those results suggest that the oxidative stress response plays a central role in successful anhydrobiosis. Similarly, protein denaturation and aggregation may be prevented by marked up-regulation of Hsps and the anhydrobiosis-specific LEA proteins. A third major feature is the predicted increase in trehalose synthesis and in the expression of various transporter proteins allowing the distribution of trehalose and other solutes to all tissues.	[Cornette, Richard; Kanamori, Yasushi; Watanabe, Masahiko; Nakahara, Yuichi; Gusev, Oleg; Mitsumasu, Kanako; Kadono-Okuda, Keiko; Mita, Kazuei; Kikawada, Takahiro; Okuda, Takashi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Shimomura, Michihiko] Mitsubishi Space Software, Tsukuba, Ibaraki 3050032, Japan	National Institute of Agrobiological Sciences - Japan	Kikawada, T (corresponding author), Natl Inst Agrobiol Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	kikawada@affrc.go.jp; okuda@affrc.go.jp	Gusev, Oleg/D-9383-2011; Kikawada, Takahiro/A-1289-2010	Gusev, Oleg/0000-0002-6203-9758; Kikawada, Takahiro/0000-0002-2329-9282; CORNETTE, Richard/0000-0002-0185-1443	Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [21688004]	Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN), a grant-in-aid (Bio Design Program) from the Ministry of Agriculture, Forestry and Fisheries of Japan, and by Grant-in-aid for Scientific Research Number 21688004 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A part of this study is also the result of the project "Characterization of the Mechanisms Underlying the Radiation Resistance Associated with Cryptobiosis" carried out under the grant "Strategic Promotion Program for Basic Nuclear Research" by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Berjak P., 2007, PLANT DESICCATION TO, P151; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chen WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-52; Clegg JS, 2006, COMP BIOCHEM PHYS B, V145, P119, DOI 10.1016/j.cbpb.2006.04.014; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; Cuming AC, 1999, SEED PROTEINS, P753; Danks HV, 2000, J INSECT PHYSIOL, V46, P837, DOI 10.1016/S0022-1910(99)00204-8; Denekamp NY, 2010, BIOL REPROD, V82, P714, DOI 10.1095/biolreprod.109.081091; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Freitas DRJ, 2007, COMP BIOCHEM PHYS A, V146, P688, DOI 10.1016/j.cbpa.2006.04.032; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Hankeln T, 1998, J MOL EVOL, V46, P589, DOI 10.1007/PL00006339; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Hinault MP, 2007, ADV EXP MED BIOL, V594, P47; HINTON HE, 1960, J INSECT PHYSIOL, V5, P286, DOI 10.1016/0022-1910(60)90011-1; HINTON HE, 1951, P ZOOL SOC LOND, V121, P371; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; HOCHACHKA DW, 1987, METABOLIC ARREST CON, P146; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kikawada T, 2005, INTEGR COMP BIOL, V45, P710, DOI 10.1093/icb/45.5.710; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Limon-Pacheco J, 2009, MUTAT RES-GEN TOX EN, V674, P137, DOI 10.1016/j.mrgentox.2008.09.015; Lopez-Martinez G, 2008, INSECT BIOCHEM MOLEC, V38, P796, DOI 10.1016/j.ibmb.2008.05.006; Lopez-Martinez G, 2009, J COMP PHYSIOL B, V179, P481, DOI 10.1007/s00360-008-0334-0; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Maulik N, 2008, BBA-GEN SUBJECTS, V1780, P1368, DOI 10.1016/j.bbagen.2007.12.008; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Mitsumasu K, 2010, FEBS J, V277, P4215, DOI 10.1111/j.1742-4658.2010.07811.x; Nakahara Y, 2008, J INSECT PHYSIOL, V54, P1220, DOI 10.1016/j.jinsphys.2008.05.007; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; SOMME L, 1995, INVERTEBRATES HOT CO, P95; Suemoto T, 2004, HYDROBIOLOGIA, V515, P107, DOI 10.1023/B:HYDR.0000027322.11005.20; Suetsugu Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-314; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Tagu D, 2004, INSECT BIOCHEM MOLEC, V34, P809, DOI 10.1016/j.ibmb.2004.05.001; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Viner RI, 2001, CELL STRESS CHAPERON, V6, P126, DOI 10.1379/1466-1268(2001)006<0126:IOTOTM>2.0.CO;2; Wajcman H, 2009, CR BIOL, V332, P273, DOI 10.1016/j.crvi.2008.07.026; Watanabe M, 2005, J INSECT PHYSIOL, V51, P727, DOI 10.1016/j.jinsphys.2005.02.008; Watanabe M, 2004, EUR J ENTOMOL, V101, P439, DOI 10.14411/eje.2004.063; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Watanabe M, 2002, J EXP BIOL, V205, P2799; Wharton DA, 2003, J COMP PHYSIOL B, V173, P621, DOI 10.1007/s00360-003-0378-0; Wu-Scharf D, 2003, SOCIOBIOLOGY, V41, P479	73	43	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35889	35899		10.1074/jbc.M110.150623	http://dx.doi.org/10.1074/jbc.M110.150623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833722	Green Published, hybrid			2022-12-25	WOS:000283845300066
J	Kwak, TK; Kim, H; Jung, O; Lee, SA; Kang, M; Kim, HJ; Park, JM; Kim, SH; Lee, JW				Kwak, Tae Kyoung; Kim, Hyeonjung; Jung, Oisun; Lee, Sin-Ae; Kang, Minkyung; Kim, Hyun Jeong; Park, Ji-Min; Kim, Sung-Hoon; Lee, Jung Weon			Glucosamine Treatment-mediated O-GlcNAc Modification of Paxillin Depends on Adhesion State of Rat Insulinoma INS-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; POSTTRANSLATIONAL MODIFICATION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; N-ACETYLGLUCOSAMINE; PROTEIN; GLYCOSYLATION; MIGRATION; APOPTOSIS; MATRIX	Protein-protein interactions and/or signaling activities at focal adhesions, where integrin-mediated adhesion to extracellular matrix occurs, are critical for the regulation of adhesion-dependent cellular functions. Although the phosphorylation and activities of focal adhesion molecules have been intensively studied, the effects of the O-GlcNAc modification of their Ser/Thr residues on cellular functions have been largely unexplored. We investigated the effects of O-GlcNAc modification on actin reorganization and morphology of rat insulinoma INS-1 cells after glucosamine (GlcN) treatment. We found that paxillin, a key adaptor molecule in focal adhesions, could be modified by O-GlcNAc in INS-1 cells treated with GlcN and in pancreatic islets from mice treated with streptozotocin. Ser-84/85 in human paxillin appeared to be modified by O-GlcNAc, which was inversely correlated to Ser-85 phosphorylation (Ser-83 in rat paxillin). Integrin-mediated adhesion signaling inhibited the GlcN treatment-enhanced O-GlcNAc modification of paxillin. Adherent INS-1 cells treated with GlcN showed restricted protrusions, whereas untreated cells showed active protrusions for multiple-elongated morphologies. Upon GlcN treatment, expression of a triple mutation (S83A/S84A/S85A) resulted in no further restriction of protrusions. Together these observations suggest that murine pancreatic beta cells may have restricted actin organization upon GlcN treatment by virtue of the O-GlcNAc modification of paxillin, which can be antagonized by a persistent cell adhesion process.	[Kwak, Tae Kyoung; Kim, Hyeonjung; Lee, Jung Weon] Seoul Natl Univ, Dept Tumor Biol, Canc Res Inst, Seoul 110799, South Korea; [Lee, Sin-Ae] Seoul Natl Univ, Dept Mol & Clin Oncol, Seoul 110799, South Korea; [Kang, Minkyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, Hyun Jeong] Seoul Natl Univ, Sch Dent, Dept Dent Anesthesiol, Seoul 110799, South Korea; [Jung, Oisun; Lee, Jung Weon] Seoul Natl Univ, Dept Genet Engn, Seoul 151742, South Korea; [Park, Ji-Min; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Cell Dynam Res Ctr,Dept Pharm, Seoul 151742, South Korea; [Kim, Sung-Hoon] Kyung Hee Univ, Canc Prevent Mat Dev Res Ctr, Seoul 131701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University	Lee, JW (corresponding author), Seoul Natl Univ, Dept Tumor Biol, Canc Res Inst, Seoul 110799, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; kim, sunghoon/0000-0002-1570-3230	Korea Science and Engineering Foundation Ministry of Education, Science, and Technology [R01-2006-000-10248-0]; Cell Dynamics Research Center [R11-2007-007-01004-0]; Ministry of Education, Science, and Technology [010-00150029]	Korea Science and Engineering Foundation Ministry of Education, Science, and Technology; Cell Dynamics Research Center(Ministry of Science & Technology (MOST), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Ministry of Education, Science, and Technology Grant R01-2006-000-10248-0, Cell Dynamics Research Center Grant R11-2007-007-01004-0), and by the Support for Senior Researchers (Leap Research) program through National Research Foundation by the Ministry of Education, Science, and Technology Grant 010-00150029 (to J.W.L.).	Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Dehennaut V, 2008, BIOCHEM BIOPH RES CO, V369, P539, DOI 10.1016/j.bbrc.2008.02.063; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Huang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Lee JW, 2004, MOL CELLS, V17, P188; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; MCEVOY RC, 1984, J CLIN INVEST, V74, P715, DOI 10.1172/JCI111487; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020; Sesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Werstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36021	36031		10.1074/jbc.M110.129601	http://dx.doi.org/10.1074/jbc.M110.129601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829364	Green Published, hybrid			2022-12-25	WOS:000283845300078
J	Abdallah, RT; Keum, JS; Lee, MH; Wang, B; Gooz, M; Luttrell, DK; Luttrell, LM; Jaffa, AA				Abdallah, Rany T.; Keum, Joo-Seob; Lee, Mi-Hye; Wang, Bing; Gooz, Monika; Luttrell, Deirdre K.; Luttrell, Louis M.; Jaffa, Ayad A.			Plasma Kallikrein Promotes Epidermal Growth Factor Receptor Transactivation and Signaling in Vascular Smooth Muscle through Direct Activation of Protease-activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; NITRIC-OXIDE PRODUCTION; SUBSTRATE-SPECIFICITY; THROMBIN RECEPTORS; CORONARY-ARTERIES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; EGF RECEPTOR; SHEAR-STRESS; PREKALLIKREIN	The kallikrein-kinin system, along with the interlocking reninangiotensin system, is a key regulator of vascular contractility and injury response. The principal effectors of the kallikrein-kinin system are plasma and tissue kallikreins, proteases that cleave high molecular weight kininogen to produce bradykinin. Most of the cellular actions of kallikrein (KK) are thought to be mediated by bradykinin, which acts via G protein-coupled B1 and B2 bradykinin receptors on VSMCs and endothelial cells. Here, we find that primary aortic vascular smooth muscle but not endothelial cells possess the ability to activate plasma prekallikrein. Surprisingly, exposing VSMCs to prekallikrein leads to activation of the ERK1/2 mitogen-activated protein kinase cascade via a mechanism that requires kallikrein activity but does not involve bradykinin receptors. In transfected HEK293 cells, we find that plasma kallikrein directly activates G protein-coupled protease-activated receptors (PARs) 1 and 2, which possess consensus kallikrein cleavage sites, but not PAR4. In vascular smooth muscles, KK stimulates ADAM (a disintegrin and metalloprotease) 17 activity via a PAR1/2 receptor-dependent mechanism, leading sequentially to release of the endogenous ADAM17 substrates, amphiregulin and tumor necrosis factor-alpha, metalloprotease-dependent transactivation of epidermal growth factor receptors, and metalloprotease and epidermal growth factor receptor-dependent ERK1/2 activation. These results suggest a novel mechanism of bradykinin-independent kallikrein action that may contribute to the regulation of vascular responses in pathophysiologic states, such as diabetes mellitus.	[Abdallah, Rany T.; Keum, Joo-Seob; Lee, Mi-Hye; Wang, Bing; Gooz, Monika; Luttrell, Deirdre K.; Luttrell, Louis M.; Jaffa, Ayad A.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Luttrell, Louis M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Jaffa, AA (corresponding author), Amer Univ Beirut, Fac Med, Dept Biochem, Beirut, Lebanon.	aj24@aub.edu.lb		Luttrell, Louis/0000-0003-2805-6949	National Institutes of Health [HL087986, HL077192, DK55524]; South Carolina Center for Biomedical Research Excellence in Cardiovascular Diseases; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077192, R01HL087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524, R56DK055524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Center for Biomedical Research Excellence in Cardiovascular Diseases; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL087986 and HL077192 (to A. A. J.), and DK55524 (to L. M. L.). This work was also supported by the South Carolina Center for Biomedical Research Excellence in Cardiovascular Diseases (to D. K. L.) and Department of Veterans Affairs Research Enhancement Award Program awards.	Al-Ani B, 2002, J PHARMACOL EXP THER, V300, P702, DOI 10.1124/jpet.300.2.702; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; BRINER VA, 1993, AM J PHYSIOL, V264, pF322, DOI 10.1152/ajprenal.1993.264.2.F322; Canault M, 2006, ATHEROSCLEROSIS, V187, P82, DOI 10.1016/j.atherosclerosis.2005.08.031; Carpenter G, 2000, SCI STKE, V2000, ppe1, DOI DOI 10.1126/SCISIGNAL.152000PE1; Chan AK, 2003, J VASC SURG, V37, P644, DOI 10.1067/mva.2003.92; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Damiano BP, 1999, THROMB HAEMOSTASIS, V81, P808; Derkach DN, 2000, BRIT J PHARMACOL, V131, P1635, DOI 10.1038/sj.bjp.0703737; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; GA B, 2004, TRENDS ENDOCRIN MET, V15, P286; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GARG UC, 1989, AM J PHYSIOL, V257, pF60, DOI 10.1152/ajprenal.1989.257.1.F60; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hermann A, 1999, IMMUNOPHARMACOLOGY, V45, P135, DOI 10.1016/S0162-3109(99)00066-1; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Igura T, 1996, ARTERIOSCL THROM VAS, V16, P1524, DOI 10.1161/01.ATV.16.12.1524; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; KANTHOU C, 1995, THROMB HAEMOSTASIS, V74, P1340; Kanthou C, 1995, BLOOD COAGUL FIBRIN, V6, P753, DOI 10.1097/00001721-199512000-00010; Kato M, 2003, BIOCHEM BIOPH RES CO, V301, P1109, DOI 10.1016/S0006-291X(03)00093-7; Kawakami A, 2005, J ATHEROSCLER THROMB, V12, P73, DOI 10.5551/jat.12.73; Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44; KU DD, 1993, J CARDIOVASC PHARM, V22, P609, DOI 10.1097/00005344-199310000-00015; Ku DD, 1997, J CARDIOVASC PHARM, V30, P649, DOI 10.1097/00005344-199711000-00016; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Mizuno O, 1998, EUR J PHARMACOL, V351, P67, DOI 10.1016/S0014-2999(98)00292-1; Mizuno O, 2000, BRIT J PHARMACOL, V130, P1140, DOI 10.1038/sj.bjp.0703420; MOMBOULI JV, 1995, ANNU REV PHARMACOL, V35, P679, DOI 10.1146/annurev.pa.35.040195.003335; MORITA T, 1993, BIOCHEM BIOPH RES CO, V197, P256, DOI 10.1006/bbrc.1993.2469; Motta G, 2001, THROMB HAEMOSTASIS, V86, P840; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Nakata A, 1996, CIRCULATION, V94, P2778, DOI 10.1161/01.CIR.94.11.2778; Napoli C, 2004, J CLIN PATHOL, V57, P513, DOI 10.1136/jcp.2003.015156; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schmaier AH, 2003, AM J PHYSIOL-REG I, V285, pR1, DOI 10.1152/ajpregu.00535.2002; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Siragy HM, 1997, HYPERTENSION, V29, P757, DOI 10.1161/01.HYP.29.3.757; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; TESFAMARIAM B, 1994, AM J PHYSIOL-HEART C, V267, pH1962, DOI 10.1152/ajpheart.1994.267.5.H1962; Touyz RM, 2006, ARTERIOSCL THROM VAS, V26, P685, DOI 10.1161/01.ATV.0000216428.90962.60; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; WILCOX JN, 1994, CIRC RES, V75, P1029, DOI 10.1161/01.RES.75.6.1029; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	66	45	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35206	35215		10.1074/jbc.M110.171769	http://dx.doi.org/10.1074/jbc.M110.171769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826789	Green Published, hybrid			2022-12-25	WOS:000283659100094
J	Ito, H; Oshiro, T; Fujita, Y; Kubota, S; Naito, C; Ohtsuka, H; Murakami, H; Aiba, H				Ito, Hirokazu; Oshiro, Tomoko; Fujita, Yasuyuki; Kubota, Sachiko; Naito, Chikako; Ohtsuka, Hokuto; Murakami, Hiroshi; Aiba, Hirofumi			Pma1, a P-type Proton ATPase, Is a Determinant of Chronological Life Span in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; COA SYNTHETASE GENE; SCHIZOSACCHAROMYCES-POMBE; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; STRESS RESISTANCE; IDENTIFICATION; LONGEVITY; ACTIVATION	Chronological life span is defined by how long a cell can survive in a non-dividing state. In yeast, it is measured by viability after entry into stationary phase. To date, some factors affecting chronological life span have been identified; however, the molecular details of how these factors regulate chronological life span have not yet been elucidated clearly. Because life span is a complicated phenomenon and is supposedly regulated by many factors, it is necessary to identify new factors affecting chronological life span to understand life span regulation. To this end, we have screened for long-lived mutants and identified Pma1, an essential P-type proton ATPase, as one of the determinants of chronological life span. We show that partial loss of Pma1 activity not only by mutations but also by treatment with the Pma1 inhibitory chemical vanadate resulted in the long-lived phenotype in Schizosaccharomyces pombe. These findings suggest a novel way to manipulate chronological life span by modulating Pma1 as a molecular target.	[Aiba, Hirofumi] Nagoya Univ, Mol Microbiol Lab, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Murakami, Hiroshi] Nagoya City Univ, Dept Biochem & Cell Biol, Grad Sch Med, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya University; Nagoya City University	Aiba, H (corresponding author), Nagoya Univ, Mol Microbiol Lab, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	aiba@agr.nagoya-u.ac.jp	Ohtsuka, Hokuto/I-6957-2014	Ohtsuka, Hokuto/0000-0001-7843-2602	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency (JST); Nagase Science and Technology Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Nagase Science and Technology Foundation	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. A.) and by Research for Promoting Technological Seeds from the Japan Science and Technology Agency (JST) and the Nagase Science and Technology Foundation (to H. A.).	Azuma K, 2009, BIOSCI BIOTECH BIOCH, V73, P2787, DOI 10.1271/bbb.90599; BRISKIN DP, 1987, METHOD ENZYMOL, V148, P542; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fujita Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3041, DOI 10.1271/bbb.70442; GHISLAIN M, 1992, EUR J BIOCHEM, V209, P275, DOI 10.1111/j.1432-1033.1992.tb17286.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; HO FERM, 1987, J GEN MICROBIOL */*, V133, P2163; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Ohmiya R, 1999, J BIOCHEM, V125, P1061, DOI 10.1093/oxfordjournals.jbchem.a022387; Ohtsuka H, 2008, FEMS YEAST RES, V8, P520, DOI 10.1111/j.1567-1364.2008.00379.x; Ohtsuka H, 2009, BIOSCI BIOTECH BIOCH, V73, P885, DOI 10.1271/bbb.80804; Oshiro T, 2003, MOL GENET GENOMICS, V269, P437, DOI 10.1007/s00438-003-0841-3; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Smith ED, 2007, MECH AGEING DEV, V128, P106, DOI 10.1016/j.mad.2006.11.017; ULASZEWSKI S, 1987, J BIOL CHEM, V262, P223; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993	24	22	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34616	34620		10.1074/jbc.M110.175562	http://dx.doi.org/10.1074/jbc.M110.175562			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20829365	Green Published, hybrid			2022-12-25	WOS:000283659100037
J	Miller, MA; Kudela, RM; Mekebri, A; Crane, D; Oates, SC; Tinker, MT; Staedler, M; Miller, WA; Toy-Choutka, S; Dominik, C; Hardin, D; Langlois, G; Murray, M; Ward, K; Jessup, DA				Miller, Melissa A.; Kudela, Raphael M.; Mekebri, Abdu; Crane, Dave; Oates, Stori C.; Tinker, M. Timothy; Staedler, Michelle; Miller, Woutrina A.; Toy-Choutka, Sharon; Dominik, Clare; Hardin, Dane; Langlois, Gregg; Murray, Michael; Ward, Kim; Jessup, David A.			Evidence for a Novel Marine Harmful Algal Bloom: Cyanotoxin (Microcystin) Transfer from Land to Sea Otters	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS; COASTAL CALIFORNIA; TOXOPLASMA-GONDII; AERUGINOSA; WATER; LR; FOOD; LAKE; TOXICITY; EXPOSURE	"Super-blooms'' of cyanobacteria that produce potent and environmentally persistent biotoxins (microcystins) are an emerging global health issue in freshwater habitats. Monitoring of the marine environment for secondary impacts has been minimal, although microcystin-contaminated freshwater is known to be entering marine ecosystems. Here we confirm deaths of marine mammals from microcystin intoxication and provide evidence implicating land-sea flow with trophic transfer through marine invertebrates as the most likely route of exposure. This hypothesis was evaluated through environmental detection of potential freshwater and marine microcystin sources, sea otter necropsy with biochemical analysis of tissues and evaluation of bioaccumulation of freshwater microcystins by marine invertebrates. Ocean discharge of freshwater microcystins was confirmed for three nutrient-impaired rivers flowing into the Monterey Bay National Marine Sanctuary, and microcystin concentrations up to 2,900 ppm (2.9 million ppb) were detected in a freshwater lake and downstream tributaries to within 1 km of the ocean. Deaths of 21 southern sea otters, a federally listed threatened species, were linked to microcystin intoxication. Finally, farmed and free-living marine clams, mussels and oysters of species that are often consumed by sea otters and humans exhibited significant biomagnification (to 107 times ambient water levels) and slow depuration of freshwater cyanotoxins, suggesting a potentially serious environmental and public health threat that extends from the lowest trophic levels of nutrient-impaired freshwater habitat to apex marine predators. Microcystin-poisoned sea otters were commonly recovered near river mouths and harbors and contaminated marine bivalves were implicated as the most likely source of this potent hepatotoxin for wild otters. This is the first report of deaths of marine mammals due to cyanotoxins and confirms the existence of a novel class of marine "harmful algal bloom'' in the Pacific coastal environment; that of hepatotoxic shellfish poisoning (HSP), suggesting that animals and humans are at risk from microcystin poisoning when consuming shellfish harvested at the land-sea interface.	[Miller, Melissa A.; Oates, Stori C.; Toy-Choutka, Sharon; Jessup, David A.] Calif Dept Fish & Game, Marine Wildlife Vet Care & Res Ctr, Off Spill Prevent & Response, Santa Cruz, CA USA; [Miller, Melissa A.; Kudela, Raphael M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Mekebri, Abdu; Crane, Dave] Calif Dept Fish & Game, Water Pollut Control Lab, Off Spill Prevent & Response, Rancho Cordova, CA USA; [Tinker, M. Timothy] US Geol Survey, Western Ecol Res Ctr, Long Marine Lab, Santa Cruz, CA USA; [Staedler, Michelle; Murray, Michael] Monterey Bay Aquarium, Monterey, CA USA; [Miller, Woutrina A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Dominik, Clare; Hardin, Dane] Appl Marine Sci, Livermore, CA USA; [Langlois, Gregg] Calif Dept Publ Hlth, Richmond, CA USA; [Ward, Kim] State Water Resources Control Board, Div Water Qual, Sacramento, CA USA	University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey; Monterey Bay Aquarium Research Institute; University of California System; University of California Davis; California Department of Public Health	Miller, MA (corresponding author), Calif Dept Fish & Game, Marine Wildlife Vet Care & Res Ctr, Off Spill Prevent & Response, Santa Cruz, CA USA.	mmiller@ospr.dfg.ca.gov	Tinker, Martin T/D-3249-2018	Tinker, Martin T/0000-0002-3314-839X; Oates, Samantha/0000-0001-9309-7873	California Division of Water Quality, State Water Resources Control Board (SWRCB); California Department of Fish and Game, Division of Spill Prevention and Respons; CDFG Water Pollution Control Laboratory	California Division of Water Quality, State Water Resources Control Board (SWRCB); California Department of Fish and Game, Division of Spill Prevention and Respons; CDFG Water Pollution Control Laboratory	Financial assistance was provided by the California Division of Water Quality, State Water Resources Control Board (SWRCB), the California Department of Fish and Game, Division of Spill Prevention and Response and the CDFG Water Pollution Control Laboratory. Co-Author Kim Ward of the SWRCB assisted with basic concepts of study design and data analysis in relation to ongoing statewide research on microcystins, but the various funding agencies had no directive or editorial role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amorim A, 1999, TOXICON, V37, P1041, DOI 10.1016/S0041-0101(98)00231-1; ASHWORTH CT, 1946, AM J PATHOL, V22, P369; Backer LC, 2008, MAR DRUGS, V6, P389, DOI 10.3390/md20080018; BISHOP CT, 1959, CAN J BIOCHEM PHYS, V37, P453, DOI 10.1139/o59-047; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; CHEN DZX, 1993, TOXICON, V31, P1407, DOI 10.1016/0041-0101(93)90206-X; Chen J, 2006, AQUACULTURE, V261, P1026, DOI 10.1016/j.aquaculture.2006.08.028; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; DEMOTT WR, 1991, ECOLOGY, V72, P1820, DOI 10.2307/1940981; Domingos P, 1999, ENVIRON TOXICOL, V14, P31, DOI 10.1002/(SICI)1522-7278(199902)14:1<31::AID-TOX6>3.3.CO;2-2; Estes JA, 2004, B MAR SCI, V74, P621; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes James A., 2005, P61; Fischer WJ, 2000, TOXICOL APPL PHARM, V164, P73, DOI 10.1006/taap.1999.8861; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; Ger KA, 2009, SCI TOTAL ENVIRON, V407, P4852, DOI 10.1016/j.scitotenv.2009.05.043; Gilroy DJ, 2000, ENVIRON HEALTH PERSP, V108, P435, DOI 10.2307/3454384; Goldberg J.D., 2003, THESIS CALIFORNIA ST; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; HANAZATO T, 1987, HYDROBIOLOGIA, V144, P251, DOI 10.1007/BF00005559; Humpage AR, 1999, ENVIRON TOXICOL, V14, P61; Jacoby JM, 2000, CAN J FISH AQUAT SCI, V57, P231, DOI 10.1139/cjfas-57-1-231; Jessup DA, 2007, JAVMA-J AM VET MED A, V231, P1648, DOI 10.2460/javma.231.11.1648; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Johnson CK, 2009, P NATL ACAD SCI USA, V106, P2242, DOI 10.1073/pnas.0806449106; Johnston BR, 2003, HYDROBIOLOGIA, V495, P79, DOI 10.1023/A:1025496922050; Kohoutek J, 2008, ANAL BIOANAL CHEM, V390, P1167, DOI 10.1007/s00216-007-1785-y; Kotak BG, 1996, CAN J FISH AQUAT SCI, V53, P1974, DOI 10.1139/cjfas-53-9-1974; Lankoff A, 2004, TOXICOLOGY, V204, P23, DOI 10.1016/j.tox.2004.05.016; Lehman PW, 2005, HYDROBIOLOGIA, V541, P87, DOI 10.1007/s10750-004-4670-0; MacKenzie L, 2004, TOXICON, V44, P901, DOI 10.1016/j.toxicon.2004.08.020; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Matthiensen A, 2000, PHYTOCHEMISTRY, V55, P383, DOI 10.1016/S0031-9422(00)00335-6; Mekebri A, 2009, J CHROMATOGR A, V1216, P3147, DOI 10.1016/j.chroma.2009.01.095; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Miller MA, 2010, VET RES, V41, DOI 10.1051/vetres/2009049; Miller WA, 2006, MICROB ECOL, V52, P198, DOI 10.1007/s00248-006-9080-6; Moisander PH, 2009, HARMFUL ALGAE, V8, P889, DOI 10.1016/j.hal.2009.04.005; Moisander PH, 2009, AQUAT MICROB ECOL, V57, P19, DOI 10.3354/ame01320; Nasri H, 2008, ECOTOX ENVIRON SAFE, V71, P535, DOI 10.1016/j.ecoenv.2007.12.009; O'Connor TP, 2006, MAR ENVIRON RES, V62, P261, DOI 10.1016/j.marenvres.2006.04.067; Oudra B, 2001, TOXICON, V39, P1375, DOI 10.1016/S0041-0101(01)00093-9; Ozawa K, 2003, LIMNOLOGY, V4, P131, DOI 10.1007/s10201-003-0106-1; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; REINIKAINEN M, 1994, LIMNOL OCEANOGR, V39, P424, DOI 10.4319/lo.1994.39.2.0424; Richardson LL, 2007, FEMS MICROBIOL LETT, V272, P182, DOI 10.1111/j.1574-6968.2007.00751.x; Robson BJ, 2003, MAR FRESHWATER RES, V54, P139, DOI 10.1071/MF02090; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Tonk L, 2007, AQUAT MICROB ECOL, V46, P117, DOI 10.3354/ame046117; TSUJI K, 1994, ENVIRON SCI TECHNOL, V28, P173, DOI 10.1021/es00050a024; Vasconcelos V, 2001, TOXICON, V39, P1461, DOI 10.1016/S0041-0101(01)00105-2; Vasconcelos VM, 1999, BRAZ J MED BIOL RES, V32, P249, DOI 10.1590/S0100-879X1999000300001; Welker M, 2000, ENVIRON SCI TECHNOL, V34, P3415, DOI 10.1021/es991274t; *WHO, 1996, CYAN TOX MICR LR DRI; Williams DE, 1997, TOXICON, V35, P1617, DOI 10.1016/S0041-0101(97)00039-1; *YUR TRIB ENV PROG, FETCH K FIN 2007 KLA; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077; Zimba PV, 2006, AQUACULTURE, V261, P1048, DOI 10.1016/j.aquaculture.2006.08.037	62	220	227	1	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12576	10.1371/journal.pone.0012576	http://dx.doi.org/10.1371/journal.pone.0012576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844747	Green Published, gold			2022-12-25	WOS:000281687300002
J	De Vooght, V; Vanoirbeek, JAJ; Luyts, K; Haenen, S; Nemery, B; Hoet, PHM				De Vooght, Vanessa; Vanoirbeek, Jeroen A. J.; Luyts, Katrien; Haenen, Steven; Nemery, Benoit; Hoet, Peter H. M.			Choice of Mouse Strain Influences the Outcome in a Mouse Model of Chemical-Induced Asthma	PLOS ONE			English	Article							TOLUENE DIISOCYANATE; OCCUPATIONAL ASTHMA; AIRWAY HYPERRESPONSIVENESS; IMMUNOLOGICAL DETERMINANTS; DERMAL SENSITIZATION; MURINE MODEL; MICE; RESPONSES; INFLAMMATION; DISEASE	Background: The development of occupational asthma is the result of interactions between environmental factors and individual susceptibility. We assessed how our model of chemical-induced asthma is influenced by using different mouse strains. Methodology/Principal Findings: On days 1 and 8, male mice of 7 different strains (BALB/c, BP/2, A/J, C57Bl/6, DBA/2, CBA and AKR) were dermally treated with toluene-2,4-diisocyanate (TDI) (0.3%) or vehicle (acetone/olive oil, AOO, 2: 3) on each ear (20 mu l). On day 15, they received an oropharyngeal instillation of TDI (0.01%) or AOO (1: 4). Airway reactivity to methacholine, total and differential cell counts in bronchoalveolar lavage (BAL) and total serum IgE and IgG(2a) levels were measured. Lymphocyte subpopulations in auricular lymph nodes and in vitro release of cytokines by ConA stimulated lymphocytes were assessed. In TDI-sensitized and challenged mice, airway hyper-reactivity was only observed in BALB/c, BP/2, A/J and AKR mice; airway inflammation was most pronounced in BALB/c mice; numbers of T-helper (CD4(+)), T-activated (CD4(+) CD25(+)), T-cytotoxic (CD8(+)) and B-lymphocytes (CD19(+)) were increased in the auricular lymph nodes of BALB/c, BP/2, A/J and CBA mice; elevated concentrations of IL-4, IL-10, IL-13 and IFN-gamma were detected in supernatant of lymphocytes from BALB/c, BP/2, A/J, C57Bl/6 and CBA mice cultured with concanavaline A, along with an increase in total serum IgE. Conclusion: The used mouse strain has considerable and variable impacts on different aspects of the asthma phenotype. The human phenotypical characteristics of chemically-induced occupational asthma were best reproduced in Th2-biased mice and in particular in BALB/c mice.	[De Vooght, Vanessa; Vanoirbeek, Jeroen A. J.; Luyts, Katrien; Haenen, Steven; Nemery, Benoit; Hoet, Peter H. M.] Katholieke Univ Leuven, Res Unit Lung Toxicol, Louvain, Belgium	KU Leuven	De Vooght, V (corresponding author), Katholieke Univ Leuven, Res Unit Lung Toxicol, Louvain, Belgium.	peter.hoet@med.kuleuven.be	Hoet, Peter/H-9987-2013; Nemery, Benoit/N-3155-2019; Nemery, Benoit/D-1224-2013; Vanoirbeek, Jeroen/D-5183-2016	Hoet, Peter/0000-0002-0292-6603; Nemery, Benoit/0000-0003-0571-4689; Vanoirbeek, Jeroen/0000-0001-5508-3518	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [FWO G.0547.08]; Belgian Science Policy [P6/35]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Belgian Science Policy(Belgian Federal Science Policy Office)	The project was supported by a grant of the Interuniversity Attraction Pole Program, Belgian State, Belgian Science Policy P6/35 and from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), FWO G.0547.08. J.V. is a post-doctoral fellow of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Qadi-Nassar B, 2007, FUND CLIN PHARMACOL, V21, P611, DOI 10.1111/j.1472-8206.2007.00523.x; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; CHANYEUNG M, 1995, NEW ENGL J MED, V333, P107, DOI 10.1056/NEJM199507133330207; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Dallas M, 2009, J ALLERGY CLIN IMMUN, V124, pS72; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Fukunaga J, 2007, INT IMMUNOPHARMACOL, V7, P1852, DOI 10.1016/j.intimp.2007.07.010; Hadeiba H, 2000, J IMMUNOL, V164, P4933, DOI 10.4049/jimmunol.164.9.4933; Herrick CA, 2003, J ALLERGY CLIN IMMUN, V111, P1087, DOI 10.1067/mai.2003.1413; Jones MG, 2006, J ALLERGY CLIN IMMUN, V117, P663, DOI 10.1016/j.jaci.2005.09.053; Liu Q, 2003, ANN ALLERG ASTHMA IM, V90, P35, DOI 10.1016/S1081-1206(10)61647-X; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Matheson JM, 2005, TOXICOL SCI, V84, P88, DOI 10.1093/toxsci/kfi050; Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003; Tankersley CG, 1999, J APPL PHYSIOL, V86, P1764, DOI 10.1152/jappl.1999.86.6.1764; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Tumes DJ, 2007, J LEUKOCYTE BIOL, V81, P1362, DOI 10.1189/jlb.0106046; Van Hove CL, 2009, INT ARCH ALLERGY IMM, V149, P195, DOI 10.1159/000199715; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vanoirbeek JAJ, 2009, TOXICOLOGY, V257, P144, DOI 10.1016/j.tox.2008.12.020; Vogelsang P, 2009, SCAND J IMMUNOL, V70, P541, DOI 10.1111/j.1365-3083.2009.02327.x; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Willis-Owen SAG, 2009, J ALLERGY CLIN IMMUN, V123, P14, DOI 10.1016/j.jaci.2008.09.016; WillsKarp M, 1997, AM J RESP CRIT CARE, V156, pS89, DOI 10.1164/ajrccm.156.4.12-tac-3; Zhu WY, 2009, IMMUNOGENETICS, V61, P199, DOI 10.1007/s00251-008-0353-8	31	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12581	10.1371/journal.pone.0012581	http://dx.doi.org/10.1371/journal.pone.0012581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830207	Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300013
J	Kochzius, M; Seidel, C; Antoniou, A; Botla, SK; Campo, D; Cariani, A; Vazquez, EG; Hauschild, J; Hervet, C; Hjorleifsdottir, S; Hreggvidsson, G; Kappel, K; Landi, M; Magoulas, A; Marteinsson, V; Nolte, M; Planes, S; Tinti, F; Turan, C; Venugopal, MN; Weber, H; Blohm, D				Kochzius, Marc; Seidel, Christian; Antoniou, Aglaia; Botla, Sandeep Kumar; Campo, Daniel; Cariani, Alessia; Garcia Vazquez, Eva; Hauschild, Janet; Hervet, Caroline; Hjorleifsdottir, Sigridur; Hreggvidsson, Gudmundur; Kappel, Kristina; Landi, Monica; Magoulas, Antonios; Marteinsson, Viggo; Noelte, Manfred; Planes, Serge; Tinti, Fausto; Turan, Cemal; Venugopal, Moleyur N.; Weber, Hannes; Blohm, Dietmar			Identifying Fishes through DNA Barcodes and Microarrays	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MOLECULAR-IDENTIFICATION; GENETIC IDENTIFICATION; CYTOCHROME-B; HYBRIDIZATION; POSITION; REVEALS; PCR; DIFFERENTIATION; DISCRIMINATION	Background: International fish trade reached an import value of 62.8 billion Euro in 2006, of which 44.6% are covered by the European Union. Species identification is a key problem throughout the life cycle of fishes: from eggs and larvae to adults in fisheries research and control, as well as processed fish products in consumer protection. Methodology/Principal Findings: This study aims to evaluate the applicability of the three mitochondrial genes 16S rRNA (16S), cytochrome b (cyt b), and cytochrome oxidase subunit I (COI) for the identification of 50 European marine fish species by combining techniques of "DNA barcoding'' and microarrays. In a DNA barcoding approach, neighbour Joining (NJ) phylogenetic trees of 369 16S, 212 cyt b, and 447 COI sequences indicated that cyt b and COI are suitable for unambiguous identification, whereas 16S failed to discriminate closely related flatfish and gurnard species. In course of probe design for DNA microarray development, each of the markers yielded a high number of potentially species-specific probes in silico, although many of them were rejected based on microarray hybridisation experiments. None of the markers provided probes to discriminate the sibling flatfish and gurnard species. However, since 16S-probes were less negatively influenced by the "position of label'' effect and showed the lowest rejection rate and the highest mean signal intensity, 16S is more suitable for DNA microarray probe design than cty b and COI. The large portion of rejected COI-probes after hybridisation experiments (>90%) renders the DNA barcoding marker as rather unsuitable for this high-throughput technology. Conclusions/Significance: Based on these data, a DNA microarray containing 64 functional oligonucleotide probes for the identification of 30 out of the 50 fish species investigated was developed. It represents the next step towards an automated and easy-to-handle method to identify fish, ichthyoplankton, and fish products.	[Kochzius, Marc; Seidel, Christian; Botla, Sandeep Kumar; Hauschild, Janet; Kappel, Kristina; Weber, Hannes; Blohm, Dietmar] Univ Bremen, Ctr Appl Gene Sensor Technol CAG, FB2 UFT, Bremen, Germany; [Kochzius, Marc] Free Univ Brussels VUB, Brussels, Belgium; [Antoniou, Aglaia; Magoulas, Antonios] Hellen Ctr Marine Res, Inst Marine Biol & Genet, Iraklion, Crete, Greece; [Campo, Daniel; Garcia Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Cariani, Alessia; Landi, Monica; Tinti, Fausto] Univ Bologna, Dept Expt Evolutionary Biol, Bologna, Italy; [Hervet, Caroline; Planes, Serge] Univ Perpignan, CNRS, EPHE, UPVD,UMR 5244, F-66025 Perpignan, France; [Hjorleifsdottir, Sigridur; Hreggvidsson, Gudmundur; Marteinsson, Viggo] Prokaria, Matis Ohf, Reykjavik, Iceland; [Hreggvidsson, Gudmundur] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Noelte, Manfred] Univ Bremen, Zentrum Technomath ZeTeM, Bremen, Germany; [Turan, Cemal] Mustafa Kemal Univ, Fac Fisheries, Iskenderun, Hatay, Turkey; [Venugopal, Moleyur N.] Univ Agr Sci Mangalore, Coll Fisheries, Mangalore 575002, Karnataka, India	University of Bremen; Vrije Universiteit Brussel; Hellenic Centre for Marine Research; University of Oviedo; University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Iceland; University of Bremen; Mustafa Kemal University; College of Fisheries, Mangalore; University of Agricultural Sciences Bangalore	Kochzius, M (corresponding author), Univ Bremen, Ctr Appl Gene Sensor Technol CAG, FB2 UFT, Bremen, Germany.	marc.kochzius@vub.ac.be	PLANES, Serge/ABF-1360-2021; Landi, Monica/J-3611-2012; Turan, Cemal/Q-7638-2019; Kochzius, Marc/AAN-3799-2021; Cariani, Alessia/L-3459-2016; Tinti, Fausto/D-4847-2012	Landi, Monica/0000-0003-2180-5062; Turan, Cemal/0000-0001-9584-0261; Cariani, Alessia/0000-0002-5513-0086; Tinti, Fausto/0000-0002-8649-5387; Antoniou, Aglaia (Cilia)/0000-0003-1119-9820; Marteinsson, Viggo/0000-0001-8340-821X; Kochzius, Marc/0000-0001-8953-4719; Nolte, Manfred/0000-0002-8029-4162; Botla, Sandeep/0000-0001-9937-0455; Hreggvidsson, Gudmundur Oli/0000-0002-4958-1673	European Commission [505491]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The research project "Fish & Chips (Towards DNA chip technology as a standard analytical tool for the identification of marine organisms in biodiversity and ecosystem research)'' (www.fish-and-chips.uni-bremen.de) was funded by the European Commission in the Framework of the 6th Framework Programme (http://ec.europa.eu/research/fp6/index_en.cfm) under the contract no. 505491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto S, 2002, FISHERIES SCI, V68, P1242, DOI 10.1046/j.1444-2906.2002.00561.x; Aoyama J, 1999, MAR ECOL PROG SER, V188, P193, DOI 10.3354/meps188193; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Branham WS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-8; Chen W, 2009, MOL ECOL RESOUR, V9, P114, DOI 10.1111/j.1755-0998.2009.02638.x; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Ducree J., 2000, Proceedings IEEE Thirteenth Annual International Conference on Micro Electro Mechanical Systems (Cat. No.00CH36308), P317, DOI 10.1109/MEMSYS.2000.838536; Espineira M, 2008, J AGR FOOD CHEM, V56, P8954, DOI 10.1021/jf800570r; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fox CJ, 2005, MOL ECOL, V14, P879, DOI 10.1111/j.1365-294X.2005.02439.x; Greig TW, 2005, FISH B-NOAA, V103, P516; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoelzel AR, 2001, CONSERV GENET, V2, P69, DOI 10.1023/A:1011590517389; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hutchison CA, 2007, NUCLEIC ACIDS RES, V35, P6227, DOI 10.1093/nar/gkm688; Jerome M, 2008, J AGR FOOD CHEM, V56, P3460, DOI 10.1021/jf703704m; Kijewska A, 2009, ICES J MAR SCI, V66, P902, DOI 10.1093/icesjms/fsp110; Kochzius M, 2008, MAR BIOTECHNOL, V10, P207, DOI 10.1007/s10126-007-9068-3; Kochzius M, 2003, MOL PHYLOGENET EVOL, V28, P396, DOI 10.1016/S1055-7903(02)00444-X; Kochzius M, 2009, FISH FISH SER, V31, P453, DOI 10.1007/978-1-4020-9210-7_24; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lemer S, 2007, CR BIOL, V330, P86, DOI 10.1016/j.crvi.2006.09.002; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; De Astarloa JMD, 2008, ZOOTAXA, P35, DOI 10.11646/zootaxa.1921.1.3; MCCLURE MR, 1992, COPEIA, P1039, DOI 10.2307/1446635; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moura T, 2008, MAR FRESHWATER RES, V59, P214, DOI 10.1071/MF07192; NOLTE M, 2002, THESIS U BREMEN GERM; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Peytavi R, 2005, BIOTECHNIQUES, V39, P89, DOI 10.2144/05391RR01; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Quinteiro J, 1998, J AGR FOOD CHEM, V46, P1662, DOI 10.1021/jf970552+; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richardson DE, 2007, MOL ECOL NOTES, V7, P199, DOI 10.1111/j.1471-8286.2006.01620.x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rocha-Olivares A, 2000, FISH B-NOAA, V98, P353; Ronning SB, 2005, J AGR FOOD CHEM, V53, P8874, DOI 10.1021/jf0514569; Santaclara FJ, 2006, EUR FOOD RES TECHNOL, V223, P609, DOI 10.1007/s00217-005-0241-5; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Smith PJ, 2008, J FISH BIOL, V73, P1170, DOI 10.1111/j.1095-8649.2008.01957.x; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Sotelo CG, 2001, J AGR FOOD CHEM, V49, P4562, DOI 10.1021/jf010452a; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Teletchea F, 2008, J APPL ECOL, V45, P967, DOI 10.1111/j.1365-2664.2007.01415.x; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timm J, 2008, MOL PHYLOGENET EVOL, V49, P268, DOI 10.1016/j.ympev.2008.04.024; Tobler NE, 2006, J MICROBIOL METH, V66, P116, DOI 10.1016/j.mimet.2005.10.016; TODT S, 2005, THESIS U BREMEN; *UN FAO, 2009, STAT WORLD FISH AQ; Ward RD, 2008, J FISH BIOL, V72, P458, DOI 10.1111/j.1095-8649.2007.01703.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Warsen AE, 2004, APPL ENVIRON MICROB, V70, P4216, DOI 10.1128/AEM.70.7.4216-4221.2004; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Yancy HF, 2008, J FOOD PROTECT, V71, P210, DOI 10.4315/0362-028X-71.1.210; Yoon HK, 2009, BIOCHIP J, V3, P87; Yoon HK, 2008, BIOCHIP J, V2, P287; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zhang L, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni156	74	122	135	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12620	10.1371/journal.pone.0012620	http://dx.doi.org/10.1371/journal.pone.0012620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838643	Green Published, gold			2022-12-25	WOS:000281631300040
J	Van der Auwera, I; Yu, W; Suo, LP; Van Neste, L; van Dam, P; van Marck, EA; Pauwels, P; Vermeulen, PB; Dirix, LY; Van Laere, SJ				Van der Auwera, Ilse; Yu, Wayne; Suo, Liping; Van Neste, Leander; van Dam, Peter; van Marck, Eric A.; Pauwels, Patrick; Vermeulen, Peter B.; Dirix, Luc Y.; Van Laere, Steven J.			Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; HORMONE-RECEPTOR STATUS; TUMOR-SUPPRESSOR GENES; ABERRANT METHYLATION; COLORECTAL-CANCER; POOR-PROGNOSIS; PROMOTER HYPERMETHYLATION; UNFAVORABLE PROGNOSIS; MULTIPLE GENES; EXPRESSION	Background: Abnormal DNA methylation is well established for breast cancer and contributes to its progression by silencing tumor suppressor genes. DNA methylation profiling platforms might provide an alternative approach to expression microarrays for accurate breast tumor subtyping. We sought to determine whether the distinction of the inflammatory breast cancer (IBC) phenotype from the non-IBC phenotype by transcriptomics could be sustained by methylomics. Methodology/Principal Findings: We performed methylation profiling on a cohort of IBC (N = 19) and non-IBC (N = 43) samples using the Illumina Infinium Methylation Assay. These results were correlated with gene expression profiles. Methylation values allowed separation of breast tumor samples into high and low methylation groups. This separation was significantly related to DNMT3B mRNA levels. The high methylation group was enriched for breast tumor samples from patients with distant metastasis and poor prognosis, as predicted by the 70-gene prognostic signature. Furthermore, this tumor group tended to be enriched for IBC samples (54% vs. 24%) and samples with a high genomic grade index (67% vs. 38%). A set of 16 CpG loci (14 genes) correctly classified 97% of samples into the low or high methylation group. Differentially methylated genes appeared to be mainly related to focal adhesion, cytokine-cytokine receptor interactions, Wnt signaling pathway, chemokine signaling pathways and metabolic processes. Comparison of IBC with non-IBC led to the identification of only four differentially methylated genes (TJP3, MOGAT2, NTSR2 and AGT). A significant correlation between methylation values and gene expression was shown for 4,981 of 6,605 (75%) genes. Conclusions/Significance: A subset of clinical samples of breast cancer was characterized by high methylation levels, which coincided with increased DNMT3B expression. Furthermore, an association was observed with molecular signatures indicative of poor patient prognosis. The results of the current study also suggest that aberrant DNA methylation is not the main force driving the molecular biology of IBC.	[Van der Auwera, Ilse; van Dam, Peter; van Marck, Eric A.; Pauwels, Patrick; Vermeulen, Peter B.; Dirix, Luc Y.; Van Laere, Steven J.] Univ Antwerp, Pathol Lab, Translat Canc Res Grp, Univ Antwerp Hosp,Oncol Ctr, B-2020 Antwerp, Belgium; [Yu, Wayne; Suo, Liping] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, DNA Microarray Core, Baltimore, MD USA; [Van Neste, Leander] Oncomethylome Sci SA, Liege, Belgium	University of Antwerp; Johns Hopkins University	Van der Auwera, I (corresponding author), Univ Antwerp, Pathol Lab, Translat Canc Res Grp, Univ Antwerp Hosp,Oncol Ctr, B-2020 Antwerp, Belgium.	steven.vanlaere@gza.be	Van Laere, Steven/GQA-8872-2022; Dirix, Luc/AAI-8880-2020	Van Laere, Steven/0000-0002-2640-0040; 	Fund for Scientific Research Flanders [G.0473.08]	Fund for Scientific Research Flanders(FWO)	This work was supported by the Fund for Scientific Research Flanders (G.0473.08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, CANCER RES, V65, P828; Bae YK, 2004, CLIN CANCER RES, V10, P5998, DOI 10.1158/1078-0432.CCR-04-0667; Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bouquet C, 2006, MOL THER, V14, P175, DOI 10.1016/j.ymthe.2006.01.017; Colpaert CG, 2003, BRIT J CANCER, V88, P718, DOI 10.1038/sj.bjc.6600807; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Eads CA, 2000, CANCER RES, V60, P5021; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; JAIYESIMI IA, 1992, J CLIN ONCOL, V10, P1014, DOI 10.1200/JCO.1992.10.6.1014; Kaneko Y, 2003, GUT, V52, P641, DOI 10.1136/gut.52.5.641; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; LI B, 2010, ANN SURG ONCOL, V17, P790; Li SY, 2006, CANCER LETT, V237, P272, DOI 10.1016/j.canlet.2005.06.011; Liang G, 1998, GENOMICS, V53, P260, DOI 10.1006/geno.1998.5502; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Melki JR, 1999, CANCER RES, V59, P3730; Moody TW, 2003, CURR PHARM DESIGN, V9, P495, DOI 10.2174/1381612033391621; Mori K, 2009, INT J ONCOL, V34, P1593, DOI 10.3892/ijo_00000289; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Sakuma M, 2007, CANCER SCI, V98, P380, DOI 10.1111/j.1349-7006.2007.00394.x; Sato H, 2010, AM J PATHOL, V176, P402, DOI 10.2353/ajpath.2010.090236; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Strathdee G, 2001, AM J PATHOL, V158, P1121, DOI 10.1016/S0002-9440(10)64059-X; Sunami E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2098; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P5438; Ueki T, 2000, CANCER RES, V60, P1835; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Van der Auwera I, 2009, CANCER BIOL THER, V8, P2252; Van Laere S, 2007, BRIT J CANCER, V97, P1165, DOI 10.1038/sj.bjc.6603967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; Vincent F, 2009, CANCER RES, V69, P2853, DOI 10.1158/0008-5472.CAN-08-2484; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yan PS, 2000, CLIN CANCER RES, V6, P1432; Zhou W, 2009, J CANCER RES CLIN, V135, P91, DOI 10.1007/s00432-008-0435-x	57	67	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12616	10.1371/journal.pone.0012616	http://dx.doi.org/10.1371/journal.pone.0012616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830311	gold, Green Published, Green Submitted			2022-12-25	WOS:000281631300036
J	Fernandez-Duque, E; de la Iglesia, H; Erkert, HG				Fernandez-Duque, Eduardo; de la Iglesia, Horacio; Erkert, Hans G.			Moonstruck Primates: Owl Monkeys (Aotus) Need Moonlight for Nocturnal Activity in Their Natural Environment	PLOS ONE			English	Article							LEMUR EULEMUR-FULVUS; CIRCADIAN PACEMAKERS; CATHEMERAL ACTIVITY; FUNCTIONAL-ANALYSIS; ACTIVITY RHYTHMS; NIGHT MONKEYS; ENTRAINMENT; AZARAI; GENES; GRISEIMEMBRA	Primates show activity patterns ranging from nocturnality to diurnality, with a few species showing activity both during day and night. Among anthropoids (monkeys, apes and humans), nocturnality is only present in the Central and South American owl monkey genus Aotus. Unlike other tropical Aotus species, the Azara's owl monkeys (A. azarai) of the subtropics have switched their activity pattern from strict nocturnality to one that also includes regular diurnal activity. Harsher climate, food availability, and the lack of predators or diurnal competitors, have all been proposed as factors favoring evolutionary switches in primate activity patterns. However, the observational nature of most field studies has limited an understanding of the mechanisms responsible for this switch in activity patterns. The goal of our study was to evaluate the hypothesis that masking, namely the stimulatory and/or inhibitory/disinhibitory effects of environmental factors on synchronized circadian locomotor activity, is a key determinant of the unusual activity pattern of Azara's owl monkeys. We use continuous long-term (6-18 months) 5-min-binned activity records obtained with actimeter collars fitted to wild owl monkeys (n = 10 individuals) to show that this different pattern results from strong masking of activity by the inhibiting and enhancing effects of ambient luminance and temperature. Conclusive evidence for the direct masking effect of light is provided by data showing that locomotor activity was almost completely inhibited when moonlight was shadowed during three lunar eclipses. Temperature also negatively masked locomotor activity, and this masking was manifested even under optimal light conditions. Our results highlight the importance of the masking of circadian rhythmicity as a determinant of nocturnality in wild owl monkeys and suggest that the stimulatory effects of dim light in nocturnal primates may have been selected as an adaptive response to moonlight. Furthermore, our data indicate that changes in sensitivity to specific environmental stimuli may have been an essential key for evolutionary switches between diurnal and nocturnal habits in primates.	[Fernandez-Duque, Eduardo] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Fernandez-Duque, Eduardo] CECOAL Conicet, Corrientes, Argentina; [de la Iglesia, Horacio] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Erkert, Hans G.] Univ Tubingen, Dept Zool, Tubingen, Germany	University of Pennsylvania; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle; Eberhard Karls University of Tubingen	Fernandez-Duque, E (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	eduardof@sas.upenn.edu			Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society; National Science Foundation [BCS-0621020]; Zoological Society of San Diego; CONICET of Argentina [PIP0051-98]; University of Pennsylvania; Deutsche Forschungsgemeinschaft [SFB 307-C5]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [R01IP000051] Funding Source: NIH RePORTER	Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Zoological Society of San Diego; CONICET of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Pennsylvania; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	EFD received financial support from the Wenner-Gren Foundation, the L.S.B. Leakey Foundation, the National Geographic Society, the National Science Foundation (BCS-0621020), the Zoological Society of San Diego, the CONICET of Argentina (PIP0051-98) and the University of Pennsylvania. Grants from the Deutsche Forschungsgemeinschaft to HGE (SFB 307-C5) and technical support from the Institute for Zoology of the Tubingen University, Germany, enabled the activity recordings in the field. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankel-Simons F, 2008, YEARB PHYS ANTHROPOL, V51, P100, DOI 10.1002/ajpa.20957; Brandt MJ, 2007, ACTA THERIOL, V52, P13, DOI 10.1007/BF03194195; Brandt MJ, 2005, ACTA THERIOL, V50, P67, DOI 10.1007/BF03192620; CHIESA JJ, J BIOL RHYT IN PRESS; Colquhoun IC, 2007, DEV PRIMATOL-PROG PR, P146, DOI 10.1007/978-0-387-34810-0_7; Colquhoun IC, 1998, FOLIA PRIMATOL, V69, P22; Curtis DJ, 2006, FOLIA PRIMATOL, V77, P178, DOI 10.1159/000089703; Curtis DJ, 1999, AM J PRIMATOL, V47, P279, DOI 10.1002/(SICI)1098-2345(1999)47:4<279::AID-AJP2>3.0.CO;2-U; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Donati G, 2001, AM J PRIMATOL, V53, P69, DOI 10.1002/1098-2345(200102)53:2<69::AID-AJP2>3.0.CO;2-R; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; Erkert HG, 2008, BIOL RHYTHM RES, V39, P229, DOI 10.1080/09291010701683391; Erkert HG, 2006, FOLIA PRIMATOL, V77, P87, DOI 10.1159/000089697; ERKERT HG, 1986, FOLIA PRIMATOL, V47, P171, DOI 10.1159/000156276; ERKERT HG, 1983, COMP BIOCHEM PHYS A, V74, P307, DOI 10.1016/0300-9629(83)90605-9; ERKERT HG, 1976, FOLIA PRIMATOL, V25, P186, DOI 10.1159/000155712; ERKERT HG, 1974, OECOLOGIA, V14, P269, DOI 10.1007/BF01039797; Fernandez-Duque E, 2006, FOLIA PRIMATOL, V77, P123, DOI 10.1159/000089699; Fernandez-Duque E, 2003, INT J PRIMATOL, V24, P1113, DOI 10.1023/A:1026284430453; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fernandez-Duque E, 2009, BEHAVIOUR, V146, P583, DOI 10.1163/156853908X397925; Fernandez-Duque E, 2001, AM J PRIMATOL, V53, P99, DOI 10.1002/1098-2345(200103)53:3<99::AID-AJP1>3.0.CO;2-N; Fernandez-Duque E., 2007, PRIMATES PERSPECTIVE, P139; Gursky S, 2003, INT J PRIMATOL, V24, P351, DOI 10.1023/A:1023053301059; Halle S., 2000, ACTIVITY PATTERNS SM; Jacobs GH, 1996, P ROY SOC B-BIOL SCI, V263, P705, DOI 10.1098/rspb.1996.0105; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kappeler PM, 2003, BEHAV ECOL SOCIOBIOL, V54, P359, DOI 10.1007/s00265-003-0652-x; Levenson DH, 2007, AM J PRIMATOL, V69, P757, DOI 10.1002/ajp.20402; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P1; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nash L.T., 1986, P357; Nash LT, 2007, DEV PRIMATOL-PROG PR, P173, DOI 10.1007/978-0-387-34810-0_8; Overdorff DJ, 1995, CREATURES OF THE DARK, P61; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; RAUTHWIDMANN B, 1991, CHRONOBIOL INT, V8, P251, DOI 10.3109/07420529109063930; Tan Y, 2005, P NATL ACAD SCI USA, V102, P14712, DOI 10.1073/pnas.0507042102; Tarnaud L, 2006, FOLIA PRIMATOL, V77, P166, DOI 10.1159/000089702; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; WRIGHT PC, 1989, J HUM EVOL, V18, P635, DOI 10.1016/0047-2484(89)90098-5; Zielinski WJ, 2000, ECOL STU AN, V141, P95	45	73	74	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12572	10.1371/journal.pone.0012572	http://dx.doi.org/10.1371/journal.pone.0012572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838447	Green Published, gold			2022-12-25	WOS:000281627700019
J	Xue, MS; Craig, TK; Shin, OH; Li, LY; Brautigam, CA; Tomchick, DR; Sudhof, TC; Rosenmund, C; Rizo, J				Xue, Mingshan; Craig, Timothy K.; Shin, Ok-Ho; Li, Liyi; Brautigam, Chad A.; Tomchick, Diana R.; Suedhof, Thomas C.; Rosenmund, Christian; Rizo, Josep			Structural and Mutational Analysis of Functional Differentiation between Synaptotagmins-1 and-7	PLOS ONE			English	Article							C2B DOMAIN; PHOSPHOLIPID-BINDING; C(2)A DOMAIN; CA2+ BINDING; NEUROTRANSMITTER RELEASE; CONFORMATIONAL SWITCH; GENETIC-ANALYSIS; SINGLE-MOLECULE; MEMBRANE-FUSION; SNARE FUNCTION	Synaptotagmins are known to mediate diverse forms of Ca 2+-triggered exocytosis through their C2 domains, but the principles underlying functional differentiation among them are unclear. Synaptotagmin-1 functions as a Ca 2+ sensor in neurotransmitter release at central nervous system synapses, but synaptotagmin-7 does not, and yet both isoforms act as Ca 2+ sensors in chromaffin cells. To shed light into this apparent paradox, we have performed rescue experiments in neurons from synaptotagmin-1 knockout mice using a chimera that contains the synaptotagmin-1 sequence with its C2B domain replaced by the synaptotagmin-7 C2B domain (Syt1/7). Rescue was not achieved either with the WT Syt1/7 chimera or with nine mutants where residues that are distinct in synaptotagmin-7 were restored to those present in synaptotagmin1. To investigate whether these results arise because of unique conformational features of the synaptotagmin-7 C2B domain, we determined its crystal structure at 1.44 A resolution. The synaptotagmin-7 C2B domain structure is very similar to that of the synaptotagmin-1 C2B domain and contains three Ca 2+-binding sites. Two of the Ca 2+-binding sites of the synaptotagmin-7 C2B domain are also present in the synaptotagmin-1 C2B domain and have analogous ligands to those determined for the latter by NMR spectroscopy, suggesting that a discrepancy observed in a crystal structure of the synaptotagmin-1 C2B domain arose from crystal contacts. Overall, our results suggest that functional differentiation in synaptotagmins arises in part from subtle sequence changes that yield dramatic functional differences.	[Xue, Mingshan; Li, Liyi; Rosenmund, Christian] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; [Craig, Timothy K.; Brautigam, Chad A.; Tomchick, Diana R.; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Craig, Timothy K.; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Shin, Ok-Ho] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Li, Liyi; Rosenmund, Christian] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenmund, Christian] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany	Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; Howard Hughes Medical Institute; Stanford University; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Xue, MS (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	christian.rosenmund@charite.de; jose@arnie.swmed.edu	Tomchick, Diana/HGV-2018-2022; Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Tomchick, Diana/0000-0002-7529-4643; Xue, Mingshan/0000-0003-1463-8884; Brautigam, Chad/0000-0001-6563-1338; Craig, Timothy/0000-0002-4625-444X	Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center; Welch Foundation [I-1304]; National Institutes of Health [NS50655, NS40944]; German Research Council [DFG Exc 257]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944, R01NS050655] Funding Source: NIH RePORTER	Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center; Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center, by a grant from the Welch Foundation (I-1304), by National Institutes of Health grants NS50655 (to CR) and NS40944 (to JR), and by the German Research Council grant DFG Exc 257 (CR). URLs: http://mrrc.bcm.tmc.edu/index.html, http://www.welch1.org,http://www.nih.gov/and http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 2008, ANN REV BIOCH; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Corbalan-Garcia S, 2010, BIOFACTORS, V36, P1, DOI 10.1002/biof.68; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; DE WH, 2009, CELL, V138, P935; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu J, 2006, PLOS BIOL, V4, P1159, DOI 10.1371/journal.pbio.0040192; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	63	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12544	10.1371/journal.pone.0012544	http://dx.doi.org/10.1371/journal.pone.0012544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824061	Green Submitted, gold, Green Published			2022-12-25	WOS:000281480900025
J	Zhao, SL; Zhou, Y; Gross, J; Miao, P; Qiu, L; Wang, DQ; Chen, QA; Feng, GP				Zhao, Shengli; Zhou, Yang; Gross, Jimmy; Miao, Pei; Qiu, Li; Wang, Dongqing; Chen, Qian; Feng, Guoping			Fluorescent Labeling of Newborn Dentate Granule Cells in GAD67-GFP Transgenic Mice: A Genetic Tool for the Study of Adult Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; GLUTAMIC-ACID; FUNCTIONAL IMPLICATIONS; GABAERGIC PHENOTYPE; SUBVENTRICULAR ZONE; GYRUS; NEURONS	Neurogenesis in the adult hippocampus is an important form of structural plasticity in the brain. Here we report a line of BAC transgenic mice (GAD67-GFP mice) that selectively and transitorily express GFP in newborn dentate granule cells of the adult hippocampus. These GFP+ cells show a high degree of colocalization with BrdU-labeled nuclei one week after BrdU injection and express the newborn neuron marker doublecortin and PSA-NCAM. Compared to mature dentate granule cells, these newborn neurons show immature morphological features: dendritic beading, fewer dendritic branches and spines. These GFP+ newborn neurons also show immature electrophysiological properties: higher input resistance, more depolarized resting membrane potentials, small and non-typical action potentials. The bright labeling of newborn neurons with GFP makes it possible to visualize the details of dendrites, which reach the outer edge of the molecular layer, and their axon (mossy fiber) terminals, which project to the CA3 region where they form synaptic boutons. GFP expression covers the whole developmental stage of newborn neurons, beginning within the first week of cell division and disappearing as newborn neurons mature, about 4 weeks postmitotic. Thus, the GAD67-GFP transgenic mice provide a useful genetic tool for studying the development and regulation of newborn dentate granule cells.	[Zhao, Shengli; Gross, Jimmy; Miao, Pei; Qiu, Li; Wang, Dongqing; Chen, Qian; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Feng, Guoping] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Zhou, Yang] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhou, Yang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China	Duke University; Duke University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhao, SL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	feng@neuro.duke.edu	Feng, Guoping/Y-2827-2019		Arnold and Mabel Beckman Foundation	Arnold and Mabel Beckman Foundation	This work was supported by a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation (to G. F.; http://www.beckmanfoundation.com/), and a Broad Fellowship from the Ruth K. Broad Biomedical Research Foundation (to S.Z.; http://broadfoundation.som.duke.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Acsady L, 1998, J NEUROSCI, V18, P3386; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Beech RD, 2004, J COMP NEUROL, V475, P128, DOI 10.1002/cne.20179; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CRAWFORD IL, 1973, NATURE, V244, P442, DOI 10.1038/244442a0; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 2004, METH MOLEC MED, P255; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lehmann H, 1996, NEUROSCI LETT, V212, P41, DOI 10.1016/0304-3940(96)12777-4; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Maqueda J, 2003, NEUROSCI LETT, V353, P69, DOI 10.1016/j.neulet.2003.08.077; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizrahi A, 2006, P NATL ACAD SCI USA, V103, P1912, DOI 10.1073/pnas.0506297103; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3783, DOI 10.1113/jphysiol.2008.155879; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	65	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12506	10.1371/journal.pone.0012506	http://dx.doi.org/10.1371/journal.pone.0012506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824075	gold, Green Published, Green Submitted			2022-12-25	WOS:000281480900004
J	Vingtdeux, V; Chandakkar, P; Zhao, HT; d'Abramo, C; Davies, P; Marambaud, P				Vingtdeux, Valerie; Chandakkar, Pallavi; Zhao, Haitian; d'Abramo, Cristina; Davies, Peter; Marambaud, Philippe			Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation	FASEB JOURNAL			English	Article						Alzheimer's disease; mTOR; resveratrol; raptor; p62	PROTEIN-KINASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; RESVERATROL; MTOR; MECHANISMS; EXPRESSION; RAPAMYCIN; PATHWAY; CELLS	AMP-activated protein kinase (AMPK) is a metabolic sensor involved in intracellular energy metabolism through the control of several homeostatic mechanisms, which include autophagy and protein degradation. Recently, we reported that AMPK activation by resveratrol promotes autophagy-dependent degradation of the amyloid-beta (A beta) peptides, the core components of the cerebral senile plaques in Alzheimer's disease. To identify more potent enhancers of A beta degradation, we screened a library of synthetic small molecules selected for their structural similarities with resveratrol. Here, we report the identification of a series of structurally related molecules, the RSVA series, which inhibited A beta accumulation in cell lines nearly 40 times more potently than did resveratrol. Two of these molecules, RSVA314 and RSVA405, were further characterized and were found to facilitate CaMKK beta-dependent activation of AMPK, to inhibit mTOR (mammalian target of rapamycin), and to promote autophagy to increase A beta degradation by the lysosomal system (apparent EC50 similar to 1 mu M). This work identifies the RSVA compounds as promising lead molecules for the development of a new class of AMPK activating drugs controlling mTOR signaling, autophagy, and A beta clearance.-Vingtdeux, V., Chandakkar, P., Zhao, H., d'Abramo, C., Davies, P., Marambaud, P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J. 25, 219-231 (2011). www.fasebj.org	[Vingtdeux, Valerie; Chandakkar, Pallavi; Zhao, Haitian; d'Abramo, Cristina; Davies, Peter; Marambaud, Philippe] N Shore Long Isl Jewish Med Ctr, Litwin Zucker Res Ctr Study Alzheimers Dis, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Davies, Peter; Marambaud, Philippe] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Northwell Health; Yeshiva University; Albert Einstein College of Medicine	Marambaud, P (corresponding author), N Shore Long Isl Jewish Med Ctr, Litwin Zucker Res Ctr Study Alzheimers Dis, Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	philippe.marambaud@einstein.yu.edu	Vingtdeux, Valerie/C-2463-2012	Vingtdeux, Valerie/0000-0003-4550-503X; Marambaud, Philippe/0000-0002-8983-1497; Davies, Peter/0000-0002-8015-1997	Weill Medical College of Cornell University, New York, NY, USA [UL1-RR024996]; National Institutes of Health, National Center for Complementary and Alternative Medicine [PO1 AT004511]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG022102] Funding Source: NIH RePORTER	Weill Medical College of Cornell University, New York, NY, USA; National Institutes of Health, National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Gopal Thinakaran (University of Chicago, Chicago, IL, USA), Dr. Luciano D'Adamio (Albert Einstein College of Medicine, Bronx, NY, USA), Dr. Luc Buee (INSERM U815, Centre Jean Pierre Aubert, Lille, France), and Dr. David Carling (Medical Research Council Clinical Sciences Centre, Imperial College, London, UK) for kindly providing cell lines and cDNA. This work was supported in part by the Institutional Clinical and Translational Science Award UL1-RR024996 (Weill Medical College of Cornell University, New York, NY, USA; Clinical and Translational Science Center Pilot Award to P. M.) and National Institutes of Health grant PO1 AT004511 (National Center for Complementary and Alternative Medicine Project 2 to P. M.).	Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; She QB, 2001, CANCER RES, V61, P1604; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Sudarsanam S, 2010, CURR OPIN DRUG DISC, V13, P31; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Wang ZR, 2006, BIOCHEM BIOPH RES CO, V346, P367, DOI 10.1016/j.bbrc.2006.05.156; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao Haitian, 2008, BMC Res Notes, V1, P38, DOI 10.1186/1756-0500-1-38; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	60	177	189	0	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					219	231		10.1096/fj.10-167361	http://dx.doi.org/10.1096/fj.10-167361			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20852062	Green Published			2022-12-25	WOS:000285869500020
J	Moller, A; Pion, E; Narayan, V; Ball, KL				Moeller, Angeli; Pion, Emmanuelle; Narayan, Vikram; Ball, Kathryn L.			Intracellular Activation of Interferon Regulatory Factor-1 by Nanobodies to the Multifunctional (Mf1) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING FUNCTION; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR; GROWTH-INHIBITION; TERMINAL REGION; IRF-1; EXPRESSION; PROTEASOME; ANTIBODIES; UBIQUITIN	IRF-1 is a tumor suppressor protein that activates gene expression from a range of promoters in response to stimuli spanning viral infection to DNA damage. Studies on the post-translational regulation of IRF-1 have been hampered by a lack of suitable biochemical tools capable of targeting the endogenous protein. In this study, phage display technology was used to develop a monoclonal nanobody targeting the C-terminal Mf1 domain (residues 301-325) of IRF-1. Intracellular expression of the nanobody demonstrated that the transcriptional activity of IRF-1 is constrained by the Mf1 domain as nanobody binding gave an increase in expression from IRF-1-responsive promoters of up to 8-fold. Furthermore, Mf1-directed nanobodies have revealed an unexpected function for this domain in limiting the rate at which the IRF-1 protein is degraded. Thus, the increase in IRF-1 transcriptional activity observed on nanobody binding is accompanied by a significant reduction in the half-life of the protein. In support of the data obtained using nanobodies, a single point mutation (P325A) involving the C-terminal residue of IRF-1 has been identified, which results in greater transcriptional activity and a significant increase in the rate of degradation. The results presented here support a role for the Mf1 domain in limiting both IRF-1-dependent transcription and the rate of IRF-1 turnover. In addition, the data highlight a route for activation of downstream genes in the IRF-1 tumor suppressor pathway using biologics.	[Moeller, Angeli; Pion, Emmanuelle; Narayan, Vikram; Ball, Kathryn L.] Univ Edinburgh Canc Res UK Ctr, Cell Signalling Unit, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Ball, KL (corresponding author), Univ Edinburgh Canc Res UK Ctr, Cell Signalling Unit, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Narayan, Vikram/AAF-3964-2020	Moller, Angeli/0000-0003-0409-1221; Narayan, Vikram/0000-0002-6128-7944	Cancer Research UK [377/A6355]	Cancer Research UK(Cancer Research UK)	This work was supported by Programme Grant 377/A6355 (to K. L. B.) from Cancer Research UK.	Bai JR, 2003, J BIOL CHEM, V278, P1433, DOI 10.1074/jbc.M208297200; BEERLI RR, 1994, J BIOL CHEM, V269, P23931; Beretta L, 1996, ONCOGENE, V12, P1593; BOULTWOOD J, 1993, BLOOD, V82, P2611; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cohen PA, 1998, ONCOGENE, V17, P2445, DOI 10.1038/sj.onc.1202190; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Cossins AJ, 2007, PROTEIN EXPRES PURIF, V51, P253, DOI 10.1016/j.pep.2006.07.013; de Fromentel CC, 1999, ONCOGENE, V18, P551, DOI 10.1038/sj.onc.1202338; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Eckert M, 2006, J BIOL CHEM, V281, P23092, DOI 10.1074/jbc.M512589200; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gongora C, 2000, NUCLEIC ACIDS RES, V28, P2333, DOI 10.1093/nar/28.12.2333; Green WB, 1999, LEUKEMIA, V13, P1960, DOI 10.1038/sj.leu.2401596; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; KIRCHHOFF S, 1995, ONCOGENE, V11, P439; Kirchhoff S, 2000, EUR J BIOCHEM, V267, P6753, DOI 10.1046/j.1432-1327.2000.01750.x; Lee EJ, 2006, BIOCHEM BIOPH RES CO, V347, P882, DOI 10.1016/j.bbrc.2006.06.145; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Paz K, 2005, MOL CANCER THER, V4, P1801, DOI 10.1158/1535-7163.MCT-05-0174; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Riley CJ, 2009, CANCER RES, V69, P1933, DOI 10.1158/0008-5472.CAN-08-2707; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tellez C, 2004, METHODS, V34, P233, DOI 10.1016/j.ymeth.2004.03.016; Visintin M, 2008, J BIOTECHNOL, V135, P1, DOI 10.1016/j.jbiotec.2008.02.012; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Zhou P, 1998, J IMMUNOL, V160, P1489	54	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38348	38361		10.1074/jbc.M110.149476	http://dx.doi.org/10.1074/jbc.M110.149476			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20817723	hybrid, Green Published			2022-12-25	WOS:000284625600041
J	Huang, Y; Zhou, YB; Wong, HC; Castiblanco, A; Chen, YY; Brown, EM; Yang, JJ				Huang, Yun; Zhou, Yubin; Wong, Hing-Cheung; Castiblanco, Adriana; Chen, Yanyi; Brown, Edward M.; Yang, Jenny J.			Calmodulin Regulates Ca2+-sensing Receptor-mediated Ca2+ Signaling and Its Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING-RECEPTOR; RESIDUAL DIPOLAR COUPLINGS; PROTEIN-KINASE-C; EXTRACELLULAR CALCIUM; TARGET RECOGNITION; STRUCTURAL BASIS; BINDING DOMAIN; ACTIVATION; GLUTAMATE; PHOSPHORYLATION	The Ca2+-sensing receptor (CaSR) is a member of family C of the GPCRs responsible for sensing extracellular Ca2+ ([Ca2+](o)) levels, maintaining extracellular Ca2+ homeostasis, and transducing Ca2+ signaling from the extracellular milieu to the intracellular environment. In the present study, we have demonstrated a Ca2+-dependent, stoichiometric interaction between CaM and a CaM-binding domain (CaMBD) located within the C terminus of CaSR (residues 871-898). Our studies suggest a wrapping around 1-14-like mode of interaction that involves global conformational changes in both lobes of CaM with concomitant formation of a helical structure in the CaMBD. More importantly, the Ca2+-dependent association between CaM and the C terminus of CaSR is critical for maintaining proper responsiveness of intracellular Ca2+ responses to changes in extracellular Ca2+ and regulating cell surface expression of the receptor.	[Yang, Jenny J.] Georgia State Univ, Dept Chem, Ctr Drug Design & Adv Biotechnol, Atlanta, GA 30303 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Univ Plaza, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu	Chen, Yanyi/H-7096-2013; Zhou, Yubin/D-4748-2011	Chen, Yanyi/0000-0002-7755-0882; Zhou, Yubin/0000-0001-7962-0517; Huang, Yun/0000-0001-5950-9168	National Institutes of Health [GM62999-1, GM081749-01, DK078331]; National Science Foundation [MCB-0092486]; American Heart Association [0655168B]; Brain and Behavior Program at Georgia State University; Molecular Basis of Disease at Georgia State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999, R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Brain and Behavior Program at Georgia State University; Molecular Basis of Disease at Georgia State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62999-1 and GM081749-01 (to J. J. Y.) and DK078331 (to E. M. B.), National Science Foundation Grant MCB-0092486, American Heart Association Grant 0655168B (to J. J. Y.), a predoctoral fellowship from the Brain and Behavior Program at Georgia State University (to Y. H.), and a predoctoral fellowship from the Molecular Basis of Disease at Georgia State University (to Y. Z.).	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Bai M, 1997, J CLIN INVEST, V99, P1917, DOI 10.1172/JCI119359; Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chang WH, 2001, J BIOL CHEM, V276, P44129, DOI 10.1074/jbc.M104834200; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; Enz R, 2002, FEBS LETT, V514, P184, DOI 10.1016/S0014-5793(02)02361-X; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Huang Y, 2007, J BIOL CHEM, V282, P9517, DOI 10.1074/jbc.M609045200; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; IKURA M, 1992, CELL CALCIUM, V13, P391, DOI 10.1016/0143-4160(92)90052-T; Kubokawa K, 1996, FEBS LETT, V392, P71, DOI 10.1016/0014-5793(96)00786-7; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; Liu YZ, 2009, J MAGN RESON, V200, P109, DOI 10.1016/j.jmr.2009.06.010; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; ROTH SM, 1991, BIOCHEMISTRY-US, V30, P10078, DOI 10.1021/bi00106a003; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Valafar H., 2004, Journal of Structural and Functional Genomics, V5, P241, DOI 10.1007/s10969-004-4899-x; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye CP, 2000, BONE, V27, P21, DOI 10.1016/S8756-3282(00)00288-X; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941	43	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35919	35931		10.1074/jbc.M110.147918	http://dx.doi.org/10.1074/jbc.M110.147918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826781	Green Published, hybrid			2022-12-25	WOS:000283845300069
J	van Wieringen, T; Kalamajski, S; Liden, A; Bihan, D; Guss, B; Heinegard, D; Farndale, RW; Rubin, K				van Wieringen, Tijs; Kalamajski, Sebastian; Liden, Asa; Bihan, Dominique; Guss, Bengt; Heinegard, Dick; Farndale, Richard W.; Rubin, Kristofer			The Streptococcal Collagen-binding Protein CNE Specifically Interferes with alpha(V)beta(3)-mediated Cellular Interactions with Triple Helical Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BB; INTERSTITIAL FLUID PRESSURE; GEL CONTRACTION; IN-VITRO; INTEGRIN; FIBRONECTIN; RECEPTOR; NORMALIZATION; RECOGNITION; ACTIVATION	Collagen fibers expose distinct domains allowing for specific interactions with other extracellular matrix proteins and cells. To investigate putative collagen domains that govern integrin alpha(V)beta(3)-mediated cellular interactions with native collagen fibers we took advantage of the streptococcal protein CNE that bound native fibrillar collagens. CNE specifically inhibited alpha(V)beta(3)-dependent cell-mediated collagen gel contraction, PDGF BB-induced and alpha(V)beta(3)-mediated adhesion of cells, and binding of fibronectin to native collagen. Using a Toolkit composed of overlapping, 27-residue triple helical segments of collagen type II, two CNE-binding sites present in peptides II-1 and II-44 were identified. These peptides lack the major binding site for collagen-binding beta(1) integrins, defined by the peptide GFOGER. Peptide II-44 corresponds to a region of collagen known to bind collagenases, discoidin domain receptor 2, SPARC (osteonectin), and fibronectin. In addition to binding fibronectin, peptide II-44 but not II-1 inhibited alpha(V)beta(3)-mediated collagen gel contraction and, when immobilized on plastic, supported adhesion of cells. Reduction of fibronectin expression by siRNA reduced PDGF BB-induced alpha(V)beta(3)-mediated contraction. Reconstitution of collagen types I and II gels in the presence of CNE reduced collagen fibril diameters and fibril melting temperatures. Our data indicate that contraction proceeded through an indirect mechanism involving binding of cell-produced fibronectin to the collagen fibers. Furthermore, our data show that cell-mediated collagen gel contraction does not directly depend on the process of fibril formation.	[van Wieringen, Tijs; Kalamajski, Sebastian; Liden, Asa; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Liden, Asa] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Guss, Bengt] Swedish Univ Agr Sci, Dept Microbiol, SE-75007 Uppsala, Sweden; [Heinegard, Dick] BMC C12 Lund Univ, Dept Clin Sci Lund, SE-22184 Lund, Sweden	Uppsala University; University of Bergen; University of Cambridge; Swedish University of Agricultural Sciences; Lund University	Rubin, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden.	Kristofer.Rubin@imbim.uu.se	Rubin, Kristofer/AAC-1810-2020	Rubin, Kristofer/0000-0003-2789-6276; Guss, Bengt/0000-0002-7044-0701; Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Science Council; Swedish Cancer Foundation; King Gustaf the V:s 80-arsfond; Swedish Research Council for Environment, Agricultural Sciences and Spatial planning [FORMAS 221-2006-989]; Swedish Horse Board [H0747197]; Medical Research Council [G0500707, G0400701] Funding Source: researchfish; MRC [G0500707, G0400701] Funding Source: UKRI	Swedish Science Council; Swedish Cancer Foundation; King Gustaf the V:s 80-arsfond; Swedish Research Council for Environment, Agricultural Sciences and Spatial planning(Swedish Research Council Formas); Swedish Horse Board; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Swedish Science Council (to K.R.), the Swedish Cancer Foundation (to K. R.), the King Gustaf the V:s 80-arsfond (to K.R.), the Swedish Research Council for Environment, Agricultural Sciences and Spatial planning Grant FORMAS 221-2006-989 (to B.G.), Swedish Horse Board Grant H0747197 (to B.G.), and the Wellcome Trust and Medical Research Council supported synthesis of the Toolkits (to R.W.F.).	Ahlen K, 1998, CELL ADHES COMMUN, V5, P461, DOI 10.3109/15419069809005604; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Berg A, 1998, AM J PHYSIOL-HEART C, V274, pH663, DOI 10.1152/ajpheart.1998.274.2.H663; Cooke ME, 2000, J CELL SCI, V113, P2375; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; GULLBERG D, 1989, J BIOL CHEM, V264, P12686; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; HAYASHI M, 1985, J BIOCHEM-TOKYO, V98, P1135, DOI 10.1093/oxfordjournals.jbchem.a135363; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Liden A, 2006, BIOCHEM BIOPH RES CO, V340, P604, DOI 10.1016/j.bbrc.2005.12.043; Liden A, 2008, J BIOL CHEM, V283, P1234, DOI 10.1074/jbc.M704827200; LUNDGREN E, 1988, J CELL PHYSIOL, V136, P43, DOI 10.1002/jcp.1041360106; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Reed RK, 2010, J MOL CELL CARDIOL, V48, P518, DOI 10.1016/j.yjmcc.2009.06.023; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; RUBIN K, 1981, EXP CELL RES, V135, P127, DOI 10.1016/0014-4827(81)90305-0; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Svendsen OS, 2008, AM J PHYSIOL-HEART C, V295, pH555, DOI 10.1152/ajpheart.00161.2008; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TINGSTROM A, 1992, J CELL SCI, V102, P315; van Wieringen T, 2009, EXP CELL RES, V315, P1745, DOI 10.1016/j.yexcr.2009.02.005; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779	36	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35803	35813		10.1074/jbc.M110.146001	http://dx.doi.org/10.1074/jbc.M110.146001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837478	Green Published, hybrid			2022-12-25	WOS:000283845300058
J	Rodriguez, E; Aburjania, N; Priedigkeit, NM; Difeo, A; Martignetti, JA				Rodriguez, Estefania; Aburjania, Nana; Priedigkeit, Nolan M.; DiFeo, Analisa; Martignetti, John A.			Nucleo-Cytoplasmic Localization Domains Regulate Kruppel-Like Factor 6 (KLF6) Protein Stability and Tumor Suppressor Function	PLOS ONE			English	Article							CELL LUNG-CANCER; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTORS; GENE; EXPORT; SEQUENCE; SIGNAL; POLYMORPHISM; INHIBITION; IMPORT	Background: The tumor suppressor KLF6 and its oncogenic cytoplasmic splice variant KLF6-SV1 represent a paradigm in cancer biology in that their antagonistic cancer functions are encoded within the same gene. As a consequence of splicing, KLF6-SV1 loses both the C-terminus C2H2 three zinc finger (ZF) domain, which characterizes all KLF proteins, as well as the adjacent 5' basic region (5BR), a putative nuclear localization signal (NLS). It has been hypothesized that this NLS is a functional domain critical to direct the distinct subcellular localization of the tumor suppressor and its splice variant. Methodology/Principal Findings: In this study, we demonstrate using EGFP fusion constructs that KLF6/KLF6-SV1 nucleocytoplasmic transport is not regulated by the 5' basic region but activated by a novel NLS encoded within the ZF domain, and a nuclear export signal (NES) located in the first 16 amino acids of the shared N-terminus sequence. We demonstrate KLF6 nuclear export to be Crm1-dependent. The dysregulation of nucleo-cytoplasmic transport when disrupting the KLF6 NLS using site-directed mutagenesis showed that its integrity is necessary for appropriate protein stability. Moreover, these mutations impaired transcriptional induction of two KLF6 well-characterized target genes, E-cadherin and p21, as shown by RT-PCR and luciferase promoter assays. The addition of the ZF domain to KLF6-SV1 results in its nuclear localization and a markedly decreased half-life similar to wild type KLF6. Conclusions/Significance: We describe the domains that control KLF6 nucleo-cytoplasmic shuttling and how these domains play a role in KLF6 protein half-life and tumor suppressor function. The results begin to mechanistically explain, at least in part, the opposing functions of KLF6 and KLF6-SV1 in cancer.	[Rodriguez, Estefania; Aburjania, Nana; Priedigkeit, Nolan M.; DiFeo, Analisa; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rodriguez, E (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu		Priedigkeit, Nolan/0000-0001-8330-5210	Department of Defense [PC080135]; National Institutes of Health [RO1 CA122332]; NATIONAL CANCER INSTITUTE [R01CA122332] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Department of Defense PC080135 (to E. R.) and National Institutes of Health RO1 CA122332 (to J.A.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Banck MS, 2006, FEBS LETT, V580, P6981, DOI 10.1016/j.febslet.2006.10.077; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Chen Han-kui, 2002, Ai Zheng, V21, P1047; Cho YG, 2008, NEOPLASMA, V55, P47; Cho YG, 2005, ONCOGENE, V24, P4588, DOI 10.1038/sj.onc.1208670; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Hartel M, 2008, EUR J CANCER, V44, P1895, DOI 10.1016/j.ejca.2008.06.030; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Jeng YM, 2003, INT J CANCER, V105, P625, DOI 10.1002/ijc.11123; Jiao W, 2008, ONCOGENE, V27, P3156, DOI 10.1038/sj.onc.1210970; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Manabe I, 2009, BIOLOGY OF KRUPPEL-LIKE FACTORS, P245, DOI 10.1007/978-4-431-87775-2_18; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Shields JM, 1997, J BIOL CHEM, V272, P18504, DOI 10.1074/jbc.272.29.18504; Spinola M, 2007, CANCER LETT, V251, P311, DOI 10.1016/j.canlet.2006.11.029; Teixeira MS, 2007, INT J CANCER, V121, P1976, DOI 10.1002/ijc.22926; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yin D, 2007, INT J ONCOL, V30, P65	55	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12639	10.1371/journal.pone.0012639	http://dx.doi.org/10.1371/journal.pone.0012639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844588	Green Submitted, Green Published, gold			2022-12-25	WOS:000281687200008
J	Sripadi, P; Shrestha, B; Easley, RL; Carpio, L; Kehn-Hall, K; Chevalier, S; Mahieux, R; Kashanchi, F; Vertes, A				Sripadi, Prabhakar; Shrestha, Bindesh; Easley, Rebecca L.; Carpio, Lawrence; Kehn-Hall, Kylene; Chevalier, Sebastien; Mahieux, Renaud; Kashanchi, Fatah; Vertes, Akos			Direct Detection of Diverse Metabolic Changes in Virally Transformed and Tax-Expressing Cells by Mass Spectrometry	PLOS ONE			English	Article							ABLATION ELECTROSPRAY-IONIZATION; VIRUS TYPE-I; ATMOSPHERIC-PRESSURE; AMBIENT CONDITIONS; GLUTATHIONE METABOLISM; ANTIVIRAL THERAPY; PROSTATE-CANCER; HIGH-THROUGHPUT; ENERGY-CHARGE; FATTY-ACIDS	Background: Viral transformation of a cell starts at the genetic level, followed by changes in the proteome and the metabolome of the host. There is limited information on the broad metabolic changes in HTLV transformed cells. Methods and Principal Findings: Here, we report the detection of key changes in metabolites and lipids directly from human T-lymphotropic virus type 1 and type 3 (HTLV1 and HTLV3) transformed, as well as Tax1 and Tax3 expressing cell lines by laser ablation electrospray ionization (LAESI) mass spectrometry (MS). Comparing LAESI-MS spectra of non-HTLV1 transformed and HTLV1 transformed cells revealed that glycerophosphocholine (PC) lipid components were dominant in the non-HTLV1 transformed cells, and PC(O-32:1) and PC(O-34:1) plasmalogens were displaced by PC(30: 0) and PC(32: 0) species in the HTLV1 transformed cells. In HTLV1 transformed cells, choline, phosphocholine, spermine and glutathione, among others, were downregulated, whereas creatine, dopamine, arginine and AMP were present at higher levels. When comparing metabolite levels between HTLV3 and Tax3 transfected 293T cells, there were a number of common changes observed, including decreased choline, phosphocholine, spermine, homovanillic acid, and glycerophosphocholine and increased spermidine and N-acetyl aspartic acid. These results indicate that the lipid metabolism pathway as well as the creatine and polyamine biosynthesis pathways are commonly deregulated after expression of HTLV3 and Tax3, indicating that the noted changes are likely due to Tax3 expression. N-acetyl aspartic acid is a novel metabolite that is upregulated in all cell types and all conditions tested. Conclusions and Significance: We demonstrate the high throughput in situ metabolite profiling of HTLV transformed and Tax expressing cells, which facilitates the identification of virus-induced perturbations in the biochemical processes of the host cells. We found virus type-specific (HTLV1 vs. HTLV3), expression-specific (Tax1 vs. Tax3) and cell-type-specific (T lymphocytes vs. kidney epithelial cells) changes in the metabolite profiles. The new insight on the affected metabolic pathways can be used to better understand the molecular mechanisms of HTLV induced transformation, which in turn can result in new treatment strategies.	[Sripadi, Prabhakar; Shrestha, Bindesh; Vertes, Akos] George Washington Univ, Dept Chem, WM Keck Inst Prote Techol & Applicat, Washington, DC 20052 USA; [Easley, Rebecca L.; Carpio, Lawrence] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20052 USA; [Kehn-Hall, Kylene; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Dept Mol & Microbiol, Manassas, VA USA; [Chevalier, Sebastien] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Mahieux, Renaud] INSERM, Ecole Normale Super Lyon, U758, Equipe Oncogenese Retrovirale, F-69008 Lyon, France	George Washington University; George Washington University; George Mason University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sripadi, P (corresponding author), Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India.	vertes@gwu.edu	Kehn-Hall, Kylene/I-5752-2013; Shrestha, Bindesh/B-8821-2008; Vertes, Akos/B-7159-2008	Shrestha, Bindesh/0000-0002-7595-3506; Vertes, Akos/0000-0001-5186-5352; mahieux, renaud/0000-0002-5129-6804; Kehn-Hall, Kylene/0000-0001-8036-7213	National Science Foundation [0719232]; W. M. Keck Foundation [041904]; Protea Biosciences, Inc.; George Washington University (GWU)	National Science Foundation(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Protea Biosciences, Inc.; George Washington University (GWU)	This work was supported, in whole and in part, by the National Science Foundation (Grant 0719232), the W. M. Keck Foundation (Grant 041904), Protea Biosciences, Inc., and the George Washington University (GWU) Selective Excellence Funds. The opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Banerjee S, 2008, BIOMED CHROMATOGR, V22, P250, DOI 10.1002/bmc.919; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Beckmann M, 2008, NAT PROTOC, V3, P486, DOI 10.1038/nprot.2007.500; Bera S, 2008, FEBS J, V275, P5899, DOI 10.1111/j.1742-4658.2008.06718.x; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; Coyle JT, 2006, ADV EXP MED BIOL, V576, P1; COYLE JT, 2006, ADV EXPT MED BIOL, V576, P361; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; FERRER A, 1985, BIOCHEM BIOPH RES CO, V132, P497, DOI 10.1016/0006-291X(85)91161-1; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Furuke K, 1997, CANCER RES, V57, P4916; Gazi E, 2009, VIB SPECTROSC, V50, P99, DOI 10.1016/j.vibspec.2008.09.006; GESSAIN A, 1985, LANCET, V2, P407; Go EP, 2006, J PROTEOME RES, V5, P2405, DOI 10.1021/pr060215t; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; Harrigan GG, 2004, TOXICOL LETT, V146, P197, DOI 10.1016/j.toxlet.2003.09.011; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; KAMMERMEIER H, 1993, BASIC RES CARDIOL, V88, P380, DOI 10.1007/BF00795405; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Lepoutre V, 2009, FRONT BIOSCI-LANDMRK, V14, P1152, DOI 10.2741/3300; Lerner A, 2000, LEUKEMIA LYMPHOMA, V37, P39, DOI 10.3109/10428190009057627; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Li Y, 2008, ANAL CHEM, V80, P407, DOI 10.1021/ac701703f; Li Y, 2007, ANAL CHEM, V79, P523, DOI 10.1021/ac061577n; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Matalon R, 2000, FRONT BIOSCI-LANDMRK, V5, pD307, DOI 10.2741/Matalon; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mattos K, 1993, Arq Neuropsiquiatr, V51, P134; MOCHIZUKI M, 1994, BRIT J OPHTHALMOL, V78, P149, DOI 10.1136/bjo.78.2.149; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nemes P, 2008, ANAL CHEM, V80, P4575, DOI 10.1021/ac8004082; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; Nemes P, 2010, ANAL CHEM, V82, P982, DOI 10.1021/ac902245p; Nemes P, 2009, ANAL CHEM, V81, P6668, DOI 10.1021/ac900745e; Pierce CY, 2007, CHEM COMMUN, P807, DOI 10.1039/b613200f; Qiu YH, 2004, NEUROIMMUNOMODULAT, V11, P75, DOI 10.1159/000075316; Ramautar R, 2009, ELECTROPHORESIS, V30, P276, DOI 10.1002/elps.200800512; Rasheed S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003003; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; RODRIGUEZ PC, 2008, ARGININE AVAILABILIT, P219; ROSENBLATT JD, 1990, BLOOD, V76, P409; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; SHERMAN MP, 1995, ARTHRITIS RHEUM, V38, P690, DOI 10.1002/art.1780380518; Shimizu M, 2003, ANAL SCI, V19, P49, DOI 10.2116/analsci.19.49; Shrestha B, 2008, METABOLOMICS, V4, P297, DOI 10.1007/s11306-008-0120-8; Shrestha B, 2010, ANALYST, V135, P751, DOI 10.1039/b922854c; Shrestha B, 2009, ANAL CHEM, V81, P8265, DOI 10.1021/ac901525g; Sidelmann UG, 2001, J PHARMACEUT BIOMED, V24, P569, DOI 10.1016/S0731-7085(00)00482-9; Song YS, 2007, CHEM COMMUN, P61, DOI 10.1039/b615724f; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sripadi P, 2009, METABOLOMICS, V5, P263, DOI 10.1007/s11306-008-0147-x; Suschek CV, 2003, CIRCULATION, V107, P2607, DOI 10.1161/01.CIR.0000066909.13953.F1; Szende Bela, 2001, Cancer Cell Int, V1, P3, DOI 10.1186/1475-2867-1-3; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vallejo M, 2009, ANAL BIOANAL CHEM, V394, P1517, DOI 10.1007/s00216-009-2610-6; Vertes A, 2008, APPL PHYS A-MATER, V93, P885, DOI 10.1007/s00339-008-4750-5; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xue RY, 2009, CLIN CHEM LAB MED, V47, P305, DOI 10.1515/CCLM.2009.083; Yasunaga Jun-ichirou, 2007, Cancer Control, V14, P133; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zulak KG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-5; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	75	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12590	10.1371/journal.pone.0012590	http://dx.doi.org/10.1371/journal.pone.0012590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830293	Green Published, gold			2022-12-25	WOS:000281631300018
J	Hildenbrand, ZL; Molugu, SK; Stock, D; Bernal, RA				Hildenbrand, Zacariah L.; Molugu, Sudheer K.; Stock, Daniela; Bernal, Ricardo A.			The C-H Peripheral Stalk Base: A Novel Component in V-1-ATPase Assembly	PLOS ONE			English	Article							YEAST V-ATPASE; PROTON-TRANSLOCATING ATPASE; SITE-DIRECTED MUTAGENESIS; ELECTRON-MICROSCOPY; VACUOLAR ATPASE; THERMUS-THERMOPHILUS; CROSS-LINKING; SUBUNIT-H; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE	Vacuolar ATPases (V-ATPases) are molecular machines responsible for creating electrochemical gradients and preserving pH-dependent cellular compartments by way of proton translocation across the membrane. V-ATPases employ a dynamic rotary mechanism that is driven by ATP hydrolysis and the central rotor stalk. Regulation of this rotational catalysis is the result of a reversible V1Vo-domain dissociation that is required to preserve ATP during instances of cellular starvation. Recently the method by which the free V-1-ATPase abrogates the hydrolytic breakdown of ATP upon dissociating from the membrane has become increasingly clear. In this instance the central stalk subunit F adopts an extended conformation to engage in a bridging interaction tethering the rotor and stator components together. However, the architecture by which this mechanism is stabilized has remained ambiguous despite previous work. In an effort to elucidate the method by which the rotational catalysis is maintained, the architecture of the peripheral stalks and their respective binding interactions was investigated using cryo-electron microscopy. In addition to confirming the bridging interaction exuded by subunit F for the first time in a eukaryotic V-ATPase, subunits C and H are seen interacting with one another in a tight interaction that provides a base for the three EG peripheral stalks. The formation of a CE(3)G(3)H sub-assembly appears to be unique to the dissociated V-ATPase and highlights the stator architecture in addition to revealing a possible intermediate in the assembly mechanism of the free V-1-ATPase.	[Hildenbrand, Zacariah L.; Molugu, Sudheer K.; Bernal, Ricardo A.] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Stock, Daniela] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of Texas System; University of Texas El Paso; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Hildenbrand, ZL (corresponding author), Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA.	rbernal@utep.edu	Bernal, Ricardo A/B-2124-2010	Bernal, Ricardo A./0000-0001-5849-8647; Molugu, Sudheer Kumar/0000-0001-9939-1950	University of Texas; MRC [MC_U105170645] Funding Source: UKRI; Medical Research Council [MC_U105170645] Funding Source: researchfish	University of Texas; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Only University startup funds were used to support the work presented here. The University of Texas at El Paso had no role in study, design, data collection and analysis, decision to publish or preparation of the manuscript.	Armbruster A, 2004, FEBS LETT, V570, P119, DOI 10.1016/j.febslet.2004.06.029; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Drory O, 2006, BBA-BIOENERGETICS, V1757, P297, DOI 10.1016/j.bbabio.2006.03.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flannery AR, 2008, J BIOL CHEM, V283, P29099, DOI 10.1074/jbc.M803280200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gregorini M, 2007, J STRUCT BIOL, V158, P445, DOI 10.1016/j.jsb.2007.01.002; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Inoue T, 2003, J BIOENERG BIOMEMBR, V35, P291, DOI 10.1023/A:1025720713747; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Liu Q, 1996, J BIOL CHEM, V271, P2018, DOI 10.1074/jbc.271.4.2018; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maegawa Y, 2006, ACTA CRYSTALLOGR D, V62, P483, DOI 10.1107/S0907444906006329; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Suzuki T, 2000, J BIOL CHEM, V275, P37902, DOI 10.1074/jbc.M007075200; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; Tomashek JJ, 1997, J BIOL CHEM, V272, P16618, DOI 10.1074/jbc.272.26.16618; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	55	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12588	10.1371/journal.pone.0012588	http://dx.doi.org/10.1371/journal.pone.0012588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838636	Green Submitted, Green Published, gold			2022-12-25	WOS:000281627700025
J	Hosoi, T; Yokoyama, S; Matsuo, S; Akira, S; Ozawa, K				Hosoi, Toru; Yokoyama, Shota; Matsuo, Suguru; Akira, Shizuo; Ozawa, Koichiro			Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; TOLL-LIKE RECEPTOR-4; DIET-INDUCED OBESITY; LEPTIN RESISTANCE; ADIPOSE-TISSUE; IKK-BETA; MYD88; INFLAMMATION; CHOLESTEROL	Background: Multiple lines of evidence suggest innate immune response pathways to be involved in the development of obesity-associated diabetes although the molecular mechanism underling the disease is unknown. Recent observations suggest that saturated fatty acids can act as a ligand for toll-like receptor (TLR) 4, which is thought to mediate obesityassociated insulin resistance. Myeloid differentiation factor 88 (MyD88) is an adapter protein for TLR/IL-1 receptor signaling, which is involved in the activation of inflammatory pathways. To evaluate molecular mechanisms linking obesity-associated diabetes down-stream of TLR4, we investigated physiological role of MyD88 in high-fat diet (HFD)-induced obesity. Methodology/Principal Findings: In the present study, we found MyD88-deficient mice fed a HFD had increased circulating levels of insulin, leptin and cholesterol, as well as liver dysfunction (increased induction of ALT levels, increased activation of JNK and cleavage of PARP), which were linked to the onset of severe diabetes. On the other hand, TNF-a would not be involved in HFD-induced diabetes in MyD88-deficient mice, because TNF-a level was attenuated in MyD88-deficient mice fed with HFD. Conclusions/Significance: The present finding of an unexpected role for MyD88 in preventing diabetes may provide a potential novel target/strategy for treating metabolic syndrome.	[Hosoi, Toru; Yokoyama, Shota; Matsuo, Suguru; Ozawa, Koichiro] Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed Sci, Hiroshima, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan	Hiroshima University; Osaka University	Hosoi, T (corresponding author), Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed Sci, Hiroshima, Japan.	toruh@hiroshima-u.ac.jp; ozawak@hiroshima-u.ac.jp	Akira, Shizuo/C-3134-2009; Hosoi, Toru/A-7954-2018	Hosoi, Toru/0000-0003-4831-487X				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; LORD KA, 1990, ONCOGENE, V5, P387; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	32	73	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12537	10.1371/journal.pone.0012537	http://dx.doi.org/10.1371/journal.pone.0012537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824098	gold, Green Published, Green Submitted			2022-12-25	WOS:000281480900020
J	Hwang, SK; Piao, L; Lim, HT; Minai-Tehrani, A; Yu, KN; Ha, YC; Chae, CH; Lee, KH; Beck, GR; Park, J; Cho, MH				Hwang, Soon-Kyung; Piao, Longzhen; Lim, Hwang-Tae; Minai-Tehrani, Arash; Yu, Kyeong-Nam; Ha, Youn-Cheol; Chae, Chan-Hee; Lee, Kee-Ho; Beck, George R., Jr.; Park, Jongsun; Cho, Myung-Haing			Suppression of Lung Tumorigenesis by Leucine Zipper/EF Hand-Containing Transmembrane-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAS NULL MICE; CELL-CYCLE PROGRESSION; AEROSOL DELIVERY; MAMMALIAN TARGET; MITOCHONDRIA; CANCER; APOPTOSIS; GROWTH; PATHWAY	Background: Leucine zipper/EF hand-containing transmembrane-1 (LETM1) encodes for the human homologue of yeast Mdm38p, which is a mitochondria-shaping protein of unclear function. However, a previous study demonstrated that LETM1 served as an anchor protein for complex formation between mitochondria and ribosome, and regulated mitochondrial biogenesis. Methodology/Principal Findings: Therefore, we examine the possibility that LETM1 may function to regulate mitochondria and lung tumor growth. In this study, we addressed this question by studying in the effect of adenovirus-mediated LETM1 in the lung cancer cell and lung cancer model mice. To investigate the effects of adenovirus-LETM1 in vitro, we infected with adenovirus-LETM1 in A549 cells. Additionally, in vivo effects of LETM1 were evaluated on K-ras LA1 mice, human non-small cell lung cancer model mice, by delivering the LETM1 via aerosol through nose-only inhalation system. The effects of LETM1 on lung cancer growth and AMPK related signals were evaluated. Adenovirus-mediated overexpression of LETM1 could induce destruction of mitochondria of lung cancer cells through depleting ATP and AMPK activation. Furthermore, adenoviral-LETM1 also altered Akt signaling and inhibited the cell cycle while facilitating apoptosis. Theses results demonstrated that adenovirus-LETM1 suppressed lung cancer cell growth in vitro and in vivo. Conclusions/Significance: Adenovirus-mediated LETM1 may provide a useful target for designing lung tumor prevention and treatment.	[Hwang, Soon-Kyung; Lim, Hwang-Tae; Minai-Tehrani, Arash; Yu, Kyeong-Nam; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea; [Lim, Hwang-Tae; Cho, Myung-Haing] Seoul Natl Univ, Nano Syst Inst, Natl Core Res Ctr, Seoul, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul, South Korea; [Piao, Longzhen] Yanbian Univ, Affiliated Hosp, Dept Oncol, Jilin, Peoples R China; [Ha, Youn-Cheol; Chae, Chan-Hee] Seoul Natl Univ, Coll Vet Med, Dept Vet Pathol, Seoul, South Korea; [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Lab Radiat Mol Oncol, Seoul, South Korea; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA; [Park, Jongsun] Chungnam Natl Univ, Dept Pharmacol, Daejeon Reg Canc Ctr, Canc Res Inst,Res Inst Med Sci,Coll Med, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yanbian University; Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences; Emory University; Chungnam National University	Hwang, SK (corresponding author), Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea.	insulin@cnu.ac.kr; mchotox@snu.ac.kr	Park, Jongsun/E-7465-2010; Beck, George/AAO-2117-2020; Cho, Myung-Haing/B-7362-2014	Park, Jongsun/0000-0002-4690-1854; Cho, Myung-Haing/0000-0002-3993-2011	Ministry of Education, Science and Technology in Korea [2010-0000784]; Nano Systems Institute-National Core Research Center (NSI-NCRC); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [FG03-0601-003-1-0-0, AR056090, CA136059]; Korea Government (MEST) [2010-0001354]; NATIONAL CANCER INSTITUTE [R03CA136059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056090] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology in Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Nano Systems Institute-National Core Research Center (NSI-NCRC); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported partially by grants from the NRL (# 2010-0000784) of the Ministry of Education, Science and Technology in Korea. MHC was also supported by the Nano Systems Institute-National Core Research Center (NSI-NCRC) program of KOSEF and Research Institute for Veterinary Science, Seoul National University, Korea. SKH, AMT, HTL are also grateful for the award of the BK21 fellowship. KHL was supported by 21C Frontier Functional Human Genome Project (FG03-0601-003-1-0-0) and National Nuclear R& D Program from Ministry of Science and Technology. GRB Jr was supported in part by grants from National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) (AR056090) and National Institutes of Health/National Cancer Institute (NIH/NCI) (CA136059). Jongsun Park was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (No. 2010-0001354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Densmore Charles L., 2006, Current Drug Delivery, V3, P55, DOI 10.2174/156720106775197547; Dias N, 2005, BIOCHEM PHARMACOL, V70, P1, DOI 10.1016/j.bcp.2005.03.021; Don AS, 2004, TRENDS MOL MED, V10, P372, DOI 10.1016/j.molmed.2004.06.005; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; HEIDI MM, 2006, CURR BIOL, V16, pR551; Hwang SK, 2007, GENE THER, V14, P1721, DOI 10.1038/sj.gt.3303042; Hwang SK, 2009, AM J RESP CRIT CARE, V179, P1131, DOI 10.1164/rccm.200810-1553OC; Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017; Jin H, 2006, MOL CANCER THER, V5, P1041, DOI 10.1158/1535-7163.MCT-05-0433; Jin Q, 2007, CANCER RES, V67, P11630, DOI 10.1158/0008-5472.CAN-07-2401; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kim HW, 2004, CANCER RES, V64, P7971, DOI 10.1158/0008-5472.CAN-04-1231; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Neill J, 2004, BBA-REV CANCER, V1705, P43, DOI 10.1016/j.bbcan.2004.09.004; Piao LZ, 2009, CELL SIGNAL, V21, P767, DOI 10.1016/j.cellsig.2009.01.020; Rauch A, 2001, AM J MED GENET, V99, P338, DOI 10.1002/ajmg.1203; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; Wang XD, 2001, GENE DEV, V15, P2922; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2008, AM J RESP CRIT CARE, V178, P60, DOI 10.1164/rccm.200707-1022OC; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	39	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12535	10.1371/journal.pone.0012535	http://dx.doi.org/10.1371/journal.pone.0012535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824095	Green Submitted, Green Published, gold			2022-12-25	WOS:000281480900018
J	Mehra, S; Pahar, B; Dutta, NK; Conerly, CN; Philippi-Falkenstein, K; Alvarez, X; Kaushal, D				Mehra, Smriti; Pahar, Bapi; Dutta, Noton K.; Conerly, Cecily N.; Philippi-Falkenstein, Kathrine; Alvarez, Xavier; Kaushal, Deepak			Transcriptional Reprogramming in Nonhuman Primate Rhesus Macaque) Tuberculosis Granulomas	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; GUINEA-PIGS; CHEMOKINES; INFECTION; LUNG; EXPRESSION; EFFICACY; VACCINE; MODEL	Background: In response to Mtb infection, the host remodels the infection foci into a dense mass of cells known as the granuloma. The key objective of the granuloma is to contain the spread of Mtb into uninfected regions of the lung. However, it appears that Mtb has evolved mechanisms to resist killing in the granuloma. Profiling granuloma transcriptome will identify key immune signaling pathways active during TB infection. Such studies are not possible in human granulomas, due to various confounding factors. Nonhuman Primates (NHPs) infected with Mtb accurately reflect human TB in clinical and pathological contexts. Methodology/Principal Findings: We studied transcriptomics of granuloma lesions in the lungs of NHPs exhibiting active TB, during early and late stages of infection. Early TB lesions were characterized by a highly pro-inflammatory environment, expressing high levels of immune signaling pathways involving IFN gamma, TNF alpha, JAK, STAT and C-C/C-X-C chemokines. Late TB lesions, while morphologically similar to the early ones, exhibited an overwhelming silencing of the inflammatory response. Reprogramming of the granuloma transcriptome was highly significant. The expression of, two-thirds of all genes induced in early lesions was later repressed. Conclusions/Significance: The transcriptional characteristics of TB granulomas undergo drastic changes during the course of infection. The overwhelming reprogramming of the initial pro-inflammatory surge in late lesions may be a host strategy to limit immunopathology. We propose that these host profiles can predict changes in bacterial replication and physiology, perhaps serving as markers for latency and reactivation.	[Mehra, Smriti; Dutta, Noton K.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA; [Mehra, Smriti; Dutta, Noton K.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, DNA Microarray & Express Core, Covington, LA USA; [Pahar, Bapi; Conerly, Cecily N.; Alvarez, Xavier] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Philippi-Falkenstein, Kathrine] Tulane Natl Primate Res Ctr, Div Vet Med, Covington, LA USA; [Kaushal, Deepak] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University	Mehra, S (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA.	dkaushal@tulane.edu	Dutta, Noton K./K-5202-2012; Pahar, Bapi/AFM-3129-2022	Dutta, Noton K./0000-0002-5066-3342; Pahar, Bapi/0000-0003-1949-973X	National Institutes of Health [AI091457, AI089323, RR026006, RR164]; Tulane Research Enhancement Fund; Louisiana Vaccine Center; Tulane Center for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, R21RR026006, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091457, R01AI089323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Research Enhancement Fund; Louisiana Vaccine Center; Tulane Center for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants AI091457 (DK), AI089323 (DK), RR026006 (DK) and RR164 and by awards from Tulane Research Enhancement Fund (DK), Louisiana Vaccine Center (DK) and Tulane Center for Infectious Diseases (SM and NKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2004, J IMMUNOL, V173, P3287; Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Ericsson A, 2006, J IMMUNOL, V176, P3642, DOI 10.4049/jimmunol.176.6.3642; Ferrara G, 2008, SCAND J IMMUNOL, V68, P668, DOI 10.1111/j.1365-3083.2008.02182.x; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hasan Z, 2003, TUBERCULOSIS, V83, P299, DOI 10.1016/S1472-9792(03)00003-9; Kaufman M, 2002, PRESERVATION, V54, P8; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; KAUSHAL D, 2004, CURR PROTOC BIOINFOR, V7, P9; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Larsen MH, 2009, VACCINE, V27, P4709, DOI 10.1016/j.vaccine.2009.05.050; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mayanja-Kizza H, 2001, J INFECT DIS, V183, P1801, DOI 10.1086/320724; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08; ORME IM, 1995, TRENDS MICROBIOL, V3, P401, DOI 10.1016/S0966-842X(00)88987-8; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Pahar B, 2007, VIROLOGY, V363, P36, DOI 10.1016/j.virol.2007.01.010; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; PHILIPS JA, 2005, SCIENCE, V309, P5738; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Sauty A, 1999, J IMMUNOL, V162, P3549; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Taylor M, 2005, SIGHT SOUND, V15, P70; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663	42	71	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12266	10.1371/journal.pone.0012266	http://dx.doi.org/10.1371/journal.pone.0012266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824205	Green Published, Green Submitted, gold			2022-12-25	WOS:000281405300004
J	Ciccolella, CO; Raynard, NA; Mei, JHM; Church, DC; Ludwig, RA				Ciccolella, Christopher O.; Raynard, Nathan A.; Mei, John H-M.; Church, Derek C.; Ludwig, Robert A.			Symbiotic Legume Nodules Employ Both Rhizobial Exo- and Endo-Hydrogenases to Recycle Hydrogen Produced by Nitrogen Fixation	PLOS ONE			English	Article							AZORHIZOBIUM-CAULINODANS ORS571; COMPLEX-I; WILD-TYPE; JAPONICUM; LEGUMINOSARUM; METABOLISM; MUTANTS; STRAINS; OXYGEN; BACTEROIDS	Background: In symbiotic legume nodules, endosymbiotic rhizobia (bacteroids) fix atmospheric N(2), an ATP-dependent catalytic process yielding stoichiometric ammonium and hydrogen gas (H(2)). While in most legume nodules this H(2) is quantitatively evolved, which loss drains metabolic energy, certain bacteroid strains employ uptake hydrogenase activity and thus evolve little or no H(2). Rather, endogenous H(2) is efficiently respired at the expense of O(2), driving oxidative phosphorylation, recouping ATP used for H(2) production, and increasing the efficiency of symbiotic nodule N(2) fixation. In many ensuing investigations since its discovery as a physiological process, bacteroid uptake hydrogenase activity has been presumed a single entity. Methodology/Principal Findings: Azorhizobium caulinodans, the nodule endosymbiont of Sesbania rostrata stems and roots, possesses both orthodox respiratory (exo-)hydrogenase and novel (endo-)hydrogenase activities. These two respiratory hydrogenases are structurally quite distinct and encoded by disparate, unlinked gene-sets. As shown here, in S. rostrata symbiotic nodules, haploid A. caulinodans bacteroids carrying single knockout alleles in either exo- or-endohydrogenase structural genes, like the wild-type parent, evolve no detectable H(2) and thus are fully competent for endogenous H(2) recycling. Whereas, nodules formed with A. caulinodans exo-, endo- hydrogenase double-mutants evolve endogenous H(2) quantitatively and thus suffer complete loss of H(2) recycling capability. More generally, from bioinformatic analyses, diazotrophic microaerophiles, including rhizobia, which respire H(2) may carry both exo- and endo- hydrogenase gene-sets. Conclusions/Significance: In symbiotic S. rostrata nodules, A. caulinodans bacteroids can use either respiratory hydrogenase to recycle endogenous H(2) produced by N(2) fixation. Thus, H(2) recycling by symbiotic legume nodules may involve multiple respiratory hydrogenases.	[Ciccolella, Christopher O.; Raynard, Nathan A.; Mei, John H-M.; Church, Derek C.; Ludwig, Robert A.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Ciccolella, CO (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	rludwig@ucsc.edu			California Energy Commission	California Energy Commission	This work was supported by the California Energy Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT SL, 1979, SCIENCE, V203, P1255, DOI 10.1126/science.203.4386.1255; Baginsky C, 2004, FEMS MICROBIOL LETT, V237, P399, DOI 10.1016/j.femsle.2004.07.003; BEDMAR EJ, 1984, CAN J BOT, V62, P1682, DOI 10.1139/b84-227; BERNHARD M, 2004, EUR J BIOCHEM, V16, P179; BOOGERD FC, 1994, APPL ENVIRON MICROB, V60, P1859, DOI 10.1128/AEM.60.6.1859-1866.1994; Brito B, 1997, P NATL ACAD SCI USA, V94, P6019, DOI 10.1073/pnas.94.12.6019; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Burris R. H., 1980, Nitrogen fixation [Proceedings of the Phytochemical Society of Europe Symposium Sussex, UK, September, 1979]., P37; CAUVIN B, 1991, MOL MICROBIOL, V5, P2519, DOI 10.1111/j.1365-2958.1991.tb02098.x; DEVRIES W, 1988, ARCH MICROBIOL, V150, P595, DOI 10.1007/BF00408256; DIXON ROD, 1972, ARCH MIKROBIOL, V85, P193, DOI 10.1007/BF00408844; DIXON ROD, 1968, ARCH MIKROBIOL, V62, P272, DOI 10.1007/BF00413898; DONALD RGK, 1986, J BACTERIOL, V165, P72, DOI 10.1128/jb.165.1.72-81.1986; DREVON JJ, 1982, PLANT PHYSIOL, V70, P1341, DOI 10.1104/pp.70.5.1341; DREYFUS BL, 1981, FEMS MICROBIOL LETT, V10, P313; EISBRENNER G, 1983, ANNU REV PLANT PHYS, V34, P105, DOI 10.1146/annurev.pp.34.060183.000541; HYNDMAN LA, 1953, J BACTERIOL, V65, P522, DOI 10.1128/JB.65.5.522-531.1953; LEPO JE, 1981, J BACTERIOL, V146, P614, DOI 10.1128/JB.146.2.614-620.1981; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOPEZ M, 1983, PLANT SCI LETT, V9, P191; LOROCH AI, 1995, J BACTERIOL, V177, P7210, DOI 10.1128/jb.177.24.7210-7221.1995; MAIER RJ, 1982, J BACTERIOL, V150, P161, DOI 10.1128/JB.150.1.161-167.1982; NELSON LM, 1985, FEMS MICROBIOL LETT, V30, P53; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Ohnishi T, 2005, FEBS LETT, V579, P4555, DOI 10.1016/j.febslet.2005.06.086; Phelps AS, 1941, P SOC EXP BIOL MED, V47, P473; RUIZARGUESO T, 1978, ARCH MICROBIOL, V116, P113, DOI 10.1007/BF00406025; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHUBERT KR, 1976, P NATL ACAD SCI USA, V73, P1207, DOI 10.1073/pnas.73.4.1207; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; VREMAN HJ, 1988, CLIN CHEM, V34, P2562	33	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12094	10.1371/journal.pone.0012094	http://dx.doi.org/10.1371/journal.pone.0012094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20838423	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900032
J	Fielding, AB; Lim, S; Montgomery, K; Dobreva, I; Dedhar, S				Fielding, A. B.; Lim, S.; Montgomery, K.; Dobreva, I.; Dedhar, S.			A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells	ONCOGENE			English	Article						integrin-linked kinase; centrosome clustering; multipolar mitosis; TACC3; ch-TOG/XMAP215; cancer	SPINDLE POLE ORGANIZATION; AURORA-A; CHROMOSOMAL INSTABILITY; EXTRA CENTROSOMES; IN-VITRO; PROTEIN; MICROTUBULES; AMPLIFICATION; ABERRATIONS; PROGRESSION	Many cancer cells contain more than two centrosomes, which imposes a potential for multipolar mitoses, leading to cell death. To circumvent this, cancer cells develop mechanisms to cluster supernumerary centrosomes to form bipolar spindles, enabling successful mitosis. Disruption of centrosome clustering thus provides a selective means of killing supernumerary centrosome-harboring cancer cells. Although the mechanisms of centrosome clustering are poorly understood, recent genetic analyses have identified requirements for both actin and tubulin regulating proteins. In this study, we demonstrate that the integrin-linked kinase (ILK), a protein critically involved in actin and mitotic microtubule organization, is required for centrosome clustering. Inhibition of ILK expression or activity inhibits centrosome clustering in several breast and prostate cancer cell lines that have centrosome amplification. Furthermore, cancer cells with supernumerary centrosomes are significantly more sensitive to ILK inhibition than cells with two centrosomes, demonstrating that inhibiting ILK offers a selective means of targeting cancer cells. Live cell analysis shows ILK perturbation leads cancer cells to undergo multipolar anaphases, mitotic arrest and cell death in mitosis. We also show that ILK performs its centrosome clustering activity in a focal adhesion-independent, but centrosome-dependent, manner through the microtubule regulating proteins TACC3 and ch-TOG. In addition, we identify a specific TACC3 phosphorylation site that is required for centrosome clustering and demonstrate that ILK regulates this phosphorylation in an Aurora-A-dependent manner. Oncogene (2011) 30, 521-534; doi: 10.1038/onc.2010.431; published online 13 September 2010	[Fielding, A. B.; Lim, S.; Montgomery, K.; Dobreva, I.; Dedhar, S.] BC Canc Agcy, Dept Integrat Oncol, British Columbia Canc Res Ctr, Vancouver, BC, Canada; [Dedhar, S.] Univ British Columbia, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia	Dedhar, S (corresponding author), Univ British Columbia, Dept Biochem, BC Canc Res Ctr, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sdedhar@interchange.ubc.ca		Dedhar, Shoukat/0000-0003-4355-1657; Fielding, Andrew/0000-0002-3170-9966	Canadian Institute of Health Research (CIHR); Canadian Cancer Society Research Institute; Canadian Cancer Society	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants to SD from the Canadian Institute of Health Research (CIHR) and the Canadian Cancer Society Research Institute, with funds raised by the Canadian Cancer Society. We thank Quadra Logic Technology Inc (QLT Inc), Vancouver, BC for supplying QLT-0267. We thank Dr Kazuhisa Kinoshita for the kind gift of anti-phospho-Ser558 TACC3 antibody and Dr Peter Lansdorp for the Aurora-A plasmid.	Albee AJ, 2008, MOL BIOL CELL, V19, P3347, DOI 10.1091/mbc.E07-11-1204; Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Gkretsi V, 2007, HEPATOLOGY, V45, P1025, DOI 10.1002/hep.21540; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Kramer A, 2002, LEUKEMIA, V16, P767, DOI 10.1038/sj.leu.2402454; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pihan GA, 2003, CANCER RES, V63, P1398; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rebacz B, 2007, CANCER RES, V67, P6342, DOI 10.1158/0008-5472.CAN-07-0663; RING D, 1982, J CELL BIOL, V94, P549, DOI 10.1083/jcb.94.3.549; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Tien AC, 2004, MOL CELL PROTEOMICS, V3, P93, DOI 10.1074/mcp.M300072-MCP200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Weber RG, 1998, CYTOGENET CELL GENET, V83, P266, DOI 10.1159/000015168; Xu FL, 2008, CANCER CELL, V14, P197, DOI 10.1016/j.ccr.2008.08.007; You FL, 2004, ONCOGENE, V23, P5792, DOI 10.1038/sj.onc.1207739; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	44	65	66	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					521	534		10.1038/onc.2010.431	http://dx.doi.org/10.1038/onc.2010.431			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20838383				2022-12-25	WOS:000286922300002
J	Ogino, K; Ramsden, SL; Keib, N; Schwarz, G; Harvey, RJ; Hirata, H				Ogino, Kazutoyo; Ramsden, Sarah L.; Keib, Natalie; Schwarz, Guenter; Harvey, Robert J.; Hirata, Hiromi			Duplicated Gephyrin Genes Showing Distinct Tissue Distribution and Alternative Splicing Patterns Mediate Molybdenum Cofactor Biosynthesis, Glycine Receptor Clustering, and Escape Behavior in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SPINAL-CORD; PROTEIN GEPHYRIN; BETA-SUBUNIT; ESCHERICHIA-COLI; INHIBITORY SYNAPSES; CRYSTAL-STRUCTURE; SPASMODIC MOUSE; SPASTIC MOUSE; MUTATION; EXPRESSION	Gephyrin mediates the postsynaptic clustering of glycine receptors (GlyRs) and GABA(A) receptors at inhibitory synapses and molybdenum-dependent enzyme (molybdoenzyme) activity in non-neuronal tissues. Gephyrin knock-out mice show a phenotype resembling both defective glycinergic transmission and molybdenum cofactor (Moco) deficiency and die within 1 day of birth due to starvation and dyspnea resulting from deficits in motor and respiratory networks, respectively. To address whether gephyrin function is conserved among vertebrates and whether gephyrin deficiency affects molybdoenzyme activity and motor development, we cloned and characterized zebrafish gephyrin genes. We report here that zebrafish have two gephyrin genes, gphna and gphnb. The former is expressed in all tissues and has both C3 and C4 cassette exons, and the latter is expressed predominantly in the brain and spinal cord and harbors only C4 cassette exons. We confirmed that all of the gphna and gphnb splicing isoforms have Moco synthetic activity. Antisense morpholino knockdown of either gphna or gphnb alone did not disturb synaptic clusters of GlyRs in the spinal cord and did not affect touch-evoked escape behaviors. However, on knockdown of both gphna and gphnb, embryos showed impairments in GlyR clustering in the spinal cord and, as a consequence, demonstrated touch-evoked startle response behavior by contracting antagonistic muscles simultaneously, instead of displaying early coiling and late swimming behaviors, which are executed by side-to-side muscle contractions. These data indicate that duplicated gephyrin genes mediate Moco biosynthesis and control postsynaptic clustering of GlyRs, thereby mediating key escape behaviors in zebrafish.	[Ogino, Kazutoyo; Hirata, Hiromi] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 4118540, Japan; [Ramsden, Sarah L.; Harvey, Robert J.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Keib, Natalie; Schwarz, Guenter] Univ Cologne, Inst Biochem, D-50674 Cologne, Germany; [Keib, Natalie; Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; [Hirata, Hiromi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Hirata, Hiromi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of London; University College London; University of London School of Pharmacy; University of Cologne; University of Cologne; Graduate University for Advanced Studies - Japan; Nagoya University	Hirata, H (corresponding author), Natl Inst Genet, Frontier Res Ctr, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	hihirata@lab.nig.ac.jp	Schwarz, Guenter/ABE-9643-2021; Harvey, Robert/D-3994-2016; Zebrafish, UCL/A-3125-2009; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; Harvey, Robert/0000-0001-5956-6664; Hirata, Hiromi/0000-0002-3769-7441	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nakajima Foundation; Takeda Science Foundation; Human Frontier Science Program; Medical Research Council [G0800111]; MRC [G0500833] Funding Source: UKRI; Medical Research Council [G0500833] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakajima Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants-in-aid for young scientists (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Nakajima Foundation, Takeda Science Foundation, and Career Development Award of the Human Frontier Science Program (to H. H.).; Supported by a Medical Research Council DTG Studentship G0800111.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; David-Watine B, 1999, NEUROSCIENCE, V90, P303, DOI 10.1016/S0306-4522(98)00430-8; David-Watine B, 2001, GENE, V271, P239, DOI 10.1016/S0378-1119(01)00511-X; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Giesemann T, 2003, J NEUROSCI, V23, P8330; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; Heck S, 1997, DEV BRAIN RES, V98, P211, DOI 10.1016/S0165-3806(96)00181-2; Hirata H, 2005, P NATL ACAD SCI USA, V102, P8345, DOI 10.1073/pnas.0500862102; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Hirata H, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.026.2009; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Paarmann I, 2006, BIOCHEM SOC T, V34, P45, DOI 10.1042/BST0340045; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; Smolinsky B, 2008, J BIOL CHEM, V283, P17370, DOI 10.1074/jbc.M800985200; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Triller A, 1997, NEUROSCIENCE, V80, P133, DOI 10.1016/S0306-4522(97)00092-4; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	69	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					806	817		10.1074/jbc.M110.125500	http://dx.doi.org/10.1074/jbc.M110.125500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20843816	Green Published, hybrid			2022-12-25	WOS:000285782800080
J	Alameda, JP; Moreno-Maldonado, R; Navarro, M; Bravo, A; Ramirez, A; Page, A; Jorcano, JL; Fernandez-Acenero, MJ; Casanova, ML				Alameda, J. P.; Moreno-Maldonado, R.; Navarro, M.; Bravo, A.; Ramirez, A.; Page, A.; Jorcano, J. L.; Fernandez-Acenero, M. J.; Casanova, M. L.			An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells	ONCOGENE			English	Article						CYLD; angiogenesis; skin cancer; tumor progression	NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; MALIGNANT-TRANSFORMATION; EXPRESSION; GENE; ACTIVATION; VEGF; CYLINDROMATOSIS; CARCINOGENESIS; STATE	In this study, we demonstrate that the expression in tumorigenic epidermal cells of a catalytically inactive form of CYLD (CYLDC/S) that mimics the identified mutations of cyld in human tumors and competes with the endogenous CYLD results in enhanced cell proliferation and inhibition of apoptosis; it also stimulates cell migration and induces the expression of angiogenic factors, including vascular endothelial growth factor-A. Altogether, these characteristics indicate an increased oncogenicity of the tumorigenic epidermal CYLDC/S mutant cells in vitro. Moreover, we show the increase in malignancy of epidermal squamous cell carcinomas that express the CYLDC/S transgene in an in vivo xenograft model. Tumors carrying the mutated CYLDC/S exhibit a fast growth, are poorly differentiated and present a robust angiogenesis. CYLDC/S tumors are also characterized by their elevated proliferation rate and decreased apoptosis. In contrast with previous studies showing the development of benign tumors by mutations in the CYLD gene, here we provide evidence that the occurrence of mutations in the CYLD gene in tumorigenic epidermal cells (carrying previous mutations) increases the aggressiveness of carcinomas, mainly through enhancement of the expression of angiogenic factors, having therefore a key role in epidermal cancer malignancy. Oncogene (2010) 29, 6522-6532; doi:10.1038/onc.2010.378; published online 13 September 2010	[Alameda, J. P.; Moreno-Maldonado, R.; Navarro, M.; Ramirez, A.; Page, A.; Jorcano, J. L.; Casanova, M. L.] CIEMAT, Div Epithelial Biomed, E-28040 Madrid, Spain; [Bravo, A.] Univ Santiago de Compostela, Fac Vet, Dept Vet Clin Sci, Lugo, Spain; [Fernandez-Acenero, M. J.] Fdn Jimenez Diaz, Dept Pathol, E-28040 Madrid, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidade de Santiago de Compostela	Casanova, ML (corresponding author), CIEMAT, Div Epithelial Biomed, Ave Complutense 22, E-28040 Madrid, Spain.	llanos.casanova@ciemat.es	Ramirez, Angel/A-4800-2018; Navarro, Manuel/S-1496-2019; Moral, Ana María Bravo/AAD-3339-2021	Ramirez, Angel/0000-0001-7745-5108; Navarro, Manuel/0000-0003-1118-8531; Moral, Ana María Bravo/0000-0002-5282-8921; Page, Angustias/0000-0002-0231-8536; Casanova, M. Llanos/0000-0001-7742-8265	Ministerio de Sanidad [PI061233, PI060655]; Ministerio de Educacion y Ciencia [PSE-010000-2008-7]	Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion y Ciencia(Spanish Government)	We thank Dr R Bernards for providing the CYLD<SUP>C/S</SUP> cDNA; M Isabel de los Santos and Federico Sanchez-Sierra for invaluable assistance in the histological and immunohistochemical analyses; Juan Manuel Luque and Soledad Moreno for technical assistance; and Jesus Martinez, Edilia Almeida and the personnel of the CIEMAT Animal Unit for care of the mice used. This work was funded by grant from the Ministerio de Sanidad (PI061233, PI060655) to MLC and AR respectively and a grant from the Ministerio de Educacion y Ciencia (PSE-010000-2008-7).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bolontrade MF, 1998, CARCINOGENESIS, V19, P2107, DOI 10.1093/carcin/19.12.2107; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Budunova IV, 1999, ONCOGENE, V18, P7423, DOI 10.1038/sj.onc.1203104; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; Casanova ML, 2002, CANCER RES, V62, P3402; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; De Francesco V, 2005, AM J DERMATOPATH, V27, P21, DOI 10.1097/01.dad.0000141548.69423.c7; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Detmar M, 2000, J DERMATOL SCI, V24, pS78, DOI 10.1016/S0923-1811(00)00145-6; Detmar M, 2000, J INVEST DERM SYMP P, V5, P20, DOI 10.1046/j.1087-0024.2000.00003.x; Durani BK, 2001, BRIT J DERMATOL, V145, P653, DOI 10.1046/j.1365-2133.2001.04460.x; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FREDERICKSON RM, 1989, NUCLEIC ACIDS RES, V17, P253, DOI 10.1093/nar/17.1.253; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Hirai Y, 2004, INT J ONCOL, V24, P977; Jenner MW, 2007, BLOOD, V110, P3291, DOI 10.1182/blood-2007-02-075069; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Larcher F, 1996, CANCER RES, V56, P5391; Li HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-110; Limmer B L, 2001, Tex Med, V97, P56; Massoumi R, 2007, BIOESSAYS, V29, P1203, DOI 10.1002/bies.20677; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Mirones I, 2009, J INVEST DERMATOL, V129, P730, DOI 10.1038/jid.2008.292; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moreno-Maldonado R, 2008, CELL CYCLE, V7, P2021, DOI 10.4161/cc.7.13.6147; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Ren Q, 2006, CANCER RES, V66, P5209, DOI 10.1158/0008-5472.CAN-05-4158; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Solovey A, 1999, BLOOD, V93, P3824, DOI 10.1182/blood.V93.11.3824.411k10_3824_3830; SPENCER JM, 1995, ARCH DERMATOL, V131, P796, DOI 10.1001/archderm.131.7.796; Strobel P, 2002, AM J SURG PATHOL, V26, P119, DOI 10.1097/00000478-200201000-00016; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Thornburg NJ, 2003, CANCER RES, V63, P8293; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; van Hogerlinden M, 1999, CANCER RES, V59, P3299; WINTER H, 1990, DIFFERENTIATION, V43, P105, DOI 10.1111/j.1432-0436.1990.tb00436.x; ZHANG W, 2010, MED ONCOL, V37, P607; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	59	32	33	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6522	6532		10.1038/onc.2010.378	http://dx.doi.org/10.1038/onc.2010.378			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20838385				2022-12-25	WOS:000285380200002
J	Lee, SH; Yu, SY; Nakayama, J; Khoo, KH; Stone, EL; Fukuda, MN; Marth, JD; Fukuda, M				Lee, Seung Ho; Yu, Shin-Yi; Nakayama, Jun; Khoo, Kai-Hooi; Stone, Erica L.; Fukuda, Michiko N.; Marth, Jamey D.; Fukuda, Minoru			Core2 O-Glycan Structure Is Essential for the Cell Surface Expression of Sucrase Isomaltase and Dipeptidyl Peptidase-IV during Intestinal Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; N-GLYCANS; COLORECTAL-CANCER; EPITHELIAL-CELLS; 2 BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; INTRACELLULAR TRAFFICKING; SECRETORY PATHWAY; MOLECULAR-CLONING; UDP-GLCNAC; GLYCOSYLATION	Alterations in glycosylation play an important role during intestinal cell differentiation. Here, we compared expression of mucin-type O-glycan synthases from proliferating and differentiated HT-29 and Caco-2 cells. Mucin-type O-glycan structures were analyzed at both stages by mass spectrometry. Core2 beta 1,6-N-acetylglucosaminyltransferase-2 (C2GnT-2) was markedly increased in differentiated HT-29 and Caco-2 cells, but the core3 structure was hardly detectable. To determine whether such differential expression of mucin-type O-glycan structures has physiological significance in intestinal cell differentiation, expression of sucrase isomaltase (SI) and dipeptidyl-peptidase IV (DPP-IV), two well known intestinal differentiation markers, was examined. Interestingly, the fully glycosylated mature form of SI was decreased in C2GnT-2 knock-out mice but not in core2 N-acetylglucosaminyltransferase-3 (C2GnT-3) nulls. In addition, expression of SI and DPP-IV was dramatically reduced in C2GnT-1-3 triple knock-out mice. These patterns were confirmed by RNAi analysis; C2GnT-2 knockdown significantly reduced cell surface expression of SI and DPP-IV in Caco-2 cells. Similarly, overexpression of the core3 structure in HT-29 cells attenuated cell surface expression of both enzymes. These findings indicate that core3 O-glycan structure regulates cell surface expression of SI and DPP-IV and that core2 O-glycan is presumably an essential mucin-type O-glycan structure found in both molecules in vivo. Finally, goblet cells in the upper part of the crypt showed impaired maturation in the core2 O-glycan-deficient mice. These studies are the first to clearly identify functional mucin-type O-glycan structures modulating cell surface expression of SI and DPP-IV during the intestinal cell differentiation.	[Lee, Seung Ho; Fukuda, Michiko N.; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, Ctr Canc, La Jolla, CA 92037 USA; [Yu, Shin-Yi; Khoo, Kai-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan; [Stone, Erica L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Marth, Jamey D.] Univ Calif Santa Barbara, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Shinshu University; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, Ctr Canc, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org	Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; YU, Shin-Yi/0000-0003-0197-9575	National Institutes of Health [CA33000, P01 CA71932]; NATIONAL CANCER INSTITUTE [R01CA033000, P01CA071932, R37CA033000] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390104] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grants CA33000 and P01 CA71932.	Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Alfalah M, 2002, J BIOL CHEM, V277, P10683, DOI 10.1074/jbc.M109357200; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Cosentino S, 2010, J NUTR BIOCHEM, V21, P247, DOI 10.1016/j.jnutbio.2008.12.016; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; GORVEL JP, 1991, GASTROENTEROLOGY, V101, P618, DOI 10.1016/0016-5085(91)90517-O; Gouyer V, 2001, J CELL SCI, V114, P1455; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Hein Z, 2009, EXP CELL RES, V315, P348, DOI 10.1016/j.yexcr.2008.10.038; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Keiser M, 2006, J BIOL CHEM, V281, P14393, DOI 10.1074/jbc.M513631200; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Machida E, 2001, CANCER RES, V61, P2226; Merzaban JS, 2005, J IMMUNOL, V174, P4051, DOI 10.4049/jimmunol.174.7.4051; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Patsos G, 2007, BIOCHEM SOC T, V35, P1372, DOI 10.1042/BST0351372; Patsos G, 2005, BIOCHEM SOC T, V33, P721, DOI 10.1042/BST0330721; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; SEMENZA G, 1983, CIBA F SYMP, V95, P92; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Tsuiji H, 2003, GLYCOBIOLOGY, V13, P521, DOI 10.1093/glycob/cwg065; VAVASSEUR F, 1995, GLYCOBIOLOGY, V5, P351, DOI 10.1093/glycob/5.3.351; VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x; Vercoutter-Edouart AS, 2008, PROTEOMICS, V8, P3236, DOI 10.1002/pmic.200800151; Wetzel G, 2009, BIOL CHEM, V390, P545, DOI 10.1515/BC.2009.077; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3	42	21	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37683	37692		10.1074/jbc.M110.162735	http://dx.doi.org/10.1074/jbc.M110.162735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20841351	Green Published, hybrid			2022-12-25	WOS:000284424000060
J	Pascal, TA; Abrol, R; Mittal, R; Wang, Y; Prasadarao, NV; Goddard, WA				Pascal, Tod A.; Abrol, Ravinder; Mittal, Rahul; Wang, Ying; Prasadarao, Nemani V.; Goddard, William A., III			Experimental Validation of the Predicted Binding Site of Escherichia coli K1 Outer Membrane Protein A to Human Brain Microvascular Endothelial Cells IDENTIFICATION OF CRITICAL MUTATIONS THAT PREVENT E. COLI MENINGITIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY; MOLECULAR-DYNAMICS; FORCE-FIELD; ENTROPY; RECEPTOR; COMPENSATION; EXPRESSION; EFFICIENT; LIGANDS; SEPSIS	Escherichia coli K1, the most common cause of meningitis in neonates, has been shown to interact with GlcNAc1-4GlcNAc epitopes of Ecgp96 on human brain microvascular endothelial cells (HBMECs) via OmpA (outer membrane protein A). However, the precise domains of extracellular loops of OmpA interacting with the chitobiose epitopes have not been elucidated. We report the loop-barrel model of these OmpA interactions with the carbohydrate moieties of Ecgp96 predicted from molecular modeling. To test this model experimentally, we generated E. coli K1 strains expressing OmpA with mutations of residues predicted to be critical for interaction with the HBMEC and tested E. coli invasion efficiency. For these same mutations, we predicted the interaction free energies (including explicit calculation of the entropy) from molecular dynamics (MD), finding excellent correlation (R-2 = 90%) with experimental invasion efficiency. Particularly important is that mutating specific residues in loops 1, 2, and 4 to alanines resulted in significant inhibition of E. coli K1 invasion in HBMECs, which is consistent with the complete lack of binding found in the MD simulations for these two cases. These studies suggest that inhibition of the interactions of these residues of Loop 1, 2, and 4 with Ecgp96 could provide a therapeutic strategy to prevent neonatal meningitis due to E. coli K1.	[Pascal, Tod A.; Abrol, Ravinder; Goddard, William A., III] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Mittal, Rahul; Wang, Ying; Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Div Infect Dis, Saban Res Inst, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA	California Institute of Technology; Children's Hospital Los Angeles; University of Southern California	Goddard, WA (corresponding author), CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.	wag@wag.caltech.edu	Abrol, Ravinder/R-3458-2019; Abrol, Ravinder/B-4980-2010	Abrol, Ravinder/0000-0001-7333-6793; 	National Institutes of Health [AI-040567, R01NS071112]; National Science Foundation [CMMI-072870, CTS-0608889]; U. S. Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040567, R01AI040567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-040567 (to N. V. P.) and R01NS071112. This work was also supported by grants to Caltech from the National Science Foundation (CMMI-072870 and CTS-0608889).; Supported by a graduate fellowship from the U. S. Department of Energy Computational Science Graduate Fellowship (CSGF).	Allen M. D., 1987, COMPUTER SIMULATION, P71; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; Cho AE, 2005, J COMPUT CHEM, V26, P48, DOI 10.1002/jcc.20118; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Datta D, 2003, PROTEINS, V50, P213, DOI 10.1002/prot.10257; GILLI P, 1994, J PHYS CHEM-US, V98, P1515, DOI 10.1021/j100056a024; GLADSTONE IM, 1990, PEDIATR INFECT DIS J, V9, P819, DOI 10.1097/00006454-199011000-00009; Goddard WA, 2007, J NUTR, V137, p1528S, DOI 10.1093/jn/137.6.1528S; Goddard WA, 2010, J STRUCT BIOL, V170, P10, DOI 10.1016/j.jsb.2010.01.001; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hummer G, 1998, J PHYS CHEM B, V102, P10469, DOI 10.1021/jp982873+; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kam VWT, 2008, J CHEM THEORY COMPUT, V4, P2160, DOI 10.1021/ct800196k; Kim S. K., 2008, COMPUTERS CHEM; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koedel U, 1999, INFECT DIS CLIN N AM, V13, P549, DOI 10.1016/S0891-5520(05)70094-5; Kong XJ, 1996, J CHEM PHYS, V105, P2414, DOI 10.1063/1.472109; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Lin ST, 2010, J PHYS CHEM B, V114, P8191, DOI 10.1021/jp103120q; Lin ST, 2003, J CHEM PHYS, V119, P11792, DOI 10.1063/1.1624057; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McQuarrie D. A., 2000, STAT MECH, V1st, P194; Meirovitch H, 2007, CURR OPIN STRUC BIOL, V17, P181, DOI 10.1016/j.sbi.2007.03.016; Niemer RK, 2008, J RECEPT SIG TRANSD, V28, P138; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Schlyer S. K., 2006, COMPUTERS CHEM B; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Taziarova M, 2007, NEUROENDOCRINOL LETT, V28, P18; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; UNHANAND M, 1993, J PEDIATR-US, V122, P15, DOI 10.1016/S0022-3476(05)83480-8; Vaidehi N, 2006, J BIOL CHEM, V281, P27613, DOI 10.1074/jbc.M601389200; WIDOM B, 1963, J CHEM PHYS, V39, P2808, DOI 10.1063/1.1734110; Williams DH, 2001, J AM CHEM SOC, V123, P737, DOI 10.1021/ja0029230; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7; 2007, JAGUAR VERSION 7 0	50	26	27	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37753	37761		10.1074/jbc.M110.122804	http://dx.doi.org/10.1074/jbc.M110.122804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851887	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-25	WOS:000284424000067
J	Bansal, K; Sinha, AY; Ghorpade, DS; Togarsimalemath, SK; Patil, SA; Kaveri, SV; Balaji, KN; Bayry, J				Bansal, Kushagra; Sinha, Akhauri Yash; Ghorpade, Devram Sampat; Togarsimalemath, Shambhuprasad Kotresh; Patil, Shripad A.; Kaveri, Srini V.; Balaji, Kithiganahalli Narayanaswamy; Bayry, Jagadeesh			Src Homology 3-interacting Domain of Rv1917c of Mycobacterium tuberculosis Induces Selective Maturation of Human Dendritic Cells by Regulating PI3K-MAPK-NF-kappa B Signaling and Drives Th2 Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; T-CELLS; PROTECTIVE IMMUNITY; SECRETING CD8(+); PE/PPE PROTEINS; INNATE IMMUNITY; KAPPA-B; ACTIVATION; INFECTION; TLR2	Mycobacterium tuberculosis, an etiological agent of pulmonary tuberculosis, causes significant morbidity and mortality worldwide. Pathogenic mycobacteria survive in the host by subverting host innate immunity. Dendritic cells (DCs) are professional antigen-presenting cells that are vital for eliciting immune responses to infectious agents, including pathogenic mycobacteria. DCs orchestrate distinct Th responses based on the signals they receive. In this perspective, deciphering the interactions of the proline-glutamic acid/proline-proline-glutamic acid (PE/PPE) family of proteins of M. tuberculosis with DCs assumes significant pathophysiological attributes. In this study, we demonstrate that Rv1917c (PPE34), a representative member of the proline-proline-glutamic-major polymorphic tandem repeat family, interacts with TLR2 and triggers functional maturation of human DCs. Signaling perturbations implicated a critical role for integrated cross-talk among PI3K-MAPK and NF-kappa B signaling cascades in Rv1917c-induced maturation of DCs. However, this maturation of DCs was associated with a secretion of high amounts of anti-inflammatory cytokine IL-10, whereas Th1-polarizing cytokine IL-12 was not induced. Consistent with these results, Rv1917c-matured DCs favored secretion of IL-4, IL-5, and IL-10 from CD4(+) T cells and contributed to Th2-skewed cytokine balance ex vivo in healthy individuals and in patients with pulmonary tuberculosis. Interestingly, the Rv1917c-skewed Th2 immune response involved induced expression of cyclooxygenase-2 (COX-2) in DCs. Taken together, these results indicate that Rv1917c facilitates a shift in the ensuing immunity toward the Th2 phenotype and could aid in immune evasion by mycobacteria.	[Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, U872, F-75006 Paris, France; [Bansal, Kushagra; Sinha, Akhauri Yash; Ghorpade, Devram Sampat; Togarsimalemath, Shambhuprasad Kotresh; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Patil, Shripad A.] Natl Inst Mental Hlth & Neurosci, Dept Microbiol, Bangalore 560029, Karnataka, India; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, Equipe Immunopathol & Therapeut Immunointervent 1, Ctr Rech Cordeliers, Unite Mixte Rech Sante 872, F-75006 Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Unite Mixte Rech Sante 872, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bayry, J (corresponding author), INSERM, U872, F-75006 Paris, France.	balaji@mcbl.iisc.ernet.in; jagadeesh.bayry@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; KOTRESH TOGARSIMALEMATH, SHAMBHUPRASAD/0000-0003-2935-5377; Kaveri, Srini/0000-0002-0837-4053	Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, India; INSERM; CNRS; Universite Pierre et Marie Curie; Universite Paris Descartes, France; Cooperation INSERM [ICMR-AO 2009/2010]	Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; Universite Paris Descartes, France; Cooperation INSERM	This work was supported in part by Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, India (to K. N. B.), INSERM, CNRS, and Universite Pierre et Marie Curie and Universite Paris Descartes, France (to S. V. K. and J. B.), and Cooperation INSERM-ICMR-AO 2009/2010 (to K. N. B. and J. B.).	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anis MM, 2008, INFECT IMMUN, V76, P671, DOI 10.1128/IAI.01079-07; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Baliko Z, 1998, FEMS IMMUNOL MED MIC, V22, P199, DOI 10.1016/S0928-8244(98)00089-3; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Bayry J, 2008, P NATL ACAD SCI USA, V105, P10221, DOI 10.1073/pnas.0803453105; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P3093, DOI 10.1128/IAI.61.7.3093-3097.1993; Boisleve F, 2005, TOXICOLOGY, V206, P233, DOI 10.1016/j.tox.2004.08.015; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chaitra MG, 2008, MICROBES INFECT, V10, P858, DOI 10.1016/j.micinf.2008.04.017; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Chandra BR, 2004, PROTEIN ENG DES SEL, V17, P175, DOI 10.1093/protein/gzh024; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coventry BJ, 2002, BRIT J CANCER, V86, P546, DOI 10.1038/sj.bjc.6600132; Daly LM, 2005, VACCINE, V23, P963, DOI 10.1016/j.vaccine.2004.03.072; Davies MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008084; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Feng CG, 1999, INFECT IMMUN, V67, P3242, DOI 10.1128/IAI.67.7.3242-3247.1999; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gordon SV, 2001, TUBERCULOSIS, V81, P157, DOI 10.1054/tube.2000.0269; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Liu LM, 1998, INT IMMUNOL, V10, P1017, DOI 10.1093/intimm/10.8.1017; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Means TK, 1999, J IMMUNOL, V163, P3920; Meyer F, 2003, J IMMUNOL, V171, P3913, DOI 10.4049/jimmunol.171.8.3913; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Brien R, 2000, J CLIN MICROBIOL, V38, P1723, DOI 10.1128/JCM.38.5.1723-1730.2000; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pathak SK, 2004, J BIOL CHEM, V279, P55127, DOI 10.1074/jbc.M409885200; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shelton H, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-24; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Sousa CRE, 2001, IMMUNITY, V14, P495; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Valentinis B, 2005, J BIOL CHEM, V280, P14264, DOI 10.1074/jbc.M410791200; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; *WHO, 2007, WHOHTMTB2007376 WHO; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	80	84	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36511	36522		10.1074/jbc.M110.158055	http://dx.doi.org/10.1074/jbc.M110.158055			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837474	hybrid, Green Published			2022-12-25	WOS:000284146100058
J	Ravenhill, L; Wagstaff, L; Edwards, DR; Ellis, V; Bass, R				Ravenhill, Lorna; Wagstaff, Laura; Edwards, Dylan R.; Ellis, Vincent; Bass, Rosemary			G-helix of Maspin Mediates Effects on Cell Migration and Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-6; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSIVE MASPIN; BREAST-CANCER CELLS; PLASMINOGEN-ACTIVATOR; UROKINASE-TYPE; CRYSTAL-STRUCTURE; INHIBITION; SERPIN; PROSTATE	Maspin is a member of the serine protease inhibitor (serpin) superfamily that lacks protease inhibitory ability, although displaying tumor metastasis-suppressing activity resulting from its influence on cell migration, invasion, proliferation, apoptosis, and adhesion. The molecular mechanisms of these actions of maspin are as yet undefined. Here, we sought to identify critical functional motifs by the expression of maspin with point mutations at sites potentially involved in protein-protein interactions: the G alpha-helix (G-helix), an internal salt bridge or the P1 position of the reactive center loop. Our findings indicate that only mutations in the G-helix attenuated inhibition of cell migration by maspin and that this structural element is also involved in the effect of maspin on cell adhesion. The action of maspin on cell migration could be mimicked by a 15-mer G-helix peptide, indicating that the G-helix is both essential and sufficient for this effect. In addition, we provide evidence that the effects of the G-helix of maspin are dependent on beta 1 integrins. These data reveal that the major extracellular functions associated with the tumor suppressive action of maspin likely involve interactions in which the G-helix plays a key role.	[Ravenhill, Lorna; Wagstaff, Laura; Edwards, Dylan R.; Ellis, Vincent; Bass, Rosemary] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Bass, R (corresponding author), Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.	r.bass@uea.ac.uk	Edwards, Dylan R/B-4734-2009; Ellis, Vincent/D-1860-2009; Bass, Rosemary A/A-5328-2009	Edwards, Dylan R/0000-0002-3292-2064; Ellis, Vincent/0000-0003-1956-073X; Bass, Rosemary A/0000-0003-4997-5207	British Heart Foundation [FS/05/063]; Big C [07-27R]; BBSRC DTA; European Union [LSHC-CT-2003-503297]; Suzie Wright Fund	British Heart Foundation(British Heart Foundation); Big C; BBSRC DTA(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Suzie Wright Fund	This work was supported by grants from the British Heart Foundation Intermediate Research Fellowship FS/05/063 (to R. B.), the Big C Appeal Project Grant 07-27R (to L. W.), a BBSRC DTA studentship (to L. R.), European Union Framework Programme 6 Cancerdegradome Project LSHC-CT-2003-503297, and the Suzie Wright Fund.	Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Al-Ayyoubi M, 2007, J BIOL CHEM, V282, P19502, DOI 10.1074/jbc.M702445200; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, J BIOL CHEM, V284, P27712, DOI 10.1074/jbc.M109.038919; Biliran H, 2001, CANCER RES, V61, P8676; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; D'Andrea LD, 2006, CHEM BIOL DRUG DES, V67, P115, DOI 10.1111/j.1747-0285.2006.00356.x; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; McGowen R, 2000, CANCER RES, V60, P4771; Messent AJ, 1998, J CELL SCI, V111, P1127; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Shao L, 2008, CANCER RES, V68, P5143, DOI 10.1158/0008-5472.CAN-08-0163; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shi HY, 2001, CANCER RES, V61, P6945; Tan M, 1999, CANCER RES, V59, P1620; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	33	30	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36285	36292		10.1074/jbc.M110.177253	http://dx.doi.org/10.1074/jbc.M110.177253			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837467	hybrid, Green Published			2022-12-25	WOS:000284146100006
J	Falkowski, MA; Thomas, DDH; Groblewski, GE				Falkowski, Michelle A.; Thomas, Diana D. H.; Groblewski, Guy E.			Complexin 2 Modulates Vesicle-associated Membrane Protein (VAMP) 2-regulated Zymogen Granule Exocytosis in Pancreatic Acini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX; REGULATED EXOCYTOSIS; EXOCRINE PANCREAS; CELLS; FUSION; IDENTIFICATION; DISTINCT; SECRETION; RELEASE; CRHSP-28	Complexins are soluble proteins that regulate the activity of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes necessary for vesicle fusion. Neuronal specific complexin 1 has inhibitory and stimulatory effects on exocytosis by clamping trans-SNARE complexes in a prefusion state and promoting conformational changes to facilitate membrane fusion following cell stimulation. Complexins are unable to bind to monomeric SNARE proteins but bind with high affinity to ternary SNARE complexes and with lower affinity to target SNARE complexes. Far less is understood about complexin function outside the nervous system. Pancreatic acini express the complexin 2 isoform by RT-PCR and immunoblotting. Immunofluorescence microscopy revealed complexin 2 localized along the apical plasma membrane consistent with a role in secretion. Accordingly, complexin 2 was found to interact with vesicle-associated membrane protein (VAMP) 2, syntaxins 3 and 4, but not with VAMP 8 or syntaxin 2. Introduction of recombinant complexin 2 into permeabilized acini inhibited Ca2+-stimulated secretion in a concentration-dependent manner with a maximal inhibition of nearly 50%. Mutations of the central alpha-helical domain reduced complexin 2 SNARE binding and concurrently abolished its inhibitory activity. Surprisingly, mutation of arginine 59 to histidine within the central alpha-helical domain did not alter SNARE binding and moreover, augmented Ca2+-stimulated secretion by 130% of control. Consistent with biochemical studies, complexin 2 colocalized with VAMP 2 along the apical plasma membrane following cholecystokinin-8 stimulation. These data demonstrate a functional role for complexin 2 outside the nervous system and indicate that it participates in the Ca2+-sensitive regulatory pathway for zymogen granule exocytosis.	[Falkowski, Michelle A.; Thomas, Diana D. H.; Groblewski, Guy E.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Groblewski, GE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	groby@nutrisci.wisc.edu			National Institutes of Health [DK07088]; United States Department of Agriculture [WISO4958]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by National Institutes of Health Grant DK07088. This work was also supported by United States Department of Agriculture HATCH Grant WISO4958 (to G. E. G.).	BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1209, DOI 10.1152/ajpcell.00159.2005; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Fujita-Yoshigaki J, 2000, J THEOR BIOL, V204, P165, DOI 10.1006/jtbi.2000.2009; Gaisano HY, 1996, GASTROENTEROLOGY, V111, P1661, DOI 10.1016/S0016-5085(96)70030-6; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Groblewski GE, 1996, J BIOL CHEM, V271, P31502, DOI 10.1074/jbc.271.49.31502; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Liu JG, 2006, BIOCHEM BIOPH RES CO, V347, P413, DOI 10.1016/j.bbrc.2006.06.085; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SINGH P, 1988, AM J PHYSIOL, V254, pG217, DOI 10.1152/ajpgi.1988.254.2.G217; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sutton R, 2003, PANCREATOLOGY, V3, P497, DOI 10.1159/000075581; Tadokoro S, 2005, J CELL SCI, V118, P2239, DOI 10.1242/jcs.02338; Tadokoro S, 2010, CELL IMMUNOL, V261, P51, DOI 10.1016/j.cellimm.2009.10.011; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Thomas DDH, 2004, AM J PHYSIOL-GASTR L, V287, pG253, DOI 10.1152/ajpgi.00033.2004; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Thomas DDH, 2001, J BIOL CHEM, V276, P28866, DOI 10.1074/jbc.M102214200; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Weng N, 2009, AM J PHYSIOL-GASTR L, V296, pG1030, DOI 10.1152/ajpgi.90592.2008; WILLIAMS JA, 1984, ANNU REV PHYSIOL, V46, P361; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446	44	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35558	35566		10.1074/jbc.M110.146597	http://dx.doi.org/10.1074/jbc.M110.146597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829354	Green Published, hybrid			2022-12-25	WOS:000283845300034
J	Gajda, A; Towpik, J; Steuerwald, U; Muller, CW; Lefebvre, O; Boguta, M				Gajda, Anna; Towpik, Joanna; Steuerwald, Ulrich; Mueller, Christoph W.; Lefebvre, Olivier; Boguta, Magdalena			Full Repression of RNA Polymerase III Transcription Requires Interaction between Two Domains of Its Negative Regulator Maf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ONCOGENIC TRANSFORMATION; RIBOSOME BIOSYNTHESIS; NUCLEAR-LOCALIZATION; YEAST; PREDICTION; DEPHOSPHORYLATION; PHOSPHORYLATION; PROLIFERATION; MACHINERY	Maf1, first identified in yeast Saccharomyces cerevisiae, is a general negative regulator of RNA polymerase III (Pol III). Transcription regulation by Maf1 is important under stress conditions and during the switch between fermentation and respiration. Maf1 is composed of two domains conserved during evolution. We report here that these two domains of human Maf1 are resistant to mild proteolysis and interact together as shown by pull-down and size-exclusion chromatography and that the comparable domains of yeast Maf1 interact in a two-hybrid assay. Additionally, in yeast, a mutation in the N-terminal domain is compensated by mutations in the C-terminal domain. Integrity of both domains and their direct interaction are necessary for Maf1 dephosphorylation and subsequent inhibition of Pol III transcription on a nonfermentable carbon source. These data relate Pol III transcription inhibition to Maf1 structural changes.	[Gajda, Anna; Lefebvre, Olivier] CEA, iBiTecS, F-91191 Gif Sur Yvette, France; [Gajda, Anna; Towpik, Joanna; Boguta, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Steuerwald, Ulrich; Mueller, Christoph W.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Boguta, Magdalena] Warsaw Univ Technol, Fac Chem, PL-00664 Warsaw, Poland	CEA; UDICE-French Research Universities; Universite Paris Saclay; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; European Molecular Biology Laboratory (EMBL); Warsaw University of Technology	Lefebvre, O (corresponding author), CEA, iBiTecS, F-91191 Gif Sur Yvette, France.	Olivier.Lefebvre@Cea.Fr; magda@ibb.waw.pl	Müller, Christoph W/I-7420-2012; LEFEBVRE, Olivier/C-3847-2014	Müller, Christoph W/0000-0003-2176-8337; LEFEBVRE, Olivier/0000-0002-3903-9450; Boguta, Magdalena/0000-0002-1545-0691	Ministry of Science and Higher Education, Poland [N301 023 32/1117, N301 243236]; French National Research Agency [ANR-07-BLAN-0039-01]; Association pour la Recherche contre le Cancer [1078]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); French National Research Agency(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Ministry of Science and Higher Education, Poland, Grants N301 023 32/1117 and N301 243236, French National Research Agency Grant ANR-07-BLAN-0039-01, and Association pour la Recherche contre le Cancer Grant 1078.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; HARPER JW, 1993, CELL, V75, P805; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Manaud N, 1998, MOL CELL BIOL, V18, P3191, DOI 10.1128/MCB.18.6.3191; Marshall L, 2008, CELL CYCLE, V7, P3327, DOI 10.4161/cc.7.21.6970; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Rollins J, 2007, INT J BIOL SCI, V3, P292; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; WERNER M, 1993, J BIOL CHEM, V268, P20721; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9	40	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35719	35727		10.1074/jbc.M110.125286	http://dx.doi.org/10.1074/jbc.M110.125286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817737	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000283845300050
J	Iwabu, Y; Kinomoto, M; Tatsumi, M; Fujita, H; Shimura, M; Tanaka, Y; Ishizaka, Y; Nolan, D; Mallal, S; Sata, T; Tokunaga, K				Iwabu, Yukie; Kinomoto, Masanobu; Tatsumi, Masashi; Fujita, Hideaki; Shimura, Mari; Tanaka, Yoshitaka; Ishizaka, Yukihito; Nolan, David; Mallal, Simon; Sata, Tetsutaro; Tokunaga, Kenzo			Differential Anti-APOBEC3G Activity of HIV-1 Vif Proteins Derived from Different Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; HUMAN APOBEC3G; TYPE-1 VIF; ANTIVIRAL ACTIVITY; LINE-1 RETROTRANSPOSITION; MONONUCLEAR PHAGOCYTES; ANTIRETROVIRAL FACTOR; RETROVIRAL INFECTION; CYTIDINE DEAMINASES	Antiretroviral cytidine deaminase APOBEC3G, which is abundantly expressed in peripheral blood lymphocytes and macrophages, strongly protects these cells against HIV-1 infection. The HIV-1 Vif protein overcomes this antiviral effect by enhancing proteasome-mediated APOBEC3G degradation and is key for maintaining viral infectivity. The 579-bp-long vif gene displays high genetic diversity among HIV-1 subtypes. Therefore, it is intriguing to address whether Vif proteins derived from different subtypes differ in their viral defense activity against APOBEC3G. Expression plasmids encoding Vif proteins derived from subtypes A, B, C, CRF01_AE, and CRF02_AG isolates were created, and their anti-APOBEC3G activities were compared. Viruses produced from cells expressing APOBEC3G and Vif proteins from different subtypes showed relatively different viral infectivities. Notably, subtype C-derived Vif proteins tested had the highest activity against APOBEC3G that was ascribed to its increased binding activity, for which the N-terminal domain of the Vif protein sequences was responsible. These results suggest that the biological differences of Vif proteins belonging to different subtypes might affect viral fitness and quasispecies in vivo.	[Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Tatsumi, Masashi] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 1628640, Japan; [Fujita, Hideaki; Tanaka, Yoshitaka] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka 8128582, Japan; [Shimura, Mari; Ishizaka, Yukihito] Int Med Ctr Japan, Dept Intractable Dis, Tokyo 1628655, Japan; [Nolan, David; Mallal, Simon] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; [Nolan, David; Mallal, Simon] Murdoch Univ, Perth, WA 6000, Australia	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kyushu University; National Center for Global Health & Medicine - Japan; Royal Perth Hospital; University of Western Australia; Murdoch University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan.	tokunaga@nih.go.jp	Tokunaga, Kenzo/Q-9914-2018; Mallal, Simon Alexander/HDM-9561-2022	Tokunaga, Kenzo/0000-0002-2625-5322; Mallal, Simon Alexander/0000-0002-7036-1309; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor, and Welfare of Japan (Research on HIV/AIDS) [H21-009]; Ministry of Education, Science, Technology, Sports and Culture of Japan	Ministry of Health, Labor, and Welfare of Japan (Research on HIV/AIDS)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (Research on HIV/AIDS; H21-009) and from the Ministry of Education, Science, Technology, Sports and Culture of Japan.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dang Y, 2010, J VIROL, V84, P8561, DOI 10.1128/JVI.00960-10; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Donahue JP, 2008, VIROLOGY, V377, P49, DOI 10.1016/j.virol.2008.04.017; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P991, DOI 10.1089/aid.2008.0077; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Koulinska IN, 2003, AIDS RES HUM RETROV, V19, P1115, DOI 10.1089/088922203771881211; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Langlois MA, 2008, J VIROL, V82, P4660, DOI 10.1128/JVI.02469-07; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; MIYAGI E, 2010, J VIROL IN PRESS; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Mulder LCF, 2010, J VIROL, V84, P9613, DOI 10.1128/JVI.02630-09; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Pollakis G, 2004, J VIROL, V78, P2841, DOI 10.1128/JVI.78.6.2841-2852.2004; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Salminen MO, 1996, AIDS RES HUM RETROV, V12, P1329, DOI 10.1089/aid.1996.12.1329; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stephens EB, 2001, AIDS RES HUM RETROV, V17, P169, DOI 10.1089/08892220150217256; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wieland U, 1997, J GEN VIROL, V78, P393, DOI 10.1099/0022-1317-78-2-393; WIELAND U, 1994, VIROLOGY, V203, P43, DOI 10.1006/viro.1994.1453; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	82	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35350	35358		10.1074/jbc.M110.173286	http://dx.doi.org/10.1074/jbc.M110.173286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833716	Green Published, hybrid			2022-12-25	WOS:000283845300013
J	Quintero, OA; Moore, JE; Unrath, WC; Manor, U; Salles, FT; Grati, M; Kachar, B; Yengo, CM				Quintero, Omar A.; Moore, Judy E.; Unrath, William C.; Manor, Uri; Salles, Felipe T.; Grati, M'hamed; Kachar, Bechara; Yengo, Christopher M.			Intermolecular Autophosphorylation Regulates Myosin IIIa Activity and Localization in Parallel Actin Bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; UNCONVENTIONAL MYOSIN; STRUCTURAL BASIS; ATPASE ACTIVITY; TAIL DOMAIN; CELL-CYCLE; MOTOR; STEREOCILIA; FILOPODIA; MUSCLE	Myosin IIIa (Myo3A) transports cargo to the distal end of actin protrusions and contains a kinase domain that is thought to autoregulate its activity. Because Myo3A tends to cluster at the tips of actin protrusions, we investigated whether intermolecular phosphorylation could regulate Myo3A biochemical activity, cellular localization, and cellular function. Inactivation of Myo3A 2IQ kinase domain with the point mutation K50R did not alter maximal ATPase activity, whereas phosphorylation of Myo3A 2IQ resulted in reduced maximal ATPase activity and actin affinity. The rate and degree of Myo3A 2IQ autophosphorylation was unchanged by the presence of actin but was found to be dependent upon Myo3A 2IQ concentration within the range of 0.1 to 1.2 mu M, indicating intermolecular autophosphorylation. In cultured cells, we observed that the filopodial tip localization of Myo3A lacking the kinase domain decreased when co-expressed with kinase-active, full-length Myo3A. The cellular consequence of reduced Myo3A tip localization was decreased filopodial density along the cell periphery, identifying a novel cellular function for Myo3A in mediating the formation and stability of actin-based protrusions. Our results suggest that Myo3A motor activity is regulated through a mechanism involving concentration-dependent autophosphorylation. We suggest that this regulatory mechanism plays an essential role in mediating the transport and actin bundle formation/stability functions of Myo3A.	[Yengo, Christopher M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Manor, Uri; Salles, Felipe T.; Grati, M'hamed; Kachar, Bechara] NIDCD, Lab Cell Struct & Dynam, NIH, Bethesda, MD 20894 USA; [Moore, Judy E.; Yengo, Christopher M.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of North Carolina; University of North Carolina Charlotte	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	cmy11@psu.edu	Salles, Felipe/H-7544-2013; Grati, M'hamed/C-9563-2011	Manor, Uri/0000-0002-9802-1955; Grati, M'hamed/0000-0002-4490-1682; Quintero-Carmona, Omar/0000-0002-9314-1704; Grati, Mhamed/0000-0001-5149-3245	National Institutes of Health [EY018141, HL093531]; NIH DIR [DC000002-22]; NATIONAL EYE INSTITUTE [R01EY018141] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018141 and HL093531 (to C.M.Y.) and NIH DIR Grant DC000002-22 (to B.K.).	Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Boger ET, 2008, MYOSINS SUPERFAMILY, P441; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cronin MA, 2004, J CELL SCI, V117, P4797, DOI 10.1242/jcs.01371; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kambara T, 2006, J BIOL CHEM, V281, P37291, DOI 10.1074/jbc.M603823200; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Komaba S, 2003, J BIOL CHEM, V278, P21352, DOI 10.1074/jbc.M300757200; Komaba S, 2010, BIOCHEMISTRY-US, V49, P3695, DOI 10.1021/bi902211w; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Lu HL, 2006, J BIOL CHEM, V281, P31987, DOI 10.1074/jbc.M605181200; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Naoz M, 2008, BIOPHYS J, V95, P5706, DOI 10.1529/biophysj.108.143453; Ng KP, 1996, BIOCHEMISTRY-US, V35, P9392, DOI 10.1021/bi960181a; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Quintero OA, 2003, MOL BIOL CELL S, V14s, P1010; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; SELLERS JR, 1999, MYOSINS, P75; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699	46	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35770	35782		10.1074/jbc.M110.144360	http://dx.doi.org/10.1074/jbc.M110.144360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826793	Green Published, hybrid			2022-12-25	WOS:000283845300055
J	Yamaji, T; Nishikawa, K; Hanada, K				Yamaji, Toshiyuki; Nishikawa, Kiyotaka; Hanada, Kentaro			Transmembrane BAX Inhibitor Motif Containing (TMBIM) Family Proteins Perturbs a trans-Golgi Network Enzyme, Gb3 Synthase, and Reduces Gb3 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBO-SERIES GLYCOSPHINGOLIPIDS; HUMAN ENDOTHELIAL-CELLS; BREAST-CANCER CELLS; ENDOPLASMIC-RETICULUM; CERAMIDE GALACTOSYLTRANSFERASE; GENE-EXPRESSION; IN-VITRO; CLONING; BINDING; GLOBOTRIAOSYLCERAMIDE	Globotriaosylceramide (Gb3) is a well known receptor for Shiga toxin (Stx), produced by enterohemorrhagic Escherichia coli and Shigella dysenteriae. The expression of Gb3 also affects several diseases, including cancer metastasis and Fabry disease, which prompted us to look for factors involved in its metabolism. In the present study, we isolated two cDNAs that conferred resistance to Stx-induced cell death in HeLa cells by expression cloning: ganglioside GM3 synthase and the COOH terminus region of glutamate receptor, ionotropic, N-methyl-D-asparate-associated protein 1 (GRINA), a member of the transmembrane BAX inhibitor motif containing (TMBIM) family. Overexpression of the truncated form, named GRINA-C, and some members of the full-length TMBIM family, including FAS inhibitory molecule 2 (FAIM2), reduced Gb3, and lactosylceramide was accumulated instead. The change of glycolipid composition was restored by overexpression of Gb3 synthase, suggesting that the synthase is affected by GRINA-C and FAIM2. Interestingly, the mRNA level of Gb3 synthase was unchanged. Rather, localization of the synthase as well as TGN46, a trans-Golgi network marker, was perturbed to form punctate structures, and degradation of the synthase in lysosomes was enhanced. Furthermore, GRINA-C was associated with Gb3 synthase. These observations may demonstrate a new type of posttranscriptional regulation of glycosyltransferases.	[Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Nishikawa, Kiyotaka] Doshisha Univ, Dept Mol Life Sci, Kyoto 6100321, Japan	National Institute of Infectious Diseases (NIID); Doshisha University	Yamaji, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tyamaji@nih.go.jp		Hanada, Kentaro/0000-0003-1383-2781	Ministry of Education, Culture, Sports, Science and Technology of Japan [20770114]; Japan Society for the Promotion of Science [22370054]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-aid for Young Scientists (B) No. 20770114 (to T. Y.) and Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (B) No. 22370054 (to K. H.).	Aikawa H, 2003, TOHOKU J EXP MED, V199, P25, DOI 10.1620/tjem.199.25; Bao XD, 2001, NEUROSCI LETT, V315, P5, DOI 10.1016/S0304-3940(01)02317-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bucan V, 2010, CELL MOL BIOL LETT, V15, P296, DOI 10.2478/s11658-010-0009-1; CICCARELLI E, 1993, EUR J BIOCHEM, V213, P271, DOI 10.1111/j.1432-1033.1993.tb17759.x; Clarke JTR, 2007, ANN INTERN MED, V146, P425, DOI 10.7326/0003-4819-146-6-200703200-00007; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Di Sano F, 2007, J NEUROCHEM, V102, P345, DOI 10.1111/j.1471-4159.2007.04479.x; FARKASHIMSLEY H, 1995, P NATL ACAD SCI USA, V92, P6996, DOI 10.1073/pnas.92.15.6996; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Harima Y, 2004, INT J RADIAT ONCOL, V60, P237, DOI 10.1016/j.ijrobp.2004.02.047; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; Lee I, 2004, J BIOL CHEM, V279, P53007, DOI 10.1074/jbc.M405717200; Lesniewski M, 2006, VIROLOGY, V354, P286, DOI 10.1016/j.virol.2006.06.035; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; NUDELMAN E, 1983, SCIENCE, V220, P509, DOI 10.1126/science.6836295; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Okemoto-Nakamura Y, 2008, MICROBIOL IMMUNOL, V52, P357, DOI 10.1111/j.1348-0421.2008.00046.x; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van der Bijl P, 1996, BIOCHEM J, V317, P589, DOI 10.1042/bj3170589; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yoshisue H, 2002, ATHEROSCLEROSIS, V162, P323, DOI 10.1016/S0021-9150(01)00735-3; Yoshizaki F, 2008, BBA-GEN SUBJECTS, V1780, P383, DOI 10.1016/j.bbagen.2007.11.004; Zheng Y, 2005, J MICROBIOL, V43, P529	56	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35505	35518		10.1074/jbc.M110.154229	http://dx.doi.org/10.1074/jbc.M110.154229			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837469	Green Published, hybrid			2022-12-25	WOS:000283845300029
J	Goshima, T; Kume, K; Koyano, T; Ohya, Y; Toda, T; Hirata, D				Goshima, Tetsuya; Kume, Kazunori; Koyano, Takayuki; Ohya, Yoshikazu; Toda, Takashi; Hirata, Dai			Fission Yeast Germinal Center (GC) Kinase Ppk11 Interacts with Pmo25 and Plays an Auxiliary Role in Concert with the Morphogenesis Orb6 Network (MOR) in Cell Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; SCHIZOSACCHAROMYCES-POMBE; GROWTH POLARITY; PROTEIN-KINASE; MO25 PROTEIN; DROSOPHILA; COMPLEX; MOUSE; NAK1; GENE	How cell morphology and the cell cycle are coordinately regulated is a fundamental subject in cell biology. In fission yeast, 2 germinal center kinases (GCKs), Sid1 and Nak1, play an essential role in septation/cytokinesis and cell separation/cell polarity control, respectively, as components of the septation initiation network (SIN) and the morphogenesis Orb6 network (MOR). Here we show that a third GCK, Ppk11, is also required for efficient cell separation particularly, at a high temperature. Although Ppk11 is not essential for cell division, this kinase plays an auxiliary role in concert with MOR in cell morphogenesis. Ppk11 physically interacts with the MOR component Pmo25 and is localized to the septum, by which Ppk11 is crucial for Pmo25 targeting/accumulation to the septum. The conserved C-terminal WDF motif of Ppk11 is essential for both septum accumulation of Pmo25 and efficient cell separation. In contrast its kinase activity is required only for cell separation. Thus, both interaction of Ppk11 with Pmo25 and Ppk11 kinase activity are critical for efficient cell separation.	[Goshima, Tetsuya; Kume, Kazunori; Koyano, Takayuki; Hirata, Dai] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Toda, Takashi] Canc Res UK, London Res Inst, Lab Cell Regulat, London WC2A 3PX, England	Hiroshima University; University of Tokyo; Cancer Research UK	Hirata, D (corresponding author), 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	dhirata@hiroshima-u.ac.jp	Ohya, Yoshikazu/AAW-2200-2021; Kume, Kazunori/T-4061-2018	Ohya, Yoshikazu/0000-0003-0837-1239; Kume, Kazunori/0000-0002-0613-8081; Koyano, Takayuki/0000-0003-1675-2525	Ministry of Education, Science, and Culture of Japan; Cancer Research UK	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research UK(Cancer Research UK)	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (to K. K. and D. H.) and the Cancer Research UK (to T. T.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; BA H, 2001, EMBO J, V20, P1064; BA H, 1998, J R YEAST */* YEAST, V14, P943; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Huang TY, 2003, J BIOL CHEM, V278, P991, DOI 10.1074/jbc.M208993200; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Karos M, 1999, MOL GEN GENET, V260, P510, DOI 10.1007/s004380050924; Koyano T, 2010, BIOSCI BIOTECH BIOCH, V74, P1129, DOI 10.1271/bbb.100223; Kume K, 2007, BIOSCI BIOTECH BIOCH, V71, P615, DOI 10.1271/bbb.60574; MARKS J, 1986, J CELL SCI, P229; MATSUSAKA T, 1995, EMBO J, V14, P3325, DOI 10.1002/j.1460-2075.1995.tb07339.x; Mendoza M, 2005, EUR J CELL BIOL, V84, P915, DOI 10.1016/j.ejcb.2005.09.013; MITCHISON JM, 1985, J CELL SCI, V75, P357; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; MIYAMOTO H, 1993, MOL REPROD DEV, V34, P1, DOI 10.1002/mrd.1080340102; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nozaki M, 1996, DNA CELL BIOL, V15, P505, DOI 10.1089/dna.1996.15.505; Simanis V, 2003, J CELL SCI, V116, P4263, DOI 10.1242/jcs.00807; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Yamamoto Y, 2008, BIOCHEM BIOPH RES CO, V366, P212, DOI 10.1016/j.bbrc.2007.11.128; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	30	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35196	35205		10.1074/jbc.M110.176867	http://dx.doi.org/10.1074/jbc.M110.176867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826805	hybrid, Green Published			2022-12-25	WOS:000283659100093
J	Bulgarelli, D; Biselli, C; Collins, NC; Consonni, G; Stanca, AM; Schulze-Lefert, P; Vale, G				Bulgarelli, Davide; Biselli, Chiara; Collins, Nicholas C.; Consonni, Gabriella; Stanca, Antonio M.; Schulze-Lefert, Paul; Vale, Giampiero			The CC-NB-LRR-Type Rdg2a Resistance Gene Confers Immunity to the Seed-Borne Barley Leaf Stripe Pathogen in the Absence of Hypersensitive Cell Death	PLOS ONE			English	Article							RACE-SPECIFIC RESISTANCE; POWDERY MILDEW FUNGUS; PYRENOPHORA-GRAMINEA; VIRUS-RESISTANCE; PLANT; EXPRESSION; IDENTIFICATION; EVOLUTION; WHEAT; DIVERSITY	Background: Leaf stripe disease on barley (Hordeum vulgare) is caused by the seed-transmitted hemi-biotrophic fungus Pyrenophora graminea. Race-specific resistance to leaf stripe is controlled by two known Rdg (Resistance to Drechslera graminea) genes: the H. spontaneum-derived Rdg1a and Rdg2a, identified in H. vulgare. The aim of the present work was to isolate the Rdg2a leaf stripe resistance gene, to characterize the Rdg2a locus organization and evolution and to elucidate the histological bases of Rdg2a-based leaf stripe resistance. Principal Findings: We describe here the positional cloning and functional characterization of the leaf stripe resistance gene Rdg2a. At the Rdg2a locus, three sequence-related coiled-coil, nucleotide-binding site, and leucine-rich repeat (CC-NB-LRR) encoding genes were identified. Sequence comparisons suggested that paralogs of this resistance locus evolved through recent gene duplication, and were subjected to frequent sequence exchange. Transformation of the leaf stripe susceptible cv. Golden Promise with two Rdg2a-candidates under the control of their native 5' regulatory sequences identified a member of the CC-NB-LRR gene family that conferred resistance against the Dg2 leaf stripe isolate, against which the Rdg2a-gene is effective. Histological analysis demonstrated that Rdg2a-mediated leaf stripe resistance involves autofluorescing cells and prevents pathogen colonization in the embryos without any detectable hypersensitive cell death response, supporting a cell wall reinforcement-based resistance mechanism. Conclusions: This work reports about the cloning of a resistance gene effective against a seed borne disease. We observed that Rdg2a was subjected to diversifying selection which is consistent with a model in which the R gene co-evolves with a pathogen effector(s) gene. We propose that inducible responses giving rise to physical and chemical barriers to infection in the cell walls and intercellular spaces of the barley embryo tissues represent mechanisms by which the CC-NB-LRR-encoding Rdg2a gene mediates resistance to leaf stripe in the absence of hypersensitive cell death.	[Bulgarelli, Davide; Biselli, Chiara; Stanca, Antonio M.; Vale, Giampiero] CRA GPG, Genom Res Ctr, Fiorenzuola Darda, Italy; [Bulgarelli, Davide; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-5000 Cologne, Germany; [Collins, Nicholas C.] Univ Adelaide, Australian Ctr Plant Funct Genom, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Consonni, Gabriella] Univ Milan, DiPROVE, Milan, Italy	Max Planck Society; University of Adelaide; University of Milan	Bulgarelli, D (corresponding author), CRA GPG, Genom Res Ctr, Fiorenzuola Darda, Italy.	giampiero.vale@entecra.it	Schulze-Lefert, Paul/B-6707-2011; Valè, Giampiero/ABF-1492-2020	Valè, Giampiero/0000-0003-2158-9726; Bulgarelli, Davide/0000-0002-2020-6642	Ministero per le Politiche Agricole, Alimentari e Forestali; MiPAF	Ministero per le Politiche Agricole, Alimentari e Forestali; MiPAF	This study was funded by grants from Ministero per le Politiche Agricole, Alimentari e Forestali, MiPAF, (PROTEO-STRESS and AGRO-NANOTECH projects) to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 1997, PLANT CELL, V9, P641, DOI 10.1105/tpc.9.4.641; Arru L, 2002, GENOME, V45, P460, DOI [10.1139/g02-004, 10.1139/G02-004]; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Biselli C, 2010, THEOR APPL GENET, V120, P1207, DOI 10.1007/s00122-009-1248-2; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Bulgarelli D, 2004, THEOR APPL GENET, V108, P1401, DOI 10.1007/s00122-003-1557-9; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Dangl JL, 2006, P NATL ACAD SCI USA, V103, P8575, DOI 10.1073/pnas.0603183103; Delogu G., 1995, Rachis, V14, P29; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; FREIALDENHOVEN A, 1994, PLANT CELL, V6, P983; Gassmann W, 2005, MOL PLANT MICROBE IN, V18, P1054, DOI 10.1094/MPMI-18-1054; GATTI A, 1992, Journal of Genetics and Breeding, V46, P179; Giuliani C, 2002, ANN BOT-LONDON, V90, P287, DOI 10.1093/aob/mcf173; GORG R, 1993, PLANT J, V3, P857, DOI 10.1111/j.1365-313X.1993.00857.x; HAEGI A, 1995, PHYSIOL MOL PLANT P, V46, P429, DOI 10.1006/pmpp.1995.1033; Haegi A, 2008, MOL PLANT PATHOL, V9, P463, DOI 10.1111/J.1364-3703.2008.00479.X; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; HAMMOUDA AM, 1988, ACTA PHYTOPATHOL HUN, V23, P73; Hayashi K, 2009, PLANT J, V57, P413, DOI 10.1111/j.1365-313X.2008.03694.x; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Jones DA, 1997, ADV BOT RES, V24, P89; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kohler RH, 1998, TRENDS PLANT SCI, V3, P317, DOI 10.1016/S1360-1385(98)01276-X; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Liu J, 2008, MOL PLANT, V1, P411, DOI 10.1093/mp/ssn010; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; McDowell JM, 2008, DEV COMP IMMUNOL, V32, P736, DOI 10.1016/j.dci.2007.11.005; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Mueller KJ, 2003, J PLANT PATHOL, V85, P9; Pecchioni N, 1996, THEOR APPL GENET, V93, P97, DOI 10.1007/BF00225733; Platenkamp R., 1976, R VET AGR U YB, P49; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; Sakata K, 2002, NUCLEIC ACIDS RES, V30, P98, DOI 10.1093/nar/30.1.98; Seeholzer S, 2010, MOL PLANT MICROBE IN, V23, P497, DOI 10.1094/MPMI-23-4-0497; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Tacconi G, 2001, THEOR APPL GENET, V102, P1286, DOI 10.1007/s001220000510; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; Wang M, 1996, PLANT MOL BIOL, V32, P1125, DOI 10.1007/BF00041396; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Wei FS, 1999, GENETICS, V153, P1929; Wulff BBH, 2009, MOL PLANT MICROBE IN, V22, P1191, DOI 10.1094/MPMI-22-10-1191; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yahiaoui N, 2009, PLANT J, V57, P846, DOI 10.1111/j.1365-313X.2008.03731.x; Yu Y, 2000, THEOR APPL GENET, V101, P1093, DOI 10.1007/s001220051584; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	66	40	48	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12599	10.1371/journal.pone.0012599	http://dx.doi.org/10.1371/journal.pone.0012599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844752	Green Published, gold			2022-12-25	WOS:000281687300003
J	Diaz-Ferguson, E; Haney, R; Wares, J; Silliman, B				Diaz-Ferguson, Edgardo; Haney, Robert; Wares, John; Silliman, Brian			Population Genetics of a Trochid Gastropod Broadens Picture of Caribbean Sea Connectivity	PLOS ONE			English	Article							ROCKY INTERTIDAL INVERTEBRATES; CITTARIUM-PICA GASTROPODA; LARVAL DISPERSAL; BIODIVERSITY HOTSPOTS; MARINE; CORAL; FLOW; PHYLOGEOGRAPHY; SPECIATION; ATLANTIC	Background: Regional genetic connectivity models are critical for successful conservation and management of marine species. Even though rocky shore invertebrates have been used as model systems to understand genetic structure in some marine environments, our understanding of connectivity in Caribbean communities is based overwhelmingly on studies of tropical fishes and corals. In this study, we investigate population connectivity and diversity of Cittarium pica, an abundant rocky shore trochid gastropod that is commercially harvested across its natural range, from the Bahamas to Venezuela. Methodology/Principal Findings: We tested for genetic structure using DNA sequence variation at the mitochondrial COI and 16S loci, AMOVA and distance-based methods. We found substantial differentiation among Caribbean sites. Yet, genetic differentiation was associated only with larger geographic scales within the Caribbean, and the pattern of differentiation only partially matched previous assessments of Caribbean connectivity, including those based on larval dispersal from hydrodynamic models. For instance, the Bahamas, considered an independent region by previous hydrodynamic studies, showed strong association with Eastern Caribbean sites in our study. Further, Bonaire (located in the east and close to the meridional division of the Caribbean basin) seems to be isolated from other Eastern sites. Conclusions/Significance: The significant genetic structure and observed in C. pica has some commonalities in pattern with more commonly sampled taxa, but presents features, such as the differentiation of Bonaire, that appear unique. Further, the level of differentiation, together with regional patterns of diversity, has important implications for the application of conservation and management strategies in this commercially harvested species.	[Diaz-Ferguson, Edgardo; Silliman, Brian] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Haney, Robert] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Wares, John] Univ Georgia, Dept Genet, Athens, GA 30602 USA	State University System of Florida; University of Florida; University of Chicago; University System of Georgia; University of Georgia	Diaz-Ferguson, E (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	edgard03@ufl.edu		Silliman, Brian/0000-0001-6360-650X; Wares, John/0000-0003-1827-0669; Diaz-Ferguson, Edgardo/0000-0002-2314-5021; Haney, Robert/0000-0002-3742-3395	Andrew Mellon Foundation	Andrew Mellon Foundation	Publication costs will be covered by the Andrew Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bertness MD., 1999, ECOLOGY ATLANTIC SHO; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; CHAPMAN L, 2008, ITME RES REPORTS, V27, P31; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dawson MN, 2006, SCIENCE, V313, P43; Dethier MN, 2003, CONSERV BIOL, V17, P1024, DOI 10.1046/j.1523-1739.2003.01606.x; Diaz-Ferguson E, 2010, ESTUAR COAST, V33, P828, DOI 10.1007/s12237-009-9220-6; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Haney RA, 2007, HEREDITY, V98, P294, DOI 10.1038/sj.hdy.6800940; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2002, B MAR SCI, V70, P273; Hidas EZ, 2007, MAR FRESHWATER RES, V58, P835, DOI 10.1071/MF06235; HUDSON RR, 1992, GENETICS, V132, P583; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kirkendale LA, 2004, MOL ECOL, V13, P2749, DOI 10.1111/j.1365-294X.2004.02284.x; Lee T, 2005, EVOLUTION, V59, P2139; Lessios HA, 2001, P ROY SOC B-BIOL SCI, V268, P2347, DOI 10.1098/rspb.2001.1806; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; MENGE BA, 1991, J EXP MAR BIOL ECOL, V146, P69, DOI 10.1016/0022-0981(91)90255-U; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Osorno Arango Adriana, 2006, Bol. Invest. Mar. Cost., V35, P133; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi Stephen R., 1996, P205; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Raffaelli D., 1999, INTERTIDAL ECOLOGY; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson R, 2003, P ACAD NAT SCI PHILA, V153, P27, DOI 10.1635/0097-3157(2003)153[0027:TEWIWC]2.0.CO;2; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Rogers CS, 2001, ENVIRON CONSERV, V28, P312, DOI 10.1017/S0376892901000340; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Schmidt S, 2002, REV BIOL TROP, V50, P1079; Shanks AL, 2003, ECOL APPL, V13, pS159; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Small MP, 2000, HEREDITY, V84, P692, DOI 10.1046/j.1365-2540.2000.00717.x; Steneck RS, 2006, SCIENCE, V311, P480, DOI 10.1126/science.1123541; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Toller Wes, 2005, POPULATION SURVEY W; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Wares JP, 2002, MOL ECOL, V11, P1131, DOI 10.1046/j.1365-294X.2002.01510.x; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams ST, 2004, EVOLUTION, V58, P2227	65	32	32	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12675	10.1371/journal.pone.0012675	http://dx.doi.org/10.1371/journal.pone.0012675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844767	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687300016
J	Downes, K; Pekalski, M; Angus, KL; Hardy, M; Nutland, S; Smyth, DJ; Walker, NM; Wallace, C; Todd, JA				Downes, Kate; Pekalski, Marcin; Angus, Karen L.; Hardy, Matthew; Nutland, Sarah; Smyth, Deborah J.; Walker, Neil M.; Wallace, Chris; Todd, John A.			Reduced Expression of IFIH1 Is Protective for Type 1 Diabetes	PLOS ONE			English	Article							RIG-I; HELICASE; MDA5; IDENTIFICATION; ASSOCIATION; GENES	IFIH1 (interferon induced with helicase C domain 1), also known as MDA5 (melanoma differentiation-associated protein 5), is one of a family of intracellular proteins known to recognise viral RNA and mediate the innate immune response. IFIH1 is causal in type 1 diabetes based on the protective associations of four rare variants, where the derived alleles are predicted to reduce gene expression or function. Originally, however, T1D protection was mapped to the common IFIH1 nsSNP, rs1990760 or Thr946Ala. This common amino acid substitution does not cause a loss of function and evidence suggests the protective allele, Ala(946), may mark a haplotype with reduced expression of IFIH1 in line with the protection conferred by the four rare loss of function alleles. We have performed allele specific expression analysis that supports this hypothesis: the T1D protective haplotype correlates with reduced IFIH1 transcription in interferon-beta stimulated peripheral blood mononuclear cells (overall p = 0.012). In addition, we have used multiflow cytometry analysis and quantitative PCR assays to prove reduced expression of IFIH1 in individuals heterozygous for three of the T1D-associated rare alleles: a premature stop codon, rs35744605 (Glu627X) and predicted splice variants, rs35337543 (IVS8+1) and rs35732034 (IVS14+1). We also show that the nsSNP, Ile923V, does not alter pre-mRNA levels of IFIH1. These results confirm and extend the new autoimmune disease pathway of reduced IFIH1 expression and protein function protecting from T1D.	[Downes, Kate; Pekalski, Marcin; Angus, Karen L.; Hardy, Matthew; Nutland, Sarah; Smyth, Deborah J.; Walker, Neil M.; Wallace, Chris; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Wellcome Trust Diabet & In, Juvenile Diabet Res Fdn,Dept Med Genet, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Downes, K (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Wellcome Trust Diabet & In, Juvenile Diabet Res Fdn,Dept Med Genet, Cambridge CB2 2QQ, England.	john.todd@cimr.cam.ac.uk	; Todd, John/A-3542-2010	Walker, Neil/0000-0001-9796-7688; Angus-Cole, Karen/0000-0002-6262-4041; smyth, deborah/0000-0002-6330-2669; Hardy, Matthew/0000-0001-6420-1715; Todd, John/0000-0003-2740-8148; Wallace, Chris/0000-0001-9755-1703	Juvenile Diabetes Research Foundation International; Wellcome Trust [079895]; National Institute for Health Research Cambridge Biomedical Centre; National Institutes of Health (USA) [P01 AI39671]; JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (DGAP) [4-2007-1003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Centre(National Institute for Health Research (NIHR)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (DGAP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Centre. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (079895). This work was also supported by a National Institutes of Health (USA) grant P01 AI39671 and a grant from the JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (DGAP; 4-2007-1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marinou I, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2179; Martinez A, 2008, ANN RHEUM DIS, V67, P137, DOI 10.1136/ard.2007.073213; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; von Herrath M, 2009, NATURE, V459, P518, DOI 10.1038/459518a; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zouk H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011564	22	68	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12646	10.1371/journal.pone.0012646	http://dx.doi.org/10.1371/journal.pone.0012646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844740	gold, Green Published, Green Submitted			2022-12-25	WOS:000281687200011
J	Khiabanian, H; Holmes, AB; Kelly, BJ; Gururaj, M; Hripcsak, G; Rabadan, R				Khiabanian, Hossein; Holmes, Antony B.; Kelly, Brendan J.; Gururaj, Mrinalini; Hripcsak, George; Rabadan, Raul			Signs of the 2009 Influenza Pandemic in the New York-Presbyterian Hospital Electronic Health Records	PLOS ONE			English	Article							A H1N1 VIRUS; CARE; CODES; CHILDREN; SURVEILLANCE; CHALLENGES; INFECTION; VACCINE; STROKE; CITY	Background: In June of 2009, the World Health Organization declared the first influenza pandemic of the 21(st) century, and by July, New York City's New York-Presbyterian Hospital (NYPH) experienced a heavy burden of cases, attributable to a novel strain of the virus (H1N1pdm). Methods and Results: We present the signs in the NYPH electronic health records (EHR) that distinguished the 2009 pandemic from previous seasonal influenza outbreaks via various statistical analyses. These signs include (1) an increase in the number of patients diagnosed with influenza, (2) a preponderance of influenza diagnoses outside of the normal flu season, and (3) marked vaccine failure. The NYPH EHR also reveals distinct age distributions of patients affected by seasonal influenza and the pandemic strain, and via available longitudinal data, suggests that the two may be associated with distinct sets of comorbid conditions as well. In particular, we find significantly more pandemic flu patients with diagnoses associated with asthma and underlying lung disease. We further observe that the NYPH EHR is capable of tracking diseases at a resolution as high as particular zip codes in New York City. Conclusion: The NYPH EHR permits early detection of pandemic influenza and hypothesis generation via identification of those significantly associated illnesses. As data standards develop and databases expand, EHRs will contribute more and more to disease detection and the discovery of novel disease associations.	[Khiabanian, Hossein; Holmes, Antony B.; Hripcsak, George; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10027 USA; [Khiabanian, Hossein; Holmes, Antony B.; Gururaj, Mrinalini; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY USA; [Kelly, Brendan J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA	Columbia University; Columbia University; Columbia University	Khiabanian, H (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10027 USA.	hossein@c2b2.columbia.edu	Khiabanian, Hossein/N-7207-2019; Rabadan, Raul/AAZ-7367-2020	Khiabanian, Hossein/0000-0003-1446-4394; Kelly, Brendan/0000-0003-2023-646X; Rabadan, Raul/0000-0001-7946-9255	Northeast Biodefence Center [U54-AI057158]; National Library of Medicine Eureka [1R01LM010140-01]; Centers for Disease Control and Prevention Center of Excellence [P01 HK000029]; National Library of Medicine [R01LM006910]; NATIONAL LIBRARY OF MEDICINE [R01LM006910, R01LM010140] Funding Source: NIH RePORTER	Northeast Biodefence Center; National Library of Medicine Eureka(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Centers for Disease Control and Prevention Center of Excellence; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	RR acknowledges support by the Northeast Biodefence Center grant U54-AI057158 and the National Library of Medicine Eureka grant 1R01LM010140-01. GH is supported by the Centers for Disease Control and Prevention Center of Excellence grant P01 HK000029 and by National Library of Medicine grant R01LM006910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burd RS, 2008, ACAD EMERG MED, V15, P466, DOI 10.1111/j.1553-2712.2008.00105.x; *CDCP, 2009, H1N1 EARL OUTBR DIS; *CDCP, 2010, CDC FLU HOM; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P8; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; *EUR CDCP, 2010, EUR INFL SURV NETW E; Flahault A, 1998, JAMA-J AM MED ASSOC, V280, P1330, DOI 10.1001/jama.280.15.1330; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; Hivert MF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-170; Kelly H, 2009, INFLUENZA OTHER RESP, V3, P183, DOI 10.1111/j.1750-2659.2009.00088.x; Keren R, 2006, EMERG INFECT DIS, V12, P1603, DOI 10.3201/eid1210.051525; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Li Li, 2008, AMIA Annu Symp Proc, P404; Lobach DF, 2007, AM J PREV MED, V32, pS104, DOI 10.1016/j.amepre.2007.01.018; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Miroballi Y, 2010, ARCH PEDIAT ADOL MED, V164, P24, DOI 10.1001/archpediatrics.2009.259; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; *NY CIT DEP HLTH M, 2009, NEW YORK CIT DEP HLT; *NY CIT DEP HLTH M, 2010, NYC INFL INF VACC; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shea S, 2010, NEW ENGL J MED, V362, P192, DOI 10.1056/NEJMp0910140; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Tsui FC, 2001, J AM MED INFORM ASSN, P711; Wang L, 2009, LANCET ONCOL, V10, P9, DOI 10.1016/S1470-2045(08)70321-8; *WHO, 2010, WHO FLUNET; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization (WHO), 2009, INFL A H1N1 UPD 47; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12658	10.1371/journal.pone.0012658	http://dx.doi.org/10.1371/journal.pone.0012658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844592	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687200019
J	Bernthal, NM; Stavrakis, AI; Billi, F; Cho, JS; Kremen, TJ; Simon, SI; Cheung, AL; Finerman, GA; Lieberman, JR; Adams, JS; Miller, LS				Bernthal, Nicholas M.; Stavrakis, Alexandra I.; Billi, Fabrizio; Cho, John S.; Kremen, Thomas J.; Simon, Scott I.; Cheung, Ambrose L.; Finerman, Gerald A.; Lieberman, Jay R.; Adams, John S.; Miller, Lloyd S.			A Mouse Model of Post-Arthroplasty Staphylococcus aureus Joint Infection to Evaluate In Vivo the Efficacy of Antimicrobial Implant Coatings	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; SURGICAL-SITE INFECTION; ANTIBIOTIC-IMPREGNATED CEMENT; TOTAL KNEE ARTHROPLASTY; REVISION TOTAL HIP; UNITED-STATES; NEUTROPHIL RECRUITMENT; TITANIUM IMPLANTS; CANINE MODEL; BIOFILMS	Background: Post-arthroplasty infections represent a devastating complication of total joint replacement surgery, resulting in multiple reoperations, prolonged antibiotic use, extended disability and worse clinical outcomes. As the number of arthroplasties in the U. S. will exceed 3.8 million surgeries per year by 2030, the number of post-arthroplasty infections is projected to increase to over 266,000 infections annually. The treatment of these infections will exhaust healthcare resources and dramatically increase medical costs. Methodology/Principal Findings: To evaluate novel preventative therapeutic strategies against post-arthroplasty infections, a mouse model was developed in which a bioluminescent Staphylococcus aureus strain was inoculated into a knee joint containing an orthopaedic implant and advanced in vivo imaging was used to measure the bacterial burden in real-time. Mice inoculated with 5 x 10(3) and 5 x 10(4) CFUs developed increased bacterial counts with marked swelling of the affected leg, consistent with an acute joint infection. In contrast, mice inoculated with 5 x 10(2) CFUs developed a low-grade infection, resembling a more chronic infection. Ex vivo bacterial counts highly correlated with in vivo bioluminescence signals and EGFP-neutrophil fluorescence of LysEGFP mice was used to measure the infection-induced inflammation. Furthermore, biofilm formation on the implants was visualized at 7 and 14 postoperative days by variable-pressure scanning electron microscopy (VP-SEM). Using this model, a minocycline/rifampin-impregnated bioresorbable polymer implant coating was effective in reducing the infection, decreasing inflammation and preventing biofilm formation. Conclusions/Significance: Taken together, this mouse model may represent an alternative pre-clinical screening tool to evaluate novel in vivo therapeutic strategies before studies in larger animals and in human subjects. Furthermore, the antibiotic-polymer implant coating evaluated in this study was clinically effective, suggesting the potential for this strategy as a therapeutic intervention to combat post-arthroplasty infections.	[Bernthal, Nicholas M.; Stavrakis, Alexandra I.; Billi, Fabrizio; Kremen, Thomas J.; Finerman, Gerald A.; Adams, John S.; Miller, Lloyd S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Orthopaed Hosp Res Ctr,Orthopaed Hosp, Los Angeles, CA 90095 USA; [Cho, John S.; Miller, Lloyd S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Simon, Scott I.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Cheung, Ambrose L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA; [Lieberman, Jay R.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, New England Musculoskeletal Inst, Farmington, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; Dartmouth College; University of Connecticut	Bernthal, NM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Orthopaed Hosp Res Ctr,Orthopaed Hosp, Los Angeles, CA 90095 USA.	lloydmiller@mednet.ucla.edu	Billi, Fabrizio/AAJ-4830-2021; Adams, John S/I-3365-2013	Billi, Fabrizio/0000-0003-2217-7694; Adams, John S/0000-0001-9607-5020; Miller, Lloyd/0000-0002-8332-2210; Kremen, Thomas/0000-0003-1643-4869	Orthopaedic Hospital Research Center; National Institutes of Health (NIH) [R24 CA92865]; NATIONAL CANCER INSTITUTE [R24CA092865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047294] Funding Source: NIH RePORTER	Orthopaedic Hospital Research Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Orthopaedic Hospital Research Center and by the UCLA Small Animal Imaging Resource Program (SAIRP) R24 CA92865 from the National Institutes of Health (NIH). The antibiotic-coated implants were provided by TyRx Pharma, Inc. No experimental costs, consulting fees or other monetary support was supplied by TyRx Pharma, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035; Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2; Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348; Bargiotas Konstantinos, 2007, J Bone Joint Surg Am, V89 Suppl 2 Pt.1, P103; Belmatoug N, 1996, J INFECT DIS, V174, P414, DOI 10.1093/infdis/174.2.414; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Bragg B, 2008, J BIOMED MATER RES B, V84B, P559, DOI 10.1002/jbm.b.30904; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chiu FY, 2009, J BONE JOINT SURG AM, V91A, P628, DOI 10.2106/JBJS.G.01570; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conway JD, 2004, J BONE JOINT SURG AM, V86A, P835, DOI 10.2106/00004623-200404000-00027; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Craig MR, 2005, J ORTHOP RES, V23, P1100, DOI 10.1016/j.orthres.2005.03.007; Cui QJ, 2007, J BONE JOINT SURG AM, V89A, P871, DOI 10.2106/JBJS.E.01070; Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Diwanji SR, 2008, J ARTHROPLASTY, V23, P656, DOI 10.1016/j.arth.2007.06.007; Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158; Epstein NJ, 2005, J ORTHOP RES, V23, P501, DOI 10.1016/j.orthres.2004.10.004; FITZGERALD RH, 1983, J BONE JOINT SURG AM, V65, P371, DOI 10.2106/00004623-198365030-00013; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Hansen LK, 2009, PACE, V32, P898, DOI 10.1111/j.1540-8159.2009.02406.x; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kim MH, 2009, AM J PHYSIOL-CELL PH, V296, pC848, DOI 10.1152/ajpcell.00520.2008; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lee J, 2006, J BONE JOINT SURG AM, V88A, P1705, DOI 10.2106/JBJS.E.01156; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; MarcellinLittle DJ, 1996, AM J VET RES, V57, P720; McGarry SA, 2004, INFECT CONT HOSP EP, V25, P461, DOI 10.1086/502422; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mittal Y, 2007, J BONE JOINT SURG AM, V89A, P1227, DOI 10.2106/JBJS.E.01192; Moojen DJF, 2009, J ORTHOP RES, V27, P1002, DOI 10.1002/jor.20854; Moojen DJF, 2009, J ORTHOP RES, V27, P710, DOI 10.1002/jor.20808; Nishimura S, 2006, J ORTHOP SCI, V11, P46, DOI 10.1007/s00776-005-0968-7; PETTY W, 1988, J BONE JOINT SURG AM, V70A, P536, DOI 10.2106/00004623-198870040-00009; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Salgado CD, 2007, CLIN ORTHOP RELAT R, P48, DOI 10.1097/BLO.0b013e3181123d4e; Sarda L, 2002, J NUCL MED, V43, P239; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Sierra RJ, 2003, J BONE JOINT SURG AM, V85A, P1000, DOI 10.2106/00004623-200306000-00003; Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stoodley P, 2008, J BONE JOINT SURG AM, V90A, P1751, DOI 10.2106/JBJS.G.00838; Toulson C, 2009, J ARTHROPLASTY, V24, P1051, DOI 10.1016/j.arth.2008.07.004; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Walls RJ, 2008, J BONE JOINT SURG BR, V90B, P292, DOI 10.1302/0301-620X.90B3.20155; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	63	152	164	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12580	10.1371/journal.pone.0012580	http://dx.doi.org/10.1371/journal.pone.0012580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830204	gold, Green Published, Green Submitted			2022-12-25	WOS:000281631300012
J	Leimu, R; Fischer, M				Leimu, Roosa; Fischer, Markus			Between-Population Outbreeding Affects Plant Defence	PLOS ONE			English	Article							LYCHNIS-FLOS-CUCULI; INBREEDING DEPRESSION; ARIANTA-ARBUSTORUM; MIMULUS-GUTTATUS; GENETIC RESCUE; HYBRID PLANTS; RESISTANCE; TOLERANCE; HERBIVORY; FITNESS	Between-population crosses may replenish genetic variation of populations, but may also result in outbreeding depression. Apart from direct effects on plant fitness, these outbreeding effects can also alter plant-herbivore interactions by influencing plant tolerance and resistance to herbivory. We investigated effects of experimental within-and between-population outbreeding on herbivore resistance, tolerance and plant fitness using plants from 13 to 19 Lychnis flos-cuculi populations. We found no evidence for outbreeding depression in resistance reflected by the amount of leaf area consumed. However, herbivore performance was greater when fed on plants from between-population compared to within-population crosses. This can reflect outbreeding depression in resistance and/or outbreeding effects on plant quality for the herbivores. The effects of type of cross on the relationship between herbivore damage and plant fitness varied among populations. This demonstrates how between-population outbreeding effects on tolerance range from outbreeding depression to outbreeding benefits among plant populations. Finally, herbivore damage strengthened the observed outbreeding effects on plant fitness in several populations. These results raise novel considerations on the impact of outbreeding on the joint evolution of resistance and tolerance, and on the evolution of multiple defence strategies.	[Leimu, Roosa; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland	University of Potsdam; University of Bern; University of Bern; University of Bern	Leimu, R (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	roosa.leimu@plants.ox.ac.uk	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	Marie Curie Intra-European Fellowship; Academy of Finland [108784]; Swiss National Science Foundation [31-56809.99, 31-67876.02]	Marie Curie Intra-European Fellowship(European Commission); Academy of Finland(Academy of Finland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by a Marie Curie Intra-European Fellowship for R.L., grant 108784 of the Academy of Finland to R.L. and grants 31-56809.99 and 31-67876.02 of the Swiss National Science Foundation to M.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Biere A, 1996, PLANT SOIL, V182, P313, DOI 10.1007/BF00029062; Bowman G, 2008, J ECOL, V96, P1056, DOI 10.1111/j.1365-2745.2008.01417.x; BURLA H, 1983, GENETICA, V62, P95; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; Crawley M. J., 1983, HERBIVORY DYNAMICS A; DUDASH M, 2000, GENETICS DEMOGRAPHY; ELMQVIST T, 1988, OECOLOGIA, V77, P225, DOI 10.1007/BF00379190; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fenster CB, 2000, CONSERV BIOL, V14, P1406, DOI 10.1046/j.1523-1739.2000.99234.x; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fritz RS, 1999, ECOLOGY, V80, P382, DOI 10.1890/0012-9658(1999)080[0382:ROHPTH]2.0.CO;2; Fritz RS, 1999, ANNU REV ECOL SYST, V30, P565, DOI 10.1146/annurev.ecolsys.30.1.565; Galeuchet DJ, 2005, ECOLOGY, V86, P1002, DOI 10.1890/03-0762; Galeuchet DJ, 2005, MOL ECOL, V14, P991, DOI 10.1111/j.1365-294X.2005.02485.x; GALEUCHET DJ, 2003, THESIS U ZURICH; Hagele BF, 2001, OECOLOGIA, V128, P228, DOI 10.1007/s004420100644; HAUSER TP, 1994, J EVOLUTION BIOL, V7, P609, DOI 10.1046/j.1420-9101.1994.7050609.x; Hauser TP, 2000, J EVOLUTION BIOL, V13, P446; Hayes CN, 2004, OECOLOGIA, V140, P601, DOI 10.1007/s00442-004-1623-2; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOEHN S, 2006, THESIS U ZURICH; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Ivey CT, 2004, ECOLOGY, V85, P567, DOI 10.1890/02-0730; Jessup CM, 2008, ECOL LETT, V11, P947, DOI 10.1111/j.1461-0248.2008.01205.x; Keller M, 2000, J APPL ECOL, V37, P647, DOI 10.1046/j.1365-2664.2000.00517.x; Kery M, 2001, J ECOL, V89, P418, DOI 10.1046/j.1365-2745.2001.00550.x; Lehtila K, 2003, EVOLUTION, V57, P677, DOI 10.1111/j.0014-3820.2003.tb01559.x; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Leimu R, 2008, ECOL LETT, V11, P1101, DOI 10.1111/j.1461-0248.2008.01222.x; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; MARQUIS RJ, 1990, EVOLUTION, V44, P104, DOI 10.1111/j.1558-5646.1990.tb04282.x; Mauricio R, 2000, EVOL ECOL, V14, P491, DOI 10.1023/A:1010909829269; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; PAINTER RH, 1958, ANNU REV ENTOMOL, V3, P267, DOI 10.1146/annurev.en.03.010158.001411; PERRET C, 2003, THESIS U ZURICH; Rausher M.D., 1992, P20; Schierup MH, 1996, HEREDITY, V77, P461, DOI 10.1038/hdy.1996.172; Schoonhoven L. M., 2005, Insect-plant biology; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; SPEISER B, 1991, OIKOS, V62, P306, DOI 10.2307/3545495; Steffan-Dewenter I, 2002, BIOL CONSERV, V104, P275, DOI 10.1016/S0006-3207(01)00192-6; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Templeton A.R., 1986, P105; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; TIFFIN P, 1999, AM NAT, V6, P700; WASER NM, 1989, EVOLUTION, V43, P1097, DOI [10.2307/2409589, 10.1111/j.1558-5646.1989.tb02554.x]; Waser NM, 1993, NATURAL HIST INBREED; WASER NM, 2000, AM NAT, V6, P700; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Willi Y, 2005, HEREDITY, V95, P437, DOI 10.1038/sj.hdy.6800732; Willi Y, 2007, P ROY SOC B-BIOL SCI, V274, P2357, DOI 10.1098/rspb.2007.0768; Wirooks Ludger, 1999, Melanargia, V11, P93; Zar J. H., 2009, BIOSTATISTICAL ANAL	62	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12614	10.1371/journal.pone.0012614	http://dx.doi.org/10.1371/journal.pone.0012614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838662	Green Published, gold			2022-12-25	WOS:000281631300034
J	Yamamoto, D; Shima, K; Matsuo, K; Nishioka, T; Chen, CY; Hu, GF; Sasaki, A; Tsuji, T				Yamamoto, Daisuke; Shima, Kaori; Matsuo, Kou; Nishioka, Takashi; Chen, Chang Yan; Hu, Guo-fu; Sasaki, Akira; Tsuji, Takanori			Ornithine Decarboxylase Antizyme Induces Hypomethylation of Genome DNA and Histone H3 Lysine 9 Dimethylation (H3K9me2) in Human Oral Cancer Cell Line	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; METHYLATION PATTERNS; NEUROSPORA-CRASSA; G9A; CHROMATIN; PROTEIN; GENES; POLYAMINES; HP1; DIFFERENTIATION	Background: Methylation of CpG islands of genome DNA and lysine residues of histone H3 and H4 tails regulates gene transcription. Inhibition of polyamine synthesis by ornithine decarboxylase antizyme-1 (OAZ) in human oral cancer cell line resulted in accumulation of decarboxylated S-adenosylmethionine (dcSAM), which acts as a competitive inhibitor of methylation reactions. We anticipated that accumulation of dcSAM impaired methylation reactions and resulted in hypomethylation of genome DNA and histone tails. Methodology/Principal Findings: Global methylation state of genome DNA and lysine residues of histone H3 and H4 tails were assayed by Methylation by Isoschizomers (MIAMI) method and western blotting, respectively, in the presence or absence of OAZ expression. Ectopic expression of OAZ mediated hypomethylation of CpG islands of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2). Protein level of DNA methyltransferase 3B (DNMT3B) and histone H3K9me specific methyltransferase G9a were down-regulated in OAZ transfectant. Conclusions/Significance: OAZ induced hypomethylation of CpG islands of global genome DNA and H3K9me2 by down-regulating DNMT3B and G9a protein level. Hypomethylation of CpG islands of genome DNA and histone H3K9me2 is a potent mechanism of induction of the genes related to tumor suppression and DNA double strand break repair.	[Yamamoto, Daisuke; Nishioka, Takashi; Chen, Chang Yan; Tsuji, Takanori] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Sch Med, Boston, MA 02215 USA; [Yamamoto, Daisuke; Sasaki, Akira] Okayama Univ, Dept Oral & Maxillofacial Surg, Grad Sch, Okayama, Japan; [Shima, Kaori] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Matsuo, Kou] Kyushu Dent Coll, Div Oral Pathol, Dept Biosci, Kitakyushu, Fukuoka 803, Japan; [Hu, Guo-fu] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Okayama University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kyushu Dental University; Harvard University; Harvard Medical School	Yamamoto, D (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Sch Med, Boston, MA 02215 USA.	ttsuji@bidmc.harvard.edu		Nishioka, Takashi/0000-0002-1144-3881	National Institutes of Health (National Cancer Institute) [RO1-CA10044]	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (National Cancer Institute) Research Grant RO1-CA10044 for Takanori Tsuji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Boner W, 2002, VIRUS RES, V90, P113, DOI 10.1016/S0168-1702(02)00145-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Deng T, 2009, BIOMED PHARMACOTHER, V63, P492, DOI 10.1016/j.biopha.2008.08.013; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HEBY O, 1988, PROGR POLYAMINE RES, P291; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Ikegami K, 2007, GENES CELLS, V12, P1, DOI 10.1111/j.1365-2443.2006.01029.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Koike C, 1999, CANCER RES, V59, P6109; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li Q, 2009, MOL PHARMACOL, V76, P1072, DOI 10.1124/mol.109.056291; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCCANN PP, 1997, BIOCHEM BIOPH RES CO, V75, P948; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; MURAKAMI Y, 1985, BIOCHEM J, V226, P893, DOI 10.1042/bj2260893; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nakayama Shuko, 1998, Invasion and Metastasis, V18, P219, DOI 10.1159/000024515; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; Tsuji T, 2007, BIOCHEMISTRY-US, V46, P8920, DOI 10.1021/bi7000328; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	53	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12554	10.1371/journal.pone.0012554	http://dx.doi.org/10.1371/journal.pone.0012554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838441	Green Published, gold, Green Submitted			2022-12-25	WOS:000281627700007
J	Benny, O; Nakai, K; Yoshimura, T; Bazinet, L; Akula, JD; Nakao, S; Hafezi-Moghadam, A; Panigrahy, D; Pakneshan, P; D'Amato, RJ				Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Akula, James D.; Nakao, Shintaro; Hafezi-Moghadam, Ali; Panigrahy, Dipak; Pakneshan, Pouya; D'Amato, Robert J.			Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases	PLOS ONE			English	Article							MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; CYTOKINE EXPRESSION; ACTIVATION STEPS; PHOTOTRANSDUCTION; ANGIOGENESIS; RANIBIZUMAB; RETINOPATHY; RPE; ROD	Pathological neovascularization is a hallmark of late stage neovascular (wet) age-related macular degeneration (AMD) and the leading cause of blindness in people over the age of 50 in the western world. The treatments focus on suppression of choroidal neovascularization (CNV), while current approved therapies are limited to inhibiting vascular endothelial growth factor (VEGF) exclusively. However, this treatment does not address the underlying cause of AMD, and the loss of VEGF's neuroprotective can be a potential side effect. Therapy which targets the key processes in AMD, the pathological neovascularization, vessel leakage and inflammation could bring a major shift in the approach to disease treatment and prevention. In this study we have demonstrated the efficacy of such broad spectrum antiangiogenic therapy on mouse model of AMD. Methods and Findings: Lodamin, a polymeric formulation of TNP-470, is a potent broad-spectrum antiangiogenic drug. Lodamin significantly reduced key processes involved in AMD progression as demonstrated in mice and rats. Its suppressive effects on angiogenesis, vascular leakage and inflammation were studied in a wide array of assays including; a Matrigel, delayed-type hypersensitivity (DTH), Miles assay, laser-induced CNV and corneal micropocket assay. Lodamin significantly suppressed the secretion of various pro-inflammatory cytokines in the CNV lesion including monocyte chemotactic protein-1 (MCP-1/Ccl2). Importantly, Lodamin was found to regress established CNV lesions, unlike soluble fms-like tyrosine kinase-1 (sFlk-1). The drug was found to be safe in mice and have little toxicity as demonstrated by electroretinography (ERG) assessing retinal and by histology. Conclusions: Lodamin, a polymer formulation of TNP-470, was identified as a first in its class, broad-spectrum antiangiogenic drug that can be administered orally or locally to treat corneal and retinal neovascularization. Several unique properties make Lodamin especially beneficial for ophthalmic use. Our results support the concept that broad spectrum antiangiogenic drugs are promising agents for AMD treatment and prevention.	[Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Panigrahy, Dipak; Pakneshan, Pouya; D'Amato, Robert J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA; [Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Panigrahy, Dipak; Pakneshan, Pouya; D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Akula, James D.; Pakneshan, Pouya; D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Childrens Hosp Boston, Boston, MA USA; [Nakao, Shintaro; Hafezi-Moghadam, Ali] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Benny, O (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA.	ofra.bennyratsaby@childrens.harvard.edu	Benny, Ofra/AAB-3294-2021	Akula, James/0000-0001-8049-1812; Yoshimura, Takeru/0000-0002-5983-7193; Hafezi-Moghadam, Ali/0000-0002-5336-0697	Departmental support fund	Departmental support fund	Departmental support fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2009, RETINA-J RET VIT DIS, V29, pS42, DOI 10.1097/IAE.0b013e3181ad2500; Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Akula JD, 2008, MOL VIS, V14, P2499; Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Benny O, 2008, NAT BIOTECHNOL, V26, P799, DOI 10.1038/nbt1415; Black C A, 1999, Dermatol Online J, V5, P7; Campochiaro PA, 2007, DRUG TODAY, V43, P529, DOI 10.1358/dot.2007.43.8.1120868; Clark AF, 2003, NAT REV DRUG DISCOV, V2, P448, DOI 10.1038/nrd1106; *CLINICALTRIALS GO, 2009, NCT00605943 CLINICAL; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; El-Asrar Ahmed M. Abu, 1997, American Journal of Ophthalmology, V123, P599; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Garber K, 2010, NAT BIOTECHNOL, V28, P311, DOI 10.1038/nbt0410-311; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; HOOD DC, 1993, EARLY VISUAL DEV NOR, P517; JAFFE GJ, 1995, EXP EYE RES, V60, P533, DOI 10.1016/S0014-4835(05)80068-5; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Marneros AG, 2007, FASEB J, V21, P3809, DOI 10.1096/fj.07-8422com; Narayanan R, 2006, NAT REV DRUG DISCOV, V5, P815, DOI 10.1038/nrd2157; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Regenfuss Birgit, 2008, Lymphatic Research and Biology, V6, P191, DOI 10.1089/lrb.2008.6348; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sugita S, 2003, J EXP MED, V198, P161, DOI 10.1084/jem.20030097; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003	32	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12515	10.1371/journal.pone.0012515	http://dx.doi.org/10.1371/journal.pone.0012515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824139	Green Submitted, Green Published, gold			2022-12-25	WOS:000281456100016
J	Chial, HJ; Lenart, P; Chen, YQ				Chial, Heidi J.; Lenart, Peter; Chen, Yong Q.			APPL Proteins FRET at the BAR: Direct Observation of APPL1 and APPL2 BAR Domain-Mediated Interactions on Cell Membranes Using FRET Microscopy	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; KINASE; YFP; PHOTOCONVERSION; TRAFFICKING; TRKA; PH	Background: Human APPL1 and APPL2 are homologous RAB5 effectors whose binding partners include a diverse set of transmembrane receptors, signaling proteins, and phosphoinositides. APPL proteins associate dynamically with endosomal membranes and are proposed to function in endosome-mediated signaling pathways linking the cell surface to the cell nucleus. APPL proteins contain an N-terminal Bin/Amphiphysin/Rvs (BAR) domain, a central pleckstrin homology (PH) domain, and a C-terminal phosphotyrosine binding (PTB) domain. Previous structural and biochemical studies have shown that the APPL BAR domains mediate homotypic and heterotypic APPL-APPL interactions and that the APPL1 BAR domain forms crescent-shaped dimers. Although previous studies have shown that APPL minimal BAR domains associate with curved cell membranes, direct interaction between APPL BAR domains on cell membranes in vivo has not been reported. Methodology: Herein, we used a laser-scanning confocal microscope equipped with a spectral detector to carry out fluorescence resonance energy transfer (FRET) experiments with cyan fluorescent protein/yellow fluorescent protein (CFP/YFP) FRET donor/acceptor pairs to examine interactions between APPL minimal BAR domains at the subcellular level. This comprehensive approach enabled us to evaluate FRET levels in a single cell using three methods: sensitized emission, standard acceptor photobleaching, and sequential acceptor photobleaching. We also analyzed emission spectra to address an outstanding controversy regarding the use of CFP donor/YFP acceptor pairs in FRET acceptor photobleaching experiments, based on reports that photobleaching of YFP converts it into a CFP-like species. Conclusions: All three methods consistently showed significant FRET between APPL minimal BAR domain FRET pairs, indicating that they interact directly in a homotypic (i.e., APPL1-APPL1 and APPL2-APPL2) and heterotypic (i.e., APPL1-APPL2) manner on curved cell membranes. Furthermore, the results of our experiments did not show photoconversion of YFP into a CFP-like species following photobleaching, supporting the use of CFP donor/YFP acceptor FRET pairs in acceptor photobleaching studies.	[Chial, Heidi J.; Chen, Yong Q.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA; [Lenart, Peter] European Mol Biol Lab, Cell Biol & Biophys Programme, Heidelberg, Germany	Wake Forest University; Wake Forest Baptist Medical Center; European Molecular Biology Laboratory (EMBL)	Chial, HJ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA.	chial.heidi@gmail.com	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708; Lenart, Peter/0000-0002-3927-248X	Marine Biological Laboratory (MBL); National Institutes of Health (NIH) [F32CA108196, NIH P01CA106742, NIH R01CA107668]; NATIONAL CANCER INSTITUTE [P01CA106742, R01CA107668, F32CA108196] Funding Source: NIH RePORTER	Marine Biological Laboratory (MBL); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by a Surdna Foundation Scholarship for the Marine Biological Laboratory (MBL) 2005 Summer Neurobiology Course (H. J. Chial), an MBL Post-Course Research Scholarship (H. J. Chial), National Institutes of Health (NIH) F32CA108196 (H. J. Chial), NIH P01CA106742 (Y. Q. Chen), and NIH R01CA107668 (Y. Q. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach-Orlowska M, 2009, BIOCHEM J, V423, P389, DOI 10.1042/BJ20090086; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bastiaens PIH, 1996, P NATL ACAD SCI USA, V93, P8407, DOI 10.1073/pnas.93.16.8407; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Calleja V, 2003, BIOCHEM J, V372, P33, DOI 10.1042/BJ20030358; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fang X, 2009, DIABETOLOGIA, V52, P2190, DOI 10.1007/s00125-009-1462-0; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gregoratto D, 2004, NUCL FUSION, V44, P1, DOI 10.1088/0029-5515/44/1/001; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Kirber MT, 2007, NAT METHODS, V4, P767, DOI 10.1038/nmeth1007-767; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; MCCREA HJ, 2008, BIOCH BIOPHYS RES CO; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Rashid S, 2009, J BIOL CHEM, V284, P18115, DOI 10.1074/jbc.M109.007237; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; SIEGEL RM, 2000, SCI STKE, pPL1; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Thaler C, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491A; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; Valentin G, 2006, NAT METHODS, V3, P492, DOI 10.1038/nmeth0706-492; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Verrier SE, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491B; WANG C, 2009, J BIOL CHEM; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	40	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12471	10.1371/journal.pone.0012471	http://dx.doi.org/10.1371/journal.pone.0012471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814572	Green Submitted, Green Published, gold			2022-12-25	WOS:000281375500006
J	Akhtar, K; Broekelmann, TJ; Miao, M; Keeley, FW; Starcher, BC; Pierce, RA; Mecham, RP; Adair-Kirk, TL				Akhtar, Kamal; Broekelmann, Thomas J.; Miao, Ming; Keeley, Fred W.; Starcher, Barry C.; Pierce, Richard A.; Mecham, Robert P.; Adair-Kirk, Tracy L.			Oxidative and Nitrosative Modifications of Tropoelastin Prevent Elastic Fiber Assembly in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; LYSINE SIDE-CHAINS; EXTRACELLULAR-MATRIX; CROSS-LINKING; HYDROPHOBIC DOMAINS; CIGARETTE-SMOKE; PROTEINS; DISEASE; COACERVATION	Elastic fibers are extracellular structures that provide stretch and recoil properties of tissues, such as lungs, arteries, and skin. Elastin is the predominant component of elastic fibers. Tropoelastin (TE), the precursor of elastin, is synthesized mainly during late fetal and early postnatal stages. The turnover of elastin in normal adult tissues is minimal. However, in several pathological conditions often associated with inflammation and oxidative stress, elastogenesis is re-initiated, but newly synthesized elastic fibers appear abnormal. We sought to determine the effects of reactive oxygen and nitrogen species (ROS/RNS) on the assembly of TE into elastic fibers. Immunoblot analyses showed that TE is oxidatively and nitrosatively modified by peroxynitrite (ONOO-) and hypochlorous acid (HOCl) and by activated monocytes and macrophages via release of ONOO- and HOCl. In an in vitro elastic fiber assembly model, oxidatively modified TE was unable to form elastic fibers. Oxidation of TE enhanced coacervation, an early step in elastic fiber assembly, but reduced cross-linking and interactions with other proteins required for elastic fiber assembly, including fibulin-4, fibulin-5, and fibrillin-2. These findings establish that ROS/RNS can modify TE and that these modifications affect the assembly of elastic fibers. Thus, we speculate that oxidative stress may contribute to the abnormal structure and function of elastic fibers in pathological conditions.	[Mecham, Robert P.; Adair-Kirk, Tracy L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Miao, Ming; Keeley, Fred W.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Starcher, Barry C.] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Adair-Kirk, TL (corresponding author), 660 S Euclid Ave,Box 8052, St Louis, MO 63110 USA.	tkirk@dom.wustl.edu			National Institutes of Health [HL29594]; Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL29594, the Alpha-1 Foundation, and the Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation.	Adair-Kirk TL, 2005, J IMMUNOL, V174, P1621, DOI 10.4049/jimmunol.174.3.1621; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; CLARK RA, 1986, BIOCHEM BIOPH RES CO, V135, P451, DOI 10.1016/0006-291X(86)90015-X; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; Deslee G, 2009, EUR RESPIR J, V34, P324, DOI 10.1183/09031936.00123008; Deslee G, 2010, AM J RESP CELL MOL, V43, P576, DOI 10.1165/rcmb.2009-0221OC; Deslee G, 2009, CHEST, V135, P965, DOI 10.1378/chest.08-2257; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Franzblau C, 1977, Adv Exp Med Biol, V79, P313; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Gole MD, 2000, AM J PHYSIOL-LUNG C, V278, pL961, DOI 10.1152/ajplung.2000.278.5.L961; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kalluri R, 2000, J BIOL CHEM, V275, P20027, DOI 10.1074/jbc.M904549199; Kanazawa H, 2003, THORAX, V58, P106, DOI 10.1136/thorax.58.2.106; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007; LAURENT P, 1983, CHEST, V83, pS63, DOI 10.1378/chest.83.5.63S; Lenz AG, 1999, EUR RESPIR J, V13, P169, DOI 10.1034/j.1399-3003.1999.13a31.x; Lin SY, 2005, PEPTIDES, V26, P543, DOI 10.1016/j.peptides.2004.11.005; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Maeda I, 2007, J BIOCHEM, V142, P627, DOI 10.1093/jb/mvm170; Mecham RP, 2008, METHODS, V45, P32, DOI 10.1016/j.ymeth.2008.01.007; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Morris JC, 1996, J BIOL CHEM, V271, P15468, DOI 10.1074/jbc.271.26.15468; Morton LW, 2003, BIOCHEM J, V370, P339, DOI 10.1042/BJ20020964; Narayanan A S, 1977, Adv Exp Med Biol, V79, P491; Osoata GO, 2009, CHEST, V135, P1513, DOI 10.1378/chest.08-2105; Petruzzelli S, 1997, AM J RESP CRIT CARE, V156, P1902, DOI 10.1164/ajrccm.156.6.9702075; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; RONGIOLETTI F, 1995, DERMATOLOGY, V191, P19, DOI 10.1159/000246478; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; STARCHER BC, 1973, BIOCHEM BIOPH RES CO, V53, P210, DOI 10.1016/0006-291X(73)91421-6; STARCHER BC, 1981, CONNECT TISSUE RES, V8, P255, DOI 10.3109/03008208109152385; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Tu YD, 2008, BIOMACROMOLECULES, V9, P1739, DOI 10.1021/bm7013153; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wachi H, 2005, CLIN BIOCHEM, V38, P643, DOI 10.1016/j.clinbiochem.2005.04.006; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Yamaguchi Y, 2004, ATHEROSCLEROSIS, V172, P259, DOI 10.1016/j.atherosclerosis.2003.09.030; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	60	36	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37396	37404		10.1074/jbc.M110.126789	http://dx.doi.org/10.1074/jbc.M110.126789			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847053	Green Published, hybrid			2022-12-25	WOS:000284424000032
J	Mani, RS; Yu, YP; Fang, SJ; Lu, ML; Fanta, M; Zolner, AE; Tahbaz, N; Ramsden, DA; Litchfield, DW; Lees-Miller, SP; Weinfeld, M				Mani, Rajam S.; Yu, Yaping; Fang, Shujuan; Lu, Meiling; Fanta, Mesfin; Zolner, Angela E.; Tahbaz, Nasser; Ramsden, Dale A.; Litchfield, David W.; Lees-Miller, Susan P.; Weinfeld, Michael			Dual Modes of Interaction between XRCC4 and Polynucleotide Kinase/Phosphatase IMPLICATIONS FOR NONHOMOLOGOUS END JOINING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-LIGASE-IV; DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; IONIZING-RADIATION; RAT-LIVER; CELL; 3'-PHOSPHATASE; COMPLEX; GENE	XRCC4 plays a crucial role in the nonhomologous end joining (NHEJ) pathway of DNA double-strand break repair acting as a scaffold protein that recruits other NHEJ proteins to double-strand breaks. Phosphorylation of XRCC4 by protein kinase CK2 promotes a high affinity interaction with the forkhead-associated domain of the end-processing enzyme polynucleotide kinase/phosphatase (PNKP). Here we reveal that unphosphorylated XRCC4 also interacts with PNKP through a lower affinity interaction site within the catalytic domain and that this interaction stimulates the turnover of PNKP. Unexpectedly, CK2-phosphorylated XRCC4 inhibited PNKP activity. Moreover, the XRCC4.DNA ligase IV complex also stimulated PNKP enzyme turnover, and this effect was independent of the phosphorylation of XRCC4 at threonine 233. Our results reveal that CK2-mediated phosphorylation of XRCC4 can have different effects on PNKP activity, with implications for the roles of XRCC4 and PNKP in NHEJ.	[Mani, Rajam S.; Lu, Meiling; Fanta, Mesfin; Tahbaz, Nasser; Weinfeld, Michael] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Mani, Rajam S.; Lu, Meiling; Fanta, Mesfin; Tahbaz, Nasser; Weinfeld, Michael] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Yu, Yaping; Fang, Shujuan; Zolner, Angela E.; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Yu, Yaping; Fang, Shujuan; Zolner, Angela E.; Lees-Miller, Susan P.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Ramsden, Dale A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Litchfield, David W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario)	Weinfeld, M (corresponding author), Cross Canc Inst, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	michaelw@cancerboard.ab.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620; Lees-Miller, Susan/0000-0001-5809-2516	Canadian Institutes of Health Research [15385, 13639]; Alberta Cancer Foundation [23817]; National Institutes of Health [CA 84442]; NATIONAL CANCER INSTITUTE [R01CA084442] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Canadian Institutes of Health Research Grants 15385(to M.W.) and 13639(to S.P.L.-M.) and Alberta Cancer Foundation Grant 23817 (to S.P.L.-M. and M. W.). This work was also supported, in whole or in part, by National Institutes of Health Grant CA 84442 (to D.A.R.).	Bernstein NK, 2008, ANTI-CANCER AGENT ME, V8, P358, DOI 10.2174/187152008784220311; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GATICA M, 1995, BIOCHEMISTRY-US, V34, P122, DOI 10.1021/bi00001a015; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; HABRAKEN Y, 1988, EUR J BIOCHEM, V171, P59, DOI 10.1111/j.1432-1033.1988.tb13758.x; Harlow E, 1988, ANTIBODIES LABORATOR, P521; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mani RS, 2007, J BIOL CHEM, V282, P28004, DOI 10.1074/jbc.M704867200; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; PHEIFFER BH, 1982, BIOCHEM BIOPH RES CO, V109, P1297, DOI 10.1016/0006-291X(82)91918-0; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5	38	50	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37619	37629		10.1074/jbc.M109.058719	http://dx.doi.org/10.1074/jbc.M109.058719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20852255	Green Published, hybrid			2022-12-25	WOS:000284424000054
J	Fernandez-Funez, P; Zhang, Y; Casas-Tinto, S; Xiao, XZ; Zou, WQ; Rincon-Limas, DE				Fernandez-Funez, Pedro; Zhang, Yan; Casas-Tinto, Sergio; Xiao, Xiangzhu; Zou, Wen-Quan; Rincon-Limas, Diego E.			Sequence-dependent Prion Protein Misfolding and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; MUSHROOM BODIES; STRAINS; GLYCOSYLATION; INFECTION; DISEASE; CELLS; ACQUISITION; RESISTANCE; RESIDUES	Prion diseases are neurodegenerative disorders caused by misfolding of the normal prion protein (PrP) into a pathogenic "scrapie" conformation. To better understand the cellular and molecular mechanisms that govern the conformational changes (conversion) of PrP, we compared the dynamics of PrP from mammals susceptible (hamster and mouse) and resistant (rabbit) to prion diseases in transgenic flies. We recently showed that hamster PrP induces spongiform degeneration and accumulates into highly aggregated, scrapie-like conformers in transgenic flies. We show now that rabbit PrP does not induce spongiform degeneration and does not convert into scrapie-like conformers. Surprisingly, mouse PrP induces weak neurodegeneration and accumulates small amounts of scrapie-like conformers. Thus, the expression of three highly conserved mammalian prion proteins in transgenic flies uncovered prominent differences in their conformational dynamics. How these properties are encoded in the amino acid sequence remains to be elucidated.	[Fernandez-Funez, Pedro] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA; [Rincon-Limas, Diego E.] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA; [Casas-Tinto, Sergio] Ctr Nacl Invest Oncol, Dept Mol Oncol, E-28029 Madrid, Spain; [Xiao, Xiangzhu; Zou, Wen-Quan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Case Western Reserve University	Fernandez-Funez, P (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA.	pedro.fernandez@neurology.ufl.edu; diego.rincon@neurology.ufl.edu	Zou, Wenquan/GWQ-3489-2022; Casas-Tinto, Sergio/G-8220-2015; ZHANG, YAN/J-7862-2012; xiao, xiangzhu/B-9300-2014; Zou, Wenquan/ABF-2875-2020	Casas-Tinto, Sergio/0000-0002-9589-9981; xiao, xiangzhu/0000-0002-8013-9074; Rincon-Limas, Diego/0000-0003-3099-0642	National Institutes of Health [R01NS062787, DP2 OD002721-01]; McGregor Foundation; Discretionary Fund; John Sealy Memorial Endowment Fund [CON 15431]; Alliance BioSecure; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGregor Foundation; Discretionary Fund; John Sealy Memorial Endowment Fund; Alliance BioSecure; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS062787 and Grant DP2 OD002721-01 (to P. F.-F.). This work was also supported by the McGregor Foundation and the President's Discretionary Fund and Alliance BioSecure (to W.-Q. Z.) and the John Sealy Memorial Endowment Fund Grant CON 15431 (to D. E. R.-L.).	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Gavin BA, 2006, J NEUROSCI, V26, P12408, DOI 10.1523/JNEUROSCI.3372-06.2006; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Jenkins DC, 2008, FEBS J, V275, P1323, DOI 10.1111/j.1742-4658.2008.06293.x; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Moore RA, 2009, CURR OPIN STRUC BIOL, V19, P14, DOI 10.1016/j.sbi.2008.12.007; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; Nitrini R, 1997, ANN NEUROL, V42, P138, DOI 10.1002/ana.410420203; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Robinson PJ, 2009, BIOCHEMISTRY-US, V48, P8551, DOI 10.1021/bi901070t; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	41	26	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36897	36908		10.1074/jbc.M110.174391	http://dx.doi.org/10.1074/jbc.M110.174391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20817727	Green Published, hybrid			2022-12-25	WOS:000284146100068
J	Pasztor, L; Ziebandt, AK; Nega, M; Schlag, M; Haase, S; Franz-Wachtel, M; Madlung, J; Nordheim, A; Heinrichs, DE; Gotz, F				Pasztor, Linda; Ziebandt, Anne-Kathrin; Nega, Mulugeta; Schlag, Martin; Haase, Sabine; Franz-Wachtel, Mirita; Madlung, Johannes; Nordheim, Alfred; Heinrichs, David E.; Goetz, Friedrich			Staphylococcal Major Autolysin (Atl) Is Involved in Excretion of Cytoplasmic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE PROTEOME ANALYSIS; BACILLUS-SUBTILIS; MEMBRANE-VESICLES; EXTRACELLULAR PROTEINS; GEL-ELECTROPHORESIS; VIRULENCE FACTORS; GENE-EXPRESSION; AUREUS; EPIDERMIDIS; SECRETION	Many microorganisms excrete typical cytoplasmic proteins into the culture supernatant. As none of the classical secretion systems appears to be involved, this type of secretion was referred to as "nonclassical protein secretion." Here, we demonstrate that in Staphylococcus aureus the major autolysin plays a crucial role in release of cytoplasmic proteins. Comparative secretome analysis revealed that in the wild type S. aureus strain, 22 typical cytoplasmic proteins were excreted into the culture supernatant, although in the atl mutant they were significantly decreased. The presence or absence of prophages had little influence on the secretome pattern. In the atl mutant, secondary peptidoglycan hydrolases were increased in the secretome; the corresponding genes were transcriptionally up-regulated suggesting a compensatory mechanism for the atl mutation. Using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a cytoplasmic indicator enzyme, we showed that all clinical isolates tested excreted this protein. In the wall teichoic acid-deficient tagO mutant with its increased autolysis activity, GAPDH was excreted in even higher amounts than in the WT, confirming the importance of autolysis in excretion of cytoplasmic proteins. To answer the question of how discriminatory the excretion of cytoplasmic proteins is, we performed a two-dimensional PAGE of cytoplasmic proteins isolated from WT. Surprisingly, the most abundant proteins in the cytoplasm were not found in the secretome of the WT, suggesting that there exists a selection mechanism in the excretion of cytoplasmic proteins. As the major autolysin binds at the septum site, we assume that the proteins are preferentially released at and during septum formation.	[Goetz, Friedrich] Univ Tubingen, Dept Microbial Genet, Proteome Ctr, D-72076 Tubingen, Germany; [Franz-Wachtel, Mirita; Madlung, Johannes; Nordheim, Alfred] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr, D-72076 Tubingen, Germany; [Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Western University (University of Western Ontario)	Gotz, F (corresponding author), Univ Tubingen, Dept Microbial Genet, Proteome Ctr, D-72076 Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de	Heinrichs, David/ABD-5702-2021	Nordheim, Alfred/0000-0003-4680-0778; Heinrichs, David/0000-0002-7217-2456	Deutsche Forschungsgemeinschaft [SFB 766]; Graduate College [GKI 685]; Ministerium fur Wissenschaft und Kunst; Landesstiftung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate College; Ministerium fur Wissenschaft und Kunst; Landesstiftung Baden-Wurttemberg	This work was supported by the Deutsche Forschungsgemeinschaft, SFB 766, and Graduate College Grant GKI 685.; We thank Regine Stemmler, Silke Wahl, and Inga Buchen for excellent technical assistance and the Ministerium fur Wissenschaft und Kunst and the Landesstiftung Baden-Wurttemberg for financial support of the Proteome Center Tubingen.	Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chatterjee I, 2009, PROTEOMICS, V9, P1152, DOI 10.1002/pmic.200800586; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; DUTHIE ES, 1952, J GEN MICROBIOL, V7, P320, DOI 10.1099/00221287-7-3-4-320; DYKE KGH, 1966, LANCET, V1, P835; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; MAJUMDAR D, 1991, BIOTECHNIQUES, V11, P94; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Otto M, 1998, FEMS MICROBIOL LETT, V166, P203, DOI 10.1016/S0378-1097(98)00333-4; Otto M, 2001, RES MICROBIOL, V152, P351, DOI 10.1016/S0923-2508(01)01206-2; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Resch A, 2005, FEMS MICROBIOL LETT, V252, P89, DOI 10.1016/j.femsle.2005.08.048; Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SCHLEIFER KH, 1982, INT J SYST BACTERIOL, V32, P153, DOI 10.1099/00207713-32-2-153; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; Vitikainen M, 2004, J BIOL CHEM, V279, P19302, DOI 10.1074/jbc.M400861200; Walker SA, 2001, APPL ENVIRON MICROB, V67, P251, DOI 10.1128/AEM.67.1.251-259.2001; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Xia XX, 2008, PROTEOMICS, V8, P2089, DOI 10.1002/pmic.200700826; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; Zell C, 2008, INT J FOOD MICROBIOL, V127, P246, DOI 10.1016/j.ijfoodmicro.2008.07.016; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	60	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36794	36803		10.1074/jbc.M110.167312	http://dx.doi.org/10.1074/jbc.M110.167312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847047	Green Published, hybrid			2022-12-25	WOS:000284146100057
J	Enomoto, Y; Yamanishi, Y; Izawa, K; Kaitani, A; Takahashi, M; Maehara, A; Oki, T; Takamatsu, R; Kajikawa, M; Takai, T; Kitamura, T; Kitaura, J				Enomoto, Yutaka; Yamanishi, Yoshinori; Izawa, Kumi; Kaitani, Ayako; Takahashi, Mariko; Maehara, Akie; Oki, Toshihiko; Takamatsu, Reiko; Kajikawa, Masunori; Takai, Toshiyuki; Kitamura, Toshio; Kitaura, Jiro			Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor ITS SIMILARITIES TO AND DIFFERENCES FROM LMIR4/CLM-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; MAST-CELL SURVIVAL; GAMMA-CHAIN; CMRF-35-LIKE MOLECULE-1; GENE SUPERFAMILY; IMMUNE-SYSTEM; ASSOCIATION; EXPRESSION; SUBUNIT	Here we characterize leukocyte mono-Ig-like receptor 7 (LMIR7)/CLM-3 and compare it with an activating receptor, LMIR4/CLM-5, that is a counterpart of an inhibitory receptor LMIR3/CLM-1. LMIR7 shares high homology with LMIR4 in the amino acid sequences of its Ig-like and transmembrane domains. Flow cytometric analysis demonstrated that LMIR4 was predominantly expressed in neutrophils, whereas LMIR7 was highly expressed in mast cells and monocytes/macrophages. Importantly, LMIR7 engagement induced cytokine production in bone marrow-derived mast cells (BMMCs). Although FcR gamma deficiency did not affect surface expression levels of LMIR7, it abolished LMIR7-mediated activation of BMMCs. Consistently we found significant interaction of LMIR7-FcR gamma, albeit with lower affinity compared with that of LMIR4-FcR gamma. Our results showed that LMIR7 transmits an activating signal through interaction with FcR gamma. In addition, like LMIR4, LMIR7 synergizes with TLR4 in signaling. Analysis of several chimera receptors composed of LMIR4 and LMIR7 revealed these findings: 1) the transmembrane of LMIR7 with no charged residues maintained its surface expression at high levels in the absence of FcR gamma; 2) the extracellular juxtamembrane region of LMIR7 had a negative effect on its surface expression levels; and 3) the strong interaction of LMIR4 with FcR gamma depended on the extracellular juxtamembrane region as well as the transmembrane domain of LMIR4. Thus, LMIR7 shares similarities with LMIR4, although they are differentially regulated in their distribution, expression, and function.	[Enomoto, Yutaka; Yamanishi, Yoshinori; Izawa, Kumi; Kaitani, Ayako; Takahashi, Mariko; Maehara, Akie; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Therapy, Div Stem Cell Signaling,Minato Ku, Tokyo 1088639, Japan; [Takamatsu, Reiko; Kajikawa, Masunori] ACTGen Inc, Komagane, Nagano 3994117, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan	University of Tokyo; University of Tokyo; Tohoku University	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021	Enomoto, Yutaka/0000-0002-6346-9362	Ministry of Education, Science, Technology, Sports, and Culture; Ministry of Health and Welfare, Japan	Ministry of Education, Science, Technology, Sports, and Culture; Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Education, Science, Technology, Sports, and Culture and the Ministry of Health and Welfare, Japan.	Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Bori-Sanz T, 2003, J BIOL CHEM, V278, P35914, DOI 10.1074/jbc.M301826200; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; DAISH A, 1993, IMMUNOLOGY, V79, P55; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Luo K, 2001, BIOCHEM BIOPH RES CO, V287, P35, DOI 10.1006/bbrc.2001.5539; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MORTON HC, 1995, J BIOL CHEM, V270, P29781; PFEFFERKORN LC, 1994, J IMMUNOL, V153, P3228; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; SCHOLL PR, 1993, P NATL ACAD SCI USA, V90, P8847, DOI 10.1073/pnas.90.19.8847; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Wines BD, 2006, J BIOL CHEM, V281, P17108, DOI 10.1074/jbc.M601640200; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	35	17	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35274	35283		10.1074/jbc.M110.137166	http://dx.doi.org/10.1074/jbc.M110.137166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817736	hybrid, Green Published			2022-12-25	WOS:000283845300005
J	Gencheva, M; Lin, TY; Wu, XW; Yang, LX; Richard, C; Jones, M; Lin, SB; Lin, RJ				Gencheva, Marieta; Lin, Ting-Yu; Wu, Xiwei; Yang, Lixin; Richard, Caroline; Jones, Matthew; Lin, Shwu-Bin; Lin, Ren-Jang			Nuclear Retention of Unspliced Pre-mRNAs by Mutant DHX16/hPRP2, a Spliceosomal DEAH-box Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSENSE-MEDIATED DECAY; FISSION YEAST; SPLICING REGULATORS; PROTEOMIC ANALYSIS; TRANSCRIPTION; INTRONS; GENES; IDENTIFICATION; MICROARRAY; COMPONENTS	Defective or imbalanced expression of spliceosomal factors has been linked to human disease; however, how a defective spliceosome affects intron-containing gene transcripts in human cells is largely unknown. DEAH-box protein DHX16 is a human orthologue of Saccharomyces cerevisiae spliceosomal protein Prp2, an RNA-dependent ATPase that activates the spliceosome before the first catalytic step of splicing. Yeast prp2 mutants accumulate unspliced RNAs from the vast majority of intron-containing genes. Here we used a genomic tiling microarray to screen transcripts from four chromosomes in human cells expressing a dominant negative DHX16 mutant and identified a number of gene transcripts that retained their introns. The mutant protein also affected gene transcripts that are sensitive to pladienolide, an SF3b inhibitor. The unspliced RNAs were retained in the nucleus, and block of nonsense-mediated decay did not affect their accumulation. Thus, a perturbation of human PRP2/DHX16 results in accumulation of unspliced transcripts, similar to the outcome in yeast prp2 mutants. The results further suggest that mutant DHX16/hPRP2 causes a defective spliceosome to retain unspliced gene transcripts in the nuclei of human cells.	[Lin, Ren-Jang] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Wu, Xiwei] Beckman Res Inst City Hope, Dept Bioinformat, Duarte, CA 91010 USA; [Richard, Caroline; Lin, Ren-Jang] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Lin, Ting-Yu; Lin, Shwu-Bin] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10016, Taiwan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; National Taiwan University	Lin, RJ (corresponding author), Beckman Res Inst City Hope, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RLin@coh.org	Lin, Ting-Yu/O-5781-2015; Lin, Ren-Jang/G-2052-2014	Lin, Ting-Yu/0000-0001-7914-2164; Lin, Ren-Jang/0000-0002-2738-2438	National Institutes of Health [GM40639]; City of Hope Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40639. This work was also supported by a City of Hope Cancer Center grant (to R.-J. L.).	Abelson J, 1989, Harvey Lect, V85, P1; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOUSQUETANTONEL.C, 2000, D CELL, V102, P765; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; FOUSER LA, 1986, CELL, V45, P81, DOI 10.1016/0092-8674(86)90540-4; Gencheva M, 2010, BIOCHEM J, V429, P25, DOI 10.1042/BJ20100266; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Imamura O, 1998, NUCLEIC ACIDS RES, V26, P2063, DOI 10.1093/nar/26.9.2063; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; KIM SH, 1993, P NATL ACAD SCI USA, V90, P888, DOI 10.1073/pnas.90.3.888; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Nilsen TW, 2007, MOL CELL, V28, P715, DOI 10.1016/j.molcel.2007.11.017; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Paz A, 2007, J MOL EVOL, V64, P248, DOI 10.1007/s00239-006-0135-6; PIKIELNY CW, 1985, CELL, V41, P119, DOI 10.1016/0092-8674(85)90066-2; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; PLUMPTON M, 1994, EMBO J, V13, P879, DOI 10.1002/j.1460-2075.1994.tb06331.x; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; ROSBASH M, 1981, CELL, V24, P679, DOI 10.1016/0092-8674(81)90094-5; RUBY SW, 1991, TRENDS GENET, V7, P79; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Sharp PA, 2005, TRENDS BIOCHEM SCI, V30, P279, DOI 10.1016/j.tibs.2005.04.002; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhang ZH, 2007, GENOME RES, V17, P503, DOI 10.1101/gr.6049107; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	50	17	18	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35624	35632		10.1074/jbc.M110.122309	http://dx.doi.org/10.1074/jbc.M110.122309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20841358	hybrid, Green Published			2022-12-25	WOS:000283845300041
J	Goto, E; Yamanaka, Y; Ishikawa, A; Aoki-Kawasumi, M; Mito-Yoshida, M; Ohmura-Hoshino, M; Matsuki, Y; Kajikawa, M; Hirano, H; Ishido, S				Goto, Eiji; Yamanaka, Yuko; Ishikawa, Akiyo; Aoki-Kawasumi, Masami; Mito-Yoshida, Mari; Ohmura-Hoshino, Mari; Matsuki, Yohei; Kajikawa, Mizuho; Hirano, Hisashi; Ishido, Satoshi			Contribution of Lysine 11-linked Ubiquitination to MIR2-mediated Major Histocompatibility Complex Class I Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; DOWN-REGULATION; MEMBRANE-PROTEINS; DEGRADATION; ENDOCYTOSIS; LIGASES; RECEPTOR; RECOGNITION; MOLECULES; SIGNALS	The polyubiquitin chain is generated by the sequential addition of ubiquitin moieties to target molecules, a reaction between specific lysine residues that is catalyzed by E3 ubiquitin ligase. The Lys(48)-linked and Lys(63)-linked polyubiquitin chains are well established inducers of proteasome-dependent degradation and signal transduction, respectively. The concept has recently emerged that polyubiquitin chain-mediated regulation is even more complex because various types of atypical polyubiquitin chains have been discovered in vivo. Here, we demonstrate that a novel complex ubiquitin chain functions as an internalization signal for major histocompatibility complex class I (MHCI) membrane proteins in vivo. Using a tetracycline-inducible expression system and quantitative mass spectrometry, we show that the polyubiquitin chain generated by the viral E3 ubiquitin ligase of Kaposi sarcoma-associated herpesvirus, MIR2, is a Lys(11) and Lys(63) mixed-linkage chain. This novel ubiquitin chain can function as an internalization signal for MHC I through its association with epsin1, an adaptor molecule containing ubiquitin-interacting motifs.	[Goto, Eiji; Aoki-Kawasumi, Masami; Mito-Yoshida, Mari; Ohmura-Hoshino, Mari; Matsuki, Yohei; Kajikawa, Mizuho; Ishido, Satoshi] RIKEN Res Ctr Allergy & Immunol, Lab Infect Immun, Tsurumi Ku, Kanagawa 230045, Japan; [Yamanaka, Yuko; Ishikawa, Akiyo; Matsuki, Yohei; Hirano, Hisashi; Ishido, Satoshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, Kanagawa 2300045, Japan	RIKEN; Yokohama City University	Ishido, S (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Kanagawa 2300045, Japan.	ishido@rcai.riken.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Japan Society for the Promotion of Science.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gay DL, 2008, IMMUNOL RES, V42, P51, DOI 10.1007/s12026-008-8034-0; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; GOMEZMARTIN D, 2008, J AUTOIMMUN REV, V7, P284; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Ishido S, 2009, CURR OPIN IMMUNOL, V21, P78, DOI 10.1016/j.coi.2009.01.002; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	41	49	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35311	35319		10.1074/jbc.M110.112763	http://dx.doi.org/10.1074/jbc.M110.112763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833710	hybrid, Green Published			2022-12-25	WOS:000283845300009
J	Amin, ARMR; Wang, DS; Zhang, HZ; Peng, SF; Shin, HJC; Brandes, JC; Tighiouart, M; Khuri, FR; Chen, ZG; Shin, DM				Amin, A. R. M. Ruhul; Wang, Dongsheng; Zhang, Hongzheng; Peng, Shifang; Shin, Hyung Ju C.; Brandes, Johann C.; Tighiouart, Mourad; Khuri, Fadlo R.; Chen, Zhuo Georgia; Shin, Dong M.			Enhanced Anti-tumor Activity by the Combination of the Natural Compounds (-)-Epigallocatechin-3-gallate and Luteolin POTENTIAL ROLE OF p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GREEN TEA EXTRACT; PHASE-I TRIAL; CANCER PREVENTION; CARCINOMA-CELLS; BREAST-CANCER; TUMOR-GROWTH; POLYPHENON-E; HIGH-RISK; APOPTOSIS	Natural dietary agents have drawn a great deal of attention toward cancer prevention because of their wide safety margin. However, single agent intervention has failed to bring the expected outcome in clinical trials; therefore, combinations of chemopreventive agents are gaining increasingly popularity. In the present study, we investigated a combinatorial approach using two natural dietary polyphenols, luteolin and EGCG, and found that their combination at low doses (at which single agents induce minimal apoptosis) synergistically increased apoptosis (3-5-fold more than the additive level of apoptosis) in both head and neck and lung cancer cell lines. This combination also significantly inhibited growth of xenografted tumors in nude mice. The in vivo findings also were supported by significant inhibition of Ki-67 expression and increase in TUNEL-positive cells in xenografted tissues. Mechanistic studies revealed that the combination induced mitochondria-dependent apoptosis in some cell lines and mitochondria-independent apoptosis in others. Moreover, we found more efficient stabilization and ATM-dependent Ser(15) phosphorylation of p53 due to DNA damage by the combination, and ablation of p53 using shRNA strongly inhibited apoptosis as evidenced by decreased poly-(ADP-ribose) polymerase and caspase-3 cleavage. In addition, we observed mitochondrial translocation of p53 after treatment with luteolin or the combination of EGCG and luteolin. Taken together, our results for the first time suggest that the combination of luteolin and EGCG has synergistic/additive growth inhibitory effects and provides an important rationale for future chemoprevention trials of head and neck and lung cancers.	[Tighiouart, Mourad; Khuri, Fadlo R.; Chen, Zhuo Georgia; Shin, Dong M.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Shin, Hyung Ju C.] Quest Diagnost, Atlanta, GA 30084 USA	Emory University	Shin, DM (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	dmshin@emory.edu	Shin, Dong Moon/G-9649-2013; Ray, Dana M/C-3470-2013; Khuri, Fadlo R./AAU-4942-2020	Shin, Dong Moon/0000-0002-8245-4174; Khuri, Fadlo R./0000-0002-8638-7618; Brandes, Johann/0000-0002-1815-8311; AMIN, ARM/0000-0001-9144-2960	National Institutes of Health [P50 CA128613, U01 CA101244, R01 CA112643]; NATIONAL CANCER INSTITUTE [R01CA112643, P50CA128613, U01CA101244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA128613, U01 CA101244, and R01 CA112643.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Amin ARMR, 2009, CANCER PREV RES, V2, P538, DOI 10.1158/1940-6207.CAPR-09-0063; Antonakopoulos N, 2007, HEPATO-GASTROENTEROL, V54, P1694; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bode AM, 2009, CANCER PREV RES, V2, P514, DOI 10.1158/1940-6207.CAPR-09-0083; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Ciardiello F, 1999, CLIN CANCER RES, V5, P909; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Hawk E, 1999, CANCER-AM CANCER SOC, V86, P2551, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2551::AID-CNCR12>3.3.CO;2-T; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Horinaka M, 2005, ONCOGENE, V24, P7180, DOI 10.1038/sj.onc.1208874; Horinaka M, 2005, BIOCHEM BIOPH RES CO, V333, P833, DOI 10.1016/j.bbrc.2005.05.179; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Meslin F, 2007, J BIOL CHEM, V282, P32991, DOI 10.1074/jbc.M705290200; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Pisters KMW, 2001, J CLIN ONCOL, V19, P1830, DOI 10.1200/JCO.2001.19.6.1830; Qin JC, 2008, CANCER RES, V68, P4150, DOI 10.1158/0008-5472.CAN-08-0839; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Shimoi K, 2000, BIOFACTORS, V12, P181, DOI 10.1002/biof.5520120129; Shin DM, 2009, CANCER PREV RES, V2, P919, DOI 10.1158/1940-6207.CAPR-09-0207; Sun SY, 1997, CANCER RES, V57, P4931; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Zhang X, 2005, CLIN CANCER RES, V11, P6261, DOI 10.1158/1078-0432.CCR-04-2102; Zhang X, 2008, INT J CANCER, V123, P1005, DOI 10.1002/ijc.23585; Zhao Y, 2010, CANCER LETT, V288, P42, DOI 10.1016/j.canlet.2009.06.021	42	89	92	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34557	34565		10.1074/jbc.M110.141135	http://dx.doi.org/10.1074/jbc.M110.141135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826787	Green Published, hybrid			2022-12-25	WOS:000283659100031
J	Li, XJ; Marchal, CC; Stull, ND; Stahelin, RV; Dinauer, MC				Li, Xing Jun; Marchal, Christophe C.; Stull, Natalie D.; Stahelin, Robert V.; Dinauer, Mary C.			p47(phox) Phox Homology Domain Regulates Plasma Membrane but Not Phagosome Neutrophil NADPH Oxidase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PHOSPHORYLATION-INDUCED ACTIVATION; PX DOMAIN; PROTEIN P40(PHOX); SH3 DOMAIN; INTRAMOLECULAR INTERACTION; RESPIRATORY BURST; RESTING STATE; CLASS-III; CLASS-I	The assembly of cytosolic subunits p47(phox), p67(phox), and p40(phox) with flavocytochrome b(558) at the membrane is required for activating the neutrophil NADPH oxidase that generates superoxide for microbial killing. The p47(phox) subunit plays a critical role in oxidase assembly. Recent studies showed that the p47(phox) Phox homology (PX) domain mediates phosphoinositide binding in vitro and regulates phorbol ester-induced NADPH oxidase activity in a K562 myeloid cell model. Because the importance of the p47(phox) PX domain in neutrophils is unclear, we investigated its role using p47(phox) knock-out (KO) mouse neutrophils to express human p47(phox) and derivatives harboring R90A mutations in the PX domain that result in loss of phosphoinositide binding. Human p47(phox) proteins were expressed at levels similar to endogenous murine p47(phox), with the exception of a chronic granulomatous disease-associated R42Q mutant that was poorly expressed, and wild type human p47(phox) rescued p47(phox) KO mouse neutrophil NADPH oxidase activity. Plasma membrane NAPDH oxidase activity was reduced in neutrophils expressing p47(phox) with Arg(90) substitutions, with substantial effects on responses to either phorbol ester or formyl-Met-Leu-Phe and more modest effects to particulate stimuli. In contrast, p47(phox) Arg(90) mutants supported normal levels of intracellular NADPH oxidase activity during phagocytosis of a variety of particles and were recruited to phagosome membranes. This study defines a differential and agonist-dependent role of the p47(phox) PX domain for neutrophil NADPH oxidase activation.	[Dinauer, Mary C.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Li, Xing Jun; Marchal, Christophe C.; Stull, Natalie D.; Dinauer, Mary C.] Indiana Univ Sch Med, Riley Hosp Children, Dept Pediat Hematol Oncol, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Dinauer, Mary C.] Indiana Univ Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA; [Stahelin, Robert V.] Univ Sch Med S Bend, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University Bloomington; University of Notre Dame	Dinauer, MC (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Box 8208, St Louis, MO 63100 USA.	Dinauer_m@kids.wustl.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	Lilly Endowment Inc.; National Institutes of Health [R01 HL45635, P30 CA082709]; Riley Children's Foundation; American Heart Association [SDG 0735350N]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER	Lilly Endowment Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Catherine M. Matthews for assistance with manuscript preparation. We also thank the Indiana Center for Biological Microscopy, which was supported in part by a grant (Indiana Genomics Initiative (INGEN)) from Lilly Endowment Inc.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL45635 (to M. C. D. and S. Atkinson) and P30 CA082709 (to the Indiana University Simon Cancer Center Grant). This work was also supported by a grant from the Riley Children's Foundation (to M. C. D.) and American Heart Association Grant SDG 0735350N (to R. V. S.).	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen J, 2007, J BIOL CHEM, V282, P30273, DOI 10.1074/jbc.M704416200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; DE MI, 1996, EMBO J, V15, P1211; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; EL B, 1994, J BIOL CHEM */* B M, V269, P23431; Ellson CD, 2002, J CELL SCI, V115, P1099; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hawkins PT, 2007, BIOCHEM SOC SYMP, V74, P59, DOI 10.1042/BSS2007c06; Heyworth PG, 2002, NAT CELL BIOL, V4, pE110, DOI 10.1038/ncb0502-e110a; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Johnson JL, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-28; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Li XJ, 2005, J BIOL CHEM, V280, P14962, DOI 10.1074/jbc.M500226200; Mardiney M, 1997, BLOOD, V89, P2268, DOI 10.1182/blood.V89.7.2268; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012; Mizuki K, 1998, EUR J BIOCHEM, V251, P573, DOI 10.1046/j.1432-1327.1998.2510573.x; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Noack D, 2001, BLOOD, V97, P305, DOI 10.1182/blood.V97.1.305; Petersen JE, 2002, J INVEST DERMATOL, V118, P424, DOI 10.1046/j.0022-202x.2001.01691.x; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shmelzer Z, 2008, J BIOL CHEM, V283, P31898, DOI 10.1074/jbc.M804674200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wientjes FB, 1996, BIOCHEM J, V317, P919, DOI 10.1042/bj3170919; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Yaffe MB, 2002, STRUCTURE, V10, P1288, DOI 10.1016/S0969-2126(02)00860-2; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200	65	38	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35169	35179		10.1074/jbc.M110.164475	http://dx.doi.org/10.1074/jbc.M110.164475			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817944	Green Published, hybrid			2022-12-25	WOS:000283659100090
J	Zhang, Z; Liu, JF; Ding, XD; Bijma, P; de Koning, DJ; Zhang, Q				Zhang, Zhe; Liu, Jianfeng; Ding, Xiangdong; Bijma, Piter; de Koning, Dirk-Jan; Zhang, Qin			Best Linear Unbiased Prediction of Genomic Breeding Values Using a Trait-Specific Marker-Derived Relationship Matrix	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; SELECTION; ACCURACY; WIDE; IMPACT; ANIMALS; SNP	Background: With the availability of high density whole-genome single nucleotide polymorphism chips, genomic selection has become a promising method to estimate genetic merit with potentially high accuracy for animal, plant and aquaculture species of economic importance. With markers covering the entire genome, genetic merit of genotyped individuals can be predicted directly within the framework of mixed model equations, by using a matrix of relationships among individuals that is derived from the markers. Here we extend that approach by deriving a marker-based relationship matrix specifically for the trait of interest. Methodology/Principal Findings: In the framework of mixed model equations, a new best linear unbiased prediction (BLUP) method including a trait-specific relationship matrix (TA) was presented and termed TABLUP. The TA matrix was constructed on the basis of marker genotypes and their weights in relation to the trait of interest. A simulation study with 1,000 individuals as the training population and five successive generations as candidate population was carried out to validate the proposed method. The proposed TABLUP method outperformed the ridge regression BLUP (RRBLUP) and BLUP with realized relationship matrix (GBLUP). It performed slightly worse than BayesB with an accuracy of 0.79 in the standard scenario. Conclusions/Significance: The proposed TABLUP method is an improvement of the RRBLUP and GBLUP method. It might be equivalent to the BayesB method but it has additional benefits like the calculation of accuracies for individual breeding values. The results also showed that the TA-matrix performs better in predicting ability than the classical numerator relationship matrix and the realized relationship matrix which are derived solely from pedigree or markers without regard to the trait. This is because the TA-matrix not only accounts for the Mendelian sampling term, but also puts the greater emphasis on those markers that explain more of the genetic variance in the trait.	[Zhang, Zhe; Liu, Jianfeng; Ding, Xiangdong; Zhang, Qin] China Agr Univ, Minist Agr, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China; [Zhang, Zhe; de Koning, Dirk-Jan] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Zhang, Zhe; de Koning, Dirk-Jan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Bijma, Piter] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	China Agricultural University; Ministry of Agriculture & Rural Affairs; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Wageningen University & Research	Zhang, Z (corresponding author), China Agr Univ, Minist Agr, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China.	dj.dekoning@roslin.ed.ac.uk; qzhang@cau.edu.cn	Zhang, Zhe/AAG-9641-2019; de Koning, Dirk Jan/F-3399-2013	Zhang, Zhe/0000-0001-7338-7718; de Koning, Dirk Jan/0000-0001-6343-8155	State High-Tech Development Plan [2008AA101002]; National Natural Science Foundation of China [30800776]; National Key Basic Research Program of China [2006CB102104]; National Transgenic Major projecct [2009ZX08009-146B]; Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Program; BBSRC [BBS/E/R/00001606] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001606] Funding Source: researchfish	State High-Tech Development Plan(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Transgenic Major projecct; Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the State High-Tech Development Plan (Grant No. 2008AA101002), the National Natural Science Foundation of China (Grant No. 30800776), the National Key Basic Research Program of China (Grant No. 2006CB102104) and the National Transgenic Major projecct (2009ZX08009-146B). DJK acknowledges support from the Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Program Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Eding H, 2001, J ANIM BREED GENET, V118, P141, DOI 10.1046/j.1439-0388.2001.00290.x; Falconer D. S., 1996, Introduction to quantitative genetics.; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HENDERSON CR, 1975, J DAIRY SCI, V58, P1727, DOI 10.3168/jds.S0022-0302(75)84776-X; Jacquard A., 1974, GENETIC STRUCTURE PO; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; KIMURA M, 1964, GENETICS, V49, P725; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Nielsen HM, 2009, AQUACULTURE, V289, P259, DOI 10.1016/j.aquaculture.2009.01.027; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-29; Sonesson AK, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-37; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu SZ, 2003, GENETICS, V163, P789; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	42	127	140	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12648	10.1371/journal.pone.0012648	http://dx.doi.org/10.1371/journal.pone.0012648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844593	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687200013
J	Dias, JP; Talbot, S; Senecal, J; Carayon, P; Couture, R				Dias, Jenny Pena; Talbot, Sebastien; Senecal, Jacques; Carayon, Pierre; Couture, Rejean			Kinin B-1 Receptor Enhances the Oxidative Stress in a Rat Model of Insulin Resistance: Outcome in Hypertension, Allodynia and Metabolic Complications	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; ALPHA-LIPOIC ACID; ANGIOTENSIN-II; SUPEROXIDE-PRODUCTION; BRADYKININ B1; PHARMACOLOGICAL BLOCKADE; SENSORY ABNORMALITIES; MYOCARDIAL-ISCHEMIA; ANTIOXIDANT ENZYMES; OXIDASE ACTIVATION	Background: Kinin B-1 receptor (B1R) is induced by the oxidative stress in models of diabetes mellitus. This study aims at determining whether B1R activation could perpetuate the oxidative stress which leads to diabetic complications. Methods and Findings: Young Sprague-Dawley rats were fed with 10% D-Glucose or tap water (controls) for 8-12 weeks. A selective B1R antagonist (SSR240612) was administered acutely (3-30 mg/kg) or daily for a period of 7 days (10 mg/kg) and the impact was measured on systolic blood pressure, allodynia, protein and/or mRNA B1R expression, aortic superoxide anion (O-2(center dot-)) production and expression of superoxide dismutase (MnSOD) and catalase. SSR240612 reduced dose-dependently (3-30 mg/kg) high blood pressure in 12-week glucose-fed rats, but had no effect in controls. Eight-week glucose-fed rats exhibited insulin resistance (HOMA index), hypertension, tactile and cold allodynia and significant increases of plasma levels of glucose and insulin. This was associated with higher aortic levels of O-2(center dot-), NADPH oxidase activity, MnSOD and catalase expression. All these abnormalities including B1R overexpression (spinal cord, aorta, liver and gastrocnemius muscle) were normalized by the prolonged treatment with SSR240612. The production of O-2(center dot-) in the aorta of glucose-fed rats was also measured in the presence and absence of inhibitors (10-100 mu M) of NADPH oxidase (apocynin), xanthine oxidase (allopurinol) or nitric oxide synthase (L-NAME) with and without Sar[D-Phe(8)]des-Arg(9)-BK (20 mu M; B1R agonist). Data show that the greater aortic O-2(center dot-) production induced by the B1R agonist was blocked only by apocynin. Conclusions: Activation of kinin B1R increased O-2(center dot-) through the activation of NADPH oxidase in the vasculature. Prolonged blockade of B1R restored cardiovascular, sensory and metabolic abnormalities by reducing oxidative stress and B1R gene expression in this model.	[Dias, Jenny Pena; Talbot, Sebastien; Senecal, Jacques; Couture, Rejean] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Carayon, Pierre] Sanofi Aventis R&D, Montpellier, France	Universite de Montreal; Sanofi-Aventis; Sanofi France	Dias, JP (corresponding author), Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada.	rejean.couture@umontreal.ca			Canadian Diabetes Association [OG-3-07-2428]; Canadian Institutes of Health Research [MOP-79471]; Fonds de la Recherche en Sante du Quebec	Canadian Diabetes Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was funded by Grants-in-Aid from the Canadian Diabetes Association (OG-3-07-2428) and the Canadian Institutes of Health Research (MOP-79471). Studentships Awards were obtained from the Canadian Diabetes Association (JPD), the Fonds de la Recherche en Sante du Quebec (JPD, ST) and the Canadian Institutes of Health Research (JPD). Dr Pierre Carayon at Sanofi-Aventis R&D provided SSR240612 and approved the submission of the article with intellectual contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1993, AM J HYPERTENS, V6, P72, DOI 10.1093/ajh/6.1.72; Aoki S, 2002, J NEUROSCI, V22, P10751; Buleon M, 2008, AM J PHYSIOL-RENAL, V294, pF1249, DOI 10.1152/ajprenal.00501.2007; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Cavarape A, 2001, J ENDOCRINOL INVEST, V24, P838, DOI 10.1007/BF03343940; Ceravolo GS, 2007, HYPERTENSION, V50, P756, DOI 10.1161/HYPERTENSIONAHA.107.094706; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; CLERCH LB, 1993, J CLIN INVEST, V91, P499, DOI 10.1172/JCI116228; Cloutier F, 2002, BRIT J PHARMACOL, V135, P1641, DOI 10.1038/sj.bjp.0704632; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Dias JP, 2007, BRIT J PHARMACOL, V152, P280, DOI 10.1038/sj.bjp.0707388; DIAS JP, 2008, THESIS U MONTREAL; DRAPEAU G, 1993, J PHARMACOL EXP THER, V266, P192; Duka A, 2008, HYPERTENSION, V51, P1352, DOI 10.1161/HYPERTENSIONAHA.107.108506; Duka I, 2001, CIRC RES, V88, P275, DOI 10.1161/01.RES.88.3.275; El Midaoui A, 2005, PEPTIDES, V26, P1323, DOI 10.1016/j.peptides.2005.03.028; El Midaoui A, 2005, J HYPERTENS, V23, P581; El Midaoui A, 2002, HYPERTENSION, V39, P303, DOI 10.1161/hy0202.104345; El Midaoui A, 2002, J HYPERTENS, V20, P1407, DOI 10.1097/00004872-200207000-00028; Fernandes L, 2006, REGUL PEPTIDES, V136, P92, DOI 10.1016/j.regpep.2006.04.018; Gabra BH, 2006, BIOL CHEM, V387, P127, DOI 10.1515/BC.2006.018; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gariepy HD, 2010, NEUROPEPTIDES, V44, P191, DOI 10.1016/j.npep.2009.12.011; Gougat J, 2004, J PHARMACOL EXP THER, V309, P661, DOI 10.1124/jpet.103.059527; HALL CE, 1966, P SOC EXP BIOL MED, V122, P362, DOI 10.3181/00379727-122-31135; Heitzer T, 1999, KIDNEY INT, V55, P252, DOI 10.1046/j.1523-1755.1999.00229.x; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Ismael MA, 2008, EUR J PHARMACOL, V589, P66, DOI 10.1016/j.ejphar.2008.05.006; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Kakoki M, 2009, KIDNEY INT, V75, P1019, DOI 10.1038/ki.2008.647; Kintsurashvili E, 2001, AM J PHYSIOL-HEART C, V281, pH1778, DOI 10.1152/ajpheart.2001.281.4.H1778; Lagneux C, 2002, INT IMMUNOPHARMACOL, V2, P815, DOI 10.1016/S1567-5769(02)00022-X; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Li Y, 2008, AM J PHYSIOL-HEART C, V294, pH2845, DOI 10.1152/ajpheart.91422.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis ED, 2005, J PHARMACOL EXP THER, V315, P1058, DOI 10.1124/jpet.105.091728; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; Majithiya JB, 2005, J CARDIOVASC PHARM, V46, P697, DOI 10.1097/01.fjc.0000183720.85014.24; Marceau F, 2002, INT IMMUNOPHARMACOL, V2, P1729, DOI 10.1016/S1567-5769(02)00189-3; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Messadi-Laribi E, 2008, CLIN EXP PHARMACOL P, V35, P489, DOI 10.1111/j.1440-1681.2008.04902.x; Methner C, 2009, ACTA PHYSIOL, V197, P265, DOI 10.1111/j.1748-1716.2009.02018.x; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; MUNZEL T, 1995, J CLIN INVEST, V95, P187, DOI 10.1172/JCI117637; NAZARALI AJ, 1989, J NEUROSCI METH, V30, P247, DOI 10.1016/0165-0270(89)90135-0; Nyby MD, 2007, HYPERTENS RES, V30, P451, DOI 10.1291/hypres.30.451; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Petcu M, 2005, PEPTIDES, V26, P1331, DOI 10.1016/j.peptides.2005.03.047; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Quintao NLM, 2008, J NEUROSCI, V28, P2856, DOI 10.1523/JNEUROSCI.4389-07.2008; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Rodrigues ES, 2009, BIOL CHEM, V390, P907, DOI 10.1515/BC.2009.081; RODRIGUES ES, 2010, BASIC CLIN PHARM S1, V107; Rodriguez AI, 2006, BIOCHEM BIOPH RES CO, V345, P652, DOI 10.1016/j.bbrc.2006.04.127; San Martin A, 2007, AM J PHYSIOL-HEART C, V292, pH2073, DOI 10.1152/ajpheart.00943.2006; Savvatis K, 2010, NEUROPEPTIDES, V44, P119, DOI 10.1016/j.npep.2009.11.007; Seguin T, 2008, INT IMMUNOPHARMACOL, V8, P217, DOI 10.1016/j.intimp.2007.08.008; Shariat-Madar Z, 2006, BLOOD, V108, P192, DOI 10.1182/blood-2006-01-0094; Sharpe PC, 1998, DIABETES, V47, P801, DOI 10.2337/diabetes.47.5.801; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tawfik HE, 2008, AM J PHYSIOL-HEART C, V295, pH1736, DOI 10.1152/ajpheart.87.2008; Thirunavukkarasu V, 2004, EXP DIABESITY RES, V5, P195, DOI 10.1080/15438600490486778; Tong X, 2009, FREE RADICAL BIO MED, V47, P1578, DOI 10.1016/j.freeradbiomed.2009.08.026; Vasdev S, 2004, CLIN BIOCHEM, V37, P1, DOI 10.1016/j.clinbiochem.2003.09.003; VASDEV S, 1999, ARTERY, V23, P10; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wang PHM, 2009, INT IMMUNOPHARMACOL, V9, P653, DOI 10.1016/j.intimp.2008.10.018; WANG PH, 2009, INT IMMUNOPHARMACOL, V9, pS1567; Xu J, 2005, HYPERTENSION, V45, P747, DOI 10.1161/01.HYP.0000153322.04859.81	79	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12622	10.1371/journal.pone.0012622	http://dx.doi.org/10.1371/journal.pone.0012622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830306	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300042
J	Soechting, JF; Rao, HM; Juveli, JZ				Soechting, John F.; Rao, Hrishikesh M.; Juveli, John Z.			Incorporating Prediction in Models for Two-Dimensional Smooth Pursuit	PLOS ONE			English	Article							VISUAL-MOTION; EYE-MOVEMENTS; TRANSIENT DISAPPEARANCE; MST NEURONS; OCULAR PURSUIT; TARGET MOTION; TRACKING; MT; EXTRAPOLATION; ACCELERATION	A predictive component can contribute to the command signal for smooth pursuit. This is readily demonstrated by the fact that low frequency sinusoidal target motion can be tracked with zero time delay or even with a small lead. The objective of this study was to characterize the predictive contributions to pursuit tracking more precisely by developing analytical models for predictive smooth pursuit. Subjects tracked a small target moving in two dimensions. In the simplest case, the periodic target motion was composed of the sums of two sinusoidal motions (SS), along both the horizontal and the vertical axes. Motions following the same or similar paths, but having a richer spectral composition, were produced by having the target follow the same path but at a constant speed (CS), and by combining the horizontal SS velocity with the vertical CS velocity and vice versa. Several different quantitative models were evaluated. The predictive contribution to the eye tracking command signal could be modeled as a low-pass filtered target acceleration signal with a time delay. This predictive signal, when combined with retinal image velocity at the same time delay, as in classical models for the initiation of pursuit, gave a good fit to the data. The weighting of the predictive acceleration component was different in different experimental conditions, being largest when target motion was simplest, following the SS velocity profiles.	[Soechting, John F.; Rao, Hrishikesh M.; Juveli, John Z.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Soechting, JF (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	soech001@umn.edu			National Institutes of Health [NS-15018]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS015018, R01NS015018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS-15018 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES GR, 1987, J PHYSIOL-LONDON, V389, P111, DOI 10.1113/jphysiol.1987.sp016649; Batschelet E, 1981, CIRCULAR STAT BIOL; BECKER W, 1985, EXP BRAIN RES, V57, P562; Bennett SJ, 2007, J NEUROPHYSIOL, V98, P1405, DOI 10.1152/jn.00132.2007; Bennett SJ, 2004, J NEUROPHYSIOL, V92, P578, DOI 10.1152/jn.01188.2003; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Chukoskie L, 2009, J NEUROPHYSIOL, V102, P3225, DOI 10.1152/jn.90692.2008; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; DENO DC, 1995, BIOSYSTEMS, V34, P107, DOI 10.1016/0303-2647(94)01446-E; deSperati C, 1997, J NEUROSCI, V17, P3932; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; Inaba N, 2007, J NEUROPHYSIOL, V97, P3473, DOI 10.1152/jn.01054.2006; Kettner RE, 1996, EXP BRAIN RES, V108, P221; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; KOWLER E, 1984, VISION RES, V24, P197, DOI 10.1016/0042-6989(84)90122-6; Kramer KA, 2006, INT J NEURAL SYST, V16, P1, DOI 10.1142/S0129065706000457; Krauzlis R J, 1994, J Comput Neurosci, V1, P265, DOI 10.1007/BF00961876; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2006, EXP BRAIN RES, V172, P175, DOI 10.1007/s00221-005-0326-1; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Osborne LC, 2009, J NEUROPHYSIOL, V102, P2013, DOI 10.1152/jn.00611.2009; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; Press W. H., 1992, ART SCI COMPUTING; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; RINGACH DL, 1995, BIOL CYBERN, V73, P561, DOI 10.1007/BF00199548; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; Schlack A, 2007, J NEUROSCI, V27, P11009, DOI 10.1523/JNEUROSCI.3165-07.2007; Soechting JF, 2005, EXP BRAIN RES, V160, P245, DOI 10.1007/s00221-004-2010-2; Soechting JF, 2008, J NEUROPHYSIOL, V99, P2956, DOI 10.1152/jn.90308.2008; Soechting JF, 2009, J NEUROPHYSIOL, V102, P1491, DOI 10.1152/jn.00398.2009; Tavassoli A, 2009, J NEUROPHYSIOL, V102, P110, DOI 10.1152/jn.91320.2008; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; WELCH G, 2003, 95041 U N CAR; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; YASUI S, 1984, J PHYSIOL-LONDON, V347, P17, DOI 10.1113/jphysiol.1984.sp015050; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	45	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12574	10.1371/journal.pone.0012574	http://dx.doi.org/10.1371/journal.pone.0012574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838450	Green Published, Green Submitted, gold			2022-12-25	WOS:000281627700021
J	de Campos-Nebel, M; Larripa, I; Gonzalez-Cid, M				de Campos-Nebel, Marcelo; Larripa, Irene; Gonzalez-Cid, Marcela			Topoisomerase II-Mediated DNA Damage Is Differently Repaired during the Cell Cycle by Non-Homologous End Joining and Homologous Recombination	PLOS ONE			English	Article							STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; HISTONE H2AX; PATHWAYS; ROLES; BETA; EXPRESSION; COMPLEX; ALPHA; PHOSPHORYLATION	Topoisomerase II (Top2) is a nuclear enzyme involved in several metabolic processes of DNA. Chemotherapy agents that poison Top2 are known to induce persistent protein-mediated DNA double strand breaks (DSB). In this report, by using knock down experiments, we demonstrated that Top2a was largely responsible for the induction of cH2AX and cytotoxicity by the Top2 poisons idarubicin and etoposide in normal human cells. As DSB resulting from Top2 poisons-mediated damage may be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR), we aimed to analyze both DNA repair pathways. We found that DNA-PKcs was rapidly activated in human cells, as evidenced by autophosphorylation at serine 2056, following Top2-mediated DNA damage. The chemical inhibition of DNA-PKcs by wortmannin and vanillin resulted in an increased accumulation of DNA DSB, as evaluated by the comet assay. This was supported by a hypersensitive phenotype to Top2 poisons of Ku80-and DNA-PKcs-defective Chinese hamster cell lines. We also showed that Rad51 protein levels, Rad51 foci formation and sister chromatid exchanges were increased in human cells following Top2-mediated DNA damage. In support, BRCA2-and Rad51C-defective Chinese hamster cells displayed hypersensitivity to Top2 poisons. The analysis by immunofluorescence of the DNA DSB repair response in synchronized human cell cultures revealed activation of DNA-PKcs throughout the cell cycle and Rad51 foci formation in S and late S/G2 cells. Additionally, we found an increase of DNA-PKcs-mediated residual repair events, but not Rad51 residual foci, into micronucleated and apoptotic cells. Therefore, we conclude that in human cells both NHEJ and HR are required, with cell cycle stage specificity, for the repair of Top2-mediated reversible DNA damage. Moreover, NHEJ-mediated residual repair events are more frequently associated to irreversibly damaged cells.	[de Campos-Nebel, Marcelo; Larripa, Irene; Gonzalez-Cid, Marcela] Acad Nacl Med Buenos Aires, Dept Genet, Inst Invest Hematol Mariano R Castex, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas	de Campos-Nebel, M (corresponding author), Acad Nacl Med Buenos Aires, Dept Genet, Inst Invest Hematol Mariano R Castex, Buenos Aires, DF, Argentina.	mnebel@hematologia.anm.edu.ar						Adachi N, 2005, DNA CELL BIOL, V24, P388, DOI 10.1089/dna.2005.24.388; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Angelis KJ, 1999, ELECTROPHORESIS, V20, P2133, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2133::AID-ELPS2133>3.0.CO;2-Q; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Betti CJ, 2003, CANCER RES, V63, P1377; Betti CJ, 2001, CANCER RES, V61, P4550; BIGIONI M, 1994, NUCLEIC ACIDS RES, V22, P2274, DOI 10.1093/nar/22.12.2274; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; CALDECOTT K, 1990, CANCER RES, V50, P5778; Calsou P, 2003, J MOL BIOL, V326, P93, DOI 10.1016/S0022-2836(02)01328-1; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Fan JR, 2008, DNA REPAIR, V7, P452, DOI 10.1016/j.dnarep.2007.12.002; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hendrickson EA, 1997, AM J HUM GENET, V61, P795, DOI 10.1086/514895; Huang X, 2004, CYTOM PART A, V58A, P99, DOI 10.1002/cyto.a.20018; Imyanitov EN, 2007, CLIN CHIM ACTA, V379, P1, DOI 10.1016/j.cca.2007.01.006; Jensen Lars H., 2004, BMC Pharmacology, V4, P31, DOI 10.1186/1471-2210-4-31; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KIMURA K, 1994, J BIOL CHEM, V269, P1173; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Malik M, 2006, MOL CANCER THER, V5, P1405, DOI 10.1158/1535-7163.MCT-05-0263; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Raderschall E, 2002, J CELL SCI, V115, P153; Rassool FV, 2003, CANCER LETT, V193, P1, DOI 10.1016/S0304-3835(02)00692-4; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Toyoda E, 2008, J BIOL CHEM, V283, P23711, DOI 10.1074/jbc.M803936200; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Turley H, 1997, BRIT J CANCER, V75, P1340, DOI 10.1038/bjc.1997.227; UEMATSU N, 2005, MOL CELL BIOL, V25, P10842; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Warburton PE, 1997, BIOESSAYS, V19, P97, DOI 10.1002/bies.950190203	57	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12541	10.1371/journal.pone.0012541	http://dx.doi.org/10.1371/journal.pone.0012541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824055	Green Submitted, Green Published, gold			2022-12-25	WOS:000281480900023
J	Goh, SH; Hong, SH; Hong, SH; Lee, BC; Ju, MH; Jeong, JS; Cho, YR; Kim, IH; Lee, YS				Goh, S-H; Hong, S-H; Hong, S-H; Lee, B-C; Ju, M-H; Jeong, J-S; Cho, Y-R; Kim, I-H; Lee, Y-S			eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer	ONCOGENE			English	Article						eukaryotic translation initiation factor; eIF3m; cell proliferation; cell death; ribonomics	INITIATION-FACTOR EIF3; MIGRATION INHIBITORY FACTOR; MALIGNANT-TRANSFORMATION; TRANSLATIONAL CONTROL; BREAST-CANCER; GROWTH; OVEREXPRESSION; ACTIVATION; DYSADHERIN; COMPLEXES	Abnormal regulation of gene expression is essential for tumorigenesis. Recent studies indicate that regulation of oncogene expression and neoplastic transformation are controlled by subunits of eukaryotic translation initiation factors (eIFs). Here we focused on eIF3 performing a pivotal role in protein synthesis and the differential expression of its subunits in cancer. The most uncharacterized non-core subunit eIF3m was confirmed to be highly expressed in human cancer cell lines and colon cancer patient tissues. By expression silencing with eIF3m-specific small interfering RNA (siRNA), we confirmed that eIF3m influences cell proliferation, cell cycle progression and cell death in human colon cancer cell line HCT-116. Using a ribonomics approach, we identified a subset of elF3m-influenced genes and showed that the expression of two highly represented tumorigenesis-related genes, MIF and MT2, were affected by eIF3m at the mRNA level. We also confirmed eIF3m-dependent regulation of MT2A downstream molecule CDC25A, which is necessary for cell cycle progression in HCT-116 cells. These results suggest that eIF3m mediates regulation of tumorigenesis-related genes in human colon cancer. Further investigations on tumorigenesis-related genes and their regulation by eIFs will provide clues for designing targeted therapy for cancer. Oncogene (2011) 30, 398-409; doi: 10.1038/onc.2010.422; published online 13 September 2010	[Lee, Y-S] Natl Canc Ctr, Res Inst, Funct Genom Branch, Div Convergence Technol, Goyang 410769, Gyeonggi Do, South Korea; [Ju, M-H; Jeong, J-S] Dong A Univ, Dept Pathol, Coll Med, Pusan, South Korea	National Cancer Center - Korea (NCC); Dong A University	Lee, YS (corresponding author), Natl Canc Ctr, Res Inst, Funct Genom Branch, Div Convergence Technol, 111 Jungbalsan Ro,809 Madu Dong, Goyang 410769, Gyeonggi Do, South Korea.	yslee2@ncc.re.kr			National Cancer Center [NCC 0710660, NCC 0810160]	National Cancer Center	We thank Dr Sri Ram for editorial assistance of manuscript. This study was funded by Intramural Research Grants of the National Cancer Center (NCC 0710660, NCC 0810160).	Ahlemann M, 2006, MOL CARCINOGEN, V45, P957, DOI 10.1002/mc.20269; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Doldan A, 2008, MOL CARCINOGEN, V47, P235, DOI 10.1002/mc.20379; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Jin RX, 2004, PATHOL ONCOL RES, V10, P74, DOI 10.1007/BF02893459; Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Koch G, 1980, Ann N Y Acad Sci, V339, P280, DOI 10.1111/j.1749-6632.1980.tb15984.x; Komatsu K, 2000, CLIN CANCER RES, V6, P172; L'Esperance S, 2006, INT J ONCOL, V29, P5; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Lim D, 2009, CANCER LETT, V276, P109, DOI 10.1016/j.canlet.2008.10.038; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Nam JS, 2007, CANCER LETT, V255, P161, DOI 10.1016/j.canlet.2007.02.018; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ramachandran A, 2000, J GASTROEN HEPATOL, V15, P109, DOI 10.1046/j.1440-1746.2000.02059.x; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tomko RJ, 2009, CELL CYCLE, V8, P299, DOI 10.4161/cc.8.2.7595; Zhang LL, 2008, J BIOL CHEM, V283, P24047, DOI 10.1074/jbc.M800956200; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	36	39	41	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2011	30	4					398	409		10.1038/onc.2010.422	http://dx.doi.org/10.1038/onc.2010.422			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20838379				2022-12-25	WOS:000286621600003
J	Strater, N; Marek, S; Kuettner, EB; Kloos, M; Keim, A; Bruser, A; Kirchberger, J; Schoneberg, T				Straeter, Norbert; Marek, Sascha; Kuettner, E. Bartholomeus; Kloos, Marco; Keim, Antje; Brueser, Antje; Kirchberger, Juergen; Schoeneberg, Torsten			Molecular architecture and structural basis of allosteric regulation of eukaryotic phosphofructokinases	FASEB JOURNAL			English	Article						metabolism; protein crystallography; structural biology	CATECHOL-O-METHYLTRANSFERASE; YEAST PHOSPHOFRUCTOKINASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; MUSCLE PHOSPHOFRUCTOKINASE; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; PICHIA-PASTORIS; BACILLUS-STEAROTHERMOPHILUS; FRUCTOSE 2,6-BISPHOSPHATE	Eukaryotic ATP-dependent 6-phosphofructokinases (Pfks) differ from their bacterial counterparts in a much more complex structural organization and allosteric regulation. Pichia pastoris Pfk (PpPfk) is, with similar to 1 MDa, the most complex and probably largest eukaryotic Pfk. We have determined the crystal structure of full-length PpPfk to 3.05 angstrom resolution in the T state. PpPfk forms a (alpha beta gamma)(4) dodecamer of D(2) symmetry with dimensions of 161 x 157 x 233 angstrom mainly via interactions of the alpha chains. The N-terminal domains of the alpha and beta chains have folds that are distantly related to glyoxalase I, but the active sites are no longer functional. Interestingly, these domains located at the 2 distal ends of this protein along the long 2-fold axis form a (alpha beta)(2) dimer as does the core Pfk domains; however, the domains are swapped across the tetramerization interface. In PpPfk, the unique gamma subunit participates in oligomerization of the alpha beta chains. This modulator protein was acquired from an ancient S-adenosylmethionine-dependent methyltransferase. The identification of novel ATP binding sites, which do not correspond to the bacterial catalytic or effector binding sites, point to marked structural and functional differences between bacterial and eukaryotic Pfks.-Strater, N., Marek, S., Kuettner, E. B., Kloos, M., Keim, A., Bruser, A., Kirchberger, J., Schoneberg, T. Molecular architecture and structural basis of allosteric regulation of eukaryotic phosphofructokinases. FASEB J. 25, 89-98 (2011). www.fasebj.org	[Straeter, Norbert; Marek, Sascha; Kuettner, E. Bartholomeus; Kloos, Marco; Keim, Antje] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; [Brueser, Antje; Kirchberger, Juergen; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Strater, N (corresponding author), Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Deutsch Pl 5, D-04103 Leipzig, Germany.	strater@bbz.uni-leipzig.de; schoberg@medizin.uni-leipzig.de	Strater, Norbert/P-4856-2018	Strater, Norbert/0000-0002-2001-0500	Deutsche Forschungsgemeinschaft [SFB 610]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The Deutsche Forschungsgemeinschaft is acknowledged for funding (SFB 610). The authors thank the Joint Berlin MX-Laboratory at BESSY II, the European Synchrotron Radiation Facility (Grenoble, France), and the European Molecular Biology Laboratory Hamburg Outstation at Deutsches Elektronen-Synchrotron (Hamburg, Germany) for beam time and assistance during synchrotron data collection, as well as the Helmholtz Zentrum Berlin for traveling support. The authors also thank Anja Hutschenreuther for performing measurements of glyoxalase I activity of PpPfk.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Barcena M, 2007, J STRUCT BIOL, V159, P135, DOI 10.1016/j.jsb.2007.03.004; Benjamin S, 2007, J STRUCT BIOL, V159, P498, DOI 10.1016/j.jsb.2007.06.001; Benjamin S, 2009, J STRUCT BIOL, V168, P345, DOI 10.1016/j.jsb.2009.06.014; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Cameron AD, 1999, BIOCHEMISTRY-US, V38, P13480, DOI 10.1021/bi990696c; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Edelmann A, 2002, YEAST, V19, P949, DOI 10.1002/yea.889; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; Fillgrove KL, 2007, BIOCHEMISTRY-US, V46, P8110, DOI 10.1021/bi700625p; FREYER R, 1977, THESIS U LEIPZIG GER; HEINISCH J, 1989, GENE, V78, P309; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; Kirchberger J, 2002, YEAST, V19, P933, DOI 10.1002/yea.885; KOPPERSCHLAGER G, 1993, EUR J BIOCHEM, V217, P527, DOI 10.1111/j.1432-1033.1993.tb18273.x; Kricke J, 1999, INT J BIOL MACROMOL, V24, P27, DOI 10.1016/S0141-8130(98)00063-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Martinez-Costa OH, 2007, FEBS LETT, V581, P3033, DOI 10.1016/j.febslet.2007.05.059; Martinez-Oyanedel J, 2007, J MOL BIOL, V366, P1185, DOI 10.1016/j.jmb.2006.10.019; Mcnae IW, 2009, J MOL BIOL, V385, P1519, DOI 10.1016/j.jmb.2008.11.047; NISSLER K, 1985, BIOMED BIOCHIM ACTA, V44, P251; Obmolova G, 1998, ACTA CRYSTALLOGR D, V54, P96, DOI 10.1107/S0907444997007555; Palma PN, 2006, MOL PHARMACOL, V70, P143, DOI 10.1124/mol.106.023119; Paricharttanakul NM, 2005, BIOCHEMISTRY-US, V44, P15280, DOI 10.1021/bi051283g; PARMEGGIANI A, 1966, J BIOL CHEM, V241, P4625; PLIETZ P, 1978, FEBS LETT, V91, P230, DOI 10.1016/0014-5793(78)81179-X; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; Rais B, 2000, BBA-PROTEIN STRUCT M, V1479, P303, DOI 10.1016/S0167-4838(00)00047-9; Riley-Lovingshimer MR, 2002, BIOCHEMISTRY-US, V41, P12967, DOI 10.1021/bi0263412; ROBERTS SJ, 1987, BIOCHEMISTRY-US, V26, P3437, DOI 10.1021/bi00386a028; Rodicio R, 2000, J BIOL CHEM, V275, P40952, DOI 10.1074/jbc.M007131200; Ruiz T, 2003, J STRUCT BIOL, V143, P124, DOI 10.1016/S1047-8477(03)00140-0; Ruiz T, 2001, J STRUCT BIOL, V136, P167, DOI 10.1006/jsbi.2002.4440; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; RYPNIEWSKI WR, 1989, J MOL BIOL, V207, P805, DOI 10.1016/0022-2836(89)90246-5; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; SOLS A, 1981, CURR TOP CELL REGUL, V19, P77; Tanneberger K, 2007, J BIOL CHEM, V282, P23687, DOI 10.1074/jbc.M611547200; TELFORD JN, 1975, P NATL ACAD SCI USA, V72, P3054, DOI 10.1073/pnas.72.8.3054; TIJANE MN, 1979, FEBS LETT, V105, P249, DOI 10.1016/0014-5793(79)80622-5; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	52	15	18	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2011	25	1					89	98		10.1096/fj.10-163865	http://dx.doi.org/10.1096/fj.10-163865			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20833871				2022-12-25	WOS:000285869500009
J	Sun, LY; Bokov, AF; Richardson, A; Miller, RA				Sun, Liou Y.; Bokov, Alex F.; Richardson, Arlan; Miller, Richard A.			Hepatic response to oxidative injury in long-lived Ames dwarf mice	FASEB JOURNAL			English	Article						ERK; Nrf2; aging; stress	GENE-EXPRESSION PROFILE; LIFE-SPAN; STRESS RESISTANCE; TRANSCRIPTION FACTOR; CELL-SURVIVAL; MUTANT MICE; BCL2 FAMILY; MAP KINASE; GROWTH; ACTIVATION	Multiple stress resistance pathways were evaluated in the liver of Ames dwarf mice before and after exposure to the oxidative toxin diquat, seeking clues to the exceptional longevity conferred by this mutation. Before diquat treatment, Ames dwarf mice, compared with nonmutant littermate controls, had 2- to 6-fold higher levels of expression of mRNAs for immediate early genes and 2- to 5-fold higher levels of mRNAs for genes dependent on the transcription factor Nrf2. Diquat led to a 2-fold increase in phosphorylation of the stress kinase ERK in control (but not Ames dwarf) mice and to a 50% increase in phosphorylation of the kinase JNK2 in Ames dwarf (but not control) mice. Diquat induction of Nrf2 protein was higher in dwarf mice than in controls. Of 6 Nrf2-responsive genes evaluated, 4 (HMOX, NQO-1, MT-1, and MT-2) remained 2- to 10-fold lower in control than in dwarf liver after diquat, and the other 2 (GCLM and TXNRD) reached levels already seen in dwarf liver at baseline. Thus, livers of Ames dwarf mice differ systematically from controls in multiple stress resistance pathways before and after exposure to diquat, suggesting mechanisms for stress resistance and extended longevity in Ames dwarf mice.-Sun, L. Y., Bokov, A. F., Richardson, A., Miller, R. A. Hepatic response to oxidative injury in long-lived Ames dwarf mice. FASEB J. 25, 398-408 (2011). www.fasebj.org	[Sun, Liou Y.; Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Sun, Liou Y.; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; [Bokov, Alex F.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Bokov, Alex F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Miller, RA (corresponding author), Univ Michigan, Geriatr Ctr, Rm 3001,BSRB Box 2200,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	millerr@umich.edu			National Institute on Aging [AG-031736, AG-024824, AG-013283, AG-021890]; San Antonio Nathan Shock Aging Center [1P30-AG-13319]; NATIONAL INSTITUTE ON AGING [T32AG021890, P30AG013283, P30AG024824, P01AG031736, P30AG013319] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); San Antonio Nathan Shock Aging Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging grants AG-031736, AG-024824, and AG-013283 (to R.A.M.); AG-021890 (to A.F.B.); and San Antonio Nathan Shock Aging Center 1P30-AG-13319 (to A.R.). The authors thank Marian Sabia and Vivian Diaz for assistance.	Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Beidelschies MA, 2008, J CELL PHYSIOL, V217, P652, DOI 10.1002/jcp.21539; Bianchet MA, 2008, VITAM HORM, V78, P63, DOI 10.1016/S0083-6729(07)00004-0; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bokov AF, 2009, J GERONTOL A-BIOL, V64, P819, DOI 10.1093/gerona/glp052; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Hsieh CC, 2009, AGING-US, V1, P784, DOI 10.18632/aging.100077; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kennedy MA, 2003, EXP GERONTOL, V38, P997, DOI 10.1016/S0531-5565(03)00164-5; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Legos JJ, 2001, BRAIN RES, V892, P70, DOI 10.1016/S0006-8993(00)03228-5; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li J, 2004, EXP GERONTOL, V39, P735, DOI 10.1016/j.exger.2004.02.008; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Lithgow G. J., 2008, MOL BIOL AGING; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Miller RA, 2009, J GERONTOL A-BIOL, V64, P179, DOI 10.1093/gerona/gln072; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; ORENTREICH N, 1993, J NUTR, V123, P269; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rabkin SW, 2009, J HEART VALVE DIS, V18, P653; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P219, DOI 10.1093/gerona/63.3.219; Sierra F, 2006, J GERONTOL A-BIOL, V61, P557, DOI 10.1093/gerona/61.6.557; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Sun LY, 2006, ENDOCRINOLOGY, V147, P5480, DOI 10.1210/en.2006-0586; Sun LY, 2009, FREE RADICAL BIO MED, V47, P1753, DOI 10.1016/j.freeradbiomed.2009.09.021; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	68	27	27	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					398	408		10.1096/fj.10-164376	http://dx.doi.org/10.1096/fj.10-164376			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20826540	Green Published, Green Submitted			2022-12-25	WOS:000285869500036
J	Grace, CRR; Perrin, MH; Gulyas, J; Rivier, JE; Vale, WW; Riek, R				Grace, Christy Rani R.; Perrin, Marilyn H.; Gulyas, Jozsef; Rivier, Jean E.; Vale, Wylie W.; Riek, Roland			NMR Structure of the First Extracellular Domain of Corticotropin-releasing Factor Receptor 1 (ECD1-CRF-R1) Complexed with a High Affinity Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; N-TERMINAL DOMAIN; LIGAND-BINDING; COMPETITIVE ANTAGONISTS; 1ST-EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; CHIMERIC RECEPTORS; ASTRESSIN ANALOGS	The corticotropin-releasing factor (CRF) peptide hormone family members coordinate endocrine, behavioral, autonomic, and metabolic responses to stress and play important roles within the cardiovascular, gastrointestinal, and central nervous systems, among others. The actions of the peptides are mediated by activation of two G-protein-coupled receptors of the B1 family, CRF receptors 1 and 2 (CRF-R1 and CRF-R2 alpha,beta). The recently reported three-dimensional structures of the first extracellular domain (ECD1) of both CRF-R1 and CRF-R2 beta (Pioszak, A. A., Parker, N. R., Suino-Powell, K., and Xu, H. E. (2008) J. Biol. Chem. 283, 32900-32912; Grace, C. R., Perrin, M. H., Gulyas, J., Digruccio, M. R., Cantle, J. P., Rivier, J. E., Vale, W. W., and Riek, R. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 4858-4863) complexed with peptide antagonists provided a starting point in understanding the binding between CRF ligands and receptors at a molecular level. We now report the three-dimensional NMR structure of the ECD1 of human CRF-R1 complexed with a high affinity agonist, alpha-helical cyclic CRF. In the structure of the complex, the C-terminal residues (23-41) of alpha-helical cyclic CRF bind to the ECD1 of CRF-R1 in a helical conformation mainly along the hydrophobic face of the peptide in a manner similar to that of the antagonists in their corresponding ECD1 complex structures. Unique to this study is the observation that complex formation between an agonist and the ECD1-CRF-R1 promotes the helical conformation of the N terminus of the former, important for receptor activation (Gulyas, J., Rivier, C., Perrin, M., Koerber, S. C., Sutton, S., Corrigan, A., Lahrichi, S. L., Craig, A. G., Vale, W., and Rivier, J. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 10575-10579).	[Perrin, Marilyn H.; Gulyas, Jozsef; Rivier, Jean E.; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Grace, Christy Rani R.; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Rivier, JE (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrivier@salk.edu; vale@salk.edu; riek@salk.edu		Riek, Roland/0000-0002-6333-066X	National Institutes of Health [DK026741]; Clayton Medical Research Foundation, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK026741 from the NIDDK. This work was also supported by Clayton Medical Research Foundation, Inc.	Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh C., 1996, PROTEIN NMR SPECTROS; Cervini L, 1999, J MED CHEM, V42, P761, DOI 10.1021/jm980607e; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; COY DH, 1987, J MED CHEM, V30, P219, DOI 10.1021/jm00384a039; Dautzenberg FM, 1998, P NATL ACAD SCI USA, V95, P4941, DOI 10.1073/pnas.95.9.4941; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Grace CRR, 2007, BIOPOLYMERS, V87, P196, DOI 10.1002/bip.20818; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; IKURA K, 1990, J MAGN RESON, V86, P204; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; KELLER RL, 2003, CANTINA COMPUTER AID; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manhart S, 2003, BIOCHEMISTRY-US, V42, P3081, DOI 10.1021/bi026868e; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; Murage EN, 2008, BIOORGAN MED CHEM, V16, P10106, DOI 10.1016/j.bmc.2008.10.006; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rijkers DTS, 2004, CHEMBIOCHEM, V5, P340, DOI 10.1002/cbic.200300769; Rivier J, 1998, J MED CHEM, V41, P5012, DOI 10.1021/jm980426c; Rivier J, 1998, J MED CHEM, V41, P2614, DOI 10.1021/jm980164e; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rivier JE, 1999, J MED CHEM, V42, P3175, DOI 10.1021/jm9902133; Rivier J, 2007, J MED CHEM, V50, P1668, DOI 10.1021/jm0613875; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Shimizu M, 2000, J BIOL CHEM, V275, P19456, DOI 10.1074/jbc.M001596200; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SUN C, 2007, P NATL ACAD SCI USA, V104, P7835; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Wille S, 1999, J NEUROCHEM, V72, P388, DOI 10.1046/j.1471-4159.1999.0720388.x; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yamada Y, 2004, J MED CHEM, V47, P1075, DOI 10.1021/jm034180+	58	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38580	38589		10.1074/jbc.M110.121897	http://dx.doi.org/10.1074/jbc.M110.121897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20843795	Green Published, hybrid			2022-12-25	WOS:000284625600063
J	Nakamura, S; Hayashi, K; Iwasaki, K; Fujioka, T; Egusa, H; Yatani, H; Sobue, K				Nakamura, Seiji; Hayashi, Ken'ichiro; Iwasaki, Kazuhiro; Fujioka, Tomoaki; Egusa, Hiroshi; Yatani, Hirofumi; Sobue, Kenji			Nuclear Import Mechanism for Myocardin Family Members and Their Correlation with Vascular Smooth Muscle Cell Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MEGAKARYOBLASTIC LEUKEMIA; ACTIN; LOCALIZATION; DIFFERENTIATION; GROWTH; COFACTOR; ALPHA	Myocardin (IMycd), which is essential for the differentiation of the smooth muscle cell lineage, is constitutively located in the nucleus, although its family members, myocardin-related transcription factors A and B (MRTF-A/B), mostly reside in the cytoplasm and translocate to the nucleus in response to Rho signaling. The mechanism for their nuclear import is unclear. Here we investigated the mechanism for the nuclear import of Mycd family members and demonstrated any correlation between such mechanism and the phenotype of vascular smooth muscle cells (IVSMCs). In cultured VSMCs, the knockdown of importin beta 1 inhibited the nuclear import of Mycd and MRTF-A/B. Their NH2-terminal basic domain was identified as a binding site for importin alpha/Chi 1 by in vitro analyses. However, Mycd had a higher affinity for importin alpha/beta 1 than did MRTF-A/B, even in the absence of G-actin, and Mycd affinity for importin alpha 1/beta 1 was stronger than for any other importin alpha/beta 1 heterodimers. The binding of Mycd to importin alpha/beta 1 was insensitive to G-actin, whereas that of MRTF-A/B was differently inhibited by G-actin. In dedifferentiated VSMCs, the levels of importins alpha 1 and beta 1 were reduced concomitant with down-regulation of Mycd, serum response factor, and smooth muscle cell markers. By contrast, in differentiated VSMCs, their expressions were up-regulated. Thus, the nuclear import of Mycd family members in VSMCs depends on importin alpha/beta 1, and their relative affinities for importin alpha/beta 1 heterodimers determine Mycd nuclear import. The expression of Mycd nuclear import machineries is related to the expression levels of VSMC phenotype-dependent smooth muscle cell markers.	[Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Suita, Osaka 5650871, Japan; [Sobue, Kenji] Osaka Univ, Grad Sch Med, Res Ctr Child Mental Dev, Suita, Osaka 5650871, Japan; [Nakamura, Seiji; Egusa, Hiroshi; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka 5650871, Japan; [Iwasaki, Kazuhiro; Fujioka, Tomoaki] Iwate Med Univ, Dept Urol, Morioka, Iwate 0208505, Japan	Osaka University; Osaka University; Osaka University; Iwate Medical University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132	Ministry of Education, Science, Sports, and Culture of Japan [20590279, 15GS0312]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan 20590279 (to K. H.) and 15GS0312 (to K. S.).	Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; THIERBACH G, 1990, APPL MICROBIOL BIOT, V32, P443, DOI 10.1007/BF00903780; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yoneda Y, 1997, J BIOCHEM, V121, P811	29	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37314	37323		10.1074/jbc.M110.180786	http://dx.doi.org/10.1074/jbc.M110.180786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847050	hybrid, Green Published			2022-12-25	WOS:000284424000024
J	Bourguignon, LYW; Wong, G; Earle, C; Krueger, K; Spevak, CC				Bourguignon, Lilly Y. W.; Wong, Gabriel; Earle, Christine; Krueger, Katherine; Spevak, Christina C.			Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD44 INTERACTION; HYALURONIC-ACID; GENE-EXPRESSION; TYROSINE KINASES; FOCAL ADHESIONS; STRESS FIBERS; CANCER CELLS; MIGRATION; PHOSPHORYLATION; METASTASIS	Dysregulation of microRNAs is observed in many cancers, including breast cancer. In particular, miR-10b appears to play an important role in tumor cell invasion and breast cancer progression. In this study, we investigated hyaluronan (HA)-induced CD44 (a primary HA receptor) interaction with c-Src kinase and the transcriptional factor, Twist, in breast tumor cells (MDA-MB-231 cells). Our results indicate that HA binding to CD44 promotes c-Src kinase activation, which, in turn, increases Twist phosphorylation, leading to the nuclear translocation of Twist and transcriptional activation. Further analyses reveal that miR-10b is controlled by an upstream promoter containing the Twist binding site(s), whereas ChIP assays demonstrate that stimulation of miR-10b expression by HA/CD44-activated c-Src is Twist-dependent in breast tumor cells. This process results in the reduction of a tumor suppressor protein (HOXD10), RhoA/RhoC up-regulation, Rho-kinase (ROK) activation, and breast tumor cell invasion. Treatment of MDA-MB-231 cells with PP2 (a c-Src inhibitor) or Twist-specific siRNAs effectively blocks HA-mediated Twist signaling events, abrogates miR-10b production, and increases HOXD10 expression. Subsequently, this c-Src/Twist signaling inhibition causes down-regulation of RhoA/RhoC expression and impairment of ROK-regulated cytoskeleton function (e.g. tumor cell invasion). To further evaluate the role of miR-10b in RhoGTPase signaling, MD-AMB-231 cells were also transfected with a specific anti-miR-10b inhibitor in order to silence miR-10b expression and block its target functions. Our results demonstrate that anti-miR-10b inhibitor not only enhances HOXD10 expression but also abrogates HA/CD44-mediated tumor cell behaviors in breast tumor cells. Taken together, these findings indicate that the HA-induced CD44 interaction with c-Src-activated Twist plays a pivotal role in miR-10b production, leading to the down-regulation of tumor suppressor protein (HOXD10), RhoGTPase-ROK activation, and tumor cell invasion. All of these events are critical prerequisite steps for the acquisition of metastatic properties by human breast cancer cells.	[Bourguignon, Lilly Y. W.] Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA; [Bourguignon, Lilly Y. W.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			National Institutes of Health [R01 CA66163, R01 CA78633, P01 AR39448]; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA66163, R01 CA78633, and P01 AR39448. This work was also supported by a Veterans Affairs merit review grant.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Auvinen P, 2005, HISTOPATHOLOGY, V47, P420, DOI 10.1111/j.1365-2559.2005.02220.x; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P89, DOI 10.1016/B978-012374178-3.10006-7; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Ilangumaran S, 1998, BLOOD, V91, P3901; JAN YN, 1993, P NATL ACAD SCI USA, V90, P8305, DOI 10.1073/pnas.90.18.8305; JIANG WG, 1994, BRIT J SURG, V81, P1576, DOI 10.1002/bjs.1800811107; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Li XY, 2003, ONCOL RES, V13, P323; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Parker BS, 2003, CANCER BIOL THER, V2, P14; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Singleton PA, 2002, CELL MOTIL CYTOSKEL, V53, P293, DOI 10.1002/cm.10078; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Taher TEI, 1996, J BIOL CHEM, V271, P2863, DOI 10.1074/jbc.271.5.2863; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Torre C, 2010, ARCH OTOLARYNGOL, V136, P493, DOI 10.1001/archoto.2010.25; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	76	167	172	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36721	36735		10.1074/jbc.M110.162305	http://dx.doi.org/10.1074/jbc.M110.162305			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843787	hybrid, Green Published			2022-12-25	WOS:000284146100084
J	Zhang, W; Na, T; Wu, GJ; Jing, HY; Peng, JB				Zhang, Wei; Na, Tao; Wu, Guojin; Jing, Haiyan; Peng, Ji-Bin			Down-regulation of Intestinal Apical Calcium Entry Channel TRPV6 by Ubiquitin E3 Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; LIDDLE SYNDROME; DISTAL NEPHRON; WW DOMAINS; TRANSPORTER; PATHWAY; BINDING; HYPERTENSION; EXPRESSION; MEMBRANE	Nedd4-2 is an archetypal HECT ubiquitin E3 ligase that disposes target proteins for degradation. Because of the proven roles of Nedd4-2 in degradation of membrane proteins, such as epithelial Na+ channel, we examined the effect of Nedd4-2 on the apical Ca2+ channel TRPV6, which is involved in transcellular Ca2+ transport in the intestine using the Xenopus laevis oocyte system. We demonstrated that a significant amount of Nedd4-2 protein was distributed to the absorptive epithelial cells in ileum, cecum, and colon along with TRPV6. When co-expressed in oocytes, Nedd4-2 and, to a lesser extent, Nedd4 down-regulated the protein abundance and Ca2+ influx of TRPV6 and TRPV5, respectively. TRPV6 ubiquitination was increased, and its stability was decreased by Nedd4-2. The Nedd4-2 inhibitory effects on TRPV6 were partially blocked by proteasome inhibitor MG132 but not by the lysosome inhibitor chloroquine. The rate of TRPV6 internalization was not significantly altered by Nedd4-2. The HECT domain was essential to the inhibitory effect of Nedd4-2 on TRPV6 and to their association. The WW1 and WW2 domains interacted with TRPV6 terminal regions, and a disruption of the interactions by D204H and D376H mutations in the WW1 and WW2 domains increased TRPV6 ubiquitination and degradation. Thus, WW1 and WW2 may serve as a molecular switch to limit the ubiquitination of TRPV6 by the HECT domain. In conclusion, Nedd4-2 may regulate TRPV6 protein abundance in intestinal epithelia by controlling TRPV6 ubiquitination.	[Zhang, Wei; Na, Tao; Wu, Guojin; Jing, Haiyan; Peng, Ji-Bin] Univ Alabama Birmingham, Div Nephrol, Dept Med, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Peng, JB (corresponding author), Univ Alabama Birmingham, Div Nephrol, Dept Med, Nephrol Res & Training Ctr, 1900 Univ Blvd,ZRB 625, Birmingham, AL 35294 USA.	jpeng@uab.edu			National Institutes of Health [R01DK072154]; American Heart Association [09GRNT2160024]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK072154 (to J.-B. P.). This work was also supported by American Heart Association Greater SE Affiliate Grant 09GRNT2160024 (to J.-B. P.).	Araki N, 2008, HYPERTENSION, V51, P773, DOI 10.1161/HYPERTENSIONAHA.107.102061; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Boehmer C, 2007, FEBS LETT, V581, P5586, DOI 10.1016/j.febslet.2007.11.006; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jiang Y, 2008, BIOCHEM BIOPH RES CO, V375, P225, DOI 10.1016/j.bbrc.2008.08.010; Jiang Y, 2007, AM J PHYSIOL-RENAL, V292, pF545, DOI 10.1152/ajprenal.00187.2006; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Na T, 2009, AM J PHYSIOL-RENAL, V296, pF1042, DOI 10.1152/ajprenal.90771.2008; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Palmada M, 2004, BIOCHEM BIOPH RES CO, V321, P1001, DOI 10.1016/j.bbrc.2004.07.064; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Peng JB, 2000, J BIOL CHEM, V275, P28186; Peng JB, 2001, GENOMICS, V76, P99, DOI 10.1006/geno.2001.6606; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Qi H, 2003, MOL CELL ENDOCRINOL, V210, P51, DOI 10.1016/j.mce.2003.08.009; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Van Cromphaut SJ, 2003, J BONE MINER RES, V18, P1725, DOI 10.1359/jbmr.2003.18.10.1725; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wood R J, 2001, BMC Physiol, V1, P11, DOI 10.1186/1472-6793-1-11; ZHANG W, 2009, FASEB J, V23; Zhang W, 2008, AM J PHYSIOL-RENAL, V295, pF1472, DOI 10.1152/ajprenal.90229.2008; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	46	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36586	36596		10.1074/jbc.M110.175968	http://dx.doi.org/10.1074/jbc.M110.175968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843805	hybrid, Green Published			2022-12-25	WOS:000284146100045
J	Bowman, BR; Lee, S; Wang, SY; Verdine, GL				Bowman, Brian R.; Lee, Seongmin; Wang, Shuyu; Verdine, Gregory L.			Structure of Escherichia coli AlkA in Complex with Undamaged DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-METHYLADENINE DNA; SACCHAROMYCES-CEREVISIAE; BASE-EXCISION; GLYCOSYLASE-I; INTRAHELICAL LESION; DUPLEX DNA; REPAIR; RECOGNITION; ENZYME; POLYMERASE	Because DNA damage is so rare, DNA glycosylases interact for the most part with undamaged DNA. Whereas the structural basis for recognition of DNA lesions by glycosylases has been studied extensively, less is known about the nature of the interaction between these proteins and undamaged DNA. Here we report the crystal structures of the DNA glycosylase AlkA in complex with undamaged DNA. The structures revealed a recognition mode in which the DNA is nearly straight, with no amino acid side chains inserted into the duplex, and the target base pair is fully intrahelical. A comparison of the present structures with that of AlkA recognizing an extrahelical lesion revealed conformational changes in both the DNA and protein as the glycosylase transitions from the interrogation of undamaged DNA to catalysis of nucleobase excision. Modeling studies with the cytotoxic lesion 3-methyladenine and accompanying biochemical experiments suggested that AlkA actively interrogates the minor groove of the DNA while probing for the presence of lesions.	[Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bowman, Brian R.; Lee, Seongmin; Wang, Shuyu; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	Gregory_verdine@harvard.edu	Wang, shuyu/GZM-3462-2022		National Institutes of Health [GM044853]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077935, R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044853 (to G.L.V.).; We thank Frank Murphy, Narayanasami Sukumar, and all of the staff of the Northeastern Collaborative Access Team (NE-CAT) at the Advanced Photon Source for assistance during data collection. We also thank Yevgeny Brudno for help with the melting temperature studies and Hariharan Jayaram, Danaya Pakotiprapha, Marie Spong, Rou-Jia Sung, Yan Qi, and members of the Verdine laboratory for useful discussions. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allan JM, 1998, CANCER RES, V58, P3965; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; BJELLAND S, 1994, J BIOL CHEM, V269, P30489; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelward BP, 1998, J BIOL CHEM, V273, P5412, DOI 10.1074/jbc.273.9.5412; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; Ezaz-Nikpay K, 1994, Chem Biol, V1, P235, DOI 10.1016/1074-5521(94)90016-7; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; HABRAKEN Y, 1989, CARCINOGENESIS, V10, P489, DOI 10.1093/carcin/10.3.489; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lee S, 2008, J AM CHEM SOC, V130, P11570, DOI 10.1021/ja8025328; Lindahl T, 2004, NATURE, V427, P598, DOI 10.1038/427598a; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; NAKABEPPU Y, 1984, J BIOL CHEM, V259, P3730; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Peng XH, 2006, NUCLEIC ACIDS RES, V34, P5987, DOI 10.1093/nar/gkl719; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; THOMAS L, 1982, BIOCHEMISTRY-US, V21, P1162, DOI 10.1021/bi00535a009; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35783	35791		10.1074/jbc.M110.155663	http://dx.doi.org/10.1074/jbc.M110.155663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843803	Green Published, hybrid			2022-12-25	WOS:000283845300056
J	Lu, LC; Hou, XH; Shi, SL; Korner, C; Stanley, P				Lu, Linchao; Hou, Xinghua; Shi, Shaolin; Koerner, Christian; Stanley, Pamela			Slc35c2 Promotes Notch1 Fucosylation and Is Required for Optimal Notch Signaling in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE-ADHESION-DEFICIENCY; NUCLEOTIDE-SUGAR TRANSPORTERS; GDP-FUCOSE TRANSPORTER; SIALIC ACID TRANSPORTER; FACTOR-LIKE REPEATS; O-FUCOSYLATION; PROTEIN O-FUCOSYL-TRANSFERASE-1; SUBSTRATE RECOGNITION; ENDOPLASMIC-RETICULUM; CONGENITAL DISORDER	Mammalian Notch receptors require modification by fucose on epidermal growth factor-like (EGF) repeats of their extracellular domain to respond optimally to signal induction by canonical Notch ligands. Inactivation of the Golgi GDP-fucose transporter Slc35c1 in mouse or human does not cause marked defects in Notch signaling during development, and shows milder fucosylation defects than those observed in mice unable to synthesize GDP-fucose, indicating the existence of another mechanism for GDP-fucose transport into the secretory pathway. We show here that fibroblasts from mice or humans lacking Slc35c1 exhibit robust Notch signaling in co-culture signaling assays. A potential candidate for a second GDP-fucose transporter is the related gene Slc35c2. Overexpression of Slc35c2 reduces expression of the fucosylated epitopes Lewis X and sialylated Lewis X in CHO cells, indicating competition with Slc35c1. The fucosylation of a Notch1 EGF repeat fragment that occurs in the endoplasmic reticulum was increased in CHO transfectants overexpressing Slc35c2. In CHO cells with low levels of Slc35c2, both Delta1- and Jagged1-induced Notch signaling were reduced, and the fucosylation of a Notch1 fragment was also decreased. Immunofluorescence microscopy of rat intestinal epithelial cells and HeLa cells, and analysis of rat liver membrane fractions showed that Slc35c2 is primarily colocalized with markers of the cis-Golgi network and endoplasmic reticulum-Golgi intermediate compartment (ERGIC). The combined results suggest that Slc35c2 is either a GDP-fucose transporter that competes with Slc35c1 for GDP-fucose, or a factor that otherwise enhances the fucosylation of Notch and is required for optimal Notch signaling in mammalian cells.	Yeshiva Univ, Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Koerner, Christian] Ctr Metab Dis Heidelberg Dept 1, Ctr Child & Adolescent Med, D-69120 Heidelberg, Germany	Yeshiva University; Albert Einstein College of Medicine		pamela.stanley@einstein.yu.edu	Lu, Linchao/F-5778-2014	Lu, Linchao/0000-0002-5560-0025; Stanley, Pamela/0000-0001-5704-3747; Shi, Shaolin/0000-0003-2297-6496	National Institutes of Health [RO1 95022]; NCI [RO1 36434, PO1 13330]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 95022 and RO1 36434 from the NCI (to P. S.) and NCI Grant PO1 13330 (to the Albert Einstein Cancer Center)	Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Aoki K, 2001, J BIOL CHEM, V276, P21555, DOI 10.1074/jbc.M101462200; Aoki K, 1999, J BIOCHEM, V126, P940, DOI 10.1093/oxfordjournals.jbchem.a022538; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2005, GLYCOBIOLOGY, V15, P259, DOI 10.1093/glycob/cwi011; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; GINSBURG V, 1960, J BIOL CHEM, V235, P2196; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Kim ML, 2008, MOL CELL NEUROSCI, V39, P452, DOI 10.1016/j.mcn.2008.07.026; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Maggioni A, 2007, BIOCHEM BIOPH RES CO, V362, P779, DOI 10.1016/j.bbrc.2007.08.070; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moran JL, 2009, DEV DYNAM, V238, P1803, DOI 10.1002/dvdy.21982; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Patnaik SK, 2004, J BIOL CHEM, V279, P49716, DOI 10.1074/jbc.M408755200; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Waterhouse CCM, 2010, GASTROENTEROLOGY, V138, P1079, DOI 10.1053/j.gastro.2009.10.049; WATZELE G, 1991, EUR J CELL BIOL, V56, P451; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035; YURCHENCO PD, 1977, BIOCHEMISTRY-US, V16, P944, DOI 10.1021/bi00624a021; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zhou L, 2008, BLOOD, V112, P308, DOI 10.1182/blood-2007-11-115204	59	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36245	36254		10.1074/jbc.M110.126003	http://dx.doi.org/10.1074/jbc.M110.126003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837470	Green Published, hybrid			2022-12-25	WOS:000283845300100
J	Ashworth, S; Teng, B; Kaufeld, J; Miller, E; Tossidou, I; Englert, C; Bollig, F; Staggs, L; Roberts, ISD; Park, JK; Haller, H; Schiffer, M				Ashworth, Sharon; Teng, Beina; Kaufeld, Jessica; Miller, Emily; Tossidou, Irini; Englert, Christoph; Bollig, Frank; Staggs, Lynne; Roberts, Ian S. D.; Park, Joon-Keun; Haller, Hermann; Schiffer, Mario			Cofilin-1 Inactivation Leads to Proteinuria - Studies in Zebrafish, Mice and Humans	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIN-DEPOLYMERIZING FACTOR; TGF-BETA; PODOCYTES; ALPHA-ACTININ-4; DYNAMICS; DISEASE; IDENTIFICATION; CYTOSKELETON; MECHANISMS	Background: Podocytes are highly specialized epithelial cells on the visceral side of the glomerulus. Their interdigitating primary and secondary foot processes contain an actin based contractile apparatus that can adjust to changes in the glomerular perfusion pressure. Thus, the dynamic regulation of actin bundles in the foot processes is critical for maintenance of a well functioning glomerular filtration barrier. Since the actin binding protein, cofilin-1, plays a significant role in the regulation of actin dynamics, we examined its role in podocytes to determine the impact of cofilin-1 dysfunction on glomerular filtration. Methods and Findings: We evaluated zebrafish pronephros function by dextran clearance and structure by TEM in cofilin-1 morphant and mutant zebrafish and we found that cofilin-1 deficiency led to foot process effacement and proteinuria. In vitro studies in murine and human podocytes revealed that PMA stimulation induced activation of cofilin-1, whereas treatment with TGF-beta resulted in cofilin-1 inactivation. Silencing of cofilin-1 led to an accumulation of F-actin fibers and significantly decreased podocyte migration ability. When we analyzed normal and diseased murine and human glomerular tissues to determine cofilin-1 localization and activity in podocytes, we found that in normal kidney tissues unphosphorylated, active cofilin-1 was distributed throughout the cell. However, in glomerular diseases that affect podocytes, cofilin-1 was inactivated by phosphorylation and observed in the nucleus. Conclusions: Based on these in vitro and in vivo studies we concluded cofilin-1 is an essential regulator for actin filament recycling that is required for the dynamic nature of podocyte foot processes. Therefore, we describe a novel pathomechanism of proteinuria development.	[Ashworth, Sharon] Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA; [Ashworth, Sharon] Univ Maine, Sch Biol & Ecol, Orono, ME USA; [Teng, Beina; Kaufeld, Jessica; Miller, Emily; Tossidou, Irini; Bollig, Frank; Staggs, Lynne; Park, Joon-Keun; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Dept Med Nephrol, D-3000 Hannover, Germany; [Ashworth, Sharon; Kaufeld, Jessica; Staggs, Lynne; Haller, Hermann; Schiffer, Mario] Mt Desert Isl Biol Labs, Salsbury Cove, ME USA; [Englert, Christoph] Fritz Lipmann Inst eV FLI, Leibniz Inst Age Res, Jena, Germany; [Roberts, Ian S. D.] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Hannover Medical School; Mount Desert Island Biological Laboratory; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Oxford	Ashworth, S (corresponding author), Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019	Schiffer, Mario/0000-0002-8414-1470; Englert, Christoph/0000-0002-5931-3189	German Research Council (DFG) [Schi587/2]; University of Maine; Mount Desert Island Biological Laboratory (MDIBL); MDIBL-INBRE (IDeA Network of Biomedical Research Excellence)	German Research Council (DFG)(German Research Foundation (DFG)); University of Maine; Mount Desert Island Biological Laboratory (MDIBL); MDIBL-INBRE (IDeA Network of Biomedical Research Excellence)	This work was supported by a German Research Council (DFG) - grant (Schi587/2) to M.S., University of Maine Faculty Research Award and start-up funds to S.A., Mount Desert Island Biological Laboratory (MDIBL) New Investigator Awards to S.A. and M.S., and a MDIBL-INBRE (IDeA Network of Biomedical Research Excellence) award to E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Djafarzadeh S, 1997, EXP CELL RES, V236, P427, DOI 10.1006/excr.1997.3731; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kriz W, 2004, KIDNEY INT, V65, P333, DOI 10.1111/j.1523-1755.2004.00421.x; KRIZ W, 1994, CONTRIB NEPHROL, V107, P1; Kriz W, 1996, KIDNEY INT, V49, P1570, DOI 10.1038/ki.1996.227; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Mundel P, 1996, EXP NEPHROL, V4, P263; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schiffer M, 2006, DEUT MED WOCHENSCHR, V131, P1541, DOI 10.1055/s-2006-947793; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2002, J AM SOC NEPHROL, V13, P2657, DOI 10.1097/01.ASN.0000033276.06451.50; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Van T. M., 2008, EUR J CELL BIOL, V87, P649; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wiggan O, 2005, NAT CELL BIOL, V7, P8, DOI 10.1038/ncb0105-8; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	34	54	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12626	10.1371/journal.pone.0012626	http://dx.doi.org/10.1371/journal.pone.0012626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838616	gold, Green Submitted, Green Published			2022-12-25	WOS:000281687100009
J	Quah-Smith, I; Sachdev, PS; Wen, W; Chen, XH; Williams, MA				Quah-Smith, Im; Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua; Williams, Mark A.			The Brain Effects of Laser Acupuncture in Healthy Individuals: An fMRI Investigation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STIMULATION; DEPRESSION; ACTIVATION; HUMANS; ELECTROACUPUNCTURE; COMPLEMENTARY; HYPOTHALAMUS; CONNECTIVITY; MODULATION	Background: As laser acupuncture is being increasingly used to treat mental disorders, we sought to determine whether it has a biologically plausible effect by using functional magnetic resonance imaging (fMRI) to investigate the cerebral activation patterns from laser stimulation of relevant acupoints. Methodology/Principal Findings: Ten healthy subjects were randomly stimulated with a fibreoptic infrared laser on 4 acupoints (LR14, CV14, LR8 and HT7) used for depression following the principles of Traditional Chinese Medicine (TCM), and 1 control non-acupoint (sham point) in a blocked design (alternating verum laser and placebo laser/rest blocks), while the blood oxygenation level-dependent (BOLD) fMRI response was recorded from the whole brain on a 3T scanner. Many of the acupoint laser stimulation conditions resulted in different patterns of neural activity. Regions with significantly increased activation included the limbic cortex (cingulate) and the frontal lobe (middle and superior frontal gyrus). Laser acupuncture tended to be associated with ipsilateral brain activation and contralateral deactivation that therefore cannot be simply attributed to somatosensory stimulation. Conclusions/Significance: We found that laser stimulation of acupoints lead to activation of frontal-limbic-striatal brain regions, with the pattern of neural activity somewhat different for each acupuncture point. This is the first study to investigate laser acupuncture on a group of acupoints useful in the management of depression. Differing activity patterns depending on the acupoint site were demonstrated, suggesting that neurological effects vary with the site of stimulation. The mechanisms of activation and deactivation and their effects on depression warrant further investigation.	[Quah-Smith, Im; Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua] Univ New S Wales, Fac Med, Sch Psychiat, Randwick, NSW, Australia; [Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua] Univ New S Wales, Brain & Ageing Res Program, Sch Psychiat, Randwick, NSW, Australia; [Williams, Mark A.] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University	Quah-Smith, I (corresponding author), Univ New S Wales, Fac Med, Sch Psychiat, Randwick, NSW, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Williams, Mark/0000-0002-3897-5167; Wen, Wei/0000-0003-2753-3870	Louise and Gary Dobson; James Fairfax; Thyne Reid Foundation	Louise and Gary Dobson; James Fairfax; Thyne Reid Foundation	The authors acknowledge financial support from Louise and Gary Dobson, James Fairfax and the Thyne Reid Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2003, FORTSCHR NEUROL PSYC, V71, P141, DOI 10.1055/s-2003-37756; Aung SKH, 2007, CLIN INTRO MED ACUPU, P99; Campbell Anthony, 2006, Acupunct Med, V24, P118; Chang S, 2008, CHINESE J PHYSIOL, V51, P167; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Fang JL, 2004, NEURORADIOLOGY, V46, P359, DOI 10.1007/s00234-003-1125-7; GENG L, 2006, J MAGN RESON IMAGING, V24, P1018; George M. S., 1996, ADV BIOL PSYCHIAT, P63; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Haker E, 2000, J AUTONOM NERV SYST, V79, P52, DOI 10.1016/S0165-1838(99)00090-9; Hsieh JC, 2001, NEUROSCI LETT, V307, P105, DOI 10.1016/S0304-3940(01)01952-8; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Jorm AF, 2002, MED J AUSTRALIA, V176, pS84; Kessler RC, 2001, AM J PSYCHIAT, V158, P289, DOI 10.1176/appi.ajp.158.2.289; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Lund Irene, 2009, Chin Med, V4, P1, DOI 10.1186/1749-8546-4-1; Lundeberg T, 2009, ACUPUNCT MED, V27, P31, DOI 10.1136/aim.2008.000133; Maciocia G., 1994, PRACTICE CHINESE MED, P197; MacPherson H, 2008, NEUROSCI LETT, V434, P144, DOI 10.1016/j.neulet.2008.01.058; Napadow V, 2007, PAIN, V130, P254, DOI 10.1016/j.pain.2006.12.003; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Paterson C, 2008, J ALTERN COMPLEM MED, V14, P199, DOI 10.1089/acm.2007.0682; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Quah-Smith Joo Im, 2005, Acupunct Med, V23, P103; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; RINDGE D, 2009, ACUPUNCTURE TODAY, V11, P5; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Siedentopf CM, 2005, LASER MED SCI, V20, P68, DOI 10.1007/s10103-005-0340-3; Siedentopf CM, 2002, NEUROSCI LETT, V327, P53, DOI 10.1016/S0304-3940(02)00383-X; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Tsukayama H, 2006, CLIN J PAIN, V22, P346, DOI 10.1097/01.ajp.0000176359.94644.mL; Napadow V, 2005, P ANN INT IEEE EMBS, P4496, DOI 10.1109/IEMBS.2005.1615466; Wu JH, 2009, PHOTOMED LASER SURG, V27, P273, DOI 10.1089/pho.2007.2235; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Zhang WT, 2004, NEUROSCI LETT, V354, P50, DOI 10.1016/j.neulet.2003.09.080; Zhang WT, 2003, BRAIN RES, V982, P168, DOI 10.1016/S0006-8993(03)02983-4	42	37	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12619	10.1371/journal.pone.0012619	http://dx.doi.org/10.1371/journal.pone.0012619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838644	gold, Green Published			2022-12-25	WOS:000281631300039
J	Daly, MJ; Gaidamakova, EK; Matrosova, VY; Kiang, JG; Fukumoto, R; Lee, DY; Wehr, NB; Viteri, GA; Berlett, BS; Levine, RL				Daly, Michael J.; Gaidamakova, Elena K.; Matrosova, Vera Y.; Kiang, Juliann G.; Fukumoto, Risaku; Lee, Duck-Yeon; Wehr, Nancy B.; Viteri, Gabriela A.; Berlett, Barbara S.; Levine, Rodney L.			Small-Molecule Antioxidant Proteome-Shields in Deinococcus radiodurans	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIATION-RESISTANCE; IONIZING-RADIATION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; MICROCOCCUS-RADIODURANS; SALMONELLA-TYPHIMURIUM; SHEWANELLA-ONEIDENSIS; SUPEROXIDE-DISMUTASE; COMPARATIVE GENOMICS	For Deinococcus radiodurans and other bacteria which are extremely resistant to ionizing radiation, ultraviolet radiation, and desiccation, a mechanistic link exists between resistance, manganese accumulation, and protein protection. We show that ultrafiltered, protein-free preparations of D. radiodurans cell extracts prevent protein oxidation at massive doses of ionizing radiation. In contrast, ultrafiltrates from ionizing radiation-sensitive bacteria were not protective. The D. radiodurans ultrafiltrate was enriched in Mn, phosphate, nucleosides and bases, and peptides. When reconstituted in vitro at concentrations approximating those in the D. radiodurans cytosol, peptides interacted synergistically with Mn(2+) and orthophosphate, and preserved the activity of large, multimeric enzymes exposed to 50,000 Gy, conditions which obliterated DNA. When applied ex vivo, the D. radiodurans ultrafiltrate protected Escherichia coli cells and human Jurkat T cells from extreme cellular insults caused by ionizing radiation. By establishing that Mn(2+)-metabolite complexes of D. radiodurans specifically protect proteins against indirect damage caused by gamma-rays delivered in vast doses, our findings provide the basis for a new approach to radioprotection and insight into how surplus Mn budgets in cells combat reactive oxygen species.	[Daly, Michael J.; Gaidamakova, Elena K.; Matrosova, Vera Y.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Kiang, Juliann G.; Fukumoto, Risaku] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA; [Lee, Duck-Yeon; Wehr, Nancy B.; Viteri, Gabriela A.; Berlett, Barbara S.; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Daly, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mdaly@usuhs.edu; rlevine@nih.gov	Levine, Rodney L/D-9885-2011; Matrosova, Vera/AAX-4125-2020		Air Force Office of Scientific Research [FA9550-07-1-0218]; National Heart, Lung, and Blood Institute, National Institutes of Health; National Institute of Allergy and Infectious Diseases; AFRRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, ZIAHL006071] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AFRRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work of E.K.G., V.Y.M. and M.J.D. was supported by the Air Force Office of Scientific Research (Grant FA9550-07-1-0218). The work of B.S.B., G.A.V., N.B.W., D.-Y.L. and R.L.L. was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health. The work of J.G.K. and R.F. was supported by the National Institute of Allergy and Infectious Diseases, and the Intramural Program of the AFRRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; [Anonymous], 2010, ENVIRON MICROBIOL, V13, P1192, DOI [DOI 10.1111/J.1462-2920.2010.02268.X, 10.1111/j.1462-2920.2010.02419.x]; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BERGMEYER HU, 1974, METHOD ENZYMAT AN, V2, P1072; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BLOK J, 1973, Current Topics in Radiation Research Quarterly, V9, P165; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; BRUCE AK, 1964, RADIAT RES, V22, P155, DOI 10.2307/3571706; Burgoyne PS, 2007, BIOESSAYS, V29, P974, DOI 10.1002/bies.20639; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Dale Walter M., 1943, BRIT JOUR RADIOL, V16, P171; Dale Walter M., 1942, BIOCHEM JOUR, V36, P80; Dale WM, 1940, BIOCHEM J, V34, P1367, DOI 10.1042/bj0341367; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Datta SK, 2006, IMMUNITY, V25, P143, DOI 10.1016/j.immuni.2006.05.013; DAVIES R, 1973, J BACTERIOL, V113, P133, DOI 10.1128/JB.113.1.133-144.1973; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gunter TE, 2009, NEUROTOXICOLOGY, V30, P727, DOI 10.1016/j.neuro.2009.05.003; He Y, 2009, J IND MICROBIOL BIOT, V36, P539, DOI 10.1007/s10295-008-0524-5; HEITMAN J, 1989, P NATL ACAD SCI USA, V86, P2281, DOI 10.1073/pnas.86.7.2281; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kiang JG, 2009, RADIAT RES, V172, P321, DOI 10.1667/RR1585.1; Knobloch B, 2005, P NATL ACAD SCI USA, V102, P7459, DOI 10.1073/pnas.0501446102; KRISCH RE, 1991, RADIAT RES, V126, P251, DOI 10.2307/3577826; KRISKO A, 2010, P NATL ACAD SCI US; LAZZARINO G, 1991, ANAL BIOCHEM, V197, P191, DOI 10.1016/0003-2697(91)90378-7; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MCNAUGHTON RL, 2010, P NATL ACAD SCI US; Omar B A, 1992, Adv Pharmacol, V23, P109, DOI 10.1016/S1054-3589(08)60964-3; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; PARISI A, 1974, APPL MICROBIOL, V28, P41, DOI 10.1128/AEM.28.1.41-46.1974; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schachman H.K., 1959, ULTRACENTRIFUGATION; Setlow B, 2006, J BACTERIOL, V188, P3740, DOI 10.1128/JB.00212-06; Shashidhar R, 2010, CAN J MICROBIOL, V56, P195, DOI [10.1139/W09-118, 10.1139/w09-118]; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; Shuryak I, 2009, J THEOR BIOL, V261, P305, DOI 10.1016/j.jtbi.2009.08.003; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Stadtman E. R., 2006, REDOX PROTEOMICS PRO, P3; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Syljuasen RG, 1996, RADIAT RES, V146, P276, DOI 10.2307/3579457; ULMER KM, 1979, J BACTERIOL, V138, P475, DOI 10.1128/JB.138.2.475-485.1979; Vilenchik MM, 2006, P NATL ACAD SCI USA, V103, P17874, DOI 10.1073/pnas.0607995103; vonFrijtag JK, 1996, DRUG DEVELOP RES, V37, P48, DOI 10.1002/(SICI)1098-2299(199601)37:1<48::AID-DDR3>3.0.CO;2-M; Wang S, 2009, INORG CHEM, V48, P719, DOI 10.1021/ic8003068; Wolfe-Simon F, 2006, PLANT PHYSIOL, V142, P1701, DOI 10.1104/pp.106.088963; Woodward C., 2007, 59896297EN AG TECHN	65	214	223	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12570	10.1371/journal.pone.0012570	http://dx.doi.org/10.1371/journal.pone.0012570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838443	Green Submitted, gold, Green Published			2022-12-25	WOS:000281627700017
J	Mancuso, DJ; Sims, HF; Yang, K; Kiebish, MA; Su, XO; Jenkins, CM; Guan, SP; Moon, SH; Pietka, T; Nassir, F; Schappe, T; Moore, K; Han, XL; Abumrad, NA; Gross, RW				Mancuso, David J.; Sims, Harold F.; Yang, Kui; Kiebish, Michael A.; Su, Xiong; Jenkins, Christopher M.; Guan, Shaoping; Moon, Sung Ho; Pietka, Terri; Nassir, Fatiha; Schappe, Timothy; Moore, Kristin; Han, Xianlin; Abumrad, Nada A.; Gross, Richard W.			Genetic Ablation of Calcium-independent Phospholipase A(2)gamma Prevents Obesity and Insulin Resistance during High Fat Feeding by Mitochondrial Uncoupling and Increased Adipocyte Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDIMENSIONAL MASS-SPECTROMETRY; SKELETAL-MUSCLE; PANCREATIC-ISLETS; A(2) IPLA(2); SHOTGUN LIPIDOMICS; ADIPOSE-TISSUE; IDENTIFICATION; BETA; CARDIOLIPIN; EXPRESSION	Phospholipases are critical enzyme mediators participating in many aspects of cellular function through modulating the generation of lipid 2nd messengers, membrane physical properties, and cellular bioenergetics. Here, we demonstrate that mice null for calcium-independent phospholipase A(2)gamma (iPLA(2)gamma(-/-)) are completely resistant to high fat diet-induced weight gain, adipocyte hypertrophy, hyperinsulinemia, and insulin resistance, which occur in iPLA(2)gamma(+/+) mice after high fat feeding. Notably, iPLA(2)gamma(-/-) mice were lean, demonstrated abdominal lipodystrophy, and remained insulin-sensitive despite having a marked impairment in glucose-stimulated insulin secretion after high fat feeding. Respirometry of adipocyte explants from iPLA(2)gamma(-/-) mice identified increased rates of oxidation of multiple different substrates in comparison with adipocyte explants from wild-type littermates. Shotgun lipidomics of adipose tissue from wild-type mice demonstrated the anticipated 2-fold increase in triglyceride content after high fat feeding. In sharp contrast, the adipocyte triglyceride content was identical in iPLA(2)gamma(-/-) mice fed either a standard diet or a high fat diet. Respirometry of skeletal muscle mitochondria from iPLA(2)gamma(-/-) mice demonstrated marked decreases in state 3 respiration using multiple substrates whose metabolism was uncoupled from ATP production. Shotgun lipidomics of skeletal muscle revealed a decreased content of cardiolipin with an altered molecular species composition thereby identifying the mechanism underlying mitochondrial uncoupling in the iPLA(2)gamma(-/-) mouse. Collectively, these results identify iPLA(2)gamma as an obligatory upstream enzyme that is necessary for efficient electron transport chain coupling and energy production through its participation in the alterations of cellular bioenergetics that promote the development of the metabolic syndrome.	[Mancuso, David J.; Sims, Harold F.; Yang, Kui; Kiebish, Michael A.; Jenkins, Christopher M.; Guan, Shaoping; Moon, Sung Ho; Han, Xianlin; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Su, Xiong; Pietka, Terri; Nassir, Fatiha; Schappe, Timothy; Moore, Kristin; Abumrad, Nada A.] Washington Univ, Sch Med, Div Nutr Sci, St Louis, MO 63110 USA; [Mancuso, David J.; Sims, Harold F.; Yang, Kui; Kiebish, Michael A.; Su, Xiong; Jenkins, Christopher M.; Guan, Shaoping; Moon, Sung Ho; Pietka, Terri; Nassir, Fatiha; Schappe, Timothy; Moore, Kristin; Han, Xianlin; Abumrad, Nada A.; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Su, Xiong; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu		Nassir, Fatiha/0000-0002-3653-3621	National Institutes of Health [5PO1HL57278, RO1HL41250.]; American Heart Association [DK56351, 835140N]; NIDDK [P30 DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. This work was also supported by Clinical Nutrition Research Unit Grant DK56351 and Scientist Development Grant 835140N from the American Heart Association (to X. S.).; The access to equipment for the DEXA and Oxy-max analyses was provided by National Institutes of Health Grant P30 DK56341 from the NIDDK.	Argiles JM, 2005, MED RES REV, V25, P49, DOI 10.1002/med.20010; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Cannon B, 2000, METH MOL B, V155, P295; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; FOURNIER B, 1994, J INHERIT METAB DIS, V17, P470, DOI 10.1007/BF00711362; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jullig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Liu YQ, 2010, AM J PHYSIOL-CELL PH, V298, pC921, DOI 10.1152/ajpcell.00541.2009; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, DIABETES, V53, pS179, DOI 10.2337/diabetes.53.2007.S179; Rasmussen UF, 2004, COMP BIOCHEM PHYS A, V137, P435, DOI 10.1016/j.cbpb.2003.11.002; Sahlin K, 2007, AM J PHYSIOL-ENDOC M, V292, pE223, DOI 10.1152/ajpendo.00266.2006; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Song HW, 2010, AM J PHYSIOL-ENDOC M, V298, pE1097, DOI 10.1152/ajpendo.00780.2009; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078; Tchoukalova YD, 2003, J LIPID RES, V44, P1795, DOI 10.1194/jlr.D300001-JLR200; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	62	60	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36495	36510		10.1074/jbc.M110.115766	http://dx.doi.org/10.1074/jbc.M110.115766			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20817734	Green Published, hybrid			2022-12-25	WOS:000284146100003
J	Wilson, PW; Osterday, KE; Heneghan, AF; Haymet, ADJ				Wilson, Peter W.; Osterday, Katie E.; Heneghan, Aaron F.; Haymet, Anthony D. J.			Type I Antifreeze Proteins Enhance Ice Nucleation above Certain Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAG-TIME APPARATUS; HETEROGENEOUS NUCLEATION; SUPERCOOLED LIQUIDS; THERMAL HYSTERESIS; AQUEOUS-SOLUTIONS; DEVITRIFICATION; GLYCOPROTEINS; INHIBITION; AGENTS; WATER	In this study, we examined the effects that antifreeze proteins have on the supercooling and ice-nucleating abilities of aqueous solutions. Very little information on such nucleation currently exists. Using an automated lag time apparatus and a new analysis, we show several dilution series of Type I antifreeze proteins. Our results indicate that, above a concentration of similar to 8 mg/ml, ice nucleation is enhanced rather than hindered. We discuss this unexpected result and present a new hypothesis outlining three components of polar fish blood that we believe affect its solution properties in certain situations.	Univ Tsukuba, Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Osterday, Katie E.; Haymet, Anthony D. J.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Heneghan, Aaron F.] Univ Wisconsin, Dept Surg, Madison, WI 53792 USA	University of Tsukuba; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Wisconsin System; University of Wisconsin Madison		wilson.peter.ge@u.tsukuba.ac.jp	Wilson, Peter W.F./J-2455-2016; FTSE, Tony Haymet PhD/A-9881-2009; Wilson, Peter/AAT-6428-2020	FTSE, Tony Haymet PhD/0000-0002-5617-2106; Wilson, Peter/0000-0002-1535-6398				ANANTHANARAYANA.VS, 1989, Rep, V7, P1; BARLOW TW, 1995, REV SCI INSTRUM, V66, P2996, DOI 10.1063/1.1145586; CHANG ZH, 1991, CRYO-LETT, V12, P215; Cheng C.C., 1991, P1; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; Du N, 2003, J BIOL CHEM, V278, P36000, DOI 10.1074/jbc.M305222200; Du N, 2006, J PHYS CHEM B, V110, P20562, DOI 10.1021/jp061969y; FRANKS F, 1987, NATURE, V325, P146, DOI 10.1038/325146a0; Heneghan AF, 2004, CHEM PHYS LETT, V385, P441, DOI 10.1016/j.cplett.2004.01.025; HEW CL, 1986, EUR J BIOCHEM, V15, P267; Holt CB, 2003, CRYOLETTERS, V24, P323; Liu XY, 2004, J BIOL CHEM, V279, P6124, DOI 10.1074/jbc.M310487200; PARODYMORREALE A, 1988, NATURE, V333, P782, DOI 10.1038/333782a0; Praebel K, 2009, COMP BIOCHEM PHYS A, V154, P564, DOI 10.1016/j.cbpa.2009.09.005; SUTTON RL, 1993, CRYO-LETT, V14, P13; Wilson PW, 2003, CRYOBIOLOGY, V46, P88, DOI 10.1016/S0011-2240(02)00182-7; WILSON PW, 1993, CRYO-LETT, V14, P31; WILSON PW, 1995, BIOPHYS J, V68, P2098, DOI 10.1016/S0006-3495(95)80389-9; Wowk B, 2000, CRYOBIOLOGY, V40, P228, DOI 10.1006/cryo.2000.2243; WU DW, 1991, BIOCHIM BIOPHYS ACTA, V1076, P416, DOI 10.1016/0167-4838(91)90485-I; Zachariassen KE, 2004, CRYOBIOLOGY, V48, P309, DOI 10.1016/j.crybiol.2004.02.005; Zachariassen KE, 2002, CRYOBIOLOGY, V44, P132, DOI 10.1016/S0011-2240(02)00014-7; Zobrist B, 2008, J PHYS CHEM A, V112, P3965, DOI 10.1021/jp7112208	26	33	35	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34741	34745		10.1074/jbc.M110.171983	http://dx.doi.org/10.1074/jbc.M110.171983			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20837472	Green Published, hybrid			2022-12-25	WOS:000283659100049
J	Xu, YF; Sengupta, T; Kukreja, L; Minella, AC				Xu, Yanfei; Sengupta, Tanushri; Kukreja, Lokesh; Minella, Alex C.			MicroRNA-223 Regulates Cyclin E Activity by Modulating Expression of F-box and WD-40 Domain Protein 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; E DEGRADATION; C-MYC; MULTISITE PHOSPHORYLATION; DEPENDENT DEGRADATION; FEEDBACK LOOP; DIFFERENTIATION; INSTABILITY	F-box and WD-40 domain protein 7 (Fbw7) provides substrate specificity for the Skp1-Cullin1-F-box protein (SCF) ubiquitin ligase complex that targets multiple oncoproteins for degradation, including cyclin E, c-Myc, c-Jun, Notch, and mammalian target of rapamycin (mTOR). Fbw7 is a bona fide tumor suppressor, and loss-of-function mutations in FBXW7 have been identified in diverse human tumors. Although much is known about targets of the Fbw7 ubiquitin ligase pathway, relatively little is known about the regulation of Fbw7 expression. We identified a panel of candidate microRNA regulators of Fbw7 expression within a study of gene expression alterations in primary erythroblasts obtained from cyclin E-T74A T393A knock-in mice, which have markedly dysregulated cyclin E expression. We found that overexpression of miR-223, in particular, significantly reduces FBXW7 mRNA levels, increases endogenous cyclin E protein and activity levels, and increases genomic instability. We next confirmed that miR-223 targets the FBXW7 3'-untranslated region. We then found that reduced miR-223 expression in primary mouse embryonic fibroblasts leads to increased Fbw7 expression and decreased cyclin E activity. Finally, we found that miR-223 expression is responsive to acute alterations in cyclin E regulation by the Fbw7 pathway. Together, our data indicate that miR-223 regulates Fbw7 expression and provide the first evidence that activity of the SCFFbw7 ubiquitin ligase can be modulated directly by the microRNA pathway.	Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Minella, Alex C.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center		a-minella@northwestern.edu	Sengupta, Tanushri/G-1725-2011	Minella, Alex/0000-0001-6693-3362	National Institutes of Health [R01HL098608, K22CA130984]; Sidney Kimmel Foundation; Schweppe Foundation; Zell Family Foundation; NATIONAL CANCER INSTITUTE [K22CA130984] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation; Schweppe Foundation; Zell Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL098608 and K22CA130984. This work was also supported by a Sidney Kimmel Foundation Translational Scholar Award, and funding from the Schweppe and Zell Family Foundations.	Anzi S, 2008, CELL SIGNAL, V20, P862, DOI 10.1016/j.cellsig.2007.12.020; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiaretti S, 2010, HAEMATOL-HEMATOL J, V95, P1114, DOI 10.3324/haematol.2009.015099; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cohen EEW, 2009, CANCER RES, V69, P65, DOI 10.1158/0008-5472.CAN-08-0377; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-8; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010; Ma Y, 2007, P NATL ACAD SCI USA, V104, P4089, DOI 10.1073/pnas.0606537104; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Minella AC, 2007, ONCOGENE, V26, P6948, DOI 10.1038/sj.onc.1210518; Minella AC, 2005, P NATL ACAD SCI USA, V102, P9649, DOI 10.1073/pnas.0503677102; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Smith APL, 2006, ONCOGENE, V25, P7245, DOI 10.1038/sj.onc.1209713; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x	57	72	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34439	34446		10.1074/jbc.M110.152306	http://dx.doi.org/10.1074/jbc.M110.152306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826802	Green Published, hybrid			2022-12-25	WOS:000283659100018
J	Dozot, M; Poncet, S; Nicolas, C; Copin, R; Bouraoui, H; Maze, A; Deutscher, J; De Bolle, X; Letesson, JJ				Dozot, Marie; Poncet, Sandrine; Nicolas, Cecile; Copin, Richard; Bouraoui, Houda; Maze, Alain; Deutscher, Josef; De Bolle, Xavier; Letesson, Jean-Jacques			Functional Characterization of the Incomplete Phosphotransferase System (PTS) of the Intracellular Pathogen Brucella melitensis	PLOS ONE			English	Article							IV SECRETION SYSTEM; 2-COMPONENT REGULATORY SYSTEM; PROTEIN-PROTEIN INTERACTION; SMALL-COLONY-VARIANT; CARBON CATABOLITE REPRESSION; GRAM-POSITIVE BACTERIA; TERMINAL GAF DOMAIN; ESCHERICHIA-COLI; AGROBACTERIUM-TUMEFACIENS; HPR KINASE/PHOSPHORYLASE	Background: In many bacteria, the phosphotransferase system (PTS) is a key player in the regulation of the assimilation of alternative carbon sources notably through catabolic repression. The intracellular pathogens Brucella spp. possess four PTS proteins (EINtr, NPr, EIIA(Ntr) and an EIIA of the mannose family) but no PTS permease suggesting that this PTS might serve only regulatory functions. Methodology/Principal Findings: In vitro biochemical analyses and in vivo detection of two forms of EIIA(Ntr) (phosphorylated or not) established that the four PTS proteins of Brucella melitensis form a functional phosphorelay. Moreover, in vitro the protein kinase HprK/P phosphorylates NPr on a conserved serine residue, providing an additional level of regulation to the B. melitensis PTS. This kinase activity was inhibited by inorganic phosphate and stimulated by fructose-1,6 bisphosphate. The genes encoding HprK/P, an EIIA(Man)-like protein and NPr are clustered in a locus conserved among a-proteobacteria and also contain the genes for the crucial two-component system BvrR-BvrS. RT-PCR revealed a transcriptional link between these genes suggesting an interaction between PTS and BvrR-BvrS. Mutations leading to the inactivation of EINtr or NPr significantly lowered the synthesis of VirB proteins, which form a type IV secretion system. These two mutants also exhibit a small colony phenotype on solid media. Finally, interaction partners of PTS proteins were identified using a yeast two hybrid screen against the whole B. melitensis ORFeome. Both NPr and HprK/P were shown to interact with an inorganic pyrophosphatase and the EIIA(Man)-like protein with the E1 component (SucA) of 2-oxoglutarate dehydrogenase. Conclusions/Significance: The B. melitensis can transfer the phosphoryl group from PEP to the EIIAs and a link between the PTS and the virulence of this organism could be established. Based on the protein interaction data a preliminary model is proposed in which this regulatory PTS coordinates also C and N metabolism.	[Dozot, Marie; Nicolas, Cecile; Copin, Richard; De Bolle, Xavier; Letesson, Jean-Jacques] Univ Namur, Res Unit Mol Biol, Namur, Belgium; [Poncet, Sandrine; Bouraoui, Houda; Maze, Alain; Deutscher, Josef] INRA CNRS AgroParisTech, Lab Microbiol & Genet Mol, Thiverval Grignon, France	University of Namur; AgroParisTech; INRAE	Dozot, M (corresponding author), Univ Namur, Res Unit Mol Biol, Namur, Belgium.	jean-jacques.letesson@fundp.ac.be	Jean-Jacques, LETESSON/AHB-6921-2022	LETESSON, Jean-Jacques/0000-0002-5838-0224; PONCET, Sandrine/0000-0002-2813-0793; copin, richard/0000-0001-7717-2183; De Bolle, Xavier/0000-0002-3845-3043; Maze, Alain/0000-0003-0873-3690	Fonds de la Recherche Fondamentale Collective (FRFC, Belgium) [2.4521.04]; Action de recherche concertee [04/09-325, 08/13-015]; Commisariat general aux Relations internationales de la Communaute franc, aise de Belgique Fonds National pour la Recherche Scientifique - Centre National de la Recherche Scientifique (CGRI-FNRS-CNRS) [PVB/ADK/FR/ad/2681]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Fonds de la Recherche Fondamentale Collective (FRFC, Belgium)(Fonds de la Recherche Scientifique - FNRS); Action de recherche concertee; Commisariat general aux Relations internationales de la Communaute franc, aise de Belgique Fonds National pour la Recherche Scientifique - Centre National de la Recherche Scientifique (CGRI-FNRS-CNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Fonds de la Recherche Fondamentale Collective (FRFC, Belgium, convention 2.4521.04), by Action de recherche concertee (ARC, No. 04/09-325 and 08/13-015) and by an agreement with Commisariat general aux Relations internationales de la Communaute franc, aise de Belgique Fonds National pour la Recherche Scientifique - Centre National de la Recherche Scientifique (CGRI-FNRS-CNRS, reference PVB/ADK/FR/ad/2681). M. Dozot held a PhD fellowship from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen GS, 2003, J MOL BIOL, V326, P1203, DOI 10.1016/S0022-2836(02)01378-5; ANDERSON JD, 1965, J GEN MICROBIOL, V38, P109, DOI 10.1099/00221287-38-1-109; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Audette GF, 2000, J MOL BIOL, V303, P545, DOI 10.1006/jmbi.2000.4166; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Cases I, 1999, J BIOL CHEM, V274, P15562, DOI 10.1074/jbc.274.22.15562; Cases I, 2007, RES MICROBIOL, V158, P666, DOI 10.1016/j.resmic.2007.08.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; CLOECKAERT A, 1990, INFECT IMMUN, V58, P3980, DOI 10.1128/IAI.58.12.3980-3987.1990; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DEUTSCHER J, 1986, BIOCHEMISTRY-US, V25, P6543, DOI 10.1021/bi00369a031; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Ding ZY, 2002, J BACTERIOL, V184, P5572, DOI 10.1128/JB.184.20.5572-5582.2002; Dozot M, 2006, CELL MICROBIOL, V8, P1791, DOI 10.1111/j.1462-5822.2006.00749.x; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Essenberg RC, 2002, VET MICROBIOL, V90, P249, DOI 10.1016/S0378-1135(02)00212-2; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; Flores N, 2008, J MOL MICROB BIOTECH, V14, P176, DOI 10.1159/000109945; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gonzalez CF, 2005, BIOCHEMISTRY-US, V44, P598, DOI 10.1021/bi048412y; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Halbedel S, 2006, J BIOL CHEM, V281, P26253, DOI 10.1074/jbc.M605010200; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Hu KY, 2002, RES MICROBIOL, V153, P405, DOI 10.1016/S0923-2508(02)01339-6; Jacob J, 2006, MICROBES INFECT, V8, P363, DOI 10.1016/j.micinf.2005.07.003; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; JONES DHA, 1994, MICROBIOL-SGM, V140, P1035, DOI 10.1099/13500872-140-5-1035; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; Little R, 2003, J BIOL CHEM, V278, P28711, DOI 10.1074/jbc.M301992200; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Martinez-Argudo I, 2004, MOL MICROBIOL, V52, P1731, DOI 10.1111/j.1365-2958.2004.04089.x; MERRICK MJ, 1989, MOL MICROBIOL, V3, P1765, DOI 10.1111/j.1365-2958.1989.tb00162.x; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Mijakovic I, 2002, P NATL ACAD SCI USA, V99, P13442, DOI 10.1073/pnas.212410399; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; OSTERAS M, 1995, J BACTERIOL, V177, P1452, DOI 10.1128/jb.177.6.1452-1460.1995; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pelletier M, 1998, BIOCHEMISTRY-US, V37, P1604, DOI 10.1021/bi9721647; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Pinedo CA, 2008, J BACTERIOL, V190, P2947, DOI 10.1128/JB.01917-07; Pinedo CA, 2009, J BACTERIOL, V191, P298, DOI 10.1128/JB.01115-08; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; Reizer J, 1996, GENE, V181, P103, DOI 10.1016/S0378-1119(96)00481-7; RHIEL E, 1994, BIOL CHEM H-S, V375, P551, DOI 10.1515/bchm3.1994.375.8.551; ROOSSIEN FF, 1983, BIOCHIM BIOPHYS ACTA, V760, P185, DOI 10.1016/0304-4165(83)90141-1; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SGANGA MW, 1992, P NATL ACAD SCI USA, V89, P6328, DOI 10.1073/pnas.89.14.6328; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; UZUREAU S, 2010, J PROTEOME RES, DOI DOI 10.1021/PR100068; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005; Wu QM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-102; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283	95	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12679	10.1371/journal.pone.0012679	http://dx.doi.org/10.1371/journal.pone.0012679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844759	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687300018
J	Feliziani, S; Lujan, AM; Moyano, AJ; Sola, C; Bocco, JL; Montanaro, P; Canigia, LF; Argarana, CE; Smania, AM				Feliziani, Sofia; Lujan, Adela M.; Moyano, Alejandro J.; Sola, Claudia; Bocco, Jose L.; Montanaro, Patricia; Fernandez Canigia, Liliana; Argarana, Carlos E.; Smania, Andrea M.			Mucoidy, Quorum Sensing, Mismatch Repair and Antibiotic Resistance in Pseudomonas aeruginosa from Cystic Fibrosis Chronic Airways Infections	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; DNA-POLYMERASE-IV; ESCHERICHIA-COLI; GENETIC ADAPTATION; LASR MUTANTS; ANTIMICROBIAL RESISTANCE; PULMONARY INFECTION; MUTATOR ALLELES; LUNG INFECTIONS; HIGH-FREQUENCY	Survival of Pseudomonas aeruginosa in cystic fibrosis (CF) chronic infections is based on a genetic adaptation process consisting of mutations in specific genes, which can produce advantageous phenotypic switches and ensure its persistence in the lung. Among these, mutations inactivating the regulators MucA (alginate biosynthesis), LasR (quorum sensing) and MexZ (multidrug-efflux pump MexXY) are the most frequently observed, with those inactivating the DNA mismatch repair system (MRS) being also highly prevalent in P. aeruginosa CF isolates, leading to hypermutator phenotypes that could contribute to this adaptive mutagenesis by virtue of an increased mutation rate. Here, we characterized the mutations found in the mucA, lasR, mexZ and MRS genes in P. aeruginosa isolates obtained from Argentinean CF patients, and analyzed the potential association of mucA, lasR and mexZ mutagenesis with MRS-deficiency and antibiotic resistance. Thus, 38 isolates from 26 chronically infected CF patients were characterized for their phenotypic traits, PFGE genotypic patterns, mutations in the mucA, lasR, mexZ, mutS and mutL gene coding sequences and antibiotic resistance profiles. The most frequently mutated gene was mexZ (79%), followed by mucA (63%) and lasR (39%) as well as a high prevalence (42%) of hypermutators being observed due to loss-of-function mutations in mutL (60%) followed by mutS (40%). Interestingly, mutational spectra were particular to each gene, suggesting that several mechanisms are responsible for mutations during chronic infection. However, no link could be established between hypermutability and mutagenesis in mucA, lasR and mexZ, indicating that MRS-deficiency was not involved in the acquisition of these mutations. Finally, although inactivation of mucA, lasR and mexZ has been previously shown to confer resistance/tolerance to antibiotics, only mutations in MRS genes could be related to an antibiotic resistance increase. These results help to unravel the mutational dynamics that lead to the adaptation of P. aeruginosa to the CF lung.	[Feliziani, Sofia; Lujan, Adela M.; Moyano, Alejandro J.; Argarana, Carlos E.; Smania, Andrea M.] Univ Nacl Cordoba, CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Sola, Claudia; Bocco, Jose L.] Univ Nacl Cordoba, CIBICI, CONICET, Dept Bioquim Clin,Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Montanaro, Patricia] Hosp Ninos Santisima Trinidad, Cordoba, Argentina; [Fernandez Canigia, Liliana] Hosp Aleman, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Hospital Aleman; University of Buenos Aires	Feliziani, S (corresponding author), Univ Nacl Cordoba, CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	asmania@mail.fcq.unc.edu.ar	Smania, Andrea/AAG-1105-2022; Smania, Andrea/AFK-2800-2022; Lujan, Adela M/K-6707-2015; Moyano, Alejandro/AAB-9092-2019	Moyano, Alejandro/0000-0002-4976-7611; Bocco, Jose Luis/0000-0002-9682-1270; Smania, Andrea/0000-0002-6527-7719; Lujan, Adela Maria/0000-0002-0365-6828	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT-2005-33589, PICT-2007-00687]; Secretaria de Ciencia y Tecnica [05/C486]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT))	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) Grants PICT-2005-33589 and PICT-2007-00687 (http://www.agencia.gov.ar/), and Secretaria de Ciencia y Tecnica (SECYT-UNC) Grant 05/C486 (http://www.secyt.unc.edu.ar/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH AL, 1995, J CLIN MICROBIOL, V33, P37, DOI 10.1128/JCM.33.1.37-40.1995; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Ferroni A, 2009, PEDIATR PULM, V44, P820, DOI 10.1002/ppul.21076; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1978, J ANTIMICROB CHEMOTH, V4, P233, DOI 10.1093/jac/4.3.233; Gutierrez O, 2004, ANTIMICROB AGENTS CH, V48, P3573, DOI 10.1128/AAC.48.9.3573-3575.2004; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hogardt M, 2006, INT J MED MICROBIOL, V296, P313, DOI 10.1016/j.ijmm.2005.12.018; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jacquelin DK, 2005, BIOCHEM J, V388, P879, DOI 10.1042/BJ20042073; Kenna DT, 2007, MICROBIOL-SGM, V153, P1852, DOI 10.1099/mic.0.2006/005082-0; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Levy DD, 2001, MUTAT RES-FUND MOL M, V474, P1, DOI 10.1016/S0027-5107(00)00169-X; Lujan AM, 2007, MICROBIOL-SGM, V153, P225, DOI 10.1099/mic.0.29021-0; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Macia MD, 2004, ANTIMICROB AGENTS CH, V48, P2665, DOI 10.1128/AAC.48.7.2665-2672.2004; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Mandsberg LF, 2009, ANTIMICROB AGENTS CH, V53, P2483, DOI 10.1128/AAC.00428-08; MARTIN C, 1995, J CLIN MICROBIOL, V33, P1461, DOI 10.1128/JCM.33.6.1461-1466.1995; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Moyano AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008203; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Pezza RJ, 2002, NUCLEIC ACIDS RES, V30, P4700, DOI 10.1093/nar/gkf606; Pezza RJ, 2002, BIOCHEM J, V361, P87, DOI 10.1042/0264-6021:3610087; Plasencia V, 2007, ANTIMICROB AGENTS CH, V51, P2574, DOI 10.1128/AAC.00174-07; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Romling U, 2000, J CLIN MICROBIOL, V38, P464; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; Shaver AC, 2002, GENETICS, V162, P557; Smania AM, 2004, MICROBIOL-SGM, V150, P1327, DOI 10.1099/mic.0.26751-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Taddei F, 1997, TRENDS MICROBIOL, V5, P427, DOI 10.1016/S0966-842X(97)01157-8; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004; Waine DJ, 2008, J CLIN MICROBIOL, V46, P3491, DOI 10.1128/JCM.00357-08; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975	62	69	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12669	10.1371/journal.pone.0012669	http://dx.doi.org/10.1371/journal.pone.0012669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844762	gold, Green Published, Green Submitted			2022-12-25	WOS:000281687300013
J	Lee, DH; Singh, P; Tsark, WMK; Szabo, PE				Lee, Dong-Hoon; Singh, Purnima; Tsark, Walter M. K.; Szabo, Piroska E.			Complete Biallelic Insulation at the H19/Igf2 Imprinting Control Region Position Results in Fetal Growth Retardation and Perinatal Lethality	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; SILVER-RUSSELL-SYNDROME; BETA-GLOBIN INSULATOR; DIRECT REPEAT ELEMENT; CTCF BINDING-SITES; TRANSCRIPTION FACTOR; METHYLATION IMPRINT; DNA METHYLATION; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL METHYLATION	Background: The H19/Igf2 imprinting control region (ICR) functions as an insulator exclusively in the unmethylated maternal allele, where enhancer-blocking by CTCF protein prevents the interaction between the Igf2 promoter and the distant enhancers. DNA methylation inhibits CTCF binding in the paternal ICR allele. Two copies of the chicken b-globin insulator (Ch beta GI)(2) are capable of substituting for the enhancer blocking function of the ICR. Insulation, however, now also occurs upon paternal inheritance, because unlike the H19 ICR, the (Ch beta GI)(2) does not become methylated in fetal male germ cells. The (Ch beta GI)(2) is a composite insulator, exhibiting enhancer blocking by CTCF and chromatin barrier functions by USF1 and VEZF1. We asked the question whether these barrier proteins protected the (Ch beta GI)(2) sequences from methylation in the male germ line. Methodology/Principal Findings: We genetically dissected the Ch beta GI in the mouse by deleting the binding sites USF1 and VEZF1. The methylation of the mutant versus normal (Ch beta GI)(2) significantly increased from 11% to 32% in perinatal male germ cells, suggesting that the barrier proteins did have a role in protecting the (Ch beta GI)(2) from methylation in the male germ line. Contrary to the H19 ICR, however, the mutant (mCh beta GI)(2) lacked the potential to attain full de novo methylation in the germ line and to maintain methylation in the paternal allele in the soma, where it consequently functioned as a biallelic insulator. Unexpectedly, a stricter enhancer blocking was achieved by CTCF alone than by a combination of the CTCF, USF1 and VEZF1 sites, illustrated by undetectable Igf2 expression upon paternal transmission. Conclusions/Significance: In this in vivo model, hypomethylation at the ICR position together with fetal growth retardation mimicked the human Silver-Russell syndrome. Importantly, late fetal/perinatal death occurred arguing that strict biallelic insulation at the H19/Igf2 ICR position is not tolerated in development.	[Lee, Dong-Hoon; Singh, Purnima; Szabo, Piroska E.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Tsark, Walter M. K.] City Hope Natl Med Ctr, Transgenic Mouse Facil, Duarte, CA 91010 USA	City of Hope; City of Hope	Lee, DH (corresponding author), City Hope Natl Med Ctr, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	pszabo@coh.org		Szabo, Piroska/0000-0001-9314-7009; Singh, Purnima/0000-0002-4968-7398	National Institute of General Medical Sciences [GM064378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064378] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grant GM064378 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Beechey CV, 1997, MAMM GENOME, V8, P236, DOI 10.1007/s003359900400; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bowman AB, 2003, MOL CELL BIOL, V23, P8345, DOI [10.1128/MCB.23.22.8345-8351.2003, 10.1128/mcb.23.22.8345-8351.2003]; Bruce S, 2009, J CLIN ENDOCR METAB, V94, P579, DOI 10.1210/jc.2008-1805; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CLARK SP, 1990, NUCLEIC ACIDS RES, V18, P5119, DOI 10.1093/nar/18.17.5119; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Dilworth MR, 2010, P NATL ACAD SCI USA, V107, P3894, DOI 10.1073/pnas.0911710107; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Eggermann T, 2008, TRENDS GENET, V24, P195, DOI 10.1016/j.tig.2008.01.003; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gebert C, 2010, MOL CELL BIOL, V30, P1108, DOI 10.1128/MCB.00575-09; Gerasimova TI, 1996, CURR OPIN GENET DEV, V6, P185, DOI 10.1016/S0959-437X(96)80049-9; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Han L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000803; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Haun WJ, 2008, PLANT J, V56, P903, DOI 10.1111/j.1365-313X.2008.03649.x; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jurinke C, 2005, MUTAT RES-FUND MOL M, V573, P83, DOI 10.1016/j.mrfmmm.2005.01.007; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; Katz DJ, 2005, MOL CELL BIOL, V25, P3855, DOI 10.1128/MCB.25.10.3855-3863.2005; Kawahara M, 2007, FEBS LETT, V581, P5178, DOI 10.1016/j.febslet.2007.10.004; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099, DOI 10.1128/MCB.14.8.5099; Kuhnert F, 2005, DEV BIOL, V283, P140, DOI 10.1016/j.ydbio.2005.04.003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lewis A, 2004, MOL CELL BIOL, V24, P5650, DOI 10.1128/MCB.24.13.5650-5656.2004; LEWIS CD, 1988, GENE DEV, V2, P863, DOI 10.1101/gad.2.7.863; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Park KY, 2004, MOL CELL BIOL, V24, P3588, DOI 10.1128/MCB.24.9.3588-3595.2004; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Reed MR, 2001, MAMM GENOME, V12, P873, DOI 10.1007/s00335-001-2027-9; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; Reinhart B, 2002, MOL CELL BIOL, V22, P2089, DOI 10.1128/MCB.22.7.2089-2098.2002; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; Srivastava M, 2000, GENE DEV, V14, P1186; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; Szabo PE, 2006, CYTOGENET GENOME RES, V113, P238, DOI 10.1159/000090838; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Szabo PE, 2002, DEVELOPMENT, V129, P897; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tanimoto K, 2005, P NATL ACAD SCI USA, V102, P10250, DOI 10.1073/pnas.0409541102; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; UEDA T, 1992, DEVELOPMENT, V116, P831; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Xiong JW, 1999, DEV BIOL, V206, P123, DOI 10.1006/dbio.1998.9144	89	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12630	10.1371/journal.pone.0012630	http://dx.doi.org/10.1371/journal.pone.0012630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838620	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687100011
J	Gilbert, GL; Cretikos, MA; Hueston, L; Doukas, G; O'Toole, B; Dwyer, DE				Gilbert, Gwendolyn L.; Cretikos, Michelle A.; Hueston, Linda; Doukas, George; O'Toole, Brian; Dwyer, Dominic E.			Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter	PLOS ONE			English	Article							INFECTION; SAMPLE	Background: The first wave of pandemic influenza A(H1N1) 2009 (pH1N1) reached New South Wales (NSW), Australia in May 2009, and led to high rates of influenza-related hospital admission of infants and young to middle-aged adults, but no increase in influenza-related or all-cause mortality. Methodology/Principal Findings: To assess the population rate of pH1N1 infection in NSW residents, pH1N1-specific haemagglutination inhibition (HI) antibody prevalence was measured in specimens collected opportunistically before (2007-2008; 474 specimens) and after (August-September 2009; 1247 specimens) the 2009 winter, and before the introduction of the pH1N1 monovalent vaccine. Age-and geographically-weighted population changes in seroprevalence were calculated. HI antibodies against four recent seasonal influenza A viruses were measured to assess cross-reactions. Pre- and post-pandemic pH1N1 seroprevalences were 12.8%, and 28.4%, respectively, with an estimated overall infection rate of 15.6%. pH1N1 antibody prevalence increased significantly -20.6% overall -in people born since 1944 (26.9% in those born between 1975 and 1997) but not in those born in or before 1944. People born before 1925 had a significantly higher pH1N1 seroprevalence than any other age-group, and against any seasonal influenza A virus. Sydney residents had a significantly greater change in prevalence of antibodies against pH1N1 than other NSW residents (19.3% vs 9.6%). Conclusions/Significance: Based on increases in the pH1N1 antibody prevalence before and after the first pandemic wave, 16% of NSW residents were infected by pH1N1 in 2009; the highest infection rates (27%) were among adolescents and young adults. Past exposure to the antigenically similar influenza A/H1N1(1918) is the likely basis for a very high prevalence (49%) of prepandemic cross-reacting pH1N1 antibody and sparing from pH1N1 infection among people over 85 years. Unless pre-season vaccine uptake is high, there are likely to be at least moderate rates including some life-threatening cases of pH1N1 infection among young people during subsequent winters.	[Gilbert, Gwendolyn L.; Hueston, Linda; O'Toole, Brian; Dwyer, Dominic E.] Univ Sydney, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia; [Cretikos, Michelle A.; Doukas, George] New S Wales Dept Hlth, Ctr Epidemiol & Res, Sydney, NSW, Australia; [Cretikos, Michelle A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney	Gilbert, GL (corresponding author), Univ Sydney, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia.	lyn.gilbert@sydney.edu.au	Gilbert, Gwendolyn/B-7733-2013; O'Toole, Brian/G-9366-2011	Gilbert, Gwendolyn/0000-0001-7490-6727; O'Toole, Brian/0000-0002-3825-0772	Population Health Division of the New South Wales Department of Health Australia; NSW Department of Health	Population Health Division of the New South Wales Department of Health Australia; NSW Department of Health	This study was funded by the Population Health Division of the New South Wales Department of Health Australia. The study sponsor represented by author Michelle Cretikos, had a major role in study design, analysis and interpretation of data and preparation of the manuscript. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication.; Michelle Cretikos is employed by the NSW Department of Health, which funded the study. She owns shares in CSL Ltd, which manufactures influenza vaccines. None of the other authors have any conflicts of interest.	Australian Bureau of Statistics, 2006, STAT GEOGR, V1; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Blyth CC, 2010, EURO SURVEILL, V15; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Efron B., 1993, INTRO BOOTSTRAP, P168; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gelman A, 2001, SURVEY NONRESPONSE, P289; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EURO SURVEILL, V15; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Izrael D., 2004, 29 ANN SAS US GROUP, P207; Janjua NZ, 2010, LANCET, V375, P801, DOI 10.1016/S0140-6736(10)60338-8; Janjua NZ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4972; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Kelly HA, 2010, MED J AUSTRALIA, V192, P81, DOI 10.5694/j.1326-5377.2010.tb03423.x; Lohr S. L., 1999, SAMPLING DESIGN ANAL, P265; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *NSW PUBL HLTH NET, 2009, EURO SURVEILL, V14; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Stephan FF, 1942, ANN MATH STAT, V13, P166, DOI 10.1214/aoms/1177731604; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	26	81	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12562	10.1371/journal.pone.0012562	http://dx.doi.org/10.1371/journal.pone.0012562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830210	Green Submitted, Green Published, gold			2022-12-25	WOS:000281631300004
J	Poulou, M; Bell, D; Bozonelos, K; Alexiou, M; Gavalas, A; Lovell-Badge, R; Remboutsika, E				Poulou, Maria; Bell, Donald; Bozonelos, Kostas; Alexiou, Maria; Gavalas, Anthony; Lovell-Badge, Robin; Remboutsika, Eumorphia			Development of a Chromosomally Integrated Metabolite-Inducible Leu3p-alpha-IPM "Off-On'' Gene Switch	PLOS ONE			English	Article							MAMMALIAN-CELLS; TRANSGENIC MICE; ALPHA-ISOPROPYLMALATE; LEUCINE BIOSYNTHESIS; CRE RECOMBINASE; IN-VITRO; EXPRESSION; YEAST; SYSTEM; LEU3P	Background: Present technology uses mostly chimeric proteins as regulators and hormones or antibiotics as signals to induce spatial and temporal gene expression. Methodology/Principal Findings: Here, we show that a chromosomally integrated yeast 'Leu3p-alpha-IRM' system constitutes a ligand-inducible regulatory "off-on'' genetic switch with an extensively dynamic action area. We find that Leu3p acts as an active transcriptional repressor in the absence and as an activator in the presence of alpha-isopropylmalate (alpha-IRM) in primary fibroblasts isolated from double transgenic mouse embryos bearing ubiquitously expressing Leu3p and a Leu3p regulated GFP reporter. In the absence of the branched amino acid biosynthetic pathway in animals, metabolically stable alpha-IPM presents an EC(50) equal to 0.8837 mM and fast "OFF-ON" kinetics (t(50)ON = 43 min, t(50)OFF = 2.18 h), it enters the cells via passive diffusion, while it is non-toxic to mammalian cells and to fertilized mouse eggs cultured ex vivo. Conclusions/Significance: Our results demonstrate that the `Leu3p-alpha-IPM' constitutes a simpler and safer system for inducible gene expression in biomedical applications.	[Poulou, Maria; Remboutsika, Eumorphia] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Stem Cell Biol Lab, Attica, Greece; [Bell, Donald; Lovell-Badge, Robin; Remboutsika, Eumorphia] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Bozonelos, Kostas; Alexiou, Maria] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Transgen Unit, Attica, Greece; [Gavalas, Anthony] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England	Alexander Fleming Biomedical Sciences Research Center; MRC National Institute for Medical Research; Alexander Fleming Biomedical Sciences Research Center; MRC National Institute for Medical Research	Poulou, M (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Stem Cell Biol Lab, Attica, Greece.	remboutsika@fleming.gr	Gavalas, Anthony/F-5817-2015; Remboutsika, Eumorphia/L-2718-2019	Remboutsika, Eumorphia/0000-0002-1243-9569; Bell, Donald/0000-0002-3788-1580; Gavalas, Anthony/0000-0003-4897-0359; Lovell-Badge, Robin/0000-0001-9364-4179	Greek Secretariat for Research and Technology of Greece [PENED 03ED394]; Medical Research Council (UK) [U117512772]; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	Greek Secretariat for Research and Technology of Greece; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Greek Secretariat for Research and Technology (PENED 03ED394) of Greece (www.gsrt.gr) and the Medical Research Council (UK) www.nimr.mrc.ac.uk (MRC file reference U117512772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrand PO, 1998, NUCLEIC ACIDS RES, V26, P3263, DOI 10.1093/nar/26.13.3263; Aubel D, 2001, J ANTIBIOT, V54, P44, DOI 10.7164/antibiotics.54.44; Auricchio A, 2002, MOL THER, V6, P238, DOI 10.1006/mthe.2002.0660; BAICHWAL VR, 1983, CURR GENET, V7, P369, DOI 10.1007/BF00445877; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Chiba H, 2000, EXP CELL RES, V260, P334, DOI 10.1006/excr.2000.5022; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gao X, 1999, NEUROCHEM RES, V24, P1181, DOI 10.1023/A:1020772706279; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guo H, 1996, FEBS LETT, V390, P191, DOI 10.1016/0014-5793(96)00653-9; Hong SB, 2006, LAB INVEST, V86, P664, DOI 10.1038/labinvest.3700431; Hummel Thomas, 2008, V420, P97, DOI 10.1007/978-1-59745-583-1_6; Jaisser F, 2000, J AM SOC NEPHROL, V11, pS95; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Magari SR, 1997, J CLIN INVEST, V100, P2865, DOI 10.1172/JCI119835; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Meissner U, 2003, PHARMACOLOGY, V69, P74, DOI 10.1159/000072359; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; OPAS J, 1977, J EMBRYOL EXP MORPH, V37, P65; REMBOUTSIKA E, 1994, MOL CELL BIOL, V14, P5547, DOI 10.1128/MCB.14.8.5547; Remboutsika E., 1994, THESIS PURDUE U US; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SPRENGEL R, 2007, HDB EXPT PHARM; SZE JY, 1993, MOL CELL BIOL, V13, P5702, DOI 10.1128/MCB.13.9.5702; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Wang D, 1999, J BIOL CHEM, V274, P19017, DOI 10.1074/jbc.274.27.19017; Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47	33	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12488	10.1371/journal.pone.0012488	http://dx.doi.org/10.1371/journal.pone.0012488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824215	Green Submitted, gold, Green Published			2022-12-25	WOS:000281405300014
J	Batt, SM; Jabeen, T; Mishra, AK; Veerapen, N; Krumbach, K; Eggeling, L; Besra, GS; Futterer, K				Batt, Sarah M.; Jabeen, Talat; Mishra, Arun K.; Veerapen, Natacha; Krumbach, Karin; Eggeling, Lothar; Besra, Gurdyal S.; Fuetterer, Klaus			Acceptor Substrate Discrimination in Phosphatidyl-myo-inositol Mannoside Synthesis STRUCTURAL AND MUTATIONAL ANALYSIS OF MANNOSYLTRANSFERASE CORYNEBACTERIUM GLUTAMICUM PimB '	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; PIMA; IDENTIFICATION; REFINEMENT; CATALYSIS; INSIGHTS; SYNTHASE; REVEALS	Long term survival of the pathogen Mycobacterium tuberculosis in humans is linked to the immunomodulatory potential of its complex cell wall glycolipids, which include the phosphatidylinositol mannoside (PIM) series as well as the related lipomannan and lipoarabinomannan glycoconjugates. PIM biosynthesis is initiated by a set of cytosolic alpha-mannosyltransferases, catalyzing glycosyl transfer from the activated saccharide donor GDP-alpha-D-mannopyranose to the acceptor phosphatidyl-myoinositol (PI) in an ordered and regio-specific fashion. Herein, we report the crystal structure of mannosyltransferase Corynebacterium glutamicum PimB' in complex with nucleotide to a resolution of 2.0 A. PimB' attaches mannosyl selectively to the 6-OH of the inositol moiety of PI. Two crystal forms and GD-Pversus GDP-alpha-D-mannopyranose-bound complexes reveal flexibility of the nucleotide conformation as well as of the structural framework of the active site. Structural comparison, docking of the saccharide acceptor, and site-directed mutagenesis pin regio-selectivity to a conserved Asp residue in the N-terminal domain that forces presentation of the correct inositol hydroxyl to the saccharide donor.	[Batt, Sarah M.; Jabeen, Talat; Mishra, Arun K.; Veerapen, Natacha; Besra, Gurdyal S.; Fuetterer, Klaus] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Krumbach, Karin; Eggeling, Lothar] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	University of Birmingham; Helmholtz Association; Research Center Julich	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	G.Besra@bham.ac.uk; K.Futterer@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395; Futterer, Klaus/0000-0001-7445-5372	Wellcome Trust [081569/Z/06/Z]; Advantage West Midlands through the Birmingham Science City Translational Medicine Platform; James Bardrick; Royal Society; MRC [G0500590] Funding Source: UKRI; Medical Research Council [G0500590] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Advantage West Midlands through the Birmingham Science City Translational Medicine Platform; James Bardrick; Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Wellcome Trust Grant 081569/Z/06/Z, and by Advantage West Midlands through the Birmingham Science City Translational Medicine Platform.; Recipient of support in the form of a Personal Research Chair from James Bardrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow. To whom correspondence may be addressed: School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Tel.: 44-121-4145895; Fax: 44-121-4145925; E-mail: G. Besra@bham.ac.uk.	Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Collier A, 2008, CHEM COMMUN, P178, DOI 10.1039/b714379f; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dobson G., 1985, CHEM METHODS BACTERI, P237; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Driessen NN, 2009, INFECT IMMUN, V77, P4538, DOI 10.1128/IAI.01256-08; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton GL, 2006, J BIOL CHEM, V281, P33910, DOI 10.1074/jbc.M604724200; Patterson JH, 2003, BIOCHEM J, V372, P77, DOI 10.1042/BJ20021700; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Steiner K, 2010, J MOL BIOL, V397, P436, DOI 10.1016/j.jmb.2010.01.035; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	54	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37741	37752		10.1074/jbc.M110.165407	http://dx.doi.org/10.1074/jbc.M110.165407			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20843801	Green Published, hybrid			2022-12-25	WOS:000284424000066
J	Steinberg, F; Gerber, SD; Rieckmann, T; Trueb, B				Steinberg, Florian; Gerber, Simon D.; Rieckmann, Thorsten; Trueb, Beat			Rapid Fusion and Syncytium Formation of Heterologous Cells upon Expression of the FGFRL1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MYOBLAST FUSION; MACROPHAGE MULTINUCLEATION; MEMBRANE-FUSION; C-ELEGANS; DROSOPHILA; PROTEIN; GENE; MICE; DISRUPTION	The fusion of mammalian cells into syncytia is a developmental process that is tightly restricted to a limited subset of cells. Besides gamete and placental trophoblast fusion, only macrophages and myogenic stem cells fuse into multinucleated syncytia. In contrast to viral cell fusion, which is mediated by fusogenic glycoproteins that actively merge membranes, mammalian cell fusion is poorly understood at the molecular level. A variety of mammalian transmembrane proteins, among them many of the immunoglobulin superfamily, have been implicated in cell-cell fusion, but none has been shown to actively fuse cells in vitro. Here we report that the FGFRL1 receptor, which is up-regulated during the differentiation of myoblasts into myotubes, fuses cultured cells into large, multinucleated syncytia. We used luciferase and GFP-based reporter assays to confirm cytoplasmic mixing and to identify the fusion inducing domain of FGFRL1. These assays revealed that Ig-like domain III and the transmembrane domain are both necessary and sufficient to rapidly fuse CHO cells into multinucleated syncytia comprising several hundred nuclei. Moreover, FGFRL1 also fused HEK293 and HeLa cells with untransfected CHO cells. Our data show that FGFRL1 is the first mammalian protein that is capable of inducing syncytium formation of heterologous cells in vitro.	[Steinberg, Florian; Gerber, Simon D.; Trueb, Beat] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Rieckmann, Thorsten] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, D-20246 Hamburg, Germany; [Trueb, Beat] Univ Hosp Bern, Dept Rheumatol, CH-3010 Bern, Switzerland	University of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; University Hospital of Bern	Trueb, B (corresponding author), Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland.	beat.trueb@dkf.unibe.ch	Trueb, Beat/AAL-9621-2020	Trueb, Beat/0000-0001-8684-6856; Rieckmann, Thorsten/0000-0001-8426-107X	Swiss National Science Foundation [31003A-127046]; Swiss Foundation for Research on Muscular Diseases; Olga Mayenfisch Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscular Diseases; Olga Mayenfisch Foundation	This study was supported by grants from the Swiss National Science Foundation (31003A-127046) and the Swiss Foundation for Research on Muscular Diseases as well as by the Olga Mayenfisch Foundation.	Artero RD, 2001, DEVELOPMENT, V128, P4251; Baertschi S, 2007, FEBS J, V274, P6241, DOI 10.1111/j.1742-4658.2007.06143.x; Berger S, 2008, J CELL SCI, V121, P1303, DOI 10.1242/jcs.022269; Bertrand S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-226; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Gildor B, 2009, EMBO REP, V10, P1043, DOI 10.1038/embor.2009.129; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huerta L, 2002, CYTOMETRY, V47, P100, DOI 10.1002/cyto.10051; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McShane Marisa P, 2005, Methods Mol Biol, V292, P187; O'Donnell CD, 2009, J BIOL CHEM, V284, P29654, DOI 10.1074/jbc.M109.037960; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Richardson BE, 2008, TRAFFIC, V9, P1050, DOI 10.1111/j.1600-0854.2008.00756.x; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Trueb B, 2006, INT J MOL MED, V17, P617; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Zhuang L, 2010, EXP THER MED, V1, P161, DOI 10.3892/etm_00000026	40	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37704	37715		10.1074/jbc.M110.140517	http://dx.doi.org/10.1074/jbc.M110.140517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851884	Green Published, hybrid			2022-12-25	WOS:000284424000062
J	Abdelkarim, M; Caron, S; Duhem, C; Prawitt, J; Dumont, J; Lucas, A; Bouchaert, E; Briand, O; Brozek, J; Kuipers, F; Fievet, C; Cariou, B; Staels, B				Abdelkarim, Mouaadh; Caron, Sandrine; Duhem, Christian; Prawitt, Janne; Dumont, Julie; Lucas, Anthony; Bouchaert, Emmanuel; Briand, Olivier; Brozek, John; Kuipers, Folkert; Fievet, Catherine; Cariou, Bertrand; Staels, Bart			The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-gamma and Interfering with the Wnt/beta-Catenin Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; BILE-ACIDS; ADIPOGENESIS; BETA; EXPRESSION; LIGANDS; PROTEIN; IDENTIFICATION; FIBROBLASTS; MYC	The bile acid receptor farnesoid X receptor (FXR) is expressed in adipose tissue, but its function remains poorly defined. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a master regulator of adipocyte differentiation and function. The aim of this study was to analyze the role of FXR in adipocyte function and to assess whether it modulates PPAR gamma action. Therefore, we tested the responsiveness of FXR-deficient mice (FXR-/-) and cells to the PPAR gamma activator rosiglitazone. Our results show that genetically obese FXR-/-/ob/ob mice displayed a resistance to rosiglitazone treatment. In vitro, rosiglitazone treatment did not induce normal adipocyte differentiation and lipid droplet formation in FXR-/- mouse embryonic fibroblasts (MEFs) and preadipocytes. Moreover, FXR-/- MEFs displayed both an increased lipolysis and a decreased de novo lipogenesis, resulting in reduced intracellular triglyceride content, even upon PPAR gamma activation. Retroviral-mediated FXR re-expression in FXR-/- MEFs restored the induction of adipogenic marker genes during rosiglitazone-forced adipocyte differentiation. The expression of Wnt/beta-catenin pathway and target genes was increased in FXR-/- adipose tissue and MEFs. Moreover, the expression of several endogenous inhibitors of this pathway was decreased early during the adipocyte differentiation of FXR-/- MEFs. These findings demonstrate that FXR regulates adipocyte differentiation and function by regulating two counteracting pathways of adipocyte differentiation, the PPAR gamma and Wnt/beta-catenin pathways.	[Staels, Bart] Inst Pasteur, INSERM, UMR1011, F-59019 Lille, France; [Abdelkarim, Mouaadh; Caron, Sandrine; Duhem, Christian; Prawitt, Janne; Dumont, Julie; Lucas, Anthony; Bouchaert, Emmanuel; Briand, Olivier; Fievet, Catherine; Cariou, Bertrand; Staels, Bart] Univ Lille Nord France, F-59000 Lille, France; [Abdelkarim, Mouaadh; Caron, Sandrine; Duhem, Christian; Prawitt, Janne; Dumont, Julie; Lucas, Anthony; Bouchaert, Emmanuel; Briand, Olivier; Fievet, Catherine; Cariou, Bertrand; Staels, Bart] Univ Lille 2, F-59000 Lille, France; [Brozek, John] Genfit, F-59120 Loos, France; [Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab, NL-9713 GZ Groningen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Groningen	Staels, B (corresponding author), Inst Pasteur, INSERM, UMR1011, 1 Rue Prof Calmette,BP245, F-59019 Lille, France.	Bart.Staels@pasteur-lille.fr	Briand, Olivier/AGV-1669-2022; BOUCHAERT, Emmanuel/AFU-7112-2022; CARON, Sandrine/R-6624-2018; Staels, Bart/N-9497-2016	Briand, Olivier/0000-0003-2979-0395; BOUCHAERT, Emmanuel/0000-0003-2558-9862; CARON, Sandrine/0000-0002-4660-7436; Staels, Bart/0000-0002-3784-1503; Dumont, Julie/0000-0001-5893-0022; Abdelkarim, Mouaadh/0000-0003-3538-2566; Kuipers, Folkert/0000-0003-2518-737X; Duhem, Christian/0000-0003-0931-3815; Cariou, Bertrand/0000-0002-1580-8040	European Union [HEPADIP 018734]; Agence Nationale de la Recherche [A05056GS]; Fondation pour la Recherche Medicale; COST Action [BM0602]	European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); COST Action(European Cooperation in Science and Technology (COST))	This work was supported by European Union Grant HEPADIP 018734, COST Action Grant BM0602, and Agence Nationale de la Recherche Grant A05056GS. This work was also supported by a grant from the Fondation pour la Recherche Medicale (to M. A.).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bhat RA, 2004, PROTEIN EXPRES PURIF, V37, P327, DOI 10.1016/j.pep.2004.06.029; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cariou B, 2007, FEBS LETT, V581, P5191, DOI 10.1016/j.febslet.2007.09.064; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fiorucci S, 2005, J PHARMACOL EXP THER, V315, P58, DOI 10.1124/jpet.105.085597; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	42	67	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36759	36767		10.1074/jbc.M110.166231	http://dx.doi.org/10.1074/jbc.M110.166231			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851881	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000284146100011
J	Lazarou, M; Stojanovski, D; Frazier, AE; Kotevski, A; Dewson, G; Craigen, WJ; Kluck, RM; Vaux, DL; Ryan, MT				Lazarou, Michael; Stojanovski, Diana; Frazier, Ann E.; Kotevski, Aneta; Dewson, Grant; Craigen, William J.; Kluck, Ruth M.; Vaux, David L.; Ryan, Michael T.			Inhibition of Bak Activation by VDAC2 Is Dependent on the Bak Transmembrane Anchor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; GENERAL IMPORT PORE; CYTOCHROME-C; ANION CHANNEL; MAMMALIAN MITOCHONDRIA; OLIGOMERIZES BAK; PROTEIN IMPORT; CELL-DEATH; COMPLEX-I; APOPTOSIS	Bax and Bak are pro-apoptotic factors that are required for cell death by the mitochondrial or intrinsic pathway. Bax is found in an inactive state in the cytosol and upon activation is targeted to the mitochondrial outer membrane where it releases cytochrome c and other factors that cause caspase activation. Although Bak functions in the same way as Bax, it is constitutively localized to the mitochondrial outer membrane. In the membrane, Bak activation is inhibited by the voltage-dependent anion channel isoform 2 (VDAC2) by an unknown mechanism. Using blue native gel electrophoresis, we show that in healthy cells endogenous inactive Bak exists in a 400-kDa complex that is dependent on the presence of VDAC2. Activation of Bak is concomitant with its release from the 400-kDa complex and the formation of lower molecular weight species. Furthermore, substitution of the Bak transmembrane anchor with that of the mitochondrial outer membrane tail-anchored protein hFis1 prevents association of Bak with the VDAC2 complex and increases the sensitivity of cells to an apoptotic stimulus. Our results suggest that VDAC2 interacts with the hydrophobic tail of Bak to sequester it in an inactive state in the mitochondrial outer membrane, thereby raising the stimulation threshold necessary for permeabilization of the mitochondrial outer membrane and cell death.	[Ryan, Michael T.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Stojanovski, Diana; Ryan, Michael T.] La Trobe Univ, Ctr Excellence Coherent Xray Sci, Bundoora, Vic 3086, Australia; [Dewson, Grant; Kluck, Ruth M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Craigen, William J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	La Trobe University; La Trobe University; Walter & Eliza Hall Institute; Baylor College of Medicine	Ryan, MT (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia.	M.Ryan@latrobe.edu.au	Ryan, Michael/X-2152-2019; Ryan, Michael T/C-6673-2011; Lazarou, Michael/G-7143-2011; Vaux, David L/C-7249-2013; Kluck, Ruth M/C-8413-2013; dewson, grant/C-7646-2013	Ryan, Michael/0000-0003-2586-8829; Ryan, Michael T/0000-0003-2586-8829; Vaux, David L/0000-0003-2703-1651; Kluck, Ruth M/0000-0002-7101-1925; dewson, grant/0000-0003-4251-8898; Lazarou, Michael/0000-0003-2150-5545; Stojanovski, Diana/0000-0002-0199-3222; Frazier, Ann/0000-0002-6491-3437	National Health and Medical Research Council; Association for International Cancer Research; Clive and Vera Ramaciotti Foundation; Australian Research Council Centre of Excellence for Coherent X-ray Science; Australian Research Council; La Trobe University	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; Clive and Vera Ramaciotti Foundation; Australian Research Council Centre of Excellence for Coherent X-ray Science(Australian Research Council); Australian Research Council(Australian Research Council); La Trobe University	This work was supported in part by grants from the National Health and Medical Research Council, Association for International Cancer Research, the Clive and Vera Ramaciotti Foundation, and the Australian Research Council Centre of Excellence for Coherent X-ray Science.; Supported by an Australian Research Council postdoctoral fellowship.; Supported by a La Trobe University postdoctoral fellowship. Present address: Murdoch Childrens Research Institute, Royal Children's Hospital, 3052 Melbourne, Australia.	Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kozjak-Pavlovic V, 2010, J MOL BIOL, V397, P219, DOI 10.1016/j.jmb.2010.01.047; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LITHGOW T, 1993, FEBS LETT, V332, P277, DOI 10.1016/0014-5793(93)80649-F; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Ren DC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000274; Ross K, 2009, CELL DEATH DIFFER, V16, P697, DOI 10.1038/cdd.2008.194; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31	55	71	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36876	36883		10.1074/jbc.M110.159301	http://dx.doi.org/10.1074/jbc.M110.159301			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851889	hybrid, Green Published			2022-12-25	WOS:000284146100014
J	Nishioka, T; Frohman, MA; Matsuda, M; Kiyokawa, E				Nishioka, Teruko; Frohman, Michael A.; Matsuda, Michiyuki; Kiyokawa, Etsuko			Heterogeneity of Phosphatidic Acid Levels and Distribution at the Plasma Membrane in Living Cells as Visualized by a Forster Resonance Energy Transfer (FRET) Biosensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D ACTIVITY; PROTEIN-KINASE-C; STIMULATED PC12 CELLS; HUMAN CANCER-CELLS; TYROSINE PHOSPHORYLATION; RECEPTOR ENDOCYTOSIS; TRANSFORMED CELLS; ACTIVATION; RAS; DYNAMICS	Phosphatidic acid (PA) is one of the major phospholipids in the plasma membrane. Although it has been reported that PA plays key roles in cell survival and morphology, it remains unknown when and where PA is produced in the living cell. Based on the principle of Forster resonance energy transfer (FRET), we generated PA biosensor, and named Pii (phosphatidic acid indicator). In these biosensors, the lipid-binding domain of DOCK2 is sandwiched with the cyan fluorescent protein and yellow fluorescent protein and is tagged with the plasma membrane-targeting sequence of K-Ras. The addition of synthetic PA, or the activation of phospholipase D or diacylglycerol kinase at the plasma membrane, changed the level of FRET in Pii-expressing cells, demonstrating the response of Pii to PA. The biosensor also detected divergent PA content among various cell lines as well as within one cell line. Interestingly, the growth factor-induced increment in PA content correlated negatively with the basal PA content before stimulation, suggesting the presence of an upper threshold in the PA concentration at the plasma membrane. The biosensor also revealed uneven PA distribution within the cell, i.e. the basal level and growth factor-induced accumulation of PA was higher at the cell-free edges than at the cell-cell contact region. An insufficient increase in PA may account for ineffective Ras activation at areas of cell-cell contact. In conclusion, the PA biosensor Pii is a versatile tool for examining heterogeneity in the content and distribution of PA in single cells as well as among different cells.	[Matsuda, Michiyuki; Kiyokawa, Etsuko] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; [Nishioka, Teruko; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA	Kyoto University; Kyoto University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kiyokawa, E (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kiyokawa@lif.kyoto-u.ac.jp		Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Health [GM0171520, GM084251]; Japan Society for the Promotion of Science for Young Scientists; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported in part by National Institute of Health Awards GM0171520 and GM084251 (to M. A. F.).; Supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kurokawa K, 2001, J BIOL CHEM, V276, P31305, DOI 10.1074/jbc.M104341200; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sung TC, 1999, J BIOL CHEM, V274, P494, DOI 10.1074/jbc.274.1.494; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Yamaguchi Y, 2006, J BIOL CHEM, V281, P31627, DOI 10.1074/jbc.M606992200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	47	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35979	35987		10.1074/jbc.M110.153007	http://dx.doi.org/10.1074/jbc.M110.153007			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826779	Green Published, hybrid			2022-12-25	WOS:000283845300074
J	Pathak, A; Goyal, R; Sinha, A; Sarkar, D				Pathak, Anuj; Goyal, Rajni; Sinha, Akesh; Sarkar, Dibyendu			Domain Structure of Virulence-associated Response Regulator PhoP of Mycobacterium tuberculosis ROLE OF THE LINKER REGION IN REGULATOR-PROMOTER INTERACTION(S)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; TUBERCLE BACILLUS; RECEIVER DOMAIN; OMPR; BIOSYNTHESIS; PHOSPHORYLATION; LIPIDS; HELIX	The PhoP and PhoR proteins from Mycobacterium tuberculosis form a highly specific two-component system that controls expression of genes involved in complex lipid biosynthesis and regulation of unknown virulence determinants. The several functions of PhoP are apportioned between a C-terminal effector domain (PhoPC) and an N-terminal receiver domain (PhoPN), phosphorylation of which regulates activation of the effector domain. Here we show that PhoPN, on its own, demonstrates PhoR-dependent phosphorylation. PhoPC, the truncated variant bearing the DNA binding domain, binds in vitro to the target site with affinity similar to that of the full-length protein. To complement the finding that residues spanning Met(1) to Arg(138) of PhoP constitute the minimal functional PhoPN, we identified Arg(150) as the first residue of the distal PhoPC domain capable of DNA binding on its own, thereby identifying an interdomain linker. However, coupling of two functional domains together in a single polypeptide chain is essential for phosphorylation-coupled DNA binding by PhoP. We discuss consequences of tethering of two domains on DNA binding and demonstrate that linker length and not individual residues of the newly identified linker plays a critical role in regulating interdomain interactions. Together, these results have implications for the molecular mechanism of transmission of conformation change associated with phosphorylation of PhoP that results in the altered DNA recognition by the C-terminal domain.	[Pathak, Anuj; Goyal, Rajni; Sinha, Akesh; Sarkar, Dibyendu] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sarkar, D (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	dibyendu@imtech.res.in			Council of Scientific and Industrial Research (CSIR) Network [NWP-05]; Supra Institutional Project [SIP-10]; Government of India Department of Science and Technology [SR/SO/BB-16/2007]; Department of Biotechnology [BT/PR8545/Med/14/1262/2006]; CSIR; Indian Council for Medical Research	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India); Supra Institutional Project; Government of India Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by Council of Scientific and Industrial Research (CSIR) Network Project NWP-05 and Supra Institutional Project SIP-10 and by Government of India Department of Science and Technology Grant SR/SO/BB-16/2007 and Department of Biotechnology Grant BT/PR8545/Med/14/1262/2006 (both to D. S.).; Predoctoral student supported by a research fellowship from CSIR.; Predoctoral student supported by a research fellowship from the Indian Council for Medical Research.	Allen MP, 2001, J BACTERIOL, V183, P2204, DOI 10.1128/JB.183.7.2204-2211.2001; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; CASON J, 1956, J BIOL CHEM, V220, P893; Chen YH, 2004, J BACTERIOL, V186, P1493, DOI 10.1128/JB.186.5.1493-1502.2004; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1988, EUR J BIOCHEM, V172, P579, DOI 10.1111/j.1432-1033.1988.tb13928.x; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Fontan PA, 2004, CURR SCI INDIA, V86, P122; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Goren M. B., 1979, TUBERCULOSIS, P63; GOREN MB, 1990, HDB LIPID RES, V6, P363; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gupta S, 2006, FEBS LETT, V580, P5328, DOI 10.1016/j.febslet.2006.09.004; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; JANIN J, 1985, C METHODS ENZYMOL, V115, P420; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; MIDDLEBROOK G, 1959, P NATL ACAD SCI USA, V45, P1801, DOI 10.1073/pnas.45.12.1801; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Perron-Savard P, 2005, MICROBIOL-SGM, V151, P3979, DOI 10.1099/mic.0.28236-0; Pragai Z, 2004, J BACTERIOL, V186, P1182, DOI 10.1128/JB.186.4.1182-1190.2004; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Sambrook J., 2002, MOL CLONING LAB MANU; Schulz G. E., 1979, PRINCIPLES PROTEIN S; Sinha A, 2008, J BACTERIOL, V190, P1317, DOI 10.1128/JB.01074-07; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Walthers D, 2003, J BACTERIOL, V185, P317, DOI 10.1128/JB.185.1.317-324.2003; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a	54	16	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34309	34318		10.1074/jbc.M110.135822	http://dx.doi.org/10.1074/jbc.M110.135822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20814030	hybrid, Green Published			2022-12-25	WOS:000283659100004
J	Yampolsky, P; Pacifici, PG; Lomb, L; Giese, G; Rudolf, R; Roder, IV; Witzemann, V				Yampolsky, Pessah; Pacifici, Pier Giorgio; Lomb, Lukas; Giese, Guenter; Rudolf, Ruediger; Roeder, Ira V.; Witzemann, Veit			Time Lapse in Vivo Visualization of Developmental Stabilization of Synaptic Receptors at Neuromuscular Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRAJUNCTIONAL ACETYLCHOLINE-RECEPTORS; TO-EPSILON-SWITCH; SKELETAL-MUSCLE; AMPA RECEPTORS; MYOSIN VA; SUBUNIT; RAPSYN; PHOSPHORYLATION; IDENTIFICATION; DEGRADATION	The lifetime of nicotinic acetylcholine receptors (AChRs) in neuromuscular junctions (NMJs) is increased from < 1 day to > 1 week during early postnatal development. However, the exact timing of AChR stabilization is not known, and its correlation to the concurrent embryonic to adult AChR channel conversion, NMJ remodeling, and neuromuscular diseases is unclear. Using a novel time lapse in vivo imaging technology we show that replacement of the entire receptor population of an individual NMJ occurs end plate-specifically within hours. This makes it possible to follow directly in live animals changing stabilities of end plate receptors. In three different, genetically modified mouse models we demonstrate that the metabolic half-life values of synaptic AChRs increase from a few hours to several days after postnatal day 6. Developmental stabilization is independent of receptor subtype and apparently regulated by an intrinsic muscle-specific maturation program. Myosin Va, an F-actin-dependent motor protein, is also accumulated synaptically during postnatal development and thus could mediate the stabilization of end plate AChR.	[Yampolsky, Pessah; Pacifici, Pier Giorgio; Witzemann, Veit] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Lomb, Lukas] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Giese, Guenter] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; [Rudolf, Ruediger; Roeder, Ira V.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76131 Karlsruhe, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology	Witzemann, V (corresponding author), Jahnstr 29, D-69120 Heidelberg, Germany.	witzeman@mpimf-heidelberg.mpg.de	Rudolf, Rüdiger/A-6476-2009	Rudolf, Rüdiger/0000-0002-0833-1053				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; BERG DK, 1974, SCIENCE, V184, P473, DOI 10.1126/science.184.4135.473; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; CHANG CC, 1975, NATURE, V253, P643, DOI 10.1038/253643a0; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Eckler SA, 2005, NEUROSCIENCE, V131, P661, DOI 10.1016/j.neuroscience.2004.11.035; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Gervasio OL, 2007, DEV BIOL, V305, P262, DOI 10.1016/j.ydbio.2007.02.008; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Prakash YS, 1998, MUSCLE NERVE, V21, P887, DOI 10.1002/(SICI)1097-4598(199807)21:7<887::AID-MUS6>3.0.CO;2-2; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005; SALPETER MM, 1986, J CELL BIOL, V103, P1399, DOI 10.1083/jcb.103.4.1399; Santos AF, 2003, J NEUROCYTOL, V32, P849, DOI 10.1023/B:NEUR.0000020628.36013.88; STEINBACH JH, 1979, P NATL ACAD SCI USA, V76, P3547, DOI 10.1073/pnas.76.7.3547; Turney SG, 2008, METHOD CELL BIOL, V89, P309, DOI 10.1016/S0091-679X(08)00611-0; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014; Yampolsky P, 2010, EUR J NEUROSCI, V31, P646, DOI 10.1111/j.1460-9568.2010.07096.x; Yumoto N, 2005, BIOCHEM BIOPH RES CO, V331, P1522, DOI 10.1016/j.bbrc.2005.04.081	31	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34589	34596		10.1074/jbc.M110.168880	http://dx.doi.org/10.1074/jbc.M110.168880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813841	hybrid, Green Published			2022-12-25	WOS:000283659100034
J	Bol, V; Desjardins, F; Reusens, B; Balligand, JL; Remacle, C				Bol, Vanesa; Desjardins, Fanny; Reusens, Brigitte; Balligand, Jen-Luc; Remacle, Claude			Does Early Mismatched Nutrition Predispose to Hypertension and Atherosclerosis, in Male Mice?	PLOS ONE			English	Article							CATCH-UP GROWTH; DIET-INDUCED OBESITY; PROTEIN RESTRICTION; BLOOD-PRESSURE; RECEPTOR EXPRESSION; METABOLIC SYNDROME; GENE-EXPRESSION; ADIPOSE-TISSUE; DEVELOPMENTAL ORIGINS; CIRCADIAN-RHYTHMS	Background: A link between early mismatched nutritional environment and development of components of the metabolic syndrome later in life has been shown in epidemiological and animal data. The aim of this study was to investigate whether an early mismatched nutrition produced by catch-up growth after fetal protein restriction could induce the appearance of hypertension and/or atherosclerosis in adult male mice. Methodology/Principal Findings: Wild-type C57BL6/J or LDLr-/- dams were fed a low protein (LP) or a control (C) diet during gestation. Catch-up growth was induced in LP offspring by feeding dams with a control diet and by culling the litter to 4 pups against 8 in controls. At weaning, male mice were fed either standard chow or an obesogenic diet (OB), leading to 4 experimental groups. Blood pressure (BP) and heart rate (HR) were assessed in conscious unrestrained wild-type mice by telemetry. Atherosclerosis plaque area was measured in aortic root sections of LDLr-/- mice. We found that: (1) postnatal OB diet increased significantly BP (P<0.0001) and HR (P<0.008) in 3-month old OB-C and OB-LP offspring, respectively; (2) that maternal LP diet induced a significant higher BP (P<0.009) and HR (P<0.004) and (3) an altered circadian rhythm in addition to higher plasma corticosterone concentration in 9 months-old LP offspring; (4) that, although LP offspring showed higher plasma total cholesterol than control offspring, atherosclerosis assessed in aortic roots of 6-mo old mice featured increased plaque area due to OB feeding but not due to early mismatched nutrition. Conclusions/Significance: These results indicate a long-term effect of early mismatched nutrition on the appearance of hypertension independently of obesity, while no effect on atherosclerosis was noticed at this age.	[Bol, Vanesa; Reusens, Brigitte; Remacle, Claude] Catholic Univ Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium; [Desjardins, Fanny; Balligand, Jen-Luc] Catholic Univ Louvain, Unit Pharmacol & Theurapeut, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Bol, V (corresponding author), Catholic Univ Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium.	claude.remacle@uclouvain.be	Balligand, Jean-Luc J/D-7543-2012	BALLIGAND, Jean-Luc/0000-0002-0522-4156	European Commission [FOOD-CT-2005-007036]; Partenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique (FNRS); Politique Scientifique Federale [PAI-P6/30]; Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)	European Commission(European CommissionEuropean Commission Joint Research Centre); Partenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Politique Scientifique Federale; Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the European Commission (FOOD-CT-2005-007036), the Partenon Trust (London, UK), the Belgian Fonds National de la Recherche Scientifique (FNRS), Politique Scientifique Federale (PAI-P6/30) and the Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BARKER DJP, 1989, LANCET, V2, P577; Bieswal F, 2004, J NUTR, V134, P1493, DOI 10.1093/jn/134.6.1493; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Breton C, 2009, AM J PHYSIOL-ENDOC M, V296, pE462, DOI 10.1152/ajpendo.90740.2008; BROUBRED F, 2009, AM J PHYSIOL-RENAL, V297, pF943; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Cole TJ, 2007, ACTA PAEDIATR, V96, P2, DOI 10.1111/j.1651-2227.2007.00162.x; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Fernandez-Twinn DS, 2006, AM J PHYSIOL-REG I, V291, pR429, DOI 10.1152/ajpregu.00608.2005; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Goharkhay N, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.08.002; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Groot PHE, 1996, ARTERIOSCL THROM VAS, V16, P926, DOI 10.1161/01.ATV.16.8.926; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALES CN, 2005, BR MED B, V60, P5; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Langley-Evans SC, 2001, P NUTR SOC, V60, P505, DOI 10.1079/PNS2001111; Langley-Evans SC, 1998, NUTRITION, V14, P39, DOI 10.1016/S0899-9007(97)00391-2; Li P, 1999, AM J PHYSIOL-REG I, V276, pR500, DOI 10.1152/ajpregu.1999.276.2.R500; Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McMullen S, 2005, HYPERTENSION, V46, P1374, DOI 10.1161/01.HYP.0000188702.96256.46; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; O'Regan D, 2008, J ENDOCRINOL, V196, P343, DOI 10.1677/JOE-07-0327; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Petry CJ, 2000, DIABETIC MED, V17, P848, DOI 10.1046/j.1464-5491.2000.00392.x; Phillips DIW, 2006, ANN NY ACAD SCI, V1083, P28, DOI 10.1196/annals.1367.027; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Remacle C, 2004, INT J OBESITY, V28, pS46, DOI 10.1038/sj.ijo.0802800; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sathishkumar K, 2009, J VASC RES, V46, P229, DOI 10.1159/000166390; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Stanner S A, 2001, Twin Res, V4, P287, DOI 10.1375/1369052012498; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Sugden MC, 2001, EUR J ENDOCRINOL, V145, P529, DOI 10.1530/eje.0.1450529; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Yates Z, 2009, BRIT J NUTR, V101, P1185, DOI 10.1017/S0007114508066786; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005	55	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12656	10.1371/journal.pone.0012656	http://dx.doi.org/10.1371/journal.pone.0012656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844591	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687200017
J	Plett, D; Safwat, G; Gilliham, M; Moller, IS; Roy, S; Shirley, N; Jacobs, A; Johnson, A; Tester, M				Plett, Darren; Safwat, Gehan; Gilliham, Matthew; Moller, Inge Skrumsager; Roy, Stuart; Shirley, Neil; Jacobs, Andrew; Johnson, Alexander; Tester, Mark			Improved Salinity Tolerance of Rice Through Cell Type-Specific Expression of AtHKT1;1	PLOS ONE			English	Article							SALT TOLERANCE; SODIUM TRANSPORTER; HKT TRANSPORTERS; NA+ EXCLUSION; DURUM-WHEAT; ARABIDOPSIS; PLANTS; GENE; STRESS	Previously, cell type-specific expression of AtHKT1;1, a sodium transporter, improved sodium (Na(+)) exclusion and salinity tolerance in Arabidopsis. In the current work, AtHKT1;1, was expressed specifically in the root cortical and epidermal cells of an Arabidopsis GAL4-GFP enhancer trap line. These transgenic plants were found to have significantly improved Na(+) exclusion under conditions of salinity stress. The feasibility of a similar biotechnological approach in crop plants was explored using a GAL4-GFP enhancer trap rice line to drive expression of AtHKT1; 1 specifically in the root cortex. Compared with the background GAL4-GFP line, the rice plants expressing AtHKT1;1 had a higher fresh weight under salinity stress, which was related to a lower concentration of Na(+) in the shoots. The root-to-shoot transport of 22 Na(+) was also decreased and was correlated with an upregulation of OsHKT1;5, the native transporter responsible for Na(+) retrieval from the transpiration stream. Interestingly, in the transgenic Arabidopsis plants overexpressing AtHKT1;1 in the cortex and epidermis, the native AtHKT1;1 gene responsible for Na(+) retrieval from the transpiration stream, was also upregulated. Extra Na(+) retrieved from the xylem was stored in the outer root cells and was correlated with a significant increase in expression of the vacuolar pyrophosphatases (in Arabidopsis and rice) the activity of which would be necessary to move the additional stored Na(+) into the vacuoles of these cells. This work presents an important step in the development of abiotic stress tolerance in crop plants via targeted changes in mineral transport.	[Plett, Darren; Safwat, Gehan; Moller, Inge Skrumsager; Roy, Stuart; Shirley, Neil; Jacobs, Andrew; Johnson, Alexander; Tester, Mark] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Plett, Darren; Safwat, Gehan; Gilliham, Matthew; Moller, Inge Skrumsager; Roy, Stuart; Shirley, Neil; Jacobs, Andrew; Johnson, Alexander; Tester, Mark] Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, Glen Osmond, SA, Australia	University of Adelaide; University of Adelaide	Plett, D (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.	mark.tester@acpfg.com.au	Gilliham, Matthew/Y-4403-2019; Tester, Mark/J-2368-2017; Jacobs, Andrew/F-4237-2013; Gilliham, Matthew/C-1998-2013	Gilliham, Matthew/0000-0003-0666-3078; Tester, Mark/0000-0002-5085-8801; Gilliham, Matthew/0000-0003-0666-3078; Shirley, Neil/0000-0001-8114-9891; Plett, Darren/0000-0002-9551-8755; JOHNSON, ALEXANDER/0000-0002-1209-6447; Roy, Stuart/0000-0003-0411-9431	Biotechnology and Biological Research Sciences Council; Australian Research Council [FF0348367, DP0557920]; International Postgraduate Research Scholarship; BP Egypt-Cambridge scholarship; Danish Research Council	Biotechnology and Biological Research Sciences Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council(Australian Research Council); International Postgraduate Research Scholarship(Australian Government); BP Egypt-Cambridge scholarship; Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by a Biotechnology and Biological Research Sciences Council (http://www.bbsrc.ac.uk) grant to MT and Australian Research Council (http://www.arc.gov.au) grants FF0348367 and DP0557920 to MT. PhD students were supported by an International Postgraduate Research Scholarship (DP), a BP Egypt-Cambridge scholarship (GS) and the Danish Research Council (ISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Johnson AAT, 2005, PLANT J, V41, P779, DOI 10.1111/j.1365-313X.2005.02339.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sottosanto JB, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-18; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wu XL, 2002, GENE DEV, V16, P151, DOI 10.1101/gad.952002; YEO AR, 1987, J EXP BOT, V38, P1141, DOI 10.1093/jxb/38.7.1141	20	100	106	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12571	10.1371/journal.pone.0012571	http://dx.doi.org/10.1371/journal.pone.0012571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838445	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000281627700018
J	Kumar, S; Sardesai, AA; Basu, D; Muniyappa, K; Hasnain, SE				Kumar, Sandeep; Sardesai, Abhijit A.; Basu, Debashree; Muniyappa, Kalappagowda; Hasnain, Seyed E.			DNA Clasping by Mycobacterial HU: The C-Terminal Region of HupB Mediates Increased Specificity of DNA Binding	PLOS ONE			English	Article							HISTONE-LIKE PROTEIN; ESCHERICHIA-COLI; CRUCIFORM DNA; IN-VITRO; TUBERCULOSIS; REPLICATION; FORM; RECOMBINATION; TRANSCRIPTION; BACTERIA	Background: HU a small, basic, histone like protein is a major component of the bacterial nucleoid. E. coli has two subunits of HU coded by hupA and hupB genes whereas Mycobacterium tuberculosis (Mtb) has only one subunit of HU coded by ORF Rv2986c (hupB gene). One noticeable feature regarding Mtb HupB, based on sequence alignment of HU orthologs from different bacteria, was that HupB(Mtb) bears at its C-terminal end, a highly basic extension and this prompted an examination of its role in Mtb HupB function. Methodology/Principal Findings: With this objective two clones of Mtb HupB were generated; one expressing full length HupB protein (HupB(Mtb)) and another which expresses only the N terminal region (first 95 amino acid) of hupB (HupB(MtbN)). Gel retardation assays revealed that HupBMtbN is almost like E. coli HU (heat stable nucleoid protein) in terms of its DNA binding, with a binding constant (K(d)) for linear dsDNA greater than 1000 nM, a value comparable to that obtained for the HU alpha alpha and HU alpha beta forms. However CTR (C-terminal Region) of HupB(Mtb) imparts greater specificity in DNA binding. HupB(Mtb) protein binds more strongly to supercoiled plasmid DNA than to linear DNA, also this binding is very stable as it provides DNase I protection even up to 5 minutes. Similar results were obtained when the abilities of both proteins to mediate protection against DNA strand cleavage by hydroxyl radicals generated by the Fenton's reaction, were compared. It was also observed that both the proteins have DNA binding preference for A: T rich DNA which may occur at the regulatory regions of ORFs and the oriC region of Mtb. Conclusions/Significance: These data thus point that HupB(Mtb) may participate in chromosome organization in-vivo, it may also play a passive, possibly an architectural role.	[Kumar, Sandeep] Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India; [Sardesai, Abhijit A.] Ctr DNA Fingerprinting & Diagnost, Lab Bacterial Genet, Hyderabad, Andhra Pradesh, India; [Basu, Debashree] Ctr DNA Fingerprinting & Diagnost, Struct Biol Lab, Hyderabad, Andhra Pradesh, India; [Muniyappa, Kalappagowda] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Hasnain, Seyed E.] Univ Hyderabad Campus, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Indian Institute of Science (IISC) - Bangalore; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Kumar, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India.	seh@uohyd.ernet.in	KUMAR, SANDEEP/GZA-7182-2022	Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partly supported by research grant under the "Centre of Excellence" to SEH from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; SK and DB thank the Council of Scientific and Industrial Research (CSIR), Government of India for Senior Research Fellowships. KM and SEH are JC Bose National Fellows. SEH is a Robert Koch Fellow of the Robert Koch Institute, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1979, BIOCHEM BIOPH RES CO, V91, P461, DOI 10.1016/0006-291X(79)91544-4; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; Furugen M, 2001, MICROB PATHOGENESIS, V30, P129, DOI 10.1006/mpat.2000.0416; Ghosh S, 2004, BIOTECHNIQUES, V37, P418, DOI 10.2144/04373ST07; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HWANG DS, 1992, J BIOL CHEM, V267, P23083; JOHNSON RC, 1986, CELL, V46, P531, DOI 10.1016/0092-8674(86)90878-0; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kar S, 2006, J BIOL CHEM, V281, P40144, DOI 10.1074/jbc.M605576200; Kumar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004139; Lavoie BD, 1996, CELL, V85, P761, DOI 10.1016/S0092-8674(00)81241-6; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; MICKA B, 1991, J BACTERIOL, V173, P3191, DOI 10.1128/JB.173.10.3191-3198.1991; Mueller-Ortiz SL, 2002, INFECT IMMUN, V70, P6751, DOI 10.1128/IAI.70.12.6751-6760.2002; Mukherjee A, 2008, BIOCHEMISTRY-US, V47, P8744, DOI 10.1021/bi800010s; PACI M, 1984, EUR J BIOCHEM, V138, P193, DOI 10.1111/j.1432-1033.1984.tb07899.x; PETTIJOHN DE, 1976, CRC CR REV BIOCH MOL, V4, P175, DOI 10.3109/10409237609105458; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; Prabhakar S, 2004, J CLIN MICROBIOL, V42, P2724, DOI 10.1128/JCM.42.6.2724-2732.2004; Prabhakar S., 1998, Tubercle and Lung Disease, V79, P43, DOI 10.1054/tuld.1998.0004; Prakash P, 2005, J BIOL CHEM, V280, P19641, DOI 10.1074/jbc.M413026200; Ross MA, 2000, J BACTERIOL, V182, P1942, DOI 10.1128/JB.182.7.1942-1948.2000; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SHINDO H, 1992, NUCLEIC ACIDS RES, V20, P1553, DOI 10.1093/nar/20.7.1553; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Wery M, 2001, BIOCHIMIE, V83, P193, DOI 10.1016/S0300-9084(01)01254-8	39	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12551	10.1371/journal.pone.0012551	http://dx.doi.org/10.1371/journal.pone.0012551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824060	Green Submitted, Green Published, gold			2022-12-25	WOS:000281480900029
J	Hsu, HJ; Lee, CF; Locke, A; Vanderzyl, SQ; Kaunas, R				Hsu, Hui-Ju; Lee, Chin-Fu; Locke, Andrea; Vanderzyl, Susan Q.; Kaunas, Roland			Stretch-Induced Stress Fiber Remodeling and the Activations of JNK and ERK Depend on Mechanical Strain Rate, but Not FAK	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; MAPK ACTIVATION; TYROSINE PHOSPHORYLATION; DYNAMIC REORIENTATION; CYCLIC STRETCH; FIBROBLASTS; ACTIN; RESPONSES	Background: Cells within tissues are subjected to mechanical forces caused by extracellular matrix deformation. Cells sense and dynamically respond to stretching of the matrix by reorienting their actin stress fibers and by activating intracellular signaling proteins, including focal adhesion kinase (FAK) and the mitogen-activated proteins kinases (MAPKs). Theoretical analyses predict that stress fibers can relax perturbations in tension depending on the rate of matrix strain. Thus, we hypothesized stress fiber organization and MAPK activities are altered to an extent dependent on stretch frequency. Principal Findings: Bovine aortic endothelial cells and human osteosarcoma cells expressing GFP-actin were cultured on elastic membranes and subjected to various patterns of stretch. Cyclic stretching resulted in strain rate-dependent increases in stress fiber alignment, cell retraction, and the phosphorylation of the MAPKs JNK, ERK and p38. Transient step changes in strain rate caused proportional transient changes in the levels of JNK and ERK phosphorylations without affecting stress fiber organization. Disrupting stress fiber contractile function with cytochalasin D or Y27632 decreased the levels of JNK and ERK phosphorylation. Previous studies indicate that FAK is required for stretch-induced cell alignment and MAPK activations. However, cyclic uniaxial stretching induced stress fiber alignment and the phosphorylation of JNK, ERK and p38 to comparable levels in FAK-null and FAK-expressing mouse embryonic fibroblasts. Conclusions: These results indicate that cyclic stretch-induced stress fiber alignment, cell retraction, and MAPK activations occur as a consequence of perturbations in fiber strain. These findings thus shed new light into the roles of stress fiber relaxation and reorganization in maintenance of tensional homeostasis in a dynamic mechanical environment.	[Hsu, Hui-Ju; Lee, Chin-Fu; Locke, Andrea; Vanderzyl, Susan Q.; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hsu, HJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	rkaunas@tamu.edu			American Heart Association [0730238N]; National Science Foundation [0854129]; Directorate For Engineering [0854129] Funding Source: National Science Foundation	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by grants from the American Heart Association (0730238N) and the National Science Foundation (0854129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Hosokawa H, 2002, BIOL PHARM BULL, V25, P1588, DOI 10.1248/bpb.25.1588; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Humphrey JD., 2002, CARDIOVASCULAR SOLID; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Mofrad M R Kaazempur, 2004, Mech Chem Biosyst, V1, P253; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; Nekouzadeh A, 2008, J BIOMECH, V41, P2964, DOI 10.1016/j.jbiomech.2008.07.033; NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Pradhan S, 2004, FRONT BIOSCI-LANDMRK, V9, P3276, DOI 10.2741/1480; Qu MJ, 2007, J VASC RES, V44, P345, DOI 10.1159/000102278; Sai XR, 1999, J CELL SCI, V112, P1365; Sato K, 2005, J BIOMECH, V38, P1895, DOI 10.1016/j.jbiomech.2004.08.012; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang JG, 2001, BIOCHEM BIOPH RES CO, V288, P356, DOI 10.1006/bbrc.2001.5775	39	123	124	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12470	10.1371/journal.pone.0012470	http://dx.doi.org/10.1371/journal.pone.0012470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814573	Green Submitted, Green Published, gold			2022-12-25	WOS:000281375500005
J	Azmi, AS; Philip, PA; Beck, FWJ; Wang, Z; Banerjee, S; Wang, S; Yang, D; Sarkar, FH; Mohammad, RM				Azmi, A. S.; Philip, P. A.; Beck, F. W. J.; Wang, Z.; Banerjee, S.; Wang, S.; Yang, D.; Sarkar, F. H.; Mohammad, R. M.			MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy	ONCOGENE			English	Article						MDM2 and p53; small molecule inhibitors; zinc; apoptosis	NF-KAPPA-B; SMALL-MOLECULE INHIBITORS; SUPPRESSOR PROTEIN P53; STRUCTURE-BASED DESIGN; DNA-BINDING ACTIVITY; ZINC-DEFICIENCY; WILD-TYPE; CANCER; APOPTOSIS; NUCLEAR	Zinc has a crucial role in the biology of p53 in that p53 binds to DNA through a structurally complex domain stabilized by zinc atom. The p53 negative regulator MDM2 protein also carries a C-terminal RING domain that coordinates two zinc atoms, which are responsible for p53 nuclear export and proteasomal degradation. In this clinically translatable study, we explored the critical role of zinc on p53 reactivation by MDM2 inhibitor, MI-219, in colon and breast cancer cells. ZnCl2 enhanced MI-219 activity (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), apoptosis and colony formation), and chelation of zinc not only blocked the activity of MI-219, but also suppressed reactivation of the p53 and its downstream effector molecules p21(WAF1) and Bax. N,N,N'N'-tetrakis(-)[2-pyridylmethyl]- ethylenediamine (TPEN), a specific zinc chelator, but not 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (Bapta-AM), a calcium chelator, blocked MI-219-induced apoptosis. Nuclear localization is a prerequisite for proper functioning of p53 and our results confirm that TPEN, and not Bapta-AM, could abrogate p53 nuclear localization and it interfered with p53 transcriptional activation. Addition of zinc suppressed the known p53 feedback MDM2 activation, which could be restored by TPEN. Co-immunoprecipitation studies verified that MI-219-mediated MDM2-p53 disruption could be suppressed by TPEN and restored by zinc. As such, single-agent therapies that target MDM2 inhibition, without supplemental zinc, may not be optimal in certain patients owing to the less recognized mild zinc deficiency among the 'at-risk population' as in the elderly who are more prone to cancers. Therefore, use of supplemental zinc with MI-219 will benefit the overall efficacy of MIs and this potent combination warrants further investigation. Oncogene (2011) 30, 117-126; doi: 10.1038/onc.2010.403; published online 6 September 2010	[Philip, P. A.; Beck, F. W. J.; Mohammad, R. M.] Wayne State Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol,Karmanos Canc Inst, Detroit, MI 48201 USA; [Azmi, A. S.; Wang, Z.; Banerjee, S.; Sarkar, F. H.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA; [Wang, S.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, S.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Wang, S.; Yang, D.] Ascenta Therapeut Inc, Malvern, PA USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mohammad, RM (corresponding author), Wayne State Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol,Karmanos Canc Inst, 732 HWCRC,4100 John R St, Detroit, MI 48201 USA.	mohammar@karmanos.org	Wang, Zhiwei/A-6809-2011	Wang, Shaomeng/0000-0002-8782-6950; AZMI, ASFAR/0000-0003-1178-9505	National Cancer Institute, NIH [R01CA109389]; NIH [5R01CA101870]; Guido foundation; NATIONAL CANCER INSTITUTE [R01CA101870, R01CA109389, R01CA121279] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guido foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute, NIH Grant R01CA109389 (RM Mohammad) and NIH Grant 5R01CA101870 (FH Sarkar) are acknowledged. We sincerely acknowledge the Guido foundation for their support.	Alshatwi AA, 2006, EXP BIOL MED, V231, P611; Azmi AS, 2010, EUR J CANCER, V46, P1122, DOI 10.1016/j.ejca.2010.01.015; Azmi AS, 2008, MOL CANCER THER, V7, P2884, DOI 10.1158/1535-7163.MCT-08-0438; Bao B, 2006, TOXICOL LETT, V166, P222, DOI 10.1016/j.toxlet.2006.07.306; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Beck FWJ, 2004, PROSTATE, V58, P374, DOI 10.1002/pros.10344; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Butler JS, 2007, BIOCHEMISTRY-US, V46, P2630, DOI 10.1021/bi062106y; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; Canner JA, 2009, BRIT J CANCER, V101, P774, DOI 10.1038/sj.bjc.6605199; Chen GD, 2006, BIOCHEM BIOPH RES CO, V344, P272, DOI 10.1016/j.bbrc.2006.03.136; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Feng ZH, 2008, CELL CYCLE, V7, P842, DOI 10.4161/cc.7.7.5657; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; Hambidge KM, 1998, AM J CLIN NUTR, V68, p410S, DOI 10.1093/ajcn/68.2.410S; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Ho E, 2009, CURR OPIN CLIN NUTR, V12, P640, DOI 10.1097/MCO.0b013e32833106ee; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lane DP, 2004, NATURE, V427, P789, DOI 10.1038/427789a; Levine AJ, 1995, ANN NY ACAD SCI, V768, P111, DOI 10.1111/j.1749-6632.1995.tb12115.x; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Meek DW, 1998, CELL SIGNAL, V10, P159, DOI 10.1016/S0898-6568(97)00119-8; Meplan C, 2000, ONCOGENE, V19, P5227, DOI 10.1038/sj.onc.1203907; Meplan C, 1999, P NUTR SOC, V58, P565, DOI 10.1017/S0029665199000749; Mohammad RM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-115; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Prasad AS, 2004, MET IONS BIOL SYST, V41, P103; Prasad AS, 2002, J LAB CLIN MED, V140, P272, DOI 10.1067/mlc.2002.127908; PRASAD AS, 1993, NUTRITION, V9, P218; Prasad AS, 2001, NUTRITION, V17, P685, DOI 10.1016/S0899-9007(01)00598-6; Prasad AS, 2001, J LAB CLIN MED, V138, P250, DOI 10.1067/mlc.2001.118108; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Verhaegh GW, 1998, MOL CARCINOGEN, V21, P205, DOI 10.1002/(SICI)1098-2744(199803)21:3<205::AID-MC8>3.0.CO;2-K; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Yu SH, 2009, J MED CHEM, V52, P7970, DOI 10.1021/jm901400z; Zalewski P D, 1994, Chem Biol, V1, P153, DOI 10.1016/1074-5521(94)90005-1; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403	51	35	36	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					117	126		10.1038/onc.2010.403	http://dx.doi.org/10.1038/onc.2010.403			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20818437	Green Accepted			2022-12-25	WOS:000285959300011
J	Leong, DJ; Li, YH; Gu, XI; Sun, L; Zhou, ZP; Nasser, P; Laudier, DM; Iqbal, J; Majeska, RJ; Schaffler, MB; Goldring, MB; Cardoso, L; Zaidi, M; Sun, HB				Leong, Daniel J.; Li, Yong H.; Gu, Xiang I.; Sun, Li; Zhou, Zuping; Nasser, Philip; Laudier, Damien M.; Iqbal, Jameel; Majeska, Robert J.; Schaffler, Mitchell B.; Goldring, Mary B.; Cardoso, Luis; Zaidi, Mone; Sun, Hui B.			Physiological loading of joints prevents cartilage degradation through CITED2	FASEB JOURNAL			English	Article						matrix metalloproteinases; mechanotransduction, chondrocyte regulation	ARTICULAR-CARTILAGE; MATRIX METALLOPROTEINASES; MECHANICAL REGULATION; COLLAGENASE MMP-1; MOLECULAR EVENTS; GENE-EXPRESSION; KNEE-JOINT; ARTHRITIS; PROTEIN; IMMOBILIZATION	Both overuse and disuse of joints up-regulate matrix metalloproteinases (MMPs) in articular cartilage and cause tissue degradation; however, moderate (physiological) loading maintains cartilage integrity. Here, we test whether CBP/p300-interacting transactivator with ED-rich tail 2 (CITED2), a mechanosensitive transcriptional coregulator, mediates this chondroprotective effect of moderate mechanical loading. In vivo, hind-limb immobilization of Sprague-Dawley rats up-regulates MMP-1 and causes rapid, histologically detectable articular cartilage degradation. One hour of daily passive joint motion prevents these changes and up-regulates articular cartilage CITED2. In vitro, moderate (2.5 MPa, 1 Hz) intermittent hydrostatic pressure (IHP) treatment suppresses basal MMP-1 expression and up-regulates CITED2 in human chondrocytes, whereas high IHP (10 MPa) down-regulates CITED2 and increases MMP-1. Competitive binding and transcription assays demonstrate that CITED2 suppresses MMP-1 expression by competing with MMP transactivator, Ets-1 for its coactivator p300. Furthermore, CITED2 up-regulation in vitro requires the p38 delta isoform, which is specifically phosphorylated by moderate IHP. Together, these studies identify a novel regulatory pathway involving CITED2 and p38 delta, which may be critical for the maintenance of articular cartilage integrity under normal physical activity levels.-Leong, D. J., Li, Y. H., Gu, X. I., Sun, L., Zhou, Z., Nasser, P., Laudier, D. M., Iqbal, J., Majeska, R. J., Schaffler, M. B., Goldring, M. B., Cardoso, L., Zaidi, M., Sun, H. B. Physiological loading of joints prevents cartilage degradation through CITED2. FASEB J. 25, 182-191 (2011). www.fasebj.org	[Leong, Daniel J.; Li, Yong H.; Zhou, Zuping; Nasser, Philip; Laudier, Damien M.; Sun, Hui B.] Mt Sinai Sch Med, Leni & Peter W May Dept Orthoped, New York, NY 10029 USA; [Leong, Daniel J.; Gu, Xiang I.; Majeska, Robert J.; Schaffler, Mitchell B.; Cardoso, Luis] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Goldring, Mary B.] Hosp Special Surg, New York, NY 10021 USA; [Sun, Li; Iqbal, Jameel; Zaidi, Mone] Mt Sinai Sch Med, Mt Sinai Bone Program, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY); Icahn School of Medicine at Mount Sinai	Sun, HB (corresponding author), Mt Sinai Sch Med, Leni & Peter W May Dept Orthoped, 1 Gustave L Levy Pl,Box 1188, New York, NY 10029 USA.	herb.sun@mssm.edu	Cardoso, Luis/F-1234-2013	Cardoso, Luis/0000-0002-2252-7802	National Institutes of Health [AR47628, AR52743, DK804590, AG23176, DK70526, AG022021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041210, R03AR047628, R01AR052743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023176, R56AG022021, R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institutes of Health to H. S. (AR47628 and AR52743), L. S. (DK804590), M.Z (AG23176, DK70526, and DK804590), and M. B. G. (AG022021).	Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Blain EJ, 2007, FRONT BIOSCI-LANDMRK, V12, P507, DOI 10.2741/2078; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Coutinho EL, 2002, BRAZ J MED BIOL RES, V35, P1329, DOI 10.1590/S0100-879X2002001100010; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Ferretti JL, 2003, MECH AGEING DEV, V124, P269, DOI 10.1016/S0047-6374(02)00194-X; Ferretti M, 2005, J ORTHOP RES, V23, P1165, DOI 10.1016/j.orthres.2005.01.025; Ferretti M, 2006, J IMMUNOL, V177, P8757, DOI 10.4049/jimmunol.177.12.8757; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Fuentes MA, 2002, ARCH ORAL BIOL, V47, P643, DOI 10.1016/S0003-9969(02)00052-3; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Gu XI, 2010, ANN BIOMED ENG, V38, P621, DOI 10.1007/s10439-009-9865-0; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; JURVELIN J, 1986, CLIN ORTHOP RELAT R, P246; Karalaki M, 2009, IN VIVO, V23, P779; Kim E. K., BIOCH BIOPHYS ACTA, V1802, P396; Leong DJ, 2010, MATRIX BIOL, V29, P420, DOI 10.1016/j.matbio.2010.02.004; MATRISIAN LM, 1994, ANN NY ACAD SCI, V732, P42, DOI 10.1111/j.1749-6632.1994.tb24723.x; Mengshol JA, 2002, ARTHRITIS RHEUM, V46, P13, DOI 10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S; Reuben PM, 2006, FRONT BIOSCI-LANDMRK, V11, P1199, DOI 10.2741/1873; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Schaffler MB, 2003, OSTEOPOROSIS INT, V14, pS73; Shlopov BV, 1997, ARTHRITIS RHEUM-US, V40, P2065, DOI 10.1002/art.1780401120; Stremme S, 2003, CLIN EXP RHEUMATOL, V21, P205; Sun H. B., ANN NY ACAD SCI, V1192, P429; Sun HB, 2001, BONE, V28, P399, DOI 10.1016/S8756-3282(00)00459-2; Torzilli PA, 2010, OSTEOARTHR CARTILAGE, V18, P97, DOI 10.1016/j.joca.2009.07.012; Trindade MCD, 2004, OSTEOARTHR CARTILAGE, V12, P729, DOI 10.1016/j.joca.2004.05.008; Vanwanseele B, 2002, ARTHRITIS RHEUM-US, V46, P2073, DOI 10.1002/art.10462; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8; Wu W, 2002, ARTHRITIS RHEUM, V46, P2087, DOI 10.1002/art.10428; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Yoshida H, 2006, J BIOMECH, V39, P1996, DOI 10.1016/j.jbiomech.2005.06.026; Yoshida Mamoru, 2005, Mod Rheumatol, V15, P180, DOI 10.1007/s10165-005-0384-z; Ziegler N., BMC CELL BIOL, V11, P10	46	58	59	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					182	191		10.1096/fj.10-164277	http://dx.doi.org/10.1096/fj.10-164277			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20826544	Green Published			2022-12-25	WOS:000285869500017
J	Pallavi, R; Roy, N; Nageshan, RK; Talukdar, P; Pavithra, SR; Reddy, R; Venketesh, S; Kumar, R; Gupta, AK; Singh, RK; Yadav, SC; Tatu, U				Pallavi, Rani; Roy, Nainita; Nageshan, Rishi Kumar; Talukdar, Pinaki; Pavithra, Soundara Raghavan; Reddy, Raghunath; Venketesh, S.; Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra; Tatu, Utpal			Heat Shock Protein 90 as a Drug Target against Protozoan Infections BIOCHEMICAL CHARACTERIZATION OF HSP90 FROM PLASMODIUM FALCIPARUM AND TRYPANOSOMA EVANSI AND EVALUATION OF ITS INHIBITOR AS A CANDIDATE DRUG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; PLASMODIUM-FALCIPARUM; HUMAN ERYTHROCYTES; ATPASE ACTIVITY; INHIBITION; GROWTH; HEAT-SHOCK-PROTEIN-90; CELLS; GELDANAMYCIN; EXPRESSION	Using a pharmacological inhibitor of Hsp90 in cultured malarial parasite, we have previously implicated Plasmodium falciparum Hsp90 (PfHsp90) as a drug target against malaria. In this study, we have biochemically characterized PfHsp90 in terms of its ATPase activity and interaction with its inhibitor geldanamycin (GA) and evaluated its potential as a drug target in a preclinical mouse model of malaria. In addition, we have explored the potential of Hsp90 inhibitors as drugs for the treatment of Trypanosoma infection in animals. Our studies with full-length PfHsp90 showed it to have the highest ATPase activity of all known Hsp90s; its ATPase activity was 6 times higher than that of human Hsp90. Also, GA brought about more robust inhibition of PfHsp90 ATPase activity as compared with human Hsp90. Mass spectrometric analysis of PfHsp90 expressed in P. falciparum identified a site of acetylation that overlapped with Aha1 and p23 binding domain, suggesting its role in modulating Hsp90 multichaperone complex assembly. Indeed, treatment of P. falciparum cultures with a histone deacetylase inhibitor resulted in a partial dissociation of PfHsp90 complex. Furthermore, we found a well known, semisynthetic Hsp90 inhibitor, namely 17-(allylamino)-17-demethoxygeldanamycin, to be effective in attenuating parasite growth and prolonging survival in a mouse model of malaria. We also characterized GA binding to Hsp90 from another protozoan parasite, namely Trypanosoma evansi. We found 17-(allylamino)-17-demethoxygeldanamycin to potently inhibit T. evansi growth in a mouse model of trypanosomiasis. In all, our biochemical characterization, drug interaction, and animal studies supported Hsp90 as a drug target and its inhibitor as a potential drug against protozoan diseases.	[Pallavi, Rani; Roy, Nainita; Nageshan, Rishi Kumar; Pavithra, Soundara Raghavan; Reddy, Raghunath; Venketesh, S.; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Talukdar, Pinaki] Indian Inst Sci Educ & Res, Pune 411021, Maharashtra, India; [Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra] Natl Res Ctr Equines, Hisar 125001, Haryana, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) Pune; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Tatu, U (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in	Viswanath, Pavithra/I-4318-2015; Sivaramakrishnan, Venketesh/J-2025-2012; Talukdar, Pinaki/B-5966-2011; Pallavi, Rani/AAR-7824-2020; Bhowmick, Nainita Roy/AAS-2908-2021	Viswanath, Pavithra/0000-0003-2980-3109; Sivaramakrishnan, Venketesh/0000-0003-3094-5905; Talukdar, Pinaki/0000-0003-3951-4335; Tatu, Utpal/0000-0003-0404-8872; Singh, Rajkumar/0000-0003-4649-2015; Nageshan, Rishi Kumar/0000-0003-1592-4452	Department of Biotechnology, New Delhi, India; Malaria Signalling Consortium; Roche (University of Bern); DST; Council of Scientific and Industrial Research; United Grants Commission, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Malaria Signalling Consortium; Roche (University of Bern)(Roche Holding); DST(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); United Grants Commission, New Delhi, India	This work was supported in part by the Department of Biotechnology, New Delhi, India; Malaria Signalling Consortium; Roche (University of Bern) and the Indo-Swiss Joint Research Programme of DST.; Supported by a junior research fellowship from the Council of Scientific and Industrial Research and United Grants Commission, New Delhi, India.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; CHULAY JD, 1983, EXP PARASITOL, V55, P138, DOI 10.1016/0014-4894(83)90007-3; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; David CL, 2003, CELL STRESS CHAPERON, V8, P93, DOI 10.1379/1466-1268(2003)8<93:EOAUDH>2.0.CO;2; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Echeverria PC, 2005, J MOL BIOL, V350, P723, DOI 10.1016/j.jmb.2005.05.031; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Graefe SEB, 2002, EUKARYOT CELL, V1, P936, DOI 10.1128/EC.1.6.936-943.2002; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rao R, 2008, BLOOD, V112, P1886, DOI 10.1182/blood-2008-03-143644; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Roy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009796; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; Vali Shireen, 2010, Syst Synth Biol, V4, P25, DOI 10.1007/s11693-009-9046-3; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wider D, 2009, MOL BIOCHEM PARASIT, V164, P147, DOI 10.1016/j.molbiopara.2008.12.011; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644	41	131	132	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37964	37975		10.1074/jbc.M110.155317	http://dx.doi.org/10.1074/jbc.M110.155317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20837488	hybrid, Green Published			2022-12-25	WOS:000284625600004
J	Zibaee, S; Fraser, G; Jakes, R; Owen, D; Serpell, LC; Crowther, RA; Goedert, M				Zibaee, Shahin; Fraser, Graham; Jakes, Ross; Owen, David; Serpell, Louise C.; Crowther, R. Anthony; Goedert, Michel			Human beta-Synuclein Rendered Fibrillogenic by Designed Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; A-BETA; AMINO-ACIDS; SEQUENCE DETERMINANTS; NACP/ALPHA-SYNUCLEIN; GENE DUPLICATION; FIBRIL FORMATION; AMYLOID FIBRILS; LEWY BODIES	Filamentous inclusions made of alpha-synuclein are found in nerve cells and glial cells in a number of human neurodegenerative diseases, including Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. The assembly and spreading of these inclusions are likely to play an important role in the etiology of common dementias and movement disorders. Both alpha-synuclein and the homologous beta-synuclein are abundantly expressed in the central nervous system; however, beta-synuclein is not present in the pathological inclusions. Previously, we observed a poor correlation between filament formation and the presence of residues 73-83 of alpha-synuclein, which are absent in beta-synuclein. Instead, filament formation correlated with the mean beta-sheet propensity, charge, and hydrophilicity of the protein (global physicochemical properties) and beta-strand contiguity calculated by a simple algorithm of sliding averages (local physicochemical property). In the present study, we rendered beta-synuclein fibrillogenic via one set of point mutations engineered to enhance global properties and a second set engineered to enhance predominantly beta-strand contiguity. Our findings show that the intrinsic physicochemical properties of synucleins influence their fibrillogenic propensity via two distinct but overlapping modalities. The implications for filament formation and the pathogenesis of neurodegenerative diseases are discussed.	[Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Serpell, Louise C.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	MRC Laboratory Molecular Biology; University of Sussex	Goedert, M (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk	zibaee, shahin/AAK-9497-2021	Serpell, Louise/0000-0001-9335-7751	Alzheimer's Research Trust; Multiple System Atrophy Trust; MRC [MC_U105178803, MC_U105184319, MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004A-5, ART-PG2007-3] Funding Source: researchfish; Medical Research Council [MC_U105178803, MC_U105184291, MC_U105184319] Funding Source: researchfish	Alzheimer's Research Trust; Multiple System Atrophy Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Alzheimer's Research Trust and the Multiple System Atrophy Trust.	Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FERRONE FA, 1980, BIOPHYS J, V32, P361, DOI 10.1016/S0006-3495(80)84962-9; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lewy FH, 1912, PATHOLOGISCHE ANATOM, P920; Lin XJ, 2006, BIOPOLYMERS, V83, P226, DOI 10.1002/bip.20550; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shoji M, 2000, J NEUROL NEUROSUR PS, V68, P605, DOI 10.1136/jnnp.68.5.605; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sopher BL, 2001, CYTOGENET CELL GENET, V93, P117, DOI 10.1159/000056962; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tiunova AA, 2000, MECH DEVELOP, V99, P195, DOI 10.1016/S0925-4773(00)00484-6; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Yoshida H, 2006, BIOCHEMISTRY-US, V45, P2599, DOI 10.1021/bi051993m; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zibaee S., 2007, THESIS U CAMBRIDGE C; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	80	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38555	38567		10.1074/jbc.M110.160721	http://dx.doi.org/10.1074/jbc.M110.160721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20833719	Green Published, hybrid			2022-12-25	WOS:000284625600061
J	Gruenig, MC; Stohl, EA; Chitteni-Pattu, S; Seifert, HS; Cox, MM				Gruenig, Marielle C.; Stohl, Elizabeth A.; Chitteni-Pattu, Sindhu; Seifert, H. Steven; Cox, Michael M.			Less Is More: Neisseria gonorrhoeae RecX Protein Stimulates Recombination by Inhibiting RecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; PILUS ANTIGENIC VARIATION; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; BINDING-PROTEIN; ATP HYDROLYSIS; NUCLEOPROTEIN FILAMENTS; GENE CONVERSION; REGULATORY GENE	Escherichia coli RecX (RecX(Ec)) is a negative regulator of RecA activities both in the bacterial cell and in vitro. In contrast, the Neisseria gonorrhoeae RecX protein (RecX(Ng)) enhances all RecA-related processes in N. gonorrhoeae. Surprisingly, the RecX(Ng) protein is not a RecA protein activator in vitro. Instead, RecX(Ng) is a much more potent inhibitor of all RecA(Ng) and RecA(Ec) activities than is the E. coli RecX ortholog. A series of RecX(Ng) mutant proteins representing a gradient of functional deficiencies provide a direct correlation between RecA(Ng) inhibition in vitro and the enhancement of RecA(Ng) function in N. gonorrhoeae. Unlike RecX(Ec), RecX(Ng) does not simply cap the growing ends of RecA filaments, but it directly facilitates a more rapid RecA filament disassembly. Thus, in N. gonorrhoeae, recombinational processes are facilitated by RecX(Ng) protein-mediated limitations on RecA(Ng) filament presence and/or length to achieve maximal function.	[Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Stohl, Elizabeth A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health [GM32335, R37 AI033493, R01 AI044239]; Dr. James Chieh-Hsia Mao Distinguished Graduate Fellowship; William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; American Cancer Society [PF-00-016-01-GMC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R37AI033493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. James Chieh-Hsia Mao Distinguished Graduate Fellowship; William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32335 (to M. M. C.) and R37 AI033493 and R01 AI044239 (to H. S. S.). This work was also supported by the Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowships (to M. C. G.) and partially supported by American Cancer Society Postdoctoral Fellowship PF-00-016-01-GMC (to E. A. S.).	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Baitin DM, 2008, J BIOL CHEM, V283, P14198, DOI 10.1074/jbc.M801511200; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DEMOT R, 1994, NUCLEIC ACIDS RES, V22, P1313, DOI 10.1093/nar/22.7.1313; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; KOOMEY JM, 1987, J BACTERIOL, V169, P790, DOI 10.1128/jb.169.2.790-795.1987; KOOMEY M, 1987, GENETICS, V117, P391; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Papavinasasundaram KG, 1997, MOL MICROBIOL, V24, P141, DOI 10.1046/j.1365-2958.1997.3441697.x; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Schnos M, 2000, MOL BIOTECHNOL, V16, P77, DOI 10.1385/MB:16:1:77; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Stohl EA, 2002, MICROBIOL-SGM, V148, P1821, DOI 10.1099/00221287-148-6-1821; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; VanLoock MS, 2003, J MOL BIOL, V333, P345, DOI 10.1016/j.jmb.2003.08.053; Vierling S, 2000, J BACTERIOL, V182, P4005, DOI 10.1128/JB.182.14.4005-4011.2000; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L	55	26	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37188	37197		10.1074/jbc.M110.171967	http://dx.doi.org/10.1074/jbc.M110.171967			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851893	hybrid, Green Published			2022-12-25	WOS:000284424000012
J	Couoh-Cardel, SJ; Uribe-Carvajal, S; Wilkens, S; Garcia-Trejo, JJ				Couoh-Cardel, Sergio J.; Uribe-Carvajal, Salvador; Wilkens, Stephan; Garcia-Trejo, Jose J.			Structure of Dimeric F1F0-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; SUPRAMOLECULAR ORGANIZATION; GXXXG MOTIF; SUBUNIT-E; TRANSMEMBRANE DOMAIN; RESPIRATORY-CHAIN; PROTEIN COMPLEXES; STATOR; SACCHAROMYCES; DIMERIZATION	The structure of the dimeric ATP synthase from yeast mitochondria was analyzed by transmission electron microscopy and single particle image analysis. In addition to the previously reported side views of the dimer, top view and intermediate projections served to resolve the arrangement of the rotary c(10) ring and the other stator subunits at the F-0-F-0 dimeric interface. A three-dimensional reconstruction of the complex was calculated from a data set of 9960 molecular images at a resolution of 27 angstrom. The structural model of the dimeric ATP synthase shows the two monomers arranged at an angle of similar to 45 degrees, consistent with our earlier analysis of the ATP synthase from bovine heart mitochondria (Minauro-Sanmiguel, F., Wilkens, S., and Garcia, J. J. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 12356-12358). In the ATP synthase dimer, the two peripheral stalks are located near the F-1-F-1 interface but are turned away from each other so that they are not in contact. Based on the three-dimensional reconstruction, a model of how dimeric ATP synthase assembles to form the higher order oligomeric structures that are required for mitochondrial cristae biogenesis is discussed.	[Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Couoh-Cardel, Sergio J.; Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Dept Biol, Fac Chem, Mexico City 04510, DF, Mexico; [Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Cell Physiol, Dept Mol Genet, Mexico City 04510, DF, Mexico	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu; jjgartre@unam.mx		Uribe-Carvajal, Salvador/0000-0002-7028-8121; Couoh-Cardel, Sergio/0000-0002-5186-4648	National Institutes of Health [GM58600]; Universidad Nacional Autonoma de Mexico [IN213809-3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM58600. This work was also supported by a grant from Universidad Nacional Autonoma de Mexico under the program Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica 2009, Project IN213809-3.	ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P272, DOI 10.1016/j.bbabio.2009.11.004; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; GARCIA JJ, 2006, J S BIOCH, V45, P12695; Garcia-Trejo JJ, 2008, J BIOL PHYS, V34, P197, DOI 10.1007/s10867-008-9114-z; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; MINAUROSANMIGUE.F, 2005, J J P NATL ACAD SCI, V102, P12356; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PENA A, 1977, FEBS LETT, V80, P209, DOI 10.1016/0014-5793(77)80441-9; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spannagel C, 1998, BBA-BIOMEMBRANES, V1414, P260, DOI 10.1016/S0005-2736(98)00174-6; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Weimann T, 2008, BIOCHEMISTRY-US, V47, P3556, DOI 10.1021/bi702000g; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Yao H, 2008, BIOCHEMISTRY-US, V47, P1910, DOI 10.1021/bi7015475	53	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36447	36455		10.1074/jbc.M110.144907	http://dx.doi.org/10.1074/jbc.M110.144907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833715	Green Published, hybrid			2022-12-25	WOS:000284146100002
J	Qi, RS; Hoose, S; Schreiter, J; Sawant, KV; Lamb, R; Ranjith-Kumar, CT; Mills, J; Mateo, LS; Jordan, JL; Kao, CC				Qi, Rongsu; Hoose, Scott; Schreiter, Jessica; Sawant, Kirti V.; Lamb, Roberta; Ranjith-Kumar, C. T.; Mills, Juliane; Mateo, Lani San; Jordan, Jarrat L.; Kao, C. Cheng			Secretion of the Human Toll-like Receptor 3 Ectodomain Is Affected by Single Nucleotide Polymorphisms and Regulated by Unc93b1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MONOCLONAL-ANTIBODY; MOLECULAR-STRUCTURE; FUNCTIONAL ANALYSES; DENDRITIC CELLS; HUMAN UNC-93B; HUMAN-DISEASE; HEPATITIS-C; TLR3; GENE	The innate immune receptor Toll-like receptor 3 (TLR3) can be present on the surface of the plasma membranes of cells and in endolysosomes. The Unc93b1 protein has been reported to facilitate localization of TLR7 and 9 and is required for TLR3, -7, and -9 signaling. We demonstrate that siRNA knockdown of Unc93b1 reduced the abundance of TLR3 on the cell surface without altering total TLR3 accumulation. In addition, siRNA to Unc93b1 reduced the secretion of the TLR3 ectodomain (T3ECD) into the cell medium. Furthermore, two human single nucleotide polymorphisms that affected herpesvirus and influenza virus encephalopathy as well as a natural isoform generated by alternative splicing were found to be impaired for T3ECD secretion and decreased the abundance of TLR3 on the cell surface. The locations of the SNP P554S and the deletion in the isoform led to the identification of a loop in the TLR3 ectodomain that is required for secretion and a second whose presence decreased secretion. Finally, a truncated protein containing the N-terminal 10 leucine-rich repeats of T3ECD was sufficient for secretion in an Unc93b1-dependent manner.	[Qi, Rongsu; Sawant, Kirti V.; Ranjith-Kumar, C. T.; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA; [Hoose, Scott] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Schreiter, Jessica; Lamb, Roberta; Mills, Juliane; Mateo, Lani San; Jordan, Jarrat L.] Centocor Res & Dev Inc, Discovery Res, Radnor, PA 19087 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station; Johnson & Johnson; Johnson & Johnson USA	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA.	ckao@indiana.edu	Kumar CT, Ranjith/J-5701-2016; Sawant, Kirti/L-1602-2013; Sawant, Kirti V/H-3778-2013	Jordan, Jarrat/0000-0002-0699-3774	National Institutes of Health [RAI075015A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RAI075015A (to R. Q. and C. T. R.-K.).	Askar E, 2009, J MED VIROL, V81, P1204, DOI 10.1002/jmv.21491; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2006, J ENDOTOXIN RES, V12, P375, DOI 10.1179/096805106X118780; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dhiman N, 2007, J INFECT DIS, V195, P21, DOI 10.1086/510596; Duffy KE, 2007, CELL IMMUNOL, V248, P103, DOI 10.1016/j.cellimm.2007.10.002; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koehn J, 2007, HUM IMMUNOL, V68, P871, DOI 10.1016/j.humimm.2007.07.007; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodgers UR, 2009, MATRIX BIOL, V28, P263, DOI 10.1016/j.matbio.2009.04.006; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Schroder NWJ, 2005, GENES IMMUN, V6, P448, DOI 10.1038/sj.gene.6364221; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tantisira K, 2004, GENES IMMUN, V5, P343, DOI 10.1038/sj.gene.6364096; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Yang EJ, 2004, YONSEI MED J, V45, P359, DOI 10.3349/ymj.2004.45.2.359; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	47	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36635	36644		10.1074/jbc.M110.144402	http://dx.doi.org/10.1074/jbc.M110.144402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855885	hybrid, Green Published			2022-12-25	WOS:000284146100039
J	Crumbley, C; Wang, YJ; Kojetin, DJ; Burris, TP				Crumbley, Christine; Wang, Yongjun; Kojetin, Douglas J.; Burris, Thomas P.			Characterization of the Core Mammalian Clock Component, NPAS2, as a REV-ERB alpha/ROR alpha Target Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; CIRCADIAN-RHYTHMS; TRANSCRIPTION FACTOR; HORMONE-RECEPTORS; MOUSE-LIVER; EXPRESSION; HEME; IDENTIFICATION; PATHWAYS; LIGAND	The mammalian clock is regulated at the cellular level by a transcriptional/translational feedback loop. BMAL1/CLOCK (or NPAS2) heterodimers activate the expression of the PERIOD (PER) and CRYPTOCHROME (CRY) genes acting as transcription factors directed to the PER and CRY promoters via E-box elements. PER and CRY proteins form heterodimers and suppress the activity of the BMAL1/CLOCK (or NPAS2) completing the feedback loop. The circadian expression of BMAL1 is influenced by retinoic acid receptor-related orphan receptor alpha (ROR alpha) and REV-ERB alpha, two nuclear receptors that target a ROR-response element in the promoter of the BMAL1 gene. Given that BMAL1 functions as an obligate heterodimer with either CLOCK or NPAS2, it is unclear how the expression of the partner is coordinated with BMAL1 expression. Here, we demonstrate that NPAS2 is also a ROR alpha and REV-ERB alpha target gene. Using a ChIP/microarray screen, we identified both ROR alpha and REV-ERB alpha occupancy of the NPAS2 promoter. We identified two functional ROREs within the NPAS2 promoter and also demonstrate that both ROR alpha and REV-ERB alpha regulate the expression of NPAS2 mRNA. These data suggest a mechanism by which ROR alpha and REV-ERB alpha coordinately regulate the expression of the positive arm of the circadian rhythm feedback loop.	[Crumbley, Christine; Wang, Yongjun; Kojetin, Douglas J.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080201 (to T. P. B.).	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Ishida M, 2008, BIOCHEM BIOPH RES CO, V368, P292, DOI 10.1016/j.bbrc.2008.01.053; Koudo R, 2005, FEBS J, V272, P4153, DOI 10.1111/j.1742-4658.2005.04828.x; Koyanagi S, 2006, MOL ENDOCRINOL, V20, P573, DOI 10.1210/me.2005-0165; Koyanagi S, 2002, MOL PHARMACOL, V62, P1393, DOI 10.1124/mol.62.6.1393; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; LEE YH, 1994, J BIOL CHEM, V269, P14681; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Mukaiyama Y, 2006, FEBS J, V273, P2528, DOI 10.1111/j.1742-4658.2006.05259.x; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Rudic RD, 2005, METHOD ENZYMOL, V393, P524, DOI 10.1016/S0076-6879(05)93027-9; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835	43	97	99	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35386	35392		10.1074/jbc.M110.129288	http://dx.doi.org/10.1074/jbc.M110.129288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817722	hybrid, Green Published			2022-12-25	WOS:000283845300016
J	Zheng, YB; Zhao, YD; Gibbons, M; Abramova, T; Chu, PY; Ash, JD; Cunningham, JM; Skapek, SX				Zheng, Yanbin; Zhao, Yi D.; Gibbons, Melissa; Abramova, Tatiana; Chu, Patricia Y.; Ash, John D.; Cunningham, John M.; Skapek, Stephen X.			Tgf beta Signaling Directly Induces Arf Promoter Remodeling by a Mechanism Involving Smads 2/3 and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; GROWTH-FACTOR-BETA; CELL-CYCLE ARREST; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; EYE DEVELOPMENT; FAMILY MEMBERS; MOUSE EYE; EXPRESSION; P19(ARF)	We have investigated how the Arf gene product, p19(Arf), is activated by Tgf beta during mouse embryo development to better understand how this important tumor suppressor is controlled. Taking advantage of new mouse models, we provide genetic evidence that Arf lies downstream of Tgf beta signaling in cells arising from the Wnt1-expressing neural crest and that the anti-proliferative effects of Tgf beta depend on Arf in vivo. Tgf beta 1, -2, and -3 (but not BMP-2, another member of the Tgf beta superfamily) induce p19(Arf) expression in wild type mouse embryo fibroblasts (MEFs), and they enhance Arf promoter activity in Arf(dacZ/lacZ) MEFs. Application of chemical inhibitors of Smad-dependent and -independent pathways show that SB431542, a Tgf beta type I receptor (T beta rI) inhibitor, and SB203580, a p38 MAPK inhibitor, impede Tgf beta 2 induction of Arf. Genetic studies confirm the findings; transient knockdown of Smad2, Smad3, or p38 MAPK blunt Tgf beta 2 effects, as does Cre recombinase treatment of Tgfbr(2fl/fl) MEFs to delete Tgf beta receptor II. Chromatin immunoprecipitation reveals that Tgf beta rapidly induces Smads 2/3 binding and histone H3 acetylation at genomic DNA proximal to Arf exon 1 beta. This is followed by increased RNA polymerase II binding and progressively increased Arf primary and mature transcripts from 24 through 72 h, indicating that increased transcription contributes to p19(Arf) increase. Last, Arf induction by oncogenic Ras depends on p38 MAPK but is independent of T beta rI activation of Smad 2. These findings add to our understanding of how developmental and tumorigenic signals control Arf expression in vivo and in cultured MEFs.	[Cunningham, John M.; Skapek, Stephen X.] Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA; [Ash, John D.] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Chicago; University of Oklahoma System; University of Oklahoma Health Sciences Center	Skapek, SX (corresponding author), Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, KCBD-5102,900 E 57th St, Chicago, IL 60637 USA.	sskapek@peds.bsd.uchicago.edu		Ash, John/0000-0002-8330-7301	National Institutes of Health [R01 EY0194368, EY019942]; American Diabetes Association [1-06-RA-05]; NATIONAL EYE INSTITUTE [R01EY019942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY0194368 and EY019942 (NEI, to S. X. S.).; Supported by American Diabetes Association Grant 1-06-RA-05) (to J. D. A.).	ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Euler-Taimor G, 2006, CARDIOVASC RES, V69, P15, DOI 10.1016/j.cardiores.2005.07.007; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; Freeman-Anderson NE, 2009, DEVELOPMENT, V136, P2081, DOI 10.1242/dev.033548; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Gromley A, 2009, P NATL ACAD SCI USA, V106, P6285, DOI 10.1073/pnas.0902310106; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Ittner L., 2005, J BIOL, V4, P111; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Katuri V, 2005, ONCOGENE, V24, P8012, DOI 10.1038/sj.onc.1208946; Khaliq S, 2001, INVEST OPHTH VIS SCI, V42, P2225; Ki KD, 2009, J GYNECOL ONCOL, V20, P117, DOI 10.3802/jgo.2009.20.2.117; Kimoto K, 2004, INVEST OPHTH VIS SCI, V45, P2431, DOI 10.1167/iovs.03-1276; Kiss A, 1997, CLIN CANCER RES, V3, P1059; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LIN AE, 1990, OPHTHALMIC PAED GEN, V11, P121, DOI 10.3109/13816819009012956; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; MARQUARDT H, 1983, P NATL ACAD SCI-BIOL, V80, P4684; Martin AC, 2004, INVEST OPHTH VIS SCI, V45, P3387, DOI 10.1167/iovs.04-0349; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2009, CANCER RES, V69, P2588, DOI 10.1158/0008-5472.CAN-08-2312; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; Thornton JD, 2007, INVEST OPHTH VIS SCI, V48, P491, DOI 10.1167/iovs.06-0765; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WANG MK, 1973, ACTA OPHTHALMOL, V51, P434; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zhao SL, 2001, DEV BIOL, V237, P45, DOI 10.1006/dbio.2001.0360; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	62	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35654	35664		10.1074/jbc.M110.128959	http://dx.doi.org/10.1074/jbc.M110.128959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826783	Green Published, hybrid			2022-12-25	WOS:000283845300044
J	Clarke, DL; Clifford, RL; Jindarat, S; Proud, D; Pang, LH; Belvisi, M; Knox, AJ				Clarke, Deborah L.; Clifford, Rachel L.; Jindarat, Sarawut; Proud, David; Pang, Linhua; Belvisi, Maria; Knox, Alan J.			TNF alpha and IFN gamma Synergistically Enhance Transcriptional Activation of CXCL10 in Human Airway Smooth Muscle Cells via STAT-1, NF-kappa B, and the Transcriptional Coactivator CREB-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HISTONE H4 ACETYLATION; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; RNA-POLYMERASE-II; INTERFERON-GAMMA; GENE-TRANSCRIPTION; GLUCOCORTICOID-RECEPTOR; DEPENDENT TRANSCRIPTION; INDUCIBLE PROTEIN-10	Asthmatic airway smooth muscle (ASM) expresses interferon-gamma-inducible protein-10 (CXCL10), a chemokine known to mediate mast cell migration into ASM bundles that has been reported in the airways of asthmatic patients. CXCL10 is elevated in patients suffering from viral exacerbations of asthma and in patients with chronic obstructive pulmonary disease (COPD), diseases in which corticosteroids are largely ineffective. IFN gamma and TNF alpha synergistically induce CXCL10 release from human ASM cells in a steroid-insensitive manner, via an as yet undefined mechanism. We report that TNF alpha activates the classical NF-kappa B (nuclear factor kappa B) pathway, whereas IFN gamma activates JAK2/STAT-1 alpha and that inhibition of the JAK/STAT pathway is more effective in abrogating CXCL10 release than the steroid fluticasone. The synergy observed with TNF alpha and IFN gamma together, however, did not lie at the level of NF-kappa B activation, STAT-1 alpha phosphorylation, or in vivo binding of these transcription factors to the CXCL10 promoter. Stimulation of human ASM cells with TNF alpha and IFN gamma induced histone H4 but not histone H3 acetylation at the CXCL10 promoter, although no synergism was observed when both cytokines were combined. We show, however, that TNF alpha and IFN gamma exert a synergistic effect on the recruitment of CREB-binding protein (CBP) to the CXCL10, which is accompanied by increased RNA polymerase II. Our results provide evidence that synergism between TNF alpha and IFN gamma lies at the level of coactivator recruitment in human ASM and suggest that inhibition of JAK/STAT signaling may be of therapeutic benefit in steroid-resistant airway disease.	[Clifford, Rachel L.; Jindarat, Sarawut; Pang, Linhua; Knox, Alan J.] Univ Nottingham, City Hosp, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Proud, David] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Clarke, Deborah L.; Belvisi, Maria] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Calgary; Imperial College London	Clarke, DL (corresponding author), MedImmune, Granta Pk, Cambridge CB21 6GH, England.	ClarkeD@MedImmune.com	Belvisi, Maria G/A-3055-2009	Clifford, Rachel/0000-0002-8677-452X; Knox, Alan/0000-0002-5906-4143	Asthma UK [06/016] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: Medline; BBSRC [BB/E52708X/1] Funding Source: UKRI	Asthma UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Boorsma DM, 1998, ARCH DERMATOL RES, V290, P335, DOI 10.1007/s004030050314; Borie DC, 2005, TRANSPLANTATION, V80, P1756, DOI 10.1097/01.tp.0000184634.25042.ea; Bradbury D, 2005, J BIOL CHEM, V280, P29993, DOI 10.1074/jbc.M414530200; Bradding P, 2007, RESP MED, V101, P1045, DOI 10.1016/j.rmed.2007.01.004; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Clarke DL, 2005, AM J PHYSIOL-LUNG C, V288, pL238, DOI 10.1152/ajplung.00313.2004; Clarke DL, 2004, BRIT J PHARMACOL, V141, P1141, DOI 10.1038/sj.bjp.0705716; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; El-Haroun H, 2008, AM J PHYSIOL-LUNG C, V294, pL553, DOI 10.1152/ajplung.00044.2006; Frangogiannis NG, 2000, CELL TISSUE RES, V302, P365, DOI 10.1007/s004410000274; Gasperini S, 1999, J IMMUNOL, V162, P4928; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Hogan JC, 2001, BIOCHEM BIOPH RES CO, V287, P484, DOI 10.1006/bbrc.2001.5606; John M, 1997, J IMMUNOL, V158, P1841; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Keslacy S, 2007, MOL PHARMACOL, V71, P609, DOI 10.1124/mol.106.030171; Kost ER, 1999, GYNECOL ONCOL, V72, P392, DOI 10.1006/gyno.1998.5257; KRAKAUER T, 1993, J IMMUNOL, V150, P1205; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Majumder S, 1998, J IMMUNOL, V161, P4736; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Milici AJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2365; Mullan CS, 2008, AM J RESP CELL MOL, V38, P600, DOI 10.1165/rcmb.2007-0082OC; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Nie M, 2005, J IMMUNOL, V175, P478, DOI 10.4049/jimmunol.175.1.478; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pang LH, 2001, FASEB J, V15, P261, DOI 10.1096/fj.00-0103com; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ren XD, 2002, SHOCK, V17, P513, DOI 10.1097/00024382-200206000-00013; Romagnani P, 2002, J AM SOC NEPHROL, V13, P53, DOI 10.1681/ASN.V13153; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Sauty A, 1999, J IMMUNOL, V162, P3549; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Stocks J, 2005, FEBS LETT, V579, P2551, DOI 10.1016/j.febslet.2005.02.083; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suk K, 2001, FEBS LETT, V495, P66, DOI 10.1016/S0014-5793(01)02335-3; Sukkar MB, 2004, AM J PHYSIOL-LUNG C, V287, pL1230, DOI 10.1152/ajplung.00014.2004; Tliba O, 2006, MOL PHARMACOL, V69, P588, DOI 10.1124/mol.105.019679; Tliba O, 2004, MOL PHARMACOL, V66, P322, DOI 10.1124/mol.104.001040; Tliba O, 2003, J BIOL CHEM, V278, P50615, DOI 10.1074/jbc.M303680200; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Wada H, 2005, BIOCHEM BIOPH RES CO, V331, P93, DOI 10.1016/j.bbrc.2005.03.138; Wagner AH, 2002, BRIT J PHARMACOL, V136, P143, DOI 10.1038/sj.bjp.0704678; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Zhu YM, 2003, J BIOL CHEM, V278, P29366, DOI 10.1074/jbc.M301785200	63	107	113	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29101	29110		10.1074/jbc.M109.0999952	http://dx.doi.org/10.1074/jbc.M109.0999952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20833730	Green Published, Bronze			2022-12-25	WOS:000281740100011
J	Li, Q; Zhang, F; Li, X; Chen, FS				Li, Qin; Zhang, Feng; Li, Xin; Chen, Fengshan			Genome Scan for Locus Involved in Mandibular Prognathism in Pedigrees from China	PLOS ONE			English	Article							LINKAGE ANALYSIS; GENE	Background: It is well known that genetic components play an important role in the etiology of mandibular prognathism, but few susceptibility loci have been mapped. Methodology: In order to identify linkage regions for mandibular prognathism, we analyzed two Chinese pedigrees with 6,090 genome-wide single-nucleotide polymorphism (SNP) markers from Illumina Linkage-12 DNA Analysis Kit (average spacing 0.58 cM). Multipoint parametric and non-parametric (model-free) linkage analyses were used for the pedigrees. Principal Finding: The most statistically significant linkage results were with markers on chromosome 4 (LOD = 3.166 and NPL = 3.65 with rs 875864, 4p16.1, 8.38 cM). Candidate genes within the 4p16.1 include EVC, EVC2. Conclusion: We detected a novel suggestive linkage locus for mandibular prognathism in two Chinese pedigrees, and this linkage region provides target for susceptibility gene identification, a process that will provide important insights into the molecular and cellular basis of mandibular prognathism.	[Li, Qin; Chen, Fengshan] Tongji Univ, Dept Orthodont, Sch Dent, Shanghai 200092, Peoples R China; [Zhang, Feng; Li, Xin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Tongji University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Li, Q (corresponding author), Tongji Univ, Dept Orthodont, Sch Dent, Shanghai 200092, Peoples R China.	Orthodboy@126.com			Shanghai Pujiang Program [07pj14081]; Shanghai Key Basic Research Program [10JC1415500]	Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Key Basic Research Program	This research was sponsored by Shanghai Pujiang Program, 07pj14081 and Shanghai Key Basic Research Program, 10JC1415500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alexander AEZ, 2009, AM J ORTHOD DENTOFAC, V135, DOI 10.1016/j.ajodo.2008.06.025; Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Bukhary Mohammed Taher, 2005, J Oral Sci, V47, P83, DOI 10.2334/josnusd.47.83; Chang HP, 2006, J FORMOS MED ASSOC, V105, P781, DOI 10.1016/S0929-6646(09)60264-3; CHEN YJ, 2010, CHONGQING MED, V39, P358; Cruz RM, 2008, AM J MED GENET A, V146A, P71, DOI 10.1002/ajmg.a.32062; El-Gheriani AA, 2003, J DENT RES, V82, P523, DOI 10.1177/154405910308200707; Frazier-Bowers S, 2009, J DENT RES, V88, P56, DOI 10.1177/0022034508327817; FU MK, 2005, ORTHODONTICS; Jena A K, 2005, J Indian Soc Pedod Prev Dent, V23, P27; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LITTON SF, 1970, AMER J ORTHODONTICS, V58, P565, DOI 10.1016/0002-9416(70)90145-4; MCNAMARA JA, 1984, AM J ORTHOD DENTOFAC, V86, P449, DOI 10.1016/S0002-9416(84)90352-X; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PASCOE J J, 1960, J Oral Surg Anesth Hosp Dent Serv, V18, P21; Ruiz-Perez VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063; Staudt CB, 2009, AM J ORTHOD DENTOFAC, V136, P715, DOI 10.1016/j.ajodo.2007.10.061; Ulucan H, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-92; Watanabe M, 2005, AM J ORTHOD DENTOFAC, V128, P466, DOI 10.1016/j.ajodo.2004.09.018; WOLFF G, 1993, J MED GENET, V30, P112, DOI 10.1136/jmg.30.2.112; Yamaguchi T, 2005, J DENT RES, V84, P255, DOI 10.1177/154405910508400309	22	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12678	10.1371/journal.pone.0012678	http://dx.doi.org/10.1371/journal.pone.0012678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844756	gold, Green Submitted, Green Published			2022-12-25	WOS:000281687300017
J	Laiakis, EC; Morris, GAJ; Fornace, AJ; Howie, SRC				Laiakis, Evagelia C.; Morris, Gerard A. J.; Fornace, Albert J., Jr.; Howie, Stephen R. C.			Metabolomic Analysis in Severe Childhood Pneumonia in The Gambia, West Africa: Findings from a Pilot Study	PLOS ONE			English	Article							GAMMA-RADIATION EXPOSURE; URIC-ACID; GUT MICROBIOTA; BIOMARKERS; CHILDREN; INFLAMMATION; NUCLEOTIDES; MORTALITY; PROFILES; ETIOLOGY	Background: Pneumonia remains the leading cause of death in young children globally and improved diagnostics are needed to better identify cases and reduce case fatality. Metabolomics, a rapidly evolving field aimed at characterizing metabolites in biofluids, has the potential to improve diagnostics in a range of diseases. The objective of this pilot study is to apply metabolomic analysis to childhood pneumonia to explore its potential to improve pneumonia diagnosis in a high-burden setting. Methodology/Principal Findings: Eleven children with World Health Organization (WHO)-defined severe pneumonia of non-homogeneous aetiology were selected in The Gambia, West Africa, along with community controls. Metabolomic analysis of matched plasma and urine samples was undertaken using Ultra Performance Liquid Chromatography (UPLC) coupled to Time-of-Flight Mass Spectrometry (TOFMS). Biomarker extraction was done using SIMCA-P+ and Random Forests (RF). 'Unsupervised' (blinded) data were analyzed by Principal Component Analysis (PCA), while 'supervised' (unblinded) analysis was by Partial Least Squares-Discriminant Analysis (PLS-DA) and Orthogonal Projection to Latent Structures (OPLS). Potential markers were extracted from S-plots constructed following analysis with OPLS, and markers were chosen based on their contribution to the variation and correlation within the data set. The dataset was additionally analyzed with the machine-learning algorithm RF in order to address issues of model overfitting and markers were selected based on their variable importance ranking. Unsupervised PCA analysis revealed good separation of pneumonia and control groups, with even clearer separation of the groups with PLS-DA and OPLS analysis. Statistically significant differences (p<0.05) between groups were seen with the following metabolites: uric acid, hypoxanthine and glutamic acid were higher in plasma from cases, while L-tryptophan and adenosine-5'-diphosphate (ADP) were lower; uric acid and L-histidine were lower in urine from cases. The key limitation of this study is its small size. Conclusions/Significance: Metabolomic analysis clearly distinguished severe pneumonia patients from community controls. The metabolites identified are important for the host response to infection through antioxidant, inflammatory and antimicrobial pathways, and energy metabolism. Larger studies are needed to determine whether these findings are pneumonia-specific and to distinguish organism-specific responses. Metabolomics has considerable potential to improve diagnostics for childhood pneumonia.	[Laiakis, Evagelia C.; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Laiakis, Evagelia C.; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Morris, Gerard A. J.; Howie, Stephen R. C.] Med Res Council UK Labs, Bacterial Dis Programme, Banjul, Gambia; [Fornace, Albert J., Jr.] Dankook Univ, WCU Res Ctr Nanobiomed Sci, Cheonan, South Korea	Georgetown University; Georgetown University; University of London; London School of Hygiene & Tropical Medicine; Dankook University	Laiakis, EC (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.	showie@mrc.gm	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Laiakis, Evagelia/0000-0002-4924-9013	Georgetown University; Medical Research Council (UK); Ministry of Education, Science and Technology [R31-10069]; MRC [MC_U190088478] Funding Source: UKRI; Medical Research Council [MC_U190088478] Funding Source: researchfish	Georgetown University; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Georgetown University and the Medical Research Council (UK). This work was supported in part by grant R31-10069 (WCU program) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burian K, 2003, IMMUNOL LETT, V89, P229, DOI 10.1016/S0165-2478(03)00154-8; CASIMIR GJ, 2009, SHOCK; Cassiday Laura, 2009, J Proteome Res, V8, P5409, DOI 10.1021/pr9009832; Combes A, 2009, CRIT CARE MED, V37, P2506, DOI 10.1097/CCM.0b013e3181a569df; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; *GAMB CENTR STAT D, 2003, 2003 CENS; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gear ARL, 2001, BLOOD, V97, P937, DOI 10.1182/blood.V97.4.937; GREENWOOD BM, 1987, ANN TROP PAEDIATR, V7, P91, DOI 10.1080/02724936.1987.11748482; Greenwood B, 2008, B WORLD HEALTH ORGAN, V86, P322, DOI 10.2471/BLT.08.053348; Griffin JL, 2007, J PROTEOME RES, V6, P498, DOI 10.1021/pr060464h; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Himmelreich U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005328; Howie SRC, 2006, LANCET, V368, P1646, DOI 10.1016/S0140-6736(06)69687-6; JABS CM, 1995, EUR J SURG, V161, P147; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jordan KW, 2007, EXPERT REV PROTEOMIC, V4, P389, DOI 10.1586/14789450.4.3.389; Kinross J, 2009, CURR PHARM DESIGN, V15, P1537, DOI 10.2174/138161209788168119; Lanz C, 2009, RADIAT RES, V172, P198, DOI 10.1667/RR1796.1; Mahadevan S, 2008, ANAL CHEM, V80, P7562, DOI 10.1021/ac800954c; MATHERS CSC, GLOBAL BURDEN DIS 20; Mene P, 2008, J HYPERTENS, V26, P2085, DOI 10.1097/HJH.0b013e32830e4945; Morris GAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001773; Mulholland K, 2003, PEDIATR PULM, V36, P469, DOI 10.1002/ppul.10344; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; MULLER A, 2008, J CELL MOL MED; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; PATTERSON AD, 2009, MASS SPECTROM REV; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; QAZI SWM, 2008, GLOBAL ACTION PLAN P; Reade MC, 2009, CRIT CARE MED, V37, P1655, DOI 10.1097/CCM.0b013e31819da853; RODRIGUEZNUNEZ A, 1993, ACTA PAEDIATR, V82, P849, DOI 10.1111/j.1651-2227.1993.tb12577.x; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schmidt H, 1997, J SURG RES, V71, P61, DOI 10.1006/jsre.1997.5098; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; Serkova NJ, 2008, AM J PHYSIOL-LUNG C, V295, pL152, DOI 10.1152/ajplung.00515.2007; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; Slupsky CM, 2009, J PROTEOME RES, V8, P3029, DOI 10.1021/pr900103y; Slupsky CM, 2009, J PROTEOME RES, V8, P5550, DOI 10.1021/pr9006427; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tuohy KM, 2009, CURR PHARM DESIGN, V15, P1415, DOI 10.2174/138161209788168182; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; *UN SECR GEN, 2001, ROAD MAP IMPL UN MIL; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; *WHO, 2003, WHOFCHCAH039; *WHO, 2002, REV GLOB BURD DIS GB, P2005; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232; YUE S, HUNAN YI KE DA XUE X, V24, P287	58	74	78	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12655	10.1371/journal.pone.0012655	http://dx.doi.org/10.1371/journal.pone.0012655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844590	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687200016
J	Rydzak, CE; Cotich, KL; Sax, PE; Hsu, HE; Wang, BX; Losina, E; Freedberg, KA; Weinstein, MC; Goldie, SJ				Rydzak, Chara E.; Cotich, Kara L.; Sax, Paul E.; Hsu, Heather E.; Wang, Bingxia; Losina, Elena; Freedberg, Kenneth A.; Weinstein, Milton C.; Goldie, Sue J.		CEPAC Investigators	Assessing the Performance of a Computer-Based Policy Model of HIV and AIDS	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNTS; MULTIPLE VIROLOGICAL FAILURES; MYCOBACTERIUM-AVIUM COMPLEX; SEQUENTIAL 3-DRUG REGIMENS; WOMENS INTERAGENCY HIV; SOCIETY-USA PANEL; COST-EFFECTIVENESS; UNITED-STATES; OPPORTUNISTIC INFECTIONS	Background: Model-based analyses, conducted within a decision analytic framework, provide a systematic way to combine information about the natural history of disease and effectiveness of clinical management strategies with demographic and epidemiological characteristics of the population. Among the challenges with disease-specific modeling include the need to identify influential assumptions and to assess the face validity and internal consistency of the model. Methods and Findings: We describe a series of exercises involved in adapting a computer-based simulation model of HIV disease to the Women's Interagency HIV Study (WIHS) cohort and assess model performance as we re-parameterized the model to address policy questions in the U.S. relevant to HIV-infected women using data from the WIHS. Empiric calibration targets included 24-month survival curves stratified by treatment status and CD4 cell count. The most influential assumptions in untreated women included chronic HIV-associated mortality following an opportunistic infection, and in treated women, the 'clinical effectiveness' of HAART and the ability of HAART to prevent HIV complications independent of virologic suppression. Good-fitting parameter sets required reductions in the clinical effectiveness of 1(st) and 2(nd) line HAART and improvements in 3(rd) and 4(th) line regimens. Projected rates of treatment regimen switching using the calibrated cohort-specific model closely approximated independent analyses published using data from the WIHS. Conclusions: The model demonstrated good internal consistency and face validity, and supported cohort heterogeneities that have been reported in the literature. Iterative assessment of model performance can provide information about the relative influence of uncertain assumptions and provide insight into heterogeneities within and between cohorts. Description of calibration exercises can enhance the transparency of disease-specific models.	[Rydzak, Chara E.; Hsu, Heather E.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rydzak, Chara E.; Cotich, Kara L.; Freedberg, Kenneth A.; Weinstein, Milton C.; Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Hsu, Heather E.; Wang, Bingxia; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Harvard University; Massachusetts General Hospital	Rydzak, CE (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	sue_goldie@harvard.edu		Losina, ELENA/0000-0002-3424-0892; Hsu, Heather/0000-0002-5863-1804; Lipsitch, Marc/0000-0003-1504-9213	National Institute of Allergy and Infectious Diseases [R37 AI042006, K24 AI062476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI062476, R37AI042006] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute of Allergy and Infectious Diseases (R37 AI042006, K24 AI062476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastos K, 2005, JAIDS-J ACQ IMM DEF, V39, P537; Anastos K, 1999, AIDS, V13, P1717, DOI 10.1097/00002030-199909100-00016; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Deeks SG, 2009, CLIN INFECT DIS, V49, P1582, DOI 10.1086/644768; Detels R, 2001, AIDS, V15, P347, DOI 10.1097/00002030-200102160-00008; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; *DHHS HJ KAIS FAM, 2001, GUID US ANT AG HIV I; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grabar S, 2005, JAIDS-J ACQ IMM DEF, V39, P284, DOI 10.1097/01.qai.0000160925.33935.72; Grant LA, 2001, AIDS, V15, P2101, DOI 10.1097/00002030-200111090-00005; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; Johnson M, 2006, AIDS, V20, P711, DOI 10.1097/01.aids.0000216371.76689.63; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Kimmel AD, 2005, ANTIVIR THER, V10, P41; Kirstein LM, 2002, J ACQ IMMUN DEF SYND, V29, P495, DOI 10.1097/00126334-200204150-00010; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Kleeberger CA, 2001, J ACQ IMMUN DEF SYND, V26, P82, DOI 10.1097/00126334-200101010-00012; Kousignian I, 2008, CLIN INFECT DIS, V46, P296, DOI 10.1086/524753; LALEZARI J, 2007, EFFICACY SAFETY MARA; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Losina E, 2006, SAMJ S AFR MED J, V96, P526; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; *NAT TECHN INF SER, MULT AIDS COH STUD M; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; NIGHTINGALE SD, 1993, NEW ENGL J MED, V329, P828, DOI 10.1056/NEJM199309163291202; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Porter K, 2008, JAIDS-J ACQ IMM DEF, V47, P202, DOI 10.1097/QAI.0b013e31815b1291; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; SAAG MS, 1998, 12 WORLD AIDS C GEN; Schackman BR, 2001, AM J PUBLIC HEALTH, V91, P1456, DOI 10.2105/AJPH.91.9.1456; Seage GR, 2002, J ACQ IMMUN DEF SYND, V30, P421, DOI [10.1097/01.QAI.0000021700.48448.69, 10.1097/00042560-200208010-00008]; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; TODD J, 1995, J ACQUIR IMMUNE D S2, V10, P35; *U CA, WOM INT HIV STUD; van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Weinstein MC, 2006, PHARMACOECONOMICS, V24, P1043, DOI 10.2165/00019053-200624110-00002; Wolf LL, 2007, JAIDS-J ACQ IMM DEF, V46, P463, DOI 10.1097/QAI.0b013e3181594c38; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yeni P, 2006, LANCET, V368, P287, DOI 10.1016/S0140-6736(06)69074-0; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	69	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12647	10.1371/journal.pone.0012647	http://dx.doi.org/10.1371/journal.pone.0012647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844741	gold, Green Published, Green Submitted			2022-12-25	WOS:000281687200012
J	Gavriouchkina, D; Fischer, S; Ivacevic, T; Stolte, J; Benes, V; Dekens, MPS				Gavriouchkina, Daria; Fischer, Sabine; Ivacevic, Tomi; Stolte, Jens; Benes, Vladimir; Dekens, Marcus P. S.			Thyrotroph Embryonic Factor Regulates Light-Induced Transcription of Repair Genes in Zebrafish Embryonic Cells	PLOS ONE			English	Article							LEUCINE-ZIPPER PROTEINS; CIRCADIAN-CLOCK; DNA-DAMAGE; EXPRESSION; CYCLE; TEF; VERTEBRATE; PHOTOLYASE; PATHWAYS; IDENTIFICATION	Numerous responses are triggered by light in the cell. How the light signal is detected and transduced into a cellular response is still an enigma. Each zebrafish cell has the capacity to directly detect light, making this organism particularly suitable for the study of light dependent transcription. To gain insight into the light signalling mechanism we identified genes that are activated by light exposure at an early embryonic stage, when specialised light sensing organs have not yet formed. We screened over 14,900 genes using micro-array GeneChips, and identified 19 light-induced genes that function primarily in light signalling, stress response, and DNA repair. Here we reveal that PAR Response Elements are present in all promoters of the light-induced genes, and demonstrate a pivotal role for the PAR bZip transcription factor Thyrotroph embryonic factor (Tef) in regulating the majority of light-induced genes. We show that tef beta transcription is directly regulated by light while transcription of tef alpha is under circadian clock control at later stages of development. These data leads us to propose their involvement in light-induced UV tolerance in the zebrafish embryo.	[Gavriouchkina, Daria; Fischer, Sabine; Ivacevic, Tomi; Stolte, Jens; Benes, Vladimir; Dekens, Marcus P. S.] European Mol Biol Lab, Genom Core Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Gavriouchkina, D (corresponding author), European Mol Biol Lab, Genom Core Unit, Heidelberg, Germany.	benes@embl.de; marcus.dekens@gmail.com	Gavriouchkina, Daria/K-8471-2019; Gavriouchkina, Daria/K-8256-2019	Gavriouchkina, Daria/0000-0002-7488-5898; Benes, Vladimir/0000-0002-0352-2547; Dekens, Marcus P.S./0000-0003-1689-3491	European Molecular Biology Laboratory	European Molecular Biology Laboratory	This work was funded by the European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bedo G, 2005, INT J DEV BIOL, V49, P431, DOI 10.1387/ijdb.041901gb; Carayon P, 1996, BLOOD, V87, P3170, DOI 10.1182/blood.V87.8.3170.bloodjournal8783170; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Delaunay F, 2003, GENE EXPR PATTERNS, V3, P319, DOI 10.1016/S1567-133X(03)00050-4; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; FALVEY E, 1995, EMBO J, V14, P4307, DOI 10.1002/j.1460-2075.1995.tb00105.x; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; HAAS NB, 1995, MOL CELL BIOL, V15, P1923; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Hirayama J, 2009, CELL CYCLE, V8, P2794, DOI 10.4161/cc.8.17.9447; Ishikawa T, 2002, GENES CELLS, V7, P1073, DOI 10.1046/j.1365-2443.2002.00579.x; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sancar A, 2004, ADV PROTEIN CHEM, V69, P73; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tanida H, 2005, FEBS J, V272, P6098, DOI 10.1111/j.1742-4658.2005.05004.x; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Xu XZ, 1998, BBA-GENE STRUCT EXPR, V1395, P13, DOI 10.1016/S0167-4781(97)00150-4; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	48	46	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12542	10.1371/journal.pone.0012542	http://dx.doi.org/10.1371/journal.pone.0012542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830285	Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300003
J	Cresci, S; Huss, JM; Beitelshees, AL; Jones, PG; Minton, MR; Dorn, GW; Kelly, DP; Spertus, JA; McLeod, HL				Cresci, Sharon; Huss, Janice M.; Beitelshees, Amber L.; Jones, Philip G.; Minton, Matt R.; Dorn, Gerald W., II; Kelly, Daniel P.; Spertus, John A.; McLeod, Howard L.			A PPAR alpha Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; ACUTE MYOCARDIAL-INFARCTION; FATTY-ACID OXIDATION; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; INSULIN-RESISTANCE; ENERGY-METABOLISM; NUCLEAR RECEPTORS; UNSTABLE ANGINA; HEART-DISEASE	Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha) occurs in animal models of diabetes (DM) and is implicated in pathological responses to myocardial ischemia. Using bioinformatics, we identified a single nucleotide polymorphism (SNP) in the PPAR alpha gene promoter (PPARA -54,642 G>A; rs135561) that altered the consensus sequence for a nuclear receptor binding site. Electrophoretic mobility shift assays showed that the domain bound two known PPARA transcriptional activators, estrogen-related receptor (ERR)-alpha and -gamma and that PPARA G bound with greater affinity than PPARA A (>2-fold; P<0.05). Likewise, promoter-reporter analyses showed enhanced transcriptional activity for PPARA G vs. PPARA A for both ERR-alpha and -gamma (3.1 vs. 1.9-fold; P,0.05). Since PPAR alpha activation impairs post-ischemic cardiac function in experimental models of DM, we tested whether decreased PPARA transcription in PPARA A carriers favorably impacted outcome after acute coronary ischemia in 705 patients hospitalized with acute coronary syndromes (ACS; 552 Caucasian, 106 African American). PPARA A allele frequencies were similar to non-diseased subjects. However, PPARA genotype correlated with 5-year mortality in diabetic (22.2% AA vs. 18.8% AG vs. 39.5% GG; P = 0.008), but not non-diabetic (P = 0.96) subjects (genotype by diabetes interaction P = 0.008). In the diabetic ACS subjects, PPARA A carriers had strikingly reduced all-cause mortality compared to PPARA G homozygotes, (unadjusted HR 0.44, 95% CI 0.26-0.75; P = 0.003; adjusted HR 0.48, 95% CI 0.27-0.83; P = 0.009). Consistent with previous descriptions of PPARa in experimental models and human disease, we describe a novel PPARA promoter SNP that decreases transcriptional activation of PPARA and protects against mortality in diabetic patients after ACS.	[Cresci, Sharon; Minton, Matt R.; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Huss, Janice M.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Beitelshees, Amber L.] Univ Maryland, Baltimore, MD 21201 USA; [Jones, Philip G.; Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Jones, Philip G.; Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA; [Kelly, Daniel P.] Burnham Inst Med Res, Orlando, FL USA; [McLeod, Howard L.] Univ N Carolina, Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC USA	Washington University (WUSTL); City of Hope; University System of Maryland; University of Maryland Baltimore; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill	Cresci, S (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	scresci@dom.wustl.edu	Spertus, John/ABD-3075-2021; Kelly, Daniel/ABG-2056-2021; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Institutes of Health (NIH) Specialized Center for Clinically-Oriented Research (SCCOR) in Cardiac Dysfunction and Disease [1 P50 HL077113]; NIH Pharmacogenetics Research Network [U01 GM63340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Specialized Center for Clinically-Oriented Research (SCCOR) in Cardiac Dysfunction and Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded by the National Institutes of Health (NIH) Specialized Center for Clinically-Oriented Research (SCCOR) in Cardiac Dysfunction and Disease # 1 P50 HL077113 and NIH Pharmacogenetics Research Network grant U01 GM63340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Behar S, 1997, AM HEART J, V133, P290, DOI 10.1016/S0002-8703(97)70222-9; Bouhanick B, 2006, DIABETES METAB, V32, P460, DOI 10.1016/S1262-3636(07)70304-X; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chen S, 2004, PHARMACOGENETICS, V14, P61, DOI 10.1097/00008571-200401000-00007; Chew CH, 2003, BIOCHEM BIOPH RES CO, V305, P235, DOI 10.1016/S0006-291X(03)00731-9; Cresci S, 1999, J BIOL CHEM, V274, P25668, DOI 10.1074/jbc.274.36.25668; Cubbon RM, 2007, EUR HEART J, V28, P540, DOI 10.1093/eurheartj/ehl510; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Doney Alex S F, 2005, Nucl Recept, V3, P4, DOI 10.1186/1478-1336-3-4; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582; Flavell DM, 2000, DIABETOLOGIA, V43, P673, DOI 10.1007/s001250051357; Franklin K, 2004, ARCH INTERN MED, V164, P1457, DOI 10.1001/archinte.164.13.1457; Fujiwara K, 2002, CIRC J, V66, P800, DOI 10.1253/circj.66.800; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hansen HHT, 2007, SCAND CARDIOVASC J, V41, P19, DOI 10.1080/14017430601099238; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2001, J BIOL CHEM, V276, P27605, DOI 10.1074/jbc.M100277200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jamshidi Y, 2002, CIRCULATION, V105, P950, DOI 10.1161/hc0802.104535; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Madsen MM, 2005, AM J CARDIOL, V96, P1469, DOI 10.1016/j.amjcard.2005.07.053; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; MALMBERG K, 1988, EUR HEART J, V9, P259, DOI 10.1093/oxfordjournals.eurheartj.a062494; Marsh S, 2005, METH MOL B, V311, P97; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Spertus J, 2005, J AM COLL CARDIOL, V46, P1838, DOI 10.1016/j.jacc.2005.05.092; Svensson AM, 2004, SCAND CARDIOVASC J, V38, P229, DOI 10.1080/14017430410016297; Tai ES, 2005, J NUTR, V135, P397, DOI 10.1093/jn/135.3.397; Tai ES, 2002, ARTERIOSCL THROM VAS, V22, P805, DOI 10.1161/01.ATV.0000012302.11991.42; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao T, 2004, HUM MUTAT, V23, P534, DOI 10.1002/humu.20049	61	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12584	10.1371/journal.pone.0012584	http://dx.doi.org/10.1371/journal.pone.0012584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838448	Green Published, Green Submitted, gold			2022-12-25	WOS:000281627700024
J	Bonifacio, LN; Jarstfer, MB				Bonifacio, Laura N.; Jarstfer, Michael B.			MiRNA Profile Associated with Replicative Senescence, Extended Cell Culture, and Ectopic Telomerase Expression in Human Foreskin Fibroblasts	PLOS ONE			English	Article							TUMOR-SUPPRESSOR NETWORK; UP-REGULATION; DNA METHYLATION; GROWTH ARREST; P53; MICRORNAS; PATHWAY; CANCER; IMMORTALIZATION; PROLIFERATION	Senescence is a highly regulated process that limits cellular replication by enforcing a G1 arrest in response to various stimuli. Replicative senescence occurs in response to telomeric DNA erosion, and telomerase expression can offset replicative senescence leading to immortalization of many human cells. Limited data exists regarding changes of microRNA (miRNA) expression during senescence in human cells and no reports correlate telomerase expression with regulation of senescence-related miRNAs. We used miRNA microarrays to provide a detailed account of miRNA profiles for early passage and senescent human foreskin (BJ) fibroblasts as well as early and late passage immortalized fibroblasts (BJ-hTERT) that stably express the human telomerase reverse transcriptase subunit hTERT. Selected miRNAs that were differentially expressed in senescence were assayed for expression in quiescent cells to identify miRNAs that are specifically associated with senescence-associated growth arrest. From this group of senescence-associated miRNAs, we confirmed the ability of miR-143 to induce growth arrest after ectopic expression in young fibroblasts. Remarkably, miR-143 failed to induce growth arrest in BJ-hTERT cells. Importantly, the comparison of late passage immortalized fibroblasts to senescent wild type fibroblasts reveals that miR-146a, a miRNA with a validated role in regulating the senescence associated secretory pathway, is also regulated during extended cell culture independently of senescence. The discovery that miRNA expression is impacted by expression of ectopic hTERT as well as extended passaging in immortalized fibroblasts contributes to a comprehensive understanding of the connections between telomerase expression, senescence and processes of cellular aging.	[Bonifacio, Laura N.; Jarstfer, Michael B.] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Bonifacio, LN (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	jarstfer@unc.edu			American Foundation for Aging Research; American Foundation for Pharmaceutical Research; National Science Foundation [MCB-0751372]	American Foundation for Aging Research; American Foundation for Pharmaceutical Research; National Science Foundation(National Science Foundation (NSF))	Supported by the American Foundation for Aging Research, an American Foundation for Pharmaceutical Research predoctoral fellowship to LNB, and the National Science Foundation (MCB-0751372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO Y, 2010, CANC GENE THER; Akao Y, 2006, ONCOL REP, V16, P845; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Katoh M, 2002, INT J ONCOL, V20, P1247; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; LI G, 2010, INVEST OPHTHALMOL VI; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; ZHAO T, 2010, AM J PHYSL ENDOCRINO	37	62	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12519	10.1371/journal.pone.0012519	http://dx.doi.org/10.1371/journal.pone.0012519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824140	Green Published, gold, Green Submitted			2022-12-25	WOS:000281456100019
J	Perez-Garay, M; Arteta, B; Pages, L; de Llorens, R; de Bolos, C; Vidal-Vanaclocha, F; Peracaula, R				Perez-Garay, Marta; Arteta, Beatriz; Pages, Lluis; de Llorens, Rafael; de Bolos, Carme; Vidal-Vanaclocha, Fernando; Peracaula, Rosa			alpha 2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo	PLOS ONE			English	Article							SIALYL-LEWIS-X; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; SINUSOIDAL ENDOTHELIAL-CELLS; MESSENGER-RNA EXPRESSION; HUMAN COLORECTAL-CANCER; NATURAL-KILLER-CELLS; HUMAN HEPATOCARCINOMA; FUCOSYL-TRANSFERASE; BREAST-CANCER; TUMOR-CELLS	Background: Cell surface sialylation is emerging as an important feature of cancer cell metastasis. Sialyltransferase expression has been reported to be altered in tumours and may account for the formation of sialylated tumour antigens. We have focused on the influence of alpha-2,3-sialyltransferase ST3Gal III in key steps of the pancreatic tumorigenic process. Methodology/Principal Findings: ST3Gal III overexpressing pancreatic adenocarcinoma cell lines Capan-1 and MDAPanc-28 were generated. They showed an increase of the tumour associated antigen sialyl-Lewis(x). The transfectants' E-selectin binding capacity was proportional to cell surface sialyl-Lewis(x) levels. Cellular migration positively correlated with ST3Gal III and sialyl-Lewis(x) levels. Moreover, intrasplenic injection of the ST3Gal III transfected cells into athymic nude mice showed a decrease in survival and higher metastasis formation when compared to the mock cells. Conclusion: In summary, the overexpression of ST3Gal III in these pancreatic adenocarcinoma cell lines underlines the role of this enzyme and its product in key steps of tumour progression such as adhesion, migration and metastasis formation.	[Perez-Garay, Marta; Pages, Lluis; de Llorens, Rafael; Peracaula, Rosa] Univ Girona, Biochem & Mol Biol Unit, Dept Biol, Girona, Spain; [Arteta, Beatriz; Vidal-Vanaclocha, Fernando] Univ Basque Country, Dept Cell Biol & Histol, Sch Med & Dent, Leioa, Spain; [de Bolos, Carme] Hosp del Mar, IMIM, Canc Res Program, Barcelona, Spain	Universitat de Girona; University of Basque Country; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Perez-Garay, M (corresponding author), Univ Girona, Biochem & Mol Biol Unit, Dept Biol, Girona, Spain.	rosa.peracaula@udg.edu	Arteta, Beatriz/N-4353-2015; Arteta, Beatriz/I-4161-2019	Arteta, Beatriz/0000-0003-3253-3162; Peracaula, Rosa/0000-0003-3513-524X	La Marato de TV3 foundation [050932]; Spanish Ministerio de Ciencia e Innovacion [BIO 2007-61323]; Government of Catalonia [2005SGR00065]; Comision Interministerial de Ciencia y Tecnologi-a (CICYT) of the Spanish Government in Madrid [SAF2006-09341]; Basque Country Government [IT-487-07]; Fundacio La Marato; University of Girona	La Marato de TV3 foundation; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Government of Catalonia(Generalitat de Catalunya); Comision Interministerial de Ciencia y Tecnologi-a (CICYT) of the Spanish Government in Madrid(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Basque Country Government(Basque Government); Fundacio La Marato; University of Girona	This work was supported by La Marato de TV3 foundation (grant 050932, awarded to R. P.), Spanish Ministerio de Ciencia e Innovacion (grant BIO 2007-61323, awarded to R. P.), the Government of Catalonia (grant 2005SGR00065, awarded to R. L.), the Comision Interministerial de Ciencia y Tecnologi-a (CICYT) of the Spanish Government in Madrid (no. SAF2006-09341, awarded to F. V. V.) and the Basque Country Government (no. IT-487-07 awarded to F. V. V.). M. P.-G. thanks Fundacio La Marato for a pre-doctoral fellowship and University of Girona for a short-term mobility fellowship. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Aubert M, 2000, CANCER RES, V60, P1449; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; CARVALHO AS, 2009, INT J BIOCH CELL BIO; Chandrasekaran EV, 2005, BIOCHEMISTRY-US, V44, P15619, DOI 10.1021/bi050246m; Cho M, 1997, EUR J CANCER, V33, P931, DOI 10.1016/S0959-8049(96)00520-5; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dimitroff CJ, 1999, BIOCHEM BIOPH RES CO, V256, P631, DOI 10.1006/bbrc.1999.0388; Edwards S, 2005, HEPATOLOGY, V41, P451, DOI 10.1002/hep.20585; Gretschel S, 2003, ONCOLOGY-BASEL, V65, P139, DOI 10.1159/000072339; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hebbar M, 2003, INT J BIOL MARKER, V18, P116, DOI 10.1177/172460080301800204; Hosono J, 1998, J SURG ONCOL, V67, P77, DOI 10.1002/(SICI)1096-9098(199802)67:2<77::AID-JSO2>3.0.CO;2-I; Hsu CC, 2005, GYNECOL ONCOL, V96, P415, DOI 10.1016/j.ygyno.2004.10.010; Huang S, 2009, MOL CELL BIOCHEM, V331, P81, DOI 10.1007/s11010-009-0147-9; Ito H, 1997, INT J CANCER, V71, P556, DOI 10.1002/(SICI)1097-0215(19970516)71:4<556::AID-IJC9>3.3.CO;2-J; Jin Xiao-Ling, 2004, Hepatobiliary Pancreat Dis Int, V3, P292; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kawarada Y, 2000, PATHOL RES PRACT, V196, P259, DOI 10.1016/S0344-0338(00)80075-8; Khatib AM, 1999, CANCER RES, V59, P1356; Kim YJ, 1996, BIOCHEM BIOPH RES CO, V228, P324, DOI 10.1006/bbrc.1996.1660; KIM YS, 1988, CANCER RES, V48, P475; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITANO H, 1993, GENETIC ALGORITHM, V1, P3; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Liu F, 2002, J CANCER RES CLIN, V128, P189, DOI 10.1007/s00432-001-0314-1; Liu F, 2001, BRIT J CANCER, V84, P1556, DOI 10.1054/bjoc.2001.1815; Liu F, 2001, EUR J BIOCHEM, V268, P3501, DOI 10.1046/j.1432-1327.2001.02254.x; Magnani JL, 2004, ARCH BIOCHEM BIOPHYS, V426, P122, DOI 10.1016/j.abb.2004.04.008; Martin-Satue N, 1999, BRIT J CANCER, V80, P1169, DOI 10.1038/sj.bjc.6690482; Mas E, 1998, GLYCOBIOLOGY, V8, P605, DOI 10.1093/glycob/8.6.605; Matsushita Y, 1998, CANCER LETT, V133, P151, DOI 10.1016/S0304-3835(98)00220-1; Matsuura N, 1997, JPN J CLIN ONCOL, V27, P135, DOI 10.1093/jjco/27.3.135; Mejias-Luque R, 2007, CANCER SCI, V98, P1000, DOI 10.1111/j.1349-7006.2007.00484.x; Nakamori S, 1997, DIS COLON RECTUM, V40, P420, DOI 10.1007/BF02258386; Nakashio T, 1997, ANTICANCER RES, V17, P293; Ohyama C, 2002, P NATL ACAD SCI USA, V99, P13789, DOI 10.1073/pnas.212456599; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Olaso E, 2003, HEPATOLOGY, V37, P674, DOI 10.1053/jhep.2003.50068; Paschos KA, 2010, J CELL MOL MED, V14, P165, DOI 10.1111/j.1582-4934.2009.00852.x; Peracaula R, 2005, GLYCOCONJUGATE J, V22, P135, DOI 10.1007/s10719-005-0734-2; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Recchi MA, 1998, CANCER RES, V58, P4066; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohfritsch PF, 2006, BBA-GEN SUBJECTS, V1760, P685, DOI 10.1016/j.bbagen.2005.12.012; ROUGER P, 1987, REV FR TRANSFUS IMMU, V30, P699, DOI 10.1016/S0338-4535(87)80138-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Saito S, 2002, ONCOL REP, V9, P1251; SAKAMOTO J, 1986, CANCER RES, V46, P1553; SATOMURA Y, 1991, PANCREAS, V6, P448, DOI 10.1097/00006676-199107000-00012; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; SINN HP, 1992, INT J PANCREATOL, V11, P125; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; VanDorst JALM, 1996, EUR J BIOCHEM, V242, P674; Varki A., 2008, ESSENTIALS GLYCOBIOL; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Vazquez-Martin C, 2005, ONCOLOGY-BASEL, V69, P436, DOI 10.1159/000089999; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; VIDALVANACLOCHA F, 1993, SEMIN LIVER DIS, V13, P60, DOI 10.1055/s-2007-1007338; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Wang PH, 2002, GYNECOL ONCOL, V86, P45, DOI 10.1006/gyno.2002.6714; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEN DX, 1992, J BIOL CHEM, V267, P21011; WLASICHUK KB, 1993, J BIOL CHEM, V268, P13971; Wu SL, 2003, MOL CELL BIOCHEM, V254, P193, DOI 10.1023/A:1027392212341; Yamamoto H, 2001, CANCER RES, V61, P6822; Zhang Y, 2002, J CANCER RES CLIN, V128, P617, DOI 10.1007/s00432-002-0382-x; Zhang Ying, 2002, Shi Yan Sheng Wu Xue Bao, V35, P271	79	67	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12524	10.1371/journal.pone.0012524	http://dx.doi.org/10.1371/journal.pone.0012524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824144	Green Published, gold			2022-12-25	WOS:000281456100021
J	Jenkins, NC; Liu, T; Cassidy, P; Leachman, SA; Boucher, KM; Goodson, AG; Samadashwily, G; Grossman, D				Jenkins, N. C.; Liu, T.; Cassidy, P.; Leachman, S. A.; Boucher, K. M.; Goodson, A. G.; Samadashwily, G.; Grossman, D.			The p16(INK4A) tumor suppressor regulates cellular oxidative stress	ONCOGENE			English	Article						p16; oxidative stress; melanocyte; 8-oxoguanine	REACTIVE OXYGEN; HUMAN MELANOCYTES; P38 MAPK; MELANOMA; SENESCENCE; INHIBITION; GENE; REPAIR; PHOSPHORYLATION; FIBROBLASTS	Mutations or deletions in the cyclin-dependent kinase inhibitor p16(INK4A) are associated with multiple cancer types, but are more commonly found in melanoma tumors and associated with familial melanoma predisposition. Although p16 is thought to function as a tumor suppressor by negatively regulating the cell cycle, it remains unclear why the genetic compromise of p16 predisposes to melanoma over other cancers. Here we describe a novel role for p16 in regulating oxidative stress in several cell types, including melanocytes. Expression of p16 was rapidly upregulated following ultraviolet-irradiation and in response to H2O2-induced oxidative stress in a p38 stress-activated protein kinase-dependent manner. Knockdown of p16 using small interfering RNA increased intracellular reactive oxygen species (ROS) and oxidative (8-oxoguanine) DNA damage, which was further enhanced by H2O2 treatment. Elevated ROS levels were also observed in p16-depleted human keratinocytes and in whole skin and dermal fibroblasts from Cdkn2a-deficient mice. Aberrant ROS and p38 signaling in Cdkn2a-deficient fibroblasts was normalized by expression of exogenous p16. The effect of p16 depletion on ROS was not recapitulated by the knockdown of retinoblastoma protein (Rb) and did not require Rb. Finally, p16-mediated suppression of ROS could not be attributed to the potential effects of p16 on cell cycle phase. These findings suggest a potential alternate Rb-independent tumor-suppressor function of p16 as an endogenous regulator of carcinogenic intracellular oxidative stress. Compared with keratinocytes and fibroblasts, we also found increased susceptibility of melanocytes to oxidative stress in the context of p16 depletion, which may explain why the compromise of p16 predisposes to melanoma over other cancers. Oncogene (2011) 30, 265-274; doi:10.1038/onc.2010.419; published online 13 September 2010	[Jenkins, N. C.; Liu, T.; Cassidy, P.; Leachman, S. A.; Boucher, K. M.; Samadashwily, G.; Grossman, D.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Jenkins, N. C.; Boucher, K. M.; Grossman, D.] Univ Utah, Hlth Sci Ctr, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Cassidy, P.; Leachman, S. A.; Goodson, A. G.; Samadashwily, G.; Grossman, D.] Univ Utah, Hlth Sci Ctr, Dept Dermatol, Salt Lake City, UT 84112 USA; [Cassidy, P.] Univ Utah, Hlth Sci Ctr, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Grossman, D (corresponding author), Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, 2000 Circle Hope,Suite 5262, Salt Lake City, UT 84112 USA.	doug.grossman@hci.utah.edu		Boucher, Kenneth/0000-0003-2833-0127	NIH [AR050102, CA125761]; Department of Dermatology; Huntsman Cancer Foundation;  [P30 CA042014]; NATIONAL CANCER INSTITUTE [R03CA125761, P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050102] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Dermatology; Huntsman Cancer Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by NIH grants AR050102 and CA125761, the Department of Dermatology, and the Huntsman Cancer Foundation. We acknowledge use of the DNA/peptide and Flow Cytometry core facilities and a pilot project grant supported by P30 CA042014 awarded to Huntsman Cancer Institute. We thank Bryan Welm for providing the pEI2 plasmid and technical support for our lentiviral production and the MMHCC at the National Cancer Institute for providing B6.129-Cdkn2a<SUP>tm1Rdp</SUP> mice.	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Becker TM, 2001, CLIN CANCER RES, V7, P3282; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; BOCKHOLT SM, 1995, CELL ADHES COMMUN, V3, P91, DOI 10.3109/15419069509081279; Bowen AR, 2003, J INVEST DERMATOL, V120, P48, DOI 10.1046/j.1523-1747.2003.12010.x; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Choi BY, 2005, NAT STRUCT MOL BIOL, V12, P699, DOI 10.1038/nsmb960; Chung JS, 2009, FREE RADICAL RES, V43, P729, DOI 10.1080/10715760903038432; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Cotter MA, 2007, CLIN CANCER RES, V13, P5952, DOI 10.1158/1078-0432.CCR-07-1187; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Eiberger W, 2008, DNA REPAIR, V7, P912, DOI 10.1016/j.dnarep.2008.03.002; Flores JF, 1996, CANCER RES, V56, P5023; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Grammatico P, 1998, EXP DERMATOL, V7, P205, DOI 10.1111/j.1600-0625.1998.tb00325.x; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Haferkamp S, 2008, AGING CELL, V7, P733, DOI 10.1111/j.1474-9726.2008.00422.x; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Herrling T, 2006, SPECTROCHIM ACTA A, V63, P840, DOI 10.1016/j.saa.2005.10.013; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Pashaei S, 2008, J CUTAN PATHOL, V35, P525, DOI 10.1111/j.1600-0560.2007.00865.x; Pavel S, 2004, EUR J CANCER, V40, P1423, DOI 10.1016/j.ejca.2003.11.035; Piepkorn M, 2000, J AM ACAD DERMATOL, V42, P741, DOI 10.1067/mjd.2000.103988; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Wang HT, 2010, P NATL ACAD SCI USA, V107, P12180, DOI 10.1073/pnas.1005244107; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wood SR, 2006, P NATL ACAD SCI USA, V103, P4111, DOI 10.1073/pnas.0511248103; Zyrek-Betts J, 2008, J CUTAN PATHOL, V35, P651, DOI 10.1111/j.1600-0560.2007.00878.x	43	80	84	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					265	274		10.1038/onc.2010.419	http://dx.doi.org/10.1038/onc.2010.419			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20838381	Green Accepted			2022-12-25	WOS:000286418800002
J	Speidl, WS; Kastl, SP; Hutter, R; Katsaros, KM; Kaun, C; Bauriedel, G; Maurer, G; Huber, K; Badimon, JJ; Wojta, J				Speidl, Walter S.; Kastl, Stefan P.; Hutter, Randolph; Katsaros, Katharina M.; Kaun, Christoph; Bauriedel, Gerhard; Maurer, Gerald; Huber, Kurt; Badimon, Juan J.; Wojta, Johann			The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro	FASEB JOURNAL			English	Article						matrix metalloproteinase; plaque rupture; atherosclerosis	PLASMINOGEN-ACTIVATOR INHIBITOR-1; RECEPTOR-DEFICIENT MICE; KAPPA-B ACTIVATION; ATHEROSCLEROTIC PLAQUES; AP-1 ACTIVATION; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; ONCOSTATIN-M; LOCALIZATION; INFLAMMATION	The complement component C5a is formed during activation of the complement cascade and exerts chemotactic and proinflammatory effects. Macrophages, which are localized in the rupture-prone shoulder regions of coronary plaques, are thought to play a major role in plaque destabilization and rupture through the production of matrix metalloproteinases (MMPs). When human monocyte-derived macrophages were stimulated in vitro with C5a, MMP-1 and MMP-9 mRNA levels were significantly increased. Furthermore, C5a up-regulated MMP-1 and MMP-9 antigens and activity, as determined by ELISA and specific activity assays. These effects were blocked by antibodies against the receptor C5aR/CD88. In addition, blocking experiments revealed that MMP-1 expression was mediated by activation of the transcription factor AP-1, and MMP-9 expression was induced by activation of NF-kappa B and AP-1. Immunohistochemical analysis of human coronary plaques demonstrated the colocalization of C5a, MMP-1, and MMP-9 in vivo. Together, these observations indicate that activation of the complement cascade and formation of C5a may play a role in the onset of acute coronary events by induction of MMPs in atherosclerotic lesions.-Speidl, W. S., Kastl, S. P., Hutter, R., Katsaros, K. M., Kaun, C., Bauriedel, G., Maurer, G., Huber, K., Badimon, J. J., Wojta, J. The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB J. 25, 35-44 (2011). www.fasebj.org	[Speidl, Walter S.; Kastl, Stefan P.; Katsaros, Katharina M.; Kaun, Christoph; Maurer, Gerald; Wojta, Johann] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Kastl, Stefan P.; Wojta, Johann] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Speidl, Walter S.; Hutter, Randolph; Badimon, Juan J.] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA; [Bauriedel, Gerhard] Univ Bonn, Dept Cardiol, Ctr Heart, D-5300 Bonn, Germany; [Huber, Kurt] Wilhelminenspital Stadt Wien, Dept Med Cardiol & Emergency Med 3, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Icahn School of Medicine at Mount Sinai; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Wilhelminenspital	Wojta, J (corresponding author), Univ Vienna, Dept Internal Med 2, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	johann.wojta@meduniwien.ac.at	Speidl, Walter S./AAU-8830-2020; Kaun, Christoph/L-7543-2015; Wojta, Johann/AAC-8433-2020; Kastl, Stefan P/B-2695-2009	Speidl, Walter S./0000-0002-7267-3138; Kaun, Christoph/0000-0003-3873-7246; Wojta, Johann/0000-0002-1282-9276; Kastl, Stefan P/0000-0002-9682-0200; Maurer, Gerald/0000-0002-9043-7657	Ludwig Boltzmann Foundation for Cardiovascular Research; Association for Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology; Hans and Blanca Moser Foundation; International Society for Fibrinolysis and Proteolysis	Ludwig Boltzmann Foundation for Cardiovascular Research; Association for Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology; Hans and Blanca Moser Foundation; International Society for Fibrinolysis and Proteolysis	This work was supported by the Ludwig Boltzmann Foundation for Cardiovascular Research; the Association for Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology; and the Hans and Blanca Moser Foundation. S. P. K. was supported by a travel grant from the International Society for Fibrinolysis and Proteolysis. W. S. S., S. P. K., R. H., K. M. K., and C. K. performed experiments; W. S. S. and S. P. K. analyzed results and made the figures; G. B., G. M. and K. H. revised the paper critically; and J.J.B. and J.W. designed the research and wrote the paper.	Bhatia VK, 2007, AM J PATHOL, V170, P416, DOI 10.2353/ajpath.2007.060406; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Davies MJ, 1998, CIRCULATION, V97, P2382, DOI 10.1161/01.CIR.97.24.2382; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; FOREMAN KE, 1994, J CLIN INVEST, V94, P1147, DOI 10.1172/JCI117430; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GALIS ZS, 1995, FASEB J, V9, P974, DOI 10.1096/fasebj.9.10.7615167; GEERTINGER P, 1970, ACTA PATH MICRO IM A, VA 78, P284; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Iles KE, 2002, FREE RADICAL BIO MED, V32, P1304, DOI 10.1016/S0891-5849(02)00840-7; Kastl SP, 2006, J THROMB HAEMOST, V4, P1790, DOI 10.1111/j.1538-7836.2006.02046.x; Kastl SP, 2008, ARTERIOSCL THROM VAS, V28, P498, DOI 10.1161/ATVBAHA.107.160580; Kastl SP, 2009, BLOOD, V114, P2812, DOI 10.1182/blood-2009-01-200915; Kostner KM, 2004, EUR J CLIN INVEST, V34, P800, DOI 10.1111/j.1365-2362.2004.01431.x; Laine P, 2002, AM J CARDIOL, V90, P404, DOI 10.1016/S0002-9149(02)02498-0; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Morgan BP, 2003, MOL IMMUNOL, V40, P159, DOI 10.1016/S0161-5890(03)00111-1; Nataf S, 1999, J IMMUNOL, V162, P4018; Niculescu F, 1999, MOL IMMUNOL, V36, P949, DOI 10.1016/S0161-5890(99)00117-0; Oksjoki R, 2003, CURR OPIN LIPIDOL, V14, P477, DOI 10.1097/00041433-200310000-00008; Oksjoki R, 2007, ATHEROSCLEROSIS, V195, P90, DOI 10.1016/j.atherosclerosis.2006.12.016; OKUSAWA S, 1988, J EXP MED, V168, P443, DOI 10.1084/jem.168.1.443; Park S, 2004, J CELL BIOCHEM, V91, P973, DOI 10.1002/jcb.10768; Patel S, 2001, BIOCHEM BIOPH RES CO, V286, P164, DOI 10.1006/bbrc.2001.5276; Rabiet MJ, 2008, J BIOL CHEM, V283, P31038, DOI 10.1074/jbc.M805260200; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmiedt W, 1998, ARTERIOSCL THROM VAS, V18, P1790, DOI 10.1161/01.ATV.18.11.1790; SCHULMAN ES, 1988, J CLIN INVEST, V81, P918, DOI 10.1172/JCI113403; SHAH PK, 1995, CIRCULATION, V92, P1565; Speidl WS, 2007, J ENDOVASC THER, V14, P62, DOI 10.1583/06-1946.1; Speidl WS, 2010, ATHEROSCLEROSIS, V208, P285, DOI 10.1016/j.atherosclerosis.2009.07.030; Speidl WS, 2005, EUR HEART J, V26, P2294, DOI 10.1093/eurheartj/ehi339; Speidl WS, 2004, FASEB J, V18, P603, DOI 10.1096/fj.03-0454fje; Takafuji S, 2003, J INVEST ALLERG CLIN, V13, P50; TIPPING PG, 1993, AM J PATHOL, V143, P875; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Torzewski J, 1997, ATHEROSCLEROSIS, V132, P131, DOI 10.1016/S0021-9150(97)00100-7; VLAICU R, 1985, ATHEROSCLEROSIS, V57, P163, DOI 10.1016/0021-9150(85)90030-9; Wojta J, 2002, BLOOD, V100, P517, DOI 10.1182/blood.V100.2.517; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160; Yasojima K, 2001, AM J PATHOL, V158, P1039, DOI 10.1016/S0002-9440(10)64051-5; Zhang YH, 1998, J IMMUNOL, V161, P3071	43	70	72	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					35	44		10.1096/fj.10-156083	http://dx.doi.org/10.1096/fj.10-156083			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20813982				2022-12-25	WOS:000285869500004
J	Kim, EO; Kim, TJ; Kim, N; Kim, ST; Kumar, V; Lee, KM				Kim, Eun-Ok; Kim, Tae-Jin; Kim, Nayoung; Kim, Sung Tae; Kumar, Vinay; Lee, Kyung-Mi			Homotypic Cell to Cell Cross-talk Among Human Natural Killer Cells Reveals Differential and Overlapping Roles of 2B4 and CD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NK CELLS; IMMUNOLOGICAL SYNAPSE; 2B4/CD48 INTERACTIONS; MOLECULAR-BASIS; CUTTING EDGE; ACTIVATION; RECEPTOR; SAP; CYTOTOXICITY; PROTEIN	Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-gamma secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.	[Kim, Eun-Ok; Kim, Tae-Jin; Kim, Nayoung; Kim, Sung Tae; Lee, Kyung-Mi] Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea; [Kim, Eun-Ok; Kim, Tae-Jin; Kim, Nayoung; Kim, Sung Tae; Lee, Kyung-Mi] Korea Univ, Coll Med, Global Res Lab, Div Brain Korea Program Biomed Sci 21, Seoul 136705, South Korea; [Kumar, Vinay] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Chicago	Lee, KM (corresponding author), Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea.	kyunglee@korea.ac.kr		Lee, Kyung-Mi/0000-0002-5378-9258	Korea Foundation for International Cooperation of Science and Technology [K20704000007-09A0500-00710, K20601000002-09E0100-00210]; Innovative Research Institute for Cell Therapy [A062260]; National Nuclear RD program; Seoul RBD Program [10920]	Korea Foundation for International Cooperation of Science and Technology; Innovative Research Institute for Cell Therapy; National Nuclear RD program; Seoul RBD Program(Seoul RBD program)	This work was supported in part by Korea Foundation for International Cooperation of Science and Technology Grants K20704000007-09A0500-00710 and K20601000002-09E0100-00210.; Supported by Innovative Research Institute for Cell Therapy Grant A062260.; Supported by the National Nuclear R&D program grant BAERI.; Supported by Seoul R&BD Program Grant 10920.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Assarsson E, 2005, MOL IMMUNOL, V42, P419, DOI 10.1016/j.molimm.2004.07.021; Assarsson E, 2005, J IMMUNOL, V175, P2045, DOI 10.4049/jimmunol.175.4.2045; Assarsson E, 2004, J IMMUNOL, V173, P174, DOI 10.4049/jimmunol.173.1.174; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Betser-Cohen G, 2010, J IMMUNOL, V184, P2761, DOI 10.4049/jimmunol.0901572; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Crawford K, 2003, BLOOD, V102, P1745, DOI 10.1182/blood-2002-07-2206; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Endt J, 2007, EUR J IMMUNOL, V37, P193, DOI 10.1002/eji.200636341; Espagnolle N, 2007, INT IMMUNOL, V19, P239, DOI 10.1093/intimm/dxl141; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kambayashi T, 2001, J IMMUNOL, V167, P6706, DOI 10.4049/jimmunol.167.12.6706; KANNER SB, 1992, J IMMUNOL, V148, P2023; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Mahajan S, 2001, EXP HEMATOL, V29, P209, DOI 10.1016/S0301-472X(00)00652-4; Mathew SO, 2009, EUR J IMMUNOL, V39, P1632, DOI 10.1002/eji.200838733; McNerney ME, 2005, MOL IMMUNOL, V42, P489, DOI 10.1016/j.molimm.2004.07.032; Messmer B, 2006, J IMMUNOL, V176, P4646, DOI 10.4049/jimmunol.176.8.4646; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Saborit-Villarroya I, 2008, MOL IMMUNOL, V45, P3446, DOI 10.1016/j.molimm.2008.03.021; Saborit-Villarroya IN, 2005, J IMMUNOL, V175, P4226, DOI 10.4049/jimmunol.175.7.4226; SADELAIN M, 1995, P NATL ACAD SCI USA, V92, P6728, DOI 10.1073/pnas.92.15.6728; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; Stark S, 2006, INT IMMUNOL, V18, P241, DOI 10.1093/intimm/dxh358; Tangye SG, 1999, J IMMUNOL, V162, P6981; Taniguchi RT, 2007, BLOOD, V110, P2020, DOI 10.1182/blood-2007-02-076927; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Vaidya SV, 2006, IMMUNOL LETT, V105, P180, DOI 10.1016/j.imlet.2006.02.006; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Wahle JA, 2007, J IMMUNOL, V179, P8009, DOI 10.4049/jimmunol.179.12.8009; Yoon SH, 2009, EXP MOL MED, V41, P161, DOI 10.3858/emm.2009.41.3.019; Zheng XD, 2009, J BIOL CHEM, V284, P21280, DOI 10.1074/jbc.M807053200	42	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41755	41764		10.1074/jbc.M110.137976	http://dx.doi.org/10.1074/jbc.M110.137976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20813844	hybrid, Green Published			2022-12-25	WOS:000285622600063
J	Glosson, NL; Gonyo, P; May, NA; Schneider, CL; Ristow, LC; Wang, QH; Hudson, AW				Glosson, Nicole L.; Gonyo, Patrick; May, Nathan A.; Schneider, Christine L.; Ristow, Laura C.; Wang, Qiuhong; Hudson, Amy W.			Insight into the Mechanism of Human Herpesvirus 7 U21-mediated Diversion of Class I MHC Molecules to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; LUMINAL ER PROTEINS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; HEAVY-CHAINS; ANTIGEN PRESENTATION; MEMBRANE-PROTEIN; N-GLYCOSYLATION; DOWN-REGULATION; CELL-SURFACE	The U21 open reading frame from human herpesvirus-7 encodes a membrane protein that associates with and redirects class I MHC molecules to the lysosomal compartment. The mechanism by which U21 accomplishes this trafficking excursion is unknown. Here we have examined the contribution of localization, glycosylation, domain structure, and the absence of substrate class I MHC molecules on the ability of U21 to traffic to lysosomes. Our results suggest the existence of a cellular protein necessary for U21-mediated rerouting of class I MHC molecules.	[Glosson, Nicole L.; Gonyo, Patrick; May, Nathan A.; Schneider, Christine L.; Ristow, Laura C.; Wang, Qiuhong; Hudson, Amy W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Hudson, AW (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ahudson@mcw.edu		Ristow, Laura/0000-0002-3569-1492	National Institutes of Health [1R01AI069099]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI069099 (to A. W. H.).	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2009, TRAFFIC; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; DEWHURST S, 1997, EXPERT REV MOL MED, P1; EICHHOLTZ T, 1992, J BIOL CHEM, V267, P22490; Glosson NL, 2007, VIROLOGY, V365, P125, DOI 10.1016/j.virol.2007.03.048; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hudson AW, 2003, TRAFFIC, V4, P824, DOI 10.1046/j.1398-9219.2003.0137.x; Hudson AW, 2001, J VIROL, V75, P12347, DOI 10.1128/JVI.75.24.12347-12358.2001; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; LITTLE AM, 1995, J IMMUNOL, V154, P5205; May NA, 2010, J VIROL, V84, P3738, DOI 10.1128/JVI.01782-09; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Reusch U, 2002, TRAFFIC, V3, P752, DOI 10.1034/j.1600-0854.2002.31007.x; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Ward KN, 2005, CURR OPIN INFECT DIS, V18, P247, DOI 10.1097/01.qco.0000168386.16519.93; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; ZERR DM, 2006, M HERPES, V13, P20	36	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37016	37029		10.1074/jbc.M110.125849	http://dx.doi.org/10.1074/jbc.M110.125849			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833720	Green Published, hybrid			2022-12-25	WOS:000284146100017
J	Ormazabal, V; Zuniga, FA; Escobar, E; Aylwin, C; Salas-Burgos, A; Godoy, A; Reyes, AM; Vera, JC; Rivas, CI				Ormazabal, Valeska; Zuniga, Felipe A.; Escobar, Elizabeth; Aylwin, Carlos; Salas-Burgos, Alexis; Godoy, Alejandro; Reyes, Alejandro M.; Carlos Vera, Juan; Rivas, Coralia I.			Histidine Residues in the Na+-coupled Ascorbic Acid Transporter-2 (SVCT2) Are Central Regulators of SVCT2 Function, Modulating pH Sensitivity, Transporter Kinetics, Na+ Cooperativity, Conformational Stability, and Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-C TRANSPORTERS; URINARY ACIDIFICATION; CELLULAR MECHANISMS; EPITHELIAL-CELLS; ENERGY-METABOLISM; INTRACELLULAR PH; SKELETAL-MUSCLE; PROTEIN; PHOSPHORYLATION; DIFFERENTIATION	Na+-coupled ascorbic acid transporter-2 (SVCT2) activity is impaired at acid pH, but little is known about the molecular determinants that define the transporter pH sensitivity. SVCT2 contains six histidine residues in its primary sequence, three of which are exofacial in the transporter secondary structure model. We used site-directed mutagenesis and treatment with diethylpyrocarbonate to identify histidine residues responsible for SVCT2 pH sensitivity. We conclude that five histidine residues, His(109), His(203), His(206), His(269), and His(413), are central regulators of SVCT2 function, participating to different degrees in modulating pH sensitivity, transporter kinetics, Na+ cooperativity, conformational stability, and subcellular localization. Our results are compatible with a model in which (i) a single exofacial histidine residue, His413, localized in the exofacial loop IV that connects transmembrane helices VII-VIII defines the pH sensitivity of SVCT2 through a mechanism involving a marked attenuation of the activation by Na+ and loss of Na+ cooperativity, which leads to a decreased V-max without altering the transport K-m; (ii) exofacial histidine residues His(203), His(206), and His(413) may be involved in maintaining a functional interaction between exofacial loops II and IV and influence the general folding of the transporter; (iii) histidines 203, 206, 269, and 413 affect the transporter kinetics by modulating the apparent transport K-m; and (iv) histidine 109, localized at the center of transmembrane helix I, might be fundamental for the interaction of SVCT2 with the transported substrate ascorbic acid. Thus, histidine residues are central regulators of SVCT2 function.	[Ormazabal, Valeska; Zuniga, Felipe A.; Escobar, Elizabeth; Aylwin, Carlos; Salas-Burgos, Alexis; Godoy, Alejandro; Carlos Vera, Juan; Rivas, Coralia I.] Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Concepcion, Chile; [Reyes, Alejandro M.] Univ Austral Chile, Fac Ciencias, Inst Bioquim, Valdivia, Chile	Universidad de Concepcion; Universidad Austral de Chile	Rivas, CI (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Casilla 160C, Concepcion, Chile.	corivas@udec.cl	Salas Burgos, Alexis/GWC-2563-2022; Godoy, Alejandro/GPS-4942-2022; Zuniga, Felipe/Q-8035-2019; Zuniga, Felipe A/L-7885-2013	Zuniga, Felipe A./0000-0003-0286-565X; Salas-Burgos, Alexis/0000-0002-6577-9970; Escobar Sagredo, Maria Elizabeth/0000-0002-9706-4312	Anillo de Investigacion en Ciencia y Tecnologia, Programa Bicentenario de Ciencia y Tecnologia, Chile [PBCT-ACT28]; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) [1090501, 1060198, 11080144]; Comision Nacional de Investigacion Cientificay Tecnologica, Chile; Chilean Education Ministry	Anillo de Investigacion en Ciencia y Tecnologia, Programa Bicentenario de Ciencia y Tecnologia, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientificay Tecnologica, Chile; Chilean Education Ministry	This work was supported in part by Anillo de Investigacion en Ciencia y Tecnologia, Programa Bicentenario de Ciencia y Tecnologia, Chile, Grant PBCT-ACT28; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) Grants 1090501, 1060198, and 11080144; doctoral fellowships from the Comision Nacional de Investigacion Cientificay Tecnologica, Chile; and equipment grants by the Mecesup program from the Chilean Education Ministry.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Daruwala R, 1999, FEBS LETT, V460, P480, DOI 10.1016/S0014-5793(99)01393-9; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Godoy A, 2007, J BIOL CHEM, V282, P615, DOI 10.1074/jbc.M608300200; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; HONEGGER CG, 1988, INT J CANCER, V41, P690, DOI 10.1002/ijc.2910410509; Jiang M, 1999, AM J PHYSIOL-HEART C, V277, pH1283, DOI 10.1152/ajpheart.1999.277.4.H1283; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Lee AH, 1998, CANCER RES, V58, P1901; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; Liang WJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1696, DOI 10.1152/ajpcell.00461.2001; Lichty BD, 2006, J GEN VIROL, V87, P3379, DOI 10.1099/vir.0.81762-0; Mackenzie B, 2008, AM J PHYSIOL-CELL PH, V294, pC451, DOI 10.1152/ajpcell.00439.2007; Maulen NP, 2003, J BIOL CHEM, V278, P9035, DOI 10.1074/jbc.M205119200; MCKINNEY TD, 1977, J CLIN INVEST, V60, P766, DOI 10.1172/JCI108830; Miles E W, 1977, Methods Enzymol, V47, P431; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Parente P, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-34; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Rajan DP, 1999, BIOCHEM BIOPH RES CO, V262, P762, DOI 10.1006/bbrc.1999.1272; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Rivas CI, 2008, J PHYSIOL BIOCHEM, V64, P357, DOI 10.1007/BF03174092; ROSEN S, 1974, J MEMBRANE BIOL, V15, P193, DOI 10.1007/BF01870087; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; SHOSHANBARMATZ V, 1994, BIOCHEM J, V299, P177, DOI 10.1042/bj2990177; Spielholz C, 1997, CANCER RES, V57, P2529; STEINMETZ PR, 1974, PHYSIOL REV, V54, P890, DOI 10.1152/physrev.1974.54.4.890; Subramanian VS, 2008, BIOCHEM BIOPH RES CO, V374, P123, DOI 10.1016/j.bbrc.2008.06.120; Subramanian VS, 2004, J BIOL CHEM, V279, P27719, DOI 10.1074/jbc.M400876200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Varma S, 2009, BIOCHEMISTRY-US, V48, P2969, DOI 10.1021/bi802294v; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Wang HP, 1999, BBA-BIOMEMBRANES, V1461, P1, DOI 10.1016/S0005-2736(99)00182-0; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; WOLF B, 1970, EUR J BIOCHEM, V13, P519, DOI 10.1111/j.1432-1033.1970.tb00955.x; Wright ME, 2005, CANCER CAUSE CONTROL, V16, P1117, DOI 10.1007/s10552-005-0348-9; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Wu XM, 2003, ARCH BIOCHEM BIOPHYS, V420, P114, DOI 10.1016/j.abb.2003.09.013; Ziane R, 2010, BIOCHEMISTRY-US, V49, P166, DOI 10.1021/bi901086v	54	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36471	36485		10.1074/jbc.M110.155630	http://dx.doi.org/10.1074/jbc.M110.155630			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843809	hybrid, Green Published			2022-12-25	WOS:000284146100044
J	Dufour, A; Zucker, S; Sampson, NS; Kuscu, C; Cao, JA				Dufour, Antoine; Zucker, Stanley; Sampson, Nicole S.; Kuscu, Cem; Cao, Jian			Role of Matrix Metalloproteinase-9 Dimers in Cell Migration DESIGN OF INHIBITORY PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; TISSUE INHIBITOR; HEMOPEXIN DOMAIN; COMPLEX-FORMATION; IV COLLAGENASE; TGF-BETA; SURFACE; CANCER; ACTIVATION; GROWTH	Non-proteolytic activities of matrix metalloproteinases (MMPs) have recently been shown to impact cell migration, but the precise mechanism remains to be understood. We previously demonstrated that the hemopexin (PEX) domain of MMP-9 is a prerequisite for enhanced cell migration. Using a biochemical approach, we now report that dimerization of MMP-9 through the PEX domain appears necessary for MMP-9-enhanced cell migration. Following a series of substitution mutations within the MMP-9 PEX domain, blade IV was shown to be critical for homodimerization, whereas blade I was required for heterodimerization with CD44. Blade I and IV mutants showed diminished enhancement of cell migration compared with wild type MMP-9-transfected cells. Peptides mimicking motifs in the outermost strands of the first and fourth blades of the MMP-9 PEX domain were designed. These peptides efficiently blockedMMP-9 dimer formation and inhibited motility of COS-1 cells overexpressing MMP-9, HT-1080, and MDA-MB-435 cells. Using a shRNA approach, CD44 was found to be a critical molecule in MMP-9-mediated cell migration. Furthermore, an axis involving a MMP-9-CD44-EGFR signaling pathway in cell migration was identified using antibody array and specific receptor tyrosine kinase inhibitors. In conclusion, we dissected the mechanism of pro-MMP-9-enhanced cell migration and developed structure-based inhibitory peptides targeting MMP-9-mediated cell migration.	[Dufour, Antoine; Kuscu, Cem; Cao, Jian] SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA; [Zucker, Stanley] SUNY Stony Brook, Div Hematol Oncol, Stony Brook, NY 11794 USA; [Dufour, Antoine; Sampson, Nicole S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cao, JA (corresponding author), SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu	Sampson, Nicole/C-4598-2014; Dufour, Antoine/AAB-7886-2019	Sampson, Nicole/0000-0002-2835-7760; KUSCU, CEM/0000-0001-7154-6762	National Institutes of Health [5RO1CA11355301A1]; Walk-for-Beauty Foundation; NYSTAR Faculty Development Program [C040076]; Veterans Affairs Merit Review; Carol Baldwin Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA113553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walk-for-Beauty Foundation; NYSTAR Faculty Development Program; Veterans Affairs Merit Review(US Department of Veterans Affairs); Carol Baldwin Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1CA11355301A1 and a Walk-for-Beauty Foundation grant (to J.C.), NYSTAR Faculty Development Program Grant C040076 (to N. S. S.), a Veterans Affairs Merit Review grant, and the Carol Baldwin Breast Cancer Foundation grant (to S. Z.).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cao JA, 1996, J BIOL CHEM, V271, P30174, DOI 10.1074/jbc.271.47.30174; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Davis BG, 2004, SCIENCE, V303, P480, DOI 10.1126/science.1093449; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Imai K, 2008, NAT PROTOC, V3, P1111, DOI 10.1038/nprot.2008.74; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Owen CA, 2003, AM J RESP CELL MOL, V29, P283, DOI 10.1165/rcmb.2003-0034OC; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Roderfeld M, 2007, BIOL CHEM, V388, P1227, DOI 10.1515/BC.2007.123; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Stefanidakis M, 2009, BLOOD, V114, P3008, DOI 10.1182/blood-2008-04-148643; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Toth M, 1997, CANCER RES, V57, P3159; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Yao JHS, 2004, CIRC RES, V95, P364, DOI 10.1161/01.RES.0000138581.04174.2f; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097; ZUCKER S, 1993, CANCER RES, V53, P140; ZUCKER S, 1987, CANCER RES, V47, P1608	47	103	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35944	35956		10.1074/jbc.M109.091769	http://dx.doi.org/10.1074/jbc.M109.091769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837483	Green Published, hybrid			2022-12-25	WOS:000283845300071
J	Hammond, DJ; Singh, SK; Thompson, JA; Beeler, BW; Rusinol, AE; Pangburn, MK; Potempa, LA; Agrawal, A				Hammond, David J.; Singh, Sanjay K.; Thompson, James A.; Beeler, Bradley W.; Rusinol, Antonio E.; Pangburn, Michael K.; Potempa, Lawrence A.; Agrawal, Alok			Identification of Acidic pH-dependent Ligands of Pentameric C-reactive Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; COMPLEMENT FACTOR-H; MONOCLONAL-ANTIBODIES; ALTERNATIVE PATHWAY; ALZHEIMERS-DISEASE; BINDING; CRP; FIBRONECTIN; CALCIUM	C-reactive protein (CRP) is a phylogenetically conserved protein; in humans, it is present in the plasma and at sites of inflammation. At physiological pH, native pentameric CRP exhibits calcium-dependent binding specificity for phosphocholine. In this study, we determined the binding specificities of CRP at acidic pH, a characteristic of inflammatory sites. We investigated the binding of fluid-phase CRP to six immobilized proteins: complement factor H, oxidized low-density lipoprotein, complement C3b, IgG, amyloid beta, and BSA immobilized on microtiter plates. At pH 7.0, CRP did not bind to any of these proteins, but, at pH ranging from 5.2 to 4.6, CRP bound to all six proteins. Acidic pH did not monomerize CRP but modified the pentameric structure, as determined by gel filtration, 1-anili-nonaphthalene-8-sulfonic acid-binding fluorescence, and phosphocholine-binding assays. Some modifications in CRP were reversible at pH 7.0, for example, the phosphocholine-binding activity of CRP, which was reduced at acidic pH, was restored after pH neutralization. For efficient binding of acidic pH-treated CRP to immobilized proteins, it was necessary that the immobilized proteins, except factor H, were also exposed to acidic pH. Because immobilization of proteins on microtiter plates and exposure of immobilized proteins to acidic pH alter the conformation of immobilized proteins, our findings suggest that conformationally altered proteins form a CRP-ligand in acidic environment, regardless of the identity of the protein. This ligand binding specificity of CRP in its acidic pH-induced pentameric state has implications for toxic conditions involving protein misfolding in acidic environments and favors the conservation of CRP throughout evolution.	[Agrawal, Alok] E Tennessee State Univ, Dept Pharmacol, Quillen Coll Med, Johnson City, TN 37614 USA; [Rusinol, Antonio E.] E Tennessee State Univ, Dept Biochem & Mol Biol, Quillen Coll Med, Johnson City, TN 37614 USA; [Pangburn, Michael K.] Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Biochem, Tyler, TX 75708 USA; [Potempa, Lawrence A.] Acphazin Inc, Deerfield, IL 60015 USA	East Tennessee State University; East Tennessee State University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Agrawal, A (corresponding author), E Tennessee State Univ, Dept Pharmacol, Quillen Coll Med, POB 70577, Johnson City, TN 37614 USA.	agrawal@etsu.edu			National Institutes of Health [R01HL071233, R01DK35081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL071233 (to A. A.) and R01DK35081 (to M. K. P.).	Agrawal A, 2002, J IMMUNOL, V169, P3217, DOI 10.4049/jimmunol.169.6.3217; AGRAWAL A, 1994, J IMMUNOL, V152, P5404; Agrawal Alok, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P231, DOI 10.2174/187153008786848321; Andersson SE, 1999, J RHEUMATOL, V26, P2018; Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blizniukov OP, 2003, MOL BIOL+, V37, P912, DOI 10.1023/B:MBIL.0000008361.22136.c8; Bliznyukov OP, 2003, BIOFIZIKA+, V48, P844; Boncler M, 2009, ACTA BIOCHIM POL, V56, P17; Brown AJ, 1997, J LIPID RES, V38, P1730; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; DeFilippis V, 1996, BIOCHEMISTRY-US, V35, P11503, DOI 10.1021/bi9604587; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; IWAMOTO N, 1994, NEUROSCI LETT, V177, P23, DOI 10.1016/0304-3940(94)90035-3; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; KILPATRICK JM, 1982, MOL IMMUNOL, V19, P1159, DOI 10.1016/0161-5890(82)90326-1; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Krijnen PAJ, 2005, J CLIN PATHOL, V58, P382, DOI 10.1136/jcp.2004.022988; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Kushner I, 2010, ARTHRIT CARE RES, V62, P442, DOI 10.1002/acr.20052; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; McGeer EG, 2001, NEUROBIOL AGING, V22, P843, DOI 10.1016/S0197-4580(01)00288-3; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; MOLD C, 1984, J IMMUNOL, V133, P882; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; PANGBURN MK, 1983, BIOCHEMISTRY-US, V22, P178, DOI 10.1021/bi00270a026; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; REYNOLDS GD, 1987, ARCH PATHOL LAB MED, V111, P265; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Rusinol AE, 2000, J BIOL CHEM, V275, P7296, DOI 10.1074/jbc.275.10.7296; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Singh SK, 2008, J IMMUNOL, V180, P4316, DOI 10.4049/jimmunol.180.6.4316; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Singh SK, 2009, CLIN CHIM ACTA, V409, P143, DOI 10.1016/j.cca.2009.08.013; Singh SK, 2009, CLIN CHIM ACTA, V406, P151, DOI 10.1016/j.cca.2009.06.018; Singh U, 2008, J LIPID RES, V49, P1015, DOI 10.1194/jlr.M700535-JLR200; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2008, VACCINE, V26, pI9, DOI 10.1016/j.vaccine.2008.11.021; Sneck M, 2005, J BIOL CHEM, V280, P37449, DOI 10.1074/jbc.M508565200; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; STEINBUCH M, 1969, ARCH BIOCHEM BIOPHYS, V134, P279, DOI 10.1016/0003-9861(69)90285-9; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Suresh MV, 2004, J BIOL CHEM, V279, P52552, DOI 10.1074/jbc.M409054200; SZALAI AJ, 1995, J IMMUNOL, V155, P2557; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Torzewski M, 2008, THROMB HAEMOSTASIS, V99, P196, DOI 10.1160/TH07-10-0595; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; TSENG J, 1988, MOL IMMUNOL, V25, P679, DOI 10.1016/0161-5890(88)90103-4; TSENG J, 1989, EXP CELL RES, V180, P303, DOI 10.1016/0014-4827(89)90059-1; van Tits L, 2005, ARTERIOSCL THROM VAS, V25, P717, DOI 10.1161/01.ATV.0000157979.51673.2c; Verma S, 2004, CIRCULATION, V109, P1914, DOI 10.1161/01.CIR.0000127085.32999.64; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wang HW, 2002, INT J MOL MED, V9, P665; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; YING SC, 1992, MOL IMMUNOL, V29, P677, DOI 10.1016/0161-5890(92)90205-C; YOTHER J, 1982, J IMMUNOL, V128, P2374	86	56	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36235	36244		10.1074/jbc.M110.142026	http://dx.doi.org/10.1074/jbc.M110.142026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843812	Green Published, hybrid			2022-12-25	WOS:000283845300099
J	Ko, S; Kang, GB; Song, SM; Lee, JG; Shin, DY; Yun, JH; Sheng, Y; Cheong, C; Jeon, YH; Jung, YK; Arrowsmith, CH; Avvakumov, GV; Dhe-Paganon, S; Yoo, YJ; Eom, SH; Lee, W				Ko, Sunggeon; Kang, Gil Bu; Song, Sung Min; Lee, Jung-Gyu; Shin, Dong Yeon; Yun, Ji-Hye; Sheng, Yi; Cheong, Chaejoon; Jeon, Young Ho; Jung, Yong-Keun; Arrowsmith, Cheryl H.; Avvakumov, George V.; Dhe-Paganon, Sirano; Yoo, Yung Joon; Eom, Soo Hyun; Lee, Weontae			Structural Basis of E2-25K/UBB+1 Interaction Leading to Proteasome Inhibition and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME E2-25K; AMYLOID PRECURSOR PROTEIN; UBIQUITIN CHAIN SYNTHESIS; UBA DOMAIN; MUTANT UBIQUITIN; NEURODEGENERATIVE DISEASES; MACROMOLECULAR STRUCTURES; MOLECULAR REPLACEMENT; ALZHEIMERS-DISEASE; BETA NEUROTOXICITY	E2-25K/Hip2 is an unusual ubiquitin-conjugating enzyme that interacts with the frameshift mutant of ubiquitin B(UBB+1) and has been identified as a crucial factor regulating amyloid-beta neurotoxicity. To study the structural basis of the neurotoxicity mediated by the E2-25K-UBB+1 interaction, we determined the three-dimensional structures of UBB+1, E2-25K and the E2-25K/ubiquitin, and E2-25K/UBB+1 complex. The structures revealed that ubiquitin or UBB+1 is bound to E2-25K via the enzyme MGF motif and residues in alpha 9 of the enzyme. Poly-ubiquitylation assays together with analyses of various E2-25K mutants showed that disrupting UBB+1 binding markedly diminishes synthesis of neurotoxic UBB+1-anchored polyubiquitin. These results suggest that the interaction between E2-25K and UBB+1 is critical for the synthesis and accumulation of UBB+1-anchored polyubiquitin, which results in proteasomal inhibition and neuronal cell death.	[Kang, Gil Bu; Lee, Jung-Gyu; Shin, Dong Yeon; Yoo, Yung Joon; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Sch Life Sci, Kwangju 500712, South Korea; Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Song, Sung Min; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, Bio Max Inst, Seoul 151742, South Korea; [Sheng, Yi; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Sheng, Yi; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Cheong, Chaejoon; Jeon, Young Ho] Korea Basic Sci Inst, Magnet Resonance Team, Ochang 363883, South Korea; [Arrowsmith, Cheryl H.; Avvakumov, George V.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.; Avvakumov, George V.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	Gwangju Institute of Science & Technology (GIST); Yonsei University; Seoul National University (SNU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Korea Basic Science Institute (KBSI); University of Toronto; Structural Genomics Consortium; University of Toronto	Eom, SH (corresponding author), Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Sch Life Sci, Kwangju 500712, South Korea.	eom@gist.ac.kr; wlee@spin.yonsei.ac.kr	Cheong, Chaejoon/GWC-3135-2022; Yoo, Yung Joon/AAH-5002-2020; Jeon, Young Ho/F-4483-2011; LEE, WEON TAE/AAQ-9088-2021	Arrowsmith, Cheryl/0000-0002-4971-3250; Lee, Weontae/0000-0003-2347-1262; Jung, Yong-Keun/0000-0002-9686-3120	Ministry of Education, Science, and Technology [R33-2009-000-10123-0]; National Research Foundation of Korea Ministry of Education, Science and Technology [R01-2007-000-10592-0, R11-2007-007-03001-0]; Brain Korea project; Ministry of Science and Technology of the Republic of Korea; Structural Genomics Consortium, a registered charity [1097737]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Brain Korea project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Science and Technology of the Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Structural Genomics Consortium, a registered charity(University of Toronto)	This work was supported by a World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant R33-2009-000-10123-0) and by National Research Foundation of Korea Ministry of Education, Science and Technology Grants R01-2007-000-10592-0 and R11-2007-007-03001-0 (to S. H. E.). This work was supported in part by a Brain Korea project and by the Basic Science Research Program (to C. C.) from the Ministry of Science and Technology of the Republic of Korea. This work was also supported in part by the Structural Genomics Consortium, a registered charity (number 1097737).	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mastrandrea LD, 1998, BIOCHEMISTRY-US, V37, P9784, DOI 10.1021/bi9800911; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Leeuwen FW, 2006, J ALZHEIMERS DIS, V9, P319; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Wilson RC, 2009, ACTA CRYSTALLOGR F, V65, P440, DOI 10.1107/S1744309109011117; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	49	39	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36070	36080		10.1074/jbc.M110.145219	http://dx.doi.org/10.1074/jbc.M110.145219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826778	hybrid, Green Published			2022-12-25	WOS:000283845300083
J	Morley, S; Thakur, V; Danielpour, D; Parker, R; Arai, H; Atkinson, J; Barnholtz-Sloan, J; Klein, E; Manor, D				Morley, Samantha; Thakur, Varsha; Danielpour, David; Parker, Robert; Arai, Hiroyuki; Atkinson, Jeffrey; Barnholtz-Sloan, Jill; Klein, Eric; Manor, Danny			Tocopherol Transfer Protein Sensitizes Prostate Cancer Cells to Vitamin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOCOPHEROL; OXIDATIVE STRESS; E-DEFICIENCY; CARCINOMA-CELLS; E TRANSPORT; IN-VIVO; MODEL; MICE; ANTIOXIDANTS; ATAXIA	Prostate cancer is a major cause of mortality in men in developed countries. It has been reported that the naturally occurring antioxidant alpha-tocopherol (vitamin E) attenuates prostate cancer cell proliferation in cultured cells and mouse models. We hypothesized that overexpression of the tocopherol transfer protein (TTP), a vitamin E-binding protein that regulates tocopherol status, will sensitize prostate cancer cells to the anti-proliferative actions of the vitamin. To test this notion, we manipulated the expression levels of TTP in cultured prostate cells (LNCaP, PC3, DU145, and RWPE-1) using overexpression and knockdown approaches. Treatment of cells with tocopherol caused a time-and dose-dependent inhibition of cell proliferation. Overexpression of TTP dramatically sensitized the cells to the apoptotic effects of alpha-tocopherol, whereas reduction ("knockdown") of TTP expression resulted in resistance to the vitamin. TTP levels also augmented the inhibitory effects of vitamin E on proliferation in semi-solid medium. The sensitizing effects of TTP were paralleled by changes in the intracellular accumulation of a fluorescent analog of vitamin E and by a reduction in intracellular levels of reactive oxygen species and were not observed when a naturally occurring, ligand binding-defective mutant of TTP was used. We conclude that TTP sensitizes prostate cancer cells to the anti-proliferative effects of vitamin E and that this activity stems from the ability of protein to increase the intracellular accumulation of the antioxidant. These observations support the notion that individual changes in the expression level or activity of TTP may determine the responsiveness of prostate cancer patients to intervention strategies that utilize vitamin E.	[Manor, Danny] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Danielpour, David; Manor, Danny] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Danielpour, David; Barnholtz-Sloan, Jill; Klein, Eric; Manor, Danny] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Parker, Robert] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Arai, Hiroyuki] Univ Tokyo, Dept Hlth Chem, Tokyo 1130033, Japan; Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada; [Klein, Eric] Cleveland Clin Fdn, Glickman Urol Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cornell University; University of Tokyo; Brock University; Cleveland Clinic Foundation	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.	dxm178@case.edu	Barnholtz-Sloan, Jill/A-4817-2011	Barnholtz-Sloan, Jill/0000-0001-6190-9304; Atkinson, Jeffrey/0000-0003-3710-4893	National Institutes of Health [DK067494, P30-CA4370]; Case Comprehensive Cancer Center [CA59366]; American Institute for Cancer [09A107]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; American Institute for Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK067494 (to D. M.) and Award P30-CA4370 (to Cytometry Core of the Case Comprehensive Cancer Center).; Recipient of National Institutes of Health Postdoctoral Fellowship CA59366 from the Case Comprehensive Cancer Center and of American Institute for Cancer Research Award 09A107.	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Blatt DH, 2001, NUTRITION, V17, P799, DOI 10.1016/S0899-9007(01)00637-2; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; deRijk MC, 1997, ARCH NEUROL-CHICAGO, V54, P762, DOI 10.1001/archneur.1997.00550180070015; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gabsi S, 2001, EUR J NEUROL, V8, P477, DOI 10.1046/j.1468-1331.2001.00273.x; Goodman GE, 2003, CANCER EPIDEM BIOMAR, V12, P518; GUARNIERI C, 1980, ITAL J BIOCHEM, V29, P176; Gunawardena K, 2000, PROSTATE, V44, P287, DOI 10.1002/1097-0045(20000901)44:4&lt;287::AID-PROS5&gt;3.0.CO;2-Z; Gunawardena K, 2004, PROSTATE, V59, P319, DOI 10.1002/pros.20018; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kelly FJ, 2004, ANN NY ACAD SCI, V1031, P22, DOI 10.1196/annals.1331.003; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Leonard SW, 2002, AM J CLIN NUTR, V75, P555, DOI 10.1093/ajcn/75.3.555; Li X, 2003, MITOCHONDRION, V3, P29, DOI 10.1016/S1567-7249(03)00058-8; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Ma Q, 2009, P NATL ACAD SCI USA, V106, P8683, DOI 10.1073/pnas.0812688106; Malins DC, 2001, CANCER RES, V61, P6025; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; Ni J, 2007, PROSTATE, V67, P463, DOI 10.1002/pros.20517; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Pathak SK, 2005, EUR J CANCER, V41, P61, DOI 10.1016/j.ejca.2004.09.028; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; PRINCEN HMG, 1995, ARTERIOSCL THROM VAS, V15, P325, DOI 10.1161/01.ATV.15.3.325; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; Ripple MO, 1999, ANTIOXID REDOX SIGN, V1, P71, DOI 10.1089/ars.1999.1.1-71; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Ripple MO, 1999, JNCI-J NATL CANCER I, V91, P1227, DOI 10.1093/jnci/91.14.1227; RUPAR CA, 1992, BIOCHEM CELL BIOL, V70, P486, DOI 10.1139/o92-075; Sano M, 1996, ALZ DIS ASSOC DIS, V10, P132, DOI 10.1097/00002093-199601030-00004; Shimohara T, 1998, ANN NEUROL, V43, P273, DOI 10.1002/ana.410430222; Sigounas G, 1997, NUTR CANCER, V28, P30, DOI 10.1080/01635589709514549; Siler U, 2004, FASEB J, V18, P1019, DOI 10.1096/fj.03-1116fje; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; Thompson TA, 2003, MOL CANCER THER, V2, P797; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Valastyan S, 2008, BIOCHEMISTRY-US, V47, P744, DOI 10.1021/bi701432q; Venkateswaran V, 2004, CANCER RES, V64, P5891, DOI 10.1158/0008-5472.CAN-04-0690; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Wright ME, 2009, CANCER RES, V69, P1429, DOI 10.1158/0008-5472.CAN-08-2343; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zhang DX, 1997, CANCER RES, V57, P2410	69	19	19	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35578	35589		10.1074/jbc.M110.169664	http://dx.doi.org/10.1074/jbc.M110.169664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826775	Green Published, hybrid			2022-12-25	WOS:000283845300036
J	Suresh, B; Ramakrishna, S; Kim, YS; Kim, SM; Kim, MS; Baek, KH				Suresh, Bharathi; Ramakrishna, Suresh; Kim, Yong-Soo; Kim, Sun-Myoung; Kim, Myung-Sun; Baek, Kwang-Hyun			Stability and Function of Mammalian Lethal Giant Larvae-1 Oncoprotein Are Regulated by the Scaffolding Protein RanBPM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEINS; BINDING-PROTEIN; CELL POLARITY; CYTOSKELETAL PROTEIN; INTERACTING PROTEIN; NUCLEAR-PROTEIN; HUMAN HOMOLOG; GENE L(2)GL; DROSOPHILA; EXPRESSION	The evolutionarily conserved lethal giant larvae (Lgl) tumor suppressor gene has an essential role in establishing apical-basal cell polarity, cell proliferation, differentiation, and tissue organization. However, the precise molecular mechanism by which the Lgl carries out its function remains obscure. In the current study, we have identified Ran-binding protein M (RanBPM) as a novel binding partner of Mgl-1, a mammalian homolog of Drosophila tumor suppressor protein lethal (2) giant larvae (L(2)gl) by yeast two-hybrid screening. RanBPM seems to act as a scaffolding protein with a modulatory function with respect to Mgl-1. The Mgl-1 and RanBPM association was confirmed by co-immunoprecipitation and GST pull-down experiments. Additionally, expression of RanBPM resulted in inhibition of Mgl-1 degradation, and thereby extended the half-life of Mgl-1. Furthermore, the ability of Mgl-1 activity in cell migration and colony formation assay was enhanced by RanBPM. Taken together, our findings reveal that RanBPM plays a novel role in regulating Mgl-1 stability and contributes to its biological function as a tumor suppressor.	[Baek, Kwang-Hyun] CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Seoul 135081, South Korea	Pochon Cha University	Baek, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, 606-16 Yeoksam 1 Dong, Seoul 135081, South Korea.	baek@cha.ac.kr	Ramakrishna, Suresh/AAX-4096-2021	Baek, Kwang-Hyun/0000-0001-7662-7190	Ministry for Health, Welfare and Family affairs, Republic of Korea [00001602]	Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (00001602).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Baek KH, 2004, INT J ONCOL, V24, P1257; Baek KH, 1999, MUTAT RES-REV MUTAT, V436, P131, DOI 10.1016/S1383-5742(98)00027-1; Baek KH, 2002, INT J ONCOL, V20, P739; Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bilder D, 2001, CURR BIOL, V11, pR132, DOI 10.1016/S0960-9822(01)00060-4; Chang Y, 2010, DEV NEUROBIOL, V70, P1, DOI 10.1002/dneu.20750; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Emberley ED, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-28; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gong XW, 2009, ACTA BIOCH BIOPH SIN, V41, P883, DOI 10.1093/abbs/gmp082; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Kim YK, 2005, BIOCHEM BIOPH RES CO, V331, P922, DOI 10.1016/j.bbrc.2005.04.017; Kim YS, 2003, INT J ONCOL, V23, P1515; Kim YS, 2002, INT J ONCOL, V20, P1219; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; KUWABARA K, 1994, GENOMICS, V20, P337, DOI 10.1006/geno.1994.1184; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lu XF, 2009, CLIN CANCER RES, V15, P3287, DOI 10.1158/1078-0432.CCR-08-2078; Lutz W, 2003, BIOCHEM BIOPH RES CO, V303, P1186, DOI 10.1016/S0006-291X(03)00499-6; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1995, ONCOGENE, V11, P291; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Tsuruga T, 2007, ONCOL RES, V16, P431, DOI 10.3727/000000007783980855; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang Y, 2002, BIOCHEM BIOPH RES CO, V297, P148, DOI 10.1016/S0006-291X(02)02020-X; Woodhouse EC, 2003, P NATL ACAD SCI USA, V100, P11463, DOI 10.1073/pnas.2031202100; Wu Y, 2006, BIOCHEM J, V396, P23, DOI 10.1042/BJ20051568; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059	58	30	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35340	35349		10.1074/jbc.M110.156836	http://dx.doi.org/10.1074/jbc.M110.156836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829363	Green Published, hybrid			2022-12-25	WOS:000283845300012
J	Jha, KN; Wong, L; Zerfas, PM; De Silva, RS; Fan, YX; Spiridonov, NA; Johnson, GR				Jha, Kula N.; Wong, Lily; Zerfas, Patricia M.; De Silva, Rukman S.; Fan, Ying-Xin; Spiridonov, Nikolay A.; Johnson, Gibbes R.			Identification of a Novel HSP70-binding Cochaperone Critical to HSP90-mediated Activation of Small Serine/Threonine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 CHAPERONE MACHINERY; MOLECULAR CHAPERONES; SIGNAL-TRANSDUCTION; MALE-INFERTILITY; PROTEIN-KINASES; CO-CHAPERONE; BINDING; CELL; SPERMATOGENESIS; RECEPTOR	We previously reported the identification of small serine/threonine kinase (SSTK) that is expressed in postmeiotic germ cells, associates with HSP90, and is indispensable for male fertility. Sperm from SSTK-null mice cannot fertilize eggs in vitro and are incapable of fusing with eggs that lack zona pellucida. Here, using the yeast two-hybrid screen, we have discovered a novel SSTK-interacting protein (SIP) that is expressed exclusively in testis. The gene encoding SIP is restricted to mammals and encodes a 125-amino acid polypeptide with a predicted tetratricopeptide repeat domain. SIP is co-localized with SSTK in the cytoplasm of spermatids as they undergo restructuring and chromatin condensation, but unlike SSTK, is not retained in the mature sperm. SIP binds to SSTK with high affinity (K-d similar to 10 nM), and the proteins associate with each other when co-expressed in cells. In vitro, SIP inhibited SSTK kinase activity, whereas the presence of SIP in cells resulted in enzymatic activation of SSTK without affecting Akt or MAPK activity. SIP was found to be associated with cellular HSP70, and analyses with purified proteins revealed that SIP directly bound HSP70. Importantly, SSTK recruited SIP onto HSP90, and treatment of cells with the specific HSP90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, completely abolished SSTK catalytic activity. Hence, these findings demonstrate that HSP90 is essential for functional maturation of the kinase and identify SIP as a cochaperone that is critical to the HSP90-mediated activation of SSTK.	[Jha, Kula N.; Wong, Lily; De Silva, Rukman S.; Fan, Ying-Xin; Spiridonov, Nikolay A.; Johnson, Gibbes R.] US FDA, Chem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Zerfas, Patricia M.] NIH, Div Vet Resources, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Johnson, GR (corresponding author), US FDA, Chem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, 29 Lincoln Dr,Bldg 29A,HFD 122, Bethesda, MD 20892 USA.	gibbes.johnson@fda.hhs.gov	Spiridonov, Nikolay/B-6287-2014					Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; CRAIG EA, 1994, CELL, V78, P365, DOI 10.1016/0092-8674(94)90416-2; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Hao ZL, 2004, MOL HUM REPROD, V10, P433, DOI 10.1093/molehr/gah052; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kierszenbaum AL, 2006, MOL REPROD DEV, V73, P399, DOI 10.1002/mrd.20456; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kueng P, 1997, J CELL BIOL, V139, P1851, DOI 10.1083/jcb.139.7.1851; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Melling CWJ, 2009, CELL STRESS CHAPERON, V14, P141, DOI 10.1007/s12192-008-0065-x; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Ogurtsov AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003599; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; PRADEEPA MM, 2007, M R Soc Reprod Ferti, V63, P1; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Visconti PE, 2001, GENOMICS, V77, P163, DOI 10.1006/geno.2001.6628; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xu BF, 2008, DEV BIOL, V319, P211, DOI 10.1016/j.ydbio.2008.03.047	39	8	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35180	35187		10.1074/jbc.M110.134767	http://dx.doi.org/10.1074/jbc.M110.134767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20829357	hybrid, Green Published			2022-12-25	WOS:000283659100091
J	Murakami, T; Takano, R; Takeo, S; Taniguchi, R; Ogawa, K; Ohashi, E; Tsurimoto, T				Murakami, Takeshi; Takano, Ryuji; Takeo, Satoshi; Taniguchi, Rina; Ogawa, Kaori; Ohashi, Eiji; Tsurimoto, Toshiki			Stable Interaction between the Human Proliferating Cell Nuclear Antigen Loader Complex Ctf18-Replication Factor C (RFC) and DNA Polymerase epsilon Is Mediated by the Cohesion-specific Subunits, Ctf18, Dcc1, and Ctf8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; CLAMP LOADER; CATALYTIC DOMAINS; YEAST; IDENTIFICATION; CLONING; PCNA	One of the proliferating cell nuclear antigen loader complexes, Ctf18-replication factor C (RFC), is involved in sister chromatid cohesion. To examine its relationship with factors involved in DNA replication, we performed a proteomics analysis of Ctf18-interacting proteins. We found that Ctf18 interacts with a replicative DNA polymerase, DNA polymerase epsilon (pol epsilon). Co-immunoprecipitation with recombinant Ctf18-RFC and pol epsilon demonstrated that their binding is direct and mediated by two distinct interactions, one weak and one stable. Three subunits that are specifically required for cohesion in yeast, Ctf18, Dcc1, and Ctf8, formed a trimeric complex (18-1-8) and together enabled stable binding with pol epsilon. The C-terminal 23-amino acid stretch of Ctf18 was necessary for the trimeric association of 18-1-8 and was required for the stable interaction. The weak interaction was observed with alternative loader complexes including Ctf18-RFC(5), which lacks Dcc1 and Ctf8, suggesting that the common loader structures, including the RFC small subunits (RFC2-5), are responsible for the weak interaction. The two interaction modes, mediated through distinguishable structures of Ctf18-RFC, both occurred through the N-terminal half of pol epsilon, which includes the catalytic domain. The addition of Ctf18-RFC or Ctf18-RFC(5) to the DNA synthesis reaction caused partial inhibition and stimulation, respectively. Thus, Ctf18-RFC has multiple interactions with pol epsilon that promote polymorphic modulation of DNA synthesis. We propose that their interaction alters the DNA synthesis mode to enable the replication fork to cooperate with the establishment of cohesion.	[Murakami, Takeshi; Takano, Ryuji; Takeo, Satoshi; Taniguchi, Rina; Ogawa, Kaori; Ohashi, Eiji; Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan	Kyushu University	Tsurimoto, T (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ttsurimoto@kyudai.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; Tsurimoto, Toshiki/0000-0001-7597-2216	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20370069, 17080006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants-in-aid 20370069 and 17080006 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Feng WY, 2003, MOL BIOL CELL, V14, P3427, DOI 10.1091/mbc.E03-02-0088; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kim JY, 2003, CURR BIOL, V13, pR873, DOI 10.1016/j.cub.2003.10.048; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; KOUPRINA N, 1994, GENETICS, V138, P1067; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Maki S, 1998, J BIOL CHEM, V273, P21332, DOI 10.1074/jbc.273.33.21332; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Ohta S, 2002, J BIOL CHEM, V277, P40362, DOI 10.1074/jbc.M206194200; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; Pospiech Helmut, 2003, ScientificWorldJournal, V3, P87; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Shiomi Y, 2004, GENES CELLS, V9, P279, DOI 10.1111/j.1356-9597.2004.00724.x; Shiomi Y, 2007, J BIOL CHEM, V282, P20906, DOI 10.1074/jbc.M610102200; SJO G, 2010, EXP CELL RES */* L E, V316, P1445; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; SPENCER F, 1990, GENETICS, V124, P237; Spiga MG, 2004, NUCLEIC ACIDS RES, V32, P4945, DOI 10.1093/nar/gkh811; SUGINO A, 1995, TRENDS BIOCHEM SCI, V20, P319, DOI 10.1016/S0968-0004(00)89059-3; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; TO THA, 1999, Genes Dev */* K GENE, V13, P320; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004	44	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34608	34615		10.1074/jbc.M110.166710	http://dx.doi.org/10.1074/jbc.M110.166710			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826785	Green Published, hybrid			2022-12-25	WOS:000283659100036
J	Zhou, Y; Plowman, SJ; Lichtenberger, LM; Hancock, JF				Zhou, Yong; Plowman, Sarah J.; Lichtenberger, Lenard M.; Hancock, John F.			The Anti-inflammatory Drug Indomethacin Alters Nanoclustering in Synthetic and Cell Plasma Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE MICROSCOPY; PHOSPHOLIPID-VESICLES; MULTIFREQUENCY PHASE; ARACHIDONIC-ACID; RAS PROTEINS; LIPID RAFTS; H-RAS; K-RAS; LAURDAN; DOMAINS	The nonsteroidal anti-inflammatory drug indomethacin exhibits diverse biological effects, many of which have no clear molecular mechanism. Membrane-bound receptors and enzymes are sensitive to their phospholipid microenvironment. Amphipathic indomethacin could therefore potentially modulate cell signaling by changing membrane properties. Here we examined the effect of indomethacin on membrane lateral heterogeneity. Fluorescence lifetime imaging of cells expressing lipid-anchored probes revealed that treatment of BHK cells with therapeutic levels of indomethacin enhances cholesterol-dependent nanoclustering, but not cholesterol-independent nanoclustering. Immuno-electron microscopy and quantitative spatial mapping of intact plasma membrane sheets similarly showed a selective effect of indomethacin on promoting cholesterol-dependent, but not cholesterol-independent, nanoclustering. To further evaluate the biophysical effects of indomethacin, we measured fluorescence polarization of the phase-sensitive probe Laurdan and FRET between phase-partitioning probes in model bilayers. Therapeutic levels of indomethacin enhanced phase seperation in DPPC/DOPC/Chol (1:1:1) and DPPC/Chol membranes in a temperature-dependent manner, but had minimal effect on the phase behavior of pure DOPC at any temperature. Taken together, the imaging results on intact epithelial cells and the biophysical assays of model membranes suggest that indomethacin can enhance phase separation and stabilize cholesterol-dependent nanoclusters in biological membranes. These effects on membrane lateral heterogeneity may have significant consequences for cell signaling cascades that are assembled on the plasma membrane.	[Zhou, Yong; Plowman, Sarah J.; Lichtenberger, Lenard M.; Hancock, John F.] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Lichtenberger, LM (corresponding author), 6431 Fannin St,MSB 4-098, Houston, TX 77030 USA.	lenard.m.lichtenberger@uth.tmc.edu; john.f.hancock@uth.tmc.edu		Zhou, Yong/0000-0002-0214-8151; Hancock, John/0000-0003-0542-4710	National Institutes of Health [F-32 DK07664, R01 GM066717]; Texas Medical Center Digestive Disease Center [PHS P-30DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007664, F32DK007664, P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Medical Center Digestive Disease Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F-32 DK07664 and R01 GM066717 and the Texas Medical Center Digestive Disease Center PHS P-30DK56338.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; BESAG JE, 1977, E J Royal Statist So, V39, P193; CHONG PLG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P260, DOI 10.1016/0005-2736(93)90209-I; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; EVANS EA, 1972, NOUV REV FR HEMATOL, V12, P851; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; GREENBERG RN, 1980, INFECT IMMUN, V29, P908; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Jacob M, 2001, CLIN SCI, V101, P493, DOI 10.1042/CS20010085; JORGENSEN K, 1991, BIOCHIM BIOPHYS ACTA, V1067, P241, DOI 10.1016/0005-2736(91)90050-I; KENNEDY TG, 1985, BIOL REPROD, V33, P140, DOI 10.1095/biolreprod33.1.140; KENNEDY TG, 1986, BIOL REPROD, V34, P327, DOI 10.1095/biolreprod34.2.327; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; LASONER E, 1990, W D J Colloid Int Sc, V139, P469; LEIDY C, 2001, J H BIOPHYS J */* BI, V80, P1819; Lichtenberger LM, 2006, J PHARM PHARMACOL, V58, P1421, DOI 10.1211/jpp.58.10.0001; PARASASSI T, 1986, CELL MOL BIOL, V32, P261; PARASASSI T, 1984, J BIOL CHEM, V259, P4011; PARASASSI T, 1993, BIOCHIM BIOPHYS ACTA, V1153, P143, DOI 10.1016/0005-2736(93)90399-K; PARASASSI T, 1984, CELL BIOCHEM FUNCT, V2, P85, DOI 10.1002/cbf.290020206; PARASASSI T, 1991, INT J RADIAT BIOL, V59, P59, DOI 10.1080/09553009114550061; PARASASSI T, 1986, CELL MOL BIOL, V32, P103; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Parasassi T, 1997, BIOPHYS J, V72, pTH322; PARASASSI T, 1992, EXP CELL RES, V202, P432, DOI 10.1016/0014-4827(92)90096-Q; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior I. A., 2003, SCI STKE, V2003, pPL9; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; STADLER P, 1991, DIGEST DIS SCI, V36, P594, DOI 10.1007/BF01297025; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Tenenbaum J, 1999, CAN J GASTROENTEROL, V13, P119, DOI 10.1155/1999/361651; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Veatch SL, 2004, BIOPHYS J, V86, p201A; Ward GR, 1998, J NUTR, V128, P2473; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou Y, 2005, BIOPHYS J, V89, P1789, DOI 10.1529/biophysj.104.054510; Zhou Y, 2009, BBA-BIOMEMBRANES, V1788, P507, DOI 10.1016/j.bbamem.2008.12.008	48	31	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35188	35195		10.1074/jbc.M110.141200	http://dx.doi.org/10.1074/jbc.M110.141200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826816	Green Published, hybrid			2022-12-25	WOS:000283659100092
J	Malinovsky, FG; Brodersen, P; Fiil, BK; McKinney, LV; Thorgrimsen, S; Beck, M; Nielsen, HB; Pietra, S; Zipfel, C; Robatzek, S; Petersen, M; Hofius, D; Mundy, J				Malinovsky, Frederikke G.; Brodersen, Peter; Fiil, Berthe Katrine; McKinney, Lea Vig; Thorgrimsen, Stephan; Beck, Martina; Nielsen, H. Bjorn; Pietra, Stefano; Zipfel, Cyril; Robatzek, Silke; Petersen, Morten; Hofius, Daniel; Mundy, John			Lazarus1, a DUF300 Protein, Contributes to Programmed Cell Death Associated with Arabidopsis acd11 and the Hypersensitive Response	PLOS ONE			English	Article							NB-LRR PROTEIN; DISEASE RESISTANCE; SALICYLIC-ACID; GENE; DEFENSE; ACCUMULATION; EXPRESSION; AVRRPT2; TOBACCO; EDS1	Background: Programmed cell death (PCD) is a necessary part of the life of multi-cellular organisms. A type of plant PCD is the defensive hypersensitive response (HR) elicited via recognition of a pathogen by host resistance (R) proteins. The lethal, recessive accelerated cell death 11 (acd11) mutant exhibits HR-like accelerated cell death, and cell death execution in acd11 shares genetic requirements for HR execution triggered by one subclass of R proteins. Methodology/Principal Findings: To identify genes required for this PCD pathway, we conducted a genetic screen for suppressors of acd11, here called lazarus (laz) mutants. In addition to known suppressors of R protein-mediated HR, we isolated 13 novel complementation groups of dominant and recessive laz mutants. Here we describe laz1, which encodes a protein with a domain of unknown function (DUF300), and demonstrate that LAZ1 contributes to HR PCD conditioned by the Toll/interleukin-1 (TIR)-type R protein RPS4 and by the coiled-coil (CC)-type R protein RPM1. Using a yeast-based topology assay, we also provide evidence that LAZ1 is a six transmembrane protein with structural similarities to the human tumor suppressor TMEM34. Finally, we demonstrate by transient expression of reporter fusions in protoplasts that localization of LAZ1 is distributed between the cytosol, the plasma membrane and FM4-64 stained vesicles. Conclusions/Significance: Our findings indicate that LAZ1 functions as a regulator or effector of plant PCD associated with the HR, in addition to its role in acd11-related death. Furthermore, the similar topology of a plant and human DUF300 proteins suggests similar functions in PCD across the eukaryotic kingdoms, although a direct role for TMEM34 in cell death control remains to be established. Finally, the subcellular localization pattern of LAZ1 suggests that it may have transport functions for yet unknown, death-related signaling molecules at the plasma membrane and/or endosomal compartments. In summary, our results validate the utility of the large-scale suppressor screen to identify novel components with functions in plant PCD, which may also have implications for deciphering cell death mechanisms in other organisms.	[Malinovsky, Frederikke G.; Brodersen, Peter; Fiil, Berthe Katrine; McKinney, Lea Vig; Thorgrimsen, Stephan; Pietra, Stefano; Petersen, Morten; Hofius, Daniel; Mundy, John] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Malinovsky, Frederikke G.; Beck, Martina; Zipfel, Cyril; Robatzek, Silke] Sainsbury Lab, Norwich, Norfolk, England; [Nielsen, H. Bjorn] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Technical University of Denmark	Malinovsky, FG (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	mundy@bio.ku.dk	McKinney, Lea Vig/B-7309-2015; Robatzek, Silke/B-6844-2013; mundy, john/A-2361-2013; ZIPFEL, CYRIL/ABD-5076-2021; mailnovsky, frederikke gro/C-1959-2015; Petersen, Morten/J-5023-2014; ZIPFEL, CYRIL B/D-7103-2011; Nielsen, Henrik Bjorn/B-8961-2019	McKinney, Lea Vig/0000-0001-6601-4614; mundy, john/0000-0001-7490-4588; ZIPFEL, CYRIL/0000-0003-4935-8583; mailnovsky, frederikke gro/0000-0002-9833-7968; Petersen, Morten/0000-0002-3035-5991; ZIPFEL, CYRIL B/0000-0003-4935-8583; Pietra, Stefano/0000-0003-4417-8153; Nielsen, Henrik Bjorn/0000-0003-2281-5713; Fiil, Berthe Katrine/0000-0002-9499-4848	Danish Research Council [274-06-0460, 272-06-0049]; European Union [LSHG-CT-2004-511983]; Danish Agricultural Research Council [23-02-0101, 23-04-0143]	Danish Research Council(Det Frie Forskningsrad (DFF)); European Union(European Commission); Danish Agricultural Research Council	This work was funded by grants to JM from the Danish Research Council (274-06-0460, 272-06-0049), and the European Union (LSHG-CT-2004-511983) and to MP (23-02-0101) and DH (23-04-0143) from the Danish Agricultural Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Akaishi J, 2007, J CANCER RES CLIN, V133, P213, DOI 10.1007/s00432-006-0159-8; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Brodersen P, 2005, PLANT PHYSIOL, V138, P1037, DOI 10.1104/pp.105.059303; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; HOFIUS D, 2009, CELL IN PRESS   0515; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Koga J, 2006, PLANT PHYSIOL, V140, P1475, DOI 10.1104/pp.105.070334; Kosters A, 2008, XENOBIOTICA, V38, P1043, DOI [10.1080/00498250802040584, 10.1080/00498250802040584 ]; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Muller J, 2007, PLANT PHYSIOL, V145, P293, DOI 10.1104/pp.107.102863; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Takahashi Y, 2009, MOL PLANT MICROBE IN, V22, P31, DOI 10.1094/MPMI-22-1-0031; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Zhang Yuelin, 2007, Methods Mol Biol, V354, P69	44	20	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12586	10.1371/journal.pone.0012586	http://dx.doi.org/10.1371/journal.pone.0012586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830211	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300015
J	Figueira, ACM; Polikarpov, I; Veprintsev, D; Santos, GM				Migliorini Figueira, Ana Carolina; Polikarpov, Igor; Veprintsev, Dmitry; Santos, Guilherme Martins			Dissecting the Relation between a Nuclear Receptor and GATA: Binding Affinity Studies of Thyroid Hormone Receptor and GATA2 on TSH beta Promoter	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; THYROTROPIN GENE-EXPRESSION; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; NEGATIVE REGULATION; RESPONSE ELEMENTS; CROSS-TALK; IN-VIVO; FLUORESCENCE ANISOTROPY; ESTROGEN-RECEPTOR	Background: Much is known about how genes regulated by nuclear receptors (NRs) are switched on in the presence of a ligand. However, the molecular mechanism for gene down-regulation by liganded NRs remains a conundrum. The interaction between two zinc-finger transcription factors, Nuclear Receptor and GATA, was described almost a decade ago as a strategy adopted by the cell to up-or down-regulate gene expression. More recently, cell-based assays have shown that the Zn-finger region of GATA2 (GATA2-Zf) has an important role in down-regulation of the thyrotropin gene (TSH beta) by liganded thyroid hormone receptor (TR). Methodology/Principal Findings: In an effort to better understand the mechanism that drives TSH beta down-regulation by a liganded TR and GATA2, we have carried out equilibrium binding assays using fluorescence anisotropy to study the interaction of recombinant TR and GATA2-Zf with regulatory elements present in the TSH beta promoter. Surprisingly, we observed that ligand (T3) weakens TR binding to a negative regulatory element (NRE) present in the TSH beta promoter. We also show that TR may interact with GATA2-Zf in the absence of ligand, but T3 is crucial for increasing the affinity of this complex for different GATA response elements (GATA-REs). Importantly, these results indicate that TR complex formation enhances DNA binding of the TR-GATA2 in a ligand-dependent manner. Conclusions: Our findings extend previous results obtained in vivo, further improving our understanding of how liganded nuclear receptors down-regulate gene transcription, with the cooperative binding of transcription factors to DNA forming the core of this process.	[Migliorini Figueira, Ana Carolina; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil; [Veprintsev, Dmitry] Paul Scherrer Inst, Biomol Res Lab, Villigen, Switzerland; [Santos, Guilherme Martins] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Universidade de Sao Paulo; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; MRC Laboratory Molecular Biology	Figueira, ACM (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil.	gsantos@mrc-lmb.cam.ac.uk	Polikarpov, Igor/D-2575-2012; Figueira, Ana Carolina/X-1649-2019; Veprintsev, Dmitry B/H-2228-2012	Figueira, Ana Carolina/0000-0002-7023-8490; Veprintsev, Dmitry B/0000-0002-3583-5409; Polikarpov, Igor/0000-0001-9496-4174	Medical Research Council, UK; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Medical Research Council, UK, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; Barros AC, 1998, NEUROREPORT, V9, P2933, DOI 10.1097/00001756-199809140-00003; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; CARR FE, 1992, J BIOL CHEM, V267, P18689; CARR FE, 1994, J BIOL CHEM, V269, P4175; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; CHIN WW, 1993, RECENT PROG HORM RES, V48, P393; Clabby ML, 2003, J BIOL CHEM, V278, P5760, DOI 10.1074/jbc.M208173200; COHEN O, 1995, J BIOL CHEM, V270, P13899, DOI 10.1074/jbc.270.23.13899; Conti E, 2009, CURR OPIN STRUC BIOL, V19, P62, DOI 10.1016/j.sbi.2009.01.003; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Figueira ACM, 2006, CELL BIOCHEM BIOPHYS, V44, P453, DOI 10.1385/CBB:44:3:453; Fischer H, 2003, J BIOL CHEM, V278, P16030, DOI 10.1074/jbc.M206953200; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lima LMTR, 2004, J BIOL CHEM, V279, P47968, DOI 10.1074/jbc.M407696200; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; MARTIN J, 1990, ORGAN SCI, V1, P1; Matozo HC, 2007, BIOPHYS J, V92, P4424, DOI 10.1529/biophysj.106.094961; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Figueira ACM, 2010, BIOCHEMISTRY-US, V49, P893, DOI 10.1021/bi901282s; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; Nagayama K, 2008, J ENDOCRINOL, V199, P113, DOI 10.1677/JOE-08-0128; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; SCHMITZ A, 1978, J MOL BIOL, V123, P431, DOI 10.1016/0022-2836(78)90089-X; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Shibusawa N, 2003, J CLIN INVEST, V112, P588, DOI 10.1172/JCI200318377; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Tsuzuki S, 2004, MOL CELL BIOL, V24, P6824, DOI 10.1128/mcb.24.15.6824-6836.2004; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Weitzel JM, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-4; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12628	10.1371/journal.pone.0012628	http://dx.doi.org/10.1371/journal.pone.0012628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838640	Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300045
J	Savas, S; Briollais, L; Ibrahim-zada, I; Jarjanazi, H; Choi, YH; Musquera, M; Fleshner, N; Venkateswaran, V; Ozcelik, H				Savas, Sevtap; Briollais, Laurent; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Choi, Yun Hee; Musquera, Mireia; Fleshner, Neil; Venkateswaran, Vasundara; Ozcelik, Hilmi			A Whole-Genome SNP Association Study of NCI60 Cell Line Panel Indicates a Role of Ca2+ Signaling in Selenium Resistance	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; CA(2+)ACTIVATED K+ CHANNELS; PREVENTION TRIAL SELECT; PROSTATE-CANCER; LARGE-CONDUCTANCE; VASCULAR SMOOTH; KCNMA1 GENE; VITAMIN-E; A-KINASE; IN-VIVO	Epidemiological studies have suggested an association between selenium intake and protection from a variety of cancer. Considering this clinical importance of selenium, we aimed to identify the genes associated with resistance to selenium treatment. We have applied a previous methodology developed by our group, which is based on the genetic and pharmacological data publicly available for the NCI60 cancer cell line panel. In short, we have categorized the NCI60 cell lines as selenium resistant and sensitive based on their growth inhibition (GI50) data. Then, we have utilized the Affymetrix 125K SNP chip data available and carried out a genome-wide case-control association study for the selenium sensitive and resistant NCI60 cell lines. Our results showed statistically significant association of four SNPs in 5q33-34, 10q11.2, 10q22.3 and 14q13.1 with selenium resistance. These SNPs were located in introns of the genes encoding for a kinase-scaffolding protein (AKAP6), a membrane protein (SGCD), a channel protein (KCNMA1), and a protein kinase (PRKG1). The knock-down of KCNMA1 by siRNA showed increased sensitivity to selenium in both LNCaP and PC3 cell lines. Furthermore, SNP-SNP interaction (epistasis) analysis indicated the interactions of the SNPs in AKAP6 with SGCD as well as SNPs in AKAP6 with KCNMA1 with each other, assuming additive genetic model. These genes were also all involved in the Ca2+ signaling, which has a direct role in induction of apoptosis and induction of apoptosis in tumor cells is consistent with the chemopreventive action of selenium. Once our findings are further validated, this knowledge can be translated into clinics where individuals who can benefit from the chemopreventive characteristics of the selenium supplementation will be easily identified using a simple DNA analysis.	[Savas, Sevtap; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Ozcelik, Hilmi] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Briollais, Laurent; Choi, Yun Hee] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Musquera, Mireia; Venkateswaran, Vasundara] Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON M4N 3M5, Canada; [Fleshner, Neil] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Savas, S (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	vasundara.venkateswaran@sunnybrook.ca; ozcelik@mshri.on.ca	Ozcelik, Hilmi/A-3952-2011; Briollais, Laurent/A-2941-2013; Jarjanazi, Hamdi/B-6221-2011	Jarjanazi, Hamdi/0000-0001-8652-2560; Musquera Felip, Mireia/0000-0002-5915-9935; Savas, Sevtap/0000-0002-7324-938X	Prostate cancer foundation; Canadian Breast Cancer Foundation - Ontario Chapter	Prostate cancer foundation; Canadian Breast Cancer Foundation - Ontario Chapter	This study was supported by grants from prostate cancer foundation (H. Ozcelik). Y.H. Choi is supported by a fellowship from the Canadian Breast Cancer Foundation - Ontario Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brinkman M, 2006, EUR J CANCER, V42, P2463, DOI 10.1016/j.ejca.2006.02.027; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Calderone V, 2002, CURR MED CHEM, V9, P1385, DOI 10.2174/0929867023369871; Chigbrow M, 2001, ANTI-CANCER DRUG, V12, P43, DOI 10.1097/00001813-200101000-00006; Combs GF, 2004, BRIT J CANCER, V91, P195, DOI 10.1038/sj.bjc.6601974; Diwadkar-Navsariwala V, 2004, J NUTR, V134, P2899, DOI 10.1093/jn/134.11.2899; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Efferth T, 2005, PHARMACOL THERAPEUT, V107, P155, DOI 10.1016/j.pharmthera.2005.02.005; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fukao M, 2001, MOL PHARMACOL, V59, P16, DOI 10.1124/mol.59.1.16; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Grunnet M, 2004, J BIOL CHEM, V279, P36445, DOI 10.1074/jbc.M402254200; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Jarjanazi H, 2008, HUM MUTAT, V29, P461, DOI 10.1002/humu.20732; Kerb R, 2006, CANCER LETT, V234, P4, DOI 10.1016/j.canlet.2005.06.051; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Koo SH, 2006, CLIN EXP PHARMACOL P, V33, P525, DOI 10.1111/j.1440-1681.2006.04402.x; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Lipskaia L, 2007, AM J PATHOL, V171, P162, DOI 10.2353/ajpath.2007.070054; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; Menter DG, 2000, CANCER EPIDEM BIOMAR, V9, P1171; Meuillet E, 2004, J CELL BIOCHEM, V91, P443, DOI 10.1002/jcb.10728; Micke O, 2009, MOLECULES, V14, P3975, DOI 10.3390/molecules14103975; Moss SB, 2001, TRENDS ENDOCRIN MET, V12, P434, DOI 10.1016/S1043-2760(01)00493-3; Nadiminty N, 2008, MOL NUTR FOOD RES, V52, P1247, DOI 10.1002/mnfr.200700369; Neill MG, 2006, CURR OPIN UROL, V16, P132, DOI 10.1097/01.mou.0000193388.31727.d2; NOGUCHI S, 1994, CANCER, V74, P872, DOI 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P; Ochiai T, 1996, Gan To Kagaku Ryoho, V23 Suppl 2, P182; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; PAPP LV, 2009, SELENIUM SELENOPROTE; Platz EA, 2001, EPIDEMIOL REV, V23, P93, DOI 10.1093/oxfordjournals.epirev.a000801; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROH S, 2007, J INVEST DERMATOL; Ruth P, 1999, PHARMACOL THERAPEUT, V82, P355, DOI 10.1016/S0163-7258(98)00067-9; Sanmartin C, 2008, MINI-REV MED CHEM, V8, P1020, DOI 10.2174/138955708785740625; SELENIUS M, 2009, ANTIOXID REDOX SIGNA; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Ueyama T, 1998, AM J PHYSIOL-HEART C, V274, pH1, DOI 10.1152/ajpheart.1998.274.1.H1; UGUZ AC, 2009, J MEMBR BIOL; Venkateswaran V, 2002, CANCER RES, V62, P2540; Vinceti Marco, 2009, Reviews on Environmental Health, V24, P231; Wang Shufang, 2002, Zhonghua Bing Li Xue Za Zhi, V31, P107; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Wheeler MT, 2003, TRENDS CARDIOVAS MED, V13, P238, DOI 10.1016/S1050-1738(03)00101-4; ZENG H, 2007, J NUTR BIOCH; Zheng Y, 2005, J CELL PHYSIOL, V205, P97, DOI 10.1002/jcp.20378	60	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12601	10.1371/journal.pone.0012601	http://dx.doi.org/10.1371/journal.pone.0012601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830292	Green Submitted, gold, Green Published			2022-12-25	WOS:000281631300025
J	Cooper, LAD; Gutman, DA; Long, Q; Johnson, BA; Cholleti, SR; Kurc, T; Saltz, JH; Brat, DJ; Moreno, CS				Cooper, Lee A. D.; Gutman, David A.; Long, Qi; Johnson, Brent A.; Cholleti, Sharath R.; Kurc, Tahsin; Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.			The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas	PLOS ONE			English	Article							GLIOBLASTOMA; GROWTH; CANCER; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; CENTROIDS; PATHWAYS; SUBTYPES; VEGF	The Cancer Genome Atlas Project (TCGA) has produced an extensive collection of '-omic' data on glioblastoma (GBM), resulting in several key insights on expression signatures. Despite the richness of TCGA GBM data, the absence of lower grade gliomas in this data set prevents analysis genes related to progression and the uncovering of predictive signatures. A complementary dataset exists in the form of the NCI Repository for Molecular Brain Neoplasia Data (Rembrandt), which contains molecular and clinical data for diffuse gliomas across the full spectrum of histologic class and grade. Here we present an investigation of the significance of the TCGA consortium's expression classification when applied to Rembrandt gliomas. We demonstrate that the proneural signature predicts improved clinical outcome among 176 Rembrandt gliomas that includes all histologies and grades, including GBMs (log rank test p = 1.16e-6), but also among 75 grade II and grade III samples (p = 2.65e-4). This gene expression signature was enriched in tumors with oligodendroglioma histology and also predicted improved survival in this tumor type (n = 43, p = 1.25e-4). Thus, expression signatures identified in the TCGA analysis of GBMs also have intrinsic prognostic value for lower grade oligodendrogliomas, and likely represent important differences in tumor biology with implications for treatment and therapy. Integrated DNA and RNA analysis of low-grade and high-grade proneural gliomas identified increased expression and gene amplification of several genes including GLIS3, TGFB2, TNC, AURKA, and VEGFA in proneural GBMs, with corresponding loss of DLL3 and HEY2. Pathway analysis highlights the importance of the Notch and Hedgehog pathways in the proneural subtype. This demonstrates that the expression signatures identified in the TCGA analysis of GBMs also have intrinsic prognostic value for low-grade oligodendrogliomas, and likely represent important differences in tumor biology with implications for treatment and therapy.	[Cooper, Lee A. D.; Gutman, David A.; Cholleti, Sharath R.; Kurc, Tahsin; Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.] Emory Univ, Sch Med, Atlanta, GA USA; [Long, Qi; Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.] Emory Winship Canc Inst, Atlanta, GA USA; [Long, Qi; Johnson, Brent A.] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Cooper, LAD (corresponding author), Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA.	cmoreno@emory.edu	Gutman, David/U-2713-2018; Moreno, Carlos S/B-3863-2009	Gutman, David/0000-0002-1386-8701; Moreno, Carlos S/0000-0002-5582-0028; Long, Qi/0000-0003-0660-5230	National Cancer Institute (NCI) [S09-094]; Center for Comprehensive Informatics, Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB000591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011119] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Comprehensive Informatics, Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by contract S09-094 from the National Cancer Institute (NCI) administered through NCI Science Applications International Corporation (SAIC) Frederick campus, and the Center for Comprehensive Informatics, Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; [CBTRUS C.B.T.R.o.t.U. States], 2010, CBTRUS STAT REP PRIM; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Febbo PG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-461; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; PEARSON CA, 1988, EMBO J, V7, P2977, DOI 10.1002/j.1460-2075.1988.tb03160.x; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Sarkar S, 2006, CANCER RES, V66, P11771, DOI 10.1158/0008-5472.CAN-05-0470; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; TAVERAS JM, 1962, AMER J ROENTGENOL RA, V87, P473; The WHO, 2020, CLASSIFICATION TUMOU; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; ZHAO Y, 1995, AM J PHYSIOL-LUNG C, V268, pL173, DOI 10.1152/ajplung.1995.268.2.L173	32	106	114	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12548	10.1371/journal.pone.0012548	http://dx.doi.org/10.1371/journal.pone.0012548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838435	Green Published, Green Submitted, gold			2022-12-25	WOS:000281627700004
J	Gu, R; Shampang, A; Nashar, T; Patil, M; Fuller, DH; Ramsingh, AI				Gu, Rui; Shampang, Anae; Nashar, Toufic; Patil, Manisha; Fuller, Deborah H.; Ramsingh, Arlene I.			Oral Immunization with a Live Coxsackievirus/HIV Recombinant Induces Gag p24-Specific T Cell Responses	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES VACCINE; HUMAN-IMMUNODEFICIENCY-VIRUS; PREEXISTING IMMUNITY; HIV-1 VACCINE; AIDS VACCINE; B4-INDUCED PANCREATITIS; GASTROINTESTINAL-TRACT; POLIOVIRUS VACCINE; CAPSID PROTEIN; INFECTION	Background: The development of an HIV/AIDS vaccine has proven to be elusive. Because human vaccine trials have not yet demonstrated efficacy, new vaccine strategies are needed for the HIV vaccine pipeline. We have been developing a new HIV vaccine platform using a live enterovirus, coxsackievirus B4 (CVB4) vector. Enteroviruses are ideal candidates for development as a vaccine vector for oral delivery, because these viruses normally enter the body via the oral route and survive the acidic environment of the stomach. Methodology/Principal Findings: We constructed a live coxsackievirus B4 recombinant, CVB4/p24(73(3)), that expresses seventy-three amino acids of the gag p24 sequence (HXB2) and assessed T cell responses after immunization of mice. The CVB4 recombinant was physically stable, replication-competent, and genetically stable. Oral or intraperitoneal immunization with the recombinant resulted in strong systemic gag p24-specific T cell responses as determined by the IFN-gamma ELISPOT assay and by multiparameter flow cytometry. Oral immunization with CVB4/p24(73(3)) resulted in a short-lived, localized infection of the gut without systemic spread. Because coxsackieviruses are ubiquitous in the human population, we also evaluated whether the recombinant was able to induce gag p24-specific T cell responses in mice pre-immunized with the CVB4 vector. We showed that oral immunization with CVB4/p24(73(3)) induced gag p24-specific immune responses in vector-immune mice. Conclusions/Significance: The CVB4/p24(73(3)) recombinant retained the physical and biological characteristics of the parental CVB4 vector. Oral immunization with the CVB4 recombinant was safe and resulted in the induction of systemic HIV-specific T cell responses. Furthermore, pre-existing vector immunity did not preclude the development of gag p24-specific T cell responses. As the search continues for new vaccine strategies, the present study suggests that live CVB4/HIV recombinants are potential new vaccine candidates for HIV.	[Gu, Rui; Shampang, Anae; Nashar, Toufic; Patil, Manisha; Ramsingh, Arlene I.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Fuller, Deborah H.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center; Albany Medical College	Gu, R (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA.	ramsingh@wadsworth.org		Fuller, Deborah/0000-0001-7315-2441	Public Health Service [AI066938]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066938] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Public Health Service grant AI066938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDINO R, 1994, SCIENCE, V265, P1448, DOI 10.1126/science.8073288; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Belyakov IM, 2008, TRENDS IMMUNOL, V29, P574, DOI 10.1016/j.it.2008.07.010; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; CAGGANA M, 1993, J VIROL, V67, P4797, DOI 10.1128/JVI.67.8.4797-4803.1993; Chapman NM, 1997, CURR TOP MICROBIOL, V223, P227; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; Crotty S, 2001, J VIROL, V75, P7435, DOI 10.1128/JVI.75.16.7435-7452.2001; Crotty S, 2004, ADV DRUG DELIVER REV, V56, P835, DOI 10.1016/j.addr.2003.10.042; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; CZERKINSKY C, 1988, J IMMUNOL METHODS, V110, P29, DOI 10.1016/0022-1759(88)90079-8; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fultz PN, 2003, VIROLOGY, V315, P425, DOI 10.1016/S0042-6822(03)00546-4; Gu R, 2009, VIROLOGY, V395, P77, DOI 10.1016/j.virol.2009.09.005; Halim SS, 2000, VACCINE, V19, P958, DOI 10.1016/S0264-410X(00)00214-0; Halim SS, 2000, AIDS RES HUM RETROV, V16, P1551, DOI 10.1089/088922200750006074; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Huber S, 2008, CURR TOP MICROBIOL, V323, P199; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Letvin NL, 2002, ANNU REV IMMUNOL, V20, P73, DOI 10.1146/annurev.immunol.20.081501.094854; Mandl S, 1998, P NATL ACAD SCI USA, V95, P8216, DOI 10.1073/pnas.95.14.8216; Mata M, 1998, J IMMUNOL, V161, P2985; Mata M, 1999, J IMMUNOL, V163, P1449; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Ostrowski SE, 2004, J VIROL, V78, P8229, DOI 10.1128/JVI.78.15.8229-8237.2004; PALLANSCH MA, 1997, CURR TOP MICROBIOL, V223, P13; Potvin DM, 2003, J VIROL, V77, P8272, DOI 10.1128/JVI.77.15.8272-8279.2003; Ramsingh AI, 2008, CURR TOP MICROBIOL, V323, P241; Ramsingh AI, 1999, J VIROL, V73, P3080, DOI 10.1128/JVI.73.4.3080-3086.1999; Ramsingh AI, 1997, J VIROL, V71, P8690, DOI 10.1128/JVI.71.11.8690-8697.1997; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Stevens R, 2005, VACCINE, V23, P1479, DOI 10.1016/j.vaccine.2004.09.033; Uberla K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000114; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Xiang ZQ, 2003, J VIROL, V77, P10780, DOI 10.1128/JVI.77.20.10780-10789.2003	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12499	10.1371/journal.pone.0012499	http://dx.doi.org/10.1371/journal.pone.0012499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824074	Green Published, Green Submitted, gold			2022-12-25	WOS:000281480900002
J	Acharyya, S; Sharma, SM; Cheng, AS; Ladner, KJ; He, W; Kline, W; Wang, HT; Ostrowski, MC; Huang, TH; Guttridge, DC				Acharyya, Swarnali; Sharma, Sudarshana M.; Cheng, Alfred S.; Ladner, Katherine J.; He, Wei; Kline, William; Wang, Huating; Ostrowski, Michael C.; Huang, Tim H.; Guttridge, Denis C.			TNF Inhibits Notch-1 in Skeletal Muscle Cells by Ezh2 and DNA Methylation Mediated Repression: Implications in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; FACTOR-ALPHA; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; PROGENITOR CELLS; SELF-RENEWAL; STEM-CELLS; ACTIVATION	Background: Classical NF-kappa B signaling functions as a negative regulator of skeletal myogenesis through potentially multiple mechanisms. The inhibitory actions of TNF alpha on skeletal muscle differentiation are mediated in part through sustained NF-kappa B activity. In dystrophic muscles, NF-kappa B activity is compartmentalized to myofibers to inhibit regeneration by limiting the number of myogenic progenitor cells. This regulation coincides with elevated levels of muscle derived TNF alpha that is also under IKK beta and NF-kappa B control. Methodology/Principal Findings: Based on these findings we speculated that in DMD, TNF alpha secreted from myotubes inhibits regeneration by directly acting on satellite cells. Analysis of several satellite cell regulators revealed that TNF alpha is capable of inhibiting Notch-1 in satellite cells and C2C12 myoblasts, which was also found to be dependent on NF-kappa B. Notch-1 inhibition occurred at the mRNA level suggesting a transcriptional repression mechanism. Unlike its classical mode of action, TNF alpha stimulated the recruitment of Ezh2 and Dnmt-3b to coordinate histone and DNA methylation, respectively. Dnmt-3b recruitment was dependent on Ezh2. Conclusions/Significance: We propose that in dystrophic muscles, elevated levels of TNF alpha and NF-kappa B inhibit the regenerative potential of satellite cells via epigenetic silencing of the Notch-1 gene.	[Acharyya, Swarnali; Sharma, Sudarshana M.; Ladner, Katherine J.; He, Wei; Kline, William; Huang, Tim H.; Guttridge, Denis C.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Cheng, Alfred S.; Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Cheng, Alfred S.; Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ostrowski, Michael C.; Huang, Tim H.; Guttridge, Denis C.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Acharyya, S (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	denis.guttridge@osumc.edu	Cheng, Alfred SL/C-3327-2014; He, Wei/J-6275-2016; Wang, Huating/C-6719-2014; Sharma, Sudarshana Mangalore/AAI-2475-2019; Ostrowski, Michael/H-3108-2011	Cheng, Alfred SL/0000-0003-2345-6951; Wang, Huating/0000-0001-5474-2905; Ostrowski, Michael/0000-0003-2948-6297; Guttridge, Denis/0000-0002-7276-6609; Sharma, Sudarshana/0000-0002-9745-0061	Muscular Dystrophy Association award (DCG); OSU; NATIONAL CANCER INSTITUTE [R01CA053271] Funding Source: NIH RePORTER	Muscular Dystrophy Association award (DCG)(Muscular Dystrophy Association); OSU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was obtained from a Muscular Dystrophy Association award (DCG) and an OSU University Presidential Fellowship (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Argiles JM, 2000, EUR CYTOKINE NETW, V11, P552; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Grounds MD, 2008, CLIN EXP PHARMACOL P, V35, P846, DOI 10.1111/j.1440-1681.2007.04868.x; Guttridge DC, 2004, CURR OPIN CLIN NUTR, V7, P443, DOI 10.1097/01.mco.0000134364.61406.26; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Nephew KP, 2003, CANCER LETT, V190, P125, DOI 10.1016/S0304-3835(02)00511-6; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pogribny IP, 2000, CANCER RES, V60, P588; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Stolzing A, 2004, REJUV RES, V7, P9, DOI 10.1089/154916804323105035; Thaloor D, 1999, AM J PHYSIOL-CELL PH, V277, pC320, DOI 10.1152/ajpcell.1999.277.2.C320; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	62	93	97	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12479	10.1371/journal.pone.0012479	http://dx.doi.org/10.1371/journal.pone.0012479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814569	Green Submitted, Green Published, gold			2022-12-25	WOS:000281375500012
J	Wuchty, S; Siwo, G; Ferdig, MT				Wuchty, Stefan; Siwo, Geoffrey; Ferdig, Michael T.			Viral Organization of Human Proteins	PLOS ONE			English	Article							INTERACTION DATABASE; INTERACTION MAP; PHOSPHORYLATION NETWORKS; SACCHAROMYCES-CEREVISIAE; INTERACTOME; COMPLEXES; IDENTIFICATION; INFECTION; LANDSCAPE; PATHWAYS	Although maps of intracellular interactions are increasingly well characterized, little is known about large-scale maps of host-pathogen protein interactions. The investigation of host-pathogen interactions can reveal features of pathogenesis and provide a foundation for the development of drugs and disease prevention strategies. A compilation of experimentally verified interactions between HIV-1 and human proteins and a set of HIV-dependency factors (HDF) allowed insights into the topology and intricate interplay between viral and host proteins on a large scale. We found that targeted and HDF proteins appear predominantly in rich-clubs, groups of human proteins that are strongly intertwined among each other. These assemblies of proteins may serve as an infection gateway, allowing the virus to take control of the human host by reaching protein pathways and diversified cellular functions in a pronounced and focused way. Particular transcription factors and protein kinases facilitate indirect interactions between HDFs and viral proteins. Discerning the entanglement of directly targeted and indirectly interacting proteins may uncover molecular and functional sites that can provide novel perspectives on the progression of HIV infection and highlight new avenues to fight this virus.	[Wuchty, Stefan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Siwo, Geoffrey; Ferdig, Michael T.] Univ Notre Dame, Dept Biol, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	National Institutes of Health (NIH) - USA; University of Notre Dame	Wuchty, S (corresponding author), NIH, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA.	wuchtys@ncbi.nlm.nih.gov	Ferdig, Michael/C-6627-2016		NCBI/NLM/NIH; NIH [AI071121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071121] Funding Source: NIH RePORTER	NCBI/NLM/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SW was supported by NCBI/NLM/NIH. MTF and GS are supported by NIH grant AI071121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; BANDYOPADHYAY S, 2006, DISCOVERING REGULATE, P354; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Francesconi M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S9; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sprinzak E, 2006, P NATL ACAD SCI USA, V103, P14718, DOI 10.1073/pnas.0603352103; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Wuchty S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000335	31	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e11796	10.1371/journal.pone.0011796	http://dx.doi.org/10.1371/journal.pone.0011796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20827298	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700001
J	Sivamani, RK; Schwartz, MP; Anseth, KS; Isseroff, RR				Sivamani, Raja K.; Schwartz, Michael P.; Anseth, Kristi S.; Isseroff, R. Rivkah			Keratinocyte proximity and contact can play a significant role in determining mesenchymal stem cell fate in human tissue	FASEB JOURNAL			English	Article						wound; healing; ex vivo; skin; coculture	MARROW-DERIVED CELLS; BONE-MARROW; STROMAL CELLS; IN-VITRO; GROWTH-FACTOR; EPITHELIAL-CELLS; DIFFERENTIATION; FUSION; SKIN; PHENOTYPE	Bone marrow-derived human mesenchymal stem cells (hMSCs) possess multipotent differentiation capabilities and are a potent source of paracrine factors. We show how the epidermal keratinocyte can direct hMSC differentiation selectively. Keratinocytes and hMSCs were either cocultured in physical contact (contact cocultures), or separated without physical contact using a transwell insert (noncontact cocultures). We also delivered hMSCs into an ex vivo human excisional wound where subpopulations of the hMSCs were either in contact or were physically separated from the epidermal keratinocytes. In comparison to control hMSCs that were not cocultured, contact cocultured hMSCs adopted an epithelial morphology and expressed keratinocyte markers while noncontact coculutred hMSCs, surprisingly, adopted phenotypes that resembled myofibroblast and early neural lineage, both of which are of dermal origin. Cell fusion was not a requirement in in vitro contact cocultures, as determined by fluorescence-activated cell sorting (FACS) and fluorescence in situ hybridization analysis (FISH). To the best of our knowledge, this work provides the first example of hMSC differentiation into different lineages depending on their proximity to a single cell type.-Sivamani, R. K., Schwartz, M. P., Anseth, K. S., Isseroff, R. R., Keratinocyte proximity and contact can play a significant role in determining mesenchymal stem cell fate in human tissue, FASEB J. 25, 122-131 (2011). www.fasebj.org	[Sivamani, Raja K.; Isseroff, R. Rivkah] Univ Calif Davis, Sch Med, Dept Dermatol, Davis, CA 95616 USA; [Sivamani, Raja K.; Schwartz, Michael P.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Schwartz, Michael P.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Isseroff, RR (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, TB 192,1 Shields Ave, Davis, CA 95616 USA.	rrisseroff@ucdavis.edu	Schwartz, Mike/O-7963-2016; Schwartz, Michael/GNW-3991-2022; Schwartz, Michael P/B-3417-2008; Isseroff, Roslyn Rivkah/AAD-8478-2021	Schwartz, Mike/0000-0003-3785-6606; Schwartz, Michael/0000-0003-3785-6606; Schwartz, Michael P/0000-0003-3785-6606; Isseroff, Roslyn Rivkah/0000-0001-7813-0858	Howard Hughes Medical Institute; National Science Foundation [EEC 444771]; National Institutes of Health (NIH) [AR 44518]; Shiners Hospitals for Children [4450]; NIH National Center for Research Resources [P40RR017447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044518] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shiners Hospitals for Children; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors are indebted to Theresa Naherini for technical expertise and assistance with FACS and to Dr. Jeffrey Spees for his helpful discussion in assistance with the FISH analysis. The authors thank Dr. Jan Nolta for her critical review of this manuscript. Support for this work was kindly provided in part by a Howard Hughes Medical Institute Research Training Fellowship (R. K. S.), a grant from the National Science Foundation (EEC 444771; K. S. A.), a grant from the National Institutes of Health (NIH; AR 44518; R. R. I.), and a grant from the Shiners Hospitals for Children (4450; R. R. I.). Some of the materials employed in this work were provided by the Tulane Center for Gene Therapy through a grant from the NIH National Center for Research Resources (P40RR017447). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Aberdam D, 2007, CELL CYCLE, V6, P291, DOI 10.4161/cc.6.3.3800; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; ANSEL JC, 1993, J CLIN INVEST, V92, P671, DOI 10.1172/JCI116636; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510; Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015; Borue X, 2004, AM J PATHOL, V165, P1767, DOI 10.1016/S0002-9440(10)63431-1; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; COOK PW, 1990, MOL ENDOCRINOL, V4, P1377, DOI 10.1210/mend-4-9-1377; Dai YC, 2007, BURNS, V33, P418, DOI 10.1016/j.burns.2006.08.028; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Emanuelsson P, 1997, BURNS, V23, P32, DOI 10.1016/S0305-4179(96)00073-3; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Gregory Carl A, 2005, Sci STKE, V2005, ppe37, DOI 10.1126/stke.2942005pe37; Han CM, 2007, DIFFERENTIATION, V75, P292, DOI 10.1111/j.1432-0436.2006.00140.x; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim WS, 2009, EXPERT OPIN BIOL TH, V9, P879, DOI 10.1517/14712590903039684; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Walter M. N., 2010, EXP CELL RES; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Yamaguchi Y, 2004, BRIT J DERMATOL, V151, P1019, DOI 10.1111/j.1365-2133.2004.06170.x; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	48	24	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					122	131		10.1096/fj.09-148775	http://dx.doi.org/10.1096/fj.09-148775			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20847231	Green Published			2022-12-25	WOS:000285869500012
J	Takacs, B; O'Neall-Hennessey, E; Hetenyi, C; Kardos, J; Szent-Gyorgyi, AG; Kovacs, M				Takacs, Balazs; O'Neall-Hennessey, Elizabeth; Hetenyi, Csaba; Kardos, Jozsef; Szent-Gyoergyi, Andrew G.; Kovacs, Mihaly			Myosin cleft closure determines the energetics of the actomyosin interaction	FASEB JOURNAL			English	Article						structure; kinetics; mechanism	RABBIT SKELETAL-MUSCLE; ACTIN-BINDING CLEFT; F-ACTIN; KINETIC CHARACTERIZATION; MOTOR; DICTYOSTELIUM; SUBFRAGMENT-1; MECHANISM; COMPLEX; FRAGMENTS	Formation of the strong binding interaction between actin and myosin is essential for force generation in muscle and in cytoskeletal motor systems. To clarify the role of the closure of myosin's actin-binding cleft in the actomyosin interaction, we performed rapid kinetic, spectroscopic, and calorimetric experiments and atomic-level energetic calculations on a variety of myosin isoforms for which atomic structures are available. Surprisingly, we found that the endothermic actin-binding profile of vertebrate skeletal muscle myosin subfragment-1 is unique among studied myosins. We show that the diverse propensity of myosins for cleft closure determines different energetic profiles as well as structural and kinetic pathways of actin binding. Depending on the type of myosin, strong actin binding may occur via induced-fit or conformational preselection mechanisms. However, cleft closure does not directly determine the kinetics and affinity of actin binding. We also show that cleft closure is enthalpically unfavorable, reflecting the development of an internal strain within myosin in order to adopt precise steric complementarity to the actin filament. We propose that cleft closure leads to an increase in the torsional strain of myosin's central beta-sheet that has been proposed to serve as an allosteric energy-transducing spring during force generation.-Takacs, B., O'Neall-Hennessey, E., Hetenyi, C., Kardos, J., Szent-Gyorgyi, A. G., Kovacs, M. Myosin cleft closure determines the energetics of the actomyosin interaction. FASEB J. 25, 111-121 (2011). www.fasebj.org	[Takacs, Balazs; Kardos, Jozsef; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Hetenyi, Csaba] Eotvos Lorand Univ, Dept Genet, H-1117 Budapest, Hungary; [O'Neall-Hennessey, Elizabeth; Szent-Gyoergyi, Andrew G.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Eotvos Lorand University; Eotvos Lorand University; Brandeis University	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	kovacsm@elte.hu	Hetenyi, Csaba/G-5249-2010; Kovacs, Mihaly/A-6841-2011; Kardos, József/J-1035-2017	Hetenyi, Csaba/0000-0002-8013-971X; Kardos, József/0000-0002-2135-2932; Kovacs, Mihaly/0000-0002-1200-4741	Hungarian Scientific Research Fund (OTKA) [K68464, K71915, NNF78783]; Fogarty International Center; U.S. National Heart, Lung, and Blood Institute [1 R01-TW-007241]; European Molecular Biology Organization-Howard Hughes Medical Institute; FOGARTY INTERNATIONAL CENTER [R01TW007241] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Molecular Biology Organization-Howard Hughes Medical Institute(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Hungarian Scientific Research Fund (OTKA) grant K68464 (to J.K.); the Fogarty International Center, U.S. National Heart, Lung, and Blood Institute grant 1 R01-TW-007241, an European Molecular Biology Organization-Howard Hughes Medical Institute startup grant, and OTKA grants K71915 and NNF78783 (to M. K.). C. H. and M. K. are Bolyai Fellows of the Hungarian Academy of Sciences. The authors thank Drs. Judit Fidy and Ferenc Tolgyesi (Semmelweis University, Budapest, Hungary) for providing the ITC instrument and Andras Malnasi-Csizmadia for discussions. The authors declare no competing financial interests.	Atkins PW., 1990, PHYS CHEM; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; Cecchini M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000129; Champ PC, 2007, NUCLEIC ACIDS RES, V35, pW556, DOI 10.1093/nar/gkm326; COATES JH, 1985, BIOCHEM J, V232, P351, DOI 10.1042/bj2320351; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; EIGEN M, 1964, PROG REACT KINET MEC, V2, P285; Fersht A., 1977, ENZYME STRUCURE MECH, P147; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; GEEVES MA, 1984, J MUSCLE RES CELL M, V5, P351, DOI 10.1007/BF00818255; Hetenyi C, 2007, BIOINFORMATICS, V23, P2678, DOI 10.1093/bioinformatics/btm431; HIGHSMITH S, 1977, ARCH BIOCHEM BIOPHYS, V180, P404, DOI 10.1016/0003-9861(77)90054-6; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kalabokis VN, 1997, BIOCHEMISTRY-US, V36, P15834, DOI 10.1021/bi971932r; Karatzaferi C, 2004, BIOPHYS J, V87, P2532, DOI 10.1529/biophygj.104.039909; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; KONRAD M, 1982, EUR J BIOCHEM, V128, P547; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Lin SH, 2005, BIOCHEMISTRY-US, V44, P1482, DOI 10.1021/bi040018c; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; MARGOSSIAN SS, 1978, BIOCHEMISTRY-US, V17, P5431, DOI 10.1021/bi00618a017; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143, DOI 10.1093/oxfordjournals.jbchem.a135365; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; SMITH SJ, 1984, J BIOL CHEM, V259, P303; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STAFFORD WF, 1979, BIOCHEMISTRY-US, V18, P5273, DOI 10.1021/bi00591a002; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200; Yengo CM, 1999, BIOCHEMISTRY-US, V38, P14515, DOI 10.1021/bi991226l	54	16	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					111	121		10.1096/fj.10-164871	http://dx.doi.org/10.1096/fj.10-164871			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20837775	Green Published			2022-12-25	WOS:000285869500011
J	Takenobu, H; Shimozato, O; Nakamura, T; Ochiai, H; Yamaguchi, Y; Ohira, M; Nakagawara, A; Kamijo, T				Takenobu, H.; Shimozato, O.; Nakamura, T.; Ochiai, H.; Yamaguchi, Y.; Ohira, M.; Nakagawara, A.; Kamijo, T.			CD133 suppresses neuroblastoma cell differentiation via signal pathway modification	ONCOGENE			English	Article						CD133; neuroblastoma; differentiation; RET p38MAPK; PI3K/Akt	CANCER STEM-CELLS; HEMATOPOIETIC STEM; IN-VITRO; RET; IDENTIFICATION; LINES; EXPRESSION; AC133; GENE; AMPLIFICATION	CD133 (prominin-1) is a transmembrane glycoprotein expressed on the surface of normal and cancer stem cells (tumor-initiating cells), progenitor cells, rod photoreceptor cells and a variety of epithelial cells. Although CD133 is widely used as a marker of various somatic and putative cancer stem cells, its contribution to the fundamental properties of cancer cells, such as tumorigenesis and differentiation, remains to be elucidated. In the present report, we found that CD133 was expressed in several neuroblastoma (NB) cell lines/tumor samples. Intriguingly, CD133 repressed NB cell differentiation, for example neurite extension and the expression of differentiation marker proteins, and was decreased by several differentiation stimuli, but accelerated cell proliferation, anchorage-independent colony formation and in vivo tumor formation of NB cells. NB cell line and primary tumor-sphere experiments indicated that the molecular mechanism of CD133-related differentiation suppression in NB was in part dependent on neurotrophic receptor RET tyrosine kinase regulation. RET transcription was suppressed by CD133 in NB cells and glial cell line-derived neurotrophic factor treatment failed to induce RET in CD133-expressing cells; RET overexpression rescued CD133-related inhibition of neurite elongation. Of note, CD133-related NB cell differentiation and RET repression were mainly dependent on p38MAPK and PI3K/Akt pathways. Furthermore, CD133 has a function in growth and RET expression in NB cell line- and primary tumor cell-derived tumor spheres. To the best of our knowledge, this is the first report of the function of CD133 in cancer cells and our findings may be applied to improve differentiation induction therapy for NB patients. Oncogene (2011) 30, 97-105; doi: 10.1038/onc.2010.383; published online 6 September 2010	[Kamijo, T.] Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chuo Ku, Chiba 2608717, Japan; [Shimozato, O.] Chiba Canc Ctr, Res Inst, Lab Antitumor Res, Chiba 2608717, Japan; [Nakamura, T.] Univ Tokyo, Inst Med Sci, Core Facil Therapeut Vectors, Tokyo, Japan; [Ochiai, H.] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Ohira, M.] Chiba Canc Ctr, Res Inst, Lab Canc Genom, Chiba 2608717, Japan; [Nakagawara, A.] Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, Chiba 2608717, Japan	Chiba Cancer Center; Chiba Cancer Center; University of Tokyo; Chiba University; Chiba Cancer Center; Chiba Cancer Center	Kamijo, T (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	tkamijo@chiba-cc.jp	Nakamura, Takafumi/AAO-8199-2020	Nakamura, Takafumi/0000-0002-0196-0754; Takenobu, Hisanori/0000-0001-7355-1565	JSPS [19790274]; Ministry of Health, Labor, and Welfare; Ministry of Health, Labor, and Welfare of Japan [20-13]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21591377]; Grants-in-Aid for Scientific Research [21790397, 21591376, 21390317] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K Sakurai and S Matsushita for technical assistance, Dr Hiroyuki Miyoshi (BioResource Center, RIKEN) for the gift of CSII-CMV-MCS-IRES2-Bsd plasmid and Daniel Mrozek, Medical English Service, for editorial assistance. This work was supported in part by a grant-in-aid from JSPS for Young Scientists (B) (number: 19790274), a grant-in-aid from the Ministry of Health, Labor, and Welfare for Third Term Comprehensive Control Research for Cancer, a grant-in-aid for Cancer Research (20-13) from the Ministry of Health, Labor, and Welfare of Japan and a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (number: 21591377).	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; BRODEUR GM, 2000, NEUROBLASTOMA; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; DALESSIO A, 1995, CELL GROWTH DIFFER, V6, P1387; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Hasegawa K, 2006, CLIN CANCER RES, V12, P6170, DOI 10.1158/1078-0432.CCR-06-0992; Iehara T, 2006, BRIT J CANCER, V94, P1510, DOI 10.1038/sj.bjc.6603149; ITOH F, 1992, ONCOGENE, V7, P1201; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kaneko M, 2002, J PEDIAT HEMATOL ONC, V24, P613, DOI 10.1097/00043426-200211000-00004; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; KLEIN RM, 1994, FASEB J, V8, pA126; Kurata K, 2008, ONCOGENE, V27, P741, DOI 10.1038/sj.onc.1210672; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; MYERS SM, 1995, ONCOGENE, V11, P2039; Nakanishi H, 2007, ONCOL REP, V17, P1315; Nikolova T, 2007, DIFFERENTIATION, V75, P100, DOI 10.1111/j.1432-0436.2006.00119.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Ohira M, 2003, ONCOGENE, V22, P5525, DOI 10.1038/sj.onc.1206853; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; Peterson S, 2004, ONCOGENE, V23, P213, DOI 10.1038/sj.onc.1206980; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Weinberg RA, 2006, BIOL CANC; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009	42	93	97	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					97	105		10.1038/onc.2010.383	http://dx.doi.org/10.1038/onc.2010.383			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20818439				2022-12-25	WOS:000285959300009
J	Kartner, N; Yao, YQ; Li, KY; Crasto, GJ; Datti, A; Manolson, MF				Kartner, Norbert; Yao, Yeqi; Li, Keying; Crasto, Gazelle J.; Datti, Alessandro; Manolson, Morris F.			Inhibition of Osteoclast Bone Resorption by Disrupting Vacuolar H+-ATPase a3-B2 Subunit Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; AMINO-TERMINAL DOMAIN; BREAST-CANCER CELLS; THERMUS-THERMOPHILUS; PARATHYROID-HORMONE; A3 ISOFORM; PLASMA-MEMBRANE; PROTON PUMPS; IN-VIVO; (H+)-ATPASES	VacuolarH(+)-ATPases (V-ATPases) are highly expressed in ruffled borders of bone-resorbing osteoclasts, where they play a crucial role in skeletal remodeling. To discover protein-protein interactions with the a subunit in mammalian V-ATPases, a GAL4 activation domain fusion library was constructed from an in vitro osteoclast model, receptor activator of NF-kappa B ligand-differentiated RAW 264.7 cells. This library was screened with a bait construct consisting of a GAL4 binding domain fused to the N-terminal domain of V-ATPase a3 subunit (NTa3), the a subunit isoform that is highly expressed in osteoclasts(a1 and a2 are also expressed, to a lesser degree, whereas a4 is kidney-specific). One of the prey proteins identified was the V-ATPase B2 subunit, which is also highly expressed in osteoclasts (B1 is not expressed). Further characterization, using pulldown and solid-phase binding assays, revealed an interaction between NTa3 and the C-terminal domains of both B1 and B2 subunits. Dual B binding domains of equal affinity were observed in NTa, suggesting a possible model for interaction between these subunits in the V-ATPase complex. Furthermore, the a3-B2 interaction appeared to be moderately favored over a1, a2, and a4 interactions with B2, suggesting a mechanism for the specific subunit assembly of plasma membrane V-ATPase in osteoclasts. Solid-phase binding assays were subsequently used to screen a chemicallibrary for inhibitors of the a3-B2 interaction. A small molecule benzohydrazide derivative was found to inhibit osteoclast resorption with an IC50 of similar to 1.2 mu M on both synthetic hydroxyapatite surfaces and dentin slices, without significantly affecting RAW 264.7 cell viability or receptor activator of NF-kappa B ligand-mediated osteoclast differentiation. Further understanding of these interactions and inhibitors may contribute to the design of novel therapeutics for bone loss disorders, such as osteoporosis and rheumatoid arthritis.	[Manolson, Morris F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON M5G 1G6, Canada; [Manolson, Morris F.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5G 1G6, Canada; [Datti, Alessandro] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Datti, Alessandro] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Perugia	Manolson, MF (corresponding author), Univ Toronto, Fac Dent, Dent Res Inst, 124 Edward St, Toronto, ON M5G 1G6, Canada.	m.manolson@dentistry.utoronto.ca	Datti, Alessandro/ABA-1108-2021	Datti, Alessandro/0000-0001-6824-7382; Manolson, Morris/0000-0001-8755-5460	Canadian Arthritis Network [2008-02-DAP-02]; Canadian Institutes for Health Research [MOP-79322, PDD-86132]	Canadian Arthritis Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Arthritis Network Grant 2008-02-DAP-02 and Canadian Institutes for Health Research Grant MOP-79322 and PDD-86132.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Drory O, 2006, PHYSIOLOGY, V21, P317, DOI 10.1152/physiol.00017.2006; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Ettinger B, 2004, J BONE MINER RES, V19, P745, DOI 10.1359/JBMR.040117; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2000, J EXP BIOL, V203, P71; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gluck SL, 1996, ANNU REV PHYSIOL, V58, P427, DOI 10.1146/annurev.physiol.58.1.427; Gruber G, 2001, J EXP BIOL, V204, P2597; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Landolt-Marticorena C, 1999, J BIOL CHEM, V274, P26057, DOI 10.1074/jbc.274.37.26057; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1996, AM J PHYSIOL-CELL PH, V270, pC382, DOI 10.1152/ajpcell.1996.270.1.C382; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merkulova M, 2010, BBA-BIOENERGETICS, V1797, P1398, DOI 10.1016/j.bbabio.2010.02.009; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nakamura I, 1997, FEBS LETT, V401, P207, DOI 10.1016/S0014-5793(96)01454-8; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	61	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37476	37490		10.1074/jbc.M110.123281	http://dx.doi.org/10.1074/jbc.M110.123281			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20837476	Green Published, hybrid			2022-12-25	WOS:000284424000040
J	Talhaoui, I; Bui, C; Oriol, R; Mulliert, G; Gulberti, S; Netter, P; Coughtrie, MWH; Ouzzine, M; Fournel-Gigleux, S				Talhaoui, Ibtissam; Bui, Catherine; Oriol, Rafael; Mulliert, Guillermo; Gulberti, Sandrine; Netter, Patrick; Coughtrie, Michael W. H.; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie			Identification of Key Functional Residues in the Active Site of Human beta 1, 4-Galactosyltransferase 7 A MAJOR ENZYME IN THE GLYCOSAMINOGLYCAN SYNTHESIS PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCURONOSYLTRANSFERASE-I GLCAT-I; HEPARAN-SULFATE BIOSYNTHESIS; PROTEIN LINKAGE REGION; GALACTOSYLTRANSFERASE-I; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; SEQUENCE ALIGNMENT; GENE FAMILY; PROTEOGLYCANS; BINDING	Glycosaminoglycans (GAGs) play a central role in many pathophysiological events, and exogenous xyloside substrates of beta 1,4-galactosyltransferase 7 (beta 4GalT7), a major enzyme of GAG biosynthesis, have interesting biomedical applications. To predict functional peptide regions important for substrate binding and activity of human beta 4GalT7, we conducted a phylogenetic analysis of the beta 1,4-galactosyltransferase family and generated a molecular model using the x-ray structure of Drosophila beta 4GalT7-UDP as template. Two evolutionary conserved motifs, (DVD165)-D-163 and (221)FWGWGREDDE(230), are central in the organization of the enzyme active site. This model was challenged by systematic engineering of point mutations, combined with in vitro and ex vivo functional assays. Investigation of the kinetic properties of purified recombinant wild-type beta 4GalT7 and selected mutants identified Trp(224) as a key residue governing both donor and acceptor substrate binding. Our results also suggested the involvement of the canonical carboxylate residue Asp(228) acting as general base in the reaction catalyzed by human beta 4GalT7. Importantly, ex vivo functional tests demonstrated that regulation of GAG synthesis is highly responsive to modification of these key active site amino acids. Interestingly, engineering mutants at position 224 allowed us to modify the affinity and to modulate the specificity of human beta 4GalT7 toward UDP-sugars and xyloside acceptors. Furthermore, the W224H mutant was able to sustain decorin GAG chain substitution but not GAG synthesis from exogenously added xyloside. Altogether, this study provides novel insight into human beta 4GalT7 active site functional domains, allowing manipulation of this enzyme critical for the regulation of GAG synthesis. A better understanding of the mechanism underlying GAG assembly paves the way toward GAG-based therapeutics.	[Talhaoui, Ibtissam; Bui, Catherine; Gulberti, Sandrine; Netter, Patrick; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie] Univ Nancy 1, UMR CNRS 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Oriol, Rafael] Univ Paris 11, INSERM, U1004, Inst Andre Lwoff, F-94807 Villejuif, France; [Mulliert, Guillermo] Univ Nancy 1, UMR CNRS 7036, Fac Sci & Tech, F-54505 Vandoeuvre Les Nancy, France; [Coughtrie, Michael W. H.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland	Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Lorraine; University of Dundee	Fournel-Gigleux, S (corresponding author), Univ Nancy 1, UMR CNRS 7561, Fac Med, BP 184, F-54505 Vandoeuvre Les Nancy, France.	sfg@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013; Coughtrie, Michael/C-3855-2009	Coughtrie, Michael/0000-0003-1989-1416	Agence Nationale de la Recherche [ANR-08-PCVI-0023-01]; INSERM-University of Dundee; Royal Society; Region Lorraine; GAG Network; CNRS-UHP Nancy I; University of Dundee	Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM-University of Dundee; Royal Society(Royal Society of London); Region Lorraine(Region Grand-Est); GAG Network; CNRS-UHP Nancy I; University of Dundee	This work was supported by Agence Nationale de la Recherche, GAG Network Grant ANR-08-PCVI-0023-01, INSERM-University of Dundee International Collaboration Contract C2I, Royal Society International Joint Grant (to M. W. H. C. and S. F.-G.), and the Region Lorraine. Part of this work was performed under the auspices of a European-associated laboratory between CNRS-UHP Nancy I and the University of Dundee.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; BANSAL SK, 1980, ANAL BIOCHEM, V109, P321, DOI 10.1016/0003-2697(80)90655-7; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Case D.A., 2022, AMBER 2020; CASE DA, 2004, AMBER 8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ciocchini AE, 2006, GLYCOBIOLOGY, V16, P679, DOI 10.1093/glycob/cwj113; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Fondeur-Gelinotte M, 2006, PROTEIN SCI, V15, P1667, DOI 10.1110/ps.062089106; FOURNELGIGLEUX S, 1989, FEBS LETT, V243, P119, DOI 10.1016/0014-5793(89)80111-5; Frisch G.W., 2016, GAUSSIAN 16 REVISION; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kisilevsky R, 2004, J MOL NEUROSCI, V24, P167, DOI 10.1385/JMN:24:1:167; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li D, 2007, J BIOL CHEM, V282, P36514, DOI 10.1074/jbc.M703107200; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Mani K, 1998, CANCER RES, V58, P1099; Martin NB, 1996, SEMIN THROMB HEMOST, V22, P247, DOI 10.1055/s-2007-999015; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Prydz K, 2000, J CELL SCI, V113, P193; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramakrishnan B, 2010, J BIOL CHEM, V285, P15619, DOI 10.1074/jbc.M109.099564; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Terrak M, 2008, J BIOL CHEM, V283, P28464, DOI 10.1074/jbc.M803223200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37342	37358		10.1074/jbc.M110.151951	http://dx.doi.org/10.1074/jbc.M110.151951			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20843813	Green Published, hybrid			2022-12-25	WOS:000284424000027
J	Ahsberg, J; Tsapogas, P; Qian, H; Zetterblad, J; Zandi, S; Mansson, R; Jonsson, JI; Sigvardsson, M				Ahsberg, Josefine; Tsapogas, Panagiotis; Qian, Hong; Zetterblad, Jenny; Zandi, Sasan; Mansson, Robert; Jonsson, Jan-Ingvar; Sigvardsson, Mikael			Interleukin-7-induced Stat-5 Acts in Synergy with Flt-3 Signaling to Stimulate Expansion of Hematopoietic Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON LYMPHOID PROGENITORS; PROMOTES B-LYMPHOPOIESIS; RECEPTOR-DEFICIENT MICE; HEAVY-CHAIN GENE; STEM-CELLS; LINEAGE COMMITMENT; BONE-MARROW; LIGAND SUPPORTS; FACTOR EBF; C-KIT	The development of lymphoid cells from bone marrow progenitors is dictated by interplay between internal cues such as transcription factors and external signals like the cytokines Flt-3 ligand and Il-7. These proteins are both of large importance for normal lymphoid development; however, it is unclear if they act in direct synergy to expand a transient Il-7R(+)Flt-3(+) population or if the collaboration is created through sequential activities. We report here that Flt-3L and Il-7 synergistically stimulated the expansion of primary Il-7R(+)Flt-3(+) progenitor cells and a hematopoietic progenitor cell line ectopically expressing the receptors. The stimulation resulted in a reduced expression of pro-apoptotic genes and also mediated survival of primary progenitor cells in vitro. However, functional analysis of single cells suggested that the anti-apoptotic effect was additive indicating that the synergy observed mainly depends on stimulation of proliferation. Analysis of downstream signaling events suggested that although Il-7 induced Stat-5 phosphorylation, Flt-3L caused activation of the ERK and AKT signaling pathways. Flt-3L could also drive proliferation in synergy with ectopically expressed constitutively active Stat-5. This synergy could be inhibited with either receptor tyrosine kinase or MAPK inhibitors suggesting that Flt-3L and Il-7 act in synergy by activation of independent signaling pathways to expand early hematopoietic progenitors.	[Ahsberg, Josefine; Tsapogas, Panagiotis; Qian, Hong; Zetterblad, Jenny; Zandi, Sasan; Mansson, Robert; Jonsson, Jan-Ingvar; Sigvardsson, Mikael] IKE Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med, S-58185 Linkoping, Sweden	Linkoping University	Sigvardsson, M (corresponding author), IKE Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.	mikael.sigvardsson@med.lu.se	Tsapogas, Panagiotis/AAN-2465-2020; Mansson, Robert/D-4372-2014; Qian, Hong/D-5588-2014	Mansson, Robert/0000-0003-0738-0328; Qian, Hong/0000-0002-2512-9199; Sigvardsson, Mikael/0000-0001-8527-7276; Tsapogas, Panagiotis/0000-0002-9450-2604; Jonsson, Jan-Ingvar/0000-0003-4814-978X	Swedish Cancer Foundation (Cancer-fonden); The Swedish Research Council (Vetenskapsradet); The Childhood Cancer Foundation (Barncancerfonden); Linkoping University	Swedish Cancer Foundation (Cancer-fonden)(Swedish Cancer Society); The Swedish Research Council (Vetenskapsradet)(Swedish Research Council); The Childhood Cancer Foundation (Barncancerfonden); Linkoping University	This work was supported by the Swedish Cancer Foundation (Cancer-fonden), The Swedish Research Council (Vetenskapsradet), The Childhood Cancer Foundation (Barncancerfonden), and Linkoping University.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; HIRAYAMA F, 1995, BLOOD, V85, P1762, DOI 10.1182/blood.V85.7.1762.bloodjournal8571762; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jensen CT, 2008, BLOOD, V111, P2083, DOI 10.1182/blood-2007-08-108563; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ray RJ, 1996, EUR J IMMUNOL, V26, P1504, DOI 10.1002/eji.1830260715; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Veiby OP, 1996, BLOOD, V88, P1256, DOI 10.1182/blood.V88.4.1256.bloodjournal8841256; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36275	36284		10.1074/jbc.M110.155531	http://dx.doi.org/10.1074/jbc.M110.155531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829349	Green Published, hybrid			2022-12-25	WOS:000284146100037
J	Mita, R; Beaulieu, MJ; Field, C; Godbout, R				Mita, Raja; Beaulieu, Michael J.; Field, Catherine; Godbout, Roseline			Brain Fatty Acid-binding Protein and omega-3/omega-6 Fatty Acids MECHANISTIC INSIGHT INTO MALIGNANT GLIOMA CELL MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; BREAST-CANCER CELLS; PPAR-GAMMA; GENE-EXPRESSION; GLIOBLASTOMA-MULTIFORME; GROWTH-INHIBITION; STRUCTURAL BASIS; MOUSE-LIVER; NUDE-MICE; B-FABP	Malignant gliomas (MG) are highly infiltrative tumors that consistently recur despite aggressive treatment. Brain fatty acid-binding protein (FABP7), which binds docosahexaenoic acid (DHA) and arachidonic acid (AA), localizes to sites of tumor infiltration and is associated with a poor prognosis in MG. Manipulation of FABP7 expression in MG cell lines affects cell migration, suggesting a role for FABP7 in tumor infiltration and recurrence. Here, we show that DHA inhibits and AA stimulates migration in an FABP7-dependent manner in U87 MG cells. We demonstrate that DHA binds to and sequesters FABP7 to the nucleus, resulting in decreased cell migration. This anti-migratory effect is partially dependent on peroxisome proliferator-activated receptor gamma, a DHA-activated transcription factor. Conversely, AA-bound FABP7 stimulates cell migration by activating cyclooxygenase-2 and reducing peroxisome proliferator-activated receptor gamma levels. Our data provide mechanistic insight as to why FABP7 is associated with a poor prognosis in MG and suggest that relative levels of DHA and AA in the tumor environment can make a profound impact on tumor growth properties. We propose that FABP7 and its fatty acid ligands may be key therapeutic targets for controlling the dissemination of MG cells within the brain.	[Mita, Raja; Beaulieu, Michael J.; Godbout, Roseline] Univ Alberta, Dept Oncol, Cross Canc Inst, Sch Canc Engn & Imaging Sci, Edmonton, AB T6G 1Z2, Canada; [Field, Catherine] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada	University of Alberta; University of Alberta	Godbout, R (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, Sch Canc Engn & Imaging Sci, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	Godbout, Roseline/I-4639-2016	Godbout, Roseline/0000-0002-4779-9265; Field, Catherine/0000-0001-7285-4767	Alberta Cancer Research Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research	Alberta Cancer Research Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Alberta Cancer Research Institute (to R. G.) and studentships from the Alberta Cancer Foundation (to R. M.) and the Canadian Institutes of Health Research (to M. J. B.).	Adida A, 2006, BBA-MOL CELL BIOL L, V1761, P172, DOI 10.1016/j.bbalip.2006.02.006; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Benedetti E, 2010, INT J IMMUNOPATH PH, V23, P235, DOI 10.1177/039463201002300121; Biondo PD, 2008, J NUTR BIOCHEM, V19, P787, DOI 10.1016/j.jnutbio.2008.02.003; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chearwae W, 2008, BRIT J CANCER, V99, P2044, DOI 10.1038/sj.bjc.6604786; Connolly JM, 1999, NUTR CANCER, V35, P44, DOI 10.1207/S1532791444-49; Coras R, 2007, MOL CANCER THER, V6, P1745, DOI 10.1158/1535-7163.MCT-06-0763; Cormack B, 2002, METHOD ENZYMOL, V350, P199, DOI 10.1016/S0076-6879(02)50964-2; Crawford MA, 2003, LIPIDS, V38, P303, DOI 10.1007/s11745-003-1065-1; Fujishiro K, 2002, MOL CELL BIOCHEM, V239, P165, DOI 10.1023/A:1020546606429; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Giese A, 1999, Neuro Oncol, V1, P3, DOI 10.1093/neuonc/1.1.3; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Grommes C, 2006, MOL PHARMACOL, V70, P1524, DOI 10.1124/mol.106.022194; Hau P, 2007, ONCOLOGY-BASEL, V73, P21, DOI 10.1159/000120028; Helledie T, 2002, MOL CELL BIOCHEM, V239, P157, DOI 10.1023/A:1020538404612; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Joki T, 2000, CANCER RES, V60, P4926; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Marszalek R, 2010, ACTA POL PHARM, V67, P129; Martin DD, 1996, LIPIDS, V31, P1283, DOI 10.1007/BF02587914; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Motojima K, 2000, INT J BIOCHEM CELL B, V32, P1085, DOI 10.1016/S1357-2725(00)00046-7; Noguchi M, 1997, BRIT J CANCER, V75, P348, DOI 10.1038/bjc.1997.57; Papi A, 2009, J NEUROCHEM, V109, P1779, DOI 10.1111/j.1471-4159.2009.06111.x; Perdiki M, 2007, MOL CELL BIOCHEM, V295, P75, DOI 10.1007/s11010-006-9275-7; Poirier H, 2001, BIOCHEM J, V355, P481, DOI 10.1042/0264-6021:3550481; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Rose DP, 1996, CLIN CANCER RES, V2, P1751; Seliger B, 2005, PROTEOMICS, V5, P2631, DOI 10.1002/pmic.200401264; Simopoulos Artemis P., 2009, V99, P1, DOI 10.1159/000192755; Slipicevic A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-276; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; Spagnolo A, 2007, J NEUROSURG, V106, P299, DOI 10.3171/jns.2007.106.2.299; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Wang MS, 2000, CANCER RES, V60, P6482; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Wu T, 2006, CANCER TREAT REV, V32, P28, DOI 10.1016/j.ctrv.2005.10.004; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Zang CB, 2003, J NEURO-ONCOL, V65, P107, DOI 10.1023/B:NEON.0000003728.80052.a8; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x	57	61	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37005	37015		10.1074/jbc.M110.170076	http://dx.doi.org/10.1074/jbc.M110.170076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20834042	hybrid, Green Published			2022-12-25	WOS:000284146100042
J	Chen, W; Lou, JZ; Zhu, C				Chen, Wei; Lou, Jizhong; Zhu, Cheng			Forcing Switch from Short- to Intermediate- and Long-lived States of the alpha A Domain Generates LFA-1/ICAM-1 Catch Bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; I-LIKE DOMAIN; HIGH-AFFINITY CONFORMATION; LIGAND BINDING-KINETICS; HIGH-STRENGTH STATES; INTEGRIN ALPHA(L)BETA(2); ADHESION RECEPTORS; MOLECULAR-DYNAMICS; BETA(2) INTEGRIN; STRUCTURAL BASIS	Binding of lymphocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1) mediates leukocyte adhesion under force. Using a biomembrane force probe capable of measuring single bond interactions, we showed ICAM-1 binding to LFA-1 at different conformations, including the bent conformation with the lowest affinity. We quantify how force and conformations of LFA-1 regulate its kinetics with ICAM-1. At zero-force, on-rates were substantially changed by conditions that differentially favor a bent or extended LFA-1 with a closed or open headpiece; but off-rates were identical. With increasing force, LFA-1/ICAM-1 bond lifetimes (reciprocal off-rates) first increased (catch bonds) and then decreased (slip bonds). Three states with distinct off-rates were identified from lifetime distributions. Force shifted the associated fractions from the short-to intermediate- and long-lived states, producing catch bonds at low forces, but increased their off-rates exponentially, converting catch to slip bonds at high forces. An internal ligand antagonist that blocks pulling of the alpha(7)-helix suppressed the intermediate-/long-lived states and eliminated catch bonds, revealing an internal catch bond between the alpha A and beta A domains. These results elucidate an allosteric mechanism for the mechanochemistry of LFA-1/ICAM-1 binding.	[Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Lou, Jizhong; Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhu, C (corresponding author), 315 Ferst Dr,IBB Bldg 3312, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Chen, Wei/C-4823-2009	Chen, Wei/0000-0001-5366-7253	National Institutes of Health [AI44902]; American Heart Association [0735224N]; Chinese Academy of Sciences; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044902, R01AI044902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Chinese Academy of Sciences(Chinese Academy of Sciences); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44902 (to C. Z.), an American Heart Association Scientist Development Grant 0735224N and the "Hundred Talents Program" of the Chinese Academy of Sciences (to J. L.), and an American Heart Association Predoctoral Fellowship (to W. C.).	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gaillard T, 2009, PROTEINS, V76, P977, DOI 10.1002/prot.22404; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Labadia ME, 1998, J IMMUNOL, V161, P836; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lomax RG, 2007, STAT CONCEPTS 2 COUR, P10; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MILLER LJ, 1986, J IMMUNOL, V137, P2891; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; [No title captured]; [No title captured]	54	131	139	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35967	35978		10.1074/jbc.M110.155770	http://dx.doi.org/10.1074/jbc.M110.155770			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20819952	Green Published, hybrid			2022-12-25	WOS:000283845300073
J	French, JB; Ealick, SE				French, Jarrod B.; Ealick, Steven E.			Structural and Mechanistic Studies on Klebsiella pneumoniae 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; URIC-ACID DEGRADATION; MOLECULAR MECHANICS; URATE OXIDASE; SOFTWARE; PATHWAY; STABILIZATION; CATALYSIS; PROTEINS; SYSTEM	The stereospecific oxidative degradation of uric acid to (S)-allantoin was recently shown to proceed via three enzymatic steps. The final conversion is a decarboxylation of the unstable intermediate 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) and is catalyzed by OHCU decarboxylase. Here we present the structures of Klebsiella pneumoniae OHCU decarboxylase in unliganded form and with bound allantoin. These structures provide evidence that ligand binding organizes the active site residues for catalysis. Modeling of the substrate and intermediates provides additional support for this hypothesis. In addition we characterize the steady state kinetics of this enzyme and report the first OHCU decarboxylase inhibitor, allopurinol, a structural isomer of hypoxanthine. This molecule is a competitive inhibitor of K. pneumoniae OHCU decarboxylase with a K-i of 30 +/- 2 mu M. Circular dichroism measurements confirm structural observations that this inhibitor disrupts the necessary organization of the active site. Our structural and biochemical studies also provide further insights into the mechanism of catalysis of OHCU decarboxylation.	[Ealick, Steven E.] Cornell Univ, Baker Lab 120, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University	Ealick, SE (corresponding author), Cornell Univ, Baker Lab 120, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	see3@cornell.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309	National Institutes of Health [GM73220, RR-15301]; National Institutes of Health (NIH) under National Science Foundation [DMR-0225180]; National Center for Research Resources, NIH [RR-01646]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) under National Science Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM73220.; We thank the staff at the Cornell High Energy Synchrotron Source (CHESS) and Northeastern Collaborative Access Team for advice with data collection and processing. The data collection performed at the CHESS was supported by the National Science Foundation and the NIGMS, National Institutes of Health (NIH) under National Science Foundation Award DMR-0225180 using the Macromolecular Diffraction at the CHESS (MacCHESS) facility, which is supported by National Center for Research Resources, NIH Award RR-01646. Data collected at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source are supported by National Center for Research Resources, National Institutes of Health Award RR-15301. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357. We acknowledge Cynthia Kinsland of the Protein Production Facility in the Department of Chemistry and Chemical Biology for help with molecular biology and Leslie Kinsland for help with manuscript preparation. We thank M. V. Airola and K. O. Gee of the B. R. Crane laboratory for assistance with the CD data collection.	ALBERY WJ, 1986, BIOCHEMISTRY-US, V25, P2572, DOI 10.1021/bi00357a043; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Begley TP, 2004, CURR OPIN CHEM BIOL, V8, P508, DOI 10.1016/j.cbpa.2004.08.004; Begley TP, 2000, CURR OPIN STRUC BIOL, V10, P711, DOI 10.1016/S0959-440X(00)00148-2; Borges F, 2002, CURR MED CHEM, V9, P195, DOI 10.2174/0929867023371229; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Doukov TI, 2007, J BIOL CHEM, V282, P6609, DOI 10.1074/jbc.M609828200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Frey P. A., 2007, ENZYMATIC REACTION M, P387; Gabison L, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-32; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Kahn K, 1997, BIOCHEMISTRY-US, V36, P4731, DOI 10.1021/bi963184w; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kahn K, 2000, BIOORG CHEM, V28, P62, DOI 10.1006/bioo.2000.1162; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCMURRY JE, 2005, ORGANIC CHEM BIOL PA, P134; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Rudik I, 2001, ARCH BIOCHEM BIOPHYS, V392, P341, DOI 10.1006/abbi.2001.2467; STILL WC, 1999, MACROMODEL; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wood BM, 2009, BIOCHEMISTRY-US, V48, P5510, DOI 10.1021/bi9006226; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	39	17	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35446	35454		10.1074/jbc.M110.156034	http://dx.doi.org/10.1074/jbc.M110.156034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826786	Green Published, hybrid			2022-12-25	WOS:000283845300022
J	Gandhi, M; Jangi, M; Goode, BL				Gandhi, Meghal; Jangi, Mohini; Goode, Bruce L.			Functional Surfaces on the Actin-binding Protein Coronin Revealed by Systematic Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTITATIVE-ANALYSIS; ARP2/3 COMPLEX; IN-VIVO; F-ACTIN; MICROTUBULE CYTOSKELETONS; LEADING-EDGE; COFILIN; YEAST; FILAMENT; DYNAMICS	Coronin is a conserved actin-binding protein that co-functions with ADF/cofilin and Arp2/3 complex to govern cellular actin dynamics. Despite emerging roles for coronin in a range of physiological processes and disease states, a detailed understanding of the molecular interactions of coronin with actin and other binding partners has been lacking. Here, we performed a systematic mutational analysis of surfaces on the yeast coronin beta-propeller domain, which binds to F-actin and is conserved in all coronin family members. We generated 21 mutant alleles and analyzed their biochemical effects on actin binding and ADF/cofilin activity. Conserved actin-binding residues mapped to a discrete ridge stretching across one side of the beta-propeller. Mutants defective in actin binding showed loss of synergy with ADF/cofilin in severing filaments, diminished localization to actin structures in vivo, and loss of coronin overexpression growth defects. In addition, one allele showed normal actin binding but impaired functional interactions with ADF/cofilin. Another allele showed normal actin binding but failed to cause coronin overexpression defects. Together, these results indicate that actin binding is critical for many of the biochemical and cellular functions of coronin and that the beta-propeller domain mediates additional functional interactions with ADF/cofilin and possibly other ligands. Conservation of the actin-binding surfaces across distant species and in all three major classes of coronin isoforms suggests that the nature of the coronin-actin association may be similar in other family members.	[Gandhi, Meghal; Jangi, Mohini; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.	goode@brandeis.edu		, Mohini/0000-0003-3138-4484	National Institutes of Health [GM63691, GM083137]; National Science Foundation, Materials Research Science and Engineering Centers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063691, R01GM083137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, Materials Research Science and Engineering Centers(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63691 and GM083137. This work was also supported by funds from the National Science Foundation, Materials Research Science and Engineering Centers (to B. L. G.).	Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; DE H, 1993, J CELL BIOL */* G J, V120, P163; DE H, 1991, EMBO J */* G EMBO J, V10, P4097; FO GERN, 2006, SCIENCE */* A C SCI, V313, P839; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Mishima M, 1999, J CELL SCI, V112, P2833; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Oku T, 2003, BIOL PHARM BULL, V26, P409; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; SMITH TF, 2008, F Subcell BIOCH, V48, P20; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; WERTMAN KF, 1992, GENETICS, V132, P337	33	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34899	34908		10.1074/jbc.M110.171496	http://dx.doi.org/10.1074/jbc.M110.171496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813846	Green Published, hybrid			2022-12-25	WOS:000283659100064
J	Rajagopal, C; Stone, KL; Mains, RE; Eipper, BA				Rajagopal, Chitra; Stone, Kathryn L.; Mains, Richard E.; Eipper, Betty A.			Secretion Stimulates Intramembrane Proteolysis of a Secretory Granule Membrane Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; AMYLOID PRECURSOR PROTEIN; PEPTIDE-PROCESSING ENZYME; GAMMA-SECRETASE; CYTOSOLIC DOMAIN; ENDOCRINE-CELLS; INHIBITOR DAPT; PAM EXPRESSION; ATT-20 CELLS; RAT-HEART	Regulated intramembrane proteolysis, a highly conserved process employed by diverse regulatory pathways, can release soluble fragments that directly or indirectly modulate gene expression. In this study we used pharmacological tools to identify peptidylglycine alpha-amidating monooxygenase (PAM), a type I secretory granule membrane protein, as a gamma-secretase substrate. PAM, an essential enzyme, catalyzes the final step in the synthesis of the majority of neuropeptides that control metabolic homeostasis. Mass spectroscopy was most consistent with the presence of multiple closely spaced NH2 termini, suggesting that cleavage occurred near the middle of the PAM transmembrane domain. The luminal domains of PAM must undergo a series of prohormone convertase or gamma-secretase-mediated cleavages before the remaining transmembrane domain/cytosolic domain fragment can undergo a gamma-secretase-like cleavage. Cleavage by gamma-secretase generates a soluble fragment of the cytosolic domain (sf-CD) that is known to localize to the nucleus. Although PAM sf-CD is unstable in AtT-20 corticotroph tumor cells, it is readily detected in primary rat anterior pituitary cells. PAM isoform expression, which is tissue-specific and developmentally regulated, affects the efficiency with which sf-CD is produced. sf-CD levels are also modulated by the phosphorylation status of the cytosolic domain and by the ability of the cytosolic domain to interact with cytosolic proteins. sf-CD is produced by primary rat anterior pituitary cells in response to secretogogue, suggesting that sf-CD acts as a signaling molecule relaying information about secretion from the secretory granule to the nucleus.	[Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA; [Stone, Kathryn L.] Yale Univ, WM Keck Facil, New Haven, CT 06511 USA	University of Connecticut; University of Connecticut; Yale University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu	, Chitra/AAC-9698-2021	, Chitra/0000-0003-2962-459X	National Institutes of Health (NIDDK) [DK32949]; National Institute on Drug Abuse Neuroproteomics Center [P30 DA018343]; National Institutes of Health National Center for Research Resources Clinical and Translational Science [UL1 RR024139, 1S10RR024617]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024617, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032949, R01DK032949, R37DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Drug Abuse Neuroproteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health National Center for Research Resources Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DK32949 (NIDDK) and National Institute on Drug Abuse Neuroproteomics Center Grant P30 DA018343.; We thank Dr. Erol Gulcicek for titanium enrichment of phosphopeptides and Yanping Wang and Darlene D'Amato for invaluable technical assistance. Instrumentation was obtained with funds from National Institutes of Health National Center for Research Resources Clinical and Translational Science Award UL1 RR024139 and Shared Instrumentation Grant 1S10RR024617.	Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Arnaoutova I, 2008, MOL ENDOCRINOL, V22, P1924, DOI 10.1210/me.2007-0434; BA CKN, 2010, TRAFFIC */* B A TRAF, V11, P972; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; BENGOECHEAALONS.MT, 2007, J CURR OPIN CELL BIO, V19, P215; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Ferraro F, 2005, J BIOL CHEM, V280, P25424, DOI 10.1074/jbc.M414156200; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kanungo J, 2008, J NEUROCHEM, V106, P2236, DOI 10.1111/j.1471-4159.2008.05551.x; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; MAINS RE, 2006, PEPTIDES, P317; MALTESE JY, 1992, MOL ENDOCRINOL, V6, P1998, DOI 10.1210/me.6.12.1998; Meskini RE, 2000, ENDOCRINOLOGY, V141, P3020; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nagai N, 2007, J BIOL CHEM, V282, P14942, DOI 10.1074/jbc.M610691200; OUAFIK L, 1989, J BIOL CHEM, V264, P5839; Rajagopal C, 2009, J BIOL CHEM, V284, P25723, DOI 10.1074/jbc.M109.035782; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Schiller M R, 2000, Pituitary, V3, P141, DOI 10.1023/A:1011491324117; SEIDAH NG, 1993, BIOCHEM SOC T, V21, P685, DOI 10.1042/bst0210685; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	40	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34632	34642		10.1074/jbc.M110.145334	http://dx.doi.org/10.1074/jbc.M110.145334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817724	hybrid, Green Published			2022-12-25	WOS:000283659100039
J	Casteel, DE; Smith-Nguyen, EV; Sankaran, B; Roh, SH; Pilz, RB; Kim, C				Casteel, Darren E.; Smith-Nguyen, Eric V.; Sankaran, Banumathi; Roh, Sung H.; Pilz, Renate B.; Kim, Choel			A Crystal Structure of the Cyclic GMP-dependent Protein Kinase I beta Dimerization/Docking Domain Reveals Molecular Details of Isoform-specific Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN4 LEUCINE-ZIPPER; TFII-I; CIRCULAR-DICHROISM; TERMINAL DOMAIN; BLOOD-PRESSURE; COILED-COIL; CGMP KINASE; IRAG; RELAXATION; REGULATOR	Cyclic GMP-dependent protein kinase (PKG) is a key mediator of the nitric oxide/cGMP signaling pathway and plays a central role in regulating cardiovascular and neuronal functions. The N-terminal similar to 50 amino acids of the kinase are required for homodimerization and association with isoform-specific PKG-anchoring proteins (GKAPs), which target the kinase to specific substrates. To understand the molecular details of PKG dimerization and gain insight into its association with GKAPs, we solved a crystal structure of the PKG I beta dimerization/docking domain. Our structure provides molecular details of this unique leucine/isoleucine zipper, revealing specific hydrophobic and ionic interactions that mediate dimerization and demonstrating the topology of the GKAP interaction surface.	[Roh, Sung H.; Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Casteel, Darren E.; Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Casteel, Darren E.; Pilz, Renate B.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Smith-Nguyen, Eric V.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kim, C (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	ckim@bcm.edu			National Institutes of Health [R01-AR051300, K22-CA124517]; American Heart Grant [09SDG2150143]; National Institutes of Health (NIGMS); Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [K22CA124517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Grant; National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR051300 (to R. B. P.) and K22-CA124517 (to D. E. C.). This work was also supported by American Heart Grant 09SDG2150143 (to C. K.).; We thank Susan. S. Taylor, Jens Schlossmann, and I. V. Khavrutskii for insights and helpful discussions; T. Koller for verifying Se-Met substitution by mass spectrometry; S. Lesley for technical support; E. Larson at Bio-Rad Laboratories for supplying the Profinia protein purification system; and P. D. Stewart for in-depth discussion on optimizing crystallization conditions using the Oryx 8 crystallization robot. Portions of this research were conducted at the Advanced Light Source operated by Lawrence Berkeley National Laboratory (on behalf of the United States Department of Energy, Office of Basic Energy Sciences). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health (NIGMS) and the Howard Hughes Medical Institute.	ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; LANDGRAF W, 1990, BIOCHEMISTRY-US, V29, P9921, DOI 10.1021/bi00494a024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schlossmann Jens, 2009, V191, P163, DOI 10.1007/978-3-540-68964-5_9; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	25	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32684	32688		10.1074/jbc.C110.161430	http://dx.doi.org/10.1074/jbc.C110.161430			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20826808	Green Published, hybrid			2022-12-25	WOS:000283048200002
J	Santos, BA; Arroyo-Rodriguez, V; Moreno, CE; Tabarelli, M				Santos, Braulio A.; Arroyo-Rodriguez, Victor; Moreno, Claudia E.; Tabarelli, Marcelo			Edge-Related Loss of Tree Phylogenetic Diversity in the Severely Fragmented Brazilian Atlantic Forest	PLOS ONE			English	Article							HABITAT FRAGMENTATION; NONRANDOM EXTINCTION; EVOLUTIONARY; BIODIVERSITY; CONSERVATION; LANDSCAPE; EROSION; DECAY	Deforestation and forest fragmentation are known major causes of nonrandom extinction, but there is no information about their impact on the phylogenetic diversity of the remaining species assemblages. Using a large vegetation dataset from an old hyper-fragmented landscape in the Brazilian Atlantic rainforest we assess whether the local extirpation of tree species and functional impoverishment of tree assemblages reduce the phylogenetic diversity of the remaining tree assemblages. We detected a significant loss of tree phylogenetic diversity in forest edges, but not in core areas of small (<80 ha) forest fragments. This was attributed to a reduction of 11% in the average phylogenetic distance between any two randomly chosen individuals from forest edges; an increase of 17% in the average phylogenetic distance to closest non-conspecific relative for each individual in forest edges; and to the potential manifestation of late edge effects in the core areas of small forest remnants. We found no evidence supporting fragmentation-induced phylogenetic clustering or evenness. This could be explained by the low phylogenetic conservatism of key life-history traits corresponding to vulnerable species. Edge effects must be reduced to effectively protect tree phylogenetic diversity in the severely fragmented Brazilian Atlantic forest.	[Santos, Braulio A.; Arroyo-Rodriguez, Victor] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Santos, Braulio A.; Tabarelli, Marcelo] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Moreno, Claudia E.] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca, Mexico	Universidad Nacional Autonoma de Mexico; Universidade Federal de Pernambuco; Universidad Autonoma del Estado de Hidalgo	Santos, BA (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	bsantos@oikos.unam.mx	Moreno, Claudia/GRJ-1036-2022; Tabarelli, Marcelo/F-1088-2010; Arroyo-Rodríguez, Víctor/C-9255-2009; Virtual, Inct Herbario/J-8725-2013; Moreno, Claudia E./B-2733-2013; Santos, Bráulio A./M-2582-2013	Tabarelli, Marcelo/0000-0001-7573-7216; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Moreno, Claudia E./0000-0002-9584-2619; Santos, Bráulio A./0000-0001-6046-4024	CNPq; Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil; Universidad Nacional Autonoma de Mexico	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	Financial support was provided by CNPq (www.cnpq.br) (graduate scholarship to B. Santos and research grant to M. Tabarelli), Fundacao O Boticario de Protecao a Natureza (www.fundacaoboticario.org.br), Conservation International-Brazil (www.conservation.org.br), and Universidad Nacional Autonoma de Mexico (postdoctoral fellowship to V. Arroyo-Rodriguez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; HARPER JL, 1994, PHILOS T R SOC B, V345, P5, DOI 10.1098/rstb.1994.0081; HUMPHRIES CJ, 1995, ANNU REV ECOL SYST, V26, P93, DOI 10.1146/annurev.es.26.110195.000521; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; SILVA JMC, 2000, NATURE, V404, P72, DOI DOI 10.1038/35003563; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	42	81	81	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12625	10.1371/journal.pone.0012625	http://dx.doi.org/10.1371/journal.pone.0012625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838613	Green Published, gold			2022-12-25	WOS:000281687100008
J	Atkins, N; Mitchell, JW; Romanova, EV; Morgan, DJ; Cominski, TP; Ecker, JL; Pintar, JE; Sweedler, JV; Gillette, MU				Atkins, Norman, Jr.; Mitchell, Jennifer W.; Romanova, Elena V.; Morgan, Daniel J.; Cominski, Tara P.; Ecker, Jennifer L.; Pintar, John E.; Sweedler, Jonathan V.; Gillette, Martha U.			Circadian Integration of Glutamatergic Signals by Little SAAS in Novel Suprachiasmatic Circuits	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; PHASE-SHIFTS; NEURONAL RHYTHMS; GENE-EXPRESSION; RAT; NUCLEUS; CLOCK; VIP; MOUSE	Background: Neuropeptides are critical integrative elements within the central circadian clock in the suprachiasmatic nucleus (SCN), where they mediate both cell-to-cell synchronization and phase adjustments that cause light entrainment. Forward peptidomics identified little SAAS, derived from the proSAAS prohormone, among novel SCN peptides, but its role in the SCN is poorly understood. Methodology/Principal Findings: Little SAAS localization and co-expression with established SCN neuropeptides were evaluated by immunohistochemistry using highly specific antisera and stereological analysis. Functional context was assessed relative to c-FOS induction in light-stimulated animals and on neuronal circadian rhythms in glutamate-stimulated brain slices. We found that little SAAS-expressing neurons comprise the third most abundant neuropeptidergic class (16.4%) with unusual functional circuit contexts. Little SAAS is localized within the densely retinorecipient central SCN of both rat and mouse, but not the retinohypothalamic tract (RHT). Some little SAAS colocalizes with vasoactive intestinal polypeptide (VIP) or gastrin-releasing peptide (GRP), known mediators of light signals, but not arginine vasopressin (AVP). Nearly 50% of little SAAS neurons express c-FOS in response to light exposure in early night. Blockade of signals that relay light information, via NMDA receptors or VIP-and GRP-cognate receptors, has no effect on phase delays of circadian rhythms induced by little SAAS. Conclusions/Significance: Little SAAS relays signals downstream of light/glutamatergic signaling from eye to SCN, and independent of VIP and GRP action. These findings suggest that little SAAS forms a third SCN neuropeptidergic system, processing light information and activating phase-shifts within novel circuits of the central circadian clock.	[Atkins, Norman, Jr.; Sweedler, Jonathan V.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Mitchell, Jennifer W.; Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Romanova, Elena V.; Sweedler, Jonathan V.; Gillette, Martha U.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Morgan, Daniel J.; Cominski, Tara P.; Pintar, John E.] Univ Med & Dent New Jersey, Dept Cell Biol & Neurosci, Newark, NJ 07103 USA; [Ecker, Jennifer L.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; University of Illinois System; University of Illinois Urbana-Champaign	Atkins, N (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.	mgillett@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Morgan, Daniel/0000-0002-9467-4019; Romanova, Elena/0000-0002-2040-3312; Atkins, Norman/0000-0002-0802-6032	National Institutes of Health [HL092571, P30 DA018310, DE018866, T32 MH/AG19957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grants from the National Institutes of Health (www.nih.gov): HL092571 (MUG), P30 DA018310 and DE018866 (JVS), and T32 MH/AG19957 (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; ALBERS HE, 1991, J NEUROSCI, V11, P846; ALBERS HE, 1995, NEUROSCI LETT, V191, P63, DOI 10.1016/0304-3940(95)11559-1; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Ashwood V, 1998, BIOORG MED CHEM LETT, V8, P2589, DOI 10.1016/S0960-894X(98)00462-4; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Beaule C, 2001, NEUROSCIENCE, V106, P249, DOI 10.1016/S0306-4522(01)00313-X; Beaule C, 2009, J BIOL RHYTHM, V24, P126, DOI 10.1177/0748730409332037; Bora A, 2008, J PROTEOME RES, V7, P4992, DOI 10.1021/pr800394e; Bradbury MJ, 1997, BRAIN RES, V768, P125, DOI 10.1016/S0006-8993(97)00629-X; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Cassone VM, 1988, J BIOL RHYTHM, V3, P71, DOI 10.1177/074873048800300106; Davidson Alec J, 2003, Novartis Found Symp, V253, P110; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Edelstein K, 2000, BRAIN RES, V870, P54, DOI 10.1016/S0006-8993(00)02401-X; EDGAR DM, 1993, J BIOL RHYTHM, V8, P17, DOI 10.1177/074873049300800102; Edgar DM, 1997, AM J PHYSIOL-REG I, V273, pR265, DOI 10.1152/ajpregu.1997.273.1.R265; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; GILLETTE MU, 1995, CIBA F SYMP, V183, P134; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Gouraud SS, 2007, ENDOCRINOLOGY, V148, P3041, DOI 10.1210/en.2007-0181; Hannibal J, 2002, ANN MED, V34, P401, DOI 10.1080/078538902320772151; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Harmar AJ, 2003, J NEUROENDOCRINOL, V15, P335, DOI 10.1046/j.1365-2826.2003.01005.x; Hatcher NG, 2008, P NATL ACAD SCI USA, V105, P12527, DOI 10.1073/pnas.0804340105; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Isobe Y, 1996, BRAIN RES BULL, V40, P287, DOI 10.1016/0361-9230(96)00023-8; Jobst EE, 2002, EUR J NEUROSCI, V16, P2469, DOI 10.1046/j.1460-9568.2002.02309.x; Kallingal GJ, 2006, EUR J NEUROSCI, V24, P2853, DOI 10.1111/j.1460-9568.2006.05165.x; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Karatsoreos IN, 2004, J NEUROSCI, V24, P68, DOI 10.1523/JNEUROSCI.1666-03.2004; Kawamoto K, 2003, J NEUROSCI RES, V74, P852, DOI 10.1002/jnr.10751; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lee JE, 2010, MOL CELL PROTEOMICS, V9, P285, DOI 10.1074/mcp.M900362-MCP200; McArthur AJ, 2000, J NEUROSCI, V20, P5496, DOI 10.1523/JNEUROSCI.20-14-05496.2000; MEDANIC M, 1992, J PHYSIOL-LONDON, V450, P629, DOI 10.1113/jphysiol.1992.sp019147; Mintz EM, 1999, J NEUROSCI, V19, P5124; Moody TW, 2006, J MOL NEUROSCI, V28, P231, DOI 10.1385/JMN:28:3:231; Morgan DJ, 2010, J NEUROCHEM; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; Nielsen HS, 2002, EUR J NEUROSCI, V15, P570, DOI 10.1046/j.0953-816x.2001.01882.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PANDOL SJ, 1986, AM J PHYSIOL, V250, pG553, DOI 10.1152/ajpgi.1986.250.4.G553; PROSSER RA, 1989, J NEUROSCI, V9, P1073; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Romanova EV, 2008, ANAL CHEM, V80, P3379, DOI 10.1021/ac7026047; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Romijn HJ, 1998, J COMP NEUROL, V391, P397; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Stamp JA, 1997, BRAIN RES, V756, P215, DOI 10.1016/S0006-8993(97)00199-6; Tanaka M, 1997, J HISTOCHEM CYTOCHEM, V45, P1231, DOI 10.1177/002215549704500906; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; WEICK RF, 1995, NEUROSCI BIOBEHAV R, V19, P251, DOI 10.1016/0149-7634(94)00057-8; WEICK RF, 1992, NEUROENDOCRINOLOGY, V56, P646, DOI 10.1159/000126288; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037	64	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12612	10.1371/journal.pone.0012612	http://dx.doi.org/10.1371/journal.pone.0012612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830308	gold, Green Published			2022-12-25	WOS:000281631300033
J	Das, J; Ghosh, J; Manna, P; Sil, PC				Das, Joydeep; Ghosh, Jyotirmoy; Manna, Prasenjit; Sil, Parames C.			Protective Role of Taurine against Arsenic-Induced Mitochondria-Dependent Hepatic Apoptosis via the Inhibition of PKC delta-JNK Pathway	PLOS ONE			English	Article							OXIDATIVE RENAL DYSFUNCTION; KINASE-C-DELTA; DRINKING-WATER; CELL-DEATH; PROTEIN; STRESS; TOXICITY; GLUTATHIONE; MICE; HEPATOTOXICITY	Background: Oxidative stress-mediated hepatotoxic effect of arsenic (As) is mainly due to the depletion of glutathione (GSH) in liver. Taurine, on the other hand, enhances intracellular production of GSH. Little is known about the mechanism of the beneficial role of taurine in As-induced hepatic pathophysiology. Therefore, in the present study we investigated its beneficial role in As-induced hepatic cell death via mitochondria-mediated pathway. Methodology/Principal Findings: Rats were exposed to NaAsO2 (2 mg/kg body weight for 6 months) and the hepatic tissue was used for oxidative stress measurements. In addition, the pathophysiologic effect of NaAsO2 (10 mu M) on hepatocytes was evaluated by determining cell viability, mitochondrial membrane potential and ROS generation. As caused mitochondrial injury by increased oxidative stress and reciprocal regulation of Bcl-2, Bcl-xL/Bad, Bax, Bim in association with increased level of Apaf-1, activation of caspase 9/3, cleavage of PARP protein and ultimately led to apoptotic cell death. In addition, As markedly increased JNK and p38 phosphorylation with minimal disturbance of ERK. Pre-exposure of hepatocytes to a JNK inhibitor SP600125 prevented As-induced caspase-3 activation, ROS production and loss in cell viability. Pre-exposure of hepatocytes to a p38 inhibitor SB2035, on the other hand, had practically no effect on these events. Besides, As activated PKC delta and pre-treatment of hepatocytes with its inhibitor, rottlerin, suppressed the activation of JNK indicating that PKC delta is involved in As-induced JNK activation and mitochondrial dependent apoptosis. Oral administration of taurine (50 mg/kg body weight for 2 weeks) both pre and post to NaAsO2 exposure or incubation of the hepatocytes with taurine (25 mM) were found to be effective in counteracting As-induced oxidative stress and apoptosis. Conclusions/Significance: Results indicate that taurine treatment improved As-induced hepatic damages by inhibiting PKC delta-JNK signalling pathways. Therefore taurine supplementation could provide a new approach for the reduction of hepatic complication due to arsenic poisoning.	[Das, Joydeep; Ghosh, Jyotirmoy; Manna, Prasenjit; Sil, Parames C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Das, J (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	parames@bosemain.boseinst.ac.in	Das, Joydeep/AAE-3501-2021; Das, Joydeep/AAO-4770-2021	Manna, Prasenjit/0000-0003-1952-6531	Bose Institute	Bose Institute(Department of Science & Technology (India))	The work was supported by Bose Institute Internal Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aposhian HV, 1997, ANNU REV PHARMACOL, V37, P397, DOI 10.1146/annurev.pharmtox.37.1.397; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter DE, 2003, TOXICOL APPL PHARM, V193, P309, DOI 10.1016/j.taap.2003.07.009; Chang SI, 2007, TOXICOL APPL PHARM, V218, P196, DOI 10.1016/j.taap.2006.11.009; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; DAS D, 1995, ANALYST, V120, P917, DOI 10.1039/an9952000917; Das J, 2010, TOXICOLOGY, V269, P24, DOI 10.1016/j.tox.2010.01.003; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; Das J, 2009, TOXICOL LETT, V187, P201, DOI 10.1016/j.toxlet.2009.03.001; Das Joydeep, 2008, Pathophysiology, V15, P181, DOI 10.1016/j.pathophys.2008.06.002; Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171; Das S, 2005, TOXICOL APPL PHARM, V204, P18, DOI 10.1016/j.taap.2004.08.010; Dogru-Abbasoglu S, 2001, HUM EXP TOXICOL, V20, P23, DOI 10.1191/096032701673031525; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Flora SJS, 2008, OXID MED CELL LONGEV, V1, P39, DOI 10.4161/oxim.1.1.6481; Flora SJS, 2009, CHEM-BIOL INTERACT, V177, P227, DOI 10.1016/j.cbi.2008.08.017; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Ghosh J, 2010, FREE RADICAL BIO MED, V48, P535, DOI 10.1016/j.freeradbiomed.2009.11.023; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hagar HH, 2004, TOXICOL LETT, V151, P335, DOI 10.1016/j.toxlet.2004.03.002; Hayes J, 2001, BRAIN RES BULL, V55, P239, DOI 10.1016/S0361-9230(01)00507-X; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HODARNAU A, 1973, J CELL BIOL, V59, P222, DOI 10.1083/jcb.59.1.222; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; KALBHEN DA, 1967, Z KLIN CHEM KLIN BIO, V5, P299; KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322; Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157; LEE CY, 1982, METHOD ENZYMOL, V89, P252; Madesh M, 1997, INDIAN J BIOCHEM BIO, V34, P535; Maioli E, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/742936; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x; Mingatto FE, 2002, J PHARMACOL EXP THER, V303, P601, DOI 10.1124/jpet.102.038620; Nardi N, 1997, J NEUROCHEM, V68, P750; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Niwa K, 2002, FREE RADICAL RES, V36, P1147, DOI 10.1080/1071576021000016409; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Powell CT, 1996, CELL GROWTH DIFFER, V7, P419; Qu W, 2002, CARCINOGENESIS, V23, P151, DOI 10.1093/carcin/23.1.151; Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Roy A, 2009, FREE RADICAL RES, V43, P995, DOI 10.1080/10715760903164998; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Santra A, 2000, Indian J Gastroenterol, V19, P112; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Schaffer S, 2003, ADV EXP MED BIOL, V526, P307; SELLINS KS, 1987, J IMMUNOL, V139, P3199; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; States JC, 2002, TOXICOL APPL PHARM, V180, P83, DOI 10.1006/taap.2002.9376; Tabassum H, 2006, CLIN CHIM ACTA, V370, P129, DOI 10.1016/j.cca.2006.02.006; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamauchi H, 2004, TOXICOL APPL PHARM, V198, P291, DOI 10.1016/j.taap.2003.10.021; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751	64	74	83	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12602	10.1371/journal.pone.0012602	http://dx.doi.org/10.1371/journal.pone.0012602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830294	Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300026
J	Liao, CY; Gock, A; Michie, M; Morton, B; Anderson, A; Trowell, S				Liao, Chunyan; Gock, Andrew; Michie, Michelle; Morton, Bethany; Anderson, Alisha; Trowell, Stephen			Behavioural and Genetic Evidence for C. elegans' Ability to Detect Volatile Chemicals Associated with Explosives	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; CHEMOSENSORY BEHAVIORS; OLFACTORY ADAPTATION; ALPHA-SUBUNITS; PROTEIN; RECEPTOR; ENCODES; NEURONS; PHOSPHORYLATION	Background: Automated standoff detection and classification of explosives based on their characteristic vapours would be highly desirable. Biologically derived odorant receptors have potential as the explosive recognition element in novel biosensors. Caenorhabditis elegans' genome contains over 1,000 uncharacterised candidate chemosensory receptors. It was not known whether any of these respond to volatile chemicals derived from or associated with explosives. Methodology/Principal Findings: We assayed C. elegans for chemotactic responses to chemical vapours of explosives and compounds associated with explosives. C. elegans failed to respond to many of the explosive materials themselves but showed strong chemotaxis with a number of compounds associated with commercial or homemade explosives. Genetic mutant strains were used to identify the likely neuronal location of a putative receptor responding to cyclohexanone, which is a contaminant of some compounded explosives, and to identify the specific transduction pathway involved. Upper limits on the sensitivity of the nematode were calculated. A sensory adaptation protocol was used to estimate the receptive range of the receptor. Conclusions/Significance:: The results suggest that C. elegans may be a convenient source of highly sensitive, narrowly tuned receptors to detect a range of explosive-associated volatiles.	[Liao, Chunyan] CSIRO Entomol, Canberra, ACT, Australia; CSIRO Food Futures Flagship, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Liao, CY (corresponding author), CSIRO Entomol, Canberra, ACT, Australia.	Stephen.Trowell@csiro.au	Trowell, Stephen/AAG-8943-2019; Trowell, Stephen C/B-8043-2008; Anderson, Alisha R/C-1499-2008; Anderson, Alisha/AAC-3505-2021	Trowell, Stephen C/0000-0002-0505-8741; Anderson, Alisha R/0000-0001-7013-116X; Anderson, Alisha/0000-0001-7013-116X	Australian Government's National Security Science and Technology Unit and Emergency Management Australia; CSIRO	Australian Government's National Security Science and Technology Unit and Emergency Management Australia(Australian Government); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was jointly funded by a competitive grant from the Australian Government's National Security Science and Technology Unit and Emergency Management Australia. It was co-funded by CSIRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the funding agencies reviewed the manuscript prior to publication solely to ensure that it did not disclose security-sensitive information.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; BROWN NG, 1992, EUR J BIOCHEM, V208, P659, DOI 10.1111/j.1432-1033.1992.tb17232.x; Chou JH, 2001, GENETICS, V157, P211; Chou JH, 1996, COLD SPRING HARB SYM, V61, P157; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; DEAN KR, 1993, EUR J BIOCHEM, V213, P881, DOI 10.1111/j.1432-1033.1993.tb17832.x; Frokjaer-Jensen C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002467; Gardner JW, 2004, NATO SCI SER II MATH, V159, P1; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Harper RJ, 2005, TALANTA, V67, P313, DOI 10.1016/j.talanta.2005.05.019; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; Marshall B, 2010, CHEM SENSES, V35, P613, DOI 10.1093/chemse/bjq050; Melkman T, 2004, DEV BIOL, V265, P302, DOI 10.1016/j.ydbio.2003.07.005; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; *NAT RES COUNC, 2003, 1 NAT RES COUNC, pR21; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Rains GC, 2008, TRENDS BIOTECHNOL, V26, P288, DOI 10.1016/j.tibtech.2008.02.007; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; SENGUPTA P, 1993, CIBA F SYMP, V179, P235; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 2007, PFLUG ARCH EUR J PHY, V454, P721, DOI 10.1007/s00424-006-0196-9; Smith RG, 2008, ANALYST, V133, P571, DOI 10.1039/b717933m; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	51	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12615	10.1371/journal.pone.0012615	http://dx.doi.org/10.1371/journal.pone.0012615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830309	Green Published, gold			2022-12-25	WOS:000281631300035
J	White, JF; Grisshammer, R				White, Jim F.; Grisshammer, Reinhard			Stability of the Neurotensin Receptor NTS1 Free in Detergent Solution and Immobilized to Affinity Resin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LARGE-SCALE PURIFICATION; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BINDING-SITE; STRUCTURAL INSTABILITY; BOVINE RHODOPSIN; CRYSTALLIZATION; ACTIVATION	Background: Purification of recombinant membrane receptors is commonly achieved by use of an affinity tag followed by an additional chromatography step if required. This second step may exploit specific receptor properties such as ligand binding. However, the effects of multiple purification steps on protein yield and integrity are often poorly documented. We have previously reported a robust two-step purification procedure for the recombinant rat neurotensin receptor NTS1 to give milligram quantities of functional receptor protein. First, histidine-tagged receptors are enriched by immobilized metal affinity chromatography using Ni-NTA resin. Second, remaining contaminants in the Ni-NTA column eluate are removed by use of a subsequent neurotensin column yielding pure NTS1. Whilst the neurotensin column eluate contained functional receptor protein, we observed in the neurotensin column flow-through misfolded NTS1. Methods and Findings: To investigate the origin of the misfolded receptors, we estimated the amount of functional and misfolded NTS1 at each purification step by radio-ligand binding, densitometry of Coomassie stained SDS-gels, and protein content determination. First, we observed that correctly folded NTS1 suffers damage by exposure to detergent and various buffer compositions as seen by the loss of [3 H] neurotensin binding over time. Second, exposure to the neurotensin affinity resin generated additional misfolded receptor protein. Conclusion: Our data point towards two ways by which misfolded NTS1 may be generated: Damage by exposure to buffer components and by close contact of the receptor to the neurotensin affinity resin. Because NTS1 in detergent solution is stabilized by neurotensin, we speculate that the occurrence of aggregated receptor after contact with the neurotensin resin is the consequence of perturbations in the detergent belt surrounding the NTS1 transmembrane core. Both effects reduce the yield of functional receptor protein.	[White, Jim F.; Grisshammer, Reinhard] NINDS, NIH, US Dept HHS, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	White, JF (corresponding author), NINDS, NIH, US Dept HHS, Rockville, MD USA.	rkgriss@helix.nih.gov	Grisshammer, Reinhard/C-3089-2015		NIH, National Institute of Neurological Disorders and Stroke	NIH, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research of JFW and RG was supported by the Intramural Research Program of the NIH, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Grisshammer R, 1997, PROTEIN EXPRES PURIF, V11, P53, DOI 10.1006/prep.1997.0766; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Grisshammer R, 1999, BIOCHEM SOC T, V27, P899, DOI 10.1042/bst0270899; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hulme Edward C., 1998, Biochemical Society Transactions, V26, pS361; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kitabgi P, 2006, PEPTIDES, V27, P2461, DOI 10.1016/j.peptides.2006.02.013; Klaassen CHW, 1999, BIOCHEM J, V342, P293, DOI 10.1042/0264-6021:3420293; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Martin S, 1999, MOL PHARMACOL, V55, P210, DOI 10.1124/mol.55.2.210; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Ohtaki T, 1998, J BIOL CHEM, V273, P15464, DOI 10.1074/jbc.273.25.15464; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pang YP, 1996, J BIOL CHEM, V271, P15060, DOI 10.1074/jbc.271.25.15060; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; WHITE JF, 2007, AUTOMATED LARGE SCAL; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Wilson MH, 2000, BIOCHEMISTRY-US, V39, P693, DOI 10.1021/bi9920275; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12579	10.1371/journal.pone.0012579	http://dx.doi.org/10.1371/journal.pone.0012579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830205	Green Submitted, gold, Green Published			2022-12-25	WOS:000281631300011
J	Wilkinson, A; Solan, M; Taylor, AFS; Alexander, IJ; Johnson, D				Wilkinson, Anna; Solan, Martin; Taylor, Andrew F. S.; Alexander, Ian J.; Johnson, David			Intraspecific Diversity Regulates Fungal Productivity and Respiration	PLOS ONE			English	Article							HEBELOMA-CYLINDROSPORUM; GENOTYPIC DIVERSITY; COMMUNITY STRUCTURE; GENETIC DIVERSITY; NITROGEN-SOURCES; ECTOMYCORRHIZAL; BIODIVERSITY; ECOSYSTEMS; ECOLOGY; SYMBIOSIS	Individuals and not just species are key components of biodiversity, yet the relationship between intraspecific diversity and ecosystem functioning in microbial systems remains largely untested. This limits our ability to understand and predict the effects of altered genetic diversity in regulating key ecosystem processes and functions. Here, we use a model fungal system to test the hypothesis that intraspecific genotypic richness of Paxillus obscurosporus stimulates biomass and CO(2) efflux, but that this is dependent on nitrogen supply. Using controlled experimental microcosms, we show that populations containing several genotypes (maximum 8) of the fungus had greater productivity and produced significantly more CO(2) than those with fewer genotypes. Moreover, intraspecific diversity had a much stronger effect than a four-fold manipulation of the carbon: nitrogen ratio of the growth medium. The effects of intraspecific diversity were underpinned by strong roles of individuals, but overall intraspecific diversity increased the propensity of populations to over-yield, indicating that both complementarity and selection effects can operate within species. Our data demonstrate the importance of intraspecific diversity over a range of nitrogen concentrations, and the need to consider fine scale phylogenetic information of microbial communities in understanding their contribution to ecosystem processes.	[Wilkinson, Anna; Alexander, Ian J.; Johnson, David] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Solan, Martin] Univ Aberdeen, Oceanlab, Newburgh, Scotland; [Taylor, Andrew F. S.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland	University of Aberdeen; University of Aberdeen; James Hutton Institute	Wilkinson, A (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	d.johnson@abdn.ac.uk	Johnson, David/N-3193-2013; Solan, Martin/E-9338-2012	Solan, Martin/0000-0001-9924-5574; Johnson, David/0000-0003-2299-2525	Natural Environment Research Council [NE/F006543/1]; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	AW was supported by a studentship (NE/F006543/1) funded by the Natural Environment Research Council. AFST receives funding from the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bangert RK, 2005, CONSERV BIOL, V19, P379, DOI 10.1111/j.1523-1739.2005.00450.x; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Driebe EM, 2000, OECOLOGIA, V123, P99, DOI 10.1007/s004420050994; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; FINLAY RD, 1992, NEW PHYTOL, V120, P105, DOI 10.1111/j.1469-8137.1992.tb01063.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fransson PMA, 2007, FEMS MICROBIOL ECOL, V61, P246, DOI 10.1111/j.1574-6941.2007.00343.x; GAY G, 1993, NEW PHYTOL, V123, P335, DOI 10.1111/j.1469-8137.1993.tb03743.x; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Gryta H, 1997, MOL ECOL, V6, P353, DOI 10.1046/j.1365-294X.1997.00200.x; Guidot A, 2005, MYCORRHIZA, V15, P167, DOI 10.1007/s00572-004-0318-1; Guidot A, 1999, APPL ENVIRON MICROB, V65, P903; Hedh J, 2009, MYCORRHIZA, V19, P549, DOI 10.1007/s00572-009-0252-3; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Korkama T, 2006, NEW PHYTOL, V171, P815, DOI 10.1111/j.1469-8137.2006.01786.x; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Malik M, 1999, STRUCTURE DYNAMICS F; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; Pickles BJ, 2010, NEW PHYTOL, V186, P755, DOI 10.1111/j.1469-8137.2010.03204.x; Piculell BJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-23; Pinheiro J., 2006, NLME R PACKAGE FITTI; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Sawyer NA, 2003, MYCORRHIZA, V13, P217, DOI 10.1007/s00572-003-0229-6; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; West B. T., 2007, LINEAR MIXED MODELS	44	27	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12604	10.1371/journal.pone.0012604	http://dx.doi.org/10.1371/journal.pone.0012604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830299	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000281631300027
J	Yao, Z; Yoon, S; Kalie, E; Raviv, Z; Seger, R				Yao, Zhong; Yoon, Seunghee; Kalie, Eyal; Raviv, Ziv; Seger, Rony			Calcium Regulation of EGF-Induced ERK5 Activation: Role of Lad1-MEKK2 Interaction	PLOS ONE			English	Article							KINASE 1 BMK1; PROTEIN-KINASE; ADAPTER PROTEIN; TRANSCRIPTIONAL ACTIVATION; TYROSINE KINASES; GROWTH-FACTOR; C-FOS; MEK5; SURVIVAL; GENE	The ERK5 cascade is a MAPK pathway that transmits both mitogenic and stress signals, yet its mechanism of activation is not fully understood. Using intracellular calcium modifiers, we found that ERK5 activation by EGF is inhibited both by the depletion and elevation of intracellular calcium levels. This calcium effect was found to occur upstream of MEKK2, which is the MAP3K of the ERK5 cascade. Co-immunoprecipitation revealed that EGF increases MEKK2 binding to the adaptor protein Lad1, and this interaction was reduced by the intracellular calcium modifiers, indicating that a proper calcium concentration is required for the interactions and transmission of EGF signals to ERK5. In vitro binding assays revealed that the proper calcium concentration is required for a direct binding of MEKK2 to Lad1. The binding of these proteins is not affected by c-Src-mediated phosphorylation on Lad1, but slightly affects the Tyr phosphorylation of MEKK2, suggesting that the interaction with Lad1 is necessary for full Tyr phosphorylation of MEKK2. In addition, we found that changes in calcium levels affect the EGF-induced nuclear translocation of MEKK2 and thereby its effect on the nuclear ERK5 activity. Taken together, these findings suggest that calcium is required for EGF-induced ERK5 activation, and this effect is probably mediated by securing proper interaction of MEKK2 with the upstream adaptor protein Lad1.	[Yao, Zhong; Yoon, Seunghee; Kalie, Eyal; Raviv, Ziv; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yao, Z (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	rony.seger@weizmann.ac.il			Israel Academy of Sciences; European Community [IST-2004-027265-SIMAP, LSHC-CT-2006-037731-GROWTHSTOP]	Israel Academy of Sciences; European Community(European Commission)	This work was supported by grants from the Israel Academy of Sciences and from the European Community's Sixth Framework Program projects IST-2004-027265-SIMAP and LSHC-CT-2006-037731-GROWTHSTOP. R.S. is an incumbent of the Yale Lewine and Ella Miller Lewine professorial chair for cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Montero JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005565; Carter EJ, 2009, J CELL SCI, V122, P3104, DOI 10.1242/jcs.045757; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Choi YB, 1999, J IMMUNOL, V163, P5242; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Chuderland Dana, 2008, Commun Integr Biol, V1, P4; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Girio A, 2007, CELL SIGNAL, V19, P1964, DOI 10.1016/j.cellsig.2007.05.005; Horbinski C, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-2; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Raviv Z, 2004, J CELL SCI, V117, P1773, DOI 10.1242/jcs.01040; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schramp M, 2008, J CELL BIOL, V181, P1195, DOI 10.1083/jcb.200801078; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Spiering D, 2009, J BIOL CHEM, V284, P24972, DOI 10.1074/jbc.M109.042911; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOROK K, 2007, SCI STKE; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Woo CH, 2006, J BIOL CHEM, V281, P32164, DOI 10.1074/jbc.M602369200; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	59	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12627	10.1371/journal.pone.0012627	http://dx.doi.org/10.1371/journal.pone.0012627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830310	gold, Green Submitted, Green Published			2022-12-25	WOS:000281631300044
J	Davidson, MR; Larsen, JE; Yang, IA; Hayward, NK; Clarke, BE; Duhig, EE; Passmore, LH; Bowman, RV; Fong, KM				Davidson, Morgan R.; Larsen, Jill E.; Yang, Ian A.; Hayward, Nicholas K.; Clarke, Belinda E.; Duhig, Edwina E.; Passmore, Linda H.; Bowman, Rayleen V.; Fong, Kwun M.			MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							SRC-FAMILY KINASES; CHROMOSOMAL-ABERRATIONS; EXPRESSION SIGNATURE; COLORECTAL-CANCER; GENOMIC MAPS; GENES; AMPLIFICATION; PROSTATE; TARGET; RNA	MicroRNAs (miRNAs) are a family of small, non-coding RNA species functioning as negative regulators of multiple target genes including tumour suppressor genes and oncogenes. Many miRNA gene loci are located within cancer-associated genomic regions. To identify potential new amplified oncogenic and/or deleted tumour suppressing miRNAs in lung cancer, we inferred miRNA gene dosage from high dimensional arrayCGH data. From miRBase v9.0 (http://microrna.sanger.ac.uk), 474 human miRNA genes were physically mapped to regions of chromosomal loss or gain identified from a high-resolution genome-wide arrayCGH study of 132 primary non-small cell lung cancers (NSCLCs) (a training set of 60 squamous cell carcinomas and 72 adenocarcinomas). MiRNAs were selected as candidates if their immediately flanking probes or host gene were deleted or amplified in at least 25% of primary tumours using both Analysis of Copy Errors algorithm and fold change (>=+/- 1.2) analyses. Using these criteria, 97 miRNAs mapped to regions of aberrant copy number. Analysis of three independent published lung cancer arrayCGH datasets confirmed that 22 of these miRNA loci showed directionally concordant copy number variation. MiR-218, encoded on 4p15.31 and 5q35.1 within two host genes (SLIT2 and SLIT3), in a region of copy number loss, was selected as a priority candidate for follow-up as it is reported as underexpressed in lung cancer. We confirmed decreased expression of mature miR-218 and its host genes by qRT-PCR in 39 NSCLCs relative to normal lung tissue. This downregulation of miR-218 was found to be associated with a history of cigarette smoking, but not human papilloma virus. Thus, we show for the first time that putative lung cancer-associated miRNAs can be identified from genome-wide arrayCGH datasets using a bioinformatics mapping approach, and report that miR-218 is a strong candidate tumour suppressing miRNA potentially involved in lung cancer.	[Davidson, Morgan R.; Larsen, Jill E.; Yang, Ian A.; Passmore, Linda H.; Bowman, Rayleen V.; Fong, Kwun M.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Davidson, Morgan R.; Larsen, Jill E.; Yang, Ian A.; Clarke, Belinda E.; Bowman, Rayleen V.; Fong, Kwun M.] Univ Queensland, Discipline Med, Brisbane, Qld, Australia; [Hayward, Nicholas K.] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia; [Clarke, Belinda E.; Duhig, Edwina E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia	Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Prince Charles Hospital	Davidson, MR (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	morgan.davidson@uqconnect.edu.au	hayward, nick/AAV-8802-2020; Fong, Kwun M/G-6369-2010; Larsen, Jill E/G-3787-2010; Bowman, Rayleen V/G-4144-2013; hayward, nicholas k/C-1367-2015; Yang, Ian A/B-9609-2008	Larsen, Jill E/0000-0001-7806-3931; hayward, nicholas k/0000-0003-4760-1033; Yang, Ian A/0000-0001-8338-1993; Davidson, Morgan/0000-0003-0881-1409; Fong, Kwun/0000-0002-6507-1403	National Health and Medical Research Council NHMRC; UQ Edwin Tooth PhD Scholarship; Cancer Council Queensland; Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; Smart State	National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UQ Edwin Tooth PhD Scholarship; Cancer Council Queensland(Cancer Council Queensland); Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; Smart State	This work was supported by NHMRC project grants; NHMRC Practitioner Fellowship (KF), NHMRC Research Fellowship (NH), NHMRC Career Development Award (IY), UQ Edwin Tooth PhD Scholarship (JL), Cancer Council Queensland PhD Scholarship (MD), Cancer Council Queensland Senior Research Fellowship (KF), Queensland Clinical Research Fellowship (KF, IY), The Prince Charles Hospital Foundation, Cancer Council Queensland, Smart State, and National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BRENNAN J, 1991, CANCER RES, V51, P1708; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dallol A, 2002, CANCER RES, V62, P5874; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; FONG KM, 1995, CANCER RES, V55, P4268; GAO C, 2009, CANCER; Garnis C, 2005, GENOMICS, V85, P790, DOI 10.1016/j.ygeno.2005.02.015; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Guida T, 2005, J CLIN ENDOCR METAB, V90, P4703, DOI 10.1210/jc.2004-2459; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Klein F, 2009, LUNG CANCER, V65, P13, DOI 10.1016/j.lungcan.2008.10.003; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; LEITE KR, 2009, UROL ONCOL; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nishihara K, 2008, INT J ONCOL, V33, P245, DOI 10.3892/ijo_00000003; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Saramaki O, 2007, FRONT BIOSCI-LANDMRK, V12, P3287, DOI 10.2741/2312; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; TAKAHASHI T, 1989, CANCER RES, V49, P2683; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2008, ONCOL REP, V19, P1155; Wright CM, 2008, J THORAC ONCOL, V3, P569, DOI 10.1097/JTO.0b013e318174e046; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	65	96	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12560	10.1371/journal.pone.0012560	http://dx.doi.org/10.1371/journal.pone.0012560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838434	Green Published, Green Submitted, gold			2022-12-25	WOS:000281627700013
J	Cornman, RS				Cornman, R. Scott			The Distribution of GYR- and YLP-Like Motifs in Drosophila Suggests a General Role in Cuticle Assembly and Other Protein-Protein Interactions	PLOS ONE			English	Article							CUTICULAR PROTEINS; CONCERTED EVOLUTION; ANOPHELES-GAMBIAE; GENOME SEQUENCE; R CONSENSUS; ANNOTATION; SILKWORM; FAMILY; TOOL; PREDICTION	Background: Arthropod cuticle is composed predominantly of a self-assembling matrix of chitin and protein. Genes encoding structural cuticular proteins are remarkably abundant in arthropod genomes, yet there has been no systematic survey of conserved motifs across cuticular protein families. Methodology/Principal Findings: Two short sequence motifs with conserved tyrosines were identified in Drosophila cuticular proteins that were similar to the GYR and YLP Interpro domains. These motifs were found in members of the CPR, Tweedle, CPF/CPFL, and (in Anopheles gambiae) CPLCG cuticular protein families, and the Dusky/Miniature family of cuticleassociated proteins. Tweedle proteins have a characteristic motif architecture that is shared with the Drosophila protein GCR1 and its orthologs in other species, suggesting that GCR1 is also cuticular. A resilin repeat, which has been shown to confer elasticity, matched one of the motifs; a number of other Drosophila proteins of unknown function exhibit a motif architecture similar to that of resilin. The motifs were also present in some proteins of the peritrophic matrix and the eggshell, suggesting molecular convergence among distinct extracellular matrices. More surprisingly, gene regulation, development, and proteolysis were statistically over-represented ontology terms for all non-cuticular matches in Drosophila. Searches against other arthropod genomes indicate that the motifs are taxonomically widespread. Conclusions: This survey suggests a more general definition for GYR and YLP motifs and reveals their contribution to several types of extracellular matrix. They may define sites of protein interaction with DNA or other proteins, based on ontology analysis. These results can help guide experimental studies on the biochemistry of cuticle assembly.	[Cornman, R. Scott] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Cornman, RS (corresponding author), USDA, Bee Res Lab, Agr Res Serv, Beltsville, MD 20705 USA.	scott.cornman@gmail.com						Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P541, DOI 10.1016/j.ibmb.2010.05.002; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blake MB, 2002, INT J ELECTRON COMM, V7, P7, DOI 10.1080/10864415.2002.11044257; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2008, INSECT BIOCHEM MOLEC, V38, P661, DOI 10.1016/j.ibmb.2008.04.001; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; DAPHNIA P, DAPHNIA PULEX GENES; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FLAVELL AJ, 1987, NUCLEIC ACIDS RES, V15, P4035, DOI 10.1093/nar/15.10.4035; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAMODRAKAS SJ, 1982, BIOCHIM BIOPHYS ACTA, V703, P216, DOI 10.1016/0167-4838(82)90051-6; Hamodrakas SJ, 2004, J STRUCT BIOL, V145, P226, DOI 10.1016/j.jsb.2003.10.004; Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Johannesson H, 2005, GENETICS, V171, P109, DOI 10.1534/genetics.105.040923; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Neville A.C., 1975, BIOL ARTHROPOD CUTIC; Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298; SMITH DS, 1971, TISSUE CELL, V3, P477, DOI 10.1016/S0040-8166(71)80047-2; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Togawa T, 2004, INSECT BIOCHEM MOLEC, V34, P1059, DOI 10.1016/j.ibmb.2004.06.008; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Williams CF, 2005, AGR HIST, V79, P109, DOI 10.1525/ah.2005.79.1.109; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Wu TD, 2000, BIOINFORMATICS, V16, P233, DOI 10.1093/bioinformatics/16.3.233; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zhang ZY, 2009, CURR BIOL, V19, P1200, DOI 10.1016/j.cub.2009.05.050	49	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12536	10.1371/journal.pone.0012536	http://dx.doi.org/10.1371/journal.pone.0012536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824096	Green Submitted, gold, Green Published			2022-12-25	WOS:000281480900019
J	Ren, JG; Seth, P; Everett, P; Clish, CB; Sukhatme, VP				Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Clish, Clary B.; Sukhatme, Vikas P.			Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2	PLOS ONE			English	Article							MYELOGENOUS LEUKEMIA-CELLS; PENTOSE-PHOSPHATE PATHWAY; MALATE-ASPARTATE SHUTTLE; TRICARBOXYLIC-ACID CYCLE; ATP-CITRATE LYASE; MEGAKARYOCYTIC DIFFERENTIATION; K562 CELLS; BCR-ABL; OXIDATIVE STRESS; TYROSINE KINASE	Malic enzyme 2 (ME2) is a mitochondrial enzyme that catalyzes the conversion of malate to pyruvate and CO2 and uses NAD as a cofactor. Higher expression of this enzyme correlates with the degree of cell de-differentiation. We found that ME2 is expressed in K562 erythroleukemia cells, in which a number of agents have been found to induce differentiation either along the erythroid or the myeloid lineage. We found that knockdown of ME2 led to diminished proliferation of tumor cells and increased apoptosis in vitro. These findings were accompanied by differentiation of K562 cells along the erythroid lineage, as confirmed by staining for glycophorin A and hemoglobin production. ME2 knockdown also totally abolished growth of K562 cells in nude mice. Increased ROS levels, likely reflecting increased mitochondrial production, and a decreased NADPH/NADP+ ratio were noted but use of a free radical scavenger to decrease inhibition of ROS levels did not reverse the differentiation or apoptotic phenotype, suggesting that ROS production is not causally involved in the resultant phenotype. As might be expected, depletion of ME2 induced an increase in the NAD+/NADH ratio and ATP levels fell significantly. Inhibition of the malate-aspartate shuttle was insufficient to induce K562 differentiation. We also examined several intracellular signaling pathways and expression of transcription factors and intermediate filament proteins whose expression is known to be modulated during erythroid differentiation in K562 cells. We found that silencing of ME2 leads to phospho-ERK1/2 inhibition, phospho-AKT activation, increased GATA-1 expression and diminished vimentin expression. Metabolomic analysis, conducted to gain insight into intermediary metabolic pathways that ME2 knockdown might affect, showed that ME2 depletion resulted in high orotate levels, suggesting potential impairment of pyrimidine metabolism. Collectively our data point to ME2 as a potentially novel metabolic target for leukemia therapy.	[Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Harvard Univ, Sch Med, Boston, MA USA; [Clish, Clary B.] Massachusetts Inst Technol & Harvard, Broad Inst, Metabolite Profiling Initiat, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ren, JG (corresponding author), Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA.	vsukhatm@bidmc.harvard.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Sukhatme, Vikas/W-2776-2019	Clish, Clary B/0000-0001-8259-9245; 	BIDMC [NCI K01- CA 104700]; NIDDK [T32 DK007199]; NATIONAL CANCER INSTITUTE [K01CA104700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007199] Funding Source: NIH RePORTER	BIDMC; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by seed funds from BIDMC to VPS, a K01 award to PS (NCI K01- CA 104700), and an NIDDK training grant to VPS (T32 DK007199) used to support JGR and PE. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1995, LEUKEMIA RES, V19, P263, DOI 10.1016/0145-2126(94)00158-7; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BECKMAN BS, 1989, J CELL PHYSIOL, V139, P370, DOI 10.1002/jcp.1041390220; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Boren J, 2001, J BIOL CHEM, V276, P37747; COLEMAN PS, 1981, CRC CR REV BIOCH MOL, V11, P341, DOI 10.1080/10409238109104421; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Elorza A, 2008, J BIOL CHEM, V283, P30461, DOI 10.1074/jbc.M805400200; French D, 2009, BLOOD, V113, P4512, DOI 10.1182/blood-2008-07-172106; Greenberg DA, 2005, AM J HUM GENET, V76, P139, DOI 10.1086/426735; Griffin JL, 2004, PHYSIOL GENOMICS, V17, P140, DOI 10.1152/physiolgenomics.00158.2003; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Huang M, 2002, MOL PHARMACOL, V62, P463, DOI 10.1124/mol.62.3.463; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; JARVINEN M, 1990, J CELL PHYSIOL, V143, P310, DOI 10.1002/jcp.1041430215; Kang SK, 2004, FEBS LETT, V577, P361, DOI 10.1016/j.febslet.2004.10.031; Kawano T, 2004, LEUKEMIA RES, V28, P623, DOI 10.1016/j.leukres.2003.10.022; Kawano T, 2004, MOL CELL BIOCHEM, V258, P25, DOI 10.1023/B:MCBI.0000012830.96393.b9; Kim KW, 2001, J BIOL CHEM, V276, P13186, DOI 10.1074/jbc.M008092200; Kohmura K, 2004, J CELL PHYSIOL, V198, P370, DOI 10.1002/jcp.10426; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; Lee BD, 2007, PSYCHIAT RES, V150, P1, DOI 10.1016/j.psychres.2006.06.001; LINDERHOROWITZ M, 1969, CANCER RES, V29, P1195; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LOEBER G, 1991, J BIOL CHEM, V266, P3016; LOPEZALARCON L, 1986, CANCER RES, V46, P5589; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARESPERLMAN JA, 1988, CANCER RES, V48, P602; MATSUMOTO SS, 1990, BIOCHEM PHARMACOL, V39, P455, DOI 10.1016/0006-2952(90)90050-U; Matsumura I, 2000, BLOOD, V96, P2440; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Meshkini A, 2008, TOXICOL IN VITRO, V22, P1503, DOI 10.1016/j.tiv.2008.05.005; Missiroli S, 2009, INT J BIOCHEM CELL B, V41, P570, DOI 10.1016/j.biocel.2008.07.002; Mitchell M, 2009, BIOL REPROD, V80, P295, DOI 10.1095/biolreprod.108.069864; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; NAGY K, 1995, LEUKEMIA RES, V19, P203, DOI 10.1016/0145-2126(94)00138-Z; Oravecz K, 2002, TISSUE CELL, V34, P33, DOI 10.1054/tice.2001.0221; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Racke FK, 2001, J BIOL CHEM, V276, P522, DOI 10.1074/jbc.M005236200; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Ren JG, 1998, CELL BIOL INT, V22, P41, DOI 10.1006/cbir.1998.0226; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; SABINE JR, 1976, EUR J CANCER, V12, P299, DOI 10.1016/0014-2964(76)90110-9; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Verrax J, 2006, BIOCHEM PHARMACOL, V72, P671, DOI 10.1016/j.bcp.2006.05.025; WASILENKO WJ, 1985, CANCER LETT, V28, P35, DOI 10.1016/0304-3835(85)90089-8; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Woessmann W, 2004, CELL BIOL INT, V28, P403, DOI 10.1016/j.cellbi.2004.03.009	65	44	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12520	10.1371/journal.pone.0012520	http://dx.doi.org/10.1371/journal.pone.0012520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824065	Green Published, gold, Green Submitted			2022-12-25	WOS:000281480900008
J	Buchanan, SS; Pyatt, DW; Carpenter, JF				Buchanan, Sandhya S.; Pyatt, David W.; Carpenter, John F.			Preservation of Differentiation and Clonogenic Potential of Human Hematopoietic Stem and Progenitor Cells during Lyophilization and Ambient Storage	PLOS ONE			English	Article							INTRACELLULAR TREHALOSE IMPROVES; EXTRACELLULAR ATP; P2X(7) RECEPTOR; BONE-MARROW; DESICCATION TOLERANCE; MAMMALIAN-CELLS; ENHANCED PROTECTION; GLASS TRANSITIONS; PHASE-TRANSITIONS; DIVALENT-CATIONS	Progenitor cell therapies show great promise, but their potential for clinical applications requires improved storage and transportation. Desiccated cells stored at ambient temperature would provide economic and practical advantages over approaches employing cell freezing and subzero temperature storage. The objectives of this study were to assess a method for loading the stabilizing sugar, trehalose, into hematopoietic stem and progenitor cells (HPC) and to evaluate the effects of subsequent freeze-drying and storage at ambient temperature on differentiation and clonogenic potential. HPC were isolated from human umbilical cord blood and loaded with trehalose using an endogenous cell surface receptor, termed P2Z. Solution containing trehalose-loaded HPC was placed into vials, which were transferred to a tray freeze-dryer and removed during each step of the freeze-drying process to assess differentiation and clonogenic potential. Control groups for these experiments were freshly isolated HPC. Control cells formed 1450 +/- 230 CFU-GM, 430 +/- 140 BFU-E, and 50 +/- 40 CFU-GEMM per 50 mu L. Compared to the values for the control cells, there was no statistical difference observed for cells removed at the end of the freezing step or at the end of primary drying. There was a gradual decrease in the number of CFU-GM and BFU-E for cells removed at different temperatures during secondary drying; however, there were no significant differences in the number of CFU-GEMM. To determine storage stability of lyophilized HPC, cells were stored for 4 weeks at 25 degrees C in the dark. Cells reconstituted immediately after lyophilization produced 580 +/- 90 CFU-GM (similar to 40%, relative to unprocessed controls p<0.0001), 170 +/- 70 BFU-E (similar to 40%, p<0.0001), and 41 +/- 22 CFU-GEMM (similar to 82%, p = 0.4171), and cells reconstituted after 28 days at room temperature produced 513 +/- 170 CFU-GM (similar to 35%, relative to unprocessed controls, p<0.0001), 112 +/- 68 BFU-E (similar to 26%, p<0.0001), and 36 +/- 17 CFU-GEMM (similar to 82%, p = 0.2164) These studies are the first to document high level retention of CFU-GEMM following lyophilization and storage for 4 weeks at 25 degrees C. This type of flexible storage stability would potentially permit the ability to ship and store HPC without the need for refrigeration.	[Buchanan, Sandhya S.; Carpenter, John F.] Univ Colorado, Ctr Pharmaceut Biotechnol, Aurora, CO USA; [Buchanan, Sandhya S.; Carpenter, John F.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Pyatt, David W.] Summit Toxicol, Superior, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Buchanan, SS (corresponding author), Intervet Schering Plough, Discovery & Technol, Elkhorn, NE USA.	Sandhya.Buchanan@Merck.com			Defense Advanced Research Projects Agency/Naval Research Laboratories [N00173-01-1 G011]; NIH [5P30CA46934-15]	Defense Advanced Research Projects Agency/Naval Research Laboratories(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Defense Advanced Research Projects Agency/Naval Research Laboratories Grant Number N00173-01-1 G011 for providing funding for these studies. Website: http://www.darpa.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Perkin-Elmer for supplying the Diamond DSC used in this study. We also would like to acknowledge the technical assistance of Karen Helm and Michael Ashton of the University of Colorado Cancer Center Flow Cytometry Core Facility who is supported by NIH grant 5P30CA46934-15.	Alessandrino E, 1999, BONE MARROW TRANSPL, V23, P533, DOI 10.1038/sj.bmt.1701609; Allison SD, 1999, ARCH BIOCHEM BIOPHYS, V365, P289, DOI 10.1006/abbi.1999.1175; Apasov SG, 1997, J IMMUNOL, V158, P5095; Ballerini P, 1996, NEUROREPORT, V7, P2533, DOI 10.1097/00001756-199611040-00026; Beattie GM, 1997, DIABETES, V46, P519, DOI 10.2337/diabetes.46.3.519; Beaujean F, 1998, BONE MARROW TRANSPL, V22, P1091, DOI 10.1038/sj.bmt.1701494; Bhatia R, 2005, J CLIN ONCOL, V23, P6699, DOI 10.1200/JCO.2005.10.330; BLOK MC, 1975, BIOCHIM BIOPHYS ACTA, V406, P187, DOI 10.1016/0005-2736(75)90003-6; BRUNI F, 1991, PLANT PHYSIOL, V96, P660, DOI 10.1104/pp.96.2.660; Buchanan S. S., 2005, CELL PRESERV TECHNOL, V3, P212, DOI DOI 10.1089/CPT.2005.3.212; Buchanan SS, 2004, STEM CELLS DEV, V13, P295, DOI 10.1089/154732804323099226; BUCHANAN SS, 2010, MECHANISTIC STUDY LO; BUCHANAN SS, 2006, PRESERVATION 2 THERA; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Cario-Toumaniantz C, 1998, CIRC RES, V83, P196, DOI 10.1161/01.RES.83.2.196; CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V250, P505, DOI 10.1016/0003-9861(86)90755-1; CARPENTER JF, 1993, ARCH BIOCHEM BIOPHYS, V303, P456, DOI 10.1006/abbi.1993.1309; CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CARPENTER JF, 1987, CRYOBIOLOGY, V24, P455, DOI 10.1016/0011-2240(87)90049-6; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; Chretien S, 1996, EMBO J, V15, P4174, DOI 10.1002/j.1460-2075.1996.tb00792.x; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; CONGDON CC, 1957, J CELL COMPAR PHYSL, V50, P103, DOI 10.1002/jcp.1030500407; CoutinhoSilva R, 1996, BBA-BIOMEMBRANES, V1278, P125, DOI 10.1016/0005-2736(95)00200-6; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1988, BIOCHIM BIOPHYS ACTA, V947, P367, DOI 10.1016/0304-4157(88)90015-9; CROWE JH, 1989, P NATL ACAD SCI USA, V86, P520, DOI 10.1073/pnas.86.2.520; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; DAVIS JM, 1990, BLOOD, V75, P781; de Castro AG, 2000, FEBS LETT, V487, P199, DOI 10.1016/S0014-5793(00)02340-1; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; ELMOATASSIM C, 1992, BIOCHIM BIOPHYS ACTA, V1134, P31, DOI 10.1016/0167-4889(92)90025-7; Eroglu A, 2003, CRYOBIOLOGY, V46, P121, DOI 10.1016/S0011-2240(03)00018-X; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4; Eschke D, 2002, N-S ARCH PHARMACOL, V365, P168, DOI 10.1007/s00210-001-0501-2; Gao D, 2000, ILAR J, V41, P187; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361; GREEN JL, 1989, J PHYS CHEM-US, V93, P2880, DOI 10.1021/j100345a006; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Gudipaty L, 2001, AM J PHYSIOL-CELL PH, V280, pC943, DOI 10.1152/ajpcell.2001.280.4.C943; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Hadzantonis M, 1999, CANCER BIOTHER RADIO, V14, P11, DOI 10.1089/cbr.1999.14.11; Halle P, 2001, TRANSFUSION, V41, P667, DOI 10.1046/j.1537-2995.2001.41050667.x; HER LM, 1994, PHARMACEUT RES, V11, P54, DOI 10.1023/A:1018989509893; HINO A, 1990, APPL ENVIRON MICROB, V56, P1386, DOI 10.1128/AEM.56.5.1386-1391.1990; HONADEL TE, 1988, CRYOBIOLOGY, V25, P331, DOI 10.1016/0011-2240(88)90041-7; JENNY FA, 2002, TRANSFUSION, V42, P1573; Kheirolomoom A, 2005, CRYOBIOLOGY, V51, P290, DOI 10.1016/j.cryobiol.2005.08.003; KITAMURA T, 1989, BLOOD, V73, P375; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lai JM, 2001, BIOCHEM J, V359, P227, DOI 10.1042/0264-6021:3590227; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Lim M, 2006, INT J FOOD SCI TECH, V41, P507, DOI 10.1111/j.1365-2621.2005.01096.x; LORENZ E, 1951, J NATL CANCER I, V12, P197; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MCGANN LE, 1978, CRYOBIOLOGY, V15, P382, DOI 10.1016/0011-2240(78)90056-1; McGee HA, 1962, CRYOGENICS, V2, P257, DOI 10.1016/0011-2275(62)90001-2; Menze MA, 2005, AM J PHYSIOL-REG I, V288, pR501, DOI 10.1152/ajpregu.00490.2004; Michel AD, 1998, BRIT J PHARMACOL, V125, P1194, DOI 10.1038/sj.bjp.0702205; Motorin Dmitri, 2003, Hematology, V8, P313, DOI 10.1080/10245330310001612134; NADEMANEE A, 1994, J CLIN ONCOL, V12, P2176, DOI 10.1200/JCO.1994.12.10.2176; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Nihei OK, 2000, MEM I OSWALDO CRUZ, V95, P415, DOI 10.1590/S0074-02762000000300019; Nihei OK, 2000, BLOOD, V96, P996, DOI 10.1182/blood.V96.3.996.015k02_996_1005; Podesta M, 2001, EXP HEMATOL, V29, P309, DOI 10.1016/S0301-472X(00)00678-0; Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324; REEB BA, 1992, BONE MARROW STEM CEL; Russo MJ, 1997, NAT BIOTECHNOL, V15, P278, DOI 10.1038/nbt0397-278; Sano F, 1999, CRYOBIOLOGY, V39, P80, DOI 10.1006/cryo.1999.2188; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Searles JA, 2001, J PHARM SCI, V90, P860, DOI 10.1002/jps.1039; Shpall EJ, 1997, BLOOD, V90, P4313, DOI 10.1182/blood.V90.11.4313.4313_4313_4320; Slade L, 1995, Adv Food Nutr Res, V38, P103, DOI 10.1016/S1043-4526(08)60084-4; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Solini A, 1999, J CELL SCI, V112, P297; SPIELES G, 1995, CRYOBIOLOGY, V32, P366, DOI 10.1006/cryo.1995.1037; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; STEINBERG TH, 1989, METHOD CELL BIOL, V31, P45; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; STRONCEK DF, 1991, TRANSFUSION, V31, P521, DOI 10.1046/j.1537-2995.1991.31691306250.x; Suh BC, 2001, J IMMUNOL, V166, P6754, DOI 10.4049/jimmunol.166.11.6754; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; TAKAHASHI T, 1988, BIOPHYS J, V54, P509, DOI 10.1016/S0006-3495(88)82983-7; Testa U, 1998, LEUKEMIA, V12, P563, DOI 10.1038/sj.leu.2400967; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Voermans C, 2001, J HEMATOTH STEM CELL, V10, P725, DOI 10.1089/152581601317210827; Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306; Woods EJ, 2000, J HEMATOTH STEM CELL, V9, P161, DOI 10.1089/152581600319379	100	32	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12518	10.1371/journal.pone.0012518	http://dx.doi.org/10.1371/journal.pone.0012518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824143	gold, Green Published, Green Submitted			2022-12-25	WOS:000281456100018
J	Bougatef, F; Menashi, S; Khayati, F; Naimi, B; Porcher, R; Podgorniak, MP; Millot, G; Janin, A; Calvo, F; Lebbe, C; Mourah, S				Bougatef, Faten; Menashi, Suzanne; Khayati, Farah; Naimi, Benyoussef; Porcher, Raphael; Podgorniak, Marie-Pierre; Millot, Guy; Janin, Anne; Calvo, Fabien; Lebbe, Celeste; Mourah, Samia			EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BASIGIN CD147; EXPRESSION; RECEPTORS; CANCER; VEGF; INVASIVENESS; ANGIOGENESIS; INVASION; PROLIFERATION	EMMPRIN's expression in melanoma tissue was reported to be predictive of poor prognosis. Here we demonstrate that EMMPRIN up-regulated VEGF receptor-2 (VEGFR-2) in two different primary melanoma cell lines and consequently increased migration and proliferation of these cells while inhibiting their apoptosis. SiRNA inhibition of VEGFR-2 expression abrogated these EMMPRIN effects. EMMPRIN regulation of VEGFR-2 was mediated through the over-expression of HIF-2 alpha and its translocation to the nucleus where it forms heterodimers with HIF-1 beta. These results were supported by an in vivo correlation between the expression of EMMPRIN with that of VEGFR-2 in human melanoma tissues as well as with the extent of HIF-2 alpha localization in the nucleus. They demonstrate a novel mechanism by which EMMPRIN promotes tumor progression through HIF-2 alpha/VEGFR-2 mediated mechanism, with an autocrine role in melanoma cell malignancy. The inhibition of EMMPRIN in cancer may thus simultaneously target both the VEGFR-2/VEGF system and the matrix degrading proteases to block tumor cell growth and invasion.	[Bougatef, Faten; Khayati, Farah; Podgorniak, Marie-Pierre; Millot, Guy; Calvo, Fabien; Mourah, Samia] INSERM, Pharmacol Lab, UMR S 940, Paris, France; [Bougatef, Faten; Khayati, Farah; Porcher, Raphael; Podgorniak, Marie-Pierre; Millot, Guy; Janin, Anne; Calvo, Fabien; Lebbe, Celeste; Mourah, Samia] Univ Paris 07, Paris, France; [Bougatef, Faten; Khayati, Farah; Podgorniak, Marie-Pierre; Janin, Anne; Calvo, Fabien; Lebbe, Celeste; Mourah, Samia] Hop St Louis, AP HP, Paris, France; [Menashi, Suzanne] Hop Henri Mondor, CNRS, UMR 7149, Lab CRRET, F-94010 Creteil, France; [Menashi, Suzanne; Naimi, Benyoussef] Univ Paris 12, F-94000 Creteil, France; [Porcher, Raphael] INSERM, Dept Biostat & Med Data Proc, U717, Paris, France; [Janin, Anne] INSERM, U728, Paris, France; [Lebbe, Celeste] Hop St Louis, Dept Dermatol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Bougatef, F (corresponding author), INSERM, Pharmacol Lab, UMR S 940, Paris, France.	samia.mourah@sls.aphp.fr		Porcher, Raphael/0000-0002-5277-4679; calvo, fabien/0000-0002-0298-7633	Societe Francaise de Dermatologie (SFD); Fondation de l Avenir [ET8-489]	Societe Francaise de Dermatologie (SFD); Fondation de l Avenir	The authors acknowledge the support of the Societe Francaise de Dermatologie (SFD) and the Fondation de l Avenir (study ET8-489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2008, BIOCHEM BIOPH RES CO, V374, P111, DOI 10.1016/j.bbrc.2008.06.122; BISWAS C, 1995, CANCER RES, V55, P434; Chen X, 2006, CANCER RES, V66, P11323, DOI 10.1158/0008-5472.CAN-06-1536; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Erhard H, 1997, MELANOMA RES, V7, pS19; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Jilaveanu L, 2009, CLIN CANCER RES, V15, P1076, DOI 10.1158/1078-0432.CCR-08-2280; Kanekura T, 2002, INT J CANCER, V99, P520, DOI 10.1002/ijc.10390; Lacal PM, 2005, INT J ONCOL, V27, P1625; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Liu B, 1995, BIOCHEM BIOPH RES CO, V217, P721, DOI 10.1006/bbrc.1995.2832; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Pisacane AM, 2005, MELANOMA RES, V15, P39, DOI 10.1097/00008390-200502000-00007; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Straume O, 2001, AM J PATHOL, V159, P223, DOI 10.1016/S0002-9440(10)61688-4; Su J, 2009, CANCER LETT, V273, P140, DOI 10.1016/j.canlet.2008.07.034; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; vandenOord JJ, 1997, AM J PATHOL, V151, P665; Voigt H, 2009, CANCER INVEST, V27, P329, DOI 10.1080/07357900802392675; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536	33	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12265	10.1371/journal.pone.0012265	http://dx.doi.org/10.1371/journal.pone.0012265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824203	Green Published, gold, Green Submitted			2022-12-25	WOS:000281405300003
J	Andradas, C; Caffarel, MM; Perez-Gomez, E; Salazar, M; Lorente, M; Velasco, G; Guzman, M; Sanchez, C				Andradas, C.; Caffarel, M. M.; Perez-Gomez, E.; Salazar, M.; Lorente, M.; Velasco, G.; Guzman, M.; Sanchez, C.			The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK	ONCOGENE			English	Article						G protein-coupled receptors; GPR55; cancer; cannabinoids	L-ALPHA-LYSOPHOSPHATIDYLINOSITOL; CANNABINOID RECEPTOR; LIGAND; IDENTIFICATION; TRANSCRIPTION; ACTIVATION; PATHWAYS; BRAIN	GPR55 is an orphan G protein-coupled receptor that may be engaged by some lipid ligands such as lysophosphatidylinositol and cannabinoid-type compounds. Very little is known about its expression pattern and physio-pathological relevance, and its pharmacology and signaling are still rather controversial. Here we analyzed the expression and function of GPR55 in cancer cells. Our data show that GPR55 expression in human tumors from different origins correlates with their aggressiveness. Moreover, GPR55 promotes cancer cell proliferation, both in cell cultures and in xenografted mice, through the overactivation of the extracellular signal-regulated kinase cascade. These findings reveal the importance of GPR55 in human cancer, and suggest that it could constitute a new biomarker and therapeutic target in oncology. Oncogene (2011) 30, 245-252; doi:10.1038/onc.2010.402; published online 6 September 2010	[Andradas, C.; Caffarel, M. M.; Perez-Gomez, E.; Salazar, M.; Lorente, M.; Velasco, G.; Guzman, M.; Sanchez, C.] Univ Complutense, Dept Biochem & Mol Biol 1, Sch Biol, E-28040 Madrid, Spain	Complutense University of Madrid	Sanchez, C (corresponding author), Univ Complutense, Dept Biochem & Mol Biol 1, Sch Biol, C Jose Antonio Novais 2, E-28040 Madrid, Spain.	cristina.sanchez@quim.ucm.es	Roa, Maria Salazar/I-1168-2015; Pérez-Gómez, Eduardo/GYA-5856-2022; Perez-gomez, Eduardo/F-5906-2015; Velasco, Guillermo/H-5260-2012; Velasco, Guillermo/AAU-9189-2020; Lorente, Mar/K-2401-2014; Lorente, Mar/O-5106-2017; Sanchez, Cristina/H-4980-2017; Sanchez, Cristina/AFQ-4745-2022	Roa, Maria Salazar/0000-0001-6784-9541; Pérez-Gómez, Eduardo/0000-0003-0160-5565; Perez-gomez, Eduardo/0000-0003-0160-5565; Velasco, Guillermo/0000-0002-1994-2386; Velasco, Guillermo/0000-0002-1994-2386; Lorente, Mar/0000-0003-0982-0956; Sanchez, Cristina/0000-0002-1428-3078; Guzman, Manuel/0000-0001-7475-118X; Caffarel, Maria/0000-0002-7442-6827	Ministerio de Ciencia e Innovacion; Fundacion Ferrer para la Investigacion; Comunidad de Madrid; Fondo de Investigaciones Sanitarias; Fundacion Mutua Madrilena; GW Pharmaceuticals/Otsuka Pharmaceuticals	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ferrer para la Investigacion; Comunidad de Madrid(Comunidad de Madrid); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); GW Pharmaceuticals/Otsuka Pharmaceuticals(Otsuka Pharmaceutical)	We are indebted to the members of our laboratory for technical support and critical discussions on this work. CA and MMC were recipients of fellowships from Ministerio de Ciencia e Innovacion and from Fundacion Ferrer para la Investigacion, respectively. MS and ML were recipients of contracts (Research Formation and Postdoctoral, respectively) from Comunidad de Madrid. This work was supported by grants from Fondo de Investigaciones Sanitarias (C Sanchez), Fundacion Mutua Madrilena (C Sanchez), Ministerio de Ciencia e Innovacion (G Velasco and M Guzman), Comunidad de Madrid (M Guzman) and GW Pharmaceuticals/Otsuka Pharmaceuticals (C Sanchez).	Brown AJ, 2009, VITAM HORM, V81, P111, DOI 10.1016/S0083-6729(09)81005-4; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Caffarel MM, 2006, CANCER RES, V66, P6615, DOI 10.1158/0008-5472.CAN-05-4566; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; ELSTON EW, 1993, J CLIN PATHOL, V46, P189; Falasca M, 1998, ONCOGENE, V16, P2357, DOI 10.1038/sj.onc.1201758; FALASCA M, 1994, EUR J BIOCHEM, V221, P383, DOI 10.1111/j.1432-1033.1994.tb18750.x; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Seno K, 2001, BIOORG MED CHEM LETT, V11, P587, DOI 10.1016/S0960-894X(01)00003-8; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xu Y, 2001, J SOC GYNECOL INVEST, V8, P1, DOI 10.1016/S1071-5576(00)00092-7; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	31	137	144	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					245	252		10.1038/onc.2010.402	http://dx.doi.org/10.1038/onc.2010.402			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20818416				2022-12-25	WOS:000286438900012
J	Fraser, JA; Madhumalar, A; Blackburn, E; Bramham, J; Walkinshaw, MD; Verma, C; Hupp, TR				Fraser, Jennifer A.; Madhumalar, Arumugam; Blackburn, Elizabeth; Bramham, Janice; Walkinshaw, Malcolm D.; Verma, Chandra; Hupp, Ted R.			A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal II. A MODEL IN WHICH PHOSPHORYLATION AT SER269 INDUCES A MUTANT CONFORMATION TO p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; DNA-BINDING DOMAIN; CORE DOMAIN; P53-DEPENDENT APOPTOSIS; DEPENDENT ACETYLATION; TYROSINE-PHOSPHATASE; CRYSTAL-STRUCTURE; COACTIVATOR P300; POINT MUTATION; WILD-TYPE	The p53 DNA-binding domain harbors a conformationally flexible multiprotein binding site that regulates p53 ubiquitination. A novel phosphorylation site exists within this region at Ser(269), whose phosphomimetic mutation inactivates p53. The phosphomimetic p53 (S269D) exhibits characteristics of mutant p53: stable binding to Hsp70 in vivo, elevated ubiquitination in vivo, inactivity in DNA binding and transcription, increased thermoinstability using thermal shift assays, and lambda(max) of intrinsic tryptophan fluorescence at 403 nm rather than 346 nm, characteristic of wild type p53. These data indicate that p53 conformational stability is regulated by a phosphoacceptor site within an exposed flexible surface loop and that this can be destabilized by phosphorylation. To test whether other motifs within p53 have similarly evolved, we analyzed the effect of Ser(215) mutation on p53 function because Ser(215) is another inactivating phosphorylation site in the conformationally flexible PAb240 epitope. The p53(S215D) protein is inactive like p53(S269D), whereas p53(S215A) is as active as p53(S269A). However, the double mutant p53(S215A/S269A) was transcriptionally inactive and more thermally unstable than either individual Ser-Ala loop mutant. Molecular dynamics simulations suggest that (i) solvation of phospho-Ser(215) and phospho-Ser(269) by positive charged residues or solvent water leads to local unfolding, which is accompanied by local destabilization of the N-terminal loop and global destabilization of p53, and (ii) the double alanine 215/269 mutation disrupts hydrogen bonding normally stabilized by both Ser(215) and Ser(269). These data indicate that p53 has evolved two serine phosphoacceptor residues within conformationally flexible epitopes that normally stabilize the p53 DNA-binding domain but whose phosphorylation	[Fraser, Jennifer A.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, CRUK Signal Transduct Grp P53, Cell Signaling Unit, Edinburgh EH4 2XR, Midlothian, Scotland; [Blackburn, Elizabeth; Bramham, Janice; Walkinshaw, Malcolm D.] Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Madhumalar, Arumugam; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore 138671, Singapore	University of Edinburgh; University of Edinburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Verma, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	chandra@bii.a-star.edu.sg; ted.hupp@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019	Fraser, Jennifer/0000-0001-5546-3916; walkinshaw, malcolm/0000-0001-5955-9325; Madhumalar, Arumugam/0000-0001-5314-7194; Blackburn, Elizabeth A/0000-0003-1325-9575	Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council; CRUK [C483/A6354]	Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK(Cancer Research UK)	We acknowledge the use of the Edinburgh Biophysical Characterization Facility (supported by the Scottish University Life Sciences Alliance and the Biotechnology and Biological Sciences Research Council).; This work was supported by CRUK Programme Grant C483/A6354 (to T. R. H.).	Allende-Vega N, 2007, ONCOGENE, V26, P4234, DOI 10.1038/sj.onc.1210209; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Fraser JA, 2007, BIOCHEMISTRY-US, V46, P2655, DOI 10.1021/bi061562j; Fraser JA, 2010, J BIOL CHEM, V285, P37762, DOI 10.1074/jbc.M110.143099; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Huggins DJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000880; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; Jabbur JR, 2002, CANCER BIOL THER, V1, P277, DOI 10.4161/cbt.81; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jorgensen W L, 1986, Ann N Y Acad Sci, V482, P198, DOI 10.1111/j.1749-6632.1986.tb20951.x; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lin SR, 1996, DNA CELL BIOL, V15, P793, DOI 10.1089/dna.1996.15.793; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Pan Y, 2000, ONCOGENE, V19, P3095, DOI 10.1038/sj.onc.1203663; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shimizu H, 2006, BIOCHEM J, V397, P355, DOI 10.1042/BJ20051521; STEPHEN CW, 1995, J MOL BIOL, V248, P58, DOI 10.1006/jmbi.1995.0202; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; VOJTESEK B, 1995, ONCOGENE, V10, P389; VOJTESEK B, 1993, J CELL SCI, V105, P607; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Walker R. C., 2003, THESIS IMPERIAL COLL; Walker RC, 2007, J COMPUT CHEM, V28, P478, DOI 10.1002/jcc.20559; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WANG Y, 1995, ONCOGENE, V10, P779; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	72	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37773	37786		10.1074/jbc.M110.143107	http://dx.doi.org/10.1074/jbc.M110.143107			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847049	Green Published, hybrid			2022-12-25	WOS:000284424000069
J	Andres, D; Hanke, C; Baxa, U; Seul, A; Barbirz, S; Seckler, R				Andres, Dorothee; Hanke, Christin; Baxa, Ulrich; Seul, Anait; Barbirz, Stefanie; Seckler, Robert			Tailspike Interactions with Lipopolysaccharide Effect DNA Ejection from Phage P22 Particles in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAD-BINDING DOMAIN; BASE-PLATE PARTS; TAIL NEEDLE GP26; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; INFECTED CELL; PROTEIN; P22; BACTERIOPHAGE-P22	Initial attachment of bacteriophage P22 to the Salmonella host cell is known to be mediated by interactions between lipopolysaccharide (LPS) and the phage tailspike proteins (TSP), but the events that subsequently lead to DNA injection into the bacterium are unknown. We used the binding of a fluorescent dye and DNA accessibility to DNase and restriction enzymes to analyze DNA ejection from phage particles in vitro. Ejection was specifically triggered by aggregates of purified Salmonella LPS but not by LPS with different O-antigen structure, by lipid A, phospholipids, or soluble O-antigen polysaccharide. This suggests that P22 does not use a secondary receptor at the bacterial outer membrane surface. Using phage particles reconstituted with purified mutant TSP in vitro, we found that the endorhamnosidase activity of TSP degrading the O-antigen polysaccharide was required prior to DNA ejection in vitro and DNA replication in vivo. If, however, LPS was pre-digested with soluble TSP, it was no longer able to trigger DNA ejection, even though it still contained five O-antigen oligosaccharide repeats. Together with known data on the structure of LPS and phage P22, our results suggest a molecular model. In this model, tail-spikes position the phage particles on the outer membrane surface for DNA ejection. They force gp26, the central needle and plug protein of the phage tail machine, through the core oligosaccharide layer and into the hydrophobic portion of the outer membrane, leading to refolding of the gp26 lazo-domain, release of the plug, and ejection of DNA and pilot proteins.	[Andres, Dorothee; Hanke, Christin; Baxa, Ulrich; Seul, Anait; Barbirz, Stefanie; Seckler, Robert] Univ Potsdam, Lab Phys Biochem, Dept Biol & Biochem, D-14476 Potsdam, Germany	University of Potsdam	Seckler, R (corresponding author), Univ Potsdam, Lab Phys Biochem, Dept Biol & Biochem, Karl Liebknecht Str 24-25,Haus 25, D-14476 Potsdam, Germany.	seckler@uni-potsdam.de	Barbirz, Stefanie/S-9158-2019	Barbirz, Stefanie/0000-0001-6101-9862; Baxa, Ulrich/0000-0002-7263-5078	Deutsche Forschungsgemeinschaft [Se517/16, Ba4046/1]; Leibniz Graduate School of Molecular Biophysics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Graduate School of Molecular Biophysics	This work was supported in part by Grants Se517/16 and Ba4046/1 from the Deutsche Forschungsgemeinschaft.; Supported by a fellowship of the Leibniz Graduate School of Molecular Biophysics.	Andres D, 2010, BIOCHEM SOC T, V38, P1386, DOI 10.1042/BST0381386; Baxa U, 1996, BIOPHYS J, V71, P2040, DOI 10.1016/S0006-3495(96)79402-X; Baxa U, 2001, BIOCHEMISTRY-US, V40, P5144, DOI 10.1021/bi0020426; BERGET PB, 1980, J VIROL, V34, P234, DOI 10.1128/JVI.34.1.234-243.1980; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; CASJENS S, 1988, J MOL BIOL, V199, P467, DOI 10.1016/0022-2836(88)90618-3; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chua JEH, 1999, MICROBIOL-UK, V145, P1649, DOI 10.1099/13500872-145-7-1649; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Eriksson M, 2007, J PHYS CHEM B, V111, P1139, DOI 10.1021/jp064322m; Freeman GG, 1942, BIOCHEM J, V36, P340, DOI 10.1042/bj0360340; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Inamdar MM, 2006, BIOPHYS J, V91, P411, DOI 10.1529/biophysj.105.070532; ISRAEL JV, 1967, P NATL ACAD SCI USA, V57, P284, DOI 10.1073/pnas.57.2.284; ISRAEL V, 1978, J GEN VIROL, V40, P669, DOI 10.1099/0022-1317-40-3-669; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; IWASHITA S, 1976, EUR J BIOCHEM, V65, P87, DOI 10.1111/j.1432-1033.1976.tb10392.x; Kamei DT, 2002, BIOTECHNOL BIOENG, V78, P190, DOI 10.1002/bit.10193; KASTOWSKY M, 1992, J BACTERIOL, V174, P4798, DOI 10.1128/JB.174.14.4798-4806.1992; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lindberg AA, 1977, SURFACE CARBOHYDRATE, P289; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; MITRAKI A, 1993, J BIOL CHEM, V268, P20071; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Molineux IJ, 2006, BACTERIOPHAGES, P277; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PREVELIGE PE, 2006, BACTERIOPHAGES, P00457; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Seckler R, 1998, J STRUCT BIOL, V122, P216, DOI 10.1006/jsbi.1998.3974; SECKLER R, 1989, J BIOL CHEM, V264, P11750; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; SUSSKIND MM, 1974, VIROLOGY, V62, P350, DOI 10.1016/0042-6822(74)90398-5; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979	54	67	72	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36768	36775		10.1074/jbc.M110.169003	http://dx.doi.org/10.1074/jbc.M110.169003			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20817910	Green Published, hybrid			2022-12-25	WOS:000284146100064
J	Chen, JX; Olivares-Navarrete, R; Wang, Y; Herman, TR; Boyan, BD; Schwartz, Z				Chen, Jiaxuan; Olivares-Navarrete, Rene; Wang, Yun; Herman, Tyler R.; Boyan, Barbara D.; Schwartz, Zvi			Protein-disulfide Isomerase-associated 3 (Pdia3) Mediates the Membrane Response to 1,25-Dihydroxyvitamin D-3 in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; GROWTH-PLATE CHONDROCYTES; MESENCHYMAL STEM-CELLS; KINASE-C; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ALKALINE-PHOSPHATASE; CARTILAGE CELLS; BINDING-PROTEIN; GENE-EXPRESSION; D METABOLITES	Protein-disulfide isomerase-associated 3 (Pdia3) is a multi-functional protein hypothesized to be a membrane receptor for 1,25(OH)(2)D-3. In intestinal epithelium and chondrocytes, 1,25(OH)(2)D-3 stimulates rapid membrane responses that are different from genomic effects via the vitamin D receptor (VDR). In this study, we show that 1,25(OH)(2)D-3 stimulates phospholipase A(2) (PLA(2))-dependent rapid release of prostaglandin E-2 (PGE(2)), activation of protein kinase C (PKC), and regulation of bone-related gene transcription and mineralization in osteoblast-like MC3T3-E1 cells (WT) via a mechanism involving Pdia3. Pdia3 was present in caveolae based on co-localization with lipid rafts and caveolin-1. In Pdia3-silenced (Sh-Pdia3) cells, 1,25(OH)(2)D-3 failed to stimulate PKC and PGE(2) responses; in Pdia3-overexpressing cells (Ov-Pdia3), responses to 1,25(OH)(2)D-3 were augmented. Downstream mediators of Pdia3, PLA(2)-activating protein (PLAA) and arachidonic acid, stimulated similar PKC activation in wild-type, Sh-Pdia3, and Ov-Pdia3 cells supporting the hypothesis that Pdia3 mediates the membrane action of 1,25(OH)(2)D-3. Treatment of MC3T3-E1 cells with 1,25(OH)(2)D-3 for 9 min stimulated rapid phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and increased expression of alkaline phosphatase, MMP-13, and osteopontin but decreased expression of osteocalcin, osteoprotegerin (mRNA and protein), and smad2. These effects were attenuated in Sh-Pdia3 cells. Sh-Pdia3 cells produced higher numbers of von Kossa-positive nodules and alizarin red-positive nodules compared with WT cells with or without 1,25(OH)(2)D-3 treatment whereas Ov-Pdia3 did not show any mineralization. Our data suggest Pdia3 is an important initiator of 1,25(OH)(2)D-3-stimulated membrane signaling pathways, which have both genomic and non genomic effects during osteoblast maturation.	[Chen, Jiaxuan; Olivares-Navarrete, Rene; Wang, Yun; Herman, Tyler R.; Boyan, Barbara D.; Schwartz, Zvi] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Boyan, BD (corresponding author), 315 Ferst Dr NW, Atlanta, GA 30332 USA.	barbara.boyan@bme.gatech.edu		Olivares-Navarrete, Rene/0000-0003-1232-9164; Chen, Jiaxuan/0000-0001-5801-9052	Price Gilbert, Jr. Foundation	Price Gilbert, Jr. Foundation	This work was supported by the Price Gilbert, Jr. Foundation.	BARAN DT, 1994, J CELL BIOCHEM, V56, P303, DOI 10.1002/jcb.240560305; Boland R, 2002, STEROIDS, V67, P477, DOI 10.1016/S0039-128X(01)00182-9; Boyan BD, 2006, J BONE MINER RES, V21, P1637, DOI 10.1359/JBMR.060713; Boyan BD, 2006, STEROIDS, V71, P286, DOI 10.1016/j.steroids.2005.09.018; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Boyan BD, 2002, STEROIDS, V67, P235, DOI 10.1016/S0039-128X(01)00160-X; BREEN EC, 1994, P NATL ACAD SCI USA, V91, P12902, DOI 10.1073/pnas.91.26.12902; BRONCKERS ALJJ, 1987, BONE MINER, V2, P361; Buitrago CG, 2003, J BIOL CHEM, V278, P2199, DOI 10.1074/jbc.M205732200; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Farach-Carson MC, 2004, STEROIDS, V69, P543, DOI 10.1016/j.steroids.2004.05.002; Farach-Carson MC, 2002, STEROIDS, V67, P467, DOI 10.1016/S0039-128X(01)00168-4; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kraichely Dennis M., 1998, Frontiers in Bioscience, V3, pD821; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Li J, 2009, J CELL BIOCHEM, V107, P1031, DOI 10.1002/jcb.22206; LIAN JB, 1985, J BIOL CHEM, V260, P8706; Liu RT, 2000, J BIOL CHEM, V275, P8711, DOI 10.1074/jbc.275.12.8711; Nemere I, 2000, STEROIDS, V65, P451, DOI 10.1016/S0039-128X(00)00107-0; NEMERE I, 1994, J BIOL CHEM, V269, P23750; Nemere I, 2004, P NATL ACAD SCI USA, V101, P7392, DOI 10.1073/pnas.0402207101; Ono N, 2008, J BIOL CHEM, V283, P19400, DOI 10.1074/jbc.M800005200; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Schwartz Z, 2005, J CELL PHYSIOL, V203, P54, DOI 10.1002/jcp.20212; Schwartz Z, 2003, STEROIDS, V68, P423, DOI 10.1016/S0039-128X(03)00044-8; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; Schwartz Z, 2002, J BIOL CHEM, V277, P11828, DOI 10.1074/jbc.M110398200; SCHWARTZ Z, 1989, J BONE MINER RES, V4, P199; Schwartz Z, 1999, BONE, V24, P475, DOI 10.1016/S8756-3282(99)00014-9; SCHWARTZ Z, 1992, BONE, V13, P51, DOI 10.1016/8756-3282(92)90361-Y; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SYLVIA VL, 1993, J CELL PHYSIOL, V157, P271, DOI 10.1002/jcp.1041570209; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Veldman CM, 1997, BONE, V21, P41, DOI 10.1016/S8756-3282(97)00077-X; Wali RK, 2003, J CELL BIOCHEM, V88, P794, DOI 10.1002/jcb.10432; Wang Y, 2010, J STEROID BIOCHEM, V121, P257, DOI 10.1016/j.jsbmb.2010.05.004; Yarram SJ, 2004, MOL CELL ENDOCRINOL, V220, P9, DOI 10.1016/j.mce.2004.04.005; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zanello LP, 1997, J BIOL CHEM, V272, P22617, DOI 10.1074/jbc.272.36.22617; Zanello LP, 2006, STEROIDS, V71, P291, DOI 10.1016/j.steroids.2005.09.012; Zanello LP, 2004, STEROIDS, V69, P561, DOI 10.1016/j.steroids.2004.05.003; Zanello LP, 2004, P NATL ACAD SCI USA, V101, P1589, DOI 10.1073/pnas.0305802101; ZERNIK J, 1990, DIFFERENTIATION, V44, P207, DOI 10.1111/j.1432-0436.1990.tb00619.x	50	63	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37041	37050		10.1074/jbc.M110.157115	http://dx.doi.org/10.1074/jbc.M110.157115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843786	Green Published, hybrid			2022-12-25	WOS:000284146100088
J	Veesler, D; Robin, G; Lichiere, J; Auzat, I; Tavares, P; Bron, P; Campanacci, V; Cambillau, C				Veesler, David; Robin, Gautier; Lichiere, Julie; Auzat, Isabelle; Tavares, Paulo; Bron, Patrick; Campanacci, Valerie; Cambillau, Christian			Crystal Structure of Bacteriophage SPP1 Distal Tail Protein (gp19.1) A BASEPLATE HUB PARADIGM IN GRAM-POSITIVE INFECTING PHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; LACTOCOCCUS-LACTIS PHAGES; LAMBDA TAIL; REVEALS; MECHANISM; MODEL; BACTERIAL; PHENIX; FIBER; IDENTIFICATION	Siphophage SPP1 infects the Gram-positive bacterium Bacillus subtilis using its long non-contractile tail and tail-tip. Electron microscopy (EM) previously allowed a low resolution assignment of most orf products belonging to these regions. We report here the structure of the SPP1 distal tail protein (Dit, gp19.1). The combination of x-ray crystallography, EM, and light scattering established that Dit is a back-to-back dimer of hexamers. However, Dit fitting in the virion EM maps was only possible with a hexamer located between the tail-tube and the tail-tip. Structure comparison revealed high similarity between Dit and a central component of lactophage baseplates. Sequence similarity search expanded its relatedness to several phage proteins, suggesting that Dit is a docking platform for the tail adsorption apparatus in Siphoviridae infecting Gram-positive bacteria and that its architecture is a paradigm for these hub proteins. Dit structural similarity extends also to non-contractile and contractile phage tail proteins (gpV(N) and XkdM) as well as to components of the bacterial type 6 secretion system, supporting an evolutionary connection between all these devices.	[Veesler, David; Lichiere, Julie; Campanacci, Valerie; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Veesler, David; Lichiere, Julie; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Veesler, David; Lichiere, Julie; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [Robin, Gautier; Bron, Patrick] CNRS, UMR 5048, INSERM, Ctr Biochim Struct,U554, F-34090 Montpellier, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, IFR 115, F-91190 Gif Sur Yvette, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, Unite Virol Mol & Struct, UPR3296, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cambillau, C (corresponding author), CNRS, UMR 6098, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr	Veesler, David/HCH-3986-2022	Campanacci, Valerie/0000-0001-6407-6395; Tavares, Paulo/0000-0002-2566-4546	Ministere francais de l'Enseignement Superieur et de la Recherche [ANR BLAN07-1_191968, ANR-07-BLAN-0095, 22976-2006]	Ministere francais de l'Enseignement Superieur et de la Recherche	This work was supported by Grant ANR BLAN07-1_191968 "Structural Insights on Siphoviridae Bacteriophages Infection," Grant ANR-07-BLAN-0095, "Siphophages," and Ph.D. Grant 22976-2006 from the "Ministere francais de l'Enseignement Superieur et de la Recherche" (to D. V.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babu KS, 1995, DEV BIOL STAND, V85, P569; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; HARAUZ G, 1986, OPTIK, V73, P146; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1976, J MOL BIOL, V107, P307, DOI 10.1016/S0022-2836(76)80007-1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; ROUSSEL A, 1991, TURBO FRODO GRAPHICS; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2009, J BIOL CHEM, V284, P30718, DOI 10.1074/jbc.M109.037812; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; VINGA I, 2006, BACTERIOPHAGE BIOL B, P161	52	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36666	36673		10.1074/jbc.M110.157529	http://dx.doi.org/10.1074/jbc.M110.157529			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843802	hybrid, Green Published			2022-12-25	WOS:000284146100069
J	Alfaro, MP; Vincent, A; Saraswati, S; Thorne, CA; Hong, CC; Lee, E; Young, PP				Alfaro, Maria P.; Vincent, Alicia; Saraswati, Sarika; Thorne, Curtis A.; Hong, Charles C.; Lee, Ethan; Young, Pampee P.			sFRP2 Suppression of Bone Morphogenic Protein (BMP) and Wnt Signaling Mediates Mesenchymal Stem Cell (MSC) Self-renewal Promoting Engraftment and Myocardial Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; DISRUPTION; ANTAGONIST; INDUCTION; APOPTOSIS; TARGETS; FAMILY; CBFA1	Transplantation of mesenchymal stem cells (MSCs) is a promising therapy for ischemic injury; however, inadequate survival of implanted cells in host tissue is a substantial impediment in the progress of cellular therapy. Secreted Frizzled-related protein 2 (sFRP2) has recently been highlighted as a key mediator of MSC-driven myocardial and wound repair. Notably, sFRP2 mediates significant enhancement of MSC engraftment in vivo. We hypothesized that sFRP2 improves MSC engraftment by modulating self-renewal through increasing stem cell survival and by inhibiting differentiation. In previous studies we demonstrated that sFRP2-expressing MSCs exhibited an increased proliferation rate. In the current study, we show that sFRP2 also decreased MSC apoptosis and inhibited both osteogenic and chondrogenic lineage commitment. sFRP2 activity occurred through the inhibition of both Wnt and bone morphogenic protein (BMP) signaling pathways. sFRP2-mediated inhibition of BMP signaling, as assessed by levels of pSMAD 1/5/8, was independent of its effects on the Wnt pathway. We further hypothesized that sFRP2 inhibition of MSC lineage commitment may reduce heterotopic osteogenic differentiation within the injured myocardium, a reported adverse side effect. Indeed, we found that sFRP2-MSC-treated hearts and wound tissue had less ectopic calcification. This work provides important new insight into the mechanisms by which sFRP2 increases MSC self-renewal leading to superior tissue engraftment and enhanced wound healing.	[Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Thorne, Curtis A.; Lee, Ethan] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hong, Charles C.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Internal Med, Nashville, TN 37232 USA; [Hong, Charles C.; Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Sch Med, 1161 21st Ave S,C2217A MCN, Nashville, TN 37232 USA.	pampee.young@vanderbilt.edu			National Institutes of Health [R01-HL088424, HL08842402S1, R01-GM081635]; Veterans Affairs merit award; National Cancer Institute [GI SPORE P50CA95103]; American Heart Association [09PRE2010035]; NIDDK, National Institutes of Health [U24 DK-59637]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040, R01HL088424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL088424, HL08842402S1, and R01-GM081635; Veterans Affairs merit award (to P. P. Y.); National Cancer Institute GI SPORE P50CA95103 (to E. L.); and American Heart Association Grant 09PRE2010035 (to M. P. A.).; MI surgeries were performed in the Cardiovascular Pathophysiology and Complications Core of the Vanderbilt Mouse Metabolic Phenotyping Center, supported by NIDDK, National Institutes of Health Grant U24 DK-59637.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gaur T, 2006, J CELL PHYSIOL, V208, P87, DOI 10.1002/jcp.20637; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jorgensen C, 2004, CURR OPIN BIOTECH, V15, P406, DOI 10.1016/j.copbio.2004.08.003; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; SCHOFIELD R, 1983, BIOMED PHARMACOTHER, V37, P375; Suzuki T, 2005, INT J HEMATOL, V82, P285, DOI 10.1532/IJH97.05115; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang ZY, 2009, J MOL CELL CARDIOL, V46, P370, DOI 10.1016/j.yjmcc.2008.11.016; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	34	92	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35645	35653		10.1074/jbc.M110.135335	http://dx.doi.org/10.1074/jbc.M110.135335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826809	Green Published, hybrid			2022-12-25	WOS:000283845300043
J	Into, T; Inomata, M; Niida, S; Murakami, Y; Shibata, K				Into, Takeshi; Inomata, Megumi; Niida, Shumpei; Murakami, Yukitaka; Shibata, Ken-ichiro			Regulation of MyD88 Aggregation and the MyD88-dependent Signaling Pathway by Sequestosome 1 and Histone Deacetylase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PATHOGEN RECOGNITION; GENE-EXPRESSION; PROTEIN; UBIQUITIN; APOPTOSIS; AUTOPHAGY; ADAPTER; FAMILY; TRAF6	MyD88 is an essential adaptor molecule for Toll-like receptors (TLRs) and interleukin (IL)-1 receptor. MyD88 is thought to be present as condensed forms or aggregated structures in the cytoplasm, although the reason has not yet been clear. Here, we show that endogenous MyD88 is present as small speckle-like condensed structures, formation of which depends on MyD88 dimerization. In addition, formation of large aggregated structures is related to cytoplasmic accumulation of sequestosome 1 (SQSTM1; also known as p62) and histone deacetylase 6 (HDAC6), which are involved in accumulation of polyubiquitinated proteins. A gene knockdown study revealed that SQSTM1 and HDAC6 were required for MyD88 aggregation and exhibited a suppressive effect on TLR ligand-induced expression of IL-6 and NOS2 in RAW264.7 cells. SQSTM1 and HDAC6 were partially involved in suppression of several TLR4-mediated signaling events, including activation of p38 and JNK, but they hardly affected degradation of I kappa B alpha (inhibitor of nuclear factor kappa B). Biochemical induction of MyD88 oligomerization induced recruitment of SQSTM1 and HDAC6 to the MyD88-TRAF6 signaling complex. Repression of SQSTM1 and HDAC6 enhanced formation of the MyD88-TRAF6 complex and conversely decreased interaction of the ubiquitin-specific negative regulator CYLD with the complex. Furthermore, ubiquitin-binding regions on SQSTM1 and HDAC6 were essential for MyD88 aggregation but were not required for interaction with the MyD88 complex. Thus, our study reveals not only that SQSTM1 and HDAC6 are important determinants of aggregated localization of MyD88 but also that MyD88 activates a machinery of polyubiquitinated protein accumulation that has a modulatory effect on MyD88-dependent signal transduction.	[Into, Takeshi; Inomata, Megumi; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu 5010296, Japan; [Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Genom & Prote, Aichi 4748522, Japan; [Shibata, Ken-ichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Lab Oral Mol Microbiol, Sapporo, Hokkaido 0608586, Japan	Asahi University; National Center for Geriatrics & Gerontology; Hokkaido University	Into, T (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, 1851-1 Hozumi, Gifu 5010296, Japan.	into@dent.asahi-u.ac.jp	Shibata, Ken-ichiro/A-4814-2012		Promotion and Mutual Aid Corporation for Private Schools of Japan; Miyata Science Research Foundation in Asahi University	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Miyata Science Research Foundation in Asahi University	This work was supported by the Science Research Promotion Fund (2010) (to T.I.) from the Promotion and Mutual Aid Corporation for Private Schools of Japan and a grant from the Miyata Science Research Foundation in Asahi University (to T.I.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fujita M, 2003, J IMMUNOL, V171, P3675, DOI 10.4049/jimmunol.171.7.3675; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hardiman G, 1997, GENOMICS, V45, P332, DOI 10.1006/geno.1997.4940; Hayashi T, 2010, J BIOL CHEM, V285, P18586, DOI 10.1074/jbc.M110.106468; Into T, 2008, MOL CELL BIOL, V28, P1338, DOI 10.1128/MCB.01412-07; Into T, 2007, J BIOL CHEM, V282, P8134, DOI 10.1074/jbc.M609962200; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; LORD KA, 1990, CELL GROWTH DIFFER, V1, P637; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	44	66	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35759	35769		10.1074/jbc.M110.126904	http://dx.doi.org/10.1074/jbc.M110.126904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837465	Green Published, hybrid			2022-12-25	WOS:000283845300054
J	Kim, H; Jung, Y; Shin, BS; Kim, H; Song, H; Bae, SH; Rhee, SG; Jeong, W				Kim, Hojin; Jung, Yuyeon; Shin, Bong Soo; Kim, Hyeryeon; Song, Hyunsook; Bae, Soo Han; Rhee, Sue Goo; Jeong, Woojin			Redox Regulation of Lipopolysaccharide-mediated Sulfiredoxin Induction, Which Depends on Both AP-1 and Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ANTIOXIDANT RESPONSE ELEMENT; PEROXIREDOXIN III; OXIDATIVE STRESS; SUBUNIT GENE; KAPPA-B; REVERSIBLE OXIDATION; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INDUCED EXPRESSION	Sulfiredoxin (Srx) is an enzyme that catalyzes the reduction of cysteine sulfinic acid of hyperoxidized peroxiredoxins and exerts a protective antioxidant role. Here we investigated the regulatory mechanism of Srx induction by lipopolysaccharide (LPS) in mouse macrophages. LPS up-regulated Srx expression on the transcriptional level. The promoter region of the Srx gene contained putative NF-kappa B and AP-1 (activator protein-1) sites, and the proximal site of three AP-1 sites was embedded within the antioxidant response element (ARE), a cis-acting element for Nrf2 (nuclear factor erythroid 2-related factor). Mutational analysis of the Srx promoter revealed that Srx induction is dependent on AP-1 sites and ARE but not on NF-kappa B sites. Consistently, both transcription factors, AP-1 and Nrf2, were required for LPS-mediated Srx induction, as revealed by chromatin immunoprecipitation using antibodies specific for c-Jun and c-Fos and little Srx induction in Nrf2-null bone marrow-derived macrophages. Among mitogen-activated protein kinases that mediate the signal transduction by LPS, JNK played a major role in Srx induction. Moreover, chemical antioxidants, such as N-acetylcysteine and butylated hydroxyanisole, and the NADPH oxidase inhibitor diphenyleneiodonium inhibited Srx induction as well as generation of reactive oxygen species, both of which were also suppressed in Nox2 (NADPH oxidase 2)-deficient bone marrow-derived macrophages. These results suggest that LPS-mediated Srx induction is dependent on both AP-1 and Nrf2, which is regulated by Nox2-derived reactive oxygen species.	Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University	Jeong, W (corresponding author), Sci Bldg C,Rm 207,11-1 Daehyun Dong, Seoul 120750, South Korea.	jeongw@ewha.ac.kr			Ministry of Education, Science, and Technology [M10642040002-07N4204-00210, R01-2008-000-11321-0, R15-2006-020]; Brain Korea 21 Scholars Program	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Bio R&D Program Grant M10642040002-07N4204-00210, Grant R01-2008-000-11321-0 and National Core Research Center Program Grant R15-2006-020 through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science, and Technology, and by funds from the Brain Korea 21 Scholars Program (to Y. J. and H. K.).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Abbas K, 2009, FREE RADICAL BIO MED, V47, P794, DOI 10.1016/j.freeradbiomed.2009.06.018; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bast A, 2010, BBA-GENE REGUL MECH, V1799, P402, DOI 10.1016/j.bbagrm.2009.11.015; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Glauser DA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-54; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Li LQ, 2009, J BIOCHEM, V145, P425, DOI 10.1093/jb/mvp011; LI Y, 1992, J BIOL CHEM, V267, P15097; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Moinova HR, 1998, J BIOL CHEM, V273, P14683, DOI 10.1074/jbc.273.24.14683; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; Rushworth SA, 2008, J IMMUNOL, V181, P6730, DOI 10.4049/jimmunol.181.10.6730; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Soriano FX, 2009, MOL CELLS, V27, P279, DOI 10.1007/s10059-009-0050-y; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Yang HP, 2002, J BIOL CHEM, V277, P35232, DOI 10.1074/jbc.M203812200; Yang HP, 2001, BIOCHEM J, V357, P447, DOI 10.1042/0264-6021:3570447; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	80	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34419	34428		10.1074/jbc.M110.126839	http://dx.doi.org/10.1074/jbc.M110.126839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826812	hybrid, Green Published			2022-12-25	WOS:000283659100016
J	Astarita, G; Jung, KM; Berchtold, NC; Nguyen, VQ; Gillen, DL; Head, E; Cotman, CW; Piomelli, D				Astarita, Giuseppe; Jung, Kwang-Mook; Berchtold, Nicole C.; Nguyen, Vinh Q.; Gillen, Daniel L.; Head, Elizabeth; Cotman, Carl W.; Piomelli, Daniele			Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PLASMALOGEN DEFICIENCY; CELL-SURVIVAL; AMYLOID-BETA; RAT-LIVER; BRAIN; DIET; RETROCONVERSION; PHOSPHOLIPIDS; METABOLISM	Reduced brain levels of docosahexaenoic acid (C22: 6n-3), a neurotrophic and neuroprotective fatty acid, may contribute to cognitive decline in Alzheimer's disease. Here, we investigated whether the liver enzyme system that provides docosahexaenoic acid to the brain is dysfunctional in this disease. Docosahexaenoic acid levels were reduced in temporal cortex, mid-frontal cortex and cerebellum of subjects with Alzheimer's disease, compared to control subjects (P = 0.007). Mini Mental State Examination (MMSE) scores positively correlated with docosahexaenoic/alpha-linolenic ratios in temporal cortex (P = 0.005) and mid-frontal cortex (P = 0.018), but not cerebellum. Similarly, liver docosahexaenoic acid content was lower in Alzheimer's disease patients than control subjects (P = 0.011). Liver docosahexaenoic/alpha-linolenic ratios correlated positively with MMSE scores (r = 0.78; P<0.0001), and negatively with global deterioration scale grades (P = 0.013). Docosahexaenoic acid precursors, including tetracosahexaenoic acid (C24:6n-3), were elevated in liver of Alzheimer's disease patients (P = 0.041), whereas expression of peroxisomal D-bifunctional protein, which catalyzes the conversion of tetracosahexaenoic acid into docosahexaenoic acid, was reduced (P = 0.048). Other genes involved in docosahexaenoic acid metabolism were not affected. The results indicate that a deficit in D-bifunctional protein activity impairs docosahexaenoic acid biosynthesis in liver of Alzheimer's disease patients, lessening the flux of this neuroprotective fatty acid to the brain.	[Astarita, Giuseppe; Jung, Kwang-Mook; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Astarita, Giuseppe] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy; [Berchtold, Nicole C.; Cotman, Carl W.] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92717 USA; [Nguyen, Vinh Q.; Gillen, Daniel L.] Univ Calif Irvine, Dept Stat, Irvine, CA 92717 USA; [Head, Elizabeth] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Piomelli, Daniele] Italian Inst Technol, Unit Drug Discovery & Dev, Genoa, Italy	University of California System; University of California Irvine; University of Rome Tor Vergata; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Kentucky; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Astarita, G (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	piomelli@uci.edu	Astarita, Giuseppe/AAD-1239-2019; Jung, Kwang-Mook/F-1035-2018; Astarita, Giuseppe/N-7346-2014	Jung, Kwang-Mook/0000-0003-4096-6953; Astarita, Giuseppe/0000-0001-6700-301X	National Institutes on Drug Abuse (ARRA); Agilent Foundation; National Institute on Aging [P50 AG016573, P01 AG00538, P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING [P30AG019610, P50AG016573, P01AG000538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012447] Funding Source: NIH RePORTER	National Institutes on Drug Abuse (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Agilent Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes on Drug Abuse (ARRA) and the Agilent Foundation (to D. Piomelli). The Alzheimer's Disease Research Center Neuropathology Core and the Institute for Brain Aging and Dementia of the University of California Irvine are supported by grants from the National Institute on Aging (P50 AG016573 and P01 AG00538). The Brain and Body Donation Program of Sun City, Arizona, is supported by a grant from the National Institute on Aging (P30 AG19610), the Arizona Department of Health Services (contract 211002), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05-901 to the Arizona Parkinson's Disease Consortium) and the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan N. G., 1990, NUTR BRAIN, V8, P1; BAZAN NG, 1986, BIOCHEM BIOPH RES CO, V141, P600, DOI 10.1016/S0006-291X(86)80215-7; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; BROOKSBANK BWL, 1989, MOL CHEM NEUROPATHOL, V11, P157, DOI 10.1007/BF03160049; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Corrigan FM, 1998, INT J BIOCHEM CELL B, V30, P197, DOI 10.1016/S1357-2725(97)00125-8; Crawford MA, 2009, ANN NUTR METAB, V55, P202, DOI 10.1159/000229003; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; MARTINEZ M, 1990, NEUROLOGY, V40, P1292, DOI 10.1212/WNL.40.8.1292; MOORE SA, 1995, J LIPID RES, V36, P2433; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Prince M, 2009, WORLD ALZHEIMER REPO; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Rapoport SI, 2010, PROSTAG LEUKOTR ESS, V82, P273, DOI 10.1016/j.plefa.2010.02.015; Rapoport SI, 2009, PROSTAG LEUKOTR ESS, V81, P119, DOI 10.1016/j.plefa.2009.05.021; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; SKINNER ER, 1993, BRAIN, V116, P717, DOI 10.1093/brain/116.3.717; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Sprecher H, 1995, J LIPID RES, V36, P2471; Su HM, 2001, J BIOL CHEM, V276, P38115; VOSS A, 1991, J BIOL CHEM, V266, P19995; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752; Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575	43	150	153	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12538	10.1371/journal.pone.0012538	http://dx.doi.org/10.1371/journal.pone.0012538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838618	Green Published, gold			2022-12-25	WOS:000281687100003
J	Frynta, D; Liskova, S; Bultmann, S; Burda, H				Frynta, Daniel; Liskova, Silvie; Bueltmann, Sebastian; Burda, Hynek			Being Attractive Brings Advantages: The Case of Parrot Species in Captivity	PLOS ONE			English	Article							ZOO VISITOR PREFERENCES; ARK; REINTRODUCTION; IMITATION; SURVIVAL; ANIMALS; AMAZON; TRADE; BIRDS; NEST	Background: Parrots are one of the most frequently kept and bred bird orders in captivity. This increases poaching and thus the potential importance of captive populations for rescue programmes managed by zoos and related institutions. Both captive breeding and poaching are selective and may be influenced by the attractiveness of particular species to humans. In this paper, we tested the hypothesis that the size of zoo populations is not only determined by conservation needs, but also by the perceived beauty of individual parrot species assessed by human observers. Methodology/Principal Findings: For the purpose of data collection, we defined four sets of species (40 parrots, 367 parrots, 34 amazons, 17 macaws). Then, we asked 776 human respondents to evaluate parrot pictures of the selected species according to perceived beauty and we analyzed its association with color and morphological characters. Irrespective of the species set, we found a good agreement among the respondents. The preferred species tended to be large, colorful, and long-tailed. Conclusions/Significance: We repeatedly confirmed significant, positive association between the perceived beauty and the size of worldwide zoo population. Moreover, the range size and body size appeared to be significant predictors of zoo population size. In contrast, the effects of other explanatory variables, including the IUCN (International Union for Conservation of Nature) listing, appeared insignificant. Our results may suggest that zoos preferentially keep beautiful parrots and pay less attention to conservation needs.	[Frynta, Daniel; Liskova, Silvie] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Bueltmann, Sebastian; Burda, Hynek] Univ Duisburg Essen, Dept Gen Zool, Fac Biosci, Essen, Germany	Charles University Prague; University of Duisburg Essen	Frynta, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	frynta@centrum.cz	Rádlová, Silvie/D-5532-2017; Frynta, Daniel/L-7350-2016; Bultmann, Sebastian/AAC-7729-2020; Rádlová, Silvie/L-3388-2019	Rádlová, Silvie/0000-0003-3581-9780; Frynta, Daniel/0000-0002-1375-7972; Rádlová, Silvie/0000-0003-3581-9780	Grant Agency of the Academy of Sciences of the Czech Republic [IAA601410803]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	The project was supported by the The Grant Agency of the Academy of Sciences of the Czech Republic (project No. IAA601410803), http://www.isvav.cz/projectDetail.do?rowId = IAA601410803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2003, SOC ANIM, V11, P393, DOI 10.1163/156853003322796109; [Anonymous], SPSS VERS 16 0; ARNDT T, 2004, LEXICON PARROTS 2 0; Balmford A, 2000, CONSERV BIOL, V14, P1193, DOI 10.1046/j.1523-1739.2000.99078.x; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; BEISSINGER SR, 1992, BIOSCIENCE, V42, P164, DOI 10.2307/1311821; *BIRDLIFE INT, BIRDLIFE CHECKL BIRD; Borsari A, 2005, ANIM COGN, V8, P48, DOI 10.1007/s10071-004-0221-3; Brightsmith D, 2005, BIOL CONSERV, V121, P465, DOI 10.1016/j.biocon.2004.05.016; BROCK MK, 1992, P NATL ACAD SCI USA, V89, P11121, DOI 10.1073/pnas.89.23.11121; Collar N.J., 1992, P1; Collazo JA, 2003, CONDOR, V105, P198, DOI 10.1650/0010-5422(2003)105[0198:SOCHPR]2.0.CO;2; Del Hoyo, 1997, HDB BIRDS WORLD SAND; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Flesness NR, 1995, ZOO BIOL, V14, P509, DOI 10.1002/zoo.1430140603; Forshaw J.M., 2006, PARROTS WORLD IDENTI; Frynta D., 2009, P299; Funk MS, 2002, ANIM COGN, V5, P167, DOI 10.1007/s10071-002-0149-4; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; HAAHR M, TRUE RANDOM NUMBERS; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Jeggo D. F., 2000, International Zoo Yearbook, V37, P214, DOI 10.1111/j.1748-1090.2000.tb00726.x; Juniper T, 2003, PARROTS GUIDE PARROT; Maresova J, 2008, ECOL ECON, V64, P554, DOI 10.1016/j.ecolecon.2007.03.012; Maresova J, 2009, THEOR BIOSCI, V128, P227, DOI 10.1007/s12064-009-0075-y; Maresova J, 2009, ETHOLOGY, V115, P297, DOI 10.1111/j.1439-0310.2009.01620.x; Meyers JM, 1996, WILDLIFE SOC B, V24, P15; Mui R, 2008, P R SOC B, V275, P2547, DOI 10.1098/rspb.2008.0566; Munn CA, 2006, MANUAL OF PARROT BEHAVIOR, P27, DOI 10.1002/9780470344651.ch3; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; PEPPERBERG IM, 1994, J COMP PSYCHOL, V108, P36, DOI 10.1037/0735-7036.108.1.36; Pepperberg IM., 1999, ALEX STUDIES COGNITI; Pepperberg IM, 2006, ANIM COGN, V9, P377, DOI 10.1007/s10071-006-0034-7; ROBILLER F, 1992, HDB VOGELPFLEGE PAPA, V1; Sanz V, 1998, CONSERV BIOL, V12, P430, DOI 10.1046/j.1523-1739.1998.96261.x; Schmitz C., LIMESURVEY OPEN SOUR; SHEPPARD C, 1995, ZOO BIOL, V14, P197, DOI 10.1002/zoo.1430140302; SNYDER NFR, 1994, CONDOR, V96, P845, DOI 10.2307/1369097; SOULE M, 1986, ZOO BIOL, V5, P101, DOI 10.1002/zoo.1430050205; *STATSOFT, STAT; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Ward PI, 2000, CONSERV BIOL, V14, P1196, DOI 10.1046/j.1523-1739.2000.00026.x; WAZA, 2005, BUILD FUT WILDL WORL; White TH, 2005, CONDOR, V107, P424, DOI 10.1650/7672; Wilkinson R., 2000, International Zoo Yearbook, V37, P36, DOI 10.1111/j.1748-1090.2000.tb00705.x; Wright TF, 2001, CONSERV BIOL, V15, P710, DOI 10.1046/j.1523-1739.2001.015003710.x; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zentall TR, 2004, LEARN BEHAV, V32, P15, DOI 10.3758/BF03196003	49	61	62	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12568	10.1371/journal.pone.0012568	http://dx.doi.org/10.1371/journal.pone.0012568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830206	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300008
J	Read, JCA; Phillipson, GP; Serrano-Pedraza, I; Milner, AD; Parker, AJ				Read, Jenny C. A.; Phillipson, Graeme P.; Serrano-Pedraza, Ignacio; Milner, A. David; Parker, Andrew J.			Stereoscopic Vision in the Absence of the Lateral Occipital Cortex	PLOS ONE			English	Article							VERGENCE EYE-MOVEMENTS; CORTICAL AREA; RELATIVE DISPARITY; DEPTH-PERCEPTION; BINOCULAR DEPTH; PSYCHOMETRIC FUNCTION; VISUAL-CORTEX; REPRESENTATION; MOTION; NEURONS	Both dorsal and ventral cortical visual streams contain neurons sensitive to binocular disparities, but the two streams may underlie different aspects of stereoscopic vision. Here we investigate stereopsis in the neurological patient D. F., whose ventral stream, specifically lateral occipital cortex, has been damaged bilaterally, causing profound visual form agnosia. Despite her severe damage to cortical visual areas, we report that DF's stereo vision is strikingly unimpaired. She is better than many control observers at using binocular disparity to judge whether an isolated object appears near or far, and to resolve ambiguous structure-from-motion. DF is, however, poor at using relative disparity between features at different locations across the visual field. This may stem from a difficulty in identifying the surface boundaries where relative disparity is available. We suggest that the ventral processing stream may play a critical role in enabling healthy observers to extract fine depth information from relative disparities within one surface or between surfaces located in different parts of the visual field.	[Read, Jenny C. A.; Serrano-Pedraza, Ignacio] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Phillipson, Graeme P.] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh, Midlothian, Scotland; [Milner, A. David] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Parker, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Newcastle University - UK; University of Edinburgh; Durham University; University of Oxford	Read, JCA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	j.c.a.read@ncl.ac.uk	Read, Jenny/A-7493-2013; Serrano-Pedraza, Ignacio/B-4862-2014; Parker, Andrew J/I-7867-2013	Read, Jenny/0000-0002-9029-5185; Serrano-Pedraza, Ignacio/0000-0002-4464-1905; Parker, Andrew J/0000-0001-5800-0407	Royal Society [UF041260]; MRC [G0601566, G0401090, G0700399]; Wellcome Trust [G0700399]; EPSRC; Medical Research Council [G0700399, G0601566, G0400132, G0401090] Funding Source: researchfish; MRC [G0400593, G0400132, G0802171, G9409531] Funding Source: UKRI	Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Royal Society (royalsociety.org): University Research Fellowship UF041260 to JCAR. MRC (www.mrc.ac.uk): New Investigator Award G0601566 to JCAR, grant G0401090 to ADM and grant G0700399 to AJP and others. Wellcome Trust (www.wellcome.ac.uk): grant G0700399 to AJP. EPSRC (www.epsrc.ac.uk): Neuroinformatics Doctoral Training Centre studentship to GPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; Bridge H, 2007, J VISION, V7, DOI 10.1167/7.14.15; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; COGAN AI, 1993, VISION RES, V33, P1959, DOI 10.1016/0042-6989(93)90021-N; Crawford JR, 2007, COGN NEUROPSYCHOL, V24, P343, DOI 10.1080/02643290701290146; Crawford JR, 2004, CORTEX, V40, P533, DOI 10.1016/S0010-9452(08)70145-X; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Dijkerman HC, 1996, EXP BRAIN RES, V112, P442; Dijkerman HC, 1999, NEUROPSYCHOLOGIA, V37, P1505, DOI 10.1016/S0028-3932(99)00063-9; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; GILLAM B, 1984, PERCEPT PSYCHOPHYS, V36, P559, DOI 10.3758/BF03207516; Gillam B, 2007, PERCEPTION, V36, P596, DOI 10.1068/p5535; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; HUMPHREY GK, 1991, PSYCHOL SCI, V2, P331, DOI 10.1111/j.1467-9280.1991.tb00161.x; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2003, NEURON, V37, P693, DOI 10.1016/S0896-6273(03)00023-0; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krug K, 2004, J NEUROPHYSIOL, V92, P1586, DOI 10.1152/jn.00851.2003; Marotta JJ, 1997, EXP BRAIN RES, V116, P113, DOI 10.1007/PL00005731; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Mon-Williams M, 2001, EXP BRAIN RES, V139, P127, DOI 10.1007/s002210000657; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Read JCA, 2000, VISION RES, V40, P3345, DOI 10.1016/S0042-6989(00)00182-6; Rice NJ, 2006, EXP BRAIN RES, V174, P176, DOI 10.1007/s00221-006-0435-5; Roe AW, 2007, J NEUROSCI, V27, P11820, DOI 10.1523/JNEUROSCI.4164-07.2007; Spang K, 2008, J VISION, V8, DOI 10.1167/8.9.10; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Tanabe S, 2004, J NEUROSCI, V24, P8170, DOI 10.1523/JNEUROSCI.5292-03.2004; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Umeda K, 2007, J NEUROPHYSIOL, V98, P241, DOI 10.1152/jn.01336.2006; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; WESTHEIMER G, 1979, EXP BRAIN RES, V36, P585; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	59	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12608	10.1371/journal.pone.0012608	http://dx.doi.org/10.1371/journal.pone.0012608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830303	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000281631300030
J	Ribak, G; Swallow, JG; Jones, DR				Ribak, Gal; Swallow, John G.; Jones, David R.			Drag-Based 'Hovering' in Ducks: The Hydrodynamics and Energetic Cost of Bottom Feeding	PLOS ONE			English	Article							LABRIFORM LOCOMOTION; DIVING ENERGETICS; BEAT CYCLE; BODY-MASS; BIRDS; BUOYANCY; PROPULSION; MECHANICS; STROKE; LIFT	Diving ducks use their webbed feet to provide the propulsive force that moves them underwater. To hold position near the bottom while feeding, ducks paddle constantly to resist the buoyant force of the body. Using video sequences from two orthogonal cameras we reconstructed the 3-dimensional motion of the feet through water and estimated the forces involved with a quasi-steady blade-element model. We found that during station holding, near the bottom, ducks use drag based propulsion with the webbed area of the foot moving perpendicular to the trajectory of the foot. The body was pitched at 76 +/- 3.47 degrees below the horizon and the propulsive force was directed 26 +/- 1.9 degrees ventral to the body so that 98% of the propulsive force in the sagittal plane of the duck worked to oppose buoyancy. The mechanical work done by moving both feet through a paddling cycle was 1.1 +/- 0.2 J which was equivalent to an energy expenditure of 3.7 +/- 0.5 W to hold position while feeding at 1.5 m depth. We conclude that in shallow water the high energetic cost of feeding in ducks is due to the need to paddle constantly against buoyancy even after reaching the bottom. The mechanical energy spent on holding position near the bottom, while feeding, is approximately 2 fold higher than previous estimates that were made for similar bottom depths but based on the presumed motion of the body instead of motion of the feet.	[Ribak, Gal; Swallow, John G.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Ribak, Gal; Jones, David R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of South Dakota; University of British Columbia	Ribak, G (corresponding author), Technion Israel Inst Technol, Fac Aerosp Engn, Technion Autonomous Syst Program, IL-32000 Haifa, Israel.	gal.ribak@gmail.com		Ribak, Gal/0000-0002-6267-5471	Company of Biologists; Natural Sciences and Engineering Research Council of Canada; National Science Foundation [IOB-00448060]	Company of Biologists; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation(National Science Foundation (NSF))	Funding for this work included a travel fellowship to GR from the Company of Biologists (www.biologists.com), a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to DRJ and National Science Foundation (http://www.nsf.gov/) CAREER award grant no. IOB-00448060 to JGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigeldinger Terrye L., 1995, Journal of Experimental Biology, V198, P1567; BAUDINETTE RV, 1985, J COMP PHYSIOL B, V155, P373, DOI 10.1007/BF00687481; BLAKE RW, 1980, J EXP BIOL, V85, P337; BLAKE RW, 1979, J EXP BIOL, V82, P255; Butler PJ, 2004, RESP PHYSIOL NEUROBI, V141, P297, DOI 10.1016/j.resp.2004.01.010; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; FISH FE, 1995, J EXP ZOOL, V273, P1, DOI 10.1002/jez.1402730102; GAL JM, 1988, J EXP BIOL, V138, P413; Heath JP, 2006, J EXP BIOL, V209, P3974, DOI 10.1242/jeb.02482; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Johansson LC, 2003, NATURE, V424, P65, DOI 10.1038/nature01695; Johansson LC, 2001, J EXP BIOL, V204, P1687; KORTRIGHT FH, 1962, DUCKS GEESE SWANS N; Lovvorn JR, 2007, PHILOS T R SOC B, V362, P2079, DOI 10.1098/rstb.2007.2110; LOVVORN JR, 1991, CAN J ZOOL, V69, P2879, DOI 10.1139/z91-406; LOVVORN JR, 1994, ESTUARIES, V17, P62, DOI 10.2307/1352335; LOVVORN JR, 1991, CAN J ZOOL, V69, P2888, DOI 10.1139/z91-407; LOVVORN JR, 1991, J EXP BIOL, V159, P98; LOVVORN JR, 2009, BERING SEA ECOL APPL, V19, P1596; McPhail LT, 1998, COMP BIOCHEM PHYS A, V120, P219, DOI 10.1016/S1095-6433(98)00005-1; Miller MR, 2006, CONDOR, V108, P166, DOI 10.1650/0010-5422(2006)108[0166:TARBRM]2.0.CO;2; PRANGE HD, 1970, J EXP BIOL, V53, P763; Ribak G, 2004, J EXP BIOL, V207, P2101, DOI 10.1242/jeb.00997; Ribak G, 2008, J EXP BIOL, V211, P3009, DOI 10.1242/jeb.018895; Richman SE, 2008, J COMP PHYSIOL B, V178, P321, DOI 10.1007/s00360-007-0225-9; STEPHENSON R, 1994, J EXP BIOL, V190, P155; Vogel S, 1994, LIFE MOVING FLUIDS; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; WOAKES AJ, 1983, J EXP BIOL, V107, P311	31	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12565	10.1371/journal.pone.0012565	http://dx.doi.org/10.1371/journal.pone.0012565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830286	Green Submitted, Green Published, gold			2022-12-25	WOS:000281631300005
J	Fischer, Y; Ganic, E; Ameri, J; Xian, XJ; Johannesson, M; Semb, H				Fischer, Yvonne; Ganic, Elvira; Ameri, Jacqueline; Xian, Xiaojie; Johannesson, Martina; Semb, Henrik			NANOG Reporter Cell Lines Generated by Gene Targeting in Human Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; HOMOLOGOUS RECOMBINATION; RNAI SCREEN; MOUSE; PLURIPOTENCY; DIFFERENTIATION; IDENTIFICATION; CLONING; SYSTEM; LOCUS	Background: Pluripotency and self-renewal of human embryonic stem cells (hESCs) is mediated by a complex interplay between extra-and intracellular signaling pathways, which regulate the expression of pluripotency-specific transcription factors. The homeodomain transcription factor NANOG plays a central role in maintaining hESC pluripotency, but the precise role and regulation of NANOG are not well defined. Methodology/Principal Findings: To facilitate the study of NANOG expression and regulation in viable hESC cultures, we generated fluorescent NANOG reporter cell lines by gene targeting in hESCs. In these reporter lines, the fluorescent reporter gene was co-expressed with endogenous NANOG and responded to experimental induction or repression of the NANOG promoter with appropriate changes in expression levels. Furthermore, NANOG reporter lines facilitated the separation of hESC populations based on NANOG expression levels and their subsequent characterization. Gene expression arrays on isolated hESC subpopulations revealed genes with differential expression in NANOG high and NANOG low hESCs, providing candidates for NANOG downstream targets hESCs. Conclusion/Significance: The newly derived NANOG reporter hESC lines present novel tools to visualize NANOG expression in viable hESCs. In future applications, these reporter lines can be used to elucidate the function and regulation of NANOG in pluripotent hESCs.	[Fischer, Yvonne; Ganic, Elvira; Ameri, Jacqueline; Semb, Henrik] Lund Univ, Stem Cell Ctr, Lund, Sweden; [Xian, Xiaojie] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Johannesson, Martina] Hagedorn Res Inst, Dept Stem Cell Biol, Gentofte, Denmark	Lund University; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute	Fischer, Y (corresponding author), Lund Univ, Stem Cell Ctr, Lund, Sweden.	henrik.semb@med.lu.se		Ameri, Jacqueline/0000-0002-6146-3944; Semb, Henrik/0000-0002-6747-787X	Juvenile Diabetes Research Foundation [1-2007-1046, 35-2008-626]; Swedish Research Council [521-2006-4163, 521-2008-2446, 521-2009-20647]; JDRF-Center for Beta cell Therapy in Europe [512145]; Swedish Foundation for Strategic Research [A302:094]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); JDRF-Center for Beta cell Therapy in Europe; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Juvenile Diabetes Research Foundation [grant number 1-2007-1046, 35-2008-626]; the Swedish Research Council [grant number 521-2006-4163, 521-2008-2446, 521-2009-20647]; the JDRF-Center for Beta cell Therapy in Europe [grant number 512145] and the Swedish Foundation for Strategic Research [grant number A302:094]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	44	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12533	10.1371/journal.pone.0012533	http://dx.doi.org/10.1371/journal.pone.0012533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824089	Green Published, Green Submitted, gold			2022-12-25	WOS:000281480900016
J	Adetifa, IMO; Ota, MOC; Walther, B; Hammond, AS; Lugos, MD; Jeffries, DJ; Donkor, SA; Adegbola, RA; Hill, PC				Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Walther, Brigitte; Hammond, Abdulrahman S.; Lugos, Moses D.; Jeffries, David J.; Donkor, Simon A.; Adegbola, Richard A.; Hill, Philip C.			Decay Kinetics of an Interferon Gamma Release Assay with Anti-Tuberculosis Therapy in Newly Diagnosed Tuberculosis Cases	PLOS ONE			English	Article							T-CELL RESPONSES; LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; PULMONARY TUBERCULOSIS; INFECTION; ELISPOT; CHILDREN; GAMBIA; CONTACTS	Background: Qualitative and quantitative changes in IGRA response offer promise as biomarkers to monitor Tuberculosis (TB) drug therapy, and for the comparison of new interventions. We studied the decay kinetics of TB-specific antigen T-cell responses measured with an in-house ELISPOT assay during the course of therapy. Methods: Newly diagnosed sputum smear positive TB cases with typical TB chest radiographs were recruited. All patients were given standard anti-TB treatment. Each subject was followed up for 6 months and treatment outcomes were documented. Blood samples were obtained for the ESAT-6 and CFP-10 (EC) ELISPOT at diagnosis, 1-, 2-, 4- and 6-months. Qualitative and quantitative reversion of the ELISPOT results were assessed with McNemar test, conditional logistic regression and mixed-effects hierarchical Poisson models. Results: A total of 116 cases were recruited and EC ELISPOT was positive for 87% (95 of 109) at recruitment. There was a significant decrease in the proportion of EC ELISPOT positive cases over the treatment period (p<0.001). Most of the reversion occurred between the start and first month of treatment and at completion at 6 months. ESAT-6 had higher median counts compared to CFP-10 at all time points. Counts for each antigen declined significantly with therapy (p<0.001). Reverters had lower median SFUs at the start of treatment compared to non-Reverters for both antigens. Apart from the higher median counts for non-Reverters, no other risk factors for non-reversion were found. Conclusions: TB treatment induces qualitative and quantitative reversion of a positive in-house IGRA in newly diagnosed cases of active TB disease. As this does not occur reliably in the majority of cured individuals, qualitative and quantitative reversion of an IGRA ELISPOT has limited clinical utility as a surrogate marker of treatment efficacy.	[Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Hammond, Abdulrahman S.; Lugos, Moses D.; Donkor, Simon A.; Adegbola, Richard A.; Hill, Philip C.] Med Res Council United Kingdom Labs, Bacterial Dis Programme, Fajara, Gambia; [Walther, Brigitte; Jeffries, David J.] Med Res Council United Kingdom Labs, Stat & Data Support Unit, Fajara, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Adetifa, IMO (corresponding author), Med Res Council United Kingdom Labs, Bacterial Dis Programme, Fajara, Gambia.	iadetifa@mrc.gm	Lugos, Moses D/AAZ-5179-2020; Hammond, Abdulrahman/F-1541-2011	Lugos, Moses D/0000-0002-4921-2691; 	Medical Research Council, The Gambia; European and Developing Countries [CG_ta_2005_40203_001]; MRC [MC_U190071468, MC_U190081968] Funding Source: UKRI; Medical Research Council [MC_U190081968, MC_U190071468] Funding Source: researchfish	Medical Research Council, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European and Developing Countries; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council, The Gambia. IMOA received funding from the European and Developing Countries Trials Partnership through a career development fellowship (grant CG_ta_2005_40203_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; Adetifa IMO, 2007, INT J TUBERC LUNG D, V11, P350; Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Bosshard V, 2009, RESP MED, V103, P30, DOI 10.1016/j.rmed.2008.09.012; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; CHEE CB, 2009, EUR RESP J; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Connell TG, 2010, PEDIATR INFECT DIS J, V29, P285, DOI 10.1097/INF.0b013e3181c4822f; Connell TG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-138; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dominguez J, 2009, DIAGN MICR INFEC DIS, V63, P43, DOI 10.1016/j.diagmicrobio.2008.09.010; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Herrmann JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004130; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Houben RMGJ, 2010, INT J TUBERC LUNG D, V14, P909; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Kobashi Y, 2009, J INFECTION, V58, P197, DOI 10.1016/j.jinf.2008.08.009; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lugos MD, 2009, IMMUNOL INVEST, V38, P341, DOI 10.1080/08820130902748744; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nicol MP, 2005, CLIN INFECT DIS, V40, P1301, DOI 10.1086/429245; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Sauzullo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005187; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; *WHO, 2007, 104 WHO; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; World Health Organization (WHO), 2009, WHOHTMTB2009420	40	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12502	10.1371/journal.pone.0012502	http://dx.doi.org/10.1371/journal.pone.0012502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824136	Green Published, gold, Green Submitted			2022-12-25	WOS:000281456100014
J	Akaneya, Y; Sohya, K; Kitamura, A; Kimura, F; Washburn, C; Zhou, RP; Ninan, I; Tsumoto, T; Ziff, EB				Akaneya, Yukio; Sohya, Kazuhiro; Kitamura, Akihiko; Kimura, Fumitaka; Washburn, Chris; Zhou, Renping; Ninan, Ipe; Tsumoto, Tadaharu; Ziff, Edward B.			Ephrin-A5 and EphA5 Interaction Induces Synaptogenesis during Early Hippocampal Development	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOGENESIS; NEURONAL GENE-EXPRESSION; DEPENDENT PROTEIN-KINASE; FOCAL ADHESION KINASE; POSTNATAL-DEVELOPMENT; SYNAPSE FORMATION; NMDA RECEPTORS; AMPA RECEPTORS; EXCITATORY SYNAPSES; FILOPODIA FORMATION	Background: Synaptogenesis is a fundamental step in neuronal development. For spiny glutamatergic synapses in hippocampus and cortex, synaptogenesis involves adhesion of pre and postsynaptic membranes, delivery and anchorage of pre and postsynaptic structures including scaffolds such as PSD-95 and NMDA and AMPA receptors, which are glutamate-gated ion channels, as well as the morphological maturation of spines. Although electrical activity-dependent mechanisms are established regulators of these processes, the mechanisms that function during early development, prior to the onset of electrical activity, are unclear. The Eph receptors and ephrins provide cell contact-dependent pathways that regulate axonal and dendritic development. Members of the ephrin-A family are glycosyl-phosphatidylinositol-anchored to the cell surface and activate EphA receptors, which are receptor tyrosine kinases. Methodology/Principal Findings: Here we show that ephrin-A5 interaction with the EphA5 receptor following neuron-neuron contact during early development of hippocampus induces a complex program of synaptogenic events, including expression of functional synaptic NMDA receptor-PSD-95 complexes plus morphological spine maturation and the emergence of electrical activity. The program depends upon voltage-sensitive calcium channel Ca(2+) fluxes that activate PKA, CaMKII and PI3 kinase, leading to CREB phosphorylation and a synaptogenic program of gene expression. AMPA receptor subunits, their scaffolds and electrical activity are not induced. Strikingly, in contrast to wild type, stimulation of hippocampal slices from P6 EphA5 receptor functional knockout mice yielded no NMDA receptor currents. Conclusions/Significance: These studies suggest that ephrin-A5 and EphA5 signals play a necessary, activity-independent role in the initiation of the early phases of synaptogenesis. The coordinated expression of the NMDAR and PSD-95 induced by eprhin-A5 interaction with EphA5 receptors may be the developmental switch that induces expression of AMPAR and their interacting proteins and the transition to activity-dependent synaptic regulation.	[Akaneya, Yukio; Ziff, Edward B.] NYU, Dept Biochem, Sch Med, New York, NY 10016 USA; [Akaneya, Yukio; Sohya, Kazuhiro; Kitamura, Akihiko; Kimura, Fumitaka; Tsumoto, Tadaharu] Osaka Univ, Grad Sch Med, Div Neurophysiol, Suita, Osaka, Japan; [Sohya, Kazuhiro; Tsumoto, Tadaharu] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Washburn, Chris; Zhou, Renping] Rutgers State Univ, Coll Pharm, Canc Res Lab, Piscataway, NJ 08855 USA; [Ninan, Ipe] NYU, Sch Med, Dept Psychiat, New York, NY USA	New York University; Osaka University; RIKEN; Rutgers State University New Brunswick; New York University	Akaneya, Y (corresponding author), Fukui Social Insurance Hosp, Katsuyama City, Fukui, Japan.	edward.ziff@nyumc.org		Kitamura, Akihiko/0000-0002-8747-2902; Ninan, Ipe/0000-0001-9774-6455; Ziff, Edward/0000-0001-7389-8649	National Institutes of Health-National Institute on Aging (NIH-NIA) [AG13620]; National Science Foundation [NSF 10B 05-48561]; Japan Science and Technology Agency; NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Aging (NIH-NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health-National Institute on Aging (NIH-NIA) grant, AG13620 ( to E.Z.) (http://www.nia.nih.gov/), and a National Science Foundation grant, NSF 10B 05-48561 ( to R.Z.) ( http://www.nsf.gov/funding/), and a grant from the Japan Science and Technology Agency ( to T. T.) ( http://www.jst.go.jp/EN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Allen KM, 1999, EPILEPSY RES, V36, P143, DOI 10.1016/S0920-1211(99)00048-0; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BENARI Y, 1991, NATURE, V353, P220, DOI 10.1038/353220a0; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Corbo JC, 2002, J NEUROSCI, V22, P7548; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukushima K, 2006, AM J PHYSIOL-GASTR L, V291, pG812, DOI 10.1152/ajpgi.00250.2005; Gerlai R, 1999, J NEUROSCI, V19, P9538; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hu ZL, 2003, J NEUROSCI, V23, P10963; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; MAISONPIERRE PC, 1993, ONCOGENE, V8, P3277; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Martinez A, 2005, NEUROSCIENCE, V135, P451, DOI 10.1016/j.neuroscience.2005.06.052; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Moody WJ, 1998, J NEUROBIOL, V37, P97, DOI 10.1002/(SICI)1097-4695(199810)37:1<97::AID-NEU8>3.0.CO;2-3; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Subramaniam S, 2005, J NEUROSCI, V25, P2838, DOI 10.1523/JNEUROSCI.5060-04.2005; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; TANAKA O, 1995, BRAIN RES MOL BRAIN, V30, P1, DOI DOI 10.1016/0169-328X(94)00265-G; TAYLOR V, 1994, NEUROSCIENCE, V63, P163, DOI 10.1016/0306-4522(94)90014-0; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Wang YF, 2001, J NEUROPHYSIOL, V86, P1252, DOI 10.1152/jn.2001.86.3.1252; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yatani A, 2005, AM J PHYSIOL-HEART C, V288, pH650, DOI 10.1152/ajpheart.00268.2004; Zhang JH, 1997, MOL BRAIN RES, V47, P202, DOI 10.1016/S0169-328X(97)00051-X; ZHANG L, 1991, J PHYSIOL-LONDON, V444, P25, DOI 10.1113/jphysiol.1991.sp018864; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	73	59	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12486	10.1371/journal.pone.0012486	http://dx.doi.org/10.1371/journal.pone.0012486			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824214	Green Published, Green Submitted, gold			2022-12-25	WOS:000281405300013
J	Xiao, Y; Ye, Y; Zou, X; Jones, S; Yearsley, K; Shetuni, B; Tellez, J; Barsky, SH				Xiao, Y.; Ye, Y.; Zou, X.; Jones, S.; Yearsley, K.; Shetuni, B.; Tellez, J.; Barsky, S. H.			The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction	ONCOGENE			English	Article						inflammatory breast cancer; lymphovascular emboli; Notch 3 signaling; gamma-secretase inhibitors; Notch 3 siRNA; apoptosis	STEM-CELLS; IN-VITRO; E-CADHERIN; C-MYC; MAMMARY; EXPRESSION; GENE; ACTIVATION; PATHWAY; DIFFERENTIATION	Inflammatory breast carcinoma (IBC) is characterized by exaggerated lymphovascular invasion (LVI), recapitulated in our human xenograft, MARY-X. This model exhibited lymphovascular emboli in vivo and corresponding spheroids in vitro. Owing to the morphological and gene profile resemblance of these spheroids to embryonal blastocysts, we wondered whether they might exhibit embryonic stem cell signaling. Specifically we investigated Notch and observed selective Notch 3 activation by expression profiling, reverse transcriptase- and real-time PCR, western blot and immunofluorescence in vitro, and immunohistochemistry in vivo. Notch 3 intracellular domain (N3icd) and six target genes, HES-5, HEY-1, c-Myc, Deltex-1, NRARP and PBX1, markedly increased in MARY-X. In addition, a significant percentage of MARY-X cells expressed aldehyde dehydrogenase (ALDH), a stem cell marker. Only the ALDH(+) cells were capable of secondary spheroidgenesis, tumorigenicity and self-renewal. Inhibiting Notch 3 activation in vitro with gamma-secretase inhibitors (GSIs) or small interfering RNA resulted in a downregulation of Notch target genes, including CD133, and an induction of caspase 3-mediated apoptosis. Transfection of N3icd but not Notch 1 intracellular domain into normal human mammary epithelial cells resulted in increased expression of Notch target genes and induction of spheroidgenesis. GSI in vivo resulted in inhibitory but diffusion-limited effects on Notch 3 signaling, resulting in xenograft growth reduction. The lymphovascular emboli of human IBC exhibited dual N3icd and ALDH1 immunoreactivities independently of molecular subtype. This Notch 3 addiction of lymphovascular emboli might be exploited in future therapeutic strategies. Oncogene (2011) 30, 287-300; doi:10.1038/onc.2010.405; published online 13 September 2010	[Ye, Y.; Tellez, J.; Barsky, S. H.] Univ Nevada, Sch Med, Dept Pathol, Reno, NV 89557 USA; [Xiao, Y.; Zou, X.; Jones, S.; Yearsley, K.; Shetuni, B.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Barsky, S. H.] Nevada Canc Inst, Las Vegas, NV USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University System of Ohio; Ohio State University; University of California System; University of California San Diego	Barsky, SH (corresponding author), Univ Nevada, Sch Med, Dept Pathol, 1 Manville Med Bldg, Reno, NV 89557 USA.	sbarsky@medicine.nevada.edu	zou, Xianghong/E-4374-2011		American Airlines-Susan G Komen for the Cure [KGO81287]; Department of Defense [BC990959, BC024258, BC053405]; Strategic Initiative, at Ohio State; Donald A Senhauser Endowment; NATIONAL CANCER INSTITUTE [R01CA113579] Funding Source: NIH RePORTER	American Airlines-Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); Strategic Initiative, at Ohio State; Donald A Senhauser Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the American Airlines-Susan G Komen for the Cure Promise Grant KGO81287, Department of Defense Breast Cancer Research Program Grants BC990959, BC024258, BC053405, the Strategic Initiative Grant Program at Ohio State and The Donald A Senhauser Endowment. Figures 1a, b, c and 2e were, in part, reprinted from Am J Pathol 2008, 173: 561-574 with permission from the American Society For Investigative Pathology.	Alpaugh ML, 1999, CANCER RES, V59, P5079; Alpaugh ML, 2002, AM J PATHOL, V161, P619, DOI 10.1016/S0002-9440(10)64217-4; Alpaugh ML, 2002, HUM GENE THER, V13, P1245, DOI 10.1089/104303402320139023; Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Barsky SH, 2003, EXP MOL PATHOL, V74, P113, DOI 10.1016/S0014-4800(03)00011-X; Bellavia D, 2008, ONCOGENE, V27, P5092, DOI 10.1038/onc.2008.230; Bertucci F, 2005, CANCER RES, V65, P2170, DOI 10.1158/0008-5472.CAN-04-4115; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Cariati M, 2005, SURG ONCOL, V14, P133, DOI 10.1016/j.suronc.2005.07.004; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Giraldez AJ, 2002, MECH DEVELOP, V115, P101, DOI 10.1016/S0925-4773(02)00124-7; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krzywinski M, 2004, NUCLEIC ACIDS RES, V32, P3651, DOI 10.1093/nar/gkh700; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; PALANGIE T, 1994, EUR J CANCER, V30A, P921, DOI 10.1016/0959-8049(94)90115-5; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; POLITI K, 2006, SEMIN CANCER BIOL, V14, P341; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; RACHEL E, 2001, CURR BIOL, V11, P514; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; SHEILA K, 2004, NATURE, V432, P396; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sternlicht MD, 1996, IN VITRO CELL DEV-AN, V32, P550; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Tomlinson JS, 2001, CANCER RES, V61, P5231; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414	65	38	40	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					287	300		10.1038/onc.2010.405	http://dx.doi.org/10.1038/onc.2010.405			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20838375				2022-12-25	WOS:000286418800004
J	Song, B; Lai, BQ; Zheng, ZH; Zhang, YY; Luo, JY; Wang, C; Chen, YA; Woodgett, JR; Li, MT				Song, Bin; Lai, Bingquan; Zheng, Zhihao; Zhang, Yuying; Luo, Jingyan; Wang, Chong; Chen, Yuan; Woodgett, James R.; Li, Mingtao			Inhibitory Phosphorylation of GSK-3 by CaMKII Couples Depolarization to Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CEREBELLAR GRANULE NEURONS; DEPENDENT PROTEIN-KINASE; MYOCYTE ENHANCER FACTOR-2; NERVE GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; POTASSIUM DEPOLARIZATION; SUBSTRATE-SPECIFICITY; NEURITE-OUTGROWTH	Glycogen synthase kinase-3 (GSK-3) plays a critical role in neuronal apoptosis. The two mammalian isoforms of the kinase, GSK-3 alpha and GSK-3 beta, are inhibited by phosphorylation at Ser-21 and Ser-9, respectively. Depolarization, which is vital for neuronal survival, causes both an increase in Ser-21/9 phosphorylation and an inhibition of GSK-3 alpha/beta. However, the role of GSK-3 phosphorylation in depolarization-dependent neuron survival and the signaling pathway contributing to GSK-3 phosphorylation during depolarization remain largely unknown. Using several approaches, we showed that both isoforms of GSK-3 are important for mediating neuronal apoptosis. Non-phosphorylatable GSK-3 alpha/beta mutants (S21A/S9A) promoted apoptosis, whereas a peptide encompassing Ser-9 of GSK-3 beta protected neurons in a phosphorylation-dependent manner; these results indicate a critical role for Ser-21/9 phosphorylation on depolarization-dependent neuron survival. We found that Ser-21/9 phosphorylation of GSK-3 was mediated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) but not by Akt/PKB, PKA, or p90(RSK). CaMKII associated with and phosphorylated GSK-3 alpha/beta. Furthermore, the pro-survival effect of CaMKII was mediated by GSK-3 phosphorylation and inactivation. These findings identify a novel Ca2+/calmodulin/CaMKII/GSK-3 pathway that couples depolarization to neuronal survival.	[Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; [Song, Bin; Lai, Bingquan; Zheng, Zhihao; Zhang, Yuying; Luo, Jingyan; Wang, Chong; Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Song, Bin; Lai, Bingquan; Zheng, Zhihao; Zhang, Yuying; Luo, Jingyan; Wang, Chong; Chen, Yuan; Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Ctr Neurosci, Guangzhou 510080, Guangdong, Peoples R China; [Woodgett, James R.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X5, Canada	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Li, MT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	limt@mail.sysu.edu.cn	Woodgett, Jim/F-1087-2010; Chen, Yuan/D-1462-2011	Woodgett, Jim/0000-0003-3731-5797; Chen, Yuan/0000-0002-9412-4623; Zheng, Zhihao/0000-0001-9406-9073	National Natural Science Foundation of China [30870786, U0632006, 81030024]; Ministry of Science and Technology of China [2009ZX09103-043]; Natural Science Foundation of Guangdong Province China [9351008901000003]; National Basic Research Program of China (973 Program) [2011CB504105]; Canadian Institutes of Health [FRN 12858]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Guangdong Province China(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by National Natural Science Foundation of China Grants 30870786, U0632006 and 81030024, the Ministry of Science and Technology of China Grant 2009ZX09103-043, the Natural Science Foundation of Guangdong Province China Grant 9351008901000003, National Basic Research Program of China (973 Program) 2011CB504105, and the Canadian Institutes of Health Research Grant FRN 12858.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Borodinsky LN, 2002, J NEUROCHEM, V80, P1062, DOI 10.1046/j.1471-4159.2002.00795.x; Borsello T, 2000, NEUROSCIENCE, V95, P163; Bulleit RF, 2008, NEURON, V60, P401, DOI 10.1016/j.neuron.2008.10.024; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Erxleben C, 2006, P NATL ACAD SCI USA, V103, P3932, DOI 10.1073/pnas.0511322103; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLIRESTA L, 1993, J NEUROSCI, V13, P243; GALLO V, 1987, J NEUROSCI, V7, P2203; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Griffith LC, 2004, J NEUROSCI, V24, P8391, DOI 10.1523/JNEUROSCI.2888-04.2004; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; HACK N, 1993, NEUROSCIENCE, V57, P9, DOI 10.1016/0306-4522(93)90108-R; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Hetman M, 2000, J NEUROSCI, V20, P2567; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kumari S, 2001, MOL BRAIN RES, V96, P157, DOI 10.1016/S0006-8993(01)03045-1; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Miller TM, 1996, J NEUROSCI, V16, P7487; Miller TM, 1997, J BIOL CHEM, V272, P9847; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Shimoke K, 1999, DEV BRAIN RES, V112, P245, DOI 10.1016/S0165-3806(98)00172-2; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zhao Z, 2009, J NEUROSCI, V29, P1350, DOI 10.1523/JNEUROSCI.3770-08.2009; Zhong J, 2004, J NEUROSCI RES, V75, P794, DOI 10.1002/jnr.20024; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	82	62	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41122	41134		10.1074/jbc.M110.130351	http://dx.doi.org/10.1074/jbc.M110.130351			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20841359	Green Published, hybrid			2022-12-25	WOS:000285414400074
J	Launay, N; Tarze, A; Vicart, P; Lilienbaum, A				Launay, Nathalie; Tarze, Agathe; Vicart, Patrick; Lilienbaum, Alain			Serine 59 Phosphorylation of alpha B-Crystallin Down-regulates Its Anti-apoptotic Function by Binding and Sequestering Bcl-2 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SIGNALING PATHWAYS; HSP27; ACTIVATION; CASPASE-3; KINASE; DIFFERENTIATION; TRANSLOCATION; MITOCHONDRIA; EXPRESSION	The small heat shock protein (sHSP) alpha B-crystallin is a new oncoprotein in breast carcinoma that predicts poor clinical outcome in breast cancer. However, although several reports have demonstrated that phosphorylation of sHSPs modify their structural and functional properties, the significance of alpha B-crystallin phosphorylation in cancer cells has not yet been investigated. In this study, we have characterized the phosphorylation status of alpha B-crystallin in breast epithelial carcinoma cells line MCF7 submitted to anti-cancer agents like vinblastine. We have showed that the main phosphorylation site of alpha B-crystallin in response to vinblastine is serine 59 and determined a correlation between this post-translational modification and higher apoptosis level. The overexpression of the serine 59 "pseudophosphorylated" mutant (S59E) induces a significant increase in the apoptosis level of vinblastine-treated MCF7 cells. In contrast, overexpression of wild-type alpha B-crystallin or "nonphosphorylatable" mutant (S59A) result in a resistance to this microtubule-depolymerizing agent, while inhibition of endogenous levels of alpha B-crystallin by expression of shRNA lowers it. Analyzing further the molecular mechanism of this phenomenon, we report for the first time that phosphorylated alpha B-crystallin preferentially interacts with Bcl-2, an anti-apoptotic protein, and this interaction prevents the translocation of Bcl-2 to mitochondria. Hence, this study identifies serine 59 phosphorylation as an important key in the down-regulation of alpha B-crystallin antiapoptotic function in breast cancer and suggests new strategies to improve anti-cancer treatments.	[Lilienbaum, Alain] Univ Paris 07, BFA, Unite Biol Fonct & Adaptat BFA, EAC4413,CNRS,Lab Stress & Pathol Crytosquelette, F-75250 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Lilienbaum, A (corresponding author), Univ Paris 07, BFA, Unite Biol Fonct & Adaptat BFA, EAC4413,CNRS,Lab Stress & Pathol Crytosquelette, Case 7006,4 Rue MarieAndree Lagroua Weill Halle, F-75250 Paris 13, France.	alain.lilienbaum@univ-paris-diderot.fr	Tarze, Agathe/R-4379-2018; Launay, Nathalie/G-1387-2016	Tarze, Agathe/0000-0001-6101-069X; Launay, Nathalie/0000-0002-7498-217X	Association Francaise contre les Myopathies (AFM); Association pour la Recherche contre le Cancer (ARC)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by grants from Association Francaise contre les Myopathies (AFM) and Association pour la Recherche contre le Cancer (ARC).	Arrigo AP, 2005, J CELL BIOCHEM, V94, P241, DOI 10.1002/jcb.20349; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Casado P, 2007, CANCER LETT, V247, P273, DOI 10.1016/j.canlet.2006.05.005; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chelouche-Lev D, 2004, CANCER-AM CANCER SOC, V100, P2543, DOI 10.1002/cncr.20304; Dimberg A, 2008, BLOOD, V111, P2015, DOI 10.1182/blood-2007-04-087841; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Gruvberger-Saal SK, 2006, J CLIN INVEST, V116, P30, DOI 10.1172/JCI27462; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200; Inaguma Y, 2001, EUR J CELL BIOL, V80, P741, DOI 10.1078/0171-9335-00203; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; Jin JK, 2008, AM J PHYSIOL-HEART C, V294, pH337, DOI 10.1152/ajpheart.00881.2007; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kase S, 2009, ARCH OPHTHALMOL-CHIC, V127, P187, DOI 10.1001/archophthalmol.2008.580; Kato K, 1996, J BIOL CHEM, V271, P26989, DOI 10.1074/jbc.271.43.26989; Kruczynski A, 2001, CRIT REV ONCOL HEMAT, V40, P159, DOI 10.1016/S1040-8428(01)00183-4; Laudanski K, 2006, ARCH IMMUNOL THER EX, V54, P103, DOI 10.1007/s00005-006-0013-3; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Maddala R, 2005, EXP CELL RES, V306, P203, DOI 10.1016/j.yexcr.2005.01.026; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Takai S, 2007, LIFE SCI, V81, P585, DOI 10.1016/j.lfs.2007.06.018; Tan Q, 2009, HUM PATHOL, V40, P300, DOI 10.1016/j.humpath.2008.09.002; van den Ijssel PRLA, 1998, BIOCHEM BIOPH RES CO, V247, P518, DOI 10.1006/bbrc.1998.8699; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Watanabe G, 2009, CANCER SCI, V100, P2368, DOI 10.1111/j.1349-7006.2009.01316.x; Welsh MJ, 1998, ANN NY ACAD SCI, V851, P28, DOI 10.1111/j.1749-6632.1998.tb08973.x; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com	43	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37324	37332		10.1074/jbc.M110.124388	http://dx.doi.org/10.1074/jbc.M110.124388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20841355	Green Published, hybrid			2022-12-25	WOS:000284424000025
J	Xia, HP; Cheung, WKC; Sze, J; Lu, G; Jiang, SS; Yao, H; Bian, XW; Poon, WS; Kung, HF; Lin, MC				Xia, Hongping; Cheung, William K. C.; Sze, Johnny; Lu, Gang; Jiang, Songshan; Yao, Hong; Bian, Xiu-Wu; Poon, Wai Sang; Kung, Hsiang-fu; Lin, Marie C.			miR-200a Regulates Epithelial-Mesenchymal to Stem-like Transition via ZEB2 and beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; E-CADHERIN; NASOPHARYNGEAL CARCINOMA; REPRESSORS ZEB1; LUNG-CANCER; IDENTIFICATION; FAMILY; MICRORNAS; MARKER; INVASION	The emerging concept of generating cancer stem cells from epithelial-mesenchymal transition has attracted great interest; however, the factors and molecular mechanisms that govern this putative tumor-initiating process remain largely elusive. We report here that miR-200a not only regulates epithelial-mesenchymal transition but also stem-like transition in nasopharyngeal carcinoma cells. We first showed that stable knockdown of miR-200a promotes the transition of epithelium-like CNE-1 cells to the mesenchymal phenotype. More importantly, it also induced several stem cell-like traits, including CD133(+) side population, sphere formation capacity, in vivo tumorigenicity in nude mice, and stem cell marker expression. Consistently, stable overexpression of miR-200a switched mesenchyme-like C666-1 cells to the epithelial state, accompanied by a significant reduction of stem-like cell features. Furthermore, in vitro differentiation of the C666-1 tumor sphere resulted in diminished stem-like cell population and miR-200a induction. To investigate the molecular mechanism, we demonstrated that miR-200a controls epithelial-mesenchymal transition by targeting ZEB2, although it regulates the stem-like transition differentially and specifically by beta-catenin signaling. Our findings reveal for the first time the function of miR-200a in shifting nasopharyngeal carcinoma cell states via a reversible process coined as epithelial-mesenchymal to stem-like transition through differential and specific mechanisms.	[Xia, Hongping; Lu, Gang; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Brain Tumour Ctr, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Xia, Hongping; Lu, Gang; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Div Neurosurg, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lin, Marie C.] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Lab Integrated Biosci, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Hong; Bian, Xiu-Wu] Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Yao, Hong; Bian, Xiu-Wu] Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Sun Yat Sen University; Army Medical University; Army Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong	Lin, MC (corresponding author), Chinese Univ Hong Kong, Brain Tumour Ctr, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	mcllin@surgery.cuhk.edu.hk	XIA, HONGPING/AAK-7100-2020; Poon, Wai S/HGD-3084-2022; Bian, Xiuwu/F-1569-2011; Poon, Wai Sang/F-1558-2011; Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; LU, Gang/0000-0001-5921-1839	Research Grants Council of Hong Kong [467109]; National Basic Research Program of China (973 Program) [2010CB529400, 2010CB912800]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Research Grants Council of Hong Kong Grant 467109 and National Basic Research Program of China (973 Program) Grants 2010CB529400 and 2010CB912800.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Visus C, 2007, CANCER RES, V67, P10538, DOI 10.1158/0008-5472.CAN-07-1346; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Zhang QZ, 2010, CANCER LETT, V289, P151, DOI 10.1016/j.canlet.2009.08.010; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	51	88	96	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36995	37004		10.1074/jbc.M110.133744	http://dx.doi.org/10.1074/jbc.M110.133744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20826811	Green Published, hybrid			2022-12-25	WOS:000284146100016
J	Anthony, CS; Corradi, HR; Schwager, SLU; Redelinghuys, P; Georgiadis, D; Dive, V; Acharya, KR; Sturrock, ED				Anthony, Colin S.; Corradi, Hazel R.; Schwager, Sylva L. U.; Redelinghuys, Pierre; Georgiadis, Dimitris; Dive, Vincent; Acharya, K. Ravi; Sturrock, Edward D.			The N Domain of Human Angiotensin-I-converting Enzyme THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASP-LYS-PRO; INHIBITOR; MODEL; PEPTIDE; SITES; ASSAY; ACE	Angiotensin-I-converting enzyme (ACE) plays a critical role in the regulation of blood pressure through its central role in the renin-angiotensin and kallikrein-kinin systems. ACE contains two domains, the N and C domains, both of which are heavily glycosylated. Structural studies of ACE have been fraught with severe difficulties because of surface glycosylation of the protein. In order to investigate the role of glycosylation in the N domain and to create suitable forms for crystallization, we have investigated the importance of the 10 potential N-linked glycan sites using enzymatic deglycosylation, limited proteolysis, and mass spectrometry. A number of glycosylation mutants were generated via site-directed mutagenesis, expressed in CHO cells, and analyzed for enzymatic activity and thermal stability. At least eight of 10 of the potential glycan sites are glycosylated; three C-terminal sites were sufficient for expression of active N domain, whereas two N-terminal sites are important for its thermal stability. The minimally glycosylated Ndom389 construct was highly suitable for crystallization studies. The structure in the presence of an N domain-selective phosphinic inhibitor RXP407 was determined to 2.0 angstrom resolution. The Ndom389 structure revealed a hinge region that may contribute to the breathing motion proposed for substrate binding.	[Corradi, Hazel R.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Sturrock, Edward D.] Univ Cape Town, Div Med Biochem, Inst Infect Dis & Mol Med, ZA-7925 Observatory, South Africa; [Redelinghuys, Pierre] Univ Aberdeen, Inst Med Sci, Sect Infect & Immunol, Aberdeen AB25 2ZD, Scotland; [Georgiadis, Dimitris] Univ Athens, Dept Chem, Organ Chem Lab, Athens 15771, Greece; [Dive, Vincent] CEA, iBiTecS, SIMOPRO, F-91191 Gif Sur Yvette, France	University of Bath; University of Cape Town; University of Aberdeen; National & Kapodistrian University of Athens; CEA; UDICE-French Research Universities; Universite Paris Saclay	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk; Edward.Sturrock@uct.ac.za	Georgiadis, Dimitris/AAB-1550-2020	Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust (United Kingdom) [070060]; National Research Foundation of South Africa; Ernst and Ethel Erikson Trust; Deutscher Austauschdienst; University of Cape Town; Medical Research Council (United Kingdom) [81272]; Royal Society (United Kingdom); MRC [G0601973] Funding Source: UKRI; Medical Research Council [G0601973] Funding Source: researchfish	Wellcome Trust (United Kingdom)(Wellcome Trust); National Research Foundation of South Africa(National Research Foundation - South Africa); Ernst and Ethel Erikson Trust; Deutscher Austauschdienst; University of Cape Town; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society (United Kingdom)(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (United Kingdom) through Senior International Research Fellowship 070060, the National Research Foundation of South Africa, the Ernst and Ethel Erikson Trust, the Deutscher Austauschdienst, and the University of Cape Town (to E. D. S.). This work was also supported by Medical Research Council (United Kingdom) Grant 81272 and a Royal Society (United Kingdom) Industry Fellowship (to K. R. A.).	Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEDDISH PA, 1994, P NATL ACAD SCI USA, V91, P7807, DOI 10.1073/pnas.91.16.7807; Dive V, 1999, P NATL ACAD SCI USA, V96, P4330, DOI 10.1073/pnas.96.8.4330; Ehlers M R, 1991, Protein Expr Purif, V2, P1, DOI 10.1016/1046-5928(91)90001-Y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Junot C, 2001, J PHARMACOL EXP THER, V297, P606; Kost OA, 2003, BIOCHEMISTRY-US, V42, P6965, DOI 10.1021/bi034645y; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroger WL, 2009, BIOCHEMISTRY-US, V48, P8405, DOI 10.1021/bi9011226; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill HG, 2008, BIOL CHEM, V389, P1153, DOI 10.1515/BC.2008.131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Peng HM, 2007, HYPERTENSION, V49, P695, DOI 10.1161/01.HYP.0000258406.66954.4f; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sadhukhan R, 1996, J BIOL CHEM, V271, P6429, DOI 10.1074/jbc.271.11.6429; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwager SL, 2006, NAT PROTOC, V1, P1961, DOI 10.1038/nprot.2006.305; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Voronov S, 2002, FEBS LETT, V522, P77, DOI 10.1016/S0014-5793(02)02888-0; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	37	59	60	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35685	35693		10.1074/jbc.M110.167866	http://dx.doi.org/10.1074/jbc.M110.167866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826823	Green Published, hybrid			2022-12-25	WOS:000283845300047
J	Golubkov, VS; Chekanov, AV; Cieplak, P; Aleshin, AE; Chernov, AV; Zhu, WH; Radichev, IA; Zhang, DH; Dong, PD; Strongin, AY				Golubkov, Vladislav S.; Chekanov, Alexei V.; Cieplak, Piotr; Aleshin, Alexander E.; Chernov, Andrei V.; Zhu, Wenhong; Radichev, Ilian A.; Zhang, Danhua; Dong, P. Duc; Strongin, Alex Y.			The Wnt/Planar Cell Polarity Protein-tyrosine Kinase-7 (PTK7) Is a Highly Efficient Proteolytic Target of Membrane Type-1 Matrix Metalloproteinase IMPLICATIONS IN CANCER AND EMBRYOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-MATRIX METALLOPROTEINASE; EXTENSION MOVEMENTS; ACTS DOWNSTREAM; RHO-KINASE; OFF-TRACK; MT1-MMP; CD44; ZEBRAFISH; INVASION; CONVERGENCE	PTK7 is an essential component of the Wnt/planar cell polarity (PCP) pathway. We provide evidence that the Wnt/PCP pathway converges with pericellular proteolysis in both normal development and cancer. Here, we demonstrate that membrane type-1 matrix metalloproteinase (MT1-MMP), a key proinvasive proteinase, functions as a principal sheddase of PTK7. MT1-MMP directly cleaves the exposed PKP621 down arrow LI sequence of the seventh Ig-like domain of the full-length membrane PTK7 and generates, as a result, an N-terminal, soluble PTK7 fragment (sPTK7). The enforced expression of membrane PTK7 in cancer cells leads to the actin cytoskeleton reorganization and the inhibition of cell invasion. MT1-MMP silencing and the analysis of the uncleavable L622D PTK7 mutant confirm the significance of MT1-MMP proteolysis of PTK7 in cell functions. Our data also demonstrate that a fine balance between the metalloproteinase activity and PTK7 levels is required for normal development of zebrafish (Danio rerio). Aberration of this balance by the proteinase inhibition or PTK7 silencing results in the PCP-dependent convergent extension defects in the zebrafish. Overall, our data suggest that the MT1-MMP-PTK7 axis plays an important role in both cancer cell invasion and normal embryogenesis in vertebrates. Further insight into these novel mechanisms may promote understanding of directional cell motility and lead to the identification of therapeutics to treat PCP-related developmental disorders and malignancy.	[Golubkov, Vladislav S.; Chekanov, Alexei V.; Cieplak, Piotr; Aleshin, Alexander E.; Chernov, Andrei V.; Zhu, Wenhong; Radichev, Ilian A.; Zhang, Danhua; Dong, P. Duc; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@burnham.org	Chernov, Andrei/I-1623-2019; Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016; 	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A.Y.S.).	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cantrell VA, 2010, CANCER LETT, V287, P54, DOI 10.1016/j.canlet.2009.05.041; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003; Grassot J, 2006, MOL BIOL EVOL, V23, P1232, DOI 10.1093/molbev/msk007; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hirayama K, 2004, INVEST OPHTH VIS SCI, V45, pU480; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Jung JW, 2004, GENE, V328, P75, DOI 10.1016/j.gene.2003.12.006; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Katoh M, 2005, ONCOL REP, V14, P1583; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Murai S, 2004, VIRCHOWS ARCH, V445, P271, DOI 10.1007/s00428-004-1029-x; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Park SK, 1996, J BIOCHEM, V119, P235; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Roghi C, 2010, FEBS J, V277, P3158, DOI 10.1111/j.1742-4658.2010.07723.x; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tada M, 2009, ZEBRAFISH, V6, P29, DOI 10.1089/zeb.2008.0566; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	80	63	69	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35740	35749		10.1074/jbc.M110.165159	http://dx.doi.org/10.1074/jbc.M110.165159			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837484	hybrid, Green Published			2022-12-25	WOS:000283845300052
J	Gupta, SC; Prasad, S; Reuter, S; Kannappan, R; Yadav, VR; Ravindran, J; Hema, PS; Chaturvedi, MM; Nair, M; Aggarwal, BB				Gupta, Subash C.; Prasad, Sahdeo; Reuter, Simone; Kannappan, Ramaswamy; Yadav, Vivek R.; Ravindran, Jayaraj; Hema, Padmanabhan S.; Chaturvedi, Madan M.; Nair, Mangalam; Aggarwal, Bharat B.			Modification of Cysteine 179 of I kappa B alpha Kinase by Nimbolide Leads to Down-regulation of NF-kappa B-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEEM LIMONOIDS AZADIRACHTIN; GENE-EXPRESSION; DIRECT INHIBITION; ACTIVATION; APOPTOSIS; SUPPRESSION; INVASION; PRODUCTS; BETA; P65	Reverse pharmacology, also called the "bedside to bench" approach, that deals with new uses for a well known molecular entity has been used extensively in cancer drug development to identify novel compounds and delineate their mechanisms of action. Here, we show that nimbolide, a triterpenoid isolated from Azadirachta indica, enhanced the apoptosis induced by inflammatory cytokines and chemotherapeutic agents in tumor cells. This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappa B. Nimbolide inhibited the activation of NF-kappa B induced by carcinogens and inflammatory stimuli. Constitutively active NF-kappa B found in most tumor cells was also inhibited. We found that suppression of NF-kappa B activation by nimbolide was caused by inhibition of I kappa B kinase (IKK), which led to suppression of I kappa B alpha phosphorylation and degradation, nuclear translocation, DNA binding, and gene transcription. Reducing agent reversed the action of the limonoid, suggesting the involvement of a cysteine residue. Replacement of Cys(179) of IKK-beta with alanine abolished the effect of nimbolide, suggesting that Cys(179) plays a critical role in inhibiting the NF-kappa B activation. Overall, our results indicate that nimbolide can sensitize tumor cells to chemotherapeutic agents through interaction with IKK, leading to inhibition of NF-kappa B-regulated proteins.	[Gupta, Subash C.; Prasad, Sahdeo; Reuter, Simone; Kannappan, Ramaswamy; Yadav, Vivek R.; Ravindran, Jayaraj; Chaturvedi, Madan M.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA; [Hema, Padmanabhan S.; Nair, Mangalam] CSIR, Natl Inst Interdisciplinary Sci & Technol, Organ Chem Sect, Trivandrum 695019, Kerala, India	University of Texas System; UTMD Anderson Cancer Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013; Gupta, Subash/AAF-2563-2019	Gupta, Subash/0000-0002-0418-1940	National Institutes of Health [CA-16672]; Clayton Foundation for Research; Center for Targeted Therapy of MD Anderson Cancer Center;  [CA-124787-01A2]; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Center for Targeted Therapy of MD Anderson Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Core Grant CA-16672 and Program Project Grant CA-124787-01A2. This work was also supported by a grant from the Clayton Foundation for Research (to B. B. A.) and a grant from the Center for Targeted Therapy of MD Anderson Cancer Center. Downloaded from www.jbc.org at ISI, Thomson Scientific, on November 7, 2010	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Ahn KS, 2007, BLOOD, V110, P2286, DOI 10.1182/blood-2007-04-084996; Anitha G, 2006, J ASIAN NAT PROD RES, V8, P445, DOI 10.1080/10286020500173267; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Bose D, 2010, LANCET ONCOL, V11, P373, DOI 10.1016/S1470-2045(09)70341-9; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cohen E, 1996, LIFE SCI, V58, P1075, DOI 10.1016/0024-3205(96)00061-6; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; EKONG DEU, 1967, CHEM COMMUN, P808; GUPTA SC, 2010, BIOCH BIOPHYS ACTA; Ha KH, 2009, BIOCHEMISTRY-US, V48, P7271, DOI 10.1021/bi900660f; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; KIGODI PGK, 1989, J NAT PROD, V52, P1246, DOI 10.1021/np50066a008; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Kumar GH, 2009, INVEST NEW DRUG, V27, P246, DOI 10.1007/s10637-008-9170-z; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Nair MS, 1997, PHYTOCHEMISTRY, V46, P1177, DOI 10.1016/S0031-9422(97)80006-4; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200; Park MH, 2005, BIOCHEMISTRY-US, V44, P8326, DOI 10.1021/bi050156h; PEZZUTO JM, 1986, NEW TRENDS NATURAL P, V26, P371; Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; ROCHANAKIJ S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P66; ROJANPO W, 1985, SCI SOC THAILAND, V11, P177; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roy MK, 2007, PHYTOTHER RES, V21, P245, DOI 10.1002/ptr.2058; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sartore-Bianchi A, 2007, INT J BIOL MARKER, V22, pS77, DOI 10.5301/JBM.2008.4310; Sastry BS, 2006, BIOORG MED CHEM LETT, V16, P4391, DOI 10.1016/j.bmcl.2006.05.105; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Siddiqui S, 1942, CURR SCI, V11, P278; Singh S, 2007, CELL, V130, P765, DOI 10.1016/j.cell.2007.08.024; Subapriya R., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P149, DOI 10.2174/1568011053174828; Suresh G, 2002, J AGR FOOD CHEM, V50, P4484, DOI 10.1021/jf025534t; Takada Y, 2004, J BIOL CHEM, V279, P26287, DOI 10.1074/jbc.M400963200; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	50	81	84	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35406	35417		10.1074/jbc.M110.161984	http://dx.doi.org/10.1074/jbc.M110.161984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829362	Green Published, hybrid			2022-12-25	WOS:000283845300018
J	Khandelwal, S; Roche, PA				Khandelwal, Sanjay; Roche, Paul A.			Distinct MHC Class II Molecules Are Associated on the Dendritic Cell Surface in Cholesterol-dependent Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; PEPTIDE COMPLEXES; PLASMA-MEMBRANE; TETRASPANIN PROTEINS; ANTIGEN PRESENTATION; T-CELLS; ACTIVATION; CD81; PALMITOYLATION; TRANSPORT	Very small amounts of MHC class II-peptide complexes expressed on the surface of antigen-presenting cells (APCs) are capable of stimulating antigen-specific CD4 T cells. There is intense interest to elucidate the molecular mechanisms by which these small amounts of MHC-II can cluster, cross-link T cell receptors, and promote T cell proliferation. We now demonstrate that a significant fraction of the total pool of MHC-II molecules on the surface of dendritic cells is physically associated in macromolecular aggregates. These MHC-II/MHC-II interactions have been probed by co-immunoprecipitation analysis of the MHC-II I-A molecule with the related I-E molecule. These molecular associations are maintained in gentle detergents but are disrupted in harsh detergents such as Triton X-100. MHC-II I-A/I-E interactions are disrupted when plasma membrane cholesterol is extracted using methyl beta-cyclodextrin, suggesting that lipid raft microdomains are important mediators of these MHC-II interactions. Although it has been proposed that tetraspanin proteins regulate molecular clustering, aggregation, and co-immunoprecipitation in APCs, genetic deletion of the tetraspanin family members CD9 or CD81 had no effect on MHC-II I-A/I-E binding. These data demonstrate that the presence of distinct forms of MHC-II with plasma membrane lipid rafts is required for MHC-II aggregation in APCs and provides a molecular mechanism allowing dendritic cells expressing small amounts of MHC-II-peptide complexes to cross-link and stimulate CD4 T cells.	[Khandelwal, Sanjay; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Rm 4B36,Bldg 10, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cherukuri A, 2004, J BIOL CHEM, V279, P31973, DOI 10.1074/jbc.M404410200; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127; Eren E, 2006, SCAND J IMMUNOL, V63, P7, DOI 10.1111/j.1365-3083.2006.01700.x; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Hammond C, 1998, J IMMUNOL, V161, P3282; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jenei A, 1997, P NATL ACAD SCI USA, V94, P7269, DOI 10.1073/pnas.94.14.7269; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maecker HT, 2000, HYBRIDOMA, V19, P15, DOI 10.1089/027245700315752; Melkonian KA, 1995, BIOCHEMISTRY-US, V34, P16161, DOI 10.1021/bi00049a031; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; Poloso NJ, 2006, J IMMUNOL, V177, P5451, DOI 10.4049/jimmunol.177.8.5451; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; Setterblad N, 2003, J LEUKOCYTE BIOL, V74, P40, DOI 10.1189/jlb.0103045; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tai XG, 1997, J IMMUNOL, V159, P3799; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; Witherden DA, 2000, J IMMUNOL, V165, P1902, DOI 10.4049/jimmunol.165.4.1902; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094	50	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35303	35310		10.1074/jbc.M110.147793	http://dx.doi.org/10.1074/jbc.M110.147793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833718	Green Published, hybrid			2022-12-25	WOS:000283845300008
J	Maier, PJ; Marin, I; Grampp, T; Sommer, A; Benke, D				Maier, Patrick J.; Marin, Isabel; Grampp, Thomas; Sommer, Andrea; Benke, Dietmar			Sustained Glutamate Receptor Activation Down-regulates GABA(B) Receptors by Shifting the Balance from Recycling to Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RECEPTOR; SUBCELLULAR-LOCALIZATION; RAT HIPPOCAMPUS; ION CHANNELS; NEURONS; SYNAPSES; SUBUNITS; TRANSMISSION; INHIBITION; DEPRESSION	Metabotropic GABA(B) receptors are abundantly expressed at glutamatergic synapses where they control excitability of the synapse. Here, we tested the hypothesis that glutamatergic neurotransmission may regulate GABA(B) receptors. We found that application of glutamate to cultured cortical neurons led to rapid down-regulation of GABA(B) receptors via lysosomal degradation. This effect was mimicked by selective activation of AMPA receptors and further accelerated by coactivation of group I metabotropic glutamate receptors. Inhibition of NMDA receptors, blockade of L-type Ca2+ channels, and removal of extracellular Ca2+ prevented glutamate-induced down-regulation of GABA(B) receptors, indicating that Ca2+ influx plays a critical role. We further established that glutamate-induced down-regulation depends on the internalization of GABA(B) receptors. Glutamate did not affect the rate of GABA(B) receptor endocytosis but led to reduced recycling of the receptors back to the plasma membrane. Blockade of lysosomal activity rescued receptor recycling, indicating that glutamate redirects GABA(B) receptors from the recycling to the degradation pathway. In conclusion, the data indicate that sustained activation of AMPA receptors down-regulates GABA(B) receptors by sorting endocytosed GABA(B) receptors preferentially to lysosomes for degradation on the expense of recycling. This mechanism may relieve glutamatergic synapses from GABA(B) receptor-mediated inhibition resulting in increased synaptic excitability.	[Maier, Patrick J.; Marin, Isabel; Grampp, Thomas; Sommer, Andrea; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch			Swiss Science Foundation [31003A_121963]	Swiss Science Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss Science Foundation Grant 31003A_121963.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BENKE D, 1991, J RECEPTOR RES, V11, P407, DOI 10.3109/10799899109066418; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chen L, 2004, J COMP NEUROL, V474, P340, DOI 10.1002/cne.20143; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kulik A, 2003, J NEUROSCI, V23, P11026; Lacey CJ, 2005, NEUROSCIENCE, V136, P1083, DOI 10.1016/j.neuroscience.2005.07.013; Lujan R, 2004, J COMP NEUROL, V475, P36, DOI 10.1002/cne.20160; MORRISETT RA, 1991, J NEUROSCI, V11, P203; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pan BX, 2009, NEURON, V61, P917, DOI 10.1016/j.neuron.2009.01.029; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Ziakopoulos Z, 2000, EUR J NEUROSCI, V12, P803, DOI 10.1046/j.1460-9568.2000.00965.x	29	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35606	35614		10.1074/jbc.M110.142406	http://dx.doi.org/10.1074/jbc.M110.142406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826795	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000283845300039
J	Williams, TL; Levy, DL; Maki-Yonekura, S; Yonekura, K; Blackburn, EH				Williams, Tanya L.; Levy, Daniel L.; Maki-Yonekura, Saori; Yonekura, Koji; Blackburn, Elizabeth H.			Characterization of the Yeast Telomere Nucleoprotein Core Rap1 BINDS INDEPENDENTLY TO EACH RECOGNITION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN RAP1; SACCHAROMYCES-CEREVISIAE; LENGTH REGULATION; CHROMATIN STRUCTURE; FISSION YEAST; DNA; COMPLEX; TRF1; ASSOCIATION; ELONGATION	At the core of Saccharomyces cerevisiae telomeres is an array of tandem telomeric DNA repeats bound site-specifically by multiple Rap1 molecules. There, Rap1 orchestrates the binding of additional telomere-associated proteins and negatively regulates both telomere fusion and length homeostasis. Using electron microscopy, viscosity, and light scattering measurements, we show that purified Rap1 is a monomer in solution that adopts a ringlike or C shape with a central cavity. Rap1 could orchestrate telomere function by binding multiple telomere array sites through either cooperative or independent mechanisms. To determine the mechanism, we analyze the distribution of Rap1 monomers on defined telomeric DNA arrays. This analysis clearly indicates that Rap1 binds independently to each non-overlapping site in an array, regardless of the spacing between sites, the total number of sites, the affinity of the sites for Rap1, and over a large concentration range. Previous experiments have not clearly separated the effects of affinity from repeat spacing on telomere function. We clarify these results by testing in vivo the function of defined telomere arrays containing the same Rap1 binding site separated by spacings that were previously defined as low or high activity. We find that Rap1 binding affinity in vitro correlates with the ability of telomeric repeat arrays to regulate telomere length in vivo. We suggest that Rap1 binding to multiple sites in a telomere array does not, by itself, promote formation of a more energetically stabile complex.	[Williams, Tanya L.; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Levy, Daniel L.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Maki-Yonekura, Saori] RIKEN SPring 8 Ctr, Harima Inst, Prot Crystallog Res Grp, Sayo, Hyogo 6795148, Japan; [Yonekura, Koji] RIKEN SPring 8 Ctr, Harima Inst, Biostruct Mech Lab, Sayo, Hyogo 6795148, Japan	University of California System; University of California San Francisco; University of California System; University of California Berkeley; RIKEN; RIKEN	Blackburn, EH (corresponding author), 600 16th St,S312F, San Francisco, CA 94158 USA.	elizabeth.blackburn@ucsf.edu	Levy, Daniel/AAA-7205-2019; YONEKURA, Koji/N-5060-2015	Levy, Daniel/0000-0002-7853-3275; 	National Research Service Award; Howard Hughes Medical Institute	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by a postdoctoral National Research Service Award fellowship.; Supported by a predoctoral fellowship from the Howard Hughes Medical Institute.	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bianchi A, 2007, GENE DEV, V21, P1726, DOI 10.1101/gad.438907; BJORK I, 1973, EUR J BIOCHEM, V36, P178, DOI 10.1111/j.1432-1033.1973.tb02899.x; BLACKBURN EH, 1981, P NATL ACAD SCI-BIOL, V78, P2263, DOI 10.1073/pnas.78.4.2263; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P849; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Feeser EA, 2008, J MOL BIOL, V380, P520, DOI 10.1016/j.jmb.2008.04.078; FERSHT A, 1999, STRUCTURE MECH PROTE, P140; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; Grossi S, 2001, MOL CELL BIOL, V21, P8117, DOI 10.1128/MCB.21.23.8117-8128.2001; HAMMERSTEDT RH, 1971, J BIOL CHEM, V246, P2069; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; KHAN MY, 1990, J BIOSCIENCE, V15, P361; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Moser BA, 2009, BIOCHEM CELL BIOL, V87, P747, DOI 10.1139/O09-037; MULLER T, 1994, J STRUCT BIOL, V113, P1, DOI 10.1006/jsbi.1994.1027; Negrini S, 2007, GENE DEV, V21, P292, DOI 10.1101/gad.400907; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Ray A, 1999, MOL CELL BIOL, V19, P31; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VIGNAIS ML, 1987, EMBO J, V6, P1451, DOI 10.1002/j.1460-2075.1987.tb02386.x; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197	59	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35814	35824		10.1074/jbc.M110.170167	http://dx.doi.org/10.1074/jbc.M110.170167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826803	Green Published, hybrid			2022-12-25	WOS:000283845300059
J	Salaun, C; Leroy, C; Rousseau, A; Boitez, V; Beck, L; Friedlander, G				Salauen, Christine; Leroy, Christine; Rousseau, Alice; Boitez, Valerie; Beck, Laurent; Friedlander, Gerard			Identification of a Novel Transport-independent Function of PiT1/SLC20A1 in the Regulation of TNF-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; APE LEUKEMIA-VIRUS; INDUCED CELL-DEATH; ALPHA-INDUCED APOPTOSIS; JNK ACTIVATION; SIGNAL-TRANSDUCTION; CANCER DEVELOPMENT; SURFACE-RECEPTORS; NA+/K+-ATPASE	PiT1/SLC20A1 is a sodium-dependent Pi transporter expressed by most mammalian cells. Interestingly, PiT1 transcription has been shown to be up-regulated by the tumor necrosis factor alpha (TNF), and we have now investigated the possible involvement of PiT1 in TNF-induced apoptosis. We show that PiT1-depleted cells are more sensitive to the proapoptotic activity of TNF (i.e. when the antiapoptotic NF kappa B pathway is inactivated). These observations were made in the human HeLa cancer cell line either transiently or stably depleted in PiT1 by RNA interference and in immortalized mouse embryonic fibroblasts isolated from PiT1 knock-out embryos. Depletion of the closely related family member PiT2 had no effect on TNF-induced apoptosis, showing that this effect was specific to PiT1. The increased sensitivity of PiT1-depleted cells was evident regardless of the presence or absence of extracellular Pi, suggesting that a defect in Pi uptake was not involved in the observed phenotype. Importantly, we show that the re-expression of a Pi uptake mutant of PiT1 in PiT1(-/-) mouse embryonic fibroblasts delays apoptosis as efficiently as the WT protein, showing that this function of PiT1 is unrelated to its transport activity. Caspase-8 is more activated in PiT1-depleted cells, and our data reveal that the sustained activation of the MAPK JNK is up-regulated in response to TNF. JNK activity is actually involved in PiT1-depleted cell death because specific JNK inhibitors delay apoptosis.	[Salauen, Christine] Univ Paris 05, Fac Med, INSERM, Ctr Rech,U845, F-75015 Paris, France; INSERM, Growth & Signaling Res Ctr, U845, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salaun, C (corresponding author), Univ Paris 05, Fac Med, INSERM, Ctr Rech,U845, 156 Rue Vaugirard, F-75015 Paris, France.	christine.salaun@inserm.fr	BECK, Laurent/P-2952-2014	BECK, Laurent/0000-0002-6730-2762; Friedlander, Gerard/0000-0002-6854-4261; Salaun, Christine/0000-0003-3002-6810	INSERM; Universite Paris Descartes; Association Laboratoires de Recherches Physiologiques	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Association Laboratoires de Recherches Physiologiques	This study was supported by grants from INSERM, the Universite Paris Descartes, and the Association Laboratoires de Recherches Physiologiques.	Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BLESA JM, 2008, CANC THER, V6, P923; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Festing MH, 2009, GENESIS, V47, P858, DOI 10.1002/dvg.20577; Horn Z, 2010, EUR J NEUROSCI, V31, P2142, DOI 10.1111/j.1460-9568.2010.07258.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin AN, 2006, DEV CELL, V10, P277, DOI 10.1016/j.devcel.2006.02.006; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nagy A., 2003, MANIPULATING MOUSE E; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; PINC ON, 1991, Dev Biol */* D DEV B, V148, P517; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Ruaud AF, 2007, DEVELOPMENT, V134, P867, DOI 10.1242/dev.02790; Sabatino DE, 1997, BLOOD CELL MOL DIS, V23, P422, DOI 10.1006/bcmd.1997.0161; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SALAU NC, 2004, J M J MOL BIOL */* J, V340, P39; Salaun C, 2002, J VIROL, V76, P4304, DOI 10.1128/JVI.76.9.4304-4311.2002; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walters ZS, 2009, J PHYSIOL-LONDON, V587, P521, DOI 10.1113/jphysiol.2008.161562; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010	66	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34408	34418		10.1074/jbc.M110.130989	http://dx.doi.org/10.1074/jbc.M110.130989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817733	Green Published, hybrid			2022-12-25	WOS:000283659100015
J	Nguyen, LT; Chau, JK; Perry, NA; de Boer, L; Zaat, SAJ; Vogel, HJ				Nguyen, Leonard T.; Chau, Johnny K.; Perry, Nicole A.; de Boer, Leonie; Zaat, Sebastian A. J.; Vogel, Hans J.			Serum Stabilities of Short Tryptophan-and Arginine-Rich Antimicrobial Peptide Analogs	PLOS ONE			English	Article							MODEL MEMBRANE INTERACTIONS; STRUCTURE-BASED DESIGN; ANTIBACTERIAL PEPTIDES; IN-VITRO; LACTOFERRICIN; CYCLIZATION; MICELLES; HEXAPEPTIDES; INFECTION; MECHANISM	Background: Several short antimicrobial peptides that are rich in tryptophan and arginine residues were designed with a series of simple modifications such as end capping and cyclization. The two sets of hexapeptides are based on the Trp- and Arg-rich primary sequences from the "antimicrobial centre" of bovine lactoferricin as well as an antimicrobial sequence obtained through the screening of a hexapeptide combinatorial library. Methodology/Principal Findings: HPLC, mass spectrometry and antimicrobial assays were carried out to explore the consequences of the modifications on the serum stability and microbicidal activity of the peptides. The results show that C-terminal amidation increases the antimicrobial activity but that it makes little difference to its proteolytic degradation in human serum. On the other hand, N-terminal acetylation decreases the peptide activities but significantly increases their protease resistance. Peptide cyclization of the hexameric peptides was found to be highly effective for both serum stability and antimicrobial activity. However the two cyclization strategies employed have different effects, with disulfide cyclization resulting in more active peptides while backbone cyclization results in more proteolytically stable peptides. However, the benefit of backbone cyclization did not extend to longer 11-mer peptides derived from the same region of lactoferricin. Mass spectrometry data support the serum stability assay results and allowed us to determine preferred proteolysis sites in the peptides. Furthermore, isothermal titration calorimetry experiments showed that the peptides all had weak interactions with albumin, the most abundant protein in human serum. Conclusions/Significance: Taken together, the results provide insight into the behavior of the peptides in human serum and will therefore aid in advancing antimicrobial peptide design towards systemic applications.	[Nguyen, Leonard T.; Chau, Johnny K.; Perry, Nicole A.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [de Boer, Leonie; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	University of Calgary; University of Amsterdam; Academic Medical Center Amsterdam	Nguyen, LT (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca		Lieberman, Nicole/0000-0001-9334-8150	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Operating support was provided by a grant of the "Novel alternatives to antibiotics" program of the Canadian Institutes for Health Research. (http://www.cihr-irsc.gc.ca/e/193.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelt C, 2005, CHEMBIOCHEM, V6, P1654, DOI 10.1002/cbic.200500095; Blondelle SE, 1996, TRENDS BIOTECHNOL, V14, P60, DOI 10.1016/0167-7799(96)80922-X; Boulanger N, 2006, TRENDS PARASITOL, V22, P262, DOI 10.1016/j.pt.2006.04.003; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brewer D, 2002, BIOCHEMISTRY-US, V41, P5526, DOI 10.1021/bi015926d; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Cudic M, 2002, PEPTIDES, V23, P2071, DOI 10.1016/S0196-9781(02)00244-9; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Deslouches B, 2007, J ANTIMICROB CHEMOTH, V60, P669, DOI 10.1093/jac/dkm253; Cabrera MPDS, 2008, J PEPT SCI, V14, P661, DOI 10.1002/psc.960; Epand RM, 2008, DRUG NEWS PERSPECT, V21, P307, DOI 10.1358/dnp.2008.21.6.1246829; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hoek KS, 1997, ANTIMICROB AGENTS CH, V41, P54, DOI 10.1128/AAC.41.1.54; Huther A, 2007, AIDS REV, V9, P208; Hunter HN, 2005, BBA-BIOMEMBRANES, V1668, P175, DOI 10.1016/j.bbamem.2004.12.004; Jang WS, 2007, ANTIMICROB AGENTS CH, V51, P4148, DOI 10.1128/AAC.00635-07; Jeu LA, 2004, CLIN THER, V26, P1728, DOI 10.1016/j.clinthera.2004.11.014; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Kovalchuk LV, 2007, ADV EXP MED BIOL, V601, P369; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06; Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Li Peng, 2002, Current Topics in Medicinal Chemistry, V2, P325, DOI 10.2174/1568026023394209; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Meyer JE, 2007, CURR PHARM DESIGN, V13, P3119, DOI 10.2174/138161207782110372; Nguyen LT, 2005, J PEPT SCI, V11, P379, DOI 10.1002/psc.629; Noto PB, 2008, PROTEIN SCI, V17, P1249, DOI 10.1110/ps.034330.108; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; Raguse TL, 2002, J AM CHEM SOC, V124, P12774, DOI 10.1021/ja0270423; Rezansoff AJ, 2005, J PEPT RES, V65, P491, DOI 10.1111/j.1399-3011.2005.00263.X; Richardson A, 2009, BIOCHEM BIOPH RES CO, V388, P736, DOI 10.1016/j.bbrc.2009.08.083; Rosengren KJ, 2004, BIOPOLYMERS, V76, P446, DOI 10.1002/bip.20159; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; Rozek A, 2003, BIOCHEMISTRY-US, V42, P14130, DOI 10.1021/bi035643g; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Shalev DE, 2002, BIOCHEMISTRY-US, V41, P7312, DOI 10.1021/bi016013m; Strom MB, 2002, J PEPT SCI, V8, P431, DOI 10.1002/psc.398; Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542; Tam JP, 2002, J BIOL CHEM, V277, P50450, DOI 10.1074/jbc.M208429200; Tomita Mamoru, 1994, Acta Paediatrica Japonica, V36, P585; Unger T, 2001, BIOCHEMISTRY-US, V40, P6388, DOI 10.1021/bi0026066; Williams JA, 2008, EXPERT OPIN PHARMACO, V9, P1575, DOI 10.1517/14656566.9.9.1575 ; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	57	214	227	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12684	10.1371/journal.pone.0012684	http://dx.doi.org/10.1371/journal.pone.0012684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844765	gold, Green Published, Green Submitted			2022-12-25	WOS:000281687300019
J	Andrews, KS; Williams, GD; Levin, PS				Andrews, Kelly S.; Williams, Greg D.; Levin, Phillip S.			Seasonal and Ontogenetic Changes in Movement Patterns of Sixgill Sharks	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; JUVENILE LEMON SHARKS; HEXANCHUS-GRISEUS; PUGET-SOUND; CARCHARODON-CARCHARIAS; ALOPIAS-SUPERCILIOSUS; CALLINECTES-SAPIDUS; GALEOCERDO-CUVIER; ACOUSTIC TRACKING; LAMNA-DITROPIS	Background: Understanding movement patterns is fundamental to population and conservation biology. The way an animal moves through its environment influences the dynamics of local populations and will determine how susceptible it is to natural or anthropogenic perturbations. It is of particular interest to understand the patterns of movement for species which are susceptible to human activities (e.g. fishing), or that exert a large influence on community structure, such as sharks. Methodology/Principal Findings: We monitored the patterns of movement of 34 sixgill sharks Hexanchus griseus using two large-scale acoustic arrays inside and outside Puget Sound, Washington, USA. Sixgill sharks were residents in Puget Sound for up to at least four years before making large movements out of the estuary. Within Puget Sound, sixgills inhabited sites for several weeks at a time and returned to the same sites annually. Across four years, sixgills had consistent seasonal movements in which they moved to the north from winter to spring and moved to the south from summer to fall. Just prior to leaving Puget Sound, sixgills altered their behavior and moved twice as fast among sites. Nineteen of the thirty-four sixgills were detected leaving Puget Sound for the outer coast. Three of these sharks returned to Puget Sound. Conclusions/Significance: For most large marine predators, we have a limited understanding of how they move through their environment, and this clouds our ability to successfully manage their populations and their communities. With detailed movement information, such as that being uncovered with acoustic monitoring, we can begin to quantify the spatial and temporal impacts of large predators within the framework of their ecosystems.	[Andrews, Kelly S.; Williams, Greg D.; Levin, Phillip S.] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Andrews, KS (corresponding author), NOAA, NW Fisheries Sci Ctr, Seattle, WA USA.	kelly.andrews@noaa.gov		Andrews, Kelly/0000-0001-7734-3800	United States Department of Commerce, Northwest Fisheries Science Center	United States Department of Commerce, Northwest Fisheries Science Center	This work was funded through United States Department of Commerce base funds for the Integrated Marine Ecology (IME) team at the Northwest Fisheries Science Center. Other than members of the IME team, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, J EXP MAR BIOL ECOL, V319, P117, DOI 10.1016/j.jembe.2004.08.030; Andrews KS, 2007, CAN J ZOOL, V85, P1136, DOI 10.1139/Z07-088; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; [Anonymous], 2020, ECONOMIST 0326; [Anonymous], 1998, QUANTITATIVE ANAL MO; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Begg CM, 2003, J ZOOL, V260, P301, DOI 10.1017/S0952836903003789; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Bolden SK, 2000, FISH B-NOAA, V98, P642; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Camhi M, 1998, SHARKS THEIR RELATIV; CAREY FG, 1982, COPEIA, P254; CAREY FG, 1995, ENVIRON BIOL FISH, V42, P7, DOI 10.1007/BF00002345; Carr SD, 2004, ESTUAR COAST SHELF S, V60, P567, DOI 10.1016/j.ecss.2004.02.012; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Chatterjee S., 2015, REGRESSION ANAL EXAM; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Dicken ML, 2007, MAR FRESHWATER RES, V58, P127, DOI 10.1071/MF06018; Dicken ML, 2006, AFR J MAR SCI, V28, P603, DOI 10.2989/18142320609504210; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dunbrack R, 2003, CAN J ZOOL, V81, P1107, DOI 10.1139/Z03-087; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; EBERT DA, 1994, S AFR J MARINE SCI, V14, P213; Ebert DA, 2002, S AFR J MARINE SCI, V24, P359, DOI 10.2989/025776102784528439; EBERT DA, 1986, COPEIA, P131; Edwards HJ, 2010, BIOL CONSERV, V143, P457, DOI 10.1016/j.biocon.2009.11.013; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fullard JH, 2001, ANIM BEHAV, V62, P349, DOI 10.1006/anbe.2001.1753; Hall-Aspland SA, 2005, MAR ECOL PROG SER, V305, P249, DOI 10.3354/meps305249; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; HOLTS DB, 1993, AUST J MAR FRESH RES, V44, P901; Hulbert LB, 2006, J FISH BIOL, V69, P406, DOI 10.1111/j.1095-8649.2006.01175.x; Hulbert LB, 2005, J FISH BIOL, V67, P490, DOI 10.1111/j.0022-1112.2005.00757.x; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; KETCHEN KS, 1972, J FISH RES BOARD CAN, V29, P1717, DOI 10.1139/f72-272; Madsen T, 1996, ECOLOGY, V77, P149, DOI 10.2307/2265663; Melnychuk MC, 2009, MAR FRESHWATER RES, V60, P1231, DOI 10.1071/MF08361; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; MORRISSEY JF, 1993, COPEIA, P425; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; Natanson LJ, 2002, FISH B-NOAA, V100, P266; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; OGDEN JC, 1973, ECOLOGY, V54, P589, DOI 10.2307/1935344; OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Reum JCP, 2008, ESTUAR COAST, V31, P790, DOI 10.1007/s12237-008-9064-5; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Ruckelshaus M.H., 2007, SOUND SCI SYNTHESIZI; *SAS I INC, 2004, SAS 9 1 3; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 2001, MAR BIOL, V139, P1165; Sinclair A.R.E., 1983, P240; Springer S., 1950, Texas Journal of Science, V2, P349; Stokesbury MJW, 2005, MAR BIOL, V148, P159, DOI 10.1007/s00227-005-0061-y; Strickland RM., 1983, FERTILE FJORD; UNDERWOOD AJ, 1997, ECOLOGICAL EXPT THEI; Weissinger MD, 2009, J WILDLIFE DIS, V45, P388, DOI 10.7589/0090-3558-45.2.388; Welbergen JA, 2008, ANIM BEHAV, V75, P1543, DOI 10.1016/j.anbehav.2007.10.007; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Williams GD, 2010, T AM FISH SOC, V139, P108, DOI 10.1577/T09-045.1; WINTER DF, 1975, MAR BIOL, V29, P139, DOI 10.1007/BF00388986; [No title captured]; [No title captured]; [No title captured]; [No title captured]	78	37	38	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12549	10.1371/journal.pone.0012549	http://dx.doi.org/10.1371/journal.pone.0012549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838617	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687100004
J	Zhang, C; Jackson, AP; Zhang, ZR; Han, Y; Yu, S; He, RQ; Perrett, S				Zhang, Chen; Jackson, Antony P.; Zhang, Zai-Rong; Han, Yan; Yu, Shun; He, Rong-Qiao; Perrett, Sarah			Amyloid-Like Aggregates of the Yeast Prion Protein Ure2 Enter Vertebrate Cells by Specific Endocytotic Pathways and Induce Apoptosis	PLOS ONE			English	Article							FORMATION IN-VITRO; SACCHAROMYCES-CEREVISIAE; NEURONAL CELLS; MAMMALIAN-CELLS; MEMBRANE DISRUPTION; MISFOLDING DISEASES; PARKINSONS-DISEASE; COMMON MECHANISM; ALPHA-SYNUCLEIN; LIPID RAFTS	Background: A number of amyloid diseases involve deposition of extracellular protein aggregates, which are implicated in mechanisms of cell damage and death. However, the mechanisms involved remain poorly understood. Methodology/Principal Findings: Here we use the yeast prion protein Ure2 as a generic model to investigate how amyloidlike protein aggregates can enter mammalian cells and convey cytotoxicity. The effect of three different states of Ure2 protein (native dimer, protofibrils and mature fibrils) was tested on four mammalian cell lines (SH-SY5Y, MES23.5, HEK-293 and HeLa) when added extracellularly to the medium. Immunofluorescence using a polyclonal antibody against Ure2 showed that all three protein states could enter the four cell lines. In each case, protofibrils significantly inhibited the growth of the cells in a dose-dependent manner, fibrils showed less toxicity than protofibrils, while the native state had no effect on cell growth. This suggests that the structural differences between the three protein states lead to their different effects upon cells. Protofibrils of Ure2 increased membrane conductivity, altered calcium homeostasis, and ultimately induced apoptosis. The use of standard inhibitors suggested uptake into mammalian cells might occur via receptormediated endocytosis. In order to investigate this further, we used the chicken DT40 B cell line DKOR, which allows conditional expression of clathrin. Uptake into the DKOR cell-line was reduced when clathrin expression was repressed suggesting similarities between the mechanism of PrP uptake and the mechanism observed here for Ure2. Conclusions/Significance: The results provide insight into the mechanisms by which amyloid aggregates may cause pathological effects in prion and amyloid diseases.	[Zhang, Chen; Zhang, Zai-Rong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Han, Yan; Yu, Shun] Capital Univ Med Sci, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Han, Yan; Yu, Shun] Capital Univ Med Sci, Xuanwu Hosp, Beijing Inst Geriatr, Sino Japan Joint Lab Neurodegenerat Dis, Beijing, Peoples R China; [He, Rong-Qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Zhang, Chen; Zhang, Zai-Rong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Cambridge; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, C (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	sarah.perrett@cantab.net	Zhang, Zairong/G-1030-2013; Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; Jackson, Antony Philip/0000-0002-2895-7387; ZHANG, ZAIRONG/0000-0001-9768-0548	National Natural Science Foundation of China [30620130109, 30670428, 30870482]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences [KSCX2-YW-R-119, KSCX2-YW-R-256]; Royal Society International Joint	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Royal Society International Joint	This work was supported by grants to S. P. from the National Natural Science Foundation of China (30620130109, 30670428, 30870482), the Chinese Ministry of Science and Technology (2006CB500703, 2006CB910903) and the Chinese Academy of Sciences (KSCX2-YW-R-119, KSCX2-YW-R-256), and was facilitated by a Royal Society International Joint-Project Grant (to Laura Itzhaki and S. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Bai Y, 2008, NEUROSCI RES, V62, P9, DOI 10.1016/j.neures.2008.05.004; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Cecchi C, 2008, NEUROCHEM RES, V33, P2516, DOI 10.1007/s11064-008-9627-7; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hirakura Y, 2000, J NEUROSCI RES, V60, P490, DOI 10.1002/(SICI)1097-4547(20000515)60:4<490::AID-JNR7>3.0.CO;2-9; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lin MX, 1997, J BIOL CHEM, V272, P44; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Pieri L, 2009, BIOPHYS J, V96, P3319, DOI 10.1016/j.bpj.2008.12.3958; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sousa MM, 2001, AM J PATHOL, V159, P1993; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wu G, 2008, NEUROSCI LETT, V446, P11, DOI 10.1016/j.neulet.2008.09.020; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zhang ZR, 2009, J BIOL CHEM, V284, P14058, DOI 10.1074/jbc.M901189200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	65	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12529	10.1371/journal.pone.0012529	http://dx.doi.org/10.1371/journal.pone.0012529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824085	Green Published, Green Submitted, gold			2022-12-25	WOS:000281480900014
J	Konigsberger, S; Peckl-Schmid, D; Zaborsky, N; Patzak, I; Kiefer, F; Achatz, G				Koenigsberger, Sebastian; Peckl-Schmid, Doris; Zaborsky, Nadja; Patzak, Irene; Kiefer, Friedemann; Achatz, Gernot			HPK1 Associates with SKAP-HOM to Negatively Regulate Rap1-Mediated B-Lymphocyte Adhesion	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR KINASE-1; MEDIATES RAP1-INDUCED ADHESION; T-CELL-ACTIVATION; INTEGRIN ACTIVATION; SYNAPSE FORMATION; IMMUNOLOGICAL-SYNAPSE; ACTIN POLYMERIZATION; RAP GTPASES; MOLECULE-1 ICAM-1; ADAPTER PROTEINS	Background: Hematopoietic progenitor kinase 1 (HPK1) is a Ste20-related serine/threonine kinase activated by a range of environmental stimuli including genotoxic stress, growth factors, inflammatory cytokines and antigen receptor triggering. Being inducibly recruited to membrane-proximal signalling scaffolds to regulate NFAT, AP-1 and NF kappa B-mediated gene transcription in T-cells, the function of HPK1 in B-cells to date remains rather ill-defined. Methodology/Principal Findings: By using two loss of function models, we show that HPK1 displays a novel function in regulating B-cell integrin activity. Wehi 231 lymphoma cells lacking HPK1 after shRNA mediated knockdown exhibit increased basic activation levels of Ras-related protein 1 (Rap1), accompanied by a severe lymphocyte function-associated antigen-1 (LFA-1) dependent homotypic aggregation and increased adhesion to intercellular adhesion molecule 1 (ICAM-1). The observed phenotype of enhanced integrin activity is caused downstream of Src, by a signalling module independent of PI3K and PLC, involving HPK1, SKAP55 homologue (SKAP-HOM) and Rap1-GTP-interacting adaptor molecule (RIAM). This alters actin dynamics and renders focal adhesion kinase (FAK) constitutively phosphorylated. Bone marrow and splenic B-cell development of HPK1(-/-) mice are largely unaffected, except age-related tendencies for increased splenic cellularity and BCR downregulation. In addition, naive splenic knockout B-cells appear hyperresponsive to a range of stimuli applied ex vivo as recently demonstrated by others for T-cells. Conclusions/Significance: We therefore conclude that HPK1 exhibits a dual function in B-cells by negatively regulating integrin activity and controlling cellular activation, which makes it an interesting candidate to study in pathological settings like autoimmunity and cancer.	[Koenigsberger, Sebastian; Peckl-Schmid, Doris; Zaborsky, Nadja; Achatz, Gernot] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Patzak, Irene] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London, England; [Kiefer, Friedemann] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany	Salzburg University; Cancer Research UK; Max Planck Society	Konigsberger, S (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	gernot.achatz@sbg.ac.at	Achatz, Gernot/E-5073-2011	Kiefer, Friedemann/0000-0002-3002-8237; Zaborsky, Nadja/0000-0002-9775-185X; Konigsberger, Sebastian/0000-0001-7514-2044	Forderung der Wissenschaftlichen Forschung (FWF) [P19017]; Oesterreichischen Nationalbank (OENB) [11710]	Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Oesterreichischen Nationalbank (OENB)	The experimental work was funded by the Forderung der Wissenschaftlichen Forschung (FWF) project P19017 (http://www.fwf.ac.at) and the Oesterreichischen Nationalbank (OENB) grant 11710 (http://www.oenb.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; Geisberger R, 2006, IMMUNOL LETT, V102, P169, DOI 10.1016/j.imlet.2005.09.001; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Le Bras S, 2004, J BIOL CHEM, V279, P15550, DOI 10.1074/jbc.M312659200; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Ling P, 1999, MOL CELL BIOL, V19, P1359; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619	46	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12468	10.1371/journal.pone.0012468	http://dx.doi.org/10.1371/journal.pone.0012468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824186	Green Published, gold, Green Submitted			2022-12-25	WOS:000281456100006
J	Doumazane, E; Scholler, P; Zwier, JM; Trinquet, E; Rondard, P; Pin, JP				Doumazane, Etienne; Scholler, Pauline; Zwier, Jurriaan M.; Trinquet, Eric; Rondard, Philippe; Pin, Jean-Philippe			A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors	FASEB JOURNAL			English	Article						GPCR; oligomerization; heteromerization; multilabeling; time-resolved fluorescence resonance energy transfer	RESONANCE ENERGY-TRANSFER; HIGHER-ORDER OLIGOMERS; TIME-RESOLVED FRET; COUPLED RECEPTORS; LIVING CELLS; GABA(B) RECEPTOR; GPCR; EXPRESSION; ACTIVATION; SUBTYPES	G-protein-coupled receptors (GPCRs) can form heteromeric complexes. Herein, we describe a new approach to test the heteromerization of 2 receptors, or 2 receptor subunits, and to study the stoichiometry of the resulting complexes. As a proof-of-concept study, we investigated whether metabotropic glutamate receptors (mGluRs), in addition to being well-known homodimers, can form heteromers. To that aim, we combine the benefits of time-resolved fluorescence resonance energy transfer (trFRET) with the specific, cell-surface labeling of SNAP- and CLIP-tagged rat mGluR subunits, expressed in a mammalian cell line. First, we show that mGlu2 and mGlu4 subunits (but not mGlu2 and mGlu1) can heteromerize. Moreover, our trFRET data are consistent with mGluR subunits forming strict homodimeric receptors on single expression, and a combination of strict heterodimeric and strict homodimeric receptors on coexpression. Second, a comprehensive analysis reveals that from the 21 possible pairs of 2 mGluR subunits out of 7 subtypes (mGlu1 to 8, but not 6), only 11 are able to form heterodimers. These findings were further validated by biochemical and functional complementation studies. In addition to describing a new method to analyze cell-surface receptor complexes, our data reveal a new level of complexity within the mGluR family.-Doumazane, E., Scholler, P., Zwier, J. M., Trinquet, E., Rondard, P., Pin, J.-P. A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors. FASEB J. 25, 66-77 (2011). www.fasebj.org	[Doumazane, Etienne; Scholler, Pauline; Rondard, Philippe; Pin, Jean-Philippe] CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier, France; [Doumazane, Etienne; Scholler, Pauline; Rondard, Philippe; Pin, Jean-Philippe] Inst Natl Sante & Rech Med, Unite 661, Montpellier, France; [Zwier, Jurriaan M.; Trinquet, Eric] Cisbio Bioassays, Bagnols Sur Ceze, France; [Doumazane, Etienne; Scholler, Pauline; Rondard, Philippe; Pin, Jean-Philippe] Univ Montpellier 1 & 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Rondard, P (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, 141 Rue Cardonille, F-34094 Montpellier, France.	philippe.rondard@igf.cnrs.fr; jean-philippe.pin@igf.cnrs.fr	Rondard, Philippe/N-9720-2018; Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Zwier, Jurriaan/0000-0001-9017-5856; RONDARD, Philippe/0000-0003-1134-2738	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; French Ministry of Research; Cisbio Bioassays; Agence Nationale pour la Recherche [06-BLANC-0087, 09-BLANC-0272]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Cisbio Bioassays; Agence Nationale pour la Recherche(French National Research Agency (ANR))	The authors thank Drs. Carsten Brock and Marie-Laure Rives [Institut de Genomique Fonctionnelle (IGF), Montpellier, France] for plasmids; Dr. Damien Maurel and Laetitia Comps-Agrar for initial work; and Dr. Kai Johnsson (Ecole Polytechnique Federale, Lausanne, Switzerland) for the CLIP plasmid. The authors also thank Drs. Sebastien Granier, Laurent Prezeau, Thierry Durroux, and Gregory D. Stewart (IGF) for helpful comments on the manuscript, and Francesco Ferraguti (University of Innsbruck, Innsbruck, Austria) for constructive discussions. The authors thank Claire Vol, Isabelle Brabet, and the screening facilities of the IGF (Plate-forme Pharmacologie Criblage Interactome, Montpellier, France). This work was supported by grants from Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, French Ministry of Research, Cisbio Bioassays, and the Agence Nationale pour la Recherche (contracts 06-BLANC-0087 and 09-BLANC-0272). Lumi4 is a registered trademark of Lumiphore, Inc.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Cabello N, 2009, J NEUROCHEM, V109, P1497, DOI 10.1111/j.1471-4159.2009.06078.x; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cottet M, 2010, CURR OPIN PHARMACOL, V10, P59, DOI 10.1016/j.coph.2009.10.003; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ferraguti F, 2005, J NEUROSCI, V25, P10520, DOI 10.1523/JNEUROSCI.2547-05.2005; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Frauli M, 2006, NEUROPHARMACOLOGY, V50, P245, DOI 10.1016/j.neuropharm.2005.09.016; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Iacovelli L, 2009, MOL PHARMACOL, V75, P991, DOI 10.1124/mol.108.052316; Jingami H, 2003, CURR OPIN NEUROBIOL, V13, P271, DOI 10.1016/S0959-4388(03)00067-9; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KLINGENBERG M, 1981, NATURE, V290, P449, DOI 10.1038/290449a0; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Koulen P, 1997, J NEUROSCI, V17, P2200; Kubo Y, 2005, CURR OPIN NEUROBIOL, V15, P289, DOI 10.1016/j.conb.2005.05.011; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Melchiorri D, 2007, NEUROPHARMACOLOGY, V53, P473, DOI 10.1016/j.neuropharm.2007.05.031; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Hare HM, 2007, CURR OPIN STRUC BIOL, V17, P488, DOI 10.1016/j.sbi.2007.07.005; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Rajapakse HE, 2010, P NATL ACAD SCI USA, V107, P13582, DOI 10.1073/pnas.1002025107; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Salter MW, 2003, TRENDS NEUROSCI, V26, P235, DOI 10.1016/S0166-2236(03)00081-X; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Tallaksen-Greene SJ, 1998, BRAIN RES, V780, P210, DOI 10.1016/S0006-8993(97)01141-4; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; van Hooft JA, 2000, J NEUROSCI, V20, P3544, DOI 10.1523/JNEUROSCI.20-10-03544.2000; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	71	209	226	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					66	77		10.1096/fj.10-163147	http://dx.doi.org/10.1096/fj.10-163147			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20826542				2022-12-25	WOS:000285869500007
J	Neely, RJ; Brose, MS; Gray, CM; McCorkell, KA; Leibowitz, JM; Ma, C; Rothstein, JL; May, MJ				Neely, R. J.; Brose, M. S.; Gray, C. M.; McCorkell, K. A.; Leibowitz, J. M.; Ma, C.; Rothstein, J. L.; May, M. J.			The RET/PTC3 oncogene activates classical NF-kappa B by stabilizing NIK	ONCOGENE			English	Article						Hashimoto's thyroiditis; IKK; NIK; NF-kappa B; RET/PTC; thyroid cancer	GENE-EXPRESSION; FUSION GENE; IKK-ALPHA; RET; NUCLEAR; ONCOPROTEIN; CARCINOMA; PATHWAY; REARRANGEMENTS; LOCALIZATION	The oncogenic fusion protein RET/PTC3 (RP3) that is expressed in papillary thyroid carcinoma (PTC) and thyroid epithelia in Hashimoto's thyroiditis activates nuclear factor-kappa B (NF-kappa B) and induces pro-inflammatory gene expression; however, the mechanism of this activation is unknown. To address this, we expressed RP3 in murine embryonic fibroblasts (MEFs) lacking key classical and noncanonical NF-kappa B signaling components. In wild-type MEFs, RP3 upregulated CCL2, CXCL1, granulocyte-macrophage colony-stimulating factor and tumor necrosis factor expression and activated classical but not noncanonical NF-kappa B. RP3-activated NF-kappa B in I kappa B kinase (IKK)beta(-/-) MEFs but not IKK alpha- or NF-kappa B essential modulator (NEMO)-deficient cells and activation was inhibited by a peptide that blocks NEMO binding to the IKKs. RP3 increased the levels of NF-kappa B-inducing kinase (NIK) and did not activate NF-kappa B in NIK-deficient MEFs. Notably, NIK stabilization was not accompanied by TRAF3 degradation demonstrating that RP3 disrupts normal basal NIK regulation. Dominant-negative NIK blocked RP3-induced NF-kappa B activation and an RP3 signaling mutant (RP3(Y588F)) did not stabilize NIK. Finally, examination of PTC specimens revealed strong positive staining for NIK. We therefore conclude that RP3 activates classical NF-kappa B via NIK, NEMO and IKK alpha. Importantly, our findings reveal a novel mechanism for oncogene-induced NF-kappa B activation via stabilization of NIK. Oncogene (2011) 30, 87-96; doi: 10.1038/onc.2010.396; published online 6 September 2010	[Neely, R. J.; Gray, C. M.; McCorkell, K. A.; May, M. J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Neely, R. J.; Rothstein, J. L.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol Otolaryngol Head & Neck, Philadelphia, PA 19107 USA; [Brose, M. S.; Leibowitz, J. M.; Ma, C.] Univ Penn, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Rothstein, J. L.] Amgen Inc, Inflammat Res, Seattle, WA USA; [May, M. J.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Jefferson University; University of Pennsylvania; Amgen; University of Pennsylvania	May, MJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St,OVH 200E, Philadelphia, PA 19104 USA.	maym@vet.upenn.edu		May, Michael/0000-0002-2485-3716	National Institutes of Health [RO1HL080612, R21CA135602, T32CA009683, T32GM07229]; Mari Lowe Center for Comparative Oncology; NATIONAL CANCER INSTITUTE [T32CA009683, R21CA135602] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mari Lowe Center for Comparative Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (RO1HL080612, R21CA135602 and T32CA009683, T32GM07229) and the Mari Lowe Center for Comparative Oncology.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bunone G, 2000, CANCER RES, V60, P2845; Ciampi R, 2007, ENDOCRINOLOGY, V148, P936, DOI 10.1210/en.2006-0921; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Eisenlohr LC, 2006, AUTOIMMUN REV, V6, P107, DOI 10.1016/j.autrev.2006.04.002; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Ludwig L, 2001, CANCER RES, V61, P4526; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Monaco C, 2001, ONCOGENE, V20, P599, DOI 10.1038/sj.onc.1204127; Muzza M, 2010, CLIN ENDOCRINOL, V72, P702, DOI 10.1111/j.1365-2265.2009.03699.x; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Nibu K, 2005, EUR ARCH OTO-RHINO-L, V262, P368, DOI 10.1007/s00405-004-0835-8; Nishina T, 2009, BIOCHEM BIOPH RES CO, V388, P96, DOI 10.1016/j.bbrc.2009.07.125; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Pufnock JS, 2009, J IMMUNOL, V182, P5498, DOI 10.4049/jimmunol.0801284; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Rhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240; Russell JP, 2003, ONCOGENE, V22, P4569, DOI 10.1038/sj.onc.1206759; SANTORO M, 1993, CELL GROWTH DIFFER, V4, P77; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sheils OM, 2000, INT J SURG PATHOL, V8, P185, DOI 10.1177/106689690000800305; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Wirtschafter A, 1997, LARYNGOSCOPE, V107, P95, DOI 10.1097/00005537-199701000-00019; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105	43	22	23	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					87	96		10.1038/onc.2010.396	http://dx.doi.org/10.1038/onc.2010.396			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20818435	Green Accepted			2022-12-25	WOS:000285959300008
J	Coudevylle, N; Geist, L; Hotzinger, M; Hartl, M; Kontaxis, G; Bister, K; Konrat, R				Coudevylle, Nicolas; Geist, Leonhard; Hoetzinger, Matthias; Hartl, Markus; Kontaxis, Georg; Bister, Klaus; Konrat, Robert			The v-myc-induced Q83 Lipocalin Is a Siderocalin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; PROTEIN FAMILY; INTERMOLECULAR NOES; IRON; ENTEROBACTIN; RECOGNITION; INFECTION; ALIGNMENT; RECEPTOR; HADDOCK	Siderocalins are atypical lipocalins able to capture siderophores with high affinity. They contribute to the innate immune response by interfering with bacterial siderophore-mediated iron uptake but are also involved in numerous physiological processes such as inflammation, iron delivery, tissue differentiation, and cancer progression. The Q83 lipocalin was originally identified based on its overexpression in quail embryo fibroblasts transformed by the v-myc oncogene. We show here that Q83 is a siderocalin, binding the siderophore enterobactin with an affinity and mode of binding nearly identical to that of neutrophil gelatinase-associated lipocalin (NGAL), the prototypical siderocalin. This strengthens the role of siderocalins in cancer progression and inflammation. In addition, we also present the solution structure of Q83 in complex with intact enterobactin and a detailed analysis of the Q83 binding mode, including mutagenesis of the critical residues involved in enterobactin binding. These data provide a first insight into the molecular details of siderophore binding and delineate the common molecular properties defining the siderocalin protein family.	[Coudevylle, Nicolas; Geist, Leonhard; Hoetzinger, Matthias; Kontaxis, Georg; Konrat, Robert] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Hartl, Markus; Bister, Klaus] Univ Innsbruck, Inst Biochem, Ctr Mol Biosci CMBI, A-6020 Innsbruck, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Innsbruck	Coudevylle, N (corresponding author), Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, Campus Vienna,Bioctr 5-1, A-1030 Vienna, Austria.	nicolas.coudevylle@univie.ac.at; robert.konrat@univie.ac.at	Bister, Klaus/AFA-9400-2022; Hoetzinger, Matthias/R-3818-2017; Hartl, Markus/O-4655-2014	Hoetzinger, Matthias/0000-0002-1932-6479; Hartl, Markus/0000-0001-7447-5920; Bister, Klaus/0000-0001-6545-5653	Austrian Science Fund (FWF) [P20549-N19, P22125-B12, P17041, P18148]; Lise Meitner FWF fellowship; Austrian Science Fund (FWF) [P 22125] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Lise Meitner FWF fellowship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P20549-N19, P22125-B12, P17041, and P18148.; Recipient of a Lise Meitner FWF fellowship.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Basler T, 2008, IMMUNOBIOLOGY, V213, P879, DOI 10.1016/j.imbio.2008.07.009; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; CANCEDDA FD, 1988, J CELL BIOL, V107, P2455, DOI 10.1083/jcb.107.6.2455; CARRANO CJ, 1979, J AM CHEM SOC, V101, P5401, DOI 10.1021/ja00512a047; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Cermelli S, 2000, EUR J CELL BIOL, V79, P155, DOI 10.1078/S0171-9335(04)70018-7; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eichmuller C, 2001, J BIOMOL NMR, V21, P107, DOI 10.1023/A:1012480532569; Fang WK, 2007, BIOCHEM J, V403, P297, DOI 10.1042/BJ20060836; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Hartl M, 2003, J MOL BIOL, V333, P33, DOI 10.1016/j.jmb.2003.08.018; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; KARPISHIN TB, 1992, ANGEW CHEM INT EDIT, V31, P466, DOI 10.1002/anie.199204661; Keller R., 2004, COMPUTER AIDED RESON, V1; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; MANDUCA P, 1989, EUR J CELL BIOL, V50, P154; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; OBRIEN IG, 1970, BIOCHIM BIOPHYS ACTA, V215, P393, DOI 10.1016/0304-4165(70)90038-3; Ottiger M, 1998, J BIOMOL NMR, V12, P361, DOI 10.1023/A:1008366116644; Pagano A, 2002, EUR J CELL BIOL, V81, P264, DOI 10.1078/0171-9335-00243; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sheng Z, 2009, EMBO J, V28, P866, DOI 10.1038/emboj.2009.35; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Slijper M, 1996, J MAGN RESON SER B, V111, P199, DOI 10.1006/jmrb.1996.0083; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	57	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41646	41652		10.1074/jbc.M110.123331	http://dx.doi.org/10.1074/jbc.M110.123331			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20826777	hybrid, Green Published			2022-12-25	WOS:000285622600052
J	Chang, CY; Hsieh, YC; Wang, TY; Chen, YC; Wang, YK; Chiang, TW; Chen, YJ; Chang, CH; Chen, CJ; Wu, TK				Chang, Chin-Yuan; Hsieh, Yin-Cheng; Wang, Ting-Yi; Chen, Yi-Chin; Wang, Yu-Kuo; Chiang, Ting-Wei; Chen, Yi-Ju; Chang, Cheng-Hsiang; Chen, Chun-Jung; Wu, Tung-Kung			Crystal Structure and Mutational Analysis of Aminoacylhistidine Dipeptidase from Vibrio alginolyticus Reveal a New Architecture of M20 Metallopeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-CARNOSINASE DEFICIENCY; CARBOXYPEPTIDASE G(2); NUCLEOTIDE-SEQUENCE; MENTAL-RETARDATION; DATA QUALITY; ENZYME; AMINOPEPTIDASE; HOMOCARNOSINE; SUBSTRATE; THERAPY	Aminoacylhistidine dipeptidases (PepD, EC 3.4.13.3) belong to the family of M20 metallopeptidases from the metallopeptidase H clan that catalyze a broad range of dipeptide and tripeptide substrates, including L-carnosine and L-homocarnosine. Homocarnosine has been suggested as a precursor for the neurotransmitter gamma-aminobutyric acid (GABA) and may mediate the antiseizure effects of GABAergic therapies. Here, we report the crystal structure of PepD from Vibrio alginolyticus and the results of mutational analysis of substrate-binding residues in the C-terminal as well as substrate specificity of the PepD catalytic domain-alone truncated protein PepD(CAT). The structure of PepD was found to exist as a homodimer, in which each monomer comprises a catalytic domain containing two zinc ions at the active site center for its hydrolytic function and a lid domain utilizing hydrogen bonds between helices to form the dimer interface. Although the PepD is structurally similar to PepV, which exists as a monomer, putative substrate-binding residues reside in different topological regions of the polypeptide chain. In addition, the lid domain of the PepD contains an "extra" domain not observed in related M20 family metallopeptidases with a dimeric structure. Mutational assays confirmed both the putative di-zinc allocations and the architecture of substrate recognition. In addition, the catalytic domain-alone truncated PepD(CAT) exhibited substrate specificity to L-homocarnosine compared with that of the wild-type PepD, indicating a potential value in applications of PepD(CAT) for GABAergic therapies or neuroprotection.	[Chang, Chin-Yuan; Wang, Ting-Yi; Chen, Yi-Chin; Wang, Yu-Kuo; Chen, Yi-Ju; Chang, Cheng-Hsiang; Wu, Tung-Kung] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan; [Hsieh, Yin-Cheng; Chiang, Ting-Wei; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Hsieh, Yin-Cheng] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Chiang, Ting-Wei; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan	National Yang Ming Chiao Tung University; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University; National Cheng Kung University	Chen, CJ (corresponding author), 101 Hsin Ann Rd, Hsinchu 30076, Taiwan.	cjchen@nsrrc.org.tw; tkwmll@mail.nctu.edu.tw	Chen, Chun-Jung/A-6880-2011; Chang, Chin-Yuan/AAM-5863-2021	Chen, Chun-Jung/0000-0002-5157-4288; Chang, Chin-Yuan/0000-0001-7314-3967; Wang, Ting-Yi/0000-0001-5536-925X	National Chiao Tung University; Ministry of Education; National Science Council [NSC-97-2627-M-009-002, NSC-97-2627-M-009-003, NSC 93-2321-B-213-001]; National Synchrotron Radiation Research Center [963RSB02]; Aiming for Top University Plan program	National Chiao Tung University; Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Research Center; Aiming for Top University Plan program	This work was supported by the National Chiao Tung University, the Ministry of Education, Aiming for Top University Plan program, and National Science Council Grants NSC-97-2627-M-009-002 and NSC-97-2627-M-009-003, National Synchrotron Radiation Research Center Grant 963RSB02, and National Science Council Grant NSC 93-2321-B-213-001) (to C.-J.C.).	Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; Boldyrev AA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P751; Bommarius A. S., 2002, ENZYME CATALYSIS ORG, P741; Chang CY, 2009, ACTA CRYSTALLOGR F, V65, P216, DOI 10.1107/S174430910900092X; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Csampai A, 2004, J CHROMATOGR A, V1031, P67, DOI 10.1016/j.chroma.2003.10.137; Decker EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P766; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hellendoorn MA, 1997, J BACTERIOL, V179, P3410, DOI 10.1128/jb.179.11.3410-3415.1997; Hipkiss AR, 1998, INT J BIOCHEM CELL B, V30, P863, DOI 10.1016/S1357-2725(98)00060-0; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Karita M, 1997, INFECT IMMUN, V65, P4158, DOI 10.1128/IAI.65.10.4158-4164.1997; Khan TH, 1999, J MED CHEM, V42, P951, DOI 10.1021/jm990004i; Klein J., 2004, HDB PROTEOLYTIC ENZY, P948; Krause AS, 2002, LEUKEMIA LYMPHOMA, V43, P2139, DOI 10.1080/1042819021000032953; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUNDE H, 1982, J NEUROCHEM, V38, P242, DOI 10.1111/j.1471-4159.1982.tb10876.x; Lundgren S, 2003, J BIOL CHEM, V278, P51851, DOI 10.1074/jbc.M308674200; Miller C. G., 2004, HDB PROTEOLYTIC ENZY, P946; MINTON NP, 1984, GENE, V31, P31, DOI 10.1016/0378-1119(84)90192-6; MURPHEY WH, 1973, PEDIATR RES, V7, P601, DOI 10.1203/00006450-197307000-00001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRY TL, 1967, NEW ENGL J MED, V277, P1219, DOI 10.1056/NEJM196712072772302; PERRY TL, 1968, LANCET, V1, P1229; Petroff OAC, 1999, NEUROLOGY, V52, P473, DOI 10.1212/WNL.52.3.473; Petroff OAC, 2001, NEUROLOGY, V56, P709, DOI 10.1212/WNL.56.6.709; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; SCHROEDER U, 1994, FEMS MICROBIOL LETT, V123, P153, DOI 10.1111/j.1574-6968.1994.tb07215.x; Seidler NW, 2000, J BIOCHEM MOL TOXIC, V14, P215, DOI 10.1002/(SICI)1099-0461(2000)14:4<215::AID-JBT6>3.0.CO;2-Z; SHERWOOD RF, 1985, EUR J BIOCHEM, V148, P447, DOI 10.1111/j.1432-1033.1985.tb08860.x; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; TERPLAN KL, 1972, NEUROLOGY, V22, P644, DOI 10.1212/WNL.22.6.644; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Unno H, 2008, J BIOL CHEM, V283, P27289, DOI 10.1074/jbc.M801657200; Vaughan FL, 2006, J INT NEUROPSYCH SOC, V12, P416, DOI 10.1017/S13556177060060504; VONGERICHTEN KF, 1994, MICROBIOL-SGM, V140, P2591, DOI 10.1099/00221287-140-10-2591; Wang TY, 2008, FEBS J, V275, P5007, DOI 10.1111/j.1742-4658.2008.06635.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227	46	14	15	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39500	39510		10.1074/jbc.M110.139683	http://dx.doi.org/10.1074/jbc.M110.139683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20819954	hybrid, Green Published			2022-12-25	WOS:000284941300076
J	Xu, Y; Zuo, Y; Zhang, HZ; Kang, XL; Yue, F; Yi, ZF; Liu, MY; Yeh, ETH; Chen, GQ; Cheng, JK				Xu, Ying; Zuo, Yong; Zhang, Haizeng; Kang, Xunlei; Yue, Fei; Yi, Zhengfang; Liu, Mingyao; Yeh, Edward T. H.; Chen, Guoqiang; Cheng, Jinke			Induction of SENP1 in Endothelial Cells Contributes to Hypoxia-driven VEGF Expression and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; SUMO-SPECIFIC PROTEASE-1; TRANSCRIPTIONAL ACTIVITY; GROWTH-FACTOR; PROLYL HYDROXYLATION; ANDROGEN RECEPTOR; HIF-1-ALPHA; SUMOYLATION; PROTEIN; CANCER	SENP1 (SUMO-specific protease 1) has been shown to be essential for the stability and activity of hypoxia-inducible factor 1 (HIF-1 alpha) under hypoxia conditions. However, it is unknown how SENP1 activation and hypoxia signaling are coordinated in the cellular response to hypoxia. Here, we report the essential role of SENP1 in endothelial cells as a positive regulator of hypoxia-driven VEGF production and angiogenesis. SENP1 expression is increased in endothelial cells following exposure to hypoxia. Silencing of HIF-1 alpha blocks SENP1 expression in cell response to hypoxia. Mutation of the hypoxia response element (HRE) on the Senp1 promoter abolishes its transactivation in response to hypoxia. Moreover, silencing of SENP1 expression decreases VEGF production and abrogates the angiogenic functions of endothelial cell. We also find that the elongated endothelial cells in embryonic brain section and vascular endothelial cells in embryonic renal glomeruli in Senp1(-/-) mice are markedly reduced than those in wild-type. Thus, these results show that hypoxia implies a positive feedback loop mediated by SENP1. This feedback loop is important in VEGF production, which is essential for angiogenesis in endothelial cells.	[Chen, Guoqiang; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Key Lab Cell Differentiat & Apoptosis Chinese Min, Shanghai 200025, Peoples R China; [Xu, Ying; Chen, Guoqiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Zuo, Yong; Kang, Xunlei; Chen, Guoqiang; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200438, Peoples R China; [Zhang, Haizeng] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Zhang, Haizeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yue, Fei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, Shanghai 200025, Peoples R China; E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; East China Normal University; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute	Chen, GQ (corresponding author), 280 Chongqing S Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn; jkcheng@shsmu.edu.cn		Liu, Mingyao/0000-0001-7339-5048; Kang, Xunlei/0000-0003-1853-1881; chen, guo qiang/0000-0003-4936-2363	State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China [30772462]; National Basic Research Program of China [2009CB918403, 2010CB912104]; Shanghai Pujiang Program; National Institutes of Health [CA 239520]; NATIONAL CANCER INSTITUTE [R01CA139520] Funding Source: NIH RePORTER	State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant 30772462 from the State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China (to J.C.), National Basic Research Program of China (973 Program) Grants 2009CB918403 and 2010CB912104 (to J.C.), the Shanghai Pujiang Program (to J.C.), and National Institutes of Health Grant CA 239520 (to E.T.H.Y.).	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raleigh JA, 1998, CANCER RES, V58, P3765; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	48	69	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36682	36688		10.1074/jbc.M110.164236	http://dx.doi.org/10.1074/jbc.M110.164236			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841360	Green Published, hybrid			2022-12-25	WOS:000284146100083
J	Carrie, C; Giraud, E; Duncan, O; Xu, L; Wang, Y; Huang, SB; Clifton, R; Murcha, M; Filipovska, A; Rackham, O; Vrielink, A; Whelan, J				Carrie, Chris; Giraud, Estelle; Duncan, Owen; Xu, Lin; Wang, Yan; Huang, Shaobai; Clifton, Rachel; Murcha, Monika; Filipovska, Aleksandra; Rackham, Oliver; Vrielink, Alice; Whelan, James			Conserved and Novel Functions for Arabidopsis thaliana MIA40 in Assembly of Proteins in Mitochondria and Peroxisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE PROTEINS; HIGHER-PLANT MITOCHONDRIA; OUTER-MEMBRANE PROTEINS; DISULFIDE RELAY SYSTEM; ALTERNATIVE OXIDASE; COMPLEX-I; NAD(P)H DEHYDROGENASES; PROCESSING PEPTIDASE; SULFHYDRYL OXIDASE; IMPORT MACHINERY	The disulfide relay system of the mitochondrial intermembrane space has been extensively characterized in Saccharomyces cerevisiae. It contains two essential components, Mia40 and Erv1. The genome of Arabidopsis thaliana contains a single gene for each of these components. Although insertional inactivation of Erv1 leads to a lethal phenotype, inactivation of Mia40 results in no detectable deleterious phenotype. A. thaliana Mia40 is targeted to and accumulates in mitochondria and peroxisomes. Inactivation of Mia40 results in an alteration of several proteins in mitochondria, an absence of copper/zinc superoxide dismutase (CSD1), the chaperone for superoxide dismutase (Ccs1) that inserts copper into CSD1, and a decrease in capacity and amount of complex I. In peroxisomes the absence of Mia40 leads to an absence of CSD3 and a decrease in abnormal inflorescence meristem 1 (Aim1), a beta-oxidation pathway enzyme. Inactivation of Mia40 leads to an alteration of the transcriptome of A. thaliana, with genes encoding peroxisomal proteins, redox functions, and biotic stress significantly changing in abundance. Thus, the mechanistic operation of the mitochondrial disulfide relay system is different in A. thaliana compared with other systems, and Mia40 has taken on new roles in peroxisomes and mitochondria.	[Carrie, Chris; Giraud, Estelle; Duncan, Owen; Xu, Lin; Wang, Yan; Huang, Shaobai; Clifton, Rachel; Murcha, Monika; Whelan, James] Univ Western Australia, ARC COE PEB, Crawley, WA 6009, Australia; [Filipovska, Aleksandra; Rackham, Oliver] Univ Western Australia, Western Australian Inst Med Res, Med Res Ctr, Crawley, WA 6009, Australia; [Vrielink, Alice] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Whelan, J (corresponding author), Univ Western Australia, ARC COE PEB, 35 Stirling Highway, Crawley, WA 6009, Australia.	seamus@cyllene.uwa.edu.au	Huang, Shaobai/D-1225-2011; Rackham, Oliver/E-1264-2013; Whelan, James/F-6402-2011; Murcha, Monika W/C-3834-2011; Rackham, Oliver/AGO-0005-2022; Vrielink, Alice/D-3652-2013; Giraud, Estelle/C-3876-2011; Murcha, Monika W/H-5495-2014; Carrie, Chris/A-2638-2010	Huang, Shaobai/0000-0003-3667-611X; Rackham, Oliver/0000-0002-5301-9624; Whelan, James/0000-0001-5754-025X; Rackham, Oliver/0000-0002-5301-9624; Vrielink, Alice/0000-0001-8197-3725; Murcha, Monika W/0000-0002-3689-6158; Carrie, Chris/0000-0002-4240-4674; WANG, YAN/0000-0003-1600-2863; Filipovska, Aleksandra/0000-0002-6998-8403; Xu, Lin/0000-0001-7476-2655; Duncan, Owen/0000-0001-6999-1509				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Banhegyi G, 2003, BIOFACTORS, V17, P37, DOI 10.1002/biof.5520170105; BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099; Eubel H, 2008, PLANT PHYSIOL, V148, P1809, DOI 10.1104/pp.108.129999; Footitt S, 2007, J EXP BOT, V58, P2959, DOI 10.1093/jxb/erm146; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Glaser E, 1999, J BIOENERG BIOMEMBR, V31, P259, DOI 10.1023/A:1005475930477; Glaser E, 2006, BIOL CHEM, V387, P1441, DOI 10.1515/BC.2006.180; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Lister R, 2003, NUCLEIC ACIDS RES, V31, P325, DOI 10.1093/nar/gkg055; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Ma C, 2008, J EXP BOT, V59, P3767, DOI 10.1093/jxb/ern221; Meyer EH, 2008, J PROTEOME RES, V7, P786, DOI 10.1021/pr700595p; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Murcha MW, 2005, J BIOL CHEM, V280, P16476, DOI 10.1074/jbc.M413299200; Murcha MW, 2004, J MOL BIOL, V344, P443, DOI 10.1016/j.jmb.2004.09.045; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Reddehase S, 2009, J MOL BIOL, V385, P331, DOI 10.1016/j.jmb.2008.10.088; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Vogtle FN, 2010, METHODS MOL BIOL, V619, P425, DOI 10.1007/978-1-60327-412-8_26; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; WHELAN J, 1995, PLANT MOL BIOL, V27, P769, DOI 10.1007/BF00020229; WHELAN J, 1995, PLANT PHYSIOL, V107, P1469, DOI 10.1104/pp.107.4.1469; Wiszniewski AAG, 2009, PLANT MOL BIOL, V69, P503, DOI 10.1007/s11103-008-9431-4	77	87	88	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36138	36148		10.1074/jbc.M110.121202	http://dx.doi.org/10.1074/jbc.M110.121202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829360	Green Published, hybrid			2022-12-25	WOS:000283845300090
J	Cid, M; Pedersen, HL; Kaneko, S; Coutinho, PM; Henrissat, B; Willats, WGT; Boraston, AB				Cid, Melissa; Pedersen, Henriette Lodberg; Kaneko, Satoshi; Coutinho, Pedro M.; Henrissat, Bernard; Willats, William G. T.; Boraston, Alisdair B.			Recognition of the Helical Structure of beta-1,4-Galactan by a New Family of Carbohydrate-binding Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; STREPTOCOCCUS-PNEUMONIAE; MOLECULAR-BASIS; PROTEIN; GLYCOGEN; IDENTIFICATION; SPECIFICITY; RESIDUES; AMYLOSE; WALLS	The microbial enzymes that depolymerize plant cell wall polysaccharides, ultimately promoting energy liberation and carbon recycling, are typically complex in their modularity and often contain carbohydrate-binding modules (CBMs). Here, through analysis of an unknown module from a Thermotoga maritima endo-beta-1,4-galactanase, we identify a new family of CBMs that are most frequently found appended to proteins with beta-1,4-galactanase activity. Polysaccharide microarray screening, immunofluorescence microscopy, and biochemical analysis of the isolated module demonstrate the specificity of the module, here called TmCBM61, for beta-1,4-linked galactose-containing ligands, making it the founding member of family CBM61. The ultra-high resolution x-ray crystal structures of TmCBM61 (0.95 and 1.4 angstrom resolution) in complex with beta-1,4-galactotriose reveal the molecular basis of the specificity of the CBM for beta-1,4-galactan. Analysis of these structures provides insight into the recognition of an unexpected helical galactan conformation through a mode of binding that resembles the recognition of starch.	[Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Pedersen, Henriette Lodberg; Willats, William G. T.] Univ Copenhagen, Fac Life Sci, DK-1870 Frederiksberg C, Denmark; [Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, Lab Architecture & Fonct Macromol Biol, CNRS, UMR6098, F-13288 Marseille 9, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, Lab Architecture & Fonct Macromol Biol, CNRS, UMR6098, F-13288 Marseille 9, France	University of Victoria; University of Copenhagen; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Boraston, Alisdair/0000-0001-6417-0592; Willats, William/0000-0003-2064-4025	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to A.B.B.). The CAZy data base is supported by GIS "IBiSA" (Infrastrutures en Biologie, Sante et Agronomie).	Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; DUDA CA, 1991, MACROMOLECULES, V24, P431, DOI 10.1021/ma00002a014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Nours J, 2009, PROTEINS, V75, P977, DOI 10.1002/prot.22310; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; Montanier C, 2010, J BIOL CHEM, V285, P31742, DOI 10.1074/jbc.M110.142133; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROY R, 1984, CAN J BIOCHEM CELL B, V62, P270, DOI 10.1139/o84-037; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; van Bueren AL, 2007, J MOL BIOL, V365, P555, DOI 10.1016/j.jmb.2006.10.018; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2004, PLANTA, V218, P673, DOI 10.1007/s00425-003-1147-8; Yang H, 2006, BIOSCI BIOTECH BIOCH, V70, P538, DOI 10.1271/bbb.70.538; Yao JX, 2006, ACTA CRYSTALLOGR D, V62, P901, DOI 10.1107/S0907444906008122	48	27	27	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35999	36009		10.1074/jbc.M110.166330	http://dx.doi.org/10.1074/jbc.M110.166330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826814	Green Published, hybrid			2022-12-25	WOS:000283845300076
J	Diskar, M; Zenn, HM; Kaupisch, A; Kaufholz, M; Brockmeyer, S; Sohmen, D; Berrera, M; Zaccolo, M; Boshart, M; Herberg, FW; Prinz, A				Diskar, Mandy; Zenn, Hans-Michael; Kaupisch, Alexandra; Kaufholz, Melanie; Brockmeyer, Stefanie; Sohmen, Daniel; Berrera, Marco; Zaccolo, Manuela; Boshart, Michael; Herberg, Friedrich W.; Prinz, Anke			Regulation of cAMP-dependent Protein Kinases THE HUMAN PROTEIN KINASE X (PrKX) REVEALS THE ROLE OF THE CATALYTIC SUBUNIT alpha H-alpha I LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER BRET; MOLECULAR SIMULATION; SACCHAROMYCES-CEREVISIAE; LIVING CELLS; PKA; ACTIVATION; EXPRESSION; DYNAMICS; BINDING; KIDNEY	cAMP-dependent protein kinases are reversibly complexed with any of the four isoforms of regulatory (R) subunits, which contain either a substrate or a pseudosubstrate autoinhibitory domain. The human protein kinase X (PrKX) is an exemption as it is inhibited only by pseudosubstrate inhibitors, i.e. RI alpha or RI beta but not by substrate inhibitors RII alpha or RII beta. Detailed examination of the capacity of five PrKX-like kinases ranging from human to protozoa (Trypanosoma brucei) to form holoenzymes with human R subunits in living cells shows that this preference for pseudosubstrate inhibitors is evolutionarily conserved. To elucidate the molecular basis of this inhibitory pattern, we applied bioluminescence resonance energy transfer and surface plasmon resonance in combination with site-directed mutagenesis. We observed that the conserved alpha H-alpha I loop residue Arg-283 in PrKX is crucial for its RI over RII preference, as a R283L mutant was able to form a holoenzyme complex with wild type RII subunits. Changing the corresponding alpha H-alpha I loop residue in PKA C alpha (L277R), significantly destabilized holoenzyme complexes in vitro, as cAMP-mediated holoenzyme activation was facilitated by a factor of 2-4, and lead to a decreased affinity of the mutant C subunit for R subunits, significantly affecting RII containing holoenzymes.	[Herberg, Friedrich W.; Prinz, Anke] Univ Kassel, Dept Biochem, D-34132 Kassel, Germany; [Sohmen, Daniel; Boshart, Michael] Univ Munich, Bioctr, Genet Sect, D-82152 Planegg Martinsried, Germany; [Berrera, Marco; Zaccolo, Manuela] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	Universitat Kassel; University of Munich; University of Glasgow	Prinz, A (corresponding author), Univ Kassel, Dept Biochem, Heinrich Plett Str 40, D-34132 Kassel, Germany.	ankeprinz@uni-kassel.de	Zaccolo, Manuela/B-3802-2011; Zaccolo, Manuela/AAP-6706-2020; Herberg, Friedrich W/B-5572-2015; Boshart, Michael/A-2700-2011	Zaccolo, Manuela/0000-0002-0934-3662; Herberg, Friedrich W/0000-0001-7117-7653; Boshart, Michael/0000-0002-5070-2663	National Science Foundation-NIH [R01 AA18060]; European Union [LSHB-CT-2006-037189]; Bundesministerium fur Bildung und Forschung NGFN2 [FKZ01GR0441]; Deutsche Forschungsgemeinschaft [BO1100/2]; Otto-Braun fonds of the University of Kassel; Fondation Leducq [O6 CVD 02]; British Heart Foundation [PG/07/091/23698]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018060] Funding Source: NIH RePORTER	National Science Foundation-NIH; European Union(European Commission); Bundesministerium fur Bildung und Forschung NGFN2(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Otto-Braun fonds of the University of Kassel; Fondation Leducq(Leducq Foundation); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AA18060 from the National Science Foundation-NIH Collaborative Research in Computational Neuroscience Program (to M. Z.), European Union Grant LSHB-CT-2006-037189 (to F. W. H. and M. Z.), Bundesministerium fur Bildung und Forschung NGFN2 Grant FKZ01GR0441 (to F. W. H.), and Deutsche Forschungsgemeinschaft BO1100/2 (to M. B.).; Supported by a Ph.D. grant of the Otto-Braun fonds of the University of Kassel.; Supported by Fondation Leducq Grant O6 CVD 02 and British Heart Foundation Grant PG/07/091/23698.	Anand GS, 2007, J MOL BIOL, V374, P487, DOI 10.1016/j.jmb.2007.09.035; ANJARD C, 1993, BIOCHEMISTRY-US, V32, P9532, DOI 10.1021/bi00088a003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berrera M, 2006, BIOPHYS J, V90, P3428, DOI 10.1529/biophysj.105.071621; Berrera M, 2007, J PHYS CHEM B, V111, P1496, DOI 10.1021/jp0667893; Berrera M, 2006, BIOPHYS J, V91, P2063, DOI 10.1529/biophysj.106.083519; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Blaschke RJ, 2000, GENOMICS, V64, P187, DOI 10.1006/geno.2000.6116; Brown SHJ, 2009, J MOL BIOL, V393, P1070, DOI 10.1016/j.jmb.2009.09.014; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; da Cruz AB, 2008, J NEUROSCI, V28, P10885, DOI 10.1523/JNEUROSCI.3015-08.2008; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; Diskar M, 2007, CELL SIGNAL, V19, P2024, DOI 10.1016/j.cellsig.2007.05.012; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Etchebehere LC, 1997, EUR J BIOCHEM, V248, P820, DOI 10.1111/j.1432-1033.1997.t01-2-00820.x; Gesellchen F, 2006, EUR J CELL BIOL, V85, P663, DOI 10.1016/j.ejcb.2006.01.009; GIBBS CS, 1992, J BIOL CHEM, V267, P4806; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Li W, 2005, J HISTOCHEM CYTOCHEM, V53, P1003, DOI 10.1369/jhc.4A6568.2005; Li XH, 2005, J AM SOC NEPHROL, V16, P3543, DOI 10.1681/ASN.2005030240; Li XH, 2002, P NATL ACAD SCI USA, V99, P9260, DOI 10.1073/pnas.132051799; Li XH, 2008, BBA-MOL BASIS DIS, V1782, P1, DOI 10.1016/j.bbadis.2007.09.003; Li XH, 2009, KIDNEY INT, V76, P54, DOI 10.1038/ki.2009.95; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; MELENDEZ A, 1995, GENETICS, V141, P1507; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prinz A, 2006, CHEMBIOCHEM, V7, P1007, DOI 10.1002/cbic.200600048; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; RUBIN CS, 1972, J BIOL CHEM, V247, P36; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Schiebel K, 1997, HUM MOL GENET, V6, P1985, DOI 10.1093/hmg/6.11.1985; Semizarov D, 1998, P NATL ACAD SCI USA, V95, P15412, DOI 10.1073/pnas.95.26.15412; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; SYMCOX MM, 1994, J BIOL CHEM, V269, P23025; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	52	12	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35910	35918		10.1074/jbc.M110.155150	http://dx.doi.org/10.1074/jbc.M110.155150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20819953	Green Published, hybrid			2022-12-25	WOS:000283845300068
J	Nukaya, M; Lin, BC; Glover, E; Moran, SM; Kennedy, GD; Bradfield, CA				Nukaya, Manabu; Lin, Bernice C.; Glover, Edward; Moran, Susan M.; Kennedy, Gregory D.; Bradfield, Christopher A.			The Aryl Hydrocarbon Receptor-interacting Protein (AIP) Is Required for Dioxin-induced Hepatotoxicity but Not for the Induction of the Cyp1a1 and Cyp1a2 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-ASSOCIATED PROTEIN-2; DOSE-RESPONSE; AH RECEPTOR; SUBCELLULAR-LOCALIZATION; LIVER DEVELOPMENT; CORE COMPLEX; MICE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; RECOMBINASE; EXPRESSION	The aryl hydrocarbon receptor (AHR) plays an essential role in the toxic response to environmental pollutants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), in the adaptive up-regulation of xenobiotic metabolizing enzymes, and in hepatic vascular development. In our model of AHR signaling, the receptor is found in a cytosolic complex with a number of molecular chaperones, including Hsp90, p23, and the aryl hydrocarbon receptor-interacting protein (AIP), also known as ARA9 and XAP2. To understand the role of AIP in adaptive and toxic aspects of AHR signaling, we generated a conditional mouse model where the Aip locus can be deleted in hepatocytes. Using this model, we demonstrate two important roles for the AIP protein in AHR biology. (i) The expression of AIP in hepatocytes is essential to maintain high levels of functional cytosolic AHR protein in the mammalian liver. (ii) Expression of the AIP protein is essential for dioxin-induced hepatotoxicity. Interestingly, classical AHR-driven genes show differential dependence on AIP expression. The Cyp1b1 and Ahrr genes require AIP expression for normal up-regulation by dioxin, whereas Cyp1a1 and Cyp1a2 do not. This differential dependence on AIP provides evidence that the mammalian genome contains more than one class of AHR-responsive genes and suggests that a search for AIP-dependent, AHR-responsive genes may guide us to the targets of the dioxin-induced hepatotoxicity.	[Nukaya, Manabu; Lin, Bernice C.; Glover, Edward; Moran, Susan M.; Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Nukaya, Manabu; Kennedy, Gregory D.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bradfield, CA (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	bradfield@oncology.wisc.edu	Kennedy, Gregory/S-2433-2016	Kennedy, Gregory/0000-0002-5981-3917; Nukaya, Manabu/0000-0002-6204-0978	National Institutes of Health [R01-ES-06883, R37-ES-05703, T32-CA-009135, P30-CA-014520, K08-ES-017283]; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES017283, R01ES006883, R37ES005703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-ES-06883, R37-ES-05703, T32-CA-009135, P30-CA-014520 (to C. A. B.), and K08-ES-017283 (to G. D. K.).	Abel J, 1996, ARCH TOXICOL, V70, P510, DOI 10.1007/s002040050307; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; Carver LA, 1997, J BIOL CHEM, V272, P11452; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harstad EB, 2006, MOL PHARMACOL, V69, P1534, DOI 10.1124/mol.105.020107; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Lin BC, 2008, MOL PHARMACOL, V74, P1367, DOI 10.1124/mol.108.047068; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; MEYER BK, 1999, G H BIOCH, V38, P8907; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nukaya M, 2009, P NATL ACAD SCI USA, V106, P4923, DOI 10.1073/pnas.0809613106; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Santostefano MJ, 1997, BIOCHEM BIOPH RES CO, V233, P20, DOI 10.1006/bbrc.1997.6389; SAVAS U, 1994, J BIOL CHEM, V269, P14905; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Thomas RS, 2002, PHARMACOGENETICS, V12, P151, DOI 10.1097/00008571-200203000-00009; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Walisser JA, 2004, P NATL ACAD SCI USA, V101, P16677, DOI 10.1073/pnas.0404379101; Walisser JA, 2004, J BIOL CHEM, V279, P16326, DOI 10.1074/jbc.M400784200; Walker NJ, 1999, TOXICOL APPL PHARM, V154, P279, DOI 10.1006/taap.1998.8595; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; Whitlock JP, 1997, DRUG METAB REV, V29, P1107, DOI 10.3109/03602539709002245; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103	35	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35599	35605		10.1074/jbc.M110.132043	http://dx.doi.org/10.1074/jbc.M110.132043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829355	hybrid, Green Published			2022-12-25	WOS:000283845300038
J	Stauber, T; Jentsch, TJ				Stauber, Tobias; Jentsch, Thomas J.			Sorting Motifs of the Endosomal/Lysosomal CLC Chloride Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PLASMA-MEMBRANE; ENDOSOMAL ACIDIFICATION; RENAL ENDOCYTOSIS; PROXIMAL TUBULE; CHANNEL; EXPRESSION; CELLS; DISEASE; PROTEIN	The CLC protein family contains plasma membrane chloride channels and the intracellular chloride-proton exchangers ClC-3-7. The latter proteins mainly reside on the various compartments of the endosomal-lysosomal system where they are involved in the luminal acidification or chloride accumulation. Although their partially overlapping subcellular distribution has been studied extensively, little is known about their targeting mechanism. In a comprehensive study we now performed pulldown experiments to systematically map the differential binding of adaptor proteins of the endosomal sorting machinery (adaptor proteins and GGAs (Golgi-localized, gamma-ear containing, Arf binding)) as well as clathrin to the cytosolic regions of the intracellular CLCs. The resulting interaction pattern fitted well to the known subcellular localizations of the CLCs. By mutating potential sorting motifs, we could locate almost all binding sites, including one already known for ClC-3 and several new motifs for ClC-5, -6, and -7. The impact of the identified binding sites on the subcellular localization of CLC transporters was determined by heterologous expression of mutants. Surprisingly, some vesicular CLCs retained their localization after disruption of interaction sites. However, ClC-7 could be partially shifted from lysosomes to the plasma membrane by combined mutation of N-terminal sorting motifs. The localization of its beta-subunit, Ostm1, was determined by that of ClC-7. Ostm1 was not capable of redirecting ClC-7 to lysosomes.	[Jentsch, Thomas J.] FMP MDC, Leibniz Inst Mol Pharmakol, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), FMP MDC, Leibniz Inst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010	Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich SFB 740, C5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the Sonderforschungsbereich SFB 740 (project C5).	Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Cornejo I, 2009, J CELL PHYSIOL, V221, P650, DOI 10.1002/jcp.21900; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ESTE VEZR, 2001, NATURE */* T J NATUR, V414, P558; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; GU N, 2003, Arch, V445, P456; GU N, 1998, P Natl Acad Sci U S, V95, P8075; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Ignoul S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000474; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mohammad-Panah R, 2002, J BIOL CHEM, V277, P566, DOI 10.1074/jbc.M106968200; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; PEN AMU, 2005, J CELL SCI */* F V J, V118, P4243; Piccirillo R, 2006, J CELL SCI, V119, P2003, DOI 10.1242/jcs.02930; POE TM, 2006, P Natl Acad Sci U S, V103, P13854; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rickheit G, 2010, J BIOL CHEM, V285, P17595, DOI 10.1074/jbc.M110.115600; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Vandewalle A, 2001, AM J PHYSIOL-CELL PH, V280, pC373, DOI 10.1152/ajpcell.2001.280.2.C373; Wang YH, 2005, AM J PHYSIOL-RENAL, V289, pF850, DOI 10.1152/ajprenal.00011.2005; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Weylandt KH, 2007, MOL CANCER THER, V6, P979, DOI 10.1158/1535-7163.MCT-06-0475; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	53	56	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34537	34548		10.1074/jbc.M110.162545	http://dx.doi.org/10.1074/jbc.M110.162545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817731	Green Published, hybrid			2022-12-25	WOS:000283659100029
J	Cong, YL; Wang, GM; Guan, ZH; Chang, SA; Zhang, QP; Yang, GL; Wang, WL; Meng, QF; Ren, WM; Wang, CF; Ding, ZA				Cong, Yanlong; Wang, Guangmei; Guan, Zhenhong; Chang, Shuang; Zhang, Quanpeng; Yang, Guilian; Wang, Weili; Meng, Qingfeng; Ren, Weiming; Wang, Chunfeng; Ding, Zhuang			Reassortant between Human-Like H3N2 and Avian H5 Subtype Influenza A Viruses in Pigs: A Potential Public Health Risk	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; GENETIC-CHARACTERIZATION; INTERSPECIES TRANSMISSION; HEMAGGLUTININ; SWINE; RECEPTOR; EVOLUTION; ORIGIN; CHINA; H9N2	Background: Human-like H3N2 influenza viruses have repeatedly been transmitted to domestic pigs in different regions of the world, but it is still uncertain whether any of these variants could become established in pig populations. The fact that different subtypes of influenza viruses have been detected in pigs makes them an ideal candidate for the genesis of a possible reassortant virus with both human and avian origins. However, the determination of whether pigs can act as a "mixing vessel'' for a possible future pandemic virus is still pending an answer. This prompted us to gather the epidemiological information and investigate the genetic evolution of swine influenza viruses in Jilin, China. Methods: Nasopharyngeal swabs were collected from pigs with respiratory illness in Jilin province, China from July 2007 to October 2008. All samples were screened for influenza A viruses. Three H3N2 swine influenza virus isolates were analyzed genetically and phylogenetically. Results: Influenza surveillance of pigs in Jilin province, China revealed that H3N2 influenza viruses were regularly detected from domestic pigs during 2007 to 2008. Phylogenetic analysis revealed that two distinguishable groups of H3N2 influenza viruses were present in pigs: the wholly contemporary human-like H3N2 viruses (represented by the Moscow/10/99-like sublineage) and double-reassortant viruses containing genes from contemporary human H3N2 viruses and avian H5 viruses, both co-circulating in pig populations. Conclusions: The present study reports for the first time the coexistence of wholly human-like H3N2 viruses and double-reassortant viruses that have emerged in pigs in Jilin, China. It provides updated information on the role of pigs in interspecies transmission and genetic reassortment of influenza viruses.	[Cong, Yanlong; Wang, Guangmei; Chang, Shuang; Zhang, Quanpeng; Ding, Zhuang] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Guan, Zhenhong] Jilin Univ, Inst Zoonoses, Changchun 130023, Jilin, Peoples R China; [Yang, Guilian; Ren, Weiming; Wang, Chunfeng] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Wang, Weili; Meng, Qingfeng] Jilin Entry Exit Inspect & Quarantine Bur, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin Agricultural University	Cong, YL (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China.	wangchunfeng@jlau.edu.cn; congyanlong@126.com		Yang, Gui-Lian/0000-0001-5224-1592	Jilin University [4305050102B6, 200903334]; National Natural Scientific Fund [30972192]	Jilin University(Jilin University); National Natural Scientific Fund	This study was supported by the Jilin University Scientific Research Startup Fund (4305050102B6), the Jilin University Basic Science Research Fund (200903334) and the National Natural Scientific Fund (30972192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brown IH, 2001, INT CONGR SER, V1219, P173, DOI 10.1016/S0531-5131(01)00666-5; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CLAAS ECJ, 1994, VIROLOGY, V204, P453, DOI 10.1006/viro.1994.1553; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; DALY JM, 1998, TXB INFLUENZA, P168; GALLAGHER PJ, 1992, J VIROL, V66, P7136, DOI 10.1128/JVI.66.12.7136-7145.1992; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; KUNDIN WD, 1970, NATURE, V228, P857, DOI 10.1038/228857a0; LI MC, 2008, PLOS PHATHOGENS, V4, P1; Lindstrom S, 1996, ARCH VIROL, V141, P1349, DOI 10.1007/BF01718836; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Nakajima K, 2003, J VIROL, V77, P10088, DOI 10.1128/JVI.77.18.10088-10098.2003; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; OLDEN K, 1982, BIOCHIM BIOPHYS ACTA, V650, P209, DOI 10.1016/0304-4157(82)90017-X; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SEIDEL W, 1991, ARCH VIROL, V120, P289, DOI 10.1007/BF01310484; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; SHORTRIDGE KF, 1977, SCIENCE, V196, P1454, DOI 10.1126/science.867041; SHU LL, 1994, VIROLOGY, V202, P825, DOI 10.1006/viro.1994.1404; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Reeth K, 2004, VIRUS RES, V103, P115, DOI 10.1016/j.virusres.2004.02.023; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Yassine HM, 2008, VACCINE, V26, P966, DOI 10.1016/j.vaccine.2007.11.094; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	46	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12591	10.1371/journal.pone.0012591	http://dx.doi.org/10.1371/journal.pone.0012591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830295	Green Submitted, Green Published, gold			2022-12-25	WOS:000281631300019
J	Ruhaak, LR; Uh, HW; Beekman, M; Koeleman, CAM; Hokke, CH; Westendorp, RGJ; Wuhrer, M; Houwing-Duistermaat, JJ; Slagboom, PE; Deelder, AM				Ruhaak, L. Renee; Uh, Hae-Won; Beekman, Marian; Koeleman, Carolien A. M.; Hokke, Cornelis H.; Westendorp, Rudi G. J.; Wuhrer, Manfred; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Deelder, Andre M.			Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity	PLOS ONE			English	Article							STRUCTURAL-CHANGES; GLYCOSYLATION; SERUM; EXPRESSION; OLIGOSACCHARIDES; MECHANISMS; BIOMARKERS; PROTEINS; CDNA; AGE	Background: Markers for longevity that reflect the health condition and predict healthy aging are extremely scarce. Such markers are, however, valuable in aging research. It has been shown previously that the N-glycosylation pattern of human immunoglobulin G (IgG) is age-dependent. Here we investigate whether N-linked glycans reflect early features of human longevity. Methodology/Principal Findings: The Leiden Longevity Study (LLS) consists of nonagenarian sibling pairs, their offspring, and partners of the offspring serving as control. IgG subclass specific glycosylation patterns were obtained from 1967 participants in the LLS by MALDI-TOF-MS analysis of tryptic IgG Fc glycopeptides. Several regression strategies were applied to evaluate the association of IgG glycosylation with age, sex, and longevity. The degree of galactosylation of IgG decreased with increasing age. For the galactosylated glycoforms the incidence of bisecting GlcNAc increased as a function of age. Sex-related differences were observed at ages below 60 years. Compared to males, younger females had higher galactosylation, which decreased stronger with increasing age, resulting in similar galactosylation for both sexes from 60 onwards. In younger participants (<60 years of age), but not in the older age group (>60 years), decreased levels of non-galactosylated glycoforms containing a bisecting GlcNAc reflected early features of longevity. Conclusions/Significance: We here describe IgG glycoforms associated with calendar age at all ages and the propensity for longevity before middle age. As modulation of IgG effector functions has been described for various IgG glycosylation features, a modulatory effect may be expected for the longevity marker described in this study.	[Ruhaak, L. Renee; Koeleman, Carolien A. M.; Hokke, Cornelis H.; Wuhrer, Manfred; Deelder, Andre M.] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Uh, Hae-Won; Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Med Stat, Leiden, Netherlands; [Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ruhaak, LR (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands.	l.r.ruhaak@lumc.nl	Wuhrer, Manfred/ABE-9168-2020; Beekman, Marian/L-3004-2019; Houwing-Duistermaat, Jeanne/V-9048-2018; Hokke, Cornelis Hendrik/AAQ-4712-2021; Slagboom, P. Eline/R-4790-2016; Ruhaak, Renee/AAE-7668-2019	Wuhrer, Manfred/0000-0002-0814-4995; Beekman, Marian/0000-0003-0585-6206; Hokke, Cornelis Hendrik/0000-0003-3545-7804; Slagboom, P. Eline/0000-0002-2875-4723; Ruhaak, Renee/0000-0003-3737-3807; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Uh, Hae-Won/0000-0003-4195-7872	IOP [IGE05007]	IOP	This work was supported by IOP Grant IGE05007. http://www.senternovem.nl/iopgenomics/index.asp. http://www.senternovem.nl/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2006, J PROTEOME RES, V5, P1626, DOI 10.1021/pr060010k; Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8; Heijmans BT, 2006, PLOS MED, V3, P2317, DOI 10.1371/journal.pmed.0030495; Iida S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-58; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shikata K, 1998, GLYCOCONJUGATE J, V15, P683, DOI 10.1023/A:1006936431276; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Yamada E, 1997, GLYCOCONJUGATE J, V14, P401, DOI 10.1023/A:1018582930906	22	87	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12566	10.1371/journal.pone.0012566	http://dx.doi.org/10.1371/journal.pone.0012566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830288	gold, Green Submitted, Green Published			2022-12-25	WOS:000281631300006
J	Schulz, P; Werner, J; Stauber, T; Henriksen, K; Fendler, K				Schulz, Patrick; Werner, Johannes; Stauber, Tobias; Henriksen, Kim; Fendler, Klaus			The G215R Mutation in the Cl-/H+-Antiporter ClC-7 Found in ADO II Osteopetrosis Does Not Abolish Function but Causes a Severe Trafficking Defect	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; LYSOSOMAL STORAGE DISEASE; CLCN7 GENE-MUTATIONS; CHLORIDE CHANNELS; PROKARYOTIC HOMOLOG; BONE-RESORPTION; BETA-SUBUNIT; OSTEOCLASTS; ACIDIFICATION; TRANSPORTERS	Background: ClC-7 is a ubiquitous transporter which is broadly expressed in mammalian tissues. It is implied in the pathogenesis of lysosomal storage disease and osteopetrosis. Because of its endosomal/lysosomal localization it is still poorly characterized. Methodology/Principal Findings: An electrophysiological characterization of rat ClC-7 using solid-supported membrane-based electrophysiology is presented. The measured currents show the characteristics of ClC-7 and confirm its function as a Cl-/H+-antiporter. We have used rat ClC-7 in CHO cells as a model system to investigate the functionality and cellular localization of the wt transporter and its variant G213R ClC-7 which is the analogue of human G215R ClC-7 responsible for autosomal dominant osteopetrosis type II. Our study shows that rat G213R ClC-7 is functional but has a localization defect in CHO cells which prevents it from being correctly targeted to the lysosomal membrane. The electrophysiological assay is tested as a tool for drug discovery. The assay is validated with a number of drug candidates. It is shown that ClC-7 is inhibited by DIDS, NPPB and NS5818 at micromolar concentrations. Conclusions/Significance: It is suggested that the scenario found in the CHO model system also applies to the human transporter and that mislocalization rather than impaired functionality of G215R ClC-7 is the primary cause of the related autosomal dominant osteopetrosis type II. Furthermore, the robust solid-supported membrane-based electrophysiological assay is proposed for rapid screening for potential ClC-7 inhibitors which are discussed for treatment of osteoporosis.	[Schulz, Patrick; Werner, Johannes; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Stauber, Tobias] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Stauber, Tobias] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Henriksen, Kim] Nord Biosci, Herlev, Denmark	Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Nordic Bioscience	Schulz, P (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	klaus.fendler@biophys.mpg.de	Stauber, Tobias/E-4005-2010; Werner, Johannes/U-4724-2019	Stauber, Tobias/0000-0003-0727-6109; Fendler, Klaus/0000-0002-5699-7060; Werner, Johannes/0000-0001-7322-4433	Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V., 80084 Munchen, Germany; Deutsche Forschungsgemeinschaft, 53170 Bonn, Germany [SFB 807, SFB 740]; Nordic Biosciences, 2730 Herlev, Denmark; Nordic Biosciences	Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V., 80084 Munchen, Germany; Deutsche Forschungsgemeinschaft, 53170 Bonn, Germany(German Research Foundation (DFG)); Nordic Biosciences, 2730 Herlev, Denmark; Nordic Biosciences	This work was funded by the Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V., 80084 Munchen, Germany (P.S., J.W., K.F.), the Deutsche Forschungsgemeinschaft, SFB 807 to K.F. (P.S.) and SFB 740 to Thomas J. Jentsch (T. S.), 53170 Bonn, Germany, and Nordic Biosciences, 2730 Herlev, Denmark (K.H.). As Nordic Biosciences have employed K.H. they did have a role in reading the manuscript and decision to publish. Apart from that Nordic Biosciences had no role in study design, data collection and analysis and have no financial interest in the manuscript.; Kim Hendriksen is an employee of Nordic Biosciences. Nordic Biosciences supported the study through salaries and materials but had no role in the study design or performance and have no financial interest of the results. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; AUTUORI F, 1982, J CELL SCI, V57, P1; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Campos-Xavier AB, 2003, HUM GENET, V112, P186, DOI 10.1007/s00439-002-0861-9; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Diewald L, 2002, BIOCHEM BIOPH RES CO, V291, P421, DOI 10.1006/bbrc.2002.6462; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Freundt EC, 2007, CELL RES, V17, P956, DOI 10.1038/cr.2007.80; Garcia-Celma JJ, 2007, LANGMUIR, V23, P10074, DOI 10.1021/la701188f; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; Henriksen K, 2008, CALCIFIED TISSUE INT, V83, P230, DOI 10.1007/s00223-008-9168-8; Henriksen K, 2009, BIOCHEM BIOPH RES CO, V378, P804, DOI 10.1016/j.bbrc.2008.11.145; HUNTER MJ, 1961, BIOCHIM BIOPHYS ACTA, V47, P580, DOI 10.1016/0006-3002(61)90553-4; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kajiya H, 2009, PFLUG ARCH EUR J PHY, V458, P1049, DOI 10.1007/s00424-009-0689-4; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Plans V, 2009, PFLUG ARCH EUR J PHY, V458, P23, DOI 10.1007/s00424-008-0597-z; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Schaller S, 2005, DRUG NEWS PERSPECT, V18, P489, DOI 10.1358/dnp.2005.18.8.944546; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; VENTURI M, 2003, MEMBRANE PROTEIN PUR; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Waguespack SG, 2007, J CLIN ENDOCR METAB, V92, P771, DOI 10.1210/jc.2006-1986; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao QX, 2009, BIOCHEM BIOPH RES CO, V384, P277, DOI 10.1016/j.bbrc.2009.04.088; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605	45	35	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12585	10.1371/journal.pone.0012585	http://dx.doi.org/10.1371/journal.pone.0012585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830208	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000281631300014
J	van Hensbroek, MB; Calis, JCJ; Phiri, KS; Vet, R; Munthali, F; Kraaijenhagen, R; van den Berg, H; Faragher, B; Bates, I; Molyneux, ME				van Hensbroek, Michael Boele; Calis, Job C. J.; Phiri, Kamija S.; Vet, Raymond; Munthali, Francis; Kraaijenhagen, Rob; van den Berg, Henk; Faragher, Brian; Bates, Imelda; Molyneux, Malcolm E.			Pathophysiological Mechanisms of Severe Anaemia in Malawian Children	PLOS ONE			English	Article							BLOOD-TRANSFUSION; NORTHERN GHANA; BONE-MARROW; IRON STORES; MALARIA; AREA	Background: Severe anaemia is a major cause of morbidity and mortality in African children. The aetiology is multi-factorial, but interventions have often targeted only one or a few causal factors, with limited success. Methods and Findings: We assessed the contribution of different pathophysiological mechanisms (red cell production failure [RCPF], haemolysis and blood loss) to severe anaemia in Malawian children in whom etiological factors have been described previously. More complex associations between etiological factors and the mechanisms were explored using structural equation modelling. In 235 children with severe anaemia (haemoglobin <3.2 mMol/L [5.0 g/dl]) studied, RCPF, haemolysis and blood loss were found in 48.1%, 21.7% and 6.9%, respectively. The RCPF figure increased to 86% when a less stringent definition of RCPF was applied. RCPF was the most common mechanism in each of the major etiological subgroups (39.7-59.7%). Multiple aetiologies were common in children with severe anaemia. In the final model, nutritional and infectious factors, including malaria, were directly or indirectly associated with RCPF, but not with haemolysis. Conclusion: RCPF was the most common pathway leading to severe anaemia, from a variety of etiological factors, often found in combination. Unlike haemolysis or blood loss, RCPF is a defect that is likely to persist to a significant degree unless all of its contributing aetiologies are corrected. This provides a further explanation for the limited success of the single factor interventions that have commonly been applied to the prevention or treatment of severe anaemia. Our findings underline the need for a package of measures directed against all of the local aetiologies of this often fatal paediatric syndrome.	[van Hensbroek, Michael Boele; Calis, Job C. J.; Phiri, Kamija S.; Munthali, Francis; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [van Hensbroek, Michael Boele; Calis, Job C. J.; van den Berg, Henk] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [van Hensbroek, Michael Boele; Faragher, Brian; Bates, Imelda; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Vet, Raymond] Univ Amsterdam, Acad Med Ctr, Dept Specialized Hematol, NL-1105 AZ Amsterdam, Netherlands; [Kraaijenhagen, Rob] Meander Med Ctr, Dept Clin Chem, Amersfoort, Netherlands	University of Malawi; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Liverpool School of Tropical Medicine; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam; Meander Medisch Centrum	van Hensbroek, MB (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	MBVH04@Gmail.com		Phiri, Kamija/0000-0003-1753-2727; Boele van Hensbroek, Michael/0000-0003-1907-5427; bates, imelda/0000-0002-0862-8199	Wellcome Trust [064722]; Royal Netherlands Academy of Arts and Sciences; Nutricia Research Foundation; Ter Meulen Fund	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Netherlands Academy of Arts and Sciences; Nutricia Research Foundation(Danone Nutricia); Ter Meulen Fund	The study was supported by a grant (064722) from the Wellcome Trust and by independent grants from the Royal Netherlands Academy of Arts and Sciences, Nutricia Research Foundation, and the Ter Meulen Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	Arbuckle J., 2007, AMOS 7 0 USERS GUIDE; Behrman RE, 2004, NELSON TXB PEDIAT, V17th; BIERI JG, 1979, AM J CLIN NUTR, V32, P2143, DOI 10.1093/ajcn/32.10.2143; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; CALIS JCJ, 2008, NEW ENGL J MED, V258, P12; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; de Gruijter JM, 2005, TROP MED INT HEALTH, V10, P574, DOI 10.1111/j.1365-3156.2005.01440.x; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; EKVALL HP, 2000, THESIS U STOCKHOLM S; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Phiri KS, 2009, J CLIN PATHOL, V62, P685, DOI 10.1136/jcp.2009.064451; Shaker Z A, 1994, J Egypt Soc Parasitol, V24, P656; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239	22	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12589	10.1371/journal.pone.0012589	http://dx.doi.org/10.1371/journal.pone.0012589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830291	gold, Green Accepted, Green Published			2022-12-25	WOS:000281631300017
J	Denzler, KL; Waters, R; Jacobs, BL; Rochon, Y; Langland, JO				Denzler, Karen L.; Waters, Robert; Jacobs, Bertram L.; Rochon, Yvan; Langland, Jeffrey O.			Regulation of Inflammatory Gene Expression in PBMCs by Immunostimulatory Botanicals	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; NF-KAPPA-B; ASTRAGALUS-MEMBRANACEUS; ALTERNATIVE MEDICINE; GLYCYRRHIZA-GLABRA; IN-VITRO; COMPLEMENTARY MEDICINE; BACTERIAL ENDOPHYTES; ECHINACEA-PURPUREA; RADIX-ASTRAGALI	Many hundreds of botanicals are used in complementary and alternative medicine for therapeutic use as antimicrobials and immune stimulators. While there exists many centuries of anecdotal evidence and few clinical studies on the activity and efficacy of these botanicals, limited scientific evidence exists on the ability of these botanicals to modulate the immune and inflammatory responses. Using botanogenomics (or herbogenomics), this study provides novel insight into inflammatory genes which are induced in peripheral blood mononuclear cells following treatment with immunomodulatory botanical extracts. These results may suggest putative genes involved in the physiological responses thought to occur following administration of these botanical extracts. Using extracts from immunostimulatory herbs (Astragalus membranaceus, Sambucus cerulea, Andrographis paniculata) and an immunosuppressive herb (Urtica dioica), the data presented supports previous cytokine studies on these herbs as well as identifying additional genes which may be involved in immune cell activation and migration and various inflammatory responses, including wound healing, angiogenesis, and blood pressure modulation. Additionally, we report the presence of lipopolysaccharide in medicinally prepared extracts of these herbs which is theorized to be a natural and active component of the immunostimulatory herbal extracts. The data presented provides a more extensive picture on how these herbs may be mediating their biological effects on the immune and inflammatory responses.	[Denzler, Karen L.; Waters, Robert; Jacobs, Bertram L.; Langland, Jeffrey O.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Waters, Robert; Rochon, Yvan; Langland, Jeffrey O.] SW Coll Naturopath Med, Dept Naturopath Res, Tempe, AZ USA; [Rochon, Yvan] Herbal Vital Inc, Sedona, AZ USA	Arizona State University; Arizona State University-Tempe	Denzler, KL (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	Jeffrey.Langland@asu.edu			Arizona State University Biodesign Institute; Southwest College of Naturopathic Medicine	Arizona State University Biodesign Institute; Southwest College of Naturopathic Medicine	Funding was provided by the Arizona State University Biodesign Institute and the Southwest College of Naturopathic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Barak V, 2001, EUR CYTOKINE NETW, V12, P290; BARAK V, 2004, ISR MED ASSOC J, V4, P919; Barnes Patricia M, 2004, Adv Data, P1; Barrios-Rodiles M, 1998, J IMMUNOL, V161, P2441; Bergner P., 2005, MED HERBALISM, V14, P1; Bezugla Y, 2006, PROSTAG OTH LIPID M, V79, P93, DOI 10.1016/j.prostaglandins.2005.11.001; Block Keith I, 2003, Integr Cancer Ther, V2, P247, DOI 10.1177/1534735403256419; Brush J, 2006, PHYTOTHER RES, V20, P687, DOI 10.1002/ptr.1938; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Chen W, 2008, EXP CLIN ENDOCR DIAB, V116, P468, DOI 10.1055/s-2008-1058081; Cho WCS, 2007, CANCER LETT, V252, P43, DOI 10.1016/j.canlet.2006.12.001; Cho WCS, 2007, J ETHNOPHARMACOL, V113, P132, DOI 10.1016/j.jep.2007.05.020; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Dong Jing, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P872; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; Fleming LW, 1999, SCOT MED J, V44, P176, DOI 10.1177/003693309904400609; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; Fu PP, 2009, J ENVIRON SCI HEAL C, V27, P91, DOI 10.1080/10590500902885676; Ganguly T, 2001, PHYTOMEDICINE, V8, P348, DOI 10.1078/0944-7113-00055; GESSANI S, 1993, J IMMUNOL, V151, P3758; Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hallemeesch MM, 2003, AM J PHYSIOL-ENDOC M, V285, pE871, DOI 10.1152/ajpendo.00004.2002; Han DO, 2009, METHOD FIND EXP CLIN, V31, P95, DOI 10.1358/mf.2009.31.2.1353846; Han SJ, 2002, J BIOL CHEM, V277, P44715, DOI 10.1074/jbc.M202524200; HIKINO H, 1976, PLANTA MED, V30, P297, DOI 10.1055/s-0028-1097733; Hmama Z, 1999, J BIOL CHEM, V274, P1050, DOI 10.1074/jbc.274.2.1050; HONG H, 1986, ORIENTAL MATERIA MED; Kang YJ, 2008, EXP BIOL MED, V233, P1059, DOI 10.3181/0802-MR-47; KAWAGUCHI H, 1995, RES COMMUN MOL PATH, V89, P317; Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004; Kusum Mayura, 2004, Journal of the Medical Association of Thailand, V87, P1065; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Lee KY, 2005, INT IMMUNOPHARMACOL, V5, P1225, DOI 10.1016/j.intimp.2005.02.020; Lei Yan, 2003, Zhongguo Zhongyao Zazhi, V28, P876; Liu J.P., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003711.PUB2; Mao Su-ping, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P121; Martin KW, 2003, ANTIVIR THER, V8, P77; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matkovic Z, 2010, PHYTOTHER RES, V24, P175, DOI [10.1002/ptr.2877, 10.1002/ptr.3062]; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Moeenrezakhanlou A, 2008, J LEUKOCYTE BIOL, V84, P519, DOI 10.1189/jlb.1207833; Nose M, 1998, BIOL PHARM BULL, V21, P1110, DOI 10.1248/bpb.21.1110; Peng Tianqing, 1995, Chinese Medical Sciences Journal, V10, P146; Pernerstorfer T, 1999, CIRCULATION, V100, P2485, DOI 10.1161/01.CIR.100.25.2485; Pollet I, 2003, BLOOD, V102, P1740, DOI 10.1182/blood-2003-01-0288; PURI A, 1993, J NAT PROD, V56, P995, DOI 10.1021/np50097a002; Qi ZH, 2006, HYPERTENSION, V48, P323, DOI 10.1161/01.HYP.0000231934.67549.b7; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Riehemann K, 1999, FEBS LETT, V442, P89, DOI 10.1016/S0014-5793(98)01622-6; Rios JL, 1997, PHYTOTHER RES, V11, P411, DOI 10.1002/(SICI)1099-1573(199709)11:6<411::AID-PTR132>3.0.CO;2-6; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Setty AR, 2005, SEMIN ARTHRITIS RHEU, V34, P773, DOI 10.1016/j.semarthrit.2005.01.011; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760; Shon YH, 2002, BIOL PHARM BULL, V25, P77, DOI 10.1248/bpb.25.77; Sinclair S, 1998, Altern Med Rev, V3, P338; Spelman K, 2006, ALTERN MED REV, V11, P128; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; SUN Y, 2004, YI JUN YI XUE XUE BA, V24, P57; Tan BKH, 2004, CURR MED CHEM, V11, P1423, DOI 10.2174/0929867043365161; Teucher T, 1996, ARZNEIMITTEL-FORSCH, V46, P906; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; THORNE, 2005, ALTERN MED REV, V10, P51; WANG F, 2008, ZHONGGUO ZHONG XI YI, V28; Wei GH, 2003, INT J SYST EVOL MICR, V53, P1575, DOI 10.1099/ijs.0.02031-0; Wei HM, 2003, ONCOL REP, V10, P1507; Yang XY, 2010, VACCINE, V28, P737, DOI 10.1016/j.vaccine.2009.10.065; Yesilada E, 2005, J ETHNOPHARMACOL, V96, P71, DOI 10.1016/j.jep.2004.08.036; YIN X, 2010, BIOCH BIOPHYS RES CO; Yu SY, 2007, J ETHNOPHARMACOL, V110, P352, DOI 10.1016/j.jep.2006.09.024; Zaks-Zilberman M, 1998, INFECT IMMUN, V66, P4669, DOI 10.1128/IAI.66.10.4669-4675.1998; ZHAO HY, 1991, CHINESE MED J-PEKING, V104, P770; Zhu XL, 2007, PHYTOTHER RES, V21, P663, DOI 10.1002/ptr.2144; Zwickey H, 2007, PHYTOTHER RES, V21, P1109, DOI 10.1002/ptr.2207	84	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12561	10.1371/journal.pone.0012561	http://dx.doi.org/10.1371/journal.pone.0012561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838436	Green Submitted, gold, Green Published			2022-12-25	WOS:000281627700014
J	Patel, VN; Bebek, G; Mariadason, JM; Wang, DH; Augenlicht, LH; Chance, MR				Patel, Vishal N.; Bebek, Gurkan; Mariadason, John M.; Wang, Donghai; Augenlicht, Leonard H.; Chance, Mark R.			Prediction and Testing of Biological Networks Underlying Intestinal Cancer	PLOS ONE			English	Article							CELL MATURATION; PROSTATE-CANCER; EXPRESSION DATA; TUMOR-FORMATION; BREAST-CANCER; PROTEIN; DIFFERENTIATION; DATABASE; GROWTH; PROLIFERATION	Colorectal cancer progresses through an accumulation of somatic mutations, some of which reside in so-called "driver'' genes that provide a growth advantage to the tumor. To identify points of intersection between driver gene pathways, we implemented a network analysis framework using protein interactions to predict likely connections - both precedented and novel - between key driver genes in cancer. We applied the framework to find significant connections between two genes, Apc and Cdkn1a (p21), known to be synergistic in tumorigenesis in mouse models. We then assessed the functional coherence of the resulting Apc-Cdkn1a network by engineering in vivo single node perturbations of the network: mouse models mutated individually at Apc (Apc(1638N+/-)) or Cdkn1a (Cdkn1a(-/-)), followed by measurements of protein and gene expression changes in intestinal epithelial tissue. We hypothesized that if the predicted network is biologically coherent (functional), then the predicted nodes should associate more specifically with dysregulated genes and proteins than stochastically selected genes and proteins. The predicted Apc-Cdkn1a network was significantly perturbed at the mRNA-level by both single gene knockouts, and the predictions were also strongly supported based on physical proximity and mRNA coexpression of proteomic targets. These results support the functional coherence of the proposed Apc-Cdkn1a network and also demonstrate how network-based predictions can be statistically tested using high-throughput biological data.	[Patel, Vishal N.; Bebek, Gurkan; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Patel, Vishal N.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Bebek, Gurkan; Chance, Mark R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Mariadason, John M.; Wang, Donghai; Augenlicht, Leonard H.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA; [Chance, Mark R.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Case Western Reserve University	Patel, VN (corresponding author), Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	mark.chance@case.edu	Mariadason, John/N-2003-2013	Mariadason, John/0000-0001-9123-7684	National Center for Research Resources [UL1-RR024989]; Case Western Reserve University Comprehensive Cancer Center [P30-CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Case Western Reserve University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the National Institutes of Health Grants UL1-RR024989 from the National Center for Research Resources (Clinical and Translational Science Awards) and P30-CA043703 from the Case Western Reserve University Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Arora S, 2003, CANCER RES, V63, P6894; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bebek G, 2006, THEOR COMPUT SCI, V369, P239, DOI 10.1016/j.tcs.2006.08.045; Bebek G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-335; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Constancio-Lund SS, 2009, MOL CARCINOGEN, V48, P156, DOI 10.1002/mc.20466; Ekins S, 2006, DRUG METAB DISPOS, V34, P495, DOI 10.1124/dmd.105.008458; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Guzman-Aranguez A, 2005, J CELL BIOCHEM, V94, P178, DOI 10.1002/jcb.20293; Halberg RB, 2008, GENETICS, V180, P601, DOI 10.1534/genetics.108.091967; Han LY, 2006, CANCER RES, V66, P8633, DOI 10.1158/0008-5472.CAN-06-1410; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Inokuchi J, 2009, INT J CANCER, V124, P68, DOI 10.1002/ijc.23928; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; Kuiper N. H., 1962, P K NED AKAD WETENSC, P38; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Martin NG, 2008, FEBS J, V275, P3099, DOI 10.1111/j.1742-4658.2008.06463.x; Mewes HW, 1999, NUCLEIC ACIDS RES, V27, P44, DOI 10.1093/nar/27.1.44; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; NIBBE RK, PLOS COMPUT IN PRESS; Nibbe RK, 2009, MOL CELL PROTEOMICS, V8, P827, DOI 10.1074/mcp.M800428-MCP200; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xing JP, 2008, AM J PHYSIOL-RENAL, V295, pF145, DOI 10.1152/ajprenal.00092.2008; Yamaguchi T, 2008, J CELL PHYSIOL, V217, P423, DOI 10.1002/jcp.21517; Yang WC, 2001, CANCER RES, V61, P565; Yao DG, 2008, J CELL SCI, V121, P1758, DOI 10.1242/jcs.021147; Zirbes TK, 2000, INT J CANCER, V89, P14, DOI 10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L	57	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12497	10.1371/journal.pone.0012497	http://dx.doi.org/10.1371/journal.pone.0012497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824133	Green Published, gold			2022-12-25	WOS:000281456100011
J	Belleudi, F; Purpura, V; Scrofani, C; Persechino, F; Leone, L; Torrisi, MR				Belleudi, Francesca; Purpura, Valeria; Scrofani, Cristina; Persechino, Flavia; Leone, Laura; Torrisi, Maria Rosaria			Expression and signaling of the tyrosine kinase FGFR2b/KGFR regulates phagocytosis and melanosome uptake in human keratinocytes	FASEB JOURNAL			English	Article						KGF; FGF10; melanosome transfer; PLC gamma; HaCaT cells	GROWTH-FACTOR RECEPTOR; CORTACTIN; SKIN; MELANOCYTES; ENDOCYTOSIS; EPIDERMIS; DYNAMICS; INVASION; PATHWAY; CELLS	Membrane and actin cytoskeleton dynamics during phagocytosis can be triggered and amplified by the signal transduction of receptor tyrosine kinases. The epidermal keratinocytes appear to use the phagocytic mechanism of uptake to ingest melanosomes released by the melanocytes and play a pivotal role in the transfer process. We have previously demonstrated that the keratinocyte growth factor KGF/FGF7 promotes the melanosome uptake through activation of its receptor tyrosine kinase FGFR2b/KGFR. The aim of the present study was to investigate the contribution of KGFR expression, activation, and signaling in regulating the phagocytic process and the melanosome transfer. Phagocytosis was analyzed in vitro using fluorescent latex beads on human keratinocytes induced to differentiate. Melanosome transfer was investigated in keratinocyte-melanocyte cocultures. KGFR depletion by small interfering RNA microinjection and overexpression by transfection of wild type or defective mutant KGFR were performed to demonstrate the direct effect of the receptor on phagocytosis and melanosome transfer. Colocalization of the phagocytosed beads with the internalized receptors in phagolysosomes was analyzed by optical sectioning and 3-dimensional reconstruction. KGFR ligands triggered phagocytosis and melanosome transfer in differentiated keratinocytes, and receptor kinase activity and signaling were required for these effects, suggesting that FGFR2b/KGFR expression/activity and PLC gamma signaling pathway play crucial roles in phagocytosis.-Belleudi, F., Purpura, V., Scrofani, C., Persechino, F., Leone, L., and Torrisi, M. R. Expression and signaling of the tyrosine kinase FGFR2b/KGFR regulates phagocytosis and melanosome uptake in human keratinocytes. FASEB J. 25, 170-181 (2011). www.fasebj.org	[Belleudi, Francesca; Purpura, Valeria; Scrofani, Cristina; Persechino, Flavia; Leone, Laura; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Ist Pasteur, Dipartimento Med Clin & Mol, Fdn Cenci Bolognetti, Rome, Italy; [Torrisi, Maria Rosaria] Azienda Osped StAndrea, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome	Torrisi, MR (corresponding author), Dip Med Clin & Mol, Piazza Sassari 3, I-00161 Rome, Italy.	mara.torrisi@uniroma1.it	Purpura, Valeria/K-3052-2018	PURPURA, VALERIA/0000-0002-1272-313X	Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR); Ministero della Salute [RF-IMG-2006-406655]; Associazione Italiana per la Ricerca sul Cancro (AIRC), Italy	Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC), Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR), from Ministero della Salute (RF-IMG-2006-406655), and from Associazione Italiana per la Ricerca sul Cancro (AIRC), Italy.	Ando H, 2010, PIGM CELL MELANOMA R, V23, P129, DOI 10.1111/j.1755-148X.2009.00640.x; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Belleudi F, 2006, FASEB J, V20, P395, DOI 10.1096/fj.05-3934fje; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Braun S, 2006, J CELL SCI, V119, P4841, DOI 10.1242/jcs.03259; Capone A, 2000, CELL GROWTH DIFFER, V11, P607; Cardinali G, 2005, J INVEST DERMATOL, V125, P1190, DOI 10.1111/j.0022-202X.2005.23929.x; Cardinali G, 2008, J INVEST DERMATOL, V128, P558, DOI 10.1038/sj.jid.5701063; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Ceridono M, 2005, BIOCHEM BIOPH RES CO, V327, P523, DOI 10.1016/j.bbrc.2004.12.031; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Duval C, 2001, PIGM CELL RES, V14, P348, DOI 10.1034/j.1600-0749.2001.140506.x; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Keller UAD, 2004, EUR J CELL BIOL, V83, P607; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Marchese C, 1998, J CELL SCI, V111, P3517; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Olazabal IM, 2001, J CELL BIOL, V154, P679, DOI 10.1083/jcb.200105061; Scott G, 2002, PIGM CELL RES, V15, P322, DOI 10.1034/j.1600-0749.2002.02056.x; Seiberg M, 2000, J INVEST DERMATOL, V115, P162, DOI 10.1046/j.1523-1747.2000.00035.x; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; Sharlow ER, 2000, J CELL SCI, V113, P3093; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Virador VM, 2001, FASEB J, V15, P105, DOI 10.1096/fj.01-0518fje; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; WOLFF K, 1972, J ULTRA MOL STRUCT R, V39, P262, DOI 10.1016/S0022-5320(72)90022-6	35	27	28	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					170	181		10.1096/fj.10-162156	http://dx.doi.org/10.1096/fj.10-162156			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20844240				2022-12-25	WOS:000285869500016
J	Pagant, S; Halliday, JJ; Kougentakis, C; Miller, EA				Pagant, Silvere; Halliday, John J.; Kougentakis, Christos; Miller, Elizabeth A.			Intragenic Suppressing Mutations Correct the Folding and Intracellular Traffic of Misfolded Mutants of Yor1p, a Eukaryotic Drug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; DISEASE-ASSOCIATED MUTATIONS; MULTIDRUG ABC TRANSPORTER; CHLORIDE CHANNEL ACTIVITY; CYSTIC-FIBROSIS; P-GLYCOPROTEIN; ATP-BINDING; TRANSMEMBRANE SEGMENTS; PROMOTE MATURATION; CYTOPLASMIC LOOP	ATP-binding cassette (ABC) transporters play pivotal physiological roles in substrate transport across membranes, and defective assembly of these proteins can cause severe disease associated with improper drug or ion flux. The yeast protein Yor1p is a useful model to study the biogenesis of ABC transporters; deletion of a phenylalanine residue in the first nucleotide-binding domain (NBD1) causes misassembly and retention in the endoplasmic reticulum (ER) of the resulting protein Yor1p-Delta F670, similar to the predominant disease-causing allele in humans, CFTR-Delta F508. Here we describe two novel Yor1p mutants, G278R and I1084P, which fail to assemble and traffic similar to Yor1p-Delta F670. These mutations are located in the two intracellular loops (ICLs) that interface directly with NBD1, and thus disrupt a functionally important structural module. We isolated 2 second-site mutations, F270S and R1168M, which partially correct the folding injuries associated with the G278R, I1084P, and Delta F670 mutants and reinstate their trafficking. The position of both corrective mutations at the cytoplasmic face of a transmembrane helix suggests that they restore biogenesis by influencing the behavior of the transmembrane domains rather than by direct restoration of the ICL1-ICL4-NBD1 structural module. Given the conserved topology of many ABC transporters, our findings provide new understanding of functionally important inter-domain interactions and suggest new potential avenues for correcting folding defects caused by abrogation of those domain interfaces.	[Pagant, Silvere; Halliday, John J.; Kougentakis, Christos; Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Miller, EA (corresponding author), 617A Fairchild Ctr, MC 2264, New York, NY 10027 USA.	em2282@columbia.edu		Miller, Elizabeth/0000-0002-1033-8369	National Institutes of Health [GM078186]; Cystic Fibrosis Foundation [PAGANT08F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078186 (to E. A. M.) and Cystic Fibrosis Foundation Grant PAGANT08F0 (to S. P.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	40	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36304	36314		10.1074/jbc.M110.142760	http://dx.doi.org/10.1074/jbc.M110.142760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837481	Green Published, hybrid			2022-12-25	WOS:000284146100043
J	Germain, C; Bihl, F; Zahn, S; Poupon, G; Dumaurier, MJ; Rampanarivo, HH; Padkjaer, SB; Spee, P; Braud, VM				Germain, Claire; Bihl, Franck; Zahn, Stefan; Poupon, Gwenola; Dumaurier, Marie-Jeanne; Rampanarivo, Hariniaina Henintsoa; Padkjaer, Soren Berg; Spee, Pieter; Braud, Veronique M.			Characterization of Alternatively Spliced Transcript Variants of CLEC2D Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NKR-P1A; CUTTING EDGE; LIGAND; RECOGNITION; CELLS; ACTIVATION; EXPRESSION; RECEPTORS; FAMILY	Lectin-like transcript 1 (LLT1) encoded by CLEC2D gene is a C-type lectin-like molecule interacting with human CD161 (NKR-P1A) receptor expressed by natural killer cells and subsets of T cells. Using RT-PCR and sequencing, we identified several CLEC2D alternatively spliced transcript variants generated by exon skipping. In addition to the reported transcript variants 1 (LLT1) and 2, we identified a novel splice variant 4 and transcripts coding for putative soluble proteins. CLEC2D transcripts were detected primarily in hematopoietic cell lines and were found to be co-induced by the same activation signals. Although very low amounts of putative soluble CLEC2D protein isoforms could be produced by transfectants, CLEC2D isoforms 2 and 4 were efficiently expressed. By contrast to LLT1, which was detected on the cell surface, isoform 2 and 4 remained in the endoplasmic reticulum where they formed homodimers or heterodimers with LLT1. They failed to interact with CD161, leaving LLT1 as the sole ligand for this receptor. CLEC2D therefore uses gene splicing to generate protein isoforms that are structurally distinct and that have different biological activities.	[Rampanarivo, Hariniaina Henintsoa; Braud, Veronique M.] UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; [Zahn, Stefan; Padkjaer, Soren Berg; Spee, Pieter] Novo Nordisk AS, Translat Immunol Dept, DK-2760 Malov, Denmark; [Zahn, Stefan; Padkjaer, Soren Berg; Spee, Pieter] Novo Nordisk AS, Prot Struture & Biophys Dept, DK-2760 Malov, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Novo Nordisk; Novo Nordisk	Braud, VM (corresponding author), UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	braud@ipmc.cnrs.fr	braud, veronique M/I-4597-2013; POUPON, Gwénola/M-4632-2016	braud, veronique M/0000-0001-8213-3947; POUPON, Gwénola/0000-0001-5772-2539; BIHL, Franck/0000-0002-8808-8152	Novo Nordisk S/A; Agence Nationale de Recherches sur le SIDA; Ensemble contre le SIDA	Novo Nordisk S/A; Agence Nationale de Recherches sur le SIDA(ANRSFrench National Research Agency (ANR)); Ensemble contre le SIDA	This work was supported by grants from Novo Nordisk S/A, Agence Nationale de Recherches sur le SIDA, and Ensemble contre le SIDA.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Atamas SP, 1996, J IMMUNOL, V156, P435; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Boles KS, 1999, IMMUNOGENETICS, V50, P1, DOI 10.1007/s002510050679; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Huarte E, 2008, BLOOD, V112, P1259, DOI 10.1182/blood-2007-12-130773; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; KOLENKO P, 2009, COMMUN, V65, P1258; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Roth P, 2007, CANCER RES, V67, P3540, DOI 10.1158/0008-5472.CAN-06-4783; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Tsytsikov VN, 1996, J BIOL CHEM, V271, P23055, DOI 10.1074/jbc.271.38.23055; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402	29	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36207	36215		10.1074/jbc.M110.179622	http://dx.doi.org/10.1074/jbc.M110.179622			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843815	Green Published, hybrid			2022-12-25	WOS:000283845300096
J	Kim, SM; Acharya, P; Engel, JC; Correia, MA				Kim, Sung-Mi; Acharya, Poulomi; Engel, Juan C.; Correia, Maria Almira			Liver Cytochrome P450 3A Ubiquitination in Vivo by gp78/Autocrine Motility Factor Receptor and C Terminus of Hsp70-interacting Protein (CHIP) E3 Ubiquitin Ligases PHYSIOLOGICAL AND PHARMACOLOGICAL RELEVANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; NITRIC-OXIDE SYNTHASE; ER-ASSOCIATED DEGRADATION; HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; RAT HEPATOCYTES; QUALITY-CONTROL; PROTEASOMAL DEGRADATION; TRIAGE DECISIONS	CYP3A4 is a dominant human liver cytochrome P450 enzyme engaged in the metabolism and disposition of >50% of clinically relevant drugs and held responsible for many adverse drug-drug interactions. CYP3A4 and its mammalian liver CYP3A orthologs are endoplasmic reticulum (ER)-anchored monotopic proteins that undergo ubiquitin (Ub)-dependent proteasomal degradation (UPD) in an ER-associated degradation (ERAD) process. These integral ER proteins are ubiquitinated in vivo, and in vitro studies have identified the ER-integral gp78 and the cytosolic co-chaperone, CHIP (C terminus of Hsp70-interacting protein), as the relevant E3 Ub-ligases, along with their cognate E2 Ub-conjugating enzymes UBC7 and UbcH5a, respectively. Using lentiviral shRNA templates targeted against each of these Ub-ligases, we now document that both E3s are indeed physiologically involved in CYP3A ERAD/UPD in cultured rat hepatocytes. Accordingly, specific RNAi resulted in approximate to 80% knockdown of each hepatic Ub-ligase, with a corresponding approximate to 2.5-fold CYP3A stabilization. Surprisingly, however, such stabilization resulted in increased levels of functionally active CYP3A, thereby challenging the previous notion that E3 recognition and subsequent ERAD of CYP3A proteins required ab initio their structural and/or functional inactivation. Furthermore, coexpression in HepG2 cells of both CYP3A4 and gp78, but not its functionally inactive RING-finger mutant, resulted in enhanced CYP3A4 loss greater than that in corresponding cells expressing only CYP3A4. Stabilization of a functionally active CYP3A after RNAi knockdown of either of the E3s, coupled with the increased CYP3A4 loss on gp78 or CHIP coexpression, suggests that ERAD-associated E3 Ub-ligases can influence clinically relevant drug metabolism by effectively regulating the physiological CYP3A content and consequently its function.	[Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Box 2280,600 16th St, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu			National Institutes of Health [GM44037, DK26506]; National Institute of Digestive Diseases and Kidney Center [P30DK26743]; US Congress; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK026506, P30DK026743, R01DK026506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Digestive Diseases and Kidney Center; US Congress; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44037 and DK26506 and the UCSF Liver Center Core on Cell and Tissue Biology funded by the National Institute of Digestive Diseases and Kidney Center Grant P30DK26743. These studies were presented orally at the 2010 International Symposium on Microsomes and Drug Oxidations, Beijing, China (May 18, 2010) and in poster form at the 2010 FASEB Summer Research Conference on Ubiquitin and Cellular Regulation, Saxtons River, VT (June 16, 2010).; We are grateful to Chris Her, University of California San Francisco (UCSF) Liver Center Cell and Tissue Biology Core Facility (Dr. J. J. Maher, Director) for hepatocyte isolation. We gratefully acknowledge the US Congress for the NIGMS-ARRA funding, without which this work would not have been possible. We thank Drs. A. M. Weissman (National Institutes of Health, NCI, Frederick, MD), Cam Patterson (University of North Carolina, Chapel Hill), and R. A. DeBose-Boyd (University of Texas Southwestern Medical Center, Dallas) for generously providing some of the plasmids used in these studies. We also thank Dr. Alex Y. So (Keith Yamamoto laboratory, UCSF) for generous advice and training in the use of lentiviral shRNAi technology, Dr. Michelle Flanniken (Raul Andino laboratory, UCSF) for technical advice, and Dr. Allan M. Weissman for valuable discussions.	Acharya P, 2009, DRUG METAB REV, V41, P53; Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Acharya P, 2009, MOL PHARMACOL, V76, P503, DOI 10.1124/mol.109.056002; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chiu CG, 2008, EXPERT REV ANTICANC, V8, P207, DOI 10.1586/14737140.8.2.207; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Correia MA, 2003, DRUG METAB REV, V35, P107, DOI 10.1081/DMR-120023683; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Denisov IG, 2007, J BIOL CHEM, V282, P26865, DOI 10.1074/jbc.M704747200; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Han XM, 2005, J PHARMACOL EXP THER, V314, P128, DOI 10.1124/jpet.105.084699; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Joshi B, 2010, J BIOL CHEM, V285, P8830, DOI 10.1074/jbc.M109.074344; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Liao MX, 2005, MOL PHARMACOL, V67, P1460, DOI 10.1124/mol.104.009654; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murray BP, 2002, MOL PHARMACOL, V61, P1146, DOI 10.1124/mol.61.5.1146; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; Shmueli A, 2009, BIOCHEM BIOPH RES CO, V390, P758, DOI 10.1016/j.bbrc.2009.10.045; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhang CH, 2005, AM J PHYSIOL-HEART C, V288, pH2154, DOI 10.1152/ajpheart.00987.2004; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453	78	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35866	35877		10.1074/jbc.M110.167189	http://dx.doi.org/10.1074/jbc.M110.167189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20819951	Green Published, hybrid			2022-12-25	WOS:000283845300064
J	Liebl, J; Weitensteiner, SB; Vereb, G; Takacs, L; Furst, R; Vollmar, AM; Zahler, S				Liebl, Johanna; Weitensteiner, Sabine B.; Vereb, Gyoergy; Takacs, Lili; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan			Cyclin-dependent Kinase 5 Regulates Endothelial Cell Migration and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ACTIN POLYMERIZATION; NEURONAL MIGRATION; RAC1 ACTIVITY; RHO-GTPASES; CDK5; PHOSPHORYLATION; CANCER; ROSCOVITINE; METASTASIS	Angiogenesis contributes to various pathological conditions. Due to the resistance against existing antiangiogenic therapy, an urgent need exists to understand the molecular basis of vessel growth and to identify new targets for antiangiogenic therapy. Here we show that cyclin-dependent kinase 5 (Cdk5), an important modulator of neuronal processes, regulates endothelial cell migration and angiogenesis, suggesting Cdk5 as a novel target for antiangiogenic therapy. Inhibition or knockdown of Cdk5 reduces endothelial cell motility and blocks angiogenesis in vitro and in vivo. We elucidate a specific signaling of Cdk5 in the endothelium; in contrast to neuronal cells, the motile defects upon inhibition of Cdk5 are not caused by an impaired function of focal adhesions or microtubules but by the reduced formation of lamellipodia. Inhibition or down-regulation of Cdk5 decreases the activity of the small GTPase Rac1 and results in a disorganized actin cytoskeleton. Constitutive active Rac1 compensates for the inhibiting effects of Cdk5 knockdown on migration, suggesting that Cdk5 exerts its effects in endothelial cell migration via Rac1. Our work elucidates Cdk5 as a pivotal new regulator of endothelial cell migration and angiogenesis. It suggests Cdk5 as a novel, pharmacologically accessible target for antiangiogenic therapy and provides the basis for a new therapeutic application of Cdk5 inhibitors as antiangiogenic agents.	[Zahler, Stefan] Univ Munich, Ctr Drug Res, D-81377 Munich, Germany; [Takacs, Lili] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; [Vereb, Gyoergy] Univ Debrecen, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary	University of Munich; University of Debrecen; University of Debrecen	Zahler, S (corresponding author), Univ Munich, Ctr Drug Res, Butenandtstr 5-13, D-81377 Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Takács, Lili/L-6660-2014; Fuerst, Robert/B-5815-2011; Vereb, György/A-4241-2008	Takács, Lili/0000-0003-1641-0154; Vereb, György/0000-0003-2157-3265; Furst, Robert/0000-0002-9926-7578; Zahler, Stefan/0000-0002-5140-7287				Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Koltermann A, 2007, CELL MOL LIFE SCI, V64, P1715, DOI 10.1007/s00018-007-7085-z; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Maggiorella L, 2009, CELL PROLIFERAT, V42, P38, DOI 10.1111/j.1365-2184.2008.00570.x; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mitsios N, 2007, BRAIN PATHOL, V17, P11, DOI 10.1111/j.1750-3639.2006.00031.x; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; NIH, 2010, GUIDE CARE USE LAB A, V8th, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sandal T, 2002, J BIOL CHEM, V277, P20783, DOI 10.1074/jbc.M112248200; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Slevin M, 2009, CURR OPIN PHARMACOL, V9, P119, DOI 10.1016/j.coph.2008.10.003; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Tripathi BK, 2009, MOL CELL BIOL, V29, P6488, DOI 10.1128/MCB.01098-09; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xin X, 2008, J CELL SCI, V121, P2601, DOI 10.1242/jcs.016089; Xin XN, 2004, J CELL SCI, V117, P4739, DOI 10.1242/jcs.01333; Yang HS, 2006, CANCER RES, V66, P2708, DOI 10.1158/0008-5472.CAN-05-3141; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031	47	81	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35932	35943		10.1074/jbc.M110.126177	http://dx.doi.org/10.1074/jbc.M110.126177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826806	hybrid, Green Published			2022-12-25	WOS:000283845300070
J	Litzinger, S; Fischer, S; Polzer, P; Diederichs, K; Welte, W; Mayer, C				Litzinger, Silke; Fischer, Stefanie; Polzer, Patrick; Diederichs, Kay; Welte, Wolfram; Mayer, Christoph			Structural and Kinetic Analysis of Bacillus subtilis N-Acetylglucosaminidase Reveals a Unique Asp-His Dyad Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-3 BETA-GLUCOSIDASE; ACETYLMURAMIC ACID; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; GENERAL ACID/BASE; CATALYTIC DYAD; WILD-TYPE; IDENTIFICATION; PROTEIN; NUCLEOPHILE	Three-dimensional structures of NagZ of Bacillus subtilis, the first structures of a two-domain beta-N-acetylglucosaminidase of family 3 of glycosidases, were determined with and without the transition state mimicking inhibitor PUGNAc bound to the active site, at 1.84- and 1.40-angstrom resolution, respectively. The structures together with kinetic analyses of mutants revealed an Asp-His dyad involved in catalysis: His(234) of BsNagZ acts as general acid/base catalyst and is hydrogen bonded by Asp(232) for proper function. Replacement of both His234 and Asp(232) with glycine reduced the rate of hydrolysis of the fluorogenic substrate 4'-methylumbelliferyl N-acetyl-beta-D-glucosaminide 1900- and 4500-fold, respectively, and rendered activity pH-independent in the alkaline range consistent with a role of these residues in acid/base catalysis. N-Acetylglucosaminyl enzyme intermediate accumulated in the H234G mutant and beta-azide product was formed in the presence of sodium azide in both mutants. The Asp-His dyad is conserved within beta-N-acetylglucosaminidases but otherwise absent in beta-glycosidases of family 3, which instead carry a "classical" glutamate acid/base catalyst. The acid/base glutamate of Hordeum vulgare exoglucanase (Exo1) superimposes with His234 of the dyad of BsNagZ and, in contrast to the latter, protrudes from a second domain of the enzyme into the active site. This is the first report of an Asp-His catalytic dyad involved in hydrolysis of glycosides resembling in function the Asp-His-Ser triad of serine proteases. Our findings will facilitate the development of mechanism-based inhibitors that selectively target family 3 beta-N-acetylglucosaminidases, which are involved in bacterial cell wall turnover, spore germination, and induction of beta-lactamase.	[Litzinger, Silke; Mayer, Christoph] Univ Konstanz, Dept Mol Microbiol, D-78457 Constance, Germany; [Fischer, Stefanie; Diederichs, Kay; Welte, Wolfram] Univ Konstanz, Dept Biophys, Fachbereich Biol, D-78457 Constance, Germany; [Polzer, Patrick] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	University of Konstanz; University of Konstanz; Max Planck Society	Mayer, C (corresponding author), Univ Str 10, D-78457 Constance, Germany.	ch.mayer@uni-konstanz.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851	Deutsche Forschungsgemeinschaft [MA2436/4, MA2436/3]; Federal Government of Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Government of Germany	This work was supported in part by Grant MA2436/4 and a Heisenberg stipend (MA2436/3) from the Deutsche Forschungsgemeinschaft (to C. M.).; Supported by a fellowship of the federal government of Germany (Landesgraduiertenfordergesetz stipend).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ash EL, 1997, SCIENCE, V278, P1128, DOI 10.1126/science.278.5340.1128; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; Chir J, 2002, BIOCHEM J, V365, P857, DOI 10.1042/BJ20020186; Cournoyer B, 2003, J MOL MICROB BIOTECH, V5, P190, DOI 10.1159/000070269; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANK HS, 1957, DISCUSS FARADAY SOC, P133, DOI 10.1039/df9572400133; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Legler PM, 2002, BIOCHEMISTRY-US, V41, P10834, DOI 10.1021/bi020362e; Li H, 2006, BIOSCI BIOTECH BIOCH, V70, P1127, DOI 10.1271/bbb.70.1127; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.0.CO;2-1; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Paal K, 2004, BIOCHEM J, V378, P141, DOI 10.1042/BJ20031028; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; Quirk DJ, 1999, BIOPHYS J, V76, P1571, DOI 10.1016/S0006-3495(99)77316-9; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Schultz LW, 1998, BIOCHEMISTRY-US, V37, P8886, DOI 10.1021/bi972766q; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stubbs KA, 2007, J BIOL CHEM, V282, P21382, DOI 10.1074/jbc.M700084200; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Uehara T, 2006, J BACTERIOL, V188, P1660, DOI 10.1128/JB.188.4.1660-1662.2006; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Whiteson KL, 2007, CHEM BIOL, V14, P121, DOI 10.1016/j.chembiol.2007.01.011; WOLFENDEN R, 1976, ANNU REV BIOPHYS BIO, V5, P271, DOI 10.1146/annurev.bb.05.060176.001415; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	54	89	94	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35675	35684		10.1074/jbc.M110.131037	http://dx.doi.org/10.1074/jbc.M110.131037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826810	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000283845300046
J	Zhou, HY; Salih, E; Glimcher, MJ				Zhou, Hai-Yan; Salih, Erdjan; Glimcher, Melvin J.			The Isolation and Characterization of Glycosylated Phosphoproteins from Herring Fish Bones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; MATRIX PROTEINS; CRYSTAL-FORMATION; COLLAGEN FIBRILS; RAT OSTEOCLASTS; OSTEOPONTIN; SIALOPROTEIN; PHOSPHORYLATION; HYDROXYAPATITE; RESORPTION	Past studies of bone extracellular matrix phosphoproteins such as osteopontin and bone sialoprotein have yielded important biological information regarding their role in calcification and the regulation of cellular activity. Most of these studies have been limited to proteins extracted from mammalian and avian vertebrates and nonvertebrates. The present work describes the isolation and purification of two major highly glycosylated and phosphorylated extracellular matrix proteins of 70 and 22 kDa from herring fish bones. The 70-kDa phosphoprotein has some characteristics of osteopontin with respect to amino acid composition and susceptibility to thrombin cleavage. Unlike osteopontin, however, it was found to contain high levels of sialic acid similar to bone sialoprotein. The 22-kDa protein has very different properties such as very high content of phosphoserine (similar to 270 Ser(P) residues/1000 amino acid residues), Ala, and Asx residues. The N-terminal amino acid sequence analysis of both the 70-kDa (NPIMA(M) ETTS(M) DSKVNPLL) and the 22-kDa (NQDMAMEASSDPEAA) fish phosphoproteins indicate that these unique amino acid sequences are unlike any published in protein databases. An enzyme-linked immunosorbent assay revealed that the 70-kDa phosphoprotein was present principally in bone and in calcified scales, whereas the 22-kDa phosphoprotein was detected only in bone. Immunohistological analysis revealed diffusely positive immunostaining for both the 70-and 22-kDa phosphoproteins throughout the matrix of the bone. Overall, this work adds additional support to the concept that the mechanism of biological calcification has common evolutionary and fundamental bases throughout vertebrate species.	Harvard Univ, Sch Med, Dept Orthoped Surg, Lab Study Skeletal Disorders & Rehabil, Boston, MA 02115 USA; Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Salih, E (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, 700 Albany St, Boston, MA 02118 USA.	Salih@bu.edu		Salih, Erdjan/0000-0003-3322-2323	National Institutes of Health [AG17969-0H, R01 AG14701-16, 2R01 AG14701-17A2]; Peabody Foundation, Inc.; NATIONAL INSTITUTE ON AGING [R01AG014701, R01AG017969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peabody Foundation, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG17969-0H (to E. S.), R01 AG14701-16, and 2R01 AG14701-17A2. This work was also supported by a grant from the Peabody Foundation, Inc. (to M. J. G.).	Alvares K, 2009, J BIOL CHEM, V284, P26149, DOI 10.1074/jbc.M109.024018; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bellahcene A, 1997, B CANCER, V84, P17; Bobe J, 2001, FEBS LETT, V489, P119, DOI 10.1016/S0014-5793(01)02090-7; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BUTTLER WT, 1996, OSTEOPONTIN PRINCIPL, P167; CHAMBERS TJ, 1986, BONE MINER, V1, P127; Cooper LF, 1998, J BONE MINER RES, V13, P620, DOI 10.1359/jbmr.1998.13.4.620; Curtin P, 2009, BIOCHEMISTRY-US, V48, P6876, DOI 10.1021/bi900066b; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; ENDO A, 1989, CONNECT TISSUE RES, V21, P509, DOI 10.3109/03008208909050008; FISHER LW, 1983, J BIOL CHEM, V258, P2723; FISHER LW, 1992, INT CONGR SER, V1002, P177; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; FUJISAWA R, 1993, J DENT RES, V72, P1222, DOI 10.1177/00220345930720081001; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; GLIMCHER MJ, 1979, CALCIFIED TISSUE INT, V27, P187, DOI 10.1007/BF02441183; GLIMCHER MJ, 1959, REV MOD PHYS, V31, P359, DOI 10.1103/RevModPhys.31.359; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; GORSKI JP, 1988, J BIOL CHEM, V263, P15938; HELFRICH MH, 1992, J BONE MINER RES, V7, P335; HORTON MA, 1995, ANN NY ACAD SCI, V760, P190, DOI 10.1111/j.1749-6632.1995.tb44630.x; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; KIDO J, 1995, ARCH ORAL BIOL, V40, P967, DOI 10.1016/0003-9969(95)00056-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DD, 1991, J MOL BIOL, V217, P487, DOI 10.1016/0022-2836(91)90752-R; LOWENSTAM H. A., 1989, BIOMINERALISATION, P1; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; MIDURA RJ, 1990, J BIOL CHEM, V265, P5285; Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078; NISHIMOTO SK, 1992, J BIOL CHEM, V267, P11600; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Okada A, 2008, J BONE MINER RES, V23, P1629, DOI 10.1359/JBMR.080514; Raynal C, 1996, ENDOCRINOLOGY, V137, P2347, DOI 10.1210/en.137.6.2347; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; RENNARD SI, 1980, ANAL BIOCHEM, V104, P205, DOI 10.1016/0003-2697(80)90300-0; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Salih E, 1996, J BIOL CHEM, V271, P16897, DOI 10.1074/jbc.271.28.16897; Salih E, 2002, BIOCHEM J, V364, P465, DOI 10.1042/BJ20011272; Salih E, 1997, J BIOL CHEM, V272, P13966, DOI 10.1074/jbc.272.21.13966; Salih E, 1996, J BONE MINER RES, V11, P1461; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; Shanmugam V, 1997, BIOCHEMISTRY-US, V36, P5729, DOI 10.1021/bi961687w; SIMKISS K, 1989, CELL MINERAL DEPOSIT, P1; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Veis A, 1985, CHEM BIOL MINERALIZE, P170; von Kossa J, 1901, BEITR PATHOL ANAT AL, V29, P163; Wang J, 1998, BONE, V22, P621, DOI 10.1016/S8756-3282(98)00057-X; Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; ZHOU HY, 1995, CALCIFIED TISSUE INT, V56, P403, DOI 10.1007/BF00301610; Zhou HY, 1998, BIOCHEM J, V330, P1423, DOI 10.1042/bj3301423	69	5	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36170	36178		10.1074/jbc.M110.146910	http://dx.doi.org/10.1074/jbc.M110.146910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833721	Green Published, hybrid			2022-12-25	WOS:000283845300093
J	Gavala, ML; Hill, LM; Lenertz, LY; Karta, MR; Bertics, PJ				Gavala, Monica L.; Hill, Lindsay M.; Lenertz, Lisa Y.; Karta, Maya R.; Bertics, Paul J.			Activation of the Transcription Factor FosB/Activating Protein-1 (AP-1) Is a Prominent Downstream Signal of the Extracellular Nucleotide Receptor P2RX7 in Monocytic and Osteoblastic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; NF-KAPPA-B; GENE-EXPRESSION; DELTA-FOSB; P2X(7) RECEPTORS; BONE-FORMATION; ATP; MODULATION; MECHANISMS; RELEASE	Activation of the ionotropic P2RX7 nucleotide receptor by extracellular ATP has been implicated in modulating inflammatory disease progression. Continuous exposure of P2RX7 to ligand can result in apoptosis in many cell types, including monocytic cells, whereas transient activation of P2RX7 is linked to inflammatory mediator production and the promotion of cell growth. Given the rapid hydrolysis of ATP in the circulation and interstitial space, transient activation of P2RX7 appears critically important for its action, yet its effects on gene expression are unclear. The present study demonstrates that short-term stimulation of human and mouse monocytic cells as well as mouse osteoblasts with P2RX7 agonists substantially induces the expression of several activating protein-1 (AP-1) members, particularly FosB. The potent activation of FosB after P2RX7 stimulation is especially noteworthy considering that little is known concerning the role of FosB in immunological regulation. Interestingly, the magnitude of FosB activation induced by P2RX7 stimulation appears greater than that observed with other known inducers of FosB expression. In addition, we have identified a previously unrecognized role for FosB in osteoblasts with respect to nucleotide-induced expression of cyclooxygenase- 2 (COX-2), which is the rate-limiting enzyme in prostaglandin biosynthesis from arachidonic acid and is critical for osteoblastic differentiation and immune behavior. The present studies are the first to link P2RX7 action to FosB/AP-1 regulation in multiple cell types, including a role in nucleotide-induced COX-2 expression, and support a role for FosB in the control of immune and osteogenic function by P2RX7.	[Gavala, Monica L.; Hill, Lindsay M.; Lenertz, Lisa Y.; Karta, Maya R.; Bertics, Paul J.] Univ Wisconsin, Dept Biomol Chem, Sch Med, Madison, WI 53706 USA; [Gavala, Monica L.; Hill, Lindsay M.; Karta, Maya R.; Bertics, Paul J.] Univ Wisconsin, Sch Med, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bertics, PJ (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med, 1300 Univ Ave, Madison, WI 53706 USA.	pbertics@wisc.edu			National Institutes of Health [AI070503, HL069116]; Predoctoral Molecular and Cellular Pharmacology Training Grant [T32 HL07899]; University of Wisconsin (National Institutes of Health) [5 T32 HL07899-09]; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069116, T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Molecular and Cellular Pharmacology Training Grant; University of Wisconsin (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070503 and HL069116.; Supported by Predoctoral Molecular and Cellular Pharmacology Training Grant T32 HL07899.; Supported by the Hematology Training 524 Program of the University of Wisconsin (National Institutes of Health Grant 5 T32 HL07899-09).; Supported by a postdoctoral fellowship from The Hartwell Foundation.	Aga M, 2004, AM J PHYSIOL-CELL PH, V286, pC923, DOI 10.1152/ajpcell.00417.2003; Aga M, 2002, J LEUKOCYTE BIOL, V72, P222; Aud D, 2006, NAT CLIN PRACT RHEUM, V2, P434, DOI 10.1038/ncprheum0222; Bowler WB, 1999, J BIOL CHEM, V274, P14315, DOI 10.1074/jbc.274.20.14315; Brautigam VM, 2005, J NEUROIMMUNOL, V166, P113, DOI 10.1016/j.jneuroim.2005.05.012; Buckley KA, 2003, FASEB J, V17, P1401, DOI 10.1096/fj.02-0940com; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Desmet C, 2005, AM J RESP CRIT CARE, V172, P671, DOI 10.1164/rccm.200410-1431OC; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 1999, J LEUKOCYTE BIOL, V66, P723, DOI 10.1002/jlb.66.5.723; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Di Virgilio Francesco, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P85; DUBYAK GR, 1991, AM J RESP CELL MOL, V4, P295, DOI 10.1165/ajrcmb/4.4.295; Fernando KC, 1999, ARCH BIOCHEM BIOPHYS, V362, P197, DOI 10.1006/abbi.1998.1045; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Franco-Martinez S, 2006, CLIN EXP IMMUNOL, V146, P253, DOI 10.1111/j.1365-2249.2006.03213.x; Gavala ML, 2008, J LEUKOCYTE BIOL, V84, P1159, DOI 10.1189/jlb.0907612; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Guerra AN, 2007, PURINERG SIGNAL, V3, P39, DOI 10.1007/s11302-006-9035-x; Guo RF, 2002, AM J PATHOL, V161, P275, DOI 10.1016/S0002-9440(10)64179-X; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; Ke HZ, 2005, J BONE MINER METAB, V23, P84, DOI 10.1007/BF03026330; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Kveiborg M, 2004, MOL CELL BIOL, V24, P2820, DOI 10.1128/MCB.24.7.2820-2830.2004; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Li X, 2007, GYNECOL ONCOL, V106, P233, DOI 10.1016/j.ygyno.2007.03.032; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; PADEH S, 1991, J IMMUNOL, V146, P1626; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sims NA, 2002, BONE, V30, P32, DOI 10.1016/S8756-3282(01)00622-6; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stefano L, 2007, J CELL PHYSIOL, V213, P36, DOI 10.1002/jcp.21085; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Watters JJ, 2001, DRUG DEVELOP RES, V53, P91, DOI 10.1002/ddr.1176; Woszczek G, 2008, J ALLERGY CLIN IMMUN, V121, P215, DOI 10.1016/j.jaci.2007.09.013	61	25	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34288	34298		10.1074/jbc.M110.142091	http://dx.doi.org/10.1074/jbc.M110.142091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20813842	hybrid, Green Published			2022-12-25	WOS:000283354000074
J	Yu, YL; Zhang, HL; Zhu, G				Yu, Yonglan; Zhang, Haili; Zhu, Guan			Plant-Type Trehalose Synthetic Pathway in Cryptosporidium and Some Other Apicomplexans	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE; UDP-GLUCOSE PYROPHOSPHORYLASE; FATTY-ACID SYNTHESIS; GENOME SEQUENCE; ARABIDOPSIS-THALIANA; PHOSPHATE SYNTHASE; EIMERIA-TENELLA; THEILERIA-PARVA; MANNITOL CYCLE; METABOLISM	Background: The trehalose synthetic pathway is present in bacteria, fungi, plants and invertebrate animals, but is absent in vertebrates. This disaccharide mainly functions as a stress protectant against desiccation, heat, cold and oxidation. Genes involved in trehalose synthesis have been observed in apicomplexan parasites, but little was known about these enzymes. Study on trehalose synthesis in apicomplexans would not only shed new light into the evolution of this pathway, but also provide data for exploring this pathway as novel drug target. Methodology/Principal Findings: We have observed the presence of the trehalose synthetic pathway in Cryptosporidium and other apicomplexans and alveolates. Two key enzymes (trehalose 6-phosphate synthase [T6PS; EC 2.4.1.15] and trehalose phosphatase [TPase; EC 3.1.3.12] are present as Class II bifunctional proteins (T6PS-TPase) in the majority of apicomplexans with the exception of Plasmodium species. The enzyme for synthesizing the precursor (UDP-glucose) is homologous to dual-substrate UDP-galactose/glucose pyrophosphorylases (UGGPases), rather than the "classic'' UDPglucose pyrophosphorylase (UGPase). Phylogenetic recontructions indicate that both T6PS-TPases and UGGPases in apicomplexans and other alveolates are evolutionarily affiliated with stramenopiles and plants. The expression level of T6PS-TPase in C. parvum is highly elevated in the late intracellular developmental stage prior to or during the production of oocysts, implying that trehalose may be important in oocysts as a protectant against environmental stresses. Finally, trehalose has been detected in C. parvum oocysts, thus confirming the trehalose synthetic activity in this parasite. Conclusions/Significance: A trehalose synthetic pathway is described in the majority of apicomplexan parasites including Cryptosporidium and the presence of trehalose was confirmed in the C. parvum oocyst. Key enzymes in the pathway (i.e., T6PS-TPase and UGGPase) are plant-type and absent in humans and animals, and may potentially serve as novel drug targets in the apicomplexans.	[Yu, Yonglan] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Yu, Yonglan; Zhang, Haili; Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Zhu, Guan] Texas A&M Univ, Fac Genet Program, College Stn, TX USA	China Agricultural University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Yu, YL (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	GZHU@CVM.TAMU.EDU	Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/D-8147-2011; ZHU, GUAN/GQB-0299-2022	Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) [R01 AI44594, R21 AI055278]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044594, R21AI055278] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work reported here is in part supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) (R01 AI44594 and R21 AI055278 to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Abrahamsen MS, 1999, MOL BIOCHEM PARASIT, V104, P141, DOI 10.1016/S0166-6851(99)00081-X; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Allocco JJ, 2001, J PARASITOL, V87, P1441, DOI 10.1645/0022-3395(2001)087[1441:NMBETD]2.0.CO;2; Allocco JJ, 1999, J PARASITOL, V85, P167, DOI 10.2307/3285614; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Bulik DA, 2000, J BIOL CHEM, V275, P14722, DOI 10.1074/jbc.275.19.14722; Cai XM, 2005, ANTIMICROB AGENTS CH, V49, P4437, DOI 10.1128/AAC.49.11.4437-4442.2005; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; CAVALIERSMITH T, 1991, SYST ASSOC SPEC VOL, V45, P113; Chary SN, 2008, PLANT PHYSIOL, V146, P97, DOI 10.1104/pp.107.107441; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai N, 2006, PLANT PHYSIOL, V142, P294, DOI 10.1104/pp.106.083634; De Silva-Udawatta MN, 2001, MOL MICROBIOL, V40, P1345, DOI 10.1046/j.1365-2958.2001.02477.x; Dmitryjuk M, 2003, COMP BIOCHEM PHYS B, V136, P61, DOI 10.1016/S1096-4959(03)00170-2; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Eastmond PJ, 2003, CURR OPIN PLANT BIOL, V6, P231, DOI 10.1016/S1369-5266(03)00037-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Frison M, 2007, FEBS LETT, V581, P4010, DOI 10.1016/j.febslet.2007.07.036; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Halford NG, 2003, PLANT BIOTECHNOL J, V1, P381, DOI 10.1046/j.1467-7652.2003.00046.x; Hanson J, 2009, CURR OPIN PLANT BIOL, V12, P562, DOI 10.1016/j.pbi.2009.07.014; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kleczkowski LA, 2004, PLANT PHYSIOL, V134, P912, DOI 10.1104/pp.103.036053; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lariviere L, 2005, J MOL BIOL, V352, P139, DOI 10.1016/j.jmb.2005.07.007; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; Li P, 2008, PHYSIOL PLANTARUM, V133, P544, DOI 10.1111/j.1399-3054.2008.01101.x; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Maruyama S, 2008, PLANT SIGNAL BEHAV, V3, P140, DOI 10.4161/psb.3.2.5066; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Meng M, 2009, PLANT CELL PHYSIOL, V50, P998, DOI 10.1093/pcp/pcp052; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Mok MTS, 2005, J BIOL CHEM, V280, P39363, DOI 10.1074/jbc.M509209200; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Moustafa A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002205; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; Oesterreicher TJ, 2001, GENE, V270, P211, DOI 10.1016/S0378-1119(01)00474-7; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Parrou JL, 2005, FEMS YEAST RES, V5, P503, DOI 10.1016/j.femsyr.2005.01.002; Paul M, 2007, CURR OPIN PLANT BIOL, V10, P303, DOI 10.1016/j.pbi.2007.04.001; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paul Matthew J, 2008, Biochem J, V412, pe1, DOI 10.1042/BJ20080598; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Ramon M, 2009, PLANT CELL ENVIRON, V32, P1015, DOI 10.1111/j.1365-3040.2009.01985.x; Rider SD, 2008, J CELL BIOCHEM, V104, P2207, DOI 10.1002/jcb.21784; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmatz DM, 1997, PARASITOLOGY, V114, pS81; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; Uhland K, 2000, J BIOL CHEM, V275, P23439, DOI 10.1074/jbc.M002793200; Whitaker JW, 2009, NUCLEIC ACIDS RES, V37, pD531, DOI 10.1093/nar/gkn826; Whitaker JW, 2009, BIOCHEM SOC T, V37, P792, DOI 10.1042/BST0370792; Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1; Wu WS, 2006, J BIOCHEM MOL BIOL, V39, P158; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Zeng B, 2006, MICROBIOL-SGM, V152, P2355, DOI 10.1099/mic.0.28944-0	70	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12593	10.1371/journal.pone.0012593	http://dx.doi.org/10.1371/journal.pone.0012593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830297	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300021
J	Kothapalli, R; Khan, AM; Basappa; Gopalsamy, A; Chong, YS; Annamalai, L				Kothapalli, Roopa; Khan, Asif M.; Basappa; Gopalsamy, Anupriya; Chong, Yap Seng; Annamalai, Loganath			Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain	PLOS ONE			English	Article							X-RAY-STRUCTURE; COLLAGEN; POTENT; OSTEOARTHRITIS; DISCOVERY; CARTILAGE; FIELD	Background: MMP-13, a zinc dependent protease which catalyses the cleavage of type II collagen, is expressed in osteoarthritis (OA) and rheumatoid arthritis (RA) patients, but not in normal adult tissues. Therefore, the protease has been intensively studied as a target for the inhibition of progression of OA and RA. Recent reports suggest that selective inhibition of MMP-13 may be achieved by targeting the hemopexin (Hpx) domain of the protease, which is critical for substrate specificity. In this study, we applied a cheminformatics-based drug design approach for the identification and characterization of inhibitors targeting the amino acid residues characteristic to Hpx domain of MMP-13; these inhibitors may potentially be employed in the treatment of OA and RA. Methodology/Principal Findings: Sequence-based mutual information analysis revealed five characteristic (completely conserved and unique), putative functional residues of the Hpx domain of MMP-13 (these residues hereafter are referred to as HCR-13(of)). Binding of a ligand to as many of the HCR-13(pf) is postulated to result in an increased selective inhibition of the Hpx domain of MMP-13. Through the in silico structure-based high-throughput virtual screening (HTVS) method of Glide, against a large public library of 16908 molecules from Maybridge, PubChem and Binding, we identified 25 ligands that interact with at least one of the HCR-13pf. Assessment of cross-reactivity of the 25 ligands with MMP-1 and MMP-8, members of the collagenase family as MMP-13, returned seven lead molecules that did not bind to any one of the putative functional residues of Hpx domain of MMP-1 and any of the catalytic active site residues of MMP-1 and -8, suggesting that the ligands are not likely to interact with the functional or catalytic residues of other MMPs. Further, in silico analysis of physicochemical and pharmacokinetic parameters based on Lipinski's rule of five and ADMET (absorption, distribution, metabolism, excretion and toxicity) respectively, suggested potential utility of the compounds as drug leads. Conclusions/Significance: We have identified seven distinct drug-like molecules binding to the HCR-13pf of MMP-13 with no observable cross-reactivity to MMP-1 and MMP-8. These molecules are potential selective inhibitors of MMP-13 that can be experimentally validated and their backbone structural scaffold could serve as building blocks in designing drug-like molecules for OA, RA and other inflammatory disorders. The systematic cheminformatics-based drug design approach applied herein can be used for rational search of other public/commercial combinatorial libraries for more potent molecules, capable of selectively inhibiting the collagenolytic activity of MMP-13.	[Kothapalli, Roopa; Gopalsamy, Anupriya; Chong, Yap Seng; Annamalai, Loganath] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore; [Khan, Asif M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Basappa] Singapore MIT Alliance Res & Technol, Ctr Life Sci, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Kothapalli, R (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore.	obgannam@nus.edu.sg	Khan, Mohammad Asif/F-4663-2010; Khan, M. Asif/ABE-7839-2021	Khan, Mohammad Asif/0000-0001-9202-279X; Khan, M. Asif/0000-0001-9202-279X; Basappa, Basappa/0000-0002-8844-468X; Chong, Yap Seng/0000-0002-7232-8473; Gopalsamy, Anupriya/0000-0002-2774-5454	Lee Foundation, Singapore	Lee Foundation, Singapore	The authors gratefully acknowledge a generous grant from the Lee Foundation, Singapore for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 2006, QIKPROP VERSION 3 0; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kim SH, 2005, BIOORG MED CHEM LETT, V15, P1101, DOI 10.1016/j.bmcl.2004.12.016; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Matter H, 1999, J MED CHEM, V42, P1908, DOI 10.1021/jm980631s; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; PIECHA D, 2009, INFLAMM RES; SCHNUTE ME, 2009, BIOORG MED CHEM LETT; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wu JJ, 2005, BIOORG MED CHEM LETT, V15, P4105, DOI 10.1016/j.bmcl.2005.06.019	29	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12494	10.1371/journal.pone.0012494	http://dx.doi.org/10.1371/journal.pone.0012494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824169	Green Published, gold, Green Submitted			2022-12-25	WOS:000281405300019
J	Maydan, M; McDonald, PC; Sanghera, J; Yan, J; Rallis, C; Pinchin, S; Hannigan, GE; Foster, LJ; Ish-Horowicz, D; Walsh, MP; Dedhar, S				Maydan, Mykola; McDonald, Paul C.; Sanghera, Jasbinder; Yan, Jun; Rallis, Charalampos; Pinchin, Sheena; Hannigan, Gregory E.; Foster, Leonard J.; Ish-Horowicz, David; Walsh, Michael P.; Dedhar, Shoukat			Integrin-Linked Kinase Is a Functional Mn2+-Dependent Protein Kinase that Regulates Glycogen Synthase Kinase-3 beta (GSK-3 beta) Phosphorylation	PLOS ONE			English	Article							PHOSPHATASE TARGET SUBUNIT; TUMOR-SUPPRESSOR PTEN; BINDING-PROTEIN; BETA-CATENIN; DEPENDENT PATHWAYS; ENDOTHELIAL-CELLS; B/AKT ACTIVATION; FOCAL ADHESIONS; ILK; SURVIVAL	Background: Integrin-linked kinase (ILK) is a highly evolutionarily conserved, multi-domain signaling protein that localizes to focal adhesions, myofilaments and centrosomes where it forms distinct multi-protein complexes to regulate cell adhesion, cell contraction, actin cytoskeletal organization and mitotic spindle assembly. Numerous studies have demonstrated that ILK can regulate the phosphorylation of various protein and peptide substrates in vitro, as well as the phosphorylation of potential substrates and various signaling pathways in cultured cell systems. Nevertheless, the ability of ILK to function as a protein kinase has been questioned because of its atypical kinase domain. Methodology/Principal Findings: Here, we have expressed full-length recombinant ILK, purified it to >94% homogeneity, and characterized its kinase activity. Recombinant ILK readily phosphorylates glycogen synthase kinase-3 (GSK-3) peptide and the 20-kDa regulatory light chains of myosin (LC20). Phosphorylation kinetics are similar to those of other active kinases, and mutation of the ATP-binding lysine (K220 within subdomain 2) causes marked reduction in enzymatic activity. We show that ILK is a Mn-dependent kinase (the K-m for MnATP is similar to 150-fold less than that for MgATP). Conclusions/Significance: Taken together, our data demonstrate that ILK is a bona fide protein kinase with enzyme kinetic properties similar to other active protein kinases.	[Maydan, Mykola; McDonald, Paul C.; Dedhar, Shoukat] BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada; [Sanghera, Jasbinder; Yan, Jun] SignalChem Inc, Richmond, BC, Canada; [Rallis, Charalampos; Pinchin, Sheena; Ish-Horowicz, David] London Res Inst, Lab Dev Genet, London, England; [Rallis, Charalampos; Pinchin, Sheena] UCL, Dept Genet Evolut & Environm, London, England; [Rallis, Charalampos; Pinchin, Sheena] UCL, Inst Canc, London, England; [Hannigan, Gregory E.] Monash Inst Med Res, Ctr Canc Res, Melbourne, Vic, Australia; [Foster, Leonard J.; Dedhar, Shoukat] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	British Columbia Cancer Agency; University of London; University College London; University of London; University College London; Monash University; University of British Columbia; University of Calgary	Maydan, M (corresponding author), BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada.	sdedhar@bccrc.ca		Ish-Horowicz, David/0000-0001-5684-7129; Dedhar, Shoukat/0000-0003-4355-1657; Rallis, Charalampos/0000-0002-4390-0266	Canadian Cancer Society Research Institute; Cancer Research UK; Canadian Institutes of Health Research	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research UK(Cancer Research UK); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Cancer Society Research Institute (SD), Cancer Research UK (DIH) and the Canadian Institutes of Health Research (MPW). SignalChem Inc (JS and JY) produced and provided the recombinant proteins used in the study. As such, they were involved in data collection and preparation of the manuscript as it relates to the production of these recombinant proteins. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Erdodi F, 2003, BIOCHEM BIOPH RES CO, V306, P382, DOI 10.1016/S0006-291X(03)00976-8; Esfandiarei M, 2006, CIRC RES, V99, P354, DOI 10.1161/01.RES.0000237022.72726.01; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Guo W, 2007, DEV BIOL, V306, P457, DOI 10.1016/j.ydbio.2007.03.019; HANKS SK, 1995, FASEB J, V9, P579; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kannan N, 2008, CELL, V133, P204, DOI 10.1016/j.cell.2008.04.005; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kiss E, 2002, BIOCHEM J, V365, P79, DOI 10.1042/BJ20011295; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Liu E, 2005, MOL CELL BIOL, V25, P11145, DOI 10.1128/MCB.25.24.11145-11155.2005; Lovitt B, 2010, BIOCHEMISTRY-US, V49, P3092, DOI 10.1021/bi901726c; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pinkse GGM, 2005, J HEPATOL, V42, P87, DOI 10.1016/j.jhep.2004.09.010; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; VANHOOK AM, 2010, SCI SIGNAL, V3, pEC133; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	61	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12356	10.1371/journal.pone.0012356	http://dx.doi.org/10.1371/journal.pone.0012356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20827300	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000281153500029
J	Ros, S; Zafra, D; Valles-Ortega, J; Garcia-Rocha, M; Forrow, S; Dominguez, J; Calbo, J; Guinovart, JJ				Ros, Susana; Zafra, Delia; Valles-Ortega, Jordi; Garcia-Rocha, Mar; Forrow, Stephen; Dominguez, Jorge; Calbo, Joaquim; Guinovart, Joan J.			Hepatic Overexpression of a Constitutively Active Form of Liver Glycogen Synthase Improves Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SUBUNIT; RAT HEPATOCYTES; INTRACELLULAR-DISTRIBUTION; PROTEIN PHOSPHATASE-1; GLUCOKINASE; EXPRESSION; PHOSPHORYLASE; METABOLISM; TRANSLOCATION; ACTIVATION	In this study, we tested the efficacy of increasing liver glycogen synthase to improve blood glucose homeostasis. The overexpression of wild-type liver glycogen synthase in rats had no effect on blood glucose homeostasis in either the fed or the fasted state. In contrast, the expression of a constitutively active mutant form of the enzyme caused a significant lowering of blood glucose in the former but not the latter state. Moreover, it markedly enhanced the clearance of blood glucose when fasted rats were challenged with a glucose load. Hepatic glycogen stores in rats overexpressing the activated mutant form of liver glycogen synthase were enhanced in the fed state and in response to an oral glucose load but showed a net decline during fasting. In order to test whether these effects were maintained during long term activation of liver glycogen synthase, we generated liver-specific transgenic mice expressing the constitutively active LGS form. These mice also showed an enhanced capacity to store glycogen in the fed state and an improved glucose tolerance when challenged with a glucose load. Thus, we conclude that the activation of liver glycogen synthase improves glucose tolerance in the fed state without compromising glycogenolysis in the postabsorptive state. On the basis of these findings, we propose that the activation of liver glycogen synthase may provide a potential strategy for improvement of glucose tolerance in the postprandial state.	[Calbo, Joaquim; Guinovart, Joan J.] Univ Barcelona, Inst Biomed Res, E-08028 Barcelona, Spain; [Ros, Susana; Zafra, Delia; Valles-Ortega, Jordi; Garcia-Rocha, Mar; Dominguez, Jorge; Calbo, Joaquim; Guinovart, Joan J.] Univ Barcelona, CIBER Diabet & Enfermedades Metab, E-08028 Barcelona, Spain; [Ros, Susana; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of Barcelona	Guinovart, JJ (corresponding author), Univ Barcelona, Inst Biomed Res, Barcelona Sci Pk,Baldiri Reixac 10-12, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org	Ros, Susana/B-6350-2019; forrow, stephen/AAG-9403-2020	Ros, Susana/0000-0002-5451-1880; Garcia-Rocha, Mar/0000-0003-2467-2090; Zafra, Delia/0000-0003-4143-0659	Ministry of Education and Science, Spain [BFU2005-02253, SAF2007-64722]; Autonomous Government of Catalonia [2005-SGR-00570]; Fundacion MarcelinoBotin	Ministry of Education and Science, Spain(Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Fundacion MarcelinoBotin	This work was supported by Ministry of Education and Science, Spain, Grants BFU2005-02253 and SAF2007-64722, Autonomous Government of Catalonia Grant 2005-SGR-00570, and a grant from the Fundacion MarcelinoBotin. The CIBER de Diabetes y Enfermedades Metabolicas Asociadas is an ISCIII project.	Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Baker DJ, 2006, DIABETES, V55, P1855, DOI 10.2337/db05-1687; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gasa R, 2002, J BIOL CHEM, V277, P1524, DOI 10.1074/jbc.M107744200; Gomis RR, 2000, BIOCHEM J, V351, P811, DOI 10.1042/0264-6021:3510811; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Kelsall IR, 2007, FEBS LETT, V581, P4749, DOI 10.1016/j.febslet.2007.08.073; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; SALAVERT A, 1982, J BIOL CHEM, V257, P13404; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Treadway JL, 2001, EXPERT OPIN INV DRUG, V10, P439, DOI 10.1517/13543784.10.3.439; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Yang RJ, 2003, J BIOL CHEM, V278, P23418, DOI 10.1074/jbc.M213112200; Yang RJ, 2002, J BIOL CHEM, V277, P1514, DOI 10.1074/jbc.M107001200	27	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37170	37177		10.1074/jbc.M110.157396	http://dx.doi.org/10.1074/jbc.M110.157396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20841354	Green Published, hybrid			2022-12-25	WOS:000284424000010
J	Beraldo, FH; Arantes, CP; Santos, TG; Queiroz, NGT; Young, K; Rylett, RJ; Markus, RP; Prado, MAM; Martins, VR				Beraldo, Flavio H.; Arantes, Camila P.; Santos, Tiago G.; Queiroz, Nicolle G. T.; Young, Kirk; Rylett, R. Jane; Markus, Regina P.; Prado, Marco A. M.; Martins, Vilma R.			Role of alpha 7 Nicotinic Acetylcholine Receptor in Calcium Signaling Induced by Prion Protein Interaction with Stress-inducible Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; BETA OLIGOMERS; AMYLOID-BETA; CROSS-TALK; NEUROPROTECTION; EXPRESSION; LAMININ	The prion protein (PrPC) is a conserved glycosylphosphatidyl-inositol-anchored cell surface protein expressed by neurons and other cells. Stress-inducible protein 1 (STI1) binds PrPC extracellularly, and this activated signaling complex promotes neuronal differentiation and neuroprotection via the extracellular signal-regulated kinase 1 and 2 (ERK1/2) and cAMP-dependent protein kinase 1 (PKA) pathways. However, the mechanism by which the PrPC-STI1 interaction transduces extracellular signals to the intracellular environment is unknown. We found that in hippocampal neurons, STI1-PrPC engagement induces an increase in intracellular Ca2+ levels. This effect was not detected in PrPC-null neurons or wild-type neurons treated with an STI1 mutant unable to bind PrPC. Using a best candidate approach to test for potential channels involved in Ca2+ influx evoked by STI1-PrPC, we found that alpha-bungarotoxin, a specific inhibitor for alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR), was able to block PrPC-STI1-mediated signaling, neuroprotection, and neuritogenesis. Importantly, when alpha 7nAChR was transfected into HEK 293 cells, it formed a functional complex with PrPC and allowed reconstitution of signaling by PrPC-STI1 interaction. These results indicate that STI1 can interact with the PrPC.alpha 7nAChR complex to promote signaling and provide a novel potential target for modulation of the effects of prion protein in neurodegenerative diseases.	[Beraldo, Flavio H.; Young, Kirk; Rylett, R. Jane; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Beraldo, Flavio H.; Arantes, Camila P.; Santos, Tiago G.; Queiroz, Nicolle G. T.; Martins, Vilma R.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, BR-01323903 Sao Paulo, Brazil; [Arantes, Camila P.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; [Santos, Tiago G.; Queiroz, Nicolle G. T.; Martins, Vilma R.] Hosp AC Camargo Fund Antonio Prudente, Ctr Tratamento & Pesquisa, BR-01508010 Sao Paulo, Brazil; [Beraldo, Flavio H.; Young, Kirk; Rylett, R. Jane; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Markus, Regina P.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508090 Sao Paulo, Brazil; [Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Ludwig Institute for Cancer Research; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Western University (University of Western Ontario); Universidade de Sao Paulo; Western University (University of Western Ontario)	Prado, MAM (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, POB 5015,100 Perth Dr, London, ON N6A 5K8, Canada.	mprado@robarts.ca; vmartins@ludwig.org.br	Neurociencia, Inct/I-1011-2013; Santos, Tiago Goss/AAQ-4272-2020; Queiroz-Hazarbassanov, Nicolle/P-4333-2014; Rylett, Rebecca Jane/K-3597-2013; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019; dos Santos, Tiago Goss/A-1538-2019; Martins, Vilma/N-5446-2019; Markus, Regina P./AAC-1505-2021; Martins, Vilma R/E-2547-2012; Prado, Marco Antonio Maximo/K-7638-2013; Santos, Tiago/F-2387-2012; Markus, Regina P/K-2954-2012	Santos, Tiago Goss/0000-0001-6641-7413; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Rylett, Rebecca Jane/0000-0002-9158-9599; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; dos Santos, Tiago Goss/0000-0001-6641-7413; Markus, Regina P./0000-0003-4606-6120; Martins, Vilma R/0000-0002-2909-8502; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Santos, Tiago/0000-0001-6641-7413; Markus, Regina P/0000-0003-4606-6120	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [03-13189-2]; Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; PrioNet-Canada; Canadian Institutes for Health Research; Department of Foreign Affairs and International Trade-Canada	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PrioNet-Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Department of Foreign Affairs and International Trade-Canada	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 03-13189-2 and Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to V. R. M.). This work was also supported by grants from PrioNet-Canada (to M. A. M. P.) and Canadian Institutes for Health Research (to R. J. R. and M. A. M. P.) and fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to F. H. B., C. P. A., T. G. S., and N. G. T. Q.) and the Department of Foreign Affairs and International Trade-Canada (to F. H. B.).	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BERALDO FH, 2010, FASEB J IN PRESS; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Brini M, 2005, MOL BIOL CELL, V16, P2799, DOI 10.1091/mbc.E04-10-0915; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Dajas-Bailador FA, 2000, NEUROPHARMACOLOGY, V39, P2799, DOI 10.1016/S0028-3908(00)00127-1; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Fierro AF, 2004, J BIOL CHEM, V279, P25646, DOI 10.1074/jbc.M400296200; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jones IW, 2006, J MOL NEUROSCI, V30, P83, DOI 10.1385/JMN:30:1:83; Jonnala RR, 2001, J NEUROSCI RES, V66, P565, DOI 10.1002/jnr.10022; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Korte S, 2003, J NEUROCHEM, V87, P1037, DOI 10.1046/j.1471-4159.2003.02080.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Linden R., 2011, UCSD NATURE MOL 0729, DOI [10.1038/mp.a003935.01, DOI 10.1038/MP.A003935.01]; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nimmrich V, 2009, REV NEUROSCIENCE, V20, P1; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Petrakis S, 2008, EUR J NEUROSCI, V27, P612, DOI 10.1111/j.1460-9568.2008.06037.x; Ren K, 2007, NEUROSCIENCE, V148, P230, DOI 10.1016/j.neuroscience.2007.05.013; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Teaktong T, 2004, J NEUROL SCI, V225, P39, DOI 10.1016/j.jns.2004.06.015; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Whatley SA, 1995, NEUROREPORT, V6, P2333, DOI 10.1097/00001756-199511270-00015; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	62	80	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36542	36550		10.1074/jbc.M110.157263	http://dx.doi.org/10.1074/jbc.M110.157263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837487	Green Published, hybrid			2022-12-25	WOS:000284146100059
J	Liu, ML; Wilk, SA; Wang, AP; Zhou, LJ; Wang, RH; Ogawa, W; Deng, CX; Dong, LQ; Liu, F				Liu, Meilian; Wilk, Sarah Ann; Wang, Anping; Zhou, Lijun; Wang, Rui-Hong; Ogawa, Wataru; Deng, Chuxia; Dong, Lily Q.; Liu, Feng			Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAMMALIAN TARGET; CELL-GROWTH; AMPK ACTIVATION; AMINO-ACIDS; INSULIN; RAPAMYCIN; PHOSPHORYLATION; METABOLISM; MECHANISM	Resveratrol (RSV) is a naturally occurring polyphenol that has been found to exert antioxidant, anti-inflammatory, and neuroprotective properties. However, how RSV exerts its beneficial health effects remains largely unknown. Here, we show that RSV inhibits insulin-and leucine-stimulated mTOR signaling in C2C12 fibroblasts via a Sirt1-independent mechanism. Treating C2C12 cells with RSV dramatically inhibited insulin-stimulated Akt, S6 kinase, and 4E-BP1 phosphorylation but had little effect on tyrosine phosphorylation of the insulin receptor and activation of the p44/42MAPK signaling pathway. RSV treatment also partially blocked mTOR and S6 kinase phosphorylation in TSC1/2-deficient mouse embryonic fibroblasts, suggesting the presence of an inhibitory site downstream of TSC1/2. Knocking out PDK1 or suppressing AMP-activated protein kinase had little effect on leucine-stimulated mTOR signaling. On the other hand, RSV significantly increased the association between mTOR and its inhibitor, DEPTOR. Furthermore, the inhibitory effect of RSV on leucine-stimulated mTOR signaling was greatly reduced in cells in which the expression levels of DEPTOR were suppressed by RNAi. Taken together, our studies reveal that RSV inhibits leucine-stimulated mTORC1 activation by promoting mTOR/DEPTOR interaction and thus uncover a novel mechanism by which RSV negatively regulates mTOR activity.	[Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Dong, Lily Q.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Wang, Rui-Hong; Deng, Chuxia] NIDDK, Mammalian Genet Sect, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Ogawa, Wataru] Kobe Univ, Grad Sch Med, Div Diabet Endocrinol & Kidney Dis, Dept Internal Med, Kobe, Hyogo 6500017, Japan	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kobe University		lium2@uthscsa.edu; liuf@uthscsa.edu	deng, chuxia/N-6713-2016; Liu, Feng/CAG-8962-2022; OGAWA, Wataru/AAQ-9586-2020; Zhou, Lijun/H-2229-2011		National Institutes of Health [RO1 DK76902, RO1 DK80344]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, ZIADK056010, ZIADK056011, ZIADK056009, ZIADK056004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK76902 (to F.L.) and RO1 DK80344 (to L.Q.D.).	Acharya SH, 2008, DIABETIC MED, V25, P360, DOI 10.1111/j.1464-5491.2007.02372.x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chen HY, 2008, VISION RES, V48, P690, DOI 10.1016/j.visres.2007.10.014; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; JIANG H, 2010, J EXP THER ONCOL, V8, P25; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2006, NATURE, V444, P280, DOI 10.1038/nature05308; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Kundu JK, 2004, MUTAT RES-FUND MOL M, V555, P65, DOI 10.1016/j.mrfmmm.2004.05.019; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenzano MM, 2006, EUR J OBSTET GYN R B, V124, P246, DOI 10.1016/j.ejogrb.2005.06.041; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	44	133	136	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36387	36394		10.1074/jbc.M110.169284	http://dx.doi.org/10.1074/jbc.M110.169284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851890	Green Published, hybrid			2022-12-25	WOS:000284146100080
J	Johnson, SS; Hanson, PK; Manoharlal, R; Brice, SE; Cowart, LA; Moye-Rowley, WS				Johnson, Soraya S.; Hanson, Pamela K.; Manoharlal, Raman; Brice, Sarah E.; Cowart, L. Ashley; Moye-Rowley, W. Scott			Regulation of Yeast Nutrient Permease Endocytosis by ATP-binding Cassette Transporters and a Seven-transmembrane Protein, RSB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRYPTOPHAN PERMEASE; AMINO-ACID; PLASMA-MEMBRANE; RECEPTOR; SPHINGOLIPIDS; TAT2; PHYTOSPHINGOSINE; TRAFFICKING; ACTIVATION	Ceramide is produced by the condensation of a long chain base with a very long chain fatty acid. In Saccharomyces cerevisiae, one of the two major long chain bases is called phytosphingosine (PHS). PHS has been shown to cause toxicity in tryptophan auxotrophic strains of yeast because this bioactive ceramide precursor causes diversion of the high affinity tryptophan permease Tat2 to the vacuole rather than the plasma membrane. Loss of the integral membrane protein Rsb1 increased PHS sensitivity, which was suggested to be due to this protein acting as an ATP-dependent long chain base efflux protein. More recent experiments demonstrated that loss of the genes encoding the ATP-binding cassette transporter proteins Pdr5 and Yor1 elevated PHS tolerance. This increased resistance was suggested to be due to increased expression of RSB1. Here, we provide an alternative view of PHS resistance influenced by Rsb1 and Pdr5/Yor1. Rsb1 has a seven-transmembrane domain topology more consistent with that of a regulatory protein like a G-protein-coupled receptor rather than a transporter. Importantly, an rsb1 Delta cell does not exhibit higher internal levels of PHS compared with isogenic wild-type cells. However, tryptophan transport is increased in pdr5 Delta yor1 strains and reduced in rsb1 Delta cells. Localization and vacuolar degradation of Tat2 are affected in these genetic backgrounds. Finally, internalization of FM4-64 dye suggests that loss of Pdr5 and Yor1 slows normal endocytic rates. Together, these data argue that Rsb1, Pdr5, and Yor1 regulate the endocytosis of Tat2 and likely other membrane transporter proteins.	[Hanson, Pamela K.; Manoharlal, Raman; Moye-Rowley, W. Scott] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Johnson, Soraya S.; Moye-Rowley, W. Scott] Univ Iowa, Carver Coll Med, Program Mol Biol, Iowa City, IA 52242 USA; [Brice, Sarah E.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	University of Iowa; University of Iowa; Medical University of South Carolina	Moye-Rowley, WS (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 6-530 Bowen Sci Bldg, Iowa City, IA 52242 USA.	scott-moye-rowley@uiowa.edu	Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120; Hanson, Pamela/0000-0002-9312-1682	National Institutes of Health [GM75120, GM49825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075120, R01GM049825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM75120 and GM49825 (to W.S.M.-R.).	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Abe F., 2007, INT C SER, V1304, P75; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHEN XH, 1994, MOL GEN GENET, V244, P260, DOI 10.1007/BF00285453; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Daicho K, 2009, FEMS MICROBIOL LETT, V298, P218, DOI 10.1111/j.1574-6968.2009.01722.x; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Heenan EJ, 2009, BIOCHEMISTRY-US, V48, P6390, DOI 10.1021/bi900621w; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hiraki T, 2010, FEBS LETT, V584, P55, DOI 10.1016/j.febslet.2009.11.076; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Khozoie C, 2009, J BIOL CHEM, V284, P17968, DOI 10.1074/jbc.M109.005843; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Panwar SL, 2006, J BIOL CHEM, V281, P6376, DOI 10.1074/jbc.M512115200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Skrzypek MS, 1998, J BIOL CHEM, V273, P2829, DOI 10.1074/jbc.273.5.2829; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sun Y, 2007, MOL BIOSYST, V3, P849, DOI 10.1039/b706343a; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Welsch CA, 2004, J BIOL CHEM, V279, P36720, DOI 10.1074/jbc.M406179200	40	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35792	35802		10.1074/jbc.M110.162883	http://dx.doi.org/10.1074/jbc.M110.162883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826817	hybrid, Green Published			2022-12-25	WOS:000283845300057
J	Goodman, B; Channels, W; Qiu, MH; Iglesias, P; Yang, G; Zheng, YX				Goodman, Benjamin; Channels, Wilbur; Qiu, Minhua; Iglesias, Pablo; Yang, Ge; Zheng, Yixian			Lamin B Counteracts the Kinesin Eg5 to Restrain Spindle Pole Separation during Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; MICROTUBULE FLUX; NUCLEAR LAMINS; IMPORTIN-BETA; RAN; MATRIX; PROTEIN; MITOSIS; CELL; ORGANIZATION	Lamin B is a component of the membranous spindle matrix isolated from Xenopus egg extracts, and it is required for proper spindle morphogenesis. Besides lamin B, the spindle matrix contains spindle assembly factors (SAFs) such as Eg5 and dynein which are known to regulate microtubule organization and SAFs known to promote microtubule assembly such as Maskin and XMAP215. Because lamin B does not bind directly to microtubules, it must affect spindle morphogenesis indirectly by influencing the function of spindle matrix-associated SAFs. Using different assays in Xenopus egg extracts, we found that depleting lamin B caused formation of elongated and multipolar spindles, which could be reversed by partially inhibiting the kinesin Eg5, revealing an antagonistic relationship between Eg5 and lamin B. However, lamin B only very weakly antagonizes Eg5 in mediating poleward microtubule-flux based on fluorescence speckle microscopy. Depleting lamin B led to a very small but statistically significant increase in flux. Furthermore, flux reduction caused by partial Eg5 inhibition is only slightly reversed by removing lamin B. Because lamin B does not bind to Eg5, our studies suggest two nonexclusive mechanisms by which lamin B can indirectly antagonize Eg5. It could function in a network that restricts Eg5-driven microtubule sliding only when microtubules come into transient contact with the network. Lamin B could also function to sequester microtubule polymerization activities within the spindle. Without lamin B, increased microtubule assembly caused by the released SAFs would lead to excessive microtubule sliding that results in formation of elongated and multipolar spindles.	[Qiu, Minhua; Yang, Ge] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Goodman, Benjamin; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; [Goodman, Benjamin; Zheng, Yixian] Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Channels, Wilbur; Iglesias, Pablo] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Carnegie Mellon University; Johns Hopkins University; Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Yang, G (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	geyang@andrew.cmu.edu; zheng@ciwemb.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X	National Institutes of Health [GM56312]; National Science Foundation [0621740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56312 (to Y. Z.). This work was also supported by National Science Foundation Grant 0621740 (to P. I.).	Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Civelekoglu-Scholey G, 2010, J CELL BIOL, V188, P49, DOI 10.1083/jcb.200908150; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; Lourim D, 1996, J CELL SCI, V109, P1775; Lourim D, 1998, J CELL SCI, V111, P3675; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mogilner M, 2006, TRENDS CELL BIOL, V16, P88, DOI 10.1016/j.tcb.2005.12.007; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zheng YX, 2006, CELL CYCLE, V5, P2345, DOI 10.4161/cc.5.20.3365; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35238	35244		10.1074/jbc.M110.140749	http://dx.doi.org/10.1074/jbc.M110.140749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826821	hybrid, Green Published			2022-12-25	WOS:000283659100097
J	Ahmed, SM; Zerihun, A				Ahmed, Syed Masud; Zerihun, Abebual			Possession and Usage of Insecticidal Bed Nets among the People of Uganda: Is BRAC Uganda Health Programme Pursuing a Pro-Poor Path?	PLOS ONE			English	Article							TREATED NETS; MALARIA CONTROL; PREGNANT-WOMEN; COVERAGE; BEDNETS; AFRICA; ACCEPTABILITY; ELIMINATION; PREFERENCE; CAMPAIGN	Background: The use of insecticidal bed nets is found to be an effective public health tool for control of malaria, especially for under-five children and pregnant women. BRAC, an indigenous Bangladeshi non-governmental development organization, started working in the East African state of Uganda in June 2006. As part of its efforts to improve the health and well-being of its participants, BRAC Uganda has been distributing long lasting insecticide-treated bed nets (LLIN) at a subsidized price through health volunteers since February 2008. This study was conducted in March-April 2009 to examine how equitable the programme had been in consistence with BRAC Uganda's pro-poor policy. Methodology/Principal Findings: Information on possession of LLINs and relevant knowledge on its proper use and maintenance was collected from households either with an under-five child and/or a pregnant woman. The sample included three villages from each of the 10 branch offices where BRAC Uganda's community-based health programme was operating. Data were collected by trained enumerators through face-to-face interviews using a hand-held personal digital assistant (PDA). Findings reveal that the study population had superficial knowledge on malaria and its transmission, including the use and maintenance of LLINs. The households' rate of possession of bed nets (41-59%), and the proportion of under-five children (17-19%) and pregnant women (25-27%) who reported sleeping under an LLIN were not encouraging. Inequity was observed in the number of LLINs possessed by the households, in the knowledge on its use and maintenance, and between the two programme areas. Conclusions/Significance: The BRAC Uganda's LLINs distribution at a subsidized price appeared to be inadequate and inequitable, and BRAC's knowledge dissemination is insufficient for initiating preventive actions such as proper use of LLINs to interrupt malaria transmission. Findings contribute to the on-going debate on LLINs distribution in Africa and make a strong case for its free distribution.	[Ahmed, Syed Masud] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Zerihun, Abebual] BRAC, Evaluat & Res Unit, E Africa Programmes, Kampala, Uganda	Bangladesh Rural Advancement Committee BRAC	Ahmed, SM (corresponding author), BRAC, Res & Evaluat Div, Dhaka, Bangladesh.	ahmed.sm@brac.net	Ahmed, Syed/GSN-7305-2022; Ahmed, Syed Masud/AGQ-4786-2022	Ahmed, Syed Masud/0000-0001-5032-7181	MasterCard Foundation	MasterCard Foundation	The MasterCard Foundation provided funding for this research including the use of PDAs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; [Anonymous], 2007, INS TREAT NETS POS S, P12; [Anonymous], 1998, COCHRANE DB SYST REV; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-298; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Bates N, 2007, AM J TROP MED HYG, V77, P314, DOI 10.4269/ajtmh.2007.77.314; BEER N, 2010, TANZANIA MALARIA J, V9, P173, DOI DOI 10.1186/1475-2875-9-173; *BRAC, 2007, ANN REP 2006; De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; GARBOWSKY M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P409, DOI 10.1046/j.1365-3156.2002.00879.x; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; *MIN HLTH MAL CONT, 2005, UG MAL CONTR STRAT P; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; *ROLL BACK MAL WHO, 2003, AB DECL AFR SUMM ROL; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3; *WHO, 2007, INS TREAT MOSQ NTS W	29	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12660	10.1371/journal.pone.0012660	http://dx.doi.org/10.1371/journal.pone.0012660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844749	Green Published, gold			2022-12-25	WOS:000281687300007
J	Law, JH; Li, Y; To, K; Wang, M; Astanehe, A; Lambie, K; Dhillon, J; Jones, SJM; Gleave, ME; Eaves, CJ; Dunn, SE				Law, Jennifer H.; Li, Yvonne; To, Karen; Wang, Michelle; Astanehe, Arezoo; Lambie, Karen; Dhillon, Jaspreet; Jones, Steven J. M.; Gleave, Martin E.; Eaves, Connie J.; Dunn, Sandra E.			Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; FACTOR RECEPTOR; NUCLEAR EXPRESSION; ANDROGEN RECEPTOR; YB-1; PROGRESSION; DIFFERENTIATION; GLIOBLASTOMA; RESISTANCE; INHIBITION	The Y-box binding protein-1 (YB-1) is an oncogenic transcription/translation factor that is activated by phosphorylation at S102 whereby it induces the expression of growth promoting genes such as EGFR and HER-2. We recently illustrated by an in vitro kinase assay that a novel peptide to YB-1 was highly phosphorylated by the serine/threonine p90 S6 kinases RSK-1 and RSK-2, and to a lesser degree PKC alpha and AKT. Herein, we sought to develop this decoy cell permeable peptide (CPP) as a cancer therapeutic. This 9-mer was designed as an interference peptide that would prevent endogenous YB-1 S-102 phosphorylation based on molecular docking. In cancer cells, the CPP blocked P-YB-1(S102) and down-regulated both HER-2 and EGFR transcript level and protein expression. Further, the CPP prevented YB-1 from binding to the EGFR promoter in a gel shift assay. Notably, the growth of breast (SUM149, MDA-MB-453, AU565) and prostate (PC3, LNCap) cancer cells was inhibited by similar to 90% with the CPP. Further, treatment with this peptide enhanced sensitivity and overcame resistance to trastuzumab in cells expressing amplified HER-2. By contrast, the CPP had no inhibitory effect on the growth of normal immortalized breast epithelial (184htert) cells, primary breast epithelial cells, nor did it inhibit differentiation of hematopoietic progenitors. These data collectively suggest that the CPP is a novel approach to suppressing the growth of cancer cells while sparing normal cells and thereby establishes a proof-of-concept that blocking YB-1 activation is a new course of cancer therapeutics.	[Law, Jennifer H.; To, Karen; Wang, Michelle; Astanehe, Arezoo; Dhillon, Jaspreet; Dunn, Sandra E.] Univ British Columbia, Lab Oncogenom Res, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Li, Yvonne; Jones, Steven J. M.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Gleave, Martin E.] Univ British Columbia, Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Lambie, Karen; Eaves, Connie J.] Univ British Columbia, Terry Fox Labs, BC Canc Agcy, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Law, JH (corresponding author), Univ British Columbia, Lab Oncogenom Res, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	sedunn@interchange.ubc.ca	Li, Yvonne/M-2459-2019; Wang, Michelle/GYA-3899-2022; Jones, Steven J/C-3621-2009	Jones, Steven J/0000-0003-3394-2208; Eaves, Connie/0000-0002-3452-1926	Canadian Institute for Health Research [CIHR PPP-82580]; National Cancer Institute of Canada [NCIC 016512, NCIC 017192]; Canadian Breast Cancer Research Alliance	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Breast Cancer Research Alliance	This work was funded through grants provided by the Canadian Institute for Health Research Proof-of-Principle Grant (CIHR PPP-82580; www.cihr-irsc.gc.ca), the National Cancer Institute of Canada (NCIC 016512 and NCIC 017192; http://www.cancer.ca/Research.aspx?sc_lang=en), and the Canadian Breast Cancer Research Alliance (www.breast.cancer.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Altieri DC, 2006, MOL CANCER THER, V5, P478, DOI 10.1158/1535-7163.MCT-05-0436; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Clark DE, 2005, CANCER RES, V65, P3108; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Gu CD, 2001, ANTICANCER RES, V21, P2357; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Hadaschik BA, 2007, CURR OPIN UROL, V17, P182, DOI 10.1097/MOU.0b013e3280dd8a4f; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kabouridis PS, 2003, TRENDS BIOTECHNOL, V21, P498, DOI 10.1016/j.tibtech.2003.09.008; Kashihara M, 2009, J THORAC ONCOL, V4, P1066, DOI 10.1097/JTO.0b013e3181ae2828; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Marrett LD, 2008, CAN MED ASSOC J, V179, P1163, DOI 10.1503/cmaj.080760; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Prive GG, 2006, CURR OPIN GENET DEV, V16, P71, DOI 10.1016/j.gde.2005.12.010; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Shibao K, 1999, INT J CANCER, V83, P732; Smith JA, 2005, CANCER RES, V65, P1027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; To K, 2007, MOL PHARMACOL, V72, P641, DOI 10.1124/mol.107.036111; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; WU J, 2007, TRANSL ONCOGENOMICS, V2, P1; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yoshikawa T, 2009, BIOMATERIALS, V30, P3318, DOI 10.1016/j.biomaterials.2009.02.031	46	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12661	10.1371/journal.pone.0012661	http://dx.doi.org/10.1371/journal.pone.0012661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844753	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687300008
J	Pham, N; Fazio, V; Cucullo, L; Teng, QS; Biberthaler, P; Bazarian, JJ; Janigro, D				Pham, Nancy; Fazio, Vincent; Cucullo, Luca; Teng, Qingshan; Biberthaler, Peter; Bazarian, Jeffrey J.; Janigro, Damir			Extracranial Sources of S100B Do Not Affect Serum Levels	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; MINOR HEAD TRAUMA; ACUTE ISCHEMIC-STROKE; S-100B PROTEIN; BARRIER DISRUPTION; CARDIAC-SURGERY; PERIPHERAL MARKERS; BLOOD; DAMAGE	S100B, established as prevalent protein of the central nervous system, is a peripheral biomarker for blood-brain barrier disruption and often also a marker of brain injury. However, reports of extracranial sources of S100B, especially from adipose tissue, may confound its interpretation in the clinical setting. The objective of this study was to characterize the tissue specificity of S100B and assess how extracranial sources of S100B affect serum levels. The extracranial sources of S100B were determined by analyzing nine different types of human tissues by ELISA and Western blot. In addition, brain and adipose tissue were further analyzed by mass spectrometry. A study of 200 subjects was undertaken to determine the relationship between body mass index (BMI) and S100B serum levels. We also measured the levels of S100B homo- and heterodimers in serum quantitatively after blood-brain barrier disruption. Analysis of human tissues by ELISA and Western blot revealed variable levels of S100B expression. By ELISA, brain tissue expressed the highest S100B levels. Similarly, Western blot measurements revealed that brain tissue expressed high levels of S100B but comparable levels were found in skeletal muscle. Mass spectrometry of brain and adipose tissue confirmed the presence of S100B but also revealed the presence of S100A1. The analysis of 200 subjects revealed no statistically significant relationship between BMI and S100B levels. The main species of S100B released from the brain was the B-B homodimer. Our results show that extracranial sources of S100B do not affect serum levels. Thus, the diagnostic value of S100B and its negative predictive value in neurological diseases in intact subjects (without traumatic brain or bodily injury from accident or surgery) are not compromised in the clinical setting.	[Pham, Nancy; Janigro, Damir] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland Clin Fdn, Cleveland, OH 44106 USA; [Fazio, Vincent; Cucullo, Luca] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; [Biberthaler, Peter] Univ Munich, Surg Dept Munich Cent, Munich, Germany; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Munich; University of Rochester	Pham, N (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland Clin Fdn, Cleveland, OH 44106 USA.	janigrd@ccf.org	Cucullo, Luca/X-2765-2019	Cucullo, Luca/0000-0002-2827-7162; Janigro, Damir/0000-0003-2165-5826	Roche Diagnostics [RO1 NS43284, RO1 NS38195, R21 HD057256]; Cleveland Clinic- Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043284, R01NS038195] Funding Source: NIH RePORTER	Roche Diagnostics; Cleveland Clinic- Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by RO1 NS43284, RO1 NS38195, R21 HD057256 to Damir Janigro. It was also supported by "A Prospective Pilot Study on S100B in TBI" funded by Roche Diagnostics and by the Cleveland Clinic- Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State. None of the funding agencies had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1173, DOI 10.1515/CCLM.2000.181; Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; BAUDIER J, 1986, J BIOL CHEM, V261, P8204; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2000, ACT NEUR S, V76, P177; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; DONATO R, 2001, INT J BIOCHEM CELL B, V637, P668; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Mann M, 2008, J PROTEOME RES, V7, P3065, DOI 10.1021/pr800463v; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Mazzone PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007242; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Mussack T, 2000, ACT NEUR S, V76, P393; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pineau JC, 2007, ANN NUTR METAB, V51, P421, DOI 10.1159/000111161; Portela LVC, 2002, CLIN CHEM, V48, P950; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rothermundt M, 2004, INT REV NEUROBIOL, V59, P445; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI [10.1089/neu.2009.0928, 10.1089/neu.2009-0928]; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004	48	94	98	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12691	10.1371/journal.pone.0012691	http://dx.doi.org/10.1371/journal.pone.0012691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844757	Green Submitted, gold, Green Published			2022-12-25	WOS:000281687300022
J	Ali, M; Al-Olayan, EM; Lewis, S; Matthews, H; Hurd, H				Ali, Medhat; Al-Olayan, Ebtesam M.; Lewis, Steven; Matthews, Holly; Hurd, Hilary			Naturally Occurring Triggers that Induce Apoptosis-Like Programmed Cell Death in Plasmodium berghei Ookinetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ANOPHELES-STEPHENSI; PUTATIVE ROLE; MIDGUT CELLS; MALARIA INFECTION; TRYPANOSOMA-CRUZI; ENDONUCLEASE-G; IN-VITRO; FALCIPARUM; MECHANISM	Several protozoan parasites have been shown to undergo a form of programmed cell death that exhibits morphological features associated with metazoan apoptosis. These include the rodent malaria parasite, Plasmodium berghei. Malaria zygotes develop in the mosquito midgut lumen, forming motile ookinetes. Up to 50% of these exhibit phenotypic markers of apoptosis; as do those grown in culture. We hypothesised that naturally occurring signals induce many ookinetes to undergo apoptosis before midgut traversal. To determine whether nitric oxide and reactive oxygen species act as such triggers, ookinetes were cultured with donors of these molecules. Exposure to the nitric oxide donor SNP induced a significant increase in ookinetes with condensed nuclear chromatin, activated caspase-like molecules and translocation of phosphatidylserine that was dose and time related. Results from an assay that detects the potential-dependent accumulation of aggregates of JC-1 in mitochondria suggested that nitric oxide does not operate via loss of mitochondrial membrane potential. L-DOPA (reactive oxygen species donor) also caused apoptosis in a dose and time dependent manner. Removal of white blood cells significantly decreased ookinetes exhibiting a marker of apoptosis in vitro. Inhibition of the activity of nitric oxide synthase in the mosquito midgut epithelium using L-NAME significantly decreased the proportion of apoptotic ookinetes and increased the number of oocysts that developed. Introduction of a nitric oxide donor into the blood meal had no effect on mosquito longevity but did reduce prevalence and intensity of infection. Thus, nitric oxide and reactive oxygen species are triggers of apoptosis in Plasmodium ookinetes. They occur naturally in the mosquito midgut lumen, sourced from infected blood and mosquito tissue. Up regulation of mosquito nitric oxide synthase activity has potential as a transmission blocking strategy.	[Ali, Medhat; Al-Olayan, Ebtesam M.; Lewis, Steven; Matthews, Holly; Hurd, Hilary] Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England; [Ali, Medhat] Ain Shams Univ, Dept Zool, Cairo, Egypt; [Al-Olayan, Ebtesam M.] King Saud Univ, Dept Zool, Riyadh, Saudi Arabia	Keele University; Egyptian Knowledge Bank (EKB); Ain Shams University; King Saud University	Ali, M (corresponding author), Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England.	h.hurd@keele.ac.uk	Ali, Medhat M/L-9546-2013	Ali, Medhat M/0000-0002-1695-9772	Wellcome Trust [069162/Z/02/Z]; Saudi Arabian Government; Egyptian Government	Wellcome Trust(Wellcome TrustEuropean Commission); Saudi Arabian Government; Egyptian Government	Funding for insectary facilities was provided by The Wellcome Trust, (069162/Z/02/Z), www.wellcome.ac.uk. EMA and MA received scholarships from the Saudi Arabian Government and the Egyptian Government, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Ameisen JC, 2004, CELL DEATH DIFFER, V11, P4, DOI 10.1038/sj.cdd.4401356; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Arambage SC, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-32; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Bai P, 2001, FREE RADICAL BIO MED, V31, P1616, DOI 10.1016/S0891-5849(01)00756-0; Balmer P, 2000, PARASITE IMMUNOL, V22, P97, DOI 10.1046/j.1365-3024.2000.00281.x; Baton Luke A., 2008, P74, DOI 10.1007/978-0-387-76717-8_7; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cao Ya-Ming, 1998, Parasitology International, V47, P225, DOI 10.1016/S1383-5769(98)00026-9; Carter V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-35; Carter V, 2007, INT J PARASITOL, V37, P1221, DOI 10.1016/j.ijpara.2007.03.005; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Colasanti M, 2001, TRENDS PARASITOL, V17, P575, DOI 10.1016/S1471-4922(01)02191-2; Crampton A, 2001, INFECT GENET EVOL, V1, P131, DOI 10.1016/S1567-1348(01)00017-X; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; Debrabant Alain, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-7; Deponte M, 2008, BBA-MOL CELL RES, V1783, P1396, DOI 10.1016/j.bbamcr.2008.01.018; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; DING AH, 1988, J IMMUNOL, V141, P2407; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; Fuertes Miguel A., 2008, P1; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Getti GT, 2008, PARASITOLOGY, V135, P1391, DOI 10.1017/S0031182008004915; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Harada M, 2001, PARASITOL RES, V87, P605, DOI 10.1007/s004360100432; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herrera-Ortiz A, 2004, INSECT BIOCHEM MOLEC, V34, P893, DOI 10.1016/j.ibmb.2004.05.007; Holzmuller P, 2006, PARASITOLOGY, V132, pS19, DOI 10.1017/S0031182006000837; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim KM, 2002, J BIOCHEM MOL BIOL, V35, P127; Kobayashi T, 2003, CELL DEATH DIFFER, V10, P634, DOI 10.1038/sj.cdd.4401216; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Lanz-Mendoza H, 2002, J PARASITOL, V88, P702, DOI 10.1645/0022-3395(2002)088[0702:SAIAAH]2.0.CO;2; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lensen AHW, 1997, INFECT IMMUN, V65, P3834, DOI 10.1128/IAI.65.9.3834-3837.1997; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luckhart S, 2003, MOL BIOCHEM PARASIT, V128, P83, DOI 10.1016/S0166-6851(03)00016-1; Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117; Mariante RM, 2003, HISTOCHEM CELL BIOL, V120, P129, DOI 10.1007/s00418-003-0548-x; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; MELLOUK S, 1994, INFECT IMMUN, V62, P4043, DOI 10.1128/IAI.62.9.4043-4046.1994; Meslin B, 2007, J INFECT DIS, V195, P1852, DOI 10.1086/518253; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; NAOTUNNE TD, 1993, IMMUNOLOGY, V78, P555; NATHAN C, 1995, CELL, V82, P873, DOI 10.1016/0092-8674(95)90019-5; Nguewa PA, 2004, TRENDS PARASITOL, V20, P375, DOI 10.1016/j.pt.2004.05.006; Ojcius DM, 1999, MICROBES INFECT, V1, P1163, DOI 10.1016/S1286-4579(99)00246-4; Peng BW, 2003, PARASITOLOGY, V126, P541, DOI 10.1017/S0031182003003226; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Picot S, 1997, T ROY SOC TROP MED H, V91, P590, DOI 10.1016/S0035-9203(97)90039-0; Rico E, 2009, MOL BIOCHEM PARASIT, V163, P28, DOI 10.1016/j.molbiopara.2008.09.007; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Skorokhod OA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-73; Sobolewski P, 2005, TRENDS PARASITOL, V21, P415, DOI 10.1016/j.pt.2005.07.002; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Taylor-Robinson AW, 1998, LANCET, V351, P1630, DOI 10.1016/S0140-6736(05)77685-6; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Welburn SC, 1997, PARASITOL TODAY, V13, P22, DOI 10.1016/S0169-4758(96)10076-4; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	87	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12634	10.1371/journal.pone.0012634	http://dx.doi.org/10.1371/journal.pone.0012634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844583	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687200004
J	Arnott, A; Jardine, D; Wilson, K; Gorry, PR; Merlin, K; Grey, P; Law, MG; Dax, EM; Kelleher, AD; Smith, DE; McPhee, DA				Arnott, Alicia; Jardine, Darren; Wilson, Kim; Gorry, Paul R.; Merlin, Kate; Grey, Patricia; Law, Matthew G.; Dax, Elizabeth M.; Kelleher, Anthony D.; Smith, Don E.; McPhee, Dale A.		Pulse Study Team	High Viral Fitness during Acute HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRUCTURED TREATMENT INTERRUPTION; TYPE-1 FITNESS; IN-VIVO; MOLECULAR EVOLUTION; RECOMBINANT VIRUSES; REPLICATIVE FITNESS; DISEASE PROGRESSION; DRUG-RESISTANCE; ENVELOPE GENE	Several clinical studies have shown that, relative to disease progression, HIV-1 isolates that are less fit are also less pathogenic. The aim of the present study was to investigate the relationship between viral fitness and control of viral load (VL) in acute and early HIV-1 infection. Samples were obtained from subjects participating in two clinical studies. In the PULSE study, antiretroviral therapy (ART) was initiated before, or no later than six months following seroconversion. Subjects then underwent multiple structured treatment interruptions (STIs). The PHAEDRA study enrolled and monitored a cohort of individuals with documented evidence of primary infection. The subset chosen were individuals identified no later than 12 months following seroconversion to HIV-1, who were not receiving ART. The relative fitness of primary isolates obtained from study participants was investigated ex vivo. Viral DNA production was quantified using a novel real time PCR assay. Following intermittent ART, the fitness of isolates obtained from 5 of 6 PULSE subjects decreased over time. In contrast, in the absence of ART the fitness of paired isolates obtained from 7 of 9 PHAEDRA subjects increased over time. However, viral fitness did not correlate with plasma VL. Most unexpected was the high relative fitness of isolates obtained at Baseline from PULSE subjects, before initiating ART. It is widely thought that the fitness of strains present during the acute phase is low relative to strains present during chronic HIV-1 infection, due to the bottleneck imposed upon transmission. The results of this study provide evidence that the relative fitness of strains present during acute HIV-1 infection may be higher than previously thought. Furthermore, that viral fitness may represent an important clinical parameter to be considered when deciding whether to initiate ART during early HIV-1 infection.	[Arnott, Alicia; Jardine, Darren; Wilson, Kim; Dax, Elizabeth M.; McPhee, Dale A.] St Vincents Inst, Natl Serol Reference Lab, Melbourne, Vic, Australia; [Arnott, Alicia; McPhee, Dale A.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gorry, Paul R.; Dax, Elizabeth M.; McPhee, Dale A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Gorry, Paul R.] Burnet Inst, Melbourne, Vic, Australia; [Gorry, Paul R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Merlin, Kate; Grey, Patricia; Law, Matthew G.; Kelleher, Anthony D.; Smith, Don E.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Kelleher, Anthony D.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia	St. Vincent's Institute of Medical Research; Monash University; University of Melbourne; Burnet Institute; Monash University; University of New South Wales Sydney; Kirby Institute	Arnott, A (corresponding author), Inst Pasteur, Phnom Penh, Cambodia.	dale@nrl.gov.au	McPhee, Dale A/D-1825-2011	Law, Matthew/0000-0002-3540-8837; Arnott, Alicia/0000-0003-2637-8936	Monash University; Australian Centre for HIV and Hepatitis; Foundation for AIDS Research (amfAR) [106669]; Australian National Health and Medical Research Council [502617]	Monash University(Monash University); Australian Centre for HIV and Hepatitis; Foundation for AIDS Research (amfAR); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Alicia Arnott, Monash University Post-graduate Scholarship; Australian Centre for HIV and Hepatitis Research Grant; the Foundation for AIDS Research (amfAR) Grant (106669) and the Australian National Health and Medical Research Council Project Grant (502617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyakov IM, 2004, IMMUNITY, V20, P247, DOI 10.1016/S1074-7613(04)00053-6; Bernardin F, 2005, J VIROL, V79, P11523, DOI 10.1128/JVI.79.17.11523-11528.2005; Bloch MT, 2006, JAIDS-J ACQ IMM DEF, V42, P192, DOI 10.1097/01.qai.0000219779.50668.e6; Borderia AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010319; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Campbell TB, 2003, J VIROL, V77, P12105, DOI 10.1128/JVI.77.22.12105-12112.2003; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CLARKE DK, 1994, P NATL ACAD SCI USA, V91, P4821, DOI 10.1073/pnas.91.11.4821; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; Dykes C, 2007, CLIN MICROBIOL REV, V20, P550, DOI 10.1128/CMR.00017-07; Falster K, 2008, SEX HEALTH, V5, P141, DOI 10.1071/SH07082; Ferbas J, 1996, J VIROL, V70, P7285, DOI 10.1128/JVI.70.10.7285-7289.1996; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; Garcia-Perez J, 2008, HIV MED, V9, P160, DOI 10.1111/j.1468-1293.2007.00540.x; Geffin R, 2000, AIDS RES HUM RETROV, V16, P1855, DOI 10.1089/08892220050195810; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gorry PR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-66; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Gray L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-75; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIERNAN R, 1990, AIDS RES HUM RETROV, V6, P743, DOI 10.1089/aid.1990.6.743; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kondo M, 2005, J INFECT DIS, V192, P56, DOI 10.1086/430739; Kong XH, 2008, J VIROL, V82, P11609, DOI 10.1128/JVI.00952-08; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Loh L, 2008, AIDS RES HUM RETROV, V24, P1067, DOI 10.1089/aid.2007.0309; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; Oelrichs RB, 2000, J BIOMED SCI, V7, P128, DOI 10.1007/BF02256619; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peut V, 2006, CURR HIV RES, V4, P191, DOI 10.2174/157016206776055110; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Sewell AK, 2000, STEM CELLS, V18, P230, DOI 10.1634/stemcells.18-4-230; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Soto-Ramirez LE, 2008, AIDS RES HUM RETROV, V24, P797, DOI 10.1089/aid.2007.0246; SPIRA AI, 1995, J VIROL, V69, P422, DOI 10.1128/JVI.69.1.422-429.1995; Tebit DM, 2007, AIDS REV, V9, P75; Trkola A, 2003, J VIROL, V77, P13146, DOI 10.1128/JVI.77.24.13146-13155.2003; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vandegraaff N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Verity EE, 2006, AIDS, V20, P505, DOI 10.1097/01.aids.0000210604.78385.95; Verity EE, 2007, J VIROL, V81, P9268, DOI 10.1128/JVI.00650-07; von Briesen H, 1999, AIDS, V13, P307, DOI 10.1097/00002030-199902250-00002; Wang YM, 2007, CURR HIV RES, V5, P235; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yun ZB, 2002, J CLIN MICROBIOL, V40, P3883, DOI 10.1128/JCM.40.10.3883-3884.2002	63	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12631	10.1371/journal.pone.0012631	http://dx.doi.org/10.1371/journal.pone.0012631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844589	gold, Green Published			2022-12-25	WOS:000281687200002
J	Li, L; Cheng, C; Xia, CH; White, TW; Fletcher, DA; Gong, XH				Li, Lin; Cheng, Catherine; Xia, Chun-hong; White, Thomas W.; Fletcher, Daniel A.; Gong, Xiaohua			Connexin Mediated Cataract Prevention in Mice	PLOS ONE			English	Article							FIBER CELL-DIFFERENTIATION; AGE-RELATED CATARACT; LENS DEVELOPMENT; POINT MUTATION; MOUSE LENS; CRYSTALLIN; GROWTH; EYE; MICROPHTHALMIA; PROTEOLYSIS	Cataracts, named for any opacity in the ocular lens, remain the leading cause of vision loss in the world. Non-surgical methods for cataract prevention are still elusive. We have genetically tested whether enhanced lens gap junction communication, provided by increased alpha 3 connexin (Cx46) proteins expressed from alpha 8(Ki alpha 3) knock-in alleles in Gja8(tm1(Gj alpha 3)Tww) mice, could prevent nuclear cataracts caused by the gamma B-crystallin S11R mutation in Crygb(S11R/S11R) mice. Remarkably, homozygous knock-in alpha 8(Ki alpha 3/Ki alpha 3) mice fully prevented nuclear cataracts, while single knock-in alpha 8(Ki alpha 3/-) allele mice showed variable suppression of nuclear opacities in Crygb(S11R/S11R) mutant mice. Cataract prevention was correlated with the suppression of many pathological processes, including crystallin degradation and fiber cell degeneration, as well as preservation of normal calcium levels and stable actin filaments in the lens. This work demonstrates that enhanced intercellular gap junction communication can effectively prevent or delay nuclear cataract formation and suggests that small metabolites transported through gap junction channels protect the stability of crystallin proteins and the cytoskeletal structures in the lens core. Thus, the use of an array of small molecules to promote lens homeostasis may become a feasible non-surgical approach for nuclear cataract prevention in the future.	[Li, Lin; Cheng, Catherine; Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Li, Lin; Cheng, Catherine; Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [White, Thomas W.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley	Li, L (corresponding author), Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA.	xgong@berkeley.edu	White, Thomas W./R-3605-2019; White, Thomas/GPG-4026-2022	White, Thomas/0000-0002-3285-7434	National Eye Institute [EY013849, EY013163]; NATIONAL EYE INSTITUTE [R01EY013849, R01EY013163] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute (http://www.nei.nih.gov/) grants EY013849 (to XG) and EY013163 (to TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Baruch A, 2001, J BIOL CHEM, V276, P28999, DOI 10.1074/jbc.M103628200; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Biswas S, 2004, TRENDS MOL MED, V10, P78, DOI 10.1016/j.molmed.2003.12.007; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Chong EW, 2008, OPHTHALMOLOGY, V115, P597, DOI 10.1016/j.ophtha.2008.01.033; De Maria A, 2009, J BIOL CHEM, V284, P13542, DOI 10.1074/jbc.M900561200; Fernandez MM, 2008, CURR OPIN OPHTHALMOL, V19, P66, DOI 10.1097/ICU.0b013e3282f2d7b6; Gao JY, 2004, J GEN PHYSIOL, V124, P289, DOI 10.1085/jgp.200409121; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; Li L, 2008, INVEST OPHTH VIS SCI, V49, P304, DOI 10.1167/iovs.07-0942; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Maraini G, 2009, ANN I SUPER SANITA, V45, P119; Martinez-Wittinghan FJ, 2004, INVEST OPHTH VIS SCI, V45, P3629, DOI 10.1167/iovs.04-0445; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; Miller JW, 2009, ARCH OPHTHALMOL-CHIC, V127, P1680, DOI 10.1001/archophthalmol.2009.321; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Puk O, 2008, INVEST OPHTH VIS SCI, V49, P1525, DOI 10.1167/iovs.07-1033; Rong P, 2002, DEVELOPMENT, V129, P167; Sonntag S, 2009, EUR J CELL BIOL, V88, P65, DOI 10.1016/j.ejcb.2008.08.004; Tan AG, 2008, AM J CLIN NUTR, V87, P1899, DOI 10.1093/ajcn/87.6.1899; Tang YJ, 2007, INVEST OPHTH VIS SCI, V48, P2685, DOI 10.1167/iovs.06-0926; Toh T, 2007, CLIN EXP OPHTHALMOL, V35, P664, DOI 10.1111/j.1442-9071.2007.01559.x; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P95, DOI 10.1167/iovs.08-1797; Xia CH, 2006, J CELL SCI, V119, P2138, DOI 10.1242/jcs.02940	35	17	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12624	10.1371/journal.pone.0012624	http://dx.doi.org/10.1371/journal.pone.0012624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844585	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687200001
J	van Soolingen, D; Hernandez-Pando, R; Orozco, H; Aguilar, D; Magis-Escurra, C; Amaral, L; van Ingen, J; Boeree, MJ				van Soolingen, Dick; Hernandez-Pando, Rogelio; Orozco, Hector; Aguilar, Diana; Magis-Escurra, Cecile; Amaral, Leonard; van Ingen, Jakko; Boeree, Martin J.			The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis	PLOS ONE			English	Article							EXPERIMENTAL PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DE-POINTES; PHENOTHIAZINES; CHEMOTHERAPY; CELLS; MICE	Multidrug- and extensively drug-resistant tuberculosis have emerged as grave threats to public health worldwide. Very few active drugs are available or likely to become available soon. To address these problems we revisited a classical observation, the applicability of phenothiazines as antimicrobial drugs. Within this pharmacological class we selected thioridazine, which is most efficacious and least toxic, when used as an antipsychotic drug. We tested thioridazine monotherapy in the Balb/c mouse model for its activity to treat both susceptible and multidrug-resistant tuberculosis by a two months daily oral administration of 32 and 70 mg/kg. In addition, we tested its additive value when combined with a standard first-line regimen for susceptible tuberculosis. Thioridazine treatment resulted in a significant reduction of colony-forming-units of the susceptible (-4.4 log CFU, p<0.05) and multidrug-resistant tuberculosis bacilli (-2.4 log CFU, p<0.009) in the lung both at one and two months after infection, compared to controls. Moreover, when thioridazine was added to a regimen containing rifampicin, isoniazid and pyrazinamide for susceptible tuberculosis, a significant synergistic effect was achieved (-6.2 vs -5.9 log CFU, p<0.01). Thioridazine may represent an effective compound for treatment of susceptible and multidrug-resistant tuberculosis. The phenothiazines and their targets represent interesting novel opportunities in the search for antituberculosis drugs.	[van Soolingen, Dick; van Ingen, Jakko] Natl Inst Publ Hlth & Environm, Natl Mycobacteria Reference Lab, Labs Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Clin Microbiol, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Resp Dis, NL-6525 ED Nijmegen, Netherlands; [Hernandez-Pando, Rogelio; Orozco, Hector; Aguilar, Diana] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico; [Magis-Escurra, Cecile; van Ingen, Jakko; Boeree, Martin J.] Radboud Univ Nijmegen, Med Ctr, Univ Ctr Chron Dis Dekkerswald, NL-6525 ED Nijmegen, Netherlands; [Amaral, Leonard] Univ Nova Lisboa, Inst Hyg & Trop Med, Mycobacteriol Unit, P-1200 Lisbon, Portugal	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	van Soolingen, D (corresponding author), Natl Inst Publ Hlth & Environm, Natl Mycobacteria Reference Lab, Labs Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands.	dick.van.soolingen@rivm.nl	Boeree, Martin J./G-6132-2010; van Ingen, Jakko/D-5526-2014; Ibanez, C. Magis-Escurra/L-4500-2015; Amaral, Leonard/I-2112-2012	van Ingen, Jakko/0000-0002-0581-2003; Amaral, Leonard/0000-0003-3127-1295; Hernandez-Pando, Rogelio/0000-0003-1292-3833				Amaral L, 2001, J ANTIMICROB CHEMOTH, V47, P505, DOI 10.1093/jac/47.5.505; Amaral L, 2010, INT J ANTIMICROB AG, V35, P524, DOI 10.1016/j.ijantimicag.2009.12.019; Bettencourt MV, 2000, INT J ANTIMICROB AG, V16, P69, DOI 10.1016/S0924-8579(00)00199-0; De Steenwinkel JEM, 2009, INT J IMMUNOPATH PH, V22, P723, DOI 10.1177/039463200902200318; DHAUNSI GS, 1993, NEUROPHARMACOLOGY, V32, P439; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Fabre RA, 2004, CLIN EXP IMMUNOL, V136, P215, DOI 10.1111/j.1365-2249.2004.02454.x; FORREST FM, 1963, REV AGRESSOLOGIE, V4, P259; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Hadjimitova V, 2003, CELL BIOL TOXICOL, V19, P3, DOI 10.1023/A:1022061513581; Hernandez-Pando R, 2006, CLIN EXP IMMUNOL, V144, P264, DOI 10.1111/j.1365-2249.2006.03049.x; Hernandez-Pando R, 2005, J INFECT DIS, V191, P299, DOI 10.1086/426453; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Iannini Paul B, 2002, Expert Opin Drug Saf, V1, P121, DOI 10.1517/14740338.1.2.121; JARNAGIN JL, 1980, STAIN TECHNOL, V55, P253, DOI 10.3109/10520298009067249; KRISTIANSEN JEH, 1979, ACTA PATH MICRO IM B, V87, P317; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Martins M, 2007, IN VIVO, V21, P771; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; van Ingen J, 2009, INT J ANTIMICROB AG, V34, P190, DOI 10.1016/j.ijantimicag.2009.02.015; Viveiros M, 2001, INT J ANTIMICROB AG, V17, P225, DOI 10.1016/S0924-8579(00)00343-5; *WHO, 2008, ANT DRUG RES WORLD	27	70	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12640	10.1371/journal.pone.0012640	http://dx.doi.org/10.1371/journal.pone.0012640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844587	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687200009
J	Jagannathan, R; Kaveti, S; Desnoyer, RW; Willard, B; Kinter, M; Karnik, SS				Jagannathan, Rajaganapathi; Kaveti, Suma; Desnoyer, Russell W.; Willard, Belinda; Kinter, Michael; Karnik, Sadashiva S.			AT(1) Receptor Induced Alterations in Histone H2A Reveal Novel Insights into GPCR Control of Chromatin Remodeling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANGIOTENSIN-II; POSTTRANSLATIONAL MODIFICATIONS; GENE-TRANSCRIPTION; MASS-SPECTROMETRY; H3 VARIANTS; IN-VIVO; ANG-II; PHOSPHORYLATION; ACTIVATION	Chronic activation of angiotensin II (AngII) type 1 receptor (AT(1)R), a prototypical G protein-coupled receptor (GPCR) induces gene regulatory stress which is responsible for phenotypic modulation of target cells. The AT(1)R-selective drugs reverse the gene regulatory stress in various cardiovascular diseases. However, the molecular mechanisms are not clear. We speculate that activation states of AT(1)R modify the composition of histone isoforms and post-translational modifications (PTM), thereby alter the structure-function dynamics of chromatin. We combined total histone isolation, FPLC separation, and mass spectrometry techniques to analyze histone H2A in HEK293 cells with and without AT(1)R activation. We have identified eight isoforms: H2AA, H2AG, H2AM, H2AO, H2AQ, Q96QV6, H2AC and H2AL. The isoforms, H2AA, H2AC and H2AQ were methylated and H2AC was phosphorylated. The relative abundance of specific H2A isoforms and PTMs were further analyzed in relationship to the activation states of AT(1)R by immunochemical studies. Within 2 hr, the isoforms, H2AA/O exchanged with H2AM. The monomethylated H2AC increased rapidly and the phosphorylated H2AC decreased, thus suggesting that enhanced H2AC methylation is coupled to Ser1p dephosphorylation. We show that H2A125Kme1 promotes interaction with the heterochromatin associated protein, HP1 alpha. These specific changes in H2A are reversed by treatment with the AT(1)R specific inhibitor losartan. Our analysis provides a first step towards an awareness of histone code regulation by GPCRs.	[Jagannathan, Rajaganapathi; Desnoyer, Russell W.; Karnik, Sadashiva S.] Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kaveti, Suma; Willard, Belinda; Kinter, Michael] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Jagannathan, R (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Kinter, Michael/0000-0001-7409-8918	National Institutes of Health [HL083243, HL57470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470, R01HL083243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by RO1 Grants HL083243 and HL57470 to S.S. Karnik from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvelo-Ceron D, 2000, MOL BIOL REP, V27, P61, DOI 10.1023/A:1007156629024; Ausio J, 2001, BIOCHEM CELL BIOL, V79, P693, DOI 10.1139/bcb-79-6-693; Balbi APC, 2009, BRAZ J MED BIOL RES, V42, P38, DOI 10.1590/S0100-879X2009000100007; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dzau VJ, 2005, J CLIN INVEST, V115, P2319, DOI 10.1172/JCI26384; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Espino PS, 2005, J CELL BIOCHEM, V94, P1088, DOI 10.1002/jcb.20387; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; Goll MG, 2002, GENE DEV, V16, P1739, DOI 10.1101/gad.1013902; Griendling KK, 1996, ANNU REV PHARMACOL, V36, P281, DOI 10.1146/annurev.pharmtox.36.1.281; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2005, P NATL ACAD SCI USA, V102, P5308, DOI 10.1073/pnas.0501853102; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; LEE JH, 2009, HUM MOL GENET; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; MacLellan WR, 1998, CIRCULATION, V97, P1433; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Mariani MR, 2003, J STEROID BIOCHEM, V86, P167, DOI 10.1016/S0960-0760(03)00267-X; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464; Nakatani Y, 2006, E SCHERING RES FDN W, V57, P89; OKA SI, 2009, J MOL MED; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strange PG, 2008, CURR OPIN DRUG DISC, V11, P196; Su XD, 2009, PROTEOMICS, V9, P1197, DOI 10.1002/pmic.200800333; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhang Y, 2004, J BIOL CHEM, V279, P21866, DOI 10.1074/jbc.M400099200	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12552	10.1371/journal.pone.0012552	http://dx.doi.org/10.1371/journal.pone.0012552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838438	gold, Green Published, Green Submitted			2022-12-25	WOS:000281627700005
J	Inaba, M; Yuan, HB; Salzmann, V; Fuller, MT; Yamashita, YM				Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria; Fuller, Margaret T.; Yamashita, Yukiko M.			E-Cadherin Is Required for Centrosome and Spindle Orientation in Drosophila Male Germline Stem Cells	PLOS ONE			English	Article							ADHERENS JUNCTIONS; OVERLAPPING ROLES; MITOTIC SPINDLES; DIVISION; APC2; ADHESION; NICHE; DIFFERENTIATION; POLARITY; PROTEIN	Many adult stem cells reside in a special microenvironment known as the niche, where they receive essential signals that specify stem cell identity. Cell-cell adhesion mediated by cadherin and integrin plays a crucial role in maintaining stem cells within the niche. In Drosophila melanogaster, male germline stem cells (GSCs) are attached to niche component cells (i.e., the hub) via adherens junctions. The GSC centrosomes and spindle are oriented toward the hub-GSC junction, where E-cadherin-based adherens junctions are highly concentrated. For this reason, adherens junctions are thought to provide a polarity cue for GSCs to enable proper orientation of centrosomes and spindles, a critical step toward asymmetric stem cell division. However, understanding the role of E-cadherin in GSC polarity has been challenging, since GSCs carrying E-cadherin mutations are not maintained in the niche. Here, we tested whether E-cadherin is required for GSC polarity by expressing a dominant-negative form of E-cadherin. We found that E-cadherin is indeed required for polarizing GSCs toward the hub cells, an effect that may be mediated by Apc2. We also demonstrated that E-cadherin is required for the GSC centrosome orientation checkpoint, which prevents mitosis when centrosomes are not correctly oriented. We propose that E-cadherin orchestrates multiple aspects of stem cell behavior, including polarization of stem cells toward the stem cell-niche interface and adhesion of stem cells to the niche supporting cells.	[Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria; Yamashita, Yukiko M.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Yamashita, Yukiko M.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Fuller, Margaret T.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Fuller, Margaret T.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University	Inaba, M (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu	Yuan, Hebao/E-2032-2011	Yuan, Hebao/0000-0003-4425-3678; Fuller, Margaret T/0000-0002-3804-4987; Yamashita, Yukiko/0000-0001-5541-0216	National Institutes of Health [R01GM086481-01, P01 DK53074]; Searle Scholar Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (R01GM086481-01), Searle Scholar Program, March of Dimes Basil O'Connor Starter Scholar Award ( to YMY); NIH P01 DK53074 ( to MTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Mirkovic I, 2006, DEVELOPMENT, V133, P3283, DOI 10.1242/dev.02468; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Van Doren M, 1998, CURR BIOL, V8, P243; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	30	100	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12473	10.1371/journal.pone.0012473	http://dx.doi.org/10.1371/journal.pone.0012473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824213	Green Published, Green Submitted, gold			2022-12-25	WOS:000281405300011
J	Pani, AM; Hobart, HH; Morris, CA; Mervis, CB; Bray-Ward, P; Kimberley, KW; Rios, CM; Clark, RC; Gulbronson, MD; Gowans, GC; Gregg, RG				Pani, Ariel M.; Hobart, Holly H.; Morris, Colleen A.; Mervis, Carolyn B.; Bray-Ward, Patricia; Kimberley, Kendra W.; Rios, Cecilia M.; Clark, Robin C.; Gulbronson, Maricela D.; Gowans, Gordon C.; Gregg, Ronald G.			Genome Rearrangements Detected by SNP Microarrays in Individuals with Intellectual Disability Referred with Possible Williams Syndrome	PLOS ONE			English	Article							MULTIPLE CONGENITAL-ANOMALIES; CONTIGUOUS GENE DELETION; COPY-NUMBER VARIATION; STRUCTURAL VARIATION; MENTAL-RETARDATION; SEGMENTAL DUPLICATIONS; OLIGONUCLEOTIDE ARRAYS; RECOMBINATION; DISORDERS; HYBRIDIZATION	Background: Intellectual disability ( ID) affects 2-3% of the population and may occur with or without multiple congenital anomalies (MCA) or other medical conditions. Established genetic syndromes and visible chromosome abnormalities account for a substantial percentage of ID diagnoses, although for similar to 50% the molecular etiology is unknown. Individuals with features suggestive of various syndromes but lacking their associated genetic anomalies pose a formidable clinical challenge. With the advent of microarray techniques, submicroscopic genome alterations not associated with known syndromes are emerging as a significant cause of ID and MCA. Methodology/Principal Findings: High-density SNP microarrays were used to determine genome wide copy number in 42 individuals: 7 with confirmed alterations in the WS region but atypical clinical phenotypes, 31 with ID and/or MCA, and 4 controls. One individual from the first group had the most telomeric gene in the WS critical region deleted along with 2 Mb of flanking sequence. A second person had the classic WS deletion and a rearrangement on chromosome 5p within the Cri du Chat syndrome ( OMIM: 123450) region. Six individuals from the ID/MCA group had large rearrangements ( 3 deletions, 3 duplications), one of whom had a large inversion associated with a deletion that was not detected by the SNP arrays. Conclusions/Significance: Combining SNP microarray analyses and qPCR allowed us to clone and sequence 21 deletion breakpoints in individuals with atypical deletions in the WS region and/or ID or MCA. Comparison of these breakpoints to databases of genomic variation revealed that 52% occurred in regions harboring structural variants in the general population. For two probands the genomic alterations were flanked by segmental duplications, which frequently mediate recurrent genome rearrangements; these may represent new genomic disorders. While SNP arrays and related technologies can identify potentially pathogenic deletions and duplications, obtaining sequence information from the breakpoints frequently provides additional information.	[Pani, Ariel M.; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Hobart, Holly H.; Bray-Ward, Patricia; Kimberley, Kendra W.; Rios, Cecilia M.] Univ Nevada, Sch Med, Pediat Genet Lab, Las Vegas, NV 89154 USA; [Morris, Colleen A.] Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89154 USA; [Mervis, Carolyn B.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Clark, Robin C.] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA; [Gulbronson, Maricela D.; Gowans, Gordon C.] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Louisville; Loma Linda University; University of Louisville	Pani, AM (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	rggreg02@gwise.louisville.edu		Gregg, Ronald/0000-0001-5805-224X	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS35102]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by R01 NS35102 from the National Institutes of Health, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; [Anonymous], ONLINE MENDELIAN INH; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Engelen JJM, 2002, AM J MED GENET, V109, P149, DOI 10.1002/ajmg.10287; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Hobart HH, 2010, AM J MED GENET C, V154C, P220, DOI 10.1002/ajmg.c.30258; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Ming JRE, 2006, HUM MUTAT, V27, P467, DOI 10.1002/humu.20322; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Padegimas LS, 1998, ANAL BIOCHEM, V260, P149, DOI 10.1006/abio.1998.2719; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rojahn J.A.M., 2007, HDB INTELLECTUAL DEV, P1, DOI DOI 10.1007/0-387-32931-5_1; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Slater HR, 2005, AM J HUM GENET, V77, P709, DOI 10.1086/497343; Slavotinek AM, 2008, HUM GENET, V124, P1, DOI 10.1007/s00439-008-0513-9; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Winnepenninckx B, 2003, BRIT J DEV DISABIL, V49, P29, DOI 10.1179/096979503799104138	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12349	10.1371/journal.pone.0012349	http://dx.doi.org/10.1371/journal.pone.0012349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824207	gold, Green Published, Green Submitted			2022-12-25	WOS:000281405300005
J	Goldblum, SE; Rai, U; Tripathi, A; Thakar, M; De Leo, L; Di Toro, N; Not, T; Ramachandran, R; Puche, AC; Hollenberg, MD; Fasano, A				Goldblum, Simeon E.; Rai, Usha; Tripathi, Amit; Thakar, Manjusha; De Leo, Luigina; Di Toro, Nicola; Not, Tarcisio; Ramachandran, Rithwik; Puche, Adam C.; Hollenberg, Morley D.; Fasano, Alessio			The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation	FASEB JOURNAL			English	Article						intestinal permeability; protein-protein interaction; zonula occludens 1	ZONULA OCCLUDENS TOXIN; TRANSMEMBRANE PROTEINS; SCAFFOLDING PROTEIN; GUT-PERMEABILITY; BARRIER FUNCTION; KINASE; EXPRESSION; CELL; LOCALIZATION; INVOLVEMENT	Vibrio cholerae-derived zonula occludins toxin (Zot) is a multifunctional protein that reversibly disassembles intestinal tight junctions (tjs). Zot structure-function analysis has mapped this activity to aa 288-293, named AT1002. AT1002 reduced transepithelial electrical resistance across rat small intestine, ex vivo, as did Zot and its processed mature form, Delta G. AT1002 increased in vivo permeability to sugar tracers, whereas scrambled control peptides did not. Binding and barrier assays in proteinase activated receptor (PAR)(2)-expressing and PAR(2)-null cells established AT1002 activity to be PAR(2) dependent. Coincident with the increased intestinal permeability, confocal microscopy of AT1002-exposed rat intestinal IEC6 cells revealed displacement of ZO-1 and occludin from intercellular boundaries. In coimmunoprecipitation assays, AT1002 decreased ZO-1-occludin and ZO-1-claudin 1 interactions coincident with PKC alpha-dependent ZO-1 serine/threonine phosphorylation. Further, AT1002 increased serine phosphorylation of myosin 1C and, at the same time, transiently diminished its association with ZO-1. The COOH-terminal domain of ZO-1 was required for its association with myosin 1C. These data indicate that the NH2-terminal portion of active Zot contains a PAR(2)-activating motif, FCIGRL, that increases PKC alpha-dependent ZO-1 and myosin 1C serine/threonine phosphorylation. These modifications provoke selective disengagement of ZO-1 from its binding partners, occludin, claudin 1, and myosin 1C, coincident with opening of tjs.-Goldblum, S. E., Rai, U., Tripathi, A., Thakar, M., De Leo, L., Di Toro, N., Not, T., Ramachandran, R., Puche, A. C., Hollenberg, M. D., Fasano, A. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J. 25, 144-158 (2011). www.fasebj.org	[Goldblum, Simeon E.; Rai, Usha; Tripathi, Amit; Thakar, Manjusha; Fasano, Alessio] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Puche, Adam C.; Hollenberg, Morley D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [De Leo, Luigina; Di Toro, Nicola; Not, Tarcisio] Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy; [De Leo, Luigina; Di Toro, Nicola; Not, Tarcisio] Children Hosp Ist Recovero & Cura Carattere Sci B, Trieste, Italy; [Ramachandran, Rithwik] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada; [Ramachandran, Rithwik] Univ Calgary, Dept Med, Calgary, AB, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Trieste; University of Calgary; University of Calgary	Fasano, A (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,Rm 345, Baltimore, MD 21201 USA.	afasano@mbrc.umaryland.edu	Not, Tarcisio/K-2616-2018; Ramachandran, Rithwik/N-7815-2015; De Leo, Luigina/K-9513-2016; Hollenberg, Morley/AFV-6966-2022; Fasano, Alessio/K-5486-2016; De leo, Luigina/AAC-3321-2022	Not, Tarcisio/0000-0003-1059-3009; Ramachandran, Rithwik/0000-0001-9557-9905; De Leo, Luigina/0000-0003-4013-1630; Fasano, Alessio/0000-0002-2134-0261; 	U.S. National Institutes of Health [DK048373]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048373] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the U.S. National Institutes of Health (grant DK048373 to A.F.).	Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; ANDERSON JM, 1989, J CELL BIOL, V109, P1047, DOI 10.1083/jcb.109.3.1047; Balda MS, 2000, SEMIN CELL DEV BIOL, V11, P281, DOI 10.1006/scdb.2000.0177; Balda MS, 1996, FEBS LETT, V399, P326, DOI 10.1016/S0014-5793(96)01352-X; Benais-Pont G., 2001, TIGHT JUNCTIONS, P367; Bueno L, 2008, NEUROGASTROENT MOTIL, V20, P580, DOI 10.1111/j.1365-2982.2008.01139.x; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Di Pierro M, 2001, J BIOL CHEM, V276, P19160, DOI 10.1074/jbc.M009674200; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning Alan S., 2006, P64; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1999, J AM SOC NEPHROL, V10, P1337; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Gonzalez-Mariscal L, 2006, TIGHT JUNCTIONS; Gopalakrishnan S, 2009, INT J PHARMACEUT, V365, P121, DOI 10.1016/j.ijpharm.2008.08.047; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hollenberg MD, 2003, LIFE SCI, V74, P237, DOI 10.1016/j.lfs.2003.09.010; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Katouzian F, 2005, CLIN CHIM ACTA, V352, P191, DOI 10.1016/j.cccn.2004.09.023; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Machesky LM, 2000, J CELL BIOL, V148, P219, DOI 10.1083/jcb.148.2.219; Medina R, 2000, J MEMBRANE BIOL, V178, P235, DOI 10.1007/s002320010031; Meyer TN, 2002, J BIOL CHEM, V277, P24855, DOI 10.1074/jbc.C200240200; Mitic LL, 1999, J CELL BIOL, V146, P683, DOI 10.1083/jcb.146.3.683; Mullin JM, 2000, ANN NY ACAD SCI, V915, P231, DOI 10.1111/j.1749-6632.2000.tb05246.x; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Redowicz MJ, 2001, J MUSCLE RES CELL M, V22, P163; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sato S, 2005, BRIT J PHARMACOL, V146, P397, DOI 10.1038/sj.bjp.0706330; Sharlow ER, 2000, J CELL SCI, V113, P3093; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Sheth B, 1997, DEVELOPMENT, V124, P2027; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Uzzau S, 1999, MICROB PATHOGENESIS, V27, P377, DOI 10.1006/mpat.1999.0312; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; VanItallie CM, 1997, J CELL SCI, V110, P1113; Wagner MC, 1997, AM J PHYSIOL-CELL PH, V272, pC1680, DOI 10.1152/ajpcell.1997.272.5.C1680; Young BA, 1998, BIOCHEM BIOPH RES CO, V251, P320, DOI 10.1006/bbrc.1998.9475	48	68	75	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					144	158		10.1096/fj.10-158972	http://dx.doi.org/10.1096/fj.10-158972			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20852064	Green Published			2022-12-25	WOS:000285869500014
J	Li, X; Martinez-Ferrer, M; Botta, V; Uwamariya, C; Banerjee, J; Bhowmick, NA				Li, X.; Martinez-Ferrer, M.; Botta, V.; Uwamariya, C.; Banerjee, J.; Bhowmick, N. A.			Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness	ONCOGENE			English	Article						Hic-5/ARA55; c-myc; AR; TGF-beta; prostate cancer; castration	GROWTH-FACTOR-BETA; ANDROGEN RECEPTOR COACTIVATORS; CANCER CELLS; CELLULAR SENESCENCE; TUMOR PROGRESSION; SIGNALING AXIS; STROMAL CELLS; LIM PROTEIN; C-MYC; HIC-5	Stromal-epithelial interactions dictate prostate tumorigenesis and response to castration. Hydrogen peroxide-inducible clone 5 (Hic-5/ARA55) is a transforming growth factor-beta (TGF-beta)-induced coactivator of androgen receptor (AR) expressed in the prostate stroma. Interestingly, following castration, we identified epithelial expression of Hic-5/ARA55 in mouse and human prostate tissues. To determine the role of epithelial Hic-5 in prostate cancer progression and castration responsiveness, we compared LNCaP cells having Hic-5 stably expressed with the parental LNCaP cells following tissue recombination xenografts with mouse prostate stromal cells. We previously identified knocking out prostate stromal TGF-beta signaling potentiated castrate-resistant prostate tumors, in a Wnt-dependent manner. The LNCaP chimeric tumors containing prostate fibroblasts conditionally knocked out for the TGF-beta type II receptor (Tgfbr2-KO) resulted in larger, more invasive, and castration-resistant tumors compared those with floxed (control) stromal cells. However, the LNCaP-Hic5 associated with Tgfbr2-KO fibroblasts generated chimeric tumors with reduced tumor volume, lack of invasion and restored castration dependence. Neutralization of canonical Wnt signaling is shown to reduce prostate tumor size and restore regression following castration. Thus, we hypothesized that epithelial Hic-5/ARA55 expression negatively regulated Wnt signaling. The mechanism of the Hic-5/ARA55 effects on castration was determined by analysis of the c-myc promoter. C-myc luciferase reporter activity suggested Hic-5/ARA55 expression inhibited c-myc activity by beta-catenin. Sequential ChIP analysis indicated beta-catenin and T-cell-specific 4 (TCF4) bound the endogenous c-myc promoter in the absence of Hic-5 expression. However, the formation of a TCF4/Hic-5 repressor complex inhibited c-myc promoter activity, by excluding beta-catenin binding with TCF4 on the promoter. The data indicate Hic-5/ARA55 expression in response to castration-enabled epithelial regression through the repression of c-myc gene at the chromatin level. Oncogene (2011) 30, 167-177; doi:10.1038/onc.2010.400; published online 6 September 2010	[Bhowmick, N. A.] Cedars Sinai Med Ctr, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Bhowmick, N. A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Li, X.; Martinez-Ferrer, M.; Botta, V.; Uwamariya, C.; Banerjee, J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Li, X.; Martinez-Ferrer, M.; Botta, V.; Uwamariya, C.; Banerjee, J.] Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Vanderbilt University; Vanderbilt University	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989; , Xiaohong/0000-0001-5074-193X	Department of Defense [DAMD17-02-1-0063, PC081246]; NIH [CA108646, CA126505]; NATIONAL CANCER INSTITUTE [U54CA126505, R01CA108646] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Robert Matusik, Roger Jackson and Veronica Placencio for help in the preparation of this paper. The work was supported through Department of Defense (DAMD17-02-1-0063, PC081246) and NIH grants (CA108646, CA126505). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Cunha GR, 2008, DIFFERENTIATION, V76, P578, DOI 10.1111/j.1432-0436.2008.00290.x; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Fujimoto N, 2001, UROLOGY, V58, P289, DOI 10.1016/S0090-4295(01)01117-7; Fujimoto N, 2007, CANCER INVEST, V25, P32, DOI 10.1080/07357900601130698; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; GLEAVE M, 1991, CANCER RES, V51, P3753; Guerrero-Santoro J, 2004, J CELL BIOCHEM, V92, P810, DOI 10.1002/jcb.20109; Guo YP, 1999, CANCER RES, V59, P1366; Gurel B, 2008, MODERN PATHOL, V21, p159A; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heitzer MD, 2007, STEROIDS, V72, P218, DOI 10.1016/j.steroids.2006.11.010; Heitzer MD, 2006, CANCER RES, V66, P7326, DOI 10.1158/0008-5472.CAN-05-2379; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jakowlew SB, 1997, ANTICANCER RES, V17, P1849; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansson A, 2007, PROSTATE, V67, P1664, DOI 10.1002/pros.20657; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kaur M, 2010, NEOPLASIA, V12, P415, DOI 10.1593/neo.10188; Kurita T, 2001, CELL DEATH DIFFER, V8, P192, DOI 10.1038/sj.cdd.4400797; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; KYPRIANOU N, 1989, MOL ENDOCRINOL, V3, P1515, DOI 10.1210/mend-3-10-1515; Lee SE, 2000, ANTICANCER RES, V20, P417; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Lu WY, 2009, EUR J PHARMACOL, V602, P8, DOI 10.1016/j.ejphar.2008.10.053; Mestayer C, 2003, PROSTATE, V56, P192, DOI 10.1002/pros.10229; Miyoshi Y, 2003, PROSTATE, V56, P280, DOI 10.1002/pros.10262; Moon Randall T, 2005, Sci STKE, V2005, pcm1; MUIR GH, 1994, BRIT J CANCER, V69, P130, DOI 10.1038/bjc.1994.21; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Mulholland DJ, 2003, ONCOGENE, V22, P5602, DOI 10.1038/sj.onc.1206802; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Rahman MM, 2003, P NATL ACAD SCI USA, V100, P5124, DOI 10.1073/pnas.0530097100; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Taylor RA, 2008, CURR CANCER DRUG TAR, V8, P490, DOI 10.2174/156800908785699351; Thomas SM, 1999, J CELL SCI, V112, P181; Truica CI, 2000, CANCER RES, V60, P4709; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; UKE E, 1983, J UROLOGY, V129, P171, DOI 10.1016/S0022-5347(17)51976-X; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Zhang J, 2000, MOL CARCINOGEN, V27, P177, DOI 10.1002/(SICI)1098-2744(200003)27:3<177::AID-MC4>3.3.CO;2-J; Zhu ML, 2008, PROSTATE, V68, P287, DOI 10.1002/pros.20698	53	31	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					167	177		10.1038/onc.2010.400	http://dx.doi.org/10.1038/onc.2010.400			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20818421	hybrid, Green Published			2022-12-25	WOS:000286438900005
J	Zibat, A; Missiaglia, E; Rosenberger, A; Pritchard-Jones, K; Shipley, J; Hahn, H; Fulda, S				Zibat, A.; Missiaglia, E.; Rosenberger, A.; Pritchard-Jones, K.; Shipley, J.; Hahn, H.; Fulda, S.			Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma	ONCOGENE			English	Article						rhabdomyosarcoma; hedgehog; ERMS; ARMS	SIGNALING PATHWAY; EXPRESSION; GLI; MEDULLOBLASTOMA; CANCER; CLASSIFICATION; IDENTIFICATION; AMPLIFICATION; INHIBITION; SARCOMA	Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and comprises two major histological subtypes: alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma (ERMS). Seventy-five percent of ARMS harbor reciprocal chromosomal translocations leading to fusion genes of the forkhead transcription factor FOXO1 and PAX3 or PAX7. The hedgehog (Hh) pathway has been implied in tumor formation and progression of various cancers including RMS. However, whether Hh pathway activation presents a general feature of RMS or whether it is restricted to specific subgroups has not yet been addressed. Here, we report that marker genes of active Hh signaling, that is, Patched1 (Ptch1), Gli1, Gli3 and Myf5, are expressed at significantly higher levels in ERMS and fusion gene-negative ARMS compared with fusion gene-positive ARMS in two distinct cohorts of RMS patients. Consistently, Gli1 expression correlates with Ptch1 expression in ERMS and fusion gene-negative ARMS, but not in fusion gene-positive ARMS. In addition, expression levels of MyoD1 are significantly lower in ERMS and fusion gene-negative ARMS, pointing to an inverse association of Hh activation and early muscle differentiation. Moreover, Myf5 is identified as a novel excellent class predictor for RMS by receiver operating characteristic analysis. Importantly, high expression of Ptch1 or low MyoD1 expression significantly correlate with reduced cumulative survival in fusion gene-negative RMS underscoring the clinical relevance of these findings. By showing that Hh signaling is preferentially activated in specific subgroups of RMS, our study has important implications for molecular targeted therapies, such as small molecule Hh inhibitors, in RMS. Oncogene (2010) 29, 6323-6330; doi:10.1038/onc.2010.368; published online 6 September 2010	[Zibat, A.; Hahn, H.] Univ Goettingen, Inst Human Genet, Gottingen, Germany; [Missiaglia, E.; Pritchard-Jones, K.; Shipley, J.] Inst Canc Res, Dept Mol Cytogenet, Sutton, Surrey, England; [Rosenberger, A.] Univ Goettingen, Dept Genet Epidemiol, Gottingen, Germany; [Fulda, S.] Univ Childrens Hosp, Dept Hematol Oncol, Ulm, Baden Wuerttemb, Germany	University of Gottingen; University of London; Institute of Cancer Research - UK; University of Gottingen; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de	Pritchard-Jones, Kathy/F-4286-2014; Fulda, Simone/D-5864-2011	Pritchard-Jones, Kathy/0000-0002-2384-9475; missiaglia, edoardo/0000-0001-9221-0117; Fulda, Simone/0000-0002-0459-6417; Shipley, Janet/0000-0001-6748-8678	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; European Community; Wilhelm-Sander-Stiftung [2003.112.3]; Chris Lucas Trust;  [IAP6/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); Wilhelm-Sander-Stiftung; Chris Lucas Trust; 	This work has been supported by grants from the Deutsche Forschungsgemeinschaft, the Bundesministerium fur Bildung und Forschung, the European Community (ApopTrain, APOSYS) and IAP6/18 (to SF), and from the Wilhelm-Sander-Stiftung 2003.112.3 (to HH). We would like to thank the Chris Lucas Trust for their support (to EM) and the Children's Cancer and Leukemia Group for providing tumor material and clinical information. La Ligue Nationale Contre Le Cancer in collaboration with Olivier Delattre kindly supported the expression profiling of tumors.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Barr FG, 2002, CANCER RES, V62, P4704; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Dagher R, 1999, Oncologist, V4, P34; Dantonello TM, 2009, J CLIN ONCOL, V27, P1446, DOI 10.1200/JCO.2007.15.0466; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Kappler R, 2004, ONCOGENE, V23, P8785, DOI 10.1038/sj.onc.1208133; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; KHATIB ZA, 1993, CANCER RES, V53, P5535; Koleva M, 2005, CELL MOL LIFE SCI, V62, P1863, DOI 10.1007/s00018-005-5072-9; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Missiaglia E, 2009, GENE CHROMOSOME CANC, V48, P455, DOI 10.1002/gcc.20655; Nicol K, 2007, PEDIATR DEVEL PATHOL, V10, P89, DOI 10.2350/06-03-0068.1; Oue T, 2010, J PEDIATR SURG, V45, P387, DOI 10.1016/j.jpedsurg.2009.10.081; Ragazzini P, 2004, HISTOL HISTOPATHOL, V19, P401, DOI 10.14670/HH-19.401; ROBERTS WM, 1989, CANCER RES, V49, P5407; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814	39	85	93	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6323	6330		10.1038/onc.2010.368	http://dx.doi.org/10.1038/onc.2010.368			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20818440				2022-12-25	WOS:000284874700003
J	Cho, YD; Yoon, WJ; Woo, KM; Baek, JH; Park, JC; Ryoo, HM				Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Park, Joo-Cheol; Ryoo, Hyun-Mo			The Canonical BMP Signaling Pathway Plays a Crucial Part in Stimulation of Dentin Sialophosphoprotein Expression by BMP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; ODONTOBLAST DIFFERENTIATION; RUNX2; DLX5; MSX2; TRANSCRIPTION; MOUSE; DSPP; PULP; DENTINOGENESIS	Dentin sialophosphoprotein (DSPP), a typical dentin-specific protein, is mainly expressed in the dentin extracellular matrix and plays a role in dentin mineralization. BMP-2 provides a strong signal for differentiation and mineralization of odontoblasts and osteoblasts. Previously, BMP-2 treatment is reported to stimulate Dspp expression in the MD10-F2 pre-odontoblast cells through activation of the heterotrimeric transcription factor Y (NF-Y). The canonical BMP signaling pathway is known to contribute greatly to biomineralization, however, it is not known whether it is involved in Dspp expression. Here, we investigated this question. Activation of the canonical BMP-2 signaling pathway in MDPC-23, preodontoblast cell, by overexpression of constitutively active Smad1/5 or downstream transcription factors Dlx5 and Runx2 stimulated Dspp expression. Conversely, knockdown of each element with siRNA significantly blocked the BMP-2-induced Dspp expression. To test whether these transcription factors downstream of BMP-2 are directly involved in regulating Dspp, we analyzed the mouse Dspp promoter. There are 5 well conserved homeodomain binding elements, H1 to H5, in Dspp proximal promoter regions (-791 to +54). A serial deletion of H1 and H2 greatly changed basal promoter activity and responsiveness to Dlx5 or Msx2. However, further deletions did not change the responsiveness to Dlx5 or Msx2. H1 and H2 sites can be suggested as specific response elements of Dlx5 and Msx2, respectively, based on their promoter activity modulation. Thus, the canonical BMP-2 signaling pathway plays a crucial part in the regulation of Dspp expression through the action of Smads, Dlx5, Runx2, and Msx2.	[Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Mol Genet, Seoul 110749, South Korea; [Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Seoul 110749, South Korea; Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Cho, Young-Dan/AAR-4573-2021; Woo, Kyung Mi/A-2793-2009; Ryoo, Hyun-Mo/D-5839-2012; Park, Joo Cheol/D-6437-2012; Baek, Jeong-Hwa/A-8628-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341; Park, Joo Cheol/0000-0002-3162-7557; 	Ministry of Health and Welfare [A090913, A010252]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare Project numbers A090913 and A010252.	Barnes GL, 2003, CANCER RES, V63, P2631; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; Davideau JL, 1999, PEDIATR RES, V46, P650, DOI 10.1203/00006450-199912000-00003; Dodig M, 1996, J BIOL CHEM, V271, P16422, DOI 10.1074/jbc.271.27.16422; Galler KM, 2007, J DENT RES, V86, P951, DOI 10.1177/154405910708601007; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Nadiri A, 2006, CELL TISSUE RES, V324, P33, DOI 10.1007/s00441-005-0120-1; Nadiri A, 2004, J HISTOCHEM CYTOCHEM, V52, P103, DOI 10.1177/002215540405200110; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Patel PI, 2001, NAT GENET, V27, P129, DOI 10.1038/84728; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Ruhin-Poncet B, 2009, J HISTOCHEM CYTOCHEM, V57, P69, DOI 10.1369/jhc.2008.951707; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Unterbrink A, 2002, CONNECT TISSUE RES, V43, P354, DOI 10.1080/03008200290000565; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; ZHU W, 1994, MAMM GENOME, V5, P234, DOI 10.1007/BF00360552	36	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36369	36376		10.1074/jbc.M110.103093	http://dx.doi.org/10.1074/jbc.M110.103093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843790	Green Published, hybrid			2022-12-25	WOS:000284146100029
J	Gupta, S; Ghosh, SK; Scott, ME; Bainbridge, B; Jiang, B; Lamont, RJ; McCormick, TS; Weinberg, A				Gupta, Sanhita; Ghosh, Santosh K.; Scott, Mary E.; Bainbridge, Brian; Jiang, Bin; Lamont, Richard J.; McCormick, Thomas S.; Weinberg, Aaron			Fusobacterium nucleatum-associated beta-Defensin Inducer (FAD-I) IDENTIFICATION, ISOLATION, AND FUNCTIONAL EVALUATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ORAL EPITHELIAL-CELLS; ANTIMICROBIAL PEPTIDE EXPRESSION; TOLL-LIKE RECEPTOR-2; PORPHYROMONAS-GINGIVALIS; HUMAN BETA-DEFENSIN-2; DENDRITIC CELLS; INNATE IMMUNITY; PERIODONTAL BACTERIA; ENDOTHELIAL-CELLS	Human beta-defensins (hBDs) are small, cationic antimicrobial peptides, secreted by mucosal epithelial cells that regulate adaptive immune functions. We previously reported that Fusobacterium nucleatum, a ubiquitous Gram-negative bacterium of the human oral cavity, induces human beta-defensin 2 (hBD2) upon contact with primary oral epithelial cells. We now report the isolation and characterization of an F. nucleatum (ATCC 25586)-associated defensin inducer (FAD-I). Biochemical approaches revealed a cell wall fraction containing four proteins that stimulated the production of hBD2 in human oral epithelial cells (HOECs). Cross-referencing of the N-terminal sequences of these proteins with the F. nucleatum genome revealed that the genes encoding the proteins were FadA, FN1527, FN1529, and FN1792. Quantitative PCR of HOEC monolayers challenged with Escherichia coli clones expressing the respective cell wall proteins revealed that FN1527 was most active in the induction of hBD2 and hence was termed FAD-I. We tagged FN1527 with a c-myc epitope on the C-terminal end to identify and purify it from the E. coli clone. Purified FN1527 (FAD-I) induced hBD2 mRNA and protein expression in HOEC monolayers. F. nucleatum cell wall and FAD-I induced hBD2 via TLR2. Porphorymonas gingivalis, an oral pathogen that does not induce hBD2 in HOECs, was able to significantly induce expression of hBD2 in HOECs only when transformed to express FAD-I. FAD-I or its derivates offer a potentially new paradigm in immunoregulatory therapeutics because they may one day be used to bolster the innate defenses of vulnerable mucosae.	[Gupta, Sanhita; Ghosh, Santosh K.; Scott, Mary E.; Jiang, Bin; Weinberg, Aaron] Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA; [McCormick, Thomas S.] Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA; [Bainbridge, Brian; Lamont, Richard J.] Univ Florida, Sch Dent, Gainesville, FL 32611 USA	Case Western Reserve University; Case Western Reserve University; State University System of Florida; University of Florida	Weinberg, A (corresponding author), Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA.	aaron.weinberg@case.edu	Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Weinberg, Aaron/0000-0002-9960-7181; McCormick, Thomas/0000-0002-3294-0326	National Institutes of Health [DE018276, DE11111]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE011111, R56DE018276, R01DE018276, R01DE011111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE018276 (to A. W.) and DE11111 (to R. J. L.).	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Caamano J, 2000, J IMMUNOL, V165, P5720, DOI 10.4049/jimmunol.165.10.5720; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Dommisch H, 2007, INFECT IMMUN, V75, P4326, DOI 10.1128/IAI.00455-07; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; GANZ T, 1992, MED MICROBIOL IMMUN, V181, P99; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Ghosh SK, 2007, CLIN CHEM, V53, P757, DOI 10.1373/clinchem.2006.081430; Gong JL, 2009, J IMMUNOL, V183, P3092, DOI 10.4049/jimmunol.0901235; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Haake SK, 2000, J BACTERIOL, V182, P1176, DOI 10.1128/JB.182.4.1176-1180.2000; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Jarnicki AG, 2008, J IMMUNOL, V180, P3797, DOI 10.4049/jimmunol.180.6.3797; Ji S, 2009, INFECT IMMUN, V77, P1044, DOI 10.1128/IAI.00449-08; Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kawsar HI, 2010, PEPTIDES, V31, P195, DOI 10.1016/j.peptides.2009.12.008; KENNELL W, 1990, ORAL MICROBIOL IMMUN, V5, P121, DOI 10.1111/j.1399-302X.1990.tb00409.x; Kobayashi-Sakamoto M, 2003, CURR MICROBIOL, V46, P109, DOI 10.1007/s00284-002-3782-x; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Liang S, 2007, J BIOL CHEM, V282, P7532, DOI 10.1074/jbc.M611722200; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Madianos PN, 1997, INFECT IMMUN, V65, P3983, DOI 10.1128/IAI.65.10.3983-3990.1997; O'Neil DA, 1999, J IMMUNOL, V163, P6718; ODA D, 1990, IN VITRO CELL DEV B, V26, P589; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park Y, 2007, FEMS MICROBIOL LETT, V273, P103, DOI 10.1111/j.1574-6968.2007.00782.x; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peyret-Lacombe A, 2009, CYTOKINE, V46, P201, DOI 10.1016/j.cyto.2009.01.006; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; SELSTED ME, 1993, J BIOL CHEM, V268, P6641; Smith C J, 1995, Methods Mol Biol, V47, P161; Starner TD, 2005, J IMMUNOL, V174, P1608, DOI 10.4049/jimmunol.174.3.1608; Takahashi A, 2001, FEBS LETT, V508, P484, DOI 10.1016/S0014-5793(01)03088-5; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xie H, 2000, INFECT IMMUN, V68, P6574, DOI 10.1128/IAI.68.12.6574-6579.2000; Yadava P, 2006, INT J ANTIMICROB AG, V28, P132, DOI 10.1016/j.ijantimicag.2006.02.021; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zasloff M, 2002, NEW ENGL J MED, V347, P1199, DOI 10.1056/NEJMe020106; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	74	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36523	36531		10.1074/jbc.M110.133140	http://dx.doi.org/10.1074/jbc.M110.133140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847052	Green Published, hybrid			2022-12-25	WOS:000284146100055
J	Valenti, A; Perugino, G; Varriale, A; D'Auria, S; Rossi, M; Ciaramella, M				Valenti, Anna; Perugino, Giuseppe; Varriale, Antonio; D'Auria, Sabato; Rossi, Mose; Ciaramella, Maria			The Archaeal Topoisomerase Reverse Gyrase Is a Helix-destabilizing Protein That Unwinds Four-way DNA Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING-PROTEIN; INSIGHT; DOMAIN; IDENTIFICATION; REPLICATION; RESOLVASE; DAMAGE; HJC	Four-way junctions are non-B DNA structures that originate as intermediates of recombination and repair (Holliday junctions) or from the intrastrand annealing of palindromic sequences (cruciforms). These structures have important functional roles but may also severely interfere with DNA replication and other genetic processes; therefore, they are targeted by regulatory and architectural proteins, and dedicated pathways exist for their removal. Although it is well known that resolution of Holliday junctions occurs either by recombinases or by specialized helicases, less is known on the mechanisms dealing with secondary structures in nucleic acids. Reverse gyrase is a DNA topoisomerase, specific to microorganisms living at high temperatures, which comprises a type IA topoisomerase fused to an SF2 helicase-like module and catalyzes ATP hydrolysis-dependent DNA positive supercoiling. Reverse gyrase is likely involved in regulation of DNA structure and stability and might also participate in the cell response to DNA damage. By applying FRET technology to multiplex fluorophore gel imaging, we show here that reverse gyrase induces unwinding of synthetic four-way junctions as well as forked DNA substrates, following a mechanism independent of both the ATPase and the strand-cutting activity of the enzyme. The reaction requires high temperature and saturating protein concentrations. Our results suggest that reverse gyrase works like an ATP-independent helix-destabilizing protein specific for branched DNA structures. The results are discussed in light of reverse gyrase function and their general relevance for protein-mediated unwinding of complex DNA structures.	[Valenti, Anna; Perugino, Giuseppe; Varriale, Antonio; D'Auria, Sabato; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	m.ciaramella@ibp.cnr.it	Perugino, Giuseppe/P-8147-2016; Varriale, Antonio/AAL-1439-2020; Ciaramella, Maria/O-1152-2015; d'auria, sabato/C-3565-2015	Ciaramella, Maria/0000-0003-1583-1694; d'auria, sabato/0000-0001-9320-494X; Valenti, Anna/0000-0002-5278-3524; Perugino, Giuseppe/0000-0003-3266-4744	Agenzia Spaziale Italiana [1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was partially supported by Agenzia Spaziale Italiana (Project MoMa Grant 1/014/06/0).	Bond CS, 2001, P NATL ACAD SCI USA, V98, P5509, DOI 10.1073/pnas.091613398; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cubeddu L, 2005, J MOL BIOL, V353, P507, DOI 10.1016/j.jmb.2005.08.050; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587; Fujikane R, 2005, J BIOL CHEM, V280, P12351, DOI 10.1074/jbc.M413417200; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; Kvaratskhelia M, 2000, J BIOL CHEM, V275, P25540, DOI 10.1074/jbc.M003420200; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lilley DMJ, 2010, BIOCHEM SOC T, V38, P399, DOI 10.1042/BST0380399; Lo YC, 2006, MOL CELL BIOL, V26, P4086, DOI 10.1128/MCB.00136-06; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Mikheikin AL, 2006, BIOCHEMISTRY-US, V45, P12998, DOI 10.1021/bi061002k; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Nadal M, 2007, BIOCHIMIE, V89, P447, DOI 10.1016/j.biochi.2006.12.010; Napoli A, 2005, NUCLEIC ACIDS RES, V33, P564, DOI 10.1093/nar/gki202; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Nishino T, 2001, STRUCTURE, V9, P197, DOI 10.1016/S0969-2126(01)00576-7; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Raja C, 2006, BIOCHEMISTRY-US, V45, P9254, DOI 10.1021/bi052560m; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; Salerno V, 2003, NUCLEIC ACIDS RES, V31, P6127, DOI 10.1093/nar/gkg831; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; Taraporewala ZF, 2001, J VIROL, V75, P4519, DOI 10.1128/JVI.75.10.4519-4527.2001; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; ZHANG HL, 1995, J BIOL CHEM, V270, P23700, DOI 10.1074/jbc.270.40.23700; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421	38	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36532	36541		10.1074/jbc.M110.169029	http://dx.doi.org/10.1074/jbc.M110.169029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851892	Green Published, hybrid			2022-12-25	WOS:000284146100021
J	Lomash, S; Nagpal, S; Salunke, DM				Lomash, Suvendu; Nagpal, Sushma; Salunke, Dinakar M.			An Antibody as Surrogate Receptor Reveals Determinants of Activity of an Innate Immune Peptide Antibiotic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ANTIMICROBIAL PEPTIDE; MONOCLONAL-ANTIBODIES; T-CELLS; INDOLICIDIN; TRYPTOPHAN; PROTEINS; BINDING; ANTIBACTERIAL; PLASTICITY; MEMBRANES	Drug discovery initiatives often depend critically on knowledge of ligand-receptor interactions. However, the identity or structure of the target receptor may not be known in every instance. The concept of receptor surrogate, a molecular environment mimic of natural receptor, may prove beneficial under such circumstances. Here, we demonstrate the potential of monoclonal antibodies (mAbs) to act as surrogate receptors for a class of innate immune peptide antibiotics, a strategy that can help comprehend their action mechanism and identify chemical entities crucial for activity. A panel of antibody surrogates was raised against indolicidin, a tryptophan-rich cationic broad spectrum antimicrobial peptide of innate immune origin. Employing an elegant combination of thermodynamics, crystallography, and molecular modeling, interactions of the peptide with a high affinity anti-indolicidin monoclonal antibody were analyzed and were used to identify a motif that contained almost the entire antibiotic activity of native indolicidin. The analysis clarified the interaction of the peptide with previously proposed targets such as bacterial cell membrane and DNA and could further be correlated with antimicrobial compounds whose actions involve varied other mechanisms. These features suggest a multipronged assault pathway for indolicidin. Remarkably, the anti-indolicidin mAb surrogate was able to isolate additional independent bactericidal sequences from a random peptide library, providing compelling evidence as to the physiological relevance of surrogate receptor concept and suggesting applications in receptor-based pharmacophore research.	[Lomash, Suvendu; Nagpal, Sushma; Salunke, Dinakar M.] Natl Inst Immunol, Struct Biol Unit, New Delhi 110067, India; [Salunke, Dinakar M.] Reg Ctr Biotechnol, Gurgaon 122016, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology	Salunke, DM (corresponding author), Natl Inst Immunol, Struct Biol Unit, Aruna Asaf Ali Rd, New Delhi 110067, India.	dinakar.salunke@gmail.com			Department of Biotechnology from the Indian government	Department of Biotechnology from the Indian government	This work was funded by the Department of Biotechnology from the Indian government.	AHMAD I, 1995, BBA-BIOMEMBRANES, V1237, P109, DOI 10.1016/0005-2736(95)00087-J; Andersen PS, 1996, P NATL ACAD SCI USA, V93, P1820, DOI 10.1073/pnas.93.5.1820; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bright SW, 1997, LIFE SCI, V61, P2305, DOI 10.1016/S0024-3205(97)00934-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHANH TC, 1987, P NATL ACAD SCI USA, V84, P3891, DOI 10.1073/pnas.84.11.3891; Chong-Cerrillo C, 2003, J PEPT RES, V61, P237, DOI 10.1034/j.1399-3011.2003.00053.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Disney MD, 2005, ANTIMICROB AGENTS CH, V49, P1326, DOI 10.1128/AAC.49.4.1326-1330.2005; Efimov AV, 2003, FEBS LETT, V554, P389, DOI 10.1016/S0014-5793(03)01189-X; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Falla TJ, 1997, ANTIMICROB AGENTS CH, V41, P771, DOI 10.1128/AAC.41.4.771; Goel M, 2004, J IMMUNOL, V173, P7358, DOI 10.4049/jimmunol.173.12.7358; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Gorfe AA, 2008, BIOPHYS J, V95, P3269, DOI 10.1529/biophysj.108.136481; Harlow E., 1988, ANTIBODIES LAB MANUA; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kawaji N, 2001, J LIPID RES, V42, P1671; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LARRICK JW, 1989, PHARMACOL REV, V41, P539; Lee DG, 2003, BIOCHEM BIOPH RES CO, V305, P305, DOI 10.1016/S0006-291X(03)00755-1; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merienne K, 1997, J BIOL CHEM, V272, P23775, DOI 10.1074/jbc.272.38.23775; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nagpal S, 2002, PROTEIN SCI, V11, P2158, DOI 10.1110/ps.0211602; Oomen CJ, 2005, J MOL BIOL, V351, P1070, DOI 10.1016/j.jmb.2005.06.061; Rozek A, 2000, BIOCHEMISTRY-US, V39, P15765, DOI 10.1021/bi000714m; SCHLUESENER HJ, 1993, J NEUROIMMUNOL, V47, P199, DOI 10.1016/0165-5728(93)90030-3; Shaw JE, 2006, J STRUCT BIOL, V154, P42, DOI 10.1016/j.jsb.2005.11.016; Sitaram N, 2003, BIOCHEM BIOPH RES CO, V309, P879, DOI 10.1016/j.bbrc.2003.08.095; Staubitz P, 2001, J PEPT SCI, V7, P552, DOI 10.1002/psc.351; Subbalakshmi C, 2000, BIOCHEM BIOPH RES CO, V274, P714, DOI 10.1006/bbrc.2000.3214; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2001, BIOPHYS J, V81, P2979, DOI 10.1016/S0006-3495(01)75938-3	45	6	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35750	35758		10.1074/jbc.M110.150516	http://dx.doi.org/10.1074/jbc.M110.150516			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837490	hybrid, Green Published			2022-12-25	WOS:000283845300053
J	Reiner, S; Ambrosio, M; Hoffmann, C; Lohse, MJ				Reiner, Susanne; Ambrosio, Manuela; Hoffmann, Carsten; Lohse, Martin J.			Differential Signaling of the Endogenous Agonists at the beta(2)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; BETA-ARRESTIN; LIVING CELLS; BETA-2-ADRENERGIC RECEPTOR; MEDIATED ACTIVATION; ERK1/2 ACTIVATION; ADENYLYL-CYCLASE; PHOSPHORYLATION; REVEALS; DESENSITIZATION	The concept of "functional selectivity" or "biased signaling" suggests that a ligand can have distinct efficacies with regard to different signaling pathways. We have investigated the question of whether biased signaling may be related to distinct agonist-induced conformational changes in receptors using the beta(2)-adrenergic receptor (beta(2)AR) and its two endogenous ligands epinephrine and norepinephrine as a model system. Agonist-induced conformational changes were determined in a fluorescently tagged beta(2)ARFRET sensor. In this beta(2)AR sensor, norepinephrine caused signals that amounted to only approximate to 50% of those induced by epinephrine and the standard "full" agonist isoproterenol. Furthermore, norepinephrine-induced changes in the beta(2)AR FRET sensor were slower than those induced by epinephrine (rate constants, 47 versus 128 ms). A similar partial beta(2)AR activation signal was revealed for the synthetic agonists fenoterol and terbutaline. However, norepinephrine was almost as efficient as epinephrine (and isoproterenol) in causing activation of G(s) and adenylyl cyclase. In contrast, fenoterol was quite efficient in triggering beta-arrestin2 recruitment to the cell surface and its interaction with beta(2)AR, as well as internalization of the receptors, whereas norepinephrine caused partial and slow changes in these assays. We conclude that partial agonism of norepinephrine at the beta(2)AR is related to the induction of a different active conformation and that this conformation is efficient in signaling to Gs and less efficient in signaling to beta-arrestin2. These observations extend the concept of biased signaling to the endogenous agonists of the beta(2)AR and link it to distinct conformational changes in the receptor.	[Hoffmann, Carsten] Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany; [Ambrosio, Manuela] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy	University of Wurzburg; University of Milan	Hoffmann, C (corresponding author), Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.	C.Hoffmann@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510	Deutsche Forschungsgemeinschaft [SFB487]; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB487 and European Research Council Advanced Investigator Grant TOPAS.	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BENOVIC JL, 1988, J BIOL CHEM, V263, P3893; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LEVITZKI A, 1993, LIFE SCI, V52, P2093, DOI 10.1016/0024-3205(93)90724-H; Lewis MM, 1998, J PHARMACOL EXP THER, V286, P345; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; LOHSE MJ, 1992, N-S ARCH PHARMACOL, V345, P444; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Nikolaev VO, 2007, J BIOL CHEM, V282, P27126, DOI 10.1074/jbc.M703272200; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276	49	87	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36188	36198		10.1074/jbc.M110.175604	http://dx.doi.org/10.1074/jbc.M110.175604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837485	hybrid, Green Published			2022-12-25	WOS:000283845300094
J	Tsvetanova, NG; Klass, DM; Salzman, J; Brown, PO				Tsvetanova, Nikoleta G.; Klass, Daniel M.; Salzman, Julia; Brown, Patrick O.			Proteome-Wide Search Reveals Unexpected RNA-Binding Proteins in Saccharomyces cerevisiae	PLOS ONE			English	Article							ASH1 MESSENGER-RNA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENDOPLASMIC-RETICULUM; GLOBAL ANALYSIS; YEAST; ACONITASE; LOCALIZATION; STABILITY; COMPLEXES; DEPENDS	The vast landscape of RNA-protein interactions at the heart of post-transcriptional regulation remains largely unexplored. Indeed it is likely that, even in yeast, a substantial fraction of the regulatory RNA-binding proteins (RBPs) remain to be discovered. Systematic experimental methods can play a key role in discovering these RBPs - most of the known yeast RBPs lack RNA-binding domains that might enable this activity to be predicted. We describe here a proteome-wide approach to identify RNA-protein interactions based on in vitro binding of RNA samples to yeast protein microarrays that represent over 80% of the yeast proteome. We used this procedure to screen for novel RBPs and RNA-protein interactions. A complementary mass spectrometry technique also identified proteins that associate with yeast mRNAs. Both the protein microarray and mass spectrometry methods successfully identify previously annotated RBPs, suggesting that other proteins identified in these assays might be novel RBPs. Of 35 putative novel RBPs identified by either or both of these methods, 12, including 75% of the eight most highly-ranked candidates, reproducibly associated with specific cellular RNAs. Surprisingly, most of the 12 newly discovered RBPs were enzymes. Functional characteristics of the RNA targets of some of the novel RBPs suggest coordinated post-transcriptional regulation of subunits of protein complexes and a possible link between mRNA trafficking and vesicle transport. Our results suggest that many more RBPs still remain to be identified and provide a set of candidates for further investigation.	[Tsvetanova, Nikoleta G.; Klass, Daniel M.; Salzman, Julia; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Tsvetanova, Nikoleta G.; Klass, Daniel M.; Salzman, Julia; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Salzman, Julia] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tsvetanova, NG (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@pmgm2.stanford.edu			National Institutes of Health [NIH RO1 CA77097]; Stanford Graduate Fellowship; National Science Foundation; National Science Foundation Mathematical Sciences [NSF-DMS 0940077]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Mathematical Sciences(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported mainly by the Howard Hughes Medical Institute and by a grant from the National Institutes of Health to POB (NIH RO1 CA77097). POB is an investigator for the Howard Hughes Medical Institute. NGT was also partially supported by a Stanford Graduate Fellowship. DMK was also partially supported by a National Science Foundation pre-doctoral fellowship. JS was supported by National Science Foundation Mathematical Sciences Grant (NSF-DMS 0940077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; CLERCH LB, 1993, FASEB J, V7, pA1233; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HENTZE MW, 2010, TRENDS BIOCH SCI; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Keene JD, 2007, COLD SPRING HARB SYM, V72, P157, DOI 10.1101/sqb.2007.72.013; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Li KQ, 2007, J MOL BIOL, V372, P194, DOI 10.1016/j.jmb.2007.06.052; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Negm RS, 2006, GENET ENG NEWS, V26, P26; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walsh C., 2006, POSTTRANSLATIONAL MO; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu J, 2007, P NATL ACAD SCI USA, V104, P3129, DOI 10.1073/pnas.0611617104	44	120	125	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12671	10.1371/journal.pone.0012671	http://dx.doi.org/10.1371/journal.pone.0012671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844764	Green Submitted, gold, Green Published			2022-12-25	WOS:000281687300015
J	Punnoose, EA; Atwal, SK; Spoerke, JM; Savage, H; Pandita, A; Yeh, RF; Pirzkall, A; Fine, BM; Amler, LC; Chen, DS; Lackner, MR				Punnoose, Elizabeth A.; Atwal, Siminder K.; Spoerke, Jill M.; Savage, Heidi; Pandita, Ajay; Yeh, Ru-Fang; Pirzkall, Andrea; Fine, Bernard M.; Amler, Lukas C.; Chen, Daniel S.; Lackner, Mark R.			Molecular Biomarker Analyses Using Circulating Tumor Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; PERIPHERAL-BLOOD; STEM-CELL; EXPRESSION; HER2; SURVIVAL; OVEREXPRESSION; HETEROGENEITY	Background: Evaluation of cancer biomarkers from blood could significantly enable biomarker assessment by providing a relatively non-invasive source of representative tumor material. Circulating Tumor Cells (CTCs) isolated from blood of metastatic cancer patients hold significant promise in this regard. Methodology/Principal Findings: Using spiked tumor-cells we evaluated CTC capture on different CTC technology platforms, including CellSearch (R) and two biochip platforms, and used the isolated CTCs to develop and optimize assays for molecular characterization of CTCs. We report similar performance for the various platforms tested in capturing CTCs, and find that capture efficiency is dependent on the level of EpCAM expression. We demonstrate that captured CTCs are amenable to biomarker analyses such as HER2 status, qRT-PCR for breast cancer subtype markers, KRAS mutation detection, and EGFR staining by immunofluorescence (IF). We quantify cell surface expression of EGFR in metastatic lung cancer patient samples. In addition, we determined HER2 status by IF and FISH in CTCs from metastatic breast cancer patients. In the majority of patients (89%) we found concordance with HER2 status from patient tumor tissue, though in a subset of patients (11%), HER2 status in CTCs differed from that observed in the primary tumor. Surprisingly, we found CTC counts to be higher in ER+ patients in comparison to HER2+ and triple negative patients, which could be explained by low EpCAM expression and a more mesenchymal phenotype of tumors belonging to the basal-like molecular subtype of breast cancer. Conclusions/Significance: Our data suggests that molecular characterization from captured CTCs is possible and can potentially provide real-time information on biomarker status. In this regard, CTCs hold significant promise as a source of tumor material to facilitate clinical biomarker evaluation. However, limitations exist from a purely EpCAM based capture system and addition of antibodies to mesenchymal markers could further improve CTC capture efficiency to enable routine biomarker analysis from CTCs.	[Punnoose, Elizabeth A.; Atwal, Siminder K.; Spoerke, Jill M.; Savage, Heidi; Amler, Lukas C.; Lackner, Mark R.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Pandita, Ajay] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [Yeh, Ru-Fang] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Pirzkall, Andrea; Fine, Bernard M.; Chen, Daniel S.] Genentech Inc, Dept Oncol Exploratory Clin Dev, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Punnoose, EA (corresponding author), Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA.	punnoose.elizabeth@gene.com	Lackner, Mark/G-4597-2012; Chen, Daniel Shin-Yu/AGD-8923-2022	Lackner, Mark/0000-0002-6375-2037; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Fine, Bernard/0000-0002-5483-476X	Genentech	Genentech(Roche HoldingGenentech)	This study was funded by Genentech (www.gene.com). All authors are employees of Genentech and Genentech played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This affiliation, however, does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; BARDELLI A, 2010, J CLIN ONCOLOGY; Bozzetti C, 2003, CANCER CYTOPATHOL, V99, P310, DOI 10.1002/cncr.11731; CARDEN CP, 2009, DRUG DISCOV TODAY; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; FLORES LM, BR J CANC, V102, P1495; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; He H, 2010, PROSTATE, V70, P518, DOI 10.1002/pros.21086; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; HUTCHINS LF, 1990, DM-DIS MON, V36, P63; Jarry A, 2004, MOL CELL PROBE, V18, P349, DOI 10.1016/j.mcp.2004.05.004; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Lackner MR, 2010, EXPERT REV MOL DIAGN, V10, P75, DOI [10.1586/erm.09.78, 10.1586/ERM.09.78]; Lange PH, 1998, CANCER METAST REV, V17, P331, DOI 10.1023/A:1006106209527; MAHESWARAN S, CURR OPIN GENET DEV; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MCCARTY KS, 1986, CANCER RES, V46, P4244; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; MOMBURG F, 1987, CANCER RES, V47, P2883; Mostert B, 2009, CANCER TREAT REV, V35, P463, DOI 10.1016/j.ctrv.2009.03.004; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Payne RE, 2009, PHARMACOGENOMICS, V10, P51, DOI 10.2217/14622416.10.1.51; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; ROSS AA, 1993, BLOOD, V82, P2605; Sekido Y, 2003, INT J ONCOL, V22, P1225; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sequist LV, 2009, J THORAC ONCOL, V4, P281, DOI 10.1097/JTO.0b013e3181989565; Shimizu C, 2000, J SURG ONCOL, V73, P17, DOI 10.1002/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.3.CO;2-U; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith GD, 2008, J CLIN PATHOL, V61, P487, DOI 10.1136/jcp.2007.051425; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Suzuki H, 1998, CANCER RES, V58, P204; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tan DSW, 2009, CANCER J, V15, P406, DOI 10.1097/PPO.0b013e3181bd0445; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; WANG LH, CLIN CANC RES, V16, P1073; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wolff AC, 2007, J CLIN ONCOL, V25, P4021, DOI 10.1200/JCO.2007.11.4363; Zidan J, 2005, BRIT J CANCER, V93, P552, DOI 10.1038/sj.bjc.6602738	55	198	215	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12517	10.1371/journal.pone.0012517	http://dx.doi.org/10.1371/journal.pone.0012517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838621	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687100002
J	Raz, L; Zhang, QG; Zhou, CF; Han, D; Gulati, P; Yang, LC; Yang, F; Wang, RM; Brann, DW				Raz, Limor; Zhang, Quan-Guang; Zhou, Cai-feng; Han, Dong; Gulati, Priya; Yang, Li-cai; Yang, Fang; Wang, Rui-min; Brann, Darrell W.			Role of Rac1 GTPase in NADPH Oxidase Activation and Cognitive Impairment Following Cerebral Ischemia in the Rat	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; KINASE ACTIVATION; CELL-DEATH; DAMAGE; ESTROGEN; NEUROPROTECTION; ATTENUATION; INHIBITION; PROTECTS; NEURONS	Background: Recent work by our laboratory and others has implicated NADPH oxidase as having an important role in reactive oxygen species (ROS) generation and neuronal damage following cerebral ischemia, although the mechanisms controlling NADPH oxidase in the brain remain poorly understood. The purpose of the current study was to examine the regulatory and functional role of the Rho GTPase, Rac1 in NADPH oxidase activation, ROS generation and neuronal cell death/cognitive dysfunction following global cerebral ischemia in the male rat. Methodology/Principal Findings: Our studies revealed that NADPH oxidase activity and superoxide (O-2(-)) production in the hippocampal CA1 region increased rapidly after cerebral ischemia to reach a peak at 3 h post-reperfusion, followed by a fall in levels by 24 h post-reperfusion. Administration of a Rac GTPase inhibitor (NSC23766) 15 min before cerebral ischemia significantly attenuated NADPH oxidase activation and O-2(-) production at 3 h after stroke as compared to vehicle-treated controls. NSC23766 also attenuated "in situ'' O-2(-) production in the hippocampus after ischemia/reperfusion, as determined by fluorescent oxidized hydroethidine staining. Oxidative stress damage in the hippocampal CA1 after ischemia/reperfusion was also significantly attenuated by NSC23766 treatment, as evidenced by a marked attenuation of immunostaining for the oxidative stress damage markers, 4-HNE, 8-OHdG and H2AX at 24 h in the hippocampal CA1 region following cerebral ischemia. In addition, Morris Water maze testing revealed that Rac GTPase inhibition after ischemic injury significantly improved hippocampal-dependent memory and cognitive spatial abilities at 7-9 d post reperfusion as compared to vehicle-treated animals. Conclusions/Significance: The results of the study suggest that Rac1 GTPase has a critical role in mediating ischemia/reperfusion injury-induced NADPH oxidase activation, ROS generation and oxidative stress in the hippocampal CA1 region of the rat, and thus contributes significantly to neuronal degeneration and cognitive dysfunction following cerebral ischemia.	[Raz, Limor; Zhang, Quan-Guang; Han, Dong; Gulati, Priya; Brann, Darrell W.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Zhou, Cai-feng; Yang, Li-cai; Yang, Fang; Wang, Rui-min] N China Coal Med Univ, Expt & Res Ctr, Tangshan, Hebei, Peoples R China	University System of Georgia; Augusta University; North China University of Science & Technology	Raz, L (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	rmwang1213@yahoo.com.cn; dbrann@mcg.edu			National Institute of Neurological Diseases and Stroke (NINDS) National Institutes of Health [NS050730]; National Natural Science Foundation in China [30970664]; National Science Foundation of Hebei Province in China [C2008000997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050730] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke (NINDS) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Hebei Province in China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a Research Grant (NS050730) from the National Institute of Neurological Diseases and Stroke (NINDS), National Institutes of Health. Additional funding for parts of the study came from the National Natural Science Foundation in China (30970664) and the National Science Foundation of Hebei Province in China (C2008000997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Chen H, 2009, J CEREB BLOOD FLOW M; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GOODRICHHUNSAKE.NJ, 2009, HIPPOCAMPUS; Gu ZL, 2001, NEUROREPORT, V12, P897, DOI 10.1097/00001756-200104170-00006; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Maneen MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1042, DOI 10.1152/ajpheart.00800.2006; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nanetti L, 2007, MOL CELL BIOCHEM, V303, P19, DOI 10.1007/s11010-007-9451-4; Ozaki M, 2001, TRANSPLANT P, V33, P863, DOI 10.1016/S0041-1345(00)02352-6; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sawada N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000162; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang QG, 2009, BRAIN RES, V1265, P138, DOI 10.1016/j.brainres.2009.01.033	32	97	100	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12606	10.1371/journal.pone.0012606	http://dx.doi.org/10.1371/journal.pone.0012606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830300	gold, Green Published, Green Submitted			2022-12-25	WOS:000281631300029
J	Al Gadban, MM; Smith, KJ; Soodavar, F; Piansay, C; Chassereau, C; Twal, WO; Klein, RL; Virella, G; Lopes-Virella, MF; Hammad, SM				Al Gadban, Mohammed M.; Smith, Kent J.; Soodavar, Farzan; Piansay, Christabelle; Chassereau, Charlyne; Twal, Waleed O.; Klein, Richard L.; Virella, Gabriel; Lopes-Virella, Maria F.; Hammad, Samar M.			Differential Trafficking of Oxidized LDL and Oxidized LDL Immune Complexes in Macrophages: Impact on Oxidative Stress	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED MACROPHAGES; SCAVENGER RECEPTORS; HEAT-SHOCK; OXLDL; CHOLESTEROL; METABOLISM; BETA(2)-GLYCOPROTEIN-I; ATHEROSCLEROSIS; CELLS	Background: Oxidized low-density lipoproteins (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribute to formation of lipid-laden macrophages (foam cells). It has been shown that oxLDL-IC are considerably more efficient than oxLDL in induction of foam cell formation, inflammatory cytokines secretion, and cell survival promotion. Whereas oxLDL is taken up by several scavenger receptors, oxLDL-IC are predominantly internalized through the FCc receptor I (FCc RI). This study examined differences in intracellular trafficking of lipid and apolipoprotein moieties of oxLDL and oxLDL-IC and the impact on oxidative stress. Methodology/Findings: Fluorescently labeled lipid and protein moieties of oxLDL co-localized within endosomal and lysosomal compartments in U937 human monocytic cells. In contrast, the lipid moiety of oxLDL-IC was detected in the endosomal compartment, whereas its apolipoprotein moiety advanced to the lysosomal compartment. Cells treated with oxLDL-IC prior to oxLDL demonstrated co-localization of internalized lipid moieties from both oxLDL and oxLDL-IC in the endosomal compartment. This sequential treatment likely inhibited oxLDL lipid moieties from trafficking to the lysosomal compartment. In RAW 264.7 macrophages, oxLDL-IC but not oxLDL induced GFP-tagged heat shock protein 70 (HSP70) and HSP70B', which co-localized with the lipid moiety of oxLDL-IC in the endosomal compartment. This suggests that HSP70 family members might prevent the degradation of the internalized lipid moiety of oxLDL-IC by delaying its advancement to the lysosome. The data also showed that mitochondrial membrane potential was decreased and generation of reactive oxygen and nitrogen species was increased in U937 cell treated with oxLDL compared to oxLDL-IC. Conclusions/Significance: Findings suggest that lipid and apolipoprotein moieties of oxLDL-IC traffic to separate cellular compartments, and that HSP70/70B' might sequester the lipid moiety of oxLDL-IC in the endosomal compartment. This mechanism could ultimately influence macrophage function and survival. Furthermore, oxLDL-IC might regulate the intracellular trafficking of free oxLDL possibly through the induction of HSP70/70B'.	[Al Gadban, Mohammed M.; Smith, Kent J.; Soodavar, Farzan; Twal, Waleed O.; Hammad, Samar M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Piansay, Christabelle] Med Univ S Carolina, Summer Undergrad Res Program, Coll Grad Studies, Charleston, SC 29425 USA; [Chassereau, Charlyne; Klein, Richard L.; Lopes-Virella, Maria F.] Med Univ S Carolina, Dept Med, Div Endocrinol, Charleston, SC 29425 USA; [Klein, Richard L.; Lopes-Virella, Maria F.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC USA; [Virella, Gabriel] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Al Gadban, MM (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	hammadsm@musc.edu		Hammad, Samar/0000-0002-1313-2542	National Institutes of Health (NIH) [HL079274]; NIH (ARRA) [R01 HL079274-04S1]; NCRR [P20 RR17677]; NIH [P01 HL55782, R01 DK081352, R01 DK081352-02S1]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, P20RR016461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079274, P01HL055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081352] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grant HL079274, NIH (ARRA) grant R01 HL079274-04S1, and the South Carolina COBRE in Lipidomics and Pathobiology (P20 RR17677 from NCRR) to SMH, and NIH grants P01 HL55782, R01 DK081352 and R01 DK081352-02S1 (ARRA) to MLV, and funding from the Department of Veterans Affairs to MLV and RLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Brown AJ, 2000, J LIPID RES, V41, P226; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Cataldi A, 2010, CURR PHARM DESIGN, V16, P1387, DOI 10.2174/138161210791033969; Deigner HP, 2001, FASEB J, V15, P807, DOI 10.1096/fj.15.3.807; Deng TL, 2008, CELL BIOL INT, V32, P1425, DOI 10.1016/j.cellbi.2008.08.013; Flaberg E, 2006, ACTA HISTOCHEM CYTOC, V39, P103, DOI 10.1267/ahc.05056; Freeman B A, 1995, Adv Pharmacol, V34, P45; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GRIFFITH RL, 1988, J EXP MED, V168, P1041, DOI 10.1084/jem.168.3.1041; Hammad SM, 2009, ATHEROSCLEROSIS, V202, P394, DOI 10.1016/j.atherosclerosis.2008.05.032; Hammad SM, 2006, PROSTAG OTH LIPID M, V79, P126, DOI 10.1016/j.prostaglandins.2005.12.004; Hoekstra KA, 2004, BIOCHEM CELL BIOL, V82, P351, DOI 10.1139/O04-006; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P1600, DOI 10.1161/01.ATV.19.7.1600; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Jerome WG, 1998, J LIPID RES, V39, P1362; Kajiwara T, 2007, J AUTOIMMUN, V29, P164, DOI 10.1016/j.jaut.2007.07.003; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Kuwana M, 2005, BLOOD, V105, P1552, DOI 10.1182/blood-2004-08-3145; Lopes-Virella MF, 2000, ATHEROSCLEROSIS, V152, P107, DOI 10.1016/S0021-9150(99)00456-6; LOPESVIRELLA MF, 1994, CLIN IMMUNOL IMMUNOP, V73, P155, DOI 10.1006/clin.1994.1184; LopesVirella MF, 1997, ATHEROSCLEROSIS, V135, P161, DOI 10.1016/S0021-9150(97)00157-3; LOPESVIRELLA MF, 1991, ARTERIOSCLER THROMB, V11, P1356, DOI 10.1161/01.ATV.11.5.1356; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881, DOI 10.1161/01.ATV.19.8.1881; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Oksjoki R, 2006, ARTERIOSCL THROM VAS, V26, P576, DOI 10.1161/01.ATV.0000201041.14438.8d; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Puddu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-112; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; Smith KJ, 2010, J BIOL CHEM, V285, P15985, DOI 10.1074/jbc.M110.113605; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Su CY, 1998, J MOL CELL CARDIOL, V30, P587, DOI 10.1006/jmcc.1997.0622; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; SUNDSTROM C, 1976, INT J CANC, V17; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Virella G, 2000, CLIN IMMUNOL, V95, P135, DOI 10.1006/clim.2000.4857; Virella G, 2004, J LIPID RES, V45, P1859, DOI 10.1194/jlr.M400095-JLR200; Virella G, 2002, CLIN IMMUNOL, V105, P81, DOI 10.1006/clim.2002.5269; VIRELLA G, 1995, CLIN IMMUNOL IMMUNOP, V75, P179, DOI 10.1006/clin.1995.1069; Yamaguchi Y, 2007, BLOOD, V110, P4312, DOI 10.1182/blood-2007-07-100008; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8	53	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12534	10.1371/journal.pone.0012534	http://dx.doi.org/10.1371/journal.pone.0012534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824093	Green Published, gold, Green Submitted			2022-12-25	WOS:000281480900017
J	Fradin, D; Cheslack-Postava, K; Ladd-Acosta, C; Newschaffer, C; Chakravarti, A; Arking, DE; Feinberg, A; Fallin, MD				Fradin, Delphine; Cheslack-Postava, Keely; Ladd-Acosta, Christine; Newschaffer, Craig; Chakravarti, Aravinda; Arking, Dan E.; Feinberg, Andrew; Fallin, M. Daniele			Parent-Of-Origin Effects in Autism Identified through Genome-Wide Linkage Analysis of 16,000 SNPs	PLOS ONE			English	Article							PRADER-WILLI; ANGELMAN SYNDROME; GENE-EXPRESSION; MELATONIN; DISORDER; LOCI; ASSOCIATION; REVEALS; COMMON; RISK	Background: Autism is a common heritable neurodevelopmental disorder with complex etiology. Several genome-wide linkage and association scans have been carried out to identify regions harboring genes related to autism or autism spectrum disorders, with mixed results. Given the overlap in autism features with genetic abnormalities known to be associated with imprinting, one possible reason for lack of consistency would be the influence of parent-of-origin effects that may mask the ability to detect linkage and association. Methods and Findings: We have performed a genome-wide linkage scan that accounts for potential parent-of-origin effects using 16,311 SNPs among families from the Autism Genetic Resource Exchange (AGRE) and the National Institute of Mental Health (NIMH) autism repository. We report parametric (GH, Genehunter) and allele-sharing linkage (Aspex) results using a broad spectrum disorder case definition. Paternal-origin genome-wide statistically significant linkage was observed on chromosomes 4 (LODGH = 3.79, empirical p, 0.005 and LODAspex = 2.96, p = 0.008), 15 (LODGH = 3.09, empirical p, 0.005 and LODAspex = 3.62, empirical p = 0.003) and 20 (LODGH = 3.36, empirical p, 0.005 and LODAspex = 3.38, empirical p = 0.006). Conclusions: These regions may harbor imprinted sites associated with the development of autism and offer fruitful domains for molecular investigation into the role of epigenetic mechanisms in autism.	[Fradin, Delphine; Fallin, M. Daniele] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Fradin, Delphine; Ladd-Acosta, Christine; Feinberg, Andrew] Johns Hopkins Univ, Sch Med, Dept Med, Ctr Epigenet,Inst Basic Biomed Sci, Baltimore, MD 21205 USA; [Cheslack-Postava, Keely] Columbia Univ, Robert Wood Johnson Fdn Hlth & Soc Scholars, New York, NY USA; [Newschaffer, Craig] Drexel Univ, Dept Epidemiol, Philadelphia, PA 19104 USA; [Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Ctr Complex Dis Gen, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Columbia University; Robert Wood Johnson Foundation (RWJF); Drexel University; Johns Hopkins University	Fradin, D (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	dfallin@jhsph.edu	Feinberg, Andrew/AAY-7666-2020; Fradin, Delphine/K-7181-2015	Fradin, Delphine/0000-0001-6231-2649; Feinberg, Andrew/0000-0002-8364-1991	CENTERS FOR DISEASE CONTROL AND PREVENTION [U10DD000183] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH052708, P01MH039437] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003233, 2P50HG003233] Funding Source: Medline; NIMH NIH HHS [MH00219, MH52708, MH00980, R01 MH064547, MH64547, MH39437] Funding Source: Medline; NCBDD CDC HHS [5U01DD000183, U10 DD000183] Funding Source: Medline	CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCBDD CDC HHS		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bolton C, 1994, Healthc Manage Forum, V7, P51; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Cook EH, 1997, AM J HUM GENET, V60, P928; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Descheemaeker MJ, 2002, J INTELL DISABIL RES, V46, P41, DOI 10.1046/j.1365-2788.2002.00354.x; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Feinberg AP, 2002, CANCER RES, V62, P6784; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kulman G, 2000, NEUROENDOCRINOL LETT, V21, P31; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Lippiello PM, 2006, MED HYPOTHESES, V66, P985, DOI 10.1016/j.mehy.2005.11.015; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McInnes LA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-21; Melke J, 2008, MOL PSYCHIATR, V13, P90, DOI 10.1038/sj.mp.4002016; Michaelis RC, 1997, AM J MED GENET, V71, P298, DOI 10.1002/(SICI)1096-8628(19970822)71:3<298::AID-AJMG10>3.0.CO;2-F; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nir I, 1995, J AUTISM DEV DISORD, V25, P641, DOI 10.1007/BF02178193; RITVO ER, 1985, AM J PSYCHIAT, V142, P187; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; Sauter S, 2003, AM J MED GENET A, V120A, P533, DOI 10.1002/ajmg.a.20089; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sukumar S, 1999, AM J MED GENET, V87, P17, DOI 10.1002/(SICI)1096-8628(19991105)87:1<17::AID-AJMG4>3.0.CO;2-G; Tordjman S, 2005, BIOL PSYCHIAT, V57, P134, DOI 10.1016/j.biopsych.2004.11.003; Trillingsgaard A, 2004, AUTISM, V8, P163, DOI 10.1177/1362361304042720; Veltman MWM, 2005, PSYCHIAT GENET, V15, P243, DOI 10.1097/00041444-200512000-00006; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wassink TH, 2005, HUM GENET, V117, P200, DOI 10.1007/s00439-005-1257-4; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wimpory D, 2002, J INTELL DISABIL RES, V46, P352, DOI 10.1046/j.1365-2788.2002.00423.x; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	55	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12513	10.1371/journal.pone.0012513	http://dx.doi.org/10.1371/journal.pone.0012513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824079	gold, Green Published, Green Submitted			2022-12-25	WOS:000281480900006
J	Osada, T; Ogino, H; Hino, T; Ichinose, S; Nakamura, K; Omori, A; Noce, T; Masutani, M				Osada, Tomoharu; Ogino, Hideki; Hino, Toshiaki; Ichinose, Sachiyo; Nakamura, Kenji; Omori, Akira; Noce, Toshiaki; Masutani, Mitsuko			PolyADP-Ribosylation Is Required for Pronuclear Fusion during Postfertilization in Mice	PLOS ONE			English	Article							ADP-RIBOSE POLYMERASE; POLY(ADP-RIBOSE) POLYMERASE; IN-VITRO; POTENT INHIBITOR; NUCLEAR; MOUSE; KINASE; PARP-1; FERTILIZATION; EXPRESSION	Background: During fertilization, pronuclear envelope breakdown (PNEB) is followed by the mingling of male and female genomes. Dynamic chromatin and protein rearrangements require posttranslational modification (PTM) for the postfertilization development. Methodology/Principal Findings: Inhibition of poly(ADP-ribose) polymerase activity (PARylation) by either PJ-34 or 5-AIQ resulted in developmental arrest of fertilized embryos at the PNEB. PARylation inhibition affects spindle bundle formation and phosphorylation of Erk molecules of metaphase II (MII) unfertilized oocytes. We found a frequent appearance of multiple pronuclei (PN) in the PARylation-inhibited embryos, suggesting defective polymerization of tubulins. Attenuated phosphorylation of lamin A/C by PARylation was detected in the PARylation-inhibited embryos at PNEB. This was associated with sustained localization of heterodomain protein 1 (HP1) at the PN of the one-cell embryos arrested by PARylation inhibition. Conclusions/Significance: Our findings indicate that PARylation is required for pronuclear fusion during postfertilization processes. These data further suggest that PARylation regulates protein dynamics essential for the beginning of mouse zygotic development. PARylation and its involving signal-pathways may represent potential targets as contraceptives.	[Osada, Tomoharu] Mitsubishi Chem Medience Corp, Adv Med Sci Res Ctr, Minato Ku, Tokyo, Japan; [Osada, Tomoharu; Noce, Toshiaki] Mitsubishi Kagaku Inst Life Sci MITILS, Dept Regenerat & Dev Biol, Tokyo, Japan; [Ogino, Hideki; Masutani, Mitsuko] Natl Inst Canc Res, Div Biochem, Chuo Ku, Tokyo, Japan; [Ogino, Hideki; Masutani, Mitsuko] Natl Inst Canc Res, ADP Ribosylat Oncol Project, Chuo Ku, Tokyo, Japan; [Hino, Toshiaki; Nakamura, Kenji] Mitsubishi Kagaku Inst Life Sci MITILS, Mouse Genome Technol Lab, Tokyo, Japan; [Ichinose, Sachiyo; Omori, Akira] Mitsubishi Kagaku Inst Life Sci MITILS, Biomol Struct Anal Lab, Tokyo, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Cancer Center - Japan; National Cancer Center - Japan; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Osada, T (corresponding author), Mitsubishi Chem Medience Corp, Adv Med Sci Res Ctr, Minato Ku, Tokyo, Japan.	osada.tomoharu@mg.medience.co.jp; mmasutan@ncc.go.jp	noce, toshiaki/L-1739-2013		Ministry of Education, Science, Sports, and Culture of Japan [18870035]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work is supported in part by Grant-in-Aid from the Ministry of Education, Science, Sports, and Culture of Japan (T. O., 18870035) (http://www.mext.go.jp), Grant-in-Aid for the Third Term Comprehensive 10-year Strategy for Cancer Control (M. M., H19-Sanjigan-Ippan-003) and Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (M. M.) (http://www.mhlw.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Arney KL, 2002, INT J DEV BIOL, V46, P317; Bakondi E, 2002, J HISTOCHEM CYTOCHEM, V50, P91, DOI 10.1177/002215540205000110; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang P, 2009, MOL BIOL CELL, V20, P4575, DOI 10.1091/mbc.E09-06-0477; CLARKE HJ, 1992, BIOCHEM CELL BIOL, V70, P856, DOI 10.1139/o92-134; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; EPEL D, 1981, CELL, V23, P543, DOI 10.1016/0092-8674(81)90150-1; Erdelyi K, 2005, MOL PHARMACOL, V68, P895, DOI 10.1124/mol.105.012518; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fossati S, 2007, NEUROCHEM INT, V50, P203, DOI 10.1016/j.neuint.2006.08.009; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; Hakelien AM, 2008, EXP CELL RES, V314, P1869, DOI 10.1016/j.yexcr.2008.02.018; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Imamura T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-4; Inbar-Rozensal D, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2445; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; McDonald MC, 2000, BRIT J PHARMACOL, V130, P843, DOI 10.1038/sj.bjp.0703391; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; Osada T, 2005, MOL REPROD DEV, V72, P329, DOI 10.1002/mrd.20319; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Quenet D, 2008, FASEB J, V22, P3853, DOI 10.1096/fj.08-113464; Rawe VY, 2003, HUM REPROD, V18, P576, DOI 10.1093/humrep/deg114; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4727, DOI 10.1073/pnas.82.14.4727; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shimokawa T, 1999, J BIOCHEM-TOKYO, V126, P748, DOI 10.1093/oxfordjournals.jbchem.a022512; SIMERLY C, 1993, METHOD ENZYMOL, V225, P516; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; SUGIMURA T, 1994, MOL CELL BIOCHEM, V138, P5, DOI 10.1007/BF00928437; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; Tong C, 2003, CELL RES, V13, P375, DOI 10.1038/sj.cr.7290183; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Vignon Xavier, 2002, Cloning and Stem Cells, V4, P363, DOI 10.1089/153623002321025041; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Yanagimachi R., 1994, P189; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	48	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12526	10.1371/journal.pone.0012526	http://dx.doi.org/10.1371/journal.pone.0012526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824066	Green Published, gold, Green Submitted			2022-12-25	WOS:000281480900012
J	Hodsoll, J; Quinn, KA; Hodsoll, S				Hodsoll, John; Quinn, Kimberly A.; Hodsoll, Sara			Attentional Prioritization of Infant Faces Is Limited to Own-Race Infants	PLOS ONE			English	Article							PERSON PERCEPTION; BABY SCHEMA; RECOGNITION; BIAS; COMPONENTS; CONTACT; FEAR	Background: Recent evidence indicates that infant faces capture attention automatically, presumably to elicit caregiving behavior from adults and leading to greater probability of progeny survival. Elsewhere, evidence demonstrates that people show deficiencies in the processing of other-race relative to own-race faces. We ask whether this other-race effect impacts on attentional attraction to infant faces. Using a dot-probe task to reveal the spatial allocation of attention, we investigate whether other-race infants capture attention. Principal Findings: South Asian and White participants (young adults aged 18-23 years) responded to a probe shape appearing in a location previously occupied by either an infant face or an adult face; across trials, the race (South Asian/White) of the faces was manipulated. Results indicated that participants were faster to respond to probes that appeared in the same location as infant faces than adult faces, but only on own-race trials. Conclusions/Significance: Own-race infant faces attract attention, but other-race infant faces do not. Sensitivity to face-specific care-seeking cues in other-race kindenschema may be constrained by interracial contact and experience.	[Hodsoll, John] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Hodsoll, John; Quinn, Kimberly A.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Hodsoll, Sara] UCL, Dept Psychol, London, England	University of London; Queen Mary University London; University of Birmingham; University of London; University College London	Hodsoll, J (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	John.Hodsoll@gmail.com	Hodsoll, John/I-3928-2012	Hodsoll, John/0000-0001-7546-9901; Lauwereyns, Jan/0000-0003-0551-2550	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council Fellowship to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2006, J COGNITIVE NEUROSCI, V18, P1406, DOI 10.1162/jocn.2006.18.8.1406; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; BERRY DS, 1985, J PERS SOC PSYCHOL, V48, P312, DOI 10.1037/0022-3514.48.2.312; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; HRDY SB, 2008, FAM RELAT, P39; Hugenberg K, 2008, SOC PERSONAL PSYCHOL, V2, P1052, DOI 10.1111/j.1751-9004.2008.00090.x; Humphreys GW, 2005, VIS COGN, V12, P249, DOI 10.1080/13506280444000148; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Lebrecht S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004215; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lipp OV, 2005, EMOTION, V5, P365, DOI 10.1037/1528-3542.5.3.365; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; LORENZ K, 1985, Z TIERPSYCHOL, V5, P233; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; McKone E, 2007, PERCEPTION, V36, P224, DOI 10.1068/p5499; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; NG WJ, 1994, J CROSS CULT PSYCHOL, V25, P217, DOI 10.1177/0022022194252004; Papesh MH, 2010, COGNITION, V116, P283, DOI 10.1016/j.cognition.2010.05.001; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Wright DB, 2003, APPL COGNITIVE PSYCH, V17, P365, DOI 10.1002/acp.898	34	31	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12509	10.1371/journal.pone.0012509	http://dx.doi.org/10.1371/journal.pone.0012509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645KT	20824137	Green Submitted, Green Published, gold			2022-12-25	WOS:000281456100015
J	Sarac, OS; Atalay, V; Cetin-Atalay, R				Sarac, Oemer Sinan; Atalay, Volkan; Cetin-Atalay, Rengul			GOPred: GO Molecular Function Prediction by Combined Classifiers	PLOS ONE			English	Article							PROTEIN FUNCTION; CLASSIFICATION; SEQUENCE; ANNOTATION; SUPPORT; DISCOVERY; SOFTWARE; GENOMES	Functional protein annotation is an important matter for in vivo and in silico biology. Several computational methods have been proposed that make use of a wide range of features such as motifs, domains, homology, structure and physicochemical properties. There is no single method that performs best in all functional classification problems because information obtained using any of these features depends on the function to be assigned to the protein. In this study, we portray a novel approach that combines different methods to better represent protein function. First, we formulated the function annotation problem as a classification problem defined on 300 different Gene Ontology (GO) terms from molecular function aspect. We presented a method to form positive and negative training examples while taking into account the directed acyclic graph (DAG) structure and evidence codes of GO. We applied three different methods and their combinations. Results show that combining different methods improves prediction accuracy in most cases. The proposed method, GOPred, is available as an online computational annotation tool (http://kinaz.fen.bilkent.edu.tr/gopred).	[Sarac, Oemer Sinan; Atalay, Volkan] Middle E Tech Univ, Dept Comp Engn, TR-06531 Ankara, Turkey; [Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Fac Sci, Ankara, Turkey	Middle East Technical University; Ihsan Dogramaci Bilkent University	Sarac, OS (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	rengul@bilkent.edu.tr	Atalay, Volkan/M-2256-2016; Cetin-Atalay, Rengul/O-9826-2014; Cetin-Atalay, Rengul/F-5780-2013	Atalay, Volkan/0000-0001-7850-0601; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606	Scientific and Technological Research Council of Turkey (TUBITAK-EEAG) [105E035]	Scientific and Technological Research Council of Turkey (TUBITAK-EEAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK-EEAG) (105E035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAY C, 1970, BLOOD-J HEMATOL, V36, P219, DOI 10.1182/blood.V36.2.219.219; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARAMPATZIS A, 2001, P 10 TEXT RETRIEVAL, P596; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; BENHUR A, 2003, ISMB S, V26, P33; Blekas K, 2005, J COMPUT BIOL, V12, P64, DOI 10.1089/cmb.2005.12.64; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cheng BYM, 2005, PROTEINS, V58, P955, DOI 10.1002/prot.20373; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; COLBY WW, 1986, MOL CELL BIOL, V6, P730, DOI 10.1128/MCB.6.2.730; Costa V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-250; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DEMOS D, 2000, PROTEINS, V41, P98; Duda R.O., 2000, PATTERN CLASSIFICATI; Eisner R.P.B., 2005, P IEEE S COMP INT BI; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Gilks WR, 2005, MATH BIOSCI, V193, P223, DOI 10.1016/j.mbs.2004.08.001; Guermeur Y, 2004, NEUROCOMPUTING, V56, P305, DOI 10.1016/j.neucom.2003.10.004; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Holloway DT, 2006, IBM J RES DEV, V50, P631, DOI 10.1147/rd.506.0631; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; King RD, 2000, YEAST, V17, P283, DOI 10.1002/1097-0061(200012)17:4<283::AID-YEA52>3.0.CO;2-F; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kunik V, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P80, DOI 10.1109/CSB.2005.39; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liu AH, 2001, IBM SYST J, V40, P379, DOI 10.1147/sj.402.0379; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; McChesney PA, 2006, CANCER RES, V66, P1346, DOI 10.1158/0008-5472.CAN-05-3593; Melvin I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-389; Pasquier C, 2001, PROTEINS, V44, P361, DOI 10.1002/prot.1101; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sarac OS, 2008, COMPUT BIOL CHEM, V32, P122, DOI 10.1016/j.compbiolchem.2007.11.004; Sasson O, 2006, PROTEIN SCI, V15, P1557, DOI 10.1110/ps.062185706; Schwanbeck R, 2008, CELLS TISSUES ORGANS, V188, P91, DOI 10.1159/000113531; Shanahan James G., 2003, CIKM ACM, P247; Sohn SY, 2007, PATTERN RECOGN, V40, P33, DOI 10.1016/j.patcog.2006.06.027; SOKOLOV A, 2008, P 2 INT WORKSH MACH, P49; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Wang JTL, 2001, IBM SYST J, V40, P426, DOI 10.1147/sj.402.0426; Wang XY, 2003, INFORM SCIENCES, V155, P1, DOI 10.1016/S0020-0255(03)00067-7; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yildiz A, 2005, TRENDS CELL BIOL, V15, P112, DOI 10.1016/j.tcb.2004.12.007; ZHAI C, 1998, P TREC 7, P96	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12382	10.1371/journal.pone.0012382	http://dx.doi.org/10.1371/journal.pone.0012382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824206	Green Submitted, gold, Green Published			2022-12-25	WOS:000281405300006
J	Cellurale, C; Weston, CR; Reilly, J; Garlick, DS; Jerry, DJ; Sluss, HK; Davis, RJ				Cellurale, Cristina; Weston, Claire R.; Reilly, Judith; Garlick, David S.; Jerry, D. Joseph; Sluss, Hayla K.; Davis, Roger J.			Role of JNK in a Trp53-Dependent Mouse Model of Breast Cancer	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; JUN NH2-TERMINAL KINASE; GLIOBLASTOMA CELLS; TUMOR-SUPPRESSOR; MICE; GROWTH; DIFFERENTIATION; PROLIFERATION; ACTIVATION; CARCINOMA	The cJun NH(2)-terminal kinase (JNK) signal transduction pathway has been implicated in mammary carcinogenesis. To test the role of JNK, we examined the effect of ablation of the Jnk1 and Jnk2 genes in a Trp53-dependent model of breast cancer using BALB/c mice. We detected no defects in mammary gland development in virgin mice or during lactation and involution in control studies of Jnk1(-/-) and Jnk2(-/-) mice. In a Trp53(-/+) genetic background, mammary carcinomas were detected in 43% of control mice, 70% of Jnk1(-/-) mice, and 53% of Jnk2(-/-) mice. These data indicate that JNK1 and JNK2 are not essential for mammary carcinoma development in the Trp53(-/+) BALB/c model of breast cancer. In contrast, this analysis suggests that JNK may partially contribute to tumor suppression. This conclusion is consistent with the finding that tumor-free survival of JNK-deficient Trp53(-/+) mice was significantly reduced compared with control Trp53(-/+) mice. We conclude that JNK1 and JNK2 can act as suppressors of mammary tumor development.	[Cellurale, Cristina; Weston, Claire R.; Reilly, Judith; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; [Garlick, David S.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Jerry, D. Joseph] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Sluss, Hayla K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Worcester	Cellurale, C (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA.	Roger.Davis@Umassmed.Edu		Davis, Roger/0000-0002-0130-1652	National Institutes of Health, National Cancer Institute (NCI) [R01CA65861]; National Institutes of Health, National Institute of Diabetes Digestive disorders and Kidney (NIDDK) [P30DK52530]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Institute of Diabetes Digestive disorders and Kidney (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, National Cancer Institute (NCI) (www.nci.nih.gov) grant number R01CA65861 to RJD. RJD is an Investigator of the Howard Hughes Medical Institute. RJD and HKS are members of the Diabetes and Endocrinology Research Center of the University of Massachusetts Medical School that is funded by the National Institutes of Health, National Institute of Diabetes Digestive disorders and Kidney (NIDDK) (www.niddk.nih.gov) grant number P30DK52530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Bost F, 1999, MOL CELL BIOL, V19, P1938; Chen NY, 2001, CANCER RES, V61, P3908; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Debies MT, 2001, J MAMMARY GLAND BIOL, V6, P441, DOI 10.1023/A:1014739131690; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Su Gloria H, 2002, Hum Mutat, V19, P81, DOI 10.1002/humu.9002; Teng DHF, 1997, CANCER RES, V57, P4177; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang YM, 2003, CLIN CANCER RES, V9, P391	30	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12469	10.1371/journal.pone.0012469	http://dx.doi.org/10.1371/journal.pone.0012469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814571	gold, Green Published, Green Submitted			2022-12-25	WOS:000281375500004
J	Chen, P; Vericel, E; Lagarde, M; Guichardant, M				Chen, Ping; Vericel, Evelyne; Lagarde, Michel; Guichardant, Michel			Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation	FASEB JOURNAL			English	Article						docosahexaenoic acid; 15-lipoxygenase; docosatrienes; thromboxane receptor	DOCOSAHEXAENOIC ACID; CARDIOVASCULAR-DISEASE; LIPOXYGENASE PRODUCTS; LIPID MEDIATORS; CELL; RESPONSES; BRAIN; NEUROPROTECTIN-D1; SUPPLEMENTATION; CHOLESTEROL	Docosahexaenoic acid (DHA), an important component of marine lipids, exhibits anti-inflammatory activity related to some of its oxygenated metabolites, such as neuroprotectin/protectin D1 [NPD1/PD1; 10(R), 17(S)-dihydroxy-docosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid] produced through the 15-lipoxygenase pathway. However, other metabolites from DHA can be produced through this pathway, and other polyunsaturated fatty acids (PUFAs) of nutritional value may be oxygenated as well. Their biological activities remain unknown. Isomers of protectin D1 were synthesized using soybean lipoxygenase and tested for their ability to inhibit human blood platelet aggregation. A geometric isomer called PDX, previously described with the 11E,13Z,15E geometry, instead of 11E, 13E, 15Z in PD1, inhibited platelet aggregation at submicromolar concentrations when induced by either collagen, arachidonic acid, or thromboxane. The inhibition occurred at the level of both the cyclooxygenase activity and thromboxane receptor site. Interestingly, all the metabolites tested exhibiting the E,Z,E-conjugated triene were active, whereas E, E, Z trienes (as in PD1) or all-trans (E, E, E) trienes were inactive. We conclude that PDX and other oxygenated products from PUFAs of nutritional interest, having the E, Z, E-conjugated triene motif and collectively named poxytrins (PUFA oxygenated trienes), might have antithrombotic potential.-Chen, P., Vericel, E., Lagarde, M., Guichardant, M. Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J. 25, 382-388 (2011). www.fasebj.org	[Lagarde, Michel] Univ Lyon, Unite Mixte Rech UMR 870, INSERM, Insa Lyon, F-69621 Villeurbanne, France; INRA, UMR 1235, F-69621 Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; INRAE	Lagarde, M (corresponding author), Univ Lyon, Unite Mixte Rech UMR 870, INSERM, Insa Lyon, Bldg IMBL,20 Ave A Einstein, F-69621 Villeurbanne, France.	michel.lagarde@insa-lyon.fr	Vericel, Evelyne/M-4187-2018		INSERM; Ministry of Education and Research; Lipides pour l'Industrie et la Sante (LISA) Carnot Institute; Chinese Educational Council	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministry of Education and Research; Lipides pour l'Industrie et la Sante (LISA) Carnot Institute; Chinese Educational Council	This work was supported by INSERM, the Ministry of Education and Research, and the Lipides pour l'Industrie et la Sante (LISA) Carnot Institute. P.C. received a grant from the Chinese Educational Council.	AVELDANO MI, 1983, J BIOL CHEM, V258, P9339; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bazan NG, 2008, ADV EXP MED BIOL, V613, P39; BORGEAT P, 1982, PROSTAGLANDINS, V23, P713, DOI 10.1016/S0090-6980(82)80009-9; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; BOUKHCHACHE D, 1982, BIOCHIM BIOPHYS ACTA, V713, P386, DOI 10.1016/0005-2760(82)90257-0; Butovich IA, 2006, J LIPID RES, V47, P854, DOI 10.1194/jlr.D500042-JLR200; Butovich IA, 2006, J LIPID RES, V47, P2462, DOI 10.1194/jlr.M600280-JLR200; Chen P, 2009, FEBS LETT, V583, P3478, DOI 10.1016/j.febslet.2009.10.004; CROSET M, 1983, BIOCHEM BIOPH RES CO, V112, P878, DOI 10.1016/0006-291X(83)91699-6; CROSET M, 1988, BIOCHEM PHARMACOL, V37, P1275, DOI 10.1016/0006-2952(88)90782-4; Dangi B, 2009, J BIOL CHEM, V284, P14744, DOI 10.1074/jbc.M809014200; de Turco EBR, 2002, J NEUROCHEM, V83, P515, DOI 10.1046/j.1471-4159.2002.01121.x; Deckelbaum RJ, 2008, AM J CLIN NUTR, V87, p2010S, DOI 10.1093/ajcn/87.6.2010S; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; Elvevoll EO, 2008, ATHEROSCLEROSIS, V200, P396, DOI 10.1016/j.atherosclerosis.2007.12.021; Galarraga B, 2008, RHEUMATOLOGY, V47, P665, DOI 10.1093/rheumatology/ken024; GALGANI JE, 2008, BR J NUTR, V8, P1; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; GORDON WC, 1990, J NEUROSCI, V10, P2190; Guillot N, 2009, FASEB J, V23, P2909, DOI 10.1096/fj.09-133421; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; KIM HY, 1990, PROSTAGLANDINS, V40, P539, DOI 10.1016/0090-6980(90)90115-C; LAGARDE M, 1980, THROMB RES, V17, P581, DOI 10.1016/0049-3848(80)90098-5; LAGARDE M, 1989, BIOCHEM PHARMACOL, V38, P1863, DOI 10.1016/0006-2952(89)90422-X; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Leaf A, 2008, CURR VASC PHARMACOL, V6, P1, DOI 10.2174/157016108783331286; MARQUIS NR, 1969, BIOCHEM BIOPH RES CO, V36, P965, DOI 10.1016/0006-291X(69)90298-8; McCann K, 2007, EXPLORE-NY, V3, P616, DOI 10.1016/j.explore.2007.09.009; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; Merzouk SA, 2008, LIPIDS, V43, P485, DOI 10.1007/s11745-008-3176-3; Mickleborough TD, 2005, J ASTHMA, V42, P305, DOI 10.1081/JAS-200062950; MILLER CC, 1989, LIPIDS, V24, P998, DOI 10.1007/BF02544068; Mirnikjoo B, 2001, J BIOL CHEM, V276, P10888, DOI 10.1074/jbc.M008150200; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Stark KD, 2004, AM J CLIN NUTR, V79, P765; Torrejon C, 2007, PROSTAG LEUKOTR ESS, V77, P319, DOI 10.1016/j.plefa.2007.10.014; Volcik KA, 2008, AM J CLIN NUTR, V87, P1926, DOI 10.1093/ajcn/87.6.1926	44	57	58	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					382	388		10.1096/fj.10-161836	http://dx.doi.org/10.1096/fj.10-161836			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20833872				2022-12-25	WOS:000285869500034
J	Leclercq, TM; Moretti, PAB; Pitson, SM				Leclercq, T. M.; Moretti, P. A. B.; Pitson, S. M.			Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis	ONCOGENE			English	Article						sphingosine kinase; sphingosine 1-phosphate; eEF1A; PTI-1; TCTP	CONTROLLED TUMOR PROTEIN; PTI-1 ONCOGENE; FACTOR EEF1A; CANCER; PHOSPHORYLATION; COMPLEX; GROWTH; REVERSION; ISOFORM; CLONING	Sphingosine kinase 1 (SK1) catalyses the formation of bioactive phospholipid sphingosine 1-phosphate (S1P). Elevated cellular SK1 activity and S1P levels enhance cell proliferation and survival, and are strongly implicated in tumourigenesis. Regulation of SK1 activity can occur through various mechanisms, including phosphorylation and protein-protein interactions. We have previously shown that eukaryotic elongation factor 1A (eEF1A) interacts with and directly activates SK1, but the mechanisms regulating this were undefined. Notably, eEF1A has GTPase activity and can exist in GTP- or GDP-bound forms, which are associated with distinct structural conformations of the protein. Here, we show that the guanine nucleotide-bound state of eEF1A regulates its ability to activate SK1, with eEF1A.GDP, but not eEF1A.GTP, enhancing SK1 activity in vitro. Furthermore, we show that enhancing cellular eEF1A. GDP levels through expression of a guanine nucleotide dissociation inhibitor of eEF1A, translationally controlled tumour protein (TCTP), increased SK1 activity in cells. We also examined a truncated isoform of eEF1A1, termed prostate tumour inducer-1 (PTI-1), which can induce neoplastic cell transformation through undefined mechanisms. PTI-1 lacks the G protein domain of eEF1A1 and is therefore unable to undergo the GTP-binding-induced conformational change. Notably, we found that PTI-1 can directly activate SK1 and that this seems to be essential for neoplastic transformation induced by PTI-1, as chemical SK1 inhibitors or overexpression of a dominant- negative SK1 blocked this process. Thus, this study defines the mechanism regulating eEF1A-mediated SK1 activation, and also establishes SK1 as being integral for PTI-1-induced oncogenesis. Oncogene (2011) 30, 372-378; doi:10.1038/onc.2010.420; published online 13 September 2010	[Pitson, S. M.] SA Pathol, Ctr Canc Biol, Div Human Immunol, Mol Signalling Lab, Adelaide, SA 5000, Australia; [Leclercq, T. M.; Pitson, S. M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide	Pitson, SM (corresponding author), SA Pathol, Ctr Canc Biol, Div Human Immunol, Mol Signalling Lab, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@health.sa.gov.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740; Moretti, Paul/0000-0002-3523-1496	Fay Fuller Foundation; Cancer Council of South Australia [399330]; National Health and Medical Research Council of Australia	Fay Fuller Foundation; Cancer Council of South Australia(Cancer Council South Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Fay Fuller Foundation, an Australian Postgraduate Award (to TML), Project Grant 399330 from the Cancer Council of South Australia and a Senior Research Fellowship from the National Health and Medical Research Council of Australia (to SMP).	Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; Al-Maghrebir M, 2005, ANTICANCER RES, V25, P2573; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Cuvillier O, 2008, EXPERT OPIN THER TAR, V12, P1009, DOI [10.1517/14728222.12.8.1009, 10.1517/14728222.12.8.1009 ]; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; French KJ, 2003, CANCER RES, V63, P5962; Gopalkrishnan RV, 1999, INT J BIOCHEM CELL B, V31, P151, DOI 10.1016/S1357-2725(98)00138-1; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; Lee Jonathan M, 2003, Reprod Biol Endocrinol, V1, P69, DOI 10.1186/1477-7827-1-69; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Mansilla F, 2005, BBA-GENE STRUCT EXPR, V1727, P116, DOI 10.1016/j.bbaexp.2004.12.012; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Roberts JL, 2004, ANAL BIOCHEM, V331, P122, DOI 10.1016/j.ab.2004.03.030; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P1764, DOI 10.1073/pnas.95.4.1764; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yu L, 2006, TOHOKU J EXP MED, V209, P141, DOI 10.1620/tjem.209.141	35	35	39	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					372	378		10.1038/onc.2010.420	http://dx.doi.org/10.1038/onc.2010.420			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20838377				2022-12-25	WOS:000286418800012
J	Pavlov, PF; Wiehager, B; Sakai, J; Frykman, S; Behbahani, H; Winblad, B; Ankarcrona, M				Pavlov, Pavel F.; Wiehager, Birgitta; Sakai, Jun; Frykman, Susanne; Behbahani, Homira; Winblad, Bengt; Ankarcrona, Maria			Mitochondrial gamma-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein	FASEB JOURNAL			English	Article						Alzheimer's disease; APP processing	CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; BETA-PROTEIN; A-BETA; BRAIN; CLEAVAGE; ACCUMULATION; PRESENILIN; ISOFORM; PEPTIDE	Intracellular amyloid-beta peptide (A beta) has been implicated in the pathogenesis of Alzheimer's disease (AD). Mitochondria were found to be the target both for amyloid precursor protein (APP) that accumulates in the mitochondrial import channels and for A beta that interacts with several proteins inside mitochondria and leads to mitochondrial dysfunction. Here, we have studied the role of mitochondrial gamma-secretase in processing different substrates. We found that a significant proportion of APP is associated with mitochondria in cultured cells and that gamma-secretase cleaves the shedded C-terminal part of APP identified as C83 associated with the outer membrane of mitochondria (OMM). Moreover, we have established the topology of the C83 in the OMM and found the APP intracellular domain (AICD) to be located inside mitochondria. Our data show for the first time that APP is a substrate for the mitochondrial gamma-secretase and that AICD is produced inside mitochondria. Thus, we provide a mechanistic view of the mitochondria-associated APP metabolism where AICD, P3 peptide and potentially A beta are produced locally and may contribute to mitochondrial dysfunction in AD.-Pavlov, P. F., Wiehager, B., Sakai, J., Frykman, S., Behbahani, H., Winblad, B., Ankarcrona, M. Mitochondrial gamma-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J. 25, 78-88 (2011). www.fasebj.org	[Pavlov, Pavel F.; Wiehager, Birgitta; Frykman, Susanne; Behbahani, Homira; Winblad, Bengt; Ankarcrona, Maria] Karolinska Inst, Dainippon Sumitomo Pharma Alzheimer Ctr, Dept Neurobiol Care Sci & Soc, SE-14157 Huddinge, Sweden; [Sakai, Jun] Dainippon Sumitomo Pharma, Osaka, Japan	Karolinska Institutet	Pavlov, PF (corresponding author), Karolinska Inst, KASPAC, Novum Floor 5, SE-14157 Huddinge, Sweden.	pavel.pavlov@ki.se		Ankarcrona, Maria/0000-0002-7022-3694	Dainippon Sumitomo Pharma (Osaka, Japan)	Dainippon Sumitomo Pharma (Osaka, Japan)	The authors thank Dr. P. M. Mathews (Nathan Kline Institute, Orangeburg, NY, USA) for C1/6.1 antibody, and Dr. Sam Gandy (Thomas Jefferson University, Philadelphia, PA, USA) for G369 antibody. Wild-type MEFs and PS<SUP>-</SUP> cells were provided by Dr. B. De Strooper (Katholieke Universiteit Leuven, Leuven, Belgium). The authors thank Dr. Helena Karlstrom (Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden) for providing BD8 and BD8 up arrow cells. The authors thank Dr. Kjell Hultenby (Karolinska Institutet, Stockholm, Sweden) for excellent help with electron microscopy. This work was supported by Dainippon Sumitomo Pharma (Osaka, Japan).	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Behbahani H, 2006, J NEUROSCI RES, V84, P891, DOI 10.1002/jnr.20990; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Franberg J, 2007, BIOCHEMISTRY-US, V46, P7647, DOI 10.1021/bi0621258; Franberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009772; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hartmann T, 1999, EUR ARCH PSY CLIN N, V249, P291, DOI 10.1007/s004060050102; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; KOO EH, 1994, J BIOL CHEM, V269, P17386; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin MT, 2006, NAT MED, V12, P1241, DOI 10.1038/nm1106-1241; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Park HJ, 2006, J BIOL CHEM, V281, P34277, DOI 10.1074/jbc.M603443200; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Valla J, 2006, MITOCHONDRION, V6, P323, DOI 10.1016/j.mito.2006.10.004; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106	44	95	97	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					78	88		10.1096/fj.10-157230	http://dx.doi.org/10.1096/fj.10-157230			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20833873				2022-12-25	WOS:000285869500008
J	Sevenich, L; Werner, F; Gajda, M; Schurigt, U; Sieber, C; Muller, S; Follo, M; Peters, C; Reinheckel, T				Sevenich, L.; Werner, F.; Gajda, M.; Schurigt, U.; Sieber, C.; Mueller, S.; Follo, M.; Peters, C.; Reinheckel, T.			Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice	ONCOGENE			English	Article						protease; tumor microenvironment; tumor-associated inflammation; lysosome	CYSTEINE CATHEPSINS; TUMOR-GROWTH; MAST-CELLS; DEGRADING PROTEASES; VEGF-A; ANGIOGENESIS; INVASION; DEGRADATION; MACROPHAGES; CARCINOMAS	Elevated expression of the cysteine protease cathepsin B (CTSB) has been correlated with a poor prognosis for cancer patients. In order to model high CTSB expression in mammary cancer, transgenic mice expressing human CTSB were crossed with transgenic polyoma virus middle T oncogene breast cancer mice (mouse mammary tumor virus-PymT), resulting in a 20-fold increase in cathepsin B activity in the tumors of double-transgenic animals. CTSB expression did not affect tumor onset, but CTSB transgenic mice showed accelerated tumor growth with significant increase in weight for end-stage tumors, as well as an overall worsening in their histopathological grades. Notably, the lung metastases in the CTSB transgenic animals were found to be both significantly larger and to occur at a significantly higher frequency. Ex vivo analysis of primary PymT tumor cells revealed no significant effects from elevated CTSB levels on tumor cell characteristics, that is, the formation of tumor cell colonies and the sprouting of invasive strands from PymT cell spheroids. However, tumors from CTSB-overexpressing mice showed increased numbers of tumor-associated B cells and mast cells. In addition, more CD31+ endothelial cells were detected in these tumors, correlating with higher levels of vascular endothelial growth factor (VEGF) being present in the tumor and serum. We conclude that elevated proteolytic CTSB activity facilitates progression and metastasis of PymT-induced mammary carcinomas, and is associated with increased immune cell infiltration, enhanced VEGF levels and the promotion of tumor angiogenesis. Oncogene (2011) 30, 54-64; doi: 10.1038/onc.2010.387; published online 6 September 2010	[Sevenich, L.; Werner, F.; Schurigt, U.; Sieber, C.; Mueller, S.; Reinheckel, T.] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Sevenich, L.; Werner, F.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Werner, F.] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Gajda, M.] Univ Jena, Inst Pathol, Jena, Germany; [Follo, M.] Univ Med Ctr, Core Facil, Dept Hematol & Oncol, Freiburg, Germany; [Peters, C.; Reinheckel, T.] Univ Freiburg, Ludwig Heilmeyer Comprehens Canc Ctr, D-79104 Freiburg, Germany; [Peters, C.; Reinheckel, T.] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Friedrich Schiller University of Jena; University of Freiburg; University of Freiburg; University of Freiburg	Reinheckel, T (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Follo, Marie/0000-0002-3090-7442; Schurigt, Uta/0000-0003-4423-5955; Muller, Sebastian/0000-0001-8071-8853	European Commission [201279]; Deutsche Forschungsgemeinschaft [SFB 850, B7]; Excellence Initiative of the German Federal and State Governments [EXC 294, GSC-4]	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	The Tg(CTSB)<SUP>+/0</SUP> mice were kindly provided by Dr L Pennacchio, Genomics Division, Lawrence Berkeley Laboratory. We thank Anne Schwinde, Ulrike Reif, Lisa Christiansson and Anna Heisswolf for excellent technical assistance. This work was supported by European Commission FP7 Grant 201279 (Microenvimet), Deutsche Forschungsgemeinschaft SFB 850 Project B7, and by the Excellence Initiative of the German Federal and State Governments (EXC 294 and GSC-4, Spemann Graduate School).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; BARRETT AJ, 1992, ANN NY ACAD SCI, V674, P1; Berdowska I, 2004, CLIN CHIM ACTA, V342, P41, DOI 10.1016/j.cccn.2003.12.016; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Caglic D, 2009, BIOL CHEM, V390, P175, DOI 10.1515/BC.2009.021; Chang SH, 2009, CANCER RES, V69, P4537, DOI 10.1158/0008-5472.CAN-08-4539; Coulibaly S, 1999, INT J CANCER, V83, P526, DOI 10.1002/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.3.CO;2-D; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Crivellato E, 2008, CANCER LETT, V269, P1, DOI 10.1016/j.canlet.2008.03.031; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Del Rosso M, 2002, CLIN EXP METASTAS, V19, P193, DOI 10.1023/A:1015531321445; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gondi CS, 2004, CANCER RES, V64, P4069, DOI 10.1158/0008-5472.CAN-04-1243; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; KATZ HR, 1995, INT ARCH ALLERGY IMM, V107, P76, DOI 10.1159/000236936; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ribatti D, 2001, BRIT J HAEMATOL, V115, P514, DOI 10.1046/j.1365-2141.2001.03202.x; ROZHIN J, 1994, CANCER RES, V54, P6517; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shin M, 2007, BIOL CHEM, V388, P1173, DOI 10.1515/BC.2007.154; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Tummalapalli P, 2007, INT J ONCOL, V31, P1039; Turk V, 2004, CANCER CELL, V5, P409, DOI 10.1016/S1535-6108(04)00117-5; Van Damme J, 2004, SEMIN CANCER BIOL, V14, P201, DOI 10.1016/j.semcancer.2003.10.007; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x	53	69	69	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					54	64		10.1038/onc.2010.387	http://dx.doi.org/10.1038/onc.2010.387			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20818432				2022-12-25	WOS:000285959300005
J	Zhu, QS; Kao, LY; Azimov, R; Abuladze, N; Newman, D; Pushkin, A; Liu, WX; Chang, C; Kurtz, I				Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Pushkin, Alexander; Liu, Weixin; Chang, Connie; Kurtz, Ira			Structural and Functional Characterization of the C-terminal Transmembrane Region of NBCe1-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; SCANNING MUTAGENESIS; COTRANSPORTER NBCE1; EXCHANGE PROTEIN; ANION TRANSPORT; RESIDUES; BAND-3; AE1; IDENTIFICATION; MECHANISM	NBCe1-A and AE1 both belong to the SLC4 HCO3- transporter family. The two transporters share 40% sequence homology in the C-terminal transmembrane region. In this study, we performed extensive substituted cysteine-scanning mutagenesis analysis of the C-terminal region of NBCe1-A covering amino acids Ala(800)-Lys(967). Location of the introduced cysteines was determined by whole cell labeling with a membrane-permeant biotin maleimide and a membrane-impermeant 2-((5(6)-tetramethylrhodamine) carboxylamino) ethyl methanethiosulfonate (MTS-TAMRA) cysteine-reactive reagent. The results show that the extracellular surface of the NBCe1-A C-terminal transmembrane region is minimally exposed to aqueous media with Met(858) accessible to both biotin maleimide and TAMRA and Thr(926)-Ala(929) only to TAMRA labeling. The intracellular surface contains a highly exposed (Met(813)-Gly(828)) region and a cryptic (Met(887)-Arg(904)) connecting loop. The lipid/aqueous interface of the last transmembrane segment is at Asp(960). Our data clearly determined that the C terminus of NBCe1-A contains 5 transmembrane segments with greater average size compared with AE1. Functional assays revealed only two residues in the region of Pro(868)-Leu(967) (a functionally important region in AE1) that are highly sensitive to cysteine substitution. Our findings suggest that the C-terminal transmembrane region of NBCe1-A is tightly folded with unique structural and functional features that differ from AE1.	[Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Pushkin, Alexander; Liu, Weixin; Chang, Connie; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, 10833 Le Conte Ave,Rm 7-155,Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; JENNINGS ML, 1982, J BIOL CHEM, V257, P7554; JENNINGS ML, 1985, ANNU REV PHYSIOL, V47, P519; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KAWANO Y, 1988, J BIOL CHEM, V263, P8232; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	23	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37178	37187		10.1074/jbc.M110.169201	http://dx.doi.org/10.1074/jbc.M110.169201			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20837482	hybrid, Green Published			2022-12-25	WOS:000284424000011
J	Morrish, F; Noonan, J; Perez-Olsen, C; Gafken, PR; Fitzgibbon, M; Kelleher, J; VanGilst, M; Hockenbery, D				Morrish, Fionnuala; Noonan, Jhoanna; Perez-Olsen, Carissa; Gafken, Philip R.; Fitzgibbon, Matthew; Kelleher, Joanne; VanGilst, Marc; Hockenbery, David			Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC NETWORKS; STRATEGIES; CITRATE	Cell reprogramming from a quiescent to proliferative state requires coordinate activation of multiple -omic networks. These networks activate histones, increase cellular bioenergetics and the synthesis of macromolecules required for cell proliferation. However, mechanisms that coordinate the regulation of these interconnected networks are not fully understood. The oncogene c-Myc (Myc) activates cellular metabolism and global chromatin remodeling. Here we tested for an interconnection between Myc regulation of metabolism and acetylation of histones. Using [C-13(6)]glucose and a combination of GC/MS and LC/ESI tandem mass spectrometry, we determined the fractional incorporation of C-13-labeled 2-carbon fragments into the fatty acid palmitate, and acetyl-lysines at the N-terminal tail of histone H4 in myc(-/-) and myc(+/+) Rat1A fibroblasts. Our data demonstrate that Myc increases mitochondrial synthesis of acetyl-CoA, as the de novo synthesis of C-13-labeled palmitate was increased 2-fold in Myc-expressing cells. Additionally, Myc induced a forty percent increase in C-13-labeled acetyl-CoA on H4-K16. This is linked to the capacity of Myc to increase mitochondrial production of acetyl-CoA, as we show that mitochondria provide 50% of the acetyl groups on H4-K16. These data point to a key role for Myc in directing the interconnection of -omic networks, and in particular, epigenetic modification of proteins in response to proliferative signals.	[Morrish, Fionnuala; Noonan, Jhoanna; Perez-Olsen, Carissa; Gafken, Philip R.; Fitzgibbon, Matthew; VanGilst, Marc; Hockenbery, David] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Perez-Olsen, Carissa] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA; [Kelleher, Joanne] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT)	Hockenbery, D (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	dhockenb@fhcrc.org			National Institutes of Health [R01CA10665-01]; Pilot funds [P30CA015704]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA106650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA10665-01 (to D. H.) and pilot funds (to D. H.) from P30CA015704 (to L. Hartwell).	BARTLEY JC, 1976, LIPIDS, V11, P774, DOI 10.1007/BF02533054; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Holleran AL, 1997, AM J PHYSIOL-ENDOC M, V272, pE945, DOI 10.1152/ajpendo.1997.272.6.E945; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; R Development Core Team, 2010, LANG ENV STAT COMP; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shia WJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-217; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; SRERE PA, 1962, BIOCHIM BIOPHYS ACTA, V59, P487, DOI 10.1016/0006-3002(62)90205-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Taplick J, 1998, FEBS LETT, V436, P349, DOI 10.1016/S0014-5793(98)01164-8; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200	28	102	103	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36267	36274		10.1074/jbc.M110.141606	http://dx.doi.org/10.1074/jbc.M110.141606			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20813845	Green Published, hybrid			2022-12-25	WOS:000284146100048
J	Olsen, JS; Brown, C; Capule, CC; Rubinshtein, M; Doran, TM; Srivastava, RK; Feng, CY; Nilsson, BL; Yang, J; Dewhurst, S				Olsen, Joanna S.; Brown, Caitlin; Capule, Christina C.; Rubinshtein, Mark; Doran, Todd M.; Srivastava, Rajesh K.; Feng, Changyong; Nilsson, Bradley L.; Yang, Jerry; Dewhurst, Stephen			Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAGINAL MICROBICIDES; THIOFLAVIN-T; TYPE-1 TRANSMISSION; EPITHELIAL-CELLS; GENITAL HERPES; FIBRILS; NONOXYNOL-9; EXPRESSION; PREVENTION; MODEL	Semen was recently shown to contain amyloid fibrils formed from a self-assembling peptide fragment of the protein prostatic acid phosphatase. These amyloid fibrils, termed semen-derived enhancer of virus infection, or SEVI, have been shown to strongly enhance HIV infectivity and may play an important role in sexual transmission of HIV, making them a potential microbicide target. One novel approach to target these fibrils is the use of small molecules known to intercalate into the structure of amyloid fibrils, such as derivatives of thioflavin-T. Here, we show that the amyloid-binding small molecule BTA-EG(6) (the hexa(ethylene glycol) derivative of benzothiazole aniline) is able to bind SEVI fibrils and effectively inhibit both SEVI-mediated and semen-mediated enhancement of HIV infection. BTA-EG(6) also blocks the interactions of SEVI with HIV-1 virions and HIV-1 target cells but does not cause any inflammation or toxicity to cervical epithelial cells. These results suggest that an amyloid-binding small molecule may have utility as a microbicide, or microbicidal supplement, for HIV-1.	[Olsen, Joanna S.; Brown, Caitlin; Dewhurst, Stephen] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Feng, Changyong] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA; [Doran, Todd M.; Nilsson, Bradley L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Srivastava, Rajesh K.] Univ Rochester, Dept Obstet & Gynecol, Rochester, NY 14627 USA; [Capule, Christina C.; Rubinshtein, Mark; Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California San Diego	Dewhurst, S (corresponding author), Univ Rochester Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	Stephen_dewhurst@urmc.rochester.edu	Nilsson, Bradley/P-3718-2016	Nilsson, Bradley/0000-0003-1193-3693; Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health [R01AI084111, T32GM007356, T32DA007232, P30AI36214]; National Science Foundation [CHE-0847530]; DuPont; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R01AI084111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); DuPont; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI084111 (to S. D., B. L. N., C. B., and C. F.), T32GM007356 (to J. S. O.), T32DA007232 (to J. S. O.), and P30AI36214 (to C. C. C., M. R., and J. Y.) as well as by a National Science Foundation CAREER award CHE-0847530 (J. Y.) and a DuPont Young Professors Award (B. L. N.).	Alt C, 2009, CURR HIV RES, V7, P639, DOI 10.2174/157016209789973682; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Bourne N, 1999, J INFECT DIS, V180, P203, DOI 10.1086/314853; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Inbar P, 2008, ANAL CHEM, V80, P3502, DOI 10.1021/ac702592f; Inbar P, 2006, CHEMBIOCHEM, V7, P1563, DOI 10.1002/cbic.200600119; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kiessling Ann A, 2005, Methods Mol Biol, V304, P71; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Levine H, 2005, AMYLOID, V12, P5, DOI 10.1080/13506120500032295; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Roan NR, 2010, J BIOL CHEM, V285, P1861, DOI 10.1074/jbc.M109.066167; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1	33	48	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35488	35496		10.1074/jbc.M110.163659	http://dx.doi.org/10.1074/jbc.M110.163659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833717	Green Published, hybrid			2022-12-25	WOS:000283845300027
J	Jarvikivi, J; Vainio, M; Aalto, D				Jarvikivi, Juhani; Vainio, Martti; Aalto, Daniel			Real-Time Correlates of Phonological Quantity Reveal Unity of Tonal and Non-Tonal Languages	PLOS ONE			English	Article							SPEECH-PERCEPTION; GENES; FREQUENCY; MOVEMENT	Discrete phonological phenomena form our conscious experience of language: continuous changes in pitch appear as distinct tones to the speakers of tone languages, whereas the speakers of quantity languages experience duration categorically. The categorical nature of our linguistic experience is directly reflected in the traditionally clear-cut linguistic classification of languages into tonal or non-tonal. However, some evidence suggests that duration and pitch are fundamentally interconnected and co-vary in signaling word meaning in non-tonal languages as well. We show that pitch information affects real-time language processing in a (non-tonal) quantity language. The results suggest that there is no unidirectional causal link from a genetically-based perceptual sensitivity towards pitch information to the appearance of a tone language. They further suggest that the contrastive categories tone and quantity may be based on simultaneously co-varying properties of the speech signal and the processing system, even though the conscious experience of the speakers may highlight only one discrete variable at a time.	[Jarvikivi, Juhani] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Vainio, Martti] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Aalto, Daniel] Aalto Univ, Inst Math, Espoo, Finland	Max Planck Society; University of Helsinki; Aalto University	Jarvikivi, J (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	juhani.jarvikivi@helsinki.fi	Aalto, Daniel/AAF-7056-2019	Vainio, Martti/0000-0003-2570-0196; Aalto, Daniel/0000-0002-8611-6404	Academy of Finland [107606]	Academy of Finland(Academy of Finland)	The study was supported by Academy of Finland grant no. 107606 to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Boersma P, 2001, GLOT INT, V5, P341; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Catford J.C., 1977, FUNDAMENTAL PROBLEMS; Coleman J., 2002, PHONETICS PHONOLOGY, P96; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Duanmu S., 2000, PHONOLOGY STANDARD C; Dupoux E., 2002, PHONETICS PHONOLOGY, P168; DURAND J., 2002, PHONOLOGY PHONETICS, P10; Eimas P. D., 1987, CATEGORICAL PERCEPTI, P161; Gordon M., 2002, STUD LANG, V25, P423, DOI DOI 10.1075/SL.25.3.03G0R; Gussenhoven C., 2002, PHONOLOGY TONE INTON, P47; HARRIKARI H, 2000, PUBLICATIONS DEP GEN, V33; Hawkins S, 2003, J PHONETICS, V31, P373, DOI 10.1016/j.wocn.2003.09.006; Hawkins S, 2010, J PHONETICS, V38, P60, DOI 10.1016/j.wocn.2009.02.001; Hirst D. J., 1998, INTONATION SYSTEMS S, P1; JACKENDOFF R, 2007, LANGUAGE CONSCIOUSNE, P79; Jun S.-A, 2005, PROSODIC TYPOLOGY PH, P430, DOI DOI 10.1093/ACPROF:OSO/9780199249633.003.0016; Karlsson F., 1969, VIRITTAJA, V73, P351; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; LADEFOGED P, 2004, UCLA WORKING PAPERS, V103, P1; Leboe LC, 2008, PSYCHON B REV, V15, P1122, DOI 10.3758/PBR.15.6.1122; LEHISTE I, 1965, LANGUAGE, V41, P447, DOI 10.2307/411787; Lehiste I., 1970, SUPRASEGMENTALS; Lehiste Ilse, 2004, P TAL 2004, P111; Lehiste L., 1976, J PHONETICS, V4, P113, DOI DOI 10.1016/S0095-4470(19)31231-8; LEHNERTLEHOUILL.H, 2006, P ICPHS, V19, P757; Lehtonen Jaakko, 1970, ASPECTS QUANTITY STA; Lippus P, 2009, J PHONETICS, V37, P388, DOI 10.1016/j.wocn.2009.07.002; Maddieson I, 1999, HDB PHONETIC SCI, P619; Maddieson I., 2005, WORLD ATLAS LANGUAGE, P58; MALMBERG B, 1952, STUDIA LINGUISTICA, V6; MARSLENWILSON W, 1994, PSYCHOL REV, V101, P3, DOI 10.1037/0033-295X.101.1.3; Myers Scott, 2000, PHONOLOGICAL KNOWLED, P245; Nettle D, 2007, P NATL ACAD SCI USA, V104, P10755, DOI 10.1073/pnas.0704517104; Norris D, 2006, COGNITIVE PSYCHOL, V53, P146, DOI 10.1016/j.cogpsych.2006.03.001; ODELL M, 2003, ACTA U TAMPERENSIS, V979; PIERREHUMBERT J, 1990, J PHONETICS, V18, P375, DOI 10.1016/S0095-4470(19)30380-8; PISONI DB, 1976, J ACOUST SOC AM, V59, pS39, DOI 10.1121/1.2002669; Sohn H.-M., 2001, KOREAN LANGUAGE; Suomi K, 2005, J PHONETICS, V33, P291, DOI 10.1016/j.wocn.2005.01.002; VAINIO M, 2006, P 2 INT S TON ASP LA, P111; van Dommelen WA, 1999, J PHONETICS, V27, P107, DOI 10.1006/jpho.1999.0087; Werker JF, 2005, TRENDS COGN SCI, V9, P519, DOI 10.1016/j.tics.2005.09.003; Werker JF, 2002, INFANT BEHAV DEV, V25, P121, DOI 10.1016/S0163-6383(02)00093-0; Ylinen S, 2005, LANG SPEECH, V48, P313, DOI 10.1177/00238309050480030401; YU ACL, 2010, LAB PHONOLO IN PRESS, V10; Zhang J., 2001, THESIS U CALIFORNIA	50	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12603	10.1371/journal.pone.0012603	http://dx.doi.org/10.1371/journal.pone.0012603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	648IV	20838615	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687100006
J	Aaron, E; Kempf, MC; Criniti, S; Tedaldi, E; Gracely, E; Warriner, A; Kumar, R; Bachmann, LH				Aaron, Erika; Kempf, Mirjam-Colette; Criniti, Shannon; Tedaldi, Ellen; Gracely, Ed; Warriner, Amy; Kumar, Ritu; Bachmann, Laura H.			Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; HEPATOTOXICITY; THERAPY; TOXICITY; SAFETY; RISK; EFFICACY; GENDER; COUNT	Background: Predictors of adverse events (AE) associated with nevirapine use are needed to better understand reports of severe rash or liver enzyme elevation (LEE) in HIV+ women. Methodology: AE rates following ART initiation were retrospectively assessed in a multi-site cohort of 612 women. Predictors of onset of rash or LEE were determined using univariate and multivariate analyses. Principal Findings: Of 612 subjects, 152 (24.8%) initiated NVP-based regimens with 86 (56.6%) pregnant; 460 (75.2%) initiated non-NVP regimens with 67 (14.6%) pregnant. LEE: No significant difference was found between regimens in the development of new grade >= 2 LEE (p = 0.885). Multivariate logistic regression demonstrated an increased likelihood of LEE with HCV co-infection (OR 2.502, 95% CI: 1.04 to 6, p = 0.040); pregnancy, NVP-based regimen, and baseline CD4 >250 cells/mm(3) were not associated with this toxicity. Rash: NVP initiation was associated with rash after controlling for CD4 and pregnancy (OR 2.78; 95% CI: 1.14-6.76), as was baseline CD4 >250 cells/mm(3) when controlling for pregnancy and type of regimen (OR 2.68; 95% CI: 1.19-6.02 p = 0.017). Conclusions: CD4 at initiation of therapy was a predictor of rash but not LEE with NVP use in HIV+ women. Pregnancy was not an independent risk factor for the development of AEs assessed. The findings from this study have significant implications for women of child-bearing age initiating NVP-based ART particularly in resource limited settings. This study sheds more confidence on the lack of LEE risk and the need to monitor rash with the use of this medication.	[Aaron, Erika; Criniti, Shannon] Drexel Univ, Div Infect Dis & HIV Med, Dept Med, Coll Med, Philadelphia, PA 19104 USA; [Kempf, Mirjam-Colette] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Tedaldi, Ellen] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Gracely, Ed] Drexel Univ, Dept Family Community & Prevent Med, Coll Med, Philadelphia, PA 19104 USA; [Warriner, Amy] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kumar, Ritu] Mercer Univ, Dept Internal Med, Macon, GA 31207 USA; [Bachmann, Laura H.] WG Hefner Med Ctr, Salisbury, NC USA; [Bachmann, Laura H.] Wake Forest Univ Hlth Sci, Winston Salem, NC USA	Drexel University; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; University of Alabama System; University of Alabama Birmingham; Mercer University; Wake Forest University; Wake Forest University School of Medicine	Aaron, E (corresponding author), Drexel Univ, Div Infect Dis & HIV Med, Dept Med, Coll Med, Philadelphia, PA 19104 USA.	eaaron@drexelmed.edu	Gracely, Ed/B-7188-2014	Gracely, Ed/0000-0002-8344-3223	Boehringer Ingelheim Pharmaceuticals, Inc.	Boehringer Ingelheim Pharmaceuticals, Inc.(Boehringer Ingelheim)	This investigator-initiated research project was funded by Boehringer Ingelheim Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylor MS, 2004, JAIDS-J ACQ IMM DEF, V35, P538, DOI 10.1097/00126334-200404150-00014; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; Bonnet F, 2002, CLIN INFECT DIS, V35, P1231, DOI 10.1086/343046; De Lazzari E, 2008, HIV MED, V9, P221, DOI 10.1111/j.1468-1293.2008.00552.x; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Diethrich Edward B, 2004, Am Heart Hosp J, V2, P89, DOI 10.1111/j.1541-9215.2004.03364.x; Ekouevi DK, 2007, AIDS RES HUM RETROV, V23, P1469, DOI 10.1089/aid.2007.0059; Harris M, 2003, JAIDS-J ACQ IMM DEF, V34, pS53, DOI 10.1097/00126334-200309011-00008; Hitti J, 2004, JAIDS-J ACQ IMM DEF, V36, P772, DOI 10.1097/00126334-200407010-00002; Jamisse L, 2007, JAIDS-J ACQ IMM DEF, V44, P371, DOI 10.1097/QAI.0b013e318032bbee; Joao EC, 2006, AM J OBSTET GYNECOL, V194, P199, DOI 10.1016/j.ajog.2005.05.015; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Lyons F, 2006, HIV MED, V7, P255, DOI 10.1111/j.1468-1293.2006.00369.x; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Medrano J, 2008, AIDS REV, V10, P110; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; MURPHY RL, 1996, EXPERT OPIN INV DRUG, V5, P1183; *NIH D, 2004, TABL GRAD SEV AD PED; Nunez M, 2006, J HEPATOL, V44, pS132, DOI 10.1016/j.jhep.2005.11.027; Ouyang DW, 2010, AIDS, V24, P109, DOI 10.1097/QAD.0b013e3283323941; Ouyang DW, 2009, AIDS, V23, P2425, DOI 10.1097/QAD.0b013e32832e34b1; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Rivero A, 2007, J ANTIMICROB CHEMOTH, V59, P342, DOI 10.1093/jac/dkl524; Stern JO, 2003, JAIDS-J ACQ IMM DEF, V34, pS21, DOI 10.1097/00126334-200309011-00005; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Sundaram M, 2009, J INFECTION, V58, P255, DOI 10.1016/j.jinf.2009.01.003; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; Vogel M, 2009, J ANTIMICROB CHEMOTH, V63, P988, DOI 10.1093/jac/dkp044; *WHO, 2009, RAP ADV US ANT DRUGS	30	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12617	10.1371/journal.pone.0012617	http://dx.doi.org/10.1371/journal.pone.0012617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838641	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300037
J	Bitto, A; Lerner, C; Torres, C; Roell, M; Malaguti, M; Perez, V; Lorenzini, A; Hrelia, S; Ikeno, Y; Matzko, ME; McCarter, R; Sell, C				Bitto, Alessandro; Lerner, Chad; Torres, Claudio; Roell, Michaela; Malaguti, Marco; Perez, Viviana; Lorenzini, Antonello; Hrelia, Silvana; Ikeno, Yuji; Matzko, Michelle Elizabeth; McCarter, Roger; Sell, Christian			Long-Term IGF-I Exposure Decreases Autophagy and Cell Viability	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHAPERONE-MEDIATED AUTOPHAGY; LIFE-SPAN EXTENSION; AGE-RELATED DECLINE; C-ELEGANS; INSULIN; RECEPTOR; MICE; DIFFERENTIATION; HORMONE	A reduction in IGF-I signaling has been found to increase lifespan in multiple organisms despite the fact that IGF-I is a trophic factor for many cell types and has been found to have protective effects against multiple forms of damage in acute settings. The increase in longevity seen in response to reduced IGF-I signaling suggests that there may be differences between the acute and chronic impact of IGF-I signaling. We have examined the possibility that long-term stimulation with IGF-I may have a negative impact at the cellular level using quiescent human fibroblasts. We find that fibroblast cells exposed to IGF-I for 14 days have reduced long-term viability as judged by colony forming assays, which is accompanied by an accumulation of senescent cells. In addition we observe an accumulation of cells with depolarized mitochondria and a reduction in autophagy in the long-term IGF-I treated cultures. An examination of mice with reduced IGF-I levels reveals evidence of enhanced autophagy and fibroblast cells derived from these mice have a larger mitochondrial mass relative to controls indicating that changes in mitochondrial turnover occurs in animals with reduced IGF-I. The results indicate that chronic IGF-I stimulation leads to mitochondrial dysfunction and reduced cell viability.	[Bitto, Alessandro; Lerner, Chad; Torres, Claudio; Lorenzini, Antonello; Sell, Christian] Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA; [Roell, Michaela; Malaguti, Marco; Lorenzini, Antonello] G Moruzzi Univ Bologna, Dept Biochem, Bologna, Italy; [Perez, Viviana; Hrelia, Silvana] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Ikeno, Yuji; McCarter, Roger] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, Res Serv, Audie Murphy VA Hosp STVHCS, San Antonio, TX 78229 USA; [Ikeno, Yuji; McCarter, Roger] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Res Serv, Audie Murphy VA Hosp STVHCS, San Antonio, TX 78229 USA; [Matzko, Michelle Elizabeth] Penn State Univ, Dept Biobehav Hlth, State Coll, PA USA	Drexel University; University of Bologna; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Bitto, A (corresponding author), Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA.	christian.sell@drexelmed.edu	Hrelia, Silvana/P-2864-2015; Malaguti, Marco/K-5994-2015; Lorenzini, Antonello/G-4463-2012; LORENZINI, ANTONELLO/E-6582-2016	Hrelia, Silvana/0000-0001-7857-4512; Malaguti, Marco/0000-0003-0349-7772; LORENZINI, ANTONELLO/0000-0001-9615-9697	National Institutes of Health, Institute on Aging [AG022443]; NATIONAL INSTITUTE ON AGING [R01AG022443] Funding Source: NIH RePORTER	National Institutes of Health, Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant AG022443 from the National Institutes of Health, Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Cristofalo VJ, 1980, J TISSUE CULTURE MET, V6, P117; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Dell'Orco R T, 1975, Adv Exp Med Biol, V53, P41; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Galvin CD, 2003, MOL CELL ENDOCRINOL, V200, P19, DOI 10.1016/S0303-7207(02)00420-3; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Gu YP, 2004, FEBS LETT, V577, P357, DOI 10.1016/j.febslet.2004.10.040; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HASHIMOTO Y, 2009, GENES CELLS; Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lembo G, 1996, J CLIN INVEST, V98, P2648, DOI 10.1172/JCI119086; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; McKeehan W L, 1976, Dev Biol Stand, V37, P97; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MIZUSHIMA N, CURR OPIN CELL BIOL, V22, P132; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SELL C, 1995, CANCER RES, V55, P303; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; TORRESALEMAN I, 1989, INT J DEV NEUROSCI, V7, P195, DOI 10.1016/0736-5748(89)90069-5; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; Valentinis B, 1998, J CELL PHYSIOL, V176, P648, DOI 10.1002/(SICI)1097-4652(199809)176:3<648::AID-JCP22>3.3.CO;2-6; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	46	44	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12592	10.1371/journal.pone.0012592	http://dx.doi.org/10.1371/journal.pone.0012592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830296	gold, Green Published, Green Submitted			2022-12-25	WOS:000281631300020
J	Loh, DH; Navarro, J; Hagopian, A; Wang, LM; Deboer, T; Colwell, CS				Loh, Dawn H.; Navarro, Juliana; Hagopian, Arkady; Wang, Louisa M.; Deboer, Tom; Colwell, Christopher S.			Rapid Changes in the Light/Dark Cycle Disrupt Memory of Conditioned Fear in Mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; LONG-TERM POTENTIATION; CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; PASSIVE-AVOIDANCE; CIRCADIAN-CLOCK; JET-LAG; CORTICOSTERONE RHYTHM; PERIODIC INTERVALS; RETENTION DEFICITS	Background: Circadian rhythms govern many aspects of physiology and behavior including cognitive processes. Components of neural circuits involved in learning and memory, e. g., the amygdala and the hippocampus, exhibit circadian rhythms in gene expression and signaling pathways. The functional significance of these rhythms is still not understood. In the present study, we sought to determine the impact of transiently disrupting the circadian system by shifting the light/dark (LD) cycle. Such "jet lag" treatments alter daily rhythms of gene expression that underlie circadian oscillations as well as disrupt the synchrony between the multiple oscillators found within the body. Methodology/Principal Findings: We subjected adult male C57Bl/6 mice to a contextual fear conditioning protocol either before or after acute phase shifts of the LD cycle. As part of this study, we examined the impact of phase advances and phase delays, and the effects of different magnitudes of phase shifts. Under all conditions tested, we found that recall of fear conditioned behavior was specifically affected by the jet lag. We found that phase shifts potentiated the stress-evoked corticosterone response without altering baseline levels of this hormone. The jet lag treatment did not result in overall sleep deprivation, but altered the temporal distribution of sleep. Finally, we found that prior experience of jet lag helps to compensate for the reduced recall due to acute phase shifts. Conclusions/Significance: Acute changes to the LD cycle affect the recall of fear-conditioned behavior. This suggests that a synchronized circadian system may be broadly important for normal cognition and that the consolidation of memories may be particularly sensitive to disruptions of circadian timing.	[Loh, Dawn H.; Navarro, Juliana; Hagopian, Arkady; Wang, Louisa M.; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Deboer, Tom] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	University of California System; University of California Los Angeles; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Loh, DH (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA.	ccolwell@mednet.ucla.edu	Colwell, Chris/AAM-6111-2020	Loh, Dawn/0000-0001-7876-5757; Colwell, Christopher/0000-0002-1059-184X	National Institutes of Health [HL84240]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Part of this work was supported by a National Institutes of Health grant to CSC [HL84240]. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Abrari K, 2008, NEUROBIOL LEARN MEM, V89, P178, DOI 10.1016/j.nlm.2007.07.005; Abrari K, 2009, NEUROBIOL LEARN MEM, V91, P260, DOI 10.1016/j.nlm.2008.10.008; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chaudhury D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-63; Cho K, 2000, J NEUROSCI, V20, part. no.; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Craig LA, 2008, BRAIN RES BULL, V76, P141, DOI 10.1016/j.brainresbull.2008.02.013; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Deboer T, 1996, J COMP PHYSIOL A, V179, P483; Deboer T, 2007, EUR J NEUROSCI, V26, P3518, DOI 10.1111/j.1460-9568.2007.05964.x; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Neto SPD, 2008, PHYSIOL BEHAV, V94, P523, DOI 10.1016/j.physbeh.2008.03.013; Eastman CI, 2009, SLEEP MED CLIN, V4, P241, DOI 10.1016/j.jsmc.2009.02.006; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Evans JA, 2009, CURR BIOL, V19, pR156, DOI 10.1016/j.cub.2009.01.023; FEKETE M, 1985, PHYSIOL BEHAV, V34, P883, DOI 10.1016/0031-9384(85)90008-3; Fernandez RI, 2003, P NATL ACAD SCI USA, V100, P14415, DOI 10.1073/pnas.2336172100; FRANKEN P, 1995, AM J PHYSIOL-REG I, V269, pR691, DOI 10.1152/ajpregu.1995.269.3.R691; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; HARRIS KM, 1983, BRAIN RES, V261, P69, DOI 10.1016/0006-8993(83)91284-2; HOLLOWAY FA, 1973, BEHAV BIOL, V9, P1, DOI 10.1016/S0091-6773(73)80164-6; HOLLOWAY FA, 1973, SCIENCE, V180, P208, DOI 10.1126/science.180.4082.208; Hui GK, 2004, NEUROBIOL LEARN MEM, V81, P67, DOI 10.1016/j.nlm.2003.09.002; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Lyons LC, 2006, J NEUROSCI, V26, P8662, DOI 10.1523/JNEUROSCI.2307-06.2006; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mueller AD, 2008, AM J PHYSIOL-REG I, V294, pR1693, DOI 10.1152/ajpregu.00858.2007; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; PITTENDRIGH C, 1958, P NATL ACAD SCI USA, V44, P965, DOI 10.1073/pnas.44.9.965; Raghavan AV, 1999, BRAIN RES, V833, P311, DOI 10.1016/S0006-8993(99)01523-1; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sage D, 2001, AM J PHYSIOL-ENDOC M, V280, pE260, DOI 10.1152/ajpendo.2001.280.2.E260; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Schwartz MD, 2005, J BIOL RHYTHM, V20, P526, DOI 10.1177/0748730405280924; SEI H, 1992, NEUROSCI LETT, V137, P161, DOI 10.1016/0304-3940(92)90394-M; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; Valentinuzzi VS, 2001, ANIM LEARN BEHAV, V29, P133, DOI 10.3758/BF03192822; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	78	73	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12546	10.1371/journal.pone.0012546	http://dx.doi.org/10.1371/journal.pone.0012546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645RB	20824058	Green Published, gold, Green Submitted			2022-12-25	WOS:000281480900027
J	Bianchi-Frias, D; Vakar-Lopez, F; Coleman, IM; Plymate, SR; Reed, MJ; Nelson, PS				Bianchi-Frias, Daniella; Vakar-Lopez, Funda; Coleman, Ilsa M.; Plymate, Stephen R.; Reed, May J.; Nelson, Peter S.			The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; GENE-EXPRESSION; VENTRAL PROSTATE; EXTRACELLULAR-MATRIX; CANCER INCIDENCE; MOUSE PROSTATE; INDUCED GROWTH; CROSS-LINKING; COLLAGEN; FIBROBLASTS	Background: Advancing age is associated with substantial increases in the incidence rates of common diseases affecting the prostate gland including benign prostatic hyperplasia (BPH) and prostate carcinoma. The prostate is comprised of a functional secretory epithelium, a basal epithelium, and a supporting stroma comprised of structural elements, and a spectrum of cell types that includes smooth muscle cells, fibroblasts, and inflammatory cells. As reciprocal interactions between epithelium and stromal constituents are essential for normal organogenesis and serve to maintain normal functions, discordance within the stroma could permit or promote disease processes. In this study we sought to identify aging-associated alterations in the mouse prostate microenvironment that could influence pathology. Methodology/Principal Findings: We quantitated transcript levels in microdissected glandular-adjacent stroma from young (age 4 months) and old (age 20-24 months) C57BL/6 mice, and identified a significant change in the expression of 1259 genes (p<0.05). These included increases in transcripts encoding proteins associated with inflammation (e. g., Ccl8, Ccl12), genotoxic/oxidative stress (e. g., Apod, Serpinb5) and other paracrine-acting effects (e. g., Cyr61). The expression of several collagen genes (e. g., Col1a1 and Col3a1) exhibited age-associated declines. By histology, immunofluorescence, and electron microscopy we determined that the collagen matrix is abundant and disorganized, smooth muscle cell orientation is disordered, and inflammatory infiltrates are significantly increased, and are comprised of macrophages, T cells and, to a lesser extent, B cells. Conclusion/Significance: These findings demonstrate that during normal aging the prostate stroma exhibits phenotypic and molecular characteristics plausibly contributing to the striking age associated pathologies affecting the prostate.	[Bianchi-Frias, Daniella; Coleman, Ilsa M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Bianchi-Frias, Daniella; Coleman, Ilsa M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Vakar-Lopez, Funda; Nelson, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Plymate, Stephen R.; Reed, May J.; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bianchi-Frias, D (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	pnelson@fhcrc.org			Department of Defense - Congressionally Directed Medical Research Programs [NCI P50 CA103728, R01 DK069690]; Tumor Microenvironment Network [U54 CA126540]; NATIONAL CANCER INSTITUTE [U54CA126540, P20CA103728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069690] Funding Source: NIH RePORTER	Department of Defense - Congressionally Directed Medical Research Programs(United States Department of Defense); Tumor Microenvironment Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a predoctoral fellowship from the Department of Defense - Congressionally Directed Medical Research Programs, a Seattle Cancer and Aging Program pilot award NCI P50 CA103728, R01 DK069690, and the Tumor Microenvironment Network U54 CA126540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Abbott DE, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r79; Antonioli E, 2004, J ANDROL, V25, P50; Antonioli E, 2007, J ANDROL, V28, P777, DOI 10.2164/jandrol.107.002873; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Baylin SB, 1998, ADV CANCER RES, V72, P141; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Berquin IM, 2005, J BIOL CHEM, V280, P36442, DOI 10.1074/jbc.M504945200; BERRY SJ, 1986, PROSTATE, V9, P363, DOI 10.1002/pros.2990090406; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bianchi-Frias D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r117; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; BORNSTEI.P, 1970, AM J MED, V49, P429, DOI 10.1016/S0002-9343(70)80036-5; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; Campos SGP, 2008, INT J EXP PATHOL, V89, P13, DOI 10.1111/j.1365-2613.2007.00550.x; Cloos PAC, 2000, BIOCHEM J, V345, P473, DOI 10.1042/0264-6021:3450473; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davidovic M, 1999, MED HYPOTHESES, V53, P329, DOI 10.1054/mehy.1998.0767; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Ilio KY, 2000, PROSTATE, V43, P3, DOI 10.1002/(SICI)1097-0045(20000401)43:1<3::AID-PROS2>3.0.CO;2-J; Izumiya K, 1997, ARCH ANDROLOGY, V38, P231, DOI 10.3109/01485019708994882; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Kiefer JA, 2001, MATRIX BIOL, V20, P429, DOI 10.1016/S0945-053X(01)00159-7; Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lau KM, 2003, LAB INVEST, V83, P743, DOI 10.1097/01.LAB.0000069519.06988.24; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Morrison C, 2000, UROL RES, V28, P304, DOI 10.1007/s002400000123; MUNTZING J, 1980, Prostate, V1, P71, DOI 10.1002/pros.2990010110; Nelson WB, 2004, J UROLOGY, V172, P6; Nickoloff BJ, 2004, CANCER RES, V64, P2956, DOI 10.1158/0008-5472.CAN-03-2388; ODONNELL MD, 1991, J ELECTRON MICR TECH, V19, P486, DOI 10.1002/jemt.1060190411; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; POLLARD M, 1987, PROSTATE, V11, P219, DOI 10.1002/pros.2990110303; POLLARD M, 1992, CANCER LETT, V67, P113, DOI 10.1016/0304-3835(92)90133-G; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Reyes I, 2005, PROSTATE, V63, P169, DOI 10.1002/pros.20164; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Ruangpanit N, 2001, MATRIX BIOL, V20, P193, DOI 10.1016/S0945-053X(01)00135-4; Rullis I, 1975, Urology, V6, P295, DOI 10.1016/0090-4295(75)90749-9; SAKR WA, 1994, IN VIVO, V8, P439; Salm SN, 2002, PROSTATE, V51, P175, DOI 10.1002/pros.10075; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; SHAIN SA, 1978, J CLIN INVEST, V61, P654, DOI 10.1172/JCI108977; SHAIN SA, 1977, ONCOLOGY, V34, P114, DOI 10.1159/000225203; SHAPIRO E, 1992, PROSTATE, V20, P259, DOI 10.1002/pros.2990200402; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 1996, ARCH ANDROLOGY, V36, P205, DOI 10.3109/01485019608987097; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Vercelli M, 2000, CRIT REV ONCOL HEMAT, V35, P133, DOI 10.1016/S1040-8428(99)00067-0; Vilamaior PSL, 2000, PROSTATE, V45, P253; WARD JM, 1980, LAB INVEST, V43, P517; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607	74	82	85	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12501	10.1371/journal.pone.0012501	http://dx.doi.org/10.1371/journal.pone.0012501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824135	Green Submitted, Green Published, gold			2022-12-25	WOS:000281456100013
J	Piechota, M; Korostynski, M; Przewlocki, R				Piechota, Marcin; Korostynski, Michal; Przewlocki, Ryszard			Identification of cis-Regulatory Elements in the Mammalian Genome: The cREMaG Database	PLOS ONE			English	Article							FACTOR-BINDING SITES; OVER-REPRESENTATION; PROMOTER PROPERTIES; SEQUENCE-ANALYSIS; 2008 UPDATE; TRANSCRIPTION; GENES; EXPRESSION; MOUSE; CONSERVATION	Background: A growing number of gene expression-profiling datasets provides a reliable source of information about gene co-expression. In silico analyses of the properties shared among the promoters of co-expressed genes facilitates the identification of transcription factors (TFs) involved in the co-regulation of those genes. Our previous experience with microarray data led to the development of a database suitable for the examination of regulatory motifs in the promoters of co-expressed genes. Methodology: We introduce the cREMaG (cis-Regulatory Elements in the Mammalian Genome) system designed for in silico studies of the promoter properties of co-regulated mammalian genes. The cREMaG system offers an analysis of data obtained from human, mouse, rat, bovine and canine gene expression-profiling studies. More than eight analysis parameters can be utilized in user-defined combinations. The selection of alternative transcription start sites and information about CpG islands are also available. Conclusions: Using the cREMaG system, we successfully identified TFs mediating transcriptional responses in reference gene sets. The cREMaG system facilitates in silico studies of mammalian transcriptional gene regulation. The resource is freely available at http://www.cremag.org.	[Piechota, Marcin; Korostynski, Michal; Przewlocki, Ryszard] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland	Polish Academy of Sciences	Piechota, M (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland.	marpiech@if-pan.krakow.pl	Piechota, Marcin/G-9464-2011; Korostynski, Michal/AAS-2626-2021	Korostynski, Michal/0000-0002-4273-7401; Piechota, Marcin/0000-0003-2468-151X	European Union [LSHM-CT-2004-005166, PBZ-MNiI-2/1/2005, NN405 274137]	European Union(European Commission)	This work was supported by European Union grants LSHM-CT-2004-005166, PBZ-MNiI-2/1/2005 and NN405 274137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Berezikov E, 2005, NUCLEIC ACIDS RES, V33, pW447, DOI 10.1093/nar/gki378; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang LW, 2007, NUCLEIC ACIDS RES, V35, pW238, DOI 10.1093/nar/gkm308; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Chiba H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-152; de Bartolomeis Andrea, 2003, Psychopharmacol Bull, V37, P51; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Hackenberg M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-7; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Jura J, 2008, BBA-GENE REGUL MECH, V1779, P383, DOI 10.1016/j.bbagrm.2008.04.006; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Korostynski M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-146; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lemberger T, 2008, FASEB J, V22, P2872, DOI 10.1096/fj.08-107888; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Parkitna JR, 2010, FASEB J, V24, P2427, DOI 10.1096/fj.09-151423; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sauer T, 2006, BIOINFORMATICS, V22, P430, DOI 10.1093/bioinformatics/bti819; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Sharov AA, 2006, DNA RES, V13, P123, DOI 10.1093/dnares/dsl005; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xuan ZY, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r72; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang GC, 2007, MOL PHARMACOL, V71, P1148, DOI 10.1124/mol.106.028399	44	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12465	10.1371/journal.pone.0012465	http://dx.doi.org/10.1371/journal.pone.0012465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824209	Green Published, gold, Green Submitted			2022-12-25	WOS:000281405300010
J	Yan, SJ; Lim, SJ; Shi, S; Dutta, P; Li, WX				Yan, Shian-Jang; Lim, Su Jun; Shi, Song; Dutta, Pranabananda; Li, Willis X.			Unphosphorylated STAT and heterochromatin protect genome stability	FASEB JOURNAL			English	Article						Drosophila; DNA damage; JAK; HP1; Su(var)205	DROSOPHILA; MECHANISMS; PATHWAY	Heterochromatin is a form of highly compacted chromatin associated with epigenetic gene silencing and chromosome organization. We have previously shown that unphosphorylated nuclear signal transducer and activator of transcription (STAT) physically interacts with heterochromatin protein 1 (HP1) to promote heterochromatin stability. To understand whether STAT and heterochromatin are important for maintenance of genome stability, we genetically manipulated the levels of unphosphorylated STAT and HP1 [encoded by Su(var)205] in Drosophila and examined the effects on chromosomal morphology and resistance to DNA damage under conditions of genotoxic stress. Here we show that, compared with wild-type controls, Drosophila mutants with reduced levels of unphosphorylated STAT or heterochromatin are more sensitive to radiation-induced cell cycle arrest, have higher levels of spontaneous and radiation-induced DNA damage, and exhibit defects in chromosomal compaction and segregation during mitosis. Conversely, animals with increased levels of heterochromatin exhibit less DNA damage and increased survival rate after irradiation. These results suggest that maintaining genome stability by heterochromatin formation and correct chromosomal packaging is essential for normal cellular functions and for survival of animals under genotoxic stress.-Yan, S.-J., Lim, S. J., Shi, S., Dutta, P., Li, W. X. Unphosphorylated STAT and heterochromatin protect genome stability. FASEB J. 25, 232-241 (2011). www.fasebj.org	[Yan, Shian-Jang; Lim, Su Jun; Shi, Song; Dutta, Pranabananda; Li, Willis X.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Li, WX (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave,KMRB 2-9654, Rochester, NY 14642 USA.	willis_li@urmc.rochester.edu	Li, Willis/ABC-5695-2020; Li, Willis X/AAL-7212-2020	Li, Willis/0000-0001-9041-7341; Li, Willis X/0000-0001-9041-7341	U.S. National Institutes of Health (NIH) [T32CA009363]; American Cancer Society; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA131326, T32CA009363] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to Dr. Robert Glaser (Wadsworth Center, New York, NY, USA) for the gift of, and advice on, the phospho-Ser-137 H2Av (gamma-H2AX) antibodies; the Goldberg lab (Cornell University, Ithaca, NY, USA) for help and advice on larval brain squash preparations, and E. Rustchenko for help with pulsed field gel electrophoresis. The authors thank D. Guo, K. Larson, A. Tsurumi, and J. Liu for technical assistance and Lori Wallrath (University of Iowa, Iowa City, IA, USA), Gunter Reuter (Martin Luther University Halle, Halle, Germany), James Birchler (University of Missouri, Columbia, MO, USA), the Developmental Hybridoma Bank (Iowa City, IA, USA), and the Bloomington Drosophila Stock Center (Bloomington, IN, USA) for various Drosophila strains and reagents. The authors thank the Edith Lord laboratory (University of Rochester, Rochester, NY, USA) for a Cs-137 irradiator. S.J.Y. was supported in part by a postdoctoral training grant (T32CA009363) from the U.S. National Institutes of Health (NIH). This study was supported, in part, by grants from the NIH, an American Cancer Society Research Scholar grant, and a Leukemia and Lymphoma Society Research Scholar grant to W. X. L. The authors declare no competing interests.	Ahmad K, 1999, GENETICS, V151, P1041; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bi XL, 2005, GENETICS, V171, P845, DOI 10.1534/genetics.105.047720; Brodsky MH, 2000, GENE DEV, V14, P666; Brown S, 2008, CURR OPIN GENET DEV, V18, P455, DOI 10.1016/j.gde.2008.09.002; EISSENBERG JC, 1992, GENETICS, V131, P345; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Johnson-Schlitz DM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030050; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; KELLUM R, 1995, J CELL SCI, V108, P1419; Laurencon A, 2003, GENETICS, V164, P589; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; McNamee LM, 2009, GENETICS, V182, P423, DOI 10.1534/genetics.109.102327; Mogila V, 2006, DEV CELL, V11, P575, DOI 10.1016/j.devcel.2006.08.010; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Yan S. J., 2011, METHODS MOL IN PRESS	30	42	43	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					232	241		10.1096/fj.10-169367	http://dx.doi.org/10.1096/fj.10-169367			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20847228	Green Published, Bronze			2022-12-25	WOS:000285869500021
J	Reuter, M; Caswell, CC; Lukomski, S; Zipfel, PF				Reuter, Michael; Caswell, Clayton C.; Lukomski, Slawomir; Zipfel, Peter F.			Binding of the Human Complement Regulators CFHR1 and Factor H by Streptococcal Collagen-like Protein 1 (Scl1) via Their Conserved C Termini Allows Control of the Complement Cascade at Multiple Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; SHORT CONSENSUS REPEAT; SURFACE PROTEIN; BORRELIA-BURGDORFERI; C4B-BINDING PROTEIN; CANDIDA-ALBICANS; IMMUNOGLOBULIN-A; FAMILY PROTEINS; IMMUNE EVASION; HUMAN-DISEASES	Group A streptococci (GAS) utilize soluble human complement regulators to evade host complement attack. Here, we characterized the binding of the terminal complement complex inhibitor complement Factor H-related protein 1 (CFHR1) and of the C3 convertase regulator Factor H to the streptococcal collagen-like proteins (Scl). CFHR1 and Factor H, but no other member of the Factor H protein family (CFHR2, CFHR3, or CFHR4A), bound to the two streptococcal proteins Scl1.6 and Scl1.55, which are expressed by GAS serotypes M6 and M55. The two human regulators bound to the Scl1 proteins via their conserved C-terminal attachment region, i.e. CFHR1 short consensus repeats 3-5 (SCR3-5) and Factor H SCR18-20. Binding was affected by ionic strength and by heparin. CFHR1 and the C-terminal attachment region of Factor H did not bind to Scl1.1 and Scl2.28 proteins but did bind to intact M1-type and M28-type GAS, which express Scl1.1 and Scl2.28, respectively, thus arguing for the presence of an additional binding mechanism to CFHR1 and Factor H. Furthermore mutations within the C-terminal heparin-binding region and Factor H mutations that are associated with the acute renal disease atypical hemolytic uremic syndrome blocked the interaction with the two streptococcal proteins. Binding of CFHR1 affected the complement regulatory functions of Factor H on the level of the C3 convertase. Apparently, streptococci utilize two types of complement regulator-acquiring surface proteins; type A proteins, as represented by Scl1.6 and Scl1.55, bind to CFHR1 and Factor H via their conserved C-terminal region and do not bind the Factor H-like protein 1 (FHL-1). On the contrary, type B proteins, represented by M-, M-like, and the fibronectin-binding protein Fba proteins, bind Factor H and FHL-1 via domain SCR7 and do not bind CFHR1. In conclusion, binding of CFHR1 is at the expense of Factor H-mediated regulatory function at the level of C3 convertase and at the gain of a regulator that controls complement at the level of the C5 convertase and formation of the terminal complement complex.	[Reuter, Michael; Zipfel, Peter F.] Hans Knoell Inst, Dept Infect Biol, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Caswell, Clayton C.; Lukomski, Slawomir] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Lukomski, Slawomir] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Hans Knoll Institute (HKI); West Virginia University; West Virginia University; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Dept Infect Biol, Leibniz Inst Nat Prod Res & Infect Biol, Beutenbergstr 11A, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de			National Institutes of Health [AI083683]; "Grundlagenfond" of the Leibniz Institute for Natural Product Research and Infection Biology; Office of Research and Graduate Education, West Virginia University Health Sciences Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Grundlagenfond" of the Leibniz Institute for Natural Product Research and Infection Biology; Office of Research and Graduate Education, West Virginia University Health Sciences Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083683 (to S. L.). This work was also supported by a grant from the "Grundlagenfond" of the Leibniz Institute for Natural Product Research and Infection Biology (to P. F. Z.) and an internal grant from the Office of Research and Graduate Education, West Virginia University Health Sciences Center (to S. L.).	AKERSTROM B, 1994, MOL IMMUNOL, V31, P393, DOI 10.1016/0161-5890(94)90117-1; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Dobrina A, 2002, BLOOD, V99, P185, DOI 10.1182/blood.V99.1.185; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 1997, BIOCHEM J, V326, P321, DOI 10.1042/bj3260321; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; HUSMANN LK, 1995, INFECT IMMUN, V63, P345, DOI 10.1128/IAI.63.1.345-348.1995; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Johnsson E, 1996, J IMMUNOL, V157, P3021; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2007, MOL IMMUNOL, V44, P2697, DOI 10.1016/j.molimm.2006.12.001; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kihlberg BM, 1999, INFECT IMMUN, V67, P1708; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; KUHN S, 1995, J IMMUNOL, V155, P5663; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pichichero M E, 1998, Pediatr Rev, V19, P291; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; SKERKA C, 1991, J BIOL CHEM, V266, P12015; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; STENBERG L, 1994, J BIOL CHEM, V269, P13458; Taylor P, 1998, CURR BIOL, V8, pR259, DOI 10.1016/S0960-9822(98)70167-8; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; THERN A, 1995, J IMMUNOL, V154, P375; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2009, INT J PEPT RES THER, V15, P87, DOI 10.1007/s10989-009-9180-5; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3	55	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38473	38485		10.1074/jbc.M110.143727	http://dx.doi.org/10.1074/jbc.M110.143727			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855886	Green Published, hybrid			2022-12-25	WOS:000284625600053
J	Arsenieva, D; Symersky, J; Wang, YM; Pagadala, V; Mueller, DM				Arsenieva, Diana; Symersky, Jindrich; Wang, Yamin; Pagadala, Vijayakanth; Mueller, David M.			Crystal Structures of Mutant Forms of the Yeast F-1 ATPase Reveal Two Modes of Uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL GENOME INTEGRITY; GAMMA-SUBUNIT; BETA-SUBUNIT; KLUYVEROMYCES-LACTIS; MOLECULAR REPLACEMENT; PERIPHERAL STALK; DELSEED MOTIF; MUTATIONS; SYNTHASE; F-1-ATPASE	The mitochondrial ATP synthase couples the flow of protons with the phosphorylation of ADP. A class of mutations, the mitochondrial genome integrity (mgi) mutations, has been shown to uncouple this process in the yeast mitochondrial ATP synthase. Four mutant forms of the yeast F-1 ATPase with mgi mutations were crystallized; the structures were solved and analyzed. The analysis identifies two mechanisms of structural uncoupling: one in which the empty catalytic site is altered and in doing so, apparently disrupts substrate (phosphate) binding, and a second where the steric hindrance predicted between gamma Leu83 and beta(DP) residues, Leu-391 and Glu-395, located in Catch 2 region, is reduced allowing rotation of the gamma-subunit with less impedance. Overall, the structures provide key insights into the critical interactions in the yeast ATP synthase involved in the coupling process.	[Arsenieva, Diana; Symersky, Jindrich; Wang, Yamin; Pagadala, Vijayakanth; Mueller, David M.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Mueller, DM (corresponding author), 3333 Green Bay Rd, N Chicago, IL 60064 USA.	david.mueller@rosalindfranklin.edu	Pagadala, Vijayakanth/ABI-8446-2020	Pagadala, Vijayakanth/0000-0001-7349-4230	National Institutes of Health [National Institutes of Health R01GM66223]; U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant National Institutes of Health R01GM66223 (to D. M. M.).; We thank the continued support and discussion of Drs. Andrew Leslie and John Walker, MRC, Cambridge, UK. Data were collected at GM/CA Collaborative Access Team (GM/CA-CAT) 23-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boltz KW, 2005, BIOCHEMISTRY-US, V44, P9497, DOI 10.1021/bi050070o; Carbajo RJ, 2004, J MOL BIOL, V342, P593, DOI 10.1016/j.jmb.2004.07.013; Chen XJ, 1999, MOL GEN GENET, V262, P898, DOI 10.1007/s004380051156; CHEN XJ, 1995, EMBO J, V14, P3277, DOI 10.1002/j.1460-2075.1995.tb07331.x; Chen XJ, 1998, MOL GEN GENET, V259, P457, DOI 10.1007/s004380050836; Chen XJ, 1996, GENETICS, V144, P1445; CHEN XJ, 1993, GENETICS, V133, P517; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Ketchum CJ, 1998, BIOCHEM J, V330, P707; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mao HZ, 2008, J BIOL CHEM, V283, P24781, DOI 10.1074/jbc.M804142200; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Mueller DM, 2004, ACTA CRYSTALLOGR D, V60, P1441, DOI 10.1107/S0907444904012661; Mueller DM, 2000, J BIOENERG BIOMEMBR, V32, P391, DOI 10.1023/A:1005532104617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200; WEBER ER, 1995, GENETICS, V140, P435; Xiao Y, 2000, J BIOL CHEM, V275, P6963, DOI 10.1074/jbc.275.10.6963; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104	41	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36561	36569		10.1074/jbc.M110.174383	http://dx.doi.org/10.1074/jbc.M110.174383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843806	hybrid, Green Published			2022-12-25	WOS:000284146100004
J	Schmitz, S; Schaap, IAT; Kleinjung, J; Harder, S; Grainger, M; Calder, L; Rosenthal, PB; Holder, AA; Veigel, C				Schmitz, Stephan; Schaap, Iwan A. T.; Kleinjung, Jens; Harder, Simone; Grainger, Munira; Calder, Lesley; Rosenthal, Peter B.; Holder, Anthony A.; Veigel, Claudia			Malaria Parasite Actin Polymerization and Filament Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM ACTIN; RAY FIBER DIFFRACTION; F-ACTIN; TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; ADP-ACTIN; FLUORESCENCE MICROSCOPY; MICROFILAMENT DYNAMICS; GLIDING MOTILITY; BINDING PROTEINS	A novel form of acto-myosin regulation has been proposed in which polymerization of new actin filaments regulates motility of parasites of the apicomplexan class of protozoa. In vivo and in vitro parasite F-actin is very short and unstable, but the structural basis and details of filament dynamics remain unknown. Here, we show that long actin filaments can be obtained by polymerizing unlabeled rabbit skeletal actin (RS-actin) onto both ends of the short rhodamine-phalloidin-stabilized Plasmodium falciparum actin I (Pf-actin) filaments. Following annealing, hybrid filaments of micron length and "zebra-striped" appearance are observed by fluorescence microscopy that are stable enough to move over myosin class II motors in a gliding filament assay. Using negative stain electron microscopy we find that pure Pf-actin stabilized by jasplakinolide (JAS) also forms long filaments, indistinguishable in length from RS-actin filaments, and long enough to be characterized structurally. To compare structures in near physiological conditions in aqueous solution we imaged Pf-actin and RS-actin filaments by atomic force microscopy (AFM). We found the monomer stacking to be distinctly different for Pf-actin compared with RS-actin, such that the pitch of the double helix of Pf-actin filaments was 10% larger. Our results can be explained by a rotational angle between subunits that is larger in the parasite compared with RS-actin. Modeling of the AFM data using high-resolution actin filament models supports our interpretation of the data. The structural differences reported here may be a consequence of weaker inter-and intra-strand contacts, and may be critical for differences in filament dynamics and for regulation of parasite motility.	[Harder, Simone; Grainger, Munira; Holder, Anthony A.] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Schmitz, Stephan; Schaap, Iwan A. T.; Harder, Simone; Calder, Lesley; Rosenthal, Peter B.; Veigel, Claudia] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; [Kleinjung, Jens] Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Holder, AA (corresponding author), Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	aholder@nimr.mrc.ac.uk; claudia.veigel@med.uni-muenchen.de	Schaap, Iwan A. T./L-3177-2013; Holder, Anthony A/A-7554-2013	Schaap, Iwan A. T./0000-0001-6665-5104; Holder, Anthony A/0000-0002-8490-6058; Kleinjung, Jens/0000-0002-7875-5724	UK Medical Research Council [U117532067, U117570593, U117581331, U117581334]; NWO; EU; German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD); Karl-Enigk-Stiftung; MRC [MC_U117581334, MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117581334, MC_U117532067] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NWO(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Karl-Enigk-Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (Reference numbers: U117532067, U117570593, U117581331, and U117581334) and NWO and the EU through a Marie Curie Intra-European Fellowship (to I. A. T. S.).; Supported by the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD) and the Karl-Enigk-Stiftung.	Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2008, INT J PARASITOL, V38, pS52; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; BUBB MR, 1994, J BIOL CHEM, V269, P14869; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COOKE R, 1975, BIOCHEMISTRY-US, V14, P3250, DOI 10.1021/bi00685a035; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Fowler RE, 2004, ADV PARASIT, V56, P213, DOI 10.1016/S0065-308X(03)56004-3; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gordon JL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-179; HANSON J, 1967, NATURE, V213, P353, DOI 10.1038/213353a0; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukoyanova N, 2000, BIOPHYS J, V78, p238A; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Oda T, 2001, BIOPHYS J, V80, P841, DOI 10.1016/S0006-3495(01)76063-8; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Poupel O, 1999, MICROBES INFECT, V1, P653, DOI 10.1016/S1286-4579(99)80066-5; Poupel O, 2000, MOL BIOL CELL, V11, P355, DOI 10.1091/mbc.11.1.355; Reisler E, 2007, J BIOL CHEM, V282, P36133, DOI 10.1074/jbc.R700030200; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schaap IAT, 2004, EUR BIOPHYS J BIOPHY, V33, P462, DOI 10.1007/s00249-003-0386-8; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2006, TRENDS PARASITOL, V22, P146, DOI 10.1016/j.pt.2006.02.005; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; STOKES DL, 1987, J CELL BIOL, V104, P1005, DOI 10.1083/jcb.104.4.1005; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030; Visegrady B, 2005, FEBS LETT, V579, P6, DOI 10.1016/j.febslet.2004.11.023; WANG F, 1988, BIOPHYS J, V53, pA572; WESSELING JG, 1988, MOL BIOCHEM PARASIT, V27, P313, DOI 10.1016/0166-6851(88)90051-5; WESSELING JG, 1988, MOL BIOCHEM PARASIT, V30, P143, DOI 10.1016/0166-6851(88)90107-7; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; WIELAND T, 1978, CRC CR REV BIOCH MOL, V5, P185, DOI 10.3109/10409237809149870; ZIMMERLE CT, 1988, BIOCHEMISTRY-US, V27, P7766, DOI 10.1021/bi00420a027	64	46	46	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36577	36585		10.1074/jbc.M110.142638	http://dx.doi.org/10.1074/jbc.M110.142638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20826799	hybrid, Green Published			2022-12-25	WOS:000284146100060
J	Coleman, SK; Moykkynen, T; Hinkkuri, S; Vaahtera, L; Korpi, ER; Pentikainen, OT; Keinanen, K				Coleman, Sarah K.; Moykkynen, Tommi; Hinkkuri, Sami; Vaahtera, Lauri; Korpi, Esa R.; Pentikainen, Olli T.; Keinanen, Kari			Ligand-binding Domain Determines Endoplasmic Reticulum Exit of AMPA Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; GLUTAMATE-RECEPTOR; REGULATORY PROTEINS; SYNAPTIC PLASTICITY; KINETIC-PROPERTIES; SUBUNIT; TRAFFICKING; CHANNELS; EXPRESSION; SUBTYPE	AMPA receptors (AMPARs) are tetrameric ion channels that mediate rapid glutamate signaling in neurons and many non-neuronal cell types. Endoplasmic reticulum (ER) quality control mechanisms permit only correctly folded functional receptors to be delivered to the cell surface. We analyzed the biosynthetic maturation and transport of all 12 GluA1-4 subunit splice variants as homomeric receptors and observed robust isoform-dependent differences in ER exit competence and surface expression. In contrast to inefficient ER exit of both GluA3 splice forms and the flop variants of GluA1 and GluA4, prominent plasma membrane expression was observed for the other AMPAR isoforms. Surprisingly, deletion of the entire N-terminal domain did not alter the transport phenotype, nor did the different cytosolic C-terminal tail splice variants. Detailed analysis of mutant receptors led to the identification of distinct residues in the ligand-binding domain as primary determinants for isoform-specific maturation. Considered together with the essential role of bound agonist, our findings reveal the ligand-binding domain as the critical quality control target in AMPAR biogenesis.	[Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, FI-00014 Helsinki, Finland; [Moykkynen, Tommi; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Biomedicum, FI-00014 Helsinki, Finland; [Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland	University of Helsinki; University of Helsinki; University of Jyvaskyla	Keinanen, K (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, POB 56,Viikinkaari 5, FI-00014 Helsinki, Finland.	kari.keinanen@helsinki.fi	Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Coleman, Sarah/0000-0002-1066-8296; Vaahtera, Lauri/0000-0003-4733-4430; Korpi, Esa R./0000-0003-0683-4009	Academy of Finland [110900]; Finnish Foundation for Alcohol Studies	Academy of Finland(Academy of Finland); Finnish Foundation for Alcohol Studies	This work was supported by Academy of Finland Grant 110900 (to K K.) and the Finnish Foundation for Alcohol Studies (to T.M.).	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Coleman SK, 2003, J NEUROSCI, V23, P798; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Koike M, 2000, J NEUROSCI, V20, P2166; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Sager C, 2009, NEUROSCIENCE, V158, P45, DOI 10.1016/j.neuroscience.2007.12.046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sans N, 2003, J NEUROSCI, V23, P9367; Sekiguchi M, 2002, BRIT J PHARMACOL, V136, P1033, DOI 10.1038/sj.bjp.0704804; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200	39	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36032	36039		10.1074/jbc.M110.156943	http://dx.doi.org/10.1074/jbc.M110.156943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837486	Green Published, hybrid			2022-12-25	WOS:000283845300079
J	Kondrikov, D; Elms, S; Fulton, D; Su, YC				Kondrikov, Dmitry; Elms, Shawn; Fulton, David; Su, Yunchao			eNOS-beta-Actin Interaction Contributes to Increased Peroxynitrite Formation during Hyperoxia in Pulmonary Artery Endothelial Cells and Mouse Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CYTOSKELETON; PHOSPHORYLATION; ACTIVATION; GENERATION; MANAGEMENT; STATE	Oxygen toxicity is the most severe side effect of oxygen therapy in neonates and adults. Pulmonary damage of oxygen toxicity is related to the overproduction of reactive oxygen species (ROS). In the present study, we investigated the effect of hyperoxia on the production of peroxynitrite in pulmonary artery endothelial cells (PAEC) and mouse lungs. Incubation of PAEC under hyperoxia (95% O-2) for 24 h resulted in an increase in peroxynitrite formation. Uric acid, a peroxynitrite scavenger, prevented hyperoxia-induced increase in peroxynitrite. The increase in peroxynitrite formation is accompanied by increases in nitric oxide (NO) release and endothelial NO synthase (eNOS) activity. We have previously reported that association of eNOS with beta-actin increases eNOS activity and NO production in lung endothelial cells. To study whether eNOS-beta-actin association contributes to increased peroxynitrite production, eNOS-beta-actin interaction were inhibited by reducing beta-actin availability or by using a synthetic peptide (P326TAT) containing a sequence corresponding to the actin binding site on eNOS. We found that disruption of eNOS-beta-actin interaction prevented hyperoxia-induced increases in eNOS-beta-actin association, eNOS activity, NO and peroxynitrite production, and protein tyrosine nitration. Hyperoxia failed to induce the increases in eNOS activity, NO and peroxynitrite formation in COS-7 cells transfected with plasmids containing eNOS mutant cDNA in which amino acids leucine and tryptophan were replaced with alanine in the actin binding site on eNOS. Exposure of mice to hyperoxia resulted in significant increases in eNOS-beta-actin association, eNOS activity, and protein tyrosine nitration in the lungs. Our data indicate that increased association of eNOS with beta-actin in PAEC contributes to hyperoxia-induced increase in the production of peroxynitrite which may cause nitrosative stress in pulmonary vasculature.	[Kondrikov, Dmitry; Fulton, David; Su, Yunchao] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Elms, Shawn; Fulton, David; Su, Yunchao] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Su, YC (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.	ysu@mcg.edu			National Institutes of Health [R01HL088261]; Flight Attendants Medical Research Institute [072104]; American Heart Association Greater Southeast Affiliate [0555322B, 0855338E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; American Heart Association Greater Southeast Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL088261. This work was also supported by Flight Attendants Medical Research Institute Grant 072104, and American Heart Association Greater Southeast Affiliate Grants 0555322B and 0855338E.	Berkowitz Diane Schleyer, 2003, Crit Care Nurs Q, V26, P28; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Brueckl C, 2006, AM J RESP CELL MOL, V34, P453, DOI 10.1165/rcmb.2005-0223OC; Cao S, 2003, J BIOL CHEM, V278, P5894, DOI 10.1074/jbc.M212546200; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; De Backer TLM, 2001, BIODRUGS, V15, P801, DOI 10.2165/00063030-200115120-00003; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Imperatore F, 2004, INTENS CARE MED, V30, P1175, DOI 10.1007/s00134-003-2138-8; Ju H, 1998, J BIOL CHEM, V273, P24025, DOI 10.1074/jbc.273.37.24025; Kobayashi H, 2001, AM J RESP CELL MOL, V24, P390, DOI 10.1165/ajrcmb.24.4.4218; Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004; Kondrikov D, 2010, J BIOL CHEM, V285, P4319, DOI 10.1074/jbc.M109.063172; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; MacFarlane C, 2000, J R Army Med Corps, V146, P185; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; PALEVSKY HI, 1991, JAMA-J AM MED ASSOC, V265, P1014, DOI 10.1001/jama.265.8.1014; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Radomski A, 1998, BRIT J PHARMACOL, V125, P1455, DOI 10.1038/sj.bjp.0702216; Saito S, 2006, PLANT CELL PHYSIOL, V47, P689, DOI 10.1093/pcp/pcj038; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; SU Y, 2007, SCI STKE; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Su YC, 2003, AM J PHYSIOL-CELL PH, V284, pC1542, DOI 10.1152/ajpcell.00248.2002; Su YC, 2000, AM J PHYSIOL-LUNG C, V278, pL1204, DOI 10.1152/ajplung.2000.278.6.L1204; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Zhang JL, 1997, RES COMMUN MOL PATH, V96, P71	33	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35479	35487		10.1074/jbc.M110.140269	http://dx.doi.org/10.1074/jbc.M110.140269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826796	Green Published, hybrid			2022-12-25	WOS:000283845300026
J	Louie, RJ; Pagant, S; Youn, JY; Halliday, JJ; Huyer, G; Michaelis, S; Miller, EA				Louie, Raymond J.; Pagant, Silvere; Youn, Ji-Young; Halliday, John J.; Huyer, Gregory; Michaelis, Susan; Miller, Elizabeth A.			Functional Rescue of a Misfolded Eukaryotic ATP-binding Cassette Transporter by Domain Replacement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; CLASS-II REGION; SACCHAROMYCES-CEREVISIAE; ABC-TRANSPORTER; ENDOPLASMIC-RETICULUM; MULTIDRUG-RESISTANCE; PROCESSING MUTANTS; NUCLEOTIDE-BINDING; ESCHERICHIA-COLI	ATP-binding cassette (ABC) transporters are integral membrane proteins that couple ATP binding/hydrolysis with the transport of hydrophilic substrates across lipid barriers. Deletion of Phe-670 in the first nucleotide-binding domain (NBD1) of the yeast ABC transporter, Yor1p, perturbs interdomain associations, reduces functionality, and hinders proper transport to the plasma membrane. Functionality of Yor1p-Delta F was restored upon co-expression of a peptide containing wild-type NBD1. To gain insight into the biogenesis of this important class of proteins, we defined the requirements for this rescue. We show that a misfolding lesion in NBD1 of the full-length protein is a prerequisite for functional rescue by exogenous NBD1, which is mediated by physical replacement of the dysfunctional domain by the soluble NBD1. This association does not restore trafficking of Yor1p-Delta F but instead confers catalytic activity to the small population of Yor1p-Delta F that escapes to the plasma membrane. An important coupling between the exogenous NBD1 and ICL4 within full-length aberrant Yor1p-Delta F is required for functional rescue but not for the physical interaction between the two polypeptides. Together, our genetic and biochemical data reveal that it is possible to modulate activity of ABC transporters by physically replacing dysfunctional domains.	[Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Huyer, Gregory; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA	Columbia University; Johns Hopkins University; Johns Hopkins Medicine	Miller, EA (corresponding author), 617A Fairchild Ctr,MC 2456, New York, NY 10027 USA.	em2282@columbia.edu		Miller, Elizabeth/0000-0002-1033-8369	National Institutes of Health [GM078186, GM51508]; Cystic Fibrosis Foundation [PAGANT08F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051508, R01GM078186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078186 (to E. A. M.) and GM51508 (to S. M.). This work was also supported by Cystic Fibrosis Foundation Grant PAGANT08F0 (to S. P.).	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Berkower C, 1996, J BIOL CHEM, V271, P22983, DOI 10.1074/jbc.271.38.22983; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clarke LL, 2004, AM J PHYSIOL-CELL PH, V287, pC192, DOI 10.1152/ajpcell.00337.2003; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; DANO K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466, DOI 10.1016/0005-2736(73)90191-0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doeven MK, 2004, J BIOL CHEM, V279, P32301, DOI 10.1074/jbc.M404343200; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Grigoras I, 2008, BBA-BIOMEMBRANES, V1778, P68, DOI 10.1016/j.bbamem.2007.08.035; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Owsianik G, 2003, FEBS LETT, V554, P173, DOI 10.1016/S0014-5793(03)01162-1; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; PANAGIOTIDIS CH, 1993, J BIOL CHEM, V268, P23685; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Reyes CL, 2006, FEBS LETT, V580, P1042, DOI 10.1016/j.febslet.2005.11.033; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SHEN DW, 1986, MOL CELL BIOL, V6, P4039, DOI 10.1128/MCB.6.11.4039; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	49	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36225	36234		10.1074/jbc.M110.160523	http://dx.doi.org/10.1074/jbc.M110.160523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843810	hybrid, Green Published			2022-12-25	WOS:000283845300098
J	Kashlan, OB; Boyd, CR; Argyropoulos, C; Okumura, S; Hughey, RP; Grabe, M; Kleyman, TR				Kashlan, Ossama B.; Boyd, Cary R.; Argyropoulos, Christos; Okumura, Sora; Hughey, Rebecca P.; Grabe, Michael; Kleyman, Thomas R.			Allosteric Inhibition of the Epithelial Na+ Channel through Peptide Binding at Peripheral Finger and Thumb Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; GAMMA-SUBUNIT; SELF-INHIBITION; ALPHA-SUBUNIT; ENAC; FURIN; CLEAVAGE; PLASMIN	The epithelial Na+ channel (ENaC) mediates the rate-limiting step in transepithelial Na+ transport in the distal segments of the nephron and in the lung. ENaC subunits are cleaved by proteases, resulting in channel activation due to the release of inhibitory tracts. Peptides derived from these tracts inhibit channel activity. The mechanism by which these intrinsic inhibitory tracts reduce channel activity is unknown, as are the sites where these tracts interact with other residues within the channel. We performed site-directed mutagenesis in large portions of the predicted periphery of the extracellular region of the alpha subunit and measured the effect of mutations on an 8-residue inhibitory tract-derived peptide. Our data show that the inhibitory peptide likely binds to specific residues within the finger and thumb domains of ENaC. Pairwise interactions between the peptide and the channel were identified by double mutant cycle experiments. Our data suggest that the inhibitory peptide has a specific peptide orientation within its binding site. Extended to the intrinsic inhibitory tract, our data suggest that proteases activate ENaC by removing residues that bind at the finger-thumb domain interface.	[Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Argyropoulos, Christos/I-2803-2019	Argyropoulos, Christos/0000-0002-9679-7805	National Institutes of Health [DK078734, DK051391, DK065161, DK079307]; American Heart Association; PNC Charitable Trust Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R01DK065161, R37DK051391, P30DK079307, R56DK065161, K01DK078734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); PNC Charitable Trust Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078734 (to O. B. K.), DK051391 (to T. R. K.), DK065161 (to T. R. K. and R. P. H.), and DK079307 (Pittsburgh Center for Kidney Research). This work was also supported by a scientist development grant from the American Heart Association and a grant from the PNC Charitable Trust Foundation (to M. G.).	Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Fajac I, 2009, EUR RESPIR J, V34, P772, DOI 10.1183/09031936.00057309; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; PINHEIRO JC, 2000, MIXED EFFECTS MODELS, P271; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	24	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35216	35223		10.1074/jbc.M110.167064	http://dx.doi.org/10.1074/jbc.M110.167064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817728	hybrid, Green Published			2022-12-25	WOS:000283659100095
J	Rorke, EA; Adhikary, G; Jans, R; Crish, JF; Eckert, RL				Rorke, E. A.; Adhikary, G.; Jans, R.; Crish, J. F.; Eckert, R. L.			AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation	ONCOGENE			English	Article						TAM67; c-jun; keratinocyte differentiation; epidermis; skin cancer	HUMAN INVOLUCRIN PROMOTER; NEGATIVE C-JUN; CONDITIONAL GENE-EXPRESSION; ACTIVATED PROTEIN-KINASES; DISTAL REGULATORY REGION; CELL-PROLIFERATION; MOUSE EPIDERMIS; TRANSGENIC MICE; IN-VIVO; KERATINOCYTE DIFFERENTIATION	Activator protein one (AP1) (jun/fos) factors comprise a family of transcriptional regulators (c-jun, junB, junD, c-fos, FosB, Fra-1 and Fra-2) that are key controllers of epidermal keratinocyte survival and differentiation, and are important drivers of cancer development. Understanding the role of these factors in epidermis is complicated by the fact that each member is expressed in defined cell layers during epidermal differentiation, and because AP1 factors regulate competing processes (that is, proliferation, apoptosis and differentiation). We have proposed that AP1 factors function differently in basal versus suprabasal epidermis. To test this, we inactivated suprabasal AP1 factor function in mouse epidermis by targeted expression of dominant-negative c-jun (TAM67), which inactivates function of all AP1 factors. This produces increased basal keratinocyte proliferation, delayed differentiation and extensive hyperkeratosis. These findings contrast with previous studies showing that basal layer AP1 factor inactivation does not perturb resting epidermis. It is interesting that in spite of extensive keratinocyte hyper-proliferation, susceptibility to carcinogen-dependent tumor induction is markedly attenuated. These novel observations strongly suggest that AP1 factors have distinct roles in the basal versus suprabasal epidermis, confirm that AP1 factor function is required for normal terminal differentiation, and suggest that AP1 factors have a different role in normal epidermis versus cancer progression. Oncogene (2010) 29, 5873-5882; doi:10.1038/onc.2010.315; published online 6 September 2010	[Rorke, E. A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Adhikary, G.; Jans, R.; Eckert, R. L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Crish, J. F.] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Obstet & Genecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Rorke, EA (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 108 N Greene St, Baltimore, MD 21201 USA.	erorke@SOM.umaryland.edu; reckert@umaryland.edu	Jans, Ralph/F-2150-2013		NIH [RO1 AR046494]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049713, R01AR046494] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH RO1 AR046494 (R Eckert).	Adhikary G, 2004, INVEST OPHTH VIS SCI, V45, P1080, DOI 10.1167/iovs.03-1180; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bickenbach J R, 2000, Adv Dermatol, V16, P159; BROWN PH, 1994, ONCOGENE, V9, P791; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Cutler TJ, 2004, VET CLIN N AM-EQUINE, V20, pXI, DOI 10.1016/S0749-0739(04)00029-X; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dunnwald M, 2001, EXP DERMATOL, V10, P45, DOI 10.1034/j.1600-0625.2001.100106.x; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; Eckert RL, 1996, CELL DEATH DIFFER, V3, P373; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Gandarillas A, 1999, EXP DERMATOL, V8, P71, DOI 10.1111/j.1600-0625.1999.tb00350.x; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; HEYDEN A, 1994, EPITHELIAL CELL BIOL, V3, P96; HEYDEN A, 1994, DIFFERENTIATION, V57, P187, DOI 10.1046/j.1432-0436.1994.5730187.x; Iizuka H, 2004, J DERMATOL, V31, P271, DOI 10.1111/j.1346-8138.2004.tb00672.x; Jaubert J, 2004, J INVEST DERMATOL, V123, P313, DOI 10.1111/j.0022-202X.2004.23203.x; KAHN CR, 1993, INVEST OPHTH VIS SCI, V34, P3429; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Matthews CP, 2007, CANCER RES, V67, P2430, DOI 10.1158/0008-5472.CAN-06-0522; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mizuno H, 2006, MOL CARCINOGEN, V45, P1, DOI 10.1002/mc.20160; MOLLOY CJ, 1987, CANCER RES, V47, P4674; Nickoloff B J, 2001, J Invest Dermatol, V117, P1; Nickoloff B J, 1999, Expert Opin Investig Drugs, V8, P393, DOI 10.1517/13543784.8.4.393; Nickoloff BJ, 2002, J INVEST DERM SYMP P, V7, P27, DOI 10.1046/j.1523-1747.2002.19633.x; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rutberg SE, 2000, CANCER RES, V60, P6332; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schreiber M, 2000, DEVELOPMENT, V127, P4937; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; She QB, 2002, CANCER RES, V62, P1343; Shi B, 2005, EXP DERMATOL, V14, P519, DOI 10.1111/j.0906-6705.2005.00317.x; SIMON M, 1985, CELL, V40, P677, DOI 10.1016/0092-8674(85)90216-8; SUN TT, 1983, J INVEST DERMATOL, V81, pS109, DOI 10.1111/1523-1747.ep12540831; Sun TT, 1984, CANCER CELLS, V1, P169; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Thompson EJ, 2002, CANCER RES, V62, P3044; TOFTGARD R, 1985, CANCER RES, V45, P5845; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; YOUNG AR, 1987, PHOTODERMATOLOGY, V4, P127; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Young MR, 2002, MOL CARCINOGEN, V34, P72, DOI 10.1002/mc.10050; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963	70	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5873	5882		10.1038/onc.2010.315	http://dx.doi.org/10.1038/onc.2010.315			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20818430	Green Accepted			2022-12-25	WOS:000283843400002
J	Gorringe, KL; George, J; Anglesio, MS; Ramakrishna, M; Etemadmoghadam, D; Cowin, P; Sridhar, A; Williams, LH; Boyle, SE; Yanaihara, N; Okamoto, A; Urashima, M; Smyth, GK; Campbell, IG; Bowtell, DDL				Gorringe, Kylie L.; George, Joshy; Anglesio, Michael S.; Ramakrishna, Manasa; Etemadmoghadam, Dariush; Cowin, Prue; Sridhar, Anita; Williams, Louise H.; Boyle, Samantha E.; Yanaihara, Nozomu; Okamoto, Aikou; Urashima, Mitsuyoshi; Smyth, Gordon K.; Campbell, Ian G.; Bowtell, David D. L.		Australian Ovarian Canc Study	Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; HIGH-RESOLUTION ANALYSIS; BREAST-CANCER; EXPRESSION ANALYSIS; COLORECTAL CANCERS; SEROUS CARCINOMAS; SPORADIC BREAST; GENE; HYBRIDIZATION; AMPLIFICATIONS	Ovarian cancer is a heterogeneous disease displaying complex genomic alterations, and consequently, it has been difficult to determine the most relevant copy number alterations with the scale of studies to date. We obtained genome-wide copy number alteration (CNA) data from four different SNP array platforms, with a final data set of 398 ovarian tumours, mostly of the serous histological subtype. Frequent CNA aberrations targeted many thousands of genes. However, high-level amplicons and homozygous deletions enabled filtering of this list to the most relevant. The large data set enabled refinement of minimal regions and identification of rare amplicons such as at 1p34 and 20q11. We performed a novel co-occurrence analysis to assess cooperation and exclusivity of CNAs and analysed their relationship to patient outcome. Positive associations were identified between gains on 19 and 20q, gain of 20q and loss of X, and between several regions of loss, particularly 17q. We found weak correlations of CNA at genomic loci such as 19q12 with clinical outcome. We also assessed genomic instability measures and found a correlation of the number of higher amplitude gains with poorer overall survival. By assembling the largest collection of ovarian copy number data to date, we have been able to identify the most frequent aberrations and their interactions.	[Gorringe, Kylie L.; Ramakrishna, Manasa; Sridhar, Anita; Boyle, Samantha E.; Campbell, Ian G.] Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium, Canc Genet Lab, Melbourne, Australia; [Gorringe, Kylie L.; Ramakrishna, Manasa; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [George, Joshy; Anglesio, Michael S.; Etemadmoghadam, Dariush; Cowin, Prue; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genet & Genom Lab, Melbourne, Australia; [George, Joshy] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Williams, Louise H.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Yanaihara, Nozomu; Okamoto, Aikou; Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Tokyo, Japan; [Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Jikei University; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Gorringe, KL (corresponding author), Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium, Canc Genet Lab, Melbourne, Australia.	ian.campbell@petermac.org; david.bowtell@petermac.org	Bowtell, David/H-1007-2016; George, Joshy/K-4841-2019; Smyth, Gordon/B-5276-2008; Gorringe, Kylie L/H-3264-2019; campbell, Ian G/F-6006-2011	Bowtell, David/0000-0001-9089-7525; Smyth, Gordon/0000-0001-9221-2892; Gorringe, Kylie L/0000-0001-5681-2022; George, Joshy/0000-0001-8510-8229; Anglesio, Michael/0000-0003-1639-5003; Campbell, Ian/0000-0002-7773-4155	National Health and Medical Research Council of Australia; Victorian Breast Cancer Research Consortium (VBCRC), Australia; Department of Defense (DOD), United States of America; Victorian Life Sciences Computation Initiative (VLSCI); United States Army Medical Research and Materiel Command [DAMD17- 01- 1- 0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania; National Health and Medical Research Council of Australia (NHMRC)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Breast Cancer Research Consortium (VBCRC), Australia; Department of Defense (DOD), United States of America(United States Department of Defense); Victorian Life Sciences Computation Initiative (VLSCI); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia; the Victorian Breast Cancer Research Consortium (VBCRC), Australia; and the Department of Defense (DOD), United States of America. JG is supported by an Australian Postgraduate Award. MR is supported by a Cancer Council of Victoria Postgraduate Scholarship. This research was also supported by a Victorian Life Sciences Computation Initiative (VLSCI) grant on its Peak Computing Facility at the University of Melbourne and at Victorian Partnership for Advanced Computing (VPAC). Australian Ovarian Cancer Study (AOCS) was supported by the United States Army Medical Research and Materiel Command under DAMD17- 01- 1- 0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania, and the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Bayani J, 2002, CANCER RES, V62, P3466; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Courjal F, 1997, CANCER RES, V57, P4360; Dimova I, 2009, ONKOLOGIE, V32, P405, DOI 10.1159/000219368; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gilks CB, 2008, HUM PATHOL, V39, P1239, DOI 10.1016/j.humpath.2008.01.003; Gorello P, 2008, LEUKEMIA, V22, P216, DOI 10.1038/sj.leu.2404894; Gorringe KL, 2008, GENE CHROMOSOME CANC, V47, P933, DOI 10.1002/gcc.20595; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Henderson LJ, 2005, BRIT J CANCER, V92, P1553, DOI 10.1038/sj.bjc.6602452; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hoglund M, 2003, CANCER RES, V63, P3378; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Partheen K, 2004, GENE CHROMOSOME CANC, V40, P342, DOI 10.1002/gcc.20053; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Sangha N, 2008, NEOPLASIA, V10, P1362, DOI 10.1593/neo.08784; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2003, INST MATH S, V40, P115; Sparks AB, 1998, CANCER RES, V58, P1130; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Watanabe T, 2002, JPN J CANCER RES, V93, P1114, DOI 10.1111/j.1349-7006.2002.tb01213.x; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657	54	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e11408	10.1371/journal.pone.0011408	http://dx.doi.org/10.1371/journal.pone.0011408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844748	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687300001
J	Sheng, T; Gheytanchi, A; Aziz-Zadeh, L				Sheng, Tong; Gheytanchi, Anahita; Aziz-Zadeh, Lisa			Default Network Deactivations Are Correlated with Psychopathic Personality Traits	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CORTICAL MIDLINE STRUCTURES; RESTING BRAIN; INDIVIDUAL-DIFFERENCES; RETROSPLENIAL CORTEX; CONSTRUCT-VALIDITY; SOCIAL COGNITION; DECISION-MAKING; SELF; MODE	Background: The posteromedial cortex (PMC) and medial prefrontal cortex (mPFC) are part of a network of brain regions that has been found to exhibit decreased activity during goal-oriented tasks. This network is thought to support a baseline of brain activity, and is commonly referred to as the "default network''. Although recent reports suggest that the PMC and mPFC are associated with affective, social, and self-referential processes, the relationship between these default network components and personality traits, especially those pertaining to social context, is poorly understood. Methodology/Principal Findings: In the current investigation, we assessed the relationship between PMC and mPFC deactivations and psychopathic personality traits using fMRI and a self-report measure. We found that PMC deactivations predicted traits related to egocentricity and mPFC deactivations predicted traits related to decision-making. Conclusions/Significance: These results suggest that the PMC and mPFC are associated with processes involving self-relevancy and affective decision-making, consistent with previous reports. More generally, these findings suggest a link between default network activity and personality traits.	[Sheng, Tong; Aziz-Zadeh, Lisa] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Sheng, Tong] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Aziz-Zadeh, Lisa] Univ So Calif, Div Occupat Sci & Occupat Therapy, Los Angeles, CA USA; [Gheytanchi, Anahita] Pacific Grad Sch Psychol, Palo Alto, CA USA	University of Southern California; University of Southern California; University of Southern California	Sheng, T (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	tsheng@usc.edu	Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD057594]; James H. Zumberge Individual Award; USC Brain and Creativity Institute; USC Dornsife Cognitive Neuroimaging Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); James H. Zumberge Individual Award; USC Brain and Creativity Institute; USC Dornsife Cognitive Neuroimaging Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Award Number R03HD057594 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. This project was also generously funded by a James H. Zumberge Individual Award and the USC Brain and Creativity Institute, and the USC Dornsife Cognitive Neuroimaging Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aziz-Zadeh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008759; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BENOIT R, 2009, NEUROIMAGE, V47, pS184; Blonigen DM, 2003, PERS INDIV DIFFER, V35, P179, DOI 10.1016/S0191-8869(02)00184-8; Brett M., 2002, 8 INT C FUNCT MAPP H; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Damasio A, 1995, DESCARTES ERROR EMOT; Dolan MC, 2002, PSYCHIAT RES-NEUROIM, V116, P133, DOI 10.1016/S0925-4927(02)00085-9; DREWE E A, 1975, Cortex, V11, P8; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fellows LK, 2007, NEUROLOGY, V68, P991, DOI 10.1212/01.wnl.0000257835.46290.57; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; GHATAN PH, 1995, NEUROIMAGE, V2, P112, DOI 10.1006/nimg.1995.1014; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Hart SD., 1992, ADV PSYCHOL ASSESS, P103, DOI 10.1007/978-1-4757-9101-3_4; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lilienfeld S.O., 2005, PROFESSIONAL MANUAL; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Patrick CJ, 2006, PSYCHOL ASSESSMENT, V18, P204, DOI 10.1037/1040-3590.18.2.204; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAINE A, 1992, SCHIZOPHR RES, V7, P237, DOI 10.1016/0920-9964(92)90018-Z; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sutin AR, 2009, CEREB CORTEX, V19, P2797, DOI 10.1093/cercor/bhp066; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uzieblo K, 2007, PERS INDIV DIFFER, V43, P657, DOI 10.1016/j.paid.2007.01.008; van den Bos W, 2009, J NEUROSCI, V29, P7631, DOI 10.1523/JNEUROSCI.1821-09.2009; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Zald DH, 2002, P NATL ACAD SCI USA, V99, P2450, DOI 10.1073/pnas.042457199	60	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12611	10.1371/journal.pone.0012611	http://dx.doi.org/10.1371/journal.pone.0012611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	647PO	20830290	Green Published, gold, Green Submitted			2022-12-25	WOS:000281631300032
J	Serb, JM; Orr, MC; Greenlee, MHW				Serb, Jeanne M.; Orr, Megan C.; Greenlee, M. Heather West			Using Evolutionary Conserved Modules in Gene Networks as a Strategy to Leverage High Throughput Gene Expression Queries	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; RETINAL GANGLION-CELL; MOUSE RETINA; BILIVERDIN REDUCTASE; FATE DETERMINATION; AMACRINE CELLS; GROWTH CONE; LOCALIZATION; DROSOPHILA; CALPAIN	Background: Large-scale gene expression studies have not yielded the expected insight into genetic networks that control complex processes. These anticipated discoveries have been limited not by technology, but by a lack of effective strategies to investigate the data in a manageable and meaningful way. Previous work suggests that using a pre-determined seednetwork of gene relationships to query large-scale expression datasets is an effective way to generate candidate genes for further study and network expansion or enrichment. Based on the evolutionary conservation of gene relationships, we test the hypothesis that a seed network derived from studies of retinal cell determination in the fly, Drosophila melanogaster, will be an effective way to identify novel candidate genes for their role in mouse retinal development. Methodology/Principal Findings: Our results demonstrate that a number of gene relationships regulating retinal cell differentiation in the fly are identifiable as pairwise correlations between genes from developing mouse retina. In addition, we demonstrate that our extracted seed-network of correlated mouse genes is an effective tool for querying datasets and provides a context to generate hypotheses. Our query identified 46 genes correlated with our extracted seed-network members. Approximately 54% of these candidates had been previously linked to the developing brain and 33% had been previously linked to the developing retina. Five of six candidate genes investigated further were validated by experiments examining spatial and temporal protein expression in the developing retina. Conclusions/Significance: We present an effective strategy for pursuing a systems biology approach that utilizes an evolutionary comparative framework between two model organisms, fly and mouse. Future implementation of this strategy will be useful to determine the extent of network conservation, not just gene conservation, between species and will facilitate the use of prior biological knowledge to develop rational systems-based hypotheses.	[Serb, Jeanne M.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Orr, Megan C.] Iowa State Univ, Dept Stat, Ames, IA USA; [Greenlee, M. Heather West] Iowa State Univ, Dept Biomed Sci, Bioinformat & Computat Biol Program, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Serb, JM (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	serb@iastate.edu		Serb, Jeanne/0000-0003-2112-470X	Center for Integrative Animal Genomics (CIAG) at Iowa State University	Center for Integrative Animal Genomics (CIAG) at Iowa State University	This work was supported by the Center for Integrative Animal Genomics (CIAG) at Iowa State University (http://www.ciag.iastate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD H, 1988, ARCH BIOCHEM BIOPHYS, V266, P416, DOI 10.1016/0003-9861(88)90273-1; Ahuja P, 2005, NEUROSCIENCE, V131, P935, DOI 10.1016/j.neuroscience.2004.11.012; Allen GW, 2001, J NEUROSCI RES, V66, P396, DOI 10.1002/jnr.1232; Amrein L, 2005, CELL TISSUE RES, V322, P365, DOI 10.1007/s00441-005-0036-9; [Anonymous], HOMOLOGENE; [Anonymous], PUBMED; Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; BORDER BG, 1993, J NEUROCHEM, V61, P2104, DOI 10.1111/j.1471-4159.1993.tb07448.x; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; BUTTE A, 2003, ANAL GENE EXPRESSION; Carpintero P, 1999, MOL BRAIN RES, V70, P141, DOI 10.1016/S0169-328X(99)00115-1; Charrier E, 2006, GENES CELLS, V11, P1337, DOI 10.1111/j.1365-2443.2006.01024.x; Chen R, 1999, DEVELOPMENT, V126, P935; Chen YN, 2006, BIOCHEM BIOPH RES CO, V341, P1, DOI 10.1016/j.bbrc.2005.12.150; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Davis JA, 1996, J NEUROSCI, V16, P5082; de Brouwer APM, 2007, AM J HUM GENET, V81, P507, DOI 10.1086/520706; Donner AL, 2004, INT J DEV BIOL, V48, P743, DOI 10.1387/ijdb.041877ad; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Dyer MA, 2001, J COMP NEUROL, V429, P601; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; El-Khodor BF, 2001, DEV BRAIN RES, V129, P47, DOI 10.1016/S0165-3806(01)00181-X; EWING JF, 1995, BRAIN RES, V672, P29, DOI 10.1016/0006-8993(94)01290-X; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; HECKER LA, 2008, BIOINFORMATICS BIOL, P91; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hwang IK, 2008, J NEUROSCI RES, V86, P1823, DOI 10.1002/jnr.21621; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Jones Stephen E., 2000, Molecular Cell Biology Research Communications, V4, P20, DOI 10.1006/mcbr.2000.0250; Kanan Y, 2007, INVEST OPHTH VIS SCI, V48, P40, DOI 10.1167/iovs.06-0592; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kielbasa SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003210; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; LAND M. F., 2006, ANIMAL EYES; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; Lee SS, 2003, YONSEI MED J, V44, P1059, DOI 10.3349/ymj.2003.44.6.1059; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Liu JW, 2006, BRAIN RES, V1098, P113, DOI 10.1016/j.brainres.2006.04.086; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lobo MK, 2008, J NEUROSCI RES, V86, P2134, DOI 10.1002/jnr.21666; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Miller NLG, 2009, HUM MOL GENET, V18, P248, DOI 10.1093/hmg/ddn344; Mitchell DC, 2007, MOL VIS, V13, P1144; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Munemasa Y, 2008, INVEST OPHTH VIS SCI, V49, P3535, DOI 10.1167/iovs.08-1716; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Nakajima E, 2006, INVEST OPHTH VIS SCI, V47, P5469, DOI 10.1167/iovs.06-0567; Nakazawa T, 2000, BRAIN RES, V861, P399, DOI 10.1016/S0006-8993(00)02056-4; Niiya A, 1998, EXP EYE RES, V67, P699, DOI 10.1006/exer.1998.0562; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Panahian N, 1999, BRAIN RES, V850, P1, DOI 10.1016/S0006-8993(99)01726-6; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; Quach TT, 2000, GENE, V242, P175, DOI 10.1016/S0378-1119(99)00528-4; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Sharma AK, 2007, CURR EYE RES, V32, P259, DOI 10.1080/02713680601161238; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Sinclair A, 2002, NOVART FDN SYMP, V244, P102; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Sweeney KJ, 2000, MECH DEVELOP, V92, P263, DOI 10.1016/S0925-4773(00)00242-2; Tang YP, 2006, BRAIN RES, V1126, P102, DOI 10.1016/j.brainres.2006.08.002; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tsim TY, 2004, NEUROSCIENCE, V123, P951, DOI 10.1016/j.neuroscience.2003.10.024; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Walls G., 1967, VERTEBRATE EYE ITS A; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Xu PX, 1997, DEVELOPMENT, V124, P219; Yona G, 2006, BIOINFORMATICS, V22, P1616, DOI 10.1093/bioinformatics/btl127; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48	105	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12525	10.1371/journal.pone.0012525	http://dx.doi.org/10.1371/journal.pone.0012525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824082	Green Submitted, gold, Green Published			2022-12-25	WOS:000281480900011
J	Tang, YQ; Jaganath, IB; Sekaran, SD				Tang, Yin-Quan; Jaganath, Indu Bala; Sekaran, Shamala Devi			Phyllanthus spp. Induces Selective Growth Inhibition of PC-3 and MeWo Human Cancer Cells through Modulation of Cell Cycle and Induction of Apoptosis	PLOS ONE			English	Article							PROSTATE-CANCER; AMARUS; EXPRESSION; ACID; EXTRACT; PLANTS	Background: Phyllanthus is a traditional medicinal plant that has been used in the treatment of many diseases including hepatitis and diabetes. The main aim of the present work was to investigate the potential cytotoxic effects of aqueous and methanolic extracts of four Phyllanthus species (P. amarus, P. niruri, P. urinaria and P. watsonii) against skin melanoma and prostate cancer cells. Methodology/Principal Findings: Phyllanthus plant appears to possess cytotoxic properties with half-maximal inhibitory concentration (IC50) values of 150-300 mu g/ml for aqueous extract and 50-150 mu g/ml for methanolic extract that were determined using the MTS reduction assay. In comparison, the plant extracts did not show any significant cytotoxicity on normal human skin (CCD-1127Sk) and prostate (RWPE-1) cells. The extracts appeared to act by causing the formation of a clear "ladder'' fragmentation of apoptotic DNA on agarose gel, displayed TUNEL-positive cells with an elevation of caspase-3 and -7 activities. The Lactate Dehydrogenase (LDH) level was lower than 15% in Phyllanthus treated-cancer cells. These indicate that Phyllanthus extracts have the ability to induce apoptosis with minimal necrotic effects. Furthermore, cell cycle analysis revealed that Phyllanthus induced a Go/G1-phase arrest on PC-3 cells and a S-phase arrest on MeWo cells and these were accompanied by accumulation of cells in the Sub-G1 (apoptosis) phase. The cytotoxic properties may be due to the presence of polyphenol compounds such as ellagitannins, gallotannins, flavonoids and phenolic acids found both in the water and methanol extract of the plants. Conclusions/Significance: Phyllanthus plant exerts its growth inhibition effect in a selective manner towards cancer cells through the modulation of cell cycle and induction of apoptosis via caspases activation in melanoma and prostate cancer cells. Hence, Phyllanthus may be sourced for the development of a potent apoptosis-inducing anticancer agent.	[Tang, Yin-Quan; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Jaganath, Indu Bala] MARDI, Ctr Biotechnol, Serdang, Malaysia	Universiti Malaya; Institute Penyelidikan Dan Kemajuan Pertanian	Tang, YQ (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	tang, yin/GXZ-6989-2022; Devi, Shamala Devi/B-9735-2010; Tang, Yin-Quan/J-5859-2013; Sekaran, Shamala Devi/B-8482-2008; Tang, Yin-Quan/K-5725-2017	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Tang, Yin-Quan/0000-0001-7327-2830; Jaganath, Indu/0000-0002-3272-9598	University Malaya [UM PS183/2009B]; Malaysian Agricultural and Research Development Institute (MARDI) [53-02-03-1002]	University Malaya(Universiti Malaya); Malaysian Agricultural and Research Development Institute (MARDI)	This study was funded by the Postgraduate Research Grant, University Malaya (UM PS183/2009B)(www.um.edu.my) and Malaysian Agricultural and Research Development Institute (MARDI) (53-02-03-1002)(www.mardi.gov.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2009, CANC FACTS FIG 2009, P19; Asha VV, 2007, FITOTERAPIA, V78, P134, DOI 10.1016/j.fitote.2006.10.009; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; BLUMBERG BS, 1990, VACCINE, V8, pS86, DOI 10.1016/0264-410X(90)90225-B; *CANC RES UK, 2010, SKIN CANC UK INC STA; Che XH, 2010, BASIC CLIN PHARMACOL, V106, P30, DOI 10.1111/j.1742-7843.2009.00465.x; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; CRAGG GM, 2007, BIOACTIVE NATURAL PR; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Faried A, 2007, INT J ONCOL, V30, P605; Guchelaar H J, 1992, Clin Oncol (R Coll Radiol), V4, P388, DOI 10.1016/S0936-6555(05)81134-3; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Huang ST, 2004, LIFE SCI, V75, P339, DOI 10.1016/j.lfs.2003.12.013; Jeena KJ, 1999, CANCER LETT, V136, P11, DOI 10.1016/S0304-3835(98)00294-8; Ji BC, 2009, J AGR FOOD CHEM, V57, P7596, DOI 10.1021/jf901308p; Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kloucek P, 2005, J ETHNOPHARMACOL, V99, P309, DOI 10.1016/j.jep.2005.01.062; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Lee CD, 1996, EUR J CLIN INVEST, V26, P1069, DOI 10.1046/j.1365-2362.1996.410595.x; Madson JG, 2009, AM J PATHOL, V174, P2357, DOI 10.2353/ajpath.2009.080638; Maecker HL, 2000, CANCER RES, V60, P4638; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; Mazumder A, 2006, NAT PROD RES, V20, P323, DOI 10.1080/14786410600650404; Mazunder UK, 2005, EURO B DRUG RES, V13, P15; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ott M, 1997, EUR J CLIN INVEST, V27, P908, DOI 10.1046/j.1365-2362.1997.2020749.x; Prakash A, 1995, PHYTOTHER RES, V9, P594, DOI 10.1002/ptr.2650090813; Puri N, 2004, FASEB J, V18, P1373, DOI 10.1096/fj.04-1774com; Rajeshkumar NV, 2000, J ETHNOPHARMACOL, V73, P215, DOI 10.1016/S0378-8741(00)00311-1; Rajeshkumar NV, 2002, J ETHNOPHARMACOL, V81, P17, DOI 10.1016/S0378-8741(01)00419-6; RAPHAEL KR, 2002, J EXP BIOL, V40, P905; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shoeb M., 2006, BANGL J PHARMACOL, V1, P35, DOI [10.3329/bjp.v1i2.486, DOI 10.3329/BJP.V1I2.486]; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; VARMA A, 2009, ECAM IN PRESS; VENKATESWARAN PS, 1997, P NATL ACAD SCI USA, V84, P274; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192; Zhou S, 1997, Zhongguo Zhong Yao Za Zhi, V22, P109	47	105	108	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12644	10.1371/journal.pone.0012644	http://dx.doi.org/10.1371/journal.pone.0012644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838625	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687100013
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; WHO, 2004, POL LAB MAN; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400031
